PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Raja, MM; Tyagi, NK; Kinne, RKH				Raja, MM; Tyagi, NK; Kinne, RKH			Phlorizin recognition in a C-terminal fragment of SGLT1 studied by tryptophan scanning and affinity labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANES; NA+/GLUCOSE COTRANSPORTER; GLUCOSE-TRANSPORT; PROTEIN; BINDING; FLUORESCENCE; REGION; NA+; CONFORMATION; INHIBITION	SGLT1 as a sodium/glucose cotransporter is strongly inhibited by phlorizin, a phloretin 2'-glucoside that has strong interactions with the C-terminal loop 13. We have examined phlorizin recognition by the protein by site-directed single Trp scanning mutagenesis experiments. Six mutants (Q581W, E591W, R601W, D611W, E621W, and L630W) of truncated loop 13 (amino acids 564 - 638) were expressed in Escherichia coli and purified to homogeneity. Changes in Trp quenching and positions of the emission maxima were determined after addition of phlorizin. D611W displayed the largest quenching of 80%, followed by R601W (67%). It also exhibited the maximum red shift in Trp fluorescence (similar to14 nm), indicating an exposure of this region to a more hydrophilic environment. Titration experiments performed for each mutant showed a similar affinity for all mutants, except for D611W, which exhibited a significantly lower affinity (K-d approximate to 54 muM). Also the maximum change in the collisional quenching constant by acrylamide was noted for D611W (K-SV = 11 M-1 in the absence of phlorizin and 55 M-1 in its presence). Similar results were obtained with phloretin. CD measurements and computer modeling revealed that D611W is positioned in a random coil situated between two alpha-helical segments. By combining gel electrophoresis, enzymatic fragmentation, and matrix-assisted laser desorption ionization mass spectrometry, we also analyzed truncated loop 13 photolabeled with 3-azidophlorizin. The attachment site of the ortho-position of aromatic ring B of phlorizin was localized to Arg-602. Taken together, these data indicate that phlorizin binding elicits changes in conformation leading to a less ordered state of loop 13. Modeling suggests an interaction of the 4- and 6-OH groups of aromatic ring A of phlorizin with the region between amino acids 606 and 611 and an interaction of ring B at or around amino acid 602. Phloretin seems to interact with the same region of the protein.	Max Planck Inst Mol Physiol, Dept Epithelial Cell Physiol, D-44227 Dortmund, Germany	Max Planck Society	Kinne, RKH (corresponding author), Max Planck Inst Mol Physiol, Dept Epithelial Cell Physiol, Otto Hahn Str 11, D-44227 Dortmund, Germany.							Callis PR, 2003, CHEM PHYS LETT, V369, P409, DOI 10.1016/S0009-2614(02)02046-8; DIEDRICH DF, 1966, ARCH BIOCHEM BIOPHYS, V117, P248, DOI 10.1016/0003-9861(66)90409-7; Diez-Sampedro A, 2001, J BIOL CHEM, V276, P49188, DOI 10.1074/jbc.M108286200; GIBBS EM, 1982, BIOCHIM BIOPHYS ACTA, V688, P547, DOI 10.1016/0005-2736(82)90366-2; Hirayama BA, 1997, J BIOL CHEM, V272, P2110; Hirayama BA, 2001, BRIT J PHARMACOL, V134, P484, DOI 10.1038/sj.bjp.0704274; LIN JT, 1982, BIOCHIM BIOPHYS ACTA, V693, P379, DOI 10.1016/0005-2736(82)90445-X; Lo B, 1998, J BIOL CHEM, V273, P29341, DOI 10.1074/jbc.273.45.29341; Loo DDF, 1998, P NATL ACAD SCI USA, V95, P7789, DOI 10.1073/pnas.95.13.7789; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Novakova R, 2001, J MEMBRANE BIOL, V184, P55, DOI 10.1007/s00232-001-0073-6; Oulianova N, 2001, J MEMBRANE BIOL, V179, P223, DOI 10.1007/s002320010049; Oulianova N, 1996, J MEMBRANE BIOL, V153, P181, DOI 10.1007/s002329900121; PANAYOTOVAHEIERMANN M, 1994, J BIOL CHEM, V269, P21016; PanayotovaHeiermann M, 1997, J BIOL CHEM, V272, P20324, DOI 10.1074/jbc.272.33.20324; Vayro S, 1998, BIOCHEM J, V332, P119, DOI 10.1042/bj3320119; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Wielert-Badt S, 2000, J MED CHEM, V43, P1692, DOI 10.1021/jm9905460; Wielert-Badt S, 2002, BIOPHYS J, V82, P2767, DOI 10.1016/S0006-3495(02)75617-8; Xia XB, 2003, BIOCHEMISTRY-US, V42, P6115, DOI 10.1021/bi020695b; Yova Dido, 1999, Proceedings of the SPIE - The International Society for Optical Engineering, V3565, P174, DOI 10.1117/12.335800; YOVA D, 2002, UV 98	23	57	57	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					49154	49163		10.1074/jbc.M306881200	http://dx.doi.org/10.1074/jbc.M306881200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12954647	hybrid			2022-12-27	WOS:000186829000079
J	Fratti, RA; Chua, J; Deretic, V				Fratti, RA; Chua, J; Deretic, V			Induction of p38 mitogen-activated protein kinase reduces early endosome autoantigen 1 (EEA1) recruitment to phagosomal membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS PHAGOSOME; CONTAINING VACUOLES; EARLY ENDOSOMES; MATURATION; TRAFFICKING; FUSION; AVIUM; EXPRESSION; HOST; RAB5	Mycobacterium tuberculosis survives in the infected host by parasitizing macrophages in which the bacillus resides in a specialized phagosome sequestered from the phagolysosomal degradative pathway. Here we report a role of the stress-induced p38 mitogen-activated protein kinase (p38 MAPK) in the component of M. tuberculosis phagosome maturation arrest that has been linked previously to the reduced recruitment of the endosomal and phagosomal membrane-tethering molecule called early endosome autoantigen 1 (EEA1; Fratti, R. A., Backer, J.M., Gruenberg, J., Corvera, S., and Deretic, V. (2001) J. Cell Biol. 154, 631-644). A pharmacological inhibition of M. tuberculosis var. bovis Bacillus Calmette-Guerin-induced p38 MAPK activity caused a marked increase in EEA1 colocalization with mycobacterial phagosomes. Consistent with the increase in EEA1 association and its role in phagosomal maturation, the pharmacological block of p38 activity caused phagosomal acidification and enrichment of the late endocytic markers lysobisphosphatidic acid and CD63 (lysosomal integral membrane protein 1) on mycobacterial phagosomes. A negative regulatory role of p38 MAPK activation in phagosome maturation was further demonstrated by converse experiments with latex bead phagosomes. Artificial activation of p38 MAPK caused a decrease in EEA1 colocalization with model latex bead phagosomes, which normally acquire EEA1 and subsequently mature into the phagolysosome. These findings show that p38 MAPK activity contributes to the arrest of M. tuberculosis phagosome maturation and demonstrate a negative regulatory role of p38 in phagolysosome biogenesis.	Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Sch Med, Albuquerque, NM 87131 USA; Univ New Mexico, Sch Med, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico	Deretic, V (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Sch Med, 915 Camino de Salud NE, Albuquerque, NM 87131 USA.	vderetic@salud.unm.edu		Chua, Jennifer/0000-0001-8156-5174; Deretic, Vojo/0000-0002-3624-5208	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045148] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 45148] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvarez-Dominguez C, 1999, J BIOL CHEM, V274, P11459, DOI 10.1074/jbc.274.17.11459; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Botelho RJ, 2000, J BIOL CHEM, V275, P15717, DOI 10.1074/jbc.M910068199; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Clemens DL, 1996, J EXP MED, V184, P1349, DOI 10.1084/jem.184.4.1349; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; CROWLE AJ, 1991, INFECT IMMUN, V59, P1823, DOI 10.1128/IAI.59.5.1823-1831.1991; DECHASTELLIER C, 1995, EUR J CELL BIOL, V68, P167; Deretic V, 1999, MOL MICROBIOL, V31, P1603, DOI 10.1046/j.1365-2958.1999.01279.x; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; DHANDAYUTHAPANI S, 1995, MOL MICROBIOL, V17, P901, DOI 10.1111/j.1365-2958.1995.mmi_17050901.x; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Fratti RA, 2000, ELECTROPHORESIS, V21, P3378, DOI 10.1002/1522-2683(20001001)21:16<3378::AID-ELPS3378>3.0.CO;2-B; Hackam DJ, 1997, J BIOL CHEM, V272, P29810, DOI 10.1074/jbc.272.47.29810; Hackstadt T, 2000, TRAFFIC, V1, P93, DOI 10.1034/j.1600-0854.2000.010201.x; Juffermans NP, 2000, J INFECT DIS, V182, P888, DOI 10.1086/315750; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Malik ZA, 2001, J IMMUNOL, V166, P3392, DOI 10.4049/jimmunol.166.5.3392; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Mordue DG, 1997, J IMMUNOL, V159, P4452; Mott J, 1999, INFECT IMMUN, V67, P1368, DOI 10.1128/IAI.67.3.1368-1378.1999; Perskvist N, 2000, J IMMUNOL, V164, P959, DOI 10.4049/jimmunol.164.2.959; Pieters J, 2002, TRENDS MICROBIOL, V10, P142, DOI 10.1016/S0966-842X(02)02305-3; Russell DG, 2002, J CELL BIOL, V158, P421, DOI 10.1083/jcb.200205034; Russell DG, 1996, J IMMUNOL, V156, P4764; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527; Vergne I, 2003, TRAFFIC, V4, P600, DOI 10.1034/j.1600-0854.2003.00120.x; Via LE, 1998, J CELL SCI, V111, P897; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; XU SM, 1994, J IMMUNOL, V153, P2568	40	89	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46961	46967		10.1074/jbc.M305225200	http://dx.doi.org/10.1074/jbc.M305225200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963735	hybrid			2022-12-27	WOS:000186569400090
J	Mohney, RP; Das, M; Bivona, TG; Hanes, R; Adams, AG; Philips, MR; O'Bryan, JP				Mohney, RP; Das, M; Bivona, TG; Hanes, R; Adams, AG; Philips, MR; O'Bryan, JP			Intersectin activates Ras but stimulates transcription through an independent pathway involving JNK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTIC PROTEIN INTERSECTIN; GROWTH-FACTOR RECEPTOR; PHOSPHOTYROSINE-BINDING DOMAINS; CLATHRIN-MEDIATED ENDOCYTOSIS; SRC HOMOLOGY 2; ADAPTER PROTEIN; EPS15 HOMOLOGY; DOWN-SYNDROME; KINASE; INHIBITOR	Intersectin (ITSN) is a molecular scaffold involved in regulating endocytosis and mitogenic signaling. We previously demonstrated that ITSN transformed rodent fibroblasts, accelerated hormone-induced maturation of Xenopus oocytes, and activated the Elk-1 transcription factor through an MEK- and Erk-independent mechanism. We now demonstrate that ITSN complexes with the Ras guanine nucleotide exchange factor Sos1 leading to increased RasGTP levels. Using fluorescence resonant energy transfer analysis, we demonstrate that ITSN complexes with Ras in living cells leading to Ras activation on intracellular vesicles. These vesicles contain epidermal growth factor receptor but are distinct from transferrin-positive vesicles. However, Ras is not required for ITSN stimulation of transcription. Rather, we demonstrate that ITSN signals through JNK to activate Elk-1. Although ITSN activation of Elk-1 was Ras-independent, ITSN cooperates with Ras to synergistically activate JNK. These findings indicate that ITSN activates multiple intracellular signaling pathways and suggest that this adaptor protein may coordinately regulate the activity of these pathways in vivo.	NYU, Sch Med, Dept Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	New York University; New York University; New York University	O'Bryan, JP (corresponding author), NIEHS, Lab Signal Transduct, NIH, US Dept HHS, Bldg 101,Rm F336,MD F3-06,POB 12233, Res Triangle Pk, NC 27709 USA.			O'Bryan, John/0000-0001-5386-1080; Mark, Philips/0000-0002-1179-8156	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES090091] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adams A, 2000, J BIOL CHEM, V275, P27414; ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; CorbalanGarcia S, 1996, ONCOGENE, V12, P1063; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Elion EA, 2001, J CELL SCI, V114, P3967; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; Gangarosa LM, 1997, J BIOL CHEM, V272, P18926, DOI 10.1074/jbc.272.30.18926; Graf D, 2002, GASTROENTEROLOGY, V122, P1411, DOI 10.1053/gast.2002.32976; Guipponi M, 1998, GENOMICS, V53, P369, DOI 10.1006/geno.1998.5521; Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Jenna S, 2002, J BIOL CHEM, V277, P6366, DOI 10.1074/jbc.M105516200; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Lamaze C, 1996, NATURE, V382, P177, DOI 10.1038/382177a0; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Martin JH, 1996, MOL BRAIN RES, V35, P47, DOI 10.1016/0169-328X(95)00181-Q; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; O'Bryan JP, 1998, J BIOL CHEM, V273, P20431, DOI 10.1074/jbc.273.32.20431; O'Bryan JP, 2001, ONCOGENE, V20, P6300, DOI 10.1038/sj.onc.1204773; OBryan JP, 1996, P NATL ACAD SCI USA, V93, P2729, DOI 10.1073/pnas.93.7.2729; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Pruitt K, 2002, J BIOL CHEM, V277, P31808, DOI 10.1074/jbc.M203964200; Pucharcos C, 1999, EUR J HUM GENET, V7, P704, DOI 10.1038/sj.ejhg.5200356; Pucharcos C, 2000, FEBS LETT, V478, P43, DOI 10.1016/S0014-5793(00)01793-2; Pucharcos C, 2001, BBA-GENE STRUCT EXPR, V1521, P1, DOI 10.1016/S0167-4781(01)00276-7; PUESCHEL SM, 1991, ARCH NEUROL-CHICAGO, V48, P318, DOI 10.1001/archneur.1991.00530150088024; QUILLIAM LA, 1994, P NATL ACAD SCI USA, V91, P8512, DOI 10.1073/pnas.91.18.8512; Ramjaun AR, 2001, J BIOL CHEM, V276, P28913, DOI 10.1074/jbc.M103198200; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; ROZAKISADCOCK M, 1995, ONCOGENE, V11, P1417; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Taylor SJ, 2001, METHOD ENZYMOL, V333, P333; Tong XK, 2000, J BIOL CHEM, V275, P29894, DOI 10.1074/jbc.M004096200; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899	47	54	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47038	47045		10.1074/jbc.M303895200	http://dx.doi.org/10.1074/jbc.M303895200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12970366	hybrid			2022-12-27	WOS:000186569400100
J	Roy, S; Khanna, S; Wallace, WA; Lappalainen, J; Rink, C; Cardounel, AJ; Zweier, JL; Sen, CK				Roy, S; Khanna, S; Wallace, WA; Lappalainen, J; Rink, C; Cardounel, AJ; Zweier, JL; Sen, CK			Characterization of perceived hyperoxia in isolated primary cardiac fibroblasts and in the reoxygenated heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGONUCLEOTIDE ARRAYS; OXYGEN-PRESSURE; GENE; EXPRESSION; RNA; HYPOXIA; GROWTH; CELLS; WIG-1; PIGS	Under normoxic conditions, pO(2) ranges from 90 to < 3 torr in mammalian organs with the heart at similar to 35 torr ( 5%) and arterial blood at similar to 100 torr. Thus, " normoxia" for cells is an adjustable variable. In response to chronic moderate hypoxia, cells adjust their normoxia set point such that reoxygenation- dependent relative elevation of pO(2) results in perceived hyperoxia. We hypothesized that O-2, even in marginal relative excess of the pO2 to which cells are adjusted, results in the activation of specific O-2- sensitive signal transduction pathways that alter cellular phenotype and function. Thus, reperfusion causes damage to the tissue at the focus of ischemia while triggering remodeling in the peri- infarct region by means of perceived hyperoxia. We reported first evidence demonstrating that perceived hyperoxia triggers the differentiation of cardiac fibroblasts ( CF) to myofibroblasts by a p21- dependent mechanism ( Roy, S., Khanna, S., Bickerstaff, A. A., Subramanian, S. V., Atalay, M., Bierl, M., Pendyala, S., Levy, D., Sharma, N., Venojarvi, M., Strauch, A., Orosz, C. G., and Sen, C. K. ( 2003) Circ. Res. 92, 264 - 271). Here, we sought to characterize the genomic response to perceived hyperoxia in CF using GeneChips(TM). Candidate genes were identified, confirmed and clustered. Cell cycle- and differentiation-associated genes represented a key target of perceived hyperoxia. Bioinformatics- assisted pathway reconstruction revealed the specific signaling processes that were sensitive to perceived hyperoxia. To test the significance of our in vitro findings, a survival model of rat heart focal ischemia- reperfusion ( I- R) was investigated. A significant induction in p21 mRNA expression was observed in I- R tissue. The current results provide a comprehensive molecular definition of perceived hyperoxia in cultured CF. Furthermore, the first evidence demonstrating activation of perceived hyperoxia sensitive genes in the cardiac I- R tissue is presented.	Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst 512, Dept Surg,Lab Mol Med, Columbus, OH 43210 USA; Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst 512, Dept Internal Med,Lab Mol Med, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Sen, CK (corresponding author), Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst 512, Dept Surg,Lab Mol Med, 473 W 12th Ave, Columbus, OH 43210 USA.	sen-1@medctr.osu.edu	Khanna, Savita/E-3378-2011; Rink, Cameron/AAA-4484-2021; Rink, Cameron/E-3954-2011; Sen, Chandan K/A-8762-2013	Wallace, William Angus/0000-0003-0468-2611; Rink, Cameron/0000-0002-3149-3624				BRITZCUNNINGHAM SH, 1995, NEW ENGL J MED, V332, P1323, DOI 10.1056/NEJM199505183322002; Chen HJ, 2003, AM J PHYSIOL-HEART C, V284, pH1612, DOI 10.1152/ajpheart.00992.2002; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DERRY JMJ, 1995, HUM MOL GENET, V4, P2307, DOI 10.1093/hmg/4.12.2307; EGHBALI M, 1988, J MOL CELL CARDIOL, V20, P267, DOI 10.1016/S0022-2828(88)80059-2; Frangogiannis NG, 2000, CARDIOVASC RES, V48, P89, DOI 10.1016/S0008-6363(00)00158-9; GONSCHIOR P, 1992, BASIC RES CARDIOL, V87, P27, DOI 10.1007/BF00795387; Grinnell F, 2003, MOL BIOL CELL, V14, P384, DOI 10.1091/mbc.E02-08-0493; Hellborg F, 2001, ONCOGENE, V20, P5466, DOI 10.1038/sj.onc.1204722; HERSKOWITZ A, 1995, AM J PATHOL, V146, P419; Jaubert J, 2003, DEVELOPMENT, V130, P2767, DOI 10.1242/dev.00477; Kuo ML, 2003, CANCER RES, V63, P1046; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li WEI, 2002, DEVELOPMENT, V129, P2031; Mendez-Vidal C, 2002, NUCLEIC ACIDS RES, V30, P1991, DOI 10.1093/nar/30.9.1991; Nabel EG, 2002, NAT REV DRUG DISCOV, V1, P587, DOI 10.1038/nrd869; Porwol T, 2001, RESP PHYSIOL, V128, P331, DOI 10.1016/S0034-5687(01)00310-3; Roy S, 2003, CIRC RES, V92, P264, DOI 10.1161/01.RES.0000056770.30922.E6; Roy S, 2002, METHOD ENZYMOL, V353, P487; Roy S, 2002, FEBS LETT, V530, P17, DOI 10.1016/S0014-5793(02)03309-4; RUMSEY WL, 1994, AM J PHYSIOL, V266, pH1676, DOI 10.1152/ajpheart.1994.266.4.H1676; Scott JN, 2000, SCI AM, V282, P72, DOI 10.1038/scientificamerican0600-72; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Siaghy EM, 2000, J MOL CELL CARDIOL, V32, P493, DOI 10.1006/jmcc.1999.1094; Staversky RJ, 2002, AM J PATHOL, V161, P1383, DOI 10.1016/S0002-9440(10)64414-8; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Whalen W J, 1971, Physiologist, V14, P69; Winegrad S, 1999, CIRC RES, V85, P690, DOI 10.1161/01.RES.85.8.690; Yoon HS, 2003, J BIOL CHEM, V278, P2101, DOI 10.1074/jbc.M211027200; Yoshida Y, 2003, GENE DEV, V17, P1201, DOI 10.1101/gad.1088003	31	66	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47129	47135		10.1074/jbc.M308703200	http://dx.doi.org/10.1074/jbc.M308703200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12952964	hybrid			2022-12-27	WOS:000186569400111
J	Anderluh, G; Dalla Serra, M; Viero, G; Guella, G; Macek, P; Menestrina, G				Anderluh, G; Dalla Serra, M; Viero, G; Guella, G; Macek, P; Menestrina, G			Pore formation by equinatoxin II, a eukaryotic protein toxin, occurs by induction of nonlamellar lipid structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEA-ANEMONE; FORMING TOXIN; INFRARED-SPECTROSCOPY; SECONDARY STRUCTURE; BILAYER-MEMBRANES; STICHOLYSIN-I; CYTOLYSIN; MECHANISM; VESICLES; PEPTIDE	Pore formation in the target cell membranes is a common mechanism used by many toxins in order to kill cells. Among various described mechanisms, a toroidal pore concept was described recently in the course of action of small antimicrobial peptides. Here we provide evidence that such mechanism may be used also by larger toxins. Membrane-destabilizing effects of equinatoxin II, a sea anemone cytolysin, were studied by various biophysical techniques. P-31 NMR showed an occurrence of an isotropic component when toxin was added to multilamellar vesicles and heated. This component was not observed with melittin, alpha-staphylococcal toxin, or myoglobin. It does not originate from isolated small lipid structures, since the size of the vesicles after the experiment was similar to the control without toxin. Electron microscopy shows occurrence of a honeycomb structure, previously observed only for some particular lipid mixtures. The analysis of FTIR spectra of the equinatoxin II-lipid complex showed lipid disordering that is consistent with isotropic component observed in NMR. Finally, the cation selectivity of the toxin-induced pores increased in the presence of negatively charged phosphatidic acid, indicating the presence of lipids in the conductive channel. The results are compatible with the toroidal pore concept that might be a general mechanism of pore formation for various membrane-interacting proteins or peptides.	ITC, CNR, Inst Biophys, Sect Trento, I-38050 Trento, Italy; Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana 1000, Slovenia; Univ Trent, Dept Phys, Bioorgan Chem Lab, I-38050 Trento, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Istituto per le Tecnologie della Costruzione (ITC-CNR); University of Ljubljana; University of Trento	Menestrina, G (corresponding author), ITC, CNR, Inst Biophys, Sect Trento, Via Sommarive 18, I-38050 Trento, Italy.	menes@itc.it	Anderluh, Gregor/C-6905-2014; Viero, Gabriella/G-2096-2012; Graziano, Guella/A-6283-2010; Serra, Mauro Dalla/A-6218-2010; Maček, Peter/Y-9877-2019; Serra, Mauro Dalla/AAK-9299-2021; Maček, Peter/U-4662-2017	Anderluh, Gregor/0000-0002-9916-8465; Viero, Gabriella/0000-0002-6755-285X; Graziano, Guella/0000-0002-1799-0819; Serra, Mauro Dalla/0000-0003-1048-2739; Maček, Peter/0000-0001-6470-7759; Serra, Mauro Dalla/0000-0003-1048-2739; Maček, Peter/0000-0001-6470-7759				Anderluh G, 1997, PROTEIN ENG, V10, P751, DOI 10.1093/protein/10.7.751; Anderluh G, 1999, EUR J BIOCHEM, V263, P128, DOI 10.1046/j.1432-1327.1999.00477.x; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; Axelsen PH, 1995, BIOPHYS J, V69, P2770, DOI 10.1016/S0006-3495(95)80150-5; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Bechinger B, 1999, BIOPOLYMERS, V51, P174, DOI 10.1002/(SICI)1097-0282(1999)51:3<174::AID-BIP2>3.0.CO;2-7; BELMONTE G, 1994, BBA-BIOMEMBRANES, V1192, P197, DOI 10.1016/0005-2736(94)90119-8; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Bonev BB, 2003, BIOPHYS J, V84, P2382, DOI 10.1016/S0006-3495(03)75044-9; Chugh JK, 2001, BIOCHEM SOC T, V29, P565, DOI 10.1042/BST0290565; de los Rios V, 1999, FEBS LETT, V455, P27, DOI 10.1016/S0014-5793(99)00846-7; DEKRUIJFF B, 1979, BIOCHIM BIOPHYS ACTA, V555, P200, DOI 10.1016/0005-2736(79)90160-3; DUFOURCQ J, 1986, BIOCHIM BIOPHYS ACTA, V859, P33, DOI 10.1016/0005-2736(86)90315-9; Epand RM, 1998, BBA-REV BIOMEMBRANES, V1376, P353, DOI 10.1016/S0304-4157(98)00015-X; Ferreras M, 1998, BBA-BIOMEMBRANES, V1414, P108, DOI 10.1016/S0005-2736(98)00160-6; FORTI S, 1989, EUR J BIOCHEM, V181, P767, DOI 10.1111/j.1432-1033.1989.tb14790.x; Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0; Grigoriev PA, 2000, IUBMB LIFE, V50, P227; Harrick N.J., 1967, INTERNAL REFLECTION; Heller WT, 1998, BIOCHEMISTRY-US, V37, P17331, DOI 10.1021/bi981314q; Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394; Hinds MG, 2002, J MOL BIOL, V315, P1219, DOI 10.1006/jmbi.2001.5321; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Hori Y, 1999, FEBS LETT, V455, P228, DOI 10.1016/S0014-5793(99)00881-9; HUBNER W, 1991, BIOPHYS J, V59, P1261, DOI 10.1016/S0006-3495(91)82341-4; KAYALAR C, 1986, BIOCHIM BIOPHYS ACTA, V860, P51, DOI 10.1016/0005-2736(86)90497-9; Lesieur C, 1997, MOL MEMBR BIOL, V14, P45, DOI 10.3109/09687689709068435; Liu F, 2001, BIOCHEMISTRY-US, V40, P760, DOI 10.1021/bi001942j; Lohner K, 1999, BIOCHEMISTRY-US, V38, P16514, DOI 10.1021/bi9913101; MACEK P, 1988, TOXICON, V26, P441, DOI 10.1016/0041-0101(88)90183-3; Malovrh P, 2000, BIOCHEM J, V346, P223, DOI 10.1042/0264-6021:3460223; Malovrh P, 2003, J BIOL CHEM, V278, P22678, DOI 10.1074/jbc.M300622200; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; Matsuzaki K, 1998, BIOCHEMISTRY-US, V37, P11856, DOI 10.1021/bi980539y; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Menestrina G, 2000, METH MOL B, V145, P115; Menestrina G, 1999, BIOCHEM BIOPH RES CO, V254, P174, DOI 10.1006/bbrc.1998.9898; Menestrina G., 2003, PORE FORMING PEPTIDE; Muller E, 1996, BIOPHYS J, V71, P1400, DOI 10.1016/S0006-3495(96)79342-6; Pereira FB, 1999, CHEM PHYS LIPIDS, V103, P11, DOI 10.1016/S0009-3084(99)00087-0; Pott T, 1998, EUR BIOPHYS J BIOPHY, V27, P237, DOI 10.1007/s002490050130; RANCE M, 1983, J MAGN RESON, V52, P221, DOI 10.1016/0022-2364(83)90190-7; Santos NC, 1996, BIOPHYS J, V71, P1641, DOI 10.1016/S0006-3495(96)79369-4; SEDDON JM, 1990, BIOCHIM BIOPHYS ACTA, V1031, P1, DOI 10.1016/0304-4157(90)90002-T; Shai Y, 2001, PEPTIDES, V22, P1629, DOI 10.1016/S0196-9781(01)00498-3; SIEGEL DP, 1984, BIOPHYS J, V45, P399, DOI 10.1016/S0006-3495(84)84164-8; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; TAMM LK, 1993, BIOCHEMISTRY-US, V32, P7720, DOI 10.1021/bi00081a017; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; Tejuca M, 2001, J MEMBRANE BIOL, V183, P125, DOI 10.1007/s00232-001-0060-y; Tejuca M, 1996, BIOCHEMISTRY-US, V35, P14947, DOI 10.1021/bi960787z; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3; van der Goot F, 2001, PORE FORMING TOXINS; VARANDA W, 1980, J MEMBRANE BIOL, V55, P203, DOI 10.1007/BF01869461; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Yeagle PL, 1997, CURR TOP MEMBR, V44, P375; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; [No title captured]	59	116	117	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45216	45223		10.1074/jbc.M305916200	http://dx.doi.org/10.1074/jbc.M305916200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12944411	hybrid			2022-12-27	WOS:000186452300022
J	Monleon, D; Moreno-Murciano, MP; Kovacs, H; Marcinkiewicz, C; Calvete, JJ; Celda, B				Monleon, D; Moreno-Murciano, MP; Kovacs, H; Marcinkiewicz, C; Calvete, JJ; Celda, B			Concerted motions of the integrin-binding loop and the C-terminal tail of the non-RGD disintegrin obtustatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-AGGREGATION INHIBITOR; CROSS-RELAXATION RATES; GLYCOPROTEIN-IIB-IIIA; HETERODIMERIC DISINTEGRIN; 3-DIMENSIONAL STRUCTURE; ALPHA-V-BETA-3 INTEGRINS; PROTEIN DYNAMICS; NMR RELAXATION; ECHISTATIN; VENOM	Obtustatin is a potent and selective inhibitor of the alpha(1)beta(1) integrin in vitro and of angiogenesis in vivo. It possesses an integrin recognition loop that harbors, in a lateral position, the inhibitory (KTS23)-K-21 motif. We report an analysis of the dynamics of the backbone and side-chain atoms of obtustatin by homonuclear NMR methods. Angular mobility has been calculated for 90 assigned cross-peaks from 22 off-resonance rotating frame nuclear Overhauser effect spectroscopy spectra recorded at three magnetic fields. Our results suggest that the integrin binding loop and the C-terminal tail display concerted motions, which can be interpreted by hinge effects. Among the integrin-binding motif, threonine 22 and serine 23 exhibit the lowest and the highest side-chain flexibility, respectively. It is noteworthy that the side chain of threonine 22 is not solvent-exposed, although based on synthetic peptides it appears to be the most critical residue for the inhibitory activity of obtustatin on the binding of integrin alpha(1)beta(1) to collagen IV. Instead, the side chain of threonine 22 is oriented toward the loop center and hydrogen-bonded to residues Thr(25) and Ser(26). This network of interactions explains the restrained mobility of threonine 22 and suggests that its functional importance lies in maintaining the active conformation of the alpha(1)beta(1) inhibitory loop.	Consejo Super Invest Cient, Inst Biomed Valencia, Valencia 46010, Spain; Univ Valencia, Dept Quim Fis, E-46100 Valencia, Spain; Univ Valencia, Serv Cent Soporte Invest Expt, E-46100 Valencia, Spain; Bruker Biospin AG, CH-8117 Fallanden, Switzerland; Temple Univ, Coll Sci & Technol, Ctr Biotechnol, Philadelphia, PA 19122 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); University of Valencia; University of Valencia; Bruker Corporation; Bruker BioSpin GmbH; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Calvete, JJ (corresponding author), Consejo Super Invest Cient, Inst Biomed Valencia, Jaume Roig 11, Valencia 46010, Spain.		Calvete, Juan J/K-9619-2014; Monleon, Daniel/GNP-4083-2022; Moreno-Murciano, Paz/D-7871-2018; Monleon, Daniel/A-5078-2010; Moreno, Paz/K-6870-2012; Calvete, Juan/P-2555-2019	Calvete, Juan J/0000-0001-5026-3122; Monleon, Daniel/0000-0002-4803-1573; Monleon, Daniel/0000-0002-4803-1573; Calvete, Juan/0000-0001-5026-3122				ADLER M, 1991, SCIENCE, V253, P445, DOI 10.1126/science.1862345; ADLER M, 1992, BIOCHEMISTRY-US, V31, P1031, DOI 10.1021/bi00119a011; Bernado P, 2002, J BIOMOL NMR, V23, P139, DOI 10.1023/A:1016359412284; Birlirakis N., 1996, BRUKER REPORT, V142, P34; BROCKEL C, 1992, BIOCHIM BIOPHYS ACTA, V1122, P196, DOI 10.1016/0167-4838(92)90324-7; BRUSCHWEILER R, 1992, J AM CHEM SOC, V114, P2289, DOI 10.1021/ja00033a002; BURGEN ASV, 1975, NATURE, V253, P753, DOI 10.1038/253753a0; Calvete JJ, 2003, BIOCHEM J, V372, P725, DOI 10.1042/BJ20021739; Calvete JJ, 2002, BIOCHEMISTRY-US, V41, P2014, DOI 10.1021/bi015627o; CALVETE JJ, 1991, BIOCHEMISTRY-US, V30, P5225, DOI 10.1021/bi00235a016; CHEN Y, 1994, J BIOMOL NMR, V4, P307; DENNIS MS, 1993, PROTEINS, V15, P312, DOI 10.1002/prot.340150308; Fischer MWF, 1998, PROG NUCL MAG RES SP, V33, P207, DOI 10.1016/S0079-6565(98)00023-5; Goddard T. D., 1999, SPARKY 3; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; KINI RM, 1992, TOXICON, V30, P265, DOI 10.1016/0041-0101(92)90869-7; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Korzhnev DM, 2001, PROG NUCL MAG RES SP, V38, P197, DOI 10.1016/S0079-6565(00)00028-5; Kuwata K, 1997, J MAGN RESON, V128, P70, DOI 10.1006/jmre.1997.1212; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEMASTER DM, 1988, FEBS LETT, V236, P71, DOI 10.1016/0014-5793(88)80287-4; Malliavin TE, 1999, J MAGN RESON, V140, P189, DOI 10.1006/jmre.1999.1818; Marcinkiewicz C, 2003, CANCER RES, V63, P2020; Marcinkiewicz C, 1999, BIOCHEMISTRY-US, V38, P13302, DOI 10.1021/bi9906930; Marcinkiewicz C, 1999, J BIOL CHEM, V274, P12468, DOI 10.1074/jbc.274.18.12468; Marcinkiewicz C, 1997, BLOOD, V90, P1565, DOI 10.1182/blood.V90.4.1565.1565_1565_1575; McLane MA, 1996, FEBS LETT, V391, P139, DOI 10.1016/0014-5793(96)00716-8; Moreno-Murciano MP, 2003, J MOL BIOL, V329, P135, DOI 10.1016/S0022-2836(03)00371-1; Moreno-Murciano MP, 2003, PROTEIN SCI, V12, P366, DOI 10.1110/ps.0230203; Neuhaus D., 1989, NUCL OVERHAUSER EFFE; PFAFF M, 1994, J BIOL CHEM, V269, P20233; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P7369, DOI 10.1021/bi00244a003; Schleucher J, 2002, J AM CHEM SOC, V124, P5881, DOI 10.1021/ja012040o; SENN H, 1993, J MOL BIOL, V232, P907, DOI 10.1006/jmbi.1993.1439; Smith KJ, 1996, INT J PEPT PROT RES, V48, P220; WILLIAMS RJP, 1989, EUR J BIOCHEM, V183, P479, DOI 10.1111/j.1432-1033.1989.tb21076.x; WRIGHT PS, 1993, BIOCHEM J, V293, P263, DOI 10.1042/bj2930263; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040	38	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45570	45576		10.1074/jbc.M307030200	http://dx.doi.org/10.1074/jbc.M307030200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12947085	hybrid			2022-12-27	WOS:000186452300065
J	Sass, E; Karniely, S; Pines, O				Sass, E; Karniely, S; Pines, O			Folding of fumarase during mitochondrial import determines its dual targeting in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE TRANSLATION PRODUCT; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; INTERMEMBRANE SPACE; PROTEIN IMPORT; FUM1 GENE; TRANSLOCATION; PREPROTEINS; BIOGENESIS; SEQUENCE	We have previously proposed that a single translation product of the FUM1 gene encoding fumarase is distributed between the cytosol and mitochondria of Saccharomyces cerevisiae and that all fumarase translation products are targeted and processed in mitochondria before distribution. Thus, fumarase processed in mitochondria returns to the cytosol. In the current work, we (i) generated mutations throughout the coding sequence which resulted in fumarases with altered conformations that are targeted to mitochondria but have lost their ability to be distributed; (ii) showed by mass spectrometry that mature cytosolic and mitochondrial fumarase isoenzymes are identical; and (iii) showed that hsp70 chaperones in the cytosol (Ssa) and mitochondria (Ssc1) can affect fumarase distribution. The results are discussed in light of our model of targeting and distribution, which suggests that rapid folding of fumarase into an import-incompetent state provides the driving force for retrograde movement of the processed protein back to the cytosol through the translocation pore.	Hebrew Univ Jerusalem, Sch Med, Dept Mol Biol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Pines, O (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Mol Biol, IL-91120 Jerusalem, Israel.		Karniely, Sharon/AAY-5499-2020; Karniely, Sharon/AAN-7886-2021; pines, ophry/C-4086-2011	pines, ophry/0000-0001-7126-2575				Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; AKIBA T, 1984, J BIOCHEM-TOKYO, V96, P189, DOI 10.1093/oxfordjournals.jbchem.a134812; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Bhagwat SV, 1999, J BIOL CHEM, V274, P24014, DOI 10.1074/jbc.274.34.24014; BLACHINSKI E, 2001, THESIS HEBREW U JERU; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; GAMBILL BD, 1993, J CELL BIOL, V123, P109, DOI 10.1083/jcb.123.1.109; Haucke V, 1997, MOL CELL BIOL, V17, P4024, DOI 10.1128/MCB.17.7.4024; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KANAREK L, 1964, J BIOL CHEM, V5, P465; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; Lim JH, 2001, EMBO J, V20, P941, DOI 10.1093/emboj/20.5.941; Okamoto K, 2002, EMBO J, V21, P3659, DOI 10.1093/emboj/cdf358; ONO H, 1995, J BIOL CHEM, V270, P16932, DOI 10.1074/jbc.270.28.16932; Peeters N, 2001, BBA-MOL CELL RES, V1541, P54, DOI 10.1016/S0167-4889(01)00146-X; PELEG Y, 1990, APPL ENVIRON MICROB, V56, P2777, DOI 10.1128/AEM.56.9.2777-2783.1990; Sass E, 2001, J BIOL CHEM, V276, P46111, DOI 10.1074/jbc.M106061200; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Sherman F, 1986, LAB COURSE MANUAL ME; SIKORSKI RS, 1989, GENETICS, V122, P19; STEIN I, 1994, MOL CELL BIOL, V14, P4770, DOI 10.1128/MCB.14.7.4770; Strobel G, 2002, MOL BIOL CELL, V13, P1439, DOI 10.1091/mbc.01-08-0396; UNGERMANN C, 1994, SCIENCE, V266, P1250, DOI 10.1126/science.7973708; VANLOON APGM, 1987, EMBO J, V6, P2441, DOI 10.1002/j.1460-2075.1987.tb02523.x; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Weaver T, 1998, J MOL BIOL, V280, P431, DOI 10.1006/jmbi.1998.1862; WEIZMAN PDJ, 1969, METHOD ENZYMOL, V13, P22; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; Worthington C.C., 1988, WORTHINGTON MANUAL, p[159, 294]; WU M, 1987, J BIOL CHEM, V262, P12275	32	66	97	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45109	45116		10.1074/jbc.M302344200	http://dx.doi.org/10.1074/jbc.M302344200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12960177	hybrid			2022-12-27	WOS:000186452300010
J	Verrills, NM; Walsh, BJ; Cobon, GS; Hains, PG; Kavallaris, M				Verrills, NM; Walsh, BJ; Cobon, GS; Hains, PG; Kavallaris, M			Proteome analysis of Vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; HEAT-SHOCK-PROTEIN; RADIATION-INDUCED APOPTOSIS; SCAFFOLD ATTACHMENT FACTOR; RNA DIFFERENTIAL DISPLAY; EPITHELIAL TUMOR-CELLS; NEURONAL PC12 CELLS; MASS-SPECTROMETRY; MULTIDRUG-RESISTANCE; MESSENGER-RNA	Vinca alkaloids are used widely in the treatment of both childhood and adult cancers. Their cellular target is the beta-tubulin subunit of alpha/beta-tubulin heterodimers, and they act to inhibit cell division by disrupting microtubule dynamics. Despite the effectiveness of these agents, drug resistance is a major clinical problem. To identify the underlying mechanisms behind vinca alkaloid resistance, we have performed high resolution differential proteome analysis. Treatment of drug-sensitive human leukemia cells (CCRF-CEM) with vincristine identified numerous proteins involved in the cellular response to vincristine. In addition, differential protein expression was analyzed in leukemia cell lines selected for resistance to vincristine (CEM/VCR R) and vinblastine (CEM/VLB100). This combined proteomic approach identified 10 proteins altered in both vinca alkaloid response and resistance: beta-tubulin, alpha-tubulin, actin, heat shock protein 90beta, 14-3-3tau, 14-3-3epsilon, L-plastin, lamin B1, heterogeneous nuclear ribonuclear protein-F, and heterogeneous nuclear ribonuclear protein-K. Several of these proteins have not previously been associated with drug resistance and are thus novel targets for elucidation of resistance mechanisms. In addition, seven of these proteins are associated with the tubulin and/or actin cytoskeletons. This study provides novel insights into the interrelationship between the microtubule and microfilament systems in vinca alkaloid resistance.	Childrens Canc Inst Australia Med Res, Randwick, NSW 2031, Australia; Macquarie Univ, Australian Proteome Anal Facil, Sydney, NSW 2109, Australia	Children's Cancer Institute; Macquarie University	Kavallaris, M (corresponding author), Childrens Canc Inst Australia Med Res, High St,POB 81, Randwick, NSW 2031, Australia.		Hains, Peter/HIK-2945-2022; Kavallaris, Maria/J-5240-2014; Hains, Peter G/E-6089-2015	Hains, Peter G/0000-0002-7276-1760; Walsh, Brad/0000-0003-3571-4399; Verrills, Nicole/0000-0002-7894-0137				AHMAD S, 1990, MOL CELL BIOL, V10, P5160, DOI 10.1128/MCB.10.10.5160; Ausubel FM., 1988, CURRENT PROTOCOLS MO; BECK WT, 1986, CANCER RES, V46, P778; Beere HM, 2001, TRENDS CELL BIOL, V11, P6, DOI 10.1016/S0962-8924(00)01874-2; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; BOGGS B, 1987, MOL CELL BIOL, V7, P2700, DOI 10.1128/MCB.7.8.2700; Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; BOUCHER D, 1994, BIOCHEMISTRY-US, V33, P12471, DOI 10.1021/bi00207a014; Brockstedt E, 1998, J BIOL CHEM, V273, P28057, DOI 10.1074/jbc.273.43.28057; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Burkhart C.A., 2001, BIOCHIM BIOPHYS ACTA, V1471, P1; CABRAL F, 1981, P NATL ACAD SCI-BIOL, V78, P4388, DOI 10.1073/pnas.78.7.4388; CORDWELL SJ, 1995, ELECTROPHORESIS, V16, P438, DOI 10.1002/elps.1150160171; daSilva CP, 1996, BIOCHEM PHARMACOL, V51, P1331, DOI 10.1016/0006-2952(96)00041-X; Drukman S, 2002, INT J ONCOL, V21, P621; FOWLER VM, 1990, J CELL BIOL, V111, P471, DOI 10.1083/jcb.111.2.471; Gachet Y, 1999, J CELL SCI, V112, P1257; Galigniana MD, 2001, J BIOL CHEM, V276, P14884, DOI 10.1074/jbc.M010809200; Garnier C, 1998, BIOCHEM BIOPH RES CO, V250, P414, DOI 10.1006/bbrc.1998.9319; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Gohring F, 1997, EMBO J, V16, P7361, DOI 10.1093/emboj/16.24.7361; Goldberg M, 1999, CRIT REV EUKAR GENE, V9, P285, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.130; Gotzmann J, 2000, CELL DEATH DIFFER, V7, P425, DOI 10.1038/sj.cdd.4400668; HABER M, 1989, CANCER RES, V49, P5281; Haber M, 1995, J BIOL CHEM, V270, P31269, DOI 10.1074/jbc.270.52.31269; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Higuchi Y, 1998, BIOCHEM BIOPH RES CO, V248, P597, DOI 10.1006/bbrc.1998.8978; Hisano T, 1996, FEBS LETT, V397, P101, DOI 10.1016/S0014-5793(96)01150-7; Huang YH, 2002, PROTEOMICS, V2, P1220, DOI 10.1002/1615-9861(200209)2:9<1220::AID-PROT1220>3.0.CO;2-3; Ishikawa T, 2000, CLIN CHEM LAB MED, V38, P893, DOI 10.1515/CCLM.2000.130; JASMIN BJ, 1990, NATURE, V344, P673, DOI 10.1038/344673a0; Jordan A, 1998, MED RES REV, V18, P259, DOI 10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.3.CO;2-T; JORDAN MA, 1985, CANCER RES, V45, P2741; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; Kavallaris M, 1997, ANTI-CANCER DRUG, V8, P17, DOI 10.1097/00001813-199701000-00002; Kavallaris M, 2001, CANCER RES, V61, P5803; Kavallaris M, 1997, J CLIN INVEST, V100, P1282, DOI 10.1172/JCI119642; Khan IA, 2003, INVEST NEW DRUG, V21, P3, DOI 10.1023/A:1022946305242; Kipp M, 2000, J BIOL CHEM, V275, P5031, DOI 10.1074/jbc.275.7.5031; KIRBY BA, 1994, J NEUROSCI, V14, P5687; KOYASU S, 1986, P NATL ACAD SCI USA, V83, P8054, DOI 10.1073/pnas.83.21.8054; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Kulms D, 2002, CELL DEATH DIFFER, V9, P598, DOI 10.1038/sj.cdd.4401002; Larsen MR, 2001, ELECTROPHORESIS, V22, P566, DOI 10.1002/1522-2683(200102)22:3<566::AID-ELPS566>3.0.CO;2-T; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; Liang P, 1997, J CELL SCI, V110, P1431; Lin CS, 1998, DNA CELL BIOL, V17, P1041, DOI 10.1089/dna.1998.17.1041; Littlefield R, 1998, ANNU REV CELL DEV BI, V14, P487, DOI 10.1146/annurev.cellbio.14.1.487; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; Luduena RF, 1998, INT REV CYTOL, V178, P207; MACEJAK DG, 1991, VIRUS RES, V19, P31, DOI 10.1016/0168-1702(91)90092-A; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Moller A, 2002, PROTEOMICS, V2, P697, DOI 10.1002/1615-9861(200206)2:6<697::AID-PROT697>3.0.CO;2-F; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; PEATTIE DA, 1992, P NATL ACAD SCI USA, V89, P10974, DOI 10.1073/pnas.89.22.10974; Percipalle P, 2002, NUCLEIC ACIDS RES, V30, P1725, DOI 10.1093/nar/30.8.1725; Percipalle P, 2001, J CELL BIOL, V153, P229, DOI 10.1083/jcb.153.1.229; PERROTAPPLANAT M, 1995, J CELL SCI, V108, P2037; Prasad S, 1998, INT J ONCOL, V13, P757; Prasad SC, 1999, ELECTROPHORESIS, V20, P1065, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<1065::AID-ELPS1065>3.3.CO;2-D; Prasad SC, 1998, BIOCHEM BIOPH RES CO, V249, P332, DOI 10.1006/bbrc.1998.9137; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; Rao S, 2001, BIOCHEMISTRY-US, V40, P2096, DOI 10.1021/bi002323d; Roach MC, 1998, CELL MOTIL CYTOSKEL, V39, P273; RONINSON IB, 1992, BIOCHEM PHARMACOL, V43, P95, DOI 10.1016/0006-2952(92)90666-7; Rosenbaum J, 2000, CURR BIOL, V10, pR801, DOI 10.1016/S0960-9822(00)00767-3; SANCHEZ C, 1994, ARCH BIOCHEM BIOPHYS, V310, P428, DOI 10.1006/abbi.1994.1188; Sinha P, 1998, J BIOCHEM BIOPH METH, V37, P105, DOI 10.1016/S0165-022X(98)00020-7; Sinha P, 2001, ELECTROPHORESIS, V22, P2990, DOI 10.1002/1522-2683(200108)22:14<2990::AID-ELPS2990>3.0.CO;2-F; Sinha P, 1999, ELECTROPHORESIS, V20, P2952, DOI 10.1002/(SICI)1522-2683(19991001)20:14<2952::AID-ELPS2952>3.0.CO;2-H; Sinha P, 2000, ELECTROPHORESIS, V21, P3048, DOI 10.1002/1522-2683(20000801)21:14<3048::AID-ELPS3048>3.0.CO;2-W; Suzuki T, 2001, CURR DRUG METAB, V2, P367, DOI 10.2174/1389200013338289; Takahashi A, 1999, INT J HEMATOL, V70, P226; Tan S, 2002, INT J CANCER, V98, P523, DOI 10.1002/ijc.10236; Thiede B, 2002, PROTEOMICS, V2, P996, DOI 10.1002/1615-9861(200208)2:8<996::AID-PROT996>3.0.CO;2-3; Vargas-Roig LM, 1998, INT J CANCER, V79, P468, DOI 10.1002/(SICI)1097-0215(19981023)79:5<468::AID-IJC4>3.0.CO;2-Z; Verdier-Pinard P, 2003, BIOCHEMISTRY-US, V42, P5349, DOI 10.1021/bi027293o; Verrills NM, 2003, CURR OPIN MOL THER, V5, P258; Verrills NM, 2000, ELECTROPHORESIS, V21, P3810, DOI 10.1002/1522-2683(200011)21:17<3810::AID-ELPS3810>3.0.CO;2-3; WALLACE W, 1993, MOL BRAIN RES, V19, P149, DOI 10.1016/0169-328X(93)90160-Q; Waterhouse N, 1996, J BIOL CHEM, V271, P29335, DOI 10.1074/jbc.271.46.29335; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yamazaki Y, 2000, EXP CELL RES, V259, P64, DOI 10.1006/excr.2000.4970; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; YENOFSKY R, 1983, MOL CELL BIOL, V3, P1197, DOI 10.1128/MCB.3.7.1197	87	68	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45082	45093		10.1074/jbc.M303378200	http://dx.doi.org/10.1074/jbc.M303378200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12949081	hybrid			2022-12-27	WOS:000186452300007
J	Gunaratnam, L; Morley, M; Franovic, A; de Paulsen, N; Mekhail, K; Parolin, DAE; Nakamura, E; Lorimer, IAJ; Lee, S				Gunaratnam, L; Morley, M; Franovic, A; de Paulsen, N; Mekhail, K; Parolin, DAE; Nakamura, E; Lorimer, IAJ; Lee, S			Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL-/- renal cell carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINDAU TUMOR-SUPPRESSOR; UBIQUITIN LIGASE COMPLEX; FACTOR-ALPHA; FAMILIAL PHEOCHROMOCYTOMA; PROLYL HYDROXYLATION/; GERMLINE MUTATIONS; TYROSINE KINASE; GENE-EXPRESSION; CANCER-CELLS; REGULATE HIF	Bi-allelic-inactivating mutations of the VHL tumor suppressor gene are found in the majority of clear cell renal cell carcinomas (VHL-/- RCC). VHL-/- RCC cells overproduce hypoxia-inducible genes as a consequence of constitutive, oxygen-independent activation of hypoxia inducible factor (HIF). While HIF activation explains the highly vascularized nature of VHL loss lesions, the relative role of HIF in oncogenesis and loss of growth control remains unknown. Here, we report that HIF plays a central role in promoting unregulated growth of VHL-/- RCC cells by activating the transforming growth factor-alpha (TGF-alpha)/epidermal growth factor receptor (EGF-R) pathway. Dominant-negative HIF and enzymatic inhibition of EGF-R were equally efficient at abolishing EGF-R activation and serum-independent growth of VHL-/- RCC cells. TGF-alpha is the only known EGF-R ligand that has a VHL-dependent expression profile and its overexpression by VHL-/- RCC cells is a direct consequence of HIF activation. In contrast to TGF-alpha, other HIF targets, including vascular endothelial growth factor ( VEGF), were unable to stimulate serum-independent growth of VHL-/- RCC cells. VHL-/- RCC cells expressing reintroduced type 2C mutants of VHL, and which retain the ability to degrade HIF, fail to overproduce TGF-alpha and proliferate in serum-free media. These data link HIF with the overproduction of a bona fide renal cell mitogen leading to activation of a pathway involved in growth of renal cancer cells. Moreover, our results suggest that HIF might be involved in oncogenesis to a much higher extent than previously appreciated.	Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; Univ Ottawa, Fac Med, Kidney Res Ctr, Ottawa, ON K1H 8M5, Canada; Univ Ottawa, Fac Med, Dept Internal Med, Ottawa, ON K1H 8M5, Canada; Univ Ottawa, Fac Med, Ottawa Reg Canc Ctr, Ottawa, ON K1H 8M5, Canada; Univ Ottawa, Fac Med, Dept Biochem & Immunol, Ottawa, ON K1H 8M5, Canada; Harvard Univ, Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Lee, S (corresponding author), Univ Ottawa, Fac Med, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.		Gunaratnam, Lakshman/G-3299-2011; Vickers, Michael M/E-4095-2010	Gunaratnam, Lakshman/0000-0002-8845-1126; Mekhail, Karim/0000-0002-6084-020X				ATLAS I, 1992, CANCER RES, V52, P3335; Bonicalzi ME, 2001, J BIOL CHEM, V276, P1407, DOI 10.1074/jbc.M008295200; Bos M, 1997, CLIN CANCER RES, V3, P2099; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chen F, 1996, J MED GENET, V33, P716, DOI 10.1136/jmg.33.8.716; Chen LN, 1996, SOMAT CELL MOLEC GEN, V22, P477, DOI 10.1007/BF02369439; Ciardiello F, 1998, JNCI-J NATL CANCER I, V90, P1087, DOI 10.1093/jnci/90.14.1087; Clifford SC, 2001, ONCOGENE, V20, P5067, DOI 10.1038/sj.onc.1204602; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; CROSSEY PA, 1995, J MED GENET, V32, P885, DOI 10.1136/jmg.32.11.885; de Paulsen N, 2001, P NATL ACAD SCI USA, V98, P1387, DOI 10.1073/pnas.031587498; DUAN DR, 1995, P NATL ACAD SCI USA, V92, P6459, DOI 10.1073/pnas.92.14.6459; ENG C, 1995, J MED GENET, V32, P934, DOI 10.1136/jmg.32.12.934; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Everitt JI, 1997, MOL CARCINOGEN, V19, P213, DOI 10.1002/(SICI)1098-2744(199707)19:3<213::AID-MC9>3.3.CO;2-W; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; GOMELLA LG, 1989, CANCER RES, V49, P6972; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; HUMES HD, 1991, LAB INVEST, V64, P538; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Iliopoulos O, 1998, P NATL ACAD SCI USA, V95, P11661, DOI 10.1073/pnas.95.20.11661; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kaelin WG, 1998, J INTERN MED, V243, P535; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Knebelmann B, 1998, CANCER RES, V58, P226; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kondo K, 2001, EXP CELL RES, V264, P117, DOI 10.1006/excr.2000.5139; KOVALENKO M, 1994, CANCER RES, V54, P6106; Koyama S, 1999, BRIT J PHARMACOL, V127, P537, DOI 10.1038/sj.bjp.0702564; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; LAGER DJ, 1994, MODERN PATHOL, V7, P544; Lee DC, 2003, ANN NY ACAD SCI, V995, P22, DOI 10.1111/j.1749-6632.2003.tb03207.x; LEE DC, 1995, PHARMACOL REV, V47, P51; LINEHAN WM, 1995, JAMA-J AM MED ASSOC, V273, P564; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; LOWDEN DA, 1994, J LAB CLIN MED, V124, P386; Luetteke N C, 1990, Semin Cancer Biol, V1, P265; Maemura K, 1999, J BIOL CHEM, V274, P31565, DOI 10.1074/jbc.274.44.31565; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MYDLO JH, 1989, CANCER RES, V49, P3407; NEUFELD TK, 1992, KIDNEY INT, V41, P1222, DOI 10.1038/ki.1992.184; NEUMANN HPH, 1995, BRAIN PATHOL, V5, P181, DOI 10.1111/j.1750-3639.1995.tb00592.x; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Pause A, 1998, P NATL ACAD SCI USA, V95, P993, DOI 10.1073/pnas.95.3.993; PETRIDES PE, 1990, CANCER RES, V50, P3934; Prewett M, 1998, CLIN CANCER RES, V4, P2957; REIFENBERGER G, 1995, AM J PATHOL, V147, P245; REYNOLDS FH, 1981, NATURE, V292, P259, DOI 10.1038/292259a0; Ritter MM, 1996, J CLIN ENDOCR METAB, V81, P1035, DOI 10.1210/jc.81.3.1035; ROSENTHAL A, 1986, CELL, V46, P301, DOI 10.1016/0092-8674(86)90747-6; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Siemeister G, 1996, CANCER RES, V56, P2299; SMITH JJ, 1987, P NATL ACAD SCI USA, V84, P7567, DOI 10.1073/pnas.84.21.7567; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; SPORN MB, 1985, NATURE, V313, P745, DOI 10.1038/313745a0; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; van der Harst E, 1998, INT J CANCER, V77, P337, DOI 10.1002/(SICI)1097-0215(19980729)77:3<337::AID-IJC5>3.3.CO;2-C; WATANABE S, 1987, P NATL ACAD SCI USA, V84, P1258, DOI 10.1073/pnas.84.5.1258; Weber KL, 2003, CANCER RES, V63, P2940; Weinberg RA, 1996, SCI AM, V275, P62, DOI 10.1038/scientificamerican0996-62; Wiesener MS, 2001, CANCER RES, V61, P5215; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zbar B, 1996, HUM MUTAT, V8, P348, DOI 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3	80	148	165	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44966	44974		10.1074/jbc.M305502200	http://dx.doi.org/10.1074/jbc.M305502200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944410	hybrid			2022-12-27	WOS:000186306700133
J	Paul, AV; Yin, J; Mugavero, J; Rieder, E; Liu, Y; Wimmer, E				Paul, AV; Yin, J; Mugavero, J; Rieder, E; Liu, Y; Wimmer, E			A "slide-back" mechanism for the initiation of protein-primed RNA synthesis by the RNA polymerase of poliovirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTING REPLICATION ELEMENT; GENOME-LINKED PROTEIN; IN-VITRO; VPG URIDYLYLATION; DNA-REPLICATION; SEQUENCE REQUIREMENTS; TERMINAL PROTEIN; STRUCTURAL BASIS; LINEAR TEMPLATE; 3 NUCLEOTIDE	Poliovirus RNA replication is initiated when a molecule of UMP is covalently linked to the hydroxyl group of a tyrosine in the terminal protein VPg. This reaction can be reproduced in vitro with an assay that utilizes two purified viral proteins, RNA polymerase 3D(pol) and viral protein 3CD(pro), synthetic VPg, UTP, and Mg2+. The template for the reaction is either poliovirus RNA or transcripts of a small RNA hairpin, termed cre(2C), located in the coding sequence of protein 2C(ATPase). The products of the reaction are VPgpU and VPgpUpU, the primers used by 3D(pol) for RNA synthesis. With mutant template RNAs in this assay we determined the precise initiation site. Our results indicate that 1) 3Dpol does not possess strict specificity toward the nucleotide it links to VPg, 2) A-5 of the conserved (1)GXXXAAAXXXXXXA(14) sequence in the loop is the template nucleotide for the linkage of both the first and second UMPs to VPg, 3) VPgpUpU is synthesized by a "slideback" mechanism, and 4) A-6 provides specificity to the reaction during the slide-back step and also modulates the uridylylation reaction. In additional experiments we determined the effect of mutations in the (5)AAA(7) sequence of cre( 2C) on viral growth, RNA replication, and on the activity of the 2CATPase protein. Furthermore, we observed that the spacing between G-1 and A-5 and the size of the loop affect the yield but not the nature of the VPg-linked products.	SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11790 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Paul, AV (corresponding author), SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11790 USA.	apaul@ms.cc.sunysb.edu	Liu, Ying/B-8752-2011		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015122] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AIO15122-30] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agol VI, 1999, VIRUS RES, V62, P129, DOI 10.1016/S0168-1702(99)00037-4; AMBROS V, 1978, J BIOL CHEM, V253, P5263; ANDINO R, 1993, EMBO J, V12, P3587, DOI 10.1002/j.1460-2075.1993.tb06032.x; CALDENTEY J, 1993, NUCLEIC ACIDS RES, V21, P3725, DOI 10.1093/nar/21.16.3725; CRAWFORD NM, 1983, P NATL ACAD SCI-BIOL, V80, P7452, DOI 10.1073/pnas.80.24.7452; FLANEGAN JB, 1977, P NATL ACAD SCI USA, V74, P3677, DOI 10.1073/pnas.74.9.3677; Gerber K, 2001, J VIROL, V75, P10979, DOI 10.1128/JVI.75.22.10979-10990.2001; Gonzalez-Huici V, 2000, J BIOL CHEM, V275, P40547, DOI 10.1074/jbc.M007170200; Goodfellow I, 2000, J VIROL, V74, P4590, DOI 10.1128/JVI.74.10.4590-4600.2000; Goodfellow IG, 2003, RNA, V9, P124, DOI 10.1261/rna.2950603; Illana B, 1996, J MOL BIOL, V264, P453, DOI 10.1006/jmbi.1996.0653; Jiang HY, 1997, J VIROL, V71, P5345, DOI 10.1128/JVI.71.7.5345-5354.1997; JORE J, 1988, J GEN VIROL, V69, P1627, DOI 10.1099/0022-1317-69-7-1627; KING AJ, 1994, EMBO J, V13, P5786, DOI 10.1002/j.1460-2075.1994.tb06917.x; KITAMURA N, 1981, NATURE, V291, P547, DOI 10.1038/291547a0; Lobert PE, 1999, P NATL ACAD SCI USA, V96, P11560, DOI 10.1073/pnas.96.20.11560; Lyle JM, 2002, J BIOL CHEM, V277, P16324, DOI 10.1074/jbc.M112429200; Martin AC, 1996, J MOL BIOL, V260, P369, DOI 10.1006/jmbi.1996.0407; Mason PW, 2002, J VIROL, V76, P9686, DOI 10.1128/JVI.76.19.9686-9694.2002; McKnight KL, 1998, RNA, V4, P1569, DOI 10.1017/S1355838298981006; MENDEZ J, 1992, P NATL ACAD SCI USA, V89, P9579, DOI 10.1073/pnas.89.20.9579; MOLLA A, 1991, SCIENCE, V254, P1647, DOI 10.1126/science.1661029; Morasco BJ, 2003, J VIROL, V77, P5136, DOI 10.1128/JVI.77.9.5136-5144.2003; Murray KE, 2003, J VIROL, V77, P4739, DOI 10.1128/JVI.77.8.4739-4750.2003; NOMOTO A, 1977, NATURE, V268, P208, DOI 10.1038/268208a0; PATA JD, 1995, RNA, V1, P466; Paul Aniko V., 2002, P227; Paul AV, 2000, J VIROL, V74, P10359, DOI 10.1128/JVI.74.22.10359-10370.2000; Paul AV, 2003, J VIROL, V77, P891, DOI 10.1128/JVI.77.2.891-904.2003; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Pilipenko EV, 1996, EMBO J, V15, P5428, DOI 10.1002/j.1460-2075.1996.tb00926.x; Rieder E, 2000, J VIROL, V74, P10371, DOI 10.1128/JVI.74.22.10371-10380.2000; ROTHBERG PG, 1978, P NATL ACAD SCI USA, V75, P4868, DOI 10.1073/pnas.75.10.4868; SALAS M, 1996, DNA REPLICATION EUKA, P131; SEEGER C, 1996, DNA REPLICATION EUKA, P815; TAKEGAMI T, 1983, P NATL ACAD SCI-BIOL, V80, P7447, DOI 10.1073/pnas.80.24.7447; TOYODA H, 1987, J VIROL, V61, P2816, DOI 10.1128/JVI.61.9.2816-2822.1987; VANDERWERF S, 1986, P NATL ACAD SCI USA, V83, P2330; WIMMER E, 1982, CELL, V28, P199, DOI 10.1016/0092-8674(82)90335-X; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Xiang WK, 1998, J VIROL, V72, P6732, DOI 10.1128/JVI.72.8.6732-6741.1998; Yang Y, 2002, J VIROL, V76, P7485, DOI 10.1128/JVI.76.15.7485-7494.2002; Yin J, 2003, J VIROL, V77, P5152, DOI 10.1128/JVI.77.9.5152-5166.2003; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; YPMAWONG MF, 1988, VIROLOGY, V166, P265, DOI 10.1016/0042-6822(88)90172-9	45	65	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					43951	43960		10.1074/jbc.M307441200	http://dx.doi.org/10.1074/jbc.M307441200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12937178	hybrid			2022-12-27	WOS:000186306700010
J	Ugarov, VI; Demidenko, AA; Chetverin, AB				Ugarov, VI; Demidenko, AA; Chetverin, AB			Q beta replicase discriminates between legitimate and illegitimate templates by having different mechanisms of initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; CELL-FREE SYSTEM; PHAGE RNA; SECONDARY STRUCTURE; QBETA-REPLICASE; VIRAL RNA; RECOMBINATION; VITRO; ELONGATION; SEQUENCES	Qbeta replicase (RNA-directed RNA polymerase of bacteriophage Qbeta) exponentially amplifies certain RNAs (RQ RNAs) in vitro. Here we characterize template properties of the 5' and 3' fragments obtained by cleaving one of such RNAs at an internal site. We unexpectedly found that, besides the 3' fragment, Qbeta replicase can copy the 5' fragment and a number of its variants, although they lack the initiator region of RQ RNA. This copying can occur as a 3'-terminal elongation or through de novo initiation. In contradistinction to RQ RNA and its 3' fragment, initiation on these templates occurs without regard to the 3'-terminal or internal oligo(C) clusters, is GTP-independent, and does not result in a stable replicative complex capable of elongation in the presence of aurintricarboxylic acid. The results suggest that, although Qbeta replicase can initiate and elongate on a variety of RNAs, only some of them are recognized as legitimate templates. GTP-dependent initiation on a legitimate template drives the enzyme to a "closed" conformation that may be important for keeping the template and the complementary nascent strand unannealed, without which the exponential replication is impossible. Triggering the GTP-dependent conformational transition at the initiation step could serve as a discriminative feature of legitimate templates providing for the high template specificity of Qbeta replicase.	Russian Acad Sci, Inst Prot Res, Pushchino 142290, Moscow Region, Russia	Russian Academy of Sciences	Chetverin, AB (corresponding author), Russian Acad Sci, Inst Prot Res, Pushchino 142290, Moscow Region, Russia.	alexch@vega.protres.ru	Ugarov, Victor/AAC-6454-2022; Chetverin, Alexander B/AAA-6511-2022; Ugarov, Victor/AAC-6502-2022					Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; AXELROD VD, 1991, VIROLOGY, V184, P595, DOI 10.1016/0042-6822(91)90430-J; BERESTOWSKAYA NH, 1988, FEBS LETT, V228, P263, DOI 10.1016/0014-5793(88)80012-7; BIEBRICHER CK, 1992, EMBO J, V11, P5129, DOI 10.1002/j.1460-2075.1992.tb05620.x; BIEBRICHER CK, 1993, BIOCHEMISTRY-US, V32, P4848, DOI 10.1021/bi00069a021; BIEBRICHER CK, 1982, J MOL BIOL, V154, P629, DOI 10.1016/S0022-2836(82)80019-3; BLUMENTHAL T, 1973, BIOCHEM BIOPH RES CO, V55, P680, DOI 10.1016/0006-291X(73)91198-4; BLUMENTHAL T, 1980, P NATL ACAD SCI-BIOL, V77, P2601, DOI 10.1073/pnas.77.5.2601; Blumenthal T, 1979, Methods Enzymol, V60, P628; BLUMENTHAL T, 1979, ANNU REV BIOCHEM, V48, P525, DOI 10.1146/annurev.bi.48.070179.002521; Brown D, 1996, P NATL ACAD SCI USA, V93, P11558, DOI 10.1073/pnas.93.21.11558; BROWN D, 1995, BIOCHEMISTRY-US, V34, P14765, DOI 10.1021/bi00045a018; BROWN D, 1995, BIOCHEMISTRY-US, V34, P14775, DOI 10.1021/bi00045a019; BROWN S, 1976, P NATL ACAD SCI USA, V73, P1131, DOI 10.1073/pnas.73.4.1131; Chetverin AB, 1997, CELL, V88, P503, DOI 10.1016/S0092-8674(00)81890-5; CHETVERIN AB, 1991, J MOL BIOL, V222, P3, DOI 10.1016/0022-2836(91)90729-P; CHETVERIN AB, 1995, PROG NUCLEIC ACID RE, V51, P225, DOI 10.1016/S0079-6603(08)60880-6; Chetverin AB, 1999, FEBS LETT, V460, P1, DOI 10.1016/S0014-5793(99)01282-X; Chetverina HV, 1999, FEBS LETT, V450, P89, DOI 10.1016/S0014-5793(99)00469-X; CHETVERINA HV, 1993, NUCLEIC ACIDS RES, V21, P2349, DOI 10.1093/nar/21.10.2349; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; FEIX G, 1975, EUR J BIOCHEM, V58, P59, DOI 10.1111/j.1432-1033.1975.tb02348.x; FEIX G, 1975, BIOCHEM BIOPH RES CO, V65, P503, DOI 10.1016/S0006-291X(75)80176-8; FEIX G, 1967, P NATL ACAD SCI USA, V57, P1401, DOI 10.1073/pnas.57.5.1401; GAILLARD C, 1990, NUCLEIC ACIDS RES, V18, P378, DOI 10.1093/nar/18.2.378; GILBERTOGONZALEZ R, 1980, BIOCHEMISTRY-US, V19, P4299, DOI 10.1021/bi00559a023; HARUNA I, 1965, P NATL ACAD SCI USA, V54, P579, DOI 10.1073/pnas.54.2.579; HORI K, 1967, P NATL ACAD SCI USA, V57, P1790, DOI 10.1073/pnas.57.6.1790; IGLOI GL, 1983, ANAL BIOCHEM, V134, P184, DOI 10.1016/0003-2697(83)90281-6; JAEGER JA, 1990, METHOD ENZYMOL, V183, P281; Kochetkov SN, 1998, FEBS LETT, V440, P264, DOI 10.1016/S0014-5793(98)01484-7; KUPPERS B, 1975, P NATL ACAD SCI USA, V72, P2640, DOI 10.1073/pnas.72.7.2640; Mooney RA, 1999, CELL, V98, P687, DOI 10.1016/S0092-8674(00)81483-X; MOROZOV IY, 1993, P NATL ACAD SCI USA, V90, P9325, DOI 10.1073/pnas.90.20.9325; MUNISHKIN AV, 1991, J MOL BIOL, V221, P463, DOI 10.1016/0022-2836(91)80067-5; PALASINGAM K, 1992, J VIROL, V66, P2435, DOI 10.1128/JVI.66.4.2435-2442.1992; PALMENBERG A, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1371, DOI 10.1073/pnas.71.4.1371; Preuss R, 1997, J MOL BIOL, V273, P600, DOI 10.1006/jmbi.1997.1343; RENSING U, 1969, NATURE, V224, P853, DOI 10.1038/224853a0; Sambrook J., 2001, MOL CLONING LAB MANU; SHAKLEE PN, 1988, VIROLOGY, V163, P209, DOI 10.1016/0042-6822(88)90250-4; SILVERMAN PM, 1973, ARCH BIOCHEM BIOPHYS, V157, P222, DOI 10.1016/0003-9861(73)90408-6; STEINSCHNEIDER A, 1966, BIOCHEMISTRY-US, V5, P2729, DOI 10.1021/bi00872a033; Tretheway DM, 2001, J VIROL, V75, P11373, DOI 10.1128/JVI.75.23.11373-11383.2001; van Duin J., 1988, BACTERIOPHAGES, P117; VOGT VM, 1973, EUR J BIOCHEM, V33, P192, DOI 10.1111/j.1432-1033.1973.tb02669.x; WEISSMANN C, 1973, ANNU REV BIOCHEM, V42, P303, DOI 10.1146/annurev.bi.42.070173.001511; WEISSMANN C, 1968, COLD SPRING HARB SYM, V33, P83, DOI 10.1101/SQB.1968.033.01.014; WEISSMANN C, 1974, FEBS LETT, V43, pS10; WERNER M, 1991, BIOCHEMISTRY-US, V30, P5832, DOI 10.1021/bi00238a004; Yoshinari S, 2000, VIROLOGY, V271, P363, DOI 10.1006/viro.2000.0334; Yoshinari S, 2000, RNA, V6, P698, DOI 10.1017/S1355838200992410; ZAMORA H, 1995, BIOCHEMISTRY-US, V34, P1261, DOI 10.1021/bi00004a020	53	20	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44139	44146		10.1074/jbc.M305992200	http://dx.doi.org/10.1074/jbc.M305992200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947121	hybrid			2022-12-27	WOS:000186306700032
J	Blundell, CD; Mahoney, DJ; Almond, A; DeAngelis, PL; Kahmann, JD; Teriete, P; Pickford, AR; Campbell, ID; Day, AJ				Blundell, CD; Mahoney, DJ; Almond, A; DeAngelis, PL; Kahmann, JD; Teriete, P; Pickford, AR; Campbell, ID; Day, AJ			The link module from ovulation- and inflammation-associated protein TSG-6 changes conformation on hyaluronan binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-STIMULATED GENE-6; INTER-ALPHA-INHIBITOR; CRYSTAL-STRUCTURE; PASTEURELLA-MULTOCIDA; RHEUMATOID-ARTHRITIS; EXTRACELLULAR-MATRIX; MICE; EXPRESSION; COMPLEX; LYASE	The solution structure of the Link module from human TSG-6, a hyaladherin with important roles in inflammation and ovulation, has been determined in both its free and hyaluronan-bound conformations. This reveals a well defined hyaluronan-binding groove on one face of the Link module that is closed in the absence of ligand. The groove is lined with amino acids that have been implicated in mediating the interaction with hyaluronan, including two tyrosine residues that appear to form essential intermolecular hydrogen bonds and two basic residues capable of supporting ionic interactions. This is the first structure of a non-enzymic hyaladherin in its active state, and identifies a ligand-induced conformational change that is likely to be conserved across the Link module superfamily. NMR and isothermal titration calorimetry experiments with defined oligosaccharides have allowed us to infer the minimum length of hyaluronan that can be accommodated within the binding site and its polarity in the groove; these data have been used to generate a model of the complex formed between the Link module and a hyaluronan octasaccharide.	Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Oxford; University of Oklahoma System; University of Oklahoma Health Sciences Center	Day, AJ (corresponding author), Univ Oxford, Dept Biochem, MRC, Immunochem Unit, S Parks Rd, Oxford OX1 3QU, England.		Teriete, Peter/N-3331-2014; Pickford, Andy/AGB-6901-2022; Day, Anthony/O-1658-2015	Teriete, Peter/0000-0003-3692-9308; Day, Anthony/0000-0002-1415-3134; Almond, Andrew/0000-0001-7471-6333; Blundell, Charles/0000-0002-1439-9126; Pickford, Andy/0000-0002-7237-0030				Almond A, 2000, J PHYS CHEM B, V104, P5634, DOI 10.1021/jp000402t; AURORA R, 1994, SCIENCE, V264, P1126, DOI 10.1126/science.8178170; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; Blundell C. D., 2002, HYALURONAN, P161; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2001, CURR OPIN STRUC BIOL, V11, P617, DOI 10.1016/S0959-440X(00)00256-6; DeAngelis PL, 1998, J BIOL CHEM, V273, P8454, DOI 10.1074/jbc.273.14.8454; DeAngelis PL, 2002, CARBOHYD RES, V337, P1547, DOI 10.1016/S0008-6215(02)00219-7; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jedrzejas MJ, 2002, J BIOL CHEM, V277, P28287, DOI 10.1074/jbc.M112009200; Kahmann JD, 2000, STRUCTURE, V8, P763, DOI 10.1016/S0969-2126(00)00163-5; Kida D, 1999, J RHEUMATOL, V26, P1230; Kogelberg H, 2001, CURR OPIN STRUC BIOL, V11, P635, DOI 10.1016/S0959-440X(00)00259-1; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; LUO Y, 2000, NATURE, V405, P1074; Mahoney DJ, 2001, GLYCOBIOLOGY, V11, P1025, DOI 10.1093/glycob/11.12.1025; Mahoney DJ, 2001, J BIOL CHEM, V276, P22764, DOI 10.1074/jbc.M100666200; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; Mello LV, 2002, J BIOL CHEM, V277, P36678, DOI 10.1074/jbc.M205140200; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Nukui M, 2003, J BIOL CHEM, V278, P3079, DOI 10.1074/jbc.M204999200; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P1008, DOI 10.1210/en.2002-220435; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Spicer AP, 2003, J BIOL CHEM, V278, P21083, DOI 10.1074/jbc.M213100200; Swaminathan GJ, 2001, J BIOL CHEM, V276, P26197, DOI 10.1074/jbc.M100848200; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Vyas NK, 1991, CURR OPIN STRUC BIOL, V1, P732, DOI 10.1016/0959-440X(91)90172-P; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	44	76	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					49261	49270		10.1074/jbc.M309623200	http://dx.doi.org/10.1074/jbc.M309623200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12972412	hybrid			2022-12-27	WOS:000186829000092
J	Kiel, MC; Raj, VS; Kaji, H; Kaji, A				Kiel, MC; Raj, VS; Kaji, H; Kaji, A			Release of ribosome-bound ribosome recycling factor by elongation factor G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RIBONUCLEIC-ACID; RNA BINDING-SITES; EF-G; GUANOSINE TRIPHOSPHATE; SOLUBLE-RNA; 4TH STEP; TRANSLOCATION; PROTEIN; MECHANISM; SUBUNITS	Elongation factor G (EF-G) and ribosome recycling factor (RRF) disassemble post-termination complexes of ribosome, mRNA, and tRNA. RRF forms stable complexes with 70 S ribosomes and 50 S ribosomal subunits. Here, we show that EF-G releases RRF from 70 S ribosomal and model post-termination complexes but not from 50 S ribosomal subunit complexes. The release of bound RRF by EF-G is stimulated by GTP analogues. The EF-G-dependent release occurs in the presence of fusidic acid and viomycin. However, thiostrepton inhibits the release. RRF was shown to bind to EF-G-ribosome complexes in the presence of GTP with much weaker affinity, suggesting that EF-G may move RRF to this position during the release of RRF. On the other hand, RRF did not bind to EF-G-ribosome complexes with fusidic acid, suggesting that EF-G stabilized by fusidic acid does not represent the natural post-termination complex. In contrast, the complexes of ribosome, EF-G and thiostrepton could bind RRF, although with lower affinity. These results suggest that thiostrepton traps an intermediate complex having RRF on a position that clashes with the P/E site bound tRNA. Mutants of EF-G that are impaired for translocation fail to disassemble post-termination complexes and exhibit lower activity in releasing RRF. We propose that the release of ribosome-bound RRF by EF-G is required for post-termination complex disassembly. Before release from the ribosome, the position of RRF on the ribosome will change from the original A/P site to a new location that clashes with tRNA on the P/E site.	Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Mol Pharmacol & Biochem, Philadelphia, PA 19107 USA	University of Pennsylvania; Jefferson University	Kaji, A (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Rm 203B Johnson Pavil,3610 Hamilton Walk, Philadelphia, PA 19104 USA.	kaji@mail.med.upenn.edu			CGH CDC HHS [GH60429] Funding Source: Medline	CGH CDC HHS		Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Agrawal RK, 2001, J MOL BIOL, V311, P777, DOI 10.1006/jmbi.2001.4907; BODLEY JW, 1970, J BIOL CHEM, V245, P5656; BODLEY JW, 1969, BIOCHEM BIOPH RES CO, V37, P437, DOI 10.1016/0006-291X(69)90934-6; Borowski C, 1996, P NATL ACAD SCI USA, V93, P4202, DOI 10.1073/pnas.93.9.4202; CABANAS MJ, 1980, BIOCHEMISTRY-US, V19, P5411, DOI 10.1021/bi00564a040; Cameron DM, 2002, J MOL BIOL, V319, P27, DOI 10.1016/S0022-2836(02)00235-8; Frank J, 2003, BIOPOLYMERS, V68, P223, DOI 10.1002/bip.10210; Frank J, 2001, COLD SPRING HARB SYM, V66, P67, DOI 10.1101/sqb.2001.66.67; Gualerzi CO, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P477; HAUSNER TP, 1988, J BIOL CHEM, V263, P13103; HIRASHIM.A, 1970, BIOCHEM BIOPH RES CO, V41, P877, DOI 10.1016/0006-291X(70)90165-8; HIRASHIM.A, 1973, J BIOL CHEM, V248, P7580; HIRASHIMA A, 1972, BIOCHEMISTRY-US, V11, P4037, DOI 10.1021/bi00772a005; HIRASHIMA A, 1972, J MOL BIOL, V65, P43, DOI 10.1016/0022-2836(72)90490-1; Hirohawa G, 2002, J BIOL CHEM, V277, P35847, DOI 10.1074/jbc.M206295200; Hirokawa G, 2002, EMBO J, V21, P2272, DOI 10.1093/emboj/21.9.2272; HOU Y, 1994, J BACTERIOL, V176, P7038, DOI 10.1128/JB.176.22.7038-7044.1994; IGARASHI K, 1967, P NATL ACAD SCI USA, V58, P1971, DOI 10.1073/pnas.58.5.1971; IGARASHI K, 1969, BIOCHEM BIOPH RES CO, V37, P499, DOI 10.1016/0006-291X(69)90943-7; INOUEYOKOSAWA N, 1974, J BIOL CHEM, V249, P4321; ISHITSUKA H, 1970, J BIOL CHEM, V245, P3346; Janosi L, 1998, EMBO J, V17, P1141, DOI 10.1093/emboj/17.4.1141; Janosi L, 1996, ADV BIOPHYS, V32, P121, DOI 10.1016/0065-227X(96)84743-5; JANOSI L, 1994, P NATL ACAD SCI USA, V91, P4249, DOI 10.1073/pnas.91.10.4249; Kaji A, 2001, COLD SPRING HARB SYM, V66, P515, DOI 10.1101/sqb.2001.66.515; KAJI A, 1963, BIOCHEM BIOPH RES CO, V13, P186, DOI 10.1016/0006-291X(63)90279-1; KAJI H, 1966, J BIOL CHEM, V241, P1251; KAZIRO Y, 1968, J BIOCHEM-TOKYO, V64, P423, DOI 10.1093/oxfordjournals.jbchem.a128913; KIRILLOV SV, 1983, FEBS LETT, V157, P91, DOI 10.1016/0014-5793(83)81122-3; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KURIKI Y, 1970, Biochimica et Biophysica Acta, V224, P487, DOI 10.1016/0005-2787(70)90581-2; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; LILL R, 1986, BIOCHEMISTRY-US, V25, P3245, DOI 10.1021/bi00359a025; LILL R, 1984, BIOCHEMISTRY-US, V23, P6710, DOI 10.1021/bi00321a066; MARSH RC, 1977, BIOCHEMISTRY-US, V16, P1278, DOI 10.1021/bi00626a006; Nierhaus KH, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P319; Noller HF, 2002, FEBS LETT, V514, P11, DOI 10.1016/S0014-5793(02)02327-X; OGAWA K, 1975, EUR J BIOCHEM, V58, P411, DOI 10.1111/j.1432-1033.1975.tb02388.x; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; PESTKA S, 1970, BIOCHEM BIOPH RES CO, V40, P667, DOI 10.1016/0006-291X(70)90956-3; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Rodnina MV, 1999, P NATL ACAD SCI USA, V96, P9586, DOI 10.1073/pnas.96.17.9586; Rodnina PV, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P301; Savelsbergh A, 2000, J MOL BIOL, V300, P951, DOI 10.1006/jmbi.2000.3886; Selmer M, 1999, SCIENCE, V286, P2349, DOI 10.1126/science.286.5448.2349; SHIMIZU I, 1991, J BACTERIOL, V173, P5181, DOI 10.1128/jb.173.16.5181-5187.1991; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; SUZUKA I, 1966, P NATL ACAD SCI USA, V55, P1483, DOI 10.1073/pnas.55.6.1483; Wilson DN, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P495; Wilson KS, 1998, CELL, V92, P131, DOI 10.1016/S0092-8674(00)80905-8; Wintermeyer W, 2001, COLD SPRING HARB SYM, V66, P449, DOI 10.1101/sqb.2001.66.449	54	39	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48041	48050		10.1074/jbc.M304834200	http://dx.doi.org/10.1074/jbc.M304834200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12960150	hybrid			2022-12-27	WOS:000186731400083
J	Li, Q; Luo, X; Zeng, WH; Muallem, S				Li, Q; Luo, X; Zeng, WH; Muallem, S			Cell-specific behavior of P2X7 receptors in mouse parotid acinar and duct cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBMANDIBULAR-GLAND ACINAR; BRILLIANT BLUE-G; P2X(7) RECEPTOR; NUCLEOTIDE RECEPTORS; PURINERGIC RECEPTORS; POLARIZED EXPRESSION; EXTRACELLULAR ATP; LOCALIZATION; TRAFFICKING; INITIATION	P2X7 receptors (P2X7Rs) affect many epithelial cell functions including transcellular ion transport, secretion, and cell death. Here we used parotid acinar and duct cells to reveal the unique cell-specific assembly and gating of the P2X7R channels. Immunolocalization indicated expression of P2X7Rs in the luminal membrane of both cell types. Stimulation with 5 mM ATP raised [Ca2+](i) levels in a cell-specific manner and activated multiple currents. The current mediated by P2X7R was isolated by infusing the cells with high [ EGTA]. The initial activation of acinar cell P2X7Rs by ATP was slow requiring similar to 2.5 min. Subsequent removal and addition of ATP, however, resulted in rapid inhibition and activation ( gating) of the P2X7Rs. By contrast, P2X7Rs in duct cells displayed only rapid gating by ATP. Activation of P2X7Rs in both cell types was verified by ( a) low Km for ATP, (b) sensitivity to external divalent ions, ( c) lack of desensitization/inactivation, (d) permeability to Na+, and (e) inhibition by Brilliant Blue G, Cu2+, and pyridoxal phosphate-6-azophenyl-2', 4'-disulfonic acid tetrasodium. The slow P2X7R activation in acinar cells was not affected by manipulation of exo-/ endocytosis. Rather, disassembly or solidification of the actin cytoskeleton prior to incubation with ATP prevented channel assembly. Remarkably, after completion of the slow activation, manipulation of the actin cytoskeleton no longer affected gating by ATP. Accordingly, manipulation of the actin cytoskeleton had no effect on P2X7R gating by ATP in duct cells. We concluded that P2X7Rs are not active in resting acinar cells. On exposure to ATP, P2X7Rs are assembled into functional channels with the aid of the actin cytoskeleton. Once assembled, P2X7Rs are subject to rapid gating by ATP. Duct cell P2X7Rs are preassembled and therefore continually subject to rapid gating by ATP. This cell-specific behavior may reflect the specific function of P2X7Rs in the two cell types.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Zeng, WH (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA.				NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE12309] Funding Source: Medline; NIDDK NIH HHS [DK38938] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Afework M, 2000, CELLS TISSUES ORGANS, V167, P297, DOI 10.1159/000016793; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Burnstock G, 2002, CLIN MED, V2, P45, DOI 10.7861/clinmedicine.2-1-45; Chaib N, 2000, BRIT J PHARMACOL, V129, P703, DOI 10.1038/sj.bjp.0703124; Communi D, 2000, CELL SIGNAL, V12, P351, DOI 10.1016/S0898-6568(00)00083-8; COOK DI, 1994, TXB PHYSL GASTROINTE, P1061; Cressman VL, 1999, J BIOL CHEM, V274, P26461, DOI 10.1074/jbc.274.37.26461; Dubyak GR, 2003, MOL PHARMACOL, V63, P773, DOI 10.1124/mol.63.4.773; Gibbons SJ, 2001, J AUTON PHARMACOL, V21, P181, DOI 10.1046/j.1365-2680.2001.00224.x; Hede SE, 1999, J BIOL CHEM, V274, P31784, DOI 10.1074/jbc.274.45.31784; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; JORGENSEN TD, 1995, BIOCHEM J, V312, P457, DOI 10.1042/bj3120457; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Lee MG, 1997, J BIOL CHEM, V272, P15765, DOI 10.1074/jbc.272.25.15765; Lee MG, 1997, J BIOL CHEM, V272, P32951, DOI 10.1074/jbc.272.52.32951; Leipziger J, 2003, AM J PHYSIOL-RENAL, V284, pF419, DOI 10.1152/ajprenal.00075.2002; Luo X, 1999, AM J PHYSIOL-CELL PH, V277, pC205, DOI 10.1152/ajpcell.1999.277.2.C205; Moe OW, 1999, J AM SOC NEPHROL, V10, P2412; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Rossier BC, 2002, J GEN PHYSIOL, V120, P67, DOI 10.1085/jgp.20028638; Sage CL, 2002, J MEMBRANE BIOL, V185, P103, DOI 10.1007/s00232-001-0116-z; Shin DM, 2001, J BIOL CHEM, V276, P44146, DOI 10.1074/jbc.M105203200; SOLTOFF SP, 1989, BIOCHEM BIOPH RES CO, V165, P1279, DOI 10.1016/0006-291X(89)92741-1; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tenneti L, 1998, J BIOL CHEM, V273, P26799, DOI 10.1074/jbc.273.41.26799; Turner JT, 1999, CRIT REV ORAL BIOL M, V10, P210, DOI 10.1177/10454411990100020701; Turner JT, 1998, EUR J MORPHOL, V36, P170; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Watano T, 2002, JPN J PHARMACOL, V89, P296, DOI 10.1254/jjp.89.296; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Xiang ZH, 1998, NEUROSCI LETT, V256, P105, DOI 10.1016/S0304-3940(98)00774-5; Zeng WZ, 1997, J BIOL CHEM, V272, P32956, DOI 10.1074/jbc.272.52.32956; Zeng WZ, 1997, AM J PHYSIOL-CELL PH, V273, pC442, DOI 10.1152/ajpcell.1997.273.2.C442	36	47	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47554	47561		10.1074/jbc.M308306200	http://dx.doi.org/10.1074/jbc.M308306200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12968021	hybrid			2022-12-27	WOS:000186731400027
J	Fitch, ME; Nakajima, S; Yasui, A; Ford, JM				Fitch, ME; Nakajima, S; Yasui, A; Ford, JM			In vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene product	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; TRANSCRIBED STRAND; EXCISION; REPAIR; BINDING; PHOTOLYASE; IRRADIATION; CELLS; P48; RECOGNITION	The initial step in mammalian nucleotide excision repair (NER) of the major UV-induced photoproducts, cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts (6-4PPs), requires lesion recognition. It is believed that the heterodimeric proteins XPC/hHR23B and UV-DDB (UV-damaged DNA binding factor, composed of the p48 and p127 subunits) perform this function in genomic DNA, but their requirement and lesion specificity in vivo remains unknown. Using repair-deficient xeroderma pigmentosum (XP)-A cells that stably express photoproduct-specific photolyases, we determined the binding characteristics of p48 and XPC to either CPDs or 6-4PPs in vivo. p48 localized to UV-irradiated sites that contained either CPDs or 6-4PPs. However, XPC localized only to UV-irradiated sites that contained 6-4PPs, suggesting that XPC does not efficiently recognize CPDs in vivo. XPC did localize to CPDs when p48 was overexpressed in the same cell, signifying that p48 activates the recruitment of XPC to CPDs and may be the initial recognition factor in the NER pathway.	Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Genet, Sendai, Miyagi 9808575, Japan	Stanford University; Stanford University; Tohoku University	Ford, JM (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Oncol, 1115 CCSR Bldg,269 Campus Dr, Stanford, CA 94305 USA.	jmf@stanford.edu		Ford, James/0000-0002-2513-7025	NATIONAL CANCER INSTITUTE [R01CA083889] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 83889] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; Chigancas V, 2000, CANCER RES, V60, P2458; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Fitch ME, 2003, CARCINOGENESIS, V24, P843, DOI 10.1093/carcin/bgg031; FITCH ME, 2003, DNA REPAIR AMST, P819; Ford JM, 1997, CURR TOP MICROBIOL, V221, P47; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hey T, 2002, BIOCHEMISTRY-US, V41, P6583, DOI 10.1021/bi012202t; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; KEENEY S, 1993, J BIOL CHEM, V268, P21293; Kosmoski JV, 1999, BIOCHEMISTRY-US, V38, P9485, DOI 10.1021/bi990297h; Kusumoto R, 2001, MUTAT RES-DNA REPAIR, V485, P219, DOI 10.1016/S0921-8777(00)00082-3; LOMMEL L, 1993, MOL CELL BIOL, V13, P970, DOI 10.1128/MCB.13.2.970; Meijer M, 1999, BIOESSAYS, V21, P596, DOI 10.1002/(SICI)1521-1878(199907)21:7<596::AID-BIES8>3.0.CO;2-5; MITCHELL DL, 1985, MUTAT RES, V143, P109, DOI 10.1016/S0165-7992(85)80018-X; MORI T, 1991, PHOTOCHEM PHOTOBIOL, V54, P225, DOI 10.1111/j.1751-1097.1991.tb02010.x; Nakajima S, 1998, NUCLEIC ACIDS RES, V26, P638, DOI 10.1093/nar/26.2.638; NG JMY, 2003, GENE DEV; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Rapic-Otrin V, 2002, NUCLEIC ACIDS RES, V30, P2588, DOI 10.1093/nar/30.11.2588; SANCAR GB, 1990, MUTAT RES, V236, P147, DOI 10.1016/0921-8777(90)90002-M; SATOKATA I, 1992, MUTAT RES, V273, P193, DOI 10.1016/0921-8777(92)90080-M; Schieferstein U, 1998, EMBO J, V17, P306, DOI 10.1093/emboj/17.1.306; Schul W, 2002, EMBO J, V21, P4719, DOI 10.1093/emboj/cdf456; Smerdon MJ, 1999, PROG NUCLEIC ACID RE, V62, P227; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Thoma F, 1999, EMBO J, V18, P6585, DOI 10.1093/emboj/18.23.6585; VENEMA J, 1991, MOL CELL BIOL, V11, P4128, DOI 10.1128/MCB.11.8.4128; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wakasugi M, 2002, J BIOL CHEM, V277, P1637, DOI 10.1074/jbc.C100610200; Wakasugi M, 2001, J BIOL CHEM, V276, P15434, DOI 10.1074/jbc.M011177200; Wang QE, 2003, DNA REPAIR, V2, P483, DOI 10.1016/S1568-7864(03)00002-8; YASUI A, 1994, EMBO J, V13, P6143, DOI 10.1002/j.1460-2075.1994.tb06961.x; You YH, 2001, J BIOL CHEM, V276, P44688, DOI 10.1074/jbc.M107696200	36	191	198	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46906	46910		10.1074/jbc.M307254200	http://dx.doi.org/10.1074/jbc.M307254200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12944386				2022-12-27	WOS:000186569400084
J	Kaser, M; Kambacheld, M; Kisters-Woike, B; Langer, T				Kaser, M; Kambacheld, M; Kisters-Woike, B; Langer, T			Oma1, a novel membrane-bound metallopeptidase in mitochondria with activities overlapping with the m-AAA protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; CYTOCHROME-OXIDASE SUBUNIT-2; CHAPERONE-LIKE ACTIVITY; INNER MEMBRANE; SPASTIC PARAPLEGIA; PROTEINS; DEGRADATION; IMPORT; SITES; REQUIREMENT	The integrity of the inner membrane of mitochondria is maintained by a membrane-embedded quality control system that ensures the removal of misfolded membrane proteins. Two ATP-dependent AAA proteases with catalytic sites at opposite membrane surfaces are key components of this proteolytic system. Here we describe the identification of a novel conserved metallopeptidase that exerts activities overlapping with the m-AAA protease and was therefore termed Oma1. Both peptidases are integral parts of the inner membrane and mediate the proteolytic breakdown of a misfolded derivative of the polytopic inner membrane protein Oxa1. The m-AAA protease cleaves off the matrix-exposed C-terminal domain of Oxa1 and processively degrades its transmembrane domain. In the absence of the m-AAA protease, proteolysis of Oxa1 is mediated in an ATP-independent manner by Oma1 and a yet unknown peptidase resulting in the accumulation of N- and C-terminal proteolytic fragments. Oma1 exposes its proteolytic center to the matrix side; however, mapping of Oma1 cleavage sites reveals clipping of Oxa1 in loop regions at both membrane surfaces. These results identify Oma1 as a novel component of the quality control system in the inner membrane of mitochondria. Proteins homologous to Oma1 are present in higher eukaryotic cells, eubacteria and archaebacteria, suggesting that Oma1 is the founding member of a conserved family of membrane-embedded metallopeptidases.	Univ Cologne, Inst Genet, D-50674 Cologne, Germany	University of Cologne	Langer, T (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47, D-50674 Cologne, Germany.	thomas.langer@uni-koeln.de		Kaser, Michael/0000-0001-8673-7238; Langer, Thomas/0000-0003-1250-1462				Arlt H, 1998, EMBO J, V17, P4837, DOI 10.1093/emboj/17.16.4837; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; ATORINO L, 2003, IN PRESS J CELL BIOL; BARRETT AJ, 1998, HDB PROTEOLYTIC ENZY, P989; BAUER M, 1994, MOL GEN GENET, V245, P272, DOI 10.1007/BF00290106; BUCHLER M, 1994, EUR J BIOCHEM, V219, P627, DOI 10.1111/j.1432-1033.1994.tb19978.x; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; DAUM G, 1982, J BIOL CHEM, V257, P3075; DESAUTELS M, 1982, P NATL ACAD SCI-BIOL, V79, P1869, DOI 10.1073/pnas.79.6.1869; Esser K, 2002, J MOL BIOL, V323, P835, DOI 10.1016/S0022-2836(02)01000-8; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Halperin T, 2001, PLANT MOL BIOL, V45, P461, DOI 10.1023/A:1010677220323; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; Herrmann JM, 1997, EMBO J, V16, P2217, DOI 10.1093/emboj/16.9.2217; Kang SG, 2002, J BIOL CHEM, V277, P21095, DOI 10.1074/jbc.M201642200; Kaser M, 2000, SEMIN CELL DEV BIOL, V11, P181, DOI 10.1006/scdb.2000.0166; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; KUZELA S, 1994, METHOD ENZYMOL, V244, P376; Langer T, 2001, BIOCHEM SOC T, V29, P431, DOI 10.1042/BST0290431; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Lemaire C, 2000, J BIOL CHEM, V275, P23471, DOI 10.1074/jbc.M002045200; Leonhard K, 1996, EMBO J, V15, P4218, DOI 10.1002/j.1460-2075.1996.tb00796.x; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Leonhard K, 1999, NATURE, V398, P348, DOI 10.1038/18704; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Meyer W, 1997, CURR GENET, V31, P401, DOI 10.1007/s002940050222; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; SERIZAWA A, 1995, J BIOL CHEM, V270, P2092, DOI 10.1074/jbc.270.5.2092; Shah ZH, 2000, FEBS LETT, V478, P267, DOI 10.1016/S0014-5793(00)01859-7; Stahl A, 2002, J BIOL CHEM, V277, P41931, DOI 10.1074/jbc.M205500200; SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THOMPSON MW, 1994, J BIOL CHEM, V269, P18209; Truscott KN, 2003, CURR BIOL, V13, pR326, DOI 10.1016/S0960-9822(03)00239-2; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; VANDYCK L, 1994, J BIOL CHEM, V269, P238; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x; WANG N, 1993, P NATL ACAD SCI USA, V90, P11247, DOI 10.1073/pnas.90.23.11247; Weber ER, 1996, MOL BIOL CELL, V7, P307, DOI 10.1091/mbc.7.2.307; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; WENZEL T, 1994, FEBS LETT, V349, P205, DOI 10.1016/0014-5793(94)00665-2; Wolfe MS, 2002, SCIENCE, V296, P2156, DOI 10.1126/science.1073844; Yen MR, 2001, FEMS MICROBIOL LETT, V204, P223, DOI 10.1111/j.1574-6968.2001.tb10889.x; Young L, 2001, SCIENCE, V291, P2135, DOI 10.1126/science.1056957	55	117	120	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46414	46423		10.1074/jbc.M305584200	http://dx.doi.org/10.1074/jbc.M305584200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963738	hybrid			2022-12-27	WOS:000186569400025
J	Petrat, F; Paluch, S; Dogruoz, E; Dorfler, P; Kirsch, M; Korth, HG; Sustmann, R; de Groot, H				Petrat, F; Paluch, S; Dogruoz, E; Dorfler, P; Kirsch, M; Korth, HG; Sustmann, R; de Groot, H			Reduction of Fe(III) ions complexed to physiological ligands by lipoyl dehydrogenase and other flavoenzymes in vitro - Implications for an enzymatic reduction of Fe(III) ions of the labile iron pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; INTRACELLULAR FREE IRON; OXIDATIVE CELL INJURY; MOLECULAR-WEIGHT IRON; CHELATABLE IRON; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; DT-DIAPHORASE; METAL-IONS; DISULFIDE OXIDOREDUCTASES	Enzymatic reduction of physiological Fe(III) complexes of the "labile iron pool" has not been studied so far. By use of spectrophotometric assays based on the oxidation of NAD(P)H and formation of [Fe(II) (1,10-phenanthroline)(3)](2+) as well as by utilizing electron paramagnetic resonance spectrometry, it was demonstrated that the NAD(P)H-dependent flavoenzyme lipoyl dehydrogenase (diaphorase, EC 1.8.1.4) effectively catalyzes the one-electron reduction of Fe(III) complexes of citrate, ATP, and ADP at the expense of the co-enzymes NAD(P) H. Deactivated or inhibited lipoyl dehydrogenase did not reduce the Fe(III) complexes. Likewise, in the absence of NAD(P) H or in the presence of NAD(P)(+), Fe(III) reduction could not be detected. The fact that reduction also occurred in the absence of molecular oxygen as well as in the presence of superoxide dismutase proved that the Fe(III) reduction was directly linked to the enzymatic activity of lipoyl dehydrogenase and not mediated by O-2.. Kinetic studies revealed different affinities of lipoyl dehydrogenase for the reduction of the low molecular weight Fe(III) complexes in the relative order Fe(III)-citrate>Fe(III)-ATP>Fe(III)-ADP (half- maximal velocities at 346-485 muM). These Fe(III) complexes were enzymatically reduced also by other flavoenzymes, namely glutathione reductase (EC 1.6.4.2), cytochrome c reductase (EC 1.6.99.3), and cytochrome P450 reductase (EC 1.6.2.4) with somewhat lower efficacy. The present data suggest a (patho) physiological role for lipoyl dehydrogenase and other flavoenzymes in intracellular iron metabolism.	Univ Klinikum, Inst Physiol Chem, D-45122 Essen, Germany; Univ Duisburg Essen, Inst Organ Chem, D-45117 Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	de Groot, H (corresponding author), Univ Klinikum, Inst Physiol Chem, Hufelandstr 55, D-45122 Essen, Germany.	h.de.groot@uni-essen.de						ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; BALIGA R, 1993, BIOCHEM J, V291, P901, DOI 10.1042/bj2910901; BALLA G, 1990, J LAB CLIN MED, V116, P546; BECKER K, 1995, METHOD ENZYMOL, V251, P173, DOI 10.1016/0076-6879(95)51120-2; BERGMEYER HU, 1983, METHOD ENZYMAT AN, V2, P180; BREUER W, 1995, AM J PHYSIOL-CELL PH, V268, pC1354, DOI 10.1152/ajpcell.1995.268.6.C1354; BREUER W, 1995, J BIOL CHEM, V270, P24209, DOI 10.1074/jbc.270.41.24209; Breuer W, 1997, FEBS LETT, V403, P213, DOI 10.1016/S0014-5793(97)00056-2; Browne P, 1998, FREE RADICAL BIO MED, V24, P1040, DOI 10.1016/S0891-5849(97)00391-2; Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271; CAROTHERS DJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P409, DOI 10.1016/0003-9861(89)90309-3; CEDERBAUM AI, 1989, FREE RADICAL BIO MED, V7, P559, DOI 10.1016/0891-5849(89)90033-6; Cheng IF, 2000, BIOMETALS, V13, P77, DOI 10.1023/A:1009229429250; CHER M, 1955, J AM CHEM SOC, V77, P793, DOI 10.1021/ja01608a086; Colman R, 1971, METHODS ENZYMOL B, V17, P500; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Cowart RE, 2002, ARCH BIOCHEM BIOPHYS, V400, P273, DOI 10.1016/S0003-9861(02)00012-7; CRICHTON R, 2001, INORGANIC BIOCH IRON, P241; Dinkova-Kostova LT, 2000, FREE RADICAL BIO MED, V29, P231, DOI 10.1016/S0891-5849(00)00300-2; EDELHOCH H, 1952, J BIOL CHEM, V197, P97; EVANS PJ, 1994, METHOD ENZYMOL, V233, P82; Fasman G.D., 1976, HDB BIOCH MOL BIOL, VI, P123; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; FUNKHOUSER EA, 1976, EUR J BIOCHEM, V66, P225, DOI 10.1111/j.1432-1033.1976.tb10511.x; GREER S, 1986, BIOCHEMISTRY-US, V25, P2736, DOI 10.1021/bi00357a069; Gurgueira SA, 1996, J BIOL CHEM, V271, P13616, DOI 10.1074/jbc.271.23.13616; Haas E, 1940, J BIOL CHEM, V136, P747; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Haramaki N, 1997, FREE RADICAL BIO MED, V22, P535, DOI 10.1016/S0891-5849(96)00400-5; HARDWICK TJ, 1957, CAN J CHEM, V35, P428, DOI 10.1139/v57-062; HEALING G, 1990, BIOCHEM PHARMACOL, V39, P1239, DOI 10.1016/0006-2952(90)90269-Q; Henle ES, 1997, J BIOL CHEM, V272, P19095, DOI 10.1074/jbc.272.31.19095; HORNIG D, 1975, ANN NY ACAD SCI, V258, P103, DOI 10.1111/j.1749-6632.1975.tb29271.x; Huang A, 2000, J BIOL CHEM, V275, P17399, DOI 10.1074/jbc.M002248200; IDE S, 1967, J BIOL CHEM, V242, P54; JONAS SK, 1991, CELL BIOCHEM FUNCT, V9, P245, DOI 10.1002/cbf.290090406; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kakhlon O, 2001, BLOOD, V97, P2863, DOI 10.1182/blood.V97.9.2863; Karczewski JM, 1999, BIOCHEM PHARMACOL, V57, P27, DOI 10.1016/S0006-2952(98)00288-3; KENNEY WC, 1972, EUR J BIOCHEM, V28, P253, DOI 10.1111/j.1432-1033.1972.tb01908.x; KOZLOV AV, 1992, FREE RADICAL BIO MED, V13, P9, DOI 10.1016/0891-5849(92)90159-E; Lehnen-Beyel I, 2002, BIOCHEM J, V368, P517, DOI 10.1042/BJ20020639; MAHLER HR, 1955, METHOD ENZYMOL, V2, P688, DOI 10.1016/S0076-6879(55)02284-2; MASSEY V, 1961, BIOCHIM BIOPHYS ACTA, V48, P33, DOI 10.1016/0006-3002(61)90512-1; MASSEY V, 1962, J BIOL CHEM, V237, P3820; MASSEY V, 1960, BIOCHIM BIOPHYS ACTA, V37, P314, DOI 10.1016/0006-3002(60)90239-0; MILLER DM, 1989, ARCH BIOCHEM BIOPHYS, V271, P113, DOI 10.1016/0003-9861(89)90261-0; Ollinger K, 1997, J BIOL CHEM, V272, P23707, DOI 10.1074/jbc.272.38.23707; Petrat F, 1999, HEPATOLOGY, V29, P1171, DOI 10.1002/hep.510290435; Petrat F, 2000, ARCH BIOCHEM BIOPHYS, V376, P74, DOI 10.1006/abbi.2000.1711; Petrat F, 2002, BIOCHEM J, V362, P137, DOI 10.1042/0264-6021:3620137; Petrat F, 2002, BIOL CHEM, V383, P489, DOI 10.1515/BC.2002.051; Petrat F, 2001, BIOCHEM J, V356, P61, DOI 10.1042/0264-6021:3560061; Pierre JL, 2000, BIOMETALS, V13, P91, DOI 10.1023/A:1009225701332; Pierre JL, 2002, BIOMETALS, V15, P341, DOI 10.1023/A:1020259021641; PILBROW JR, 1990, TRANSITION ION ELECT, P135; PREUSCH PC, 1991, FREE RADICAL BIO MED, V11, P77, DOI 10.1016/0891-5849(91)90191-5; Puskas F, 2000, FASEB J, V14, P1352, DOI 10.1096/fj.14.10.1352; Qian SY, 1999, FREE RADICAL BIO MED, V26, P1447, DOI 10.1016/S0891-5849(99)00002-7; Rauen U, 2000, FASEB J, V14, P1953, DOI 10.1096/fj.00-0071com; REED J, 1970, J BIOL CHEM, V245, P5297; REINKE LA, 1995, ARCH BIOCHEM BIOPHYS, V316, P758, DOI 10.1006/abbi.1995.1101; SCHIERBEEK AJ, 1983, J MOL BIOL, V165, P563, DOI 10.1016/S0022-2836(83)80221-6; SEARLS RL, 1961, J BIOL CHEM, V236, P2317; SERGENT O, 1995, BIOL TRACE ELEM RES, V47, P185, DOI 10.1007/BF02790116; SEVANIAN A, 1990, FREE RADICAL BIO MED, V8, P145, DOI 10.1016/0891-5849(90)90087-Y; SHI XL, 1990, FEBS LETT, V276, P189, DOI 10.1016/0014-5793(90)80539-U; Smith R. M., 1990, CRITICAL STABILITY C, V2, P251; SRERE PA, 1967, SCIENCE, V158, P936, DOI 10.1126/science.158.3803.936; Staubli A, 1998, AM J PHYSIOL-GASTR L, V274, pG1031, DOI 10.1152/ajpgi.1998.274.6.G1031; STEINMAN CR, 1967, J BIOL CHEM, V242, P5019; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Straub FB, 1939, BIOCHEM J, V33, P787, DOI 10.1042/bj0330787; VANDOP C, 1977, J BIOL CHEM, V252, P1303; VOOGD A, 1992, J CLIN INVEST, V90, P2050, DOI 10.1172/JCI116086; WEAVER J, 1989, BIOCHEM J, V261, P787, DOI 10.1042/bj2610787; WEAVER J, 1993, BRIT J HAEMATOL, V83, P138, DOI 10.1111/j.1365-2141.1993.tb04644.x; Welch KD, 2002, ARCH BIOCHEM BIOPHYS, V397, P360, DOI 10.1006/abbi.2001.2694; Welch KD, 2002, FREE RADICAL BIO MED, V32, P577, DOI 10.1016/S0891-5849(02)00760-8; WILLIAMS CH, 1976, CHEM BIOCH FLAVOENZY, V3, P121; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200; YEGOROV DY, 1993, FREE RADICAL BIO MED, V15, P565, DOI 10.1016/0891-5849(93)90158-Q; Young Stephen P., 1994, P597; Zager RA, 1998, KIDNEY INT, V53, P1661, DOI 10.1046/j.1523-1755.1998.00919.x	86	59	61	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46403	46413		10.1074/jbc.M305291200	http://dx.doi.org/10.1074/jbc.M305291200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963736	hybrid			2022-12-27	WOS:000186569400024
J	Sanchez, T; Estrada-Hernandez, T; Paik, JH; Wu, MT; Venkataraman, K; Brinkmann, V; Claffey, K; Hla, T				Sanchez, T; Estrada-Hernandez, T; Paik, JH; Wu, MT; Venkataraman, K; Brinkmann, V; Claffey, K; Hla, T			Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; SPHINGOSINE 1-PHOSPHATE; FUNCTIONAL-CHARACTERIZATION; SPHINGOLIPID METABOLISM; DIFFERENTIAL REGULATION; LYMPHOCYTE TRAFFICKING; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; KINASE; EDG-1	FTY720, a potent immunosuppressive agent, is phosphorylated in vivo into FTY720-P, a high affinity agonist for sphingosine 1-phosphate (S1P) receptors. The effects of FTY720 on vascular cells, a major target of S1P action, have not been addressed. We now report the metabolic activation of FTY720 by sphingosine kinase-2 and potent activation of vascular endothelial cell functions in vitro and in vivo by phosphorylated FTY720 (FTY720-P). Incubation of endothelial cells with FTY720 resulted in phosphorylation by sphingosine kinase activity and formation of FTY720-P. Sphingosine kinase-2 effectively phosphorylated FTY720 in the human embryonic kidney 293T heterologous expression system. FTY720-P treatment of endothelial cells stimulated extracellular signal-activated kinase and Akt phosphorylation and adherens junction assembly and promoted cell survival. The effects of FTY720-P were inhibited by pertussis toxin, suggesting the requirement for G(i)-coupled S1P receptors. Indeed, transmonolayer permeability induced by vascular endothelial cell growth factor was potently reversed by FTY720-P. Furthermore, oral FTY720 administration in mice potently blocked VEGF-induced vascular permeability in vivo. These findings suggest that FTY720 or its analogs may find utility in the therapeutic regulation of vascular permeability, an important process in angiogenesis, inflammation, and pathological conditions such as sepsis, hypoxia, and solid tumor growth.	Univ Connecticut, Ctr Hlth, Dept Cell Biol, Ctr Vasc Biol, Farmington, CT 06030 USA; Novartis Inst Biomed Res, Dept Transplantat & Immunol, Basel, Switzerland	University of Connecticut; Novartis	Hla, T (corresponding author), Univ Connecticut, Ctr Hlth, Dept Cell Biol, Ctr Vasc Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	hla@nso2.uchc.edu	Hla, Timothy/G-5873-2012; Venktaraman, Krishnan/U-5460-2019	Hla, Timothy/0000-0001-8355-4065; 	NCI NIH HHS [CA 64436] Funding Source: Medline; NHLBI NIH HHS [HL 70694, HL 67330] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA064436, R01CA064436] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070694, R37HL067330, R01HL067330] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ancellin N, 1999, J BIOL CHEM, V274, P18997, DOI 10.1074/jbc.274.27.18997; Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; Avirutnan P, 1998, J IMMUNOL, V161, P6338; Biedermann BC, 2002, LANCET, V359, P2078, DOI 10.1016/S0140-6736(02)08907-9; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2002, CURR OPIN IMMUNOL, V14, P569, DOI 10.1016/S0952-7915(02)00374-6; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; CORONEOS E, 1995, J BIOL CHEM, V270, P23305, DOI 10.1074/jbc.270.40.23305; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Esser S, 1998, J CELL SCI, V111, P1853; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; GIMBRONE MA, 1969, NATURE, V222, P33, DOI 10.1038/222033a0; Heringdorf DM, 1999, FEBS LETT, V461, P217, DOI 10.1016/S0014-5793(99)01463-5; HLA T, 1990, J BIOL CHEM, V265, P9308; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Hordijk PL, 1999, J CELL SCI, V112, P1915; Hotchkiss RS, 2002, CRIT CARE MED, V30, pS225, DOI 10.1097/00003246-200205001-00009; Huang MC, 2002, BBA-MOL CELL BIOL L, V1582, P161, DOI 10.1016/S1388-1981(02)00151-8; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; Im DS, 2003, TRENDS PHARMACOL SCI, V24, P2, DOI 10.1016/S0165-6147(02)00012-3; Jenison S, 1995, Semin Respir Infect, V10, P259; Koshiba T, 2003, TRANSPLANTATION, V75, P945, DOI 10.1097/01.TP0000058469.38572.10; Koshiba T, 2002, TRANSPLANT P, V34, P748, DOI 10.1016/S0041-1345(01)02901-3; Le Stunff H, 2002, J BIOL CHEM, V277, P8920, DOI 10.1074/jbc.M109968200; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu H, 2002, PROG NUCLEIC ACID RE, V71, P493, DOI 10.1016/S0079-6603(02)71049-0; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; MCMILLAN DE, 1984, MICROCIRC ENDOTH LYM, V1, P3; Morales-Ruiz M, 2001, J BIOL CHEM, V276, P19672, DOI 10.1074/jbc.M009993200; Nava VE, 2000, FEBS LETT, V473, P81, DOI 10.1016/S0014-5793(00)01510-6; NikolovaKarakashian M, 1997, J BIOL CHEM, V272, P18718, DOI 10.1074/jbc.272.30.18718; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Shu XD, 2002, MOL CELL BIOL, V22, P7758, DOI 10.1128/MCB.22.22.7758-7768.2002; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Sukocheva OA, 2003, MOL ENDOCRINOL, V17, P2002, DOI 10.1210/me.2003-0119; Van Brocklyn JR, 2000, BLOOD, V95, P2624; Van Brocklyn JR, 1999, J BIOL CHEM, V274, P4626, DOI 10.1074/jbc.274.8.4626; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Wong ML, 2000, P NATL ACAD SCI USA, V97, P8681, DOI 10.1073/pnas.150098097; Xia P, 1998, P NATL ACAD SCI USA, V95, P14196, DOI 10.1073/pnas.95.24.14196; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499; Yanagawa Y, 1998, J IMMUNOL, V160, P5493; Yang LB, 1999, BRIT J HAEMATOL, V107, P282, DOI 10.1046/j.1365-2141.1999.01697.x; Yatomi Y, 1997, J BIOL CHEM, V272, P5291, DOI 10.1074/jbc.272.8.5291; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193	57	320	347	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47281	47290		10.1074/jbc.M306896200	http://dx.doi.org/10.1074/jbc.M306896200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12954648	hybrid			2022-12-27	WOS:000186569400130
J	Yagi, M; Sakurai, K; Kalidas, C; Batt, CA; Goto, Y				Yagi, M; Sakurai, K; Kalidas, C; Batt, CA; Goto, Y			Reversible unfolding of bovine beta-lactoglobulin mutants without a free thiol group	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOMER-DIMER EQUILIBRIUM; CONFORMATIONAL STABILITY; INTERMEDIATE; SHEET; STABILIZATION; DISSOCIATION; TRANSITION; PH	Bovine beta-lactoglobulin (beta-lg) has been used extensively as a model for studying protein folding. One of the problems preventing clarification of the folding mechanism is the incomplete reversibility from the unfolded state, probably caused by the thiol-disulfide exchange between a free thiol at Cys-121 and two disulfide bonds. We constructed and expressed three beta-lg subtype A mutants in which Cys-121 was replaced by Ala, Ser, or Val (i.e. C121A, C121S, and C121V). We studied the reversibilities of these mutants from urea denaturation using circular dichroism, tryptophan fluorescence, reversed-phase and gel-filtration high performance liquid chromatographies, and SDS-PAGE. The folded structure of each mutant was similar to that of wild-type beta-lg. Urea-induced unfolding at pH 7.0 and 3.0 showed that although the C121S mutation notably decreases the stability, the destabilizing effects of the C121A and C121V mutations are less severe. For all of the mutants, complete refolding from the unfolded state in 8 M urea at both pH 7.0 and 3.0 was observed. Kinetics of the formation of the irreversibly unfolded species of wild-type beta-lg in 8 M urea at pH 7.0 indicated that, first, an intramolecular thiol-disulfide exchange occurs to produce a mixture of species with non-native disulfide bonds followed by the intermolecular thiol-disulfide exchange producing the oligomers. These results indicate that intramolecular and intermolecular thiol-disulfide exchange reactions cause the low reversibility of wild-type beta-lg especially at neutral pH and that the mutation of Cys-121 improves the reversibility, enabling us to study the folding of beta-lg more exactly under various conditions.	Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; Japan Sci Corp, CREST, Suita, Osaka 5650871, Japan; Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; Cornell Univ, Nanobiotechnol Ctr, Ithaca, NY 14853 USA	Osaka University; Japan Science & Technology Agency (JST); Cornell University; Cornell University	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp						Apenten RKO, 1998, INT J BIOL MACROMOL, V23, P19, DOI 10.1016/S0141-8130(98)00008-7; Brownlow S, 1997, STRUCTURE, V5, P481, DOI 10.1016/S0969-2126(97)00205-0; Burova TV, 1998, PROTEIN ENG, V11, P1065, DOI 10.1093/protein/11.11.1065; Carrotta R, 2001, PROTEIN SCI, V10, P1312, DOI 10.1110/ps.42501; CHO YJ, 1994, PROTEIN ENG, V7, P263, DOI 10.1093/protein/7.2.263; Cohen FE, 1999, J MOL BIOL, V293, P313, DOI 10.1006/jmbi.1999.2990; Croguennec T, 2003, BIOCHEM BIOPH RES CO, V301, P465, DOI 10.1016/S0006-291X(02)02997-2; CUPO JF, 1983, BIOCHEMISTRY-US, V22, P2654, DOI 10.1021/bi00280a010; Forge V, 2000, J MOL BIOL, V296, P1039, DOI 10.1006/jmbi.1999.3515; Fujiwara K, 1999, BIOCHEMISTRY-US, V38, P4455, DOI 10.1021/bi982683p; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRIKO YV, 1994, BIOPHYS J, V67, P356, DOI 10.1016/S0006-3495(94)80488-6; Hamada D, 1996, NAT STRUCT BIOL, V3, P868, DOI 10.1038/nsb1096-868; Hamada D, 1997, J MOL BIOL, V269, P479, DOI 10.1006/jmbi.1997.1055; HAMADA D, 1995, J MOL BIOL, V254, P737, DOI 10.1006/jmbi.1995.0651; Hambling S. G., 1992, ADV DAIRY CHEM, V1, P141; Kim TR, 1997, PROTEIN ENG, V10, P1339, DOI 10.1093/protein/10.11.1339; Kontopidis G, 2002, J MOL BIOL, V318, P1043, DOI 10.1016/S0022-2836(02)00017-7; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuroda Y, 1996, FOLD DES, V1, P255, DOI 10.1016/S1359-0278(96)00039-9; Kuwata K, 2001, NAT STRUCT BIOL, V8, P151, DOI 10.1038/84145; Kuwata K, 1999, PROTEIN SCI, V8, P2541; Kuwata K, 1998, J MOL BIOL, V283, P731, DOI 10.1006/jmbi.1998.2117; MILLS OE, 1975, BIOCHIM BIOPHYS ACTA, V379, P618, DOI 10.1016/0005-2795(75)90168-3; PACE CN, 1990, TRENDS BIOCHEM SCI, V15, P14, DOI 10.1016/0968-0004(90)90124-T; Qin BY, 1998, FEBS LETT, V438, P272, DOI 10.1016/S0014-5793(98)01199-5; Qin BY, 1998, BIOCHEMISTRY-US, V37, P14014, DOI 10.1021/bi981016t; Ragona L, 1999, J MOL BIOL, V293, P953, DOI 10.1006/jmbi.1999.3191; Ragona L, 2002, BIOCHEMISTRY-US, V41, P2786, DOI 10.1021/bi011615r; Renard D, 1998, INT J BIOL MACROMOL, V22, P41, DOI 10.1016/S0141-8130(97)00086-X; Sakai K, 2000, PROTEIN SCI, V9, P1719; Sakurai K, 2002, J BIOL CHEM, V277, P25735, DOI 10.1074/jbc.M203659200; Sakurai K, 2001, PROTEIN SCI, V10, P2325, DOI 10.1110/ps.17001; Sawyer L, 2000, BBA-PROTEIN STRUCT M, V1482, P136, DOI 10.1016/S0167-4838(00)00160-6; Schokker EP, 1999, INT DAIRY J, V9, P791, DOI 10.1016/S0958-6946(99)00148-X; SHIRAKI K, 1995, J MOL BIOL, V245, P180, DOI 10.1006/jmbi.1994.0015; Surroca Y, 2002, J CHROMATOGR A, V970, P275, DOI 10.1016/S0021-9673(02)00884-1; TELLER DC, 1969, ANN NY ACAD SCI, V164, P66, DOI 10.1111/j.1749-6632.1969.tb14033.x; Uhrinova S, 2000, BIOCHEMISTRY-US, V39, P3565, DOI 10.1021/bi992629o; Wal JM, 1998, ALLERGY, V53, P1013, DOI 10.1111/j.1398-9995.1998.tb03811.x; Yamasaki R, 1999, J MOL BIOL, V292, P965, DOI 10.1006/jmbi.1999.3129; ZIMMERMAN JK, 1970, ARCH BIOCHEM BIOPHYS, V138, P101, DOI 10.1016/0003-9861(70)90289-4	42	52	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47009	47015		10.1074/jbc.M308592200	http://dx.doi.org/10.1074/jbc.M308592200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963719	hybrid			2022-12-27	WOS:000186569400096
J	Ghirlando, R; Trainor, CD				Ghirlando, R; Trainor, CD			Determinants of GATA-1 binding to DNA - The role of non-finger residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; PROTEIN-PROTEIN INTERACTION; IN-VIVO; ZINC-FINGER; MEGAKARYOCYTIC CELLS; REGULATORY ELEMENT; SELF-ASSOCIATION; CUTTING EDGE; N-FINGER; COMPLEX	Mammalian GATA transcription factors are expressed in various tissues in a temporally regulated manner. The prototypic member, GATA-1, is required for normal erythroid, megakaryocytic, and mast cell development. This family of DNA-binding proteins recognizes a consensus (A/T) GATA(A/G) motif and possesses homologous DNA binding domains consisting of two zinc fingers. The C-terminal finger of GATA-1 recognizes the consensus motif with nanomolar affinities, whereas the N-terminal finger shows a binding preference for a GATC motif, albeit with much reduced affinity (K(d)approximate tomuM). The N-terminal finger of GATA-2 also shows a preference for an AGATCT binding site, with an increased affinity attributed to N- and C-terminal flanking basic residues (K(d)approximate tonM). To understand the differences in the binding specificities of the N- and C-terminal zinc fingers of GATA-1, we have constructed a series of swapped domain peptides. We show that the specificity for AGATAA over AGATCT arises from the C-terminal non-finger basic domain. Thus, the N- terminal finger binds preferentially to AGATAA once appended to the C-terminal arm of the C-terminal finger. We further show that this specificity arises from the highly conserved QTRNRK residues. The converse is, however, untrue in the case of the C-terminal finger; swapping of QTRNRK with the corresponding LVSKRA does not switch the DNA binding specificity from AGATAA to AGATCT. These results highlight the important role of residues adjacent to the CXXCX(17)CNAC zinc finger motif (i.e. non-finger residues) in the specific recognition of DNA residues.	NIDDK, Mol Biol Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ghirlando, R (corresponding author), NIDDK, Mol Biol Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.		Ghirlando, Rodolfo/A-8880-2009		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK011005, ZIADK011005] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boyes J, 1998, J MOL BIOL, V279, P529, DOI 10.1006/jmbi.1998.1783; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Chen ML, 2001, EUR J IMMUNOL, V31, P1696, DOI 10.1002/1521-4141(200106)31:6<1696::AID-IMMU1696>3.3.CO;2-E; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; CROSSLEY M, 1995, MOL CELL BIOL, V15, P2448; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Eisbacher M, 2003, MOL CELL BIOL, V23, P3427, DOI 10.1128/MCB.23.10.3427-3441.2003; EVANS T, 1991, MOL CELL BIOL, V11, P843, DOI 10.1128/MCB.11.2.843; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Ghirlando R, 2000, J BIOL CHEM, V275, P28152; HANNON R, 1991, P NATL ACAD SCI USA, V88, P3004, DOI 10.1073/pnas.88.8.3004; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Lowry JA, 2000, J MOL EVOL, V50, P103, DOI 10.1007/s002399910012; Mackay JP, 1998, J BIOL CHEM, V273, P30560, DOI 10.1074/jbc.273.46.30560; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; Mead PE, 2001, DEVELOPMENT, V128, P2301; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Migliaccio AR, 2003, J EXP MED, V197, P281, DOI 10.1084/jem.20021149; Newton A, 2001, J BIOL CHEM, V276, P35794, DOI 10.1074/jbc.M106256200; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Ohneda K, 2002, GENES CELLS, V7, P1243, DOI 10.1046/j.1365-2443.2002.00595.x; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; OMICHINSKI JG, 1993, P NATL ACAD SCI USA, V90, P1676, DOI 10.1073/pnas.90.5.1676; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; Pedone PV, 1997, EMBO J, V16, P2874, DOI 10.1093/emboj/16.10.2874; SCHWARTZBAUER G, 1992, NUCLEIC ACIDS RES, V20, P4429, DOI 10.1093/nar/20.17.4429; Shimizu R, 2001, EMBO J, V20, P5250, DOI 10.1093/emboj/20.18.5250; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Starich MR, 1998, J MOL BIOL, V277, P605, DOI 10.1006/jmbi.1998.1625; Takahashi S, 1998, BLOOD, V92, P434, DOI 10.1182/blood.V92.2.434.414k24_434_442; Takemoto N, 2002, J IMMUNOL, V169, P4103, DOI 10.4049/jimmunol.169.8.4103; Trainor CD, 2000, J BIOL CHEM, V275, P28157; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; Vyas P, 1999, DEVELOPMENT, V126, P2799; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Waltzer L, 2002, EMBO J, V21, P5477, DOI 10.1093/emboj/cdf545; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; WHYATT DJ, 1993, EMBO J, V12, P4993, DOI 10.1002/j.1460-2075.1993.tb06193.x; YANG HY, 1995, MOL CELL BIOL, V15, P1353; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Yu CN, 2002, BLOOD, V100, P2040, DOI 10.1182/blood-2002-02-0387; Zhang DH, 1998, J IMMUNOL, V161, P3817	46	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45620	45628		10.1074/jbc.M306410200	http://dx.doi.org/10.1074/jbc.M306410200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12941967	hybrid			2022-12-27	WOS:000186452300071
J	Hassa, PO; Buerki, C; Lombardi, C; Imhof, R; Hottiger, MO				Hassa, PO; Buerki, C; Lombardi, C; Imhof, R; Hottiger, MO			Transcriptional coactivation of nuclear factor-kappa B-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSACTIVATION DOMAIN; RIBOSE POLYMERASE; IMMUNE-RESPONSES; BINDING PROTEIN; ENDOTOXIC-SHOCK; P50 SUBUNIT; ACTIVATION; MICE; PARP; P65	Nuclear factor kappaB (NF-kappaB) plays an important role in the transcriptional regulation of genes involved in inflammation and cell survival. In this study, we demonstrated that NF-kappaB-dependent gene expression was inhibited by E1A in poly(ADP)- ribose polymerase-1 knock out (PARP-1 (-/-)) cells complemented with wild type PARP-1 after tumor necrosis factor alpha (TNFalpha) or lipopolysaccharide (LPS) treatment. PARP-1 and p300 synergistically coactivated NF-kappaB-dependent gene expression in response to TNFalpha and LPS. Furthermore, PARP-1 interacted directly with p300 and enhanced the interaction of NF-kappaB1/p50 to p300. The C terminus, harboring the catalytic domain of PARP-1 but not its enzymatic activity, was required for complete transcriptional coactivation of NF-kappaB by p300 in response to TNFalpha and LPS. Together, these results indicate that PARP-1 acts synergistically with p300 and plays an essential regulatory role in NF-kappaB-dependent gene expression.	Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland	University of Zurich	Hottiger, MO (corresponding author), Univ Zurich, Inst Vet Biochem & Mol Biol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		Hottiger, Michael O./J-7747-2013	Hottiger, Michael O./0000-0002-7323-2270				Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bauer PI, 2001, FEBS LETT, V506, P239, DOI 10.1016/S0014-5793(01)02919-2; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Felzien LK, 1999, MOL CELL BIOL, V19, P4241; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Goodman RH, 2000, GENE DEV, V14, P1553; Guermah M, 1998, MOL CELL BIOL, V18, P3234, DOI 10.1128/MCB.18.6.3234; Hasan S, 2001, MOL CELL, V7, P1221, DOI 10.1016/S1097-2765(01)00272-6; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Kaiser K, 1996, TRENDS BIOCHEM SCI, V21, P342, DOI 10.1016/S0968-0004(96)10043-8; Kannan P, 1999, NUCLEIC ACIDS RES, V27, P866, DOI 10.1093/nar/27.3.866; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; KARIN M, 1998, CANC J SCI AM S1, V4, P92; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Mabley JG, 2001, BRIT J PHARMACOL, V133, P909, DOI 10.1038/sj.bjp.0704156; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Meisterernst M, 1997, P NATL ACAD SCI USA, V94, P2261, DOI 10.1073/pnas.94.6.2261; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Paal K, 1997, NUCLEIC ACIDS RES, V25, P1050, DOI 10.1093/nar/25.5.1050; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Perkins ND, 1997, INT J BIOCHEM CELL B, V29, P1433, DOI 10.1016/S1357-2725(97)00088-5; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; SCHMITZ ML, 1995, J BIOL CHEM, V270, P7219, DOI 10.1074/jbc.270.13.7219; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Szabo C, 1997, J CLIN INVEST, V100, P723, DOI 10.1172/JCI119585; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Yamit-Hezi A, 1998, EMBO J, V17, P5161, DOI 10.1093/emboj/17.17.5161; Yamit-Hezi E, 2000, J BIOL CHEM, V275, P18180, DOI 10.1074/jbc.275.24.18180; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	47	193	198	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45145	45153		10.1074/jbc.M307957200	http://dx.doi.org/10.1074/jbc.M307957200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12960163	hybrid			2022-12-27	WOS:000186452300014
J	Hess, A; Wijayanti, N; Neuschafer-Rube, AP; Katz, N; Kietzmann, T; Immenschuh, S				Hess, A; Wijayanti, N; Neuschafer-Rube, AP; Katz, N; Kietzmann, T; Immenschuh, S			Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; THIOL-SPECIFIC ANTIOXIDANT; HEME OXYGENASE-1 GENE; OXIDATIVE STRESS; TRANSCRIPTIONAL REGULATION; MAMMALIAN PEROXIREDOXIN; THIOREDOXIN PEROXIDASE; TRANSDUCTION PATHWAY; HYDROGEN-PEROXIDE; CELLS	The antioxidant protein peroxiredoxin (Prx) I is a thioredoxin peroxidase that is involved in the regulation of proliferation and differentiation of mammalian cells. Here, it is shown that Prx I gene expression was induced transcriptionally by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) in cultured rat liver tissue macrophages and RAW264.7 monocytic cells. TPA-dependent induction of Prx I gene expression was mediated by two proximal activator protein-1 sites of the rat Prx I promoter region that were nuclear targets of c-Jun as determined by transfection studies with luciferase reporter gene constructs and electrophoretic mobility shift assays. The transcription factor Nrf2, however, was not involved in the regulation of Prx I promoter activity. Prx I gene induction by TPA was decreased by protein kinase C inhibitors and overexpressed dominant negative forms of Ras and MEKK1, but not Raf-1. The p38 MAPK inhibitor SB202190 and overexpression of dominant negative mutants of MAPK kinase 4 (MKK4), MKK6, and p38 inhibited the TPA-dependent induction of Prx I gene transcription. In contrast, inhibitors of the JNK, SP600125, and the NF-kappaB signaling pathway, caffeic acid phenethyl ester, respectively, as well as overexpressed dominant negative MKK7 and IkappaB, had no effect on the up-regulation of Prx I reporter gene activity by TPA. Cotransfection of wild-type p38alpha and p38beta, but not that of p38gamma and p38delta, increased Prx I promoter activity. The data indicate that a protein kinase C, Ras, MEKK1, p38 MAPK signaling pathway plays a major role for the transcriptional up-regulation of Prx I gene expression.	Univ Giessen, Inst Klin Chem & Pathobiochem, D-35392 Giessen, Germany; Univ Gottingen, Inst Biochem & Mol Zellbiol, D-37073 Gottingen, Germany	Justus Liebig University Giessen; University of Gottingen	Immenschuh, S (corresponding author), Univ Giessen, Inst Klin Chem & Pathobiochem, Gaffkystr 11, D-35392 Giessen, Germany.		Immenschuh, Stephan/AAM-9181-2020	Immenschuh, Stephan/0000-0003-3722-5791; Kietzmann, Thomas/0000-0003-0242-8636; Wijayanti, Nastiti/0000-0001-6483-2816				Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Carter AB, 2001, J BIOL CHEM, V276, P33826, DOI 10.1074/jbc.M100209200; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Immenschuh S, 1999, HEPATOLOGY, V30, P118, DOI 10.1002/hep.510300142; IMMENSCHUH S, 1995, BIOCHEMISTRY-US, V34, P13407, DOI 10.1021/bi00041a018; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; ISHII T, 1993, J BIOL CHEM, V268, P18633; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; JENNER P, 1994, LANCET, V344, P796, DOI 10.1016/S0140-6736(94)92347-7; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kietzmann T, 2003, J BIOL CHEM, V278, P17927, DOI 10.1074/jbc.M203929200; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; KNOOK DL, 1976, EXP CELL RES, V99, P444, DOI 10.1016/0014-4827(76)90605-4; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee HW, 2002, J BIOL CHEM, V277, P32624, DOI 10.1074/jbc.M200353200; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Li BJ, 2002, J BIOL CHEM, V277, P12418, DOI 10.1074/jbc.M111443200; Majumdar S, 2002, J IMMUNOL, V168, P2644, DOI 10.4049/jimmunol.168.6.2644; Mayo MW, 2001, METHOD ENZYMOL, V333, P73; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Oberley TD, 2002, AM J PATHOL, V160, P403, DOI 10.1016/S0002-9440(10)64857-2; Pramanik R, 2003, J BIOL CHEM, V278, P4831, DOI 10.1074/jbc.M207732200; PROSPERI MT, 1993, J BIOL CHEM, V268, P11050; PROSPERI MT, 1994, GENOMICS, V19, P236, DOI 10.1006/geno.1994.1053; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rebollo A, 1999, BLOOD, V94, P2971, DOI 10.1182/blood.V94.9.2971.421k43_2971_2980; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Simon C, 2001, EXP CELL RES, V271, P344, DOI 10.1006/excr.2001.5374; SIOW RCM, 1995, FEBS LETT, V368, P239, DOI 10.1016/0014-5793(95)00650-X; Takahashi H, 1998, J BIOL CHEM, V273, P17375, DOI 10.1074/jbc.273.28.17375; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wong WK, 2002, J BIOL CHEM, V277, P22222, DOI 10.1074/jbc.M202844200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	51	39	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45419	45434		10.1074/jbc.M307871200	http://dx.doi.org/10.1074/jbc.M307871200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12960165	hybrid			2022-12-27	WOS:000186452300047
J	Le Gall, SM; Auger, R; Dreux, C; Mauduit, P				Le Gall, SM; Auger, R; Dreux, C; Mauduit, P			Regulated cell surface Pro-EGF ectodomain shedding is a zinc metalloprotease-dependent process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; ACTIVATED PROTEIN-KINASE; LACTATING MAMMARY-GLAND; TGF-ALPHA; CONVERTING-ENZYME; MEMBRANE-PROTEIN; FACTOR PRECURSOR; MESSENGER-RNA; FACTOR CDNA	Epidermal growth factor receptor (EGFR) ligands are synthesized as type I membrane protein precursors exposed at the cell surface. Shedding of the ectodomain of these proteins is the way cells regulate the equilibrium between cell-associated and diffusible forms of these growth factors. Whereas the regulated shedding of transforming growth factor-alpha, HB-EGF, and amphiregulin precursors have been clearly established, regulation of full-length pro-EGF shedding has not been clearly demonstrated. Here, using both wild-type and M2 mutant CHO-K1 as well as HeLa cell lines transiently transfected with epitope-tagged rat pro-EGF expression plasmid, we demonstrate that these cells synthesize EGF as a high molecular weight membrane-associated precursor glycoprotein expressed at the cell surface. All cell lines are able to release the entire ectodomain of pro-EGF in the extracellular medium following juxtamembrane cleavage of the precursor once it is present at the cell surface. More significantly we clearly established that CHO-M2 and HeLa cells only constitutively release low levels of pro-EGF. This shedding is a regulated phenomenon in wild-type CHO cells where it can be induced by different agents such as phorbol 12-myristate 13-acetate (PMA), pervanadate, and serum but not by calcium ionophores. Using specific inhibitors as well as protein kinase C (PKC) depletion, PMA stimulation was shown to be completely dependent on PKC activation whereas pervanadate and serum stimulation were not. Regulated ectodomain shedding involves the activity of a zinc metalloprotease as determined by inhibition with phenantrolin and TAPI-2 and by the results obtained with the CHO-M2 shedding defective mutant cell line. Comparison of the ability of CHO and HeLa cell lines to shed pro-EGF and pro-TNF-alpha upon stimulation greatly suggests that TACE (ADAM 17) may not be the ectoprotease involved in the secretion of pro-EGF ectodomain and that this protease, which remains to be identified, shows a restricted cellular expression pattern.	Univ Paris 11, UMR 819, Inst Biochim Biophys Mol & Cellulaire, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay	Mauduit, P (corresponding author), Univ Paris 11, UMR 819, Inst Biochim Biophys Mol & Cellulaire, F-91405 Orsay, France.	philippe.mauduit@bbmpc.u-psud.fr						Amour A, 2002, FEBS LETT, V524, P154, DOI 10.1016/S0014-5793(02)03047-8; ANKLESARIA P, 1990, P NATL ACAD SCI USA, V87, P3289, DOI 10.1073/pnas.87.9.3289; ARRIBAS J, 1995, J CELL BIOL, V128, P433, DOI 10.1083/jcb.128.3.433; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; BEARDMORE JM, 1983, J ENDOCRINOL, V96, P287, DOI 10.1677/joe.0.0960287; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Borroto A, 2003, J BIOL CHEM, V278, P25933, DOI 10.1074/jbc.M301673200; BRACHMANN R, 1989, CELL, V56, P691, DOI 10.1016/0092-8674(89)90591-6; BREYER JA, 1990, J BIOL CHEM, V265, P16564; BROWN CF, 1989, MOL ENDOCRINOL, V3, P1077, DOI 10.1210/mend-3-7-1077; Brown CL, 1998, J BIOL CHEM, V273, P17258, DOI 10.1074/jbc.273.27.17258; BYYNY RL, 1974, ENDOCRINOLOGY, V95, P776, DOI 10.1210/endo-95-3-776; CARPENTER G, 1985, J CELL SCI, P1; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; COHEN S, 1962, J BIOL CHEM, V237, P1555; Davis-Fleischer KM, 2001, GROWTH FACTORS, V19, P127, DOI 10.3109/08977190109001081; DEMPSEY PJ, 1994, J BIOL CHEM, V269, P16878; Dempsey PJ, 1997, J CELL BIOL, V138, P747, DOI 10.1083/jcb.138.4.747; DERYNCK R, 1992, ADV CANCER RES, V58, P27, DOI 10.1016/S0065-230X(08)60289-4; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Dong JY, 2000, J BIOL CHEM, V275, P557, DOI 10.1074/jbc.275.1.557; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; FISHER DA, 1990, ENDOCR REV, V11, P418, DOI 10.1210/edrv-11-3-418; FISHER DA, 1989, ANNU REV PHYSIOL, V51, P67, DOI 10.1146/annurev.physiol.51.1.67; Gechtman Z, 1999, J BIOL CHEM, V274, P28828, DOI 10.1074/jbc.274.40.28828; GRAY A, 1983, NATURE, V303, P722, DOI 10.1038/303722a0; HAMMERMAN MR, 1993, ANNU REV PHYSIOL, V55, P305, DOI 10.1146/annurev.physiol.55.1.305; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; JAHNKE GD, 1994, ENDOCRINOLOGY, V135, P2022, DOI 10.1210/en.135.5.2022; JORGENSEN PE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P284, DOI 10.1016/0304-4165(91)90165-D; Journe F, 1997, BBA-MOL CELL RES, V1357, P18, DOI 10.1016/S0167-4889(97)00012-8; LAKSHMANAN J, 1992, AM J PHYSIOL, V263, pE142, DOI 10.1152/ajpendo.1992.263.1.E142; LAKSHMANAN J, 1990, BIOCHEM BIOPH RES CO, V173, P902, DOI 10.1016/S0006-291X(05)80871-X; LEE LS, 1981, P NATL ACAD SCI-BIOL, V78, P1042, DOI 10.1073/pnas.78.2.1042; Marechal H, 1999, AM J PHYSIOL-CELL PH, V276, pC734, DOI 10.1152/ajpcell.1999.276.3.C734; Marechal H, 1996, AM J PHYSIOL-CELL PH, V270, pC1164, DOI 10.1152/ajpcell.1996.270.4.C1164; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; MAUDUIT P, 1998, P 13 INT C EY RES PA; MELOCHE S, 1992, MOL BIOL CELL, V3, P63, DOI 10.1091/mbc.3.1.63; Merlos-Suarez A, 1998, J BIOL CHEM, V273, P24955, DOI 10.1074/jbc.273.38.24955; Merlos-Suarez A, 2001, J BIOL CHEM, V276, P48510, DOI 10.1074/jbc.M103488200; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; MROCZKOWSKI B, 1989, MOL CELL BIOL, V9, P2771, DOI 10.1128/MCB.9.7.2771; Nakagawa T, 1996, J BIOL CHEM, V271, P30858, DOI 10.1074/jbc.271.48.30858; NEXO E, 1990, BIOCHIM BIOPHYS ACTA, V1037, P388, DOI 10.1016/0167-4838(90)90041-D; Nishi E, 2001, EMBO J, V20, P3342, DOI 10.1093/emboj/20.13.3342; OHASHI Y, 1989, INVEST OPHTH VIS SCI, V30, P1879; PANDIELLA A, 1991, J BIOL CHEM, V266, P5769; PANDIELLA A, 1991, P NATL ACAD SCI USA, V88, P1726, DOI 10.1073/pnas.88.5.1726; PARRIES G, 1995, J BIOL CHEM, V270, P27954, DOI 10.1074/jbc.270.46.27954; PASQUINI F, 1974, EXP CELL RES, V86, P233, DOI 10.1016/0014-4827(74)90708-3; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; RALL LB, 1985, NATURE, V313, P228, DOI 10.1038/313228a0; ROBERTS ML, 1978, BIOCHIM BIOPHYS ACTA, V540, P246, DOI 10.1016/0304-4165(78)90137-X; SAGGI SJ, 1992, DNA CELL BIOL, V11, P481, DOI 10.1089/dna.1992.11.481; SALIDO EC, 1991, HISTOCHEMISTRY, V96, P65, DOI 10.1007/BF00266763; SCHAUDIES RP, 1990, AM J PHYSIOL, V259, pG1056, DOI 10.1152/ajpgi.1990.259.6.G1056; SCHAUDIES RP, 1993, AM J PHYSIOL, V264, pF523, DOI 10.1152/ajprenal.1993.264.3.F523; SCOTT J, 1983, SCIENCE, V221, P236, DOI 10.1126/science.6602382; SCOTT J, 1985, J CELL SCI, P19; SHING Y, 1993, SCIENCE, V259, P1604, DOI 10.1126/science.8456283; SHOYAB M, 1989, SCIENCE, V269, P234; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Toyoda H, 1995, FEBS LETT, V377, P403, DOI 10.1016/0014-5793(95)01403-9; TSUTSUMI O, 1988, J CLIN INVEST, V81, P1067, DOI 10.1172/JCI113418; VANSETTEN GB, 1989, GRAEFES ARCH CLIN EX, V227, P82; Vecchi M, 1998, J BIOL CHEM, V273, P20589, DOI 10.1074/jbc.273.32.20589; WONG ST, 1989, CELL, V56, P495, DOI 10.1016/0092-8674(89)90252-3	74	63	65	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45255	45268		10.1074/jbc.M307745200	http://dx.doi.org/10.1074/jbc.M307745200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12947092	hybrid			2022-12-27	WOS:000186452300027
J	Rousset, S; Alves-Guerra, MC; Ouadghiri-Bencherif, S; Kozak, LP; Miroux, B; Richard, D; Bouillaud, F; Ricquier, D; Cassard-Doulcier, AM				Rousset, S; Alves-Guerra, MC; Ouadghiri-Bencherif, S; Kozak, LP; Miroux, B; Richard, D; Bouillaud, F; Ricquier, D; Cassard-Doulcier, AM			Uncoupling protein 2, but not uncoupling protein 1, is expressed in the female mouse reproductive tract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCATOR; IN-VIVO; MEMBRANE; OBESITY; CELLS; GENE; UCP1; FAT; MITOCHONDRIA; OVULATION	Uncoupling proteins (UCPs) are transporters of the inner mitochondrial membrane. Whereas UCP1 is uniquely present in brown adipose tissue where it uncouples respiration from ATP synthesis and activates respiration and heat production, UCP2 is present in numerous tissues, and its exact function remains to be clarified. Two sets of data provided the rationale for this study: (i) the intriguing report that UCP1 is present in uterus of mice (Nibbelink, M., Moulin, K., Arnaud, E., Duval, C., Penicaud, L., and Casteilla, L. (2001) J. Biol. Chem. 276, 47291-47295); and (ii) an observation that Ucp2(-/-) female mice (homozygous matings) have smaller litters compared with Ucp2(+/+) animals (S. Rousset and A.-M. Cassard-Doulcier, unpublished observations). These data prompted us to examine the expression of UCP1 and UCP2 in the reproductive tract of female mice. Using wild type, Ucp1(-/-) mice, and Ucp2(-/-) mice, we were unable to detect UCP1 in uterus of mice with appropriate antibodies, and we conclude that the signal assigned to UCP1 by others was neither UCP1 nor UCP2. Using a polyclonal antibody against UCP2 and tissues from Ucp2(-/-) mice as controls, UCP2 was detected in ovary, oviduct, and uterus. Expression of Ucp2 mRNA was also observed in ovary and uterus using in situ hybridization analysis. Bone marrow transplantation experiments revealed that the UCP2 signal of the ovary was restricted to ovarian cells. UCP2 level in ovary decreased during follicular growth and increased during the pre-ovulatory period, during which aspects of an inflammatory process are known to exist. Because UCP2 down-regulates reactive oxygen species, a role in the regulation of inflammatory events linked to the preparation of ovulation is suggested.	Fac Med Necker Enfants Malad, CNRS, Unite Propre Rech 9078, F-75730 Paris 15, France; Univ Laval, Fac Med, Dept Anat & Physiol, Quebec City, PQ G1K 7P4, Canada; Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Laval University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Cassard-Doulcier, AM (corresponding author), Fac Med Necker Enfants Malad, CNRS, Unite Propre Rech 9078, 156 Rue Vaugirard, F-75730 Paris 15, France.	cassard-doulcier@necker.fr	Bouillaud, Frédéric R/L-3238-2017; CASSARD, Anne-Marie/B-6095-2019; Alves-Guerra, Marie-Clotilde/P-4356-2017; Miroux, Bruno/E-9267-2017	Bouillaud, Frédéric R/0000-0002-7518-9237; CASSARD, Anne-Marie/0000-0002-1813-5128; Alves-Guerra, Marie-Clotilde/0000-0002-7918-1216; Miroux, Bruno/0000-0002-3066-4700				AQUILA H, 1985, EMBO J, V4, P2369, DOI 10.1002/j.1460-2075.1985.tb03941.x; Arcuri F, 2001, BIOL REPROD, V64, P1200, DOI 10.1095/biolreprod64.4.1200; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Aten RF, 1998, BIOL REPROD, V59, P1069, DOI 10.1095/biolreprod59.5.1069; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; CANNON B, 1985, ESSAYS BIOCHEM, V20, P110; Cohen PE, 1999, J LEUKOCYTE BIOL, V66, P765, DOI 10.1002/jlb.66.5.765; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; ESPEY LL, 1994, BIOL REPROD, V50, P233, DOI 10.1095/biolreprod50.2.233; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900; HIMMSHAGEN J, 1998, HDB OBESITY, P415; Hofmann WE, 2001, J BIOL CHEM, V276, P12460, DOI 10.1074/jbc.M100466200; Hunt J S, 1998, Dev Immunol, V6, P105, DOI 10.1155/1998/87527; Kizaki T, 2002, P NATL ACAD SCI USA, V99, P9392, DOI 10.1073/pnas.142206299; Kozak LP, 1999, INT J OBESITY, V23, pS33, DOI 10.1038/sj.ijo.0800941; Kozak LP, 2000, ANNU REV NUTR, V20, P339, DOI 10.1146/annurev.nutr.20.1.339; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Larrouy D, 1997, BIOCHEM BIOPH RES CO, V235, P760, DOI 10.1006/bbrc.1997.6852; LEDESMA A, 2002, GENOME BIOL; Machelon V, 1997, EUR CYTOKINE NETW, V8, P137; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; Masaki T, 1999, BBA-MOL CELL BIOL L, V1440, P81, DOI 10.1016/S1388-1981(99)00104-3; Medvedev AV, 2002, J BIOL CHEM, V277, P42639, DOI 10.1074/jbc.M208645200; MIROUX B, 1992, J BIOL CHEM, V267, P13603; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nibbelink M, 2001, J BIOL CHEM, V276, P47291, DOI 10.1074/jbc.M105658200; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Rial E, 1999, EMBO J, V18, P5827, DOI 10.1093/emboj/18.21.5827; Richard D, 1998, J COMP NEUROL, V397, P549; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Sanchis D, 1998, J BIOL CHEM, V273, P34611, DOI 10.1074/jbc.273.51.34611; SCHULTHEISS HP, 1984, BIOCHIM BIOPHYS ACTA, V771, P235, DOI 10.1016/0005-2736(84)90538-8; Shabalina I, 2002, AM J PHYSIOL-GASTR L, V283, pG1107, DOI 10.1152/ajpgi.00193.2002; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Skulachev VP, 1997, BIOSCIENCE REP, V17, P347, DOI 10.1023/A:1027344914565; Vyssokikh MY, 2001, BIOCHEM J, V358, P349, DOI 10.1042/0264-6021:3580349; Yu XX, 2000, FASEB J, V14, P1611, DOI 10.1096/fj.14.11.1611; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	45	28	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45843	45847		10.1074/jbc.M306980200	http://dx.doi.org/10.1074/jbc.M306980200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12941933	hybrid			2022-12-27	WOS:000186452300097
J	Shang, X; Zhou, YT; Low, BC				Shang, X; Zhou, YT; Low, BC			Concerted regulation of cell dynamics by BNIP-2 and Cdc42GAP Homology/Sec14p-like, Proline-rich, and GTPase-activating protein domains of a novel Rho GTPase-activating protein, BPGAP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST MOTILITY; ENA/VASP PROTEINS; BINDING; MIGRATION; ADHESION; FAMILY; RAC; IDENTIFICATION; CYTOSKELETON; STIMULATION	RhoA, Cdc42, and Rac1 are small GTPases that regulate cytoskeletal reorganization leading to changes in cell morphology and cell motility. Their signaling pathways are activated by guanine nucleotide exchange factors and inactivated by GTPase-activating proteins ( GAPs). We have identified a novel RhoGAP, BPGAP1 ( for (B) under bar NIP- 2 and Cdc42GAP Homology (BCH) domain-containing, (P) under bar roline-rich and Cdc42 (GAP) under bar -like protein subtype-(1) under bar), that is ubiquitously expressed and shares 54% sequence identity to Cdc42GAP/p50RhoGAP. BPGAP1 selectively enhanced RhoA GTPase activity in vivo although it also interacted strongly with Cdc42 and Rac1. "Pull- down" and co-immunoprecipitation studies indicated that it formed homophilic or heterophilic complexes with other BCH domain-containing proteins. Fluorescence studies of epitope-tagged BPGAP1 revealed that it induced pseudopodia and increased migration of MCF7 cells. Formation of pseudopodia required its BCH and GAP domains but not the proline-rich region, and was differentially inhibited by coexpression of the constitutively active mutant of RhoA, or dominant negative mutants of Cdc42 and Rac1. However, the mutant without the proline-rich region failed to confer any increase in cell migration despite the induction of pseudopodia. Our findings provide evidence that cell morphology changes and migration are coordinated via multiple domains in BPGAP1 and present a novel mode of regulation for cell dynamics by a RhoGAP protein.	Natl Univ Singapore, Dept Biol Sci, Cell Signaling & Dev Biol Lab, Singapore 117543, Singapore	National University of Singapore	Low, BC (corresponding author), Natl Univ Singapore, Dept Biol Sci, Cell Signaling & Dev Biol Lab, 14 Sci Dr 4, Singapore 117543, Singapore.		Low, Boon Chuan/AAU-7685-2021; Low, Boon Chuan/H-8049-2012	Low, Boon Chuan/0000-0003-0756-096X; Low, Boon Chuan/0000-0003-0756-096X; Zhou, Yi-Ting/0000-0003-4543-3099				Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; BARFOD ET, 1993, J BIOL CHEM, V268, P26059; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Christerson LB, 2002, J CELL PHYSIOL, V192, P200, DOI 10.1002/jcp.10125; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Evers EE, 2000, EUR J CANCER, V36, P1269, DOI 10.1016/S0959-8049(00)00091-5; Fidyk NJ, 2002, BIOCHEMISTRY-US, V41, P15644, DOI 10.1021/bi026413p; Furman C, 2002, J BIOL CHEM, V277, P7962, DOI 10.1074/jbc.M109149200; Gamblin SJ, 1998, CURR OPIN STRUC BIOL, V8, P195, DOI 10.1016/S0959-440X(98)80038-9; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HOMMA Y, 1995, EMBO J, V14, P286, DOI 10.1002/j.1460-2075.1995.tb07002.x; Koo TH, 2002, ONCOGENE, V21, P4080, DOI 10.1038/sj.onc.1205514; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; LANCASTER CA, 1994, J BIOL CHEM, V269, P1137; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Low BC, 1999, J BIOL CHEM, V274, P33123, DOI 10.1074/jbc.274.46.33123; Low BC, 2000, J BIOL CHEM, V275, P14415, DOI 10.1074/jbc.275.19.14415; Low BC, 2000, J BIOL CHEM, V275, P37742, DOI 10.1074/jbc.M004897200; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Moon SY, 2003, J BIOL CHEM, V278, P4151, DOI 10.1074/jbc.M207789200; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Peck J, 2002, FEBS LETT, V528, P27, DOI 10.1016/S0014-5793(02)03331-8; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sekimata M, 1999, J BIOL CHEM, V274, P17757, DOI 10.1074/jbc.274.25.17757; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Wittmann T, 2001, J CELL SCI, V114, P3795; Wu G, 2000, PLANT PHYSIOL, V124, P1625, DOI 10.1104/pp.124.4.1625; Zhou YT, 2002, J BIOL CHEM, V277, P7483, DOI 10.1074/jbc.M109459200; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	40	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45903	45914		10.1074/jbc.M304514200	http://dx.doi.org/10.1074/jbc.M304514200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12944407	hybrid			2022-12-27	WOS:000186452300103
J	Zhang, DW; Gu, HM; Situ, D; Haimeur, A; Cole, SPC; Deeley, RG				Zhang, DW; Gu, HM; Situ, D; Haimeur, A; Cole, SPC; Deeley, RG			Functional importance of polar and charged amino acid residues in transmembrane helix 14 of multidrug resistance protein 1 (MRP1/ABCC1) - Identification of an aspartate residue critical for conversion from a high to low affinity substrate binding state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATE EXPORT PUMP; ATP-BINDING; LEUKOTRIENE C-4; P-GLYCOPROTEIN; PHARMACOLOGICAL CHARACTERIZATION; DRUG-RESISTANCE; LUNG-CANCER; TRANSPORTER SUPERFAMILY; VINCRISTINE TRANSPORT; MONOCLONAL-ANTIBODIES	Human multidrug resistance protein 1 (MRP1) confers resistance to many chemotherapeutic agents and transports diverse conjugated organic anions. We previously demonstrated that Glu(1089) in transmembrane (TM) 14 is critical for the protein to confer anthracycline resistance. We have now assessed the functional importance of all polar and charged amino acids in this TM helix. Asn(1100), Ser(1097), and Lys(1092), which are all predicted to be on the same face of the helix as to Glu1089, are involved in determining the substrate specificity of the protein. Notably, elimination of the positively charged side chain of Lys(1092), increased resistance to the cationic drugs vincristine and doxorubicin, but not the electroneutral drug etoposide (VP-16). In addition, mutations S1097A and N1100A selectively decreased transport of 17beta-estradiol 17-(beta-D-glucuronide) (E(2)17betaG) but not cysteinyl leukotriene 4 (LTC4), demonstrating the importance of multiple residues in this helix in determining substrate specificity. In contrast, mutations of Asp(1084) that eliminate the carboxylate side chain markedly decreased resistance to all drugs tested, as well as transport of both E(2)17betaG and LTC4, despite the fact that LTC4 binding was unaffected. We show that these mutations prevent the ATP-dependent transition of the protein from a high to low affinity substrate binding state and drastically diminish ADP trapping at nucleotide binding domain 2. Based on results presented here and crystal structures of prokaryotic ATP binding cassette transporters, Asp(1084) may be critical for interaction between the cytoplasmic loop connecting TM13 and TM14 and a region of nucleotide binding domain 2 between the conserved Walker A and ABC signature motifs.	Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada; McMaster University; Queens University - Canada; Queens University - Canada; Queens University - Canada	Deeley, RG (corresponding author), Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Suite 300,10 Stuart St, Kingston, ON K7L 3N6, Canada.		Deeley, Roger/J-4828-2012; Cole, Susan P.C./I-6389-2017; Zhang, Dawei/ABD-8990-2022	Cole, Susan P.C./0000-0001-6571-6884; Zhang, Dawei/0000-0001-8279-8041				Bakos E, 1996, J BIOL CHEM, V271, P12322, DOI 10.1074/jbc.271.21.12322; Bera TK, 2001, MOL MED, V7, P509, DOI 10.1007/BF03401856; BREUNINGER LM, 1995, CANCER RES, V55, P5342; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chang G, 2003, J MOL BIOL, V330, P419, DOI 10.1016/S0022-2836(03)00587-4; COLE SPC, 1994, CANCER RES, V54, P5902; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Efferth T, 2001, INT J ONCOL, V19, P367; Filipits M, 1996, CLIN CANCER RES, V2, P1231; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; GRANT CE, 1994, CANCER RES, V54, P357; Hafkemeyer P, 1998, BIOCHEMISTRY-US, V37, P16400, DOI 10.1021/bi980871+; Haimeur A, 2002, J BIOL CHEM, V277, P41326, DOI 10.1074/jbc.M206228200; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Hipfner DR, 1998, BRIT J CANCER, V78, P1134, DOI 10.1038/bjc.1998.642; Hipfner DR, 1999, J BIOL CHEM, V274, P15420, DOI 10.1074/jbc.274.22.15420; Hopper E, 2001, CANCER LETT, V162, P181, DOI 10.1016/S0304-3835(00)00646-7; Hou YX, 2003, J BIOL CHEM, V278, P3599, DOI 10.1074/jbc.M210480200; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Jedlitschky G, 1996, CANCER RES, V56, P988; Kao HH, 2002, GENE, V286, P299, DOI 10.1016/S0378-1119(02)00461-4; Kast C, 1997, J BIOL CHEM, V272, P26479, DOI 10.1074/jbc.272.42.26479; Koike K, 2002, J BIOL CHEM, V277, P49495, DOI 10.1074/jbc.M206896200; Leier I, 1996, BIOCHEM J, V314, P433, DOI 10.1042/bj3140433; LEIER I, 1994, J BIOL CHEM, V269, P27807; Leslie EM, 2001, J BIOL CHEM, V276, P27846, DOI 10.1074/jbc.M102453200; Loe DW, 2000, J PHARMACOL EXP THER, V293, P530; Loe DW, 1996, J BIOL CHEM, V271, P9683, DOI 10.1074/jbc.271.16.9683; Loe DW, 1998, CANCER RES, V58, P5130; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Loo TW, 2002, J BIOL CHEM, V277, P44332, DOI 10.1074/jbc.M208433200; Mao QC, 2000, J BIOL CHEM, V275, P34166, DOI 10.1074/jbc.M004584200; MULLER M, 1994, P NATL ACAD SCI USA, V91, P13033, DOI 10.1073/pnas.91.26.13033; Nooter K, 1997, BRIT J CANCER, V76, P486, DOI 10.1038/bjc.1997.414; Nunoya K, 2003, DRUG METAB DISPOS, V31, P1016, DOI 10.1124/dmd.31.8.1016; Oleschuk CJ, 2003, AM J PHYSIOL-GASTR L, V284, pG280, DOI 10.1152/ajpgi.00331.2002; Payen LF, 2003, J BIOL CHEM, V278, P38537, DOI 10.1074/jbc.M305786200; Qian YM, 2002, J BIOL CHEM, V277, P35225, DOI 10.1074/jbc.M206058200; Qian YM, 2001, J BIOL CHEM, V276, P38636, DOI 10.1074/jbc.M107025200; Qian YM, 2001, J BIOL CHEM, V276, P6404, DOI 10.1074/jbc.M008251200; Rappa G, 1997, CANCER RES, V57, P5232; Ren XQ, 2002, BIOCHEMISTRY-US, V41, P14132, DOI 10.1021/bi026443s; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Song JM, 2001, MOL PHARMACOL, V60, P254, DOI 10.1124/mol.60.2.254; Stride BD, 1999, J BIOL CHEM, V274, P22877, DOI 10.1074/jbc.274.32.22877; Stride BD, 1997, MOL PHARMACOL, V52, P344, DOI 10.1124/mol.52.3.344; Tada Y, 2002, INT J CANCER, V98, P630, DOI 10.1002/ijc.10246; Taguchi Y, 2002, FEBS LETT, V521, P211, DOI 10.1016/S0014-5793(02)02816-8; Tammur J, 2001, GENE, V273, P89, DOI 10.1016/S0378-1119(01)00572-8; UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P8742, DOI 10.1073/pnas.90.18.8742; van der Kolk DM, 2000, CLIN CANCER RES, V6, P3205; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; Yabuuchi H, 2001, BIOCHEM BIOPH RES CO, V288, P933, DOI 10.1006/bbrc.2001.5865; Yokoyama Y, 1999, J Obstet Gynaecol Res, V25, P387; Young LC, 2001, CLIN CANCER RES, V7, P1798; Young LC, 1999, CLIN CANCER RES, V5, P673; ZAMAN GJR, 1994, P NATL ACAD SCI USA, V91, P8822, DOI 10.1073/pnas.91.19.8822; Zhang DW, 2003, BIOCHEMISTRY-US, V42, P9989, DOI 10.1021/bi034462b; Zhang DW, 2002, J BIOL CHEM, V277, P20934, DOI 10.1074/jbc.M201311200; Zhang DW, 2001, J BIOL CHEM, V276, P34966, DOI 10.1074/jbc.M105063200; Zhang DW, 2001, J BIOL CHEM, V276, P13231, DOI 10.1074/jbc.M010008200	61	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46052	46063		10.1074/jbc.M308403200	http://dx.doi.org/10.1074/jbc.M308403200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954620	hybrid			2022-12-27	WOS:000186452300122
J	Anderson, PJ; Bock, PE				Anderson, PJ; Bock, PE			Role of prothrombin fragment 1 in the pathway of regulatory exosite I formation during conversion of human prothrombin to thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR SUBSTRATE RECOGNITION; HUMAN-FACTOR V; PROEXOSITE-I; CATALYZED ACTIVATION; BINDING; MEIZOTHROMBIN; SITE; DOMAIN; CLEAVAGE; BOTHROJARACIN	Prothrombin (Pro) activation by factor Xa generates the thrombin catalytic site and exosites I and II. The role of fragment 1 (F1) in the pathway of exosite I expression during Pro activation was characterized in equilibrium binding studies using hirudin(54-65) labeled with 6-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino) hexanoate ([NBD]Hir(54-65)(SO3-)) or 5-(carboxy)fluorescein ([5F]Hir(54-65)(SO3-)). [NBD]Hir(54-65)(SO3-) distinguished exosite I environments on Pro, prethrombin 1 (Pre 1), and prethrombin 2 (Pre 2) but bound with the same affinities as [5F]Hir(54-65)(SO3-). Conversion of Pro to Pre 1 caused a 7- fold increase in affinity for the peptides. Conversely, fragment 1.2 (F1.2) decreased the affinity of Pre 2 for [5F]Hir(54-65)(SO3-) by 3-fold. This was correlated with a 16-fold increased affinity of F1.2 for Pre 2 in comparison to thrombin, demonstrating an enhancing effect of F1 on F1.2 binding. The active intermediate, meizothrombin, demonstrated a 50- to 220-fold increase in exosite affinity. Free thrombin and thrombin.F1.2 complex bound [5F]Hir(54-65)(SO3-) with indistinguishable affinity, indicating that the effect of F1 on peptide binding was eliminated upon expression of catalytic activity and exosite I. The results demonstrate a new zymogen-specific role for F1 in modulating the affinity of ligands for exosite I. This may reflect a direct interaction between the F1 and Pre 2 domains in Pro that is lost upon folding of the zymogen activation domain. The effect of F1 on (pro) exosite I and the role of (pro) exosite I in factor Va-dependent substrate recognition suggest that the Pro activation pathway may be regulated by (pro) exosite I interactions with factor Va.	Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA	Vanderbilt University	Bock, PE (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol, C3321A Med Ctr N, Nashville, TN 37232 USA.	paul.bock@vanderbilt.edu			NHLBI NIH HHS [HL38779] Funding Source: Medline; NIDDK NIH HHS [DK07186] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038779, R29HL038779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007186] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akhavan S, 2002, BLOOD, V100, P1347, DOI 10.1182/blood-2002-01-0243; Anderson PJ, 2000, J BIOL CHEM, V275, P16428, DOI 10.1074/jbc.M001254200; Anderson PJ, 2003, J BIOL CHEM, V278, P44482, DOI 10.1074/jbc.M306917200; Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Blostein MD, 2000, J BIOL CHEM, V275, P38120, DOI 10.1074/jbc.M007174200; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1992, J BIOL CHEM, V267, P14963; Boskovic DS, 2000, J BIOL CHEM, V275, P38561, DOI 10.1074/jbc.M006637200; BOSKOVIC DS, 1990, J BIOL CHEM, V265, P10497; Brufatto N, 2003, J BIOL CHEM, V278, P6755, DOI 10.1074/jbc.M206413200; Butenas S, 2002, BIOCHEMISTRY-MOSCOW+, V67, P3; CARLISLE TL, 1990, J BIOL CHEM, V265, P22044; Chen L, 2003, J BIOL CHEM, V278, P27564, DOI 10.1074/jbc.M302707200; Deguchi H, 1997, BIOCHEM J, V321, P729, DOI 10.1042/bj3210729; Dharmawardana KR, 1999, J BIOL CHEM, V274, P18635, DOI 10.1074/jbc.274.26.18635; Dharmawardana KR, 1998, BIOCHEMISTRY-US, V37, P13143, DOI 10.1021/bi9812165; DiCera E, 1997, CELL MOL LIFE SCI, V53, P701, DOI 10.1007/s000180050091; ESMON CT, 1974, J BIOL CHEM, V249, P7791; FENTON JW, 1977, J BIOL CHEM, V252, P3587; GUINTO ER, 1984, J BIOL CHEM, V259, P3986; HAMMES GG, 2000, THERMODYNAMICS KINET, P30; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; KOTKOW KJ, 1995, J BIOL CHEM, V270, P4551, DOI 10.1074/jbc.270.9.4551; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P3319, DOI 10.1021/bi9623993; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; LINDAHL P, 1991, BIOCHEM J, V276, P387, DOI 10.1042/bj2760387; LIU LW, 1991, J BIOL CHEM, V266, P23632; LUCKOW EA, 1989, BIOCHEMISTRY-US, V26, P103; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1990, BLOOD, V76, P1; Martin PD, 1997, STRUCTURE, V5, P1681, DOI 10.1016/S0969-2126(97)00314-6; Monteiro RQ, 2001, PROTEIN SCI, V10, P1897, DOI 10.1110/ps.09001; Monteiro RQ, 2002, THROMB HAEMOSTASIS, V87, P288; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; OLSON ST, 1991, ARCH BIOCHEM BIOPHYS, V286, P533, DOI 10.1016/0003-9861(91)90076-U; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; Petrovan RJ, 1998, BIOCHEMISTRY-US, V37, P1185, DOI 10.1021/bi971948h; ROSING J, 1986, J BIOL CHEM, V261, P4224; ROSING J, 1980, J BIOL CHEM, V255, P274; SEGEL IH, 1976, BIOCH CALCULATIONS, P150; Stevens WK, 1996, J BIOL CHEM, V271, P8062, DOI 10.1074/jbc.271.14.8062; STUBBS MT, 1993, THROMB RES, V69, P1, DOI 10.1016/0049-3848(93)90002-6; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; WU QY, 1994, J BIOL CHEM, V269, P3725	47	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44489	44495		10.1074/jbc.M306916200	http://dx.doi.org/10.1074/jbc.M306916200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12939270	hybrid			2022-12-27	WOS:000186306700077
J	Hellmann, N; Weber, RE; Decker, H				Hellmann, N; Weber, RE; Decker, H			Nested allosteric interactions in extracellular hemoglobin of the leech Macrobdella decora	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUMBRICUS-TERRESTRIS; OXYGEN-BINDING; 3-DIMENSIONAL RECONSTRUCTION; HEMOCYANIN; SUBUNITS; PH; ERYTHROCRUORIN; COOPERATIVITY; TEMPERATURE; HIERARCHY	Hemoglobin from the leech Macrobdella decora belongs to the class of giant extracellular hexagonal bilayer globin structures found in annelid and vestimentiferan worms. These complexes consist of 144 heme-bearing subunits, exhibit a characteristic quaternary structure (2 x (6 x (3 x 4))), and contain tetramers as basic substructures that express cooperative oxygen binding and thus provide a structural basis for a hierarchy in allosteric interactions. A thorough analysis of the isolated tetramer indicates that it functions as a trimer of cooperatively interacting subunits and a noncooperative monomer rather than as four interacting subunits. A thermodynamic analysis of the whole molecule favors the application of a nested Monod-Wyman-Changeux model with six cooperatively interacting 12-mer allosteric units. In contrast to the isolated tetramers, all subunits of the tetramers seem to be coupled cooperatively within the oligomerized 144-mer. Thus, besides hemocyanins and GroEL, the hexagonal bilayer hemoglobins represent another class of proteins in which the hierarchical quaternary structure provides the basis for nested interaction in their functional properties.	Univ Mainz, Inst Mol Biophys, D-55128 Mainz, Germany; Aarhus Univ, Dept Zoophysiol, DK-8000 Aarhus, Denmark	Johannes Gutenberg University of Mainz; Aarhus University	Hellmann, N (corresponding author), Univ Mainz, Inst Mol Biophys, Jakob Welder Weg 26, D-55128 Mainz, Germany.							Dainese E, 1998, EUR J BIOCHEM, V256, P350, DOI 10.1046/j.1432-1327.1998.2560350.x; DECKER H, 1990, J MOL BIOL, V211, P281, DOI 10.1016/0022-2836(90)90027-J; Decker H., 1986, P383; DECKER H, 1990, BIOPHYS CHEM, V37, P257, DOI 10.1016/0301-4622(90)88025-N; deHaas F, 1996, BIOPHYS J, V70, P1973, DOI 10.1016/S0006-3495(96)79762-X; deHaas F, 1997, BIOCHEMISTRY-US, V36, P7330, DOI 10.1021/bi970131l; FUSHITANI K, 1986, J BIOL CHEM, V261, P8414; FUSHITANI K, 1988, J BIOL CHEM, V263, P6502; FUSHITANI K, 1991, J BIOL CHEM, V266, P10275; GIBSON QH, 1991, J BIOL CHEM, V266, P13097; GREEN DN, 2001, J MOL BIOL, V309, P563; Hellmann N, 2002, BBA-PROTEINS PROTEOM, V1599, P45, DOI 10.1016/S1570-9639(02)00399-0; ILAN E, 1993, BIOCHIM BIOPHYS ACTA, V1162, P77, DOI 10.1016/0167-4838(93)90130-J; KAPP OH, 1990, J MOL BIOL, V213, P141, DOI 10.1016/S0022-2836(05)80127-5; Krebs A, 1996, J BIOL CHEM, V271, P18695, DOI 10.1074/jbc.271.31.18695; Lamy JN, 1996, CHEM REV, V96, P3113, DOI 10.1021/cr9600058; MAKINO N, 1993, BIOCHIM BIOPHYS ACTA, V1162, P237, DOI 10.1016/0167-4838(93)90287-2; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; ROBERT CH, 1987, P NATL ACAD SCI USA, V84, P1891, DOI 10.1073/pnas.84.7.1891; Royer WE, 2000, P NATL ACAD SCI USA, V97, P7107, DOI 10.1073/pnas.97.13.7107; van Holde KE, 2001, J BIOL CHEM, V276, P15563, DOI 10.1074/jbc.R100010200; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; WEBER RE, 1987, J COMP PHYSIOL B, V157, P145, DOI 10.1007/BF00692358; WEBER RE, 1995, J MOL BIOL, V251, P703, DOI 10.1006/jmbi.1995.0466; WEBER RE, 1981, NATURE, V292, P386, DOI 10.1038/292386a0; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; Wyman J., 1990, BINDING LINKAGE	27	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44355	44360		10.1074/jbc.M307810200	http://dx.doi.org/10.1074/jbc.M307810200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944389	hybrid			2022-12-27	WOS:000186306700059
J	Lin, MI; Fulton, D; Babbitt, R; Fleming, I; Busse, R; Pritchard, KA; Sessa, WC				Lin, MI; Fulton, D; Babbitt, R; Fleming, I; Busse, R; Pritchard, KA; Sessa, WC			Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; HSP90; DEPHOSPHORYLATION; IDENTIFICATION; ASSOCIATION; GENERATION; SITES; GOLGI; CELLS	There is evidence that endothelial nitric-oxide synthase ( eNOS) is regulated by reciprocal dephosphorylation of Thr(497) and phosphorylation of Ser(1179). To examine the interrelationship between these sites, cells were transfected with wild-type (WT), T497A, T497D, S1179D, and T497A/S1179D eNOS and activity, NO release and eNOS localization were assessed. Although eNOS T497A, S1179D and T497A/S1179D eNOS had greater enzymatic activity than did WT eNOS in lysates, basal production of NO from cells was markedly reduced in cells transfected with T497A and T497A/S1179D eNOS but augmented in cells transfected with S1179D eNOS. Stimulating cells with ATP or ionophore normalized the loss of function seen with T497A and T497A/S1179D eNOS to levels observed with WT and S1179D eNOS, respectively. Despite these functional differences, the localization of eNOS mutants were similar to WT. Because both T497A and T497A/S1179D eNOS exhibited higher enzyme activity but reduced production of NO, we examined whether these mutations were "uncoupling" NO synthesis. T497A and T497A/S1179D eNOS generated 2 - 3 times more superoxide anion than WT eNOS, and both basal and stimulated interactions of T497A/S1179D eNOS with hsp90 were reduced in co- immunoprecipitation experiments. Thus, the phosphorylation/dephosphorylation of Thr497 may be an intrinsic switch mechanism that determines whether eNOS generates NO versus superoxide in cells.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pharmacol, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Program Vasc Cell Signaling & Therapeut, New Haven, CT 06536 USA; Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; Univ Frankfurt Klinikum, Inst Kardiovaskulaere Physiol, D-60590 Frankfurt, Germany; Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA	Yale University; Yale University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Medical College of Wisconsin	Sessa, WC (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pharmacol, 295 Congress Ave, New Haven, CT 06536 USA.	william.sessa@yale.edu	Fleming, Ingrid/L-1225-2014; Fleming, Ingrid/AAB-6123-2022; Sessa, William C/B-6844-2011	Fleming, Ingrid/0000-0003-1881-3635; Fleming, Ingrid/0000-0003-1881-3635; Sessa, William C/0000-0001-5759-1938	NHLBI NIH HHS [HL 61417, HL71214, HL64793, HL61371, HL68769, R01 HL57665] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064793, R01HL061371, R01HL071214, R01HL061417, R01HL057665, P01HL068769, R37HL061371] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; de Montellano PRO, 1998, DRUG METAB DISPOS, V26, P1185; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; Greif DM, 2002, BIOCHEMISTRY-US, V41, P15845, DOI 10.1021/bi026732g; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Kou RQ, 2002, J BIOL CHEM, V277, P29669, DOI 10.1074/jbc.M204519200; Lane P, 2002, J BIOL CHEM, V277, P19087, DOI 10.1074/jbc.M200258200; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Ou J, 2003, FREE RADICAL BIO MED, V34, P269, DOI 10.1016/S0891-5849(02)01299-6; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; PRITCHARD KA, 1995, CIRC RES, V77, P510, DOI 10.1161/01.RES.77.3.510; SESSA WC, 1995, J BIOL CHEM, V270, P17641, DOI 10.1074/jbc.270.30.17641; Shi Y, 2002, CIRC RES, V91, P300, DOI 10.1161/01.RES.0000031799.12850.1E; Song Y, 2001, BIOCHEM J, V355, P357, DOI 10.1042/0264-6021:3550357; Song Y, 2001, AM J PHYSIOL-CELL PH, V281, pC1819, DOI 10.1152/ajpcell.2001.281.6.C1819	24	198	201	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44719	44726		10.1074/jbc.M302836200	http://dx.doi.org/10.1074/jbc.M302836200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12952971	hybrid			2022-12-27	WOS:000186306700105
J	Kikuchi, K; Kishino, A; Konishi, O; Kumagai, K; Hosotani, N; Saji, I; Nakayama, C; Kimura, T				Kikuchi, K; Kishino, A; Konishi, O; Kumagai, K; Hosotani, N; Saji, I; Nakayama, C; Kimura, T			In vitro and in vivo characterization of a novel semaphorin 3A inhibitor, SM-216289 or xanthofulvin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; GROWTH CONE GUIDANCE; NEURITE GROWTH; AXON REGENERATION; NEUROPILIN; ADULT; CHEMOREPELLENT; EXPRESSION; PROTEIN; COLLAPSIN	SM-216289 (xanthofulvin) isolated from the fermentation broth of a fungal strain, Penicillium sp. SPF-3059, was identified as a strong semaphorin 3A (Sema3A) inhibitor. Sema3A-induced growth cone collapse of dorsal root ganglion neurons in vitro was completely abolished in the presence of SM-216289 at levels less than 2 muM (IC50=0.16 muM). When dorsal root ganglion explants were co-cultured with Sema3A-producing COS7 cells in a collagen gel matrix, SM-216289 enabled neurites to grow toward the COS7 cells. SM-216289 diminished the binding of Sema3A to its receptor neuropilin-1 in vitro, suggesting a direct interference of receptor-ligand association. Moreover, our data suggest that SM-216289 interacted with Sema3A directly and blocked the binding of Sema3A to its receptor. We examined the efficacy of SM-216289 in vivo using a rat olfactory nerve axotomy model, in which strong Sema3A induction has been reported around regenerating axons. The regeneration of olfactory nerves was significantly accelerated by a local administration of SM-216289 in the lesion site, suggesting the involvement of Sema3A in neural regeneration as an inhibitory factor. SM-216289 is an excellent molecular probe to investigate the function of Sema3A, in vitro and in vivo, and may be useful for the treatment of traumatic neural injuries.	Sumitomo Pharmaceut Co Ltd, Div Res, Konohana Ku, Osaka 5540022, Japan; Sumitomo Pharmaceut Co Ltd, Div Res, Takaraduka, Hyogo 6650051, Japan		Kimura, T (corresponding author), Sumitomo Pharmaceut Co Ltd, Div Res, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, Japan.	tkimura@sumitomopharm.co.jp	Kumagai, Kazuo/D-7676-2016	Kumagai, Kazuo/0000-0003-2312-5765				Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; BAKER H, 1986, EXP BRAIN RES, V63, P461, DOI 10.1007/BF00237470; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; COSTANZO RM, 1985, BRAIN RES, V361, P258, DOI 10.1016/0006-8993(85)91297-1; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Encinas JA, 1999, P NATL ACAD SCI USA, V96, P2491, DOI 10.1073/pnas.96.5.2491; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Goshima Y, 2000, JPN J PHARMACOL, V82, P273, DOI 10.1254/jjp.82.273; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GUTHRIE S, 1994, NEUROPROTOCOLS, V4, P116; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; INAGAKI S, 1995, FEBS LETT, V370, P269, DOI 10.1016/0014-5793(95)00850-9; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kikuchi K, 1999, MOL CELL NEUROSCI, V13, P9, DOI 10.1006/mcne.1998.0732; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kumagai K, 2003, J ANTIBIOT, V56, P610, DOI 10.7164/antibiotics.56.610; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Merkler D, 2001, J NEUROSCI, V21, P3665, DOI 10.1523/JNEUROSCI.21-10-03665.2001; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Owesson C, 2000, EXP NEUROL, V165, P394, DOI 10.1006/exnr.2000.7477; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Pasterkamp RJ, 2001, EUR J NEUROSCI, V13, P457, DOI 10.1046/j.0953-816X.2000.01398.x; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Qiu J, 2000, GLIA, V29, P166, DOI 10.1002/(SICI)1098-1136(20000115)29:2<166::AID-GLIA10>3.0.CO;2-G; Reza JN, 1999, MOL CELL NEUROSCI, V14, P317, DOI 10.1006/mcne.1999.0786; SHIMAMOTO A, 1993, FEBS LETT, V333, P61, DOI 10.1016/0014-5793(93)80375-5; Shirvan A, 2002, J BIOL CHEM, V277, P49799, DOI 10.1074/jbc.M204793200; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1997, J NEUROSCI, V17, P9183; Tanelian DL, 1997, NAT MED, V3, P1398, DOI 10.1038/nm1297-1398; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VACTOR DV, 1999, CURR BIOL, V9, pR201; WALTER J, 1990, J PHYSIOL-PARIS, V84, P104	50	70	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					42985	42991		10.1074/jbc.M302395200	http://dx.doi.org/10.1074/jbc.M302395200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12933805	hybrid			2022-12-27	WOS:000186157000033
J	Yin, W; Mu, J; Birnbaum, MJ				Yin, W; Mu, J; Birnbaum, MJ			Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis in 3T3-L1 adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; FATTY-ACID OXIDATION; INSULIN-INDUCED PHOSPHORYLATION; SKELETAL-MUSCLE; GLUCOSE-TRANSPORT; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; PHOSPHODIESTERASE 3B; CARDIAC-HYPERTROPHY; GAMMA(2) SUBUNIT; RAT ADIPOCYTES	AMP-activated protein kinase (AMPK) is a phylogenetically conserved intracellular energy sensor that has been implicated as a major regulator of glucose and lipid metabolism in mammals. However, its possible role in mediating or influencing the adrenergic control of lipolysis in adipocytes remains uncertain. In this study, we utilized the murine cultured preadipocyte line 3T3-L1 to examine this question. Treatment of adipocytes with isoproterenol or forskolin promoted the phosphorylation of AMPK at a critical activating Thr-172 residue in a dose- and time-dependent manner. This correlated well with a stimulation of the activity of AMPK, as measured in the immune complex. Analogs of cAMP mimicked the effect of isoproterenol and forskolin on AMPK phosphorylation. Treatment of adipocytes with insulin reduced both basal and forskolin-induced AMPK phosphorylation via a pathway dependent on phosphatidylinositol 3'-kinase. Overexpression of a dominant-inhibitory mutant of AMPK blocked isoproterenol-induced lipolysis by similar to50%. These data indicate that there exists a novel pathway by which cAMP can lead to the activation of AMPK, and in adipocytes, this is required for maximal activation of lipolysis.	Univ Penn, Sch Med, Dept Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Birnbaum, MJ (corresponding author), Univ Penn, Sch Med, Dept Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.			Birnbaum, Morris/0000-0001-9972-8680; Mu, James/0000-0001-8081-2401	NIDDK NIH HHS [P30-DK-019525] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Birnbaum MJ, 2003, J CELL BIOL, V161, P1011, DOI 10.1083/jcb.200306008; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; GARTON AJ, 1989, EUR J BIOCHEM, V179, P249, DOI 10.1111/j.1432-1033.1989.tb14548.x; Garza LA, 2000, J BIOL CHEM, V275, P2560, DOI 10.1074/jbc.275.4.2560; Gollob MH, 2001, CIRCULATION, V104, P3030, DOI 10.1161/hc5001.102111; Hamilton SR, 2001, FEBS LETT, V500, P163, DOI 10.1016/S0014-5793(01)02602-3; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hayashi T, 1997, AM J PHYSIOL-ENDOC M, V273, pE1039, DOI 10.1152/ajpendo.1997.273.6.E1039; Holm C, 2000, ANNU REV NUTR, V20, P365, DOI 10.1146/annurev.nutr.20.1.365; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Lawrence JTR, 2001, MOL CELL BIOL, V21, P5276, DOI 10.1128/MCB.21.15.5276-5285.2001; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Moule SK, 1998, FEBS LETT, V439, P287, DOI 10.1016/S0014-5793(98)01392-1; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Orlicky DJ, 2001, J LIPID RES, V42, P460; Salt IP, 2000, DIABETES, V49, P1649, DOI 10.2337/diabetes.49.10.1649; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; SU CL, 2003, J BIOL CHEM; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Syu LJ, 1999, MOL CELL, V4, P109, DOI 10.1016/S1097-2765(00)80192-6; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Wijkander J, 1998, ENDOCRINOLOGY, V139, P219, DOI 10.1210/en.139.1.219; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	41	235	237	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43074	43080		10.1074/jbc.M308484200	http://dx.doi.org/10.1074/jbc.M308484200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12941946	hybrid			2022-12-27	WOS:000186157000045
J	Shaw, N; Elholm, M; Noy, N				Shaw, N; Elholm, M; Noy, N			Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor beta/delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED GROWTH ARREST; BREAST-CANCER CELLS; BINDING-PROTEINS; X-RECEPTOR; ECTOPIC EXPRESSION; NUCLEAR RECEPTORS; INDUCED APOPTOSIS; EPITHELIAL-CELLS; FATTY-ACIDS; DIFFERENTIATION	Retinoic acid (RA) modulates transcription of numerous target genes, thereby regulating a myriad of biological processes. It is well established that RA functions by activating retinoic acid receptors (RARs), which, in turn, control cell differentiation, proliferation, and apoptosis. However, perplexing reports of diverse and sometime opposing actions of RA have been published. Hence, while RA induces apoptosis and inhibits cell growth in some settings, it potentiates proliferation and acts as an anti-apoptotic agent in others. These observations raise the possibility that signaling pathways other than RAR may be involved in mediating RA activities. Here we show that RA is a high affinity ligand for another nuclear receptor, namely the orphan receptor peroxisome proliferator-activated receptor (PPAR) beta/delta. We demonstrate that while RA does not activate PPARalpha and PPARgamma, it binds to PPARbeta/delta with nanomolar affinity, modulates the conformation of the receptor, promotes interaction with the coactivator SRC-1, and efficiently activates PPARbeta/delta-mediated transcription. Transcriptional signaling by RA is thus exerted by a dual pathway, providing a rationale for understanding divergent cellular responses to this hormone.	Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University	Noy, N (corresponding author), Cornell Univ, Div Nutr Sci, 225 Savage Hall, Ithaca, NY 14853 USA.							Ahlemeyer B, 2000, J NEUROSCI RES, V60, P767, DOI 10.1002/1097-4547(20000615)60:6<767::AID-JNR9>3.3.CO;2-Y; ALLAN GF, 1992, J BIOL CHEM, V267, P19513; BREITMAN TR, 1981, BLOOD, V57, P1000; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Dowell P, 1997, J BIOL CHEM, V272, P2013, DOI 10.1074/jbc.272.3.2013; Evans TRJ, 1999, BRIT J CANCER, V80, P1, DOI 10.1038/sj.bjc.6690312; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Jinno H, 2002, INT J ONCOL, V21, P127; Jorgensen C, 2002, ANN NY ACAD SCI, V967, P431; KERSTEN S, 1995, BIOCHEMISTRY-US, V34, P14263, DOI 10.1021/bi00043a034; Kersten S, 1997, J BIOL CHEM, V272, P29759, DOI 10.1074/jbc.272.47.29759; KISTLER A, 1986, CARCINOGENESIS, V7, P1175, DOI 10.1093/carcin/7.7.1175; Kitamura M, 2002, NEPHROL DIAL TRANSPL, V17, P84, DOI 10.1093/ndt/17.suppl_9.84; KOMURA H, 1986, ENDOCRINOLOGY, V118, P1530, DOI 10.1210/endo-118-4-1530; Lee HY, 1996, CELL GROWTH DIFFER, V7, P997; Lin QO, 1999, BIOCHEMISTRY-US, V38, P185, DOI 10.1021/bi9816094; Lotan R, 1996, FASEB J, V10, P1031, DOI 10.1096/fasebj.10.9.8801164; Mangelsdorf David J., 1994, P319; Miller WH, 1998, CANCER, V83, P1471, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1471::AID-CNCR1>3.0.CO;2-6; Niu MY, 2001, ONCOGENE, V20, P3506, DOI 10.1038/sj.onc.1204453; NORRIS AW, 1994, BBA-PROTEIN STRUCT M, V1209, P10, DOI 10.1016/0167-4838(94)90130-9; Raffo P, 2000, ANTICANCER RES, V20, P1535; Rohwedel J, 1999, CELLS TISSUES ORGANS, V165, P190, DOI 10.1159/000016699; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Saluja I, 2001, GLIA, V33, P191, DOI 10.1002/1098-1136(200103)33:3<191::AID-GLIA1018>3.0.CO;2-M; Sapi E, 1999, CANCER RES, V59, P5578; SEEWALDT VL, 1995, CELL GROWTH DIFFER, V6, P1077; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Westin S, 2000, ADV PHARMACOL, V47, P89; Wightman J, 2002, MOL CANCER THER, V1, P493; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yen A, 1998, CANCER RES, V58, P3163; Zhao Q, 2000, J MOL BIOL, V296, P509, DOI 10.1006/jmbi.1999.3457	39	184	189	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 24	2003	278	43					41589	41592		10.1074/jbc.C300368200	http://dx.doi.org/10.1074/jbc.C300368200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FP	12963727	hybrid			2022-12-27	WOS:000185989500005
J	Murphy, MP; Echtay, KS; Blaikie, FH; Asin-Cayuela, J; Cocheme, HM; Green, K; Buckingham, JA; Taylor, ER; Hurrell, F; Hughes, G; Miwa, S; Cooper, CE; Svistunenko, DA; Smith, RAJ; Brand, MD				Murphy, MP; Echtay, KS; Blaikie, FH; Asin-Cayuela, J; Cocheme, HM; Green, K; Buckingham, JA; Taylor, ER; Hurrell, F; Hughes, G; Miwa, S; Cooper, CE; Svistunenko, DA; Smith, RAJ; Brand, MD			Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation - Studies using a mitochondria-targeted spin trap derived from alpha-phenyl-N-tert-butylnitrone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; OXIDATIVE STRESS; HYDROXYL RADICALS; BUTYL NITRONE; IN-VIVO; ANTIOXIDANTS; ACONITASE; DEOXYRIBOSE; UBIQUINONE; ELECTRODE	Although the physiological role of uncoupling proteins (UCPs) 2 and 3 is uncertain, their activation by superoxide and by lipid peroxidation products suggest that UCPs are central to the mitochondrial response to reactive oxygen species. We examined whether superoxide and lipid peroxidation products such as 4-hydroxy-2- trans-nonenal act independently to activate UCPs, or if they share a common pathway, perhaps by superoxide exposure leading to the formation of lipid peroxidation products. This possibility can be tested by blocking the putative reactive oxygen species cascade with selective antioxidants and then reactivating UCPs with distal cascade components. We synthesized a mitochondria-targeted derivative of the spin trap alpha-phenyl-N-tert-butylnitrone, which reacts rapidly with carbon-centered radicals but is unreactive with superoxide and lipid peroxidation products. [4-[4-[[(1,1-Dimethylethyl)oxidoimino] methyl] phenoxy] butyl] triphenylphosphonium bromide (MitoPBN) prevented the activation of UCPs by superoxide but did not block activation by hydroxynonenal. This was not due to MitoPBN reacting with superoxide or the hydroxyl radical or by acting as a chain-breaking antioxidant. MitoPBN did react with carbon-centered radicals and also prevented lipid peroxidation by the carbon-centered radical generator 2,2'-azobis( 2-methyl propionamidine) dihydrochloride ( AAPH). Furthermore, AAPH activated UCPs, and this was blocked by MitoPBN. These data suggest that superoxide and lipid peroxidation products share a common pathway for the activation of UCPs. Superoxide releases iron from iron-sulfur center proteins, which then generates carbon-centered radicals that initiate lipid peroxidation, yielding breakdown products that activate UCPs.	MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; Univ Otago, Dept Chem, Dunedin, New Zealand; Univ Otago, Dept Biochem, Dunedin, New Zealand; Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Otago; University of Otago; University of Essex	Murphy, MP (corresponding author), MRC, Dunn Human Nutr Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.		Cooper, Chris/AAK-9729-2020; Murphy, Michael P/C-2120-2009; Brand, Martin D/A-9423-2012	Cooper, Chris/0000-0003-0381-3990; Murphy, Michael P/0000-0003-1115-9618; Brand, Martin D/0000-0003-4418-6153; Miwa, Satomi/0000-0002-1239-1198; Svistunenko, Dimitri/0000-0001-8060-2738; Cocheme, Helena/0000-0001-8637-0042				AIKENS J, 1991, J BIOL CHEM, V266, P15091; Atamna H, 2000, J BIOL CHEM, V275, P6741, DOI 10.1074/jbc.275.10.6741; AZZONE GF, 1984, CURR TOP BIOENERG, V13, P1; Barclay LRC, 2000, FREE RADICAL BIO MED, V28, P1079, DOI 10.1016/S0891-5849(00)00197-0; Brand M. D., 1995, BIOENERGETICS, V154, P62; Brand MD, 2002, BIOCHEM J, V368, P597, DOI 10.1042/BJ20021077; BRAND MD, 2003, IN PRESS BIOCH SOC S; BROWN GC, 1985, BIOCHEM J, V225, P399, DOI 10.1042/bj2250399; Chappell J. B., 1972, SUBCELLULAR COMPONEN, P77; COOPER CE, 1994, FREE RADICAL RES, V20, P219, DOI 10.3109/10715769409147518; DAVEY GP, 1992, BIOCHEM J, V288, P439, DOI 10.1042/bj2880439; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FIESER LF, 1967, REAGENTS ORGANIC SYN, V1, P1276; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GREENSTOCK CL, 1982, CAN J CHEM, V60, P1560, DOI 10.1139/v82-503; GUTTERIDGE JMC, 1987, BIOCHEM J, V243, P709, DOI 10.1042/bj2430709; HAFNER RP, 1990, BIOCHEM J, V265, P731, DOI 10.1042/bj2650731; HAFNER RP, 1988, BIOCHEM J, V250, P477, DOI 10.1042/bj2500477; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; HINTON RD, 1992, J ORG CHEM, V57, P2646, DOI 10.1021/jo00035a020; James AM, 2003, EUR J BIOCHEM, V270, P2827, DOI 10.1046/j.1432-1033.2003.03660.x; JANZEN EG, 1992, TETRAHEDRON LETT, V33, P1257, DOI 10.1016/S0040-4039(00)91595-8; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kotake Y, 1999, ANTIOXID REDOX SIGN, V1, P481, DOI 10.1089/ars.1999.1.4-481; LI ASW, 1988, J MAGN RESON, V79, P140, DOI 10.1016/0022-2364(88)90329-0; Lin TK, 2002, J BIOL CHEM, V277, P17048, DOI 10.1074/jbc.M110797200; Nedergaard J, 2003, EXP PHYSIOL, V88, P65, DOI 10.1113/eph8802502; OHTO N, 1977, J CHEM SOC P2, V13, P1770; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; POU S, 1994, ANAL BIOCHEM, V217, P76, DOI 10.1006/abio.1994.1085; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; ROSE IA, 1967, J BIOL CHEM, V242, P1870; ROSEN GM, 1999, FREE RADICALS BIOL D, P442; SAWYER DT, 1981, ACCOUNTS CHEM RES, V14, P393, DOI 10.1021/ar00072a005; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P19771; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Smith RAJ, 1999, EUR J BIOCHEM, V263, P709, DOI 10.1046/j.1432-1327.1999.00543.x; Smith RAJ, 2003, P NATL ACAD SCI USA, V100, P5407, DOI 10.1073/pnas.0931245100; SMITH RAJ, 2004, IN PRESS METHODS ENZ; SRIDHAR R, 1986, J RADIOAN NUCL CH AR, V101, P227, DOI 10.1007/BF02042423; TRIBBLE DL, 1994, P NATL ACAD SCI USA, V91, P1183, DOI 10.1073/pnas.91.3.1183; Vasquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Walker JE, 1995, METHOD ENZYMOL, V260, P14, DOI 10.1016/0076-6879(95)60127-9; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Welch KD, 2002, ARCH BIOCHEM BIOPHYS, V397, P360, DOI 10.1006/abbi.2001.2694; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	56	268	275	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					48534	48545		10.1074/jbc.M308529200	http://dx.doi.org/10.1074/jbc.M308529200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12972420	hybrid			2022-12-27	WOS:000186829000005
J	Broos, J; Gabellieri, E; van Boxel, GI; Jackson, JB; Strambini, GB				Broos, J; Gabellieri, E; van Boxel, GI; Jackson, JB; Strambini, GB			Tryptophan phosphorescence spectroscopy reveals that a domain in the NAD(H)-binding component (dI) of transhydrogenase from Rhodospirillum rubrum has an extremely rigid and conformationally homogeneous protein core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING TRANSHYDROGENASE; NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; NADP(H)-BINDING COMPONENT; HYDRIDE TRANSFER; GLUTAMATE-DEHYDROGENASE; CRYSTAL-STRUCTURE; ALTERNATING-SITE; BINDING; LUMINESCENCE; RECOMBINANT	The characteristics of tryptophan phosphorescence from the NAD(H)-binding component (dI) component of Rhodospirillum rubrum transhydrogenase are described. This enzyme couples hydride transfer between NAD( H) and NADP( H) to proton translocation across a membrane and is only active as a dimer. Tryptophan phosphorescence spectroscopy is a sensitive technique for the detection of protein conformational changes and was used here to characterize dI under mechanistically relevant conditions. Our results indicate that the single tryptophan in dI, Trp-72, is embedded in a rigid, compact, and homogeneous protein matrix that efficiently suppresses collisional quenching processes and results in the longest triplet lifetime for Trp ever reported in a protein at ambient temperature (2.9 s). The protein matrix surrounding Trp-72 is extraordinarily rigid up to 50degreesC. In all previous studies on Trp-containing proteins, changes in structure were reflected in a different triplet lifetime. In dI, the lifetime of Trp-72 phosphorescence was barely affected by protein dimerization, cofactor binding, complexation with the NADP(H)-binding component (dIII), or by the introduction of two amino acid substitutions at the hydride-transfer site. It is suggested that the rigidity and structural invariance of the protein domain ( dI. 1) housing this Trp residue are important to the mechanism of transhydrogenase: movement of dI. 1 affects the width of a cleft which, in turn, regulates the positioning of bound nucleotides ready for hydride transfer. The unique protein core in dI may be a paradigm for the design of compact and stable de novo proteins.	Univ Birmingham, Sch Biochem, Birmingham B15 2TT, W Midlands, England; Univ Groningen, Dept Biochem, NL-9747 AG Groningen, Netherlands; Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; CNRS, Inst Biofis, Area Ric Pisa, I-56010 Pisa, Italy	University of Birmingham; University of Groningen; University of Groningen	Jackson, JB (corresponding author), Univ Birmingham, Sch Biochem, POB 363, Birmingham B15 2TT, W Midlands, England.			Gabellieri, Edi/0000-0003-0750-4095				Buckley PA, 2000, STRUCTURE, V8, P809, DOI 10.1016/S0969-2126(00)00171-4; Cioni P, 1998, J AM CHEM SOC, V120, P11749, DOI 10.1021/ja9820543; CIONI P, 1994, J MOL BIOL, V242, P291, DOI 10.1006/jmbi.1994.1579; CIONI P, 1994, BIOPHYS CHEM, V52, P25, DOI 10.1016/0301-4622(94)00039-5; CIONI P, 1989, J MOL BIOL, V207, P237, DOI 10.1016/0022-2836(89)90453-1; Cotton NPJ, 2001, STRUCTURE, V9, P165, DOI 10.1016/S0969-2126(01)00571-8; DIGGLE C, 1995, EUR J BIOCHEM, V228, P719, DOI 10.1111/j.1432-1033.1995.0719m.x; Diggle C, 1996, EUR J BIOCHEM, V241, P162, DOI 10.1111/j.1432-1033.1996.0162t.x; Gabellieri E, 1996, BIOCHEMISTRY-US, V35, P12549, DOI 10.1021/bi960231b; GALLEY WC, 1976, BIOCH FLUORESCENCE C, P409; GONNELLI M, 1995, BIOCHEMISTRY-US, V34, P13847, DOI 10.1021/bi00042a017; HERSHBERGER MV, 1980, BIOCHEMISTRY-US, V19, P2204, DOI 10.1021/bi00551a032; Jackson JB, 2002, BIOCHEMISTRY-US, V41, P4173, DOI 10.1021/bi012078d; Kerwin BA, 2002, PROTEIN SCI, V11, P1825, DOI 10.1110/ps.0208102; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; PHELPS DC, 1984, BIOCHEMISTRY-US, V23, P4475, DOI 10.1021/bi00314a037; Prasad GS, 1999, NAT STRUCT BIOL, V6, P1126; Prasad GS, 2002, BIOCHEMISTRY-US, V41, P12745, DOI 10.1021/bi020251f; Quirk PG, 1999, FEBS LETT, V446, P127, DOI 10.1016/S0014-5793(99)00198-2; Quirk PG, 1999, BBA-BIOENERGETICS, V1412, P139, DOI 10.1016/S0005-2728(99)00057-2; Rodrigues DJ, 2001, EUR J BIOCHEM, V268, P1430, DOI 10.1046/j.1432-1327.2001.02008.x; Schauerte JA, 1997, METHOD ENZYMOL, V278, P49; STRAMBINI GB, 1995, J AM CHEM SOC, V117, P7646, DOI 10.1021/ja00134a008; Strambini GB, 1999, J AM CHEM SOC, V121, P8337, DOI 10.1021/ja9915596; STRAMBINI GB, 1992, BIOCHEMISTRY-US, V31, P7535, DOI 10.1021/bi00148a014; Strambini GB, 1996, BIOPHYS J, V70, P971, DOI 10.1016/S0006-3495(96)79640-6; STRAMBINI GB, 1991, J PHYS CHEM-US, V95, P4347, DOI 10.1021/j100164a033; STRAMBINI GB, 1989, BIOCHEMISTRY-US, V28, P3808, DOI 10.1021/bi00435a028; STRAMBINI GB, 1990, BIOCHEMISTRY-US, V29, P196, DOI 10.1021/bi00453a027; van Boxel GI, 2003, BIOCHEMISTRY-US, V42, P1217, DOI 10.1021/bi027032e; VANDERKOOI JM, 1992, TOPICS FLUORESCENCE, V3, P113; Venning JD, 2001, J BIOL CHEM, V276, P30678, DOI 10.1074/jbc.M104429200; White SA, 2000, STRUCT FOLD DES, V8, P1, DOI 10.1016/S0969-2126(00)00075-7	33	15	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47578	47584		10.1074/jbc.M309287200	http://dx.doi.org/10.1074/jbc.M309287200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12972415	hybrid, Green Published			2022-12-27	WOS:000186731400030
J	Kolker, S; Schwab, M; Horster, F; Sauer, S; Hinz, A; Wolf, NI; Mayatepek, E; Hoffmann, GF; Smeitink, JAM; Okun, JG				Kolker, S; Schwab, M; Horster, F; Sauer, S; Hinz, A; Wolf, NI; Mayatepek, E; Hoffmann, GF; Smeitink, JAM; Okun, JG			Methylmalonic acid, a biochemical hallmark of methylmalonic acidurias but no inhibitor of mitochondrial respiratory chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUCCINATE-DEHYDROGENASE; CEREBRAL-CORTEX; METABOLISM; MUSCLE; BRAIN; MANAGEMENT; DISORDERS; BINDING; LESIONS; LIVER	Methylmalonic acidurias are biochemically characterized by an accumulation of methylmalonic acid and alternative metabolites. An impairment of energy metabolism plays a key role in the pathophysiology of this disease, resulting in neurodegeneration of the basal ganglia and renal failure. It has become the subject of intense debates whether methylmalonic acid is the major toxin, inhibiting respiratory chain complex II. To elucidate whether methylmalonic acid is a respiratory chain inhibitor, we used spectrophotometric analysis of complex II activity in submitochondrial particles from bovine heart, radiometric analysis of C-14-labeled substrates ( pyruvate, malate, succinate), and analysis of ATP production in muscle from mice. Methylmalonic acid revealed no direct effects on the respiratory chain function, i.e. on single electron transferring complexes I-IV, ATPase, and mitochondrial transporters. However, we identified a variety of variables that must be carefully controlled to avoid an artificial inhibition of complex II activity. In summary, the study verifies our hypothesis that methylmalonic acid is not the major toxic metabolite in methylmalonic acidurias. Inhibition of respiratory chain and tricarboxylic acid cycle is most likely induced by synergistically acting alternative metabolites, in particular 2-methylcitric acid, malonic acid, and propionyl-CoA.	Univ Childrens Hosp, Dept Gen Pediat, Div Metab & Endocrine Dis, D-69120 Heidelberg, Germany; Univ Childrens Hosp, Dept Pediat Neurol, D-69120 Heidelberg, Germany; Univ Childrens Hosp, Dept Gen Pediat, D-40225 Dusseldorf, Germany; Univ Med Ctr Nijmegen, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, NL-6500 HB Nijmegen, Netherlands	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Radboud University Nijmegen	Kolker, S (corresponding author), Univ Childrens Hosp, Div Metab & Endocrine Dis, Neuenheimer Feld 150, D-69115 Heidelberg, Germany.	Stefan_Koelker@med.uni-heidelberg.de	Wolf, Nicole I/H-3943-2014; Smeitink, Jan A.M./D-6064-2011; Smeitink, Jan/C-1351-2013	Wolf, Nicole I/0000-0003-1721-0728; 				ALBIN RL, 1992, NEUROLOGY, V42, P733, DOI 10.1212/WNL.42.4.733; BEAL MF, 1993, J NEUROSCI, V13, P4181; Brandt U, 1997, BIOCHEMISTRY-US, V36, P11234, DOI 10.1021/bi970968g; BRISMAR J, 1994, AM J NEURORADIOL, V15, P1459; Brusque AM, 2002, NEUROCHEM INT, V40, P593, DOI 10.1016/S0197-0186(01)00130-9; CHEEMADHADLI S, 1975, PEDIATR RES, V9, P905, DOI 10.1203/00006450-197512000-00008; deMello CF, 1996, BRAIN RES, V721, P120, DOI 10.1016/0006-8993(96)00117-5; DUTRA JC, 1993, J INHERIT METAB DIS, V16, P147, DOI 10.1007/BF00711328; Fenton WA, 2001, METABOLIC MOL BASES, P2165; Fighera MR, 1999, NEUROREPORT, V10, P2039, DOI 10.1097/00001756-199907130-00009; FISCHER JC, 1985, CLIN CHIM ACTA, V145, P89, DOI 10.1016/0009-8981(85)90022-1; GREENE JG, 1993, J NEUROCHEM, V61, P1151, DOI 10.1111/j.1471-4159.1993.tb03634.x; HALPERIN ML, 1971, J CLIN INVEST, V50, P2276, DOI 10.1172/JCI106725; HEIDENREICH R, 1988, J PEDIATR-US, V113, P1022, DOI 10.1016/S0022-3476(88)80574-2; HELENIUS A, 1972, J BIOL CHEM, V247, P3656; Kolker S, 2000, J INHERIT METAB DIS, V23, P355, DOI 10.1023/A:1005631230455; Kolker S, 2001, J NEUROSCI RES, V66, P666, DOI 10.1002/jnr.10012; Larnaout A, 1998, J INHERIT METAB DIS, V21, P639, DOI 10.1023/A:1005428432730; LEDLEY FD, 1988, AM J HUM GENET, V42, P839; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHONEY MJ, 1975, P NATL ACAD SCI USA, V72, P2799, DOI 10.1073/pnas.72.7.2799; MARTIN JJ, 1988, J NEUROL SCI, V84, P189, DOI 10.1016/0022-510X(88)90124-4; McLaughlin BA, 1998, NEUROSCIENCE, V86, P279, DOI 10.1016/S0306-4522(97)00594-0; Narasimhan P, 1996, J NEUROSCI, V16, P7336; OBERHOLZ.VG, 1967, ARCH DIS CHILD, V42, P492, DOI 10.1136/adc.42.225.492; Okun JG, 1999, J BIOL CHEM, V274, P2625, DOI 10.1074/jbc.274.5.2625; Okun JG, 2002, J BIOL CHEM, V277, P14674, DOI 10.1074/jbc.M200997200; RUITENBEEK W, 1981, J INHERIT METAB DIS, V4, P91, DOI 10.1007/BF02263606; SPERL W, 1993, ENZYME PROTEIN, V47, P37, DOI 10.1159/000468654; Srere PA., 1969, METHODS ENZYMOLOGY, P3, DOI DOI 10.1016/0076-6879(69)13005-0; TRIJBELS JMF, 1988, EUR J PEDIATR, V148, P92, DOI 10.1007/BF00445910; Trinh BC, 2001, AM J NEURORADIOL, V22, P831; VANDERMEER SB, 1994, J PEDIATR-US, V125, P903, DOI 10.1016/S0022-3476(05)82005-0; Wajner M, 1997, J INHERIT METAB DIS, V20, P761, DOI 10.1023/A:1005359416197; Wyse ATS, 2000, NEUROREPORT, V11, P2331, DOI 10.1097/00001756-200007140-00052	35	68	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47388	47393		10.1074/jbc.M308861200	http://dx.doi.org/10.1074/jbc.M308861200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12972416	hybrid, Green Published			2022-12-27	WOS:000186731400007
J	Leung, L; Kwong, M; Hou, S; Lee, C; Chan, JY				Leung, L; Kwong, M; Hou, S; Lee, C; Chan, JY			Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; GENE-EXPRESSION; TARGETED DISRUPTION; MOUSE DEVELOPMENT; CELL-SURVIVAL; SUBUNIT GENE; FACTOR NF-E2; MICE; INDUCTION; FAMILY	Nrf1 and Nrf2 are members of the CNC family of bZIP transcription factors that exhibit structural similarities, and they are co-expressed in a wide range of tissues during development. Nrf2 has been shown to be dispensable for growth and development in mice. Nrf2-deficient mice, however, are impaired in oxidative stress defense. We previously showed that loss of Nrf1 function in mice results late gestational embryonic lethality. To determine whether Nrf1 and Nrf2 have overlapping functions during early development and in the oxidative stress response, we generated mice that are deficient in both Nrf1 and Nrf2. In contrast to the late embryonic lethality in Nrf1 mutants, compound Nrf1, Nrf2 mutants die early between embryonic days 9 and 10 and exhibit extensive apoptosis that is not observed in the single mutants. Loss of Nrf1 and Nrf2 leads to marked oxidative stress in cells that is indicated by elevated intracellular reactive oxygen species levels and cell death that is reversed by culturing under reduced oxygen tension or the addition of antioxidants. Compound mutant cells also show increased levels of p53 and induction of Noxa, a death effector p53 target gene, suggesting that cell death is potentially mediated by reactive oxygen species activation of p53. Moreover, we show that expression of genes related to antioxidant defense is severely impaired in compound mutant cells compared with single mutant cells. Together, these findings indicate that the functions of Nrf1 and Nrf2 overlap during early development and to a large extent in regulating antioxidant gene expression in cells.	Univ Calif Irvine, Dept Pathol, Irvine, CA 92697 USA; Univ Calif Irvine, Opt Biol Core Ctr, Irvine, CA 92697 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Francisco	Chan, JY (corresponding author), Univ Calif Irvine, Dept Pathol, D440 Med Sci, Irvine, CA 92697 USA.							AKAZAWA S, 1994, METABOLISM, V43, P830, DOI 10.1016/0026-0495(94)90262-3; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Aoki Y, 2001, TOXICOL APPL PHARM, V173, P154, DOI 10.1006/taap.2001.9176; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Chan D, 2000, AUSTRALAS J AGEING, V19, P26; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; CHAN JY, 1995, HUM GENET, V95, P265; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11366, DOI 10.1073/pnas.90.23.11366; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; CHASE JW, 1972, DEV BIOL, V27, P504, DOI 10.1016/0012-1606(72)90189-3; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; CIACCIO PJ, 1994, J BIOL CHEM, V269, P15558; CLOUGH JR, 1985, BIOCHEM SOC T, V13, P77, DOI 10.1042/bst0130077; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Farmer SC, 1997, GENE DEV, V11, P786, DOI 10.1101/gad.11.6.786; FAVREAU LV, 1993, J BIOL CHEM, V268, P19875; FAVREAU LV, 1995, J BIOL CHEM, V270, P24468, DOI 10.1074/jbc.270.41.24468; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Halliwell B, 1999, FREE RADICAL BIO MED, P105, DOI DOI 10.1093/ACPR0F:0S0/9780198717478.003.0005; Hayes JD, 2000, BIOCHEM SOC T, V28, P33, DOI 10.1042/bst0280033; HOGAN B, 1994, MANIPULATING MOUSE E, P260; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; JAISWAL AK, 1994, BIOCHEM PHARMACOL, V48, P439, DOI 10.1016/0006-2952(94)90272-0; JAISWAL AK, 1994, PHARMACOGENETICS, V4, P1, DOI 10.1097/00008571-199402000-00001; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; NEY PA, 1993, MOL CELL BIOL, V13, P5604, DOI 10.1128/MCB.13.9.5604; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; NGUYEN T, 1994, J BIOL CHEM, V269, P13656; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Schuler M, 2003, CELL DEATH DIFFER, V10, P451, DOI 10.1038/sj.cdd.4401180; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; Shi ZZ, 2000, P NATL ACAD SCI USA, V97, P5101, DOI 10.1073/pnas.97.10.5101; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wasserman WW, 1997, ARCH BIOCHEM BIOPHYS, V344, P387, DOI 10.1006/abbi.1997.0215; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; [No title captured]	55	232	243	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48021	48029		10.1074/jbc.M308439200	http://dx.doi.org/10.1074/jbc.M308439200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12968018	hybrid			2022-12-27	WOS:000186731400081
J	Godreau, D; Vranckx, R; Maguy, A; Goyenvalle, C; Hatem, SN				Godreau, D; Vranckx, R; Maguy, A; Goyenvalle, C; Hatem, SN			Different isoforms of synapse-associated protein, SAP97, are expressed in the heart and have distinct effects on the voltage-gated K+ channel Kv1.5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANYLATE KINASE DOMAINS; POTASSIUM CHANNEL; HUMAN HOMOLOG; DISCS LARGE; MEMBRANE; PSD-95; AGGRESOMES; HDLG; SH3; IDENTIFICATION	The SAP97 isoforms differ by alternatively spliced insertion domains that regulate protein localization and oligomerization. We used reverse transcription-PCR to identify SAP97 isoforms of human and rat myocardium. In Chinese hamster ovary cells, cloned protein expression was studied using Western blot, confocal imaging of green fluorescent protein-tagged proteins, and patch clamp technique. The two main cardiac SAP97 isoforms contained both I3 and I1B inserts and differed by the I1A insert. Both isoforms co-precipitated with hKv1.5 channels. Only the isoform lacking I1A increased the current (by 215+/-22%), whatever the level of channel expression. To examine the involvement of the proline-rich I1A insert in the effect of SAP97, a W623F mutation in the Src homology 3 domain was created, and that restored the effect of the SAP97 on current. SAP97 isoform containing an I1A and I2 domain instead of the I3 domain stimulated the current, whereas SAP97 after deletion of the Src homology 3 and guanylate kinase-like domains did not. In cells co-expressing I3(+I1A) or I3(+I1A), green fluorescent protein-tagged Kv1.5 channels were organized in plaque-like structures at the plasma membrane level, whereas intracellular aggregates of channels predominated with the I2 isoform. The two cardiac SAP97 isoforms have different effects on the hKv1.5 current, depending on their capacity to form channel clusters.	Med Hosp Xavier Bichat Claude Bernard, INSERM, U460, F-75018 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Hatem, SN (corresponding author), Med Hosp Xavier Bichat Claude Bernard, INSERM, U460, 46 Rue Henri Huchard, F-75018 Paris, France.		Maguy, Ange/ABG-9298-2021; Hatem, Stephane/D-1016-2017	hatem, stephane/0000-0002-9790-0755; Maguy, Ange/0000-0003-0170-7430				Bron P, 1999, J STRUCT BIOL, V128, P287, DOI 10.1006/jsbi.1999.4196; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DeMarco SJ, 2001, J BIOL CHEM, V276, P21594, DOI 10.1074/jbc.M101448200; Eldstrom J, 2002, FEBS LETT, V531, P529, DOI 10.1016/S0014-5793(02)03572-X; Godreau D, 2002, CARDIOVASC RES, V56, P433, DOI 10.1016/S0008-6363(02)00602-8; Godreau D, 2002, J PHARMACOL EXP THER, V300, P612, DOI 10.1124/jpet.300.2.612; Hanada T, 2003, J BIOL CHEM, V278, P34445, DOI 10.1074/jbc.M305209200; Hibino H, 2000, EMBO J, V19, P78, DOI 10.1093/emboj/19.1.78; Horio Y, 1997, J BIOL CHEM, V272, P12885, DOI 10.1074/jbc.272.20.12885; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jugloff DGM, 2000, J BIOL CHEM, V275, P1357, DOI 10.1074/jbc.275.2.1357; Kim E, 1996, NEUROPHARMACOLOGY, V35, P993, DOI 10.1016/0028-3908(96)00093-7; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kohu K, 2002, GENES CELLS, V7, P707, DOI 10.1046/j.1365-2443.2002.00555.x; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Leonoudakis D, 2001, J CELL SCI, V114, P987; Li DQ, 2000, J BIOL CHEM, V275, P11597, DOI 10.1074/jbc.275.16.11597; Lu XY, 2000, BRAIN RES, V863, P143, DOI 10.1016/S0006-8993(00)02112-0; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Marfatia SM, 2000, J BIOL CHEM, V275, P13759, DOI 10.1074/jbc.275.18.13759; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; McLaughlin M, 2002, J BIOL CHEM, V277, P6406, DOI 10.1074/jbc.M108724200; Murata M, 2001, AM J PHYSIOL-HEART C, V281, pH2575, DOI 10.1152/ajpheart.2001.281.6.H2575; Nix SL, 2000, J BIOL CHEM, V275, P41192, DOI 10.1074/jbc.M002078200; Paarmann I, 2002, J BIOL CHEM, V277, P40832, DOI 10.1074/jbc.M205618200; Reuver SM, 1998, J CELL SCI, V111, P1071; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; Wong W, 2002, J BIOL CHEM, V277, P20423, DOI 10.1074/jbc.M109412200; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Wu HJ, 1998, J CELL SCI, V111, P2365; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	32	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47046	47052		10.1074/jbc.M308463200	http://dx.doi.org/10.1074/jbc.M308463200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12970345	hybrid			2022-12-27	WOS:000186569400101
J	Lee, JH; Lau, KF; Perkinton, MS; Standen, CL; Shemilt, SJA; Mercken, L; Cooper, JD; McLoughlin, DM; Miller, CCJ				Lee, JH; Lau, KF; Perkinton, MS; Standen, CL; Shemilt, SJA; Mercken, L; Cooper, JD; McLoughlin, DM; Miller, CCJ			The neuronal adaptor protein X11 alpha reduces A beta levels in the brains of Alzheimer's APPswe Tg2576 transgenic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-PRECURSOR-PROTEIN; PHOSPHOTYROSINE-BINDING DOMAIN; INTRACELLULAR DOMAIN; MUTANT PRESENILIN-1; CYTOPLASMIC DOMAIN; FE65 PROTEIN; MOUSE MODEL; SECRETASE; DISEASE; X11	Increased production and deposition of the 40-42-amino acid beta-amyloid peptide (Abeta) is believed to be central to the pathogenesis of Alzheimer's disease. Abeta is derived from the amyloid precursor protein (APP), but the mechanisms that regulate APP processing to produce Abeta are not fully understood. X11alpha (also known as munc-18-interacting protein-1 (Mint1)) is a neuronal adaptor protein that binds APP and modulates APP processing in transfected non-neuronal cells. To investigate the in vivo effect of X11alpha on Abeta production in the brain, we created transgenic mice that overexpress X11alpha and crossed these with transgenics harboring a familial Alzheimer's disease mutant APP that produces increased levels of Abeta (APPswe Tg2576 mice). Analyses of Abeta levels in the offspring generated from two separate X11alpha founder mice revealed a significant, approximate 20% decrease in Abeta(1-40) in double transgenic mice expressing APPswe/X11alpha compared with APPswe mice. At a key time point in Abeta plaque deposition (8 months old), the number of Abeta plaques was also deceased in APPswe/X11alpha mice. Thus, we report here the first demonstration that X11alpha inhibits Abeta production and deposition in vivo in the brain.	Kings Coll London, Inst Psychiat, Dept Neurosci, London SE5 8AF, England; Kings Coll London, Inst Psychiat, Old Age Psychiat Sect, London SE5 8AF, England; Aventis Pharma, F-94403 Paris, France	University of London; King's College London; University of London; King's College London; Sanofi-Aventis; Sanofi France	Miller, CCJ (corresponding author), Kings Coll London, Inst Psychiat, Dept Neurosci, POB P037De Crespigny Pk,Denmark Hill, London SE5 8AF, England.	chris.miller@iop.kcl.ac.uk	Cooper, Jonathan/V-9962-2019; Miller, Christopher/H-5733-2012; Cooper, Jonathan/C-8117-2009	Cooper, Jonathan/0000-0003-1339-4750; Cooper, Jonathan/0000-0003-1339-4750; Miller, Christopher/0000-0002-5130-1845; McLoughlin, Declan/0000-0003-4574-2799; Lau, Kwok-Fai/0000-0002-0193-1152	Medical Research Council [G0000749] Funding Source: Medline; MRC [G0000749] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Biederer T, 2002, J NEUROSCI, V22, P7340; Bodendorf U, 2002, J NEUROCHEM, V80, P799, DOI 10.1046/j.0022-3042.2002.00770.x; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borg JP, 1999, J NEUROSCI, V19, P1307; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Bressler SL, 1996, HUM MOL GENET, V5, P1589, DOI 10.1093/hmg/5.10.1589; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Duff K, 2001, CURR OPIN NEUROL, V14, P441, DOI 10.1097/00019052-200108000-00003; Duilio A, 1998, BIOCHEM J, V330, P513, DOI 10.1042/bj3300513; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Guenette SY, 1996, P NATL ACAD SCI USA, V93, P10832, DOI 10.1073/pnas.93.20.10832; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Ho CS, 2002, J BIOL CHEM, V277, P27021, DOI 10.1074/jbc.M201823200; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Ide N, 1998, BIOCHEM BIOPH RES CO, V244, P258, DOI 10.1006/bbrc.1998.8243; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kurt MA, 2001, EXP NEUROL, V171, P59, DOI 10.1006/exnr.2001.7717; Lau KF, 2002, MOL CELL NEUROSCI, V20, P13, DOI 10.1006/mcne.2002.1108; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Matsuda S, 2001, J NEUROSCI, V21, P6597; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; McLoughlin DM, 2001, J BIOL CHEM, V276, P9303, DOI 10.1074/jbc.M010023200; McLoughlin DM, 1996, FEBS LETT, V397, P197; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Mueller HT, 2000, J BIOL CHEM, V275, P39302, DOI 10.1074/jbc.M008453200; Nakajima Y, 2001, MOL BRAIN RES, V92, P27, DOI 10.1016/S0169-328X(01)00126-7; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Okamoto M, 1998, EUR J CELL BIOL, V77, P161, DOI 10.1016/S0171-9335(98)80103-9; Russo T, 1998, FEBS LETT, V434, P1, DOI 10.1016/S0014-5793(98)00941-7; Sastre M, 1998, J BIOL CHEM, V273, P22351, DOI 10.1074/jbc.273.35.22351; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V255, P663, DOI 10.1006/bbrc.1999.0265; Taru H, 2002, J BIOL CHEM, V277, P20070, DOI 10.1074/jbc.M108372200; Tienari PJ, 1997, P NATL ACAD SCI USA, V94, P4125, DOI 10.1073/pnas.94.8.4125; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966; Van Gassen G, 2000, NEUROBIOL DIS, V7, P135, DOI 10.1006/nbdi.2000.0306; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong PC, 2002, NAT NEUROSCI, V5, P633, DOI 10.1038/nn0702-633; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141	59	66	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47025	47029		10.1074/jbc.M300503200	http://dx.doi.org/10.1074/jbc.M300503200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12970358	hybrid			2022-12-27	WOS:000186569400098
J	Saito, N; Courtois, G; Chiba, A; Yamamoto, N; Nitta, T; Hironaka, N; Rowe, M; Yamamoto, N; Yamaoka, S				Saito, N; Courtois, G; Chiba, A; Yamamoto, N; Nitta, T; Hironaka, N; Rowe, M; Yamamoto, N; Yamaoka, S			Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappa B through distinct signaling pathways in fibroblast cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN 1; LYMPHOTOXIN-BETA-RECEPTOR; IKK-ALPHA; MICE LACKING; LYMPHOCYTE TRANSFORMATION; CONSTITUTIVE ACTIVATION; LIVER DEGENERATION; KINASE-ALPHA; JNK PATHWAY; C-TERMINUS	Latent membrane protein 1 ( LMP1), an Epstein- Barr virus transforming protein, is able to activate NF-kappaB through its carboxyl- terminal activation region 1 ( CTAR1) and 2 ( CTAR2), but the exact role of each domain is not fully understood. Here we show that LMP1 activates NF-kappaB in different NF-kappaB essential modulator ( NEMO)- defective cell lines, but not in cells lacking both IkappaB kinase 1 ( IKK1) and 2 ( IKK2). Mutational studies reveal that CTAR1, but not CTAR2, mediates NEMO-independent NF-kappaB activation and that this process largely depends on IKK1. Retroviral expression of LMP1 mutants in cells lacking either functional NF-kappaB inducing kinase ( NIK), NEMO, IKK1, or IKK2 further illustrates distinct signals from the two activation regions of LMP1 for persistent NF-kappaB activation. One originates in CTAR2, operates through the canonical NEMO- dependent pathway, and induces NFKB2 p100 production; the second signal originates in CTAR1, utilizes NIK and IKK1, and induces the processing of p100. Our results thus help clarify how two functional domains of LMP1 persistently activate NF-kappaB through distinct signaling pathways.	Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Bunkyo Ku, Tokyo 1138519, Japan; Inst Pasteur, Unite Biol Mol Express Gen, F-75724 Paris 15, France; Cardiff Univ, Sect Infect & Immun, Cardiff CF14 4XX, S Glam, Wales	Tokyo Medical & Dental University (TMDU); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Cardiff University	Yamaoka, S (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138519, Japan.	shojmmb@tmd.ac.jp	Rowe, Martin/B-2880-2009	Rowe, Martin/0000-0003-4139-7326; COURTOIS, Gilles/0000-0003-3117-9595				BAICHWAL VR, 1989, ONCOGENE, V4, P67; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Chinanonwait N, 2002, FEBS LETT, V531, P553, DOI 10.1016/S0014-5793(02)03618-9; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Courtois G, 1997, MOL CELL BIOL, V17, P1441, DOI 10.1128/MCB.17.3.1441; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Devergne O, 1998, J VIROL, V72, P7900, DOI 10.1128/JVI.72.10.7900-7908.1998; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Eliopoulos AG, 1999, J VIROL, V73, P1023, DOI 10.1128/JVI.73.2.1023-1035.1999; Eliopoulos AG, 1999, J BIOL CHEM, V274, P16085, DOI 10.1074/jbc.274.23.16085; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Eliopoulos AG, 2002, J VIROL, V76, P4567, DOI 10.1128/JVI.76.9.4567-4579.2002; Eliopoulos AG, 1998, ONCOGENE, V16, P1731, DOI 10.1038/sj.onc.1201694; Floettmann JE, 1997, ONCOGENE, V15, P1851, DOI 10.1038/sj.onc.1201359; FRACCHIOLLA NS, 1993, ONCOGENE, V8, P2839; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gires O, 1999, EMBO J, V18, P3064, DOI 10.1093/emboj/18.11.3064; HAMMARSKJOLD ML, 1992, J VIROL, V66, P6496; Hatzivassiliou E, 1998, J IMMUNOL, V160, P1116; He ZM, 2000, CANCER RES, V60, P1845; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; HUEN DS, 1995, ONCOGENE, V10, P549; Izumi KM, 1999, MOL CELL BIOL, V19, P5759; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P1447, DOI 10.1073/pnas.94.4.1447; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P12592, DOI 10.1073/pnas.94.23.12592; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kawakami Y, 1997, P NATL ACAD SCI USA, V94, P3938, DOI 10.1073/pnas.94.8.3938; Kaye KM, 1999, J VIROL, V73, P10525, DOI 10.1128/JVI.73.12.10525-10530.1999; KAYE KM, 1995, J VIROL, V69, P675, DOI 10.1128/JVI.69.2.675-683.1995; Kaykas A, 2001, EMBO J, V20, P2641, DOI 10.1093/emboj/20.11.2641; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; Kieser A, 1997, EMBO J, V16, P6478, DOI 10.1093/emboj/16.21.6478; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; Lam N, 2003, CELL SIGNAL, V15, P9, DOI 10.1016/S0898-6568(02)00083-9; LEE B, 1989, TOHOKU J EXP MED, V157, P1, DOI 10.1620/tjem.157.1; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; LIEBOWITZ D, 1992, J VIROL, V66, P4612, DOI 10.1128/JVI.66.7.4612-4616.1992; LOMBARDI L, 1995, NUCLEIC ACIDS RES, V23, P2328, DOI 10.1093/nar/23.12.2328; Luftig MA, 2001, J BIOL CHEM, V276, P14602, DOI 10.1074/jbc.C100103200; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; MOORTHY RK, 1993, J VIROL, V67, P1638, DOI 10.1128/JVI.67.3.1638-1646.1993; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Mosialos G, 2001, CYTOKINE GROWTH F R, V12, P259, DOI 10.1016/S1359-6101(00)00035-6; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pai S, 2002, J VIROL, V76, P1914, DOI 10.1128/JVI.76.4.1914-1921.2002; PAINE E, 1995, J VIROL, V69, P4572, DOI 10.1128/JVI.69.7.4572-4576.1995; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; ROWE M, 1987, J GEN VIROL, V68, P1575, DOI 10.1099/0022-1317-68-6-1575; Saitoh T, 2002, FEBS LETT, V532, P45, DOI 10.1016/S0014-5793(02)03622-0; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Sylla BS, 1998, P NATL ACAD SCI USA, V95, P10106, DOI 10.1073/pnas.95.17.10106; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Yamaoka S, 1996, EMBO J, V15, P873, DOI 10.1002/j.1460-2075.1996.tb00422.x; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	73	58	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46565	46575		10.1074/jbc.M302549200	http://dx.doi.org/10.1074/jbc.M302549200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12968033	hybrid			2022-12-27	WOS:000186569400042
J	van der Giessen, K; Di-Marco, S; Clair, E; Gallouzi, IE				van der Giessen, K; Di-Marco, S; Clair, E; Gallouzi, IE			RNAi-mediated HuR depletion leads to the inhibition of muscle cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY FACTOR PROTEINS; MYOSIN HEAVY-CHAIN; MYOD MESSENGER-RNA; BINDING PROTEINS; SKELETAL MYOGENESIS; GENE-EXPRESSION; KINASE-ACTIVITY; IN-VIVO; ELAV; STABILITY	The formation of muscle fibers involves the sequential expression of many proteins that regulate key steps during myoblast- to- myotube transition. MyoD, myogenin, and the cyclin- dependent kinase inhibitor p21(cip1) are major players in the initiation and maintenance of the differentiated state of mouse embryonic muscle cells ( C2C12). The messenger RNAs encoding these three proteins contain typical AU- rich elements ( AREs) in their 3 '- untranslated regions ( 3 '- UTRs), which are known to affect the half- life of many short- lived mRNAs. HuR, an RNA- binding protein that regulates both the stability and cellular movement of ARE- containing mRNAs, interacts and stabilizes the p21(cip1) message under UV stress in human RKO colorectal carcinoma cells. Here, by the use of gel shift experiments and immunoprecipitation followed by reverse transcription- PCR analysis, we show that HuR interacts with MyoD, myogenin, and p21cip1 mRNAs through specific sequences in their 3 '-UTRs. To demonstrate the implication of endogenous HuR in myogenesis, we knocked down its expression in myoblasts using RNA interference and observed a significant reduction of HuR expression, associated with complete inhibition of myogenesis. Moreover, the expression of MyoD and myogenin mRNAs, as well as proteins, is significantly reduced in the HuR knockdown C2C12 cells. We were able to completely re- establish the myogenic process of these defective cells by introducing back HuR protein conjugated to a cell- permeable peptide. Finally, HuR accumulates in the cytoplasm during myogenesis. Thus, our results clearly demonstrated that endogenous HuR plays a crucial role in muscle differentiation by regulating the expression and/ or the nuclear export of ARE- containing mRNAs that are essential for this process.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University	Gallouzi, IE (corresponding author), McGill Univ, Dept Biochem, McIntyre Bldg,Rm 904,3655 Promenade Sir William O, Montreal, PQ H3G 1Y6, Canada.			Di Marco, Sergio/0000-0002-4039-0600				Akamatsu W, 1999, P NATL ACAD SCI USA, V96, P9885, DOI 10.1073/pnas.96.17.9885; Antic D, 1999, GENE DEV, V13, P449, DOI 10.1101/gad.13.4.449; Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Bisbal C, 2000, MOL CELL BIOL, V20, P4959, DOI 10.1128/MCB.20.14.4959-4969.2000; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; CAMPOS AR, 1985, J NEUROGENET, V2, P197, DOI 10.3109/01677068509100150; Coletti D, 2002, EMBO J, V21, P631, DOI 10.1093/emboj/21.4.631; Di Marco S, 2001, NUCLEIC ACIDS RES, V29, P863, DOI 10.1093/nar/29.4.863; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Figueroa A, 2003, MOL CELL BIOL, V23, P4991, DOI 10.1128/MCB.23.14.4991-5004.2003; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gallouzi IE, 2001, RNA, V7, P1348, DOI 10.1017/s1355838201016089; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; GUO K, 1995, MOL CELL BIOL, V15, P3823; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Jain RG, 1997, MOL CELL BIOL, V17, P954, DOI 10.1128/MCB.17.2.954; Kasashima K, 1999, GENES CELLS, V4, P667, DOI 10.1046/j.1365-2443.1999.00292.x; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; Kim S, 1999, J BIOL CHEM, V274, P33035, DOI 10.1074/jbc.274.46.33035; Lambermon MHL, 2002, MOL CELL BIOL, V22, P4346, DOI 10.1128/MCB.22.12.4346-4357.2002; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; LUDOLPH DC, 1994, DEV BIOL, V166, P18, DOI 10.1006/dbio.1994.1294; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Okano HJ, 1997, J NEUROSCI, V17, P3024; Pederson T, 2002, J STRUCT BIOL, V140, P3, DOI 10.1016/S1047-8477(02)00528-2; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Polesskaya A, 2002, DEV CELL, V3, P757, DOI 10.1016/S1534-5807(02)00372-6; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Reynaud EG, 1999, MOL CELL BIOL, V19, P7621; Rios R, 2001, BIOCHEM BIOPH RES CO, V280, P561, DOI 10.1006/bbrc.2000.4159; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; Singh OP, 2001, INDIAN J BIOCHEM BIO, V38, P129; Siomi H, 1997, CURR OPIN GENET DEV, V7, P345, DOI 10.1016/S0959-437X(97)80148-7; SMITH TH, 1994, J CELL BIOL, V127, P95, DOI 10.1083/jcb.127.1.95; SMITH TH, 1993, DEVELOPMENT, V117, P1125; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Torgan CE, 2001, MOL BIOL CELL, V12, P1499, DOI 10.1091/mbc.12.5.1499; Wakamatsu Y, 1997, DEVELOPMENT, V124, P3449; Weighardt F, 1996, BIOESSAYS, V18, P747, DOI 10.1002/bies.950180910; Wojciechowski W, 1999, J IMMUNOL, V163, P2688; YAMAGUCHI A, 1995, SEMIN CELL BIOL, V6, P165, DOI 10.1006/scel.1995.0023; Yan Z, 2001, J BIOL CHEM, V276, P17361, DOI 10.1074/jbc.M101251200	58	101	103	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47119	47128		10.1074/jbc.M308889200	http://dx.doi.org/10.1074/jbc.M308889200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12944397	hybrid			2022-12-27	WOS:000186569400110
J	Arnesano, F; Banci, L; Benvenuti, M; Bertini, I; Calderone, V; Mangani, S; Viezzoli, MS				Arnesano, F; Banci, L; Benvenuti, M; Bertini, I; Calderone, V; Mangani, S; Viezzoli, MS			The evolutionarily conserved trimeric structure of CutA1 proteins suggests a role in signal transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; P-II; BRAIN ACETYLCHOLINESTERASE; CRYSTAL-STRUCTURE; COPPER; SEQUENCE; PROGRAM; GLNK	CutA1 are a protein family present in bacteria, plants, and animals, including humans. Escherichia coli CutA1 is involved in copper tolerance, whereas mammalian proteins are implicated in the anchoring of acetylcholinesterase in neuronal cell membranes. The x-ray structures of CutA1 from E. coli and rat were determined. Both proteins are trimeric in the crystals and in solution through an inter-subunit beta-sheet formation. Each subunit consists of a ferredoxin-like (beta1alpha1beta2beta3alpha2beta4) fold with an additional strand (beta5), a C-terminal helix (alpha3), and an unusual extended beta-hairpin involving strands beta2 and beta3. The bacterial CutA1 is able to bind copper(II) in vitro through His(2)Cys coordination in a type II water-accessible site, whereas the rat protein precipitates in the presence of copper(II). The evolutionarily conserved trimeric assembly of CutA1 is reminiscent of the architecture of PII signal transduction proteins. This similarity suggests an intriguing role of CutA1 proteins in signal transduction through allosteric communications between subunits.	Univ Florence, Magnet Resonance Ctr CERM, I-50019 Florence, Italy; Univ Florence, Dept Chem, I-50019 Florence, Italy; Univ Siena, Dept Chem, I-53100 Siena, Italy	University of Florence; University of Florence; University of Siena	Bertini, I (corresponding author), Univ Florence, Magnet Resonance Ctr CERM, Via Luigi Sacconi 6, I-50019 Florence, Italy.	bertini@cerm.unifi.it	Calderone, Vito/A-2917-2014; Arnesano, Fabio/C-3066-2016	Calderone, Vito/0000-0002-7963-6241; Arnesano, Fabio/0000-0002-8399-0964; BANCI, LUCIA/0000-0003-0562-5774				Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banci L, 2003, ACCOUNTS CHEM RES, V36, P215, DOI 10.1021/ar010120r; Binsted N, 1996, J SYNCHROTRON RADIAT, V3, P185, DOI 10.1107/S0909049596005651; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; Carr PD, 1996, ACTA CRYSTALLOGR D, V52, P93, DOI 10.1107/S0907444995007293; CHEAH E, 1994, STRUCTURE, V2, P981, DOI 10.1016/S0969-2126(94)00100-6; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; Daugherty RG, 2002, INORG CHEM, V41, P2623, DOI 10.1021/ic010555a; Edeling MA, 2002, STRUCTURE, V10, P973, DOI 10.1016/S0969-2126(02)00794-3; Evans W, 1997, CHEM BRIT, V33, P22; FONG ST, 1995, MOL MICROBIOL, V15, P1127, DOI 10.1111/j.1365-2958.1995.tb02286.x; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Kinch LN, 2002, PROTEINS, V48, P75, DOI 10.1002/prot.10110; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krupp R, 2001, J BIOL CHEM, V276, P3696, DOI 10.1074/jbc.M009500200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P50; Lever A. B. P., 1984, INORGANIC ELECT SPEC; Lieberman RL, 2001, BIOCHEMISTRY-US, V40, P5674, DOI 10.1021/bi0102611; LINDER MC, 1991, BIOCH COPPER, P1; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Lu Y, 1996, INORG CHEM, V35, P1692, DOI 10.1021/ic9513189; LYTLE FW, 1989, PHYS REV B, V11, P2795; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mira H, 2001, BIOCHEM J, V357, P545, DOI 10.1042/0264-6021:3570545; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaratnam DS, 2000, J NEUROCHEM, V74, P2146, DOI 10.1046/j.1471-4159.2000.0742146.x; Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Perrier AL, 2000, J BIOL CHEM, V275, P34260, DOI 10.1074/jbc.M004289200; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; ROBERTS WL, 1991, J BIOL CHEM, V266, P7481; Rosenzweig AC, 2000, CURR OPIN CHEM BIOL, V4, P140, DOI 10.1016/S1367-5931(99)00066-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Heeswijk WC, 2000, P NATL ACAD SCI USA, V97, P3942, DOI 10.1073/pnas.97.8.3942; Xu YB, 1998, J MOL BIOL, V282, P149, DOI 10.1006/jmbi.1998.1979; Xu YB, 2001, EUR J BIOCHEM, V268, P2028, DOI 10.1046/j.1432-1327.2001.02074.x	44	49	54	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45999	46006		10.1074/jbc.M304398200	http://dx.doi.org/10.1074/jbc.M304398200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12949080	hybrid			2022-12-27	WOS:000186452300115
J	Griffitts, JS; Huffman, DL; Whitacre, JL; Barrows, BD; Marroquin, LD; Muller, R; Brown, JR; Hennet, T; Esko, JD; Aroian, RV				Griffitts, JS; Huffman, DL; Whitacre, JL; Barrows, BD; Marroquin, LD; Muller, R; Brown, JR; Hennet, T; Esko, JD; Aroian, RV			Resistance to a bacterial toxin is mediated by removal of a conserved glycosylation pathway required for toxin-host interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-THURINGIENSIS; DROSOPHILA-MELANOGASTER; PORE FORMATION; PROTEINS; SYNTHASE	Crystal (Cry) proteins made by the bacterium Bacillus thuringiensis are pore-forming toxins that specifically target insects and nematodes and are used around the world to kill insect pests. To better understand how pore-forming toxins interact with their host, we have screened for Caenorhabditis elegans mutants that resist Cry protein intoxication. We find that Cry toxin resistance involves the loss of two glycosyltransferase genes, bre-2 and bre-4. These glycosyltransferases function in the intestine to confer susceptibility to toxin. Furthermore, they are required for the interaction of active toxin with intestinal cells, suggesting they make an oligosaccharide receptor for toxin. Similarly, the bre-3 resistance gene is also required for toxin interaction with intestinal cells. Cloning of the bre-3 gene indicates it is the C. elegans homologue of the Drosophila egghead (egh) gene. This identification is striking given that the previously identified bre-5 has homology to Drosophila brainiac (brn) and that egh-brn likely function as consecutive glycosyltransferases in Drosophila epithelial cells. We find that, like in Drosophila, bre-3 and bre-5 act in a single pathway in C. elegans. bre-2 and bre-4 are also part of this pathway, thereby extending it. Consistent with its homology to brn, we demonstrate that C. elegans bre-5 rescues the Drosophila brn mutant and that BRE-5 encodes the dominant UDP-GlcNAc:Man GlcNAc transferase activity in C. elegans. Resistance to Cry toxins has uncovered a four component glycosylation pathway that is functionally conserved between nematodes and insects and that provides the basis of the dominant mechanism of resistance in C. elegans.	Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Zurich; University of California System; University of California San Diego	Aroian, RV (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, 9500 Gilman Dr,Dept 0349,Bonner Hall 4430, La Jolla, CA 92093 USA.	raroian@ucsd.edu		Barrows, Brad/0000-0003-4069-525X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033063, R37GM033063] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33063] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Betz FS, 2000, REGUL TOXICOL PHARM, V32, P156, DOI 10.1006/rtph.2000.1426; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRENNER S, 1974, GENETICS, V77, P71; Britton C, 1998, J MOL BIOL, V283, P15, DOI 10.1006/jmbi.1998.2093; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Gilbert RJC, 2002, CELL MOL LIFE SCI, V59, P832, DOI 10.1007/s00018-002-8471-1; Goode S, 1996, DEVELOPMENT, V122, P3863; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Jurat-Fuentes JL, 2002, APPL ENVIRON MICROB, V68, P5711, DOI 10.1128/AEM.68.11.5711-5717.2002; Kawar ZS, 2002, J BIOL CHEM, V277, P34924, DOI 10.1074/jbc.M206112200; Kumaraswami NS, 2001, COMP BIOCHEM PHYS B, V129, P173, DOI 10.1016/S1096-4959(01)00327-X; Marroquin LD, 2000, GENETICS, V155, P1693; Muller R, 2002, J BIOL CHEM, V277, P32417, DOI 10.1074/jbc.C200381200; Nishikawa K, 2002, P NATL ACAD SCI USA, V99, P7669, DOI 10.1073/pnas.112058999; Panin VM, 1998, SEMIN CELL DEV BIOL, V9, P609, DOI 10.1006/scdb.1998.0263; PERRIMON N, 1989, GENETICS, V121, P333; Ramakrishnan B, 2002, BIOCHEM BIOPH RES CO, V291, P1113, DOI 10.1006/bbrc.2002.6506; Saxena IM, 2001, PHYTOCHEMISTRY, V57, P1135, DOI 10.1016/S0031-9422(01)00048-6; Schmitt CK, 1999, EMERG INFECT DIS, V5, P224, DOI 10.3201/eid0502.990206; Schwientek T, 2002, J BIOL CHEM, V277, P32421, DOI 10.1074/jbc.M206213200; Uawithya P, 1998, BIOCHEM MOL BIOL INT, V44, P825; Vachon V, 2002, BIOCHEMISTRY-US, V41, P6178, DOI 10.1021/bi011572e; Wandall HH, 2003, J BIOL CHEM, V278, P1411, DOI 10.1074/jbc.C200619200; Wei JZ, 2003, P NATL ACAD SCI USA, V100, P2760, DOI 10.1073/pnas.0538072100	26	99	118	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45594	45602		10.1074/jbc.M308142200	http://dx.doi.org/10.1074/jbc.M308142200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12944392	hybrid			2022-12-27	WOS:000186452300068
J	Jiang, JXS; Choi, RCY; Siow, NL; Lee, HHC; Wan, DCC; Tsim, KWK				Jiang, JXS; Choi, RCY; Siow, NL; Lee, HHC; Wan, DCC; Tsim, KWK			Muscle induces neuronal expression of acetylcholinesterase in neuron-muscle co-culture - Transcriptional regulation mediated by camp-dependent signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-RELATED PEPTIDE; DEVELOPING NEUROMUSCULAR-JUNCTIONS; P2Y(1) NUCLEOTIDE RECEPTOR; TISSUE-SPECIFIC EXPRESSION; MESSENGER-RNA LEVELS; NEUREGULIN EXPRESSION; PROMOTER ELEMENTS; FORM; AGGREGATION; MYOTUBES	Presynaptic motor neuron synthesizes and secretes acetylcholinesterase (AChE) at vertebrate neuromuscular junctions. In order to determine the retrograde role of muscle in regulating the expression of AChE in motor neuron, a chimeric co-culture of NG108-15 cell, a cholinergic cell line that resembles motor neuron, with chick myotube was established to mimic the neuromuscular contact in vitro. A DNA construct of human AChE promoter tagged with luciferase (pAChE-Luc) was stably transfected into NG108-15 cells. The co-culture with myotubes robustly stimulated the promoter activity as well as the endogenous expression of AChE in pAChE-Luc stably transfected NG108-15 cells. Muscle extract derived from chick embryos when applied onto pAChE-Luc-expressing NG108-15 cells induced expressions of AChE promoter and endogenous AChE. The cAMP-responsive element mutation on human AChE promoter blocked the muscle-induced AChE transcriptional activity in cultured NG108-15 cells either in co-culturing with myotube or in applying muscle extract. The accumulation of intracellular cAMP and the phosphorylation of cAMP-responsive element-binding protein in cultured NG108-15 cells were stimulated by applied muscle extract. Part of the muscle-induced signaling was mimicked by application of calcitonin gene-related peptide in cultured NG108-15 cells. These results suggest the muscle-induced neuronal AChE expression in the co-culture is mediated by a cAMP-dependent signaling.	Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese University of Hong Kong	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Dept Biol, Clear Water Bay Rd, Kowloon, Hong Kong, Peoples R China.	BOTSIM@UST.HK	Lee, Henry HC/S-6014-2016; Lee, Henry/GVS-2114-2022; Wan, David C/H-3335-2014	Lee, Henry HC/0000-0003-4975-7330; Tsim, Karl/0000-0003-4808-1674				ANGLISTER L, 1991, J CELL BIOL, V115, P755, DOI 10.1083/jcb.115.3.755; ANGLISTER L, 1994, NEURON, V12, P783, DOI 10.1016/0896-6273(94)90331-X; BENAZIZALOYA R, 1993, P NATL ACAD SCI USA, V90, P2471, DOI 10.1073/pnas.90.6.2471; Boudreau-Lariviere C, 1999, FEBS LETT, V444, P22, DOI 10.1016/S0014-5793(99)00015-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenner T, 2003, FASEB J, V17, P214, DOI 10.1096/fj.02-0609com; BRIMIJOIN S, 1978, J PHYSIOL-LONDON, V285, P143, DOI 10.1113/jphysiol.1978.sp012563; BUSIS NA, 1984, BRAIN RES, V324, P201, DOI 10.1016/0006-8993(84)90030-1; Chakravarty P, 2000, BRIT J PHARMACOL, V130, P189, DOI 10.1038/sj.bjp.0702975; Chan RYY, 1999, P NATL ACAD SCI USA, V96, P4627, DOI 10.1073/pnas.96.8.4627; Cheng AWM, 2003, NEUROREPORT, V14, P351, DOI 10.1097/01.wnr.0000058033.29600.a3; Choi RCY, 1997, NEUROSCI LETT, V236, P167, DOI 10.1016/S0304-3940(97)00789-1; Choi RCY, 2001, J NEUROSCI, V21, P9224, DOI 10.1523/JNEUROSCI.21-23-09224.2001; Choi RCY, 1998, NEUROSCI LETT, V248, P17, DOI 10.1016/S0304-3940(98)00320-6; Choi RCY, 2003, J NEUROSCI, V23, P4445; Choi RCY, 1998, J NEUROCHEM, V71, P152; Choi RCY, 2001, MOL CELL NEUROSCI, V17, P732, DOI 10.1006/mcne.2001.0968; CHRISTIAN CN, 1978, P NATL ACAD SCI USA, V75, P4011, DOI 10.1073/pnas.75.8.4011; Coleman BA, 1996, J BIOL CHEM, V271, P4410; Day T, 2002, NEUROSCIENCE, V111, P649, DOI 10.1016/S0306-4522(02)00031-3; Deschenes-Furry J, 2003, J BIOL CHEM, V278, P5710, DOI 10.1074/jbc.M209383200; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; EKSTROM TJ, 1993, DNA CELL BIOL, V12, P63, DOI 10.1089/dna.1993.12.63; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Farchi N, 2003, J PHYSIOL-LONDON, V546, P165, DOI 10.1113/jphysiol.2002.030841; Fernandes KJL, 1998, J NEUROSCI, V18, P9936; FERNANDEZVALLE C, 1989, J BIOL CHEM, V264, P14043; FONTAINE B, 1987, J CELL BIOL, V105, P1337, DOI 10.1083/jcb.105.3.1337; Fu AKY, 1997, NEUROREPORT, V8, P3895, DOI 10.1097/00001756-199712220-00011; FUNAKOSHI H, 1995, SCIENCE, V268, P1495, DOI 10.1126/science.7770776; GETMAN DK, 1995, J BIOL CHEM, V270, P23511, DOI 10.1074/jbc.270.40.23511; GLANTZ SA, 1988, PRIMER BIOSTATISTICS; GOEMAEREVANNESTE J, 1988, J NEUROCHEM, V51, P1746, DOI 10.1111/j.1471-4159.1988.tb01154.x; LAYER PG, 1991, CELL MOL NEUROBIOL, V11, P7, DOI 10.1007/BF00712798; LI Y, 1993, J BIOL CHEM, V268, P5790; Loeb JA, 1997, J NEUROSCI, V17, P1416; Loeb JA, 2002, J NEUROSCI, V22, P2206, DOI 10.1523/JNEUROSCI.22-06-02206.2002; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MICHEL RN, 1994, J CELL BIOL, V127, P1061, DOI 10.1083/jcb.127.4.1061; MUTERO A, 1995, J BIOL CHEM, V270, P1866, DOI 10.1074/jbc.270.40.23511; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; Pun S, 1997, MOL CELL NEUROSCI, V10, P87, DOI 10.1006/mcne.1997.0637; Pun S, 1997, FEBS LETT, V418, P275, DOI 10.1016/S0014-5793(97)01369-0; Reiss Y, 1996, CELL TISSUE RES, V286, P13, DOI 10.1007/s004410050670; Rossi SG, 2003, J BIOL CHEM, V278, P24994, DOI 10.1074/jbc.M211379200; Rossi SG, 1996, J BIOL CHEM, V271, P1979, DOI 10.1074/jbc.271.4.1979; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SEIDMAN S, 1994, J NEUROCHEM, V62, P1670; Seybold VS, 2003, J NEUROSCI, V23, P1816; SHAPIRA M, 1994, P NATL ACAD SCI USA, V91, P9072, DOI 10.1073/pnas.91.19.9072; Siow NL, 2002, J BIOL CHEM, V277, P36129, DOI 10.1074/jbc.M206498200; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Sternfeld M, 1998, J NEUROSCI, V18, P1240; Stoop R, 1996, J NEUROSCI, V16, P3256; Tsim KWK, 1997, J NEUROCHEM, V68, P479; Tsim KWK, 2002, NEUROSIGNALS, V11, P58, DOI 10.1159/000057322; TSIM KWK, 1988, P NATL ACAD SCI USA, V85, P1262, DOI 10.1073/pnas.85.4.1262; VALLETTE FM, 1991, J NEUROCHEM, V56, P1518, DOI 10.1111/j.1471-4159.1991.tb02046.x; Wan DCC, 2000, NEUROSCI LETT, V288, P81, DOI 10.1016/S0304-3940(00)01200-3; Wan DCC, 1997, NEUROSCI LETT, V232, P83, DOI 10.1016/S0304-3940(97)00577-6	60	38	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45435	45444		10.1074/jbc.M306320200	http://dx.doi.org/10.1074/jbc.M306320200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12963741	hybrid			2022-12-27	WOS:000186452300048
J	Kunz, M; Moeller, S; Koczan, D; Lorenz, P; Wenger, RH; Glocker, MO; Thiesen, HJ; Gross, G; Ibrahim, SM				Kunz, M; Moeller, S; Koczan, D; Lorenz, P; Wenger, RH; Glocker, MO; Thiesen, HJ; Gross, G; Ibrahim, SM			Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE-EARLY GENE; FIBROBLAST-GROWTH-FACTOR; HEPARAN-SULFATE PROTEOGLYCANS; HUMAN-MALIGNANT MELANOMA; VEIN ENDOTHELIAL-CELLS; INDUCED UP-REGULATION; TUMOR-GROWTH; INDUCIBLE FACTOR-1-ALPHA; NUDE-MICE; INTEGRIN ALPHA(6)BETA(1)	Hypoxia has a profound influence on progression and metastasis of malignant tumors. In the present report, we used the oligonucleotide microarray technique to identify new hypoxia-inducible genes in malignant melanoma with a special emphasis on angiogenesis factors. A commercially available Affymetrix(R) gene chip system was used to analyze five melanoma cell lines of different aggressiveness. A total of 160 hypoxia-inducible genes were identified, clustering in four different functional clusters. In search of putative angiogenesis and tumor progression factors within these clusters, Cyr61, a recently discovered angiogenesis factor, was identified. Cyr61 was hypoxia-inducible in low aggressive melanoma cells; however, it showed constitutive high expression in highly aggressive melanoma cells. Further analyses of transcriptional mechanisms underlying Cyr61 gene expression under hypoxia demonstrated that an AP-1 binding motif within the Cyr61 promoter plays a central role in the hypoxic regulation of Cyr61. It could be shown by use of in vitro luciferase assays, electrophoretic mobility shift assays, and immunoprecipitation that hypoxia-inducible factor-1alpha interacts with c-Jun/AP-1 and may thereby contribute to Cyr61 transcriptional regulation under hypoxia. Taken together, the presented data show that Cyr61 is a hypoxia-inducible angiogenesis factor in malignant melanoma with tumor stage-dependent expression. This may argue for a hypoxia-induced selection process during tumor progression toward melanoma cells with constitutive high Cyr61 expression.	Univ Rostock, Dept Dermatol & Venereol, D-18055 Rostock, Germany; Univ Rostock, Inst Immunol, D-18055 Rostock, Germany; Univ Rostock, Proteome Ctr, D-18055 Rostock, Germany; Univ Leipzig, Carl Ludwig Inst Physiol, D-04103 Leipzig, Germany	University of Rostock; University of Rostock; University of Rostock; Leipzig University	Kunz, M (corresponding author), Univ Rostock, Dept Dermatol & Venereol, Augusten Str 80, D-18055 Rostock, Germany.	manfred.kunz@med.uni-rostock.de	Ibrahim, Saleh/AAO-9541-2020; GROSS, Gerd/AAF-8938-2019; Wenger, Roland H./B-7953-2009	Wenger, Roland H./0000-0001-7592-4839; Lorenz, Peter A./0000-0001-7925-1002; Ibrahim, Saleh/0000-0001-7827-2290				Alfranca A, 2002, MOL CELL BIOL, V22, P12, DOI 10.1128/MCB.22.1.12-22.2002; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Beavon IRG, 1999, J CLIN PATHOL-MOL PA, V52, P179, DOI 10.1136/mp.52.4.179; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; Desbaillets I, 1997, J EXP MED, V186, P1201, DOI 10.1084/jem.186.8.1201; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FIDLER IJ, 1994, CELL, V79, P185, DOI 10.1016/0092-8674(94)90187-2; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Goldberg M, 1997, J CLIN INVEST, V99, P55, DOI 10.1172/JCI119133; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Grzeszkiewicz TM, 2002, ENDOCRINOLOGY, V143, P1441, DOI 10.1210/en.143.4.1441; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hartmann A, 1999, CANCER RES, V59, P1578; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hess AR, 2001, CANCER RES, V61, P3250; Hoffmeyer A, 1999, J BIOL CHEM, V274, P4319, DOI 10.1074/jbc.274.7.4319; Jedsadayanmata A, 1999, J BIOL CHEM, V274, P24321, DOI 10.1074/jbc.274.34.24321; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; Kolesnikova TV, 1998, ONCOGENE, V16, P747, DOI 10.1038/sj.onc.1201572; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Kunz M, 1999, AM J PATHOL, V155, P753, DOI 10.1016/S0002-9440(10)65174-7; KUWABARA K, 1995, P NATL ACAD SCI USA, V92, P4606, DOI 10.1073/pnas.92.10.4606; Laderoute KR, 1999, J BIOL CHEM, V274, P12890, DOI 10.1074/jbc.274.18.12890; Laderoute KR, 2002, MOL CELL BIOL, V22, P2515, DOI 10.1128/MCB.22.8.2515-2523.2002; Laderoute KR, 1997, CIRC RES, V80, P336, DOI 10.1161/01.RES.80.3.336; LINDEBRO MC, 1995, EMBO J, V14, P3528, DOI 10.1002/j.1460-2075.1995.tb07359.x; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Luca M, 1997, AM J PATHOL, V151, P1105; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Rak J, 2000, J INVEST DERM SYMP P, V5, P24, DOI 10.1046/j.1087-0024.2000.00012.x; Rofstad EK, 1998, BRIT J CANCER, V77, P897, DOI 10.1038/bjc.1998.148; RUPEC RA, 1995, EUR J BIOCHEM, V234, P632, DOI 10.1111/j.1432-1033.1995.632_b.x; Ryan HE, 2000, CANCER RES, V60, P4010; Schutze N, 2001, J CLIN PATHOL-MOL PA, V54, P170, DOI 10.1136/mp.54.3.170; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Shimo T, 2001, CANCER LETT, V174, P57, DOI 10.1016/S0304-3835(01)00683-8; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SINGH RK, 1994, CANCER RES, V54, P3242; Straume O, 2002, AM J PATHOL, V160, P1009, DOI 10.1016/S0002-9440(10)64922-X; Tsai MS, 2000, CANCER RES, V60, P5603; VANMUIJEN GNP, 1991, INT J CANCER, V48, P85; VANMUIJEN GNP, 1991, CLIN EXP METASTAS, V9, P259, DOI 10.1007/BF01753729; Vaupel P, 2001, SEMIN ONCOL, V28, P29, DOI 10.1016/S0093-7754(01)90210-6; Wang YP, 1997, NAT MED, V3, P887, DOI 10.1038/nm0897-887; WENG HQ, 1995, J BIOL CHEM, V270, P13637, DOI 10.1074/jbc.270.23.13637; Wenger RH, 2000, J EXP BIOL, V203, P1253; WENGER RH, 1995, J BIOL CHEM, V270, P27865, DOI 10.1074/jbc.270.46.27865; Wenger RH, 1998, CANCER RES, V58, P5678; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Westphal JR, 1997, BRIT J CANCER, V76, P561, DOI 10.1038/bjc.1997.427; Xie D, 2001, CANCER RES, V61, P8917; Xu L, 1999, CANCER RES, V59, P5822; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9; YOUNG SD, 1988, P NATL ACAD SCI USA, V85, P9533, DOI 10.1073/pnas.85.24.9533	65	88	96	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45651	45660		10.1074/jbc.M301373200	http://dx.doi.org/10.1074/jbc.M301373200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12939282	hybrid, Green Accepted			2022-12-27	WOS:000186452300074
J	Karsdal, MA; Hjorth, P; Henriksen, K; Kirkegaard, T; Nielsen, KL; Lou, H; Delaisse, JM; Foged, NT				Karsdal, MA; Hjorth, P; Henriksen, K; Kirkegaard, T; Nielsen, KL; Lou, H; Delaisse, JM; Foged, NT			Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-LIGAND; ACTIVATED PROTEIN-KINASE; TGF-BETA; RECEPTOR ACTIVATOR; SIGNAL-TRANSDUCTION; BONE-RESORPTION; ACCELERATED OSTEOCLASTOGENESIS; PHOSPHATIDYLINOSITOL 3-KINASE; INHIBITORY FACTOR; GENE-EXPRESSION	Although RANK-L is essential for osteoclast formation, factors such as transforming growth factor-beta (TGF-beta) are potent modulators of osteoclastogenic stimuli. To systematically investigate the role of TGF-beta in human osteoclastogenesis, monocytes were isolated from peripheral blood by three distinct approaches, resulting in either a lymphocyte-rich, a lymphocyte-poor, or a pure osteoclast precursor (CD14-positive) cell population. In each of these osteoclast precursor populations, the effect of TGF-beta on proliferation, TRAP activity, and bone resorption was investigated with respect to time and length of exposure. When using the highly pure CD14 osteoclast precursor cell population, the effect of TGF-beta was strongly dependent on the stage of osteoclast maturation. When monocytes were exposed to TGF-beta during the initial culture period ( days 1 - 7), TRAP activity and bone resorption were increased by 40%, whereas the cell number was reduced by 25%. A similar decrease in cell number was observed when TGF-beta was present during the entire culture period ( days 1 - 21), but in direct contrast, TRAP activity, cell fusion, cathepsin K, and matrix metalloproteinase (MMP)-9 expression as well as bone resorption were almost completely abrogated. Moreover, we found that latent TGF-beta was strongly activated by incubation with MMP-9 and suggest this to be a highly relevant mechanism for regulating osteoclast activity. To further investigate the molecular mechanism responsible for the divergent effects of continuous versus discontinuous exposure to TGF-beta, we examined RANK expression and p38 MAPK activation. We found the TGF-beta strongly induced p38 MAPK in monocytes, but not in mature osteoclasts, and that continuous exposure of TGF-beta to monocytes down-regulated RANK expression. The current results suggest that TGF-beta promotes human osteoclastogenesis in monocytes through stimulation of the p38 MAPK, whereas continuous exposure to TGF-beta abrogates osteoclastogenesis through down-regulation of RANK expression and therefore attenuation of RANK-RANK-L signaling.	Nord Biosci AS, CCBR, DK-2730 Herlev, Denmark	Center Clinical & Basic Research; Nordic Bioscience; Synarc	Karsdal, MA (corresponding author), Nord Biosci AS, CCBR, Herlev Hovedgade 207, DK-2730 Herlev, Denmark.	mk@nordicbioscience.com	Foged, Niels T/AHA-2122-2022	Karsdal, Morten/0000-0001-5026-8740; Delaisse, Jean-Marie/0000-0001-7370-1500				Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Andrades JA, 1999, EXP CELL RES, V250, P485, DOI 10.1006/excr.1999.4528; Andresen JL, 1998, CURR EYE RES, V17, P79; Bonewald L. F., 1996, P647; BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312; BONEWALD LF, 1990, CLIN ORTHOP RELAT R, P261; Bonewald LF, 1997, ENDOCRINOLOGY, V138, P657, DOI 10.1210/en.138.2.657; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; Boyce Brendan F., 1996, P739; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; CENTRELLA M, 1994, ENDOCR REV, V15, P27, DOI 10.1210/er.15.1.27; Chambers TJ, 2000, J PATHOL, V192, P4; Chirgwin JM, 2000, CRIT REV EUKAR GENE, V10, P159; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Erlebacher A, 1998, MOL BIOL CELL, V9, P1903, DOI 10.1091/mbc.9.7.1903; Festuccia C, 1999, INT J CANCER, V81, P395, DOI 10.1002/(SICI)1097-0215(19990505)81:3<395::AID-IJC13>3.0.CO;2-V; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; Fox SW, 2000, J IMMUNOL, V165, P4957, DOI 10.4049/jimmunol.165.9.4957; Fox SW, 2003, J IMMUNOL, V170, P3679, DOI 10.4049/jimmunol.170.7.3679; Fuller K, 2000, J CELL SCI, V113, P2445; Galvin RJS, 1999, BIOCHEM BIOPH RES CO, V265, P233, DOI 10.1006/bbrc.1999.1632; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Hannigan M, 1998, BIOCHEM BIOPH RES CO, V246, P55, DOI 10.1006/bbrc.1998.8570; Heino TJ, 2002, J CELL BIOCHEM, V85, P185, DOI 10.1002/jcb.10109; Kaneda T, 2000, J IMMUNOL, V165, P4254, DOI 10.4049/jimmunol.165.8.4254; Kanematsu M, 2000, J BONE MINER RES, V15, P1321, DOI 10.1359/jbmr.2000.15.7.1321; Karsdal MA, 2002, J BIOL CHEM, V277, P44061, DOI 10.1074/jbc.M207205200; Karsdal MA, 2001, J BIOL CHEM, V276, P39350, DOI 10.1074/jbc.M008738200; KNIGHT CG, 1995, METHOD ENZYMOL, V248, P85; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Koseki T, 2002, CELL SIGNAL, V14, P31, DOI 10.1016/S0898-6568(01)00221-2; Koyama S, 1998, AM J PHYSIOL-LUNG C, V275, pL223, DOI 10.1152/ajplung.1998.275.2.L223; Lakkakorpi PT, 2003, J BIOL CHEM, V278, P11502, DOI 10.1074/jbc.M206579200; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; LIND M, 1995, APMIS, V103, P140, DOI 10.1111/j.1699-0463.1995.tb01089.x; Manabe N, 2001, J IMMUNOL, V167, P2625, DOI 10.4049/jimmunol.167.5.2625; Massey HM, 2001, BONE, V28, P577, DOI 10.1016/S8756-3282(01)00432-X; Massey HM, 1999, BRIT J HAEMATOL, V106, P167; Matsumoto M, 2000, FEBS LETT, V486, P23, DOI 10.1016/S0014-5793(00)02231-6; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; MORODOMI T, 1992, BIOCHEM J, V285, P603, DOI 10.1042/bj2850603; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; Mundy GR, 2001, SEMIN ONCOL, V28, P35, DOI 10.1053/sonc.2001.24158; Mundy GR, 1999, PRIMER METABOLIC BON, P30, DOI DOI 10.1080/10255840802136150; Murakami T, 1998, BIOCHEM BIOPH RES CO, V252, P747, DOI 10.1006/bbrc.1998.9723; Nicholson GC, 2000, CLIN SCI, V99, P133, DOI 10.1042/CS19990355; Onoe Y, 2000, J BONE MINER RES, V15, P541, DOI 10.1359/jbmr.2000.15.3.541; OURSLER MJ, 1994, J BONE MINER RES, V9, P443; Parfitt AM, 1996, J BONE MINER RES, V11, P150; PFEILSCHIFTER J, 1990, J BONE MINER RES, V5, P49, DOI 10.1002/jbmr.5650050109; Pilkington MF, 2001, J BONE MINER RES, V16, P1237, DOI 10.1359/jbmr.2001.16.7.1237; POSTLETHWAITE AE, 1995, J CELL PHYSIOL, V164, P587, DOI 10.1002/jcp.1041640317; Quinn JMW, 2001, J BONE MINER RES, V16, P1787, DOI 10.1359/jbmr.2001.16.10.1787; ROSIER RN, 1998, CLIN ORTHOP S, V355, P294; Sato K, 2000, J IMMUNOL, V164, P2285, DOI 10.4049/jimmunol.164.5.2285; Sato T, 2001, J BONE MINER RES, V16, P2215, DOI 10.1359/jbmr.2001.16.12.2215; Shalhoub V, 2000, BRIT J HAEMATOL, V111, P501, DOI 10.1046/j.1365-2141.2000.02379.x; Sugatani T, 2003, J BIOL CHEM, V278, P5001, DOI 10.1074/jbc.M209299200; Takai H, 1998, J BIOL CHEM, V273, P27091, DOI 10.1074/jbc.273.42.27091; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tanaka S, 2003, J BONE MINER METAB, V21, P123, DOI 10.1007/s007740300021; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Thirunavukkarasu K, 2001, J BIOL CHEM, V276, P36241, DOI 10.1074/jbc.M104319200; Tong GM, 2002, ANTICANCER RES, V22, P103; Toyosaki-Maeda T, 2001, ARTHRITIS RES, V3, P306, DOI 10.1186/ar320; WAHL SM, 1993, P NATL ACAD SCI USA, V90, P4577, DOI 10.1073/pnas.90.10.4577; Wang RX, 2002, EUR J IMMUNOL, V32, P1090, DOI 10.1002/1521-4141(200204)32:4<1090::AID-IMMU1090>3.0.CO;2-P; Weitzmann MN, 2000, J CELL BIOCHEM, V78, P318, DOI 10.1002/(SICI)1097-4644(20000801)78:2<318::AID-JCB13>3.0.CO;2-N; Yan T, 2001, J CELL BIOCHEM, V83, P320, DOI 10.1002/jcb.1200; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; ZHENG MH, 1994, AM J PATHOL, V145, P1095	78	115	126	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44975	44987		10.1074/jbc.M303905200	http://dx.doi.org/10.1074/jbc.M303905200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12933809	hybrid			2022-12-27	WOS:000186306700134
J	Wallas, TR; Smith, MD; Sanchez-Nieto, S; Schnell, DJ				Wallas, TR; Smith, MD; Sanchez-Nieto, S; Schnell, DJ			The roles of Toc34 and Toc75 in targeting the Toc159 preprotein receptor to chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT APPARATUS; OUTER ENVELOPE; MEMBRANE; GTP; MACHINERY; COMPONENT; BINDING; DOMAIN; TRANSLOCATION; ATTOC159	The Toc complex at the outer envelope of chloroplasts initiates the import of nuclear-encoded preproteins from the cytosol into the organelle. The core of the Toc complex is composed of two receptor GTPases, Toc159 and Toc34, as well as Toc75, a beta-barrel membrane channel. Toc159 is equally distributed between a soluble cytoplasmic form and a membrane-inserted form, suggesting that assembly of the Toc complex is dynamic. In the present study, we used the Arabidopsis thaliana orthologs of Toc159 and Toc34, atToc159 and atToc33, respectively, to investigate the requirements for assembly of the trimeric Toc complex. In addition to its intrinsic GTPase activity, we demonstrate that integration of atToc159 into the Toc complex requires atToc33 GTPase activity. Additionally, we show that the interaction of the two GTPase domains stimulates association of the membrane anchor of atToc159 with the translocon. Finally, we employ reconstituted proteoliposomes to demonstrate that proper insertion of the receptor requires both Toc75 and Toc34. Collectively these data suggest that Toc34 and Toc75 act sequentially to mediate docking and insertion of Toc159 resulting in assembly of the functional translocon.	Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Schnell, DJ (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.		Smith, Matthew/M-4726-2014	Smith, Matthew/0000-0002-2855-5126; Sanchez-Nieto, Sobeida/0000-0002-2315-450X	NIGMS NIH HHS [GM61893] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061893] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bauer J, 2002, J CELL BIOL, V159, P845, DOI 10.1083/jcb.200208018; Bauer J, 2001, CELL MOL LIFE SCI, V58, P420, DOI 10.1007/PL00000867; Chen DD, 1997, J BIOL CHEM, V272, P6614, DOI 10.1074/jbc.272.10.6614; Chen KH, 2000, PLANT PHYSIOL, V122, P813, DOI 10.1104/pp.122.3.813; Clark PL, 1998, FOLD DES, V3, P401, DOI 10.1016/S1359-0278(98)00053-4; Fitzpatrick LM, 2001, PLANT J, V27, P59, DOI 10.1046/j.0960-7412.2001.01061.x; Gutensohn M, 2000, PLANT J, V23, P771, DOI 10.1046/j.1365-313x.2000.00849.x; Hiltbrunner A, 2001, J CELL BIOL, V154, P309, DOI 10.1083/jcb.200104022; Hinnah SC, 1997, EMBO J, V16, P7351, DOI 10.1093/emboj/16.24.7351; HIRSCH S, 1994, SCIENCE, V266, P1989, DOI 10.1126/science.7801125; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Jelic M, 2003, BIOCHEMISTRY-US, V42, P5906, DOI 10.1021/bi034001q; Jelic M, 2002, BIOL CHEM, V383, P1875, DOI 10.1515/BC.2002.211; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; KESSLER F, 1994, SCIENCE, V266, P1035, DOI 10.1126/science.7973656; Kouranov A, 1997, J CELL BIOL, V139, P1677, DOI 10.1083/jcb.139.7.1677; Ling MM, 1997, ANAL BIOCHEM, V254, P157, DOI 10.1006/abio.1997.2428; MA Y, 1996, J CELL BIOL, V134, P1; PERRY SE, 1994, PLANT CELL, V6, P93, DOI 10.1105/tpc.6.1.93; Schleiff E, 2003, J CELL BIOL, V160, P541, DOI 10.1083/jcb.200210060; Schleiff E, 2000, PLANTA, V211, P449, DOI 10.1007/s004250000357; Schleiff E, 2003, P NATL ACAD SCI USA, V100, P4604, DOI 10.1073/pnas.0730860100; Schleiff E, 2002, BIOCHEMISTRY-US, V41, P1934, DOI 10.1021/bi011361+; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; Smith MD, 2002, J CELL BIOL, V159, P833, DOI 10.1083/jcb.200208017; SMITH MD, 2002, CURRENT PROTOCOLS CE; Sveshnikova N, 2000, P NATL ACAD SCI USA, V97, P4973, DOI 10.1073/pnas.080491597	27	61	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44289	44297		10.1074/jbc.M307873200	http://dx.doi.org/10.1074/jbc.M307873200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12951325	hybrid			2022-12-27	WOS:000186306700050
J	Zhao, C; Fu, DC; Dave, V; Ma, J				Zhao, C; Fu, DC; Dave, V; Ma, J			A composite motif of the Drosophila morphogenetic protein bicoid critical to transcription control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE COMPLEX; TERMINAL DOMAIN; MESSENGER-RNA; CO-REPRESSORS; GENE; IDENTIFICATION; HOMEODOMAIN; YEAST; RECRUITMENT; PROMOTERS	Bicoid is a molecular morphogen-controlling embryonic patterning in Drosophila. It is a homeodomain-containing protein that activates specific target genes during early embryogenesis. Our recent studies have identified a domain of Bcd located outside its homeodomain and referred to as a self-inhibitory domain that can dramatically repress its own ability to activate transcription. Here we present evidence that the self-inhibitory function is evolutionarily conserved. A systematic analysis of this domain reveals a composite 10-amino acid motif with interdigitating residues that regulate Bcd activity in opposite manners. Mutations within the Bcd motif can exert their respective effects when the self-inhibitory domain is grafted to an entirely heterologous activator, but they do not affect DNA binding in vitro or subcellular localization of Bcd in cells. We further show that the self-inhibitory domain of Bcd can interact with Sin3A, a component of the histone deacetylase co-repressor complex. Our study suggests that the activity of Bcd is intricately controlled by multiple mechanisms involving the actions of co-repressor proteins.	Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Ma, J (corresponding author), Childrens Hosp Res Fdn, Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	jun.ma@cchmc.org	Zhao, Chen/A-9987-2011; Dave, Vrushank/K-5262-2012; Ma, Jun/GLT-4809-2022	Dave, Vrushank/0000-0003-4044-2658; Ma, Jun/0000-0002-1609-3294				Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Bi WL, 1998, ANAL BIOCHEM, V256, P137, DOI 10.1006/abio.1997.2516; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Brubaker K, 2000, CELL, V103, P655, DOI 10.1016/S0092-8674(00)00168-9; Burke LJ, 2000, FASEB J, V14, P1876, DOI 10.1096/fj.99-0943rev; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Driever W., 1992, TRANSCRIPTIONAL REGU, P1221; Fu DC, 2003, MOL CELL BIOL, V23, P4439, DOI 10.1128/MCB.23.13.4439-4448.2003; Gao Q, 1998, DEVELOPMENT, V125, P4185; Jenster G, 1997, P NATL ACAD SCI USA, V94, P7879, DOI 10.1073/pnas.94.15.7879; JOHNSON AD, 1995, CURR OPIN GENET DEV, V5, P552, DOI 10.1016/0959-437X(95)80022-0; Johnson KD, 2002, NUCLEIC ACIDS RES, V30, P1522, DOI 10.1093/nar/30.7.1522; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; Ma XG, 1996, DEVELOPMENT, V122, P1195; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Niessing D, 2002, GENE DEV, V16, P2576, DOI 10.1101/gad.240002; NUSSLEINVOLHARD C, 1991, DEVELOPMENT, P1; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; SEEGER MA, 1990, EMBO J, V9, P2977, DOI 10.1002/j.1460-2075.1990.tb07490.x; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; Shaw PJ, 2002, EVOL DEV, V4, P265, DOI 10.1046/j.1525-142X.2002.02016.x; Shaw PJ, 2001, EVOL DEV, V3, P251, DOI 10.1046/j.1525-142x.2001.003004251.x; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; Stauber M, 1999, P NATL ACAD SCI USA, V96, P3786, DOI 10.1073/pnas.96.7.3786; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; Uesugi M, 1999, P NATL ACAD SCI USA, V96, P14801, DOI 10.1073/pnas.96.26.14801; Yamamoto KR, 1998, COLD SPRING HARB SYM, V63, P587, DOI 10.1101/sqb.1998.63.587; Yochum GS, 2001, MOL CELL BIOL, V21, P4110, DOI 10.1128/MCB.21.13.4110-4118.2001; Yuan D, 1996, J BIOL CHEM, V271, P21660, DOI 10.1074/jbc.271.35.21660; Zhang DY, 2002, NUCLEIC ACIDS RES, V30, P3078, DOI 10.1093/nar/gkf422; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhao C, 2000, MOL CELL BIOL, V20, P8112, DOI 10.1128/MCB.20.21.8112-8123.2000; Zhao C, 2002, DEVELOPMENT, V129, P1669; ZHAO C, 2003, IN PRESS RECENT DEV, V3; Zhu WC, 2000, GENE, V245, P329, DOI 10.1016/S0378-1119(00)00048-2; Zhu WC, 2001, DEV GENES EVOL, V211, P109, DOI 10.1007/s004270100135	45	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					43901	43909		10.1074/jbc.M302714200	http://dx.doi.org/10.1074/jbc.M302714200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12939280	hybrid			2022-12-27	WOS:000186306700005
J	Zhou, Y; Zhang, J; King, ML				Zhou, Y; Zhang, J; King, ML			Xenopus autosomal recessive hypercholesterolemia protein couples lipoprotein receptors with the AP-2 complex in oocytes and embryos and is required for vitellogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; PHOSPHOTYROSINE-BINDING DOMAIN; ASYMMETRIC CELL-DIVISION; ALPHA-ADAPTIN; LDL RECEPTOR; ENDOCYTIC PROTEIN; APPENDAGE DOMAIN; LAEVIS DAUDIN; VLDL RECEPTOR; NUMB	ARH is required for normal endocytosis of the low density lipoprotein (LDL) receptor in liver and mutations within this gene cause autosomal recessive hypercholesterolemia in humans. xARH is a localized maternal RNA in Xenopus with an unknown function in oogenesis and embryogenesis. Like ARH, xARH contains a highly conserved phosphotyrosine binding domain and a clathrin box. To address the function of xARH, we examined its expression pattern in development and used pull-down experiments to assess interactions between xARH, lipoprotein receptors and proteins in embryo extracts. xARH was detected concentrated at the cell periphery as well as in the perinuclear region of oocytes and embryos. In pull-down experiments, the xARH phosphotyrosine binding domain interacted with the LDL and vitellogenin receptors found in Xenopus oocytes and embryos. Mutations within the receptor internalization signal specifically abolished this interaction. The xARH C-terminal region pulled-down several proteins from embryo extracts including alpha- and beta-adaptins, subunits of the AP-2 endocytic complex. Mutations within either of the two Dphi(F/W) motifs found in xARH abolished binding to alpha- and beta-adaptins. Expression of a dominant negative mutant of xARH missing the clathrin box and one functional Dphi(F/W) motif severely inhibited endocytosis of vitellogenin in cultured oocytes. The data indicate that xARH acts as an adaptor protein linking LDL and vitellogenin receptors directly with the AP-2 complex. In oocytes, we propose that xARH mediates the uptake of lipoproteins from the blood for storage in endosomes and later use in the embryo. Our findings point to an evolutionarily conserved function for ARH in lipoprotein uptake.	Univ Miami, Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; Chinese Acad Sci, Ctr Dev Biol, Inst Genet & Dev Biol, Beijing 100101, Peoples R China	University of Miami; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	King, ML (corresponding author), Univ Miami, Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA.	mking@med.miami.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033932] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33932] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALL CL, 1995, J CELL SCI, V108, P2865; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; BERRIDGE MV, 1976, CELL, V8, P283, DOI 10.1016/0092-8674(76)90012-X; Boll W, 2002, TRAFFIC, V3, P590, DOI 10.1034/j.1600-0854.2002.30808.x; Bujo H, 1997, J NUTR, V127, pS801, DOI 10.1093/jn/127.5.801S; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Cheon HM, 2001, INSECT BIOCHEM MOLEC, V31, P753, DOI 10.1016/S0965-1748(01)00068-6; Chien CT, 1998, MOL CELL BIOL, V18, P598, DOI 10.1128/MCB.18.1.598; CLEMENS MJ, 1975, J BIOL CHEM, V250, P2213; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; DUMONT JN, 1978, J EXP ZOOL, V204, P193, DOI 10.1002/jez.1402040208; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; FAGOTTO F, 1994, J CELL SCI, V107, P3325; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Hawkins N, 1998, GENE DEV, V12, P3625, DOI 10.1101/gad.12.23.3625; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; JACOBSEN L, 1995, J BIOL CHEM, V270, P6468, DOI 10.1074/jbc.270.12.6468; Jones C, 2003, J BIOL CHEM, V278, P29024, DOI 10.1074/jbc.M304855200; Kibbey RG, 1998, J CELL BIOL, V142, P59, DOI 10.1083/jcb.142.1.59; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Li SC, 1997, P NATL ACAD SCI USA, V94, P7204, DOI 10.1073/pnas.94.14.7204; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; MacArthur H, 1999, MECH DEVELOP, V84, P75, DOI 10.1016/S0925-4773(99)00075-1; MACLACHLAN I, 1994, J BIOL CHEM, V269, P24127; Margolis B, 1999, KIDNEY INT, V56, P1230, DOI 10.1046/j.1523-1755.1999.00700.x; MEHTA KD, 1991, J BIOL CHEM, V266, P10406; Meisner H, 1997, MOL CELL BIOL, V17, P2217, DOI 10.1128/MCB.17.4.2217; Mishra SK, 2002, P NATL ACAD SCI USA, V99, P16099, DOI 10.1073/pnas.252630799; NIEUWKOOP PD, 1975, NORMAL TABLE XENOPUS, P16; NIMPF J, 1989, J BIOL CHEM, V264, P1393; Okabayashi K, 1996, BIOCHEM BIOPH RES CO, V224, P406, DOI 10.1006/bbrc.1996.1040; OPRESKO LK, 1991, METHOD CELL BIOL, V36, P117; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; RICHTER HP, 1990, EUR J CELL BIOL, V51, P53; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; SCHONBAUM CP, 1995, P NATL ACAD SCI USA, V92, P1485, DOI 10.1073/pnas.92.5.1485; Seto ES, 2002, GENE DEV, V16, P1314, DOI 10.1101/gad.989602; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; UCHIYAMA H, 1994, BIOCHEM BIOPH RES CO, V202, P484, DOI 10.1006/bbrc.1994.1954; Warren RA, 1998, J BIOL CHEM, V273, P17056, DOI 10.1074/jbc.273.27.17056; Wilund KR, 2002, HUM MOL GENET, V11, P3019, DOI 10.1093/hmg/11.24.3019; Yan KS, 2002, FEBS LETT, V513, P67, DOI 10.1016/S0014-5793(01)03305-1; Zhang J, 2000, METH MOL B, V136, P309; ZHOU Y, 2003, THESIS U MIAMI SCH M	50	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44584	44592		10.1074/jbc.M308870200	http://dx.doi.org/10.1074/jbc.M308870200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944396	hybrid			2022-12-27	WOS:000186306700088
J	Yuan, LP; Yu, WM; Qu, CK				Yuan, LP; Yu, WM; Qu, CK			DNA damage-induced G(2)/M checkpoint in SV40 large T antigen-immortalized embryonic fibroblast cells requires SHP-2 tyrosine phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CYCLE ARREST; C-JUN; CELLULAR-RESPONSE; ERK ACTIVATION; MAP KINASE; IN-VITRO; PATHWAY; P53; RADIATION	DNA damage induced by radiation or DNA-damaging agents leads to apoptosis and cell cycle arrest. However, DNA damage-triggered signal transduction involved in these cellular responses is not well understood. We previously demonstrated an important role for SHP-2, a ubiquitously expressed SH2 domain-containing tyrosine phosphatase, in the DNA damage-induced apoptotic response. Here we report a potential role for SHP-2 in a DNA damage-activated cell cycle checkpoint. Cell cycle analysis and the mitotic index assay showed that following DNA damage induced by cisplatin or gamma-irradiation, the G(2) (but not S) arrest response was diminished in SV40 large T antigen-immortalized embryonic fibroblast cells lacking functional SHP-2. Notably, reintroduction of wild-type SHP-2 into the mutant cells fully restored the DNA damage-induced G(2) arrest response, suggesting a direct role of SHP-2 in the G(2)/M checkpoint. Further biochemical analysis revealed that SHP-2 constitutively associated with 14-3-3beta, and that Cdc25C cytoplasmic translocation induced by DNA damage was essentially blocked in SHP-2 mutant cells. Additionally, we showed that following DNA damage, activation of p38 kinase was significantly elevated, while Erk kinase activation was decreased in mutant cells, and treatment of SHP-2 mutant cells with SB203580, a selective inhibitor for p38 kinase, partially restored the DNA damage-induced G(2) arrest response. These results together provide the first evidence that SHP-2 tyrosine phosphatase enhances the DNA damage G(2)/M checkpoint in SV40 large T antigen immortalized murine embryonic fibroblast cells.	Amer Red Cross, Jerome H Holland Lab Biomed Sci, Dept Hematopoiesis, Rockville, MD 20855 USA; George Washington Univ, Med Ctr, Dept Anat & Cell Biol, Washington, DC 20037 USA	American Red Cross; George Washington University	Qu, CK (corresponding author), Amer Red Cross, Holland Lab, Dept Hematopoiesis, 15601 Crabbs Branch Way, Rockville, MD 20855 USA.				NHLBI NIH HHS [R01HL68212-01A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068212] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bennett AM, 1996, MOL CELL BIOL, V16, P1189; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carter S, 1998, ONCOGENE, V16, P2787, DOI 10.1038/sj.onc.1201802; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Ghahremani MH, 2002, J BIOL CHEM, V277, P35586, DOI 10.1074/jbc.M204362200; Guadagno TM, 1998, SCIENCE, V282, P1312, DOI 10.1126/science.282.5392.1312; Hayakawa J, 1999, J BIOL CHEM, V274, P31648, DOI 10.1074/jbc.274.44.31648; Hayne C, 2000, J BIOL CHEM, V275, P31876, DOI 10.1074/jbc.M002766200; Heron-Milhavet L, 2001, J BIOL CHEM, V276, P18185, DOI 10.1074/jbc.M011490200; Jasani B, 2001, SEMIN CANCER BIOL, V11, P49, DOI 10.1006/scbi.2000.0346; Liu QH, 2000, GENE DEV, V14, P1448; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; MILARSKI KL, 1994, J BIOL CHEM, V269, P21239; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Pipas JM, 2001, SEMIN CANCER BIOL, V11, P23, DOI 10.1006/scbi.2000.0343; Potapova O, 2001, J BIOL CHEM, V276, P28546, DOI 10.1074/jbc.M102075200; Qu CK, 1999, P NATL ACAD SCI USA, V96, P8528, DOI 10.1073/pnas.96.15.8528; Qu CK, 2002, BBA-MOL CELL RES, V1592, P297, DOI 10.1016/S0167-4889(02)00322-1; Qu CK, 1998, MOL CELL BIOL, V18, P6075, DOI 10.1128/MCB.18.10.6075; Qu CK, 1997, MOL CELL BIOL, V17, P5499, DOI 10.1128/MCB.17.9.5499; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Shi ZQ, 1998, J BIOL CHEM, V273, P4904, DOI 10.1074/jbc.273.9.4904; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Weinert T, 1997, SCIENCE, V277, P1450, DOI 10.1126/science.277.5331.1450; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; You M, 2001, J EXP MED, V193, P101, DOI 10.1084/jem.193.1.101; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Yuan LP, 2003, J BIOL CHEM, V278, P15208, DOI 10.1074/jbc.M211327200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	45	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					42812	42820		10.1074/jbc.M305075200	http://dx.doi.org/10.1074/jbc.M305075200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12937170	hybrid			2022-12-27	WOS:000186157000012
J	Gum, JR; Hicks, JW; Crawley, SC; Dahl, CM; Yang, SC; Roberton, AM; Kim, YS				Gum, JR; Hicks, JW; Crawley, SC; Dahl, CM; Yang, SC; Roberton, AM; Kim, YS			Initiation of transcription of the MUC3A human intestinal mucin from a TATA-less promoter and comparison with the MUC3B amino terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-ASSOCIATED MUCIN; PEPTIDASE-IV GENE; MOLECULAR-CLONING; 5'-FLANKING REGION; REPETITIVE REGION; EPITHELIAL MUCIN; CLEAVAGE SITES; MESSENGER-RNAS; IDENTIFICATION; SEQUENCE	Human intestinal mucin genes MUC3A and MUC3B are members of a membrane mucin gene family residing at chromosome 7q22. In this paper, we utilized genomic and cDNA cloning to elucidate the sequence of the 5' region of the MUC3A gene including the gene promoter and the amino terminus coding sequence. Following its 21-residue signal peptide, the amino terminus of the mucin consists of a 233-residue Thr-, Ser-, and Pro- rich nonrepetitive sequence that is contiguous with its hypervariable domain of 375-residue repeats. RNase protection analysis and 5'-GeneRacer PCR indicated that MUC3A gene transcripts initiate from multiple start sites along a region spanning similar to 180 bases. The 5'-flanking region of the gene had promoter activity when fused to a luciferase reporter gene in all of the tested cell lines. This region contained binding sites for several transcription factors, including those implicated in the regulation of intestinal genes, but lacked a cognate TATA box. These features of the gene promoter may enable the gene to be expressed at variable levels in several cell types with different repertoires of transcription factors. We also utilized 5'-GeneRacer PCR to determine the sequence of the 5'-terminus of the MUC3B message. The amino termini of the MUC3A and MUC3B mucins are 91% conserved at the amino acid level. Thus, MUC3A and MUC3B have highly conserved amino and carboxyl termini, suggesting a recent duplication of the entire ancestral gene. It remains to be determined whether other members of the 7q22 membrane mucin gene family have amino-terminal domains similar to MUC3A and MUC3B.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94121 USA; Dept Vet Affairs Med Ctr, Gastrointestinal Res Lab, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gum, JR (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94121 USA.	jgum@maelstrom.ucsf.edu						BOHM SK, 1995, BIOCHEM J, V311, P835; Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; Carraway KL, 1999, J BIOL CHEM, V274, P5263, DOI 10.1074/jbc.274.9.5263; Crawley SC, 1999, BIOCHEM BIOPH RES CO, V263, P728, DOI 10.1006/bbrc.1999.1466; Debailleul V, 1998, J BIOL CHEM, V273, P881, DOI 10.1074/jbc.273.2.881; Dekker J, 2002, TRENDS BIOCHEM SCI, V27, P126, DOI 10.1016/S0968-0004(01)02052-7; DENG T, 1986, J BIOL CHEM, V261, P6000; Erickson RH, 2000, GENE, V258, P77, DOI 10.1016/S0378-1119(00)00422-4; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; GUM JR, 1990, BIOCHEM BIOPH RES CO, V171, P407, DOI 10.1016/0006-291X(90)91408-K; Gum JR, 1997, J BIOL CHEM, V272, P26678, DOI 10.1074/jbc.272.42.26678; Gum JR, 1999, AM J PHYSIOL-GASTR L, V276, pG666, DOI 10.1152/ajpgi.1999.276.3.G666; Gum JR, 1997, BIOCHEM J, V325, P259, DOI 10.1042/bj3250259; GUM JR, 1992, J BIOL CHEM, V267, P21375; Gum JR, 2002, BIOCHEM BIOPH RES CO, V291, P466, DOI 10.1006/bbrc.2002.6475; GUM JR, 1994, J BIOL CHEM, V269, P2440; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; Hinojosa-Kurtzberg AM, 2003, AM J PHYSIOL-GASTR L, V284, pG853, DOI 10.1152/ajpgi.00326.2002; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Kyo K, 2001, J HUM GENET, V46, P5, DOI 10.1007/s100380170118; LANS MS, 1994, J BIOL CHEM, V269, P14170; Li DZ, 1998, J BIOL CHEM, V273, P6812, DOI 10.1074/jbc.273.12.6812; Liu WF, 2002, J BIOL CHEM, V277, P8273, DOI 10.1074/jbc.M110768200; MANNORI G, 1995, CANCER RES, V55, P4425; Marshall E, 2001, SCIENCE, V292, P1982, DOI 10.1126/science.292.5524.1982; Moniaux N, 2000, EUR J BIOCHEM, V267, P4536, DOI 10.1046/j.1432-1327.2000.01504.x; Moniaux N, 1999, BIOCHEM J, V338, P325, DOI 10.1042/0264-6021:3380325; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Pallesen LT, 2002, EUR J BIOCHEM, V269, P2755, DOI 10.1046/j.1432-1033.2002.02949.x; Parry S, 2001, BIOCHEM BIOPH RES CO, V283, P715, DOI 10.1006/bbrc.2001.4775; Pratt WS, 2000, BIOCHEM BIOPH RES CO, V275, P916, DOI 10.1006/bbrc.2000.3406; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ren J, 2002, J BIOL CHEM, V277, P17616, DOI 10.1074/jbc.M200436200; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Taylor-Papadimitriou J, 2002, J MAMMARY GLAND BIOL, V7, P209, DOI 10.1023/A:1020360121451; Traber PG, 1996, ANNU REV PHYSIOL, V58, P275, DOI 10.1146/annurev.physiol.58.1.275; Verrijzer CP, 2001, SCIENCE, V293, P2010, DOI 10.1126/science.1064980; Williams SJ, 1999, BIOCHEM BIOPH RES CO, V261, P83, DOI 10.1006/bbrc.1999.1001; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; Wreschner DH, 2002, PROTEIN SCI, V11, P698, DOI 10.1110/ps.16502; WRESCHNER DH, 1990, EUR J BIOCHEM, V189, P463, DOI 10.1111/j.1432-1033.1990.tb15511.x; Yin BWT, 2001, J BIOL CHEM, V276, P27371, DOI 10.1074/jbc.M103554200	45	19	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					49600	49609		10.1074/jbc.M305769200	http://dx.doi.org/10.1074/jbc.M305769200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12958310	hybrid			2022-12-27	WOS:000186829000131
J	Parker, AR; O'Meally, RN; Sahin, F; Su, GH; Racke, FK; Nelson, WG; DeWeese, TL; Eshleman, JR				Parker, AR; O'Meally, RN; Sahin, F; Su, GH; Racke, FK; Nelson, WG; DeWeese, TL; Eshleman, JR			Defective human MutY phosphorylation exists in colorectal cancer cell lines with wild-type MutY alleles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BASE EXCISION-REPAIR; OXIDATIVE DNA-DAMAGE; HUMAN-COLON; HUMAN HOMOLOG; EXPRESSION; GLYCOSYLASE; MUTATIONS; CLONING; TUMORS	Oxidative DNA damage can generate a variety of cytotoxic DNA lesions such as 8-oxoguanine (8-oxoG), which is one of the most mutagenic bases formed from oxidation of genomic DNA because 8-oxoG can readily mispair with either cytosine or adenine. If unrepaired, further replication of A . 8-oxoG mispairs results in C: G to A: T transversions, a form of genomic instability. We reported previously that repair of A . 8-oxoG mispairs was defective and that 8-oxoG levels were elevated in several microsatellite stable human colorectal cancer cell lines lacking MutY mutations ( human MutY homolog gene, hmyh, MYH MutY homolog protein). In this report, we provide biochemical evidence that the defective repair of A . 8- oxoG may be due, at least in part, to defective phosphorylation of the MutY protein in these cell lines. In MutY-defective cell extracts, but not extracts with functional MutY, A . 8-oxoG repair was increased by incubation with protein kinases A and C (PKA and PKC) and caesin kinase II. Treatment of these defective cells, but not cells with functional MutY, with phorbol-12-myristate-13- acetate also increased the cellular A . 8- oxoG repair activity and decreased the elevated 8- oxoG levels. We show that MutY is serine-phosphorylated in vitro by the action of PKC and in the MutY-defective cells by phorbol-12-myristate-13- acetate but that MutY is already phosphorylated at baseline in proficient cell lines. Finally, using antibody-isolated MutY protein, we show that MutY can be directly phosphorylated by PKC that directly increases the level of MutY catalyzed A . 8-oxoG repair.	Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med & Pharmacol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Eshleman, JR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, 720 Rutland Ave,632 Ross Bldg, Baltimore, MD 21205 USA.			Su, Gloria/0000-0002-5158-6019	NCI NIH HHS [R01CA81439] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081439] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; BAUM CL, 1990, CANCER RES, V50, P3915; CHENG KC, 1992, J BIOL CHEM, V267, P166; Christiansen M, 2003, NUCLEIC ACIDS RES, V31, P963, DOI 10.1093/nar/gkg164; Christmann M, 2002, NUCLEIC ACIDS RES, V30, P1959, DOI 10.1093/nar/30.9.1959; DOI S, 1994, MOL CARCINOGEN, V11, P197, DOI 10.1002/mc.2940110405; DUTTA A, 1992, EMBO J, V11, P2189, DOI 10.1002/j.1460-2075.1992.tb05278.x; ESHLEMAN JR, 1995, ONCOGENE, V10, P33; Gu YS, 2002, J BIOL CHEM, V277, P11135, DOI 10.1074/jbc.M108618200; Gu YS, 2001, NUCLEIC ACIDS RES, V29, P2666, DOI 10.1093/nar/29.12.2666; KAHLRAINER P, 1994, CARCINOGENESIS, V15, P779, DOI 10.1093/carcin/15.4.779; Klein IK, 2000, CANCER RES, V60, P2077; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; KUSUNOKI M, 1992, CANCER, V69, P24, DOI 10.1002/1097-0142(19920101)69:1<24::AID-CNCR2820690107>3.0.CO;2-1; NGHIEM Y, 1988, P NATL ACAD SCI USA, V85, P2709, DOI 10.1073/pnas.85.8.2709; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Olinski R, 2002, FREE RADICAL BIO MED, V33, P192, DOI 10.1016/S0891-5849(02)00878-X; Parker A, 2001, J BIOL CHEM, V276, P5547, DOI 10.1074/jbc.M008463200; Parker AR, 2002, CANCER RES, V62, P7230; PARKER AR, 2003, IN PRESS CELL MOL LI; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Rossi R, 1999, EMBO J, V18, P5745, DOI 10.1093/emboj/18.20.5745; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; Seidman MD, 1999, HEAD NECK-J SCI SPEC, V21, P467, DOI 10.1002/(SICI)1097-0347(199908)21:5<467::AID-HED14>3.0.CO;2-C; Sieber OM, 2003, NEW ENGL J MED, V348, P791, DOI 10.1056/NEJMoa025283; Verstovsek G, 1998, GASTROENTEROLOGY, V115, P75, DOI 10.1016/S0016-5085(98)70367-1; WALI RK, 1991, BIOCHIM BIOPHYS ACTA, V1092, P119, DOI 10.1016/0167-4889(91)90185-Z; WILLSON JKV, 1987, CANCER RES, V47, P2704; Yacoub A, 1997, CANCER RES, V57, P5457	30	38	40	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47937	47945		10.1074/jbc.M306598200	http://dx.doi.org/10.1074/jbc.M306598200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12966098	hybrid			2022-12-27	WOS:000186731400072
J	Han, BG; Dong, ZZ; Zhang, JT				Han, BG; Dong, ZZ; Zhang, JT			Tight control of platelet-derived growth factor B/c-sis expression by interplay between the 5 '-untranslated region sequence and the major upstream promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME ENTRY SITES; B-CHAIN EXPRESSION; MESSENGER-RNA; GENE-EXPRESSION; TRANSLATION INITIATION; INTERNAL TRANSLATION; REGULATORY ELEMENTS; FACTOR-II; CELLS; PROTEIN	The long and GC- rich 5'-untranslated region (5'-UTR) of the known 3.8-kb platelet-derived growth factor B (PDGF-B)/c-sis mRNA is highly conserved and inhibits its own translation. It has been thought that this 5'-UTR functions by regulating translation possibly using an internal ribosome entry site (IRES)-mediated mechanism. However, in the present study we found no evidence that the 5'-UTR sequence of PDGF-B mRNA contains any IRES activity. Instead, we found that the 5'-UTR sequence of PDGF-B functions as a promoter both constitutively and upon induction in a variety of cell lines. The 5'-UTR sequence contains two promoters (termed P1 and P2) when only the 5'-UTR sequence is analyzed. In the presence of the upstream TATA-box-containing promoter (P0), P1 and P0 promoters are integrated into one promoter, whereas the P2 promoter still functions. The full promoter with combined P0, P1, and P2 produced two transcripts, with the major one having the full-length 5'-UTR and the minor one the short 5'-UTR. The integrated P0/P1 promoter and P2 promoter are likely responsible for producing the endogenous 3.8- and 2.8-kb PDGF-B mRNAs that are detected in cultured human renal microvascular endothelial cells, a few tumor cells, and rat brain tissues. Furthermore, we detected the 2.8-kb PDGF-B mRNA in erythroleukemia K562 cells upon 12-O-tetradecanoylphorbol-13-acetate-induced differentiation. Considering that the 5'-UTR in the 3.8-kb mRNA contains no IRES activity and inhibits cap-dependent translation, we believe that the endogenous 2.8-kb mRNA produced from the 5'-UTR promoter is likely the major template responsible for protein production both constitutively and upon induction. We also found that the transcription from the 5'-UTR P2 promoter might be coordinated by the major upstream P0 promoter upon stimulation. Based on these observations, we propose that the TATA-containing P0 promoter and the 5'-UTR promoter work together to tightly control the expression of PDGF-B.	Indiana Univ, Sch Med, IUCC,Walther Oncol Ctr,Walther Canc Inst, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute	Zhang, JT (corresponding author), Indiana Univ, Sch Med, IUCC,Walther Oncol Ctr,Walther Canc Inst, Dept Pharmacol & Toxicol, 1044 W Walnut St,R4-166, Indianapolis, IN 46202 USA.		Zhang, Jian-Ting/L-8334-2015		NCI NIH HHS [CA 64539] Funding Source: Medline; NIGMS NIH HHS [GM 59475] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA064539, R01CA064539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059475] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernstein J, 1997, J BIOL CHEM, V272, P9356; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; CLARKE MF, 1984, NATURE, V308, P464, DOI 10.1038/308464a0; COLAMONICI OR, 1986, MOL CELL BIOL, V6, P1847, DOI 10.1128/MCB.6.5.1847; FEN Z, 1991, ONCOGENE, V6, P953; Gerlitz G, 2002, EUR J BIOCHEM, V269, P2810, DOI 10.1046/j.1432-1033.2002.02974.x; Han BG, 2003, ONCOGENE, V22, P5325, DOI 10.1038/sj.onc.1206783; Han BG, 2002, MOL CELL BIOL, V22, P7372, DOI 10.1128/MCB.22.21.7372-7384.2002; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Heller S, 2000, INT J CANCER, V85, P211; IGARASHI H, 1987, ONCOGENE, V1, P79; JIN HM, 1993, P NATL ACAD SCI USA, V90, P7563, DOI 10.1073/pnas.90.16.7563; JIN HM, 1994, J BIOL CHEM, V269, P28648; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; KHACHIGIAN LM, 1994, J BIOL CHEM, V269, P22647; Kozak M, 2001, MOL CELL BIOL, V21, P1899, DOI 10.1128/MCB.21.6.1899-1907.2001; Kujoth GC, 1998, CELL GROWTH DIFFER, V9, P523; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; Mariani S, 2002, TRENDS ENDOCRIN MET, V13, P11, DOI 10.1016/S1043-2760(01)00518-5; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; PECH M, 1989, MOL CELL BIOL, V9, P396, DOI 10.1128/MCB.9.2.396; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RAO CD, 1988, MOL CELL BIOL, V8, P284, DOI 10.1128/MCB.8.1.284; RATNER L, 1987, NUCLEIC ACIDS RES, V15, P6017, DOI 10.1093/nar/15.15.6017; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Sachs AB, 2000, CELL, V101, P243, DOI 10.1016/S0092-8674(00)80834-X; Sasahara M, 1998, ONCOGENE, V16, P1571, DOI 10.1038/sj.onc.1201679; Schneider R, 2001, MOL CELL BIOL, V21, P8238, DOI 10.1128/MCB.21.23.8238-8246.2001; Sella O, 1999, MOL CELL BIOL, V19, P5429; Taylor LM, 2000, J BIOL CHEM, V275, P16709, DOI 10.1074/jbc.275.22.16709; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; WANG J, 1994, CANCER RES, V54, P560; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232	35	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46983	46993		10.1074/jbc.M304976200	http://dx.doi.org/10.1074/jbc.M304976200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12960151	hybrid			2022-12-27	WOS:000186569400093
J	Swan, MK; Solomons, JTG; Beeson, CC; Hansen, T; Schonheit, P; Davies, C				Swan, MK; Solomons, JTG; Beeson, CC; Hansen, T; Schonheit, P; Davies, C			Structural evidence for a hydride transfer mechanism of catalysis in phosphoglucose isomerase from Pyrococcus furiosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; RABBIT; PROGRAM	In the Euryarchaeota species Pyrococcus furiosus and Thermococcus litoralis, phosphoglucose isomerase (PGI) activity is catalyzed by an enzyme unrelated to the well known family of PGI enzymes found in prokaryotes, eukaryotes, and some archaea. We have determined the crystal structure of PGI from Pyrococcus furiosus in native form and in complex with two active site ligands, 5-phosphoarabinonate and gluconate 6-phosphate. In these structures, the metal ion, which in vivo is presumed to be Fe2+, is located in the core of the cupin fold and is immediately adjacent to the C1-C2 region of the ligands, suggesting that Fe2+ is involved in catalysis rather than serving a structural role. The active site contains a glutamate residue that contacts the substrate, but, because it is also coordinated to the metal ion, it is highly unlikely to mediate proton transfer in a cis-enediol mechanism. Consequently, we propose a hydride shift mechanism of catalysis. In this mechanism, Fe2+ is responsible for proton transfer between O1 and O2, and the hydride shift between C1 and C2 is favored by a markedly hydrophobic environment in the active site. The absence of any obvious enzymatic machinery for catalyzing ring opening of the sugar substrates suggests that pyrococcal PGI has a preference for straight chain substrates and that metabolism in extreme thermophiles may use sugars in both ring and straight chain forms.	Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA; Univ Sussex, Sch Biol Sci, Grad Program, Brighton BN1 9QG, E Sussex, England; Univ Kiel, Inst Allgemeine Mikrobiol, D-24118 Kiel, Germany	Medical University of South Carolina; Medical University of South Carolina; University of Sussex; University of Kiel	Davies, C (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	davies@musc.edu						Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; Arsenieva D, 2002, J MOL BIOL, V323, P77, DOI 10.1016/S0022-2836(02)00892-6; Berrisford JM, 2003, J BIOL CHEM, V278, P33290, DOI 10.1074/jbc.M305170200; CHIRGWIN JM, 1975, J BIOL CHEM, V250, P7272; Davies C, 2003, ACTA CRYSTALLOGR D, V59, P453, DOI 10.1107/S0907444902023387; DELANO WL, 2002, PYMOL MOL MODELING S; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; DYSON JED, 1968, J BIOL CHEM, V243, P1401; Hansen T, 2001, J BACTERIOL, V183, P3428, DOI 10.1128/JB.183.11.3428-3435.2001; Jeffery CJ, 2001, BIOCHEMISTRY-US, V40, P1560, DOI 10.1021/bi0018483; Jeong JJ, 2003, FEBS LETT, V535, P200, DOI 10.1016/S0014-5793(02)03900-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JH, 2001, BIOCHEMISTRY-US, V40, P7799, DOI 10.1021/bi002916o; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ostermeier M, 2001, ADV PROTEIN CHEM, V55, P29, DOI 10.1016/S0065-3233(01)55002-0; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; RAINES RT, 1986, BIOCHEMISTRY-US, V25, P7142, DOI 10.1021/bi00370a057; Read J, 2001, J MOL BIOL, V309, P447, DOI 10.1006/jmbi.2001.4680; ROSE IA, 1975, ADV ENZYMOL RAMB, V43, P491; Swan MK, 2003, PROTEIN PEPTIDE LETT, V10, P517, DOI 10.2174/0929866033478762; SWENSON CA, 1971, BIOCHEMISTRY-US, V10, P3151, DOI 10.1021/bi00792a026; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Verhees CH, 2001, J BIOL CHEM, V276, P40926, DOI 10.1074/jbc.M104603200; Watanabe H, 1996, CANCER RES, V56, P2960; WHITLOW M, 1991, PROTEINS, V9, P153, DOI 10.1002/prot.340090302; Xu W, 1996, BLOOD, V87, P4502, DOI 10.1182/blood.V87.11.4502.bloodjournal87114502	32	35	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47261	47268		10.1074/jbc.M308603200	http://dx.doi.org/10.1074/jbc.M308603200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12970347	hybrid			2022-12-27	WOS:000186569400127
J	Wang, P; Wang, CT; Bai, JH; Jackson, MB; Chapman, ER				Wang, P; Wang, CT; Bai, JH; Jackson, MB; Chapman, ER			Mutations in the effector binding loops in the C2A and C2B domains of synaptotagmin I disrupt exocytosis in a nonadditive manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE; CA2+ BINDING; C(2)A DOMAIN; 3-DIMENSIONAL STRUCTURE; PHOSPHOLIPID-BINDING; MEMBRANE-FUSION; SNARE COMPLEX; C-2 DOMAIN; PC12 CELLS; CALCIUM	The secretory vesicle protein synaptotagmin I (syt) plays a critical role in Ca2+-triggered exocytosis. Its cytoplasmic domain is composed of tandem C2 domains, C2A and C2B; each C2 domain binds Ca2+. Upon binding Ca2+, positively charged residues within the Ca2+-binding loops are thought to interact with negatively charged phospholipids in the target membrane to mediate docking of the cytoplasmic domain of syt onto lipid bilayers. The C2 domains of syt also interact with syntaxin and SNAP-25, two components of a conserved membrane fusion complex. Here, we have neutralized single positively charged residues at the membrane-binding interface of C2A (R233Q) and C2B (K366Q). Either of these mutations shifted the Ca2+ requirements for syt-liposome interactions from similar to20 to similar to40 muM Ca2+. Kinetic analysis revealed that the reduction in Ca2+-sensing activity was associated with a decrease in affinity for membranes. These mutations did not affect syt-syntaxin interactions but resulted in a similar to50% loss in SNAP-25 binding activity, suggesting that these residues lie at an interface between membranes and SNAP-25. Expression of full-length versions of syt that harbored these mutations reduced the rate of exocytosis in PC12 cells. In both biochemical and functional assays, effects of the R233Q and K366Q mutations were not additive, indicating that mutations in one domain affect the activity of the adjacent domain. These findings indicate that the tandem C2 domains of syt cooperate with one another to trigger release via loop-mediated electrostatic interactions with effector molecules.	Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), Univ Wisconsin, Dept Physiol, 1300 Univ Ave,SMI 129, Madison, WI 53706 USA.		Wang, Chih-Tien/GRE-8232-2022	Wang, Chih-Tien/0000-0001-7639-7508; Chapman, Edwin/0000-0001-9787-8140	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044057] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 56827] Funding Source: Medline; NIMH NIH HHS [MH 61876] Funding Source: Medline; NINDS NIH HHS [NS 44057] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arac D, 2003, BIOCHEMISTRY-US, V42, P2774, DOI 10.1021/bi0272050; Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; Bai JH, 2000, J BIOL CHEM, V275, P25427, DOI 10.1074/jbc.M906729199; BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; CHAPMAN ER, 1992, BIOCHEMISTRY-US, V31, P12819, DOI 10.1021/bi00166a016; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Craxton M, 2001, GENOMICS, V77, P43, DOI 10.1006/geno.2001.6619; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2002, J NEUROSCI, V22, P8438; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Grobler JA, 1996, NAT STRUCT BIOL, V3, P788, DOI 10.1038/nsb0996-788; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Mackler JM, 2001, J COMP NEUROL, V436, P4, DOI 10.1002/cne.1049; Mahal LK, 2002, J CELL BIOL, V158, P273, DOI 10.1083/jcb.200203135; Marqueze B, 2000, BIOCHIMIE, V82, P409, DOI 10.1016/S0300-9084(00)00220-0; Matos MF, 2000, EUR J CELL BIOL, V79, P377, DOI 10.1078/0171-9335-00063; Osborne SL, 1999, J BIOL CHEM, V274, P59, DOI 10.1074/jbc.274.1.59; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tucker WC, 2003, J CELL BIOL, V162, P199, DOI 10.1083/jcb.200302060; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wu Y, 2003, P NATL ACAD SCI USA, V100, P2082, DOI 10.1073/pnas.0435872100; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	47	53	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47030	47037		10.1074/jbc.M306728200	http://dx.doi.org/10.1074/jbc.M306728200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963743	hybrid			2022-12-27	WOS:000186569400099
J	Prokop, Z; Monincova, M; Chaloupkova, R; Klvana, M; Nagata, Y; Janssen, DB; Damborsky, J				Prokop, Z; Monincova, M; Chaloupkova, R; Klvana, M; Nagata, Y; Janssen, DB; Damborsky, J			Catalytic mechanism of the haloalkane dehalogenase LinB from Sphingomonas paucimobilis UT26	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXACHLOROCYCLOHEXANE-DEGRADING BACTERIUM; SITE-DIRECTED MUTAGENESIS; X-RAY-STRUCTURE; KINETIC-ANALYSIS; SUBSTRATE CLASS; HALIDE-BINDING; STEADY-STATE; SPECIFICITY; EVOLUTION; MUTATIONS	Haloalkane dehalogenases are bacterial enzymes capable of carbon-halogen bond cleavage in halogenated compounds. To obtain insights into the mechanism of the haloalkane dehalogenase from Sphingomonas paucimobilis UT26 (LinB), we studied the steady-state and presteady-state kinetics of the conversion of the substrates 1-chlorohexane, chlorocyclohexane, and bromocyclohexane. The results lead to a proposal of a minimal kinetic mechanism consisting of three main steps: (i) substrate binding, (ii) cleavage of the carbon-halogen bond with simultaneous formation of an alkyl-enzyme intermediate, and (iii) hydrolysis of the alkyl-enzyme intermediate. Release of both products, halide and alcohol, is a fast process that was not included in the reaction mechanism as a distinct step. Comparison of the kinetic mechanism of LinB with that of haloalkane dehalogenase DhlA from Xantobacter autotrophicus GJ10 and the haloalkane dehalogenase DhaA from Rhodococcus rhodochrous NCIMB 13064 shows that the overall mechanisms are similar. The main difference is in the rate-limiting step, which is hydrolysis of the alkylenzyme intermediate in LinB, halide release in DhlA, and liberation of an alcohol in DhaA. The occurrence of different rate-limiting steps for three enzymes that belong to the same protein family indicates that extrapolation of this important catalytic property from one enzyme to another can be misleading even for evolutionary closely related proteins. The differences in the rate-limiting step were related to: (i) number and size of the entrance tunnels, (ii) protein flexibility, and (iii) composition of the halide-stabilizing active site residues based on comparison of protein structures.	Masaryk Univ, Natl Ctr Biomol Res, CS-61137 Brno, Czech Republic; Tohoku Univ, Grad Sch Life Sci, Dept Life Sci, Sendai, Miyagi 9808577, Japan; Univ Groningen, NL-9747 AG Groningen, Netherlands	Masaryk University Brno; Tohoku University; University of Groningen	Prokop, Z (corresponding author), Masaryk Univ, Natl Ctr Biomol Res, Kotlarska 2, CS-61137 Brno, Czech Republic.		Prokop, Zbynek/H-5707-2012; Chaloupkova, Radka/M-5565-2016; Damborsky, Jiri/H-3799-2012; Klvana, Martin/B-1299-2015	Prokop, Zbynek/0000-0001-9358-4081; Chaloupkova, Radka/0000-0002-3539-7445; Damborsky, Jiri/0000-0002-7848-8216; Klvana, Martin/0000-0002-5076-4936				Bohac M, 2002, BIOCHEMISTRY-US, V41, P14272, DOI 10.1021/bi026427v; Bosma T, 2003, BIOCHEMISTRY-US, V42, P8047, DOI 10.1021/bi026907m; Bosma T, 2002, APPL ENVIRON MICROB, V68, P3582, DOI 10.1128/AEM.68.7.3582-3587.2002; Damborsky J, 1999, PROTEIN ENG, V12, P989, DOI 10.1093/protein/12.11.989; Damborsky J, 1998, PURE APPL CHEM, V70, P1375, DOI 10.1351/pac199870071375; Gray KA, 2001, ADV SYNTH CATAL, V343, P607, DOI 10.1002/1615-4169(200108)343:6/7<607::AID-ADSC607>3.0.CO;2-M; Hynkova K, 1999, FEBS LETT, V446, P177, DOI 10.1016/S0014-5793(99)00199-4; JANSSEN DB, 1988, EUR J BIOCHEM, V171, P67, DOI 10.1111/j.1432-1033.1988.tb13759.x; KENNES C, 1995, EUR J BIOCHEM, V228, P403; Kmunicek J, 2001, BIOCHEMISTRY-US, V40, P8905, DOI 10.1021/bi010464p; Krooshof GH, 1998, BIOCHEMISTRY-US, V37, P15013, DOI 10.1021/bi9815187; Krooshof GH, 1997, BIOCHEMISTRY-US, V36, P9571, DOI 10.1021/bi971014t; Kulakova AN, 1997, MICROBIOL-SGM, V143, P109, DOI 10.1099/00221287-143-1-109; Lewandowicz A, 2001, J AM CHEM SOC, V123, P4550, DOI 10.1021/ja003503d; Marek J, 2000, BIOCHEMISTRY-US, V39, P14082, DOI 10.1021/bi001539c; Marvanova S, 2001, J MICROBIOL METH, V44, P149, DOI 10.1016/S0167-7012(00)00250-5; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nagata Y, 1999, PROTEIN EXPRES PURIF, V17, P299, DOI 10.1006/prep.1999.1143; Nagata Y, 2003, APPL ENVIRON MICROB, V69, P2349, DOI 10.1128/AEM.69.4.2349-2355.2003; Nagata Y, 1997, APPL ENVIRON MICROB, V63, P3707, DOI 10.1128/AEM.63.9.3707-3710.1997; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otyepka M, 2002, PROTEIN SCI, V11, P1206, DOI 10.1110/ps.ps3830102; Paneth P, 2003, ACCOUNTS CHEM RES, V36, P120, DOI 10.1021/ar010101h; Pikkemaat MG, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.8.e35; PRIES F, 1994, J BIOL CHEM, V269, P17490; PRIES F, 1995, J BIOL CHEM, V270, P10405, DOI 10.1074/jbc.270.18.10405; PRIES F, 1994, BIOCHEMISTRY-US, V33, P1242, DOI 10.1021/bi00171a026; Schanstra JP, 1996, J BIOL CHEM, V271, P14747, DOI 10.1074/jbc.271.25.14747; Schanstra JP, 1996, BIOCHEMISTRY-US, V35, P5624, DOI 10.1021/bi952904g; Schanstra JP, 1997, PROTEIN ENG, V10, P53, DOI 10.1093/protein/10.1.53; Schanstra JP, 1996, BIOCHEMISTRY-US, V35, P13186, DOI 10.1021/bi961151a; Schindler JF, 1999, BIOCHEMISTRY-US, V38, P5772, DOI 10.1021/bi982853y; TERADA I, 1990, J BIOL CHEM, V265, P6576; VERSCHUEREN KHG, 1993, NATURE, V363, P693, DOI 10.1038/363693a0; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V	36	70	72	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45094	45100		10.1074/jbc.M307056200	http://dx.doi.org/10.1074/jbc.M307056200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952988	hybrid, Green Published			2022-12-27	WOS:000186452300008
J	Ruone, S; Rhoades, AR; Formosa, T				Ruone, S; Rhoades, AR; Formosa, T			Multiple Nhp6 molecules are required to recruit Spt16-Pob3 to form yFACT complexes and to reorganize nucleosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; CATALYTIC SUBUNIT; PROTEINS NHP6A/B; HMG PROTEINS; DNA-BINDING; POB3; DETERMINANTS; ELONGATION; INTERACTS; GENES	Saccharomyces cerevisiae Nhp6 protein contains a DNA-binding motif that is similar to those found in the high mobility group B family of chromatin proteins. Nhp6 bound to nucleosomes and made at least two changes in them: the nucleosomal DNA became more sensitive to DNase I at specific sites, and the nucleosomes became competent to bind Spt16-Pob3 to form yFACT.nucleosome complexes. Both changes occurred at similar concentrations of Nhp6, suggesting that they reflect the same structural reorganization of the nucleosome. Nucleosomes have multiple binding sites for Nhp6, and structural reorganization was associated with a concentration of Nhp6 about 10-fold higher than that needed for simple binding. We propose that the coordinated action of multiple Nhp6 molecules is required to convert nucleosomes to an alternative form as the first step in a two-step reorganization of nucleosomes with the second step being dependent on Spt16-Pob3. The presence of linker DNA had only subtle effects on these processes, indicating that both Nhp6 and yFACT act on core nucleosome structure rather than on the interaction between nucleosomes and adjacent DNA. These results suggest that Nhp6 and the related high mobility group B proteins may have a general role in promoting rearrangements of chromatin by initiating the destabilization of core nucleosomal structure.	Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Formosa, T (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA.	Tim@biochem.utah.edu		Formosa, Tim/0000-0002-8477-2483				Allain FHT, 1999, EMBO J, V18, P2563, DOI 10.1093/emboj/18.9.2563; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; BRUHN SL, 1992, P NATL ACAD SCI USA, V89, P2307, DOI 10.1073/pnas.89.6.2307; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P152, DOI 10.1016/S0968-0004(00)01777-1; Bustin M, 1999, MOL CELL BIOL, V19, P5237; COSTIGAN C, 1994, MOL CELL BIOL, V14, P2391, DOI 10.1128/MCB.14.4.2391; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2003, CURR TOP MICROBIOL, V274, P171; Formosa T, 2002, GENETICS, V162, P1557; GRAZIANO V, 1988, J MOL BIOL, V203, P997, DOI 10.1016/0022-2836(88)90124-6; John S, 2000, GENE DEV, V14, P1196; Kolodrubetz D, 2001, GENE, V272, P93, DOI 10.1016/S0378-1119(01)00568-6; KOLODRUBETZ D, 1990, J BIOL CHEM, V265, P3234; Luger K, 1999, METHOD ENZYMOL, V304, P3; Okuhara K, 1999, CURR BIOL, V9, P341, DOI 10.1016/S0960-9822(99)80160-2; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Paull TT, 1996, GENE DEV, V10, P2769, DOI 10.1101/gad.10.21.2769; PAULL TT, 1995, J BIOL CHEM, V270, P8744, DOI 10.1074/jbc.270.15.8744; Ross ED, 2001, MOL CELL BIOL, V21, P6598, DOI 10.1128/MCB.21.19.6598-6605.2001; SAMBROOK J., 1989, MOL CLONING LAB MANU, pB23; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; TRAVERS AA, 1994, CELL, V77, P167, DOI 10.1016/0092-8674(94)90306-9; van Holde K.E., 1988, CHROMATIN; Wittmeyer J, 1999, BIOCHEMISTRY-US, V38, P8961, DOI 10.1021/bi982851d; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Yen YM, 1998, J BIOL CHEM, V273, P4424, DOI 10.1074/jbc.273.8.4424; Yu YX, 2000, MOL CELL BIOL, V20, P2350, DOI 10.1128/MCB.20.7.2350-2357.2000	31	61	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45288	45295		10.1074/jbc.M307291200	http://dx.doi.org/10.1074/jbc.M307291200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952948	hybrid			2022-12-27	WOS:000186452300030
J	Seibold, SA; Ball, T; Hsi, LC; Mills, DA; Abeysinghe, RD; Micielli, R; Rieke, CJ; Cukier, RI; Smith, WL				Seibold, SA; Ball, T; Hsi, LC; Mills, DA; Abeysinghe, RD; Micielli, R; Rieke, CJ; Cukier, RI; Smith, WL			Histidine 386 and its role in cyclooxygenase and peroxidase catalysis by prostaglandin-endoperoxide H synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHER OXIDATION-STATE; MOLECULAR-DYNAMICS; ARACHIDONIC-ACID; NITRIC-OXIDE; SELECTIVE-INHIBITION; PROXIMAL LIGAND; FATTY-ACIDS; COMPOUND-I; HEME; BINDING	Prostaglandin-endoperoxide H synthases (PGHSs) have a cyclooxygenase that forms prostaglandin (PG) G(2) from arachidonic acid (AA) plus oxygen and a peroxidase that reduces the PGG(2) to PGH(2). The peroxidase activates the cyclooxygenase. This involves an initial oxidation of the peroxidase heme group by hydroperoxide, followed by oxidation of Tyr(385) to a tyrosyl radical within the cyclooxygenase site. His(386) of PGHS-1 is not formally part of either active site, but lies in an extended helix between Tyr(385), which protrudes into the cyclooxygenase site, and His(388), the proximal ligand of the peroxidase heme. When His(386) was substituted with alanine in PGHS-1, the mutant retained < 2.5% of the native peroxidase activity, but > 20% of the native cyclooxygenase activity. However, peroxidase activity could be restored (10-30%) by treating H386A PGHS-1 with cyclooxygenase inhibitors or AA, but not with linoleic acid; in contrast, mere occupancy of the cyclooxygenase site of native PGHS-1 had no effect on peroxidase activity. Heme titrations indicated that H386A PGHS-1 binds heme less tightly than does native PGHS-1. The low peroxidase activity and decreased affinity for heme of H386A PGHS-1 imply that His(386) helps optimize heme binding. Molecular dynamic simulations suggest that this is accomplished in part by a hydrogen bond between the heme D-ring propionate and the N-delta of Asn(382) of the extended helix. The structure of the extended helix is, in turn, strongly supported by stable hydrogen bonding between the N-delta of His(386) and the backbone carbonyl oxygens of Asn(382) and Gln(383). We speculate that the binding of cyclooxygenase inhibitors or AA to the cyclooxygenase site of ovine H386A PGHS-1 reopens the constriction in the cyclooxygenase site between the extended helix and a helix containing Gly(526) and Ser(530) and restores native-like structure to the extended helix. Being less bulky than AA, linoleic acid is apparently unable to reopen this constriction.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	University of Michigan System; University of Michigan; Michigan State University; Michigan State University	Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5416 Med Sci I,1301 Catherine St, Ann Arbor, MI 48109 USA.	smithww@umich.edu			NIGMS NIH HHS [R01 GM68848, P01 GM57323] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM057323, R01GM068848] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bakovic M, 1996, J BIOL CHEM, V271, P2048, DOI 10.1074/jbc.271.4.2048; BARNETT J, 1994, BBA-PROTEIN STRUCT M, V1209, P130, DOI 10.1016/0167-4838(94)90148-1; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; Case DA, 2002, AMBER SIMULATION SOF; Cukier RI, 2002, J PHYS CHEM B, V106, P12031, DOI 10.1021/jp021232i; Deinum G, 1996, BIOCHEMISTRY-US, V35, P1540; DeWitt DL, 1999, MOL PHARMACOL, V55, P625; DIETZ R, 1988, EUR J BIOCHEM, V171, P321, DOI 10.1111/j.1432-1033.1988.tb13793.x; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Goodwin DC, 2000, BIOCHEMISTRY-US, V39, P5422, DOI 10.1021/bi992752f; Goodwin DC, 1998, J BIOL CHEM, V273, P8903, DOI 10.1074/jbc.273.15.8903; HAMBERG M, 1967, J BIOL CHEM, V242, P5336; HEMLER M, 1976, J BIOL CHEM, V251, P5575; HEMLER ME, 1980, J BIOL CHEM, V255, P6253; Hirst J, 2001, BIOCHEMISTRY-US, V40, P1274, DOI 10.1021/bi002090q; HSI LC, 1994, BIOCHEM BIOPH RES CO, V202, P1592, DOI 10.1006/bbrc.1994.2114; Hwang D, 2001, FASEB J, V15, P2556, DOI 10.1096/fj.01-0432com; Koljak R, 2001, J BIOL CHEM, V276, P7033, DOI 10.1074/jbc.M009803200; Kozak KR, 2001, J BIOL CHEM, V276, P30072, DOI 10.1074/jbc.M104467200; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; LANEUVILLE O, 1994, J PHARMACOL EXP THER, V271, P927; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; Loll PJ, 2001, MOL PHARMACOL, V60, P1407, DOI 10.1124/mol.60.6.1407; Lu GQ, 1999, J BIOL CHEM, V274, P16162, DOI 10.1074/jbc.274.23.16162; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; MARNETT LJ, 1988, J BIOL CHEM, V263, P16532; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; Marnett LJ, 1999, TRENDS PHARMACOL SCI, V20, P465, DOI 10.1016/S0165-6147(99)01385-1; MIZUNO K, 1982, PROSTAGLANDINS, V23, P743; MUNOZ V, 1995, CURR OPIN BIOTECH, V6, P382, DOI 10.1016/0958-1669(95)80066-2; Newmyer SL, 1996, BIOCHEMISTRY-US, V35, P12788, DOI 10.1021/bi9609331; ODENWALLER R, 1992, J BIOL CHEM, V267, P13863; OTTO JC, 1994, J BIOL CHEM, V269, P19868; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Poulos TL, 1996, J BIOL INORG CHEM, V1, P356, DOI 10.1007/s007750050064; POULOS TL, 1997, BIOCHEMISTRY-US, V36, P1010; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SANCHO J, 1992, BIOCHEMISTRY-US, V31, P2253, DOI 10.1021/bi00123a006; SCHAFMEISTER CEA, 1995, LEAP SOFTWARE PACKAG; Schelvis JPM, 2000, J PHYS CHEM B, V104, P10844, DOI 10.1021/jp0016434; Schneider C, 2000, J BIOL CHEM, V275, P4743, DOI 10.1074/jbc.275.7.4743; Seibold SA, 2000, BIOCHEMISTRY-US, V39, P6616, DOI 10.1021/bi0002333; SHIMOKAWA T, 1991, J BIOL CHEM, V266, P6168; SHIMOKAWA T, 1990, J BIOL CHEM, V265, P20073; Smith T, 2000, ARCH BIOCHEM BIOPHYS, V375, P195, DOI 10.1006/abbi.1999.1659; SMITH WL, 1972, BIOCHEMISTRY-US, V11, P3276, DOI 10.1021/bi00767a024; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; Smulevich G, 1998, BIOSPECTROSCOPY, V4, pS3, DOI 10.1002/(SICI)1520-6343(1998)4:5+<S3::AID-BSPY2>3.0.CO;2-R; Song I, 2001, BIOCHEM BIOPH RES CO, V289, P869, DOI 10.1006/bbrc.2001.6071; Spencer AG, 1999, J BIOL CHEM, V274, P32936, DOI 10.1074/jbc.274.46.32936; STRIEDER S, 1992, J BIOL CHEM, V267, P13870; Tamura K, 1996, J AM CHEM SOC, V118, P9434, DOI 10.1021/ja9543457; Taniura S, 2002, J BIOL CHEM, V277, P16823, DOI 10.1074/jbc.M200527200; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Tsai AL, 2002, J BIOL CHEM, V277, P38311, DOI 10.1074/jbc.M206961200; TSAI AL, 1995, J BIOL CHEM, V270, P10503, DOI 10.1074/jbc.270.18.10503; UENO R, 1982, J BIOL CHEM, V257, P5584; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; WEI CH, 1995, BIOCHEMISTRY-US, V34, P8499, DOI 10.1021/bi00026a034; Zou J, 1999, BIOCHEM J, V340, P153, DOI 10.1042/bj3400153	66	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46163	46170		10.1074/jbc.M306319200	http://dx.doi.org/10.1074/jbc.M306319200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952981	hybrid			2022-12-27	WOS:000186452300134
J	Shan, YX; Yang, TL; Mestril, R; Wang, PH				Shan, YX; Yang, TL; Mestril, R; Wang, PH			Hsp10 and Hsp60 suppress ubiquitination of insulin-like growth factor-1 receptor and augment insulin-like growth factor-1 receptor signaling in cardiac muscle - Implications on decreased myocardial protection in diabetic cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC HEAT-SHOCK-PROTEIN-60; PHOSPHATIDYLINOSITOL 3-KINASE; EXPRESSION; APOPTOSIS; OVEREXPRESSION; ACTIVATION; ISCHEMIA; STRESS; CELLS; RAT	We have investigated the effects of two heat shock proteins, Hsp10 and Hsp60, on insulin-like growth factor-1 receptor (IGF-1R) signaling in cardiac muscle cells. Neonatal cardiomyocytes were transduced with Hsp10 or Hsp60 via adenoviral vector. Compared with the cells transduced with a control vector, overexpression of Hsp10 or Hsp60 increased the abundance of IGF-1R and IGF-1-stimulated receptor autophosphorylation. Thus, Hsp10 and Hsp60 overexpression increased the number of functioning receptors and amplified activation of IGF-1R signaling. IGF-1 stimulation of MEK, Erk, p90Rsk, and Akt were accordingly augmented. Transducing cardiomyocytes with antisense Hsp60 oligonucleotides reduced Hsp60 expression, decreased the abundance of IGF-1R, attenuated IGF-1R autophosphorylation, and suppressed the pro-survival action of IGF-1 in cardiomyocytes. Using cycloheximide to inhibit protein synthesis did not alter the effect of Hsp60 on IGF-1R signaling, and IGF-1R mRNA levels were not up-regulated by Hsp10 or Hsp60. Additional experiments showed that Hsp10 and Hsp60 suppressed polyubiquitination of IGF-1 receptor. These data indicate that Hsp10 and Hsp60 can modulate IGF-1R signaling through post-translational modification. In animal models of diabetes, diabetic myocardium is associated with decreased abundance of Hsp60, increased ubiquitination of IGF-1R, and lower level of IGF-1R protein. Declined myocardial protection is a major feature of diabetic cardiomyopathy. These data suggest that decreased Hsp60 expression and subsequent decline of IGF-1R signaling may be a fundamental mechanism underlying the development of diabetic cardiomyopathy.	Univ Calif Irvine, Ctr Cardiovasc Hormone Res, Dept Med Biol Chem Physiol & Biophys, Irvine, CA 92697 USA; First Med Univ, Nanfang Hosp, Dept Med, Guangzhou 510515, Peoples R China; Loyola Univ, Dept Physiol, Maywood, IL 60153 USA	University of California System; University of California Irvine; Southern Medical University - China; Loyola University Chicago	Wang, PH (corresponding author), Univ Calif Irvine, Dept Med, C240, Irvine, CA 92697 USA.	phwang@uci.edu		Mestril, Ruben/0000-0003-3631-2236				Barazi HO, 2002, CANCER RES, V62, P1541; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Basso AD, 2002, ONCOGENE, V21, P1159, DOI 10.1038/sj.onc.1205184; CONDORELLI G, 1994, J BIOL CHEM, V269, P8510; Czar MJ, 1997, BIOCHEMISTRY-US, V36, P7776, DOI 10.1021/bi970648x; Dalle S, 2002, MOL CELL BIOL, V22, P6272, DOI 10.1128/MCB.22.17.6272-6285.2002; Gupta S, 2002, CIRCULATION, V106, P2727, DOI 10.1161/01.CIR.0000038112.64503.6E; Izaki K, 2001, MOL BRAIN RES, V88, P14, DOI 10.1016/S0169-328X(01)00012-2; Kajstura J, 2001, DIABETES, V50, P1414, DOI 10.2337/diabetes.50.6.1414; Kim JJ, 2002, GROWTH HORM IGF RES, V12, P84, DOI 10.1054/ghir.2002.0265; Kirchhoff SR, 2002, CIRCULATION, V105, P2899, DOI 10.1161/01.CIR.0000019403.35847.23; Latchman DS, 2001, CARDIOVASC RES, V51, P637, DOI 10.1016/S0008-6363(01)00354-6; Lau S, 1997, CIRCULATION, V96, P2287; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730; Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787; Parrizas M, 1997, J BIOL CHEM, V272, P154; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Schafler AE, 2002, BASIC RES CARDIOL, V97, P258, DOI 10.1007/s003950200019; SEPPLORENZINO L, 1995, J BIOL CHEM, V270, P16580, DOI 10.1074/jbc.270.28.16580; Shah M, 2002, J BIOL CHEM, V277, P45662, DOI 10.1074/jbc.M205935200; Wang PH, 1999, ENDOCRINOLOGY, V140, P1141, DOI 10.1210/en.140.3.1141; Wang PH, 2001, CIRC RES, V88, P552, DOI 10.1161/01.RES.88.6.552; Wu WH, 2000, J BIOL CHEM, V275, P40113, DOI 10.1074/jbc.M004108200	25	67	72	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45492	45498		10.1074/jbc.M304498200	http://dx.doi.org/10.1074/jbc.M304498200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12970367	hybrid			2022-12-27	WOS:000186452300055
J	Srivastava, S; Matsuda, M; Hou, ZY; Bailey, JP; Kitazawa, R; Herbst, MP; Horseman, ND				Srivastava, S; Matsuda, M; Hou, ZY; Bailey, JP; Kitazawa, R; Herbst, MP; Horseman, ND			Receptor activator of NF-kappa B ligand induction via Jak2 and Stat5a in mammary epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN D1 EXPRESSION; GLAND DEVELOPMENT; OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN-LIGAND; PROGESTERONE-RECEPTOR; SIGNAL TRANSDUCER; GENE-EXPRESSION; PROLACTIN; GROWTH; PROMOTER	Prolactin (PRL) is the primary hormone that, in conjunction with local factors, leads to lobuloalveolar development during pregnancy. Recently, receptor activator of NF-kappaB ligand (RANKL) has been identified as one of the effector molecules essential for lobuloalveolar development. The molecular mechanisms by which PRL may induce RANKL expression have not been carefully examined. Here we report that RANKL expression in the mammary gland is developmentally regulated and dependent on PRL and progesterone, whereas its receptor RANK (receptor activator of NF-kappaB) and decoy receptor osteoprotegerin (OPG) are constitutively expressed at all stages in both normal (PRL+/-) and prolactin knockout (PRL-/-) mice. In vitro, PRL markedly increased RANKL expression in primary mammary epithelial cells and RANKL-luciferase reporter activity in CHOD6 cells, which constitutively express the PRL receptor. We identified a gamma-interferon activation sequence (GAS) in the region between residues -965 to -725 of the RANKL promoter, which conferred a PRL response. Using dominant negative mutants of recombinant Jak2 and Stat5 in CHOD6 cells, and by reconstituting the Jak2/Stat5 pathway in COS7 cells, we determined that Jak2 and Stat5a are essential for the PRL-induced RANKL expression in mammary gland.	Univ Cincinnati, Dept Cellular & Mol Physiol, Cincinnati, OH 45267 USA; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113003, Japan; Kobe Univ, Dept Pathol, Kobe, Hyogo 6500017, Japan	University System of Ohio; University of Cincinnati; University of Tokyo; Kobe University	Horseman, ND (corresponding author), Univ Cincinnati, Dept Cellular & Mol Physiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	nelson.horseman@uc.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R43DK053124] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-53124] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Brantley DM, 2001, MOL BIOL CELL, V12, P1445, DOI 10.1091/mbc.12.5.1445; Brisken C, 2002, DEV CELL, V3, P877, DOI 10.1016/S1534-5807(02)00365-9; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Brisken C, 2002, J MAMMARY GLAND BIOL, V7, P39, DOI 10.1023/A:1015718406329; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Clarkson RWE, 1999, J MAMMARY GLAND BIOL, V4, P165, DOI 10.1023/A:1018725207969; Fantl V, 1999, DEV BIOL, V212, P1, DOI 10.1006/dbio.1999.9329; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Gao J, 1996, MOL ENDOCRINOL, V10, P847, DOI 10.1210/me.10.7.847; Hennighausen L, 1998, GENE DEV, V12, P449, DOI 10.1101/gad.12.4.449; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; Horseman ND, 1999, J MAMMARY GLAND BIOL, V4, P79, DOI 10.1023/A:1018708704335; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Hou ZY, 2003, MOL ENDOCRINOL, V17, P1910, DOI 10.1210/me.2003-0045; Hovey RC, 2003, MOL ENDOCRINOL, V17, P460, DOI 10.1210/me.2002-0214; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; IMAGAWA W, 1982, P NATL ACAD SCI-BIOL, V79, P4074, DOI 10.1073/pnas.79.13.4074; Kelly PA, 2002, MOL CELL ENDOCRINOL, V197, P127, DOI 10.1016/S0303-7207(02)00286-1; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kim HJ, 2002, J BIOL CHEM, V277, P5339, DOI 10.1074/jbc.M108342200; Kitazawa R, 1999, BBA-GENE STRUCT EXPR, V1445, P134, DOI 10.1016/S0167-4781(99)00032-9; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Matsuda M, 2003, ENDOCRINE, V20, P91, DOI 10.1385/ENDO:20:1-2:91; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; NANDI S, 1958, J NATL CANCER I, V21, P1039; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Ormandy CJ, 1997, J MAMMARY GLAND BIOL, V2, P355, DOI 10.1023/A:1026395229025; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Shyamala G, 1999, J MAMMARY GLAND BIOL, V4, P89, DOI 10.1023/A:1018760721173; Silberstein GB, 1996, CELL GROWTH DIFFER, V7, P945; Srivastava S, 1999, J CLIN INVEST, V104, P503, DOI 10.1172/JCI7094; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; TOPPER YJ, 1980, PHYSIOL REV, V60, P1049, DOI 10.1152/physrev.1980.60.4.1049; Verdier F, 1998, MOL CELL BIOL, V18, P5852, DOI 10.1128/MCB.18.10.5852; Vomachka AJ, 2000, ONCOGENE, V19, P1077, DOI 10.1038/sj.onc.1203348; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; Watson CJ, 2001, J MAMMARY GLAND BIOL, V6, P115, DOI 10.1023/A:1009524817155; Xie J, 2002, J BIOL CHEM, V277, P14020, DOI 10.1074/jbc.M112399200	44	94	96	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46171	46178		10.1074/jbc.M308545200	http://dx.doi.org/10.1074/jbc.M308545200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952963	hybrid			2022-12-27	WOS:000186452300135
J	Johansson, K; Bourhis, JM; Campanacci, V; Cambillau, C; Canard, B; Longhi, S				Johansson, K; Bourhis, JM; Campanacci, V; Cambillau, C; Canard, B; Longhi, S			Crystal structure of the measles virus phosphoprotein domain responsible for the induced folding of the C-terminal domain of the nucleoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOCAPSID-LIKE STRUCTURES; P-PROTEIN; RNA-SYNTHESIS; PARAINFLUENZA VIRUS; GENOME REPLICATION; IN-VITRO; NP-P; BINDING; RECOGNITION; COMPLEX	Measles virus is a negative-sense, single-stranded RNA virus belonging to the Mononegavirales order which comprises several human pathogens such as Ebola, Nipah, and Hendra viruses. The phosphoprotein of measles virus is a modular protein consisting of an intrinsically disordered N-terminal domain (Karlin, D., Longhi, S., Receveur, V., and Canard, B. (2002) Virology 296, 251 - 262) and of a C-terminal moiety (PCT) composed of alternating disordered and globular regions. We report the crystal structure of the extreme C-terminal domain (XD) of measles virus phosphoprotein (aa 459 - 507) at 1.8 Angstrom resolution. We have previously reported that the C-terminal domain of measles virus nucleoprotein, N-TAIL, is intrinsically unstructured and undergoes induced folding in the presence of PCT ( Longhi, S., Receveur-Brechot, V., Karlin, D., Johansson, K., Darbon, H., Bhella, D., Yeo, R., Finet, S., and Canard, B. (2003) J. Biol. Chem. 278, 18638 - 18648). Using far-UV circular dichroism, we show that within PCT, XD is the region responsible for the induced folding of N-TAIL. The crystal structure of XD consists of three helices, arranged in an anti-parallel triple-helix bundle. The surface of XD formed between helices alpha2 and alpha3 displays a long hydrophobic cleft that might provide a complementary hydrophobic surface to embed and promote folding of the predicted alpha-helix of N-TAIL. We present a tentative model of the interaction between XD and N-TAIL. These results, beyond presenting the first measles virus protein structure, shed light both on the function of the phosphoprotein at the molecular level and on the process of induced folding.	CNRS, UMR Architecture & Fonct Macromol Biol 6098, ESIL, F-13288 Marseille 09, France; Univ Aix Marseille, F-13288 Marseille, France; Univ Aix Marseille, F-13402 Marseille, France; CNRS, UMR Architecture & Fonct Macromol Biol 6098, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Longhi, S (corresponding author), CNRS, UMR Architecture & Fonct Macromol Biol 6098, ESIL, Case 925,163 Av Luminy, F-13288 Marseille 09, France.		LONGHI, Sonia/M-5305-2014	LONGHI, Sonia/0000-0002-6829-6771; Canard, Bruno/0000-0003-4924-1991; Campanacci, Valerie/0000-0001-6407-6395				Bankamp B, 1996, VIROLOGY, V216, P272, DOI 10.1006/viro.1996.0060; Bhella D, 2002, J GEN VIROL, V83, P1831, DOI 10.1099/0022-1317-83-8-1831; BUCHHOLZ CJ, 1994, VIROLOGY, V204, P770, DOI 10.1006/viro.1994.1592; Coronel EC, 2001, J VIROL, V75, P1117, DOI 10.1128/JVI.75.3.1117-1123.2001; CURRAN J, 1991, EMBO J, V10, P3079, DOI 10.1002/j.1460-2075.1991.tb07860.x; Curran J, 1999, ADV VIRUS RES, V54, P403, DOI 10.1016/S0065-3527(08)60373-5; CURRAN J, 1995, J VIROL, V69, P849, DOI 10.1128/JVI.69.2.849-855.1995; CURRAN J, 1988, EMBO J, V7, P2869, DOI 10.1002/j.1460-2075.1988.tb03143.x; Curran J, 1998, J VIROL, V72, P4274, DOI 10.1128/JVI.72.5.4274-4280.1998; Curran J, 1996, VIROLOGY, V221, P130, DOI 10.1006/viro.1996.0359; CURRAN J, 1994, VIROLOGY, V202, P875, DOI 10.1006/viro.1994.1409; CURRAN J, 1995, VIROLOGY, V214, P139, DOI 10.1006/viro.1995.9946; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; FOOKS AR, 1993, J GEN VIROL, V74, P1439, DOI 10.1099/0022-1317-74-7-1439; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HARTY RN, 1995, J GEN VIROL, V76, P2863, DOI 10.1099/0022-1317-76-11-2863; HEGGENESS MH, 1981, VIROLOGY, V114, P555, DOI 10.1016/0042-6822(81)90235-X; HEGGENESS MH, 1980, P NATL ACAD SCI-BIOL, V77, P2631, DOI 10.1073/pnas.77.5.2631; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3191, DOI 10.1073/pnas.0436100100; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HORIKAMI SM, 1992, J VIROL, V66, P4901, DOI 10.1128/JVI.66.8.4901-4908.1992; HUBER M, 1991, VIROLOGY, V185, P299, DOI 10.1016/0042-6822(91)90777-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlin D, 2002, VIROLOGY, V302, P420, DOI 10.1006/viro.2002.1634; Karlin D, 2002, VIROLOGY, V296, P251, DOI 10.1006/viro.2001.1296; KARLIN D, 2003, IN PRESS J GEN VIROL, V84; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; Liston P, 1997, ARCH VIROL, V142, P305, DOI 10.1007/s007050050078; LISTON P, 1995, VIRUS RES, V38, P241, DOI 10.1016/0168-1702(95)00067-Z; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; Marion D, 2001, J BIOMOL NMR, V21, P75, DOI 10.1023/A:1011990021282; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Morris MC, 1999, J PEPT SCI, V5, P263, DOI 10.1002/(SICI)1099-1387(199906)5:6<263::AID-PSC191>3.3.CO;2-1; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Nishio M, 1996, J GEN VIROL, V77, P2457, DOI 10.1099/0022-1317-77-10-2457; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PRECIOUS B, 1995, J VIROL, V69, P8001, DOI 10.1128/JVI.69.12.8001-8010.1995; Rost B, 1996, METHOD ENZYMOL, V266, P525; RYAN KW, 1990, VIROLOGY, V174, P515, DOI 10.1016/0042-6822(90)90105-Z; SMALLWOOD S, 1994, VIROLOGY, V202, P154, DOI 10.1006/viro.1994.1331; Spehner D, 1997, VIROLOGY, V232, P260, DOI 10.1006/viro.1997.8568; SPEHNER D, 1991, J VIROL, V65, P6296, DOI 10.1128/JVI.65.11.6296-6300.1991; Sulzenbacher G, 2002, ACTA CRYSTALLOGR D, V58, P2109, DOI 10.1107/S0907444902013938; Tarbouriech N, 2000, NAT STRUCT BIOL, V7, P777; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Turnbull AP, 2001, STRUCTURE, V9, P347, DOI 10.1016/S0969-2126(01)00595-0; VANGUNSTEREN WF, 1995, COMPUT PHYS COMMUN, V91, P305, DOI 10.1016/0010-4655(95)00055-K; Wahlberg E, 2003, P NATL ACAD SCI USA, V100, P3185, DOI 10.1073/pnas.0436086100; WARNES A, 1995, GENE, V160, P173, DOI 10.1016/0378-1119(95)00227-W; Zhang XS, 2002, J VIROL, V76, P8737, DOI 10.1128/JVI.76.17.8737-8746.2002	56	133	144	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44567	44573		10.1074/jbc.M308745200	http://dx.doi.org/10.1074/jbc.M308745200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944395	hybrid			2022-12-27	WOS:000186306700086
J	Cai, Y; Jin, JJ; Tomomori-Sato, C; Sato, S; Sorokina, I; Parmely, TJ; Conaway, RC; Conaway, JW				Cai, Y; Jin, JJ; Tomomori-Sato, C; Sato, S; Sorokina, I; Parmely, TJ; Conaway, RC; Conaway, JW			Identification of new subunits of the multiprotein mammalian TRRAP/TIP60-containing histone acetyltransferase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ACETYLASE COMPLEX; TRANSCRIPTIONAL ACTIVATION; NUCLEOSOME ACETYLATION; BINDING PROTEIN; YEAST; NUA4; CHROMATIN; MRG15; ENHANCER	The mammalian ATM/PI 3-kinase-related TRRAP protein was previously found to be a component of a multiprotein histone acetyltransferase ( HAT) complex containing the HAT TIP60. In this report, we identify a previously uncharacterized protein encoded by the FLJ10914 ORF, which we designate MRGBP, as a new component of the TRRAP/TIP60 HAT complex. In addition, through purification of MRGBP and its associated proteins from HeLa cell nuclear extracts, we identify the thyroid receptor coactivating protein (TRCp120), DMAP1, and the related MRG15 and MRGX proteins as MRGBP-associating proteins, and we present biochemical evidence that they are previously unrecognized components of the TRRAP/TIP60 HAT complex. Taken together, our findings shed new light on the structure and function of the mammalian TRRAP/TIP60 histone acetyltransferase complex.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Conaway, JW (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.			Conaway, Joan/0000-0002-2786-0663; Sorokina, Irina/0000-0003-1531-1832; Tomomori-Sato, Chieri/0000-0002-2543-293X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM41628] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Bertram MJ, 1999, MOL CELL BIOL, V19, P1479; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Brand M, 2001, EMBO J, V20, P3187, DOI 10.1093/emboj/20.12.3187; Brower CS, 2002, P NATL ACAD SCI USA, V99, P10353, DOI 10.1073/pnas.162424199; Cavusoglu N, 2003, PROTEOMICS, V3, P217, DOI 10.1002/pmic.200390030; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eisen A, 2001, J BIOL CHEM, V276, P3484, DOI 10.1074/jbc.M008159200; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1998, TRENDS CELL BIOL, V8, P193, DOI 10.1016/S0962-8924(98)01263-X; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Le Masson I, 2003, MOL CELL BIOL, V23, P6086, DOI 10.1128/MCB.23.17.6086-6102.2003; Leung JK, 2001, J BIOL CHEM, V276, P39171, DOI 10.1074/jbc.M103435200; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Monden T, 1997, J BIOL CHEM, V272, P29834, DOI 10.1074/jbc.272.47.29834; Nourani A, 2001, MOL CELL BIOL, V21, P7629, DOI 10.1128/MCB.21.22.7629-7640.2001; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Pardo PS, 2002, J BIOL CHEM, V277, P50860, DOI 10.1074/jbc.M203839200; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sato S, 2003, J BIOL CHEM, V278, P15123, DOI 10.1074/jbc.C300054200; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; Yochum GS, 2002, MOL CELL BIOL, V22, P7868, DOI 10.1128/MCB.22.22.7868-7876.2002	26	167	185	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					42733	42736		10.1074/jbc.C300389200	http://dx.doi.org/10.1074/jbc.C300389200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12963728	hybrid			2022-12-27	WOS:000186157000002
J	Mu, XM; Chang, CS				Mu, XM; Chang, CS			TR3 orphan nuclear receptor mediates apoptosis through up-regulating E2F1 in human prostate cancer LNCaP cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; NGFI-B; DNA-BINDING; INDUCTION; SUPERFAMILY; NUR77; MEMBER; PROTEINS; PATHWAY; DEATH	Early studies suggested both TR3 orphan receptor ( TR3) and apoptosis mediator E2F1 might play an important role in mediating prostate cancer cell apoptosis. Their linkage and relationship, however, remain unclear. Here we found that 12-O-tetradecanoylphorbol-13- acetate (TPA) could induce cell apoptosis via induction of TR3 and E2F1 expression in LNCaP prostate cancer cells. Addition of antisense E2F1 could partially rescue the TR3-mediated cell apoptosis, and transfection of the TR3 dominant-negative plasmid could block the TR3-induced E2F1 expression. These data suggest that TPA is able to induce LNCaP cell apoptosis via induction of TR3 resulting in the induction of E2F1. Promoter reporter assays show that TR3 can induce E2F1 expression via binding to the TR3 response element (TR3RE) in the E2F1 promoter - 316 to - 324 bp region. TR3 can bind specifically to this TR3RE with a K-d of 6.29 nM, and mutations of this E2F1-TR3RE can partially block the TR3-mediated E2F1 expression. Taken together, these data suggest that TPA is able to induce cell apoptosis via a TPA 3 TR3 3 E2F1 3 apoptosis pathway in LNCaP cells. Further studies of how to modulate this pathway may allow us to better understand how to control the prostate cancer growth.	Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Urol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Chang, CS (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA.			Chang, Chawnshang/0000-0001-8510-3516	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047258, R01DK056984] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 47258, DK56984] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BUTTYAN R, 1988, MOL ENDOCRINOL, V2, P650, DOI 10.1210/mend-2-7-650; CHANG C, 1989, J STEROID BIOCHEM, V34, P391; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; ISAACS JT, 1992, J ANDROL, V13, P457; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Katagiri Y, 2000, NAT CELL BIOL, V2, P435, DOI 10.1038/35017072; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li Y, 1998, MOL CELL BIOL, V18, P4719, DOI 10.1128/MCB.18.8.4719; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Mu XM, 1998, ENDOCRINE, V9, P27, DOI 10.1385/ENDO:9:1:27; Mu XM, 2000, J BIOL CHEM, V275, P23877, DOI 10.1074/jbc.M910158199; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Phillips AC, 1997, GENE DEV, V11, P1853, DOI 10.1101/gad.11.14.1853; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Strathdee CA, 1999, GENE, V229, P21, DOI 10.1016/S0378-1119(99)00045-1; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; Uemura H, 1998, ENDOCRINOLOGY, V139, P2329, DOI 10.1210/en.139.5.2329; vanGinkel PR, 1997, J BIOL CHEM, V272, P18367, DOI 10.1074/jbc.272.29.18367; Wang WL, 1999, MOL ENDOCRINOL, V13, P1373, DOI 10.1210/me.13.8.1373; WATSON MA, 1989, MOL CELL BIOL, V9, P4213, DOI 10.1128/MCB.9.10.4213; Weih F, 1996, P NATL ACAD SCI USA, V93, P5533, DOI 10.1073/pnas.93.11.5533; WILSON TE, 1992, SCIENCE, V256, P107, DOI 10.1126/science.1314418; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; YOUNG CYF, 1994, ONCOL RES, V6, P203	38	38	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					42840	42845		10.1074/jbc.M305594200	http://dx.doi.org/10.1074/jbc.M305594200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12947120	hybrid			2022-12-27	WOS:000186157000015
J	Saxowsky, TT; Choudhary, G; Klingbeil, MM; Englund, PT				Saxowsky, TT; Choudhary, G; Klingbeil, MM; Englund, PT			Trypanosoma brucei has two distinct mitochondrial DNA polymerase beta enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRITHIDIA-FASCICULATA; KINETOPLAST DNA; TOPOISOMERASE-II; REPLICATION; PROTEINS; IDENTIFICATION; LOCALIZATION; MINICIRCLES; EQUIPERDUM; REPAIR	In higher eukaryotes, DNA polymerase (pol) beta resides in the nucleus and participates primarily in DNA repair. The DNA polymerase beta from the trypanosomatid Crithidia fasciculata, however, was the first mitochondrial enzyme of this type described. Upon searching the nearly completed genome data base of the related parasite Trypanosoma brucei, we discovered genes for two pol beta-like proteins. One is similar to 70% identical to the C. fasciculata pol beta and is likely the homolog of this enzyme. The other, although similar to 30% identical within the polymerase region, has unusual structural features including a short C-terminal tail and a long N-terminal extension rich in prolines, alanines, and lysines. Both proteins, when expressed recombinantly, are active as DNA polymerases and deoxyribose phosphate lyases, but their polymerase activity optima differ with respect to pH and KCl and MgCl2 concentrations. Remarkably, green fluorescent protein fusion proteins and immunofluorescence demonstrate that both are mitochondrial, but their locations with respect to the mitochondrial DNA ( kinetoplast DNA network) in this organism are strikingly different.	Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Englund, PT (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.			Klingbeil, Michele/0000-0002-7236-8424	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027608, R37GM027608] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM27608] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu-Elneel K, 2001, J CELL BIOL, V153, P725, DOI 10.1083/jcb.153.4.725; BIRKENMEYER L, 1986, J BIOL CHEM, V261, P2362; Burgers PMJ, 1998, CHROMOSOMA, V107, P218, DOI 10.1007/s004120050300; CavalierSmith T, 1997, TRENDS GENET, V13, P6, DOI 10.1016/S0168-9525(96)30116-9; Drew ME, 2001, J CELL BIOL, V153, P735, DOI 10.1083/jcb.153.4.735; Engel ML, 1999, P NATL ACAD SCI USA, V96, P8455, DOI 10.1073/pnas.96.15.8455; FERGUSON M, 1992, CELL, V70, P621, DOI 10.1016/0092-8674(92)90431-B; Fuenmayor J, 1998, J EUKARYOT MICROBIOL, V45, P404, DOI 10.1111/j.1550-7408.1998.tb05091.x; Haltiwanger BM, 2000, BIOCHEMISTRY-US, V39, P763, DOI 10.1021/bi9923151; HARLOW E, 1988, ANTIBODIES LAB MANUA, P498; Hausler T, 1997, EUR J CELL BIOL, V73, P240; Hines JC, 1998, MOL BIOCHEM PARASIT, V94, P41, DOI 10.1016/S0166-6851(98)00048-6; Hines JC, 2001, MOL BIOCHEM PARASIT, V115, P63, DOI 10.1016/S0166-6851(01)00272-9; Johnson CE, 1998, J CELL BIOL, V143, P911, DOI 10.1083/jcb.143.4.911; KITCHIN PA, 1985, J BIOL CHEM, V260, P3844; Klingbeil MM, 2002, MOL CELL, V10, P175, DOI 10.1016/S1097-2765(02)00571-3; Klingbeil MM, 2001, PROTIST, V152, P255, DOI 10.1078/1434-4610-00066; Li CJ, 1997, J BIOL CHEM, V272, P20787, DOI 10.1074/jbc.272.33.20787; Marchetti MA, 2000, J CELL SCI, V113, P899; MELENDY T, 1988, CELL, V55, P1083, DOI 10.1016/0092-8674(88)90252-8; Morris JC, 2001, INT J PARASITOL, V31, P453, DOI 10.1016/S0020-7519(01)00156-4; RYAN KA, 1989, J BIOL CHEM, V264, P823; RYAN KA, 1989, MOL CELL BIOL, V9, P3212, DOI 10.1128/MCB.9.8.3212; Saxowsky TT, 2002, J BIOL CHEM, V277, P37201, DOI 10.1074/jbc.M206654200; SHAPIRO TA, 1995, ANNU REV MICROBIOL, V49, P117, DOI 10.1146/annurev.mi.49.100195.001001; Sogin ML, 1991, CURR OPIN GENET DEV, V1, P457, DOI 10.1016/S0959-437X(05)80192-3; Taladriz S, 2001, NUCLEIC ACIDS RES, V29, P3822, DOI 10.1093/nar/29.18.3822; TORRI AF, 1995, J BIOL CHEM, V270, P3495, DOI 10.1074/jbc.270.8.3495; TORRI AF, 1992, J BIOL CHEM, V267, P4786; TORRI AF, 1994, J BIOL CHEM, V269, P8165; Wang ZF, 2001, EMBO J, V20, P4674, DOI 10.1093/emboj/20.17.4674	31	68	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					49095	49101		10.1074/jbc.M308565200	http://dx.doi.org/10.1074/jbc.M308565200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12966090	hybrid			2022-12-27	WOS:000186829000072
J	Munshi, A; Cannella, D; Brickner, H; Salles-Passador, I; Podust, V; Fotedar, R; Fotedar, A				Munshi, A; Cannella, D; Brickner, H; Salles-Passador, I; Podust, V; Fotedar, R; Fotedar, A			Cell cycle-dependent phosphorylation of the large subunit of replication factor C (RF-C) leads to its dissociation from the RF-C complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE ALPHA-PRIMASE; DNA-REPLICATION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; 37-KDA SUBUNIT; S-PHASE; RECONSTITUTION; CLONING; RAD24; GENE	The five subunit replication factor C (RF-C) complex plays a critical role in DNA elongation. We find that the large subunit of RF-C (RF-Cp145) is phosphorylated in vivo whereas the smaller RF- C subunits are not phosphorylated. The phosphorylation of endogenous RF-Cp145 is modulated in a cell cycle-dependent manner. Phosphorylation is maximal in G(2)/M and is inhibited by an inhibitor of cyclin-dependent kinases. Phosphorylation of purified recombinant RF-C complex in vitro reveals that RF-Cp145 is preferentially phosphorylated by cdc2-cyclin B but not by cdk2-cyclin A or cdk2-cyclin E. In vitro phosphorylation of RF-C complex by cdc2-cyclin B kinases leads to dissociation of phosphorylated RF-Cp145 from the RF-C complex. Using different approaches we demonstrate that phosphorylated RF-Cp145 is indeed dissociated from RF-Cp40 and RF-Cp37 in vivo. These results suggest that destabilization of the RF-C complex by CDKs may inactivate the RF-C complex at the end of S phase.	Inst Biol Struct, F-38027 Grenoble 1, France; Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; Vanderbilt Univ, Dept Mol Biol, Nashville, TN 37235 USA	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Vanderbilt University	Fotedar, A (corresponding author), Inst Biol Struct, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	afotedar@skcc.org	Cannella, Dominique/F-4879-2019	Cannella, Dominique/0000-0002-1665-9833	NCI NIH HHS [CA92321, CA74435] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092321, R01CA074435] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bellaoui M, 2003, EMBO J, V22, P4304, DOI 10.1093/emboj/cdg406; BROEK D, 1991, NATURE, V349, P388, DOI 10.1038/349388a0; BUNZ F, 1993, P NATL ACAD SCI USA, V90, P11014, DOI 10.1073/pnas.90.23.11014; BURBELO PD, 1993, P NATL ACAD SCI USA, V90, P11543, DOI 10.1073/pnas.90.24.11543; Cai JS, 1996, P NATL ACAD SCI USA, V93, P12896, DOI 10.1073/pnas.93.23.12896; CHEN M, 1992, P NATL ACAD SCI USA, V89, P5211, DOI 10.1073/pnas.89.12.5211; CHEN M, 1992, P NATL ACAD SCI USA, V89, P2516, DOI 10.1073/pnas.89.7.2516; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; Ellison V, 1998, J BIOL CHEM, V273, P5979, DOI 10.1074/jbc.273.10.5979; FOTEDAR R, 1991, COLD SH Q B, V56, P325; Fotedar R, 1996, EMBO J, V15, P4423, DOI 10.1002/j.1460-2075.1996.tb00815.x; Fotedar R, 1996, ONCOGENE, V12, P2155; Frouin I, 2002, EMBO J, V21, P2485, DOI 10.1093/emboj/21.10.2485; Green CM, 2000, CURR BIOL, V10, P39, DOI 10.1016/S0960-9822(99)00263-8; HAYLES J, 1994, CELL, V78, P813, DOI 10.1016/S0092-8674(94)90542-8; HOWELL EA, 1994, MOL CELL BIOL, V14, P255, DOI 10.1128/MCB.14.1.255; HUBSCHER U, 1996, DNA REPLICATION EUKA, P525; Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258; Jallepalli PV, 1997, GENE DEV, V11, P2767, DOI 10.1101/gad.11.21.2767; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Jiang W, 1999, P NATL ACAD SCI USA, V96, P6193, DOI 10.1073/pnas.96.11.6193; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; LI XY, 1994, P NATL ACAD SCI USA, V91, P868, DOI 10.1073/pnas.91.3.868; LI XY, 1994, J BIOL CHEM, V269, P21880; Maga G, 1997, BIOCHEMISTRY-US, V36, P5300, DOI 10.1021/bi962809n; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Meijer L, 1997, METHOD ENZYMOL, V283, P113; Naiki T, 2000, MOL CELL BIOL, V20, P5888, DOI 10.1128/MCB.20.16.5888-5896.2000; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; O'Donnell M, 2001, CURR BIOL, V11, pR935, DOI 10.1016/S0960-9822(01)00559-0; Pennaneach V, 2001, MOL CELL, V7, P715, DOI 10.1016/S1097-2765(01)00217-9; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; Podust VN, 1997, J BIOL CHEM, V272, P6303, DOI 10.1074/jbc.272.10.6303; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; Shimomura T, 1998, MOL CELL BIOL, V18, P5485, DOI 10.1128/MCB.18.9.5485; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; Treuner K, 1999, J BIOL CHEM, V274, P15556, DOI 10.1074/jbc.274.22.15556; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; Uhlmann F, 1996, P NATL ACAD SCI USA, V93, P6521, DOI 10.1073/pnas.93.13.6521; Voitenleitner C, 1997, ONCOGENE, V14, P1611, DOI 10.1038/sj.onc.1200975; Voitenleitner C, 1999, MOL CELL BIOL, V19, P646; Wuarin J, 2002, CELL, V111, P419, DOI 10.1016/S0092-8674(02)01042-5	45	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48467	48473		10.1074/jbc.M309349200	http://dx.doi.org/10.1074/jbc.M309349200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12947101	hybrid			2022-12-27	WOS:000186731400132
J	Belting, M; Mani, K; Jonsson, M; Cheng, F; Sandgren, S; Jonsson, S; Ding, K; Delcros, JG; Fransson, LA				Belting, M; Mani, K; Jonsson, M; Cheng, F; Sandgren, S; Jonsson, S; Ding, K; Delcros, JG; Fransson, LA			Glypican-1 is a vehicle for polyamine uptake in mammalian cells - A pivotal role for nitrosothiol-derived nitric oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; N-UNSUBSTITUTED GLUCOSAMINE; FIBROBLAST-GROWTH-FACTOR; ORNITHINE DECARBOXYLASE; ENDOTHELIAL-CELLS; S-NITROSYLATION; BINDING SITES; DEGRADATION; GLYCOSIDES; TRANSPORT	Polyamines ( putrescine, spermidine, and spermine) are essential for growth and survival of all cells. When polyamine biosynthesis is inhibited, there is up- regulation of import. The mammalian polyamine transport system is unknown. We have previously shown that the heparan sulfate ( HS) side chains of recycling glypican- 1 ( Gpc- 1) can sequester spermine, that intracellular polyamine depletion increases the number of NO- sensitive N- unsubstituted glucosamines in HS, and that NO- dependent cleavage of HS at these sites is required for spermine uptake. The NO is derived from S- nitroso groups in the Gpc- 1 protein. Using RNA interference technology as well as biochemical and microscopic techniques applied to both normal and uptake- deficient cells, we demonstrate that inhibition of Gpc- 1 expression abrogates spermine uptake and intracellular delivery. In unperturbed cells, spermine and recycling Gpc- 1 carrying HS chains rich in N-unsubstituted glucosamines were co- localized. By exposing cells to ascorbate, we induced release of NO from the S- nitroso groups, resulting in HS degradation and unloading of the sequestered polyamines as well as nuclear targeting of the deglycanated Gpc- 1 protein. Polyamine uptake-deficient cells appear to have a defect in the NO release mechanism. We have managed to restore spermine uptake partially in these cells by providing spermine NONOate and ascorbate. The former bound to the HS chains of recycling Gpc- 1 and S- nitrosylated the core protein. Ascorbate released NO, which degraded HS and liberated the bound spermine. Recycling HS proteoglycans of the glypican- type may be plasma membrane carriers for cargo taken up by caveolar endocytosis.	Lund Univ, Dept Cell & Mol Biol, SE-22184 Lund, Sweden; Univ Rennes 1, Fac Med, Grp Rech Therapeut Anticanc, CNRS FRE22 61, F-35043 Rennes, France	Lund University; Universite de Rennes	Fransson, LA (corresponding author), Lund Univ, Dept Cell & Mol Biol, BMC C13, SE-22184 Lund, Sweden.		delcros, jean-guy/N-5813-2017	delcros, jean-guy/0000-0002-9593-4046; Belting, Mattias/0000-0003-1585-5434				Bauer PM, 1999, BIOCHEM BIOPH RES CO, V262, P355, DOI 10.1006/bbrc.1999.1210; Belting M, 1999, BIOCHEM J, V338, P317, DOI 10.1042/0264-6021:3380317; Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8; Belting M, 2002, P NATL ACAD SCI USA, V99, P371, DOI 10.1073/pnas.012346499; Belting M, 1996, GLYCOBIOLOGY, V6, P121, DOI 10.1093/glycob/6.2.121; BYERS TL, 1989, BIOCHEM J, V263, P745, DOI 10.1042/bj2630745; Cheng F, 2002, J BIOL CHEM, V277, P44431, DOI 10.1074/jbc.M205241200; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Delcros JG, 1997, CYTOMETRY, V27, P255; Ding K, 2002, J BIOL CHEM, V277, P33353, DOI 10.1074/jbc.M203383200; Ding K, 2001, J BIOL CHEM, V276, P46779, DOI 10.1074/jbc.M105419200; Ding K, 2001, J BIOL CHEM, V276, P3885, DOI 10.1074/jbc.M005238200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fransson LA, 2003, INT J BIOCHEM CELL B, V35, P125, DOI 10.1016/S1357-2725(02)00095-X; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; HEBY O, 1990, TRENDS BIOCHEM SCI, V15, P153, DOI 10.1016/0968-0004(90)90216-X; HORTON D, 1973, CARBOHYD RES, V30, P367, DOI 10.1016/S0008-6215(00)81823-6; HSU SM, 1981, AM J CLIN PATHOL, V75, P816, DOI 10.1093/ajcp/75.6.816; IGNARRO LJ, 1993, P NATL ACAD SCI USA, V90, P8103, DOI 10.1073/pnas.90.17.8103; Jones M, 2000, J BIOL CHEM, V275, P7964, DOI 10.1074/jbc.275.11.7964; Liang Y, 1997, J CELL BIOL, V139, P851, DOI 10.1083/jcb.139.4.851; Liu J, 2002, J BIOL CHEM, V277, P33456, DOI 10.1074/jbc.M202034200; LOWENSTEIN CJ, 1992, P NATL ACAD SCI USA, V89, P6711, DOI 10.1073/pnas.89.15.6711; Mani K, 2000, GLYCOBIOLOGY, V10, P577, DOI 10.1093/glycob/10.6.577; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Murakami M, 2000, BBA-MOL CELL BIOL L, V1488, P159, DOI 10.1016/S1388-1981(00)00118-9; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; PEGG AE, 1988, CANCER RES, V48, P759; PERSSON L, 1988, CANCER RES, V48, P4807; Sakata K, 2000, BIOCHEM J, V347, P297, DOI 10.1042/0264-6021:3470297; Sandback-Pikas D., 1998, J BIOL CHEM, V273, P18770; Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200; Seiler N, 1996, INT J BIOCHEM CELL B, V28, P843, DOI 10.1016/1357-2725(96)00021-0; SHIVELY JE, 1970, BIOCHEMISTRY-US, V9, P33, DOI 10.1021/bi00803a005; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; TOMITORI H, 1999, BIOCHEM J, V344, P633; Tumova S, 1999, BIOCHEM J, V337, P471, DOI 10.1042/0264-6021:3370471; Vilar RE, 1997, BIOCHEM J, V324, P473, DOI 10.1042/bj3240473; Vincent JP, 2003, CELL, V112, P745, DOI 10.1016/S0092-8674(03)00198-3; Westling C, 2002, J BIOL CHEM, V277, P49247, DOI 10.1074/jbc.M209139200; XIA H, 1996, METHOD ENZYMOL, V268, P434	45	122	128	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47181	47189		10.1074/jbc.M308325200	http://dx.doi.org/10.1074/jbc.M308325200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12972423	hybrid			2022-12-27	WOS:000186569400117
J	Irvin, BJ; Wood, LD; Wang, LI; Fenrick, R; Sansam, CG; Packham, G; Kinch, M; Yang, E; Hiebert, SW				Irvin, BJ; Wood, LD; Wang, LI; Fenrick, R; Sansam, CG; Packham, G; Kinch, M; Yang, E; Hiebert, SW			TEL, a putative tumor suppressor, induces apoptosis and represses transcription of Bcl-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOMONOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; BETA-R FUSION; TYROSINE KINASE; ETS-FAMILY; TRANSFORMED-CELLS; FREQUENT LOSS; KAPPA-B; GENE; PROTEIN	The ETS family transcriptional repressor TEL is frequently disrupted by chromosomal translocations, including the t(12;21) in which the second allele of TEL is deleted in up to 90% of the cases. Consistent with its role as a putative tumor suppressor, TEL expression inhibits colony formation by Ras-transformed NIH 3T3 cells and hinders proliferation of a variety of cell types. Although we observed no alteration in the cell cycle of TEL-expressing cells, we did find a marked increase in apoptosis of serum-starved TEL-expressing NIH 3T3 cells. This decrease in cell survival required the DNA binding domain of TEL, suggesting that TEL repressed an antiapoptotic gene. These observations prompted us to search for genes regulated by ETS family proteins that regulate apoptosis. The anti-apoptotic molecule Bcl-X-L contains multiple ets-factor binding sites within its promoters, and TEL repressed a Bcl-X-L promoter-linked reporter gene. Moreover, the enforced expression of TEL decreased the endogenous expression of both Bcl-X-L mRNA and protein. TEL-mediated repression of Bcl-X-L likely affects cell survival via regulation of the apoptotic pathway.	Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pediat & Canc Biol, Nashville, TN 37232 USA; Univ Southampton, Sch Med, Southampton Gen Hosp, Canc Res UK Oncol Unit, Southampton SO16 6YD, Hants, England; Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Vanderbilt University; Vanderbilt University; University of Southampton; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hiebert, SW (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Biochem, Preston Res Bldg,Rm 512,23rd & Pierce, Nashville, TN 37232 USA.	scott.hiebert@mcmail.vanderbilt.edu	Hiebert, Scott W/C-9979-2010	Sansam, Courtney/0000-0002-0253-8643; Packham, Graham/0000-0002-9232-5691; Kinch, Michael/0000-0003-3939-3756	NATIONAL CANCER INSTITUTE [R01CA064140, T32CA009385, R01CA087549, P30CA068485, R01CA078443, R01CA077274] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA 09385, R01 CA 87549, R01 CA 77274, R01 CA 64140, CA 68485, 1R01 CA 78443] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andreasson P, 2001, CANCER GENET CYTOGEN, V130, P93, DOI 10.1016/S0165-4608(01)00518-0; BUIJS A, 1995, ONCOGENE, V10, P1511; Buijs A, 2000, MOL CELL BIOL, V20, P9281, DOI 10.1128/MCB.20.24.9281-9293.2000; Carroll M, 1996, P NATL ACAD SCI USA, V93, P14845, DOI 10.1073/pnas.93.25.14845; Cave H, 1997, LEUKEMIA, V11, P1459, DOI 10.1038/sj.leu.2400798; Chakrabarti SR, 2000, P NATL ACAD SCI USA, V97, P13281, DOI 10.1073/pnas.240315897; Chakrabarti SR, 1999, BIOCHEM BIOPH RES CO, V264, P871, DOI 10.1006/bbrc.1999.1605; Chattopadhyay A, 2001, ONCOGENE, V20, P4507, DOI 10.1038/sj.onc.1204584; de Groot Rolf P., 2000, Molecular Cell Biology Research Communications, V3, P299, DOI 10.1006/mcbr.2000.0231; Eischen CM, 2001, MOL CELL BIOL, V21, P5063, DOI 10.1128/MCB.21.15.5063-5070.2001; Fenrick R, 2000, MOL CELL BIOL, V20, P5828, DOI 10.1128/MCB.20.16.5828-5839.2000; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Giancotti FG, 1997, CURR OPIN CELL BIOL, V9, P691, DOI 10.1016/S0955-0674(97)80123-8; Golub TR, 1996, CURR TOP MICROBIOL, V211, P279; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Golub TR, 1996, MOL CELL BIOL, V16, P4107; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Grad JM, 2000, CURR OPIN ONCOL, V12, P543, DOI 10.1097/00001622-200011000-00006; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Grillot DAM, 1997, J IMMUNOL, V158, P4750; Gu XS, 2001, J BIOL CHEM, V276, P9421, DOI 10.1074/jbc.M010070200; Guidez F, 2000, BLOOD, V96, P2557; Hatta Y, 1997, BRIT J CANCER, V75, P1256, DOI 10.1038/bjc.1997.214; Hiebert SW, 1996, MOL CELL BIOL, V16, P1349; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; Kirito K, 2002, J BIOL CHEM, V277, P8329, DOI 10.1074/jbc.M109824200; Lopez R, 1999, J BIOL CHEM, V274, P30132, DOI 10.1074/jbc.274.42.30132; MacCarthy-Morrogh L, 2000, ONCOGENE, V19, P5534, DOI 10.1038/sj.onc.1203949; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Packham G, 1996, ONCOGENE, V13, P461; PAPADOPOULOS P, 1995, CANCER RES, V55, P34; Poirel H, 2000, ONCOGENE, V19, P4802, DOI 10.1038/sj.onc.1203830; Potter MD, 2000, BLOOD, V95, P3341, DOI 10.1182/blood.V95.11.3341.011k44_3341_3348; Raynaud S, 1996, BLOOD, V87, P2891, DOI 10.1182/blood.V87.7.2891.bloodjournal8772891; ROMANA SP, 1995, BLOOD, V85, P3662, DOI 10.1182/blood.V85.12.3662.bloodjournal85123662; ROMANA SP, 1995, BLOOD, V86, P4263, DOI 10.1182/blood.V86.11.4263.bloodjournal86114263; SATO Y, 1995, BLOOD, V86, P1525, DOI 10.1182/blood.V86.4.1525.bloodjournal8641525; Sevilla L, 2001, HISTOL HISTOPATHOL, V16, P595, DOI 10.14670/HH-16.595; Sevilla L, 1999, MOL CELL BIOL, V19, P2624; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Sillaber C, 2000, BLOOD, V95, P2118, DOI 10.1182/blood.V95.6.2118; Spiekermann K, 2002, EXP HEMATOL, V30, P262, DOI 10.1016/S0301-472X(01)00787-1; Spirin KS, 1996, CANCER RES, V56, P2400; STEGMAIER K, 1995, BLOOD, V86, P38, DOI 10.1182/blood.V86.1.38.bloodjournal86138; Szymczyna BR, 2000, J BIOL CHEM, V275, P28363, DOI 10.1074/jbc.M004294200; Trojanowska M, 2000, ONCOGENE, V19, P6464, DOI 10.1038/sj.onc.1204043; Tsukahara T, 1999, J VIROL, V73, P7981, DOI 10.1128/JVI.73.10.7981-7987.1999; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Uchida H, 1999, ONCOGENE, V18, P1015, DOI 10.1038/sj.onc.1202383; Van Rompaey L., 1999, Neoplasia (New York), V1, P526; Van Rompaey L, 2000, ONCOGENE, V19, P5244, DOI 10.1038/sj.onc.1203899; Van Rompaey L, 2002, BIOCHEM BIOPH RES CO, V291, P820, DOI 10.1006/bbrc.2002.6513; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; Wang LC, 1998, GENE DEV, V12, P2392, DOI 10.1101/gad.12.15.2392; Wang LL, 2001, ONCOGENE, V20, P3716, DOI 10.1038/sj.onc.1204479; Wilbanks AM, 2000, EXP HEMATOL, V28, P584, DOI 10.1016/S0301-472X(00)00138-7; Wood LD, 2003, P NATL ACAD SCI USA, V100, P3257, DOI 10.1073/pnas.0637114100; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036	58	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46378	46386		10.1074/jbc.M305189200	http://dx.doi.org/10.1074/jbc.M305189200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12960174	hybrid			2022-12-27	WOS:000186569400021
J	Begg, M; Mo, FM; Offertaler, L; Batkai, S; Pacher, P; Razdan, RK; Lovinger, DM; Kunos, G				Begg, M; Mo, FM; Offertaler, L; Batkai, S; Pacher, P; Razdan, RK; Lovinger, DM; Kunos, G			G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; EPOXYEICOSATRIENOIC ACIDS; CA2+-INDUCED RELAXATION; MESENTERIC-ARTERY; GUANYLYL CYCLASE; HIGH-CONDUCTANCE; CELLS; ANANDAMIDE; CALCIUM; INHIBITION	The cannabinoid analog "abnormal cannabidiol" (abn-cbd) causes endothelium-dependent vasodilation in rat isolated mesenteric arteries through a G protein-coupled receptor distinct from CB1 or CB2. We examined the actions of abn-cbd on the electrophysiology of human umbilical vein endothelial cells (HUVEC), using the whole cell version of the patch clamp technique. Voltage steps produced noninactivating outward currents, which were abolished by iberiotoxin or by chelation of intracellular calcium. The presence of a BKCa channel in HUVEC was documented by reverse transcriptase-PCR. Abn-cbd concentration dependently potentiated the outward current produced by a single voltage step. This potentiation was abolished by the cannabidiol analog O-1918 or by pertussis toxin but was unaffected by CB1 or CB2 antagonists. HU-210, a CB1/CB2 receptor agonist, had no effect on the outward current. Clamping [Ca2+](i) did not prevent abn-cbd-induced increases in outward current. cGMP potentiated the outward current, and abn-cbd increased the cellular levels of cGMP. The increase in outward current produced by abn-cbd was blocked by KT-5823, an inhibitor of protein kinase G, or 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline-1-one (ODQ), an inhibitor of soluble guanylate cyclase. We conclude that a Ca2+-activated K+ current in HUVEC is potentiated by activation of a G(i)/G(o)-coupled receptor distinct from CB1 or CB2, which signals through cGMP and protein kinase G to increase channel availability or the sensitivity of the channel to voltage and/or Ca2+. Because iberiotoxin also inhibited abn-cbd-induced relaxation of intact, but not of endothelium-denuded, rat mesenteric artery segments, modulation of endothelial BKCa channels may underlie the mesenteric vasodilator action of abn-cbd.	NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA; NIAAA, Lab Physiol Studies, NIH, Bethesda, MD 20892 USA; Organix Inc, Woburn, MA 01801 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Lovinger, DM (corresponding author), NIAAA, Lab Integrat Neurosci, NIH, 12420 Parklawn Dr,MSC-8115, Bethesda, MD 20892 USA.		Batkai, Sandor/G-3889-2010; Pacher, Pal/B-6378-2008; Batkai, Sandor/H-7983-2014	Pacher, Pal/0000-0001-7036-8108; Begg, Malcolm/0000-0001-9508-3424	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000351, ZIAAA000407, Z01AA000407, Z01AA000351] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ADAMS DJ, 1989, FASEB J, V3, P2389, DOI 10.1096/fasebj.3.12.2477294; ADAMS MD, 1977, EXPERIENTIA, V33, P1204, DOI 10.1007/BF01922330; Alfonzo MJ, 1998, ARCH BIOCHEM BIOPHYS, V350, P19, DOI 10.1006/abbi.1997.0469; ANDRIANTSITOHAINA R, 1995, AM J PHYSIOL-HEART C, V268, pH1223, DOI 10.1152/ajpheart.1995.268.3.H1223; Bang L, 1999, CARDIOVASC RES, V43, P772, DOI 10.1016/S0008-6363(99)00116-9; Baron A, 1997, J PHYSIOL-LONDON, V504, P537, DOI 10.1111/j.1469-7793.1997.537bd.x; Bukoski RD, 2002, HYPERTENSION, V39, P251, DOI 10.1161/hy0202.102702; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Bychkov R, 2002, BRIT J PHARMACOL, V137, P1346, DOI 10.1038/sj.bjp.0705057; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; DEWEY WL, 1986, PHARMACOL REV, V38, P151; ESGUERRA M, 1994, NATURE, V369, P563, DOI 10.1038/369563a0; Frieden M, 1999, J PHYSIOL-LONDON, V519, P361, DOI 10.1111/j.1469-7793.1999.0361m.x; Fukao M, 2001, MOL PHARMACOL, V59, P16, DOI 10.1124/mol.59.1.16; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; GARCIA ML, 1995, AM J PHYSIOL-CELL PH, V269, pC1, DOI 10.1152/ajpcell.1995.269.1.C1; GARCIA ML, 1991, J BIOENERG BIOMEMBR, V23, P615, DOI 10.1007/BF00785814; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Gauthier KM, 2002, J PHYSIOL-LONDON, V545, P829, DOI 10.1113/jphysiol.2002.029843; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Ho WSV, 2003, BRIT J PHARMACOL, V138, P1320, DOI 10.1038/sj/bjp.0705160; HOYER J, 1994, P NATL ACAD SCI USA, V91, P2367, DOI 10.1073/pnas.91.6.2367; Ishac EJN, 1996, BRIT J PHARMACOL, V118, P2023, DOI 10.1111/j.1476-5381.1996.tb15639.x; Ishioka N, 1999, J PHARMACOL EXP THER, V289, P245; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Jow F, 1999, J MEMBRANE BIOL, V171, P127, DOI 10.1007/s002329900565; Jow F, 2000, J MEMBRANE BIOL, V173, P107, DOI 10.1007/s002320001012; Kestler HA, 1998, RES EXP MED, V198, P133, DOI 10.1007/s004330050097; KO FN, 1994, BLOOD, V84, P4226, DOI 10.1182/blood.V84.12.4226.bloodjournal84124226; Kohler R, 2000, CIRC RES, V87, P496; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; LUCKHOFF A, 1990, PFLUG ARCH EUR J PHY, V416, P305, DOI 10.1007/BF00392067; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mechoulam R, 1998, EUR J PHARMACOL, V359, P1, DOI 10.1016/S0014-2999(98)00649-9; Mukhopadhyay S, 2002, AM J PHYSIOL-HEART C, V282, pH2046, DOI 10.1152/ajpheart.00497.2001; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Offertaler L, 2003, MOL PHARMACOL, V63, P699, DOI 10.1124/mol.63.3.699; OLESEN SP, 1994, EUR J PHARMACOL, V251, P53, DOI 10.1016/0014-2999(94)90442-1; Price JM, 1997, LIFE SCI, V61, P1185, DOI 10.1016/S0024-3205(97)00660-7; Stefani E, 1997, P NATL ACAD SCI USA, V94, P5427, DOI 10.1073/pnas.94.10.5427; Sun D, 2001, MICROVASC RES, V61, P179, DOI 10.1006/mvre.2000.2291; TANIGUCHI J, 1993, PFLUG ARCH EUR J PHY, V423, P167, DOI 10.1007/BF00374390; VARGA K, 1995, EUR J PHARMACOL, V278, P279, DOI 10.1016/0014-2999(95)00181-J; VOLLMER RR, 1974, J PHARM PHARMACOL, V26, P186, DOI 10.1111/j.2042-7158.1974.tb09252.x; Wagner JA, 1999, HYPERTENSION, V33, P429, DOI 10.1161/01.HYP.33.1.429; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	49	73	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46188	46194		10.1074/jbc.M307258200	http://dx.doi.org/10.1074/jbc.M307258200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952947	hybrid			2022-12-27	WOS:000186452300137
J	Huber, WE; Price, ER; Widlund, HR; Du, JY; Davis, IJ; Wegner, M; Fisher, DE				Huber, WE; Price, ER; Widlund, HR; Du, JY; Davis, IJ; Wegner, M; Fisher, DE			A tissue-restricted cAMP transcriptional response - SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WAARDENBURG-SYNDROME; FACTOR GENE; MOUSE MODEL; PROMOTER; MITF; ACTIVATION; PAX3; MUTATION; DEAFNESS; PATHWAY	alpha-Melanocyte-stimulating hormone (MSH) utilizes cAMP to trigger pigmentation of melanocytes via activation of melanocyte-restricted microphthalmia-associated transcription factor (M-MITF) expression. M-MITF is a melanocyte-restricted helix-loop-helix transcription factor capable of transactivating promoters for multiple genes whose products modulate pigmentation. Although M-MITF promoter activation by MSH is known to occur through a conserved cAMP-response element (CRE), it remains unclear how this CRE exhibits such exquisitely tissue-restricted responsiveness. Here we show that cAMP-mediated CRE-binding protein activation of the M-MITF promoter requires a second DNA element located similar to100 bp upstream, a site that is bound and activated by SOX10. Mutations in the SOX10 transcription factor, like MITF, results in a disorder known as Waardenburg Syndrome. The cAMP response of the M-MITF promoter was analyzed in melanoma and neuroblastoma cells (which are neural crest-derived but lack both M-MITF and SOX10 expression). M-MITF promoter responsiveness to cAMP was found to depend upon SOX10, and reciprocally, SOX10 transactivation was dependent upon the CRE. Ectopic SOX10 expression, in cooperation with cAMP signaling, activated the M-MITF promoter function and the expression of measurable endogenous M-MITF transcripts in neuroblastoma cells. SOX10(dom), a mutant allele, failed to cooperate with cAMP in neuroblastoma cells and attenuated the cAMP responsiveness of the M-MITF promoter in melanoma cells. These observations demonstrate a means whereby the ubiquitous cAMP signaling machinery is harnessed to produce a highly tissue-restricted transcriptional response by cooperating with architectural factors, in this case SOX10.	Dana Farber Canc Inst, Div Pediat Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA; Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Erlangen Nuremberg	Fisher, DE (corresponding author), Dana Farber Canc Inst, Div Pediat Hematol Oncol, 44 Binney St, Boston, MA 02115 USA.			Widlund, Hans/0000-0002-7506-2447; Wegner, Michael/0000-0002-4586-3294; Davis, Ian/0000-0002-1552-0960	NIAMS NIH HHS [AR43369] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BENTLEY NJ, 1994, MOL CELL BIOL, V14, P7996, DOI 10.1128/MCB.14.12.7996; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Dorsky RI, 2000, GENE DEV, V14, P158; Fuse N, 1996, BIOCHEM BIOPH RES CO, V219, P702, DOI 10.1006/bbrc.1996.0298; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lee M, 2000, J BIOL CHEM, V275, P37978, DOI 10.1074/jbc.M003816200; Mayall TP, 1997, GENE DEV, V11, P887, DOI 10.1101/gad.11.7.887; MOORE KJ, 1995, TRENDS GENET, V11, P442, DOI 10.1016/S0168-9525(00)89143-X; Pan L, 2001, J BIOL CHEM, V276, P45530, DOI 10.1074/jbc.M103010200; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Price ER, 1998, J BIOL CHEM, V273, P33042, DOI 10.1074/jbc.273.49.33042; Price ER, 2001, NEURON, V30, P15, DOI 10.1016/S0896-6273(01)00259-8; Price ER, 1998, J BIOL CHEM, V273, P17983, DOI 10.1074/jbc.273.29.17983; Saito H, 2002, J BIOL CHEM, V277, P28787, DOI 10.1074/jbc.M203719200; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Tabuchi A, 2002, J BIOL CHEM, V277, P35920, DOI 10.1074/jbc.M204784200; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; Verastegui C, 2000, J BIOL CHEM, V275, P30757, DOI 10.1074/jbc.C000445200; Watanabe A, 1998, NAT GENET, V18, P283, DOI 10.1038/ng0398-283; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058	27	72	76	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45224	45230		10.1074/jbc.M309036200	http://dx.doi.org/10.1074/jbc.M309036200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12944398	hybrid			2022-12-27	WOS:000186452300023
J	Le Goff, MM; Hindson, VJ; Jowitt, TA; Scott, PG; Bishop, PN				Le Goff, MM; Hindson, VJ; Jowitt, TA; Scott, PG; Bishop, PN			Characterization of opticin and evidence of stable dimerization in solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE TAG ANALYSIS; PROTEODERMATAN SULFATE; OSTEOINDUCTIVE FACTOR; ARTICULAR-CARTILAGE; MOLECULAR-CLONING; NEIBANK PROJECT; PROTEIN; PROTEOGLYCAN; SCATTERING; COLLAGEN	Opticin is a class III member of the extracellular matrix small leucine-rich repeat protein (SLRP) family that was initially identified in the eye in association with the collagen fibrils of the vitreous humor. Recombinant and tissue-extracted forms of bovine opticin were subjected to biochemical and biophysical characterization. Following SDS-PAGE the predominant component produced by both forms was a broad band between 45-52 kDa. There was evidence for two-stage processing and, additionally, a proteolytic cleavage product of similar to25 kDa. Deconvolution of circular dichroism spectra revealed beta-sheet (41%), beta-turn (21%), and alpha-helix (10%), and thermal denaturation experiments showed a transition with a midpoint of 47degreesC. Weight-averaged molecular mass measurements using both light scattering and analytical ultracentrifugation demonstrated that opticin exists in solution as a stable dimer of similar to90 kDa, which can be dissociated into a monomer by denaturation with 2.5 M guanidine hydrochloride or during SDS-polyacrylamide electrophoresis. Opticin remains a dimer after removal of the amino-terminal region by O-sialoglycoprotein endopeptidase digestion, suggesting that dimer formation is mediated by the leucine-rich repeats. Dimerization could have a number of functional consequences, including divalent ligand interactions.	Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Univ Manchester, Sch Med, Res Grp Eye & Vis Sci, Manchester M13 9PT, Lancs, England; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Manchester; University of Manchester; University of Alberta	Bishop, PN (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Sch Biol Sci, Rm 2-205,Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.			Bishop, Paul/0000-0001-7937-7932; Jowitt, Thomas/0000-0002-4045-0933				Font B, 1998, EUR J BIOCHEM, V254, P580, DOI 10.1046/j.1432-1327.1998.2540580.x; Friedman JS, 2002, HUM MOL GENET, V11, P1333, DOI 10.1093/hmg/11.11.1333; Friedman JS, 2000, INVEST OPHTH VIS SCI, V41, P2059; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Jiang P, 1998, ANAL BIOCHEM, V259, P8, DOI 10.1006/abio.1998.2637; Johnson HJ, 1997, J BIOL CHEM, V272, P18709, DOI 10.1074/jbc.272.30.18709; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; LARSSON T, 1991, J BIOL CHEM, V266, P20428; LIU J, 1994, J BIOL CHEM, V269, P28366; MADISEN L, 1990, DNA CELL BIOL, V9, P303, DOI 10.1089/dna.1990.9.303; Mansson B, 2001, J BIOL CHEM, V276, P32883, DOI 10.1074/jbc.M101680200; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Pellegrini B, 2002, GENE, V282, P121, DOI 10.1016/S0378-1119(01)00842-3; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Ramamurthy P, 1996, J BIOL CHEM, V271, P19578, DOI 10.1074/jbc.271.32.19578; Reardon AJ, 2000, J BIOL CHEM, V275, P2123, DOI 10.1074/jbc.275.3.2123; Roughley PJ, 1996, BIOCHEM J, V318, P779, DOI 10.1042/bj3180779; SCOTT P G, 1991, Biochemical Society Transactions, V19, p377S; SCOTT PG, 1986, BIOCHEM BIOPH RES CO, V138, P1348, DOI 10.1016/S0006-291X(86)80431-4; Scott PG, 2003, J BIOL CHEM, V278, P18353, DOI 10.1074/jbc.M211936200; SHINOMURA T, 1992, J BIOL CHEM, V267, P1265; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Takanosu M, 2001, INVEST OPHTH VIS SCI, V42, P2202; Tanford C., 1961, PHYSICAL CHEMISTRY M, P381; Wistow G, 2002, MOL VIS, V8, P205; Wistow G, 2002, MOL VIS, V8, P185; ZANGRANDO D, 1989, BIOPOLYMERS, V28, P1295, DOI 10.1002/bip.360280710	31	37	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45280	45287		10.1074/jbc.M303117200	http://dx.doi.org/10.1074/jbc.M303117200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12951322	hybrid			2022-12-27	WOS:000186452300029
J	Lim, HK; Choi, YA; Park, W; Lee, T; Ryu, SH; Kim, SY; Kim, JR; Kim, JH; Baek, SH				Lim, HK; Choi, YA; Park, W; Lee, T; Ryu, SH; Kim, SY; Kim, JR; Kim, JH; Baek, SH			Phosphatidic acid regulates systemic inflammatory responses by modulating the Akt-mammalian target of rapamycin-p70 S6 kinase 1 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRONCHIAL EPITHELIAL-CELLS; NITRIC-OXIDE PRODUCTION; PHOSPHOLIPASE-D; INNATE IMMUNITY; INTERLEUKIN-8 SECRETION; MACROPHAGE ACTIVATION; PLASMA-MEMBRANE; ENDOTOXIC-SHOCK; HUMAN MONOCYTES; SEPTIC SHOCK	Macrophages are pivotal effector cells in the innate immune system. When microbial products bind to pathogen recognition receptors, macrophages are activated and release a broad array of mediators, such as cytokines, that orchestrate the inflammatory responses of the host. Phosphatidic acid (PA) has been implicated as an important metabolite of phospholipid biosynthesis and in membrane remodeling and has been further suggested to be a crucial second messenger in various cellular signaling events. Here we show that PA is an essential regulator of inflammatory response. Deleterious effects of PA are associated with the secretion of proinflammatory cytokines, such as tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and the production of nitric oxide, prostaglandin E-2, which are predominantly released by macrophage Raw264.7 cells. Furthermore, the administration of PA to mice increased the serum cytokine level. Moreover, direct or lipopolysaccharide-induced PA accumulation by macrophages led to the Akt-dependent activation of the mammalian target of rapamycin-p70 S6 kinase 1, a process required for the induction of inflammatory mediators. These findings demonstrate the importance of the role of PA in systemic inflammatory responses, and provide a potential usefulness as specific targets for the development of therapies.	Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea; Kyungpook Natl Univ, Coll Nat Sci, Dept Microbiol, Taegu 702701, South Korea; Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea	Yeungnam University; Kyungpook National University; Pohang University of Science & Technology (POSTECH)	Baek, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, 317-1 Daemyung 5 Dong, Taegu 705717, South Korea.			Ryu, Sung Ho/0000-0003-0913-3048				ABRAHAM E, 1995, J EXP MED, V181, P569, DOI 10.1084/jem.181.2.569; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Bandyopadhyay R, 2000, MOL CELL BIOCHEM, V203, P127, DOI 10.1023/A:1007055804978; Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Castrillo A, 2001, J EXP MED, V194, P1231, DOI 10.1084/jem.194.9.1231; Choi WS, 2002, ANN NY ACAD SCI, V968, P198, DOI 10.1111/j.1749-6632.2002.tb04336.x; Coutant A, 2002, HEPATOLOGY, V36, P1079, DOI 10.1053/jhep.2002.36160; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; Cummings RJ, 2002, J BIOL CHEM, V277, P30227, DOI 10.1074/jbc.M111078200; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Exton JH, 1997, PHYSIOL REV, V77, P303, DOI 10.1152/physrev.1997.77.2.303; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; FUKAMI K, 1992, J BIOL CHEM, V267, P10988; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GLAUSER MP, 1991, LANCET, V338, P732, DOI 10.1016/0140-6736(91)91452-Z; Gonzalez-Garcia A, 2002, J BIOL CHEM, V277, P1500, DOI 10.1074/jbc.M103808200; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hasegawa N, 1997, AM J RESP CRIT CARE, V155, P928, DOI 10.1164/ajrccm.155.3.9117028; HIGGINS GC, 1994, J EXP MED, V180, P607, DOI 10.1084/jem.180.2.607; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Kim JH, 2002, BIOCHEMISTRY-US, V41, P3414, DOI 10.1021/bi015700a; Kim Y, 2000, J BIOL CHEM, V275, P13621, DOI 10.1074/jbc.275.18.13621; Kusner DJ, 1999, J IMMUNOL, V162, P2266; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; MCPHAIL LC, 1995, P NATL ACAD SCI USA, V92, P7931, DOI 10.1073/pnas.92.17.7931; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; MORITZ A, 1992, J BIOL CHEM, V267, P7207; Morris AJ, 1996, TRENDS PHARMACOL SCI, V17, P182, DOI 10.1016/0165-6147(96)10016-X; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Olivera A, 1996, J CELL BIOCHEM, V60, P529, DOI 10.1002/(SICI)1097-4644(19960315)60:4<529::AID-JCB9>3.0.CO;2-U; Park DW, 2003, J IMMUNOL, V170, P2093, DOI 10.4049/jimmunol.170.4.2093; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Potter MW, 2001, J SURG RES, V97, P54, DOI 10.1006/jsre.2001.6111; PUGIN J, 1993, J EXP MED, V178, P2193, DOI 10.1084/jem.178.6.2193; Reeves HL, 2000, HEPATOLOGY, V31, P95, DOI 10.1002/hep.510310116; RICE GC, 1994, P NATL ACAD SCI USA, V91, P3857, DOI 10.1073/pnas.91.9.3857; RICE GC, 1994, SHOCK, V1, P254, DOI 10.1097/00024382-199404000-00003; Rizzo MA, 2002, PHARMACOL THERAPEUT, V94, P35, DOI 10.1016/S0163-7258(02)00170-5; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sekulic A, 2000, CANCER RES, V60, P3504; Sergeant S, 2001, J BIOL CHEM, V276, P4737, DOI 10.1074/jbc.M006571200; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Szabo C, 1998, ANN NY ACAD SCI, V851, P422, DOI 10.1111/j.1749-6632.1998.tb09019.x; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Wang LX, 2002, BIOCHEM J, V367, P751, DOI 10.1042/BJ20020586; Weinstein SL, 2000, J LEUKOCYTE BIOL, V67, P405, DOI 10.1002/jlb.67.3.405; Zhang FH, 2001, INT IMMUNOPHARMACOL, V1, P1375, DOI 10.1016/S1567-5769(01)00069-8; ZHANG XK, 1993, J EXP MED, V177, P511, DOI 10.1084/jem.177.2.511	60	107	114	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45117	45127		10.1074/jbc.M303789200	http://dx.doi.org/10.1074/jbc.M303789200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12960176	hybrid			2022-12-27	WOS:000186452300011
J	Uemura, S; Kihara, A; Inokuchi, J; Igarashi, Y				Uemura, S; Kihara, A; Inokuchi, J; Igarashi, Y			Csg1p and newly identified Csh1p function in mannosylinositol phosphorylceramide synthesis by interacting with Csg2p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL KINASE HOMOLOG; CELL-CYCLE ARREST; SACCHAROMYCES-CEREVISIAE; SERINE PALMITOYLTRANSFERASE; LIPID RAFTS; HEAT-STRESS; YEAST; PROTEIN; GENE; MEMBRANE	Csg1p and Csg2p have been shown to be involved in the synthesis of mannosylinositol phosphorylceramide (MIPC) from inositol phosphorylceramide. YBR161w, termed CSH1 here, encodes a protein that exhibits a strong similarity to Csg1p. To examine whether Csh1p also functions in MIPC synthesis, we performed a [H-3] dihydrosphingosine labeling experiment. Deltacsg1 cells exhibited only a reduction in the synthesis of mannosylated sphingolipids compared with wild-type cells, whereas the Deltacsg1 Deltacsh1 double deletion mutant exhibited a total loss. These results indicated that Csg1p and Csh1p have redundant functions in MIPC synthesis. Analyses using Deltacsg1 and Deltacsh1 cells in the Deltaipt1, Deltasur2, or Deltascs7 genetic background demonstrated that Csh1p has a different substrate specificity from Csg1p. We also revealed that Csg2p interacts with both Csg1p and Csh1p. Deletion of the CSG2 gene reduced the Csg1p activity and abolished the Csh1p activity. These results suggested that two distinct inositol phosphorylceramide mannosyltransferase complexes, Csg1p-Csg2p and Csh1p-Csg2p, exist.	Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biomembrane & Biofunct Chem, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hokkaido University	Igarashi, Y (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biomembrane & Biofunct Chem, Kita Ku, Kita 12 Jo,Nishi 6 Choume, Sapporo, Hokkaido 0600812, Japan.		Inokuchi, Jin-ichi/AAW-9964-2020; KIHARA, AKIO/A-3802-2012	Inokuchi, Jin-ichi/0000-0002-0703-5746; KIHARA, AKIO/0000-0001-5889-0788				Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; BEELER T, 1994, J BIOL CHEM, V269, P7279; Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688; Beeler TJ, 1997, MOL GEN GENET, V255, P570, DOI 10.1007/s004380050530; Birchwood CJ, 2001, J BIOL CHEM, V276, P11712, DOI 10.1074/jbc.M010221200; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; Dickson RC, 1997, J BIOL CHEM, V272, P29620, DOI 10.1074/jbc.272.47.29620; Dunn TM, 1998, YEAST, V14, P311, DOI 10.1002/(SICI)1097-0061(19980315)14:4<311::AID-YEA220>3.0.CO;2-B; FISHBEIN JD, 1993, J BIOL CHEM, V268, P9255; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Gottlieb D, 1999, Mol Cell Biol Res Commun, V1, P66, DOI 10.1006/mcbr.1999.0109; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; HANSON BA, 1980, J LIPID RES, V21, P309; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; Homma K, 1998, J BIOL CHEM, V273, P15779, DOI 10.1074/jbc.273.25.15779; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; Mao CG, 1999, BIOCHEM J, V342, P667, DOI 10.1042/0264-6021:3420667; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Nickels JT, 1996, GENE DEV, V10, P382, DOI 10.1101/gad.10.4.382; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Skrzypek MS, 1999, J BACTERIOL, V181, P1134, DOI 10.1128/JB.181.4.1134-1140.1999; TAKITA Y, 1995, MOL GEN GENET, V246, P269, DOI 10.1007/BF00288599; Tanida I, 1996, FEBS LETT, V379, P38, DOI 10.1016/0014-5793(95)01478-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824; ZHAO C, 1994, J BIOL CHEM, V269, P21480	38	71	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45049	45055		10.1074/jbc.M305498200	http://dx.doi.org/10.1074/jbc.M305498200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954640	hybrid			2022-12-27	WOS:000186452300003
J	van Rossum, AGSH; de Graaf, JH; Schuuring-Scholtes, E; Kluin, PM; Fan, YX; Zhan, X; Moolenaar, WH; Schuuring, E				van Rossum, AGSH; de Graaf, JH; Schuuring-Scholtes, E; Kluin, PM; Fan, YX; Zhan, X; Moolenaar, WH; Schuuring, E			Alternative splicing of the actin binding domain of human cortactin affects cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FILAMENT NETWORK FORMATION; CHROMOSOME 11Q13 REGION; TYROSINE PHOSPHORYLATION; ARP2/3 COMPLEX; BREAST-CANCER; EMS1 GENE; PROTEIN CORTACTIN; HUMAN CARCINOMAS; CONTACT SITES; CYCLIN D1	Cortactin is a filamentous actin (F-actin)-binding protein that regulates cytoskeletal dynamics by activating the Arp2/3 complex; it binds to F-actin by means of six N-terminal "cortactin repeats". Gene amplification of 11q13 and consequent overexpression of cortactin in several human cancers is associated with lymph node metastasis. Overexpression as well as tyrosine phosphorylation of cortactin has been reported to enhance cell migration, invasion, and metastasis. Here we report the identification of two alternative splice variants (SV1 and SV2) that affect the cortactin repeats: SV1-cortactin lacks the 6th repeat (exon 11), whereas SV2-cortactin lacks the 5th and 6th repeats (exons 10 and 11). SV-1 cortactin is found co-expressed with wild type (wt)-cortactin in all tissues and cell lines examined, whereas the SV2 isoform is much less abundant. SV1-cortactin binds F-actin and promotes Arp2/3-mediated actin polymerization equally well as wt-cortactin, whereas SV2-cortactin shows reduced F-actin binding and polymerization. Alternative splicing of cortactin does not affect its subcellular localization or growth factor-induced tyrosine phosphorylation. However, cells that overexpress SV1- or SV2-cortactin show significantly reduced cell migration when compared with wt-cortactin-overexpressing cells. Thus, in addition to overexpression and tyrosine phosphorylation, alternative splicing of the F-actin binding domain of cortactin is a new mechanism by which cortactin influences cell migration.	Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, NL-9700 RB Groningen, Netherlands; Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands; Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; Amer Red Cross, Holland Lab, Dept Expt Pathol, Rockville, MD 20855 USA	University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute; American Red Cross	Schuuring, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, POB 30001, NL-9700 RB Groningen, Netherlands.	e.schuuring@path.azg.nl						Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Campbell DH, 1996, INT J CANCER, V68, P485, DOI 10.1002/(SICI)1097-0215(19961115)68:4<485::AID-IJC14>3.0.CO;2-4; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Hermsen MAJA, 1996, GENE CHROMOSOME CANC, V15, P1; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Hui R, 1998, ONCOGENE, V17, P1053, DOI 10.1038/sj.onc.1202023; Kaksonen M, 2000, J CELL SCI, V113, P4421; Katsube T, 1998, J BIOL CHEM, V273, P29672, DOI 10.1074/jbc.273.45.29672; Kranenburg O, 1997, J CELL SCI, V110, P2417; Li YS, 2001, CANCER RES, V61, P6906; MARGOLIS B, 1990, EMBO J, V9, P4375, DOI 10.1002/j.1460-2075.1990.tb07887.x; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Mulder J, 2003, J BIOL CHEM, V278, P27216, DOI 10.1074/jbc.M302399200; Ohoka Y, 1998, GENES CELLS, V3, P603, DOI 10.1046/j.1365-2443.1998.00216.x; Patel AM, 1996, ONCOGENE, V12, P31; Patel AS, 1998, ONCOGENE, V16, P3227, DOI 10.1038/sj.onc.1201850; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Schuuring E, 1998, CELL ADHES COMMUN, V6, P185, DOI 10.3109/15419069809004475; SCHUURING E, 1993, MOL CELL BIOL, V13, P2891, DOI 10.1128/MCB.13.5.2891; SCHUURING E, 1995, GENE, V159, P83, DOI 10.1016/0378-1119(94)00562-7; SCHUURING E, 1992, CANCER RES, V52, P5229; SCHUURING E, 1992, ONCOGENE, V7, P355; Small JV, 1999, CURR OPIN CELL BIOL, V11, P54, DOI 10.1016/S0955-0674(99)80007-6; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; vanDamme H, 1997, J BIOL CHEM, V272, P7374, DOI 10.1074/jbc.272.11.7374; vanHam SM, 1997, CURR BIOL, V7, P950, DOI 10.1016/S0960-9822(06)00414-3; Vidal C, 2002, BLOOD, V100, P4462, DOI 10.1182/blood.V100.13.4462; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 1998, J CELL SCI, V111, P2433; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; ZHAN X, 1993, J BIOL CHEM, V268, P24427; ZHAN X, 1994, J BIOL CHEM, V269, P20221; Zondag GCM, 1996, J CELL BIOL, V134, P1513, DOI 10.1083/jcb.134.6.1513	38	49	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45672	45679		10.1074/jbc.M306688200	http://dx.doi.org/10.1074/jbc.M306688200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952985	hybrid			2022-12-27	WOS:000186452300076
J	Bloom, DA; Jaiswal, AK				Bloom, DA; Jaiswal, AK			Phosphorylation of Nrf2 at Ser(40) by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H : quinone oxidoreductase-1 gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCTION; ENZYMES; KEAP1; SUSCEPTIBILITY; DEGRADATION; DISRUPTION; DEFICIENCY; MECHANISM; NAD(P)H; CELLS	The antioxidant response element ( ARE) and transcription factor Nrf2 regulate basal expression and antioxidant induction of NAD(P)H: quinone oxidoreductase-1 (NQO1) and other detoxifying genes. Under normal conditions, Nrf2 is targeted for proteasomal degradation by INrf2. Oxidative stress causes release of Nrf2 from INrf2. Nrf2 translocates to the nucleus, binds to the ARE, and activates gene expression. In this study, we demonstrate that protein kinase C (PKC) plays a significant role in the regulation of ARE-mediated NQO1 gene expression and induction in response to t-butylhydroquinone. Treatment of HepG2 cells with the PKC inhibitors staurosporine and calphostin C repressed ARE-mediated induction of a luciferase reporter as well as that of the endogenous NQO1 gene. Similar experiments with inhibitors of MEK/ERK, p38, phosphatidylinositol 3-kinase, and tyrosine kinases failed to repress ARE-mediated gene expression. The PKC inhibitor staurosporine blocked the nuclear translocation of Nrf2, suggesting that Nrf2 might be the target for PKC regulation. A Prosite search revealed the presence of seven putative PKC sites in mouse Nrf2. The PKC site at Ser(40) is conserved among species and lies in the Neh2 domain, which interacts with INrf2. We demonstrate that phosphorylation of Ser40 is necessary for Nrf2 release from INrf2, but is not required for Nrf2 stabilization/ accumulation in the nucleus and transcriptional activation of ARE-mediated NQO1 gene expression. A peptide that competes with endogenous Nrf2 for INrf2 binding was able to induce ARE activity more effectively than t-butylhydroquinone, and Nrf2 that accumulated in the nucleus as a result was not phosphorylated.	Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine	Jaiswal, AK (corresponding author), Baylor Coll Med, Dept Pharmacol, 1 Baylor Plaza, Houston, TX 77030 USA.	ajaiswal@bcm.tmc.edu			NIGMS NIH HHS [GM47466] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM047466, R01GM047466] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; Dieter MZ, 2001, BIOCHEM PHARMACOL, V61, P215, DOI 10.1016/S0006-2952(00)00525-6; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Gaikwad A, 2001, J BIOL CHEM, V276, P22559, DOI 10.1074/jbc.M101053200; Gong PF, 2001, J BIOL CHEM, V276, P27018, DOI 10.1074/jbc.M103658200; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Kang KW, 2000, MOL PHARMACOL, V58, P1017, DOI 10.1124/mol.58.5.1017; Long DJ, 2000, CANCER RES, V60, P5913; Long DJ, 2002, CANCER RES, V62, P3030; Long DJ, 2001, JNCI-J NATL CANCER I, V93, P1166, DOI 10.1093/jnci/93.15.1166; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Radjendirane V, 1998, J BIOL CHEM, V273, P7382, DOI 10.1074/jbc.273.13.7382; SHAW PM, 1991, EUR J BIOCHEM, V195, P171, DOI 10.1111/j.1432-1033.1991.tb15691.x; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Yu R, 1996, CANCER RES, V56, P2954; Yu R, 1999, J BIOL CHEM, V274, P27545, DOI 10.1074/jbc.274.39.27545; Yu R, 2000, J BIOL CHEM, V275, P2322, DOI 10.1074/jbc.275.4.2322; Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200	28	399	414	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44675	44682		10.1074/jbc.M307633200	http://dx.doi.org/10.1074/jbc.M307633200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947090	hybrid			2022-12-27	WOS:000186306700100
J	Hinoi, T; Loda, M; Fearon, ER				Hinoi, T; Loda, M; Fearon, ER			Silencing of CDX2 expression in colon cancer via a dominant repression pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN EXPRESSION; HOMEOBOX GENE CDX2; COLORECTAL-CANCER; PROTEIN EXPRESSION; BREAST-CANCER; MUTANT MICE; CARCINOMAS; EPITHELIUM; DROSOPHILA; CELLS	CDX2 is a caudal-related homeobox transcription factor whose expression in the adult is normally restricted to intestinal epithelium. Mice heterozygous for germ line Cdx2 inactivation develop intestinal polyps, and the lesions lack Cdx2 expression. Prior studies indicate some human colon carcinomas also lack CDX2 expression. To address the role of CDX2 defects in colon cancer development, we analyzed CDX2 expression in 45 primary colorectal carcinomas. Four carcinomas lacked CDX2 expression, and three others showed aberrant cytoplasmic localization of CDX2, although no significant CDX2 gene defects were seen in the seven tumors. Marked reductions in CDX2 transcript and protein levels were seen in five of 13 colorectal cell lines, and nuclear run-off data indicated reduced transcription was a major factor in CDX2 silencing. Treatment with the DNA demethylating agent 5-aza- 2'-deoxycytidine and/or the histone deacetylase inhibitor trichostatin A did not restore CDX2 expression in CDX2-negative lines. However, consistent with a role for dominant repression mechanisms in CDX2 silencing, all somatic cell hybrids resulting from pairwise fusions between colon cancer lines with intact CDX2 expression and lines lacking CDX2 had reduced CDX2 transcripts and protein. A roughly 9.5-kb 5'-flanking region from the human CDX2 gene contained key cis elements for regulating transcription in colon cancer cells. Restoration of CDX2 expression suppressed proliferation and soft agar growth in the CDX2-negative HT-29 colon cancer cell line. Our findings suggest CDX2 inactivation in colon cancer results from defects in trans-acting pathways regulating CDX2 transcription, and CDX2 silencing contributes to the altered phenotype of some colorectal cancers.	Univ Michigan, Med Ctr, Div Mol Med & Genet, Dept Internal Med,Sch Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Canc, Ann Arbor, MI 48109 USA; Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Sch Med,Dept Adult Oncol, Boston, MA 02115 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Fearon, ER (corresponding author), Univ Michigan, Med Ctr, Div Mol Med & Genet, Dept Internal Med,Sch Med, 1150 W Med Ctr Dr,4301 MSRB 3, Ann Arbor, MI 48109 USA.		Hinoi, Takao/AAI-1443-2020	Hinoi, Takao/0000-0003-0462-6177	NCI NIH HHS [CA82223] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R56CA082223, R01CA082223] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beck F, 1999, P NATL ACAD SCI USA, V96, P7318, DOI 10.1073/pnas.96.13.7318; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; Drummond F, 1997, ANN HUM GENET, V61, P393, DOI 10.1017/S0003480097006465; EE HC, 1995, AM J PATHOL, V147, P586; Freshney RI, 1994, CULTURE ANIMAL CELLS, P166; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; GRAFF JR, 1995, CANCER RES, V55, P5195; GREENBERG ME, 1997, CURRENT PROTOCOLS MO; Hajra KM, 2002, CANCER RES, V62, P1613; Hajra KM, 1999, ONCOGENE, V18, P7274, DOI 10.1038/sj.onc.1203336; Hinoi T, 2001, AM J PATHOL, V159, P2239, DOI 10.1016/S0002-9440(10)63074-X; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; JAMES R, 1994, J BIOL CHEM, V269, P15229; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kim S, 2002, GASTROENTEROLOGY, V123, P1163, DOI 10.1053/gast.2002.36043; KIMURA K, 1994, J BIOL CHEM, V269, P18961; MACDONALD PM, 1986, NATURE, V324, P537, DOI 10.1038/324537a0; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Mallo GV, 1998, J BIOL CHEM, V273, P14030, DOI 10.1074/jbc.273.22.14030; Mallo GV, 1997, INT J CANCER, V74, P35, DOI 10.1002/(SICI)1097-0215(19970220)74:1<35::AID-IJC7>3.0.CO;2-1; MLODZIK M, 1987, CELL, V48, P465, DOI 10.1016/0092-8674(87)90197-8; Qualtrough D, 2002, GUT, V51, P184, DOI 10.1136/gut.51.2.184; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Silberg DG, 1997, GASTROENTEROLOGY, V113, P478, DOI 10.1053/gast.1997.v113.pm9247467; Sivagnanasundaram S, 2001, BRIT J CANCER, V84, P218, DOI 10.1054/bjoc.2000.1544; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; Suh ER, 2002, J BIOL CHEM, V277, P35795, DOI 10.1074/jbc.M205567200; Tamai Y, 1999, CANCER RES, V59, P2965; Tamura G, 2000, J NATL CANCER I, V92, P569, DOI 10.1093/jnci/92.7.569; Vogelstein B, 2002, GENETIC BASIS HUMAN, P583; Wicking C, 1998, ONCOGENE, V17, P657, DOI 10.1038/sj.onc.1201971; Woodford-Richens KL, 2001, BRIT J CANCER, V84, P1314, DOI 10.1054/bjoc.2001.1800; Yagi OK, 1999, BRIT J CANCER, V79, P440, DOI 10.1038/sj.bjc.6690068	37	83	85	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44608	44616		10.1074/jbc.M307435200	http://dx.doi.org/10.1074/jbc.M307435200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947088	hybrid			2022-12-27	WOS:000186306700091
J	Shan, B; Xu, J; Zhuo, Y; Morris, CA; Morris, GF				Shan, B; Xu, J; Zhuo, Y; Morris, CA; Morris, GF			Induction of p53-dependent activation of the human proliferating cell nuclear antigen gene in chromatin by ionizing radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING FUNCTION; WILD-TYPE P53; IN-VIVO; TRANSCRIPTIONAL REGULATION; HUMAN-FIBROBLASTS; PROMOTER ACTIVITY; CYCLE CHECKPOINT; TYPE-1 TAX; PCNA; PROTEIN	A human fibroblast cell line with conditional p53 expression displayed a p53-dependent increase in both the protein and mRNA levels of proliferating cell nuclear antigen (PCNA) after exposure to ionizing radiation (IR). The combination of p53 induction and IR cooperated to activate a transiently expressed human PCNA promoter-reporter gene via a p53-responsive element. Chromatin immunoprecipitation assays with antibodies specific for p53 or p300/CREB-binding protein revealed specific p53-dependent enrichment of PCNA promoter sequences in immunoprecipitates of sheared chromatin prepared from irradiated cells. Maximal and specific association of acetylated histone H4 with the PCNA promoter also depended on p53 induction and exposure to IR. These data demonstrate p53 binding to a target site in the PCNA promoter, recruitment of p300/CREB-binding protein, and localized acetylation of histone H4 in an IR-dependent manner. These molecular events are likely to play a role in mediating activation of PCNA gene expression by p53 during the cellular response to DNA damage. The analyses indicate that the combination of p53 induction and IR activate the PCNA gene via mechanisms similar to that of p21/wild-type p53-activated factor but to a lesser extent. This differential regulation of PCNA and p21/wild-type p53-activated factor may establish the proper ratio of the two proteins to coordinate DNA repair with cell cycle arrest.	Tulane Canc Ctr, Dept Pathol, Programs Mol & Cellular Biol & Lung Biol, New Orleans, LA 70112 USA; Tulane Canc Ctr, Dept Med, Programs Mol & Cellular Biol & Lung Biol, New Orleans, LA 70112 USA; Tulane Canc Ctr, Dept Microbiol & Immunol, Programs Mol & Cellular Biol & Lung Biol, New Orleans, LA 70112 USA; Tulane Xavier Ctr Bioenvironm Res, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University; Tulane University; Xavier University of Louisiana	Morris, GF (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Pathol, SL-79,1430 Tulane Ave, New Orleans, LA 70112 USA.			Shan, Bin/0000-0002-6869-2678; Xu, Jin/0000-0001-6617-5311	NIEHS NIH HHS [ES07856] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES007856] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; ALMENDRAL JM, 1987, P NATL ACAD SCI USA, V84, P1575, DOI 10.1073/pnas.84.6.1575; Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Appella E, 2000, PATHOL BIOL, V48, P227; Ard PG, 2002, MOL CELL BIOL, V22, P5650, DOI 10.1128/MCB.22.16.5650-5661.2002; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Boyd KE, 1999, MOL CELL BIOL, V19, P8393; Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543; Chan HM, 2001, J CELL SCI, V114, P2363; CHANG CD, 1990, MOL CELL BIOL, V10, P3289, DOI 10.1128/MCB.10.7.3289; Chang HW, 1999, J CELL BIOCHEM, V73, P423, DOI 10.1002/(SICI)1097-4644(19990601)73:3<423::AID-JCB13>3.0.CO;2-9; Cook JL, 1999, ONCOGENE, V18, P2373, DOI 10.1038/sj.onc.1202566; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Goldring JPD, 1996, ANAL BIOCHEM, V242, P197, DOI 10.1006/abio.1996.0453; Gottifredi V, 2001, P NATL ACAD SCI USA, V98, P1036, DOI 10.1073/pnas.021282898; Goukassian DA, 1999, J INVEST DERMATOL, V112, P25, DOI 10.1046/j.1523-1747.1999.00468.x; Grossman SR, 2001, EUR J BIOCHEM, V268, P2773, DOI 10.1046/j.1432-1327.2001.02226.x; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; HALL PA, 1993, ONCOGENE, V8, P203; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; HUANG DY, 1994, MOL CELL BIOL, V14, P4233, DOI 10.1128/MCB.14.6.4233; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; JACKSON P, 1994, BIOCHEM BIOPH RES CO, V203, P133, DOI 10.1006/bbrc.1994.2159; JASKULSKI D, 1988, J BIOL CHEM, V263, P10175; JASKULSKI D, 1988, SCIENCE, V240, P1544, DOI 10.1126/science.2897717; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Kannabiran C, 1999, ONCOGENE, V18, P7825, DOI 10.1038/sj.onc.1203294; Kao SY, 2000, J BIOL CHEM, V275, P35926, DOI 10.1074/jbc.M004397200; Karuppayil SM, 1998, J BIOL CHEM, V273, P17303, DOI 10.1074/jbc.273.28.17303; Kawabe T, 2002, ONCOGENE, V21, P1717, DOI 10.1038/sj.onc.1205229; Lemoine FJ, 2000, AIDS RES HUM RETROV, V16, P1623, DOI 10.1089/08892220050193056; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; MacCallum DE, 1996, ONCOGENE, V13, P2575; MACK DH, 1993, NATURE, V363, P281, DOI 10.1038/363281a0; MIDGLEY CA, 1995, J CELL SCI, V108, P1843; Mishra A, 2000, AM J RESP CELL MOL, V22, P543, DOI 10.1165/ajrcmb.22.5.3851; Mishra A, 1997, AM J RESP CELL MOL, V16, P479, DOI 10.1165/ajrcmb.16.4.9115760; Momand J, 1997, J CELL BIOCHEM, V64, P343; Morris GF, 1996, P NATL ACAD SCI USA, V93, P895, DOI 10.1073/pnas.93.2.895; MORRIS GF, 1991, J VIROL, V65, P6397, DOI 10.1128/JVI.65.12.6397-6406.1991; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; North S, 2000, PATHOL BIOL, V48, P255; Noya F, 2002, J BIOL CHEM, V277, P17271, DOI 10.1074/jbc.M112441200; Oren M, 2002, BIOCHEM PHARMACOL, V64, P865, DOI 10.1016/S0006-2952(02)01149-8; Paunesku T, 2001, INT J RADIAT BIOL, V77, P1007, DOI 10.1080/09553000110069335; Prives C, 1999, J PATHOL, V187, P112; Saifudeen Z, 2002, AM J PHYSIOL-RENAL, V283, pF727, DOI 10.1152/ajprenal.00114.2002; Scott M, 2001, J CELL SCI, V114, P3455; SHIVAKUMAR CV, 1995, MOL CELL BIOL, V15, P6785; SPAETE RR, 1985, J VIROL, V56, P135, DOI 10.1128/JVI.56.1.135-143.1985; SUBLER MA, 1992, J VIROL, V66, P4757, DOI 10.1128/JVI.66.8.4757-4762.1992; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tommasi S, 1999, J BIOL CHEM, V274, P27829, DOI 10.1074/jbc.274.39.27829; Tournier S, 1996, MOL BIOL CELL, V7, P651, DOI 10.1091/mbc.7.4.651; Tsurimoto T., 1999, FRONT BIOSCI, V4, P849; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Wenz F, 1998, RADIAT RES, V149, P32, DOI 10.2307/3579679; Woloschak Gayle E, 2002, Mil Med, V167, P42; Woloschak GE, 1996, CARCINOGENESIS, V17, P2357, DOI 10.1093/carcin/17.11.2357; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; Xu J, 1999, MOL CELL BIOL, V19, P12; YAMAGUCHI M, 1994, EUR J BIOCHEM, V221, P227, DOI 10.1111/j.1432-1033.1994.tb18733.x; ZERLER B, 1987, MOL CELL BIOL, V7, P821, DOI 10.1128/MCB.7.2.821	77	36	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44009	44017		10.1074/jbc.M302671200	http://dx.doi.org/10.1074/jbc.M302671200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947108	hybrid			2022-12-27	WOS:000186306700016
J	Migliaccio, G; Tomassini, JE; Carroll, SS; Tomei, L; Altamura, S; Bhat, B; Bartholomew, L; Bosserman, MR; Ceccacci, A; Colwell, LF; Cortese, R; De Francesco, R; Eldrup, AB; Getty, KL; Hou, XS; LaFemina, RL; Ludmerer, SW; MacCoss, M; McMasters, DR; Stahlhut, MW; Olsen, DB; Hazuda, DJ; Flores, OA				Migliaccio, G; Tomassini, JE; Carroll, SS; Tomei, L; Altamura, S; Bhat, B; Bartholomew, L; Bosserman, MR; Ceccacci, A; Colwell, LF; Cortese, R; De Francesco, R; Eldrup, AB; Getty, KL; Hou, XS; LaFemina, RL; Ludmerer, SW; MacCoss, M; McMasters, DR; Stahlhut, MW; Olsen, DB; Hazuda, DJ; Flores, OA			Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; PHOSPHONIC ACID ANALOGS; REVERSE-TRANSCRIPTASE; IDENTIFICATION; GANCICLOVIR; ACYCLOVIR; MECHANISM; VIRAZOLE; SYSTEM; SITE	The urgent need for efficacious drugs to treat chronic hepatitis C virus (HCV) infection requires a concerted effort to develop inhibitors specific for virally encoded enzymes. We demonstrate that 2'-C-methyl ribonucleosides are efficient chain-terminating inhibitors of HCV genome replication. Characterization of drug-resistant HCV replicons defined a single S282T mutation within the active site of the viral polymerase that conferred loss of sensitivity to structurally related compounds in both replicon and isolated polymerase assays. Biochemical analyses demonstrated that resistance at the level of the enzyme results from a combination of reduced affinity of the mutant polymerase for the drug and an increased ability to extend the incorporated nucleoside analog. Importantly, the combination of these agents with interferon-alpha results in synergistic inhibition of HCV genome replication in cell culture. Furthermore, 2'-C-methyl-substituted ribonucleosides also inhibited replication of genetically related viruses such as bovine diarrhea virus, yellow fever, and West African Nile viruses. These observations, together with the finding that 2'-C-methyl-guanosine in particular has a favorable pharmacological profile, suggest that this class of compounds may have broad utility in the treatment of HCV and other flavivirus infections.	Merck Res Labs, Dept Biol Chem, West Point, PA 19486 USA; Ist Ric Biol Mol P Angeletti, Dept Biochem, I-00040 Pomezia, Italy; Isis Pharmaceut, Dept Med Chem, Carlsbad, CA 92008 USA; Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA; Merck Res Labs, Dept Biometr, West Point, PA 19486 USA; Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA	Merck & Company; Merck & Company; Isis Pharmaceuticals Inc; Merck & Company; Merck & Company; Merck & Company	Flores, OA (corresponding author), Merck Res Labs, Dept Biol Chem, POB 4,WP26A-4000, West Point, PA 19486 USA.	osvaldo_flores@merck.com	De Francesco, Raffaele/J-6003-2012	De Francesco, Raffaele/0000-0001-8754-5123; olsen, david/0000-0001-5521-0206; McMasters, Daniel/0000-0003-3794-8666				Barnard DL, 2001, ANTIVIR CHEM CHEMOTH, V12, P241, DOI 10.1177/095632020101200405; BARTON CN, 1993, BIOMETRICS, V49, P95, DOI 10.2307/2532605; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; Carroll SS, 2000, BIOCHEMISTRY-US, V39, P8243, DOI 10.1021/bi991992s; Dhanak D, 2002, J BIOL CHEM, V277, P38322, DOI 10.1074/jbc.M205566200; el Kouni MH, 2002, CURR PHARM DESIGN, V8, P581, DOI 10.2174/1381612024607171; GROB PM, 1992, AIDS RES HUM RETROV, V8, P145, DOI 10.1089/aid.1992.8.145; HUFFMAN JH, 1994, NUCLEOS NUCLEOT, V13, P607, DOI 10.1080/15257779408013266; HUFFMAN JH, 1973, ANTIMICROB AGENTS CH, V3, P235, DOI 10.1128/AAC.3.2.235; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Liang J. T., 2000, HEPATITIS C BIOMEDIC, P185; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Murray EM, 2003, J VIROL, V77, P2928, DOI 10.1128/JVI.77.5.2928-2935.2003; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; SIDWELL RW, 1989, NUCLEOS NUCLEOT, V8, P833, DOI 10.1080/07328318908054224; SIDWELL RW, 1971, APPL MICROBIOL, V22, P797, DOI 10.1128/AEM.22.5.797-801.1971; Tomassini JE, 2003, VIROLOGY, V313, P274, DOI 10.1016/S0042-6822(03)00314-3; Trozzi C, 2003, J VIROL, V77, P3669, DOI 10.1128/JVI.77.6.3669-3679.2003; Tucker TJ, 1996, METHOD ENZYMOL, V275, P440; Wang MT, 2003, J BIOL CHEM, V278, P9489, DOI 10.1074/jbc.M209397200; Wang QM, 2002, J VIROL, V76, P3865, DOI 10.1128/JVI.76.8.3865-3872.2002; Wilson JE, 1996, METHOD ENZYMOL, V275, P398	27	272	311	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					49164	49170		10.1074/jbc.M305041200	http://dx.doi.org/10.1074/jbc.M305041200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12966103	hybrid			2022-12-27	WOS:000186829000080
J	Wang, LH; Ho, B; Ding, JL				Wang, LH; Ho, B; Ding, JL			Transcriptional regulation of limulus factor C - Repression of an NF kappa B motif modulates its responsiveness to bacterial lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HORSESHOE-CRAB; SERINE-PROTEASE; DROSOPHILA TOLL; FACTOR-X; INNATE IMMUNITY; MOLECULAR-BASIS; COAGULATION; GENE; SEQUENCE	Serine proteases play fundamental roles in invertebrate development, hemostasis, and innate immunity. This is exemplified by the limulus Factor C, which is a serine protease that binds a pathogen-associated molecule, lipopolysaccharide (LPS) to trigger a blood coagulation cascade. As a central molecule in the limulus innate immunity and hemostasis, Factor C gene expression has been detected in two major immune defense tissues, the amebocytes and hepatopancreas. Infection of the limulus with live Gram-negative bacteria induces a 2-3-fold increase in mRNA transcripts in both tissues. However, in vitro studies in Drosophila cell lines using Factor C promoter-reporter chimera DNA constructs, and site-directed mutagenesis of the promoter demonstrated that a proximal kappaB binding site, aided by an adjacent dorsal-like binding motif responds dramatically to LPS and dorsal transcription factor overexpression. Electrophoretic mobility shift assay further confirmed a strong interaction of the limulus kappaB motif with Rel proteins. However, deletion constructs of the Factor C promoter harboring different numbers of dorsal-like binding sites upstream of the kappaB motif as well as the electrophoretic mobility shift assay of these motifs with Rel proteins strongly suggest that the up-regulation of Factor C gene expression is attenuated during microbial challenge. The repression of the dramatic activation of this pathogen-responsive gene by LPS is probably effected via competition between the dorsal-like motifs over the proximal LPS-responsive kappaB unit, or through inhibition from the upstream repressive element(s), which accounts for the gene expression pattern observed in vivo. Our findings demonstrate that blood coagulation and innate immune response are integrated at the transcriptional level in this ancient organism, and that this LPS-responsive serine protease is controlled by an evolutionarily conserved NFkappaB pathway.	Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Natl Univ Singapore, Dept Microbiol, Singapore 117543, Singapore	National University of Singapore; National University of Singapore	Ding, JL (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsdjl@nus.edu.sg	Ding, Jeak/H-8057-2012					Akira S, 1997, ADV IMMUNOL, V65, P1, DOI 10.1016/S0065-2776(08)60740-3; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Bergner A, 1996, EMBO J, V15, P6789, DOI 10.1002/j.1460-2075.1996.tb01070.x; CHOW BKC, 1991, J BIOL CHEM, V266, P18927; Cicala C, 1998, LIFE SCI, V62, P1817, DOI 10.1016/S0024-3205(97)01167-3; Citarella F, 1997, BLOOD, V90, P1501, DOI 10.1182/blood.V90.4.1501.1501_1501_1507; CITARELLA F, 1993, BIOCHIM BIOPHYS ACTA, V1172, P197, DOI 10.1016/0167-4781(93)90294-N; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ding Jeak L., 1995, Molecular Marine Biology and Biotechnology, V4, P90; DING JL, 1993, BIOCHIM BIOPHYS ACTA, V1202, P149, DOI 10.1016/0167-4838(93)90076-4; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; ERDMANN D, 1995, J BIOL CHEM, V270, P22988, DOI 10.1074/jbc.270.39.22988; Gateff E., 1980, INVERTEBRATE SYSTEMS, P517; GAY NJ, 1992, BIOCHIM BIOPHYS ACTA, V1132, P290, DOI 10.1016/0167-4781(92)90163-T; GEORGEL P, 1995, NUCLEIC ACIDS RES, V23, P1140, DOI 10.1093/nar/23.7.1140; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hader T, 2000, CURR BIOL, V10, P51, DOI 10.1016/S0960-9822(99)00265-1; HASSAN JH, 1992, THROMB HAEMOSTASIS, V67, P478; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Hoffman M, 1996, HAEMOSTASIS, V26, P12; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; HUANG MN, 1992, J BIOL CHEM, V267, P15440; Inamori K, 2000, J ENDOTOXIN RES, V6, P397, DOI 10.1179/096805100101532342; IP YT, 1991, CELL, V64, P439; Iwanaga S, 2002, CURR OPIN IMMUNOL, V14, P87, DOI 10.1016/S0952-7915(01)00302-8; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Khush RS, 2000, TRENDS GENET, V16, P442, DOI 10.1016/S0168-9525(00)02095-3; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; KURACHI S, 1994, BIOCHEMISTRY-US, V33, P1580, DOI 10.1021/bi00172a039; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Mackay IS, 1996, CLIN EXP ALLERGY, V26, P1; MACKMAN N, 1995, FASEB J, V9, P883, DOI 10.1096/fasebj.9.10.7615158; MASON P, 1993, GENE TRANSCRIPTION P, P47; MIAO CH, 1992, J BIOL CHEM, V267, P7395; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Misra S, 1998, DEVELOPMENT, V125, P1261; Mizuguchi K, 1998, TRENDS BIOCHEM SCI, V23, P239, DOI 10.1016/S0968-0004(98)01216-X; MOON DK, 1988, J IMMUNOL, V141, P1536; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; MUTA T, 1991, J BIOL CHEM, V266, P6554; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Opal SM, 2000, CRIT CARE MED, V28, pS77, DOI 10.1097/00003246-200009001-00017; PETERSEN UM, 1995, EMBO J, V14, P3146, DOI 10.1002/j.1460-2075.1995.tb07317.x; Pollak ES, 1996, J BIOL CHEM, V271, P1738, DOI 10.1074/jbc.271.3.1738; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Sambrook J, 1988, MOL CLONING LAB MANU; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Tan NS, 2000, FASEB J, V14, P859, DOI 10.1096/fasebj.14.7.859; Tetsuka T, 2000, J BIOL CHEM, V275, P4383, DOI 10.1074/jbc.275.6.4383; THISSE C, 1991, CELL, V65, P1191, DOI 10.1016/0092-8674(91)90014-P; Wang J, 2002, J BIOL CHEM, V277, P36363, DOI 10.1074/jbc.M202837200; WAY M, 1995, J CELL BIOL, V128, P51, DOI 10.1083/jcb.128.1.51; Wilberding JA, 2000, THROMB HAEMOSTASIS, V84, P1031	60	10	11	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					49428	49437		10.1074/jbc.M306641200	http://dx.doi.org/10.1074/jbc.M306641200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12949077	hybrid			2022-12-27	WOS:000186829000111
J	Miele, C; Riboulet, A; Maitan, MA; Oriente, F; Romano, C; Formisano, P; Giudicelli, J; Beguinot, F; Van Obberghen, E				Miele, C; Riboulet, A; Maitan, MA; Oriente, F; Romano, C; Formisano, P; Giudicelli, J; Beguinot, F; Van Obberghen, E			Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR-KAPPA-B; END-PRODUCTS; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; DIABETIC NEPHROPATHY; DEPENDENT PATHWAY; FACTOR EXPRESSION; OXIDATIVE STRESS; MESANGIAL CELLS	Nonenzymatic glycation is increased in diabetes and leads to increased levels of glycated proteins. Most studies have focused on the role of glycation products in vascular complications. Here, we have investigated the action of human glycated albumin (HGA) on insulin signaling in L6 skeletal muscle cells. Exposure of these cells to HGA inhibited insulin-stimulated glucose uptake and glycogen synthase activity by 95 and 80%, respectively. These effects were time- and dose-dependent, reaching a maximum after 12 h incubation with 0.1 mg/ml HGA. In contrast, exposure of the cells to HGA had no effect on thymidine incorporation. Further, HGA reduced insulin-stimulated serine phosphorylation of PKB and GSK3, but did not alter ERK1/2 activation. HGA did not affect either insulin receptor kinase activity or insulin-induced Shc phosphorylation on tyrosine. In contrast, insulin-dependent IRS-1 and IRS-2 tyrosine phosphorylation was severely reduced in cells preincubated with HGA for 24 h. Insulin-stimulated association of PI3K with IRS-1 and IRS-2, and PI3K activity were reduced by HGA in parallel with the changes in IRS tyrosine phosphorylation, while Grb2-IRS association was unchanged. In L6 myotubes, exposure to HGA increased PKC activity by 2-fold resulting in a similar increase in Ser/Thr phosphorylation of IRS-1 and IRS-2. These phosphorylations were blocked by the PKC inhibitor bisindolylmaleimide (BDM). BDM also blocked the action of HGA on insulin-stimulated PKB and GSK3alpha. Simultaneously, BDM rescued insulin-stimulation of glucose uptake and glycogen synthase activity in cells exposed to HGA. The use of antibodies specific to PKC isoforms shows that this effect appears to be mediated by activated PKCalpha, independent of reactive oxygen species production. In summary, in L6 skeletal muscle cells, exposure to HGA leads to insulin resistance selectively in glucose metabolism with no effect on growth-related pathways regulated by the hormone.	Fac Med, INSERM, U145, F-06107 Nice 2, France; Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; Univ Naples Federico II, Ctr Endocrinol & Oncol Sperimentale, CNR, I-80131 Naples, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II	Van Obberghen, E (corresponding author), Fac Med, INSERM, U145, 28 Ave Valombrose, F-06107 Nice 2, France.		Formisano, Pietro/J-4237-2018; ORIENTE, Francesco/J-6652-2018	ORIENTE, Francesco/0000-0003-4375-4526; Formisano, Pietro/0000-0001-7020-6870				Aiello LP, 2002, SURV OPHTHALMOL, V47, pS263, DOI 10.1016/S0039-6257(02)00391-0; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Bossenmaier B, 1997, DIABETOLOGIA, V40, P863, DOI 10.1007/s001250050761; Brownlee M, 2000, METABOLISM, V49, P9, DOI 10.1016/S0026-0495(00)80078-5; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cabrero A, 2002, J BIOL CHEM, V277, P10100, DOI 10.1074/jbc.M110321200; CHIN JE, 1994, MOL ENDOCRINOL, V8, P51, DOI 10.1210/me.8.1.51; Cohen MP, 1999, AM J PHYSIOL-RENAL, V276, pF684, DOI 10.1152/ajprenal.1999.276.5.F684; DAVIDSON MB, 1994, AM J PHYSIOL-ENDOC M, V267, pE808, DOI 10.1152/ajpendo.1994.267.6.E808; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; Farese RV, 2002, AM J PHYSIOL-ENDOC M, V283, pE1, DOI 10.1152/ajpendo.00045.2002; FIELDS R, 1971, BIOCHEM J, V124, P581, DOI 10.1042/bj1240581; Filippa N, 1999, MOL CELL BIOL, V19, P4989; Flyvbjerg A, 2000, DIABETOLOGIA, V43, P1205, DOI 10.1007/s001250051515; FORMISANO P, 1993, J BIOL CHEM, V268, P5241; Formisano P, 2000, MOL CELL BIOL, V20, P6323, DOI 10.1128/MCB.20.17.6323-6333.2000; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; HAGER SR, 1991, AM J PHYSIOL, V260, pE353, DOI 10.1152/ajpendo.1991.260.3.E353; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hattori Y, 2002, HYPERTENSION, V39, P22, DOI 10.1161/hy1201.097300; Hawkins M, 1997, J CLIN INVEST, V99, P2173, DOI 10.1172/JCI119390; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; Hoffmann S, 2002, GRAEF ARCH CLIN EXP, V240, P996, DOI 10.1007/s00417-002-0568-6; Hofmann SM, 2002, DIABETES, V51, P2082, DOI 10.2337/diabetes.51.7.2082; Ido Y, 2001, MICROCIRCULATION, V8, P251, DOI 10.1038/sj.mn.7800079; Idris I, 2002, ANN NY ACAD SCI, V967, P176; Jiang ZY, 1999, DIABETES, V48, P1120, DOI 10.2337/diabetes.48.5.1120; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kellerer M, 1998, DIABETOLOGIA, V41, P833, DOI 10.1007/s001250050995; Kim YB, 2000, DIABETES, V49, P847, DOI 10.2337/diabetes.49.5.847; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Kurowski TG, 1999, DIABETES, V48, P658, DOI 10.2337/diabetes.48.3.658; Makita Z, 1995, J DIABETES COMPLICAT, V9, P265, DOI 10.1016/1056-8727(95)80018-A; Mamputu JC, 2002, J DIABETES COMPLICAT, V16, P284, DOI 10.1016/S1056-8727(01)00229-X; Matsuoka T, 1997, J CLIN INVEST, V99, P144, DOI 10.1172/JCI119126; Maziere C, 2003, FREE RADICAL BIO MED, V34, P629, DOI 10.1016/S0891-5849(02)01329-1; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Morcos M, 2002, DIABETES, V51, P3532, DOI 10.2337/diabetes.51.12.3532; Motley ED, 2001, CELL MOL BIOL, V47, P1059; Nagai R, 2000, DIABETES, V49, P1714, DOI 10.2337/diabetes.49.10.1714; Naitoh T, 2001, CELL SIGNAL, V13, P331, DOI 10.1016/S0898-6568(01)00152-8; Nakajima K, 2000, J BIOL CHEM, V275, P20880, DOI 10.1074/jbc.M905410199; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Peraldi P, 1998, MOL CELL BIOCHEM, V182, P169, DOI 10.1023/A:1006865715292; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; PONGOR S, 1984, P NATL ACAD SCI-BIOL, V81, P2684, DOI 10.1073/pnas.81.9.2684; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; Rossetti L, 2000, ENDOCRINOLOGY, V141, P1922, DOI 10.1210/en.141.6.1922; RuggieroLopez D, 1997, DIABETES RES CLIN PR, V34, P135, DOI 10.1016/S0168-8227(96)01352-6; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; SCIMECA JC, 1991, BIOCHEMISTRY-US, V30, P9313, DOI 10.1021/bi00102a025; Scivittaro V, 2000, AM J PHYSIOL-RENAL, V278, pF676, DOI 10.1152/ajprenal.2000.278.4.F676; SMITH PR, 1992, EUR J BIOCHEM, V210, P729, DOI 10.1111/j.1432-1033.1992.tb17474.x; SMITH RE, 1978, ANAL BIOCHEM, V90, P246, DOI 10.1016/0003-2697(78)90029-5; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Strack V, 2000, DIABETOLOGIA, V43, P443, DOI 10.1007/s001250051327; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Tomas E, 2002, ANN NY ACAD SCI, V967, P43; Treins C, 2001, J BIOL CHEM, V276, P43836, DOI 10.1074/jbc.M106534200; Valverde AM, 2000, FEBS LETT, V472, P153, DOI 10.1016/S0014-5793(00)01448-4; Van Obberghen E, 2001, EUR J CLIN INVEST, V31, P966, DOI 10.1046/j.1365-2362.2001.00896.x; WELLSKNECHT KJ, 1995, BIOCHEMISTRY-US, V34, P3702, DOI 10.1021/bi00011a027; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Wu CH, 2002, MOL CELL ENDOCRINOL, V194, P9, DOI 10.1016/S0303-7207(02)00212-5; Wu VY, 2001, BIOCHEM BIOPH RES CO, V284, P602, DOI 10.1006/bbrc.2001.4982; Xu B, 2003, FASEB J, V17, P1289, DOI 10.1096/fj.02-0490fje; Yamagishi S, 2002, J BIOL CHEM, V277, P20309, DOI 10.1074/jbc.M202634200; YAN SD, 1994, J BIOL CHEM, V269, P9889; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495; Yerneni KKV, 1999, DIABETES, V48, P855, DOI 10.2337/diabetes.48.4.855	72	114	120	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47376	47387		10.1074/jbc.M301088200	http://dx.doi.org/10.1074/jbc.M301088200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12970360	hybrid			2022-12-27	WOS:000186731400006
J	Yun, TH; Baglia, FA; Myles, T; Navaneetham, D; Lopez, JA; Walsh, PN; Leung, LLK				Yun, TH; Baglia, FA; Myles, T; Navaneetham, D; Lopez, JA; Walsh, PN; Leung, LLK			RETRACTED: Thrombin activation of factor XI on activated platelets requires the interaction of factor XI and platelet glycoprotein Ib alpha with thrombin anion-binding exosites I and II, respectively (Retracted Article. See vol 282, pg 29067, 2007)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							COAGULATION-FACTOR-XI; PRO-ARG CHLOROMETHYLKETONE; MOLECULAR-WEIGHT KININOGEN; BLOOD-COAGULATION; CRYSTAL-STRUCTURE; V COMPLEX; ANTITHROMBIN-III; HIGH-AFFINITY; FACTOR-VIII; FACTOR IXA	Activation of factor XI (FXI) by thrombin on stimulated platelets plays a physiological role in hemostasis, providing additional thrombin generation required in cases of severe hemostatic challenge. Using a collection of 53 thrombin mutants, we identified 16 mutants with < 50% of the wild-type thrombin FXI-activating activity in the presence of dextran sulfate. These mutants mapped to anion-binding exosite (ABE) I, ABE-II, the Na+-binding site, and the 50-insertion loop. Only the ABE-II mutants showed reduced binding to dextran sulfate-linked agarose. Selected thrombin mutants in ABE-I (R68A, R70A, and R73A), ABE-II (R98A, R245A, and K248A), the 50-insertion loop (W50A), and the Na+-binding site ( E229A and R233A) with < 10% of the wildtype activity also showed a markedly reduced ability to activate FXI in the presence of stimulated platelets. The ABE-I, 50-insertion loop, and Na+-binding site mutants had impaired binding to FXI, but normal binding to glycocalicin, the soluble form of glycoprotein Ibalpha (GPIbalpha). In contrast, the ABE-II mutants were defective in binding to glycocalicin, but displayed normal binding to FXI. Our data support a quaternary complex model of thrombin activation of FXI on stimulated platelets. Thrombin bound to one GPIbalpha molecule, via ABE-II on its posterior surface, is properly oriented for its activation of FXI bound to a neighboring GPIalpha molecule, via ABE-I on its anterior surface. GPIbalpha plays a critical role in the co-localization of thrombin and FXI and the resultant efficient activation of FXI.	Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA; Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19140 USA; Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; Baylor Coll Med, Dept Med, Thrombosis Res Sect, Houston, TX 77030 USA; Houston Vet Affairs Med Ctr, Houston, TX 77030 USA	Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center	Leung, LLK (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Hematol, 269 Campus Dr, Stanford, CA 94305 USA.	lawrence.leung@stanford.edu			NHLBI NIH HHS [HL69493, HL46213, HL57530, HL70683] Funding Source: Medline; PHS HHS [P5065967] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057530, R01HL046213, R01HL070683] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AHMAD SS, 1994, BIOCHEMISTRY-US, V33, P12048, DOI 10.1021/bi00206a006; AYALA YH, 1994, J MOL BIOL, V235, P733, DOI 10.1006/jmbi.1994.1024; Baglia FA, 2000, J BIOL CHEM, V275, P20514, DOI 10.1074/jbc.M000464200; Baglia FA, 2002, J BIOL CHEM, V277, P1662, DOI 10.1074/jbc.M108319200; BAGLIA FA, 1995, J BIOL CHEM, V270, P6734, DOI 10.1074/jbc.270.12.6734; Baglia FA, 1996, J BIOL CHEM, V271, P3652; Baglia FA, 1998, BIOCHEMISTRY-US, V37, P2271, DOI 10.1021/bi972113+; BERLINER LJ, 1985, BIOCHEMISTRY-US, V24, P7005, DOI 10.1021/bi00345a038; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BODE W, 1992, PROTEIN SCI, V1, P426; BOUMA BN, 1977, J BIOL CHEM, V252, P6432; DANG QD, 1995, P NATL ACAD SCI USA, V92, P5977, DOI 10.1073/pnas.92.13.5977; De Cristofaro R, 2000, J BIOL CHEM, V275, P3887, DOI 10.1074/jbc.275.6.3887; De Cristofaro R, 2003, BIOCHEM J, V373, P593, DOI 10.1042/BJ20030167; De Cristofaro R, 2001, BIOCHEMISTRY-US, V40, P13268, DOI 10.1021/bi010491f; DECRISTOFARO R, 1998, BIOCHEM J, V332, P6403; DICERA E, 1995, J BIOL CHEM, V270, P22089, DOI 10.1074/jbc.270.38.22089; EDSON JR, 1967, THROMB DIATH HAEMOST, V18, P342, DOI 10.1055/s-0038-1655041; FUJIKAWA K, 1986, BIOCHEMISTRY-US, V25, P2417, DOI 10.1021/bi00357a018; Furman MI, 2000, THROMB HAEMOSTASIS, V84, P897, DOI 10.1055/s-0037-1614134; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; Gailani D, 2001, BLOOD, V97, P3117, DOI 10.1182/blood.V97.10.3117; GIBBS CS, 1995, NATURE, V378, P413, DOI 10.1038/378413a0; GRALNICK HR, 1994, P NATL ACAD SCI USA, V91, P6334, DOI 10.1073/pnas.91.14.6334; GREENGARD JS, 1986, BIOCHEMISTRY-US, V25, P3884, DOI 10.1021/bi00361a022; Hall SW, 1999, J BIOL CHEM, V274, P25510, DOI 10.1074/jbc.274.36.25510; Hall SW, 2001, THROMB HAEMOSTASIS, V86, P1466, DOI 10.1055/s-0037-1616750; HENRIKSEN RA, 1988, BIOCHEMISTRY-US, V27, P9160, DOI 10.1021/bi00426a013; Ho DH, 2000, J BIOL CHEM, V275, P25139, DOI 10.1074/jbc.M001890200; Ho DH, 2000, BIOCHEMISTRY-US, V39, P316, DOI 10.1021/bi991851q; HOFSTEENGE J, 1988, BIOCHEMISTRY-US, V27, P2144, DOI 10.1021/bi00406a049; Huntington JA, 2003, STRUCTURE, V11, P469, DOI 10.1016/S0969-2126(03)00049-2; KITCHENS CS, 1991, SEMIN THROMB HEMOST, V17, P55, DOI 10.1055/s-2007-1002590; Krishnan R, 2000, ACTA CRYSTALLOGR D, V56, P406, DOI 10.1107/S0907444900001487; Leung LLK, 2000, TRENDS CARDIOVAS MED, V10, P89, DOI 10.1016/S1050-1738(00)00047-5; Li CQ, 2001, J BIOL CHEM, V276, P6161, DOI 10.1074/jbc.M004164200; LIU LW, 1991, J BIOL CHEM, V266, P16977; MCMULLEN BA, 1991, BIOCHEMISTRY-US, V30, P2056, DOI 10.1021/bi00222a008; Myles T, 2002, BLOOD, V100, P2820, DOI 10.1182/blood-2002-03-0843; Myles T, 2001, J BIOL CHEM, V276, P25143, DOI 10.1074/jbc.M011324200; NAITO K, 1991, J BIOL CHEM, V266, P7353; RAGNI MV, 1985, BLOOD, V65, P719; Ramakrishnan V, 2001, P NATL ACAD SCI USA, V98, P1823, DOI 10.1073/pnas.98.4.1823; Richardson JL, 2000, EMBO J, V19, P5650, DOI 10.1093/emboj/19.21.5650; Romo GM, 1999, J EXP MED, V190, P803, DOI 10.1084/jem.190.6.803; ROSENTHAL RL, 1955, BLOOD, V10, P120, DOI 10.1182/blood.V10.2.120.120; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; SEAMAN FS, 1994, BIOCHEM J, V304, P715, DOI 10.1042/bj3040715; SHEEHAN JP, 1993, J BIOL CHEM, V268, P3639; SINHA D, 1984, J CLIN INVEST, V73, P1550, DOI 10.1172/JCI111361; STONE SR, 1987, BIOCHEMISTRY-US, V26, P4617, DOI 10.1021/bi00389a004; SUTTIE JW, 1985, ANNU REV BIOCHEM, V54, P459, DOI 10.1146/annurev.bi.54.070185.002331; THOMPSON RE, 1977, J CLIN INVEST, V60, P1376, DOI 10.1172/JCI108898; TSIANG M, 1995, J BIOL CHEM, V270, P16854, DOI 10.1074/jbc.270.28.16854; Tsiang M, 1996, BIOCHEMISTRY-US, V35, P16449, DOI 10.1021/bi9616108; van Zanten GH, 1998, BLOOD, V91, P2353, DOI 10.1182/blood.V91.7.2353.2353_2353_2359	56	64	67	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48112	48119		10.1074/jbc.M306925200	http://dx.doi.org/10.1074/jbc.M306925200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12968031	hybrid			2022-12-27	WOS:000186731400092
J	Zhu, Y; Cai, XL; Wang, ZY; Hong, MM				Zhu, Y; Cai, XL; Wang, ZY; Hong, MM			An interaction between a MYC protein and an EREBP protein is involved in transcriptional regulation of the rice Wx gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; FUNCTIONAL-ANALYSIS; ARABIDOPSIS; EXPRESSION; ENDOSPERM; IDENTIFICATION; SEQUENCE; ENCODES; REGION	We previously demonstrated that a 31-bp nucleotide sequence located upstream of the rice Wx gene played an important role in its expression. We further showed that this cis-acting regulator interacts with nuclear proteins extracted from developing rice endosperm. We used the 31-bp sequence as bait in a yeast one-hybrid system to isolate several cDNA clones from a rice cDNA expression library. One of these cDNAs encodes a MYC protein, designated OsBP-5, which is 335 amino acids long and contains a putative basic helix-loop-helix-ZIP DNA-binding domain. This domain exhibits 50% amino acid sequence identity with the R/B proteins that regulate the expression of genes involved in anthocyanin biosynthesis in plants. The results of electrophoretic mobility shift assays (EMSAs) and Southwestern gel blots indicate that this protein binds specifically to the CAACGTG motif within the 31-bp sequence. However, by itself, the OsBP-5 protein is unable to trans-activate a lacZ reporter gene controlled by the 31-bp sequence when tested in a yeast expression system. Interestingly, OsBP-5 can trans-activate this reporter gene when another protein, OsEBP-89, a member of the EREBP family of transcription factors, is present. Furthermore, in vitro pull-down experiments show that a protein isolated from developing rice endosperm interacts with the OsBP-5 protein, and Western blots confirm that the interacting protein is OsEBP-89. The formation of a supershift band in EMSAs also indicates that two proteins interact with each other. Interference of OsBP-5 gene expression by double-stranded RNA reduces the amylose content in mature seed of transgenic rice plants but has no visible effect on their phenotype. These results suggest that the OsBP-5 and OsEBP-89 proteins act synergistically, perhaps as a heterodimer, to regulate the transcription of the rice Wx gene.	Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Hong, MM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	Hongmm@iris.sipp.ac.cn		cai, xiu ling/0000-0001-8333-4556				Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Chen Li, 1999, Acta Phytophysiologica Sinica, V25, P110; Chen Li, 1997, Acta Phytophysiologica Sinica, V23, P313; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; DANG CV, 1991, MOL CELL BIOL, V11, P954, DOI 10.1128/MCB.11.2.954; Diaz I, 2002, PLANT J, V29, P453, DOI 10.1046/j.0960-7412.2001.01230.x; Fink G., 1991, METHOD ENZYMOL, V194, P14; Ge Hong-Fei, 2000, Acta Phytophysiologica Sinica, V26, P159; GOFF SA, 1992, GENE DEV, V6, P864, DOI 10.1101/gad.6.5.864; HALAZONETIS TD, 1991, P NATL ACAD SCI USA, V88, P6162, DOI 10.1073/pnas.88.14.6162; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; LI YZ, 1995, PLANT SCI, V108, P181, DOI 10.1016/0168-9452(95)04143-I; Liu Qiao-Quan, 1998, Acta Phytophysiologica Sinica, V24, P259; LLOYD AM, 1992, SCIENCE, V258, P1773, DOI 10.1126/science.1465611; Miller J. H, 1972, EXPT MOL GENETICS; Mol J, 1996, CRIT REV PLANT SCI, V15, P525, DOI 10.1080/07352689609382369; Moon YH, 1999, PLANT MOL BIOL, V40, P167, DOI 10.1023/A:1026429922616; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Payne CT, 2000, GENETICS, V156, P1349; ROTH BA, 1991, PLANT CELL, V3, P317, DOI 10.1105/tpc.3.3.317; Sambrook J, 1989, MOL CLONING LAB MANU, V2; SCHMITZ ML, 1989, J BIOL CHEM, V264, P1467; Singh KB, 1998, PLANT PHYSIOL, V118, P1111, DOI 10.1104/pp.118.4.1111; TAKAIWA F, 1990, MOL GEN GENET, V224, P289, DOI 10.1007/BF00271563; WANG ZY, 1995, PLANT J, V7, P613, DOI 10.1046/j.1365-313X.1995.7040613.x; WANG ZY, 1990, NUCLEIC ACIDS RES, V18, P5898, DOI 10.1093/nar/18.19.5898; WANG ZY, 1994, SCI CHINA SER B, V37, P437; Yang HJ, 2002, PLANT MOL BIOL, V50, P379, DOI 10.1023/A:1019859612791; Yao CaiPing, 1996, Acta Phytophysiologica Sinica, V22, P431; ZACHGO S, 1995, DEVELOPMENT, V121, P2861; Zheng FQ, 1993, PLANT PHYSL COMMUN, V29, P438	35	99	116	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47803	47811		10.1074/jbc.M302806200	http://dx.doi.org/10.1074/jbc.M302806200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12947109	hybrid			2022-12-27	WOS:000186731400056
J	Bracci, L; Falciani, C; Lelli, B; Lozzi, L; Runci, Y; Pini, A; De Montis, MG; Tagliamonte, A; Neri, P				Bracci, L; Falciani, C; Lelli, B; Lozzi, L; Runci, Y; Pini, A; De Montis, MG; Tagliamonte, A; Neri, P			Synthetic peptides in the form of dendrimers become resistant to protease activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-BUNGAROTOXIN; HIGH-AFFINITY; RECEPTOR; NEUROTENSIN; DESIGN; PEPTIDOMIMETICS; ANALOGS; BINDING; DRUG	In previous papers, we observed that dendrimers of peptide mimotopes of the nicotinic receptor ligand site are strong antidotes against the lethality of the nicotinic receptor ligand alpha- bungarotoxin. Although their in vitro activity is identical to that of dendrimers, the corresponding monomeric peptide mimotopes are not effective in vivo. Because the higher in vivo efficiency of dendrimers could not in this case be related to polyvalent interaction, the stability to blood protease activity of monomeric versus tetrabranched dendrimeric mimotope peptides was compared here by incubating three different mimotopes with human plasma and serum. Unmodified peptides and cleaved sequences were followed by high pressure liquid chromatography and mass spectrometry. Tetrabranched peptides were shown to be much more stable in plasma and also in serum. To assess the notable stability of multimeric peptides, different bioactive neuropeptides, including enkephalins, neurotensin and nociceptin, were synthesized in monomeric and tetrabranched forms and incubated with human plasma and serum and with rat brain membrane extracts. All the tetrabranched neuropeptides fully retained biological activity and generally showed much greater stability to blood and brain protease activity. Some tetrabranched peptides were also resistant to trypsin and chymotrypsin. Our findings provide new insights into the possible therapeutic use of bioactive peptides.	Univ Siena, Dept Mol Biol, Biochem & Mol Biol Lab, I-53100 Siena, Italy; Univ Siena, Dept Neurosci, Pharmacol Unit, I-53100 Siena, Italy	University of Siena; University of Siena	Bracci, L (corresponding author), Univ Siena, Dept Mol Biol, Biochem & Mol Biol Lab, Via Fiorentina 1, I-53100 Siena, Italy.	braccil@unisi.it	Falciani, Chiara/R-1330-2018; Pini, Alessandro/R-1359-2018; Lozzi, Luisa/Q-8542-2018; Bracci, Luisa/V-9913-2018	Falciani, Chiara/0000-0002-1027-8482; Pini, Alessandro/0000-0002-3832-8349; Lozzi, Luisa/0000-0002-1603-8770; Bracci, Luisa/0000-0002-0738-5746; DE MONTIS, Maria Graziella/0000-0001-5835-1880				Adessi C, 2002, CURR MED CHEM, V9, P963, DOI 10.2174/0929867024606731; Binder EB, 2001, PHARMACOL REV, V53, P453; Bracci L, 2002, BIOCHEMISTRY-US, V41, P10194, DOI 10.1021/bi0256025; Bruehlmeier M, 2002, NUCL MED BIOL, V29, P321, DOI 10.1016/S0969-8051(01)00304-3; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; de Boisferon MH, 2002, BIOCONJUGATE CHEM, V13, P654, DOI 10.1021/bc015585g; Dooley CT, 1999, BIOPOLYMERS, V51, P379, DOI 10.1002/(SICI)1097-0282(1999)51:6<379::AID-BIP2>3.3.CO;2-5; Feng HJ, 2002, BIOORGAN MED CHEM, V10, P3849, DOI 10.1016/S0968-0896(02)00342-5; Garcia-Garayoa E, 2001, NUCL MED BIOL, V28, P75; Goodman M, 2001, BIOPOLYMERS, V60, P229, DOI 10.1002/1097-0282(2001)60:3<229::AID-BIP10034>3.0.CO;2-P; Gully D, 1997, J PHARMACOL EXP THER, V280, P802; Hruby VJ, 2002, NAT REV DRUG DISCOV, V1, P847, DOI 10.1038/nrd939; Lozzi L, 2003, CHEM BIOL, V10, P411, DOI 10.1016/S1074-5521(03)00094-2; Meloen RH, 2000, J MOL RECOGNIT, V13, P352, DOI 10.1002/1099-1352(200011/12)13:6<352::AID-JMR509>3.0.CO;2-C; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; Mogil JS, 2001, PHARMACOL REV, V53, P381; Mourez M, 2001, NAT BIOTECHNOL, V19, P958, DOI 10.1038/nbt1001-958; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Sadler Kristen, 2002, J Biotechnol, V90, P195; Shrimpton CN, 2002, ENDOCR REV, V23, P647, DOI 10.1210/er.2001-0032; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x	22	140	157	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46590	46595		10.1074/jbc.M308615200	http://dx.doi.org/10.1074/jbc.M308615200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12972419	hybrid			2022-12-27	WOS:000186569400045
J	Melo, EO; Dhalia, R; de Sa, CM; Standart, N; Neto, OPD				Melo, EO; Dhalia, R; de Sa, CM; Standart, N; Neto, OPD			Identification of a C-terminal poly(A)-binding protein (PABP)-PABP interaction domain - Role in cooperative binding to poly(A) and efficient cap distal translational repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; INITIATION; YEAST; REGION; MECHANISMS; POSITION; IRON; LOCALIZATION; ABUNDANCE; COMPLEX	The poly(A)-binding protein (PABP), bound to the 3' poly(A) tail of eukaryotic mRNAs, plays critical roles in mRNA translation and stability. PABP autoregulates its synthesis by binding to a conserved A-rich sequence present in the 5'-untranslated region of PABP mRNA and repressing its translation. PABP is composed of two parts: the highly conserved N terminus, containing 4 RNA recognition motifs (RRMs) responsible for poly(A) and eIF4G binding; and the more variable C terminus, which includes the recently described PABC domain, and promotes intermolecular interaction between PABP molecules as well as cooperative binding to poly(A). Here we show that, in vitro, GST-PABP represses the translation of reporter mRNAs containing 20 or more A residues in their 5'-untranslated regions and remains effective as a repressor when an A(61) tract is placed at different distances from the cap, up to 126 nucleotides. Deletion of the PABP C terminus, but not the PABC domain alone, significantly reduces its ability to inhibit translation when bound to sequences distal to the cap, but not to proximal ones. Moreover, cooperative binding by multiple PABP molecules to poly(A) requires the C terminus, but not the PABC domain. Further analysis using pull-down assays shows that the interaction between PABP molecules, mediated by the C terminus, does not require the PABC domain and is enhanced by the presence of RRM 4. In vivo, fusion proteins containing parts of the PABP C terminus fused to the viral coat protein MS2 have an enhanced ability to prevent the expression of chloramphenicol acetyltransferase reporter mRNAs containing the MS2 binding site at distal distances from the cap. Altogether, our results identify a proline- and glutamine-rich linker located between the RRMs and the PABC domain as being strictly required for PABP/PABP interaction, cooperative binding to poly(A) and enhanced translational repression of reporter mRNAs in vitro and in vivo.	Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, BR-50670420 Recife, PE, Brazil; Univ Brasilia, Dept Biol Celular, BR-70910900 Brasilia, DF, Brazil; Embrapa Recursos Genet & Biotecnol, BR-70770900 Brasilia, DF, Brazil; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	Fundacao Oswaldo Cruz; Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Cambridge	Neto, OPD (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Campus Univ Fed Pernambuco,Ave Moraes Rego S-N, BR-50670420 Recife, PE, Brazil.	opmn@cpqam.fiocruz.br	de Melo Neto, Osvaldo P/B-1366-2015; Melo, Eduardo O/K-8305-2015; Dhalia, Rafael/AAD-5432-2020	de Melo Neto, Osvaldo P/0000-0001-5402-7346; Melo, Eduardo O/0000-0003-0797-920X; 				ADAM SA, 1986, MOL CELL BIOL, V6, P2932, DOI 10.1128/MCB.6.8.2932; Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Bag J, 1996, EUR J BIOCHEM, V237, P143, DOI 10.1111/j.1432-1033.1996.0143n.x; Bag J, 2001, J BIOL CHEM, V276, P47352, DOI 10.1074/jbc.M107676200; Bates EJ, 2000, NUCLEIC ACIDS RES, V28, P1211, DOI 10.1093/nar/28.5.1211; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; BERNSTEIN P, 1989, MOL CELL BIOL, V9, P659, DOI 10.1128/MCB.9.2.659; BIGNON C, 1993, BIOTECHNIQUES, V15, P243; Caponigro G, 1996, MICROBIOL REV, V60, P233, DOI 10.1128/MMBR.60.1.233-249.1996; Coller JM, 1998, GENE DEV, V12, P3226, DOI 10.1101/gad.12.20.3226; Cosson B, 2002, MOL CELL BIOL, V22, P3301, DOI 10.1128/MCB.22.10.3301-3315.2002; DE SA MFG, 1988, EUR J BIOCHEM, V176, P521; Deardorff JA, 1997, J MOL BIOL, V269, P67, DOI 10.1006/jmbi.1997.1013; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Deo RC, 2001, P NATL ACAD SCI USA, V98, P4414, DOI 10.1073/pnas.071552198; GOOSSEN B, 1990, EMBO J, V9, P4127, DOI 10.1002/j.1460-2075.1990.tb07635.x; GOOSSEN B, 1992, MOL CELL BIOL, V12, P1959, DOI 10.1128/MCB.12.5.1959; GORLACH M, 1994, EXP CELL RES, V211, P400, DOI 10.1006/excr.1994.1104; GRANGE T, 1987, NUCLEIC ACIDS RES, V15, P4771, DOI 10.1093/nar/15.12.4771; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Hornstein E, 1999, FEBS LETT, V457, P209, DOI 10.1016/S0014-5793(99)01039-X; Hornstein E, 1999, J BIOL CHEM, V274, P1708, DOI 10.1074/jbc.274.3.1708; Hoshino S, 1999, J BIOL CHEM, V274, P16677, DOI 10.1074/jbc.274.24.16677; Hotchkiss TL, 1999, MOL BIOCHEM PARASIT, V98, P117, DOI 10.1016/S0166-6851(98)00156-X; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; JOSHI B, 1994, J BIOL CHEM, V269, P2048; Kessler SH, 1998, MOL CELL BIOL, V18, P51, DOI 10.1128/MCB.18.1.51; Koloteva N, 1997, J BIOL CHEM, V272, P16531, DOI 10.1074/jbc.272.26.16531; Kozlov G, 2001, P NATL ACAD SCI USA, V98, P4409, DOI 10.1073/pnas.071024998; Kuhn U, 1996, J MOL BIOL, V256, P20, DOI 10.1006/jmbi.1996.0065; Le H, 2000, J BIOL CHEM, V275, P17452, DOI 10.1074/jbc.M001186200; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; Melo EO, 2003, FEBS LETT, V546, P329, DOI 10.1016/S0014-5793(03)00620-3; Meyuhas O, 2000, COLD SPRING HARBOR M, V39, P671; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; Neto OPD, 2000, NUCLEIC ACIDS RES, V28, P3346, DOI 10.1093/nar/28.17.3346; NETO OPD, 1995, NUCLEIC ACIDS RES, V23, P2198, DOI 10.1093/nar/23.12.2198; Otero LJ, 1999, EMBO J, V18, P3153, DOI 10.1093/emboj/18.11.3153; Paraskeva E, 1999, MOL CELL BIOL, V19, P807; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Preiss T, 1999, CURR OPIN GENET DEV, V9, P515, DOI 10.1016/S0959-437X(99)00005-2; Rouault TA, 2000, COLD SPRING HARBOR M, V39, P655; Roy G, 2002, MOL CELL BIOL, V22, P3769, DOI 10.1128/MCB.22.11.3769-3782.2002; Sachs A, 2000, COLD SPRING HARBOR M, V39, P447; SACHS AB, 1986, CELL, V45, P827, DOI 10.1016/0092-8674(86)90557-X; SACHS AB, 1987, MOL CELL BIOL, V7, P3268, DOI 10.1128/MCB.7.9.3268; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; STRIPECKE R, 1994, MOL CELL BIOL, V14, P5898, DOI 10.1128/MCB.14.9.5898; STRIPECKE R, 1992, NUCLEIC ACIDS RES, V20, P5555, DOI 10.1093/nar/20.21.5555; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Tucker M, 2000, ANNU REV BIOCHEM, V69, P571, DOI 10.1146/annurev.biochem.69.1.571; Walker James, 1998, V77, P365; Wang ZR, 2000, MOL CELL BIOL, V20, P6334, DOI 10.1128/MCB.20.17.6334-6341.2000; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wickens M, 1997, CURR OPIN GENET DEV, V7, P220, DOI 10.1016/S0959-437X(97)80132-3; Wormington M, 1996, EMBO J, V15, P900, DOI 10.1002/j.1460-2075.1996.tb00424.x; Wu J, 1998, J BIOL CHEM, V273, P34535, DOI 10.1074/jbc.273.51.34535	59	62	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46357	46368		10.1074/jbc.M307624200	http://dx.doi.org/10.1074/jbc.M307624200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12952955	hybrid			2022-12-27	WOS:000186569400019
J	Rao, US; Nuti, SL				Rao, US; Nuti, SL			Identification of two different states of P-glycoprotein in its catalytic cycle - Role of the linker region in the transition between these two states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE PROTEIN; NUCLEOTIDE-BINDING SITES; DRUG-INTERACTION SITES; ATP HYDROLYSIS; INSECT CELLS; MDR1; VINBLASTINE; EXPRESSION; TRANSPORT; GENE	P- glycoprotein ( Pgp) is a drug- translocating ATPase responsible for multidrug resistance in cancer. Although it is well- established that Pgp exhibits drug- dependent ATPase and ATP- dependent drug transport functions, the mechanism by which these two reactions are coupled remains unclear. We have shown recently that proteolytic cleavage of the linker region, which joins the NH2 and COOH halves of the Pgp molecule, results in a Pgp form that exhibits drug- independent and - dependent ATPase activities ( Nuti et al., ( 2000) Biochemistry 39, 3424 - 3432; Nuti, S. L., and Rao, U. S. ( 2002) J. Biol. Chem. 277, 29417 - 29423). To understand the mechanism underlying this phenomenon, we used the procedure of vanadate- mediated trapping of the Pgp transport cycle intermediates to determine the steps in the catalytic cycle that are being regulated by the linker region. We show that vanadate stably traps Pgp under two different conditions, one in the presence of ATP alone and the other in the presence of ATP and drug, suggesting the existence of two Pgp conformations. These two conformations, one mediating basal and the other drug- stimulated ATPase reactions, represent different transport cycle intermediates of Pgp, because arresting Pgp in either conformation prevents the catalytic cycle from proceeding to completion. The results also show that these two conformations are uncoupled and appear simultaneously in Pgp that was cleaved in the linker region. These results together suggest that Pgp assumes at least two distinct conformational states, which catalyze two ATP hydrolysis events in the drug transport cycle, and the linker region mediates the transition between these two states of Pgp.	Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Rao, US (corresponding author), Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Nebraska Med Ctr 984525, Omaha, NE 68198 USA.				NIDDK NIH HHS [DK 51529] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK051529, R01DK051529] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CHOI K, 1988, CELL, V53, P519, DOI 10.1016/0092-8674(88)90568-5; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Germann UA, 1996, EUR J CANCER, V32A, P927, DOI 10.1016/0959-8049(96)00057-3; GREENBERGER LM, 1993, J BIOL CHEM, V268, P11417; GROS P, 1986, NATURE, V323, P728, DOI 10.1038/323728a0; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; HORIO M, 1988, P NATL ACAD SCI USA, V85, P3580, DOI 10.1073/pnas.85.10.3580; HORIO M, 1991, BIOCHIM BIOPHYS ACTA, V1061, P106, DOI 10.1016/0005-2736(91)90274-C; Hrycyna CA, 1999, BIOCHEMISTRY-US, V38, P13887, DOI 10.1021/bi991115m; Hrycyna CA, 1998, BIOCHEMISTRY-US, V37, P13660, DOI 10.1021/bi9808823; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; MANTSCH HH, 1991, CHEM PHYS LIPIDS, V57, P213, DOI 10.1016/0009-3084(91)90077-O; Muller M, 1996, J BIOL CHEM, V271, P1877; Nuti SL, 2000, BIOCHEMISTRY-US, V39, P3424, DOI 10.1021/bi992392w; Nuti SL, 2002, J BIOL CHEM, V277, P29417, DOI 10.1074/jbc.M204054200; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; RAO US, 1995, J BIOL CHEM, V270, P6686; Rao US, 2002, J BIOL CHEM, V277, P4900, DOI 10.1074/jbc.M108258200; Rao US, 1998, BIOCHEMISTRY-US, V37, P14981, DOI 10.1021/bi980072r; SAFA AR, 1986, J BIOL CHEM, V261, P6137; SAFA AR, 1988, P NATL ACAD SCI USA, V85, P7187, DOI 10.1073/pnas.85.19.7187; Safa AR, 1998, METHOD ENZYMOL, V292, P289; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Sauna ZE, 2001, J BIOL CHEM, V276, P21199, DOI 10.1074/jbc.M100886200; Sauna ZE, 2001, J BIOL CHEM, V276, P11653, DOI 10.1074/jbc.M011294200; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Shepard RL, 1998, BIOCHEM PHARMACOL, V56, P719, DOI 10.1016/S0006-2952(98)00212-3; Szabo K, 1998, J BIOL CHEM, V273, P10132, DOI 10.1074/jbc.273.17.10132; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Urbatsch IL, 1998, BIOCHEMISTRY-US, V37, P4592, DOI 10.1021/bi9728001; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956	37	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46576	46582		10.1074/jbc.M308078200	http://dx.doi.org/10.1074/jbc.M308078200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12968025	hybrid			2022-12-27	WOS:000186569400043
J	Wongtrakool, C; Malpel, S; Gorenstein, J; Sedita, J; Ramirez, MI; Underhill, TM; Cardoso, WV				Wongtrakool, C; Malpel, S; Gorenstein, J; Sedita, J; Ramirez, MI; Underhill, TM; Cardoso, WV			Down-regulation of retinoic acid receptor alpha signaling is required for sacculation and type I cell formation in the developing lung	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRANCHING MORPHOGENESIS; TRANSCRIPTION FACTOR; ALVEOLUS FORMATION; DIFFERENTIATION; EXPRESSION; GENE; DEFECTS; PATTERN; GATA-6; BETA	Although retinoic acid (RA) has been shown to be critical for lung development, little is known about when RA is required and the role of individual RA receptors (RAR) in this process. Previously reported data from an RA responsive element RARE-lacZ reporter mouse show that when epithelial tubules are branching and differentiating RA signaling becomes markedly down-regulated in the epithelium. It is unclear why this down-regulation occurs and what role it might play in the developing lung. Here we analyze the effects of preventing potential progenitors of the distal lung from turning off RA signaling by locally expressing constitutively activated RARalpha or RARbeta chimeric receptors (RARVP16) in branching airways of transgenic mice. Continued RA activation resulted in lung immaturity in both cases, but the phenotypes were remarkably different. RARalphaVP16 lungs did not expand to form saccules or morphologically identifiable type I cells. High levels of surfactant protein C (Sp-C), thyroid transcription factor-1 (Ttf1), and Gata6, but not Sp-A or Sp-B in the epithelium at birth suggested that in these lungs differentiation was arrested at an early stage. These alterations were not observed in RARbetaVP16 lungs, which showed relatively less severe changes. Our data suggest a model in which activation of RAR signaling at the onset of lung development establishes an initial program that assigns distal cell fate to the prospective lung epithelium. Downregulation of RA signaling, however, is required to allow completion of later steps of this differentiation program that ultimately form mature type I and II cells.	Boston Univ, Sch Med, Ctr Pulm, Dept Med, Boston, MA 02118 USA; Univ Western Ontario, Sch Dent, London, ON N6A 5B8, Canada	Boston University; Western University (University of Western Ontario)	Cardoso, WV (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Dept Med, 80 E Concord St,R-304, Boston, MA 02118 USA.	wcardoso@lung.bumc.bu.edu		Ramirez, Maria Isabel/0000-0001-6294-4419; Cardoso, Wellington/0000-0002-2550-3697	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067129] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL067129, R01 HL067129-01, R01 HL/HD 67129-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bellusci S, 1997, DEVELOPMENT, V124, P4867; CARDOSO WV, 1995, AM J RESP CELL MOL, V12, P464, DOI 10.1165/ajrcmb.12.5.7742011; Cardoso WV, 1996, DEV DYNAM, V207, P47, DOI 10.1002/(SICI)1097-0177(199609)207:1<47::AID-AJA6>3.0.CO;2-W; Celli G, 1998, EMBO J, V17, P1642, DOI 10.1093/emboj/17.6.1642; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chazaud C, 1999, DEVELOPMENT, V126, P2589; Colbert MC, 1997, J CLIN INVEST, V100, P1958, DOI 10.1172/JCI119727; Dickman ED, 1997, DEVELOPMENT, V124, P3111; DOLLE P, 1990, DEVELOPMENT, V110, P1133; Ghatpande S, 2000, DEV BIOL, V219, P59, DOI 10.1006/dbio.1999.9601; Gove C, 1997, EMBO J, V16, P355, DOI 10.1093/emboj/16.2.355; Hind M, 2002, AM J PHYSIOL-LUNG C, V282, pL468, DOI 10.1152/ajplung.00196.2001; IKEDA K, 1994, AM J PHYSIOL, V267, pL309, DOI 10.1152/ajplung.1994.267.3.L309; Kastner P, 1997, DEVELOPMENT, V124, P4749; Keijzer R, 2001, DEVELOPMENT, V128, P503; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Koutsourakis M, 2001, MECH DEVELOP, V105, P105, DOI 10.1016/S0925-4773(01)00386-0; Liu C, 2002, AM J PHYSIOL-LUNG C, V283, pL468, DOI 10.1152/ajplung.00044.2002; Malpel S, 2000, DEVELOPMENT, V127, P3057; Massaro D, 2002, AM J PHYSIOL-LUNG C, V282, pL345, DOI 10.1152/ajplung.00374.2001; Massaro GD, 2000, PHYSIOL GENOMICS, V4, P51, DOI 10.1152/physiolgenomics.2000.4.1.51; Massaro GD, 2003, AM J PHYSIOL-LUNG C, V284, pL431, DOI 10.1152/ajplung.00245.2002; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; METZLER MD, 1993, ENDOCRINOLOGY, V133, P1990, DOI 10.1210/en.133.5.1990; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Mollard R, 2000, INT J DEV BIOL, V44, P457; Mollard R, 2000, MECH DEVELOP, V94, P223, DOI 10.1016/S0925-4773(00)00303-8; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Park WY, 1998, DEV BIOL, V201, P125, DOI 10.1006/dbio.1998.8994; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Perl AKT, 2003, DEV BIOL, V258, P154, DOI 10.1016/S0012-1606(03)00106-4; PETERS K, 1994, EMBO J, V13, P3296, DOI 10.1002/j.1460-2075.1994.tb06631.x; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; SCHUGER L, 1993, DEV BIOL, V159, P462, DOI 10.1006/dbio.1993.1256; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Taneja R, 1996, P NATL ACAD SCI USA, V93, P6197, DOI 10.1073/pnas.93.12.6197; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; UNDERHILL TM, 1994, MOL ENDOCRINOL, V8, P274, DOI 10.1210/me.8.3.274; Weaver M, 2000, DEVELOPMENT, V127, P2695; WERT SE, 1993, DEV BIOL, V156, P426, DOI 10.1006/dbio.1993.1090; Weston AD, 2000, J CELL BIOL, V148, P679, DOI 10.1083/jcb.148.4.679; Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Yang HH, 2002, DEVELOPMENT, V129, P2233; YOUNG SL, 1991, AM J PHYSIOL, V260, pL113, DOI 10.1152/ajplung.1991.260.2.L113	48	46	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46911	46918		10.1074/jbc.M307977200	http://dx.doi.org/10.1074/jbc.M307977200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12947094	Green Accepted, hybrid			2022-12-27	WOS:000186569400085
J	Yu, J; Leibiger, B; Yang, SN; Caffery, JJ; Shears, SB; Leibiger, IB; Barker, CJ; Berggren, PO				Yu, J; Leibiger, B; Yang, SN; Caffery, JJ; Shears, SB; Leibiger, IB; Barker, CJ; Berggren, PO			Cytosolic multiple inositol polyphosphate phosphatase in the regulation of cytoplasmic free Ca2+ concentration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; ENDOPLASMIC-RETICULUM; TRISPHOSPHATE RECEPTOR; RYANODINE RECEPTOR; CALCIUM-CHANNEL; ACTIVATION; 1,4,5-TRISPHOSPHATE; 5-PHOSPHATASE; INHIBITION; RELEASE	Multiple inositol polyphosphate phosphatase (MIPP) is an enzyme that, in vitro, has the interesting property of degrading higher inositol polyphosphates to the Ca2+ second messenger, inositol 1,4,5-trisphosphate (Ins(1,4,5)P-3), independently of inositol lipid breakdown. We hypothesized that a truncated cytosolic form of the largely endoplasmic reticulum-confined MIPP (cyt-MIPP) could represent an important new tool in the investigation of Ins( 1,4,5)P-3-dependent intracellular Ca2+ homeostasis. To optimize our ability to judge the impact of cyt-MIPP on intracellular Ca2+ concentration ([Ca2+](i)) we chose a poorly responsive beta-cell line (HIT M2.2.2) with an abnormally low [Ca2+](i). Our results show for the first time in an intact mammalian cell that cyt-MIPP expression leads to a significant enhancement of Ins(1,4,5)P-3 concentration. This is achieved without a significant interference from other cyt-MIPP-derived inositol phosphates. Furthermore, the low basal [Ca2+](i) of these cells was raised to normal levels (35 to 115 nM) when they expressed cyt-MIPP. Noteworthy is that the normal feeble glucose-induced Ca2+ response of HIT M2.2.2 cells was enhanced dramatically by mechanisms related to this increase in basal [Ca2+](i). These data support the use of cyt-MIPP as an important tool in investigating Ins(1,4,5)P-3-dependent Ca2+ homeostasis and suggest a close link between Ins(1,4,5)P-3 concentration and basal [Ca2+](i), the latter being an important modulator of Ca2+ signaling in the pancreatic beta-cell.	Karolinska Hosp, Karolinska Inst, Rolf Luft Ctr Diabet Res, Dept Mol Med, SE-17176 Stockholm, Sweden; NIEHS, Inositide Signaling Sect, NIH, Res Triangle Pk, NC 27709 USA	Karolinska Institutet; Karolinska University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Barker, CJ (corresponding author), Karolinska Hosp, Karolinska Inst, Rolf Luft Ctr Diabet Res, Dept Mol Med, L3, SE-17176 Stockholm, Sweden.	chris.barker@molmed.ki.se	Tuluc, Petronel/C-2527-2011; Shears, Stephen B/C-6335-2019	Shears, Stephen B/0000-0001-7309-8916; Berggren, Per-Olof/0000-0001-8991-413X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES080046] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 58508] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALI N, 1993, J BIOL CHEM, V268, P6161; BARKER CJ, 1995, BIOCHEM J, V306, P557, DOI 10.1042/bj3060557; BARKER CJ, 1994, BIOCHEM J, V297, P265, DOI 10.1042/bj2970265; Barker CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1113, DOI 10.1152/ajpendo.00088.2002; BERGGREN PO, 1994, BIOCHEM SOC T, V22, P12, DOI 10.1042/bst0220012; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Bruton JD, 2002, FASEB J, V16, P301, DOI 10.1096/fj.02-0481fje; Chi HB, 2000, MOL CELL BIOL, V20, P6496, DOI 10.1128/MCB.20.17.6496-6507.2000; Craxton A, 1997, BIOCHEM J, V328, P75, DOI 10.1042/bj3280075; DELISLE S, 1994, AM J PHYSIOL, V266, pC429, DOI 10.1152/ajpcell.1994.266.2.C429; ESTRADAGARCIA T, 1991, P ROY SOC B-BIOL SCI, V244, P63, DOI 10.1098/rspb.1991.0052; Hayashi M, 1999, J AM SOC NEPHROL, V10, P2094; Hermosura MC, 2000, NATURE, V408, P735, DOI 10.1038/35047115; Hirata M, 1997, BIOCHEM J, V328, P93, DOI 10.1042/bj3280093; Irvine R, 2001, CURR BIOL, V11, pR172, DOI 10.1016/S0960-9822(01)00086-0; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Islam MS, 2002, DIABETES, V51, P1299, DOI 10.2337/diabetes.51.5.1299; ISLAM MS, 1993, SCIENCE, V262, P1499, DOI 10.1126/science.8248793; Islam MS, 1997, BIOCHEM J, V321, P347, DOI 10.1042/bj3210347; Islam MS, 1998, P NATL ACAD SCI USA, V95, P6145, DOI 10.1073/pnas.95.11.6145; Kavalali ET, 1997, J NEUROSCI, V17, P5334; Kermode H, 1998, FEBS LETT, V431, P59, DOI 10.1016/S0014-5793(98)00725-X; Larsson O, 1997, SCIENCE, V278, P471, DOI 10.1126/science.278.5337.471; Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9; LEIBIGER IB, 1994, FEBS LETT, V337, P161, DOI 10.1016/0014-5793(94)80265-3; Lemmens R, 2001, J BIOL CHEM, V276, P9971, DOI 10.1074/jbc.M009463200; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Ouzzine M, 1999, J BIOL CHEM, V274, P31401, DOI 10.1074/jbc.274.44.31401; Putney JW, 2001, J CELL SCI, V114, P2223; Shears SB, 1998, BBA-MOL CELL BIOL L, V1436, P49, DOI 10.1016/S0005-2760(98)00131-3; Speed CJ, 1999, J CELL SCI, V112, P669; Speed CJ, 1996, EMBO J, V15, P4852, DOI 10.1002/j.1460-2075.1996.tb00866.x; Speed CJ, 2000, J CELL SCI, V113, P2631; STEPHENS LR, 1989, BIOCHEM J, V262, P727, DOI 10.1042/bj2620727; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; STUART JA, 1994, BIOCHEM J, V303, P517, DOI 10.1042/bj3030517; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; VALVERDE I, 1979, SCIENCE, V206, P225, DOI 10.1126/science.225798; VANDIJKEN P, 1995, J BIOL CHEM, V270, P29724; Williams RSB, 1999, EMBO J, V18, P2734, DOI 10.1093/emboj/18.10.2734; WOLLHEIM CB, 1986, ANN NY ACAD SCI, V488, P317; Zhang WJ, 2003, FREE RADICAL BIO MED, V34, P674, DOI 10.1016/S0891-5849(02)01375-8	44	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46210	46218		10.1074/jbc.M303743200	http://dx.doi.org/10.1074/jbc.M303743200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963730	hybrid			2022-12-27	WOS:000186569400004
J	Sukumaran, SK; McNamara, G; Prasadarao, NV				Sukumaran, SK; McNamara, G; Prasadarao, NV			Escherichia coli K-1 interaction with human brain micro-vascular endothelial cells triggers phospholipase C-gamma 1 activation downstream of phosphatidylinositol 3-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PROTEIN-A; FOCAL ADHESION KINASE; C-GAMMA; TYROSINE RESIDUES; K1 INVASION; PHOSPHORYLATION; CALCIUM; RECEPTOR; BINDING; IDENTIFICATION	Escherichia coli, the most common Gram-negative bacterium that causes meningitis in neonates, invades human brain microvascular endothelial cells (HBMEC) by rearranging host cell actin via the activation of phosphatidylinositol 3-kinase (PI3K) and PKC-alpha. Here, further, we show that phospholipase (PLC)-gamma1 is phosphorylated on tyrosine 783 and condenses at the HBMEC membrane beneath the E. coli entry site. Overexpression of a dominant negative (DN) form of PLC-gamma, the PLC-z fragment, in HBMEC inhibits PLC-gamma1 activation and significantly blocks E. coli invasion. PI3K activation is not affected in PLC-z/HBMEC upon infection, whereas PKC-alpha phosphorylation is completely abolished, indicating that PLC-gamma1 is downstream of PI3K. Concomitantly, the phosphorylation of PLC-gamma1 is blocked in HBMEC overexpressing a dominant negative form of the p85 subunit of PI3K but not in HBMEC overexpressing a dominant negative form of PKC-alpha. In addition, the recruitment of PLC-gamma1 to the cell membrane in both PLC-z/HBMEC and DN-p85/HBMEC is inhibited. Activation of PI3K is associated with the conversion of phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 1,4,5-trisphosphate (PIP3), which in turn recruits PLC-gamma1 to the cell membrane via its interaction with pleckstrin homology domain of PLC-gamma1. Utilizing the pleckstrin homology domains of PKC-delta and Btk proteins fused to green fluorescent protein (GFP), which specifically interact with PIP2 and PIP3, respectively, we show herein that E. coli invasion induces the break-down of PIP2 at the plasma membrane near the site of E. coli interaction. PIP3, on the other hand, recruits the GFP(Bkt) to the cell membrane beneath the sites of E. coli attachment. Our studies further show that E. coli invasion induces the release of Ca2+ from intracellular pools as well as the influx of Ca2+ from the extracellular medium. This elevation in Ca2+ levels is completely blocked both in PLC-z/HBMEC and DN-p85/HBMEC, but not in DN-PKC/HBMEC. Taken together, these results suggest that E. coli infection of HBMEC induces PLC-gamma1 activation in a PI3K-dependent manner to increase Ca2+ levels in HBMEC. This is the first report demonstrating the recruitment of activated PLC-gamma1 to the sites of bacterial entry.	Childrens Hosp Los Angeles, Div Infect Dis, Los Angeles, CA 90027 USA; Univ So Calif, Keck Sch Med, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles; University of Southern California	Prasadarao, NV (corresponding author), Childrens Hosp Los Angeles, Div Infect Dis, MS 51,4650 Sunset Blvd, Los Angeles, CA 90027 USA.	pnemani@chla.usc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040567, R29AI040567] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40567] Funding Source: Medline; NICHD NIH HHS [HD50325] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Bierne H, 2000, CELL MICROBIOL, V2, P465, DOI 10.1046/j.1462-5822.2000.00069.x; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; FOUBISTER V, 1994, J EXP MED, V179, P993, DOI 10.1084/jem.179.3.993; HOMMA Y, 1992, J BIOL CHEM, V267, P21844; Kassis J, 1999, CLIN CANCER RES, V5, P2251; Kenny B, 1997, INFECT IMMUN, V65, P2528, DOI 10.1128/IAI.65.7.2528-2536.1997; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Prasadarao NV, 1999, INFECT IMMUN, V67, P5775, DOI 10.1128/IAI.67.11.5775-5783.1999; Prasadarao NV, 2003, INFECT IMMUN, V71, P1680, DOI 10.1128/IAI.71.4.1680-1688.2003; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Prasadarao NV, 2002, INFECT IMMUN, V70, P4556, DOI 10.1128/IAI.70.8.4556-4563.2002; Rameh LE, 1998, J BIOL CHEM, V273, P23750, DOI 10.1074/jbc.273.37.23750; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Reddy MA, 2000, INFECT IMMUN, V68, P6423, DOI 10.1128/IAI.68.11.6423-6430.2000; Reddy MA, 2000, J BIOL CHEM, V275, P36769, DOI 10.1074/jbc.M007382200; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rhinehart K, 2002, AM J PHYSIOL-RENAL, V283, pF852, DOI 10.1152/ajprenal.00065.2002; Rudrabhatla RS, 2003, INFECT IMMUN, V71, P2787, DOI 10.1128/IAI.71.5.2787-2797.2003; RUSCHKOWSKI S, 1992, FEMS MICROBIOL LETT, V95, P121; Stins MF, 1999, INFECT IMMUN, V67, P5522, DOI 10.1128/IAI.67.10.5522-5525.1999; STINS MF, 1994, AM J PATHOL, V145, P1228; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; Sukumaran SK, 2002, J BIOL CHEM, V277, P50716, DOI 10.1074/jbc.M208830200; Sukumaran SK, 2002, J BIOL CHEM, V277, P12253, DOI 10.1074/jbc.M110740200; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Watanabe D, 2001, J BIOL CHEM, V276, P38595, DOI 10.1074/jbc.M103675200; Xie ZJ, 1999, J BIOL CHEM, V274, P20421, DOI 10.1074/jbc.274.29.20421	29	28	31	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45753	45762		10.1074/jbc.M307374200	http://dx.doi.org/10.1074/jbc.M307374200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952950	hybrid			2022-12-27	WOS:000186452300086
J	Olsson, T; Thelander, M; Ronne, H				Olsson, T; Thelander, M; Ronne, H			A novel type of chloroplast stromal hexokinase is the major glucose-phosphorylating enzyme in the moss Physcomitrella patens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER ENVELOPE MEMBRANE; SUBCELLULAR-LOCALIZATION; PROTEIN IMPORT; SUGAR SENSOR; REPRESSION; STARCH; IDENTIFICATION; MECHANISMS; GENETICS; LEAVES	Hexokinase catalyzes the first step in the metabolism of glucose but has also been proposed to be involved in sugar sensing and signaling both in yeast and in plants. We have cloned a hexokinase gene, PpHXK1, in the moss Physcomitrella patens where gene function can be studied directly by gene targeting. PpHxk1 is a novel type of chloroplast stromal hexokinase that differs from previously studied membrane-bound plant hexokinases. Enzyme assays on a knock-out mutant revealed that PpHxk1 is the major glucose-phosphorylating enzyme in Physcomitrella, accounting for 80% of the total activity in protonemal tissue. The mutant is deficient in the response to glucose, which in wild type moss induces the formation of caulonemal filaments that protrude from the edge of the colony. Growth on glucose in the dark is strongly reduced in the mutant. Sequence data suggest that most plants including Physcomitrella and Arabidopsis have both chloroplast-imported hexokinases similar to PpHxk1 and traditional membrane-bound hexokinases. We propose that the two types of plant hexokinases have distinct physiological roles.	Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, SE-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences	Ronne, H (corresponding author), Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, Box 7080, SE-75007 Uppsala, Sweden.	Hans.Ronne@vbsg.slu.se		Ronne, Hans/0000-0002-1645-6091				ASHTON NW, 1979, PLANTA, V144, P427, DOI 10.1007/BF00380118; COSIO E, 1984, J BIOL CHEM, V259, P7688; Cove D J, 1991, Symp Soc Exp Biol, V45, P31; da-Silva WS, 2001, J EXP BOT, V52, P1191, DOI 10.1093/jexbot/52.359.1191; David S., 1996, WEEDS WORLD, V3, P43; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; ENTIAN KD, 1980, MOL GEN GENET, V178, P633, DOI 10.1007/BF00337871; Frommer WB, 2003, SCIENCE, V300, P261, DOI 10.1126/science.1084120; Halford NG, 1999, TRENDS PLANT SCI, V4, P117, DOI 10.1016/S1360-1385(99)01377-1; Halford NG, 1999, TRENDS PLANT SCI, V4, P251, DOI 10.1016/S1360-1385(99)01432-6; Imaizumi T, 2002, PLANT CELL, V14, P373, DOI 10.1105/tpc.010388; JANG JC, 1994, PLANT CELL, V6, P1665, DOI 10.1105/tpc.6.11.1665; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Johnston M, 1999, TRENDS GENET, V15, P29, DOI 10.1016/S0168-9525(98)01637-0; KANG F, 1994, PLANT J, V6, P795, DOI 10.1046/j.1365-313X.1994.6060795.x; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; MIERNYK JA, 1983, ARCH BIOCHEM BIOPHYS, V226, P458, DOI 10.1016/0003-9861(83)90315-6; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Moore BD, 1999, TRENDS PLANT SCI, V4, P250, DOI 10.1016/S1360-1385(99)01433-8; Neuhaus HE, 2000, BBA-BIOMEMBRANES, V1465, P307, DOI 10.1016/S0005-2736(00)00146-2; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; QI QG, 1995, PLANT PHYSIOL, V107, P413, DOI 10.1104/pp.107.2.413; Reski R, 1998, BOT ACTA, V111, P1; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; RONNE H, 1995, TRENDS GENET, V11, P12, DOI 10.1016/S0168-9525(00)88980-5; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; SCHAEFER D, 1991, MOL GEN GENET, V226, P418, DOI 10.1007/BF00260654; Schaefer DG, 2002, ANNU REV PLANT BIOL, V53, P477, DOI 10.1146/annurev.arplant.53.100301.135202; Schaefer DG, 2001, PLANT PHYSIOL, V127, P1430, DOI 10.1104/pp.010786; SCHAFER G, 1977, PLANT PHYSIOL, V60, P286, DOI 10.1104/pp.60.2.286; Schleiff E, 2001, BBA-MOL CELL RES, V1541, P22, DOI 10.1016/S0167-4889(01)00152-5; Schumaker KS, 1997, PLANT CELL, V9, P1099, DOI 10.1105/tpc.9.7.1099; SIEBERT PD, 1992, NATURE, V359, P557, DOI 10.1038/359557a0; SINGH KK, 1993, PLANT PHYSIOL, V102, P587, DOI 10.1104/pp.102.2.587; STITT M, 1978, BIOCHIM BIOPHYS ACTA, V544, P200, DOI 10.1016/0304-4165(78)90223-4; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tranel PJ, 1996, PLANT CELL, V8, P2093, DOI 10.1105/tpc.8.11.2093; TRANEL PJ, 1995, EMBO J, V14, P2436, DOI 10.1002/j.1460-2075.1995.tb07241.x; Veramendi J, 1999, PLANT PHYSIOL, V121, P123, DOI 10.1104/pp.121.1.123; Veramendi J, 2002, PLANT MOL BIOL, V49, P491, DOI 10.1023/A:1015528014562; Weber A, 2000, PLANT CELL, V12, P787, DOI 10.1105/tpc.12.5.787; Wiese A, 1999, FEBS LETT, V461, P13, DOI 10.1016/S0014-5793(99)01417-9	44	85	96	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44439	44447		10.1074/jbc.M306265200	http://dx.doi.org/10.1074/jbc.M306265200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941966	hybrid			2022-12-27	WOS:000186306700071
J	Wang, L; Han, YQ; Kim, CS; Lee, YK; Moore, DD				Wang, L; Han, YQ; Kim, CS; Lee, YK; Moore, DD			Resistance of SHP-null mice to bile acid-induced liver damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTOR; NEGATIVE FEEDBACK-REGULATION; PRIMARY RAT HEPATOCYTES; X-RECEPTOR; SALT TRANSPORTERS; IN-VIVO; EXPRESSION; 7-ALPHA-HYDROXYLASE; CHOLESTEROL; PATHWAY	The orphan nuclear hormone receptor SHP ( gene designation NROB2) is an important component of a negative regulatory cascade by which high levels of bile acids repress bile acid biosynthesis. Short term studies in SHP null animals confirm this function and also reveal the existence of additional pathways for bile acid negative feedback regulation. We have used long term dietary treatments to test the role of SHP in response to chronic elevation of bile acids, cholesterol, or both. In contrast to the increased sensitivity predicted from the loss of negative feedback regulation, the SHP null mice were relatively resistant to the hepatotoxicity associated with a diet containing 0.5% cholic acid and the much more severe effects of a diet containing both 0.5% cholic acid and 2% cholesterol. This was associated with decreased hepatic accumulation of cholesterol and triglycerides in the SHP null mice. There were also alterations in the expression of a number of genes involved in cholesterol and bile acid homeostasis, notably cholesterol 12alpha-hydroxylase (CYP8B1), which was strongly re-expressed in the SHP null mice, but not the wild type mice fed either bile acid containing diet. This contrasts with the strong repression of CYP8B1 observed with short term bile acid feeding, as well as the effects of long term feeding on other bile acid biosynthetic enzymes such as cholesterol 7alpha-hydroxylase (CYP7A1). CYP8B1 expression could contribute to the decreased toxicity of the chronic bile acid treatment by increasing the hydrophilicity of the bile acid pool. These results identify an unexpected role for SHP in hepatotoxicity and suggest new approaches to modulating effects of chronically elevated bile acids in cholestasis.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Moore, DD (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053366, P01DK057743] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK53366, P01-DK57743] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AXELSON M, 1992, J BIOL CHEM, V267, P1701; Bahar RJ, 1999, GASTROENTEROL CLIN N, V28, P27, DOI 10.1016/S0889-8553(05)70042-X; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CHIANG JYL, 1998, FRONT BIOSCI, V3, P176; Denson LA, 2001, GASTROENTEROLOGY, V121, P140, DOI 10.1053/gast.2001.25503; Fayard E, 2001, CURR OPIN LIPIDOL, V12, P113, DOI 10.1097/00041433-200104000-00004; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Hartmann G, 2002, J PHARMACOL EXP THER, V303, P273, DOI 10.1124/jpet.102.039404; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Johansson L, 2000, MOL CELL BIOL, V20, P1124, DOI 10.1128/MCB.20.4.1124-1133.2000; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lee YK, 2002, J BIOL CHEM, V277, P2463, DOI 10.1074/jbc.M105161200; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; Meier PJ, 2002, ANNU REV PHYSIOL, V64, P635, DOI 10.1146/annurev.physiol.64.082201.100300; Pandak WM, 2001, GASTROENTEROLOGY, V120, P1801, DOI 10.1053/gast.2001.24833; PAYNE DW, 1995, J BIOL CHEM, V270, P18888, DOI 10.1074/jbc.270.32.18888; Rust C, 2000, J BIOL CHEM, V275, P20210, DOI 10.1074/jbc.M909992199; SCHMUCKER DL, 1990, HEPATOLOGY, V12, P1216, DOI 10.1002/hep.1840120523; Schwarz M, 1998, CURR OPIN LIPIDOL, V9, P113, DOI 10.1097/00041433-199804000-00006; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; St-Pierre MV, 2001, J EXP BIOL, V204, P1673; Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Torchia EC, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-11; VANDEHEIJNING BJM, 1994, J LIPID RES, V35, P1002; Vlahcevic ZR, 1997, GASTROENTEROLOGY, V113, P1949, DOI 10.1016/S0016-5085(97)70015-5; vonDippe P, 1996, J BIOL CHEM, V271, P18176, DOI 10.1074/jbc.271.30.18176; Wang DQH, 1999, AM J PHYSIOL-GASTR L, V276, pG751, DOI 10.1152/ajpgi.1999.276.3.G751; Wang L, 2001, P NATL ACAD SCI USA, V98, P361, DOI 10.1073/pnas.011508498; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wolters H, 2002, J HEPATOL, V37, P556, DOI 10.1016/S0168-8278(02)00247-7; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398; Yu CD, 2000, J BIOL CHEM, V275, P15482, DOI 10.1074/jbc.275.20.15482	38	90	91	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44475	44481		10.1074/jbc.M305258200	http://dx.doi.org/10.1074/jbc.M305258200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12933814	hybrid			2022-12-27	WOS:000186306700075
J	Polit, A; Bonarek, P; Kepys, B; Kedracka-Krok, S; Gorecki, A; Wasylewski, Z				Polit, A; Bonarek, P; Kepys, B; Kedracka-Krok, S; Gorecki, A; Wasylewski, Z			Kinetic studies of cAMP-induced allosteric changes in mutants T127I, S128A, and T127I/S128A of the cAMP receptor protein from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; ACTIVATOR PROTEIN; BINDING; SITE; DNA; TRANSCRIPTION; MUTAGENESIS; COMPLEX	The cAMP receptor protein (CRP) regulates the expression of several genes in Escherichia coli. The protein is a homodimer, and each monomer is folded into two distinct structural domains. After allosteric transitions resulting from the binding of cAMP, CRP specifically binds to DNA and activates transcription. We have used stopped-flow fluorometry measurements of CRP mutants bearing amino acid substitutions T127I, S128A, and T127I/S128A to study the kinetics of conformational changes in the protein induced by cAMP binding. Amino acid substitutions at positions 127 and 128 were chosen because these residues play a crucial role in interdomain and intersubunit communication during allosteric transition. Using N-iodoacetylaminoethyl-5-naphthylamine-1-sulfonic acid-labeled Cys(178), localized in the protein helix-turn helix motif, we observed conformational changes in the helix-turn helix, localized in the C-terminal domain, upon binding of cAMP to high affinity sites (CRP.cAMP(2)) in the N-terminal domain of CRP. The rate constants for the forward and backward conformational changes depend on the amino acid substitution: k(c)=3.62 s(-1) and k(-c)=3.13 s(-1) for CRP T127I and k(c)=0.42 s(-1) and k(-c)=0.78 s(-1) for CRP S128A. These values can be compared with k(c)=9.7 s(-1) and k(-c)=0.31 s(-1) for wild-type CRP. The observed conformational changes can be described by the sequential model of allostery, with the amino acid substitutions influencing the allosteric changes. In the case of the double mutant, the observed rate constant of cAMP binding supports the suggestion that this unligated mutant possesses the structure that is close to the allosteric conformation necessary for promoter binding. The results of intrinsic fluorescence measurements suggest that the formation of the CRP.cAMP(4) complex results from displacement of equilibrium between the two forms of the CRP.cAMP(2) complex in the mutants studied, similar to wild-type CRP. The observed conformational changes occur according to a concerted model of allostery, and isomerization equilibrium between the two CRP states depends on the amino acid substitution. The data presented in this study indicate that Ser(128) and Thr(127) in CRP play an important role in the kinetics of intramolecular transitions triggered by cAMP.	Jagiellonian Univ, Fac Biotechnol, Dept Phys Biochem, PL-30387 Krakow, Poland	Jagiellonian University	Wasylewski, Z (corresponding author), Jagiellonian Univ, Fac Biotechnol, Dept Phys Biochem, Ul Gronostajowa 7, PL-30387 Krakow, Poland.	wasylewski@mol.uj.edu.pl		Polit, Agnieszka/0000-0001-5811-9838; Bonarek, Piotr/0000-0002-5408-6220; Gorecki, Andrzej/0000-0002-4159-447X				ANDERSON WB, 1971, J BIOL CHEM, V246, P5929; Blaszczyk U, 2001, J PROTEIN CHEM, V20, P601, DOI 10.1023/A:1013708000833; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; CANTOR CR, 1980, BIOPHYSICAL CHEM, P887; CHENG XD, 1995, BIOCHEMISTRY-US, V34, P10816, DOI 10.1021/bi00034a014; Chu SY, 2001, J BIOL CHEM, V276, P11230, DOI 10.1074/jbc.M010428200; EILEN E, 1977, J MOL BIOL, V114, P47, DOI 10.1016/0022-2836(77)90282-0; Fersht A, 1999, STRUCTURE MECH PROTE, P132; HARMAN JG, 2001, BIOCHIM BIOPHYS ACTA, V1574, P1; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; LEE FJ, 1994, NUCLEIC ACIDS RES, V22, P2894; Leu SF, 1999, BIOCHEMISTRY-US, V38, P6222, DOI 10.1021/bi982938z; Lin SH, 2002, BIOCHEMISTRY-US, V41, P11857, DOI 10.1021/bi026099z; Malecki J, 2000, J BIOL CHEM, V275, P8480, DOI 10.1074/jbc.275.12.8480; *MERCK CO INC, 1976, MERCK IND; Mukhopadhyay J, 1999, FEBS LETT, V453, P215, DOI 10.1016/S0014-5793(99)00719-X; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Polit A, 2003, EUR J BIOCHEM, V270, P1413, DOI 10.1046/j.1432-1033.2003.03497.x; TAKAHASHI M, 1980, BIOCHEMISTRY-US, V19, P5124, DOI 10.1021/bi00563a029; TANIGUCHI T, 1979, P NATL ACAD SCI USA, V76, P5090, DOI 10.1073/pnas.76.10.5090; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Won HS, 2000, BIOCHEMISTRY-US, V39, P13953, DOI 10.1021/bi000012x; WU CW, 1974, BIOCHEMISTRY-US, V13, P2573, DOI 10.1021/bi00709a016	24	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43020	43026		10.1074/jbc.M306398200	http://dx.doi.org/10.1074/jbc.M306398200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12939272	hybrid			2022-12-27	WOS:000186157000038
J	Jiang, XC; Beyer, TP; Li, ZQ; Liu, J; Quan, W; Schmidt, RJ; Zhang, YY; Bensch, WR; Eacho, PI; Cao, GQ				Jiang, XC; Beyer, TP; Li, ZQ; Liu, J; Quan, W; Schmidt, RJ; Zhang, YY; Bensch, WR; Eacho, PI; Cao, GQ			Enlargement of high density lipoprotein in mice via liver X receptor activation requires apolipoprotein E and is abolished by cholesteryl ester transfer protein expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID TRANSFER PROTEIN; TRANSGENIC MICE; TANGIER-DISEASE; A-I; ABCA1 TRANSPORTER; HUMAN CETP; GENE; BINDING; IDENTIFICATION; METABOLISM	The factors involved in the generation of larger high density lipoprotein (HDL) particles, HDL1 and HDLc, are still not well understood. Administration of a specific synthetic liver X receptor (LXR) agonist, T0901317, in mice resulted in an increase of not only HDL cholesterol but also HDL particle size (Cao, G., Beyer, T. P., Yang, X. P., Schmidt, R. J., Zhang, Y., Bensch, W. R., Kauffman, R. F., Gao, H., Ryan, T. P., Liang, Y., Eacho, P. I., and Jiang, X. C. (2002) J. Biol. Chem. 277, 39561 - 39565). We have investigated the roles that apoE and CETP may play in this process. We treated apoE-deficient, cholesterol ester transport protein (CETP) transgenic, and wild type mice with various doses of the LXR agonist and monitored their HDL levels. Fast protein liquid chromatography and apolipoprotein analysis revealed that in apoE knockout mouse plasma, there was neither induction of larger HDL formation nor increase of HDL cholesterol, suggesting that apoE is essential for the LXR agonist effects on HDL metabolism. In CETP transgenic mice, CETP expression completely abolished LXR agonist-mediated HDL enlargement and greatly attenuated HDL cholesterol levels. Analysis of HDL particles by electron microscope and nondenaturing gel electrophoresis revealed similar findings. In apoE-deficient mice, LXR agonist also produced a significant increase in very low density lipoprotein/low density lipoprotein cholesterol and apolipoprotein B content. Our studies provide direct evidence that apoE and CETP are intimately involved in the accumulation of the enlarged HDL ( HDL1 or HDLc) particles in mice.	Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; SUNY Downstate Med Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA	Eli Lilly; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Jiang, XC (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	xjiang@downstate.edu; Guoqing_Cao@lilly.com			NHLBI NIH HHS [HL-69817, HL-64735] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064735, R01HL069817] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; AGELLON LB, 1991, J BIOL CHEM, V266, P10796; Attie AD, 2001, J LIPID RES, V42, P1717; Basso F, 2003, J LIPID RES, V44, P296, DOI 10.1194/jlr.M200414-JLR200; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Cao GQ, 2002, J BIOL CHEM, V277, P39561, DOI 10.1074/jbc.M207187200; Costet P, 2000, J BIOL CHEM, V275, P28240; DESILVA HV, 1994, J LIPID RES, V35, P1297; EISENBERG S, 1984, J LIPID RES, V25, P1017; Fowler AJ, 2003, J INVEST DERMATOL, V120, P246, DOI 10.1046/j.1523-1747.2003.12033.x; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; GORDON V, 1983, J BIOL CHEM, V258, P6202; GRASS DS, 1995, J LIPID RES, V36, P1082; HAYEK T, 1992, J CLIN INVEST, V90, P505, DOI 10.1172/JCI115887; Herrera VLM, 1999, NAT MED, V5, P1383, DOI 10.1038/70956; INNERARITY TL, 1978, BIOCHEMISTRY-US, V17, P1440, DOI 10.1021/bi00601a013; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jiang XC, 1999, J CLIN INVEST, V103, P907, DOI 10.1172/JCI5578; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kiss RS, 2003, J BIOL CHEM, V278, P10119, DOI 10.1074/jbc.M300137200; KOO C, 1985, J BIOL CHEM, V260, P1934; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; Luo Y, 2000, J CLIN INVEST, V105, P513, DOI 10.1172/JCI8573; MAHLEY RW, 1982, MED CLIN N AM, V66, P375, DOI 10.1016/S0025-7125(16)31426-2; Mak PA, 2002, J LIPID RES, V43, P2037, DOI 10.1194/jlr.C200014-JLR200; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Neufeld EB, 2002, BIOCHEM BIOPH RES CO, V297, P974, DOI 10.1016/S0006-291X(02)02274-X; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; PLUMP AS, 1995, ANNU REV NUTR, V15, P495, DOI 10.1146/annurev.nu.15.070195.002431; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Singaraja RR, 2001, J BIOL CHEM, V276, P33969, DOI 10.1074/jbc.M102503200; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Tall AR, 2000, ARTERIOSCL THROM VAS, V20, P1185, DOI 10.1161/01.ATV.20.5.1185; TALL AR, 1986, J LIPID RES, V27, P361; Vaisman BL, 2001, J CLIN INVEST, V108, P303; Wierzbicki AS, 2002, CURR MED RES OPIN, V18, P36, DOI 10.1185/030079902125000165; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; YAMASHITA S, 1990, J CLIN INVEST, V86, P688, DOI 10.1172/JCI114764; Zak Z, 2002, J LIPID RES, V43, P2164, DOI 10.1194/jlr.M200253-JLR200	47	42	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					49072	49078		10.1074/jbc.M304274200	http://dx.doi.org/10.1074/jbc.M304274200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12947111	hybrid			2022-12-27	WOS:000186829000069
J	Hiller, NL; Akompong, T; Morrow, JS; Holder, AA; Haldar, K				Hiller, NL; Akompong, T; Morrow, JS; Holder, AA; Haldar, K			Identification of a stomatin orthologue in vacuoles induced in human erythrocytes by malaria parasites - A role for microbial raft proteins in apicomplexan vacuole biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE-PROTEIN; RED-CELL INVASION; PLASMODIUM-FALCIPARUM; PARASITOPHOROUS VACUOLE; CAENORHABDITIS-ELEGANS; TOXOPLASMA-GONDII; SURFACE-ANTIGEN; BLOOD-CELLS; C-ELEGANS; IN-VITRO	When the human malaria parasite Plasmodium falciparum infects erythrocytes, proteins associated with host-derived detergent-resistant membrane (DRM) rafts are selectively recruited into the newly formed vacuole, but parasite proteins that contribute to raft-based vacuole development are unknown. In mammalian cells, DRM-associated integral membrane proteins such as caveolin-1 and flotillin-1 that form oligomers have been linked to the formation of DRM-based invaginations called caveolae. Here we show that the P. falciparum genome does not encode caveolins or flotillins but does contain an orthologue of human band 7 stomatin, a protein known to oligomerize, associate with non-caveolar DRMs and is distantly related to flotillins. Stomatins are members of a large protein family conserved in evolution and P. falciparum (Pf) stomatin appears to be a prokaryotic-like molecule. Evidence is presented that it associates with DRMs and may oligomerize, suggesting that these features are conserved in the stomatin family. Further, Pfstomatin is an integral membrane protein concentrated at the apical end of extracellular parasites, where it co-localizes with invasion-associated rhoptry organelles. A resident rhoptry protein, RhopH2 also resides in DRMs. This provides the first evidence that rhoptries of an apicomplexan parasite contain DRM rafts. Further, when the parasite invades erythrocytes, rhoptry Pfstomatin and RhopH2 are inserted into the newly formed vacuole. Thus, like caveolin-1 and flotillin-1, a stomatin may also associate with non-clathrin coated, DRM-enriched vacuoles. We propose a new model of invasion and vacuole formation involving DRM-based interactions of both host and parasite molecules.	Northwestern Univ, Dept Pathol & Microbiol Immunol, Chicago, IL 60611 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; Natl Inst Med Res, Div Parasitol, London NW7 1AA, England	Northwestern University; Yale University; MRC National Institute for Medical Research	Haldar, K (corresponding author), Northwestern Univ, Dept Pathol & Microbiol Immunol, Chicago, IL 60611 USA.		Haldar, Kasturi/C-6685-2014; Hiller, N. Luisa/A-3739-2016; Holder, Anthony A/A-7554-2013	Hiller, N. Luisa/0000-0001-6572-1368; Holder, Anthony A/0000-0002-8490-6058	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039071] Funding Source: NIH RePORTER; MRC [MC_U117532067] Funding Source: UKRI; Medical Research Council [MC_U117532067] Funding Source: Medline; NHLBI NIH HHS [HL28560] Funding Source: Medline; NIAID NIH HHS [AI39071] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bahl A, 2002, NUCLEIC ACIDS RES, V30, P87, DOI 10.1093/nar/30.1.87; BANNISTER LH, 1989, J PROTOZOOL, V36, P362, DOI 10.1111/j.1550-7408.1989.tb05527.x; Barnes TM, 1996, J NEUROCHEM, V67, P46; Berzins K, 2002, CHEM IMMUNOL, V80, P125; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Cheresh P, 2002, J BIOL CHEM, V277, P16265, DOI 10.1074/jbc.M109331200; COOPER JA, 1988, MOL BIOCHEM PARASIT, V29, P251, DOI 10.1016/0166-6851(88)90080-1; DeRocher A, 2000, J CELL SCI, V113, P3969; Dluzewski AR, 1995, EUR J CELL BIOL, V68, P446; DLUZEWSKI AR, 1992, J CELL SCI, V102, P527; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; ELMENDORF HG, 1993, EMBO J, V12, P4763, DOI 10.1002/j.1460-2075.1993.tb06165.x; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; FOUSSARD F, 1991, PARASITOLOGY, V102, P367, DOI 10.1017/S0031182000064313; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; GALLAGHER PG, 1995, J BIOL CHEM, V270, P26358, DOI 10.1074/jbc.270.44.26358; GLENNEY JR, 1992, P NATL ACAD SCI USA, V89, P10517, DOI 10.1073/pnas.89.21.10517; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; HALDAR K, 1994, METHOD CELL BIOL, V45, P221; HALDAR K, 1985, J BIOL CHEM, V260, P4969; Haldar K, 2002, CELL MICROBIOL, V4, P383, DOI 10.1046/j.1462-5822.2002.00204.x; HALL SJ, 1991, MOL BIOCHEM PARASIT, V45, P317, DOI 10.1016/0166-6851(91)90100-K; HIEBLDIRSCHMIED CM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P123, DOI 10.1016/0167-4781(91)90047-P; Hoessli DC, 2003, EUR J BIOCHEM, V270, P366, DOI 10.1046/j.1432-1033.2003.03397.x; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Huttner WB, 2001, CURR OPIN CELL BIOL, V13, P478, DOI 10.1016/S0955-0674(00)00239-8; Kadekoppala M, 2000, INFECT IMMUN, V68, P2328, DOI 10.1128/IAI.68.4.2328-2332.2000; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; Li SW, 1996, J BIOL CHEM, V271, P28647, DOI 10.1074/jbc.271.45.28647; Ling IT, 2003, MOL BIOCHEM PARASIT, V127, P47, DOI 10.1016/S0166-6851(02)00302-X; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Nagao E, 2002, EXP PARASITOL, V102, P57, DOI 10.1016/S0014-4894(02)00143-1; Rajaram S, 1999, GENETICS, V153, P1673; Rajaram S, 1998, P NATL ACAD SCI USA, V95, P8761, DOI 10.1073/pnas.95.15.8761; Riese MJ, 2002, J BIOL CHEM, V277, P12082, DOI 10.1074/jbc.M109039200; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; SALZER U, 1993, BIOCHIM BIOPHYS ACTA, V1151, P149, DOI 10.1016/0005-2736(93)90098-K; Samuel BU, 2001, J BIOL CHEM, V276, P29319, DOI 10.1074/jbc.M101268200; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; SCHRIER SL, 1987, METHOD ENZYMOL, V149, P260; Sedensky MM, 2001, AM J PHYSIOL-CELL PH, V280, pC1340, DOI 10.1152/ajpcell.2001.280.5.C1340; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Snyers L, 1998, J BIOL CHEM, V273, P17221, DOI 10.1074/jbc.273.27.17221; Stewart GW, 1997, INT J BIOCHEM CELL B, V29, P271, DOI 10.1016/S1357-2725(96)00072-6; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wang YJ, 2000, J BIOL CHEM, V275, P8062, DOI 10.1074/jbc.275.11.8062; WARD GE, 1993, J CELL SCI, V106, P237; Zhu YW, 1999, BLOOD, V93, P2404, DOI 10.1182/blood.V93.7.2404.407k13_2404_2410	61	76	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48413	48421		10.1074/jbc.M307266200	http://dx.doi.org/10.1074/jbc.M307266200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12968029	hybrid			2022-12-27	WOS:000186731400127
J	Allouch, J; Jam, M; Helbert, W; Barbeyron, T; Kloareg, B; Henrissat, B; Czjzek, M				Allouch, J; Jam, M; Helbert, W; Barbeyron, T; Kloareg, B; Henrissat, B; Czjzek, M			The three-dimensional structures of two beta-agarases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LICHENIFORMIS 1,3-1,4-BETA-D-GLUCAN 4-GLUCANOHYDROLASE; SEQUENCE-BASED CLASSIFICATION; ACTIVE-SITE; PSEUDOMONAS-ATLANTICA; KAPPA-CARRAGEENASE; CRYSTAL-STRUCTURE; GLYCOSYL; MECHANISMS; EVOLUTION	Agars are important gelifying agents for biochemical use and the food industry. To cleave the beta- 1,4- linkages between beta- D- galactose and alpha- L- 3,6- anhydro- galactose residues in the red algal galactans known as agars, marine bacteria produce polysaccharide hydrolases called beta- agarases. beta- Agarases A and B from Zobellia galactanivorans Dsij have recently been biochemically characterized. Here we report the first crystal structure of these two beta- agarases. The two proteins were overproduced in Escherichia coli and crystallized, and the crystal structures were determined at 1.48 and 2.3 Angstrom for beta- agarases A and B, respectively. The structure of beta- agarase A was solved by the multiple anomalous diffraction method, whereas beta- agarase B was solved with molecular replacement using beta- agarase A as model. Their structures adopt a jelly roll fold with a deep active site channel harboring the catalytic machinery, namely the nucleophilic residues Glu- 147 and Glu- 184 and the acid/ base residues Glu- 152 and Glu- 189 for beta- agarases A and B, respectively. The structures of the agarases were compared with those of two lichenases and of a kappa- carrageenase, which all belong to family 16 of the glycoside hydrolases in order to pinpoint the residues responsible for their widely differing substrate specificity. The relationship between structure and enzymatic activity of the two beta- agarases from Z. galactanivorans Dsij was studied by analysis of the degradation products starting with different oligosaccharides. The combination of the structural and biochemical results allowed the determination of the number of subsites present in the catalytic cleft of the beta- agarases.	CNRS, UMR 6098, F-13402 Marseille 20, France; Univ Aix Marseille 1, F-13402 Marseille 20, France; Univ Aix Marseille 2, F-13402 Marseille 20, France; CNRS, UMR 1931, F-29682 Roscoff, France; CNRS, Biol Stn, Labs Goemar, F-29682 Roscoff, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Czjzek, M (corresponding author), CNRS, UMR 6098, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	czjzek@afmb.cnrs-mrs.fr	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588				ARNOTT S, 1974, J MOL BIOL, V90, P269, DOI 10.1016/0022-2836(74)90372-6; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbeyron T, 1998, MOL BIOL EVOL, V15, P528, DOI 10.1093/oxfordjournals.molbev.a025952; BELAS R, 1989, J BACTERIOL, V171, P602, DOI 10.1128/jb.171.1.602-605.1989; BUTTNER MJ, 1987, MOL GEN GENET, V209, P101, DOI 10.1007/BF00329843; Czjzek M, 2000, P NATL ACAD SCI USA, V97, P13555, DOI 10.1073/pnas.97.25.13555; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; De Ruiter GA, 1997, TRENDS FOOD SCI TECH, V8, P389, DOI 10.1016/S0924-2244(97)01091-1; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; GEBLER J, 1992, J BIOL CHEM, V267, P12559; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HAHN M, 1995, J BIOL CHEM, V270, P3081, DOI 10.1074/jbc.270.7.3081; HAHN M, 1995, FEBS LETT, V374, P221, DOI 10.1016/0014-5793(95)01111-Q; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Johansson P, 2003, ACTA CRYSTALLOGR D, V59, P535, DOI 10.1107/S090744490202348X; JUNCOSA M, 1994, J BIOL CHEM, V269, P14530; KEITEL T, 1993, P NATL ACAD SCI USA, V90, P5287, DOI 10.1073/pnas.90.11.5287; KLOAREG B, 1988, OCEANOGR MAR BIOL, V26, P259; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LICHU T, 2003, J MOL BIOL, V330, P607; MALET C, 1993, BIOCHEM J, V296, P753, DOI 10.1042/bj2960753; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Michel G, 2001, STRUCTURE, V9, P513, DOI 10.1016/S0969-2126(01)00612-8; MORRICE LM, 1983, EUR J BIOCHEM, V137, P149, DOI 10.1111/j.1432-1033.1983.tb07808.x; MORRICE LM, 1983, EUR J BIOCHEM, V135, P553, DOI 10.1111/j.1432-1033.1983.tb07688.x; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; ROCHAS C, 1986, CARBOHYD RES, V148, P199, DOI 10.1016/S0008-6215(00)90388-4; ROUSSEL A, 1991, SILICON GRAPHICS GEO; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SUGANO Y, 1993, APPL ENVIRON MICROB, V59, P1549; SUGANO Y, 1994, BBA-GENE STRUCT EXPR, V1218, P105, DOI 10.1016/0167-4781(94)90109-0; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Terwilliger TC, 1997, ACTA CRYSTALLOGR D, V53, P571, DOI 10.1107/S0907444997005398; Weinberger F, 2001, J PHYCOL, V37, P418, DOI 10.1046/j.1529-8817.2001.037003418.x	46	106	117	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47171	47180		10.1074/jbc.M308313200	http://dx.doi.org/10.1074/jbc.M308313200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12970344	hybrid			2022-12-27	WOS:000186569400116
J	Fukusumi, S; Yoshida, H; Fujii, R; Maruyama, M; Komatsu, H; Habata, Y; Shintani, Y; Hinuma, S; Fujino, M				Fukusumi, S; Yoshida, H; Fujii, R; Maruyama, M; Komatsu, H; Habata, Y; Shintani, Y; Hinuma, S; Fujino, M			A new peptidic ligand and its receptor regulating adrenal function in rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; PROLACTIN-RELEASING PEPTIDE; NEUROMEDIN U; IDENTIFICATION; NEUROPEPTIDE; RFAMIDE; GENE; ASSAY; BRAIN; FF	We searched for peptidic ligands for orphan G protein-coupled receptors utilizing a human genome data base and identified a new gene encoding a preproprotein that could generate a peptide. This peptide consisted of 43 amino acid residues starting from N-terminal pyroglutamic acid and ending at C-terminal arginine-phenylalanine-amide. We therefore named it QRFP after pyroglutamylated arginine-phenylalanineamide peptide. We subsequently searched for its receptor and found that Chinese hamster ovary cells expressing an orphan G protein-coupled receptor, AQ27, specifically responded to QRFP. We analyzed tissue distributions of QRFP and its receptor mRNAs in rats utilizing quantitative reverse transcription-polymerase chain reaction and in situ hybridization. QRFP mRNA was highly expressed in the hypothalamus, whereas its receptor mRNA was highly expressed in the adrenal gland. The intravenous administration of QRFP caused the release of aldosterone, suggesting that QRFP and its receptor have a regulatory function in the rat adrenal gland.	Takeda Chem Ind Ltd, Div Pharmaceut Res, Discovery Res Labs, Tsukuba, Ibaraki 3004293, Japan	Takeda Chemical Industries	Hinuma, S (corresponding author), Takeda Chem Ind Ltd, Div Pharmaceut Res, Discovery Res Labs, Wadai 10, Tsukuba, Ibaraki 3004293, Japan.			Komatsu, Hidetoshi/0000-0003-1630-0537; Maruyama, Minoru/0000-0002-1478-9415				BUSBY WH, 1987, J BIOL CHEM, V262, P8532; CAMPBELL WB, 1974, SCIENCE, V184, P994, DOI 10.1126/science.184.4140.994; CHEN WB, 1995, ANAL BIOCHEM, V226, P349, DOI 10.1006/abio.1995.1235; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Durocher Y, 2000, ANAL BIOCHEM, V284, P316, DOI 10.1006/abio.2000.4698; Elshourbagy NA, 2000, J BIOL CHEM, V275, P25965, DOI 10.1074/jbc.M004515200; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Fujiwara K, 2003, NEUROSCI LETT, V338, P127, DOI 10.1016/S0304-3940(02)01395-2; Fukusumi S, 2001, BBA-MOL CELL RES, V1540, P221, DOI 10.1016/S0167-4889(01)00135-5; Fukusumi S, 1997, BIOCHEM BIOPH RES CO, V232, P157, DOI 10.1006/bbrc.1997.6252; Hinuma S, 1999, J MOL MED, V77, P495, DOI 10.1007/s001090050403; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; HINUMA S, 1994, BBA-GENE STRUCT EXPR, V1219, P251, DOI 10.1016/0167-4781(94)90046-9; Hosoya M, 2000, J BIOL CHEM, V275, P29528, DOI 10.1074/jbc.M004261200; Jiang Y, 2003, J BIOL CHEM, V278, P27652, DOI 10.1074/jbc.M302945200; JOOST P, 2002, GENOME BIOL; JOPEZGIMENEZ JF, 2001, MOL PHARMACOL, V60, P690; Labrouche S, 1998, J NEUROENDOCRINOL, V10, P559, DOI 10.1046/j.1365-2826.1998.00241.x; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; MEKLER DJ, 1994, ENZYME MICROB TECHNO, V16, P450; Monti JM, 2000, LIFE SCI, V66, P1999, DOI 10.1016/S0024-3205(99)00649-9; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; PERRY SJ, 1997, FEBS LETT, V409, P420; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Yoshida H, 2003, BBA-MOL CELL RES, V1593, P151, DOI 10.1016/S0167-4889(02)00389-0	29	145	162	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46387	46395		10.1074/jbc.M305270200	http://dx.doi.org/10.1074/jbc.M305270200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12960173	hybrid			2022-12-27	WOS:000186569400022
J	Kim, E; Xie, SZ; Yeh, SD; Lee, YF; Collins, LL; Hu, YC; Shyr, CR; Mu, XM; Liu, NC; Chen, YT; Wang, PH; Chang, CS				Kim, E; Xie, SZ; Yeh, SD; Lee, YF; Collins, LL; Hu, YC; Shyr, CR; Mu, XM; Liu, NC; Chen, YT; Wang, PH; Chang, CS			Disruption of TR4 orphan nuclear receptor reduces the expression of liver apolipoprotein E/C-I/C-II gene cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC CONTROL REGION; RESPONSE ELEMENT; TRANSGENIC MICE; RXR HETERODIMERS; TRANSCRIPTION; SUPERFAMILY; TRANSACTIVATION; PROMOTER; MEMBER; HNF-4	Apolipoprotein E (apoE) is synthesized in many tissues, and the liver is the primary site from which apoE redistributes cholesterol and other lipids to peripheral tissues. Here we demonstrate that the TR4 orphan nuclear receptor (TR4) can induce apoE expression in HepG2 cells. This TR4-mediated regulation of apoE gene expression was further confirmed in vivo using TR4 knockout mice. Both serum apoE protein and liver apoE mRNA levels were significantly reduced in TR4 knockout mice. Gel shift and luciferase reporter gene assays further demonstrated that TR4 can induce apoE gene expression via a TR4 response element located in the hepatic control region that is 15 kb downstream of the apoE gene. Furthermore our in vivo data from TR4 knockout mice prove that TR4 can also regulate apolipoprotein C-I and C-II gene expression via the TR4 response element within the hepatic control region. Together our data show that loss of TR4 down-regulates expression of the apoE/C-I/C-II gene cluster in liver cells, demonstrating important roles of TR4 in the modulation of lipoprotein metabolism.	Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Radiat Oncol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Ctr Canc, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Chang, CS (corresponding author), Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.		Hu, Yueh-Chiang/AAX-2370-2020	Chang, Chawnshang/0000-0001-8510-3516; Hu, Yueh-Chiang/0000-0002-7992-0525	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047258, R01DK056984] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 47258, DK 56984] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLAN CM, 1995, J BIOL CHEM, V270, P26278, DOI 10.1074/jbc.270.44.26278; Allan CM, 1997, J BIOL CHEM, V272, P29113, DOI 10.1074/jbc.272.46.29113; Choi HS, 1997, J BIOL CHEM, V272, P23565, DOI 10.1074/jbc.272.38.23565; DANG Q, 1995, J BIOL CHEM, V270, P22577, DOI 10.1074/jbc.270.38.22577; DRISCOLL DM, 1984, J LIPID RES, V25, P1368; DURAND B, 1992, CELL, V71, P73, DOI 10.1016/0092-8674(92)90267-G; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Fraser JD, 1998, NUCLEIC ACIDS RES, V26, P2702, DOI 10.1093/nar/26.11.2702; GALSON DL, 1995, MOL CELL BIOL, V15, P2135; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Kardassis D, 1998, J BIOL CHEM, V273, P17810, DOI 10.1074/jbc.273.28.17810; Kassam A, 2000, J BIOL CHEM, V275, P4345, DOI 10.1074/jbc.275.6.4345; Kast HR, 2001, MOL ENDOCRINOL, V15, P1720, DOI 10.1210/me.15.10.1720; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; KTISTAKI E, 1994, NUCLEIC ACIDS RES, V22, P4689, DOI 10.1093/nar/22.22.4689; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lee HJ, 2001, BIOCHEM BIOPH RES CO, V285, P1361, DOI 10.1006/bbrc.2001.5342; LEE HJ, 1995, J BIOL CHEM, V270, P30129; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Lee YF, 1998, J BIOL CHEM, V273, P13437, DOI 10.1074/jbc.273.22.13437; Lee YF, 1999, J BIOL CHEM, V274, P16198, DOI 10.1074/jbc.274.23.16198; Lee YF, 1997, J BIOL CHEM, V272, P12215, DOI 10.1074/jbc.272.18.12215; Lee YF, 1999, P NATL ACAD SCI USA, V96, P14724, DOI 10.1073/pnas.96.26.14724; LIN TM, 1995, J BIOL CHEM, V270, P30121; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mak PA, 2002, J BIOL CHEM, V277, P31900, DOI 10.1074/jbc.M202993200; Makita T, 2001, GENE DEV, V15, P889, DOI 10.1101/gad.871601; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mazzone T, 1996, CURR OPIN LIPIDOL, V7, P303, DOI 10.1097/00041433-199610000-00008; METZGER S, 1993, J BIOL CHEM, V268, P16831; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; Nakshatri H, 1998, NUCLEIC ACIDS RES, V26, P2491, DOI 10.1093/nar/26.10.2491; NAKSHATRI H, 1994, J BIOL CHEM, V269, P890; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Ribeiro A, 1999, J BIOL CHEM, V274, P1216, DOI 10.1074/jbc.274.3.1216; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Smirlis D, 2001, J BIOL CHEM, V276, P12822, DOI 10.1074/jbc.M005930200; SMITH JD, 1990, J BIOL CHEM, V265, P14709; Tsukamoto K, 1999, ARTERIOSCL THROM VAS, V19, P2162, DOI 10.1161/01.ATV.19.9.2162; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Yan ZH, 1998, J BIOL CHEM, V273, P10948, DOI 10.1074/jbc.273.18.10948; Young WJ, 1997, J BIOL CHEM, V272, P3109, DOI 10.1074/jbc.272.5.3109	46	39	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46919	46926		10.1074/jbc.M304088200	http://dx.doi.org/10.1074/jbc.M304088200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12954636	hybrid			2022-12-27	WOS:000186569400086
J	Suzuki, N; Khoo, KH; Chen, CM; Chen, HC; Lee, YC				Suzuki, N; Khoo, KH; Chen, CM; Chen, HC; Lee, YC			N-glycan structures of pigeon IgG - A major serum glycoprotein containing Gal alpha 1-4Gal termini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED SUGAR CHAINS; IMMUNOGLOBULIN-G; FERTILIZED-EGGS; JAPANESE-QUAIL; BIOSYNTHETIC-PATHWAY; MAPPING TECHNIQUE; ESCHERICHIA-COLI; FANCIERS LUNG; CYST MEMBRANE; VH-GENE	We had shown previously that all major glycoproteins of pigeon egg white contain Galalpha1-4Gal epitopes (Suzuki, N., Khoo, K.H., Chen, H.C., Johnson, J.R., and Lee, Y.C. (2001) J. Biol. Chem. 276, 23221-23229). We now report that Galalpha1-4Gal-bearing glycoproteins are also present in pigeon serum, lymphocytes, and liver, as probed by Western blot with Griffonia simplicifolia-I lectin (specific for terminal alpha-Gal) and anti-P-1 (specific for Galalpha1-4Galbeta1-4GlcNAcbeta1-) monoclonal antibody. One of the major glycoproteins from pigeon plasma was identified as IgG (also known as IgY), which has Galalpha1-4Gal in its heavy chains. High pressure liquid chromatography, mass spectrometric (MS), and MS/MS analyses revealed that N-glycans of pigeon serum IgG included (i) high mannose-type (33.3%), (ii) disialylated biantennary complex-type (19.2%), and (iii) alpha-galactosylated complex-type N-glycans (47.5%). Bi- and tri-antennary oligosaccharides with bisecting GlcNAc and alpha1-6 Fuc on the Asn-linked GlcNAc were abundant among N-glycans possessing terminal Galalpha1-4Gal sequences. Moreover, MS/MS analysis identified Galalpha1-4Galbeta1-4Galbeta1-4GlcNAc branch terminals, which are not found in pigeon egg white glycoproteins. An additional interesting aspect is that about two-thirds of high mannose-type N-glycans from pigeon IgG were monoglucosylated. Comparison of the N-glycan structures with chicken and quail IgG indicated that the presence of high mannose-type oligosaccharides may be a characteristic of these avian IgG.	Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; NICHD, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Academia Sinica - Taiwan; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lee, YC (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.		Khoo, Kay-Hooi/E-1989-2019	Khoo, Kay-Hooi/0000-0003-2906-406X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK009970, R37DK009970] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 09970] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baldwin CI, 1999, CLIN EXP IMMUNOL, V117, P230; Bengten E, 2000, CURR TOP MICROBIOL, V248, P189; Bouhours D, 2000, GLYCOBIOLOGY, V10, P857, DOI 10.1093/glycob/10.9.857; BROCTEUR J, 1975, Haematologia, V9, P43; BURLEY RW, 1989, AVIAN EGG CHEM BIOL, P129; Burton D. R, 1987, MOL GENETICS IMMUNOG, V17, P1; Calvert JE, 1999, CLIN EXP ALLERGY, V29, P166; COSSEY A, 1979, EUR J BIOCHEM, V98, P53, DOI 10.1111/j.1432-1033.1979.tb13159.x; DAHAN A, 1983, NUCLEIC ACIDS RES, V11, P5381, DOI 10.1093/nar/11.16.5381; DELL A, 1994, METHOD ENZYMOL, V230, P108; Delplace F, 2002, BIOCHEM J, V363, P457, DOI 10.1042/0264-6021:3630457; DORLAND L, 1984, BIOCHEM BIOPH RES CO, V122, P859, DOI 10.1016/S0006-291X(84)80113-8; ENDO T, 1995, MOL IMMUNOL, V32, P931, DOI 10.1016/0161-5890(95)00078-S; ENGBERG RM, 1992, AVIAN PATHOL, V21, P409, DOI 10.1080/03079459208418859; FRANCOISGERARD C, 1980, REV FR TRANSFUS IMMU, V23, P95, DOI 10.1016/S0338-4535(80)80050-X; FRANCOISGERARD C, 1980, VOX SANG, V39, P141, DOI 10.1111/j.1423-0410.1980.tb01849.x; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; GAHMBERG CG, 1975, J BIOL CHEM, V250, P2438; GALILI U, 1988, J BIOL CHEM, V263, P17755; GALILI U, 1987, P NATL ACAD SCI USA, V84, P1369, DOI 10.1073/pnas.84.5.1369; Guerardel Y, 2000, BIOCHEM J, V352, P449, DOI 10.1042/0264-6021:3520449; HAMAKO J, 1993, COMP BIOCHEM PHYS B, V106, P949, DOI 10.1016/0305-0491(93)90056-B; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; HASE S, 1986, J BIOCHEM-TOKYO, V99, P1725, DOI 10.1093/oxfordjournals.jbchem.a135649; HASE S, 1982, J BIOCHEM-TOKYO, V91, P735, DOI 10.1093/oxfordjournals.jbchem.a133748; Hooper LV, 2001, GLYCOBIOLOGY, V11, p1R, DOI 10.1093/glycob/11.2.1R; IWASAKI M, 1992, J BIOL CHEM, V267, P24287; JOHNSON JR, 1992, INFECT IMMUN, V60, P578, DOI 10.1128/IAI.60.2.578-583.1992; Khoo KH, 1997, MOL BIOCHEM PARASIT, V86, P237, DOI 10.1016/S0166-6851(97)00036-4; KOBATA A, 1990, Glycobiology, V1, P5, DOI 10.1093/glycob/1.1.5; KOTANI M, 1994, ARCH BIOCHEM BIOPHYS, V310, P89, DOI 10.1006/abbi.1994.1144; LESLIE GA, 1969, J EXP MED, V130, P1337, DOI 10.1084/jem.130.6.1337; Lopez M, 1998, J BIOL CHEM, V273, P33644, DOI 10.1074/jbc.273.50.33644; LYERLA T, 1986, J CELL PHYSIOL, V129, P390, DOI 10.1002/jcp.1041290318; MAGOR KE, 1992, J IMMUNOL, V149, P2627; MANSIKKA A, 1992, J IMMUNOL, V149, P855; MATSUURA F, 1993, GLYCOCONJUGATE J, V10, P202, DOI 10.1007/BF00702201; Mimura Y, 2000, MOL IMMUNOL, V37, P697, DOI 10.1016/S0161-5890(00)00105-X; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P130, DOI 10.1006/abio.1995.1200; NAKAMURA K, 1984, J BIOCHEM-TOKYO, V95, P1137, DOI 10.1093/oxfordjournals.jbchem.a134702; OHTA M, 1991, GLYCOCONJUGATE J, V8, P400, DOI 10.1007/BF00731292; PARVARI R, 1988, EMBO J, V7, P739, DOI 10.1002/j.1460-2075.1988.tb02870.x; Radaev S, 2001, J BIOL CHEM, V276, P16478, DOI 10.1074/jbc.M100351200; Raju TS, 2000, GLYCOBIOLOGY, V10, P477, DOI 10.1093/glycob/10.5.477; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; Rother RP, 1996, CELL, V86, P185, DOI 10.1016/S0092-8674(00)80090-2; RUSSI S, 1974, J IMMUNOL, V112, P1061; Schmidt H, 2000, APPL ENVIRON MICROB, V66, P1205, DOI 10.1128/AEM.66.3.1205-1208.2000; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STRECKER G, 1992, EUR J BIOCHEM, V207, P995, DOI 10.1111/j.1432-1033.1992.tb17135.x; Suzuki N, 2001, J BIOL CHEM, V276, P23221, DOI 10.1074/jbc.M101379200; TAGUCHI T, 1995, GLYCOBIOLOGY, V5, P611, DOI 10.1093/glycob/5.6.611; TAGUCHI T, 1993, J BIOL CHEM, V268, P2353; TAGUCHI T, 1994, J BIOL CHEM, V269, P8762; TAKAHASHI N, 1993, GLYCOCONJUGATE J, V10, P425, DOI 10.1007/BF00737962; TAKAHASHI N, 1995, ANAL BIOCHEM, V226, P139, DOI 10.1006/abio.1995.1201; Takahashi N, 2001, J BIOL CHEM, V276, P23230, DOI 10.1074/jbc.M101380200; TAKAHASHI N, 1995, ANAL BIOCHEM, V230, P333, DOI 10.1006/abio.1995.1483; THALL A, 1990, BIOCHEMISTRY-US, V29, P3959, DOI 10.1021/bi00468a024; Tomiya N, 1998, ANAL BIOCHEM, V264, P204, DOI 10.1006/abio.1998.2849; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; Welsh RM, 1998, J VIROL, V72, P4650, DOI 10.1128/JVI.72.6.4650-4656.1998; WIERUSZESKI JM, 1987, J BIOL CHEM, V262, P6650; YAMASHITA K, 1983, J BIOL CHEM, V258, P3099; YAMASHITA K, 1982, J BIOL CHEM, V257, P2809; YANG ZT, 1994, J BIOL CHEM, V269, P14620	68	43	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46293	46306		10.1074/jbc.M307132200	http://dx.doi.org/10.1074/jbc.M307132200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12966096	hybrid			2022-12-27	WOS:000186569400013
J	Illario, M; Cavallo, AL; Bayer, KU; Di Matola, T; Fenzi, G; Rossi, G; Vitale, M				Illario, M; Cavallo, AL; Bayer, KU; Di Matola, T; Fenzi, G; Rossi, G; Vitale, M			Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; FOCAL ADHESION KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; CELL-ADHESION; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; HUMAN NEUTROPHILS; THYROID-CELLS; PATHWAY; CALMODULIN	Integrin activation generates different signalings in a cell type-dependent manner and stimulates cell proliferation through the Ras/Raf-1/Mek/Erk pathway. In this study, we demonstrate that integrin stimulation by fibronectin (FN), besides activating the Ras/Erk pathway, generates an auxiliary calcium signal that activates calmodulin and the Ca2+/calmodulin-dependent protein kinase II (CaMKII). This signal regulates Raf-1 activation by Ras and modulates the FN-stimulated extracellular signal-regulated kinase (Erk-1/2). The binding of soluble FN to integrins induced increase of intracellular calcium concentration associated with phosphorylation and activation of CaMKII. In two different cell lines, inhibition of CaMKII activity by specific inhibitors inhibited Erk-1/2 phosphorylation. Whereas CaMK inhibition affected neither integrin-stimulated Akt phosphorylation nor p21Ras or Mek-1 activity, it was necessary for Raf-1 activity. FN-induced Raf-1 activity was abrogated by the CaMKII specific inhibitory peptide antCaNtide. Integrin activation by FN induced the formation of a Raf-1/CaMKII complex, abrogated by inhibition of CaMKII. Active CaMKII phosphorylated Raf-1 in vitro. This is the first demonstration that CaMKII interplays with Raf-1 and regulates Erk activation induced by Ras-stimulated Raf-1. These findings also provide evidence supporting the possible existence of cross-talk between other intracellular pathways involving CaMKII and Raf-1.	Univ Naples Federico II, Dipartimento Endocrinol & Oncol Mol & Clin, I-80131 Naples, Italy; Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; CNR, Ist Endocrinol & Oncol Sperimentale G Salvatore, I-80131 Naples, Italy; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA	University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Vitale, M (corresponding author), Univ Naples Federico II, Dipartimento Endocrinol & Oncol Mol & Clin, Via S Pansini 5, I-80131 Naples, Italy.			Illario, Maddalena/0000-0001-9834-6517				Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Bilato C, 1997, J CLIN INVEST, V100, P693, DOI 10.1172/JCI119582; Blystone SD, 1999, J CELL BIOL, V145, P889, DOI 10.1083/jcb.145.4.889; Borgquist JD, 2002, J LEUKOCYTE BIOL, V71, P764; Bouvard D, 1998, BIOCHEM BIOPH RES CO, V252, P46, DOI 10.1006/bbrc.1998.9592; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; CHAO TSO, 1992, J BIOL CHEM, V267, P19876; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Cheng JJ, 2001, J BIOL CHEM, V276, P31368, DOI 10.1074/jbc.M011317200; Colomer JM, 2000, MOL ENDOCRINOL, V14, P1125, DOI 10.1210/me.14.8.1125; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Cowen DS, 1996, J BIOL CHEM, V271, P22297, DOI 10.1074/jbc.271.37.22297; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; CRUZALEGUI FH, 1993, J BIOL CHEM, V268, P26171; Egea J, 2000, MOL CELL BIOL, V20, P1931, DOI 10.1128/MCB.20.6.1931-1946.2000; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heemskerk JWM, 1997, BLOOD, V90, P2615, DOI 10.1182/blood.V90.7.2615.2615_2615_2625; HEMLER ME, 1987, J BIOL CHEM, V262, P3300; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Illario M, 2003, J CLIN ENDOCR METAB, V88, P260, DOI 10.1210/jc.2002-020774; JACONI MEE, 1991, J CELL BIOL, V112, P1249, DOI 10.1083/jcb.112.6.1249; KARNITZ LM, 1995, MOL CELL BIOL, V15, P3049; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Knall C, 1996, J BIOL CHEM, V271, P2832, DOI 10.1074/jbc.271.5.2832; Kwon MS, 2000, MOL BIOL CELL, V11, P1433, DOI 10.1091/mbc.11.4.1433; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; Schlaepfer DD, 1997, J BIOL CHEM, V272, P13189, DOI 10.1074/jbc.272.20.13189; SCHLAEPFER DD, 1994, NATURE, V372, P786; SCHWARTZ MA, 1993, J CELL BIOL, V120, P1003, DOI 10.1083/jcb.120.4.1003; Tebar F, 2002, FEBS LETT, V517, P206, DOI 10.1016/S0014-5793(02)02624-8; UEHARA T, 1995, BIOCHEM BIOPH RES CO, V210, P574, DOI 10.1006/bbrc.1995.1698; Villalonga P, 2002, J BIOL CHEM, V277, P37929, DOI 10.1074/jbc.M202245200; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Vitale M, 1997, ENDOCRINOLOGY, V138, P1642, DOI 10.1210/en.138.4.1642; Vitale M, 1998, J CLIN ENDOCR METAB, V83, P3673, DOI 10.1210/jc.83.10.3673; vonWillebrand M, 1996, EUR J BIOCHEM, V235, P828; YANG SD, 1994, J BIOL CHEM, V269, P29855	44	122	124	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45101	45108		10.1074/jbc.M305355200	http://dx.doi.org/10.1074/jbc.M305355200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954639	hybrid			2022-12-27	WOS:000186452300009
J	Zeng, YC; Tao, NB; Chung, KN; Heuser, JE; Lublin, DM				Zeng, YC; Tao, NB; Chung, KN; Heuser, JE; Lublin, DM			Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE-DERIVED MACROPHAGES; DECAY-ACCELERATING FACTOR; GPI-ANCHORED PROTEINS; MEMBRANE-PROTEIN; GOLGI-COMPLEX; BINDING-SITE; CELL-SURFACE; IN-VIVO; TRANSPORT; DOMAINS	The scavenger receptor CD36 binds a diverse array of ligands, including thrombospondin-1, oxidized low density lipoprotein (OxLDL), fatty acids, anionic phospholipids, and apoptotic cells. CD36 has been reported to be present in lipid rafts/caveolae, but little is known about the membrane trafficking of this protein at baseline or following ligand binding. Here, we determined that expression of CD36 in Chinese hamster ovary (CHO) cells and endogenous expression of CD36 in C32 cells led to a homogeneous distribution of the protein on the plasma membrane, as judged by confocal fluorescence microscopy. This homogeneous pattern was observed both by anti-CD36 antibody staining and by live cell imaging of CHO cells expressing a chimeric CD36-green fluorescent protein construct. In contrast, caveolin-1 displayed its usual punctate surface distribution. Correspondingly, dual labeling of CD36 and caveolin-1 showed essentially no overlap, neither by immunofluorescence light microscopy nor by immunogold electron microscopy. Furthermore, isolation of lipid rafts by sucrose gradient ultracentrifugation of cold Triton X-100 cell lysates yielded both CD36 and caveolin-1, but immunoprecipitates of caveolin-1 did not contain CD36. Binding of OxLDL led to internalization of CD36 and OxLDL into endosomal structures that did not contain caveolin-1 or transferrin but that co-internalized the glycosyl-phosphatidylinositol-anchored protein decay accelerating factor, a lipid raft protein. Furthermore, expression of CD36 in the caveolin-1-negative KB cell line is sufficient for OxLDL-induced internalization of CD36, indicating that caveolin-1 is not required for this endocytic process. Taken together, these data demonstrate that at steady state, CD36 is localized in lipid rafts but not in caveolae, and that binding of OxLDL to CD36 leads to endocytosis through a lipid raft pathway that is distinct from the clathrin-mediated or caveolin internalization pathways.	Washington Univ, Sch Med, Dept Pathol, Div Lab Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Lublin, DM (corresponding author), Washington Univ, Sch Med, Dept Pathol, Div Lab Med, 660 S Euclid Ave,Box 8118, St Louis, MO 63110 USA.		Heuser, John/H-5940-2012; Eckhardt, Erik/G-1567-2010		NHLBI NIH HHS [T32-HL07038] Funding Source: Medline; NIGMS NIH HHS [GM41297] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM041297, R01GM041297] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; COYNE KE, 1992, J IMMUNOL, V149, P2906; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Gargalovic P, 2001, J BIOL CHEM, V276, P26164, DOI 10.1074/jbc.M011291200; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GREENWALT DE, 1990, BIOCHEMISTRY-US, V29, P7054, DOI 10.1021/bi00482a015; GRIFFITHS G, 1984, J ULTRA MOL STRUCT R, V89, P65, DOI 10.1016/S0022-5320(84)80024-6; KNOWLES DM, 1984, J IMMUNOL, V132, P2170; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; LUBLIN DM, 1991, J EXP MED, V174, P35, DOI 10.1084/jem.174.1.35; MONTESANO R, 1982, NATURE, V296, P651, DOI 10.1038/296651a0; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2001, J BIOL CHEM, V276, P38121; REN Y, 1995, J EXP MED, V181, P1857, DOI 10.1084/jem.181.5.1857; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200; SILVERSTEIN RL, 1989, J CLIN INVEST, V84, P546, DOI 10.1172/JCI114197; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Souto RP, 2003, J BIOL CHEM, V278, P18321, DOI 10.1074/jbc.M211541200; TANDON NN, 1989, J BIOL CHEM, V264, P7570; Tao NB, 1996, J BIOL CHEM, V271, P22315, DOI 10.1074/jbc.271.37.22315; Thorne RF, 2000, J BIOL CHEM, V275, P35264, DOI 10.1074/jbc.M003969200	52	94	96	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45931	45936		10.1074/jbc.M307722200	http://dx.doi.org/10.1074/jbc.M307722200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12947091	hybrid			2022-12-27	WOS:000186452300106
J	Joaquin, M; Watson, RJ				Joaquin, M; Watson, RJ			The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYB; S PHASE; A-MYB; PHOSPHORYLATION; EXPRESSION; PROLIFERATION; PROTEIN; GENE; DIFFERENTIATION; ACTIVATION	The cell cycle-regulated B-Myb transcription factor is required for early embryonic development and is implicated in regulating cell growth and differentiation. In addition to its transcriptional regulatory properties, recent data indicate that B-Myb can release active cyclin/ Cdk2 activity from the retinoblastoma-related p107 protein by directly interacting with the p107 N terminus. As this p107 domain has homology to the cyclin-binding domains of the p21(Waf1/Cip1) family of cyclin-dependent kinase inhibitors (CKIs), we investigated in this study whether B-Myb could also interact with these CKIs. No in vivo interaction was found with either p21(Waf1/Cip1) or p27(KIP1), however, binding to p57(KIP2) was readily detectable in both in vivo and in vitro assays. The B-Myb-interacting region of p57(KIP2) mapped to the cyclin-binding domain. Consistent with this, B-Myb competed with cyclin A2 for binding to p57(KIP2), resulting in release of active cyclin/ Cdk2 kinase. Moreover, B-Myb partially overcame the ability of p57(KIP2) to induce G(1) arrest in Saos-2 cells. Despite similarities with previous p107 studies, the B-Myb domains required for interaction with p57(KIP2) were quite different from those implicated for p107. Thus, it is evident that B-Myb may promote cell proliferation by a non-transcriptional mechanism that involves release of active cyclin/ Cdk2 from p57(KIP2) as well as p107.	Univ London Imperial Coll Sci Technol & Med, Ludwig Inst Canc Res, London W2 1PG, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Virol, London W2 1PG, England	Imperial College London; Ludwig Institute for Cancer Research; Imperial College London	Watson, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ludwig Inst Canc Res, Norfolk Pl, London W2 1PG, England.		Joaquin, Manel/E-2216-2015; Joaquin, Manel/O-6533-2019	Joaquin, Manel/0000-0001-8973-5916; Joaquin, Manel/0000-0001-8973-5916				Ansieau S, 1997, J MOL MED-JMM, V75, P815, DOI 10.1007/s001090050170; ARSURA M, 1992, BLOOD, V79, P2708; Bartsch O, 1999, EUR J BIOCHEM, V260, P384, DOI 10.1046/j.1432-1327.1999.00191.x; Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; Bessa M, 2001, BLOOD CELL MOL DIS, V27, P416, DOI 10.1006/bcmd.2001.0399; Bessa M, 2001, ONCOGENE, V20, P3376, DOI 10.1038/sj.onc.1204439; Bies J, 1996, ONCOGENE, V12, P355; Castano E, 1998, MOL CELL BIOL, V18, P5380, DOI 10.1128/MCB.18.9.5380; Engelhard A, 2000, EXP CELL RES, V254, P153, DOI 10.1006/excr.1999.4742; Golay J, 1997, CELL GROWTH DIFFER, V8, P1305; Hashimoto Y, 1998, J BIOL CHEM, V273, P16544, DOI 10.1074/jbc.273.26.16544; Iolascon A, 1998, HAEMATOLOGICA, V83, P771; Iwai N, 2001, ONCOGENE, V20, P1425, DOI 10.1038/sj.onc.1204236; Joaquin M, 2002, ONCOGENE, V21, P7923, DOI 10.1038/sj.onc.1206001; Johnson LR, 2002, J BIOL CHEM, V277, P4088, DOI 10.1074/jbc.M105112200; Johnson TK, 1999, J BIOL CHEM, V274, P36741, DOI 10.1074/jbc.274.51.36741; Kikuchi J, 2003, MOL BIOTECHNOL, V23, P203, DOI 10.1385/MB:23:3:203; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; Lane S, 1997, ONCOGENE, V14, P2445, DOI 10.1038/sj.onc.1201086; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; LIN D, 1994, P NATL ACAD SCI USA, V91, P10079, DOI 10.1073/pnas.91.21.10079; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; RASCHELLA G, 1995, J BIOL CHEM, V270, P8540, DOI 10.1074/jbc.270.15.8540; Reynaud EG, 2000, J BIOL CHEM, V275, P18767, DOI 10.1074/jbc.M907412199; Robinson C, 1996, ONCOGENE, V12, P1855; Rushton JJ, 2003, ONCOGENE, V22, P308, DOI 10.1038/sj.onc.1206131; SALA A, 1992, P NATL ACAD SCI USA, V89, P10415, DOI 10.1073/pnas.89.21.10415; Sala A, 1996, J BIOL CHEM, V271, P9363, DOI 10.1074/jbc.271.16.9363; Sala A, 1997, P NATL ACAD SCI USA, V94, P532, DOI 10.1073/pnas.94.2.532; Santilli G, 2001, ONCOGENE, V20, P8167, DOI 10.1038/sj.onc.1204943; Saville MK, 1998, ONCOGENE, V17, P2679, DOI 10.1038/sj.onc.1202503; Sitzmann J, 1996, ONCOGENE, V12, P1889; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0; Watanabe H, 1998, P NATL ACAD SCI USA, V95, P1392, DOI 10.1073/pnas.95.4.1392; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Ziebold U, 1997, CURR BIOL, V7, P253, DOI 10.1016/S0960-9822(06)00121-7	39	25	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44255	44264		10.1074/jbc.M308953200	http://dx.doi.org/10.1074/jbc.M308953200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947099	hybrid			2022-12-27	WOS:000186306700046
J	Mendez, CF; Leibiger, IB; Leibiger, B; Hoy, M; Gromada, J; Berggren, PO; Bertorello, AM				Mendez, CF; Leibiger, IB; Leibiger, B; Hoy, M; Gromada, J; Berggren, PO; Bertorello, AM			Rapid association of protein kinase C-epsilon with insulin granules is essential for insulin exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; SIGNAL-TRANSDUCTION; GLUCOSE; TRANSLOCATION; LOCALIZATION; SECRETION; ISLETS; TRANSCRIPTION; STIMULATION; ACTIVATION	Glucose-dependent exocytosis of insulin requires activation of protein kinase C (PKC). However, because of the great variety of isoforms and their ubiquitous distribution within the beta-cell, it is difficult to predict the importance of a particular isoform and its mode of action. Previous data revealed that two PKC isoforms (alpha and epsilon) translocate to membranes in response to glucose (Zaitzev, S.V., Efendic, S., Arkhammar, P., Bertorello, A.M., and Berggren, P. O. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 9712-9716). Using confocal microscopy, we have now established that in response to glucose, PKC-epsilon but not PKC-alpha associates with insulin granules and that green fluorescent protein-tagged PKC-epsilon changes its distribution within the cell periphery upon stimulation of beta-cells with glucose. Definite evidence of PKC-epsilon requirement during insulin granule exocytosis was obtained by using a dominant negative mutant of this isoform. The presence of this mutant abolished glucose-induced insulin secretion, whereas transient expression of the wildtype PKC-epsilon led to a significant increase in insulin exocytosis. These results suggest that association of PKC-epsilon with insulin granule membranes represents an important component of the secretory network because it is essential for insulin exocytosis in response to glucose.	Karolinska Hosp, Karolinska Inst, Dept Mol Med, Rolf Luft Ctr Diabet Res, SE-17176 Stockholm, Sweden; Univ Buenos Aires, Fac Med, Dept Bioquim Humana, Buenos Aires, DF, Argentina; Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark	Karolinska Institutet; Karolinska University Hospital; University of Buenos Aires; Novo Nordisk	Berggren, PO (corresponding author), Karolinska Hosp, Karolinska Inst, Dept Mol Med, Rolf Luft Ctr Diabet Res, SE-17176 Stockholm, Sweden.			Mendez, Carlos Fernando/0000-0002-9659-1866; Berggren, Per-Olof/0000-0001-8991-413X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058508] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-58508] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363; Eliasson L, 1996, SCIENCE, V271, P813, DOI 10.1126/science.271.5250.813; GANESAN S, 1992, J CELL BIOL, V119, P313, DOI 10.1083/jcb.119.2.313; GANESAN S, 1990, P NATL ACAD SCI USA, V87, P9893, DOI 10.1073/pnas.87.24.9893; Jones PM, 1998, ENDOCR REV, V19, P429, DOI 10.1210/er.19.4.429; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Leibiger B, 1998, P NATL ACAD SCI USA, V95, P9307, DOI 10.1073/pnas.95.16.9307; LERNMARK A, 1974, DIABETOLOGIA, V10, P431, DOI 10.1007/BF01221634; MARTELL AE, 1971, CRITICAL STABILITY C, V2; MARTELL AE, 1971, CRITICAL STABILITY C, V1; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Moede T, 1999, FEBS LETT, V461, P229, DOI 10.1016/S0014-5793(99)01446-5; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; NILSSON T, 1987, BIOCHEM J, V248, P329, DOI 10.1042/bj2480329; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Pinton P, 2002, J BIOL CHEM, V277, P37702, DOI 10.1074/jbc.M204478200; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Vaaraniemi J, 1999, J CELL PHYSIOL, V181, P83, DOI 10.1002/(SICI)1097-4652(199910)181:1<83::AID-JCP9>3.0.CO;2-G; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; ZAITSEV SV, 1995, P NATL ACAD SCI USA, V92, P9712, DOI 10.1073/pnas.92.21.9712	21	57	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44753	44757		10.1074/jbc.M308664200	http://dx.doi.org/10.1074/jbc.M308664200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941947	hybrid			2022-12-27	WOS:000186306700109
J	Schmidt, A; Jelsch, C; Ostergaard, P; Rypniewski, W; Lamzin, VS				Schmidt, A; Jelsch, C; Ostergaard, P; Rypniewski, W; Lamzin, VS			Trypsin revisited crystallography at (sub) atomic resolution and quantum chemistry revealing details of catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARRIER HYDROGEN-BONDS; X-RAY-STRUCTURE; DENSITY PARAMETERS; PROTEIN-STRUCTURE; DIFFRACTION DATA; WATER MOLECULE; ACYL-ENZYME; SERINE; BINDING; REFINEMENT	A series of crystal structures of trypsin, containing either an autoproteolytic cleaved peptide fragment or a covalently bound inhibitor, were determined at atomic and ultra-high resolution and subjected to ab initio quantum chemical calculations and multipole refinement. Quantum chemical calculations reproduced the observed active site crystal structure with severe deviations from standard stereochemistry and indicated the protonation state of the catalytic residues. Multipole refinement directly revealed the charge distribution in the active site and proved the validity of the ab initio calculations. The combined results confirmed the catalytic function of the active site residues and the two water molecules acting as the nucleophile and the proton donor. The crystal structures represent snapshots from the reaction pathway, close to a tetrahedral intermediate. The de-acylation of trypsin then occurs in true S(N)2 fashion.	DESY, European Mol Biol Lab, D-22607 Hamburg, Germany; Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland; DESY, Inst Biochem & Mol Biol, Univ Hosp, D-22603 Hamburg, Germany; UHP, Fac Sci, LCM3B CNRS, Lab Cristallog & Modelisat Mat Mineraux & Biol, F-54506 Vandoeuvre Les Nancy, France; Novozymes Prot Design, DK-2880 Bagsvaerd, Denmark	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; Universite de Lorraine; Novozymes	Schmidt, A (corresponding author), DESY, European Mol Biol Lab, D-22607 Hamburg, Germany.	andrea@embl-hamburg.de	Rypniewski, Wojciech/W-5330-2018	Rypniewski, Wojciech/0000-0002-6097-5518; jelsch, christian/0000-0002-2655-0313; Lamzin, Victor/0000-0002-6058-7793				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brandsdal BO, 2001, PROTEIN SCI, V10, P1584, DOI 10.1110/ps.940101; CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219; Cleland WW, 1998, J BIOL CHEM, V273, P25529, DOI 10.1074/jbc.273.40.25529; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fokine A, 2002, ACTA CRYSTALLOGR D, V58, P1387, DOI 10.1107/S0907444902010284; FREY PA, 1994, SCIENCE, V264, P1927, DOI 10.1126/science.7661899; HANSEN NK, 1978, ACTA CRYSTALLOGR A, V34, P909, DOI 10.1107/S0567739478001886; Jelsch C, 1998, ACTA CRYSTALLOGR D, V54, P1306, DOI 10.1107/S0907444998004466; Katona G, 2002, J BIOL CHEM, V277, P21962, DOI 10.1074/jbc.M200676200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lamzin VS, 1999, J BIOL CHEM, V274, P20753, DOI 10.1074/jbc.274.30.20753; Lin J, 1998, BIOCHEMISTRY-US, V37, P11940, DOI 10.1021/bi980278s; Lu WY, 1997, J MOL BIOL, V266, P441, DOI 10.1006/jmbi.1996.0781; MARQUART M, 1983, ACTA CRYSTALLOGR B, V39, P480, DOI 10.1107/S010876818300275X; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Meijers R, 2001, J BIOL CHEM, V276, P9316, DOI 10.1074/jbc.M010870200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otlewski J, 2001, ACTA BIOCHIM POL, V48, P419; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pal D, 2002, ANGEW CHEM INT EDIT, V41, P4663, DOI 10.1002/anie.200290009; PERONA JJ, 1993, SCIENCE, V261, P620, DOI 10.1126/science.8342029; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PICHONPESME V, 1995, J PHYS CHEM-US, V99, P6242, DOI 10.1021/j100016a071; RYPNIEWSKI WR, 1993, PROTEIN ENG, V6, P341, DOI 10.1093/protein/6.4.341; Rypniewski WR, 2001, ACTA CRYSTALLOGR D, V57, P8, DOI 10.1107/S0907444900014116; Schiott B, 1998, P NATL ACAD SCI USA, V95, P12799, DOI 10.1073/pnas.95.22.12799; Schmidt A, 2002, CURR OPIN STRUC BIOL, V12, P698, DOI 10.1016/S0959-440X(02)00394-9; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; SINGER PT, 1993, SCIENCE, V259, P669, DOI 10.1126/science.8430314; Talhout R, 2001, EUR J BIOCHEM, V268, P1554, DOI 10.1046/j.1432-1327.2001.01991.x; Topf M, 2002, PROTEINS, V47, P357, DOI 10.1002/prot.10097; Tronrud DE, 1997, METHOD ENZYMOL, V277, P306, DOI 10.1016/S0076-6879(97)77017-4; TSILIKOUNAS E, 1992, BIOCHEMISTRY-US, V31, P12839, DOI 10.1021/bi00166a019; WARSHEL A, 1995, SCIENCE, V269, P102, DOI 10.1126/science.7661987; Wilmouth RC, 2001, NAT STRUCT BIOL, V8, P689, DOI 10.1038/90401	37	59	60	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43357	43362		10.1074/jbc.M306944200	http://dx.doi.org/10.1074/jbc.M306944200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12937176	hybrid			2022-12-27	WOS:000186157000079
J	Shimizu, S; Ugi, S; Maegawa, H; Egawa, K; Nishio, Y; Yoshizaki, T; Shi, K; Nagai, Y; Morino, K; Nemoto, K; Nakamura, T; Bryer-Ash, M; Kashiwagi, A				Shimizu, S; Ugi, S; Maegawa, H; Egawa, K; Nishio, Y; Yoshizaki, T; Shi, K; Nagai, Y; Morino, K; Nemoto, K; Nakamura, T; Bryer-Ash, M; Kashiwagi, A			Protein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN SENSITIVITY; RESISTANCE; MICE; PATHWAY; GLUCOSE; LIVERS; SP1; 2A; PHOSPHORYLATION; OVEREXPRESSION	Like hyperglycemia, postprandial (diet-induced) hypertriglyceridemia is thought to play crucial roles in the pathogenesis of insulin resistant/metabolic syndrome. Sterol regulatory element-binding protein-1 (SREBP-1) is a key transcription factor to induce postprandial hypertriglyceridemia. We found that insulin-resistant rats fed a diet high in fructose showed an increased protein-tyrosine phosphatase 1B (PTP1B) content with strong expression of SREBP-1 mRNA in the liver. To clarify the association of PTP1B with SREBP-1 gene expression, we overexpressed PTP1B in rat hepatocytes, which led to increased mRNA content and promoter activity of SREBP-1a and -1c, resulting in the increased mRNA expression of fatty-acid synthase, one of the SREBP-1-responsive lipogenic genes. Because PTP1B overexpression increased phosphatase 2A (PP2A) activity, we inhibited PP2A activity by expression of its selective inhibitor, SV40 small t antigen and found that this normalized the PTP1B-enhanced SREBP-1a and -1c mRNA expressions through activation of the Sp1 site. These results indicate that PTP1B may regulate gene expression of SREBP-1 via enhancement of PP2A activity, thus mediating hepatic lipogenesis and postprandial hypertriglyceridemia. We demonstrate here a unique serial activation of the PTP1B-PP2A axis as a novel mechanism for the regulation of gene expression in the biosynthesis of triglyceride.	Shiga Univ Med Sci, Dept Med, Div Endocrinol & Metab, Shiga 5202192, Japan; Shiga Univ Med Sci, Dept Anat, Shiga 5202192, Japan; Univ Calif Los Angeles, Dept Med, Div Endocrinol Diabet & Hypertens, Gonda Goldschmied Diabet Ctr, Los Angeles, CA 90095 USA; W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90095 USA	Shiga University of Medical Science; Shiga University of Medical Science; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Maegawa, H (corresponding author), Shiga Univ Med Sci, Dept Med, Div Endocrinol & Metab, Shiga 5202192, Japan.		MORINO, KATSUTARO/I-3207-2019	MORINO, KATSUTARO/0000-0003-2420-3817; Maegawa, Hiroshi/0000-0002-4611-8149				Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; CHEN J, 1994, J BIOL CHEM, V269, P7957; Cheng A, 2002, EUR J BIOCHEM, V269, P1050, DOI 10.1046/j.0014-2956.2002.02756.x; Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148; Di Paola R, 2002, AM J HUM GENET, V70, P806, DOI 10.1086/339270; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Egawa K, 2001, J BIOL CHEM, V276, P10207, DOI 10.1074/jbc.M009489200; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Lacroix I, 2002, J BIOL CHEM, V277, P9598, DOI 10.1074/jbc.M111444200; MAEGAWA H, 1995, J BIOL CHEM, V270, P7724, DOI 10.1074/jbc.270.13.7724; Miserez AR, 1997, GENOMICS, V40, P31, DOI 10.1006/geno.1996.4525; Nagai Y, 2002, AM J PHYSIOL-ENDOC M, V282, pE1180, DOI 10.1152/ajpendo.00471.2001; Obata T, 1998, J BIOCHEM-TOKYO, V123, P813; Rondinone CM, 2002, DIABETES, V51, P2405, DOI 10.2337/diabetes.51.8.2405; Samson SLA, 2002, J MOL ENDOCRINOL, V29, P265, DOI 10.1677/jme.0.0290265; Sekine O, 2002, J BIOL CHEM, V277, P36631, DOI 10.1074/jbc.M206266200; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Shimizu S, 2002, ENDOCRINOLOGY, V143, P4563, DOI 10.1210/en.2002-220517; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Tobe K, 2001, J BIOL CHEM, V276, P38337, DOI 10.1074/jbc.C100160200; Ugi S, 2002, MOL CELL BIOL, V22, P2375, DOI 10.1128/MCB.22.7.2375-2387.2002; Wang J, 2001, DIABETES OBES METAB, V3, P367, DOI 10.1046/j.1463-1326.2001.00173.x; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	32	65	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43095	43101		10.1074/jbc.M306880200	http://dx.doi.org/10.1074/jbc.M306880200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12941932	hybrid			2022-12-27	WOS:000186157000048
J	Kubiak, TM; Larsen, MJ; Zantello, MR; Bowman, JW; Nulf, SC; Lowery, DE				Kubiak, TM; Larsen, MJ; Zantello, MR; Bowman, JW; Nulf, SC; Lowery, DE			Functional annotation of the putative orphan Caenorhabditis elegans G-protein-coupled receptor C10C6.2 as a FLP15 peptide receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FMRFAMIDE-RELATED PEPTIDES; DROSOPHILA-MELANOGASTER; NEUROPEPTIDES; IDENTIFICATION; CLONING; ALLATOSTATINS; RFAMIDE; LIGANDS; FAMILY; FARPS	This report describes the cloning and functional annotation of a Caenorhabditis elegans orphan G-protein-coupled receptor (GPCR) (C10C6.2) as a receptor for the FMRFamide-related peptides (FaRPs) encoded on the flp15 precursor gene, leading to the receptor designation FLP15-R. A cDNA encoding C10C6.2 was obtained using PCR techniques, confirmed identical to the Worm-pep-predicted sequence, and cloned into a vector appropriate for eucaryotic expression. A [S-35]guanosine 5'-O-(thiotriphosphate) (GTPgammaS) assay with membranes prepared from Chinese hamster ovary (CHO) cells transiently transfected with FLP15-R was used as a read-out for receptor activation. FLP15-R was activated by putative FLP15 peptides, GGPQGPLRF-NH2 (FLP15-1), RG-PSGPLRF-NH2 (FLP15-2A), its des-Arg(1) counterpart, GPSGPLRF-NH2 (FLP15-2B), and to a lesser extent, by a tobacco hornworm Manduca sexta FaRP, GNSFLRF-NH2 (F7G) (potency ranking FLP15-2A > FLP15-1 > FLP15-2B >> F7G). FLP15-R activation was abolished in the transfected cells pretreated with pertussis toxin, suggesting a preferential receptor coupling to G(i)/G(o) proteins. The functional expression of FLP15-R in mammalian cells was temperature-dependent. Either no stimulation or significantly lower ligand-evoked [S-35]GTPgammaS binding was observed in membranes prepared from transfected FLP15-R/CHO cells cultured at 37 degreesC. However, a 37 to 28 degreesC temperature shift implemented 24 h post-transfection consistently resulted in an improved activation signal and was essential for detectable functional expression of FLP15-R in CHO cells. To our knowledge, the FLP15 receptor is only the second deorphanized C. elegans neuropeptide GPCR reported to date.	Pharmacia Corp, Anim Hlth Discovery Res, Kalamazoo, MI 49001 USA	Pfizer	Kubiak, TM (corresponding author), Pfizer Inc, Vet Med R&D, 7000 Portage Rd, Kalamazoo, MI 49001 USA.	teresa.m.kubiak@pfizer.com		Lowery, David/0000-0001-5111-4719				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ausubel FM, 1991, CURRENT PROTOCOLS MO; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Belles X, 1999, PEPTIDES, V20, P11, DOI 10.1016/S0196-9781(98)00155-7; Brownlee DJA, 1996, PARASITOL TODAY, V12, P343, DOI 10.1016/0169-4758(96)10052-1; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Civelli O, 2001, TRENDS NEUROSCI, V24, P230, DOI 10.1016/S0166-2236(00)01763-X; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; COWDEN C, 1995, PEPTIDES, V16, P491, DOI 10.1016/0196-9781(94)00211-N; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; DOCKRAY GJ, 1986, REGUL PEPTIDES, V16, P27, DOI 10.1016/0167-0115(86)90192-8; Espinoza E, 2000, MOL NEUROBIOL, V21, P35; Fujisawa Y, 1999, J NEUROSCI, V19, P9618; Furukawa Y, 2001, J NEUROSCI, V21, P8247, DOI 10.1523/JNEUROSCI.21-20-08247.2001; Geary TG, 1999, ANN NY ACAD SCI, V897, P212, DOI 10.1111/j.1749-6632.1999.tb07893.x; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GREENBERG MJ, 1992, PROG BRAIN RES, V92, P25, DOI 10.1016/S0079-6123(08)61162-0; HALTON DW, 1994, ADV PARASIT, V34, P163, DOI 10.1016/S0065-308X(08)60139-6; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Kingan TG, 1997, MOL CELL ENDOCRINOL, V133, P19, DOI 10.1016/S0303-7207(97)00140-8; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kubiak TM, 2003, J BIOL CHEM, V278, P33724, DOI 10.1074/jbc.M304861200; Kubiak TM, 2002, BIOCHEM BIOPH RES CO, V291, P313, DOI 10.1006/bbrc.2002.6459; KUBIAK TM, 2002, PEPTIDES 2002, P540; Larsen MJ, 2001, BIOCHEM BIOPH RES CO, V286, P895, DOI 10.1006/bbrc.2001.5476; Lenz C, 2000, BIOCHEM BIOPH RES CO, V273, P1126, DOI 10.1006/bbrc.2000.3062; Lenz C, 2001, BIOCHEM BIOPH RES CO, V286, P1117, DOI 10.1006/bbrc.2001.5475; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Maule AG, 1996, PARASITOLOGY, V113, pS119, DOI 10.1017/S0031182000077933; Maule AG, 1996, INT J PARASITOL, V26, P927, DOI 10.1016/S0020-7519(96)80066-X; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Nelson LS, 1998, MOL BRAIN RES, V58, P103, DOI 10.1016/S0169-328X(98)00106-5; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PRICE DA, 1989, BIOL BULL, V177, P198, DOI 10.2307/1541933; Shaw C, 1996, INT J PARASITOL, V26, P335, DOI 10.1016/0020-7519(96)00012-4; Siehler S, 1999, N-S ARCH PHARMACOL, V360, P500, DOI 10.1007/s002109900142; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; WALKER RJ, 1992, COMP BIOCHEM PHYS C, V102, P213, DOI 10.1016/0742-8413(92)90104-F; YANG HYT, 1985, P NATL ACAD SCI USA, V82, P7757, DOI 10.1073/pnas.82.22.7757	41	41	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2003	278	43					42115	42120		10.1074/jbc.M304056200	http://dx.doi.org/10.1074/jbc.M304056200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FP	12937167	hybrid			2022-12-27	WOS:000185989500069
J	Heddle, J; Scott, DJ; Unzai, S; Park, SY; Tame, JRH				Heddle, J; Scott, DJ; Unzai, S; Park, SY; Tame, JRH			Crystal structures of the liganded and unliganded nickel-binding protein NikA from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TREPONEMA-PALLIDUM TROA; PERIPLASMIC RECEPTORS; TRANSPORT; AFFINITY; OPPA; METALLOCHAPERONE; SPECIFICITY; CHEMOTAXIS; MUTANTS; REVEALS	Bacteria have evolved a number of tightly controlled import and export systems to maintain intracellular levels of the essential but potentially toxic metal nickel. Nickel homeostasis systems include the dedicated nickel uptake system nik found in Escherichia coli, a member of the ABC family of transporters, that involves a periplasmic nickel-binding protein, NikA. This is the initial nickel receptor and mediator of the chemotactic response away from nickel. We have solved the crystal structure of NikA protein in the presence and absence of nickel, showing that it behaves as a "classical" periplasmic binding protein. In contrast to other binding proteins, however, the ligand remains accessible to the solvent and is not completely enclosed. No direct bonds are formed between the metal cation and the protein. The nickel binding site is apolar, quite unlike any previously characterized protein nickel binding site. Despite relatively weak binding, NikA is specific for nickel. Using isothermal titration calorimetry, the dissociation constant for nickel was found to be similar to 10 muM and that for cobalt was approximately 20 times higher.	Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 2300045, Japan; Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England	Yokohama City University; University of Bristol	Tame, JRH (corresponding author), Yokohama City Univ, Prot Design Lab, Suehiro 1-7-29, Yokohama, Kanagawa 2300045, Japan.	jtame@tsurumi.yokohama-cu.ac.jp	Heddle, Jonathan/AAP-7167-2020; Heddle, Jonathan G/H-4586-2014	Scott, David/0000-0002-6726-2078				ANKE M, 1984, IARC SCI PUBL, P339; BABICH H, 1983, ADV APPL MICROBIOL, V29, P195, DOI 10.1016/S0065-2164(08)70358-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benini S, 1999, STRUCTURE, V7, P205, DOI 10.1016/S0969-2126(99)80026-4; Carrington PE, 2003, NAT STRUCT BIOL, V10, P126, DOI 10.1038/nsb890; Chivers PT, 2000, J BIOL CHEM, V275, P19735, DOI 10.1074/jbc.M002232200; Chivers PT, 2002, CHEM BIOL, V9, P1141, DOI 10.1016/S1074-5521(02)00241-7; Claverys JP, 2001, RES MICROBIOL, V152, P231, DOI 10.1016/S0923-2508(01)01195-0; Clugston SL, 1998, BIOCHEMISTRY-US, V37, P8754, DOI 10.1021/bi972791w; Davies TG, 1999, PROTEIN SCI, V8, P1432, DOI 10.1110/ps.8.7.1432; De Lorimier RM, 2002, PROTEIN SCI, V11, P2655, DOI 10.1110/ps.021860; De Pina K, 1999, J BACTERIOL, V181, P670, DOI 10.1128/JB.181.2.670-674.1999; Deng X, 2003, WATER RES, V37, P2505, DOI 10.1016/S0043-1354(03)00027-7; DEPINA K, 1995, EUR J BIOCHEM, V227, P857; Eitinger T, 1997, J BIOL CHEM, V272, P17139, DOI 10.1074/jbc.272.27.17139; Foote J, 2000, P NATL ACAD SCI USA, V97, P978, DOI 10.1073/pnas.97.3.978; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Grass G, 2001, J BACTERIOL, V183, P2803, DOI 10.1128/JB.183.9.2803-2807.2001; HAUSINGER RP, 1987, MICROBIOL REV, V51, P22, DOI 10.1128/MMBR.51.1.22-42.1987; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Kobayashi M, 1999, EUR J BIOCHEM, V261, P1, DOI 10.1046/j.1432-1327.1999.00186.x; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Lawson DM, 1998, STRUCTURE, V6, P1529, DOI 10.1016/S0969-2126(98)00151-8; Ledvina PS, 1996, P NATL ACAD SCI USA, V93, P6786, DOI 10.1073/pnas.93.13.6786; Lee YH, 2002, J BACTERIOL, V184, P2300, DOI 10.1128/JB.184.8.2300-2304.2002; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; Linton KJ, 1998, MOL MICROBIOL, V28, P5, DOI 10.1046/j.1365-2958.1998.00764.x; MAIER T, 1993, J BACTERIOL, V175, P630, DOI 10.1128/JB.175.3.630-635.1993; Maroney MJ, 1999, CURR OPIN CHEM BIOL, V3, P188, DOI 10.1016/S1367-5931(99)80032-5; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; NAVARRO C, 1993, MOL MICROBIOL, V9, P1181, DOI 10.1111/j.1365-2958.1993.tb01247.x; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Nickitenko AV, 1995, BIOCHEMISTRY-US, V34, P16585, DOI 10.1021/bi00051a006; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Remaut H, 2001, J BIOL CHEM, V276, P49365, DOI 10.1074/jbc.M108304200; Roussel A., 1989, SILICON GRAPHICS GEO; Salins LLE, 2002, ANAL BIOANAL CHEM, V372, P174, DOI 10.1007/s00216-001-1169-7; SCHMIDT T, 1994, J BACTERIOL, V176, P7045, DOI 10.1128/JB.176.22.7045-7054.1994; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Shilton BH, 1996, J MOL BIOL, V264, P350, DOI 10.1006/jmbi.1996.0645; SILHAVY TJ, 1975, P NATL ACAD SCI USA, V72, P2120, DOI 10.1073/pnas.72.6.2120; Sleigh SH, 1997, BIOCHEMISTRY-US, V36, P9747, DOI 10.1021/bi970457u; Song HK, 2001, J BIOL CHEM, V276, P49359, DOI 10.1074/jbc.M108619200; STOCK JB, 1977, J BIOL CHEM, V252, P7850; SUTCLIFFE IC, 1995, J BACTERIOL, V177, P1123, DOI 10.1128/jb.177.5.1123-1128.1995; Tame JRH, 1995, STRUCTURE, V3, P1395, DOI 10.1016/S0969-2126(01)00276-3; Tame JRH, 1996, NAT STRUCT BIOL, V3, P998, DOI 10.1038/nsb1296-998; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Uthus EO, 1996, BIOL TRACE ELEM RES, V52, P23, DOI 10.1007/BF02784087; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; VANWIELINK JE, 1990, TRENDS BIOCHEM SCI, V15, P136, DOI 10.1016/0968-0004(90)90208-S; Watt RK, 1999, CELL MOL LIFE SCI, V56, P604, DOI 10.1007/s000180050456; Wolfram L, 2002, J BACTERIOL, V184, P1438, DOI 10.1128/JB.184.5.1438-1443.2002; WOLFRAM L, 1995, J BACTERIOL, V177, P1840, DOI 10.1128/jb.177.7.1840-1843.1995; WU LF, 1989, MOL MICROBIOL, V3, P1709, DOI 10.1111/j.1365-2958.1989.tb00156.x; WU LF, 1991, GENE, V107, P37; WU LF, 1986, BIOCHIMIE, V68, P167, DOI 10.1016/S0300-9084(86)81081-1	64	62	65	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2003	278	50					50322	50329		10.1074/jbc.M307941200	http://dx.doi.org/10.1074/jbc.M307941200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751LH	12960164	hybrid			2022-12-27	WOS:000187068200081
J	Dietrich, A; Schnitzler, MMY; Emmel, J; Kalwa, H; Hofmann, T; Gudermann, T				Dietrich, A; Schnitzler, MMY; Emmel, J; Kalwa, H; Hofmann, T; Gudermann, T			N-linked protein glycosylation is a major determinant for basal TRPC3 and TRPC6 channel activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR POTENTIAL CHANNELS; CAPACITATIVE CA2+ ENTRY; CA2+-PERMEABLE CATION CHANNEL; MOUSE TRANSIENT RECEPTOR; CALCIUM-ENTRY; EXPRESSION; CELLS; ACTIVATION; CURRENTS; CLONING	The TRPC family of receptor-activated cation channels ( TRPC channels) can be subdivided into four subfamilies based on sequence homology as well as functional similarities. Members of the TRPC3/6/7 subfamily share common biophysical characteristics and are activated by diacylglycerol in a membrane-delimited manner. At present, it is only poorly understood whether members of the TRPC3/6/7 subfamily are functionally redundant or whether they serve distinct cellular roles. By electrophysiological and fluorescence imaging strategies we show that TRPC3 displays considerable constitutive activity, while TRPC6 is a tightly regulated channel. To identify potential molecular correlates accounting for the functional difference, we analyzed the glycosylation pattern of TRPC6 compared with TRPC3. Two NX(S/T) motifs in TRPC6 were mutated (Asn to Gln) by in vitro mutagenesis to delete one or both extracellular N-linked glycosylation sites. Immunoblotting analysis of HEK 293 cell lysates expressing TRPC6 wild type and mutants favors a model of TRPC6 that is dually glycosylated within the first (e1) and second extracelluar loop (e2) as opposed to the monoglycosylated TRPC3 channel (Vannier, B., Zhu, X., Brown, D., and Birnbaumer, L. (1998) J. Biol. Chem. 273, 8675 - 8679). Elimination of the e2 glycosylation site, missing in the monoglycosylated TRPC3, was sufficient to convert the tightly receptor-regulated TRPC6 into a constitutively active channel, displaying functional characteristics of TRPC3. Reciprocally, engineering of an additional second glycosylated site in TRPC3 to mimic the glycosylation status in TRPC6 markedly reduced TRPC3 basal activity. We conclude that the glycosylation pattern plays a pivotal role for the tight regulation of TRPC6 through phospholipase C-activating receptors.	Univ Marburg, Inst Pharmakol & Toxikol, D-35033 Marburg, Germany	Philipps University Marburg	Gudermann, T (corresponding author), Univ Marburg, Inst Pharmakol & Toxikol, Karl von Frisch Str 1, D-35033 Marburg, Germany.	guderman@staff.uni-marburg.de	Kalwa, Hermann/ABG-2323-2021; Dietrich, Alexander/G-8619-2013	Dietrich, Alexander/0000-0002-1168-8707				Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Birnbaumer L, 2000, RECENT PROG HORM RES, V55, P127; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; FOZZARD HA, 2002, SCI STKE 2002, pE19; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Garcia RL, 1997, BIOCHEM BIOPH RES CO, V239, P279, DOI 10.1006/bbrc.1997.7458; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Hofmann T, 2000, BIOCHEM J, V351, P115, DOI 10.1042/0264-6021:3510115; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hurst RS, 1998, FEBS LETT, V422, P333, DOI 10.1016/S0014-5793(98)00035-0; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Jung S, 2002, AM J PHYSIOL-CELL PH, V282, pC347, DOI 10.1152/ajpcell.00283.2001; Khanna R, 2001, J BIOL CHEM, V276, P34028, DOI 10.1074/jbc.M105248200; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; McKay RR, 2000, BIOCHEM J, V351, P735, DOI 10.1042/0264-6021:3510735; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Putney JW, 2001, J CELL SCI, V114, P2223; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Trevino CL, 2001, FEBS LETT, V509, P119, DOI 10.1016/S0014-5793(01)03134-9; Vannier B, 1998, J BIOL CHEM, V273, P8675, DOI 10.1074/jbc.273.15.8675; Welsh DG, 2002, CIRC RES, V90, P248, DOI 10.1161/hh0302.105662; Wu XY, 2000, AM J PHYSIOL-CELL PH, V278, pC526, DOI 10.1152/ajpcell.2000.278.3.C526; Yu Y, 2003, AM J PHYSIOL-CELL PH, V284, pC316, DOI 10.1152/ajpcell.00125.2002; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	36	154	164	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47842	47852		10.1074/jbc.M302983200	http://dx.doi.org/10.1074/jbc.M302983200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12970363	hybrid			2022-12-27	WOS:000186731400061
J	Gusarova, V; Brodsky, JL; Fisher, EA				Gusarova, V; Brodsky, JL; Fisher, EA			Apolipoprotein B100 exit from the endoplasmic reticulum (ER) is COPII-dependent, and its lipidation to very low density lipoprotein occurs post-ER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY SECRETORY PATHWAY; TRANSPORT VESICLES; MCA-RH7777 CELLS; TRANSFER PROTEIN; RAT HEPATOCYTES; B DEGRADATION; APO-B; MEMBRANE; TRANSLOCATION; APOPROTEIN	Hepatic apolipoprotein B100 (apoB100) associates with lipids to form dense lipoprotein particles in the endoplasmic reticulum (ER) and is further lipidated to very low density lipoproteins ( VLDL). Because the VLDL diameter can exceed 200 nm, classical ER-derived vesicles may be unable to accommodate VLDLs. Using hepatic membranes and cytosol to reconstitute ER budding, apoB100-containing vesicles sedimented distinct from those harboring more typical cargo but contained Sec23. Moreover, ER exit of apoB was inhibited by dominant-negative Sar1. Budding required Sar1 regardless of whether oleic acid (OA) was added to stimulate apoB lipidation; therefore, either large apoB100-lipoproteins reside in secretory vesicles, or full lipidation occurs post-ER. Using membranes from cells incubated in the presence or absence of OA, we determined that apoB100-lipoproteins in ER vesicles had not become lipidated to VLDLs. VLDL particles resided in the Golgi, but not the ER, after fractionation of OA-treated cells. We conclude that apoB100-lipoproteins exit the ER in COPII vesicles, but under conditions favorable for VLDL formation final lipid loading occurs post-ER.	CUNY Mt Sinai Sch Med, Dept Med & Biochem, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Mol Biol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Cardiovasc Inst, New York, NY 10029 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fisher, EA (corresponding author), CUNY Mt Sinai Sch Med, Dept Med & Biochem, Box 1269,1 Gustave Levy Pl, New York, NY 10029 USA.	edward.fisher@mssm.edu	Fisher, Edward/ABE-7469-2020; Adiels, Martin/C-9278-2011		NHLBI NIH HHS [HL58541] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058541] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALEXANDER CA, 1976, J CELL BIOL, V69, P241, DOI 10.1083/jcb.69.2.241; Asp L, 2000, J BIOL CHEM, V275, P26285, DOI 10.1074/jbc.M003520200; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; BAMBERGER MJ, 1990, P NATL ACAD SCI USA, V87, P2390, DOI 10.1073/pnas.87.7.2390; Barlowe C, 2000, TRAFFIC, V1, P371, DOI 10.1034/j.1600-0854.2000.010501.x; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4; Bonifacino J. S., 1998, CURRENT PROTOCOLS CE; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; BOREN J, 1994, J BIOL CHEM, V269, P25879; Cartwright IJ, 2001, J BIOL CHEM, V276, P48048, DOI 10.1074/jbc.M104229200; DAVIS RA, 1990, J BIOL CHEM, V265, P10005; Du XB, 1998, J CELL BIOL, V141, P585, DOI 10.1083/jcb.141.3.585; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gusarova V, 2001, J BIOL CHEM, V276, P24891, DOI 10.1074/jbc.M100633200; HIGGINS JA, 1988, FEBS LETT, V232, P405, DOI 10.1016/0014-5793(88)80780-4; Ingram MF, 1996, J LIPID RES, V37, P2202; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Kummrow E, 2002, J LIPID RES, V43, P2155, DOI 10.1194/jlr.M200249-JLR200; Liang JS, 2000, J BIOL CHEM, V275, P32003, DOI 10.1074/jbc.M004646200; LIN YG, 1995, BBA-LIPID LIPID MET, V1256, P88, DOI 10.1016/0005-2760(95)00006-X; Mitchell DM, 1998, P NATL ACAD SCI USA, V95, P14733, DOI 10.1073/pnas.95.25.14733; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Rowe T, 1996, J CELL BIOL, V135, P895, DOI 10.1083/jcb.135.4.895; RUSINOL A, 1993, J BIOL CHEM, V268, P3555; Schekman R, 1997, CELL, V90, P197, DOI 10.1016/S0092-8674(00)80326-8; Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973; Siddiqi SA, 2003, J CELL SCI, V116, P415, DOI 10.1242/jcs.00215; Stephens DJ, 2002, J CELL SCI, V115, P1149; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Tran K, 2002, J BIOL CHEM, V277, P31187, DOI 10.1074/jbc.M200249200; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x; Xu Y, 1998, J BIOL CHEM, V273, P21783, DOI 10.1074/jbc.273.34.21783; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200	42	104	106	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48051	48058		10.1074/jbc.M306898200	http://dx.doi.org/10.1074/jbc.M306898200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12960170	hybrid			2022-12-27	WOS:000186731400084
J	Kirchner, U; Westphal, AH; Muller, R; van Berkel, WJH				Kirchner, U; Westphal, AH; Muller, R; van Berkel, WJH			Phenol hydroxylase from Bacillus thermoglucosidasius A7, a two-protein component monooxygenase with a dual role for FAD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYBENZOATE HYDROXYLASE; ARCHAEON ARCHAEOGLOBUS-FULGIDUS; NADPH-FMN OXIDOREDUCTASE; FLAVIN-REDUCTASE-P; ESCHERICHIA-COLI; NAD(P)H-FLAVIN OXIDOREDUCTASE; PSEUDOMONAS-FLUORESCENS; CRYSTAL-STRUCTURE; 4-HYDROXYPHENYLACETATE 3-MONOOXYGENASE; SUBSTRATE-SPECIFICITY	A novel phenol hydroxylase (PheA) that catalyzes the first step in the degradation of phenol in Bacillus thermoglucosidasius A7 is described. The two-protein system, encoded by the pheA1 and pheA2 genes, consists of an oxygenase (PheA1) and a flavin reductase (PheA2) and is optimally active at 55 degreesC. PheA1 and PheA2 were separately expressed in recombinant Escherichia coli BL21 (DE3) pLysS cells and purified to apparent homogeneity. The pheA1 gene codes for a protein of 504 amino acids with a predicted mass of 57.2 kDa. PheA1 exists as a homodimer in solution and has no enzyme activity on its own. PheA1 catalyzes the efficient ortho-hydroxylation of phenol to catechol when supplemented with PheA2 and FAD/NADH. The hydroxylase activity is strictly FAD-dependent, and neither FMN nor riboflavin can replace FAD in this reaction. The pheA2 gene codes for a protein of 161 amino acids with a predicted mass of 17.7kDa. PheA2 is also a homodimer, with each subunit containing a highly fluorescent FAD prosthetic group. PheA2 catalyzes the NADH-dependent reduction of free flavins according to a Ping Pong Bi Bi mechanism. PheA2 is structurally related to ferric reductase, an NAD(P) H-dependent reductase from the hyperthermophilic Archaea Archaeoglobus fulgidus that catalyzes the flavin-mediated reduction of iron complexes. However, PheA2 displays no ferric reductase activity and is the first member of a newly recognized family of short-chain flavin reductases that use FAD both as a substrate and as a prosthetic group.	Univ Wageningen & Res Ctr, Biochem Lab, NL-6703 HA Wageningen, Netherlands; Tech Univ Hamburg, Dept Tech Biochem, D-21071 Hamburg, Germany	Wageningen University & Research; Hamburg University of Technology	van Berkel, WJH (corresponding author), Univ Wageningen & Res Ctr, Biochem Lab, Dreijenlaan 3, NL-6703 HA Wageningen, Netherlands.	willem.vanberkel@wur.nl	van Berkel, Willem J.H./O-2431-2014; Westphal, Adrie Herman/L-3517-2019	van Berkel, Willem J.H./0000-0002-6551-2782; Westphal, Adrie Herman/0000-0003-4264-6267				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARUNACHALAM U, 1994, J BIOL CHEM, V269, P150; ARUNACHALAM U, 1994, J BIOL CHEM, V269, P11795; ARUNACHALAM U, 1992, J BIOL CHEM, V267, P25848; Beltrametti F, 1997, APPL ENVIRON MICROB, V63, P2232, DOI 10.1128/AEM.63.6.2232-2239.1997; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Chiu HJ, 2001, STRUCTURE, V9, P311, DOI 10.1016/S0969-2126(01)00589-5; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; DEJONG E, 1992, EUR J BIOCHEM, V208, P651; DeLano W, 2002, PYMOL 0 99; Duffner FM, 2000, GENE, V256, P215, DOI 10.1016/S0378-1119(00)00352-8; Duffner FM, 1997, SYST APPL MICROBIOL, V20, P602, DOI 10.1016/S0723-2020(97)80032-X; Duffner FM, 1998, FEMS MICROBIOL LETT, V161, P37, DOI 10.1016/S0378-1097(98)00047-0; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Enroth C, 1998, STRUCTURE, V6, P605, DOI 10.1016/S0969-2126(98)00062-8; ENTSCH B, 1995, FASEB J, V9, P476, DOI 10.1096/fasebj.9.7.7737455; Eppink MHM, 1999, J MOL BIOL, V292, P87, DOI 10.1006/jmbi.1999.3015; Eppink MHM, 1997, J BACTERIOL, V179, P6680, DOI 10.1128/jb.179.21.6680-6687.1997; ESCHENBRENNER M, 1995, J BIOL CHEM, V270, P20550, DOI 10.1074/jbc.270.35.20550; Fieschi F, 1995, J BIOL CHEM, V270, P30392, DOI 10.1074/jbc.270.51.30392; Filisetti L, 2003, J BIOL CHEM, V278, P296, DOI 10.1074/jbc.M209689200; Fromm H J, 1979, Methods Enzymol, V63, P467; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; GATTI DL, 1994, SCIENCE, V266, P110, DOI 10.1126/science.7939628; Gray KA, 1996, NAT BIOTECHNOL, V14, P1705, DOI 10.1038/nbt1296-1705; GURUJEYALAKSHMI G, 1989, APPL ENVIRON MICROB, V55, P500, DOI 10.1128/AEM.55.2.500-502.1989; Habeeb A F, 1972, Methods Enzymol, V25, P457, DOI 10.1016/S0076-6879(72)25041-8; Hubner A, 1998, APPL ENVIRON MICROB, V64, P2086; Ingelman M, 1999, BIOCHEMISTRY-US, V38, P7040, DOI 10.1021/bi982849m; Jeffers CE, 2003, BIOCHEMISTRY-US, V42, P529, DOI 10.1021/bi026877n; Jeffers CE, 2001, BIOCHEMISTRY-US, V40, P1749, DOI 10.1021/bi0024310; KENDREW SG, 1995, J BIOL CHEM, V270, P17339, DOI 10.1074/jbc.270.29.17339; KIM IC, 1995, APPL ENVIRON MICROB, V61, P1252, DOI 10.1128/AEM.61.4.1252-1256.1995; Koike H, 1998, J MOL BIOL, V280, P259, DOI 10.1006/jmbi.1998.1871; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEI BF, 1994, J BACTERIOL, V176, P3552, DOI 10.1128/JB.176.12.3552-3558.1994; Lei BF, 1998, BIOCHEMISTRY-US, V37, P14623, DOI 10.1021/bi981841+; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P975, DOI 10.1038/nsb1297-975; Louie TM, 2003, BIOCHEMISTRY-US, V42, P7509, DOI 10.1021/bi034092r; Louie TM, 2002, J BIOL CHEM, V277, P39450, DOI 10.1074/jbc.M206339200; Low JC, 2003, PHOTOCHEM PHOTOBIOL, V77, P446, DOI 10.1562/0031-8655(2003)077<0446:ETEFIV>2.0.CO;2; MASSEY V, 1994, J BIOL CHEM, V269, P22459; May BJ, 2001, P NATL ACAD SCI USA, V98, P3460, DOI 10.1073/pnas.051634598; Mayhew S G, 1980, Methods Enzymol, V66, P217; Medina M, 1998, BIOCHEMISTRY-US, V37, P2715, DOI 10.1021/bi971795y; Moiseeva OV, 2002, J BACTERIOL, V184, P5282, DOI 10.1128/JB.184.19.5282-5292.2002; Moonen MJH, 2002, ADV SYNTH CATAL, V344, P1023, DOI 10.1002/1615-4169(200212)344:10<1023::AID-ADSC1023>3.0.CO;2-T; Mutzel A, 1996, APPL MICROBIOL BIOT, V46, P593, DOI 10.1007/s002530050866; Niviere V, 1999, J BIOL CHEM, V274, P18252, DOI 10.1074/jbc.274.26.18252; Niviere V, 1998, BIOCHEMISTRY-US, V37, P11879, DOI 10.1021/bi980396f; Palfey BA, 1999, BIOCHEMISTRY-US, V38, P1153, DOI 10.1021/bi9826613; PALFEY BA, 1996, COMPREHENSIVE BIOCH, P83; Parry RJ, 1997, J BIOL CHEM, V272, P23303, DOI 10.1074/jbc.272.37.23303; Reinscheid UM, 1997, BIODEGRADATION, V7, P455, DOI 10.1007/BF00115292; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHREUDER HA, 1994, BIOCHEMISTRY-US, V33, P10161, DOI 10.1021/bi00199a044; Sen Gupta S, 2002, SCIENCE, V296, P326, DOI 10.1126/science.1069297; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Takami H, 2002, NUCLEIC ACIDS RES, V30, P3927, DOI 10.1093/nar/gkf526; TAKIZAWA N, 1995, J FERMENT BIOENG, V80, P318, DOI 10.1016/0922-338X(95)94198-Z; Tanner JJ, 1996, BIOCHEMISTRY-US, V35, P13531, DOI 10.1021/bi961400v; THIBAUT D, 1995, J BACTERIOL, V177, P5199, DOI 10.1128/jb.177.18.5199-5205.1995; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Timmis KN, 1999, TRENDS BIOTECHNOL, V17, P201, DOI 10.1016/S0167-7799(98)01295-5; UETZ T, 1992, J BACTERIOL, V174, P1179, DOI 10.1128/jb.174.4.1179-1188.1992; Vadas A, 1999, J BIOL CHEM, V274, P36715, DOI 10.1074/jbc.274.51.36715; van den Berg WAM, 2000, EUR J BIOCHEM, V267, P666, DOI 10.1046/j.1432-1327.2000.01032.x; VANBERKEL WJH, 1991, EUR J BIOCHEM, V197, P769; VANBERKEL WJH, 1989, EUR J BIOCHEM, V179, P307; vanderBolt FJT, 1997, BIOCHEMISTRY-US, V36, P14192, DOI 10.1021/bi971213c; Wang J, 2002, P NATL ACAD SCI USA, V99, P608, DOI 10.1073/pnas.022640199; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3; Xi L, 1997, BIOCHEM BIOPH RES CO, V230, P73, DOI 10.1006/bbrc.1996.5878; Xu D, 2002, BIOCHEMISTRY-US, V41, P13627, DOI 10.1021/bi020446n; Xu YR, 1997, J BACTERIOL, V179, P1112, DOI 10.1128/jb.179.4.1112-1116.1997; Xun LY, 2000, APPL ENVIRON MICROB, V66, P481, DOI 10.1128/AEM.66.2.481-486.2000	80	115	119	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47545	47553		10.1074/jbc.M307397200	http://dx.doi.org/10.1074/jbc.M307397200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12968028	hybrid			2022-12-27	WOS:000186731400026
J	Huang, HC; Shi, GY; Jiang, SJ; Shi, CS; Wu, CM; Yang, HY; Wu, HL				Huang, HC; Shi, GY; Jiang, SJ; Shi, CS; Wu, CM; Yang, HY; Wu, HL			Thrombomodulin-mediated cell adhesion - Involvement of its lectin-like domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPH-NODE METASTASIS; E-CADHERIN; EPIDERMAL DIFFERENTIATION; TUMOR-CELLS; EXPRESSION; CARCINOMA; MICE; THROMBIN; RECEPTOR; PROTEIN	Thrombomodulin (TM) is an integral membrane glycoprotein that is a potent anticoagulant factor. TM may also possess functions distinct from its anticoagulant activity. Here the influence of TM on cell adhesion was studied in TM-negative melanoma A2058 cells transfected with green fluorescent protein-tagged TM (TMG) or lectin domain-deleted TM (TMG(DeltaL)). Confocal microscopy demonstrated that both TMG and TMG(DeltaL) were distributed in the plasma membrane. TMG-expressed cells grew as closely clustered colonies, with TM localized prominently in the intercellular boundaries. TMG(DeltaL)-expressed cells grew singly. Overexpression of TMG, but not TMG(DeltaL), decreased monolayer permeability in vitro and tumor growth in vivo. The cell-to-cell adhesion in TMG-expressed cells was Ca2+-dependent and was inhibited by monoclonal antibody against the lectin-like domain of TM. The effects of TM-mediated cell adhesion were abolished by the addition of mannose, chondroitin sulfate A, or chondroitin sulfate C. In addition, anti-lectin-like domain antibody disrupted the close clustering of the endogenous TM-expressed keratinocyte HaCaT cell line derived from normal human epidermis. Double-labeling immunofluorescence staining revealed similar distributions of TM and actin filament in the cortex region of the TMG-expressed cells. Thus, TM can function as a Ca2+-dependent cell-to-cell adhesion molecule. Binding of specific carbohydrates to the lectin-like domain is essential for this specific function.	Natl Cheng Kung Univ, Coll Med, Dept Biochem, Tainan 701, Taiwan; Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 701, Taiwan; China Med Coll, Dept Med Technol, Taichung 404, Taiwan; Natl Taiwan Univ, Inst Mol & Cell Biol, Taipei 107, Taiwan	National Cheng Kung University; National Cheng Kung University; China Medical University Taiwan; National Taiwan University	Wu, HL (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem, Tainan 701, Taiwan.	halnwu@mail.ncku.edu.tw	Huang, Huey-Chun/O-3852-2015	Huang, Huey-Chun/0000-0002-3300-5946; Shi, Chung-Sheng/0000-0002-5548-7675				BOFFA MC, 1987, J HISTOCHEM CYTOCHEM, V35, P1267, DOI 10.1177/35.11.2821107; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chay CH, 2000, J CELL BIOCHEM, P123; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Conway EM, 1997, BLOOD, V89, P652, DOI 10.1182/blood.V89.2.652; Conway EM, 1999, BLOOD, V93, P3442, DOI 10.1182/blood.V93.10.3442.410k17_3442_3450; Conway EM, 2002, J EXP MED, V196, P565, DOI 10.1084/jem.20020077; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; ESMON CT, 1982, J BIOL CHEM, V257, P7944; GABIUS H, 1997, J CANC INVEST, V15, P454; HEALY AM, 1995, P NATL ACAD SCI USA, V92, P850, DOI 10.1073/pnas.92.3.850; Herren B, 2001, EXP CELL RES, V271, P152, DOI 10.1006/excr.2001.5353; HIRANO S, 1987, J CELL BIOL, V105, P2501, DOI 10.1083/jcb.105.6.2501; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Hynes RO, 1996, J CLIN INVEST, V98, P2193, DOI 10.1172/JCI119027; Jackson DE, 1996, PATHOLOGY, V28, P225, DOI 10.1080/00313029600169024; JACOB GS, 1995, ADV EXP MED BIOL, V376, P283; KINCH MS, 1995, J CELL BIOL, V130, P461, DOI 10.1083/jcb.130.2.461; Lane DA, 2000, BLOOD, V95, P1517, DOI 10.1182/blood.V95.5.1517.005k48_1517_1532; LARGER DJ, 1995, AM J PATHOL, V146, P933; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Matsushita Y, 1998, CANCER LETT, V127, P195, DOI 10.1016/S0304-3835(98)00038-X; MODY R, 1995, J PHARMACOL TOX MET, V33, P1, DOI 10.1016/1056-8719(94)00052-6; NAWA K, 1990, BIOCHEM BIOPH RES CO, V171, P729, DOI 10.1016/0006-291X(90)91207-9; Ogawa H, 2000, CANCER LETT, V149, P95, DOI 10.1016/S0304-3835(99)00348-1; PETERSEN TE, 1988, FEBS LETT, V231, P51, DOI 10.1016/0014-5793(88)80700-2; PIGNATELLI M, 1992, BRIT J CANCER, V66, P629, DOI 10.1038/bjc.1992.328; Pokutta S, 2002, CURR OPIN STRUC BIOL, V12, P255, DOI 10.1016/S0959-440X(02)00318-4; POLLACK L, 1983, J CELL BIOL, V97, P293, DOI 10.1083/jcb.97.2.293; Raife TJ, 1998, J INVEST MED, V46, P127; RAIFE TJ, 1994, J CLIN INVEST, V93, P1846, DOI 10.1172/JCI117171; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; STAHL PD, 1992, CURR OPIN IMMUNOL, V4, P49, DOI 10.1016/0952-7915(92)90123-V; SUEHIRO T, 1995, HEPATOLOGY, V21, P1285, DOI 10.1002/hep.1840210511; SUZUKI K, 1987, EMBO J, V6, P1891, DOI 10.1002/j.1460-2075.1987.tb02448.x; Tabata M, 1997, J ORAL PATHOL MED, V26, P258, DOI 10.1111/j.1600-0714.1997.tb01234.x; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TEZUKA Y, 1995, CANCER RES, V55, P4196; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Varki A, 2001, BRAZ J MED BIOL RES, V34, P711, DOI 10.1590/S0100-879X2001000600003; Wilhelm S, 1998, INT J ONCOL, V13, P645; Zhang YM, 1998, J CLIN INVEST, V101, P1301, DOI 10.1172/JCI925	42	132	136	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46750	46759		10.1074/jbc.M305216200	http://dx.doi.org/10.1074/jbc.M305216200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12951323	hybrid			2022-12-27	WOS:000186569400066
J	Nair, VD; Sealfon, SC				Nair, VD; Sealfon, SC			Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D-2 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; SRC-DEPENDENT PHOSPHORYLATION; BETA(2) ADRENERGIC-RECEPTOR; PARKINSONS-DISEASE; COUPLED RECEPTOR; TYROSINE KINASE; MAP KINASE; C-SRC; PHOSPHATIDYLINOSITOL 3-KINASE	Bromocriptine, acting through the dopamine D-2 receptor, provides robust protection against apoptosis induced by oxidative stress in PC12-D2R and immortalized nigral dopamine cells. We now report the characterization of the D-2 receptor signaling pathways mediating the cytoprotection. Bromocriptine caused protein kinase B (Akt) activation in PC12-D2R cells and the inhibition of either phosphoinositide (PI)3-kinase, epidermal growth factor receptor (EGFR), or c-Src eliminated the Akt activation and the cytoprotective effects of bromocriptine against oxidative stress. Co-immunoprecipitation studies showed that the D-2 receptor forms a complex with the EGFR and c-Src that was augmented by bromocriptine, suggesting a cross-talk between these proteins in mediating the activation of Akt. EGFR repression by inhibitor or by RNA interference eliminated the activation of Akt by bromocriptine. D-2 receptor stimulation by bromocriptine induced c-Src tyrosine 418 phosphorylation and EGFR phosphorylation specifically at tyrosine 845, a known substrate of Src kinase. Furthermore, Src tyrosine kinase inhibitor or dominant negative Src interfered with Akt translocation and phosphorylation. Thus, the predominant signaling cascade mediating cytoprotection by the D-2 receptor involves c-Src/EGFR transactivation by D-2 receptor, activating PI 3-kinase and Akt. We also found that the agonist pramipexole failed to stimulate activation of Akt in PC12-D2R cells, providing an explanation for our previous observations that, despite efficiently activating G-protein signaling, this agonist had little cytoprotective activity in this experimental system. These results support the hypothesis that specific dopamine agonists stabilize distinct conformations of the D-2 receptor that differ in their coupling to G-proteins and to a cytoprotective c-Src/EGFR-mediated PI-3 kinase/Akt pathway.	Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sealfon, SC (corresponding author), Mt Sinai Sch Med, Dept Neurol, Box 1137,1 Gustave L Levy Pl, New York, NY 10029 USA.			Nair, Venugopalan/0000-0002-0299-0998; Nair, Venugopalan/0000-0002-8231-6230; SEALFON, Stuart/0000-0001-5791-1217				Ahlskog JE, 2003, NEUROLOGY, V60, P381, DOI 10.1212/01.WNL.0000044047.58984.2F; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Berg KA, 1998, MOL PHARMACOL, V54, P94, DOI 10.1124/mol.54.1.94; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Ching TT, 2001, J BIOL CHEM, V276, P43932, DOI 10.1074/jbc.M105159200; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; Cordeaux Y, 2001, J BIOL CHEM, V276, P28667, DOI 10.1074/jbc.M008644200; Cussac D, 1999, MOL PHARMACOL, V56, P1025, DOI 10.1124/mol.56.5.1025; DATTA K, 1995, MOL CELL BIOL, V15, P2304; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Fahn S., 1988, CECILS TXB MED, P2143; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; FRIDOVICH I, 1983, ANNU REV PHARMACOL, V23, P239, DOI 10.1146/annurev.pa.23.040183.001323; Gao YL, 2001, J PHARMACOL EXP THER, V296, P426; Hartmann A, 2001, ADV NEUROL, V86, P143; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; HORNYKIEWICZ O, 1987, PARKINSONS DIS, P19; Keely SJ, 2000, J BIOL CHEM, V275, P12619, DOI 10.1074/jbc.275.17.12619; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; Kihara T, 2002, J NEUROSCI RES, V70, P274, DOI 10.1002/jnr.10426; Kotecha SA, 2002, NEURON, V35, P1111, DOI 10.1016/S0896-6273(02)00859-0; Kurrasch-Orbaugh DM, 2003, J PHARMACOL EXP THER, V304, P229, DOI 10.1124/jpet.102.042184; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; Lachowicz JE, 1997, PHARMACOL TOXICOL, V81, P105, DOI 10.1111/j.1600-0773.1997.tb00039.x; Le WD, 2001, DRUG AGING, V18, P389, DOI 10.2165/00002512-200118060-00001; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Marie J, 2001, J BIOL CHEM, V276, P41100, DOI 10.1074/jbc.M104875200; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Nair VD, 2003, BIOCHEM J, V373, P25, DOI 10.1042/BJ20030017; Oak JN, 2001, MOL PHARMACOL, V60, P92, DOI 10.1124/mol.60.1.92; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Oldenhof J, 2001, CELL SIGNAL, V13, P411, DOI 10.1016/S0898-6568(01)00157-7; Pauwels PJ, 2002, NEUROPHARMACOLOGY, V42, P855, DOI 10.1016/S0028-3908(01)00201-5; Peleg G, 2001, P NATL ACAD SCI USA, V98, P8469, DOI 10.1073/pnas.151239698; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Piiper A, 2002, J BIOL CHEM, V277, P43623, DOI 10.1074/jbc.M203926200; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Prioleau C, 2002, J BIOL CHEM, V277, P36577, DOI 10.1074/jbc.M206223200; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Sakmar TP, 1998, PROG NUCLEIC ACID RE, V59, P1; Sealfon SC, 2000, ANN NEUROL, V47, pS12; Seifert R, 2001, J PHARMACOL EXP THER, V297, P1218; Shaw M, 1998, BIOCHEM J, V336, P241, DOI 10.1042/bj3360241; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Venkatakrishnan G, 2000, J BIOL CHEM, V275, P6868, DOI 10.1074/jbc.275.10.6868; Vogel R, 2002, BIOCHEMISTRY-US, V41, P3529, DOI 10.1021/bi016023n; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; WILSON LK, 1989, MOL CELL BIOL, V9, P1536, DOI 10.1128/MCB.9.4.1536; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yan Z, 1999, P NATL ACAD SCI USA, V96, P11607, DOI 10.1073/pnas.96.20.11607	67	76	78	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47053	47061		10.1074/jbc.M303364200	http://dx.doi.org/10.1074/jbc.M303364200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12970364	hybrid			2022-12-27	WOS:000186569400102
J	Song, JJ; Lee, YJ				Song, JJ; Lee, YJ			Role of the ASK1-SEK1-JNK1-HIPK1 signal in Daxx trafficking and ASK1 oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC OXIDATIVE STRESS; ACTIVATED PROTEIN-KINASE; FAS-BINDING-PROTEIN; TRANSCRIPTION FACTOR; TRANSDUCTION PATHWAY; REGULATING KINASE-1; CELL-DEATH; APOPTOSIS; GLUTAREDOXIN; THIOREDOXIN	Overexpression of JNK binding domain inhibited glucose deprivation-induced JNK1 activation, relocalization of Daxx from the nucleus to the cytoplasm, and apoptosis signal-regulating kinase 1 (ASK1) oligomerization in human prostate adenocarcinoma DU-145 cells. However, SB203580, a p38 inhibitor, did not prevent relocalization of Daxx and oligomerization of ASK1 during glucose deprivation. Studies from in vivo labeling and immune complex kinase assay demonstrated that phosphorylation of Daxx occurred during glucose deprivation, and its phosphorylation was mediated through the ASK1-SEK1-JNK1-HIPK1 signal transduction pathway. Data from immunofluorescence staining and protein interaction assay suggest that phosphorylated Daxx may be translocated to the cytoplasm, bind to ASK1, and subsequently lead to ASK1 oligomerization. Mutation of Daxx Ser(667) to Ala results in suppression of Daxx relocalization during glucose deprivation, suggesting that Ser667 residue plays an important role in the relocalization of Daxx. Unlike wild-type Daxx, a Daxx deletion mutant ( amino acids 501 - 625) mainly localized to the cytoplasm, where it associated with ASK1, activated JNK1, and induced ASK1 oligomerization without glucose deprivation. Taken together, these results show that glucose deprivation activates the ASK1-SEK1-JNK1- HIPK1 pathway, and the activated HIPK1 is probably involved in the relocalization of Daxx from the nucleus to the cytoplasm. The relocalized Daxx may play an important role in glucose deprivation-induced ASK1 oligomerization.	Univ Pittsburgh, Dept Surg, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lee, YJ (corresponding author), Univ Pittsburgh, Dept Surg, Hillman Canc Ctr, 5117 Ctr Ave,Rm G-5A, Pittsburgh, PA 15213 USA.			Song, Jae/0000-0001-8183-9550	NATIONAL CANCER INSTITUTE [R01CA095191, R01CA048000, R01CA096989] Funding Source: NIH RePORTER; NCI NIH HHS [CA 48000, CA 95191, CA 96989] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; CHRESTENSEN CA, 1995, FEBS LETT, V374, P25, DOI 10.1016/0014-5793(95)01066-N; Chung KC, 2000, EUR J BIOCHEM, V267, P4676, DOI 10.1046/j.1432-1327.2000.01517.x; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Ecsedy JA, 2003, MOL CELL BIOL, V23, P950, DOI 10.1128/MCB.23.3.950-960.2003; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Janknecht R, 1997, J BIOL CHEM, V272, P4219, DOI 10.1074/jbc.272.7.4219; Ko YG, 2001, J BIOL CHEM, V276, P39103, DOI 10.1074/jbc.M105928200; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; MILNE DM, 1995, J BIOL CHEM, V270, P5511, DOI 10.1074/jbc.270.10.5511; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; PADILLA CA, 1995, EUR J BIOCHEM, V227, P27, DOI 10.1111/j.1432-1033.1995.tb20356.x; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Ryu SW, 2000, BIOCHEM BIOPH RES CO, V279, P6, DOI 10.1006/bbrc.2000.3882; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Song JJ, 2003, J CELL BIOCHEM, V90, P304, DOI 10.1002/jcb.10619; Song JJ, 2003, BIOCHEM J, V373, P845, DOI 10.1042/BJ20030275; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Toone WM, 2001, ONCOGENE, V20, P2336, DOI 10.1038/sj.onc.1204384; Torii S, 1999, EMBO J, V18, P6037, DOI 10.1093/emboj/18.21.6037; Wang XHS, 1996, J BIOL CHEM, V271, P31607; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9	28	68	73	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47245	47252		10.1074/jbc.M213201200	http://dx.doi.org/10.1074/jbc.M213201200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12968034	hybrid			2022-12-27	WOS:000186569400125
J	Antoine, M; Boschi-Muller, S; Branlant, G				Antoine, M; Boschi-Muller, S; Branlant, G			Kinetic characterization of the chemical steps involved in the catalytic mechanism of methionine sulfoxide reductase a from Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; ENZYME; PILB; MUTAGENESIS; OXIDATION	Oxidation of methionine into methionine sulfoxide is associated with many pathologies and is described to exert regulatory effects on protein functions. Two classes of methionine sulfoxide reductases, called MsrA and MsrB, have been described to reduce the S and the R isomers of the sulfoxide of methionine sulfoxide back to methionine, respectively. Although MsrAs and MsrBs display quite different x-ray structures, they share a similar, new catalytic mechanism that proceeds via the sulfenic acid chemistry and that includes at least three chemical steps with 1) the formation of a sulfenic acid intermediate and the concomitant release of methionine; 2) the formation of an intra-disulfide bond; and 3) the reduction of the disulfide bond by thioredoxin. In the present study, it is shown that for the Neisseria meningitidis MsrA, 1) the rate-limiting step is associated with the reduction of the Cys-51/Cys-198 disulfide MsrA bond by thioredoxin; 2) the formation of the sulfenic acid intermediate is very efficient, thus suggesting catalytic assistance via amino acids of the active site; 3) the rate-determining step in the formation of the Cys-51/Cys-198 disulfide bond is that leading to the formation of the sulfenic intermediate on Cys-51; and 4) the apparent affinity constant for methionine sulfoxide in the methionine sulfoxide reductase step is 80-fold higher than the K-m value determined under steady-state conditions.	Fac Sci, CNRS, UMR 7567, UHP Maturat ARN & Enzymol Mol, F-54506 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Branlant, G (corresponding author), Fac Sci, CNRS, UMR 7567, UHP Maturat ARN & Enzymol Mol, Bld Aiguillettes,BP 239, F-54506 Vandoeuvre Les Nancy, France.			Boschi, Sandrine/0000-0001-8962-4749				Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2001, PROTEIN SCI, V10, P2272, DOI 10.1110/ps.10701; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; HOLMGREN A, 1972, J BIOL CHEM, V247, P1992; HOLMGREN A, 1981, BIOCHEMISTRY-US, V20, P3204, DOI 10.1021/bi00514a033; Kauffmann B, 2002, ACTA CRYSTALLOGR D, V58, P1467, DOI 10.1107/S0907444902010570; Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269; Lowther WT, 2000, P NATL ACAD SCI USA, V97, P6463, DOI 10.1073/pnas.97.12.6463; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Mossner E, 1998, PROTEIN SCI, V7, P1233; Mulrooney SB, 1997, PROTEIN EXPRES PURIF, V9, P372, DOI 10.1006/prep.1996.0698; Olry A, 2002, J BIOL CHEM, V277, P12016, DOI 10.1074/jbc.M112350200; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Schoneich C, 1999, EXP GERONTOL, V34, P19, DOI 10.1016/S0531-5565(98)00066-7; Slaby I, 1996, J BIOL CHEM, V271, P3091, DOI 10.1074/jbc.271.6.3091; Taylor AB, 2003, J BACTERIOL, V185, P4119, DOI 10.1128/JB.185.14.4119-4126.2003; Tete-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G	19	47	47	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45352	45357		10.1074/jbc.M307471200	http://dx.doi.org/10.1074/jbc.M307471200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954610	Green Published, hybrid			2022-12-27	WOS:000186452300038
J	Haurie, V; Boucherie, H; Sagliocco, F				Haurie, V; Boucherie, H; Sagliocco, F			The snf1 protein kinase controls the induction of genes of the iron uptake pathway at the diauxic shift in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE LIMITATION; CARBON SOURCE; HEAT-SHOCK; YEAST; EXPRESSION; AFT1; PHOSPHORYLATION; REPRESSOR; ACTIVATION	In Saccharomyces cerevisiae the transition between the fermentative and the oxidative metabolism, called the diauxic shift, is associated with major changes in gene expression. In this study, we characterized a novel family of five genes whose expression is induced during the diauxic shift. These genes, FET3, FTR1, TIS11, SIT1, and FIT2, are involved in the iron uptake pathway. We showed that their induction at the diauxic shift is positively controlled by the Snf1/Snf4 kinase pathway. The transcriptional factor Aft1p, which is known to control their induction in response to iron limitation, is also required for their induction during the diauxic shift. The increase of the extracellular iron concentration does not affect this induction, indicating that glucose exhaustion by itself would be the signal. The possibility that the Snf1/Snf4 pathway was also involved in the induction of the same set of genes in response to iron starvation was considered. We demonstrate here that this is not the case. Thus, the two signals, glucose exhaustion and iron starvation, use two independent pathways to activate the same set of genes through the Aft1p transcriptional factor.	Inst Biochim & Genet Cellulaires, UMR 5095, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Sagliocco, F (corresponding author), Inst Biochim & Genet Cellulaires, UMR 5095, F-33077 Bordeaux, France.	francis.sagliocco@ibgc.u-bordeaux2.fr						BATAILLE N, 1988, ELECTROPHORESIS, V9, P774, DOI 10.1002/elps.1150091113; BATAILLE N, 1991, YEAST, V7, P367, DOI 10.1002/yea.320070407; BOUCHERIE H, 1985, J BACTERIOL, V161, P385, DOI 10.1128/JB.161.1.385-392.1985; BoyMarcotte E, 1996, MICROBIOL-UK, V142, P459, DOI 10.1099/13500872-142-3-459; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Casas C, 1997, YEAST, V13, P621, DOI 10.1002/(SICI)1097-0061(19970615)13:7<621::AID-YEA121>3.0.CO;2-U; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Hardie DG, 1999, BIOCHEM SOC SYMP, P13; Hassett RF, 1998, J BIOL CHEM, V273, P7628, DOI 10.1074/jbc.273.13.7628; Haurie V, 2001, J BIOL CHEM, V276, P76, DOI 10.1074/jbc.M008752200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LINDQUIST S, 1981, NATURE, V293, P311, DOI 10.1038/293311a0; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Ostling J, 1998, EUR J BIOCHEM, V252, P162, DOI 10.1046/j.1432-1327.1998.2520162.x; Pinson B, 2000, NUCLEIC ACIDS RES, V28, P4665, DOI 10.1093/nar/28.23.4665; Protchenko O, 2001, J BIOL CHEM, V276, P49244, DOI 10.1074/jbc.M109220200; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; Rahner A, 1996, NUCLEIC ACIDS RES, V24, P2331, DOI 10.1093/nar/24.12.2331; Robertson LS, 2000, P NATL ACAD SCI USA, V97, P5984, DOI 10.1073/pnas.100113397; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; Urbanowski JL, 1999, J BIOL CHEM, V274, P38061, DOI 10.1074/jbc.274.53.38061; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Yun CW, 2000, J BIOL CHEM, V275, P10709, DOI 10.1074/jbc.275.14.10709	31	64	67	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45391	45396		10.1074/jbc.M307447200	http://dx.doi.org/10.1074/jbc.M307447200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12960168	hybrid			2022-12-27	WOS:000186452300043
J	Bylebyl, GR; Belichenko, I; Johnson, ES				Bylebyl, GR; Belichenko, I; Johnson, ES			The SUMO isopeptidase Ulp2 prevents accumulation of SUMO chains in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYME; PROTEIN SMT3P; IN-VITRO; UBIQUITIN; SUMOYLATION; ENCODES; HOMOLOG; BINDING; LIGASE; UBC9P	The ubiquitin-related protein SUMO functions by becoming covalently attached to lysine residues in other proteins. Unlike ubiquitin, which is often linked to its substrates as a polyubiquitin chain, only one SUMO moiety is attached per modified site in most substrates. However, SUMO has recently been shown to form chains in vitro and in mammalian cells, with a lysine in the non-ubiquitin-like N-terminal extension serving as the major SUMO-SUMO branch site. To investigate the physiological function of SUMO chains, we generated Saccharomyces cerevisiae strains that expressed mutant SUMOs lacking various lysine residues. Otherwise wildtype strains lacking any of the nine lysines in SUMO were viable, had no obvious growth defects or stress sensitivities, and had SUMO conjugate patterns that did not differ dramatically from wild type. However, mutants lacking the SUMO-specific isopeptidase Ulp2 accumulated high molecular weight SUMO-containing species, which formed only when the N-terminal lysines of SUMO were present, suggesting that they contained SUMO chains. Furthermore SUMO branch-site mutants suppressed several of the phenotypes of ulp2Delta, consistent with the possibility that some ulp2Delta phenotypes are caused by accumulation of SUMO chains. We also found that a mutant SUMO whose non-ubiquitin- like N-terminal domain had been entirely deleted still carried out all the essential functions of SUMO. Thus, the ubiquitin-like domain of SUMO is sufficient for conjugation and all downstream functions required for yeast viability. Our data suggest that SUMO can form chains in vivo in yeast but demonstrate conclusively that chain formation is not required for the essential functions of SUMO in S. cerevisiae.	Thomas Jefferson Univ, Dept Mol Pharmacol & Biochem, Philadelphia, PA 19107 USA	Jefferson University	Johnson, ES (corresponding author), Thomas Jefferson Univ, Dept Mol Pharmacol & Biochem, 233 S 10th St,BLSB 231, Philadelphia, PA 19107 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062268] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62268] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Best JL, 2002, MOL CELL, V10, P843, DOI 10.1016/S1097-2765(02)00699-8; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 2002, NAT CELL BIOL, V4, pE295, DOI 10.1038/ncb1202-e295; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kim KI, 2002, J CELL PHYSIOL, V191, P257, DOI 10.1002/jcp.10100; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Li YH, 2003, P NATL ACAD SCI USA, V100, P259, DOI 10.1073/pnas.0235361100; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Schwienhorst I, 2000, MOL GEN GENET, V263, P771, DOI 10.1007/s004380000254; Sherman F., 1986, METHODS YEAST GENETI; Smith J.A., 2000, CURRENT PROTOCOLS MO; Strunnikov AV, 2001, GENETICS, V158, P95; Takahashi Y, 1999, BIOCHEM BIOPH RES CO, V259, P582, DOI 10.1006/bbrc.1999.0821; Takahashi Y, 2003, J BIOCHEM, V133, P415, DOI 10.1093/jb/mvg054; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819	32	197	201	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44113	44120		10.1074/jbc.M308357200	http://dx.doi.org/10.1074/jbc.M308357200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941945	hybrid			2022-12-27	WOS:000186306700029
J	Chen, H; Montagnani, M; Funahashi, T; Shimomura, I; Quon, MJ				Chen, H; Montagnani, M; Funahashi, T; Shimomura, I; Quon, MJ			Adiponectin stimulates production of nitric oxide in vascular endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; MICROVASCULAR RECRUITMENT; HORMONE ADIPONECTIN; GLOBULAR DOMAIN; PLASMA-PROTEIN; GLUCOSE-UPTAKE; MUSCLE; GENE	Adiponectin is secreted by adipose cells and mimics many metabolic actions of insulin. However, mechanisms by which adiponectin acts are poorly understood. The vascular action of insulin to stimulate endothelial production of nitric oxide ( NO), leading to vasodilation and increased blood flow is an important component of insulin-stimulated whole body glucose utilization. Therefore, we hypothesized that adiponectin may also stimulate production of NO in endothelium. Bovine aortic endothelial cells in primary culture loaded with the NO-specific fluorescent dye 4,5-diaminofluorescein diacetate (DAF-2 DA) were treated with lysophosphatidic acid (LPA) (a calcium-releasing agonist) or adiponectin (10 mug/ml bacterially produced full-length adiponectin). LPA treatment increased production of NO by similar to4-fold. Interestingly, adiponectin treatment significantly increased production of NO by similar to3-fold. Preincubation of cells with wortmannin ( phosphatidylinositol 3-kinase inhibitor) blocked only adiponectin- but not LPA-mediated production of NO. Using phospho-specific antibodies, we observed that either adiponectin or insulin treatment ( but not LPA treatment) caused phosphorylation of both Akt at Ser(473) and endothelial nitric-oxide synthase (eNOS) at Ser(1179) that was inhibitable by wortmannin. We next transfected bovine aortic endothelial cells with dominant-inhibitory mutants of Akt (Akt-AAA) or AMP-activated protein kinase (AMPK) (AMPK-K45R). Neither mutant affected production of NO in response to LPA treatment. Importantly, only AMPK-K45R, but not Akt-AAA, caused a significant partial inhibition of NO production in response to adiponectin. Moreover, AMPK-K45R inhibited phosphorylation of eNOS at Ser(1179) in response to adiponectin but not in response to insulin. We conclude that adiponectin has novel vascular actions to directly stimulate production of NO in endothelial cells using phosphatidylinositol 3-kinase-dependent pathways involving phosphorylation of eNOS at Ser(1179) by AMPK. Thus, the effects of adiponectin to augment metabolic actions of insulin in vivo may be due, in part, to vasodilator actions of adiponectin.	NCCAM, Diabet Unit, Clin Invest Lab, NIH, Bethesda, MD 20892 USA; Univ Bari, Sch Med, Dept Pharmacol & Human Physiol, I-70124 Bari, Italy; Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan	National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine; Universita degli Studi di Bari Aldo Moro; Osaka University	Quon, MJ (corresponding author), NCCAM, Diabet Unit, Clin Invest Lab, NIH, Bldg 10,Rm 6C-205,10 Ctr Dr MSC 1632, Bethesda, MD 20892 USA.	quonm@nih.gov	Montagnani, Monica/AAV-2057-2020; Quon, Michael/B-1970-2008	Montagnani, Monica/0000-0002-5697-8185; Quon, Michael/0000-0002-9601-9915; QUON, MICHAEL/0000-0002-5289-3707	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [Z02AT000001, ZIAAT000001, Z01AT000001] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [ZIFAT000001] Funding Source: NIH RePORTER	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Baron AD, 1999, CONT ENDOCRINOL, V12, P247; Beltowski Jerzy, 2003, Med Sci Monit, V9, pRA55; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Clark MG, 2003, AM J PHYSIOL-ENDOC M, V284, pE241, DOI 10.1152/ajpendo.00408.2002; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Heilbronn LK, 2003, CURR PHARM DESIGN, V9, P1411, DOI 10.2174/1381612033454766; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Kishida K, 2003, BIOCHEM BIOPH RES CO, V306, P286, DOI 10.1016/S0006-291X(03)00940-9; Kondo H, 2002, DIABETES, V51, P2325, DOI 10.2337/diabetes.51.7.2325; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Matsuda M, 2002, J BIOL CHEM, V277, P37487, DOI 10.1074/jbc.M206083200; Montagnani M, 2002, MOL ENDOCRINOL, V16, P1931, DOI 10.1210/me.2002-0074; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Montagnani M, 2000, DIABETES OBES METAB, V2, P285, DOI 10.1046/j.1463-1326.2000.00092.x; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Pellme F, 2003, DIABETES, V52, P1182, DOI 10.2337/diabetes.52.5.1182; QUON MJ, 1992, BIOCHEMISTRY-US, V31, P9947, DOI 10.1021/bi00156a013; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shimabukuro M, 2003, J CLIN ENDOCR METAB, V88, P3236, DOI 10.1210/jc.2002-021883; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Vincent MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE123, DOI 10.1152/ajpendo.00021.2003; Vincent MA, 2002, DIABETES, V51, P42, DOI 10.2337/diabetes.51.1.42; Vincent Michelle A, 2003, Curr Diab Rep, V3, P279, DOI 10.1007/s11892-003-0018-9; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Yu JG, 2002, DIABETES, V51, P2968, DOI 10.2337/diabetes.51.10.2968; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200	47	818	865	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					45021	45026		10.1074/jbc.M307878200	http://dx.doi.org/10.1074/jbc.M307878200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944390	hybrid			2022-12-27	WOS:000186306700139
J	Redko, Y; Tock, MR; Adams, CJ; Kaberdin, VR; Grasby, JA; McDowall, KJ				Redko, Y; Tock, MR; Adams, CJ; Kaberdin, VR; Grasby, JA; McDowall, KJ			Determination of the catalytic parameters of the N-terminal half of Escherichia coli ribonuclease E and the identification of critical functional groups in RNA substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; RIBOSOMAL-RNA; RESTRICTION-ENDONUCLEASE; AFFINITY-CHROMATOGRAPHY; DIRECT EXPRESSION; GENE-PRODUCT; CLONED GENES; CAFA PROTEIN; IN-VIVO; CLEAVAGE	Ribonuclease E is required for the rapid decay and correct processing of RNA in Escherichia coli. A detailed understanding of the hydrolysis of RNA by this and related enzymes will require the integration of structural and molecular data with quantitative measurements of RNA hydrolysis. Therefore, an assay for RNaseE that can be set up to have relatively high throughput while being sensitive and quantitative will be advantageous. Here we describe such an assay, which is based on the automated high pressure liquid chromatography analysis of fluorescently labeled RNA samples. We have used this assay to optimize reaction conditions, to determine for the first time the catalytic parameters for a polypeptide of RNaseE, and to investigate the RNaseE-catalyzed reaction through the modification of functional groups within an RNA substrate. We find that catalysis is dependent on both protonated and unprotonated functional groups and that the recognition of a guanosine sequence determinant that is upstream of the scissile bond appears to consist of interactions with the exocyclic 2-amino group, the 7N of the nucleobase and the imino proton or 6-keto group. Additionally, we find that a ribose-like sugar conformation is preferred in the 5'-nucleotide of the scissile phosphodiester bond and that a 2'-hydroxyl group proton is not essential. Steric bulk at the 2' position in the 5'-nucleotide appears to be inhibitory to the reaction. Combined, these observations establish a foundation for the functional interpretation of a three-dimensional structure of the catalytic domain of RNaseE when solved.	Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Sheffield, Dept Chem, Krebs Inst, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England; Vienna Bioctr, Dept Genet & Microbiol, Max F Perutz Labs, A-1030 Vienna, Austria	University of Leeds; University of Sheffield; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	McDowall, KJ (corresponding author), Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Manton Bldg, Leeds LS2 9JT, W Yorkshire, England.		McDowall, Kenneth/GYA-5735-2022; Kaberdin, Vladimir/C-3870-2017	Kaberdin, Vladimir/0000-0002-7166-5136; McDowall, Kenneth/0000-0003-2528-2190				Baldwin GS, 1999, J MOL BIOL, V288, P87, DOI 10.1006/jmbi.1999.2672; Bessarab DA, 1998, P NATL ACAD SCI USA, V95, P3157, DOI 10.1073/pnas.95.6.3157; Blackburn G.M, 1996, NUCL ACIDS CHEM BIOL; Carpousis AJ, 1999, TRENDS GENET, V15, P24, DOI 10.1016/S0168-9525(98)01627-8; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; Condon C, 2002, NUCLEIC ACIDS RES, V30, P5339, DOI 10.1093/nar/gkf691; CORMACK RS, 1993, P NATL ACAD SCI USA, V90, P9006, DOI 10.1073/pnas.90.19.9006; Cornish-Bowden A, 2001, FUNDAMENTALS ENZYME; Dickman MJ, 2002, RNA, V8, P247, DOI 10.1017/S1355838202012888; EHRETSMANN CP, 1992, GENE DEV, V6, P149, DOI 10.1101/gad.6.1.149; EHRETSMANN CP, 1992, FASEB J, V6, P3186, DOI 10.1096/fasebj.6.13.1397840; Feng YA, 2002, P NATL ACAD SCI USA, V99, P14746, DOI 10.1073/pnas.202590899; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; GHORA BK, 1978, CELL, V15, P1055, DOI 10.1016/0092-8674(78)90289-1; Grunberg-Manago M, 1999, ANNU REV GENET, V33, P193, DOI 10.1146/annurev.genet.33.1.193; GUSCHLBAUER W, 1980, NUCLEIC ACIDS RES, V8, P1421, DOI 10.1093/nar/8.6.1421; Huang HJ, 1998, NATURE, V391, P99, DOI 10.1038/34219; Jain C, 2002, MOL MICROBIOL, V43, P1053, DOI 10.1046/j.1365-2958.2002.02808.x; Jiang XQ, 2000, J BACTERIOL, V182, P2468, DOI 10.1128/JB.182.9.2468-2475.2000; Kaberdin VR, 2003, NUCLEIC ACIDS RES, V31, P4710, DOI 10.1093/nar/gkg690; Kaberdin VR, 1998, P NATL ACAD SCI USA, V95, P11637, DOI 10.1073/pnas.95.20.11637; Kaberdin VR, 2000, J MOL BIOL, V301, P257, DOI 10.1006/jmbi.2000.3962; KANAYA S, 1990, BIOCHEM J, V271, P59, DOI 10.1042/bj2710059; Keck JL, 1998, J BIOL CHEM, V273, P34128, DOI 10.1074/jbc.273.51.34128; Kido M, 1996, J BACTERIOL, V178, P3917, DOI 10.1128/jb.178.13.3917-3925.1996; Lee K, 2002, MOL MICROBIOL, V43, P1445, DOI 10.1046/j.1365-2958.2002.02848.x; Leroy A, 2002, MOL MICROBIOL, V45, P1231, DOI 10.1046/j.1365-2958.2002.03104.x; Li ZW, 1999, EMBO J, V18, P2878, DOI 10.1093/emboj/18.10.2878; LINCHAO S, 1994, J BIOL CHEM, V269, P10797; LODI PJ, 1991, BIOCHEMISTRY-US, V30, P6948, DOI 10.1021/bi00242a020; Lopez PJ, 1999, MOL MICROBIOL, V33, P188, DOI 10.1046/j.1365-2958.1999.01465.x; MACKIE GA, 1992, J BIOL CHEM, V267, P1054; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Mackie GA, 2000, J BIOL CHEM, V275, P25069, DOI 10.1074/jbc.C000363200; MCDOWALL KJ, 1995, NATURE, V374, P287, DOI 10.1038/374287a0; McDowall KJ, 1996, J MOL BIOL, V255, P349, DOI 10.1006/jmbi.1996.0027; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; MORITA M, 1979, EUR J BIOCHEM, V97, P435, DOI 10.1111/j.1432-1033.1979.tb13131.x; Nilsson RP, 2002, BIOTECHNIQUES, V33, P272, DOI 10.2144/02332bm03; Ow MC, 2000, MOL MICROBIOL, V38, P854, DOI 10.1046/j.1365-2958.2000.02186.x; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; Price N., 1999, FUNDAMENTALS ENZYMOL; Regnier P, 2000, BIOESSAYS, V22, P235; ROSENBERG AH, 1987, GENE, V59, P191, DOI 10.1016/0378-1119(87)90327-1; SMITH MC, 1988, J BIOL CHEM, V263, P7211; Steinhardt J., 1969, MULTIPLE EQUILIBRIA; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5; TAMM J, 1985, P NATL ACAD SCI USA, V82, P2257, DOI 10.1073/pnas.82.8.2257; TARASEVICIENE L, 1995, J BIOL CHEM, V270, P26391, DOI 10.1074/jbc.270.44.26391; Tock MR, 2000, J BIOL CHEM, V275, P8726, DOI 10.1074/jbc.275.12.8726; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770; Walsh AP, 2001, NUCLEIC ACIDS RES, V29, P1864, DOI 10.1093/nar/29.9.1864; WATERS TR, 1994, BIOCHEMISTRY-US, V33, P1812, DOI 10.1021/bi00173a026	56	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44001	44008		10.1074/jbc.M306760200	http://dx.doi.org/10.1074/jbc.M306760200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947103	hybrid			2022-12-27	WOS:000186306700015
J	Hall, AM; Smith, AJ; Bernlohr, DA				Hall, AM; Smith, AJ; Bernlohr, DA			Characterization of the acyl-CoA synthetase activity of purified murine fatty acid transport protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; CARDIAC MYOCYTES; BINDING-PROTEIN; MAMMALIAN-CELLS; RAT-LIVER; EXPRESSION; METABOLISM; CLONING; CD36	Fatty acid transport protein 1 (FATP1) is an similar to63-kDa plasma membrane protein that facilitates the influx of fatty acids into adipocytes as well as skeletal and cardiac myocytes. Previous studies with FATP1 expressed in COS1 cell extracts suggested that FATP1 exhibits very long chain acyl-CoA synthetase (ACS) activity and that such activity may be linked to fatty acid transport. To address the enzymatic activity of the isolated protein, murine FATP1 and ACS1 were engineered to contain a C-terminal Myc-His tag expressed in COS1 cells via adenoviral-mediated infection and purified to homogeneity using nickel affinity chromatography. Kinetic analysis of the purified enzymes was carried out for long chain palmitic acid (C16:0) and very long chain lignoceric acid (C24:0) as well as for ATP and CoA. FATP1 exhibited similar substrate specificity for fatty acids 16-24 carbons in length, whereas ACS1 was 10-fold more active on long chain fatty acids relative to very long chain fatty acids. The very long chain acyl-CoA synthetase activity of the two enzymes was comparable as were the K-m values for both ATP and coenzyme A. Interestingly, FATP1 was insensitive to inhibition by triacsin C, whereas ACS1 was inhibited by micromolar concentrations of the compound. These data represent the first characterization of purified FATP1 and indicate that the enzyme is a broad substrate specificity acyl-CoA synthetase. These findings are consistent with the hypothesis that that fatty acid uptake into cells is linked to their esterification with coenzyme A.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Bernlohr, DA (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 321 Church St SE,6-155 Jackson Hall, Minneapolis, MN 55455 USA.			Hall, Angela Marie/0000-0003-0006-7910				Abumrad N, 1999, BBA-MOL CELL BIOL L, V1441, P4, DOI 10.1016/S1388-1981(99)00137-7; Abumrad N, 1998, J LIPID RES, V39, P2309; ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; BABBITT PC, 1992, BIOCHEMISTRY-US, V31, P5594, DOI 10.1021/bi00139a024; Coe NR, 1999, J BIOL CHEM, V274, P36300, DOI 10.1074/jbc.274.51.36300; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Faergeman NJ, 1997, J BIOL CHEM, V272, P8531, DOI 10.1074/jbc.272.13.8531; Frohnert BI, 2000, PROG LIPID RES, V39, P83, DOI 10.1016/S0163-7827(99)00018-1; Gargiulo CE, 1999, J LIPID RES, V40, P881; Hamilton JA, 2002, MOL CELL BIOCHEM, V239, P17, DOI 10.1023/A:1020542220599; Hamilton JA, 2001, J MOL NEUROSCI, V16, P99, DOI 10.1385/JMN:16:2-3:99; Hatch GM, 2002, J LIPID RES, V43, P1380, DOI 10.1194/jlr.M200130-JLR200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Irie H, 2003, P NATL ACAD SCI USA, V100, P6819, DOI 10.1073/pnas.1132094100; Kim JH, 2001, J BIOL CHEM, V276, P24667, DOI 10.1074/jbc.M010793200; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; Luiken JJFP, 1997, J LIPID RES, V38, P745; Luiken JJFP, 1999, J LIPID RES, V40, P1007; Moulson CL, 2003, P NATL ACAD SCI USA, V100, P5274, DOI 10.1073/pnas.0431186100; NAGAMATSU K, 1986, LIPIDS, V21, P328, DOI 10.1007/BF02535695; NAGAMATSU K, 1985, BIOCHIM BIOPHYS ACTA, V836, P80, DOI 10.1016/0005-2760(85)90223-1; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; SORRENTINO D, 1988, J CLIN INVEST, V82, P928, DOI 10.1172/JCI113700; Stuhlsatz-Krouper SM, 1998, J BIOL CHEM, V273, P28642, DOI 10.1074/jbc.273.44.28642; STUMP DD, 1993, AM J PHYSIOL, V265, pG894, DOI 10.1152/ajpgi.1993.265.5.G894; Uchiyama A, 1996, J BIOL CHEM, V271, P30360, DOI 10.1074/jbc.271.48.30360; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zou ZY, 2003, J BIOL CHEM, V278, P16414, DOI 10.1074/jbc.M210557200; Zou ZY, 2002, J BIOL CHEM, V277, P31062, DOI 10.1074/jbc.M205034200	32	134	141	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43008	43013		10.1074/jbc.M306575200	http://dx.doi.org/10.1074/jbc.M306575200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12937175	hybrid			2022-12-27	WOS:000186157000036
J	Lushnikov, AY; Bogdanov, A; Lyubchenko, YL				Lushnikov, AY; Bogdanov, A; Lyubchenko, YL			DNA recombination - Holliday junctions dynamics and branch migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; GENETIC RECOMBINATION; CRYSTAL-STRUCTURES; REPLICATION FORKS; 4-WAY JUNCTIONS; COMPLEX	Holliday junctions are critical intermediates for homologous, site-specific recombination, DNA repair, and replication. A wealth of structural information is available for immobile four-way junctions, but the controversy on the mechanism of branch migration of Holliday junctions remains unsolved. Two models for the mechanism of branch migration were suggested. According to the early model of Alberts-Meselson-Sigal (Sigal, N., and Alberts, B. (1972) J. Mol. Biol. 71, 789-793 and Meselson, M. (1972) J. Mol. Biol. 71, 795-798), exchanging DNA strands around the junction remain parallel during branch migration. Kinetic studies of branch migration (Panyutin, I. G., and Hsieh, P. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 2021-2025) suggest an alternative model in which the junction adopts an extended conformation. We tested these models using a Holliday junction undergoing branch migration and time-lapse atomic force microscopy, an imaging technique capable of imaging DNA dynamics. The single molecule atomic force microscopy experiments performed in the presence and in the absence of divalent cations show that mobile Holliday junctions adopt an unfolded conformation during branch migration that is retained despite a broad range of motion in the arms of the junction. This conformation of the junction remains unchanged until strand separation. The data obtained support the model for branch migration having the extended conformation of the Holliday junction.	Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; St Petersburg State Univ, Dept Phys, St Petersburg 188512, Russia	Arizona State University; Arizona State University-Tempe; Saint Petersburg State University	Lyubchenko, YL (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.		Bogdanov, Alexey A./P-1231-2017; Alexey, Bogdanov/AHD-2822-2022	Bogdanov, Alexey A./0000-0002-7887-4635; Alexey, Bogdanov/0000-0002-7887-4635	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062235] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 62235] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Biswas I, 1998, J MOL BIOL, V279, P795, DOI 10.1006/jmbi.1998.1769; CHURCHILL MEA, 1988, P NATL ACAD SCI USA, V85, P4653, DOI 10.1073/pnas.85.13.4653; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Eichman BF, 2002, J MOL BIOL, V320, P1037, DOI 10.1016/S0022-2836(02)00540-5; Fogg JM, 2000, BIOCHEMISTRY-US, V39, P4082, DOI 10.1021/bi992785v; Grompone G, 2002, MOL MICROBIOL, V44, P1331, DOI 10.1046/j.1365-2958.2002.02962.x; Ho PS, 2001, CURR OPIN STRUC BIOL, V11, P302, DOI 10.1016/S0959-440X(00)00219-0; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Huffman KE, 1999, J MOL BIOL, V286, P1, DOI 10.1006/jmbi.1998.2468; LEACH DRF, 1996, GENETIC RECOMBINATIO; Lilley DMJ, 1999, NAT STRUCT BIOL, V6, P897, DOI 10.1038/13255; Lilley DMJ, 1997, P NATL ACAD SCI USA, V94, P9513, DOI 10.1073/pnas.94.18.9513; Lyubchenko YL, 1997, P NATL ACAD SCI USA, V94, P496, DOI 10.1073/pnas.94.2.496; Lyubchenko YL, 2002, MICROSC MICROANAL, V8, P170; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; MESELSON M, 1972, J MOL BIOL, V71, P795, DOI 10.1016/0022-2828(72)90048-X; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; PANYUTIN IG, 1995, EMBO J, V14, P1819, DOI 10.1002/j.1460-2075.1995.tb07170.x; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; SEEMAN NC, 1994, ANNU REV BIOPH BIOM, V23, P53, DOI 10.1146/annurev.bb.23.060194.000413; Sha R, 2000, BIOCHEMISTRY-US, V39, P11514, DOI 10.1021/bi0010468; Sha RJ, 2002, BIOCHEMISTRY-US, V41, P5950, DOI 10.1021/bi020001z; Shlyakhtenko LS, 2000, NUCLEIC ACIDS RES, V28, P3472, DOI 10.1093/nar/28.18.3472; Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P279, DOI 10.1016/S0304-3991(03)00053-6; Shlyakhtenko LS, 1998, J MOL BIOL, V280, P61, DOI 10.1006/jmbi.1998.1855; Shlyakhtenko LS, 2000, J MOL BIOL, V296, P1169, DOI 10.1006/jmbi.2000.3542; SIGAL N, 1972, J MOL BIOL, V71, P789, DOI 10.1016/S0022-2836(72)80039-1; SRINIVASAN AR, 1994, BIOCHEMISTRY-US, V33, P9389, DOI 10.1021/bi00198a004; Van Duyne GD, 2001, ANNU REV BIOPH BIOM, V30, P87, DOI 10.1146/annurev.biophys.30.1.87	31	29	29	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43130	43134		10.1074/jbc.M308228200	http://dx.doi.org/10.1074/jbc.M308228200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12949070	hybrid			2022-12-27	WOS:000186157000053
J	Miyakawa-Naito, A; Uhlen, P; Lal, M; Aizman, O; Mikoshiba, K; Brismar, H; Zelenin, S; Aperia, A				Miyakawa-Naito, A; Uhlen, P; Lal, M; Aizman, O; Mikoshiba, K; Brismar, H; Zelenin, S; Aperia, A			Cell signaling Microdomain with Na,K-ATPase and inositol 1,4,5-trisphosphate receptor generates calcium oscillations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; 2-AMINOETHOXYDIPHENYL BORATE 2-APB; NA+/K+-ATPASE; CA2+ RELEASE; OUABAIN; IDENTIFICATION; SPECIFICITY; INVOLVEMENT; INHIBITION; EXPRESSION	Recent studies indicate novel roles for the ubiquitous ion pump, Na,K-ATPase, in addition to its function as a key regulator of intracellular sodium and potassium concentration. We have previously demonstrated that ouabain, the endogenous ligand of Na, K-ATPase, can trigger intracellular Ca2+ oscillations, a versatile intracellular signal controlling a diverse range of cellular processes. Here we report that Na, K-ATPase and inositol 1,4,5-trisphosphate (InsP(3)) receptor (InsP(3)R) form a cell signaling microdomain that, in the presence of ouabain, generates slow Ca2+ oscillations in renal cells. Using fluorescent resonance energy transfer ( FRET) measurements, we detected a close spatial proximity between Na, K-ATPase and InsP(3)R. Ouabain significantly enhanced FRET between Na, K-ATPase and InsP(3)R. The FRET effect and ouabain-induced Ca2+ oscillations were not observed following disruption of the actin cytoskeleton. Partial truncation of the NH2 terminus of Na, K-ATPase catalytic alpha1-subunit abolished Ca2+ oscillations and downstream activation of NF-kappaB. Ouabain-induced Ca2+ oscillations occurred in cells expressing an InsP3 sponge and were hence independent of InsP3 generation. Thus, we present a novel principle for a cell signaling microdomain where an ion pump serves as a receptor.	Astrid Lindgren Childrens Hosp, Karolinska Inst, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden; Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Minato Ku, Tokyo 1088639, Japan	Karolinska Institutet; University of Tokyo	Aperia, A (corresponding author), Astrid Lindgren Childrens Hosp, Karolinska Inst, Dept Woman & Child Hlth, Q2-09, S-17176 Stockholm, Sweden.	anita.aperia@ks.se	Mikoshiba, Katsuhiko/N-7943-2015; Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003; Uhlen, Per/0000-0003-1446-1062				Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; Belusa R, 1997, J BIOL CHEM, V272, P20179, DOI 10.1074/jbc.272.32.20179; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Blaustein MR, 2001, TRENDS NEUROSCI, V24, P602, DOI 10.1016/S0166-2236(00)01891-9; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; BOURGUIGNON LYW, 1993, J BIOL CHEM, V268, P7290; Boxenbaum N, 1998, J BIOL CHEM, V273, P23086, DOI 10.1074/jbc.273.36.23086; DALY SE, 1994, J BIOL CHEM, V269, P23944; Daly SE, 1996, J BIOL CHEM, V271, P23683, DOI 10.1074/jbc.271.39.23683; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; DEVARAJAN P, 1994, P NATL ACAD SCI USA, V91, P2965, DOI 10.1073/pnas.91.8.2965; DIBARTOLO V, 1995, LIFE SCI, V57, P1417, DOI 10.1016/0024-3205(95)02104-Q; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; FELDER CC, 1995, FASEB J, V9, P619, DOI 10.1096/fasebj.9.8.7768353; Haas M, 2000, J BIOL CHEM, V275, P27832; HAMLYN JM, 1991, P NATL ACAD SCI USA, V88, P6259, DOI 10.1073/pnas.88.14.6259; Haux J, 1999, MED HYPOTHESES, V53, P543, DOI 10.1054/mehy.1999.0985; Ichitani Y, 2001, CELL TISSUE RES, V303, P235, DOI 10.1007/s004410000296; Johenning FW, 2002, NEURON, V34, P173, DOI 10.1016/S0896-6273(02)00665-7; JORGENSEN PL, 1982, ANN NY ACAD SCI, V402, P207, DOI 10.1111/j.1749-6632.1982.tb25743.x; Karin M., 1999, SCI SIGNAL TRANSDUCT, V5, P1; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Lichtstein D, 2000, HYPERTENS RES, V23, pS51, DOI 10.1291/hypres.23.Supplement_S51; Lingrel JB, 1997, ANN NY ACAD SCI, V834, P194, DOI 10.1111/j.1749-6632.1997.tb52251.x; MONKAWA T, 1995, J BIOL CHEM, V270, P14700, DOI 10.1074/jbc.270.24.14700; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Peng M, 1996, J BIOL CHEM, V271, P10372, DOI 10.1074/jbc.271.17.10372; Peppiatt CM, 2003, CELL CALCIUM, V34, P97, DOI 10.1016/S0143-4160(03)00026-5; REPKE KRH, 1995, ANTI-CANCER DRUG DES, V10, P177; Segall L, 2002, J BIOL CHEM, V277, P35202, DOI 10.1074/jbc.M206115200; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; SUGIYAMA T, 1994, FEBS LETT, V354, P149, DOI 10.1016/0014-5793(94)01099-4; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Uchiyama T, 2002, J BIOL CHEM, V277, P8106, DOI 10.1074/jbc.M108337200; Uhlen P, 2000, NATURE, V405, P694, DOI 10.1038/35015091; Vakkuri O, 2000, J ENDOCRINOL, V165, P669, DOI 10.1677/joe.0.1650669; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; Zelenina M, 2002, AM J PHYSIOL-RENAL, V283, pF309, DOI 10.1152/ajprenal.00260.2001	47	148	152	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2003	278	50					50355	50361		10.1074/jbc.M305378200	http://dx.doi.org/10.1074/jbc.M305378200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751LH	12947118	hybrid			2022-12-27	WOS:000187068200085
J	Balboa, MA; Shirai, Y; Gaietta, G; Ellisman, MH; Balsinde, J; Dennis, EA				Balboa, MA; Shirai, Y; Gaietta, G; Ellisman, MH; Balsinde, J; Dennis, EA			Localization of Group V phospholipase A(2) in caveolin-enriched granules in activated P388D1 macrophage-like cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID MOBILIZATION; MAST-CELLS; PROSTAGLANDIN PRODUCTION; LEUKOTRIENE BIOSYNTHESIS; HUMAN NEUTROPHILS; ENZYMES; INHIBITION; EXPRESSION; GENERATION; SYNTHASE-2	In murine P388D(1) macrophages, the generation of prostaglandin E-2 in response to long term stimulation by lipopolysaccharide involves the action of Group V secreted phospholipase A(2) (PLA(2)), Group IV cytosolic PLA(2) (cPLA(2)), and cyclooxygenase-2 (COX-2). There is an initial activation of cPLA(2) that induces expression of Group V PLA(2), which in turn induces both the expression of COX-2 and most of the arachidonic acid substrate for COX-2-dependent prostaglandin E-2 generation. Because Group V PLA(2) is a secreted enzyme, it has been assumed that after cellular stimulation, it must be released to the extracellular medium and re-associates with the outer membrane to release arachidonic acid from phospholipids. In the present study, confocal laser scanning microscopy experiments utilizing both immunofluorescence and green fluorescent protein-labeled Group V PLA(2) shows that chronic exposure of the macrophages to lipopolysaccharide results in Group V PLA(2) being associated with caveolin-2-containing granules close to the perinuclear region. Heparin, a cell-impermeable complex carbohydrate with high affinity for Group V PLA(2), blocks that association, suggesting that the granules are formed by internalization of the Group V sPLA(2) previously associated with the outer cellular surface. Localization of Group V PLA(2) in perinuclear granules is not observed if the cells are treated with the Group IV PLA(2) inhibitor methyl arachidonyl fluorophosphonate, confirming the important role for Group IV PLA(2) in the activation process. Cellular staining with antibodies against COX-2 reveals the presence of COX-2-rich granules in close proximity to those containing Group V PLA(2). Collectively, these results suggest that encapsulation of Group V PLA(2) into granules brings the enzyme to the perinuclear envelope during cell activation where it may be closer to Group IV PLA(2) and COX-2 for efficient prostaglandin synthesis.	Univ Calif San Diego, Sch Med, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Valladolid, Sch Med, Inst Mol Biol & Genet, E-47005 Valladolid, Spain; Univ Calif San Diego, Sch Med, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; University of California System; University of California San Diego; University of California System; University of California San Diego	Dennis, EA (corresponding author), Univ Calif San Diego, Sch Med, Dept Chem & Biochem, La Jolla, CA 92093 USA.	edennis@ucsd.edu	Shirai, Yasuhito/O-3255-2018; Balsinde, Jesús/C-7833-2018; Balboa, María A./V-9493-2018; Dennis, Edward A./M-5554-2019	Balsinde, Jesús/0000-0002-4157-6714; Balboa, María A./0000-0002-2130-5298; Dennis, Edward A./0000-0003-3738-3140	NCRR NIH HHS [P41 RR04050] Funding Source: Medline; NICHD NIH HHS [HD26171] Funding Source: Medline; NIGMS NIH HHS [GM20501] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026171] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Balboa MA, 1996, J BIOL CHEM, V271, P32381, DOI 10.1074/jbc.271.50.32381; Balsinde J, 2000, J BIOL CHEM, V275, P22544, DOI 10.1074/jbc.M910163199; Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175; Balsinde J, 1998, P NATL ACAD SCI USA, V95, P7951, DOI 10.1073/pnas.95.14.7951; BALSINDE J, 1994, P NATL ACAD SCI USA, V91, P11060, DOI 10.1073/pnas.91.23.11060; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; BARBOUR SE, 1993, J BIOL CHEM, V268, P21875; Bingham CO, 1999, J BIOL CHEM, V274, P31476, DOI 10.1074/jbc.274.44.31476; Bingham CO, 1996, J BIOL CHEM, V271, P25936, DOI 10.1074/jbc.271.42.25936; CHEN J, 1994, J BIOL CHEM, V269, P2365; Cho W, 2000, BBA-MOL CELL BIOL L, V1488, P48, DOI 10.1016/S1388-1981(00)00109-8; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Gargalovic P, 2003, J LIPID RES, V44, P11, DOI 10.1194/jlr.R200005-JLR200; Kim KP, 2001, J BIOL CHEM, V276, P11126, DOI 10.1074/jbc.M004604200; Kim YJ, 2002, J BIOL CHEM, V277, P36479, DOI 10.1074/jbc.M205399200; Kim YJ, 2002, J BIOL CHEM, V277, P9358, DOI 10.1074/jbc.M110987200; Munoz NM, 2003, J BIOL CHEM, V278, P38813, DOI 10.1074/jbc.M302476200; Murakami M, 2000, BBA-MOL CELL BIOL L, V1488, P159, DOI 10.1016/S1388-1981(00)00118-9; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Murakami M, 1999, J BIOL CHEM, V274, P29927, DOI 10.1074/jbc.274.42.29927; MURAKAMI M, 2002, PROSTAGLANDINS, V68, P3; Reddy ST, 1997, J BIOL CHEM, V272, P3231, DOI 10.1074/jbc.272.6.3231; Reddy ST, 1997, J BIOL CHEM, V272, P13591, DOI 10.1074/jbc.272.21.13591; Shinohara H, 1999, J BIOL CHEM, V274, P12263, DOI 10.1074/jbc.274.18.12263; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886	28	59	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48059	48065		10.1074/jbc.M305904200	http://dx.doi.org/10.1074/jbc.M305904200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12963740	Green Published, hybrid			2022-12-27	WOS:000186731400085
J	Gaboriaud, C; Juanhuix, J; Gruez, A; Lacroix, M; Darnault, C; Pignol, D; Verger, D; Fontecilla-Camps, JC; Arlaud, GJ				Gaboriaud, C; Juanhuix, J; Gruez, A; Lacroix, M; Darnault, C; Pignol, D; Verger, D; Fontecilla-Camps, JC; Arlaud, GJ			The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; TUMOR-NECROSIS-FACTOR; B-CHAIN; IMMUNOGLOBULIN-G; 1ST COMPONENT; BINDING-SITE; 3-DIMENSIONAL STRUCTURE; ARGININE RESIDUES; SUBCOMPONENT C1Q; INNATE IMMUNITY	C1q is a versatile recognition protein that binds to an amazing variety of immune and non-immune ligands and triggers activation of the classical pathway of complement. The crystal structure of the C1q globular domain responsible for its recognition properties has now been solved and refined to 1.9 Angstrom of resolution. The structure reveals a compact, almost spherical heterotrimeric assembly held together mainly by non-polar interactions, with a Ca2+ ion bound at the top. The heterotrimeric assembly of the C1q globular domain appears to be a key factor of the versatile recognition properties of this protein. Plausible three-dimensional models of the C1q globular domain in complex with two of its physiological ligands, C-reactive protein and IgG, are proposed, highlighting two of the possible recognition modes of C1q. The C1q/human IgG1 model suggests a critical role for the hinge region of IgG and for the relative orientation of its Fab domain in C1q binding.	Univ Grenoble 1, CNRS, CEA,Inst Biol Struct Jean Pierre Ebel, Lab Enzymol Mol, F-38027 Grenoble 1, France; Univ Grenoble 1, CNRS, CEA,Inst Biol Struct Jean Pierre Ebel, Lab Cristallog & Cristallog Prot, F-38027 Grenoble, France; Lab Llum Sincrotro, Barcelona 08193, Spain; CEA Cadarache, Dept Ecophysiol Vegetale & Microbiol, Lab Bioenerget Cellulaire, F-13108 St Paul Les Durance, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA	Arlaud, GJ (corresponding author), Univ Grenoble 1, CNRS, CEA,Inst Biol Struct Jean Pierre Ebel, Lab Enzymol Mol, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.		Juanhuix, Judith/AAS-5222-2020	Juanhuix, Judith/0000-0003-3728-8215; PIGNOL, David/0000-0002-8070-0319				Agrawal A, 2001, J IMMUNOL, V166, P3998, DOI 10.4049/jimmunol.166.6.3998; Arlaud GJ, 2002, MOL IMMUNOL, V39, P383, DOI 10.1016/S0161-5890(02)00143-8; ARLAUD GJ, 1979, MOL IMMUNOL, V16, P445, DOI 10.1016/0161-5890(79)90069-5; Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4; BREDT W, 1977, INFECT IMMUN, V15, P7, DOI 10.1128/IAI.15.1.7-12.1977; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURTON DR, 1980, NATURE, V288, P338, DOI 10.1038/288338a0; COMIS A, 1985, BIOCHIM BIOPHYS ACTA, V842, P45, DOI 10.1016/0304-4165(85)90291-0; COOPER NR, 1985, ADV IMMUNOL, V37, P151, DOI 10.1016/S0065-2776(08)60340-5; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Ferrer JL, 1998, J SYNCHROTRON RADIAT, V5, P1346, DOI 10.1107/S0909049598004257; GUDDAT LW, 1993, P NATL ACAD SCI USA, V90, P4271, DOI 10.1073/pnas.90.9.4271; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Idusogie EE, 2001, J IMMUNOL, V166, P2571, DOI 10.4049/jimmunol.166.4.2571; ISENMAN DE, 1975, J IMMUNOL, V114, P1726; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KILCHHERR E, 1985, J MOL BIOL, V186, P403, DOI 10.1016/0022-2836(85)90114-7; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kishore U, 2003, J IMMUNOL, V171, P812, DOI 10.4049/jimmunol.171.2.812; Kishore U, 1998, BIOCHEM J, V333, P27, DOI 10.1042/bj3330027; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Kojouharova MS, 1998, J IMMUNOL, V161, P4325; Lacroix M, 1997, BIOCHEMISTRY-US, V36, P6270, DOI 10.1021/bi962719i; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; MARQUES G, 1993, J BIOL CHEM, V268, P10393; MCCALL MN, 1989, BIOCHEM J, V257, P845, DOI 10.1042/bj2570845; MIZUOCHI T, 1978, J BIOL CHEM, V253, P7404; MOY JP, 1994, NUCL INSTRUM METH A, V348, P641, DOI 10.1016/0168-9002(94)90815-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Navratil JS, 2001, J IMMUNOL, V166, P3231, DOI 10.4049/jimmunol.166.5.3231; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PETRY F, 1991, J IMMUNOL, V147, P3988; Pidcock E, 2001, J BIOL INORG CHEM, V6, P479, DOI 10.1007/s007750100214; Rainey JK, 2002, PROTEIN SCI, V11, P2748, DOI 10.1110/ps.0218502; REID KBM, 1982, BIOCHEM J, V203, P559, DOI 10.1042/bj2030559; Ritchie DW, 2003, PROTEINS, V52, P98, DOI 10.1002/prot.10379; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; ROSSI V, 1995, BIOCHEMISTRY-US, V34, P7311, DOI 10.1021/bi00022a004; SANTORO F, 1980, J IMMUNOL, V124, P2886; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; STORRS SB, 1981, J BIOL CHEM, V256, P924; Szalai AJ, 1999, CLIN CHEM LAB MED, V37, P265, DOI 10.1515/CCLM.1999.046; Tacnet-Delorme P, 2001, J IMMUNOL, V167, P6374, DOI 10.4049/jimmunol.167.11.6374; Thielens NM, 2002, IMMUNOBIOLOGY, V205, P563, DOI 10.1078/0171-2985-00155; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; VILLIERS CL, 1980, FEBS LETT, V117, P289, DOI 10.1016/0014-5793(80)80964-1; VUILLARD L, 1994, FEBS LETT, V353, P294, DOI 10.1016/0014-5793(94)01060-9	59	272	328	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46974	46982		10.1074/jbc.M307764200	http://dx.doi.org/10.1074/jbc.M307764200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12960167	hybrid			2022-12-27	WOS:000186569400092
J	Mutucumarana, VP; Acher, F; Straight, DL; Jin, DY; Stafford, DW				Mutucumarana, VP; Acher, F; Straight, DL; Jin, DY; Stafford, DW			A conserved region of human vitamin K-dependent carboxylase between residues 393 and 404 is important for its interaction with the glutamate substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; BLOOD-COAGULATION FACTORS; POSTTRANSLATIONAL MODIFICATION; COMBINED DEFICIENCY; PROPEPTIDE REGION; PEPTIDE-SUBSTRATE; RECOGNITION SITE; ENZYME-ACTIVITY; ACTIVE-SITE; FACTOR-IX	Certain individuals with combined deficiencies of vitamin K- dependent proteins have a mutation, L394R, in their gamma- glutamyl carboxylase causing impaired glutamate binding. The sequence surrounding Leu(394) is similar in all known carboxylases, suggesting that the region is functionally important. To test this hypothesis we made the following mutant enzymes: W390A, Y395A, S398A, W399A, and H404A. We purified the enzymes and corrected the activity measurements for active enzyme concentration. Carboxylases W390A, S398A, and H404A had activities similar to that of wild type; however, Y395A and W399A had lower activities than did wild type. In the following descriptions we include our previously reported results for L394R. Kinetic studies with the substrate FLEEL, revealed K-m values of 0.5 ( wild type), 6.5 ( L394R), 15 ( Y395A), and 24 ( W399A) mM. The k(cat) values relative to wild type were 51% ( L394R), 1% ( Y395A), and 2% ( W399A). The k(cat)/ K-m values were 24- fold ( L394R) and > 2000- fold lower for Y395A and W399A than for wild- type carboxylase. Inhibition of FLEEL carboxylation by the competitive inhibitor, Boc- mEEV, gave K-i values of 0.013 ( wild type), 1.4 ( L394R), 2.1 ( Y395A), and > 5 ( W399A) mM. The Y395A propeptide affinity was similar to that of wild type, but those of L394R and W399A were 16 - 22- fold less than that of wild type. Results of kinetic studies with a propeptide- containing substrate were consistent with results of propeptide binding and FLEEL kinetics. Although propeptide and vitamin K binding in some mutants were affected, our data provide compelling evidence that glutamate recognition is the primary function of the conserved region around Leu(394).	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ Paris 05, CNRS, UMR 8601, Chim & Biochim Pharmacol & Toxicol Lab, F-75270 Paris 06, France	University of North Carolina; University of North Carolina Chapel Hill; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Stafford, DW (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.				NHLBI NIH HHS [HL 48318] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048318] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AZERAD R, 1988, CURRENT ADV VITAMIN, P17; Bandyopadhyay PK, 2002, P NATL ACAD SCI USA, V99, P1264, DOI 10.1073/pnas.022637099; Begley GS, 2000, J BIOL CHEM, V275, P36245, DOI 10.1074/jbc.M003944200; BRENNER B, 1990, BRIT J HAEMATOL, V75, P537, DOI 10.1111/j.1365-2141.1990.tb07795.x; Brenner B, 1998, BLOOD, V92, P4554, DOI 10.1182/blood.V92.12.4554.424k42_4554_4559; CARLISLE TL, 1980, BIOCHEMISTRY-US, V19, P1161, DOI 10.1021/bi00547a019; CHEUNG A, 1989, ARCH BIOCHEM BIOPHYS, V274, P574, DOI 10.1016/0003-9861(89)90472-4; DOWD P, 1995, SCIENCE, V269, P1684, DOI 10.1126/science.7569894; ESMON CT, 1975, J BIOL CHEM, V250, P4744; Houben RJTJ, 2002, BIOCHEM J, V364, P323, DOI 10.1042/bj3640323; HUBBARD BR, 1989, J BIOL CHEM, V264, P14145; KNOBLOCH JE, 1987, J BIOL CHEM, V262, P15334; KULIOPULOS A, 1994, J BIOL CHEM, V269, P21364; Kulman JD, 1997, P NATL ACAD SCI USA, V94, P9058, DOI 10.1073/pnas.94.17.9058; Kulman JD, 2001, P NATL ACAD SCI USA, V98, P1370, DOI 10.1073/pnas.98.4.1370; Li T, 2000, J BIOL CHEM, V275, P18291, DOI 10.1074/jbc.M001790200; Maillet M, 1997, FEBS LETT, V413, P1, DOI 10.1016/S0014-5793(97)00831-4; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; MORRIS DP, 1993, J BIOL CHEM, V268, P8735; Morris DP, 1995, J BIOL CHEM, V270, P30491, DOI 10.1074/jbc.270.51.30491; Mutucumarana VP, 2000, J BIOL CHEM, V275, P32572, DOI 10.1074/jbc.M006808200; Presnell SR, 2001, BIOCHEMISTRY-US, V40, P11723, DOI 10.1021/bi010332w; PRICE PA, 1988, ANNU REV NUTR, V8, P565, DOI 10.1146/annurev.nu.08.070188.003025; Pudota BN, 2000, P NATL ACAD SCI USA, V97, P13033, DOI 10.1073/pnas.97.24.13033; Pudota BN, 2001, J BIOL CHEM, V276, P46878, DOI 10.1074/jbc.M108696200; REHEMTULLA A, 1993, P NATL ACAD SCI USA, V90, P4611, DOI 10.1073/pnas.90.10.4611; RICH DH, 1981, J MED CHEM, V24, P706, DOI 10.1021/jm00138a013; Romero EE, 1998, BIOCHEM BIOPH RES CO, V248, P783, DOI 10.1006/bbrc.1998.8987; Shimizu A, 1998, BIOCHEM BIOPH RES CO, V251, P22, DOI 10.1006/bbrc.1998.9410; SOUTE BAM, 1990, BIOCHIM BIOPHYS ACTA, V1034, P11, DOI 10.1016/0304-4165(90)90146-N; Spronk HMH, 2000, BLOOD, V96, P3650; Stanley TB, 1998, BIOCHEMISTRY-US, V37, P13262, DOI 10.1021/bi981031y; Stanley TB, 1999, J BIOL CHEM, V274, P16940, DOI 10.1074/jbc.274.24.16940; Stanley TB, 1999, BIOCHEMISTRY-US, V38, P15681, DOI 10.1021/bi991544k; STEARNS DJ, 1988, J BIOL CHEM, V263, P826; Sugiura I, 1996, J BIOL CHEM, V271, P17837, DOI 10.1074/jbc.271.30.17837; Sugiura I, 1997, P NATL ACAD SCI USA, V94, P9069, DOI 10.1073/pnas.94.17.9069; SUTTIE JW, 1980, CRC CR REV BIOCH MOL, V8, P191, DOI 10.3109/10409238009105469; THIJSSEN HHW, 1986, BIOCHEM PHARMACOL, V35, P3277, DOI 10.1016/0006-2952(86)90424-7; Tie J, 2000, BLOOD, V96, P973, DOI 10.1182/blood.V96.3.973.015k55_973_978; ULRICH MMW, 1988, J BIOL CHEM, V263, P9697; UOTILA L, 1988, ARCH BIOCHEM BIOPHYS, V264, P135, DOI 10.1016/0003-9861(88)90578-4; Walker CS, 2001, J BIOL CHEM, V276, P7769, DOI 10.1074/jbc.M009576200; WALLIN R, 1982, ARCH BIOCHEM BIOPHYS, V214, P155, DOI 10.1016/0003-9861(82)90017-0; WOOD GM, 1988, J BIOL CHEM, V263, P3234; WU SM, 1990, J BIOL CHEM, V265, P13124; WU SM, 1991, SCIENCE, V254, P1634, DOI 10.1126/science.1749935; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117	48	27	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46488	46493		10.1074/jbc.M307707200	http://dx.doi.org/10.1074/jbc.M307707200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12968027	hybrid, Green Published			2022-12-27	WOS:000186569400034
J	Peterson, JH; Woolhead, CA; Bernstein, HD				Peterson, JH; Woolhead, CA; Bernstein, HD			Basic amino acids in a distinct subset of signal peptides promote interaction with the signal recognition particle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; MALTOSE-BINDING PROTEIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; NASCENT PREPROLACTIN; TARGETING PATHWAYS; SECRETORY PROTEIN; ANCHOR SEQUENCES; TRIGGER FACTOR; IN-VITRO	Previous studies have demonstrated that signal peptides bind to the signal recognition particle (SRP) primarily via hydrophobic interactions with the 54-kDa protein subunit. The crystal structure of the conserved SRP ribonucleoprotein core, however, raised the surprising possibility that electrostatic interactions between basic amino acids in signal peptides and the phosphate backbone of SRP RNA may also play a role in signal sequence recognition. To test this possibility we examined the degree to which basic amino acids in a signal peptide influence the targeting of two Escherichia coli proteins, maltose binding protein and OmpA. Whereas both proteins are normally targeted to the inner membrane by SecB, we found that replacement of their native signal peptides with another moderately hydrophobic but unusually basic signal peptide (DeltaEspP) rerouted them into the SRP pathway. Reduction in either the net positive charge or the hydrophobicity of the DeltaEspP signal peptide decreased the effectiveness of SRP recognition. A high degree of hydrophobicity, however, compensated for the loss of basic residues and restored SRP binding. Taken together, the data suggest that the formation of salt bridges between SRP RNA and basic amino acids facilitates the binding of a distinct subset of signal peptides whose hydrophobicity falls slightly below a threshold level.	NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bernstein, HD (corresponding author), NIDDK, Genet & Biochem Branch, NIH, Bldg 5,Rm 201, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK052022, ZIADK052022] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDREWS DW, 1992, J BIOL CHEM, V267, P7761; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Clemons WM, 1999, J MOL BIOL, V292, P697, DOI 10.1006/jmbi.1999.3090; COLLIER DN, 1989, J BACTERIOL, V171, P4640, DOI 10.1128/jb.171.9.4640-4647.1989; CONNOLLY T, 1991, SCIENCE, V252, P1171, DOI 10.1126/science.252.5009.1171; de Gier JWL, 1998, P NATL ACAD SCI USA, V95, P14646, DOI 10.1073/pnas.95.25.14646; DEGIER JW, 1996, FEBS LETT, V99, P307; Freymann DM, 1997, NATURE, V385, P361, DOI 10.1038/385361a0; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; HIGH S, 1991, J CELL BIOL, V113, P35, DOI 10.1083/jcb.113.1.35; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Koch HG, 1999, MOL BIOL CELL, V10, P2163, DOI 10.1091/mbc.10.7.2163; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; KUMAMOTO CA, 1985, J BACTERIOL, V163, P267, DOI 10.1128/JB.163.1.267-274.1985; KURZCHALIA TV, 1986, NATURE, V320, P634, DOI 10.1038/320634a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee HC, 2002, J BIOL CHEM, V277, P43527, DOI 10.1074/jbc.M205950200; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; LESLEY SA, 1991, J BIOL CHEM, V266, P2632; Lu Y, 2001, EMBO J, V20, P6724, DOI 10.1093/emboj/20.23.6724; MEYER DI, 1982, NATURE, V297, P647, DOI 10.1038/297647a0; MILLER JD, 1993, NATURE, V366, P351, DOI 10.1038/366351a0; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; NOTHWEHR SF, 1990, J BIOL CHEM, V265, P17202; Park SK, 2002, J BACTERIOL, V184, P2642, DOI 10.1128/JB.184.10.2642-2653.2002; PORITZ MA, 1990, SCIENCE, V250, P1111, DOI 10.1126/science.1701272; RANDALL LL, 1986, CELL, V46, P921, DOI 10.1016/0092-8674(86)90074-7; SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16; Sijbrandi R, 2003, J BIOL CHEM, V278, P4654, DOI 10.1074/jbc.M211630200; SZCZESNASKORUPA E, 1987, J BIOL CHEM, V262, P8896; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; Voigt S, 1996, J CELL BIOL, V134, P25, DOI 10.1083/jcb.134.1.25; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545	39	66	67	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46155	46162		10.1074/jbc.M309082200	http://dx.doi.org/10.1074/jbc.M309082200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12949068	hybrid			2022-12-27	WOS:000186452300133
J	Wang, YN; Chang, WC				Wang, YN; Chang, WC			Induction of disease-associated keratin 16 gene expression by epidermal growth factor is regulated through cooperation of transcription factors Sp1 and c-Jun	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FACTOR-ALPHA; IN-VIVO; HUMAN 12(S)-LIPOXYGENASE; FUNCTIONAL INTERACTION; 12-LIPOXYGENASE GENE; CELL-PROLIFERATION; PROMOTER ACTIVITY; DNA-BINDING; ACTIVATION	Overexpression of keratin 16 has been observed in keratinocytes in those skin diseases characterized by hyperproliferation such as psoriasis. Therefore, keratin 16 is usually referred to as a disease-associated keratin. In the present study, we found that epidermal growth factor (EGF) increased the expression of keratin 16 mRNA and protein synthesis in a time-dependent manner in HaCaT cells. Reporter assays revealed that the EGF response region was in the range of -162 to -114 bp. Disruption of the Sp1 site <LF>(-127 to -122 bp) and the AP1 site (-148 to -142 bp) of the keratin 16 promoter by site-directed mutagenesis significantly inhibited keratin 16 promoter activity induced by EGF. Furthermore, keratin 16 gene expression induced by Ras activation was also regulated in the same manner as the EGF response. By using the DNA affinity precipitation assay in HaCaT and SL2 cells, Sp1 directly interacted with the Sp1 site of the promoter, and c-Jun and c-Fos precipitated with the Sp1 oligonucleotide was attributable to the interaction between the Sp1 and AP1 proteins. Moreover, cotransfection assays revealed that Sp1 acted synergistically with c-Jun to activate keratin 16. The coactivators p300/CBP could collaborate with Sp1 and c-Jun in the activation of keratin 16 promoter, and EGF-induced promoter activation was blocked by the viral oncoprotein E1A. Taken together, these results suggest that Sp1 and AP1 sites in the essential promoter region are critical for EGF response, and Sp1 showed a functional cooperation with c-Jun and coactivators p300/CBP in driving the transcriptional regulation of EGF-induced keratin 16 gene expression.	Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 701, Taiwan	National Cheng Kung University	Chang, WC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 701, Taiwan.							Abate C, 1990, Semin Cancer Biol, V1, P19; ARAKAWA T, 1995, FEBS LETT, V363, P105, DOI 10.1016/0014-5793(95)00293-I; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; Bannister AJ, 1995, ONCOGENE, V11, P2509; Brembeck FH, 2000, J BIOL CHEM, V275, P28230; Chen BK, 2000, P NATL ACAD SCI USA, V97, P10406, DOI 10.1073/pnas.180321497; Chen BK, 2002, J BIOMED SCI, V9, P156, DOI 10.1159/000048212; Chen BK, 2000, MOL PHARMACOL, V57, P153; Corden L D, 1996, Exp Dermatol, V5, P297, DOI 10.1111/j.1600-0625.1996.tb00133.x; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; ELDER JT, 1989, SCIENCE, V243, P811, DOI 10.1126/science.2916128; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; FUCHS E, 1994, CURR OPIN GENET DEV, V4, P725, DOI 10.1016/0959-437X(94)90140-X; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hirano F, 1998, MOL CELL BIOL, V18, P1266, DOI 10.1128/MCB.18.3.1266; Hu PPC, 1999, MOL ENDOCRINOL, V13, P2039, DOI 10.1210/me.13.12.2039; JIANG CK, 1993, P NATL ACAD SCI USA, V90, P6786, DOI 10.1073/pnas.90.14.6786; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Komine M, 2001, J INVEST DERMATOL, V116, P330, DOI 10.1046/j.1523-1747.2001.01249.x; Komine M, 2000, J BIOL CHEM, V275, P32077, DOI 10.1074/jbc.M001253200; LEE JS, 1993, P NATL ACAD SCI USA, V90, P6145, DOI 10.1073/pnas.90.13.6145; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Liu YW, 1997, BIOCHEM J, V324, P133, DOI 10.1042/bj3240133; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; Machesney M, 1998, AM J PATHOL, V152, P1133; MAGNALDO T, 1993, DNA CELL BIOL, V12, P911, DOI 10.1089/dna.1993.12.911; May GHW, 1998, J BIOL CHEM, V273, P33429, DOI 10.1074/jbc.273.50.33429; MCLEAN WHI, 1995, NAT GENET, V9, P273, DOI 10.1038/ng0395-273; NANNEY LB, 1986, J INVEST DERMATOL, V86, P260, DOI 10.1111/1523-1747.ep12285389; Paramio JM, 1999, MOL CELL BIOL, V19, P3086; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Rossi A, 1998, J INVEST DERMATOL, V110, P34, DOI 10.1046/j.1523-1747.1998.00071.x; Sano Y, 1998, J BIOL CHEM, V273, P29098, DOI 10.1074/jbc.273.44.29098; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Smith CL, 1996, P NATL ACAD SCI USA, V93, P8884, DOI 10.1073/pnas.93.17.8884; Somasundaram K, 1997, ONCOGENE, V14, P1047, DOI 10.1038/sj.onc.1201002; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; WETZELS RHW, 1991, AM J PATHOL, V138, P751; Xiao HY, 2000, J BIOL CHEM, V275, P1371, DOI 10.1074/jbc.275.2.1371; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009; ZHANG K, 1990, P NATL ACAD SCI USA, V87, P6281, DOI 10.1073/pnas.87.16.6281; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200	48	50	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45848	45857		10.1074/jbc.M302630200	http://dx.doi.org/10.1074/jbc.M302630200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954631	hybrid			2022-12-27	WOS:000186452300098
J	Bruck, I; Goodman, MF; O'Donnell, M				Bruck, I; Goodman, MF; O'Donnell, M			The essential C family DnaE polymerase is error-prone and efficient at lesion bypass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; III HOLOENZYME; MYCOBACTERIUM-TUBERCULOSIS; TRANSLESION REPLICATION; REVERSE-TRANSCRIPTASE; STAPHYLOCOCCUS-AUREUS; PROOFREADING FUNCTION; BASE SUBSTITUTION; EPSILON-SUBUNIT; SOS MUTAGENESIS	DnaE-type DNA polymerases belong to the C family of DNA polymerases and are responsible for chromosomal replication in prokaryotes. Like most closely related Gram-positive cells, Streptococcus pyogenes has two DnaE homologs Pol C and DnaE; both are essential to cell viability. Pol C is an established replicative polymerase, and DnaE has been proposed to serve a replicative role. In this report, we characterize S. pyogenes DnaE polymerase and find that it is highly error-prone. DnaE can bypass coding and noncoding lesions with high efficiency. Error-prone extension is accomplished by either of two pathways, template-primer misalignment or direct primer extension. The bypass of abasic sites is accomplished mainly through "dNTP-stabilized" misalignment of template, thereby generating (-1) deletions in the newly synthesized strand. This mechanism may be similar to the dNTP-stabilized misalignment mechanism used by the Y family of DNA polymerases and is the first example of lesion bypass and error-prone synthesis catalyzed by a C family polymerase. Thus, DnaE may function in an error-prone capacity that may be essential in Gram-positive cells but not Gram-negative cells, suggesting a fundamental difference in DNA metabolism between these two classes of bacteria.	Rockefeller Univ, New York, NY 10021 USA; Univ So Calif, Dept Biol Sci & Chem, Los Angeles, CA 90089 USA	Rockefeller University; University of Southern California	Bruck, I (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	bruck@mod.rockefeller.edu; odonnel@rockvax.rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062540, R37GM038839, R37GM021422, R01GM021422, R01GM038839] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38839, GM62540, GM21422] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARNES MH, 1994, MOL MICROBIOL, V13, P843, DOI 10.1111/j.1365-2958.1994.tb00476.x; Barnes MH, 2002, J BACTERIOL, V184, P3834, DOI 10.1128/JB.184.14.3834-3838.2002; BAZILL GW, 1973, NATURE-NEW BIOL, V243, P241, DOI 10.1038/newbio243241a0; Berdichevsky A, 2002, MOL CELL, V10, P917, DOI 10.1016/S1097-2765(02)00679-2; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; BOITEUX S, 1982, BIOCHEMISTRY-US, V21, P6746, DOI 10.1021/bi00269a020; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Borden A, 2002, J BACTERIOL, V184, P2674, DOI 10.1128/JB.184.10.2674-2681.2002; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Bruck I, 2000, J BIOL CHEM, V275, P28971, DOI 10.1074/jbc.M003565200; CAI H, 1995, J BIOL CHEM, V270, P15327, DOI 10.1074/jbc.270.25.15327; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; COZZARELLI NR, 1973, BIOCHEM BIOPH RES CO, V51, P151, DOI 10.1016/0006-291X(73)90521-4; CRAIG RJ, 1984, MOL GEN GENET, V194, P539, DOI 10.1007/BF00425572; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Davis EO, 2002, J BACTERIOL, V184, P3287, DOI 10.1128/JB.184.12.3287-3295.2002; Dervyn E, 2001, SCIENCE, V294, P1716, DOI 10.1126/science.1066351; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Efrati E, 1997, J BIOL CHEM, V272, P2559; Foster KA, 2003, PROTEIN EXPRES PURIF, V27, P90, DOI 10.1016/S1046-5928(02)00577-6; FREESE E, 1959, J MOL BIOL, V1, P87, DOI 10.1016/S0022-2836(59)80038-3; Goodman MF, 2000, NAT REV MOL CELL BIO, V1, P101, DOI 10.1038/35040051; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; Haracska L, 2002, P NATL ACAD SCI USA, V99, P16000, DOI 10.1073/pnas.252524999; HOPKINS R, 1979, J MOL BIOL, V135, P1, DOI 10.1016/0022-2836(79)90337-1; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Inoue R, 2001, MOL GENET GENOMICS, V266, P564, DOI 10.1007/s004380100564; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; KESPI T, 1999, MOL CELL, V3, P679; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; Kornberg A., 1992, DNA REPLICATION, P165; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Leu FP, 2003, MOL CELL, V11, P315, DOI 10.1016/S1097-2765(03)00042-X; MAKI H, 1987, P NATL ACAD SCI USA, V84, P4389, DOI 10.1073/pnas.84.13.4389; MAKI S, 1988, J BIOL CHEM, V263, P6561; MCHENRY CS, 1988, ANNU REV BIOCHEM, V57, P519; Mo JY, 1996, J BIOL CHEM, V271, P18947, DOI 10.1074/jbc.271.31.18947; PACITTI DF, 1995, GENE, V165, P51, DOI 10.1016/0378-1119(95)00377-I; Patel PH, 2000, P NATL ACAD SCI USA, V97, P5095, DOI 10.1073/pnas.97.10.5095; Pham P, 2001, P NATL ACAD SCI USA, V98, P8350, DOI 10.1073/pnas.111007198; Pham PT, 1999, J BIOL CHEM, V274, P3705, DOI 10.1074/jbc.274.6.3705; Pham PT, 1998, J BIOL CHEM, V273, P23575, DOI 10.1074/jbc.273.36.23575; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; RANDALL SK, 1987, J BIOL CHEM, V262, P6864; RUNDNER R, 1960, BIOCHEM BIOPH RES CO, V3, P275, DOI 10.1016/0006-291X(60)90239-4; SAGHER D, 1985, NUCLEIC ACIDS RES, V13, P4285, DOI 10.1093/nar/13.12.4285; SCHAAPER RM, 1983, P NATL ACAD SCI-BIOL, V80, P487, DOI 10.1073/pnas.80.2.487; SCHEUERMANN RH, 1984, P NATL ACAD SCI-BIOL, V81, P7747, DOI 10.1073/pnas.81.24.7747; SIMILI M, 1990, MUTAT RES, V244, P157, DOI 10.1016/0165-7992(90)90066-S; SLATER SC, 1994, J BACTERIOL, V176, P815, DOI 10.1128/jb.176.3.815-821.1994; SOMMER S, 1993, MOL MICROBIOL, V10, P963, DOI 10.1111/j.1365-2958.1993.tb00968.x; SONNENSHEIN AL, 2002, BACILLUS SUBTILIS IT; STRAUSS BS, 1991, BIOESSAYS, V13, P79, DOI 10.1002/bies.950130206; STUDWELLVAUGHAN PS, 1993, J BIOL CHEM, V268, P11785; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Vandewiele D, 1998, P NATL ACAD SCI USA, V95, P15519, DOI 10.1073/pnas.95.26.15519; Wang ZJ, 2002, J BIOL CHEM, V277, P4446, DOI 10.1074/jbc.M110006200; Xu Y, 2000, J BIOL CHEM, V275, P20949, DOI 10.1074/jbc.M909135199; YU H, 1992, J BIOL CHEM, V267, P10888	64	37	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44361	44368		10.1074/jbc.M308307200	http://dx.doi.org/10.1074/jbc.M308307200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12949067	hybrid			2022-12-27	WOS:000186306700060
J	Shi, XL; Stoj, C; Romeo, A; Kosman, DJ; Zhu, ZW				Shi, XL; Stoj, C; Romeo, A; Kosman, DJ; Zhu, ZW			Fre1p Cu2+ reduction and fet3p Cu1+ oxidation modulate copper toxicity in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED FORM; AFFINITY IRON TRANSPORT; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; TRANSCRIPTION FACTOR; YEAST; CERULOPLASMIN; GENE; PROTEIN; EXPRESSION	Fre1p is a metalloreductase in the yeast plasma membrane that is essential to uptake of environmental Cu2+ and Fe3+. Fet3p is a multicopper oxidase in this membrane essential for high affinity iron uptake. In the uptake of Fe3+, Fre1p produces Fe2+ that is a substrate for Fet3p; the Fe3+ produced by Fet3p is a ligand for the iron permease, Ftr1p. Deletion of FET3 leads to iron deficiency; this deletion also causes a copper sensitivity not seen in wild type. Deletion of FTR1 leads to copper sensitivity also. Production in the ftr1Delta strain of an iron-uptake negative Ftr1p mutant, Ftr1p(RAGLA), suppressed this copper sensitivity. This Ftr1p mutant supported the plasma membrane targeting of active Fet3p that is blocked in the parental ftr1Delta strain. A ferroxidase-negative Fet3p did not suppress the copper sensitivity in a fet3Delta strain, although it supported the plasma membrane localization of the Fet3p . Ftr1p complex. Thus, loss of membrane-associated Fet3p oxidase activity correlated with copper sensitivity. Furthermore, in vitro Cu1+ was shown to be an excellent substrate for Fet3p. Last, the copper sensitivity of the fet3Delta strain was suppressed by co-deletion of FRE1, suggesting that the cytotoxic species was Cu1+. In contrast, deletion of CTR1 or of FET4 did not suppress the copper sensitivity in the fet3Delta strain; these genes encode the two major copper transporters in laboratory yeast strains. This result indicated that the apparent cuprous ion toxicity was not due to excess intracellular copper. These biochemical and physiologic results indicate that at least with respect to cuprous and ferrous ions, Fet3p can be considered a metallo-oxidase and appears to play an essential role in both iron and copper homeostasis in yeast. Its functional homologs, e. g. ceruloplasmin and hephaestin, could play a similar role in mammals.	Univ Calif Santa Cruz, Dept Environm Toxicol, Santa Cruz, CA 95064 USA; SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	University of California System; University of California Santa Cruz; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zhu, ZW (corresponding author), Univ Calif Santa Cruz, Dept Environm Toxicol, Santa Cruz, CA 95064 USA.		Shi, Xianglin/B-8588-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053820] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK53820] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANG TP, 2003, IN PRESS J BIOL INOR, V8; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; BESWICK PH, 1976, CHEM-BIOL INTERACT, V14, P347, DOI 10.1016/0009-2797(76)90113-7; Buettner G R, 1986, Free Radic Res Commun, V1, P349, DOI 10.3109/10715768609051638; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; DESILVA DM, 1995, J BIOL CHEM, V270, P1098, DOI 10.1074/jbc.270.3.1098; Dix D, 1997, J BIOL CHEM, V272, P11770, DOI 10.1074/jbc.272.18.11770; Fortna RR, 1999, BIOL REPROD, V61, P1042, DOI 10.1095/biolreprod61.4.1042; Georgatsou E, 1999, YEAST, V15, P573, DOI 10.1002/(SICI)1097-0061(199905)15:7<573::AID-YEA404>3.3.CO;2-Z; Graden JA, 1997, P NATL ACAD SCI USA, V94, P5550, DOI 10.1073/pnas.94.11.5550; Grass G, 2001, J BACTERIOL, V183, P2145, DOI 10.1128/JB.183.6.2145-2147.2001; Gross C, 2000, J BIOL CHEM, V275, P32310, DOI 10.1074/jbc.M005946200; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Hassett R, 2000, BIOCHEM J, V351, P477, DOI 10.1042/0264-6021:3510477; Hassett RF, 1998, J BIOL CHEM, V273, P23274, DOI 10.1074/jbc.273.36.23274; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; Kim C, 2001, J BACTERIOL, V183, P4866, DOI 10.1128/JB.183.16.4866-4875.2001; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Li LT, 1998, J BIOL CHEM, V273, P22181, DOI 10.1074/jbc.273.35.22181; Machonkin TE, 2001, J AM CHEM SOC, V123, P5507, DOI 10.1021/ja003975s; Martins LJ, 1998, J BIOL CHEM, V273, P23716, DOI 10.1074/jbc.273.37.23716; McKie A. T., 2001, Redox Report, V6, P133; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Patel BN, 2000, J BIOL CHEM, V275, P4305, DOI 10.1074/jbc.275.6.4305; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; Pena MMO, 1998, MOL CELL BIOL, V18, P2514, DOI 10.1128/MCB.18.5.2514; Radisky D, 1999, J BIOL CHEM, V274, P4481, DOI 10.1074/jbc.274.8.4481; Rutherford JC, 2001, P NATL ACAD SCI USA, V98, P14322, DOI 10.1073/pnas.261381198; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Szczypka MS, 1997, YEAST, V13, P1423, DOI 10.1002/(SICI)1097-0061(199712)13:15<1423::AID-YEA190>3.3.CO;2-3; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	37	62	68	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 12	2003	278	50					50309	50315		10.1074/jbc.M307019200	http://dx.doi.org/10.1074/jbc.M307019200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751LH	12954629	hybrid			2022-12-27	WOS:000187068200079
J	Kainov, DE; Pirttimaa, M; Tuma, R; Butcher, SJ; Thomas, GJ; Bamford, DH; Makeyev, EV				Kainov, DE; Pirttimaa, M; Tuma, R; Butcher, SJ; Thomas, GJ; Bamford, DH; Makeyev, EV			RNA packaging device of double-stranded RNA bacteriophages, possibly as simple as hexamer of P4 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3 GENOMIC SEGMENTS; POLYMERASE COMPLEX; RAMAN-SPECTROSCOPY; ASSEMBLY PATHWAY; PURIFIED PROTEIN; DNA TRANSPORT; VIRUS; PHI-6; BINDING; PARTICLES	Genomes of complex viruses have been demonstrated, in many cases, to be packaged into preformed empty capsids (procapsids). This reaction is performed by molecular motors translocating nucleic acid against the concentration gradient at the expense of NTP hydrolysis. At present, the molecular mechanisms of packaging remain elusive due to the complex nature of packaging motors. In the case of the double-stranded RNA bacteriophage phi6 from the Cystoviridae family, packaging of single-stranded genomic precursors requires a hexameric NTPase, P4. In the present study, the purified P4 proteins from two other cystoviruses, phi8 and phi13, were characterized and compared with phi6 P4. All three proteins are hexameric, single-stranded RNA-stimulated NTPases with alpha/beta folds. Using a direct motor assay, we found that phi8 and phi13 P4 hexamers translocate 5' to 3' along ssRNA, whereas the analogous activity of phi6 P4 requires association with the procapsid. This difference is explained by the intrinsically high affinity of phi8 and phi13 P4s for nucleic acids. The unidirectional translocation results in RNA helicase activity. Thus, P4 proteins of Cystoviridae exhibit extensive similarity to hexameric helicases and are simple models for studying viral packaging motor mechanisms.	Univ Helsinki, Dept Biosci, FIN-00014 Helsinki, Finland; Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA	University of Helsinki; University of Helsinki; University of Missouri System; University of Missouri Kansas City	Bamford, DH (corresponding author), Univ Helsinki, Dept Biosci, POB 56,Viikinkaari 5, FIN-00014 Helsinki, Finland.	dbamford@mappi.helsinki.fi	Tuma, Roman/AAL-4436-2020; kainov, denis/I-5526-2019; Butcher, Sarah J/H-5579-2012	Tuma, Roman/0000-0003-0047-0013; kainov, denis/0000-0001-7716-6955; Butcher, Sarah/0000-0001-7060-5871; Makeyev, Eugene/0000-0001-6034-6896; Bamford, Dennis/0000-0002-6438-8118	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050776] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50776] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANDEKAR J, 1992, BIOCHIM BIOPHYS ACTA, V1120, P123, DOI 10.1016/0167-4838(92)90261-B; Baumann RG, 2003, J BIOL CHEM, V278, P4618, DOI 10.1074/jbc.M208574200; Benevides JM, 2002, BIOCHEMISTRY-US, V41, P11946, DOI 10.1021/bi0201623; Butcher SJ, 1997, EMBO J, V16, P4477, DOI 10.1093/emboj/16.14.4477; Catalano CE, 2000, CELL MOL LIFE SCI, V57, P128, DOI 10.1007/s000180050503; de Haas F, 1999, J MOL BIOL, V294, P357, DOI 10.1006/jmbi.1999.3260; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRILANDER M, 1995, J MOL BIOL, V246, P418, DOI 10.1006/jmbi.1994.0096; GOTTLIEB P, 1992, J VIROL, V66, P2611, DOI 10.1128/JVI.66.5.2611-2616.1992; GOTTLIEB P, 1992, J VIROL, V66, P6220, DOI 10.1128/JVI.66.10.6220-6222.1992; Grimes S, 2002, ADV VIRUS RES, V58, P255, DOI 10.1016/S0065-3527(02)58007-6; Guo PX, 2002, PROG NUCLEIC ACID RE, V72, P415, DOI 10.1016/S0079-6603(02)72076-X; Hendrix RW, 1998, CELL, V94, P147, DOI 10.1016/S0092-8674(00)81413-0; Hoogstraten D, 2000, VIROLOGY, V272, P218, DOI 10.1006/viro.2000.0374; Ibarra B, 2001, NUCLEIC ACIDS RES, V29, P4264, DOI 10.1093/nar/29.21.4264; Ikonen T, 2003, J APPL CRYSTALLOGR, V36, P525, DOI 10.1107/S0021889803001857; JUUTI JT, 1995, J MOL BIOL, V249, P545, DOI 10.1006/jmbi.1995.0317; Juuti JT, 1998, J MOL BIOL, V279, P347, DOI 10.1006/jmbi.1998.1772; Juuti JT, 1997, J MOL BIOL, V266, P891, DOI 10.1006/jmbi.1996.0817; Kadare G, 1997, J VIROL, V71, P2583; Kainov DE, 2003, J MOL BIOL, V328, P791, DOI 10.1016/S0022-2836(03)00322-X; King JA, 2001, EMBO J, V20, P3282, DOI 10.1093/emboj/20.12.3282; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Makeyev EV, 2000, EMBO J, V19, P6275, DOI 10.1093/emboj/19.22.6275; Makeyev EV, 2000, EMBO J, V19, P124, DOI 10.1093/emboj/19.1.124; Meijer WJJ, 2001, MICROBIOL MOL BIOL R, V65, P261, DOI 10.1128/MMBR.65.2.261-287.2001; Mindich L, 1999, MICROBIOL MOL BIOL R, V63, P149, DOI 10.1128/MMBR.63.1.149-160.1999; Moore SD, 2002, CURR BIOL, V12, pR96, DOI 10.1016/S0960-9822(02)00670-X; PAATERO AO, 1995, J VIROL, V69, P6729, DOI 10.1128/JVI.69.11.6729-6734.1995; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; Pirttimaa MJ, 2002, J VIROL, V76, P10122, DOI 10.1128/JVI.76.20.10122-10127.2002; Pirttimaa MJT, 2000, RNA, V6, P880, DOI 10.1017/S1355838200992598; Poranen MM, 2001, MOL CELL, V7, P845, DOI 10.1016/S1097-2765(01)00228-3; Qiao XY, 2000, VIROLOGY, V275, P218, DOI 10.1006/viro.2000.0501; Qiao XY, 1997, P NATL ACAD SCI USA, V94, P4074, DOI 10.1073/pnas.94.8.4074; SAMBROOK J, 2001, MOL CLONING LAB MANU, P1017; Schmid S I, 1995, Curr Top Microbiol Immunol, V199 ( Pt 1), P67; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; STEVEN AC, 1997, STRUCTURAL BIOL VIRU, P312; Sun Y, 2003, VIROLOGY, V308, P354, DOI 10.1016/S0042-6822(03)00013-8; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; TABOR S, 1990, CURRENT PROTOCOLS MO, P8322; Thomas GJ, 1999, ANNU REV BIOPH BIOM, V28, P1, DOI 10.1146/annurev.biophys.28.1.1; Thomas GJ, 2002, BIOPOLYMERS, V67, P214, DOI 10.1002/bip.10105; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yang HY, 2003, J VIROL, V77, P1195, DOI 10.1128/JVI.77.2.1195-1203.2003	51	52	57	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48084	48091		10.1074/jbc.M306928200	http://dx.doi.org/10.1074/jbc.M306928200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12966097	hybrid			2022-12-27	WOS:000186731400088
J	Most, P; Boerries, M; Eicher, C; Schweda, C; Ehlermann, P; Pleger, ST; Loeffler, E; Koch, WJ; Katus, HA; Schoenenberger, CA; Remppis, A				Most, P; Boerries, M; Eicher, C; Schweda, C; Ehlermann, P; Pleger, ST; Loeffler, E; Koch, WJ; Katus, HA; Schoenenberger, CA; Remppis, A			Extracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PATHWAY; NEURITE OUTGROWTH; KINASE; CELL; CA2+; MYOCYTES; GROWTH; FAMILY; RAS; CONTRACTILITY	S100A1 is a Ca2+-binding protein of the EF-hand type that belongs to the S100 protein family. It is specifically expressed in the myocardium at high levels and is considered to be an important regulator of cardiac contractility. Because the S100A1 protein is released into the extracellular space during ischemic myocardial injury, we examined the cardioprotective potential of the extracellular S100A1 protein on ventricular cardiomyocytes in vitro. In this report we show that extracellularly added S100A1 protein is endocytosed into the endosomal compartment of neonatal ventricular cardiomyocytes via a Ca2+-dependent clathrin-mediated process. S100A1 uptake protects neonatal ventricular cardiomyocytes from 2-deoxyglucose and oxidative stress-induced apoptosis in vitro. S100A1-mediated antiapoptotic effects involve specific activation of the extracellular signal-regulated kinase 1/2 (ERK1/2) prosurvival pathway, including activation of phospholipase C, protein kinase C, mitogen-activated protein kinase kinase 1, and ERK1/2. In contrast, neither transsarcolemmal Ca2+ influx via the L-type channel nor protein kinase A activity seems to take part in the S100A1-mediated signaling pathway. In conclusion, this study provides evidence for the S100A1 protein serving as a novel cardioprotective factor in vitro. These findings warrant speculation that injury-dependent release of the S100A1 protein from cardiomyocytes may serve as an intrinsic mechanism to promote survival of the myocardium in vivo.	Univ Heidelberg, D-69115 Heidelberg, Germany; Univ Basel, Biozentrum, Maurice E Muller Inst, CH-4056 Basel, Switzerland; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Ruprecht Karls University Heidelberg; University of Basel; Duke University	Most, P (corresponding author), Univ Heidelberg, Bergheimer Str 58, D-69115 Heidelberg, Germany.		Boerries, Melanie/AAM-2602-2021					Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Alexanian AR, 1999, FASEB J, V13, P1611, DOI 10.1096/fasebj.13.12.1611; Bianchi R, 1996, BBA-MOL CELL RES, V1313, P258, DOI 10.1016/0167-4889(96)00098-5; Braz JC, 2002, J CELL BIOL, V156, P905, DOI 10.1083/jcb.200108062; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Convery MK, 1998, PFLUG ARCH EUR J PHY, V436, P581, DOI 10.1007/s004240050675; Davey GE, 2001, J BIOL CHEM, V276, P30819, DOI 10.1074/jbc.M103541200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Windt LJ, 2000, J BIOL CHEM, V275, P13571, DOI 10.1074/jbc.275.18.13571; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Du XJ, 2002, MOL CELL BIOL, V22, P2821, DOI 10.1128/MCB.22.8.2821-2829.2002; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172; Hobai IA, 1997, PFLUG ARCH EUR J PHY, V433, P455, DOI 10.1007/s004240050300; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Kiewitz R, 2000, BIOCHEM BIOPH RES CO, V274, P865, DOI 10.1006/bbrc.2000.3229; Mehrhof FB, 2001, CIRCULATION, V104, P2088, DOI 10.1161/hc4201.097133; Mikkelsen SE, 2001, J NEUROCHEM, V79, P767, DOI 10.1046/j.1471-4159.2001.00605.x; Most P, 2003, J BIOL CHEM, V278, P33809, DOI 10.1074/jbc.M301788200; Most P, 2003, J BIOL CHEM, V278, P26356, DOI 10.1074/jbc.M303338200; Most P, 2001, P NATL ACAD SCI USA, V98, P13889, DOI 10.1073/pnas.241393598; Novitskaya V, 2000, J BIOL CHEM, V275, P41278, DOI 10.1074/jbc.M007058200; Parrizas M, 1997, J BIOL CHEM, V272, P154; Pinson A., 1990, CELL CULTURE TECHNIQ, P20; Pol A, 1998, FEBS LETT, V441, P34, DOI 10.1016/S0014-5793(98)01517-8; Rammes A, 1997, J BIOL CHEM, V272, P9496; Remppis A, 1996, BBA-MOL CELL RES, V1313, P253, DOI 10.1016/0167-4889(96)00097-3; Remppis Andrew, 2002, Basic Research in Cardiology, V97; Reppel M, 2002, EUR HEART J, V23, P41; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Sheng ZL, 1997, J BIOL CHEM, V272, P5783, DOI 10.1074/jbc.272.9.5783; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	36	62	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48404	48412		10.1074/jbc.M308587200	http://dx.doi.org/10.1074/jbc.M308587200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12960148	hybrid			2022-12-27	WOS:000186731400126
J	Pawlyk, AC; Giasson, BI; Sampathu, DM; Perez, FA; Lim, KL; Dawson, VL; Dawson, TM; Palmiter, RD; Trojanowski, JQ; Lee, VMY				Pawlyk, AC; Giasson, BI; Sampathu, DM; Perez, FA; Lim, KL; Dawson, VL; Dawson, TM; Palmiter, RD; Trojanowski, JQ; Lee, VMY			Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SYSTEM ATROPHY; RECESSIVE JUVENILE PARKINSONISM; UBIQUITIN-PROTEIN LIGASE; ALPHA-SYNUCLEIN; LEWY BODIES; DISEASE; MUTATIONS; DEMENTIA; GENE; EXPRESSION	Autosomal recessive juvenile parkinsonism is a movement disorder associated with the degeneration of dopaminergic neurons in substantia nigra pars compacta. The loss of functional parkin caused by parkin gene mutations is the most common single cause of juvenile parkinsonism. Parkin has been shown to aid in protecting cells from endoplasmic reticulum and oxidative stressors presumably due to ubiquitin ligase activity of parkin that targets proteins for proteasomal degradation. However, studies on parkin have been impeded because of limited reagents specific for this protein. Here we report the generation and characterization of a panel of parkin-specific monoclonal antibodies. Biochemical analyses indicate that parkin is present only in the high salt-extractable fraction of mouse brain, whereas it is present in both the high salt-extractable and RIPA-resistant, SDS-extractable fraction in young human brain. Parkin is present at decreased levels in the high salt-extractable fraction and at increased levels in the SDS-extractable fraction from aged human brain. This shift in the extractability of parkin upon aging is seen in humans but not in mice, demonstrating species-specific differences in the biochemical characteristics of murine versus human parkin. Finally, by using these highly specific anti-parkin monoclonal antibodies, it was not possible to detect parkin in alpha-synuclein-containing lesions in alpha-synucleinopathies, thereby challenging prior inferences about the role of parkin in movement disorders other than autosomal recessive juvenile parkinsonism.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Natl Inst Neurosci, Neurodegenerat Res Lab, Singapore 308433, Singapore; Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21287 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Washington; University of Washington Seattle; National Neuroscience Institute (NNI); Johns Hopkins University; Johns Hopkins University	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu	Dawson, Valina/Y-9757-2019; Lim, Kah-Leong/AAY-3308-2020; Lim, Kah/L-5426-2019	Lim, Kah-Leong/0000-0002-5440-2588; Dawson, Valina/0000-0002-2915-3970				Baba M, 1998, AM J PATHOL, V152, P879; Choi P, 2001, NEUROREPORT, V12, P2839, DOI 10.1097/00001756-200109170-00017; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; D'Agata V, 2000, EUR J NEUROSCI, V12, P3583, DOI 10.1046/j.1460-9568.2000.00244.x; Dickson DW, 1999, AM J PATHOL, V155, P1241, DOI 10.1016/S0002-9440(10)65226-1; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Duda JE, 2000, J NEUROPATH EXP NEUR, V59, P830, DOI 10.1093/jnen/59.9.830; Duda JE, 2002, ANN NEUROL, V52, P205, DOI 10.1002/ana.10279; Forman MS, 2002, AM J PATHOL, V160, P1725, DOI 10.1016/S0002-9440(10)61119-4; Galvin JE, 2000, AM J PATHOL, V157, P361, DOI 10.1016/S0002-9440(10)64548-8; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Gu WJ, 2000, J NEUROCHEM, V74, P1773, DOI 10.1046/j.1471-4159.2000.0741773.x; Hase A, 2002, BRAIN RES, V930, P143, DOI 10.1016/S0006-8993(02)02241-2; Hilker R, 2002, NEUROSCI LETT, V323, P50, DOI 10.1016/S0304-3940(01)02529-0; Horowitz JM, 2001, DEV BRAIN RES, V126, P31, DOI 10.1016/S0165-3806(00)00133-4; Horowitz JM, 2001, J CHEM NEUROANAT, V21, P75, DOI 10.1016/S0891-0618(00)00111-3; Huynh DP, 2001, DEV BRAIN RES, V130, P173, DOI 10.1016/S0165-3806(01)00234-6; Huynh DP, 2000, ANN NEUROL, V48, P737, DOI 10.1002/1531-8249(200011)48:5<737::AID-ANA7>3.3.CO;2-4; Hyun DH, 2002, J BIOL CHEM, V277, P28572, DOI 10.1074/jbc.M200666200; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kubo S, 2001, J NEUROCHEM, V78, P42, DOI 10.1046/j.1471-4159.2001.00364.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Schlossmacher MG, 2002, AM J PATHOL, V160, P1655, DOI 10.1016/S0002-9440(10)61113-3; SCHMIDT ML, 1991, AM J PATHOL, V139, P53; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Stichel CC, 2000, EUR J NEUROSCI, V12, P4181, DOI 10.1111/j.1460-9568.2000.01314.x; Van der Reijden BA, 1999, PROTEIN SCI, V8, P1557, DOI 10.1110/ps.8.7.1557; West A, 2002, AM J MED GENET, V114, P584, DOI 10.1002/ajmg.10525; Zarate-Lagunes M, 2001, J COMP NEUROL, V432, P184, DOI 10.1002/cne.1096; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	38	119	122	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48120	48128		10.1074/jbc.M306889200	http://dx.doi.org/10.1074/jbc.M306889200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12972409	hybrid			2022-12-27	WOS:000186731400093
J	Uetani, T; Matsubara, T; Nomura, H; Murohara, T; Nakayama, S				Uetani, T; Matsubara, T; Nomura, H; Murohara, T; Nakayama, S			Ca2+-dependent modulation of intracellular Mg2+ concentration with amiloride and KB-R7943 in pig carotid artery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE MAGNESIUM CONCENTRATION; ACTIVATED POTASSIUM CHANNELS; PROTEIN-KINASE-C; SMOOTH-MUSCLE; TAENIA-CECI; NA+/CA2+ EXCHANGER; REVERSE-MODE; RAT HEARTS; RED-CELLS; PH	It has long been recognized that magnesium is associated with several important diseases, including diabetes, hypertension, cardiovascular, and cerebrovascular diseases. In the present study, we measured the intracellular free Mg2+ concentration ([Mg2+](i)) using P-31 nuclear magnetic resonance (NMR) in pig carotid artery smooth muscle. In normal solution, application of amiloride (1 mM) decreased [Mg2+](i) by similar to12% after 100 min. Subsequent washout tended to further decrease [Mg2+](i). In contrast, application of amiloride significantly increased [Mg2+](i) (by similar to 13% after 100 min) under Ca2+-free conditions, where passive Mg2+ influx is facilitated. The treatments had little effect on intracellular ATP and pH (pH(i)). Essentially the same Ca2+-dependent changes in [Mg2+](i) were produced with KB-R7943, a selective blocker of reverse mode Na+-Ca2+ exchange. Application of dimethyl amiloride (0.1 mM) in the presence of Ca2+ did not significantly change [Mg2+](i), although it inhibited Na+-H+ exchange at the same concentration. Removal of extracellular Na+ caused a marginal increase in [Mg2+](i) after 100 - 200 min, as seen in intestinal smooth muscle in which Na+- Mg2+ exchange is known to be the primary mechanism of maintaining a low [Mg2+](i) against electrochemical equilibrium. In Na+-free solution (containing Ca2+), neither amiloride nor KB-R7943 decreased [Mg2+](i), but they rather increased it. The results suggest that these inhibitory drugs for Na+-Ca2+ exchange directly modulate Na+- Mg2+ exchange in a Ca2+-dependent manner, and consequently produce the paradoxical decrease in [Mg2+](i) in the presence of Ca2+.	Nagoya Univ, Grad Sch Med, Dept Cell Physiol, Nagoya, Aichi 4668550, Japan; Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; Nagoya Univ, Grad Sch Med, Dept Geriatr, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University; Nagoya University	Nakayama, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cell Physiol, Nagoya, Aichi 4668550, Japan.	h44673a@nucc.cc.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014	Matsubara, Tatsuaki/0000-0002-0647-5475				AICKEN CC, 1989, SODIUM CALCIUM EXCHA, P233; AICKIN CC, 1988, CIBA F SYMP, V139, P3; ALMULLA HA, 2003, J PHYSIOL-LONDON, V547, pC19; Amano T, 2000, BRIT J PHARMACOL, V130, P731, DOI 10.1038/sj.bjp.0703361; BLAUSTEIN MP, 1989, SODIUM CALCIUM EXCHA, P208; BOEHM EA, 1995, AM J PHYSIOL-CELL PH, V268, pC628, DOI 10.1152/ajpcell.1995.268.3.C628; Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; BRIGGMAN JV, 1983, HISTOCHEM J, V15, P239, DOI 10.1007/BF01006239; CLARK JF, 1995, J VASC RES, V32, P24, DOI 10.1159/000159074; DILLON PF, 1996, BIOCH SMOOTH MUSCLE, P393; FELDMAN GM, 1992, AMILORIDE ITS ANALOG, P265; FERAY JC, 1988, N-S ARCH PHARMACOL, V338, P332; FLATMAN PW, 1991, J PHYSIOL-LONDON, V443, P217, DOI 10.1113/jphysiol.1991.sp018831; FLATMAN PW, 1991, ANNU REV PHYSIOL, V53, P259, DOI 10.1146/annurev.ph.53.030191.001355; FREUDENRICH CC, 1992, AM J PHYSIOL, V262, pC1024, DOI 10.1152/ajpcell.1992.262.4.C1024; HADDY FJ, 1992, AMILORIDE ITS ANALOG, P279; HEADRICK JP, 1989, MAGNET RESON MED, V12, P328, DOI 10.1002/mrm.1910120305; Hisamitsu T, 2001, LIFE SCI, V69, P2775, DOI 10.1016/S0024-3205(01)01351-0; Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391; Iwamoto T, 1996, J BIOL CHEM, V271, P13609, DOI 10.1074/jbc.271.23.13609; Kao WHL, 1999, ARCH INTERN MED, V159, P2151, DOI 10.1001/archinte.159.18.2151; KUSHMERICK MJ, 1986, J BIOL CHEM, V261, P4420; Ladilov Y, 1999, AM J PHYSIOL-HEART C, V276, pH1868, DOI 10.1152/ajpheart.1999.276.6.H1868; LUDI H, 1987, J PHYSIOL-LONDON, V390, P367; MCGUIGAN JAS, 2002, J CLIN BASIC CARDIOL, V5, P5; Mottet I, 1997, CAN J PHYSIOL PHARM, V75, P1015, DOI 10.1139/cjpp-75-8-1015; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; NAKAYAMA S, 1991, J PHYSIOL-LONDON, V435, P559, DOI 10.1113/jphysiol.1991.sp018525; NAKAYAMA S, 1995, J PHYSIOL-LONDON, V488, P1; NAKAYAMA S, 1995, JPN J PHYSIOL, V45, P411, DOI 10.2170/jjphysiol.45.411; NAKAYAMA S, 1994, J GEN PHYSIOL, V103, P833, DOI 10.1085/jgp.103.5.833; NAKAYAMA S, 1990, J PHYSIOL-LONDON, V421, P363, DOI 10.1113/jphysiol.1990.sp017949; NISHIMURA H, 1993, BRIT J PHARMACOL, V109, P443, DOI 10.1111/j.1476-5381.1993.tb13589.x; Paolisso G, 1997, AM J HYPERTENS, V10, P346, DOI 10.1016/S0895-7061(96)00342-1; Paul Richard J., 1996, P315; Satoh H, 2000, CIRCULATION, V101, P1441, DOI 10.1161/01.CIR.101.12.1441; SHATTOCK MJ, 1987, J AM COLL NUTR, V6, P27; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Simchowitz L., 1992, AMILORIDE ITS ANALOG, P9; Tashiro M, 1997, BIOPHYS J, V73, P3358, DOI 10.1016/S0006-3495(97)78360-7; TASHIRO M, 2002, PFLUGERS ARCH, V440, P819; VAUGHANJONES RD, 1983, NATURE, V301, P522, DOI 10.1038/301522a0; Watanabe J, 1998, J MOL CELL CARDIOL, V30, P2307, DOI 10.1006/jmcc.1998.0791; Watano T, 1996, BRIT J PHARMACOL, V119, P555, DOI 10.1111/j.1476-5381.1996.tb15708.x; WEISS RG, 1990, CIRC RES, V66, P1012, DOI 10.1161/01.RES.66.4.1012; WHITE JR, 1993, ANN PHARMACOTHER, V27, P775, DOI 10.1177/106002809302700619; WRAY S, 1988, AM J PHYSIOL, V254, pC213; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang CY, 1998, STROKE, V29, P411, DOI 10.1161/01.STR.29.2.411; Zeitz O, 2002, CIRC RES, V90, P988, DOI 10.1161/01.RES.0000018625.25212.1E; Zhang WQ, 1997, ANAL BIOCHEM, V251, P246, DOI 10.1006/abio.1997.2238; [No title captured]	52	19	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47491	47497		10.1074/jbc.M307898200	http://dx.doi.org/10.1074/jbc.M307898200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12958315	hybrid			2022-12-27	WOS:000186731400020
J	Wolucka, BA; Van Montagu, M				Wolucka, BA; Van Montagu, M			GDP-mannose 3 ',5 '-epimerase forms GDP-L-gulose, a putative intermediate for the de novo biosynthesis of vitamin C in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-LACTONE DEHYDROGENASE; L-ASCORBIC-ACID; PERFORMANCE LIQUID-CHROMATOGRAPHY; SHOCK COGNATE PROTEIN; ARABIDOPSIS-THALIANA; CATALYTIC MECHANISM; L-GALACTOSE; D-GLUCOSE; FUCOSE SYNTHETASE; ESCHERICHIA-COLI	Despite its importance for agriculture, bioindustry, and nutrition, the fundamental process of L-ascorbic acid ( vitamin C) biosynthesis in plants is not completely elucidated, and little is known about its regulation. The recently identified GDP-Man 3', 5'-epimerase catalyzes a reversible epimerization of GDP-D-mannose that precedes the committed step in the biosynthesis of vitamin C, resulting in the hydrolysis of the highly energetic glycosyl-pyrophosphoryl linkage. Here, we characterize the native and recombinant GDP-Man 3', 5'-epimerase of Arabidopsis thaliana. GDP and GDP-D-glucose are potent competitive inhibitors of the enzyme, whereas GDP-L-fucose gives a complex type of inhibition. The epimerase contains a modified version of the NAD binding motif and is inhibited by NAD(P) H and stimulated by NAD(P)(+). A feedback inhibition of vitamin C biosynthesis is observed apparently at the level of GDP-Man 3', 5'-epimerase. The epimerase catalyzes at least two distinct epimerization reactions and releases, besides the well known GDP-L-galactose, a novel intermediate: GDP- L-gulose. The yield of the epimerization varies and seems to depend on the molecular form of the enzyme. Both recombinant and native enzymes co-purified with a Hsp70 heat-shock protein ( Escherichia coli DnaK and A. thaliana Hsc70.3, respectively). We speculate, therefore, that the Hsp70 molecular chaperones might be involved in folding and/or regulation of the epimerase. In summary, the plant epimerase undergoes a complex regulation and could control the carbon flux into the vitamin C pathway in response to the redox state of the cell, stress conditions, and GDP- sugar demand for the cell wall/glycoprotein biosynthesis. Exogenous L-gulose and L-gulono-1,4-lactone serve as direct precursors of L-ascorbic acid in plant cells. We propose an L-gulose pathway for the de novo biosynthesis of vitamin C in plants.	VIB, Dept Mol Microbiol, B-3001 Louvain, Belgium; State Univ Ghent VIB, Dept Plant Syst Biol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Ghent University	Wolucka, BA (corresponding author), VIB, Dept Mol Microbiol, Kasteelpk Arenberg 31, B-3001 Louvain, Belgium.	beata.wolucka@bio.kuleuven.ac.be						Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Allard STM, 2001, CELL MOL LIFE SCI, V58, P1650, DOI 10.1007/PL00000803; Blankenfeldt W, 2000, EMBO J, V19, P6652, DOI 10.1093/emboj/19.24.6652; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURKHARD B, 1998, J PHYCOL, V34, P779; DAVIES MB, 1991, VITAMIN C ITS CHEM B, P81; Du LC, 2000, CHEM BIOL, V7, P623, DOI 10.1016/S1074-5521(00)00011-9; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; GABRIEL O, 1978, TRENDS BIOCHEM SCI, V3, P193, DOI 10.1016/S0968-0004(78)91666-3; Gatzek S, 2002, PLANT J, V30, P541, DOI 10.1046/j.1365-313X.2002.01315.x; Hancock RD, 2002, TRENDS BIOTECHNOL, V20, P299, DOI 10.1016/S0167-7799(02)01991-1; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HAUS U, 1993, EMBO J, V12, P3763, DOI 10.1002/j.1460-2075.1993.tb06054.x; He XM, 1996, BIOCHEMISTRY-US, V35, P4721, DOI 10.1021/bi952706p; HEBDA PA, 1979, ARCH BIOCHEM BIOPHYS, V194, P496, DOI 10.1016/0003-9861(79)90644-1; HONDA S, 1989, ANAL BIOCHEM, V180, P351, DOI 10.1016/0003-2697(89)90444-2; Imai T, 1998, PLANT CELL PHYSIOL, V39, P1350, DOI 10.1093/oxfordjournals.pcp.a029341; ISHERWOOD FA, 1954, BIOCHEM J, V56, P1; ISHERWOOD FA, 1953, NATURE, V171, P348, DOI 10.1038/171348a0; Jain AK, 2000, MOL BREEDING, V6, P73, DOI 10.1023/A:1009680818138; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; KORNFELD RH, 1966, BIOCHIM BIOPHYS ACTA, V117, P79, DOI 10.1016/0304-4165(66)90154-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOEWUS FA, 1961, NATURE, V191, P1059, DOI 10.1038/1911059a0; Lutz W, 2001, BIOCHEM BIOPH RES CO, V282, P1211, DOI 10.1006/bbrc.2001.4711; MELO A, 1965, J BIOL CHEM, V240, P398; MENGELE R, 1992, FEBS LETT, V298, P14, DOI 10.1016/0014-5793(92)80011-5; Menon S, 1999, J BIOL CHEM, V274, P26743, DOI 10.1074/jbc.274.38.26743; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; OBA K, 1994, PLANT CELL PHYSIOL, V35, P473; Ono K, 2001, PLANT SCI, V160, P455, DOI 10.1016/S0168-9452(00)00412-X; Ostergaard J, 1997, J BIOL CHEM, V272, P30009, DOI 10.1074/jbc.272.48.30009; Pallanca JE, 2000, J EXP BOT, V51, P669, DOI 10.1093/jexbot/51.345.669; Panchuk II, 2002, PLANT PHYSIOL, V129, P838, DOI 10.1104/pp.001362; Rayon C, 1999, PLANT PHYSIOL, V119, P725, DOI 10.1104/pp.119.2.725; Rosano C, 2000, J MOL BIOL, V303, P77, DOI 10.1006/jmbi.2000.4106; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; SHIGEOKA S, 1979, AGR BIOL CHEM TOKYO, V43, P2187, DOI 10.1080/00021369.1979.10863782; Smirnoff N, 2000, CRIT REV PLANT SCI, V19, P267, DOI 10.1016/S0735-2689(00)80005-2; Somers WS, 1998, STRUCTURE, V6, P1601, DOI 10.1016/S0969-2126(98)00157-9; Somoza JR, 2000, STRUCTURE, V8, P123, DOI 10.1016/S0969-2126(00)00088-5; Sturla L, 1997, FEBS LETT, V412, P126, DOI 10.1016/S0014-5793(97)00762-X; Sugino M, 1999, PLANT SCI, V146, P81, DOI 10.1016/S0168-9452(99)00086-2; Swain M, 1997, BBA-LIPID LIPID MET, V1345, P56, DOI 10.1016/S0005-2760(96)00163-4; Wagner C, 2003, PHYTOCHEMISTRY, V62, P887, DOI 10.1016/S0031-9422(02)00703-3; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2001, P NATL ACAD SCI USA, V98, P14843, DOI 10.1073/pnas.011578198; Wolucka BA, 2001, ANAL BIOCHEM, V294, P161, DOI 10.1006/abio.2001.5165; WU SH, 1994, PLANT MOL BIOL, V25, P577, DOI 10.1007/BF00043887; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Zablackis E, 1996, SCIENCE, V272, P1808, DOI 10.1126/science.272.5269.1808	52	277	312	3	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47483	47490		10.1074/jbc.M309135200	http://dx.doi.org/10.1074/jbc.M309135200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12954627	hybrid			2022-12-27	WOS:000186731400019
J	Ananthanarayanan, B; Stahelin, RV; Digman, MA; Cho, WH				Ananthanarayanan, B; Stahelin, RV; Digman, MA; Cho, WH			Activation mechanisms of conventional protein kinase C isoforms are determined by the ligand affinity and conformational flexibility of their C1 domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; PHORBOL ESTER BINDING; CYTOSOLIC PHOSPHOLIPASE A(2); MEMBRANE-BINDING; MOLECULAR-BASIS; PKC-GAMMA; ALPHA; MONOLAYERS; CALCIUM; DELTA	The regulatory domains of conventional and novel protein kinases C (PKC) have two C1 domains (C1A and C1B) that have been identified as the interaction site for diacylglycerol (DAG) and phorbol ester. It has been reported that C1A and C1B domains of individual PKC isoforms play different roles in their membrane binding and activation; however, DAG affinity of individual C1 domains has not been quantitatively determined. In this study, we measured the affinity of isolated C1A and C1B domains of two conventional PKCs, PKCalpha and PKCgamma, for soluble and membrane-incorporated DAG and phorbol ester by isothermal calorimetry and surface plasmon resonance. The C1A and C1B domains of PKCalpha have opposite affinities for DAG and phorbol ester; i.e. the C1A domain with high affinity for DAG and the C1B domain with high affinity for phorbol ester. In contrast, the C1A and C1b domains of PKCgamma have comparably high affinities for both DAG and phorbol ester. Consistent with these results, mutational studies of full-length proteins showed that the C1A domain is critical for the DAG-induced activation of PKCalpha, whereas both C1A and C1B domains are involved in the DAG-induced activation of PKCgamma. Further mutational studies in conjunction with in vitro activity assay and monolayer penetration analysis indicated that, unlike the C1A domain of PKCalpha, neither the C1A nor the C1B domain of PKCgamma is conformationally restricted. Cell studies with enhanced green fluorescent protein-tagged PKCs showed that PKCalpha did not translocate to the plasma membrane in response to DAG at a basal intracellular calcium concentration due to the inaccessibility of its C1A domain, whereas PKCgamma rapidly translocated to the plasma membrane under the same conditions. These data suggest that differential activation mechanisms of PKC isoforms are determined by the DAG affinity and conformational flexibility of their C1 domains.	Univ Illinois, Dept Chem, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cho, WH (corresponding author), Univ Illinois, Dept Chem MC 111, 845 W Taylor St, Chicago, IL 60607 USA.		Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863; , Michelle/0000-0003-4611-7100	NIGMS NIH HHS [GM 53987, GM 52598] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052598, R01GM053987] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAZZI MD, 1988, BIOCHEMISTRY-US, V27, P6776, DOI 10.1021/bi00418a020; BERS DM, 1982, AM J PHYSIOL, V242, P404; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; Bittova L, 2001, J BIOL CHEM, V276, P4218, DOI 10.1074/jbc.M008491200; BLUME A, 1979, BIOCHIM BIOPHYS ACTA, V557, P32, DOI 10.1016/0005-2736(79)90087-7; Bogi K, 1998, CANCER RES, V58, P1423; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; BURNS DJ, 1991, J BIOL CHEM, V266, P18330; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Cho Wonhwa, 2003, Methods Mol Biol, V233, P291; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Geiges D, 1997, BIOCHEM PHARMACOL, V53, P865, DOI 10.1016/S0006-2952(96)00885-4; Irie K, 1998, J AM CHEM SOC, V120, P9159, DOI 10.1021/ja981087f; Kashiwagi K, 2002, J BIOL CHEM, V277, P18037, DOI 10.1074/jbc.M111761200; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; Kohout SC, 2002, BIOCHEMISTRY-US, V41, P11411, DOI 10.1021/bi026041k; MARAIS RM, 1990, FEBS LETT, V277, P151, DOI 10.1016/0014-5793(90)80831-3; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Medkova M, 1998, BIOCHEMISTRY-US, V37, P4892, DOI 10.1021/bi972495j; Mozsolits H, 2003, J PEPT SCI, V9, P77, DOI 10.1002/psc.439; Mozsolits H, 2002, BIOPOLYMERS, V66, P3, DOI 10.1002/bip.10200; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Saito N, 2002, J BIOCHEM, V132, P683, DOI 10.1093/oxfordjournals.jbchem.a003274; SLATER SJ, 1994, J BIOL CHEM, V269, P17160; Slater SJ, 2002, J BIOL CHEM, V277, P15277, DOI 10.1074/jbc.M112207200; Slater SJ, 1996, J BIOL CHEM, V271, P4627; SLATER SJ, 1994, J BIOL CHEM, V269, P4866; SOUVIGNET C, 1991, J BIOL CHEM, V266, P40; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Szallasi Z, 1996, J BIOL CHEM, V271, P18299, DOI 10.1074/jbc.271.31.18299; VERGER R, 1982, CHEM PHYS LIPIDS, V30, P189, DOI 10.1016/0009-3084(82)90052-4; Xu RX, 1997, BIOCHEMISTRY-US, V36, P10709, DOI 10.1021/bi970833a; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	44	115	116	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46886	46894		10.1074/jbc.M307853200	http://dx.doi.org/10.1074/jbc.M307853200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12954613	Green Published, hybrid			2022-12-27	WOS:000186569400082
J	Canals, M; Marcellino, D; Fanelli, F; Ciruela, F; de Benedetti, P; Goldberg, SR; Neve, K; Fuxe, K; Agnati, LF; Woods, AS; Ferre, S; Lluis, C; Bouvier, M; Franco, R				Canals, M; Marcellino, D; Fanelli, F; Ciruela, F; de Benedetti, P; Goldberg, SR; Neve, K; Fuxe, K; Agnati, LF; Woods, AS; Ferre, S; Lluis, C; Bouvier, M; Franco, R			Adenosine A(2A)-dopamine D2 receptor-receptor heteromerization - Qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; FUNCTIONAL GABA(B) RECEPTOR; ADENOSINE A(2A) RECEPTORS; DOPAMINE D2 RECEPTORS; INTEGRATIVE MECHANISM; LIGAND-BINDING; TRANSFER BRET; LIVE CELLS; HETERODIMERIZATION; OLIGOMERIZATION	There is evidence for strong functional antagonistic interactions between adenosine A(2A) receptors (A(2A)Rs) and dopamine D-2 receptors (D(2)Rs). Although a close physical interaction between both receptors has recently been shown using co-immunoprecipitation and co-localization assays, the existence of a A(2A)R-D2R protein-protein interaction still had to be demonstrated in intact living cells. In the present work, fluorescence resonance energy transfer ( FRET) and bioluminescence resonance energy transfer (BRET) techniques were used to confirm the occurrence of A(2A)R-D2R interactions in cotransfected cells. The degree of A(2A)R-D2R heteromerization, measured by BRET, did not vary after receptor activation with selective agonists, alone or in combination. BRET competition experiments were performed using a chimeric D2R-D1R in which helices 5 and 6, the third intracellular loop (I3), and the third extracellular loop (E3) of the D2R were replaced by those of the dopamine D-1 receptor (D1R). Although the wild type D2R was able to decrease the BRET signal, the chimera failed to achieve any effect. This suggests that the helix 5-I3-helix 6-E3 portion of D2R holds the site(s) for interaction with A(2A)R. Modeling of A(2A)R and D2R using a modified rhodopsin template followed by molecular dynamics and docking simulations gave essentially two different possible modes of interaction between D2R and A(2A)R. In the most probable one, helix 5 and/or helix 6 and the N-terminal portion of I3 from D2R approached helix 4 and the C-terminal portion of the C-tail from the A(2A)R, respectively.	Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; Univ Modena & Reggio Emilia, Dulbecco Telethon Inst, I-41100 Modena, Italy; Univ Modena & Reggio Emilia, Dept Chem, I-41100 Modena, Italy; Univ Modena & Reggio Emilia, Dept Biomed Sci, I-41100 Modena, Italy; NIDA, DHHS, NIH, Intramural Res Program, Baltimore, MD 21224 USA; Karolinska Inst, Dept Neurosci, Div Cellular & Mol Neurochem, S-17177 Stockholm, Sweden; Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; Dept Vet Affairs Med Ctr, Portland, OR 97239 USA	University of Barcelona; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Karolinska Institutet; Universite de Montreal; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Franco, R (corresponding author), Univ Barcelona, Dept Biochem & Mol Biol, Marti & Franques 1, E-08028 Barcelona, Spain.		soler, martha maricel m gomez/L-6025-2014; Marcellino, Daniel/HDM-8433-2022; Franco, Rafael/C-3694-2015; Bouvier, Michel/H-2758-2014; Ferre, Sergi/K-6115-2014; Fanelli, Francesca/O-8807-2014; Ciruela, F./A-5096-2013	soler, martha maricel m gomez/0000-0002-4412-8108; Marcellino, Daniel/0000-0002-4618-7267; Franco, Rafael/0000-0003-2549-4919; Bouvier, Michel/0000-0003-1128-0100; Ferre, Sergi/0000-0002-1747-1779; Fanelli, Francesca/0000-0002-7620-6895; Ciruela, F./0000-0003-0832-3739; Fuxe, Kjell/0000-0001-8491-4288; Canals, Meritxell/0000-0002-7942-5006	Telethon [TCP00068] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000003] Funding Source: NIH RePORTER	Telethon(Fondazione Telethon); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Agnati LF, 2003, PHARMACOL REV, V55, P509, DOI 10.1124/pr.55.3.2; AGNATI LF, 1980, MED BIOL, V58, P182; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Ausiello G, 1997, PROTEINS, V28, P556, DOI 10.1002/(SICI)1097-0134(199708)28:4<556::AID-PROT9>3.3.CO;2-C; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Dasgupta S, 1996, EUR J PHARMACOL, V316, P325, DOI 10.1016/S0014-2999(96)00665-6; Diaz-Cabiale Z, 2001, NEUROREPORT, V12, P1831; Dixon AK, 1997, J NEUROCHEM, V69, P315; Ferre S, 1997, TRENDS NEUROSCI, V20, P482, DOI 10.1016/S0166-2236(97)01096-5; FERRE S, 1991, P NATL ACAD SCI USA, V88, P7238, DOI 10.1073/pnas.88.16.7238; Ferre Sergi, 2003, Current Medicinal Chemistry - Central Nervous System Agents, V3, P1, DOI 10.2174/1568015033357779; Franco R, 2003, TRENDS BIOCHEM SCI, V28, P238, DOI 10.1016/S0968-0004(03)00065-3; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; FUXE K, 1985, MED RES REV, V5, P441, DOI 10.1002/med.2610050404; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Gines S, 2000, P NATL ACAD SCI USA, V97, P8606, DOI 10.1073/pnas.150241097; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Hillion J, 2002, J BIOL CHEM, V277, P18091, DOI 10.1074/jbc.M107731200; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Jensen AA, 2002, EUR J BIOCHEM, V269, P5076, DOI 10.1046/j.1432-1033.2002.03218.x; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kammerer RA, 1999, BIOCHEMISTRY-US, V38, P13263, DOI 10.1021/bi991018t; Kniazeff J, 2002, J NEUROSCI, V22, P7352; Kozell LB, 1997, MOL PHARMACOL, V52, P1137, DOI 10.1124/mol.52.6.1137; Kull B, 1999, BIOCHEM PHARMACOL, V58, P1035, DOI 10.1016/S0006-2952(99)00184-7; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Milligan G, 2001, TRENDS PHARMACOL SCI, V22, P513, DOI 10.1016/S0165-6147(00)01801-0; Ng GYK, 1996, BIOCHEM BIOPH RES CO, V227, P200, DOI 10.1006/bbrc.1996.1489; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Patel RC, 2002, P NATL ACAD SCI USA, V99, P3294, DOI 10.1073/pnas.042705099; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salim H, 2000, J NEUROCHEM, V74, P432, DOI 10.1046/j.1471-4159.2000.0740432.x; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; TORVINEN M, 2001, SOC NEUR ABSTR, V27, P379; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1; ZOLI M, 1993, MOL NEUROBIOL, V7, P293, DOI 10.1007/BF02769180	48	361	366	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46741	46749		10.1074/jbc.M306451200	http://dx.doi.org/10.1074/jbc.M306451200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12933819	hybrid, Green Published			2022-12-27	WOS:000186569400065
J	Chew, O; Whelan, J; Millar, AH				Chew, O; Whelan, J; Millar, AH			Molecular definition of the ascorbate-glutathione cycle in Arabidopsis mitochondria reveals dual targeting of antioxidant defenses in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-RADICAL REDUCTASE; OXIDATIVE STRESS; DEHYDROASCORBATE REDUCTASE; ELECTRON-TRANSPORT; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; PEROXIDASE; PROTEIN; IMPORT; EXPRESSION	Key components of the ascorbate-glutathione cycle in Arabidopsis cell organelles are encoded by single organellar targeted isoforms that are dual localized in the chloroplast stroma and the mitochondrion. We demonstrate the presence of the ascorbate-glutathione cycle in purified Arabidopsis mitochondria using enzymatic activity, proteomic and in vitro and in vivo subcellular targeting data that identify the gene products responsible. In vitro experiments using a dual import assay assessing mitochondrial and chloroplast imports simultaneously show dual targeting of ascorbate peroxidase, monodehydroascorbate reductase, and glutathione reductase gene products to mitochondria and chloroplasts, while a putative dehydroascorbate reductase protein is only imported into mitochondria. In vivo subcellular localization using green fluorescent protein fusion proteins show clear targeting of all gene products to mitochondria. Transcript levels show these genes are induced by oxidative chemical stresses targeted to chloroplasts and/or mitochondria and are elevated during photosynthetic operation in the light. Together these data present a model of an integrated ascorbate-glutathione antioxidant defense common to plastids and mitochondria that is linked at the level of the genome in Arabidopsis.	Univ Western Australia, Fac Life & Phys Sci, Sch Biomed & Chem Sci, Plant Mol Biol Grp, Crawley, WA 6009, Australia	University of Western Australia	Millar, AH (corresponding author), Univ Western Australia, Fac Life & Phys Sci, Sch Biomed & Chem Sci, Plant Mol Biol Grp, Crawley, WA 6009, Australia.	hmillar@cyllene.uwa.edu.au	Whelan, James/F-6402-2011; Millar, A. Harvey/A-5452-2008	Whelan, James/0000-0001-5754-025X; Millar, A. Harvey/0000-0001-9679-1473				ANDERSON S, 1986, BIOCHEM J, V240, P709, DOI 10.1042/bj2400709; ARRIGONI O, 1981, FEBS LETT, V125, P242, DOI 10.1016/0014-5793(81)80729-6; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Asada K., 1987, PHOTOINHIBITION, P227; Babiychuk E, 2003, PLANT J, V33, P899, DOI 10.1046/j.1365-313X.2003.01680.x; Bartoli CG, 2000, PLANT PHYSIOL, V123, P335, DOI 10.1104/pp.123.1.335; Beardslee TA, 2002, PLANT J, V31, P199, DOI 10.1046/j.1365-313X.2002.01344.x; Berthold DA, 2000, BBA-BIOENERGETICS, V1460, P241, DOI 10.1016/S0005-2728(00)00149-3; BRUCE BD, 1994, PLANT MOL BIOL MANUA, pJ1; Chabregas SM, 2003, J CELL SCI, V116, P285, DOI 10.1242/jcs.00228; Charizanis C, 1999, MOL GEN GENET, V262, P437, DOI 10.1007/s004380051103; CHEN GX, 1989, PLANT CELL PHYSIOL, V30, P987; Chew O, 2003, FUNCT PLANT BIOL, V30, P805, DOI 10.1071/FP03077; CREISSEN G, 1995, PLANT J, V8, P167, DOI 10.1046/j.1365-313X.1995.08020167.x; DAHLIN C, 1991, PLANT CELL, V3, P1131, DOI 10.1105/tpc.3.10.1131; DALTON DA, 1993, PLANT PHYSIOL, V102, P481, DOI 10.1104/pp.102.2.481; DALTON DA, 1986, P NATL ACAD SCI USA, V83, P3811, DOI 10.1073/pnas.83.11.3811; DAY DA, 1985, AUST J PLANT PHYSIOL, V12, P219, DOI 10.1071/PP9850219; De Leonardis S, 2000, PLANT PHYSIOL BIOCH, V38, P773, DOI 10.1016/S0981-9428(00)01188-8; DELEONARDIS S, 1995, PLANT PHYSIOL, V109, P847, DOI 10.1104/pp.109.3.847; Dutilleul C, 2003, PLANT CELL, V15, P1212, DOI 10.1105/tpc.009464; EDWARDS EA, 1990, PLANTA, V180, P278, DOI 10.1007/BF00194008; Elo A, 2003, PLANT CELL, V15, P1619, DOI 10.1105/tpc.010009; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Fryer MJ, 2003, PLANT J, V33, P691, DOI 10.1046/j.1365-313X.2003.01656.x; Giglione C, 2000, EMBO J, V19, P5916, DOI 10.1093/emboj/19.21.5916; Goggin DE, 2003, PLANT PHYSIOL, V131, P1033, DOI 10.1104/pp.102.015081; Gomez JM, 1999, FREE RADICAL RES, V31, pS11, DOI 10.1080/10715769900301261; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P85; Ishikawa T, 1997, BIOCHEM J, V328, P795, DOI 10.1042/bj3280795; Iturbe-Ormaetxe I, 2001, MOL PLANT MICROBE IN, V14, P1189, DOI 10.1094/MPMI.2001.14.10.1189; Jespersen HM, 1997, BIOCHEM J, V326, P305, DOI 10.1042/bj3260305; Jimenez A, 1997, PLANT PHYSIOL, V114, P275, DOI 10.1104/pp.114.1.275; Jimenez A, 1998, PHYSIOL PLANTARUM, V104, P687, DOI 10.1034/j.1399-3054.1998.1040424.x; Karpinski S, 1997, PLANT CELL, V9, P627, DOI 10.1105/tpc.9.4.627; Kobayashi Y, 2001, BIOCHEM BIOPH RES CO, V289, P1106, DOI 10.1006/bbrc.2001.6130; Kubis S, 2003, PLANT CELL, V15, P1859, DOI 10.1105/tpc.012955; KUBO A, 1993, PLANT CELL PHYSIOL, V34, P1259; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Lister R, 2002, PLANT J, V30, P555, DOI 10.1046/j.1365-313X.2002.01316.x; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Madhusudhan R, 2003, PHYSIOL PLANTARUM, V117, P550, DOI 10.1034/j.1399-3054.2003.00066.x; MAELLARO E, 1994, BIOCHEM J, V301, P471, DOI 10.1042/bj3010471; Millar AH, 2001, PLANT PHYSIOL, V127, P1711, DOI 10.1104/pp.010387; Millar AH, 2001, METHOD CELL BIOL, V65, P53, DOI 10.1016/S0091-679X(01)65004-0; Millar H, 2001, IUBMB LIFE, V51, P201, DOI 10.1080/152165401753311735; Miranda-Vizuete A, 2000, ANTIOXID REDOX SIGN, V2, P801, DOI 10.1089/ars.2000.2.4-801; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Murcha MW, 2003, PLANT PHYSIOL, V131, P1737, DOI 10.1104/pp.102.016808; Netto LES, 2002, METHOD ENZYMOL, V348, P260, DOI 10.1016/S0076-6879(02)48644-2; NEWMAN T, 1994, PLANT PHYSIOL, V106, P1241, DOI 10.1104/pp.106.4.1241; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Obara K, 2002, PLANT CELL PHYSIOL, V43, P697, DOI 10.1093/pcp/pcf103; Pedrajas JR, 2000, J BIOL CHEM, V275, P16296, DOI 10.1074/jbc.275.21.16296; Peeters N, 2001, BBA-MOL CELL RES, V1541, P54, DOI 10.1016/S0167-4889(01)00146-X; PRASAD TK, 1995, PLANT PHYSIOL, V108, P1597, DOI 10.1104/pp.108.4.1597; Rial DV, 2002, EUR J BIOCHEM, V269, P5431, DOI 10.1046/j.1432-1033.2002.03233.x; Rudhe C, 2002, PLANT J, V30, P213, DOI 10.1046/j.1365-313X.2002.01280.x; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; Sweetlove LJ, 2001, FEBS LETT, V508, P272, DOI 10.1016/S0014-5793(01)03069-1; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Szederkenyi J, 1997, PLANTA, V202, P349, DOI 10.1007/s004250050137; Taylor NL, 2002, J BIOL CHEM, V277, P42663, DOI 10.1074/jbc.M204761200; Waegemann K, 1995, METHOD CELL BIOL, V50, P255, DOI 10.1016/S0091-679X(08)61035-3; Watanabe N, 2001, J BIOL CHEM, V276, P20474, DOI 10.1074/jbc.M101140200; WELLS WW, 1990, J BIOL CHEM, V265, P15361; WHELAN J, 1993, PLANT PHYSIOL, V103, P1481, DOI 10.1104/pp.103.4.1481	68	329	366	6	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46869	46877		10.1074/jbc.M307525200	http://dx.doi.org/10.1074/jbc.M307525200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12954611	hybrid			2022-12-27	WOS:000186569400080
J	Foster, CE; Colonna, M; Sun, PD				Foster, CE; Colonna, M; Sun, PD			Crystal structure of the human natural killer (NK) cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-2-DEFICIENT LYMPHOMA VARIANTS; IMMUNOGLOBULIN-LIKE RECEPTOR; HEAVY-ATOM DERIVATIVES; QUICK-SOAK METHOD; FC-ALPHA-RI; INHIBITORY RECEPTOR; CYTOTOXICITY RECEPTORS; SURFACE-MOLECULE; LIGAND-BINDING; T-CELLS	Natural cytotoxicity receptors (NCR) mediate lysis of a variety of tumor and virus-infected cells by natural killer (NK) cells. Upon engagement, NCR trigger the cytolytic activity and cytokine release of NK cells through association with ITAM-containing signaling molecules. To further understand the function of these receptors in activation of natural cytotoxicity, we determined the crystal structure of the extracellular ligand binding domain of human NKp46, one of three known NCR, at 2.2-Angstrom resolution. The overall fold and disposition of the two C2-set immunoglobulin domains are similar to the D1D2 domains of inhibitory killer cell Ig-like receptor (KIR) and Ig-like transcript (ILT) receptors. As the cellular ligands of NKp46 have not yet been defined, the known ligand binding sites of KIR and ILT were compared with the corresponding structural regions of NKp46 in an effort to identify potential areas suitable for molecular recognition. A potential binding site for influenza hemagglutinin is located near the interdomain hinge, a region that mediates ligand binding in KIR. The structural similarity of NKp46 to inhibitory KIR receptors may have implications for how NK cells balance activating and inhibitory signals.	NIAID, Struct Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Washington University (WUSTL)	Sun, PD (corresponding author), NIAID, Struct Immunol Sect, Immunogenet Lab, NIH, 12441 Parklawn Dr, Rockville, MD 20852 USA.	psun@niaid.nih.gov		Colonna, Marco/0000-0001-5222-4987	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000697, Z01AI000697] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Augugliaro R, 2003, EUR J IMMUNOL, V33, P1235, DOI 10.1002/eji.200323896; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO;2-O; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cantoni C, 2003, STRUCTURE, V11, P725, DOI 10.1016/S0969-2126(03)00095-9; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Chapman TL, 2000, IMMUNITY, V13, P727, DOI 10.1016/S1074-7613(00)00071-6; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; DeLano W.L, PYMOL MOL GRAPHICS S; Ding Y, 2003, J BIOL CHEM, V278, P27966, DOI 10.1074/jbc.C300223200; Dustin ML, 2002, ARTHRITIS RES THER, V4, pS119, DOI 10.1186/ar559; Falco M, 1999, IMMUNOL LETT, V68, P411, DOI 10.1016/S0165-2478(99)00052-8; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Garman SC, 1999, ANNU REV IMMUNOL, V17, P973, DOI 10.1146/annurev.immunol.17.1.973; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Herr AB, 2003, NATURE, V423, P614, DOI 10.1038/nature01685; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Martin AM, 2002, TRENDS IMMUNOL, V23, P81, DOI 10.1016/S1471-4906(01)02155-X; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta A, 1999, CURR TOP MICROBIOL, V244, P69; Moretta A, 2000, IMMUNOL TODAY, V21, P228, DOI 10.1016/S0167-5699(00)01596-6; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Storset AK, 2003, EUR J IMMUNOL, V33, P980, DOI 10.1002/eji.200323710; Sun PD, 2000, ACTA CRYSTALLOGR D, V56, P161, DOI 10.1107/S0907444999015188; Sun PD, 2002, ACTA CRYSTALLOGR D, V58, P1099, DOI 10.1107/S0907444902006522; Sun PD, 2002, ACTA CRYSTALLOGR D, V58, P1092, DOI 10.1107/S0907444902006510; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vankayalapati R, 2002, J IMMUNOL, V168, P3451, DOI 10.4049/jimmunol.168.7.3451; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Wagtmann N, 1997, CURR BIOL, V7, P615, DOI 10.1016/S0960-9822(06)00263-6; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; WILLCOX BE, 2002, BMC STRUCTURE BIOL; Wines BD, 1999, J IMMUNOL, V162, P2146; Wines BD, 2001, J IMMUNOL, V166, P1781, DOI 10.4049/jimmunol.166.3.1781; Zhang YH, 2000, IMMUNITY, V13, P387, DOI 10.1016/S1074-7613(00)00038-8	57	50	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46081	46086		10.1074/jbc.M308491200	http://dx.doi.org/10.1074/jbc.M308491200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12960161	hybrid			2022-12-27	WOS:000186452300125
J	Cavet, JS; Graham, AI; Meng, WM; Robinson, NJ				Cavet, JS; Graham, AI; Meng, WM; Robinson, NJ			A cadmium-lead-sensing ArsR-SmtB repressor with novel sensory sites - Complementary metal discrimination by NMTR and CMTR in a common cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUREUS PI258 CADC; STAPHYLOCOCCUS-AUREUS; METALLOREGULATORY PROTEINS; BINDING-SITES; PLASMID PI258; ZINC SENSOR; RESISTANCE; OPERON; GENE; SELECTIVITY	We report a cadmium- and lead-detecting transcriptional repressor from Mycobacterium tuberculosis designated CmtR. Two genes were co-transcribed with cmtR, one encoding a deduced P-1 type ATPase. Purified CmtR bound to the cmt operator-promoter, and repression of transcription was lost after introduction of a stop codon into cmtR. Assays of metal-dependent expression from cmt and nmt operator-promoters established that the metal specificity of CmtR in vivo was perfectly inverted relative to the nickel-cobalt sensor NmtR from the same organism, with CmtR totally insensitive to Co(II) or Ni(II) and NmtR totally insensitive to Cd(II) or Pb(II). Absorption spectroscopy of Cd(II)-, Co( II)-, and Ni( II)substituted CmtR revealed S- to metal-charge-transfer which was absent in NmtR, providing diagnostic metal-difference spectra that discriminated between metal-binding to these two proteins. Ni( II)- binding isothermal titrations of CmtR are complex, with K-app = 1.8 x 10(4) M-1 for site(1), three orders of magnitude weaker than K-Ni for NmtR. Mixing equimolar apo-NmtR and apo-CmtR with 0.9 equivalents of Cd( II) gave Cd( II)- dependent difference spectra almost identical to Cd( II)(0.9)-CmtR. Thus, Cd( II) bound to CmtR in preference to NmtR, whereas the converse was true for Ni( II); this correlates faithfully with and provides a simplistic basis for metal-sensing preferences. In contrast, CmtR and NmtR had similar affinities for Co( II), and alternative explanations for Co(II) sensitivities are invoked. ArsR-SmtB repressors detect metals through derivatives of one or both of two possible allosteric sites at either carboxyl-terminal alpha5 helices or helix alpha3 proximal to the DNA-binding site. Unexpectedly, neither site was required for inducer recognition by CmtR. The mutants in potential metal ligands in, or near, these regions, Cys(4), Cys(35), Asp(79), His(81), Asp(97), Asp(99), Glu(105), Glu(111), and Glu(114), retained both repression and inducer recognition. Crucially, substitution of Cys(57), Cys(61), and Cys(102) with Ser revealed that each of these three residues is obligatory for Cd( II) detection, and this defines completely new sensory sites.	Univ Newcastle, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Manchester, Manchester M13 9PT, Lancs, England	Newcastle University - UK; University of Manchester	Robinson, NJ (corresponding author), Univ Newcastle, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.		Robinson, Nigel J/J-6363-2012	Robinson, Nigel J/0000-0001-5586-1092; Cavet, Jennifer/0000-0001-5913-7157				Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Busenlehner LS, 2002, J MOL BIOL, V319, P685, DOI 10.1016/S0022-2836(02)00299-1; Busenlehner LS, 2001, BIOCHEMISTRY-US, V40, P4426, DOI 10.1021/bi010006g; Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cook WJ, 1998, J MOL BIOL, V275, P337, DOI 10.1006/jmbi.1997.1443; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; ENDO G, 1995, J BACTERIOL, V177, P4437, DOI 10.1128/jb.177.15.4437-4441.1995; HUCKLE JW, 1993, MOL MICROBIOL, V7, P177, DOI 10.1111/j.1365-2958.1993.tb01109.x; Kuroda M, 1999, MICROBIOL IMMUNOL, V43, P115, DOI 10.1111/j.1348-0421.1999.tb02382.x; MORBY AP, 1993, NUCLEIC ACIDS RES, V21, P921, DOI 10.1093/nar/21.4.921; NUCIFORA G, 1989, P NATL ACAD SCI USA, V86, P3544, DOI 10.1073/pnas.86.10.3544; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pennella MA, 2003, P NATL ACAD SCI USA, V100, P3713, DOI 10.1073/pnas.0636943100; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rother D, 1999, MOL GEN GENET, V262, P154, DOI 10.1007/s004380051070; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Sambrook J., 2002, MOL CLONING LAB MANU; SAUTON MB, 1912, CR HEBD ACAD SCI, V155, P860; Shi WP, 1996, J BIOL CHEM, V271, P9291, DOI 10.1074/jbc.271.16.9291; SHI WP, 1994, J BIOL CHEM, V269, P19826; Singh VK, 1999, MOL MICROBIOL, V33, P200, DOI 10.1046/j.1365-2958.1999.01466.x; Sun Y, 2001, J BIOL CHEM, V276, P14955, DOI 10.1074/jbc.M010595200; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; TIMM JL, 1994, J BACTERIOL, V176, P6749, DOI 10.1128/JB.176.21.6749-6753.1994; Turner JS, 1996, NUCLEIC ACIDS RES, V24, P3714, DOI 10.1093/nar/24.19.3714; VanZile ML, 2000, BIOCHEMISTRY-US, V39, P11818, DOI 10.1021/bi001140o; VanZile ML, 2002, BIOCHEMISTRY-US, V41, P9776, DOI 10.1021/bi020178t; VanZile ML, 2002, BIOCHEMISTRY-US, V41, P9765, DOI 10.1021/bi0201771; Wong MD, 2002, J BIOL CHEM, V277, P40930, DOI 10.1074/jbc.M206536200; Xu C, 1996, J BIOL CHEM, V271, P2427, DOI 10.1074/jbc.271.5.2427	31	63	69	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44560	44566		10.1074/jbc.M307877200	http://dx.doi.org/10.1074/jbc.M307877200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12939264	hybrid			2022-12-27	WOS:000186306700085
J	Dowdy, SC; Mariani, A; Janknecht, R				Dowdy, SC; Mariani, A; Janknecht, R			HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ER81; N-TERMINAL KINASE; SIGNAL-TRANSDUCTION; DNA-BINDING; OVARIAN CARCINOMAS; COLORECTAL-CANCER; BREAST-CANCER; CELL-CYCLE; GENE; RECEPTOR	The cytokine transforming growth factor beta (TGF-beta) plays an important role in preventing tumor formation by blocking cell cycle progression. Accordingly, many cancers demonstrate mutations in TGF-beta signaling components or enhanced expression of inhibitors of the TGF-beta pathway such as Smad7. In this report we show that the oncoprotein HER2/Neu is able to collaborate with the ETS transcription factor ER81 to activate Smad7 transcription in breast, endometrial, and ovarian cancer cell lines. ER81 binds to two ETS sites within the Smad7 promoter, and mutation of one of these ETS sites greatly decreases Smad7 induction by HER2/Neu and ER81. Furthermore, we show that Smad7 activation involves the processing of signals from HER2/Neu to ER81 via the ERK mitogen-activated protein kinase pathway. Thus, we have uncovered a novel mechanism by which oncogenic HER2/Neu, in collaboration with ER81, can induce carcinogenesis through Smad7 upregulation. Moreover, we show that TAK1, a TGF-beta-activated protein kinase, stimulates ER81 via the p38 mitogen-activated protein kinase pathway and thereby induces the Smad7 promoter. This suggests that attenuation of TGF-beta signaling by activating Smad7 transcription may proceed not only through TGF-beta receptor-regulated Smad proteins but also through an independent pathway involving ER81 and TAK1.	Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Janknecht, R (corresponding author), Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Guggenheim Bldg 1501A,200 1st St SW, Rochester, MN 55905 USA.			Janknecht, Ralf/0000-0003-1741-1562	NATIONAL CANCER INSTITUTE [R01CA085257] Funding Source: NIH RePORTER; NCI NIH HHS [CA085257, R01 CA085257] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; BENLEVY R, 1994, EMBO J, V13, P3302, DOI 10.1002/j.1460-2075.1994.tb06632.x; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Benz CC, 1997, ONCOGENE, V15, P1513, DOI 10.1038/sj.onc.1201331; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; Bojovic BB, 2001, J BIOL CHEM, V276, P4509, DOI 10.1074/jbc.M005509200; Bosc DG, 2002, J CELL BIOCHEM, V86, P174, DOI 10.1002/jcb.10205; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Boulay JL, 2001, GENE CHROMOSOME CANC, V31, P240, DOI 10.1002/gcc.1140; BredemeierErnst I, 1997, FEBS LETT, V408, P47, DOI 10.1016/S0014-5793(97)00387-6; Brodin G, 2000, J BIOL CHEM, V275, P29023, DOI 10.1074/jbc.M002815200; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; Cahill MA, 1996, CURR BIOL, V6, P16, DOI 10.1016/S0960-9822(02)00410-4; Chen T, 2001, CANCER RES, V61, P4679; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; De Haro L, 2002, NUCLEIC ACIDS RES, V30, P2972; de Launoit Y, 2000, ADV EXP MED BIOL, V480, P107; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Goel A, 2003, MOL CELL BIOL, V23, P6243, DOI 10.1128/MCB.23.17.6243-6254.2003; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hellstrom I, 2001, CANCER RES, V61, P2420; HETZEL DJ, 1992, GYNECOL ONCOL, V47, P179, DOI 10.1016/0090-8258(92)90103-P; Holtmann H, 2001, J BIOL CHEM, V276, P3508, DOI 10.1074/jbc.M004376200; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Janknecht R, 1996, MOL CELL BIOL, V16, P1550; Janknecht R, 2003, ONCOGENE, V22, P746, DOI 10.1038/sj.onc.1206185; Janknecht R, 2001, J BIOL CHEM, V276, P41856, DOI 10.1074/jbc.M106630200; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Kim SJ, 2000, CYTOKINE GROWTH F R, V11, P159, DOI 10.1016/S1359-6101(99)00039-8; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Kleeff J, 1999, ONCOGENE, V18, P5363, DOI 10.1038/sj.onc.1202909; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Lynch MA, 1998, CANCER RES, V58, P4227; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Nagarajan RP, 1999, J BIOL CHEM, V274, P33412, DOI 10.1074/jbc.274.47.33412; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; PARSONS R, 1995, CANCER RES, V55, P5548; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; PIETENPOL JA, 1990, P NATL ACAD SCI USA, V87, P3758, DOI 10.1073/pnas.87.10.3758; Riggins GJ, 1997, CANCER RES, V57, P2578; Shepherd TG, 2001, CURR BIOL, V11, P1739, DOI 10.1016/S0960-9822(01)00536-X; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Stein B, 1997, J BIOL CHEM, V272, P19509, DOI 10.1074/jbc.272.31.19509; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Terada Y, 1999, KIDNEY INT, V56, P1378, DOI 10.1046/j.1523-1755.1999.00665.x; Tsai CM, 1996, CANCER RES, V56, P1068; Uchida K, 2001, BIOCHEM BIOPH RES CO, V289, P376, DOI 10.1006/bbrc.2001.5984; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; von Gersdorff G, 2000, J BIOL CHEM, V275, P11320, DOI 10.1074/jbc.275.15.11320; Wong C, 1999, MOL CELL BIOL, V19, P1821; Wu JM, 2002, J BIOL CHEM, V277, P42669, DOI 10.1074/jbc.M205501200; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zimmerman CM, 2000, GENE, V249, P17, DOI 10.1016/S0378-1119(00)00162-1	75	76	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44377	44384		10.1074/jbc.M307202200	http://dx.doi.org/10.1074/jbc.M307202200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947087	hybrid			2022-12-27	WOS:000186306700062
J	Ott, C; Iwanciw, D; Graness, A; Giehl, K; Goppelt-Struebe, M				Ott, C; Iwanciw, D; Graness, A; Giehl, K; Goppelt-Struebe, M			Modulation of the expression of connective tissue growth factor by alterations of the cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; SERUM RESPONSE FACTOR; RAT MESANGIAL CELLS; BINDING PROTEIN-RHO; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; AGENTS STIMULATE; FOCAL ADHESIONS; STRESS FIBERS; TGF-BETA	Modulation of the cytoskeletal architecture was shown to regulate the expression of CTGF ( connective tissue growth factor, CCN2). The microtubule disrupting agents nocodazole and colchicine strongly up-regulated CTGF expression, which was prevented upon stabilization of the microtubules by paclitaxel. As a consequence of microtubule disruption, RhoA was activated and the actin stress fibers were stabilized. Both effects were related to CTGF induction. Overexpression of constitutively active RhoA induced CTGF synthesis. Interference with RhoA signaling by simvastatin, toxinB, C3 toxin, and Y27632 prevented up-regulation of CTGF. Likewise, direct disintegration of the actin cytoskeleton by latrunculin B interfered with nocodazole-mediated up-regulation of CTGF expression. Disassembly of actin fibers by cytochalasin D, however, unexpectedly increased CTGF expression indicating that the content of F-actin per se was not the major determinant for CTGF gene expression. Given the fact that cytochalasin D sequesters G-actin, a decrease in G-actin increased CTGF, while increased levels of G-actin corresponded to reduced CTGF expression. These data link alterations in the microtubule and actin cytoskeleton to the expression of CTGF and provide a molecular basis for the observation that CTGF is up-regulated in cells exposed to mechanical stress.	Univ Erlangen Nurnberg, Med Klin 4, D-91054 Erlangen, Germany; Univ Ulm, Inst Pharmakol & Toxikol, D-89081 Ulm, Germany	University of Erlangen Nuremberg; Ulm University	Goppelt-Struebe, M (corresponding author), Univ Erlangen Nurnberg, Med Klin 4, Loschgestr 8, D-91054 Erlangen, Germany.							Abraham DJ, 2000, J BIOL CHEM, V275, P15220, DOI 10.1074/jbc.275.20.15220; Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Cipolla MJ, 2002, FASEB J, V16, P72, DOI 10.1096/cj.01-0104hyp; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Eberlein M, 2001, BRIT J PHARMACOL, V133, P1172, DOI 10.1038/sj.bjp.0704173; Enomoto T, 1996, CELL STRUCT FUNCT, V21, P317, DOI 10.1247/csf.21.317; Galle J, 2003, J AM SOC NEPHROL, V14, P1471, DOI 10.1097/01.ASN.0000067412.18899.9B; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; GOPPELTSTRUEBE M, 2001, MOL PATHOL, V3, P176; Grinnell F, 1999, J BIOL CHEM, V274, P918, DOI 10.1074/jbc.274.2.918; Hahn A, 2000, J BIOL CHEM, V275, P37429, DOI 10.1074/jbc.M000976200; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heusinger-Ribeiro J, 2001, J AM SOC NEPHROL, V12, P1853, DOI 10.1681/ASN.V1291853; Hishikawa K, 2001, J BIOL CHEM, V276, P16797, DOI 10.1074/jbc.M010722200; Ihn H, 2002, CURR OPIN RHEUMATOL, V14, P681, DOI 10.1097/00002281-200211000-00009; IWANCIW D, 2003, IN PRESS ARTERIOSCLE; JAKOBISIAK M, 1991, P NATL ACAD SCI USA, V88, P3628, DOI 10.1073/pnas.88.9.3628; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; MANIE S, 1993, J BIOL CHEM, V268, P13675; MULLER GA, 1995, EXP NEPHROL, V3, P127; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; ROSETTE C, 1995, J CELL BIOL, V128, P1111, DOI 10.1083/jcb.128.6.1111; Schild C, 2002, EXP CELL RES, V274, P83, DOI 10.1006/excr.2001.5458; Small JV, 1999, FEBS LETT, V452, P96, DOI 10.1016/S0014-5793(99)00530-X; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; STROEBEL M, 1994, J BIOL CHEM, V269, P22952; Subbaramaiah K, 2000, J BIOL CHEM, V275, P14838, DOI 10.1074/jbc.275.20.14838; Tomasek JJ, 1997, J BIOL CHEM, V272, P7482, DOI 10.1074/jbc.272.11.7482; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Wahab NA, 2001, BIOCHEM J, V359, P77, DOI 10.1042/0264-6021:3590077; Wei L, 2001, FASEB J, V15, P785, DOI 10.1096/fj.00-026com; Zhang QH, 1997, MOL BIOL CELL, V8, P1415, DOI 10.1091/mbc.8.8.1415	42	67	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44305	44311		10.1074/jbc.M309140200	http://dx.doi.org/10.1074/jbc.M309140200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12951326	hybrid			2022-12-27	WOS:000186306700052
J	Smith, SM; Pentlicky, S; Klase, Z; Singh, M; Neuveut, C; Lu, CY; Reitz, MS; Yarchoan, R; Marx, PA; Jeang, KT				Smith, SM; Pentlicky, S; Klase, Z; Singh, M; Neuveut, C; Lu, CY; Reitz, MS; Yarchoan, R; Marx, PA; Jeang, KT			An in vivo replication-important function in the second coding exon of Tat is constrained against mutation despite cytotoxic T lymphocyte selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELLULAR IMMUNE-RESPONSES; HIV-1 INFECTION; CYNOMOLGUS MONKEYS; VIRAL REPLICATION; RHESUS MACAQUES; VACCINE; PROTEIN; ESCAPE; DISEASE	Human and simian immunodeficiency virus (HIV/SIV) Tat proteins are specified by two coding exons. Tat functions in the transcription of primate lentiviruses. A plethora of in vitro data currently suggests that the second coding exon of Tat is largely devoid of function. However, whether the second exon of Tat contributes functionally to viral pathogenesis in vivo remains unknown. To address this question directly, we compared infection of rhesus macaques with an SIV, engineered to express only the first coding exon of Tat (SIVtat1ex), to counterpart infection with wild-type SIVmac239 virus, which expresses the full 2-exon Tat. This comparison showed that the second coding exon of Tat contributes to chronic SIV replication in vivo. Interestingly, in macaques, we observed a cytotoxic T lymphocytes (CTL) response to the second coding exon of Tat, which appears to durably control SIV replication. When SIV mutated in an attempt to escape this second Tat-exon-CTL, the resulting virus was less replicatively fit and failed to populate the host in vivo. Our study provides the first evidence that the second coding exon in Tat embodies an important function for in vivo replication. We suggest the second coding exon of Tat as an example of a functionally constrained "epitope" whose elicited CTL response cannot be escaped by virus mutation without producing a virus that replicates poorly in vivo.	St Michaels Hosp, Newark, NJ 07102 USA; Univ Med & Dent New Jersey, Newark, NJ 07102 USA; Inst Pasteur, Unite Recombinaison & Express, F-75015 Paris, France; NIAID, Mol Virol Sect, NIH, Bethesda, MD 20892 USA; Univ Maryland, Inst Biotechnol, Inst Human Virol, Baltimore, MD 21201 USA; NCI, HIV & AIDS Malignancy Branch, Div Clin Sci, NIH, Bethesda, MD 20892 USA; Tulane Univ, Hlth Sci Ctr, Dept Trop Med, Covington, LA 70433 USA; Tulane Natl Primate Res Ctr, Covington, LA 70433 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tulane University; Tulane University	Smith, SM (corresponding author), St Michaels Hosp, Newark, NJ 07102 USA.		Jeang, Kuan-Teh/A-2424-2008; Smith, Stephen/GQQ-5975-2022	Smith, Stephen/0000-0002-9158-6136; Neuveut, Christine/0000-0001-6520-271X; LU, CHUN-YI/0000-0002-5240-2808	NATIONAL CANCER INSTITUTE [ZIASC006737, Z01SC006737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000547, ZIAAI000547] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Addo MM, 2001, P NATL ACAD SCI USA, V98, P1781, DOI 10.1073/pnas.98.4.1781; Agwale SM, 2002, P NATL ACAD SCI USA, V99, P10037, DOI 10.1073/pnas.152313899; Allen TM, 2002, J VIROL, V76, P4108, DOI 10.1128/JVI.76.8.4108-4112.2002; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2003, J VIROL, V77, P7367, DOI 10.1128/JVI.77.13.7367-7375.2003; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; BOOTH J, 1998, 16 ANN S NONH PRIM M; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Boucher C, 1996, AIDS, V10, pS15; BUONAGURO L, 1992, J VIROL, V66, P7159, DOI 10.1128/JVI.66.12.7159-7167.1992; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; Cafaro A, 2001, VACCINE, V19, P2862, DOI 10.1016/S0264-410X(01)00002-0; Cafaro A, 2000, J MED PRIMATOL, V29, P193, DOI 10.1034/j.1600-0684.2000.290313.x; CARMICHAEL A, 1993, J EXP MED, V177, P249, DOI 10.1084/jem.177.2.249; Dailey P. J., 1995, Journal of Medical Primatology, V24, P209; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; GALLO RC, 1987, NATURE, V326, P435; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Hirsch VM, 1996, J VIROL, V70, P3741, DOI 10.1128/JVI.70.6.3741-3752.1996; HOPE TJ, 1990, J VIROL, V64, P5360, DOI 10.1128/JVI.64.11.5360-5366.1990; Izmailova E, 2003, NAT MED, V9, P191, DOI 10.1038/nm822; Jeang K T, 1994, Curr Top Microbiol Immunol, V188, P123; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Katzenstein TL, 1996, AIDS, V10, P167, DOI 10.1097/00002030-199602000-00006; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; Klenerman P, 2002, CURR OPIN MICROBIOL, V5, P408, DOI 10.1016/S1369-5274(02)00339-9; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lafrenie RM, 1997, J IMMUNOL, V159, P4077; Li CJ, 1997, P NATL ACAD SCI USA, V94, P8116, DOI 10.1073/pnas.94.15.8116; Mayers D, 1996, AIDS, V10, pS9; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; MOORE JP, 1994, J VIROL, V68, P6836, DOI 10.1128/JVI.68.11.6836-6847.1994; Mortara L, 1998, J VIROL, V72, P1403, DOI 10.1128/JVI.72.2.1403-1410.1998; Neuveut C, 1996, J VIROL, V70, P5572, DOI 10.1128/JVI.70.8.5572-5581.1996; NEUVEUT C, 2003, IN PRESS J BIOMED SC; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; O'Connor DH, 2002, DNA CELL BIOL, V21, P659, DOI 10.1089/104454902760330192; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Pauza CD, 2000, P NATL ACAD SCI USA, V97, P3515, DOI 10.1073/pnas.070049797; PINCUS SH, 1994, J CLIN INVEST, V93, P2505, DOI 10.1172/JCI117260; Reed L.J., 1983, AM J HYG, V27, P493; RINALDO C, 1995, J VIROL, V69, P5838, DOI 10.1128/JVI.69.9.5838-5842.1995; SCALA G, 1994, J EXP MED, V179, P961, DOI 10.1084/jem.179.3.961; Silvera P, 2002, J VIROL, V76, P3800, DOI 10.1128/JVI.76.8.3800-3809.2002; Singh MK, 2001, AIDS RES HUM RETROV, V17, P1265, DOI 10.1089/088922201750461320; Smith SM, 1999, AIDS RES HUM RETROV, V15, P1691, DOI 10.1089/088922299309739; Smith SM, 2002, J BIOMED SCI, V9, P100, DOI 10.1159/000048205; STERN TL, 1995, J VIROL, V69, P1860, DOI 10.1128/JVI.69.3.1860-1867.1995; Stittelaar KJ, 2002, VACCINE, V20, P2921, DOI 10.1016/S0264-410X(02)00219-0; Verhoef K, 1998, AIDS RES HUM RETROV, V14, P1553, DOI 10.1089/aid.1998.14.1553; WESTENDORP MO, 1994, J VIROL, V68, P4177, DOI 10.1128/JVI.68.7.4177-4185.1994; Yang OO, 2003, J EXP MED, V197, P1365, DOI 10.1084/jem.20022138	56	45	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44816	44825		10.1074/jbc.M307546200	http://dx.doi.org/10.1074/jbc.M307546200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947089	hybrid			2022-12-27	WOS:000186306700116
J	Van Komen, S; Reddy, MS; Krejci, L; Klein, H; Sung, P				Van Komen, S; Reddy, MS; Krejci, L; Klein, H; Sung, P			ATPase and DNA helicase activities of the Saccharomyces cerevisiae anti-recombinase Srs2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; REPLICATION PROTEIN-A; ESCHERICHIA-COLI; STRAND EXCHANGE; YEAST RAD51; MUTATIONS; GENE; FILAMENT; REQUIRES; ALLELE	Saccharomyces cerevisiae SRS2 encodes an ATP-dependent DNA helicase that is needed for DNA damage checkpoint responses and that modulates the efficiency of homologous recombination. Interestingly, strains simultaneously mutated for SRS2 and a variety of DNA repair genes show low viability that can be overcome by inactivating homologous recombination, thus implicating inappropriate recombination as the cause of growth impairment in these mutants. Here, we report on our biochemical characterization of the ATPase and DNA helicase activities of Srs2. ATP hydrolysis by Srs2 occurs efficiently only in the presence of DNA, with ssDNA being considerably more effective than dsDNA in this regard. Using homopolymeric substrates, the minimal DNA length for activating ATP hydrolysis is found to be 5 nucleotides, but a length of 10 nucleotides is needed for maximal activation. In its helicase action, Srs2 prefers substrates with a 3' ss overhang, and similar to10 bases of 3' overhanging DNA is needed for efficient targeting of Srs2 to the substrate. Even though a 3' overhang serves to target Srs2, under optimized conditions blunt-end DNA substrates are also dissociated by this protein. The ability of Srs2 to unwind helicase substrates with a long duplex region is enhanced by the inclusion of the single-strand DNA-binding factor replication protein A.	Univ Texas, Hlth Sci Ctr, Inst Biotechnol, San Antonio, TX 78245 USA; Univ Texas, Hlth Sci Ctr, Dept Mol Med, San Antonio, TX 78245 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; NYU, Sch Med, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; New York University; New York University	Sung, P (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, 333 Cedar St,C130 Sterling Hall Med, New Haven, CT 06520 USA.	Patrick.Sung@yale.edu	Krejci, Lumir/B-7842-2009	Krejci, Lumir/0000-0002-4732-1405; Klein, Hannah/0000-0003-4228-8535	NCI NIH HHS [CA96593] Funding Source: Medline; NIEHS NIH HHS [ES07061] Funding Source: Medline; NIGMS NIH HHS [GM57814, GM53738] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA096593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053738] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; AGUILERA A, 1988, GENETICS, V119, P779; Aylon Y, 2003, MOL CELL BIOL, V23, P1403, DOI 10.1128/MCB.23.4.1403-1417.2003; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; He ZG, 1996, J BIOL CHEM, V271, P28243, DOI 10.1074/jbc.271.45.28243; Klein H, 2001, GENETICS, V157, P557; Klein HL, 2000, NAT GENET, V25, P132, DOI 10.1038/75957; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Liberi G, 2000, EMBO J, V19, P5027, DOI 10.1093/emboj/19.18.5027; MATSON SW, 1987, J BIOL CHEM, V262, P2066; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; Nakagawa T, 2001, J BIOL CHEM, V276, P31487, DOI 10.1074/jbc.M104003200; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; PALLADINO F, 1992, GENETICS, V132, P23; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Petukhova G, 2000, GENE DEV, V14, P2206, DOI 10.1101/gad.826100; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; RONG L, 1991, GENETICS, V127, P75; RONG L, 1993, J BIOL CHEM, V268, P1252; SCHIESTL RH, 1990, GENETICS, V124, P817; SCHILD D, 1995, GENETICS, V140, P115; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sung P, 2000, MUTAT RES-FUND MOL M, V451, P257, DOI 10.1016/S0027-5107(00)00054-3; TSANEVA IR, 1993, P NATL ACAD SCI USA, V90, P1315, DOI 10.1073/pnas.90.4.1315; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu L, 2002, MUTAT RES-FUND MOL M, V509, P35, DOI 10.1016/S0027-5107(02)00225-7	32	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44331	44337		10.1074/jbc.M307256200	http://dx.doi.org/10.1074/jbc.M307256200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12966095	hybrid			2022-12-27	WOS:000186306700056
J	Yu, SW; Girotto, S; Zhao, XB; Magliozzo, RS				Yu, SW; Girotto, S; Zhao, XB; Magliozzo, RS			Rapid formation of Compound II and a tyrosyl radical in the Y229F mutant of Mycobacterium tuberculosis catalase-peroxidase disrupts catalase but not peroxidase function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ISONIAZID ACTIVATION; HORSERADISH-PEROXIDASE; KATG; SUSCEPTIBILITY; PURIFICATION; OXIDATION; ENZYME; PLANT	Catalase-peroxidases (KatG), which belong to Class I heme peroxidase enzymes, have high catalase activity and substantial peroxidase activity. The Y229F mutant of Mycobacterium tuberculosis KatG was prepared and characterized to investigate the functional role of this conserved residue unique to KatG enzymes. Purified, overexpressed KatG[ Y229F] exhibited severely reduced steady-state catalase activity while the peroxidase activity was enhanced. Optical stopped-flow experiments showed rapid formation of Compound (Cmpd) II ( oxyferryl heme intermediate) in the reaction of resting KatG[ Y229F] with peroxyacetic acid or chloroperoxybenzoic acid, without detectable accumulation of Cmpd I ( oxyferryl heme pi-cation radical intermediate), the latter being readily observed in the wild-type enzyme under similar conditions. Facile formation of Cmpd III ( oxyferrous enzyme) also occurred in the mutant in the presence of micromolar hydrogen peroxide. Thus, the lost catalase function may be explained in part because of formation of intermediates that do not participate in catalatic turnover. The source of the reducing equivalent required for generation of Cmpd II from Cmpd I was shown by rapid freeze-quench electron paramagnetic resonance spectroscopy to be a tyrosine residue, just as in wild-type KatG. The kinetic coupling of radical generation and Cmpd II formation was shown in KatG[ Y229F]. Residue Y229, which is a component of a newly defined three amino acid adduct in catalase-peroxidases, is critically important for protecting the catalase activity of KatG.	CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; CUNY Brooklyn Coll, Dept Biochem, Brooklyn, NY 11210 USA; CUNY, Grad Ctr, Brooklyn, NY 11210 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System	Magliozzo, RS (corresponding author), CUNY Brooklyn Coll, Dept Chem, 2900 Bedford Ave, Brooklyn, NY 11210 USA.		Girotto, Stefania/F-5997-2012		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043582] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-43582] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Carpena X, 2003, J MOL BIOL, V327, P475, DOI 10.1016/S0022-2836(03)00122-0; Chouchane S, 2000, BIOCHEMISTRY-US, V39, P9975, DOI 10.1021/bi0005815; Chouchane S, 2002, J BIOL CHEM, V277, P42633, DOI 10.1074/jbc.M207916200; DUNFORD H, 1999, HEME PEROXIDASES, P140; Goodwin DC, 1997, BIOCHEMISTRY-US, V36, P139, DOI 10.1021/bi961465y; Heering HA, 2002, BIOCHEMISTRY-US, V41, P9237, DOI 10.1021/bi025740u; HEYM B, 1993, J BACTERIOL, V175, P4255, DOI 10.1128/JB.175.13.4255-4259.1993; Hillar A, 2000, BIOCHEMISTRY-US, V39, P5868, DOI 10.1021/bi0000059; Jakopitsch C, 2003, BIOCHEMISTRY-US, V42, P5292, DOI 10.1021/bi026944d; Jakopitsch C, 2003, EUR J BIOCHEM, V270, P1006, DOI 10.1046/j.1432-1033.2003.03476.x; Jakopitsch C, 2003, J BIOL CHEM, V278, P20185, DOI 10.1074/jbc.M211625200; Johnsson K, 1997, J BIOL CHEM, V272, P2834, DOI 10.1074/jbc.272.5.2834; LOEWEN PC, 1990, MOL GEN GENET, V224, P147, DOI 10.1007/BF00259461; Magliozzo RS, 1996, J AM CHEM SOC, V118, P11303, DOI 10.1021/ja962047j; Magliozzo RS, 1997, J BIOL CHEM, V272, P8867; MARCINKEVICIENE JA, 1995, J BIOL CHEM, V270, P22290, DOI 10.1074/jbc.270.38.22290; MILLER MA, 1994, NAT STRUCT BIOL, V1, P524, DOI 10.1038/nsb0894-524; NAKAJIMA R, 1987, J BIOL CHEM, V262, P2576; Regelsberger G, 2000, J BIOL CHEM, V275, P22854, DOI 10.1074/jbc.M002371200; Regelsberger G, 2001, BIOCHEM SOC T, V29, P99; RodriguezLopez JN, 1997, J BIOL CHEM, V272, P5469, DOI 10.1074/jbc.272.9.5469; Saint-Joanis B, 1999, BIOCHEM J, V338, P753, DOI 10.1042/0264-6021:3380753; SANDERS BC, 1964, PEROXIDASE, P218; WELINDER KG, 1992, BIOCHEM SOC T, V20, P337, DOI 10.1042/bst0200337; WELINDER KG, 1991, BIOCHIM BIOPHYS ACTA, V1080, P215; Wengenack NL, 1999, J AM CHEM SOC, V121, P9748, DOI 10.1021/ja992590a; WITTENBE.BA, 1967, BIOCHEMISTRY-US, V6, P1970, DOI 10.1021/bi00859a013; Yamada Y, 2002, NAT STRUCT BIOL, V9, P691, DOI 10.1038/nsb834; Yu SW, 2003, J BIOL CHEM, V278, P14769, DOI 10.1074/jbc.M300326200; Yu SW, 2002, PROTEIN SCI, V11, P58, DOI 10.1110/ps.ps.09902; Zamocky M, 2001, FEBS LETT, V492, P177, DOI 10.1016/S0014-5793(01)02237-2	31	54	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44121	44127		10.1074/jbc.M304757200	http://dx.doi.org/10.1074/jbc.M304757200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944408	hybrid			2022-12-27	WOS:000186306700030
J	Krug, AW; Grossmann, C; Schuster, C; Freudinger, R; Mildenberger, S; Govindan, MV; Gekle, M				Krug, AW; Grossmann, C; Schuster, C; Freudinger, R; Mildenberger, S; Govindan, MV; Gekle, M			Aldosterone stimulates epidermal growth factor receptor expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC FIBROSIS; RAPID ACTIONS; TRANSCRIPTION; SPIRONOLACTONE; CELL; MINERALOCORTICOIDS; DYSFUNCTION; ACTIVATION; BINDING; DNA	The steroid hormone aldosterone plays an important role during pathological tissue modifications, similar to cardiovascular or renal fibrosis. The underlying mechanisms for the pathological actions are not understood. Interaction of aldosterone with the epidermal growth factor (EGF) receptor is an attractive hypothesis to explain pathological tissue remodeling elicited by aldosterone, because (i) mineralocorticoids can sensitize cells for EGF, (ii) mineralocorticoid receptor (MR)-antagonists reduce EGFR-mRNA expression, (iii) EGFR itself supports the development of cardiovascular or renal fibrosis, and (iv) signaling elements involved in the pathological action of aldosterone (similar to ERK1/2 or NFkappaB) are typical downstream modules during EGF signaling. In addition, an interaction of aldosterone and EGF with respect to ERK1/2 activation has been described. Here we show that aldosterone stimulates EGFR expression in renal tissue of adrenalectomized rats and in human renal primary cell cultures. Furthermore, Chinese hamster ovary (CHO) cells normally devoid of EGFR or MR express EGFR after transfection with human MR (CHO-MR cells) but not after transfection with human glucocorticoid receptor (CHO-GR cells). In CHO-MR cells, EGFR-expression is up-regulated by aldosterone and inhibited by spironolactone. CHO-MR cells but not CHO-GR cells respond with ERK1/2 phosphorylation to EGF exposure. The responsiveness to other peptide hormones was virtually not affected. These data suggest that EGFR is an aldosterone-induced protein and is involved in the manifold (patho) biological actions of aldosterone.	Univ Wurzburg, Inst Physiol, D-97070 Wurzburg, Germany; Univ Laval, Hotel Dieu Quebec, Ctr Rech, Quebec City, PQ G1R 2J6, Canada	University of Wurzburg; Laval University	Gekle, M (corresponding author), Univ Wurzburg, Inst Physiol, Rontgenring 9, D-97070 Wurzburg, Germany.	michael.gekle@mail.uni-wuerzburg.de						ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Bauersachs J, 2002, J AM COLL CARDIOL, V39, P351, DOI 10.1016/S0735-1097(01)01729-6; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Bonvalet JP, 1998, KIDNEY INT, pS49; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; CHAIDARUN SS, 1994, J ENDOCRINOL, V143, P489, DOI 10.1677/joe.0.1430489; Croxtall JD, 2000, BRIT J PHARMACOL, V130, P289, DOI 10.1038/sj.bjp.0703272; Dorrance AM, 2001, AM J PHYSIOL-REG I, V281, pR944, DOI 10.1152/ajpregu.2001.281.3.R944; Eaton DC, 2001, J MEMBRANE BIOL, V184, P313, DOI 10.1007/s00232-001-0098-x; Epstein M, 2001, AM J KIDNEY DIS, V37, P677, DOI 10.1016/S0272-6386(01)80115-3; Epstein M, 2001, J ROY SOC MED, V94, P378, DOI 10.1177/014107680109400803; Fiebeler A, 2001, HYPERTENSION, V37, P787, DOI 10.1161/01.HYP.37.2.787; Flamant M, 2002, FASEB J, V16, P327, DOI 10.1096/fj.02-0115fje; Florian JA, 2001, AM J PHYSIOL-REG I, V281, pR878, DOI 10.1152/ajpregu.2001.281.3.R878; Funder J, 2001, CLIN EXP PHARMACOL P, V28, P1002, DOI 10.1046/j.1440-1681.2001.03586.x; GEKLE M, 1994, PFLUG ARCH EUR J PHY, V428, P157, DOI 10.1007/BF00374853; Gekle M, 2002, AM J PHYSIOL-RENAL, V282, pF669, DOI 10.1152/ajprenal.00159.2001; Gekle M, 2002, STEROIDS, V67, P499, DOI 10.1016/S0039-128X(01)00183-0; GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Johnson AC, 2000, MOL MED, V6, P17, DOI 10.1007/BF03401931; Johnson AC, 1996, J BIOL CHEM, V271, P3033; KAGEYAMA R, 1989, J BIOL CHEM, V264, P15508; Kagiyama S, 2003, HYPERTENSION, V41, P824, DOI 10.1161/01.HYP.0000047104.42047.9B; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Krug AW, 2003, PFLUG ARCH EUR J PHY, V446, P492, DOI 10.1007/s00424-003-1033-z; Krug AW, 2002, J BIOL CHEM, V277, P45892, DOI 10.1074/jbc.M208851200; Lijnen P, 2000, J MOL CELL CARDIOL, V32, P865, DOI 10.1006/jmcc.2000.1129; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nishi H, 2001, J BIOL CHEM, V276, P41717, DOI 10.1074/jbc.M101241200; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; REDEMANN N, 1992, MOL CELL BIOL, V12, P491, DOI 10.1128/MCB.12.2.491; Rubinstein YR, 1998, FEBS LETT, V431, P268, DOI 10.1016/S0014-5793(98)00774-1; Stockand JD, 2003, AM J PHYSIOL-HEART C, V284, pH176, DOI 10.1152/ajpheart.00421.2002; Stockand JD, 2002, AM J PHYSIOL-RENAL, V282, pF559, DOI 10.1152/ajprenal.00320.2001; Terzi F, 2000, J CLIN INVEST, V106, P225, DOI 10.1172/JCI8315; Verrey F, 2000, KIDNEY INT, V57, P1277, DOI 10.1046/j.1523-1755.2000.00962.x; Verrey F, 1999, AM J PHYSIOL-RENAL, V277, pF319, DOI 10.1152/ajprenal.1999.277.3.F319; Versteeg HH, 2000, BIOCHEM J, V350, P717, DOI 10.1042/0264-6021:3500717; WIEDERHOLT M, 1966, PFLUG ARCH GES PHYS, V292, P316, DOI 10.1007/BF00363200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; ZENNARO MC, 1995, J BIOL CHEM, V270, P21016, DOI 10.1074/jbc.270.36.21016	45	88	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43060	43066		10.1074/jbc.M308134200	http://dx.doi.org/10.1074/jbc.M308134200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12939263	hybrid			2022-12-27	WOS:000186157000043
J	Ziegler, J; Sticht, H; Marx, UC; Muller, W; Rosch, P; Schwarzinger, S				Ziegler, J; Sticht, H; Marx, UC; Muller, W; Rosch, P; Schwarzinger, S			CD and NMR studies of prion protein (PrP) helix 1 - Novel implications for its role in the PrPC -> PrPSc conversion process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL PEPTIDES; EMPIRICAL PARAMETERS; SECONDARY STRUCTURE; CHEMICAL-SHIFTS; FOLDING PROBLEM; ALPHA-HELICES; DYNAMIC CHARACTERIZATION; CIRCULAR-DICHROISM; COHERENCE-TRANSFER; WATER SUPPRESSION	The conversion of prion helix 1 from an alpha-helical into an extended conformation is generally assumed to be an essential step in the conversion of the cellular isoform PrPC of the prion protein to the pathogenic isoform PrPSc. Peptides encompassing helix 1 and flanking sequences were analyzed by nuclear magnetic resonance and circular dichroism. Our results indicate a remarkably high instrinsic helix propensity of the helix 1 region. In particular, these peptides retain significant helicity under a wide range of conditions, such as high salt, pH variation, and presence of organic co-solvents. As evidenced by a data base search, the pattern of charged residues present in helix 1 generally favors helical structures over alternative conformations. Because of its high stability against environmental changes, helix 1 is unlikely to be involved in the initial steps of the pathogenic conformational change. Our results implicate that interconversion of helix 1 is rather representing a barrier than a nucleus for the PrPC-->PrPSc conversion.	Univ Bayreuth, Lehrstuhl Biopolymere, D-95440 Bayreuth, Germany; Univ Erlangen Nurnberg, Inst Biochem, Abt Bioinformat, D-91054 Erlangen, Germany	University of Bayreuth; University of Erlangen Nuremberg	Schwarzinger, S (corresponding author), Univ Bayreuth, Lehrstuhl Biopolymere, POB 101251, D-95440 Bayreuth, Germany.	stephan.schwarzinger@uni-bayreuth.de	Schwarzinger, Stephan/GWV-5819-2022; Rösch, Paul/I-5445-2014; Schwarzinger, Stephan/O-4318-2014	Rösch, Paul/0000-0003-3330-2446; Schwarzinger, Stephan/0000-0002-0894-5290; Sticht, Heinrich/0000-0001-5644-045X; Marx, Ute C./0000-0002-7077-9940				ARMSTRONG KM, 1993, J MOL BIOL, V230, P284, DOI 10.1006/jmbi.1993.1142; Bai YW, 2001, PROTEIN SCI, V10, P1056, DOI 10.1110/ps.00601; Baskakov IV, 2000, BIOCHEMISTRY-US, V39, P2792, DOI 10.1021/bi9923353; BODENHAUSEN G, 1984, J MAGN RESON, V58, P370, DOI 10.1016/0022-2364(84)90142-2; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brown DR, 2001, BRAIN RES BULL, V55, P165, DOI 10.1016/S0361-9230(01)00453-1; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Butterfield SM, 2002, J AM CHEM SOC, V124, P9751, DOI 10.1021/ja026668q; CHAKRABARTTY A, 1993, BIOCHEMISTRY-US, V32, P5560, DOI 10.1021/bi00072a010; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Eberl H, 2002, BIOPHYS CHEM, V96, P293, DOI 10.1016/S0301-4622(02)00015-7; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Eigen M, 1996, BIOPHYS CHEM, V63, pA1, DOI 10.1016/S0301-4622(96)02250-8; Fernandez A, 2002, EUR J BIOCHEM, V269, P4165, DOI 10.1046/j.1432-1033.2002.03116.x; FRIEDRICHS MS, 1995, J BIOMOL NMR, V5, P147, DOI 10.1007/BF00208805; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Hornemann S, 1997, FEBS LETT, V413, P277, DOI 10.1016/S0014-5793(97)00921-6; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jamin N, 2002, FEBS LETT, V529, P256, DOI 10.1016/S0014-5793(02)03353-7; Jobling MF, 1999, J NEUROCHEM, V73, P1557, DOI 10.1046/j.1471-4159.1999.0731557.x; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; Martins VR, 2002, FEBS LETT, V512, P25, DOI 10.1016/S0014-5793(02)02291-3; Morrissey MP, 1999, P NATL ACAD SCI USA, V96, P11293, DOI 10.1073/pnas.96.20.11293; MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; MUNOZ V, 1995, J MOL BIOL, V245, P275, DOI 10.1006/jmbi.1994.0023; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; SCHOLTZ JM, 1991, J AM CHEM SOC, V113, P5102, DOI 10.1021/ja00013a079; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Schwarzinger S, 2002, BIOCHEMISTRY-US, V41, P12681, DOI 10.1021/bi020381o; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; SHOEMAKER KR, 1990, BIOPOLYMERS, V29, P1, DOI 10.1002/bip.360290104; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Speare JO, 2003, J BIOL CHEM, V278, P12522, DOI 10.1074/jbc.M211599200; Suzuki T, 2002, BIOCHEM BIOPH RES CO, V294, P912, DOI 10.1016/S0006-291X(02)00546-6; VANGEET AL, 1970, ANAL CHEM, V42, P679, DOI 10.1021/ac60288a022; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yao J, 2001, BIOCHEMISTRY-US, V40, P3561, DOI 10.1021/bi002776i; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; ZHANG H, 1995, J MOL BIOL, V250, P514, DOI 10.1006/jmbi.1995.0395	55	73	76	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2003	278	50					50175	50181		10.1074/jbc.M305234200	http://dx.doi.org/10.1074/jbc.M305234200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751LH	12952977	hybrid			2022-12-27	WOS:000187068200063
J	Poppenberger, B; Berthiller, F; Lucyshyn, D; Sieberer, T; Schuhmacher, R; Krska, R; Kuchler, K; Glossl, J; Luschnig, C; Adam, G				Poppenberger, B; Berthiller, F; Lucyshyn, D; Sieberer, T; Schuhmacher, R; Krska, R; Kuchler, K; Glossl, J; Luschnig, C; Adam, G			Detoxification of the Fusarium mycotoxin deoxynivalenol by a UDP-glucosyltransferase from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; HEAD-BLIGHT; MULTIGENE FAMILY; GENE DISRUPTION; STRESS-RESPONSE; SALICYLIC-ACID; TOBACCO GENES; WHEAT SPIKES; EXPRESSION; GRAMINEARUM	Plant pathogenic fungi of the genus Fusarium cause agriculturally important diseases of small grain cereals and maize. Trichothecenes are a class of mycotoxins produced by different Fusarium species that inhibit eukaryotic protein biosynthesis and presumably interfere with the expression of genes induced during the defense response of the plants. One of its members, deoxynivalenol, most likely acts as a virulence factor during fungal pathogenesis and frequently accumulates in grain to levels posing a threat to human and animal health. We report the isolation and characterization of a gene from Arabidopsis thaliana encoding a UDP-glycosyltransferase that is able to detoxify deoxynivalenol. The enzyme, previously assigned the identifier UGT73C5, catalyzes the transfer of glucose from UDP-glucose to the hydroxyl group at carbon 3 of deoxynivalenol. Using a wheat germ extract-coupled transcription/ translation system we have shown that this enzymatic reaction inactivates the mycotoxin. This deoxynivalenol-glucosyltransferase (DOGT1) was also found to detoxify the acetylated derivative 15-acetyl-deoxynivalenol, whereas no protective activity was observed against the structurally similar nivalenol. Expression of the glucosyltransferase is developmentally regulated and induced by deoxynivalenol as well as salicylic acid, ethylene, and jasmonic acid. Constitutive overexpression in Arabidopsis leads to enhanced tolerance against deoxynivalenol.	BOKU Univ Nat Resources & Appl Life Sci, Ctr Appl Genet, A-1190 Vienna, Austria; Inst Agrobiotechnol IFA Tullin, Ctr Analyt Chem, A-3430 Tulln, Austria; Univ Vienna, Dept Biochem Med, Div Mol Genet, Max F Perutz Labs, A-1030 Vienna, Austria; Bioctr Vienna, A-1030 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Vienna Biocenter (VBC)	Adam, G (corresponding author), BOKU Univ Nat Resources & Appl Life Sci, Ctr Appl Genet, Muthgasse 18, A-1190 Vienna, Austria.		Glössl, Josef/H-8208-2013; kuchler, karl/AAL-6937-2020; Schuhmacher, Rainer/U-5174-2019	Glössl, Josef/0000-0002-5042-8828; kuchler, karl/0000-0003-2719-5955; Schuhmacher, Rainer/0000-0002-7520-4943; Luschnig, Christian/0000-0003-2099-9280; Lucyshyn, Doris/0000-0001-8558-1219; Krska, Rudolf/0000-0001-6843-9755; Berthiller, Franz/0000-0001-5883-2879; Adam, Gerhard/0000-0002-3008-3797				ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Bai GH, 2002, MYCOPATHOLOGIA, V153, P91, DOI 10.1023/A:1014419323550; BALLESTER R, 1989, CELL, V59, P681, DOI 10.1016/0092-8674(89)90014-7; Betina V, 1989, MYCOTOXINS, P192; Canady C.R., 2001, WHO FOOD ADDITIVES S, P419; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; *COD COMM FOOD ADD, 2003, JOINT FAO WHO FOOD S; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; CUNDLIFFE E, 1977, ANTIMICROB AGENTS CH, V11, P491, DOI 10.1128/AAC.11.3.491; Desjardins AE, 1996, MOL PLANT MICROBE IN, V9, P775, DOI 10.1094/MPMI-9-0775; Diener AC, 2000, PLANT CELL, V12, P853, DOI 10.1105/tpc.12.6.853; EGNER R, 1995, MOL CELL BIOL, V15, P5879; Engelhardt Gabriele, 1999, Advances in Food Sciences, V21, P71; Eudes F, 2000, CAN J PLANT PATHOL, V22, P286, DOI 10.1080/07060660009500477; FARRAND SK, 1989, J BACTERIOL, V171, P5314, DOI 10.1128/jb.171.10.5314-5321.1989; Fraissinet-Tachet L, 1998, FEBS LETT, V437, P319, DOI 10.1016/S0014-5793(98)01257-5; GROVE JF, 1996, PROGR CHEM ORGANIC N, P1; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Horvath DM, 1996, PLANT MOL BIOL, V31, P1061, DOI 10.1007/BF00040724; Horvath DM, 1998, MOL PLANT MICROBE IN, V11, P895, DOI 10.1094/MPMI.1998.11.9.895; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jenczmionka NJ, 2003, CURR GENET, V43, P87, DOI 10.1007/s00294-003-0379-2; Jones P, 2001, PLANTA, V213, P164, DOI 10.1007/s004250000492; Kang Z, 1999, PHYSIOL MOL PLANT P, V55, P275, DOI 10.1006/pmpp.1999.0233; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Laskin JD, 2002, TOXICOL SCI, V69, P289, DOI 10.1093/toxsci/69.2.289; LEAH JM, 1992, PESTIC SCI, V34, P81, DOI 10.1002/ps.2780340112; Li Y, 2001, J BIOL CHEM, V276, P4338, DOI 10.1074/jbc.M007447200; Lim EK, 2003, GLYCOBIOLOGY, V13, P139, DOI 10.1093/glycob/cwg017; Lu SW, 2003, P NATL ACAD SCI USA, V100, P5980, DOI 10.1073/pnas.0931375100; McCormick S, 2003, FUSARIUM HEAD BLIGHT OF WHEAT & BARLEY, P165; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; Messner B, 2003, PLANTA, V217, P138, DOI 10.1007/s00425-002-0969-0; Mesterhazy A, 2003, FUSARIUM HEAD BLIGHT OF WHEAT & BARLEY, P363; MILLER JD, 1986, CAN J PLANT PATHOL, V8, P147; MINET M, 1992, PLANT J, V2, P417; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NGANJE WE, 2001, AGRIBUS APPL EC REP, V464; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; Okubara PA, 2002, THEOR APPL GENET, V106, P74, DOI 10.1007/s00122-002-1066-2; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; SAVARD ME, 1991, J AGR FOOD CHEM, V39, P570, DOI 10.1021/jf00003a027; SCOTT PM, 1984, APPL ENVIRON MICROB, V48, P884, DOI 10.1128/AEM.48.4.884-886.1984; SEWALD N, 1992, TETRAHEDRON-ASYMMETR, V3, P953, DOI 10.1016/S0957-4166(00)82193-X; SIKORSKI RS, 1989, GENETICS, V122, P19; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; Truesdale M. R., 1996, PLANT PHYSIOL, V112, P446; Vogt T, 1999, PLANT J, V19, P509, DOI 10.1046/j.1365-313X.1999.00540.x; WETZEL A, 1994, ARCH BIOCHEM BIOPHYS, V314, P323, DOI 10.1006/abbi.1994.1449; Wolfger H, 2001, RES MICROBIOL, V152, P375, DOI 10.1016/S0923-2508(01)01209-8	53	396	443	5	138	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47905	47914		10.1074/jbc.M307552200	http://dx.doi.org/10.1074/jbc.M307552200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12970342	hybrid			2022-12-27	WOS:000186731400068
J	De Felice, M; Esposito, L; Pucci, B; Carpentieri, F; De Falco, M; Rossi, M; Pisani, FM				De Felice, M; Esposito, L; Pucci, B; Carpentieri, F; De Falco, M; Rossi, M; Pisani, FM			Biochemical characterization of a CDC6-like protein from the crenarchaeon Sulfolobus solfataricus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; MCM PROTEINS; GENE-PRODUCT; HELICASE; ORIGIN; CDC6P; SITE; RECOGNITION; INITIATION; BACTERIA	Cdc6 proteins play an essential role in the initiation of chromosomal DNA replication in Eukarya. Genes coding for putative homologs of Cdc6 have been also identified in the genomic sequence of Archaea, but the properties of the corresponding proteins have been poorly investigated so far. Herein, we report the biochemical characterization of one of the three putative Cdc6-like factors from the hyperthermophilic crenarchaeon Sulfolobus solfataricus (SsoCdc6-1). SsoCdc6-1 was overproduced in Escherichia coli as a His-tagged protein and purified to homogeneity. Gel filtration and glycerol gradient ultracentrifugation experiments indicated that this protein behaves as a monomer in solution (molecular mass of about 45 kDa). We demonstrated that SsoCdc6-1 binds single- and double-stranded DNA molecules by electrophoretic mobility shift assays. SsoCdc6-1 undergoes autophosphorylation in vitro and possesses a weak ATPase activity, whereas the protein with a mutation in the Walker A motif (Lys-59-->Ala) is completely unable to hydrolyze ATP and does not autophosphorylate. We found that SsoCdc6-1 strongly inhibits the ATPase and DNA helicase activity of the S. solfataricus MCM protein. These findings provide the first in vitro biochemical evidence of a functional interaction between a MCM complex and a Cdc6 factor and have important implications for the understanding of the Cdc6 biological function.	CNR, Ist Biochim Prot, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Pisani, FM (corresponding author), CNR, Ist Biochim Prot, Via P Castellino 111, I-80131 Naples, Italy.	pisani@dafne.ibpe.na.cnr.it	Pucci, Biagio/AAS-7502-2021; pucci, biagio/AAA-9268-2020; Pisani, Francesca M./AAX-4025-2020	pucci, biagio/0000-0003-4502-1748; 				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Carpentieri F, 2002, J BIOL CHEM, V277, P12118, DOI 10.1074/jbc.M200091200; Carr KM, 2002, J BIOL CHEM, V277, P39815, DOI 10.1074/jbc.M205031200; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Feng L, 2000, MOL BIOL CELL, V11, P1673, DOI 10.1091/mbc.11.5.1673; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; GABROWSKI B, 2001, J BACTERIOL, V183, P5459; GILLE H, 1991, EMBO J, V10, P1579, DOI 10.1002/j.1460-2075.1991.tb07678.x; Giraldo R, 2003, FEMS MICROBIOL REV, V26, P533, DOI 10.1111/j.1574-6976.2003.tb00629.x; Herbig U, 1999, MOL BIOL CELL, V10, P2631, DOI 10.1091/mbc.10.8.2631; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Kelman LM, 2003, MOL MICROBIOL, V48, P605, DOI 10.1046/j.1365-2958.2003.03369.x; KOBORI JA, 1982, J BIOL CHEM, V257, P13770; Kornberg A, 1992, DNA REPLICATION, P471; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lee DG, 2000, CURR OPIN CELL BIOL, V12, P280, DOI 10.1016/S0955-0674(00)00089-2; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; Manco G, 2001, J BIOL CHEM, V276, P37482, DOI 10.1074/jbc.M103017200; Neuwald AF, 1999, GENOME RES, V9, P27; Perkins G, 1998, MOL CELL, V2, P23, DOI 10.1016/S1097-2765(00)80110-0; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Tye BK, 2000, P NATL ACAD SCI USA, V97, P2399, DOI 10.1073/pnas.97.6.2399; Weinreich M, 1999, P NATL ACAD SCI USA, V96, P441, DOI 10.1073/pnas.96.2.441; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P921, DOI 10.1073/pnas.72.3.921; Zhang R, 2003, BIOCHEM BIOPH RES CO, V302, P728, DOI 10.1016/S0006-291X(03)00252-3	36	40	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46424	46431		10.1074/jbc.M306075200	http://dx.doi.org/10.1074/jbc.M306075200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12966100	hybrid			2022-12-27	WOS:000186569400026
J	Maira, M; Couture, C; Le Martelot, G; Pulichino, AM; Bilodeau, S; Drouin, J				Maira, M; Couture, C; Le Martelot, G; Pulichino, AM; Bilodeau, S; Drouin, J			The T-box factor Tpit recruits SRC/p 160Co-activators and mediates hormone action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICOTROPIN-RELEASING HORMONE; ORPHAN NUCLEAR RECEPTORS; GENE-EXPRESSION; PROTEIN-KINASE; GLUCOCORTICOID-RECEPTOR; DNA-BINDING; TRANSCRIPTION; PHOSPHORYLATION; NUR77; ACTIVATION	Tpit ( Tbx19) is a transcription factor belonging to the T- box family, and it is essential for late differentiation of pituitary pro- opiomelanocortin ( POMC)- expressing corticotroph and melanotroph cells. Tpit is also required, both in humans and mice, for cell- specific expression of the POMC gene in cooperation with the homeoprotein Pitx1. Despite their important roles as developmental regulators, the molecular mechanisms underpinning the functions of T- box factors in general, and of Tpit in particular, are still poorly defined. We now report that Tpit functions as an activator of transcription by recruiting SRC/ p160 co- activators to its cognate DNA target in the POMC promoter, the Tpit/ Pitx- RE. We also show that Tpit is a mediator of hormone signaling and that the Tpit/ Pitx- RE is responsive to signals elicited by hypothalamic corticotropin- releasing hormone. These signals are mediated by the cAMP- dependent protein kinase and mitogen- activated protein kinase pathways, and activation of cAMP- dependent protein kinase also enhances Tpit and SRC- dependent transcription. We have previously shown that corticotropin- releasing hormone action is also exerted at the POMC promoter through the orphan nuclear receptor NGFI- B and its recruitment of SRC co- activators. Given that Tpit exhibits transcriptional synergy with NGFI- B, our results suggest that Tpit, along with NGFI- B and SRC- 2, is part of a transcription regulatory complex assembled on the POMC promoter in response to hormonal stimulation.	Inst Rech Clin Montreal, Genet Mol Lab, Montreal, PQ H2W 1R7, Canada; Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal	Drouin, J (corresponding author), Inst Rech Clin Montreal, Genet Mol Lab, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada.	drouinj@ircm.qc.ca		Bilodeau, Steve/0000-0002-9799-3832; Pulichino, Anne-Marie/0000-0002-2419-8344; Drouin, Jacques/0000-0001-8226-5691				Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; BOUTILLIER AL, 1995, MOL ENDOCRINOL, V9, P745, DOI 10.1210/me.9.6.745; Chen SL, 2000, GENE DEV, V14, P1209; Chen SL, 2001, MOL ENDOCRINOL, V15, P783, DOI 10.1210/me.15.5.783; DAVIS IJ, 1993, MOL ENDOCRINOL, V7, P953, DOI 10.1210/me.7.8.953; DAVIS IJ, 1994, MOL CELL BIOL, V14, P3469, DOI 10.1128/MCB.14.5.3469; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; FAHRNER TJ, 1990, MOL CELL BIOL, V10, P6454, DOI 10.1128/MCB.10.12.6454; GAGNER JP, 1987, MOL ENDOCRINOL, V1, P677, DOI 10.1210/mend-1-10-677; GAGNER JP, 1985, MOL CELL ENDOCRINOL, V40, P25, DOI 10.1016/0303-7207(85)90154-6; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Kuryshev YA, 1996, ENDOCRINOLOGY, V137, P2269, DOI 10.1210/en.137.6.2269; LABRIE F, 1982, SCIENCE, V216, P1007, DOI 10.1126/science.6281886; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Lazaro JB, 2002, GENE DEV, V16, P1792, DOI 10.1101/gad.U-9988R; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li YZ, 1997, ENDOCRINOLOGY, V138, P4138, DOI 10.1210/en.138.10.4138; Lugo DI, 1996, DEV BIOL, V173, P95, DOI 10.1006/dbio.1996.0009; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Maira M, 1999, MOL CELL BIOL, V19, P7549; McKenna NJ, 1998, P NATL ACAD SCI USA, V95, P11697, DOI 10.1073/pnas.95.20.11697; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Papaioannou VE, 2001, INT REV CYTOL, V207, P1; Papaioannou VE, 1998, BIOESSAYS, V20, P9, DOI 10.1002/(SICI)1521-1878(199801)20:1<9::AID-BIES4>3.0.CO;2-Q; Parker KL, 2002, RECENT PROG HORM RES, V57, P19, DOI 10.1210/rp.57.1.19; Phillips A, 1997, MOL CELL BIOL, V17, P5952, DOI 10.1128/MCB.17.10.5952; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Pulichino AM, 2003, GENE DEV, V17, P738, DOI 10.1101/gad.1065703; Pulichino AM, 2003, GENE DEV, V17, P711, DOI 10.1101/gad.1065603; Qutob MS, 2002, MOL CELL BIOL, V22, P6611, DOI 10.1128/MCB.22.18.6611-6626.2002; REISINE T, 1985, P NATL ACAD SCI USA, V82, P8261, DOI 10.1073/pnas.82.23.8261; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; Rowan BG, 2000, J BIOL CHEM, V275, P4475, DOI 10.1074/jbc.275.6.4475; Sinha S, 2000, GENE, V258, P15, DOI 10.1016/S0378-1119(00)00417-0; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Teyssier C, 2001, J BIOL CHEM, V276, P36361, DOI 10.1074/jbc.M101806200; THERRIEN M, 1991, MOL CELL BIOL, V11, P3492, DOI 10.1128/MCB.11.7.3492; Zanger K, 1999, MOL ENDOCRINOL, V13, P268, DOI 10.1210/me.13.2.268	46	49	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46523	46532		10.1074/jbc.M305626200	http://dx.doi.org/10.1074/jbc.M305626200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12970370	hybrid			2022-12-27	WOS:000186569400037
J	Wu, GY; Zhao, GQ; He, Y				Wu, GY; Zhao, GQ; He, Y			Distinct pathways for the trafficking of angiotensin II and adrenergic receptors from the endoplasmic reticulum to the cell surface - Rab1-independent transport of a G protein-coupled receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; BETA(2)-ADRENERGIC RECEPTOR; VESICULAR TRANSPORT; INTRACELLULAR-TRANSPORT; GOLGI COMPARTMENTS; SECRETORY PATHWAY; PLASMA-MEMBRANE; DOWN-REGULATION; RAB PROTEINS; EXPRESSION	The molecular mechanism underlying the transport of G protein-coupled receptors from the endoplasmic reticulum (ER) to the cell surface is poorly understood. This issue was addressed by determining the role of Rab1, a Ras-related small GTPase that coordinates vesicular protein transport in the early secretory pathway, in the subcellular distribution and function of the angiotensin II type 1A receptor (AT1R), beta(2)-adrenergic receptor (AR), and alpha(2B)-AR in HEK293T cells. Inhibition of endogenous Rab1 function by transient expression of dominant-negative Rab1 mutants or Rab1 small interfering RNA (siRNA) induced a marked perinuclear accumulation and a significant reduction in cell-surface expression of AT1R and beta(2)-AR. The accumulated receptors were colocalized with calregulin (an ER marker) and GM130 (a Golgi marker), consistent with Rab1 function in regulating protein transport from the ER to the Golgi. In contrast, dominant-negative Rab1 mutants and siRNA had no effect on the subcellular distribution of alpha(2B)-AR. Similarly, expression of dominant-negative Rab1 mutants and siRNA depletion of Rab1 significantly attenuated AT1R-mediated inositol phosphate accumulation and ERK1/2 activation and beta(2)-AR- mediated ERK1/2 activation, but not alpha(2B)-AR-stimulated ERK1/2 activation. These data indicate that Rab1 GTPase selectively regulates intracellular trafficking and signaling of G protein-coupled receptors and suggest a novel, as yet undefined pathway for movement of G protein-coupled receptors from the ER to the cell surface.	Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wu, GY (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, 1901 Perdido St, New Orleans, LA 70112 USA.	gwu@lsuhsc.edu						Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Castellano F, 1995, J RECEPT SIGNAL TR R, V15, P847, DOI 10.3109/10799899509049861; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DOHLMAN HG, 1987, J BIOL CHEM, V262, P14282; DOWNES CP, 1982, BIOCHEM J, V203, P169, DOI 10.1042/bj2030169; DOWNES CP, 1981, BIOCHEM J, V198, P133, DOI 10.1042/bj1980133; DUGAN JM, 1995, J BIOL CHEM, V270, P10982, DOI 10.1074/jbc.270.18.10982; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; GALLWITZ D, 1983, NATURE, V306, P704, DOI 10.1038/306704a0; Hughes RJ, 1997, BBA-MOL CELL RES, V1356, P281, DOI 10.1016/S0167-4889(97)00005-0; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; Jayadev S, 1999, ENDOCRINOLOGY, V140, P2010, DOI 10.1210/en.140.5.2010; Jin MJ, 1996, J BIOL CHEM, V271, P30105, DOI 10.1074/jbc.271.47.30105; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Lanctot PM, 1999, BIOCHEMISTRY-US, V38, P8621, DOI 10.1021/bi9830516; Li JG, 2000, MOL PHARMACOL, V58, P795, DOI 10.1124/mol.58.4.795; Lupashin VV, 1997, SCIENCE, V276, P1255, DOI 10.1126/science.276.5316.1255; Martinez O, 1998, BBA-MOL CELL RES, V1404, P101, DOI 10.1016/S0167-4889(98)00050-0; Montiel M, 1998, J MOL ENDOCRINOL, V20, P299, DOI 10.1677/jme.0.0200299; MOORE RH, 1995, J CELL SCI, V108, P2983; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; Olkkonen VM, 2000, NEW ENGL J MED, V343, P1095, DOI 10.1056/NEJM200010123431507; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Rosenfeld JL, 2002, RECEPTOR CHANNEL, V8, P87, DOI 10.1080/10606820212398; Satoh AK, 1997, J CELL SCI, V110, P2943; SCHWANINGER R, 1992, J CELL BIOL, V119, P1077, DOI 10.1083/jcb.119.5.1077; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tisdale EJ, 1999, MOL BIOL CELL, V10, P1837, DOI 10.1091/mbc.10.6.1837; Tisdale EJ, 1996, J BIOL CHEM, V271, P29372, DOI 10.1074/jbc.271.46.29372; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Volpicelli LA, 2001, J BIOL CHEM, V276, P47590, DOI 10.1074/jbc.M106535200; Waters MG, 2000, TRAFFIC, V1, P588, DOI 10.1034/j.1600-0854.2000.010802.x; WILSON BS, 1994, J CELL BIOL, V125, P557, DOI 10.1083/jcb.125.3.557; Wu GY, 2000, J BIOL CHEM, V275, P29927, DOI 10.1074/jbc.C000380200; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Wu GY, 2000, J BIOL CHEM, V275, P9026, DOI 10.1074/jbc.275.12.9026; Wu GY, 2001, CIRC RES, V89, P1130, DOI 10.1161/hh2401.100427; Wu GY, 1998, J BIOL CHEM, V273, P7197, DOI 10.1074/jbc.273.13.7197; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Zhang XY, 2002, MOL THER, V5, P555, DOI 10.1006/mthe.2002.0585	51	88	90	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47062	47069		10.1074/jbc.M305707200	http://dx.doi.org/10.1074/jbc.M305707200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12970354	hybrid			2022-12-27	WOS:000186569400103
J	Zimmer, G; Rohn, M; McGregor, GP; Schemann, M; Conzelmann, KK; Herrler, G				Zimmer, G; Rohn, M; McGregor, GP; Schemann, M; Conzelmann, KK; Herrler, G			Virokinin, a bioactive peptide of the tachykinin family, is released from the fusion protein of bovine respiratory syncytial virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; AIRWAY EPITHELIAL-CELLS; SUBSTANCE-P; NEUROGENIC INFLAMMATION; GENE-EXPRESSION; T-CELLS; RECEPTOR; INFECTION; ACTIVATION; CLEAVAGE	Tachykinins, an evolutionary conserved family of peptide hormones in both invertebrates and vertebrates, are produced by neuronal cells as inactive preprotachykinins that are post-translationally processed into different neuropeptides such as substance P, neurokinin A, and neurokinin B. We show here that furin-mediated cleavage of the bovine respiratory syncytial virus fusion protein results in the release of a peptide that is converted into a biologically active tachykinin ( virokinin) by additional posttranslational modifications. An antibody directed to substance P cross-reacted with the C terminus of mature virokinin that contains a classical tachykinin motif. The cellular enzymes involved in the C-terminal maturation of virokinin were found to be present in many established cell lines. Virokinin is secreted by virus-infected cells and was found to act on the tachykinin receptor 1 (TACR1), leading to rapid desensitization of this G protein-coupled receptor as shown by TACR1-green fluorescent protein conjugate translocation from the cell surface to endosomes and by co-internalization of the receptor with beta-arrestin 1-green fluorescent protein conjugates. In vitro experiments with isolated circular muscle from guinea pig stomach indicated that virokinin is capable of inducing smooth muscle contraction by acting on the tachykinin receptor 3. Tachykinins and their cognate receptors are present in the mammalian respiratory tract, where they have potent effects on local inflammatory and immune processes. The viral tachykinin-like peptide represents a novel form of molecular mimicry, which may benefit the virus by affecting the host immune response.	Tierarztl Hsch Hanover, Inst Virol, D-30559 Hannover, Germany; Tech Univ Munich, Lehrstuhl Humanbiol, D-85350 Freising Weihenstephan, Germany; Univ Marburg, Inst Normale & Pathol Physiol, D-35037 Marburg, Germany; Univ Munich, Max von Pettenkofer Inst, D-81377 Munich, Germany; Univ Munich, Genzentrum, D-81377 Munich, Germany	Technical University of Munich; Philipps University Marburg; University of Munich; University of Munich	Herrler, G (corresponding author), Tierarztl Hsch Hanover, Inst Virol, Bunteweg 17, D-30559 Hannover, Germany.	Georg.Herrler@tiho-hannover.de	Conzelmann, Karl-Klaus/L-7239-2013	Conzelmann, Karl-Klaus/0000-0002-8614-3656; mcgregor, gerard/0000-0003-3087-0018; Schemann, Michael/0000-0003-1007-9843; Zimmer, Gert/0000-0002-2708-2507				Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Becker S, 1999, IMMUNOBIOLOGY, V201, P88, DOI 10.1016/S0171-2985(99)80049-7; Bolt G, 2000, VIRUS RES, V68, P25, DOI 10.1016/S0168-1702(00)00149-0; BOWDEN JJ, 1994, P NATL ACAD SCI USA, V91, P8964, DOI 10.1073/pnas.91.19.8964; Bramley AM, 1999, EUR RESPIR J, V14, P1061, DOI 10.1183/09031936.99.14510619; Casola A, 2000, J IMMUNOL, V164, P5944, DOI 10.4049/jimmunol.164.11.5944; Castagliuolo I, 2000, J BIOL CHEM, V275, P26545, DOI 10.1074/jbc.M003990200; Chang J, 2002, NAT MED, V8, P54, DOI 10.1038/nm0102-54; COLLINS PL, 1996, VIROLOGY, P1313; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Di Maria GU, 1998, EUR RESPIR J, V12, P1454, DOI 10.1183/09031936.98.12061454; Domachowske JB, 1999, CLIN MICROBIOL REV, V12, P298, DOI 10.1128/CMR.12.2.298; Domachowske JB, 2001, RESPIR RES, V2, P225, DOI 10.1186/rr61; Emonds-Alt X, 2002, CAN J PHYSIOL PHARM, V80, P482, DOI 10.1139/y02-041; Feldman SA, 2000, J VIROL, V74, P6442, DOI 10.1128/JVI.74.14.6442-6447.2000; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fiebich BL, 2000, J IMMUNOL, V165, P5606, DOI 10.4049/jimmunol.165.10.5606; Garofalo RP, 2001, J INFECT DIS, V184, P393, DOI 10.1086/322788; GARTEN W, 1983, J GEN VIROL, V64, P2127, DOI 10.1099/0022-1317-64-10-2127; GOETZL EJ, 1992, FASEB J, V6, P2646, DOI 10.1096/fasebj.6.9.1612288; Gonzalez-Reyes L, 2001, P NATL ACAD SCI USA, V98, P9859, DOI 10.1073/pnas.151098198; GOODING LR, 1992, CELL, V71, P5; Guo CJ, 2002, J NEUROIMMUNOL, V131, P160, DOI 10.1016/S0165-5728(02)00277-1; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Haynes LM, 2002, J VIROL, V76, P6873, DOI 10.1128/JVI.76.14.6873-6881.2002; Heaney LG, 1998, THORAX, V53, P357, DOI 10.1136/thx.53.5.357; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; Jaovisidha P, 1999, J IMMUNOL, V163, P2816; Joos GF, 2001, EUR J PHARMACOL, V429, P239, DOI 10.1016/S0014-2999(01)01323-1; Kahn JS, 1999, VIROLOGY, V254, P81, DOI 10.1006/viro.1998.9535; Keles I, 1998, J COMP PATHOL, V118, P337, DOI 10.1016/S0021-9975(07)80009-0; Khawaja AM, 1996, INT J BIOCHEM CELL B, V28, P721, DOI 10.1016/1357-2725(96)00017-9; KincyCain T, 1997, J IMMUNOL, V158, P2334; King KA, 2001, AM J RESP CELL MOL, V24, P101, DOI 10.1165/ajrcmb.24.2.4264; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; Lambrecht BN, 2001, RESP RES, V2, P133, DOI 10.1186/rr49; LAMPRECHT CL, 1976, J INFECT DIS, V134, P211, DOI 10.1093/infdis/134.3.211; Lecci A, 2000, NEUROPEPTIDES, V34, P303, DOI 10.1054/npep.2000.0825; Levite M, 1998, P NATL ACAD SCI USA, V95, P12544, DOI 10.1073/pnas.95.21.12544; LOTZ M, 1988, SCIENCE, V241, P1218, DOI 10.1126/science.2457950; Lukacs NW, 2001, J IMMUNOL, V167, P1060, DOI 10.4049/jimmunol.167.2.1060; MACLEOD AM, 1993, J MED CHEM, V36, P2044, DOI 10.1021/jm00066a015; Maggi CA, 1997, REGUL PEPTIDES, V70, P75, DOI 10.1016/S0167-0115(97)00029-3; Matsuse H, 2000, J IMMUNOL, V164, P6583, DOI 10.4049/jimmunol.164.12.6583; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; MCGILLIS JP, 1990, ANN NY ACAD SCI, V594, P85; MCGREGOR GP, 1983, LIFE SCI, V32, P655, DOI 10.1016/0024-3205(83)90211-4; Olszewska-Pazdrak B, 1998, J VIROL, V72, P4756, DOI 10.1128/JVI.72.6.4756-4764.1998; PASCUAL DW, 1999, MUCOSAL IMMUNOLOGY, P631; Patacchini R, 2001, EUR J PHARMACOL, V429, P13, DOI 10.1016/S0014-2999(01)01301-2; Payne CM, 2001, J VIROL, V75, P10467, DOI 10.1128/JVI.75.21.10467-10471.2001; Piedimonte G, 1999, AM J PHYSIOL-LUNG C, V277, pL831, DOI 10.1152/ajplung.1999.277.4.L831; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; Quartara L, 1997, NEUROPEPTIDES, V31, P537, DOI 10.1016/S0143-4179(97)90001-9; SCHEMANN M, 1991, PFLUG ARCH EUR J PHY, V419, P566, DOI 10.1007/BF00370296; Schlender J, 2002, J VIROL, V76, P1163, DOI 10.1128/JVI.76.3.1163-1170.2002; Schmidlin F, 2002, P NATL ACAD SCI USA, V99, P3324, DOI 10.1073/pnas.052161299; Schwarze J, 2002, EUR RESPIR J, V19, P341, DOI 10.1183/09031936.02.00254302; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; SHARMA R, 1990, J COMP PATHOL, V103, P411, DOI 10.1016/S0021-9975(08)80029-1; SHARMA R, 1991, RES VET SCI, V50, P152, DOI 10.1016/0034-5288(91)90098-9; Small BA, 2001, J EXP MED, V194, P1835, DOI 10.1084/jem.194.12.1835; Techaarpornkul S, 2002, VIROLOGY, V294, P296, DOI 10.1006/viro.2001.1340; Tripp RA, 2000, J VIROL, V74, P1614, DOI 10.1128/JVI.74.4.1614-1622.2000; Valarcher JF, 2001, VIROLOGY, V291, P55, DOI 10.1006/viro.2001.1083; Vanden Broeck J, 1999, ANN NY ACAD SCI, V897, P374, DOI 10.1111/j.1749-6632.1999.tb07907.x; WOLDEHIWET Z, 1992, SCAND J IMMUNOL, V36, P75, DOI 10.1111/j.1365-3083.1992.tb01624.x; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002; Zimmer G, 2002, J VIROL, V76, P9218, DOI 10.1128/JVI.76.18.9218-9224.2002; Zimmer G, 2001, J BIOL CHEM, V276, P31642, DOI 10.1074/jbc.M102633200	71	41	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46854	46861		10.1074/jbc.M306949200	http://dx.doi.org/10.1074/jbc.M306949200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12952986	hybrid			2022-12-27	WOS:000186569400078
J	Dowell, P; Otto, TC; Adi, S; Lane, MD				Dowell, P; Otto, TC; Adi, S; Lane, MD			Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; PROTEIN-KINASE-B; GENE-EXPRESSION; PPAR-GAMMA; FACTOR FKHR; CAENORHABDITIS-ELEGANS; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; NUCLEAR RECEPTORS; PROMOTER ACTIVITY	The forkhead factor Foxo1 (or FKHR) was identified in a yeast two-hybrid screen as a peroxisome proliferator-activated receptor (PPAR) gamma-interacting protein. Foxo1 antagonized PPARgamma activity and vice versa indicating that these transcription factors functionally interact in a reciprocal antagonistic manner. One mechanism by which Foxo1 antagonizes PPARgamma activity is through disruption of DNA binding as Foxo1 inhibited the DNA binding activity of a PPARgamma/retinoid X receptor alpha heterodimeric complex. The Caenorhabditis elegans nuclear hormone receptor, DAF-12, interacted with the C. elegans forkhead factor, DAF-16, paralleling the interaction between PPARgamma and Foxo1. daf-12 and daf-16 have been implicated in C. elegans insulin-like signaling pathways, and PPARgamma and Foxo1 likewise have been linked to mammalian insulin signaling pathways. These results suggest a convergence of PPARgamma and Foxo1 signaling that may play a role in insulin action and the insulinomimetic properties of PPARgamma ligands. A more general convergence of nuclear hormone receptor and forkhead factor pathways may be important for multiple biological processes and this convergence may be evolutionarily conserved.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, WBSB 509, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Dowell, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, WBSB 509, 725 N Wolfe St, Baltimore, MD 21205 USA.				NIDDK NIH HHS [DK64934, DK38418, DK09894] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009894, R01DK038418, K01DK064934] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adi S, 2000, J CELL BIOCHEM, V78, P617, DOI 10.1002/1097-4644(20000915)78:4<617::AID-JCB11>3.3.CO;2-0; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; Dowell P, 1997, J BIOL CHEM, V272, P33435, DOI 10.1074/jbc.272.52.33435; Dowell P, 2002, J BIOL CHEM, V277, P1712, DOI 10.1074/jbc.M108589200; Dowell P, 2000, J BIOL CHEM, V275, P41325, DOI 10.1074/jbc.M006474200; DREYER C, 1993, BIOL CELL, V77, P67, DOI 10.1016/S0248-4900(05)80176-5; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; IKEDA H, 1990, ARZNEIMITTEL-FORSCH, V40-1, P156; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu D, 2000, CURR BIOL, V10, P1233, DOI 10.1016/S0960-9822(00)00733-8; Murakami S, 2000, ANN NY ACAD SCI, V908, P40; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nasrin N, 2000, P NATL ACAD SCI USA, V97, P10412, DOI 10.1073/pnas.190326997; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; ONATE SA, 1995, SCIENCE, V270, P1354; Perrot V, 2003, J BIOL CHEM, V278, P26111, DOI 10.1074/jbc.M212750200; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Schuur ER, 2001, J BIOL CHEM, V276, P33554, DOI 10.1074/jbc.M105555200; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; TRAN H, 2003, SCI STKE; Wolfrum C, 2003, J CLIN INVEST, V112, P345, DOI 10.1172/JCI18698; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200	54	176	185	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45485	45491		10.1074/jbc.M309069200	http://dx.doi.org/10.1074/jbc.M309069200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12966085	hybrid			2022-12-27	WOS:000186452300054
J	Nuhse, TS; Boller, T; Peck, SC				Nuhse, TS; Boller, T; Peck, SC			A plasma membrane syntaxin is phosphorylated in response to the bacterial elicitor flagellin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASES; DISEASE RESISTANCE; MASS-SPECTROMETRY; CALCIUM CHANNELS; PLANT-CELLS; ARABIDOPSIS; GENE; DEFENSE; EXOCYTOSIS; LOCALIZATION	In vivo pulse labeling of suspension-cultured Arabidopsis cells with [P-32] orthophosphate allows a systematic analysis of dynamic changes in protein phosphorylation. Here, we use this technique to investigate signal transduction events at the plant plasma membrane triggered upon perception of microbial elicitors of defense responses, using as a model elicitor flg22, a peptide corresponding to the most conserved domain of bacterial flagellin. We demonstrate that two-dimensional gel electrophoresis in conjunction with mass spectrometry is a suitable tool for the identification of intrinsic membrane proteins, and we show that among them a syntaxin, AtSyp122, is phosphorylated rapidly in response to flg22. Although incorporation of radioactive phosphate into the protein only occurs significantly after elicitation, immunoblot analysis after two-dimensional gel separation indicates that the protein is also phosphorylated prior to elicitation. These results indicate that flg22 elicits either an increase in the rate of turnover of phosphate or an additional de novo phosphorylation event. In vitro, phosphorylation of AtSyp122 is calcium-dependent. In vitro phosphorylated peptides separated by two-dimensional thin layer chromatography comigrate with two of the three in vivo phosphopeptides, indicating that this calcium-dependent phosphorylation is biologically relevant. These results indicate a regulatory link between elicitor-induced calcium fluxes and the rapid phosphorylation of a syntaxin. Because syntaxins are known to be important in membrane fusion and exocytosis, we hypothesize that one of the functions of the calcium signal is to stimulate exocytosis of defense-related proteins and compounds.	Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Peck, SC (corresponding author), Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland.	scott.peck@bbsrc.ac.uk	Boller, Thomas/G-3500-2012	Boller, Thomas/0000-0001-6768-7503				Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; BOLLER T, 1995, ANNU REV PLANT PHYS, V46, P189, DOI 10.1146/annurev.arplant.46.1.189; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Chang SY, 2002, J CELL SCI, V115, P783; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Chung SH, 2000, J BIOL CHEM, V275, P25286, DOI 10.1074/jbc.M004204200; Dubois T, 2002, EUR J BIOCHEM, V269, P909, DOI 10.1046/j.0014-2956.2001.02725.x; Durrant WE, 2000, PLANT CELL, V12, P963, DOI 10.1105/tpc.12.6.963; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FELIX G, 1991, P NATL ACAD SCI USA, V88, P8831, DOI 10.1073/pnas.88.19.8831; Foletti DL, 2000, J NEUROSCI, V20, P4535, DOI 10.1523/JNEUROSCI.20-12-04535.2000; Foster LJ, 1998, BIOCHEMISTRY-US, V37, P11089, DOI 10.1021/bi980253t; Geelen D, 2002, PLANT CELL, V14, P387, DOI 10.1105/tpc.010328; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; HARLOW DL, 1999, USING ANTIBODIES LAB; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jarvis SE, 2002, J BIOL CHEM, V277, P44399, DOI 10.1074/jbc.M206902200; Klenchin VA, 2000, BIOCHIMIE, V82, P399, DOI 10.1016/S0300-9084(00)00208-X; LARSSON C, 1994, METHOD ENZYMOL, V228, P451; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Leyman B, 2000, PLANT J, V24, P369, DOI 10.1046/j.1365-313x.2000.00886.x; Leyman B, 1999, SCIENCE, V283, P537, DOI 10.1126/science.283.5401.537; LINTHORST HJM, 1991, CRIT REV PLANT SCI, V10, P123, DOI 10.1080/07352689109382309; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Marash M, 2001, EMBO J, V20, P411, DOI 10.1093/emboj/20.3.411; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Martin ML, 2000, PLANT J, V24, P429, DOI 10.1046/j.1365-313x.2000.00889.x; Masaki R, 1998, J BIOCHEM-TOKYO, V124, P311, DOI 10.1093/oxfordjournals.jbchem.a022113; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Peck SC, 2001, PLANT CELL, V13, P1467, DOI 10.1105/tpc.13.6.1467; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Rabilloud T, 1998, ELECTROPHORESIS, V19, P758, DOI 10.1002/elps.1150190526; Romeis T, 2001, CURR OPIN PLANT BIOL, V4, P407, DOI 10.1016/S1369-5266(00)00193-X; Romeis T, 1999, PLANT CELL, V11, P273, DOI 10.1105/tpc.11.2.273; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; Sanderfoot AA, 2000, PLANT PHYSIOL, V124, P1558, DOI 10.1104/pp.124.4.1558; Sanderfoot AA, 2001, PLANT CELL, V13, P659, DOI 10.1105/tpc.13.3.659; Santoni V, 1999, BIOCHIMIE, V81, P655, DOI 10.1016/S0300-9084(99)80122-9; Santoni V, 2000, ELECTROPHORESIS, V21, P3329, DOI 10.1002/1522-2683(20001001)21:16<3329::AID-ELPS3329>3.0.CO;2-F; Schaller GE, 1995, METHOD CELL BIOL, V50, P129, DOI 10.1016/S0091-679X(08)61027-4; Schmelzer E, 2002, TRENDS PLANT SCI, V7, P411, DOI 10.1016/S1360-1385(02)02307-5; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Stensballe A, 2001, PROTEOMICS, V1, P207, DOI 10.1002/1615-9861(200102)1:2<207::AID-PROT207>3.3.CO;2-V; Sutter JU, 2000, PLANT CELL, V12, P1127, DOI 10.1105/tpc.12.7.1127; Turner KM, 1999, TRENDS NEUROSCI, V22, P459, DOI 10.1016/S0166-2236(99)01436-8; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; WIDELL S, 1990, PLANT PLASMA MEMBRAN, P17; Wu CC, 2003, NAT BIOTECHNOL, V21, P532, DOI 10.1038/nbt819; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3	55	86	92	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45248	45254		10.1074/jbc.M307443200	http://dx.doi.org/10.1074/jbc.M307443200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12949074	hybrid			2022-12-27	WOS:000186452300026
J	Chandran, D; Reinders, A; Ward, JM				Chandran, D; Reinders, A; Ward, JM			Substrate specificity of the Arabidopsis thaliana sucrose transporter AtSUC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; EXPRESSION; IDENTIFICATION; SYMPORTER; MODEL; SUC1	The Arabidopsis sucrose transporter AtSUC2 is expressed in the companion cells of the phloem (specialized vascular tissue) and is essential for the long distance transport of carbohydrates within the plant. A variety of glucosides are known to inhibit sucrose uptake into yeast expressing AtSUC2; however, it remains unknown whether glucosides other than sucrose could serve as transported substrates. By expression of AtSUC2 in Xenopus oocytes and two-electrode voltage clamping, we have tested the ability of AtSUC2 to transport a range of physiological and synthetic glucosides. Sucrose induced inward currents with a K-0.5 of 1.44 mM at pH 5 and a membrane potential of -137 mV. Of the 24 additional sugars tested, 8 glucosides induced large inward currents allowing kinetic analysis. These glucosides were maltose, arbutin (hydroquinone-beta-D-glucoside), salicin (2-(hydroxymethyl)phenyl-beta-D- glucoside), alpha-phenylglucoside, beta-phenylglucoside, alpha-paranitrophenylglucoside, beta-paranitrophenylglucoside, and paranitrophenyl-beta-thioglucoside. In addition, turanose and alpha-methylglucoside induced small but significant inward currents indicating that they were transported by AtSUC2. The results indicate that AtSUC2 is not highly selective for alpha- over beta-glucosides and may function in transporting glucosides besides sucrose into the phloem, and the results provide insight into the structural requirements for transport by AtSUC2.	Univ Minnesota Twin Cities, Dept Plant Biol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Ward, JM (corresponding author), Univ Minnesota Twin Cities, Dept Plant Biol, St Paul, MN 55108 USA.	jward@tc.umn.edu	Chandran, Divya/A-4236-2012	Ward, John/0000-0001-8185-0434; Reinders, Anke/0000-0001-5351-3940; Chandran, Divya/0000-0001-6206-8826				Boorer KJ, 1996, J BIOL CHEM, V271, P25139, DOI 10.1074/jbc.271.41.25139; Chen SX, 2001, PLANT PHYSIOL, V127, P194, DOI 10.1104/pp.127.1.194; GAHRTZ M, 1994, PLANT J, V6, P697, DOI 10.1046/j.1365-313X.1994.6050697.x; Gottwald JR, 2000, P NATL ACAD SCI USA, V97, P13979, DOI 10.1073/pnas.250473797; HECHT R, 1992, PLANT PHYSIOL, V99, P439, DOI 10.1104/pp.99.2.439; Hefner T, 2002, BIOORGAN MED CHEM, V10, P1731, DOI 10.1016/S0968-0896(02)00029-9; HITZ WD, 1986, J BIOL CHEM, V261, P1986; Ilic N, 1996, PLANT PHYSIOL, V111, P781, DOI 10.1104/pp.111.3.781; Lalonde S, 1999, PLANT CELL, V11, P707, DOI 10.1105/tpc.11.4.707; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Noiraud N, 2000, PLANT PHYSIOL, V122, P1447, DOI 10.1104/pp.122.4.1447; Patrick JW, 2001, J EXP BOT, V52, P551, DOI 10.1093/jexbot/52.356.551; Reinders A, 2002, PLANT CELL, V14, P1567, DOI 10.1105/tpc.002428; RIESMEIER JW, 1992, EMBO J, V11, P4705, DOI 10.1002/j.1460-2075.1992.tb05575.x; RIESMEIER JW, 1993, PLANT CELL, V5, P1591, DOI 10.1105/tpc.5.11.1591; SAUER N, 1994, PLANT J, V6, P67, DOI 10.1046/j.1365-313X.1994.6010067.x; Schulze W, 2000, FEBS LETT, V485, P189, DOI 10.1016/S0014-5793(00)02180-3; Sinha AK, 2002, PLANT PHYSIOL, V128, P1480, DOI 10.1104/pp.010771; Stadler R, 1996, BOT ACTA, V109, P299, DOI 10.1111/j.1438-8677.1996.tb00577.x; Veach YK, 2003, PLANT PHYSIOL, V131, P1374, DOI 10.1104/pp.017210; Ward JM, 1998, INT REV CYTOL, V178, P41; Weise A, 2000, PLANT CELL, V12, P1345, DOI 10.1105/tpc.12.8.1345; Zhou JJ, 1997, J MEMBRANE BIOL, V159, P113, DOI 10.1007/s002329900275	23	97	106	2	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44320	44325		10.1074/jbc.M308490200	http://dx.doi.org/10.1074/jbc.M308490200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12954621	hybrid			2022-12-27	WOS:000186306700054
J	Liu, J; Batkai, S; Pacher, P; Harvey-White, J; Wagner, JA; Cravatt, BF; Gao, B; Kunos, G				Liu, J; Batkai, S; Pacher, P; Harvey-White, J; Wagner, JA; Cravatt, BF; Gao, B; Kunos, G			Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappa B independently of platelet-activating factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; CB1 CANNABINOID RECEPTORS; NECROSIS-FACTOR-ALPHA; ACID AMIDE HYDROLASE; ENDOGENOUS CANNABINOIDS; BACTERIAL LIPOPOLYSACCHARIDE; N-ARACHIDONOYLETHANOLAMINE; HEMORRHAGIC-SHOCK; HUMAN MONOCYTES; TNF-ALPHA	Macrophage-derived endocannabinoids have been implicated in endotoxin (lipopolysaccharide (LPS))-induced hypotension, but the endocannabinoid involved and the mechanism of its regulation by LPS are unknown. In RAW264.7 mouse macrophages, LPS (10 ng/ ml) increases anandamide (AEA) levels > 10-fold via CD14-, NF-kappaB-, and p44/42-dependent, platelet-activating factor-independent activation of the AEA biosynthetic enzymes, N-acyltransferase and phospholipase D. LPS also induces the AEA-degrading enzyme fatty acid amidohydrolase ( FAAH), and inhibition of FAAH activity potentiates, whereas actinomycin D or cycloheximide blocks the LPS-induced increase in AEA levels and N-acyltransferase and phospholipase D activities. In contrast, cellular levels of the endocannabinoid 2-arachidonoylglycerol (2-AG) are unaffected by LPS but increased by platelet-activating factor. LPS similarly induces AEA, but not 2-AG, in mouse peritoneal macrophages where basal AEA levels are higher, and the LPS-stimulated increase in AEA is potentiated in cells from FAAH(-/-) as compared with FAAH(+/+) mice. Intravenous administration of 10(7) LPS-treated mouse macrophages to anesthetized rats elicits hypotension, which is much greater in response to FAAH(-/-) than FAAH(+/+) cells and is susceptible to inhibition by SR141716, a cannabinoid CB1 receptor antagonist. We conclude that AEA and 2-AG synthesis are differentially regulated in macrophages, and AEA rather than 2-AG is a major contributor to LPS-induced hypotension.	NIAAA, Lab Physiol Sci, Bethesda, MD 20892 USA; Univ Wurzburg, Dept Med, D-97080 Wurzburg, Germany; Scripps Inst, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Wurzburg; Scripps Research Institute	Kunos, G (corresponding author), NIAAA, Lab Physiol Sci, 12420 Parklawn Dr,MSC-8115, Bethesda, MD 20892 USA.		Pacher, Pal/B-6378-2008; Batkai, Sandor/G-3889-2010; Batkai, Sandor/H-7983-2014	Pacher, Pal/0000-0001-7036-8108; 	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000351, Z01AA000368, ZIAAA000351, ZIAAA000368] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Altavilla D, 2001, FREE RADICAL BIO MED, V30, P1055, DOI 10.1016/S0891-5849(01)00492-0; Batkai S, 2001, NAT MED, V7, P827, DOI 10.1038/89953; Berdyshev EV, 2001, FASEB J, V15, P2171, DOI 10.1096/fj.01-0181com; BRAQUET P, 1987, IMMUNOL TODAY, V8, P345, DOI 10.1016/0167-5699(87)90010-7; Bulger EM, 2002, SHOCK, V17, P173, DOI 10.1097/00024382-200203000-00003; Cadas H, 1997, J NEUROSCI, V17, P1226; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; DENTENER MA, 1993, J IMMUNOL, V150, P2885; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1999, EUR J BIOCHEM, V264, P258, DOI 10.1046/j.1432-1327.1999.00631.x; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; diMarzo V, 1996, BIOCHEM J, V316, P977, DOI 10.1042/bj3160977; Dinh TP, 2002, CHEM PHYS LIPIDS, V121, P149, DOI 10.1016/S0009-3084(02)00150-0; DOHERTY DE, 1989, J IMMUNOL, V143, P3673; Facchinetti F, 2003, GLIA, V41, P161, DOI 10.1002/glia.10177; Fowler CJ, 2000, BRIT J PHARMACOL, V131, P498, DOI 10.1038/sj.bjp.0703569; Gardiner SM, 1998, BRIT J PHARMACOL, V125, P1543, DOI 10.1038/sj.bjp.0702250; GIUFFRIDA A, 1998, LIPID 2 MESSENGERS, P113; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; HERBERT JM, 1991, J PHARMACOL EXP THER, V259, P44; Hillard CJ, 1997, J NEUROCHEM, V69, P631, DOI 10.1046/j.1471-4159.1997.69020631.x; Ibuki Y, 2003, BBA-MOL CELL RES, V1593, P159, DOI 10.1016/S0167-4889(02)00385-3; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; LUMSDEN AB, 1988, HEPATOLOGY, V8, P232, DOI 10.1002/hep.1840080207; Maccarrone M, 2001, ARCH BIOCHEM BIOPHYS, V393, P321, DOI 10.1006/abbi.2001.2500; MINGHETTI L, 1995, J NEUROCHEM, V65, P2690; Moesgaard B, 2002, COMP BIOCHEM PHYS B, V131, P475, DOI 10.1016/S1096-4959(02)00003-9; Mukhopadhyay S, 2002, AM J PHYSIOL-HEART C, V282, pH2046, DOI 10.1152/ajpheart.00497.2001; MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233; Offertaler L, 2003, MOL PHARMACOL, V63, P699, DOI 10.1124/mol.63.3.699; Pestonjamasp VK, 1998, BBA-LIPID LIPID MET, V1394, P249, DOI 10.1016/S0005-2760(98)00110-6; RANKIN JA, 1990, J CLIN INVEST, V86, P1556, DOI 10.1172/JCI114875; Ros J, 2002, GASTROENTEROLOGY, V122, P85, DOI 10.1053/gast.2002.30305; Sancho R, 2003, MOL PHARMACOL, V63, P429, DOI 10.1124/mol.63.2.429; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Sugiura T, 1996, EUR J BIOCHEM, V240, P53, DOI 10.1111/j.1432-1033.1996.0053h.x; Sugiura T, 1998, BIOCHEM BIOPH RES CO, V243, P838, DOI 10.1006/bbrc.1998.8187; Swantek JL, 1999, J BIOL CHEM, V274, P11667, DOI 10.1074/jbc.274.17.11667; SZABO C, 1993, CIRC RES, V73, P991, DOI 10.1161/01.RES.73.6.991; VALONE FH, 1988, J IMMUNOL, V140, P2389; Varga K, 1998, FASEB J, V12, P1035, DOI 10.1096/fasebj.12.11.1035; VARGA K, 1995, EUR J PHARMACOL, V278, P279, DOI 10.1016/0014-2999(95)00181-J; Wagner JA, 2001, J AM COLL CARDIOL, V38, P2048, DOI 10.1016/S0735-1097(01)01671-0; Wagner JA, 1997, NATURE, V390, P518, DOI 10.1038/37371; Wang L, 2003, P NATL ACAD SCI USA, V100, P1393, DOI 10.1073/pnas.0336351100; WEBER C, 1993, EUR J IMMUNOL, V23, P852, DOI 10.1002/eji.1830230413; WRIGHT SD, 1991, SCIENCE, V252, P1321, DOI 10.1126/science.252.5010.1321-a	50	179	187	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					45034	45039		10.1074/jbc.M306062200	http://dx.doi.org/10.1074/jbc.M306062200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12949078	hybrid			2022-12-27	WOS:000186306700141
J	McDearmon, EL; Combs, AC; Ervasti, JM				McDearmon, EL; Combs, AC; Ervasti, JM			Core 1 glycans on alpha-dystroglycan mediate laminin-induced acetylcholine receptor clustering but not laminin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; SYNAPSE-SPECIFIC CARBOHYDRATE; SKELETAL-MUSCLE; NEUROMUSCULAR-JUNCTION; ALPHA-7-BETA-1 INTEGRIN; MUSK; ACTIVATION; PROTEINS; PATHWAY; GLYCOSYLATION	Although unique O-linked oligosaccharides on alpha-dystroglycan are important for binding to a variety of extracellular ligands, the function(s) of more generic carbohydrate structures on alpha-dystroglycan remain unclear. Recent studies suggest a role for glycoconjugates bearing the core 1 disaccharide Galbeta(1-3) GalNAc in acetylcholine receptor (AChR) clustering on the surface of muscle cells. Here, we report experiments demonstrating that the core 1-specific lectin jacalin almost completely abrogated laminin-induced AChR clustering in C2C12 myotubes and that alpha-dystroglycan was the predominant jacalin-binding protein detected in C2C12 myotube lysates. Although jacalin likely inhibited laminin-induced AChR clustering by directly binding to alpha-dystroglycan, jacalin had no effect on laminin binding to the myotube surface or to alpha-dystroglycan. Like jacalin, peanut agglutinin lectin also binds the core 1 disaccharide but not when it is terminally sialylated as expressed on alpha-dystroglycan. We show that C2C12 alpha-dystroglycan bound to peanut agglutinin only after digestion with neuraminidase. Simultaneous treatment of myotubes with neuraminidase and endo-O-glycosidase diminished alpha-dystroglycan binding to peanut agglutinin and inhibited neuraminidase-induced AChR clustering. We conclude that sialylated core 1 oligosaccharides of alpha-dystroglycan are important for laminin-induced AChR clustering and that their function in this process is distinct from the established role of alpha-dystroglycan oligosaccharides in laminin binding.	Univ Wisconsin, Sch Med, Dept Physiol, Serv Mem Inst 127, Madison, WI 53706 USA; Univ Wisconsin, Sch Med, Grad Program Mol & Cellular Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ervasti, JM (corresponding author), Univ Wisconsin, Sch Med, Dept Physiol, Serv Mem Inst 127, 1300 Univ Ave, Madison, WI 53706 USA.		Ervasti, James/AAZ-4786-2020		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR001985] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR01985] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Arikawa-Hirasawa E, 2002, NAT NEUROSCI, V5, P119, DOI 10.1038/nn801; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; Burkin DJ, 1998, J CELL BIOL, V143, P1067, DOI 10.1083/jcb.143.4.1067; Burkin DJ, 2000, J CELL SCI, V113, P2877; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Ervasti JM, 1997, J BIOL CHEM, V272, P22315, DOI 10.1074/jbc.272.35.22315; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; GEE SH, 1993, J BIOL CHEM, V268, P14972; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Grow WA, 1999, J NEUROBIOL, V40, P356, DOI 10.1002/(SICI)1097-4695(19990905)40:3<356::AID-NEU7>3.3.CO;2-6; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; HORTIN GL, 1990, ANAL BIOCHEM, V188, P271, DOI 10.1016/0003-2697(90)90605-9; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; Jacobson C, 1998, J NEUROSCI, V18, P6340; Marangi PA, 2002, J CELL BIOL, V157, P883, DOI 10.1083/jcb.200202110; Martin PT, 1999, MOL CELL NEUROSCI, V13, P105, DOI 10.1006/mcne.1999.0737; MARTIN PT, 1995, NEURON, V14, P743, DOI 10.1016/0896-6273(95)90218-X; McDearmon EL, 1998, J BIOL CHEM, V273, P24139, DOI 10.1074/jbc.273.37.24139; McDearmon EL, 2001, J BIOL CHEM, V276, P35078, DOI 10.1074/jbc.M103843200; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Montanaro F, 1998, J NEUROSCI, V18, P1250; Pall EA, 1996, J BIOL CHEM, V271, P3817; Parkhomovskiy N, 2000, MOL CELL NEUROSCI, V15, P380, DOI 10.1006/mcne.2000.0835; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; SANES JR, 1982, NATURE, V300, P646, DOI 10.1038/300646a0; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SCOTT LJC, 1988, J NEUROSCI, V8, P932; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Sugiyama JE, 1997, J CELL BIOL, V139, P181, DOI 10.1083/jcb.139.1.181; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Watty A, 2002, J BIOL CHEM, V277, P50457, DOI 10.1074/jbc.M208664200; Xia B, 2002, MOL CELL NEUROSCI, V19, P539, DOI 10.1006/mcne.2001.1095	38	28	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44868	44873		10.1074/jbc.M307026200	http://dx.doi.org/10.1074/jbc.M307026200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12952987	hybrid			2022-12-27	WOS:000186306700122
J	Ozaslan, D; Wang, S; Ahmed, BA; Kocabas, AM; McCastlain, JC; Bene, A; Kilic, F				Ozaslan, D; Wang, S; Ahmed, BA; Kocabas, AM; McCastlain, JC; Bene, A; Kilic, F			Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter - A specific role for sialic acid residues (Publication with Expression of Concern. See vol. 294, pg. 5210, 2019) (Withdrawn Publication. See vol. 294, pg. 9657, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							HUMAN DOPAMINE TRANSPORTER; HUMAN NOREPINEPHRINE TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; FUNCTIONAL EXPRESSION; PROTEINS; CLONING; RECEPTORS; REUPTAKE; 5-HYDROXYTRYPTAMINE; IDENTIFICATION	The serotonin transporter (SERT) is an oligomeric glycoprotein with two sialic acid residues on each of two complex oligosaccharide molecules. In this study, we investigated the contribution of N-glycosyl modification to the structure and function of SERT in two model systems: wild-type SERT expressed in sialic acid-defective Lec Chinese hamster ovary (CHO) cells and a mutant form (after site-directed mutagenesis of Asn-208 and Asn-217 to Gln) of SERT, QQ, expressed in parental CHO cells. In both systems, SERT monomers required modification with both complex oligosaccharide residues to associate with each other and to function in homo-oligomeric forms. However, defects in sialylated N-glycans did not alter surface expression of the SERT protein. Furthermore, in heterologous (CHO and Lec) and endogenous (placental choriocarcinoma JAR cells) expression systems, we tested whether glycosyl modification also manipulates the hetero-oligomeric interactions of SERT, specifically with myosin IIA. SERT is phosphorylated by cGMP-dependent protein kinase G through interactions with anchoring proteins, and myosin is a protein kinase G-anchoring protein. A physical interaction between myosin and SERT was apparent; however, defects in sialylated N-glycans impaired association of SERT with myosin as well as the stimulation of the serotonin uptake function in the cGMP-dependent pathway. We propose that sialylated N-glycans provide a favorable conformation to SERT that allows the transporter to function most efficiently via its protein-protein interactions.	Univ Arkansas Med Sci, Coll Med, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Kilic, F (corresponding author), Univ Arkansas Med Sci, Coll Med, Dept Biochem & Mol Biol, 4301 W Markham St,516, Little Rock, AR 72205 USA.	kilicfusun@uams.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD053477] Funding Source: NIH RePORTER; NICHD NIH HHS [R03 HD053477-01, R03 HD053477] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amara S G, 1993, Curr Opin Neurobiol, V3, P337, DOI 10.1016/0959-4388(93)90126-J; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Barker EL, 1998, METHOD ENZYMOL, V296, P475; Bass J, 1998, J CELL BIOL, V141, P637, DOI 10.1083/jcb.141.3.637; BERGER SP, 1994, MOL PHARMACOL, V46, P726; BLAKELY RD, 1994, J EXP BIOL, V196, P263; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; CHANEY W, 1989, J CELL BIOL, V109, P2089, DOI 10.1083/jcb.109.5.2089; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen NH, 2001, J NEUROCHEM, V77, P1116, DOI 10.1046/j.1471-4159.2001.00312.x; DETTE GA, 1979, EXPERIENTIA, V35, P1152, DOI 10.1007/BF01963255; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GIELEN W, 1974, EXPERIENTIA, V30, P1177, DOI 10.1007/BF01923675; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Harlow E., 1988, ANTIBODIES LAB MANUA; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; HELENIUS A, 1992, CELL BIOL BIOTECHNOL; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Jess U, 1996, FEBS LETT, V394, P44, DOI 10.1016/0014-5793(96)00916-7; Jones BJ, 2002, PHARMACOL BIOCHEM BE, V71, P555, DOI 10.1016/S0091-3057(01)00745-6; KANNER BI, 1994, J EXP BIOL, V196, P237; Kilic F, 2003, MOL PHARMACOL, V64, P440, DOI 10.1124/mol.64.2.440; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Kim S, 2001, J BIOL CHEM, V276, P12864, DOI 10.1074/jbc.M001492200; KLAUSNER R D, 1989, New Biologist, V1, P3; Kocabas AM, 2003, J NEUROCHEM, V85, P1513, DOI 10.1046/j.1471-4159.2003.01793.x; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUNAY JM, 1992, J BIOL CHEM, V267, P11344; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MELIKIAN HE, 1994, J BIOL CHEM, V269, P12290; Melikian HE, 1996, MOL PHARMACOL, V50, P266; MILLER KJ, 1994, J BIOL CHEM, V269, P27351; Murphy DL, 1998, J CLIN PSYCHIAT, V59, P4; Nguyen TT, 1996, J NEUROCHEM, V67, P645; Patel Amrat P., 2002, P355; QIAN Y, 1995, J NEUROSCI, V15, P1261; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Reith MEA., 1997, NEUROTRANSMITTER TRA, P29, DOI 10.1007/978-1-59259-470-2_2; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Stahl SM, 1998, J AFFECT DISORDERS, V51, P215, DOI 10.1016/S0165-0327(98)00221-3; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; STANLEY P, 1984, ARCH BIOCHEM BIOPHYS, V230, P363, DOI 10.1016/0003-9861(84)90119-X; SZABADOS L, 1975, BIOCHEM J, V148, P335, DOI 10.1042/bj1480335; Tate CG, 1999, J BIOL CHEM, V274, P17551, DOI 10.1074/jbc.274.25.17551; TATE CG, 1994, J BIOL CHEM, V269, P26303; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UHL GR, 1992, TRENDS NEUROSCI, V15, P265, DOI 10.1016/0166-2236(92)90068-J; UHL GR, 1994, J EXP BIOL, V196, P229; Vo NK, 1998, BIOCHEM BIOPH RES CO, V246, P831, DOI 10.1006/bbrc.1998.8722; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Zhen YJ, 2003, BIOCHEMISTRY-US, V42, P5478, DOI 10.1021/bi027101p	60	47	49	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					43991	44000		10.1074/jbc.M306360200	http://dx.doi.org/10.1074/jbc.M306360200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944413	hybrid, Green Accepted			2022-12-27	WOS:000186306700014
J	Putney, LK; Barber, DL				Putney, LK; Barber, DL			Na-H exchange-dependent increase in intracellular pH times G(2)/M entry and transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER; CELL-CYCLE; PHOSPHORYLATION; PROLIFERATION; NHE1; TRANSLOCATION; CYTOSKELETON; MIGRATION; AMILORIDE; ISOFORMS	It is well established that activation of the Na-H exchanger NHE1 and increases in intracellular pH (pH(i)) are early and universal responses to mitogens and have permissive effects in promoting cell proliferation. Despite this evidence, a specific role for NHE1 or pH(i) in cell cycle progression remains undetermined. We now show that NHE1 activity and pH(i) regulate the timing of G(2)/M entry and transition. Prior to G(2)/M entry there is a rapid and transient increase in NHE1 activity and pH(i), but in fibroblasts expressing a mutant NHE1 that lacks ion translocation activity, this increase in pH(i) is attenuated, S phase is delayed, and G(2)/M transition is impaired. In the absence of ion translocation by NHE1, expression of cyclin B1 and the kinase activity of Cdc2 are decreased and Wee1 kinase expression increases. Increasing pH(i) in the absence of NHE1 activity, however, is sufficient to restore Cdc2 activity and cyclin B1 expression and to promote G(2)/M entry and transition. These data indicate that a transient increase in pH(i) induced by NHE1 promotes the timing of G(2)/M, and they suggest that increases in pH(i) at the completion of S phase may constitute a previously unrecognized checkpoint for progression to G(2) and mitosis.	Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Barber, DL (corresponding author), Univ Calif San Francisco, Dept Stomatol, HSW604, San Francisco, CA 94143 USA.	barber@itsa.ucsf.edu			NIGMS NIH HHS [GM63465, GM47413] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047413, F32GM063465] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATHERTONFESSLER S, 1993, MOL CELL BIOL, V13, P1675, DOI 10.1128/MCB.13.3.1675; BUSSOLINO F, 1989, J BIOL CHEM, V264, P18284; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; COUNILLON L, 1994, BIOCHEMISTRY-US, V33, P10463, DOI 10.1021/bi00200a030; DELVAUX M, 1990, AM J PHYSIOL, V259, pG842, DOI 10.1152/ajpgi.1990.259.5.G842; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2002, CURR OPIN CELL BIOL, V14, P214, DOI 10.1016/S0955-0674(02)00304-6; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; FRANCHI A, 1986, P NATL ACAD SCI USA, V83, P9388, DOI 10.1073/pnas.83.24.9388; Furnari B, 1999, MOL BIOL CELL, V10, P833, DOI 10.1091/mbc.10.4.833; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; HORVAT B, 1993, EUR J CANCER, V29A, P132, DOI 10.1016/0959-8049(93)90591-3; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; KAPUS A, 1994, J BIOL CHEM, V269, P23544; KREK W, 1991, EMBO J, V10, P305, DOI 10.1002/j.1460-2075.1991.tb07951.x; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; VOYNOYASENETSKAYA T, 1994, J BIOL CHEM, V269, P4721	25	201	207	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44645	44649		10.1074/jbc.M308099200	http://dx.doi.org/10.1074/jbc.M308099200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947095	hybrid			2022-12-27	WOS:000186306700096
J	Shi, XL; Chabarek, K; Budai, A; Zhu, ZW				Shi, XL; Chabarek, K; Budai, A; Zhu, ZW			Iron requirement for GAL gene induction in the yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER TRANSPORT; FET3 PROTEIN; DEGRADATION; DEFICIENCY; METABOLISM; EXPRESSION; HOMOLOG; DISEASE; CLUSTER; SYSTEM	Iron is an essential nutrient. Its deficiency hinders the synthesis of ATP and DNA. We report that galactose metabolism is defective when iron availability is restricted. Our data support this connection because 1) galactose-mediated induction of GAL promoter-dependent gene expression was diminished by iron limitation, and 2) iron-deficient mutants grew slowly on galactose-containing medium. These two defects were immediately corrected by iron replacement. Inherited defects in human galactose metabolism are characteristic of the disease called galactosemia. Our findings suggest that iron-deficient galactosemic individuals might be more severely compromised than iron-replete individuals. This work shows that iron homeostasis and galactose metabolism are linked with one another.	Univ Calif Santa Cruz, Dept Environm Toxicol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Zhu, ZW (corresponding author), Univ Calif Santa Cruz, Dept Environm Toxicol, Santa Cruz, CA 95064 USA.	zhu@biology.ucsc.edu		Budai, Alice/0000-0002-6675-4548				ALGERI AA, 1981, GENETICS, V97, P27; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Askwith C, 1997, J BIOL CHEM, V272, P401; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Askwith CC, 1998, J BIOL CHEM, V273, P22415, DOI 10.1074/jbc.273.35.22415; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; BOMFORD A, 1976, Q J MED, V45, P611; BROACH JR, 1979, J MOL BIOL, V131, P41, DOI 10.1016/0022-2836(79)90300-0; Cammack R, 1990, IRON TRANSPORT STORA, P17; Casas C, 1997, YEAST, V13, P621, DOI 10.1002/(SICI)1097-0061(19970615)13:7<621::AID-YEA121>3.0.CO;2-U; DALLMAN PR, 1986, ANNU REV NUTR, V6, P13, DOI 10.1146/annurev.nu.06.070186.000305; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; deSilva D, 1997, J BIOL CHEM, V272, P14208, DOI 10.1074/jbc.272.22.14208; Halliwell B., 1991, FREE RADICALS BIOL M; Hassett RF, 1998, J BIOL CHEM, V273, P23274, DOI 10.1074/jbc.273.36.23274; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; JESEN L, 2000, MOL CELL BIOL, V20, P3918; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; KARLIN KD, 1993, SCIENCE, V261, P701, DOI 10.1126/science.7688141; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; LEE RL, 1966, J CLIN INVEST, V47, P2058; LELOIR LF, 1951, ARCH BIOCHEM BIOPHYS, V33, P186, DOI 10.1016/0003-9861(51)90096-3; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; MAGUIRE PH, 2000, HUM MOL GENET, V9, P2789; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; OSAKI S, 1971, J BIOL CHEM, V246, P3018; Palmer AE, 2002, BIOCHEMISTRY-US, V41, P6438, DOI 10.1021/bi011979j; Petry KG, 1998, TRENDS GENET, V14, P98, DOI 10.1016/S0168-9525(97)01379-6; POLLITT E, 1993, ANNU REV NUTR, V13, P521, DOI 10.1146/annurev.nu.13.070193.002513; Rutherford JC, 2001, P NATL ACAD SCI USA, V98, P14322, DOI 10.1073/pnas.261381198; RUZICKA FJ, 1995, BIOCHEMISTRY-US, V34, P5610, DOI 10.1021/bi00016a036; Segal S, 1995, METABOLIC MOL BASIS, P967; Sia RAL, 1996, MOL BIOL CELL, V7, P1657, DOI 10.1091/mbc.7.11.1657; Spizzo T, 1997, MOL GEN GENET, V256, P547; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; Yonkovich J, 2002, J BIOL CHEM, V277, P23981, DOI 10.1074/jbc.C200203200; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	44	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43110	43113		10.1074/jbc.M307011200	http://dx.doi.org/10.1074/jbc.M307011200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12944385	hybrid			2022-12-27	WOS:000186157000050
J	Ishikita, H; Knapp, EW				Ishikita, H; Knapp, EW			Redox potential of quinones in both electron transfer branches of photosystem I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC REACTION-CENTER; IRON-SULFUR CENTERS; BIOSYNTHETIC-PATHWAY MUTANTS; NUCLEAR DOUBLE-RESONANCE; SPECIAL TRIPLE-RESONANCE; RHODOBACTER-SPHAEROIDES; F-X; TRANSIENT EPR; ACCEPTOR A(1); PRIMARY DONOR	The redox potentials of the two electron transfer ( ET) active quinones in the central part of photosystem I ( PSI) were determined by evaluating the electrostatic energies from the solution of the Poisson-Boltzmann equation based on the crystal structure. The calculated redox potentials are - 531 mV for A(1A) and - 686 mV for A(1B). From these results we conclude the following. (i) Both branches are active with a much faster ET in the B-branch than in the A-branch. (ii) The measured lifetime of 200 - 290 ns of reduced quinones agrees with the estimate for the A-branch and corroborates with an uphill ET from this quinone to the iron-sulfur cluster as observed in recent kinetic measurements. (iii) The electron paramagnetic resonance spectroscopic data refer to the A-branch quinone where the corresponding ET is uphill in energy. The negative redox potential of A(1) in PSI is primarily because of the influence from the negatively charged F-X, in contrast to the positive shift on the quinone redox potential in bacterial reaction center and PSII that is attributed to the positively charged non-heme iron atom. The conserved residue Asp-B575 changes its protonation state after quinone reduction. The difference of 155 mV in the quinone redox potentials of the two branches were attributed to the conformation of the backbone with a large contribution from Ser-A692 and Ser-B672 and to the side chain of Asp-B575, whose protonation state couples differently with the formation of the quinone radicals.	Free Univ Berlin, Inst Chem, Dept Biol Chem & Pharm, D-14195 Berlin, Germany	Free University of Berlin	Knapp, EW (corresponding author), Free Univ Berlin, Inst Chem, Dept Biol Chem & Pharm, Takustr 6, D-14195 Berlin, Germany.	knapp@chemie.fu-berlin.de	Knapp, Ernst-Walter/E-4493-2010; Knapp, Ernst-Walter/AAH-6720-2021; Ishikita, Hiroshi/G-9864-2018	Knapp, Ernst-Walter/0000-0002-2858-0460; Knapp, Ernst-Walter/0000-0002-2858-0460; Ishikita, Hiroshi/0000-0002-5849-8150				Agalarov R, 2003, BBA-BIOENERGETICS, V1604, P7, DOI 10.1016/S0005-2728(03)00024-0; Alexov EG, 1999, BIOCHEMISTRY-US, V38, P8253, DOI 10.1021/bi982700a; ARATA H, 1983, BIOCHIM BIOPHYS ACTA, V725, P394, DOI 10.1016/0005-2728(83)90214-1; ARATA H, 1981, BIOCHIM BIOPHYS ACTA, V638, P201, DOI 10.1016/0005-2728(81)90228-0; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BEROZA P, 1991, P NATL ACAD SCI USA, V88, P5804, DOI 10.1073/pnas.88.13.5804; Bittl R, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P509; Bittl R, 1997, BIOCHEMISTRY-US, V36, P12001, DOI 10.1021/bi971645n; BOCK CH, 1989, FEBS LETT, V247, P91, DOI 10.1016/0014-5793(89)81247-5; Boudreaux B, 2001, J BIOL CHEM, V276, P37299, DOI 10.1074/jbc.M102327200; BRETTEL K, 1988, FEBS LETT, V239, P93, DOI 10.1016/0014-5793(88)80552-0; Brettel K, 2001, BBA-BIOENERGETICS, V1507, P100, DOI 10.1016/S0005-2728(01)00202-X; Brettel K, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P611; Brettel K, 1995, PHOTOSYNTH RES, V45, P183, DOI 10.1007/BF00015559; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brzezinski P, 1997, BBA-BIOENERGETICS, V1321, P149, DOI 10.1016/S0005-2728(97)00052-2; CHAMOROVSKY SK, 1982, PHOTOBIOCH PHOTOBIOP, V4, P195; DAVIS IH, 1993, BIOCHIM BIOPHYS ACTA, V1143, P183, DOI 10.1016/0005-2728(93)90141-2; Evans MCW, 1999, PHOTOSYNTH RES, V61, P33, DOI 10.1023/A:1006205811407; Evans MCW, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL II, P183; Fromme P, 2001, BBA-BIOENERGETICS, V1507, P5, DOI 10.1016/S0005-2728(01)00195-5; Gibas CJ, 1996, BIOPHYS J, V71, P138, DOI 10.1016/S0006-3495(96)79209-3; Grafton AK, 1999, J PHYS CHEM B, V103, P5380, DOI 10.1021/jp9901139; Guergova-Kuras M, 2001, P NATL ACAD SCI USA, V98, P4437, DOI 10.1073/pnas.081078898; Hagio M, 2000, PLANT PHYSIOL, V124, P795, DOI 10.1104/pp.124.2.795; Hanley J, 1997, BIOCHEMISTRY-US, V36, P11543, DOI 10.1021/bi971360a; Hastings G, 2001, BIOCHEMISTRY-US, V40, P3681, DOI 10.1021/bi0023100; Hastings SF, 2000, EUR J BIOCHEM, V267, P5638, DOI 10.1046/j.1432-1327.2000.01643.x; HIENERWADEL R, 1995, BIOCHEMISTRY-US, V34, P2832, DOI 10.1021/bi00009a013; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Ishikita H, 2003, BIOCHEMISTRY-US, V42, P3882, DOI 10.1021/bi026781t; IWAKI M, 1991, BIOCHEMISTRY-US, V30, P5347, DOI 10.1021/bi00236a004; IWAKI M, 1994, PLANT CELL PHYSIOL, V35, P983; Joliot P, 1999, BIOCHEMISTRY-US, V38, P11130, DOI 10.1021/bi990857c; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kamlowski A, 1998, J PHYS CHEM B, V102, P8278, DOI 10.1021/jp9824611; Kass H, 1996, CHEM PHYS LETT, V251, P193, DOI 10.1016/0009-2614(96)00129-7; Kass H, 1996, CHEM PHYS LETT, V257, P197, DOI 10.1016/0009-2614(96)00533-7; Kaupp M, 2002, BIOCHEMISTRY-US, V41, P2895, DOI 10.1021/bi0159783; Klukas O, 1999, J BIOL CHEM, V274, P7361, DOI 10.1074/jbc.274.11.7361; Krabben L, 2000, BIOCHEMISTRY-US, V39, P13012, DOI 10.1021/bi001200q; KRIEGER A, 1995, BBA-BIOENERGETICS, V1229, P193, DOI 10.1016/0005-2728(95)00002-Z; Krieger-Liszkay A, 1998, BIOCHEMISTRY-US, V37, P17339, DOI 10.1021/bi9822628; LEIBL W, 1995, BIOCHEMISTRY-US, V34, P10237, DOI 10.1021/bi00032a018; Mac M, 1998, J AM CHEM SOC, V120, P13215, DOI 10.1021/ja982662i; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MAROTI P, 1988, BIOCHIM BIOPHYS ACTA, V934, P329, DOI 10.1016/0005-2728(88)90092-8; MOUESCA JM, 1994, J AM CHEM SOC, V116, P11898, DOI 10.1021/ja00105a033; Muhiuddin IP, 2001, FEBS LETT, V503, P56, DOI 10.1016/S0014-5793(01)02696-5; NABEDRYK E, 1995, BIOCHEMISTRY-US, V34, P14722, DOI 10.1021/bi00045a013; Nabedryk E, 1998, BIOCHEMISTRY-US, V37, P14457, DOI 10.1021/bi981139d; O'Malley PJ, 1999, BBA-BIOENERGETICS, V1411, P101, DOI 10.1016/S0005-2728(99)00036-5; O'Malley PJ, 1998, CHEM PHYS LETT, V285, P99, DOI 10.1016/S0009-2614(97)01456-5; OMalley PJ, 1997, CHEM PHYS LETT, V274, P251, DOI 10.1016/S0009-2614(97)00643-X; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PARRETT KG, 1989, BIOCHIM BIOPHYS ACTA, V973, P324, DOI 10.1016/S0005-2728(89)80439-6; Popovic DM, 2002, J AM CHEM SOC, V124, P3775, DOI 10.1021/ja016249d; Popovic DM, 2001, J AM CHEM SOC, V123, P6040, DOI 10.1021/ja003878z; PRINCE RC, 1986, METHOD ENZYMOL, V125, P109; PRINCE RC, 1983, FEBS LETT, V160, P273, DOI 10.1016/0014-5793(83)80981-8; PRINCE RC, 1976, ARCH BIOCHEM BIOPHYS, V172, P329, DOI 10.1016/0003-9861(76)90084-9; Purton S, 2001, BIOCHEMISTRY-US, V40, P2167, DOI 10.1021/bi0019489; Rabenstein B, 1998, BIOCHEMISTRY-US, V37, P2488, DOI 10.1021/bi971921y; Rabenstein B, 2001, BIOPHYS J, V80, P1141, DOI 10.1016/S0006-3495(01)76091-2; Rabenstein B, 2000, BIOCHEMISTRY-US, V39, P10487, DOI 10.1021/bi000413c; RABENSTEIN B, 1998, EUR BOPHYS J, P626; Rabenstein B, 1999, KARLSBERG ONLINE MAN; RABENSTEIN B, 2003, IN PRESS BIOENERGETI; RIGBY SEJ, 1994, BIOCHEMISTRY-US, V33, P10043, DOI 10.1021/bi00199a031; Rigby SEJ, 1996, BIOCHEMISTRY-US, V35, P6651, DOI 10.1021/bi952619x; Sakuragi Y, 2002, BIOCHEMISTRY-US, V41, P394, DOI 10.1021/bi011297w; Schlodder E, 1998, BIOCHEMISTRY-US, V37, P9466, DOI 10.1021/bi973182r; Semenov AY, 2000, J BIOL CHEM, V275, P23429, DOI 10.1074/jbc.M000508200; SETIF P, 1990, CURRENT RES PHOTOSYN, V2, P539; Shinkarev VP, 2000, BIOPHYS J, V78, P363, DOI 10.1016/S0006-3495(00)76599-4; SMITH JC, 1992, J AM CHEM SOC, V114, P801, DOI 10.1021/ja00029a001; Stowell MHB, 1997, SCIENCE, V276, P812, DOI 10.1126/science.276.5313.812; Torres RA, 2003, J AM CHEM SOC, V125, P1923, DOI 10.1021/ja0211104; ULLMANN GM, 1996, REACTION CTR PHOTOSY, P143; VANDENBRINK JS, 1994, FEBS LETT, V353, P273, DOI 10.1016/0014-5793(94)01047-1; VANDEREST A, 1995, CHEM PHYS, V194, P349, DOI 10.1016/0301-0104(95)00046-Q; VANDEREST A, 1994, BIOCHEMISTRY-US, V33, P11789, DOI 10.1021/bi00205a015; vanderEst A, 1997, J PHYS CHEM B, V101, P1437, DOI 10.1021/jp9622086; vanderEst A, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL II, P143; Vassiliev IR, 1999, J BIOL CHEM, V274, P9993, DOI 10.1074/jbc.274.15.9993; Vassiliev IR, 2001, BBA-BIOENERGETICS, V1507, P139, DOI 10.1016/S0005-2728(01)00197-9; Veselov AV, 2000, BIOCHEMISTRY-US, V39, P3169, DOI 10.1021/bi9926835; Warshel A, 1997, J BIOL INORG CHEM, V2, P143, DOI 10.1007/s007750050119; WARSHEL A, 1984, Q REV BIOPHYS, V17, P283, DOI 10.1017/S0033583500005333; WARSHEL A, 1991, ANNU REV BIOPHYS BIO, V20, P267, DOI 10.1146/annurev.biophys.20.1.267; Webber AN, 2001, BBA-BIOENERGETICS, V1507, P61, DOI 10.1016/S0005-2728(01)00198-0; Xu W, 2003, J BIOL CHEM, V278, P27864, DOI 10.1074/jbc.M302962200; Yang F, 1998, J PHYS CHEM B, V102, P8288, DOI 10.1021/jp981952i; Zech SG, 2000, J PHYS CHEM B, V104, P9728, DOI 10.1021/jp002125w; Zybailov B, 2000, J BIOL CHEM, V275, P8531, DOI 10.1074/jbc.275.12.8531	96	85	94	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2003	278	52					52002	52011		10.1074/jbc.M306434200	http://dx.doi.org/10.1074/jbc.M306434200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756LX	12972408	hybrid			2022-12-27	WOS:000187480700006
J	Missirlis, F; Hu, JG; Kirby, K; Hilliker, AJ; Rouault, TA; Phillips, JP				Missirlis, F; Hu, JG; Kirby, K; Hilliker, AJ; Rouault, TA; Phillips, JP			Compartment-specific protection of iron-sulfur proteins by superoxide dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; DROSOPHILA-MELANOGASTER; SACCHAROMYCES-CEREVISIAE; REGULATORY PROTEIN; RESPONSIVE ELEMENT; MOTOR-NEURONS; CU,ZN-SUPEROXIDE DISMUTASE; CAENORHABDITIS-ELEGANS; ACONITASE ACTIVITY; MESSENGER-RNA	Iron and oxygen are essential but potentially toxic constituents of most organisms, and their transport is meticulously regulated both at the cellular and systemic levels. Compartmentalization may be a homeostatic mechanism for isolating these biological reactants in cells. To investigate this hypothesis, we have undertaken a genetic analysis of the interaction between iron and oxygen metabolism in Drosophila. We show that Drosophila iron regulatory protein-1 (IRP1) registers cytosolic iron and oxidative stress through its labile iron sulfur cluster by switching between cytosolic aconitase and RNA-binding functions. IRP1 is strongly activated by silencing and genetic mutation of the cytosolic superoxide dismutase (Sod1), but is unaffected by silencing of mitochondrial Sod2. Conversely, mitochondrial aconitase activity is relatively insensitive to loss of Sod1 function, but drops dramatically if Sod2 activity is impaired. This strongly suggests that the mitochondrial boundary limits the range of superoxide reactivity in vivo. We also find that exposure of adults to paraquat converts cytosolic aconitase to IRP1 but has no affect on mitochondrial aconitase, indicating that paraquat generates superoxide in the cytosol but not in mitochondria. Accordingly, we find that transgene-mediated overexpression of Sod2 neither enhances paraquat resistance in Sod1(+) flies nor compensates for lack of SOD1 activity in Sod1-null mutants. We conclude that in vivo, superoxide is confined to the subcellular compartment in which it is formed, and that the mitochondrial and cytosolic SODs provide independent protection to compartment-specific protein iron-sulfur clusters against attack by superoxide generated under oxidative stress within those compartments.	Univ Guelph, Dept Mol Biol & Genet, Guelph, ON N1G 2W1, Canada; NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA; York Univ, Dept Biol, N York, ON M3J 1P3, Canada	University of Guelph; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); York University - Canada	Phillips, JP (corresponding author), Univ Guelph, Dept Mol Biol & Genet, Guelph, ON N1G 2W1, Canada.		Missirlis, Fanis/C-1137-2011	Missirlis, Fanis/0000-0003-0467-8444	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001602] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001602] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BALZAN R, 1995, P NATL ACAD SCI USA, V92, P4219, DOI 10.1073/pnas.92.10.4219; Balzan R, 1999, BIOCHEM BIOPH RES CO, V256, P63, DOI 10.1006/bbrc.1999.0285; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bouton C, 1996, J BIOL CHEM, V271, P2300, DOI 10.1074/jbc.271.4.2300; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cairo G, 1996, FASEB J, V10, P1326, DOI 10.1096/fasebj.10.11.8836047; Corson LB, 1999, J BIOL CHEM, V274, P27590, DOI 10.1074/jbc.274.39.27590; De Freitas JM, 2000, J BIOL CHEM, V275, P11645, DOI 10.1074/jbc.275.16.11645; Dussmann H, 2003, J BIOL CHEM, V278, P12645, DOI 10.1074/jbc.M210826200; Duttaroy A, 1997, DNA CELL BIOL, V16, P391, DOI 10.1089/dna.1997.16.391; Elia AJ, 1999, FREE RADICAL BIO MED, V26, P1332, DOI 10.1016/S0891-5849(98)00333-5; Fillebeen C, 2002, REDOX REP, V7, P15, DOI 10.1179/135100002125000136; FLINT DH, 1993, J BIOL CHEM, V268, P22369; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Gourley BL, 2003, J BIOL CHEM, V278, P3227, DOI 10.1074/jbc.M210333200; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; HEIKKILA RE, 1976, ANAL BIOCHEM, V75, P356, DOI 10.1016/0003-2697(76)90089-0; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; Kohler SA, 1995, J BIOL CHEM, V270, P30781, DOI 10.1074/jbc.270.51.30781; Li QY, 2001, J NEUROCHEM, V78, P746, DOI 10.1046/j.1471-4159.2001.00457.x; Lind MI, 1998, FEBS LETT, V436, P476, DOI 10.1016/S0014-5793(98)01186-7; Missirlis F, 2003, BIOL CHEM, V384, P463, DOI 10.1515/BC.2003.052; Missirlis F, 2002, J BIOL CHEM, V277, P11521, DOI 10.1074/jbc.M111692200; Mockett RJ, 1999, ARCH BIOCHEM BIOPHYS, V371, P260, DOI 10.1006/abbi.1999.1460; Muckenthaler M, 1998, EUR J BIOCHEM, V254, P230, DOI 10.1046/j.1432-1327.1998.2540230.x; Pani G, 2001, IUBMB LIFE, V52, P7, DOI 10.1080/15216540252774702; PANTOPOULOS K, 1995, EMBO J, V14, P2917, DOI 10.1002/j.1460-2075.1995.tb07291.x; Park JI, 1998, J BIOL CHEM, V273, P22921, DOI 10.1074/jbc.273.36.22921; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; PHILLIPS JP, 1995, P NATL ACAD SCI USA, V92, P8574, DOI 10.1073/pnas.92.19.8574; PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; REVEILLAUD I, 1991, MOL CELL BIOL, V11, P632, DOI 10.1128/MCB.11.2.632; Rouault T, 1997, CURR TOP CELL REGUL, V35, P1, DOI 10.1016/S0070-2137(97)80001-5; Rouault TA, 1996, TRENDS BIOCHEM SCI, V21, P174, DOI 10.1016/0968-0004(96)10024-4; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Srinivasan C, 2000, J BIOL CHEM, V275, P29187, DOI 10.1074/jbc.M004239200; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Strain J, 1998, J BIOL CHEM, V273, P31138, DOI 10.1074/jbc.273.47.31138; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Tabuchi A, 2003, J NEUROSCI RES, V71, P504, DOI 10.1002/jnr.10505	44	89	91	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47365	47369		10.1074/jbc.M307700200	http://dx.doi.org/10.1074/jbc.M307700200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12972424	hybrid			2022-12-27	WOS:000186731400004
J	Gotte, G; Libonati, M; Laurents, DV				Gotte, G; Libonati, M; Laurents, DV			Glycosylation and specific deamidation of ribonuclease B affect the formation of three-dimensional domain-swapped oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE PANCREATIC RIBONUCLEASE; DOUBLE-STRANDED-RNA; CRYSTAL-STRUCTURE; AMYLOID FORMATION; SEMINAL RIBONUCLEASE; ISOASPARTYL RESIDUE; MASS-SPECTROMETRY; PROTEIN; AGGREGATION; RESOLUTION	RNase A oligomerizes via the three-dimensional domain-swapping mechanism to form a variety of oligomers, including two dimers. One, called the N-dimer, forms by swapping of the N termini of the protein; the other, called the C-dimer, forms by swapping of the C termini. RNase B is identical in protein sequence and conformation to RNase A, but its Asn(34) bears an oligosaccharide chain that might affect oligomerization. The ability of RNase B to oligomerize under two sets of conditions has been examined. The amount of oligomers formed via lyophilization was somewhat lower for RNase B than RNase A, and RNase B oligomerized more rapidly in 40% ethanol solution at high temperature than RNase A. The ratio of the N-dimer to C-dimer formed increased with the size of the carbohydrate chain under both sets of conditions. These results suggest that the oligosaccharide chain either favors productive collisions or stabilizes the oligomers, especially the N-dimer. Endoglycosidase H treatment of RNase B partially restored RNase A-like oligomerization. Derivatives of RNase A conjugated at the amine groups to polyethylene glycol chains showed a greatly reduced capacity for oligomerization, suggesting that oligomerization can be impeded sterically. Commercial preparations of RNase B eluted as two main peaks by cation exchange chromatography. Using chromatography, mass spectroscopy, and two-dimensional NMR, the major peak was identified as RNase B selectively deamidated at Asn(67). This deamidated protein showed a >4degreesC drop in thermal stability, disruption of the native structure of residues 67-69, and a decreased ability to oligomerize compared with unmodified RNase B.	CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; Univ Verona, Fac Med & Chirurg, Sez Chim Biol, Dipartimento Sci Neurol & Vis, I-37134 Verona, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Verona	Laurents, DV (corresponding author), CSIC, Inst Quim Fis Rocasolano, Serrano 119, E-28006 Madrid, Spain.		Laurents, Douglas V/E-7527-2015	Laurents, Douglas V/0000-0002-4187-165X; Gotte, Giovanni/0000-0003-3179-7158				Anfinsen C B, 1975, Adv Protein Chem, V29, P205, DOI 10.1016/S0065-3233(08)60413-1; Arnold U, 1997, BIOCHEMISTRY-US, V36, P2166, DOI 10.1021/bi962723u; Beintema J.J., 1982, P43; BEINTEMA JJ, 1988, PROG BIOPHYS MOL BIO, V51, P165, DOI 10.1016/0079-6107(88)90001-6; BENNETT MJ, 1994, PROTEIN SCI, V3, P1444, DOI 10.1002/pro.5560030911; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Bornstein P, 1977, Methods Enzymol, V47, P132; BROWN LR, 1975, EUR J BIOCHEM, V54, P219, DOI 10.1111/j.1432-1033.1975.tb04131.x; CAPASSO S, 1989, Peptide Research, V2, P195; Capasso S, 1996, J MOL BIOL, V257, P492, DOI 10.1006/jmbi.1996.0179; Capasso S, 1999, J PEPT RES, V54, P377, DOI 10.1034/j.1399-3011.1999.00111.x; CARSANA A, 1981, BIOCHIM BIOPHYS ACTA, V654, P77, DOI 10.1016/0005-2787(81)90138-6; Catanzano F, 1997, PROTEIN SCI, V6, P1682, DOI 10.1002/pro.5560060808; Chakrabartty A, 2001, P NATL ACAD SCI USA, V98, P14757, DOI 10.1073/pnas.261596398; Chen PY, 2002, P NATL ACAD SCI USA, V99, P12633, DOI 10.1073/pnas.192137799; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; COOK KH, 1979, P NATL ACAD SCI USA, V76, P6157, DOI 10.1073/pnas.76.12.6157; CRESTFIELD A M, 1962, Arch Biochem Biophys, VSuppl 1, P217; DIDONATO A, 1993, J BIOL CHEM, V268, P4745; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; EAKER DL, 1965, BIOCHEMISTRY-US, V4, P1479, DOI 10.1021/bi00884a003; Esposito L, 2000, J MOL BIOL, V297, P713, DOI 10.1006/jmbi.2000.3597; FU DT, 1994, CARBOHYD RES, V261, P173, DOI 10.1016/0008-6215(94)84015-6; Gonzalez L, 2000, ARCH BIOCHEM BIOPHYS, V383, P17, DOI 10.1006/abbi.2000.2031; Gorman PM, 2003, J MOL BIOL, V325, P743, DOI 10.1016/S0022-2836(02)01279-2; Gotte G, 2003, J BIOL CHEM, V278, P10763, DOI 10.1074/jbc.M213146200; Gotte G, 1999, EUR J BIOCHEM, V265, P680, DOI 10.1046/j.1432-1327.1999.00761.x; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; JOAO HC, 1992, FEBS LETT, V307, P343, DOI 10.1016/0014-5793(92)80709-P; JOAO J, 1993, EUR J BIOCHEM, V21, P239; Kawasaki N, 1999, ANAL BIOCHEM, V269, P297, DOI 10.1006/abio.1999.4026; KIEFHABER T, 1992, J MOL BIOL, V224, P231, DOI 10.1016/0022-2836(92)90586-9; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; KUNITZ M, 1946, J BIOL CHEM, V164, P563; Libonati M, 2001, METHOD ENZYMOL, V341, P234, DOI 10.1016/S0076-6879(01)41155-4; Libonati M, 1996, BIOCHEM J, V318, P287, DOI 10.1042/bj3180287; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; Liu YS, 2002, PROTEIN SCI, V11, P371, DOI 10.1110/ps.36602; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; MARZOTTO A, 1970, ARCH BIOCHEM BIOPHYS, V137, P373, DOI 10.1016/0003-9861(70)90451-0; Matousek J, 2002, J CONTROL RELEASE, V82, P29, DOI 10.1016/S0168-3659(02)00082-2; MAZZARELLA L, 1993, ACTA CRYSTALLOGR D, V49, P389, DOI 10.1107/S0907444993003403; Narhi LO, 2001, PROTEIN ENG, V14, P135, DOI 10.1093/protein/14.2.135; Nenci A, 2001, PROTEIN SCI, V10, P2017, DOI 10.1110/ps.14101; Nilsson MR, 2002, PROTEIN SCI, V11, P342, DOI 10.1110/ps.48702; PACE CN, 1989, BIOCHEMISTRY-US, V28, P2520, DOI 10.1021/bi00432a026; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Park C, 2000, PROTEIN SCI, V9, P2026, DOI 10.1110/ps.9.10.2026; PLUMMER TH, 1963, J BIOL CHEM, V238, P1396; PUETT D, 1973, J BIOL CHEM, V248, P3566; RICO M, 1993, APPL MAGN RESON, V4, P385, DOI 10.1007/BF03162456; Solis D, 2001, GLYCOBIOLOGY, V11, P31, DOI 10.1093/glycob/11.1.31; SORRENTINO S, 1985, BIOCHIM BIOPHYS ACTA, V827, P135, DOI 10.1016/0167-4838(85)90081-0; TERZI E, 1994, BIOCHEMISTRY-US, V33, P1345, DOI 10.1021/bi00172a009; THANNHAUSER TW, 1985, BIOCHEMISTRY-US, V24, P7681, DOI 10.1021/bi00347a027; Uversky VN, 2002, FEBS LETT, V517, P239, DOI 10.1016/S0014-5793(02)02638-8; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704; WANG FFC, 1977, J BIOL CHEM, V252, P8358; WEICKMANN JL, 1981, BIOCHEMISTRY-US, V20, P1272, DOI 10.1021/bi00508a035; WILLIAMS RL, 1987, J BIOL CHEM, V262, P16020; Zou WQ, 2001, EUR J BIOCHEM, V268, P4885, DOI 10.1046/j.1432-1327.2001.02415.x	65	35	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46241	46251		10.1074/jbc.M308470200	http://dx.doi.org/10.1074/jbc.M308470200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12966091	hybrid			2022-12-27	WOS:000186569400007
J	Larijani, B; Hume, AN; Tarafder, AK; Seabra, MC				Larijani, B; Hume, AN; Tarafder, AK; Seabra, MC			Multiple factors contribute to inefficient prenylation of Rab27a in Rab prenylation diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERANYLGERANYL TRANSFERASE; ESCORT PROTEIN; GUNMETAL MOUSE; SMALL GTPASES; BINDING; CHOROIDEREMIA; DISSOCIATION; MECHANISM; ASSOCIATION; RESOLUTION	Post-translational geranylgeranylation of Rab GTPases is essential for their membrane association and function as regulators of intracellular vesicular transport. The reaction is catalyzed by Rab geranylgeranyltransferase (RGGT) and is assisted by the Rab escort proteins ( REP), which form stable complexes with newly synthesized GDP-bound Rabs. Two genetic diseases involve the Rab geranylgeranylation machinery: choroideremia, an X-linked retinal degeneration resulting from loss-of-function mutations in REP1, and gunmetal, a mouse model of Hermansky-Pudlak syndrome resulting from mutations in the alpha-subunit of RGGT. A small subset of Rab proteins is selectively under-prenylated in both diseases, most notably Rab27a. Here we analyze why Rab27a is selectively affected in diseases of Rab geranylgeranylation. Semi-quantitative immunoblotting suggests that mass action, i.e. the amount of Rab27a relative to other Rabs, is unlikely to be a factor as the expression level of Rab27a is similar to other Rabs not affected in these diseases. In vitro binding assays and fluorescence resonance energy transfer detected by fluorescence lifetime imaging microscopy in intact cells demonstrate that Rab27a binds equally well to both REP1 and REP2, suggesting differential affinity of Rab27a for REP isoforms is not an important factor. However, steady-state kinetic analysis of the geranylgeranylation reaction indicates that REP2-Rab27a has lower affinity for RGGT compared with REP1-Rab27a. Furthermore, we show that Rab27a has relatively low GTPase activity, presumably decreasing the affinity of the REP interaction in vivo. We suggest that the restricted phenotypes observed in these diseases result from multiple contributing factors.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Biomed Sci, London SW7 2AZ, England; Canc Res UK, London Res Inst, Cell Biophys Lab, London WC2A 3PX, England	Imperial College London; Cancer Research UK	Seabra, MC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Biomed Sci, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	m.seabra@imperial.ac.uk	Larijani, Banafshe/H-3909-2015; Seabra, Miguel/AAC-3099-2019; Seabra, Miguel C/M-3280-2013	Larijani, Banafshe/0000-0003-4735-1169; Seabra, Miguel C/0000-0002-6404-4892; Tarafder, Abul/0000-0002-0368-6111; Hume, Alistair/0000-0001-9443-1087				ALEXANDROV K, 1994, EMBO J, V13, P5262, DOI 10.1002/j.1460-2075.1994.tb06860.x; Alexandrov K, 1998, FEBS LETT, V425, P460, DOI 10.1016/S0014-5793(98)00290-7; Anant JS, 1998, BIOCHEMISTRY-US, V37, P12559, DOI 10.1021/bi980881a; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Arland V, 2003, VISION RES, V43, P919, DOI 10.1016/S0042-6989(02)00389-9; ARMSTRONG SA, 1995, METHOD ENZYMOL, V257, P30; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; Desnoyers L, 1998, P NATL ACAD SCI USA, V95, P12266, DOI 10.1073/pnas.95.21.12266; Detter JC, 2000, P NATL ACAD SCI USA, V97, P4144, DOI 10.1073/pnas.080517697; FARNSWORTH CC, 1994, P NATL ACAD SCI USA, V91, P11963, DOI 10.1073/pnas.91.25.11963; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; Hughes WE, 2002, J BIOL CHEM, V277, P22974, DOI 10.1074/jbc.M201391200; Larijani B, 2003, CURR BIOL, V13, P78, DOI 10.1016/S0960-9822(02)01395-7; Liang ZM, 2000, BIOCHEM J, V346, P501, DOI 10.1042/0264-6021:3460501; Long SB, 2002, NATURE, V419, P645, DOI 10.1038/nature00986; Pereira-Leal JB, 2003, BIOCHEM BIOPH RES CO, V301, P92, DOI 10.1016/S0006-291X(02)02963-7; Pereira-Leal JB, 2001, FEBS LETT, V498, P197, DOI 10.1016/S0014-5793(01)02483-8; Pereira-Leal Jose B, 2002, Methods Mol Biol, V189, P157; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; Seabra MC, 1996, OPHTHALMIC GENET, V17, P43, DOI 10.3109/13816819609057869; Seabra MC, 1996, J BIOL CHEM, V271, P14398, DOI 10.1074/jbc.271.24.14398; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; Seabra MC, 1998, METH MOL B, V84, P251; SEABRA MC, 2000, ENZYMES, V21, P131; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; SHAPIRO AD, 1993, J BIOL CHEM, V268, P6925; Shen F, 1996, J BIOL CHEM, V271, P3692; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; Thoma NH, 2001, J BIOL CHEM, V276, P48631, DOI 10.1074/jbc.M106470200; Thoma NH, 2001, BIOCHEMISTRY-US, V40, P268, DOI 10.1021/bi002034p; Thoma NH, 2001, J BIOL CHEM, V276, P48637, DOI 10.1074/jbc.M108241200; Wilson AL, 1996, J BIOL CHEM, V271, P10932, DOI 10.1074/jbc.271.18.10932; YOKOYAMA K, 2000, LIPID MODIFICATIONS, V21, P106; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang H, 2000, STRUCTURE, V8, P241, DOI 10.1016/S0969-2126(00)00102-7; Zhang Q, 2002, BRIT J HAEMATOL, V117, P414, DOI 10.1046/j.1365-2141.2002.03444.x	39	60	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46798	46804		10.1074/jbc.M307799200	http://dx.doi.org/10.1074/jbc.M307799200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12941939	hybrid			2022-12-27	WOS:000186569400071
J	Sathyamurthy, A; Allen, MD; Murzin, AG; Bycroft, M				Sathyamurthy, A; Allen, MD; Murzin, AG; Bycroft, M			Crystal structure of the malignant brain tumor (MBT) repeats in Sex Comb on Midleg-like 2 (SCML2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCOMB-GROUP PROTEINS; SMN TUDOR DOMAIN; X-RAY; DROSOPHILA; CHROMATIN; EXPRESSION; REPRESSOR; INTERACTS; FAMILY; PWWP	Sex Comb on Midleg (SCM) belongs to the Polycomb group of proteins, which are involved in transcriptional regulation in Drosophila. It is one of the components of Polycomb repressive complex 1, a multiprotein complex of Polycomb group proteins involved in the maintenance of repression and the blocking of chromatin remodeling. SCM contains two similar to100-residue malignant brain tumor (MBT) repeats at the N terminus. These repeats are also found in other proteins involved in transcriptional repression. Here, we report the 1.78-Angstrom crystal structure of the two MBT repeats of SCM-like 2 (SCML2), a human homologue of SCM. Each repeat consists of an extended arm and a beta-barrel core. There are significant structural similarities to the Tudor, PWWP, and chromo domains, suggesting probable evolutionary relationships and functional similarities between the MBT repeats and these domains.	MRC, Ctr Prot Engn, Cambridge CB2 2QH, England	University of Cambridge	Bycroft, M (corresponding author), MRC, Ctr Prot Engn, Hills Rd, Cambridge CB2 2QH, England.	mb10031@cus.cam.ac.uk	Bycroft, Mark/D-9446-2017	Bycroft, Mark/0000-0002-0673-2216				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Bornemann D, 1996, DEVELOPMENT, V122, P1621; Bornemann D, 1998, GENETICS, V150, P675; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; FRANKE A, 1992, EMBO J, V11, P2941, DOI 10.1002/j.1460-2075.1992.tb05364.x; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jones CA, 1998, MOL CELL BIOL, V18, P2825, DOI 10.1128/MCB.18.5.2825; JONES RS, 1990, GENETICS, V126, P185; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; King IFG, 2002, MOL CELL BIOL, V22, P7919, DOI 10.1128/MCB.22.22.7919-7928.2002; Koga H, 1999, ONCOGENE, V18, P3799, DOI 10.1038/sj.onc.1202732; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LESLIE AGW, 1991, RECENT CHANGES MOSFL; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; MESSMER S, 1992, GENE DEV, V6, P1241, DOI 10.1101/gad.6.7.1241; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Peterson AJ, 1997, MOL CELL BIOL, V17, P6683, DOI 10.1128/MCB.17.11.6683; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Qiu C, 2002, NAT STRUCT BIOL, V9, P217, DOI 10.1038/nsb759; Rousseau F, 2003, STRUCTURE, V11, P243, DOI 10.1016/S0969-2126(03)00029-7; Satijn DPE, 1999, MOL CELL BIOL, V19, P57; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; SEWALT RG, 1993, MOL CELL BIOL, V18, P3586; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; SIMON J, 1995, CURR OPIN CELL BIOL, V7, P376, DOI 10.1016/0955-0674(95)80093-X; SLATER LM, 2003, J MOL BIOL; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TURK D, 1992, THESIS TU MUNCHEN MU; van Lohuizen M, 1998, MOL CELL BIOL, V18, P3572, DOI 10.1128/MCB.18.6.3572; Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8	37	36	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46968	46973		10.1074/jbc.M306469200	http://dx.doi.org/10.1074/jbc.M306469200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12952983	hybrid			2022-12-27	WOS:000186569400091
J	George, KM; Schule, T; Sandoval, LE; Jennings, LL; Taylor, P; Thompson, CM				George, KM; Schule, T; Sandoval, LE; Jennings, LL; Taylor, P; Thompson, CM			Differentiation between acetylcholinesterase and the organophosphate-inhibited form using antibodies and the correlation of antibody recognition with reactivation mechanism and rate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUTYRYLCHOLINESTERASE; CHOLINESTERASES; ISOMALATHION; EXPRESSION; PRODUCTS; KINETICS; SITE	Two types of polyclonal antibodies were generated from (a) a decapeptide sequence that includes the active site serine of acetylcholinesterase (anti-AChE(10S)) and (b) the identical decapeptide sequence phosphorylated at the active site serine of acetylcholinesterase (anti-AChE(10SP)). The anti-AChE(10S) antiserum was found to specifically recognize native, control, and vehicle-treated recombinant mouse AChE (rMoAChE) but did not recognize rMoAChE that was phosphorylated by the four organophosphate (OP) compounds tested. Conversely the anti-AChE(10SP) antiserum recognized phosphoserine rMoAChE that resulted from reaction with phosphorous oxychloride (POCl3) but did not recognize native or vehicle-treated rMoAChE. Anti-AChE(10SP) also did not recognize OP-AChE conjugates that resulted from the reaction of rMoAChE with other OP compounds that afford neutral or monoanionic phosphoserine groups thereby indicating a high specificity for a precise OP conjugate. Antisera recognition correlated well with the rates of enzyme inhibition, aging, and oxime-induced reactivation indicating these antisera can both quantify the extent and type of inhibition and also differentiate between select mechanisms of inhibition. The ability to discern mechanistic differences between native AChE and OP-AChE conjugates suggests that these antisera can be used to identify biomarkers of OP exposure in a mechanism-based approach.	Univ Montana, Ctr Environm Hlth Sci, Missoula, MT 59812 USA; Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA; Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; University of Montana System; University of Montana; University of California System; University of California San Diego	Thompson, CM (corresponding author), Univ Montana, Ctr Environm Hlth Sci, Missoula, MT 59812 USA.	cmthomp@selway.umt.edu	Jennings, Lori/R-7152-2019					ASHANI Y, 1990, BIOCHEMISTRY-US, V29, P2456, DOI 10.1021/bi00462a004; Barak R, 1997, FEBS LETT, V407, P347, DOI 10.1016/S0014-5793(97)00375-X; Barnes JM, 1999, INT ARCH OCC ENV HEA, V72, pM68, DOI 10.1007/PL00014219; BERKMAN CE, 1993, CHEM RES TOXICOL, V6, P28, DOI 10.1021/tx00031a004; BERKMAN CE, 1993, CHEM RES TOXICOL, V6, P724, DOI 10.1021/tx00035a019; Carr RL, 1996, TOXICOL APPL PHARM, V139, P365, DOI 10.1006/taap.1996.0177; CHATEL JM, 1993, P NATL ACAD SCI USA, V90, P2476, DOI 10.1073/pnas.90.6.2476; Doorn JA, 2001, TOXICOL APPL PHARM, V176, P73, DOI 10.1006/taap.2001.9279; Elhanany E, 2001, CHEM RES TOXICOL, V14, P912, DOI 10.1021/tx0100542; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FRANK AW, 1984, CRC CR REV BIOCH MOL, V16, P51, DOI 10.3109/10409238409102806; FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245, DOI 10.2307/3431032; GENTRY MK, 1993, CHEM-BIOL INTERACT, V87, P227, DOI 10.1016/0009-2797(93)90046-2; GENTRY MK, 1995, J NEUROCHEM, V64, P842; George KM, 2002, TOXICOL LETT, V126, P99, DOI 10.1016/S0378-4274(01)00449-0; HARLOW E, 1998, ANTIBODIES LAB MANUA, P471; JARV J, 1984, BIOORG CHEM, V12, P259, DOI 10.1016/0045-2068(84)90010-5; Jianmongkol S, 1999, TOXICOL APPL PHARM, V155, P43, DOI 10.1006/taap.1998.8608; Lessenger J E, 1999, J Am Board Fam Pract, V12, P307; Marchot P, 1996, PROTEIN SCI, V5, P672; Millard CB, 1999, BIOCHEMISTRY-US, V38, P7032, DOI 10.1021/bi982678l; OGERT RA, 1990, J NEUROCHEM, V55, P756, DOI 10.1111/j.1471-4159.1990.tb04556.x; Ordentlich A, 1996, J BIOL CHEM, V271, P11953, DOI 10.1074/jbc.271.20.11953; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; Quistad GB, 2000, CHEM RES TOXICOL, V13, P652, DOI 10.1021/tx000028o; REIGART JR, 1999, PUBLICATION USEPA; SEGALL Y, 1993, BIOCHEMISTRY-US, V32, P13441, DOI 10.1021/bi00212a009; Simon S, 1997, J BIOL CHEM, V272, P33045, DOI 10.1074/jbc.272.52.33045; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; THOMPSON CM, 1992, J AM CHEM SOC, V114, P10710, DOI 10.1021/ja00053a005; WASSERMAN L, 1993, J NEUROCHEM, V61, P2124, DOI 10.1111/j.1471-4159.1993.tb07450.x; Wierdl M, 2000, BIOCHEM PHARMACOL, V59, P773, DOI 10.1016/S0006-2952(99)00389-5; Wilson BH, 1992, ORGANOPHOSPHATES CHE, P107; WILSON BW, 1992, REV ENVIRON CONTAM T, V128, P55; Worek F, 1999, ARCH TOXICOL, V73, P7, DOI 10.1007/s002040050580	35	26	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45512	45518		10.1074/jbc.M304781200	http://dx.doi.org/10.1074/jbc.M304781200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12933813	hybrid			2022-12-27	WOS:000186452300058
J	Ozawa, M				Ozawa, M			p120-independent modulation of E-cadherin adhesion activity by the membrane-proximal region of the cytoplasmic domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ENDOTHELIAL-CELLS; CATENIN COMPLEX; ALPHA-CATENIN; N-CADHERIN; JUXTAMEMBRANE REGION; MOLECULE UVOMORULIN; IN-VIVO; PROTEIN; BINDING; ACTIN	Cadherins are transmembrane glycoproteins that function as Ca2+-dependent cell-cell adhesion molecules and are linked to the actin cytoskeleton via catenins. Previously, we showed that, although E-cadherin lacking its cytoplasmic tail is active in aggregation assays, partially truncated E-cadherin lacking the carboxyl-terminal catenin-binding site is not. Contrary to this observation, a similar N-cadherin construct is found to be functional. Chimeric constructs, in which the membrane-proximal region of the partially truncated E-cadherin was replaced by that of N-cadherin, are active in aggregation assays. N-cadherin constructs in the opposite manner are nonfunctional. Although deletion of the membrane-proximal region, which eliminates the binding site for p120, results in activation of the nonfunctional E-cadherin mutant polypeptides, amino acid substitutions in the membrane-proximal region, which uncouple p120 binding, do not. The p120 uncoupling could not activate a full-length E-cadherin construct, which was beta-catenin-uncoupled by amino acid substitutions in the catenin-binding site. These results indicate that the membrane-proximal region determines the activity of these cadherin constructs but that p120 does not seem directly involved in the modulation of E-cadherin activity.	Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Biol, Kagoshima 8908544, Japan	Kagoshima University	Ozawa, M (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Biol, Kagoshima 8908544, Japan.			Ozawa, Masayuki/0000-0002-7887-8441				ABERLE H, 1994, J CELL SCI, V107, P3655; Aono S, 1999, J CELL BIOL, V145, P551, DOI 10.1083/jcb.145.3.551; Baki L, 2001, P NATL ACAD SCI USA, V98, P2381, DOI 10.1073/pnas.041603398; Calkins CC, 2003, J BIOL CHEM, V278, P1774, DOI 10.1074/jbc.M205693200; Chen HY, 1997, J CELL SCI, V110, P345; Chitaev NA, 1998, J CELL BIOL, V142, P837, DOI 10.1083/jcb.142.3.837; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; GEIGER B, 1992, ANNU REV CELL BIOL, V8, P307, DOI 10.1146/annurev.cb.08.110192.001515; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; JOU TS, 1995, P NATL ACAD SCI USA, V92, P5067, DOI 10.1073/pnas.92.11.5067; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marie H, 2003, J BIOL CHEM, V278, P1220, DOI 10.1074/jbc.M205391200; Marrs JA, 1996, INT REV CYTOL, V165, P159, DOI 10.1016/S0074-7696(08)62222-6; Myster SH, 2003, J CELL BIOL, V160, P433, DOI 10.1083/jcb.200211083; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NAGAFUCHI A, 1989, CELL REGUL, V1, P37, DOI 10.1091/mbc.1.1.37; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Navarro P, 1995, J BIOL CHEM, V270, P30965, DOI 10.1074/jbc.270.52.30965; Nieset JE, 1997, J CELL SCI, V110, P1013; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Ohkubo T, 1999, J BIOL CHEM, V274, P21409, DOI 10.1074/jbc.274.30.21409; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Ozawa M, 2002, J BIOL CHEM, V277, P19600, DOI 10.1074/jbc.M202029200; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Ozawa M, 1998, J CELL BIOL, V142, P1605, DOI 10.1083/jcb.142.6.1605; Pacquelet A, 2003, J CELL BIOL, V160, P313, DOI 10.1083/jcb.200207160; Paulson AF, 2000, J BIOL CHEM, V275, P30124, DOI 10.1074/jbc.M003048200; REID RA, 1990, NUCLEIC ACIDS RES, V18, P5896, DOI 10.1093/nar/18.19.5896; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; RINGWALD M, 1987, EMBO J, V6, P3647, DOI 10.1002/j.1460-2075.1987.tb02697.x; SALOMON D, 1992, J CELL SCI, V102, P7; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779	42	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46014	46020		10.1074/jbc.M307778200	http://dx.doi.org/10.1074/jbc.M307778200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952959	hybrid			2022-12-27	WOS:000186452300117
J	Rotter, V; Nagaev, I; Smith, U				Rotter, V; Nagaev, I; Smith, U			Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA; GLUCOSE-TRANSPORT; ADIPOSE-TISSUE; IRS 1; EXPRESSION; PROTEIN; RECEPTOR; LIPOLYSIS; SENSITIVITY; RELEASE	Several studies have shown a relationship between interleukin (IL) 6 levels and insulin resistance. We here show that human subcutaneous adipose cells, like 3T3-L1 cells, are target cells for IL-6. To examine putative mechanisms and cross-talk with insulin, 3T3-L1 adipocytes were cultured for different times with IL-6 and tumor necrosis factor alpha (TNF-alpha). IL-6, in contrast to TNF-alpha, did not increase pS-307 of insulin-receptor substrate (IRS)-1 or JNK activation. However, IL-6, like TNF-alpha exerted long term inhibitory effects on the gene transcription of IRS-1, GLUT-4, and peroxisome proliferator-activated receptor gamma. This effect of IL-6 was accompanied by a marked reduction in IRS-1, but not IRS-2, protein expression, and insulin-stimulated tyrosine phosphorylation, whereas no inhibitory effect was seen on the insulin receptor tyrosine phosphorylation. Consistent with the reduced GLUT-4 mRNA, insulin-stimulated glucose transport was also significantly reduced by IL-6. An important interaction with TNF-alpha was found because TNF-alpha markedly increased IL-6 mRNA and protein secretion. These results show that IL-6, through effects on gene transcription, is capable of impairing insulin signaling and action but, in contrast to TNF-alpha, IL-6 does not increase pS-307 (or pS-612) of IRS-1. The link between IL-6 and insulin resistance in man was further corroborated by the finding that the expression of IL-6, like that of TNF-alpha and IL-8, was markedly increased (similar to15-fold) in human fat cells from insulin-resistant individuals. We conclude that IL-6 can play an important role in insulin resistance in man and, furthermore, that it may act in concert with other cytokines that also are up-regulated in adipose cells in insulin resistance.	Univ Gothenburg, Sahlgrenska Acad, Lundberg Lab Diabet Res, Dept Internal Med, SE-41345 Gothenburg, Sweden	University of Gothenburg	Smith, U (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Lundberg Lab Diabet Res, Dept Internal Med, SE-41345 Gothenburg, Sweden.	ulf.smith@medic.gu.se	Nagaev, Ivan/B-7269-2008					BRADLEY DC, 1989, ANAL BIOCHEM, V180, P11, DOI 10.1016/0003-2697(89)90081-X; Bruun JM, 2002, OBES RES, V10, P499, DOI 10.1038/oby.2002.68; Carvalho E, 1999, FASEB J, V13, P2173, DOI 10.1096/fasebj.13.15.2173; Carvalho Eugenia, 2001, FASEB Journal, V15, P1101; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FEINGOLD KR, 1992, ENDOCRINOLOGY, V130, P10, DOI 10.1210/en.130.1.10; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Gasic S, 1999, J BIOL CHEM, V274, P6770, DOI 10.1074/jbc.274.10.6770; GREEN A, 1994, ENDOCRINOLOGY, V134, P2581, DOI 10.1210/en.134.6.2581; HAUNER H, 1995, DIABETOLOGIA, V38, P764, DOI 10.1007/s001250050350; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huppertz C, 1996, DIABETOLOGIA, V39, P1432, DOI 10.1007/s001250050595; Jansson PA, 2003, FASEB J, V17, P1434, DOI 10.1096/fj.02-1132com; Kado S, 1999, ACTA DIABETOL, V36, P67, DOI 10.1007/s005920050147; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Kubaszek A, 2003, DIABETES, V52, P558, DOI 10.2337/diabetes.52.2.558; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Muller S, 2002, DIABETOLOGIA, V45, P805, DOI 10.1007/s00125-002-0829-2; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Paquot N, 2000, J CLIN ENDOCR METAB, V85, P1316, DOI 10.1210/jc.85.3.1316; Path G, 2001, J CLIN ENDOCR METAB, V86, P2281, DOI 10.1210/jc.86.5.2281; Peraldi P, 1998, MOL CELL BIOCHEM, V182, P169, DOI 10.1023/A:1006865715292; Peters M, 1997, J IMMUNOL, V159, P1474; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rondinone CM, 1997, P NATL ACAD SCI USA, V94, P4171, DOI 10.1073/pnas.94.8.4171; Rosenstock M, 2001, DIABETOLOGIA, V44, P55, DOI 10.1007/s001250051580; RUBIN CS, 1977, J BIOL CHEM, V252, P3554; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; SMITH U, 1972, J LIPID RES, V13, P822; Smith U, 2001, FASEB J, V15, P215, DOI 10.1096/fj.00-0020com; Steensberg A, 2003, J PHYSIOL-LONDON, V548, P631, DOI 10.1113/jphysiol.2002.032938; STEPHENS JM, 1992, J BIOL CHEM, V267, P13580; Stouthard JML, 1996, BIOCHEM BIOPH RES CO, V220, P241, DOI 10.1006/bbrc.1996.0389; Straub RH, 2000, J CLIN ENDOCR METAB, V85, P1340, DOI 10.1210/jc.85.3.1340; TILG H, 1994, BLOOD, V83, P113; Trujillo ME, 2001, DIABETES, V50, pA12; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Xu HY, 2002, DIABETES, V51, P1876, DOI 10.2337/diabetes.51.6.1876; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yu ZW, 1997, DIABETOLOGIA, V40, P1197, DOI 10.1007/s001250050807	50	759	833	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45777	45784		10.1074/jbc.M301977200	http://dx.doi.org/10.1074/jbc.M301977200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952969	hybrid			2022-12-27	WOS:000186452300089
J	Searfoss, GH; Jordan, WH; Calligaro, DO; Galbreath, EJ; Schirtzinger, LM; Berridge, BR; Gao, H; Higgins, MA; May, PC; Ryan, TP				Searfoss, GH; Jordan, WH; Calligaro, DO; Galbreath, EJ; Schirtzinger, LM; Berridge, BR; Gao, H; Higgins, MA; May, PC; Ryan, TP			Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; AMYLOID PRECURSOR PROTEIN; CELL-DIFFERENTIATION; ADIPOSE-TISSUE; NOTCH; GENE; INTESTINE; DOMAIN; ADIPOGENESIS; PRESENILINS	Functional gamma-secretase inhibitors (FGSIs) can block the cleavage of several transmembrane proteins including amyloid precursor protein (APP), and the cell fate regulator Notch-1. FGSIs, by inhibiting APP processing, block the generation of amyloid beta (Abeta) peptides and may slow the development of Alzheimer's disease. FGSIs used to inhibit APP processing may disrupt Notch processing, thus interfering with cell fate determination. Described herein is a FGSI-mediated gastrointestinal toxicity characterized by cell population changes in the ileum of rats, which are indicative of Notch signaling disruption. Microarray analysis of ileum from FGSI-treated rats revealed differential expression responses in a number of genes indicative of Notch signaling perturbation, including the serine protease adipsin. We were able to show that FGSI-treated rats had elevated levels of adipsin protein in gastrointestinal contents and feces, and by immunohistochemistry demonstrated that adipsin containing ileum crypt cells were increased in FGSI-treated rats. The mouse Adipsin proximal promoter contains a putative binding site for the Notch-induced transcriptional regulator Hes-1, which we demonstrate is able to bind Hes-1. Additional studies in 3T3-L1 preadipocytes demonstrate that this FGSI inhibits Hes-1 expression while up-regulating adipsin expression. Overexpression of Hes-1 was able to down-regulate adipsin expression and block pre-adipocyte differentiation. We propose that adipsin is a Hes-1-regulated gene that is de-repressed during FGSI-mediated disruption of Notch/Hes-1 signaling. Additionally, the aberrant expression of adipsin, and its presence in feces may serve as a noninvasive biomarker of gastrointestinal toxicity associated with perturbed Notch signaling.	Lilly Res Labs, Dept Lead Optimizat Toxicol, Greenfield, IN 46140 USA; Lilly Res Labs, Dept Pathol, Greenfield, IN 46140 USA; Lilly Res Labs, Dept Invest Toxicol, Greenfield, IN 46140 USA; Lilly Res Labs, Dept BioRTP, Greenfield, IN 46140 USA; Lilly Res Labs, Dept Neurosci, Greenfield, IN 46140 USA	Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly	Ryan, TP (corresponding author), Lilly Res Labs, Dept Lead Optimizat Toxicol, Greenfield, IN 46140 USA.	timryan@lilly.com		Galbreath, Elizabeth/0000-0003-0162-8329				Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; BAKER BC, 1991, BIOCHEM J, V279, P775, DOI 10.1042/bj2790775; BALKE N, 1995, FEBS LETT, V371, P300, DOI 10.1016/0014-5793(95)00926-Z; Beher D, 2001, J BIOL CHEM, V276, P45394, DOI 10.1074/jbc.M103075200; BJARNASON I, 1994, PHARMACOL THERAPEUT, V62, P145, DOI 10.1016/0163-7258(94)90008-6; Bray S, 1998, CELL, V93, P499, DOI 10.1016/S0092-8674(00)81180-0; Chan YM, 1999, NEURON, V23, P201, DOI 10.1016/S0896-6273(00)80771-0; Chen FS, 2002, J BIOL CHEM, V277, P36521, DOI 10.1074/jbc.M205093200; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; COOK KS, 1987, SCIENCE, V237, P402, DOI 10.1126/science.3299705; DAVIES NM, 1995, DIS COLON RECTUM, V38, P1311, DOI 10.1007/BF02049158; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Doerfler P, 2001, P NATL ACAD SCI USA, V98, P9312, DOI 10.1073/pnas.161102498; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Garces C, 1997, J BIOL CHEM, V272, P29729, DOI 10.1074/jbc.272.47.29729; Hoyne GF, 2000, IMMUNOLOGY, V100, P281, DOI 10.1046/j.1365-2567.2000.00073.x; Iso T, 2002, J BIOL CHEM, V277, P6598, DOI 10.1074/jbc.M110495200; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Mills JC, 2001, P NATL ACAD SCI USA, V98, P12334, DOI 10.1073/pnas.231487198; Miner JL, 2001, PROTEIN EXPRES PURIF, V23, P14, DOI 10.1006/prep.2001.1482; Moldes M, 1997, MOL CELL BIOL, V17, P1796, DOI 10.1128/MCB.17.4.1796; NEWBERNE PM, 1988, TOXICOL PATHOL, V16, P184, DOI 10.1177/019262338801600211; Palaparti A, 1997, J BIOL CHEM, V272, P26604, DOI 10.1074/jbc.272.42.26604; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Skipper M, 2000, NAT GENET, V24, P3, DOI 10.1038/71653; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Suh E, 1996, MOL CELL BIOL, V16, P619; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; WHITE RT, 1992, J BIOL CHEM, V267, P9210; WILKISON WO, 1990, J BIOL CHEM, V265, P477; Wolfe MS, 2001, J BIOL CHEM, V276, P5413, DOI 10.1074/jbc.R000026200; WU J, 1998, Patent No. [09828268, 9828268]; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zheng JL, 2000, DEVELOPMENT, V127, P4551	42	277	292	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46107	46116		10.1074/jbc.M307757200	http://dx.doi.org/10.1074/jbc.M307757200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12949072	hybrid			2022-12-27	WOS:000186452300128
J	Tetaud, C; Falguieres, T; Carlier, K; Lecluse, Y; Garibal, J; Coulaud, D; Busson, P; Steffensen, R; Clausen, H; Johannes, L; Wiels, J				Tetaud, C; Falguieres, T; Carlier, K; Lecluse, Y; Garibal, J; Coulaud, D; Busson, P; Steffensen, R; Clausen, H; Johannes, L; Wiels, J			Two distinct Gb3/CD77 signaling pathways leading to apoptosis are triggered by anti-Gb3/CD77 mAb and verotoxin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BURKITTS-LYMPHOMA CELLS; CYTOCHROME-C RELEASE; SHIGA TOXIN; RETROGRADE TRANSPORT; INDUCE APOPTOSIS; ENDOTHELIAL-CELLS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; B-SUBUNIT; ACTIVATION	Globotriasosylceramide (Gb3), a neutral glycosphingolipid, is the B-cell differentiation antigen CD77 and acts as the receptor for most Shiga toxins, including verotoxin-1 (VT-1). We have shown that both anti-Gb3/CD77 mAb and VT-1 induce apoptosis in Burkitt's lymphoma cells. We compared the apoptotic pathways induced by these two molecules by selecting cell lines sensitive to only one of these inducers or to both. In all these cell lines (including the apoptosis-resistant line), VT-1 was transported to the endoplasmic reticulum and inhibited protein synthesis similarly, suggesting that VT-1-induced apoptosis is dissociated from these processes. VT-1 triggered a caspase- and mitochondria-dependent pathway (rapid activation of caspases 8 and 3 associated with a loss of mitochondrial membrane potential (Deltapsi(m)) and the release of cytochrome c from mitochondria). In contrast, the anti-Gb3/CD77 mAb-induced pathway was caspase- independent and only involved partial depolarization of mitochondria. Antioxidant compounds had only marginal effects on VT-1-induced apoptosis but strongly protected cells from anti-Gb3/CD77 mAb-induced apoptosis. VT-1- and anti-Gb3/CD77 mAb-treated cells displayed very different features on electron microscopy. These results clearly indicate that the binding of different ligands to Gb3/CD77 triggers completely different apoptotic pathways.	Inst Gustave Roussy, CNRS, UMR 8126, Lab Interact Mol & Canc, F-94805 Villejuif, France; Inst Curie, Unite Mixte Rech 144, F-75248 Paris 05, France; Inst Gustave Roussy, Serv Commun Cytometrie, Inst Federat Rech 54, F-94805 Villejuif, France; Univ Copenhagen, Sch Dent, DK-2200 Copenhagen N, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Sorbonne Universite; UNICANCER; Gustave Roussy; University of Copenhagen	Wiels, J (corresponding author), Inst Gustave Roussy, CNRS, UMR 8126, Lab Interact Mol & Canc, Rue Camille Desmoulins, F-94805 Villejuif, France.		Johannes, Ludger/W-8593-2019; Wiels, Joëlle/AGL-2319-2022; Johannes, Ludger/M-9778-2017; clausen, henrik/AAD-8016-2021	Johannes, Ludger/0000-0002-2168-0004; Wiels, Joëlle/0000-0002-3313-2937; Johannes, Ludger/0000-0002-2168-0004; Falguieres, Thomas/0000-0003-2867-0500; Busson, Pierre/0000-0003-1027-3400; Clausen, Henrik/0000-0002-0915-5055; Garibal, Julie/0000-0002-6583-0561				ABE A, 1992, J BIOCHEM-TOKYO, V111, P191, DOI 10.1093/oxfordjournals.jbchem.a123736; Andrieu-Abadie N, 2001, FREE RADICAL BIO MED, V31, P717, DOI 10.1016/S0891-5849(01)00655-4; Arab S, 1998, J NEURO-ONCOL, V40, P137, DOI 10.1023/A:1006010019064; Arab S, 1998, J CELL PHYSIOL, V177, P646, DOI 10.1002/(SICI)1097-4652(199812)177:4<646::AID-JCP15>3.0.CO;2-B; Brigotti M, 2002, FASEB J, V16, DOI 10.1096/fj.01-0521com; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Ching JCY, 2002, INFECT IMMUN, V70, P4669, DOI 10.1128/IAI.70.8.4669-4677.2002; Deas O, 1997, INT IMMUNOL, V9, P117, DOI 10.1093/intimm/9.1.117; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Falguieres T, 2001, MOL BIOL CELL, V12, P2453, DOI 10.1091/mbc.12.8.2453; Garcia-Ruiz C, 2000, FASEB J, V14, P847, DOI 10.1096/fasebj.14.7.847; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Gorman A, 1997, FEBS LETT, V404, P27, DOI 10.1016/S0014-5793(97)00069-0; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; HARDIE DL, 1993, EUR J IMMUNOL, V23, P997, DOI 10.1002/eji.1830230502; Johannes L, 2000, TRAFFIC, V1, P119, DOI 10.1034/j.1600-0854.2000.010204.x; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Kiyokawa N, 2001, J CELL BIOCHEM, V81, P128, DOI 10.1002/1097-4644(20010401)81:1<128::AID-JCB1029>3.0.CO;2-G; KOJIMA H, 1987, BIOCHEM BIOPH RES CO, V143, P716, DOI 10.1016/0006-291X(87)91413-6; Kojio S, 2000, FEMS IMMUNOL MED MIC, V29, P275, DOI 10.1111/j.1574-695X.2000.tb01534.x; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; Liu B, 1998, J BIOL CHEM, V273, P11313, DOI 10.1074/jbc.273.18.11313; MANGENEY M, 1993, CANCER RES, V53, P5314; MANGENEY M, 1991, EUR J IMMUNOL, V21, P1131, DOI 10.1002/eji.1830210507; Marcato P, 2002, INFECT IMMUN, V70, P1279, DOI 10.1128/IAI.70.3.1279-1286.2002; MARCUS DM, 1981, SEMIN HEMATOL, V18, P63; Muramatsu T, 2000, J BIOCHEM, V127, P171, DOI 10.1093/oxfordjournals.jbchem.a022590; Nakagawa I, 1999, MOL MICROBIOL, V33, P1190, DOI 10.1046/j.1365-2958.1999.01564.x; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Pijpers AHJM, 2001, J AM SOC NEPHROL, V12, P767, DOI 10.1681/ASN.V124767; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; Sandvig K, 2000, EMBO J, V19, P5943, DOI 10.1093/emboj/19.22.5943; SANDVIG K, 1992, EXP CELL RES, V200, P253, DOI 10.1016/0014-4827(92)90171-4; Sandvig K, 2001, TOXICON, V39, P1629, DOI 10.1016/S0041-0101(01)00150-7; Steffensen R, 2000, J BIOL CHEM, V275, P16723, DOI 10.1074/jbc.M000728200; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; Taga S, 1997, BLOOD, V90, P2757, DOI 10.1182/blood.V90.7.2757.2757_2757_2767; Taguchi T, 1998, KIDNEY INT, V53, P1681, DOI 10.1046/j.1523-1755.1998.00939.x; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Williams JM, 1997, TOXICOL LETT, V91, P121, DOI 10.1016/S0378-4274(97)03879-4; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142	46	62	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45200	45208		10.1074/jbc.M303868200	http://dx.doi.org/10.1074/jbc.M303868200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12944404	hybrid			2022-12-27	WOS:000186452300020
J	Yan, B; Zemskova, M; Holder, S; Chin, V; Kraft, A; Koskinen, PJ; Lilly, M				Yan, B; Zemskova, M; Holder, S; Chin, V; Kraft, A; Koskinen, PJ; Lilly, M			The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; C-MYC; INHIBITS APOPTOSIS; MYELOID CELLS; PROTEIN; SURVIVAL; ACTIVATION; EXPRESSION; ONCOGENE; LYMPHOMAGENESIS	Hematopoietic growth factors mediate the survival and proliferation of blood-forming cells, but the mechanisms through which these proteins produce their effects are incompletely known. Recent studies have identified the pim family of kinases as mediators of cytokine-dependent survival signals. Several studies have identified substrates for the pim-1 kinase, but little is known about the other family members, pim-2 and pim-3. We have investigated potential functions for the pim-2 kinase in factor-dependent murine hematopoietic cells. We find that pim-2 mRNA and protein expression are regulated by cytokines similarly to pim-1. Three PIM-2 protein isoforms are produced in cytokine-treated cells. All three forms are active kinases, and the short (PIM-2(34 kDa)) form is the most active at enhancing survival of FDCP1 cells after cytokine withdrawal. This pro-survival function involves inhibition of apoptosis and caspase activation. Enforced expression of PIM-2 (34 kDa) kinase does not appear to regulate expression of BCL-2, BCL-xL, BIM, or BAX proteins. However, the kinase can phosphorylate the pro-apoptotic protein BAD on serine 112, which accounts in part for its ability to reverse Bad-induced cell death. Our results indicate that pim-2 functions similarly to pim-1 as a pro-survival kinase and suggest that BAD is a legitimate PIM-2 substrate.	Loma Linda Univ, Sch Med, Ctr Mol Biol & Gene therapy, Loma Linda, CA 92354 USA; Loma Linda Univ, Sch Med, Dept Microbiol, Loma Linda, CA 92354 USA; Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA; Univ Turku, Abo Akad, Turku Ctr Biotechnol, Turku 20521, Finland	Loma Linda University; Loma Linda University; Loma Linda University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Abo Akademi University; University of Turku	Lilly, M (corresponding author), Loma Linda Univ, Sch Med, Ctr Mol Biol & Gene therapy, 11085 Campus St, Loma Linda, CA 92354 USA.		Koskinen, Päivi J/G-8939-2014	Zemskova, Marina/0000-0002-1454-3714	NATIONAL CANCER INSTITUTE [R01CA045672] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA45672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allen JD, 1997, ONCOGENE, V15, P1133, DOI 10.1038/sj.onc.1201288; Bertolotto C, 2000, J BIOL CHEM, V275, P37246, DOI 10.1074/jbc.M007732200; BREUER M, 1991, CANCER RES, V51, P958; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; DAUTRY F, 1988, J BIOL CHEM, V263, P17615; Eichmann A, 2000, ONCOGENE, V19, P1215, DOI 10.1038/sj.onc.1203355; Feldman JD, 1998, J BIOL CHEM, V273, P16535, DOI 10.1074/jbc.273.26.16535; FRIEDMANN M, 1992, ARCH BIOCHEM BIOPHYS, V298, P594, DOI 10.1016/0003-9861(92)90454-5; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hinton HJ, 1999, J IMMUNOL, V162, P7002; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; LAIRD PW, 1993, NUCLEIC ACIDS RES, V21, P4750, DOI 10.1093/nar/21.20.4750; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; Lilly M, 1997, CANCER RES, V57, P5348; LILLY M, 1992, ONCOGENE, V7, P727; Maita H, 2000, EUR J BIOCHEM, V267, P5168, DOI 10.1046/j.1432-1327.2000.01585.x; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Neshat MS, 2000, MOL CELL BIOL, V20, P1179, DOI 10.1128/MCB.20.4.1179-1186.2000; Pircher TJ, 2000, ONCOGENE, V19, P3684, DOI 10.1038/sj.onc.1203684; Rainio EM, 2002, J IMMUNOL, V168, P1524, DOI 10.4049/jimmunol.168.4.1524; Salomoni P, 2000, BLOOD, V96, P676; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; SELTEN G, 1986, CELL, V46, P603, DOI 10.1016/0092-8674(86)90886-X; She QB, 2002, J BIOL CHEM, V277, P24039, DOI 10.1074/jbc.M109907200; VANDERLUGT NMT, 1995, EMBO J, V14, P2536, DOI 10.1002/j.1460-2075.1995.tb07251.x; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; Wang ZP, 2002, BBA-MOL CELL RES, V1593, P45, DOI 10.1016/S0167-4889(02)00347-6; Wang ZP, 2001, ARCH BIOCHEM BIOPHYS, V390, P9, DOI 10.1006/abbi.2001.2370	30	215	229	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45358	45367		10.1074/jbc.M307933200	http://dx.doi.org/10.1074/jbc.M307933200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954615	hybrid			2022-12-27	WOS:000186452300039
J	Cho, IJ; Kim, SG				Cho, IJ; Kim, SG			Oltipraz inhibits 3-methylcholanthrene induction of CYP1A1 by CCAAT/enhancer-binding protein activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; GLUTATHIONE-S-TRANSFERASE; NUCLEAR TRANSLOCATOR ARNT; AH RECEPTOR; SIGNAL-TRANSDUCTION; ENZYME-INDUCTION; GENE-EXPRESSION; H4IIE CELLS; RAT-LIVER; HEPATOCYTES	Oltipraz, a cancer chemopreventive agent, induces CYP1A1 to a certain extent by transactivation of the gene via the Ah receptor (AhR)-xenobiotic response element (XRE) pathway. Previously, we showed that oltipraz promoted CCAAT/enhancer binding protein beta (C/EBPbeta) activation, which leads to the induction of glutathione S-transferase. Given that oltipraz activates C/EBPbeta for gene transactivation and that the putative C/EBP binding site is located in the CYP1A1 promoter region, this study investigated the effect of oltipraz on CYP1A1 induction by 3-methylcholanthrene (3-MC). 3-MC induced CYP1A1 in H4IIE cells in a time- and concentration-dependent manner. Gel shift analysis showed that 3-MC increased the band intensity of protein binding to the XRE. Immunocompetition analysis verified the specificity of AhR-XRE binding. Oltipraz (30 muM) induced CYP1A1 and the CYP1A1 promoter-luciferase gene and increased AhR DNA binding activity, which was 10 - 20% of those in 3-MC (100 nM)-treated cells. However, AhR-XRE binding was not increased after 10 muM oltipraz treatment. Oltipraz (10 muM) significantly inhibited CYP1A1 and CYP1A1-luciferase gene induction by 3-MC with no increase in AhR DNA binding. Oltipraz enhanced protein binding to the C/EBP binding site in the gene promoter and the binding complex comprised of C/EBPbeta and partly C/EBPdelta. Overexpression of dominant-negative mutant C/EBP significantly abolished the ability of oltipraz to suppress 3-MC-inducible CYP1A1 and the CYP1A1 reporter gene expression. Consistently, C/EBPbeta overexpression blocked CYP1A1 reporter gene induction by 3-MC. These results provide evidence that oltipraz suppresses 3-MC induction of CYP1A1 gene expression and that activation of C/EBPbeta by oltipraz contributes to suppression of 3-MC-inducible AhR-mediated CYP1A1 expression.	Seoul Natl Univ, Coll Pharm, Natl Res Lab, Seoul 151742, South Korea; Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, SG (corresponding author), Seoul Natl Univ, Coll Pharm, Natl Res Lab, Seoul 151742, South Korea.							Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Alexandrov K, 2002, CARCINOGENESIS, V23, P1969, DOI 10.1093/carcin/23.12.1969; Baba T, 2001, J BIOL CHEM, V276, P33101, DOI 10.1074/jbc.M011497200; Backlund M, 1997, J BIOL CHEM, V272, P31755, DOI 10.1074/jbc.272.50.31755; Beischlag TV, 2002, MOL CELL BIOL, V22, P4319, DOI 10.1128/MCB.22.12.4319-4333.2002; BERGELSON S, 1994, ONCOGENE, V9, P565; BOLTON MG, 1993, CANCER RES, V53, P3499; CARRIER F, 1994, BIOCHEM PHARMACOL, V48, P1767, DOI 10.1016/0006-2952(94)90463-4; Cho MK, 2003, HEPATOLOGY, V37, P686, DOI 10.1053/jhep.2003.50078; CONNEY AH, 1986, LIFE SCI, V39, P2493, DOI 10.1016/0024-3205(86)90103-7; deSousa G, 1996, CELL BIOL TOXICOL, V12, P351, DOI 10.1007/BF00438170; Diehl AM, 1998, J BIOL CHEM, V273, P30843, DOI 10.1074/jbc.273.47.30843; EGNER PA, 1994, CARCINOGENESIS, V15, P177, DOI 10.1093/carcin/15.2.177; FERREC EL, 2001, CARCINOGENESIS, V21, P49; Ferrec Eric Le, 2002, Journal of Biological Chemistry, V277, P24780; GUENGERICH FP, 1990, CRIT REV BIOCHEM MOL, V25, P97; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Iwanari M, 2002, ARCH TOXICOL, V76, P287, DOI 10.1007/s00204-002-0340-z; Jover R, 2002, FASEB J, V16, P1799, DOI 10.1096/fj.02-0195fje; Kang KW, 2001, MOL PHARMACOL, V59, P1147, DOI 10.1124/mol.59.5.1147; Kang KW, 2003, CARCINOGENESIS, V24, P475, DOI 10.1093/carcin/24.3.475; Kang KW, 2003, J NATL CANCER I, V95, P53, DOI 10.1093/jnci/95.1.53; Kang KW, 2002, FREE RADICAL BIO MED, V32, P1017, DOI 10.1016/S0891-5849(02)00788-8; Kobayashi A, 1997, J BIOCHEM, V122, P703; Kwak MK, 2001, MUTAT RES-FUND MOL M, V480, P305, DOI 10.1016/S0027-5107(01)00190-7; LANGOUET S, 1995, CANCER RES, V55, P5574; Langouet S, 1997, CARCINOGENESIS, V18, P1343, DOI 10.1093/carcin/18.7.1343; Lewis DFV., 1996, CYTOCHROMES P450 STR, P115; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Moinova HR, 1999, BIOCHEM BIOPH RES CO, V261, P661, DOI 10.1006/bbrc.1999.1109; Morel Y, 1998, J BIOL CHEM, V273, P26969, DOI 10.1074/jbc.273.41.26969; Nguyen TA, 1999, ARCH BIOCHEM BIOPHYS, V367, P250, DOI 10.1006/abbi.1999.1282; Reiners JJ, 1998, MOL PHARMACOL, V53, P438, DOI 10.1124/mol.53.3.438; Rowlands JC, 1997, CRIT REV TOXICOL, V27, P109, DOI 10.3109/10408449709021615; SCHREIBER E, 1990, NUCLEIC ACIDS RES, V18, P5495, DOI 10.1093/nar/18.18.5495; Sofowora GG, 2001, CANCER CHEMOTH PHARM, V47, P505, DOI 10.1007/s002800000245; SOGAWA K, 1986, P NATL ACAD SCI USA, V83, P8044, DOI 10.1073/pnas.83.21.8044; THOMAS PE, 1983, J BIOL CHEM, V258, P4590; Vasiliou V, 1995, BIOCHEM PHARMACOL, V50, P1885, DOI 10.1016/0006-2952(95)02083-7; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; WHITLOCK JP, 1987, PHARMACOL REV, V39, P147	42	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44103	44112		10.1074/jbc.M307597200	http://dx.doi.org/10.1074/jbc.M307597200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941938	hybrid			2022-12-27	WOS:000186306700028
J	Clark, RJ; McDonough, PM; Swanson, E; Trost, SU; Suzuki, M; Fukuda, M; Dillmann, WH				Clark, RJ; McDonough, PM; Swanson, E; Trost, SU; Suzuki, M; Fukuda, M; Dillmann, WH			Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; INSULIN-RESISTANCE; CARDIAC MYOCYTES; GENE-EXPRESSION; MUSCLE-CELLS; PROTEINS; GLYCOSYLATION; CA2+; HEART; CONTRACTILITY	Diabetic cardiomyopathy is characterized by impaired cardiac contractility leading to poor myocardial performance. We investigated the role that the hexosamine pathway, and especially altered nuclear O-Glc-NAcylation, plays in the development of diabetic cardiomyopathy. Incubating neonatal rat cardiomyocytes in high glucose ( 25 mM) resulted in prolonged calcium transients when compared with myocytes incubated in normal glucose (5.5 mM), which is consistent with delayed myocardial relaxation. High glucose-treated myocytes also exhibited reduced sarcoendoplasmic reticulum Ca2+-ATPase 2a (SERCA2a) mRNA and protein expression, decreased SERCA2a promoter activity, and increased O-GlcNAcylation of nuclear proteins compared with myocytes treated with normal glucose. Exposure of myocytes to 8 mM glucosamine or an adenovirus expressing O-GlcNAc-transferase (OGT) resulted in prolonged calcium transient decays and significantly reduced SERCA2a protein levels, whereas treatment with an adenovirus encoding O-GlcNAcase (GCA) resulted in improved calcium transients and SERCA2a protein levels in myocytes exposed to high glucose. Effects of elevated glucose or altered O-GlcNAcylation were also observed on essential transcription factors involved in cardiomyocyte function. High glucose-treated myocytes ( with or without OGT adenovirus) exhibited increased levels of O-GlcNAcylated specificity protein 1 compared with control myocytes, whereas infecting high glucose-treated myocytes with GCA adenovirus reduced the degree of specificity protein 1 Glc-NAcylation. Treatment of myocytes with 25 mM glucose, 8 mM glucosamine, or OGT adenovirus also significantly reduced levels of myocytes enhancer factor-2A protein compared with control myocytes, whereas infection with GCA adenovirus resulted in improved myocytes enhancer factor-2 expression. Our results suggest that the hexosamine pathway, and O-GlcNAcylation in particular, is important in impaired cardiac myocyte function and the development of diabetic cardiomyopathy.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Burnham Inst, Glycobiol Program, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Dillmann, WH (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.				NCI NIH HHS [R37CA33000] Funding Source: Medline; NHLBI NIH HHS [HL66917] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA033000] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066917] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AHMED SS, 1975, AM HEART J, V89, P153, DOI 10.1016/0002-8703(75)90039-3; Baker DL, 1996, J BIOL CHEM, V271, P5921, DOI 10.1074/jbc.271.10.5921; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; BOUCHARD RA, 1991, AM J PHYSIOL, V260, pH341, DOI 10.1152/ajpheart.1991.260.2.H341; CAGLIERO E, 1988, J MOL CELL CARDIOL, V20, P427, DOI 10.1016/S0022-2828(88)80134-2; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DILLMANN WH, 1988, DIABETES METAB REV, V4, P789, DOI 10.1002/dmr.5610040807; DUKSIN D, 1982, J BIOL CHEM, V257, P3105; FEIN FS, 1980, CIRC RES, V47, P922, DOI 10.1161/01.RES.47.6.922; GALDERISI M, 1991, AM J CARDIOL, V68, P85, DOI 10.1016/0002-9149(91)90716-X; GANGULY PK, 1983, AM J PHYSIOL, V244, pE528, DOI 10.1152/ajpendo.1983.244.6.E528; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; GUPTA RK, 1993, BIOPHYS J, V65, P2547, DOI 10.1016/S0006-3495(93)81320-1; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Hartong R, 1996, J MOL CELL CARDIOL, V28, P2467, DOI 10.1006/jmcc.1996.0239; Hawkins M, 1997, J CLIN INVEST, V99, P2173, DOI 10.1172/JCI119390; He HP, 1999, CIRCULATION, V100, P974, DOI 10.1161/01.CIR.100.9.974; He HP, 1997, J CLIN INVEST, V100, P380, DOI 10.1172/JCI119544; LagadicGossmann D, 1996, AM J PHYSIOL-HEART C, V270, pH1529, DOI 10.1152/ajpheart.1996.270.5.H1529; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; MCCLAIN DA, 1992, P NATL ACAD SCI USA, V89, P8150, DOI 10.1073/pnas.89.17.8150; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; MCDONOUGH PM, 1994, J BIOL CHEM, V269, P9466; Moriscot AS, 1997, ENDOCRINOLOGY, V138, P26, DOI 10.1210/en.138.1.26; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; PENPARGKUL S, 1981, J MOL CELL CARDIOL, V13, P303, DOI 10.1016/0022-2828(81)90318-7; PENPARGKUL S, 1980, CIRC RES, V47, P911, DOI 10.1161/01.RES.47.6.911; Periasamy M, 2001, J MOL CELL CARDIOL, V33, P1053, DOI 10.1006/jmcc.2001.1366; Pierce GN, 1997, CARDIOVASC RES, V34, P41, DOI 10.1016/S0008-6363(97)00010-2; Ren J, 1997, AM J PHYSIOL-HEART C, V273, pH2876, DOI 10.1152/ajpheart.1997.273.6.H2876; ROBINSON KA, 1995, DIABETES, V44, P1438, DOI 10.2337/diabetes.44.12.1438; ROHRER DK, 1991, J BIOL CHEM, V266, P8638; Schannwell CM, 2002, CARDIOLOGY, V98, P33, DOI 10.1159/000064682; Trost SU, 2002, DIABETES, V51, P1166, DOI 10.2337/diabetes.51.4.1166; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; WECKBECKER G, 1983, ANAL BIOCHEM, V132, P405, DOI 10.1016/0003-2697(83)90027-1; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; ZARICH SW, 1988, J AM COLL CARDIOL, V12, P114, DOI 10.1016/0735-1097(88)90364-6; ZORZANO A, 1997, AM J CARDIOL, V80, P65	47	281	288	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44230	44237		10.1074/jbc.M303810200	http://dx.doi.org/10.1074/jbc.M303810200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941958	hybrid			2022-12-27	WOS:000186306700043
J	Kataoka, Y; Matsumura, I; Ezoe, S; Nakata, S; Takigawa, E; Sato, Y; Kawasaki, A; Yokota, T; Nakajima, K; Felsani, A; Kanakura, Y				Kataoka, Y; Matsumura, I; Ezoe, S; Nakata, S; Takigawa, E; Sato, Y; Kawasaki, A; Yokota, T; Nakajima, K; Felsani, A; Kanakura, Y			Reciprocal inhibition between MyoD and STAT3 in the regulation of growth and differentiation of myoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; CELL-CYCLE; C-MYC; MYOGENIC DIFFERENTIATION; SIGNALING PATHWAYS; SKELETAL-MUSCLE; KINASE PATHWAY; MET RECEPTOR; PROLIFERATION	The development of myoblasts is regulated by various growth factors as well as by intrinsic muscle-specific transcriptional factors. In this study, we analyzed the roles for STAT3 in the growth and differentiation of myoblasts in terms of cell cycle regulation and interaction with MyoD using C2C12 cells. Here we found that STAT3 inhibited myogenic differentiation induced by low serum or MyoD as efficiently as the Ras/mitogen-activated protein kinase cascade. As for this mechanism, we found that STAT3 not only promoted cell cycle progression through the induction of c-myc but also inhibited MyoD activities through direct interaction. STAT3 inhibited not only DNA binding activities of MyoD but also its transcriptional activities. However, the inhibited transcriptional activities were restored by the supplement of p300/CBP and PCAF, suggesting that STAT3 might deprive MyoD of these transcriptional cofactors. In addition, we found that MyoD inhibited DNA binding activities of STAT3, thereby inhibiting STAT3-dependent cell growth and survival of Ba/F3 cells. These results suggest that the development of muscle cells is regulated by the coordination of cytokine signals and intrinsic transcription factors.	Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan; Kanazawa Univ, Grad Sch Med Sci, Dept Canc Med, Div Stem Cell Biol, Kanazawa, Ishikawa 9208640, Japan; Osaka City Univ, Sch Med, Dept Immunol, Abeno Ku, Osaka 5450051, Japan; Inst Technol Biomed, I-00137 Rome, Italy	Osaka University; Kanazawa University; Osaka Metropolitan University	Matsumura, I (corresponding author), Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Felsani, Armando/D-1784-2010; Yokota, Takashi/F-6021-2011; Yokota, Takashi/J-8483-2015	Felsani, Armando/0000-0001-8851-6295; 				Bellido T, 1998, J BIOL CHEM, V273, P21137, DOI 10.1074/jbc.273.33.21137; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cenciarelli C, 1999, MOL CELL BIOL, V19, P5203; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; CRESCENZI M, 1990, P NATL ACAD SCI USA, V87, P8442, DOI 10.1073/pnas.87.21.8442; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Giraud S, 2002, J BIOL CHEM, V277, P8004, DOI 10.1074/jbc.M111486200; Gires O, 1999, EMBO J, V18, P3064, DOI 10.1093/emboj/18.11.3064; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hansen SH, 2000, MOL CELL BIOL, V20, P9364, DOI 10.1128/MCB.20.24.9364-9375.2000; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; HOLLENBERG SM, 1993, P NATL ACAD SCI USA, V90, P8028, DOI 10.1073/pnas.90.17.8028; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Ihara S, 1997, EMBO J, V16, P5345, DOI 10.1093/emboj/16.17.5345; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Kerkhoff E, 1998, ONCOGENE, V16, P211, DOI 10.1038/sj.onc.1201520; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Lawlor MA, 2000, J CELL BIOL, V151, P1131, DOI 10.1083/jcb.151.6.1131; Leshem Y, 2002, EXP CELL RES, V274, P288, DOI 10.1006/excr.2002.5473; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; MARTELLI F, 1994, ONCOGENE, V9, P3579; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Matsumura I, 1998, MOL CELL BIOL, V18, P4282, DOI 10.1128/MCB.18.7.4282; Matsumura I, 1997, MOL CELL BIOL, V17, P2933, DOI 10.1128/MCB.17.5.2933; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Perry RLS, 2001, MOL CELL, V8, P291, DOI 10.1016/S1097-2765(01)00302-1; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Polesskaya A, 2001, MOL CELL BIOL, V21, P5312, DOI 10.1128/MCB.21.16.5312-5320.2001; Rawls A, 1997, CELL, V89, P5, DOI 10.1016/S0092-8674(00)80175-0; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Simon AR, 2002, AM J PHYSIOL-LUNG C, V282, pL1296, DOI 10.1152/ajplung.00315.2001; SORRENTINO V, 1990, NATURE, V345, P813, DOI 10.1038/345813a0; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tureckova J, 2001, J BIOL CHEM, V276, P39264, DOI 10.1074/jbc.M104991200; Wei Q, 2001, FEBS LETT, V490, P171, DOI 10.1016/S0014-5793(01)02120-2; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Yanagisawa M, 1999, NEUROSCI LETT, V269, P169, DOI 10.1016/S0304-3940(99)00447-4; Zauberman A, 2001, J BIOL CHEM, V276, P24719, DOI 10.1074/jbc.M005813200; Zhang JM, 1999, EMBO J, V18, P926, DOI 10.1093/emboj/18.4.926; Zhang XK, 1999, MOL CELL BIOL, V19, P7138; Zong CS, 2000, J BIOL CHEM, V275, P15099, DOI 10.1074/jbc.M000089200	57	46	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44178	44187		10.1074/jbc.M304884200	http://dx.doi.org/10.1074/jbc.M304884200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947115	hybrid			2022-12-27	WOS:000186306700037
J	Rehli, M; Niller, HH; Ammon, C; Langmann, S; Schwarzfischer, L; Andreesen, R; Krause, SW				Rehli, M; Niller, HH; Ammon, C; Langmann, S; Schwarzfischer, L; Andreesen, R; Krause, SW			Transcriptional regulation of CHI3L1, a gene for late stages of macrophage differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CARTILAGE GP-39; CHITINASE PROTEIN FAMILY; LIGATION-MEDIATED PCR; PU.1 TRANSCRIPTION; MONOCYTIC DIFFERENTIATION; MYELOID DEVELOPMENT; MAMMALIAN MEMBER; POTENTIAL MARKER; SERUM YKL-40; FACTORS SP1	The protein product of the CHI3L1 gene, human cartilage 39-kDa glycoprotein (HC-gp39), is a tissue-restricted, chitin-binding lectin and member of glycosyl hydrolase family 18. In contrast to many other monocyte/macrophage markers, its expression is absent in monocytes and strongly induced during late stages of human macrophage differentiation. To gain insights into the molecular mechanisms underlying its cell type-restricted and maturation-associated expression in macrophages, we initiated a detailed study of the proximal HC-gp39 promoter. Deletion analysis of reporter constructs in macrophage-like THP-1 cells localized a region directing high levels of macrophage-specific reporter gene expression to similar to300 bp adjacent to the major transcriptional start site. The promoter sequence contained consensus binding sites for several known factors, and specific binding of nuclear PU.1, Sp1, Sp3, USF, AML-1, and C/EBP proteins was detectable in gel shift assays. In vivo footprinting assays with dimethyl sulfate demonstrate that the protection of corresponding sequences was enhanced in macrophages compared with monocytes. Mutational analysis of transcription factor binding sites indicated a predominant role for a single Sp1 binding site in regulating HC-gp39 promoter activity. In addition, gel shift assays using nuclear extracts of monocytes and macrophages demonstrated that the binding of nuclear Sp1, but not Sp3, markedly increases during macrophage differentiation. Our results further highlight the important role of Sp1 in macrophage gene regulation.	Univ Regensburg, Dept Hematol & Oncol, D-93042 Regensburg, Germany; Univ Regensburg, Inst Med Microbiol & Hyg, D-93042 Regensburg, Germany	University of Regensburg; University of Regensburg	Rehli, M (corresponding author), Univ Regensburg, Dept Hematol & Oncol, D-93042 Regensburg, Germany.		Rehli, Michael/E-9093-2011	Rehli, Michael/0000-0003-3992-932X; Krause, Stefan/0000-0002-5259-4651				Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Behre G, 1999, J BIOL CHEM, V274, P4939, DOI 10.1074/jbc.274.8.4939; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; CHEN HM, 1995, ONCOGENE, V11, P1549; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cintin C, 1999, BRIT J CANCER, V79, P1494, DOI 10.1038/sj.bjc.6690238; Eichbaum Q, 1997, BLOOD, V90, P4135, DOI 10.1182/blood.V90.10.4135; EICHBAUM QG, 1994, J EXP MED, V179, P1985, DOI 10.1084/jem.179.6.1985; FEINMAN R, 1994, EMBO J, V13, P3852, DOI 10.1002/j.1460-2075.1994.tb06696.x; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; GARRITY PA, 1992, P NATL ACAD SCI USA, V89, P1021, DOI 10.1073/pnas.89.3.1021; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Heydemann A, 1996, MOL CELL BIOL, V16, P1676; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; JOHANSEN JS, 1995, EUR J CANCER, V31A, P1437, DOI 10.1016/0959-8049(95)00196-P; Johansen JS, 1997, SCAND J GASTROENTERO, V32, P582, DOI 10.3109/00365529709025104; JOHANSEN JS, 1993, BRIT J RHEUMATOL, V32, P949; Krause SW, 1996, J LEUKOCYTE BIOL, V60, P540, DOI 10.1002/jlb.60.4.540; Langmann T, 1999, J LIPID RES, V40, P870; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Maxam A M, 1980, Methods Enzymol, V65, P499; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; NILLER HH, 1995, J BIOL CHEM, V270, P12864, DOI 10.1074/jbc.270.21.12864; PAHL HL, 1993, J BIOL CHEM, V268, P5014; Querfurth E, 2000, GENE DEV, V14, P2515, DOI 10.1101/gad.177200; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Rehli M, 1999, J IMMUNOL, V162, P1559; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; Ries S, 1998, J LIPID RES, V39, P2125; ROSMARIN AG, 1995, P NATL ACAD SCI USA, V92, P801, DOI 10.1073/pnas.92.3.801; SAKAMOTO S, 2001, J BIOL CHEM; SANFANG C, 2003, EUR J BIOCHEM, V270, P1855; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Vangala RK, 2003, BLOOD, V101, P270, DOI 10.1182/blood-2002-04-1288; Volck B, 1998, P ASSOC AM PHYSICIAN, V110, P351; Vos K, 2000, ANN RHEUM DIS, V59, P544, DOI 10.1136/ard.59.7.544; Westendorf JJ, 1998, MOL CELL BIOL, V18, P322, DOI 10.1128/MCB.18.1.322; ZHANG DE, 1994, J IMMUNOL, V153, P3276; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	47	175	185	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44058	44067		10.1074/jbc.M306792200	http://dx.doi.org/10.1074/jbc.M306792200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12933821	hybrid			2022-12-27	WOS:000186306700022
J	Saxena, P; Yadav, G; Mohanty, D; Gokhale, RS				Saxena, P; Yadav, G; Mohanty, D; Gokhale, RS			A new family of type III polyketide synthases in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHALCONE SYNTHASE; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; GENOME SEQUENCE; ESCHERICHIA-COLI; CARRIER; BIOSYNTHESIS; ACID; IDENTIFICATION; ALIGNMENT	The Mycobacterium tuberculosis genome has revealed a remarkable array of polyketide synthases (PKSs); however, no polyketide product has been isolated thus far. Most of the PKS genes have been implicated in the biosynthesis of complex lipids. We report here the characterization of two novel type III PKSs from M. tuberculosis that are involved in the biosynthesis of long-chain alpha-pyrones. Measurement of steady-state kinetic parameters demonstrated that the catalytic efficiency of PKS18 protein was severalfold higher for long-chain acyl-coenzyme A substrates as compared with the small-chain precursors. The specificity of PKS18 and PKS11 proteins toward long-chain aliphatic acyl-coenzyme A (C-12 to C-20) substrates is unprecedented in the chalcone synthase (CHS) family of condensing enzymes. Based on comparative modeling studies, we propose that these proteins might have evolved by fusing the catalytic machinery of CHS and beta-ketoacyl synthases, the two evolutionarily related members with conserved thiolase fold. The mechanistic and structural importance of several active site residues, as predicted by our structural model, was investigated by performing site-directed mutagenesis. The functional identification of diverse catalytic activity in mycobacterial type III PKSs provide a fascinating example of metabolite divergence in CHS-like proteins.	Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Gokhale, RS (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	rsg@nii.res.in	Mohanty, Debasisa/A-1428-2009	MOHANTY, DEBASISA/0000-0002-3374-0588; Yadav, Gitanjali/0000-0001-6591-9964				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Bangera MG, 1999, J BACTERIOL, V181, P3155, DOI 10.1128/JB.181.10.3155-3163.1999; Benson DA, 2002, NUCLEIC ACIDS RES, V30, P17, DOI 10.1093/nar/30.1.17; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Buckle AM, 1996, BIOCHEMISTRY-US, V35, P4298, DOI 10.1021/bi9524676; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chen HW, 2001, P NATL ACAD SCI USA, V98, P14901, DOI 10.1073/pnas.221582098; CHOUDHURY D, 2001, THESIS SWEDISH U AGR; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cortes J, 2002, MOL MICROBIOL, V44, P1213, DOI 10.1046/j.1365-2958.2002.02975.x; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; Eckermann S, 1998, NATURE, V396, P387, DOI 10.1038/24652; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Funa N, 1999, NATURE, V400, P897, DOI 10.1038/23748; Funa N, 2002, J BIOL CHEM, V277, P4628, DOI 10.1074/jbc.M110357200; Funa N, 2002, BIOCHEM J, V367, P781, DOI 10.1042/BJ20020953; Gokhale RS, 2001, BIOTECHNOLOGY, P341; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Jez JM, 2002, P NATL ACAD SCI USA, V99, P5319, DOI 10.1073/pnas.082590499; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; KATZ L, 1993, ANNU REV MICROBIOL, V47, P875, DOI 10.1146/annurev.mi.47.100193.004303; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Khosla C, 1999, ANNU REV BIOCHEM, V68, P219, DOI 10.1146/annurev.biochem.68.1.219; Kolattukudy PE, 1997, MOL MICROBIOL, V24, P263, DOI 10.1046/j.1365-2958.1997.3361705.x; Li TL, 2001, CHEM COMMUN, P2156, DOI 10.1039/b106638b; McGuire KA, 2001, BIOCHEMISTRY-US, V40, P9836, DOI 10.1021/bi0105577; Moche M, 2001, J MOL BIOL, V305, P491, DOI 10.1006/jmbi.2000.4272; Moore BS, 2002, J NAT PROD, V65, P1956, DOI 10.1021/np020230m; Moore BS, 2001, CHEMBIOCHEM, V2, P35, DOI 10.1002/1439-7633(20010105)2:1<35::AID-CBIC35>3.3.CO;2-T; OHAGAN D, 1993, NAT PROD REP, V10, P593, DOI 10.1039/np9931000593; Olsen JG, 1999, FEBS LETT, V460, P46, DOI 10.1016/S0014-5793(99)01303-4; Olsen JG, 2001, STRUCTURE, V9, P233, DOI 10.1016/S0969-2126(01)00583-4; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Pan H, 2002, STRUCTURE, V10, P1559, DOI 10.1016/S0969-2126(02)00889-4; Pfeifer V, 2001, J BIOL CHEM, V276, P38370, DOI 10.1074/jbc.M106580200; Ratnaparkhi GS, 2000, BIOCHEMISTRY-US, V39, P12365, DOI 10.1021/bi000775k; Russell DG, 2002, J CELL BIOL, V158, P421, DOI 10.1083/jcb.200205034; Scarsdale JN, 2001, J BIOL CHEM, V276, P20516, DOI 10.1074/jbc.M010762200; Schroder J, 2000, RECENT ADV PHYTOCHEM, V34, P55, DOI 10.1016/S0079-9920(00)80004-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Val D, 2000, STRUCT FOLD DES, V8, P565, DOI 10.1016/S0969-2126(00)00146-5; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200	49	91	103	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44780	44790		10.1074/jbc.M306714200	http://dx.doi.org/10.1074/jbc.M306714200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941968	hybrid			2022-12-27	WOS:000186306700112
J	Shelness, GS; Hou, L; Ledford, AS; Parks, JS; Weinberg, RB				Shelness, GS; Hou, L; Ledford, AS; Parks, JS; Weinberg, RB			Identification of the lipoprotein initiating domain of apolipoprotein B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LOW-DENSITY-LIPOPROTEIN; CARBOXYL-TERMINAL TRUNCATION; APO-B; ENDOPLASMIC-RETICULUM; LIPID TRANSFER; RAT-LIVER; SECRETION; EXPRESSION; VITELLOGENIN	We have explored the minimum sequence requirement for the initiation of apolipoprotein B ( apoB)-mediated triglyceride-rich lipoprotein assembly. A series of apoB COOH-terminal truncation mutants, spanning a range from apoB34 (amino acid residues 1-1544 of apoB100) to apoB19 (residues 1-862) were transfected into COS cells with and without coexpression of the microsomal triglyceride transfer protein (MTP). ApoB34, - 25, - 23, - 21, - 20.5, and - 20.1 underwent efficient conversion to buoyant lipoproteins when coexpressed with MTP. ApoB19.5 (amino acids 1 - 884) also directed MTP-dependent particle assembly, although at reduced efficiency. When apoB19.5 was truncated by another 22 amino acids to form apoB19, MTP-dependent lipoprotein assembly was abolished. Analysis of the lipid stoichiometry of secreted lipoproteins revealed that all apoB truncation mutants formed spherical particles containing a hydrophobic core. Even highly truncated assembly-competent forms of apoB, such as apoB19.5 and 20.1, formed lipoproteins with surface: core lipid ratios of < 1. We conclude that the translation of the first &SIM; 884 amino acids of apoB completes a domain capable of initiating nascent lipoprotein assembly. The composition of lipids recruited into lipoproteins by this initiating domain is consistent with formation of small emulsion particles, perhaps by simultaneous desorption of both polar and neutral lipids from a saturated bilayer.	Wake Forest Univ, Sch Med, Dept Pathol, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University	Shelness, GS (corresponding author), Wake Forest Univ, Sch Med, Dept Pathol, Winston Salem, NC 27157 USA.				NHLBI NIH HHS [R01 HL030897-23, R01 HL030897, HL49373, HL54176, HL30897] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030897, R01HL054176, R23HL030897, P01HL049373] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALEXANDER CA, 1976, J CELL BIOL, V69, P241, DOI 10.1083/jcb.69.2.241; Anderson TA, 1998, STRUCT FOLD DES, V6, P895, DOI 10.1016/S0969-2126(98)00091-4; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Babin PJ, 1999, J MOL EVOL, V49, P150, DOI 10.1007/PL00006528; BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carraway M, 2000, BIOCHEMISTRY-US, V39, P9737, DOI 10.1021/bi000791h; CHAN L, 1992, J BIOL CHEM, V267, P25621; Chevet E, 2001, CURR OPIN STRUC BIOL, V11, P120, DOI 10.1016/S0959-440X(00)00168-8; Dashti N, 2002, BIOCHEMISTRY-US, V41, P6978, DOI 10.1021/bi011757l; Davis RA, 1999, BBA-MOL CELL BIOL L, V1440, P1, DOI 10.1016/S1388-1981(99)00083-9; DeLozier JA, 2001, J LIPID RES, V42, P399; Farese RV, 1996, J LIPID RES, V37, P347; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Fisher EA, 2001, J BIOL CHEM, V276, P27855, DOI 10.1074/jbc.M008885200; Gordon DA, 2000, BBA-MOL CELL BIOL L, V1486, P72, DOI 10.1016/S1388-1981(00)00049-4; GRAHAM DL, 1991, BIOCHEMISTRY-US, V30, P5616, DOI 10.1021/bi00236a040; HERSCOVITZ H, 1991, P NATL ACAD SCI USA, V88, P7313, DOI 10.1073/pnas.88.16.7313; HERSCOVITZ H, 1995, P NATL ACAD SCI USA, V92, P659, DOI 10.1073/pnas.92.3.659; Herscovitz H, 2001, J LIPID RES, V42, P51; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Ingram MF, 1997, J BIOL CHEM, V272, P10279; Mann CJ, 1999, J MOL BIOL, V285, P391, DOI 10.1006/jmbi.1998.2298; MCLEOD RS, 1994, J BIOL CHEM, V269, P2852; OHLENDORF DH, 1977, J BIOL CHEM, V252, P7992; OLOFSSON SO, 1987, ATHEROSCLEROSIS, V68, P1, DOI 10.1016/0021-9150(87)90088-8; PEASE RJ, 1991, NATURE, V353, P448, DOI 10.1038/353448a0; SCHUMAKER VN, 1994, ADV PROTEIN CHEM, V45, P205; Segrest JP, 1999, J LIPID RES, V40, P1401; Segrest JP, 2001, J LIPID RES, V42, P1346; SEGREST JP, 1994, ARTERIOSCLER THROMB, V14, P1674, DOI 10.1161/01.ATV.14.10.1674; Sellers JA, 2001, J LIPID RES, V42, P1897; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; Shelness GS, 1996, J LIPID RES, V37, P408; SHELNESS GS, 1994, J BIOL CHEM, V269, P9310; SPRING DJ, 1992, J BIOL CHEM, V267, P14839; Weinberg RB, 2000, J LIPID RES, V41, P1419; YANG CY, 1990, P NATL ACAD SCI USA, V87, P5523, DOI 10.1073/pnas.87.14.5523; YAO ZM, 1991, J BIOL CHEM, V266, P3300	39	50	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44702	44707		10.1074/jbc.M307562200	http://dx.doi.org/10.1074/jbc.M307562200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941937	hybrid			2022-12-27	WOS:000186306700103
J	Wang, J; Galgoci, A; Kodali, S; Herath, KB; Jayasuriya, H; Dorso, K; Vicente, F; Gonzalez, A; Cully, D; Bramhill, D; Singh, S				Wang, J; Galgoci, A; Kodali, S; Herath, KB; Jayasuriya, H; Dorso, K; Vicente, F; Gonzalez, A; Cully, D; Bramhill, D; Singh, S			Discovery of a small molecule that inhibits cell division by blocking FtsZ, a novel therapeutic target of antibiotics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; LOCALIZATION; PROTEIN; POLYMERIZATION; TUBULIN; SEPTUM; GENES; VIRIDITOXIN; HOMOLOG; ZIPA	The emergence of bacterial resistance to antibiotics is a major health problem and, therefore, it is critical to develop new antibiotics with novel modes of action. FtsZ, a tubulin-like GTPase, plays an essential role in bacterial cell division, and its homologs are present in almost all eubacteria and archaea. During cell division, FtsZ forms polymers in the presence of GTP that recruit other division proteins to make the cell division apparatus. Therefore, inhibition of FtsZ polymerization will prevent cells from dividing, leading to cell death. Using a fluorescent FtsZ polymerization assay, the screening of >100,000 extracts of microbial fermentation broths and plants followed by fractionation led to the identification of viriditoxin, which blocked FtsZ polymerization with an IC50 of 8.2 mug/ml and concomitant GTPase inhibition with an IC50 of 7.0 mug/ml. That the mode of antibacterial action of viriditoxin is via inhibition of FtsZ was confirmed by the observation of its effects on cell morphology, macromolecular synthesis, DNA-damage response, and increased minimum inhibitory concentration as a result of an increase in the expression of the FtsZ protein. Viriditoxin exhibited broad-spectrum antibacterial activity against clinically relevant Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci, without affecting the viability of eukaryotic cells.	Merck Res Labs, Dept Human & Anim Infect Dis, Rahway, NJ 07065 USA; Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA	Merck & Company; Merck & Company	Wang, J (corresponding author), Merck & Co Inc, POB 2000,R80Y-205, Rahway, NJ 07065 USA.	jun_wang2@merck.com	vicente, francisca/N-5126-2014	vicente, francisca/0000-0003-3198-9205				Addinall SG, 1997, MOL MICROBIOL, V25, P303, DOI 10.1046/j.1365-2958.1997.4641833.x; Addinall SG, 1996, J BACTERIOL, V178, P7167, DOI 10.1128/jb.178.24.7167-7172.1996; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; BARONDESS JJ, 1991, RES MICROBIOL, V142, P295, DOI 10.1016/0923-2508(91)90044-B; BEGG KJ, 1995, J BACTERIOL, V177, P6211, DOI 10.1128/jb.177.21.6211-6222.1995; BI E, 1991, RES MICROBIOL, V142, P249, DOI 10.1016/0923-2508(91)90037-B; Bramhill D, 1997, ANNU REV CELL DEV BI, V13, P395, DOI 10.1146/annurev.cellbio.13.1.395; Buddelmeijer N, 1998, J BACTERIOL, V180, P6107; Chen JC, 1999, J BACTERIOL, V181, P521, DOI 10.1128/JB.181.2.521-530.1999; DAI K, 1991, J BACTERIOL, V173, P3500, DOI 10.1128/jb.173.11.3500-3506.1991; DEWAR SJ, 1993, J BACTERIOL, V175, P7097, DOI 10.1128/jb.175.21.7097-7101.1993; Erickson HP, 1997, TRENDS CELL BIOL, V7, P362, DOI 10.1016/S0962-8924(97)01108-2; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Ghigo JM, 1999, MOL MICROBIOL, V31, P725, DOI 10.1046/j.1365-2958.1999.01213.x; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; HOOD RD, 1976, FOOD COSMET TOXICOL, V14, P175, DOI 10.1016/S0015-6264(76)80419-1; HUISMAN O, 1983, J BACTERIOL, V153, P169, DOI 10.1128/JB.153.1.169-175.1983; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; KHATTAR MM, 1994, J BACTERIOL, V176, P7140, DOI 10.1128/JB.176.23.7140-7147.1994; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Liu Z, 1999, MOL MICROBIOL, V31, P1853, DOI 10.1046/j.1365-2958.1999.01322.x; Miller JH, 1972, EXPT MOL GENETICS, P201; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Ross EM, 1999, CRC METH SIG TRANS, P123; Rothfield L, 1999, ANNU REV GENET, V33, P423, DOI 10.1146/annurev.genet.33.1.423; Sossong TM, 1999, BIOCHEMISTRY-US, V38, P14843, DOI 10.1021/bi990917e; SUZUKI K, 1990, CHEM PHARM BULL, V38, P3180, DOI 10.1248/cpb.38.3180; Trusca D, 1998, J BACTERIOL, V180, P3946, DOI 10.1128/JB.180.15.3946-3953.1998; Trusca D, 2002, ANAL BIOCHEM, V307, P322, DOI 10.1016/S0003-2697(02)00036-2; Wang L, 1998, J BACTERIOL, V180, P2810, DOI 10.1128/JB.180.11.2810-2816.1998; WEISLEDER D, 1971, TETRAHEDRON LETT, P4705; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; YOUNG K, 1991, J BACTERIOL, V173, P3609, DOI 10.1128/JB.173.12.3609-3614.1991	36	156	165	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44424	44428		10.1074/jbc.M307625200	http://dx.doi.org/10.1074/jbc.M307625200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12952956	hybrid			2022-12-27	WOS:000186306700069
J	Weljie, AM; Robertson, KM; Vogel, HJ				Weljie, AM; Robertson, KM; Vogel, HJ			Conformational changes in the Ca2+-regulatory region from soybean calcium-dependent protein kinase-alpha - Fluorescence resonance energy transfer studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-LIKE DOMAIN; TRANSFER DISTANCE MEASUREMENTS; TROPONIN-C; INTRAMOLECULAR BINDING; INHIBITORY REGION; NMR-SPECTROSCOPY; COLICIN-A; COMPLEX; SIGNAL; CDPK	Calcium-dependent protein kinases are key proteins involved in plant and protozoal Ca2+ signaling. These unique molecules include a calcium regulatory calmodulin-like domain (CLD), which binds to another small regulatory domain named the junction domain (JD). Both CLD and JD are part of the same polypeptide as the protein kinase domain. The CLD consists of N- and C-terminal lobes, each having two helix-loop-helix Ca2+-binding motifs. In this study, fluorescence resonance energy transfer using a series of Trp and Cys site-directed mutants was undertaken to probe the relative motions of the two lobes of CLD between the apo- and Ca2+-saturated forms, as well as bound to a peptide encoding the JD sequence. Using an IAEDANS-modified Cys, a total of 15 Trp-->Cys distances were measured in these three states from the five donor-acceptor combinations F334W-Cys(436), L371W-Cys(436), L403W-Cys(436), F334W-L403C, and L371W-L403C. Consistent with recently reported NMR diffusion measurements and with H-1, N-15 heteronuclear correlation NMR spectra, the distances derived from fluorescence resonance energy transfer measurements in apoCLD indicate partial unfolding and a subsequent contraction on binding Ca2+, which is maintained on addition of the JD peptide. Interpretation of the distances suggests that the Ca2+-saturated form is open with the two lobes sitting side-by-side although highly flexible. The transition to the JD-CLD state appears to be accompanied by a rotation of the N- and C-terminal domains with respect to each other inducing a slightly more closed overall complex. The observed differences between the behavior of CLD and the well studied related protein calmodulin are likely because of different physiological requirements for activation in vivo.	Univ Calgary, Dept Biol Sci, Struct Biol Res Lab, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Struct Biol Res Lab, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.		Weljie, Aalim M/B-6203-2012; Weljie, Aalim/V-6952-2019	Weljie, Aalim/0000-0002-7145-4494				BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong WJ, 2000, PROTEIN SCI, V9, P280; Dong WJ, 2003, J BIOL CHEM, V278, P8686, DOI 10.1074/jbc.M212886200; Dong WJ, 2001, J MOL BIOL, V314, P51, DOI 10.1006/jmbi.2001.5118; DOSREMEDIOS CG, 1995, J STRUCT BIOL, V115, P175, DOI 10.1006/jsbi.1995.1042; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; Huang JF, 1996, BIOCHEMISTRY-US, V35, P13222, DOI 10.1021/bi960498a; Kohno T, 1998, J BIOMOL NMR, V12, P109, DOI 10.1023/A:1008254603368; LAKEY JH, 1993, J MOL BIOL, V230, P1055, DOI 10.1006/jmbi.1993.1218; LAKEY JH, 1991, J MOL BIOL, V218, P639, DOI 10.1016/0022-2836(91)90707-D; Lakowicz J R, 1999, PRINCIPLES FLUORESCE, P367, DOI 10.1007/978-1-4757-3061-6; LAKOWICZ JR, 1988, BIOCHEMISTRY-US, V27, P9149, DOI 10.1021/bi00426a012; Lee SY, 2000, BIOCHEMISTRY-US, V39, P4225, DOI 10.1021/bi992697a; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Neuhaus D., 1989, NUCL OVERHAUSER EFFE, P451; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Sheldahl C, 2003, BIOPHYS J, V84, P1057, DOI 10.1016/S0006-3495(03)74922-4; VOGEL HJ, 1983, FEBS LETT, V157, P241, DOI 10.1016/0014-5793(83)80554-7; WANG CK, 1986, J MOL BIOL, V191, P509, DOI 10.1016/0022-2836(86)90145-2; Weljie AM, 2003, PROTEIN SCI, V12, P228, DOI 10.1110/ps.0226203; Weljie AM, 2000, PROTEINS, V39, P343, DOI 10.1002/(SICI)1097-0134(20000601)39:4<343::AID-PROT70>3.0.CO;2-2; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Yoo BC, 1996, BIOCHEMISTRY-US, V35, P12029, DOI 10.1021/bi9606612; Yoshino H, 1996, BIOCHEMISTRY-US, V35, P2388, DOI 10.1021/bi952121v; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhao XM, 2000, BBA-PROTEIN STRUCT M, V1479, P247, DOI 10.1016/S0167-4838(00)00026-1	34	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43764	43769		10.1074/jbc.M306799200	http://dx.doi.org/10.1074/jbc.M306799200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12941950	hybrid			2022-12-27	WOS:000186157000126
J	Goldstein, S; Russo, A; Samuni, A				Goldstein, S; Russo, A; Samuni, A			Reactions of PTIO and carboxy-PTIO with (NO)-N-center dot, (NO2)-N-center dot, and O-2(center dot)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; NITRONYL NITROXIDES; SUPEROXIDE-DISMUTASE; PULSE-RADIOLYSIS; NITROGEN-DIOXIDE; AQUEOUS-SOLUTION; HUMAN-CELLS; CENTER-DOT; NO; PEROXYNITRITE	Nitronyl nitroxides, such as derivatives of 2- phenyl-4,4,5,5,- tetramethylimidazoline- 1- oxyl 3- oxide ( PTIOs), react with (.) NO to form the corresponding imino nitroxides ( PTIs) and (.) NO2. PTIOs are considered as monitors of (NO)-N-., stoichiometric sources of (NO2)-N-., biochemical and physiological effectors, specific tools for the elimination of (NO)-N-., and potential therapeutic agents. However, a better understanding of the chemical properties of PTIOs, especially following their reaction with (NO)-N-., is necessary to resolve many of the reported discrepancies surrounding the effects of PTIOs and to better characterize their potential therapeutic activity. We have generated electrochemically the oxidized and reduced forms of PTIO and carboxy- PTIO ( C- PTIO), characterized their absorption spectra, and determined the reduction potentials for the oxoammonium/ nitroxide and nitroxide/ hydroxylamine couples. The rate constants for the reaction of (NO2)-N-. with PTIO and C- PTIO to form the corresponding oxoammonium cations ( PTIO (+) s) and nitrite were determined to be ( 1.5 - 2) x 10(7) M-1 s(-1). We have also shown that the reactions of PTIO(+)s with (NO)-N-. form PTIOs and NO2-. The rate constants for these reactions are approximately 30- fold higher than those for the reactions of PTIOs with (NO)-N-. or O-2. The present results show that ( i) the reaction of PTIOs with (NO)-N-. forms solely PTIs and NO2- where [NO2-]/[ PTI] varies between 1 and 2 depending on the steady- state concentrations of (NO)-N-.. Consequently, quantitation of (NO)-N-. is valid only at sufficiently low fluxes of (NO)-N-.; ( ii) the reaction of PTIOs with (NO)-N-. can be used as a valid source of (NO2)-N-. only when the latter is effectively scavenged by an appropriate reductant; and ( iii) the formation of peroxynitrite cannot be efficiently inhibited by PTIOs even under relatively low fluxes of (NO)-N-. and O-2. and millimolar levels of PTIOs.	Hebrew Univ Jerusalem, Dept Phys Chem, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91120 Jerusalem, Israel; NCI, Radiat Biol Branch, NIH, Bethesda, MD 20892 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Goldstein, S (corresponding author), Hebrew Univ Jerusalem, Dept Phys Chem, IL-91904 Jerusalem, Israel.							AKAIKE T, 1993, BIOCHEMISTRY-US, V32, P827, DOI 10.1021/bi00054a013; [Anonymous], 1998, NIST STANDARD REFERE; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BISSOT TC, 1957, J AM CHEM SOC, V79, P796, DOI 10.1021/ja01561a005; Eiserich Jason P., 1998, Molecular Aspects of Medicine, V19, P221, DOI 10.1016/S0098-2997(99)00002-3; Espey MG, 2002, P NATL ACAD SCI USA, V99, P3481, DOI 10.1073/pnas.062604199; Espey MG, 2001, J BIOL CHEM, V276, P30085, DOI 10.1074/jbc.M101723200; Espey MG, 2002, P NATL ACAD SCI USA, V99, P11127, DOI 10.1073/pnas.152157599; Ford E, 2002, FREE RADICAL BIO MED, V32, P1314, DOI 10.1016/S0891-5849(02)00850-X; GOLDSTEIN S, 1995, J AM CHEM SOC, V117, P12078, DOI 10.1021/ja00154a007; Goldstein S, 1996, J AM CHEM SOC, V118, P3419, DOI 10.1021/ja9536680; GOLDSTEIN S, 1995, FREE RADICAL BIO MED, V19, P505, DOI 10.1016/0891-5849(95)00034-U; GOLDSTEIN S, 2003, CHEM RES TOXICOL, V125, P836; GOLDSTEIN S, 2003, IN PRESS J AM CHEM S; GRATZEL M, 1970, BERICH BUNSEN GESELL, V74, P488; Haseloff RF, 1997, FREE RADICAL RES, V26, P7, DOI 10.3109/10715769709097780; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; HOGG N, 1995, FREE RADICAL RES, V22, P47, DOI 10.3109/10715769509147527; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Janssen YMW, 1998, AM J PHYSIOL-LUNG C, V275, pL1100, DOI 10.1152/ajplung.1998.275.6.L1100; JOSEPH J, 1993, BIOCHEM BIOPH RES CO, V192, P926, DOI 10.1006/bbrc.1993.1504; Jourd'heuil D, 2003, J BIOL CHEM, V278, P15720, DOI 10.1074/jbc.M300203200; KUTHAN H, 1982, BIOCHEM J, V203, P551, DOI 10.1042/bj2030551; LEWIS RS, 1994, CHEM RES TOXICOL, V7, P568, DOI 10.1021/tx00040a013; Lymar SV, 2002, J PHYS CHEM A, V106, P7245, DOI 10.1021/jp026107l; MCCORD JM, 1970, J BIOL CHEM, V245, P1374; MONCADA S, 1991, PHARMACOL REV, V43, P109; Noble DR, 2002, J CHEM SOC PERK T 2, P1834, DOI 10.1039/b206854k; Noda Y, 1997, RES COMMUN MOL PATH, V96, P115; NOWICKI JP, 1991, EUR J PHARMACOL, V204, P339, DOI 10.1016/0014-2999(91)90862-K; Pfeiffer S, 1997, FREE RADICAL BIO MED, V22, P787, DOI 10.1016/S0891-5849(96)00407-8; PIRES M, 1994, INT J CHEM KINET, V26, P1207, DOI 10.1002/kin.550261208; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699, DOI 10.1152/ajplung.1995.268.5.L699; Rosen GM, 2003, MACROMOLECULES, V36, P1021, DOI 10.1021/ma021292m; Rubbo H, 1996, CHEM RES TOXICOL, V9, P809, DOI 10.1021/tx960037q; SAMUNI A, 1988, J BIOL CHEM, V263, P17921; SAMUNI A, 1990, FREE RADICAL RES COM, V9, P241, DOI 10.3109/10715769009145682; Sarti P, 2000, BIOCHEM BIOPH RES CO, V274, P183, DOI 10.1006/bbrc.2000.3117; Simon DI, 1996, P NATL ACAD SCI USA, V93, P4736, DOI 10.1073/pnas.93.10.4736; TREININ A, 1970, J AM CHEM SOC, V92, P5821, DOI 10.1021/ja00723a001; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; WOLDMAN YY, 1994, BIOCHEM BIOPH RES CO, V202, P195, DOI 10.1006/bbrc.1994.1912; YOSHIDA M, 1994, BIOCHEM BIOPH RES CO, V202, P923, DOI 10.1006/bbrc.1994.2018; Yoshioka T, 1996, J AM SOC NEPHROL, V7, P961	44	151	157	5	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 19	2003	278	51					50949	50955		10.1074/jbc.M308317200	http://dx.doi.org/10.1074/jbc.M308317200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	752ZM	12954619	hybrid			2022-12-27	WOS:000187206300016
J	Fraser, JA; Kansagra, P; Kotecki, C; Saunders, RDC; McLellan, LI				Fraser, JA; Kansagra, P; Kotecki, C; Saunders, RDC; McLellan, LI			The modifier subunit of Drosophila glutamate-cysteine ligase regulates catalytic activity by covalent and noncovalent interactions and influences glutathione homeostasis in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; OXIDATIVE STRESS; MECHANISM; ENZYMES	Glutamate-cysteine ligase (GCL) has a key influence on glutathione homeostasis. It has been proposed that mammalian GCL is regulated by the redox environment, and we show here that cysteine residues in the Drosophila melanogaster GCL modifier subunit (DmGCLM) can form covalent interactions with the catalytic subunit (DmGCLC) and modify its activity. Candidate components of intersubunit disulfides (Cys(213), Cys(214), and Cys(267)) were identified using matrix-assisted laser desorption ionization time-of-flight spectroscopy of iodoacetamide-modified DmGCLM as well as examination of the evolutionary conservation of cysteines. Mutation of the 3 cysteine residues allowed DmGCLM to associate with DmGCLC, but inhibited the formation of intersubunit disulfides. This caused a 2-fold reduction in the catalytic efficiency of Drosophila GCL, although activity remained significantly higher than the catalytic subunit alone. The cysteine mutant was also more sensitive to inhibition by glutathione than the unmodified holoenzyme. Notably, human GCLM could substitute for DmGCLM in modification of DmGCLC activity. The role of DmGCLM in vivo was examined by analysis of a Drosophila mutant (l(3)L0580) containing a P-element insertion in Gclm. We found that the P-element is not responsible for the lethal phenotype and separated the recessive lethal mutation from the P-element by recombination. This yielded two fully viable and fertile recombinants bearing the P-element insertion, which Western and Northern blotting indicated is a severely hypomorphic allele of Gclm. Glutathione levels were similar to2-fold lower in the Gclm(L0580) mutants than in control strains, demonstrating the importance of DmGCLM in the regulation of glutathione homeostasis in vivo.	Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Open Univ, Dept Biol Sci, Milton Keynes MK7 6AA, Bucks, England	University of Dundee; Open University - UK	McLellan, LI (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland.		Kotecki, Claire/ABA-3677-2020	Fraser, Jennifer/0000-0001-5546-3916				Brekken DL, 1998, J BIOL CHEM, V273, P26317, DOI 10.1074/jbc.273.41.26317; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; EASTERBY JS, 1996, HYPER VERSION 1 1S; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fraser JA, 2002, J BIOL CHEM, V277, P1158, DOI 10.1074/jbc.M106683200; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; HUANG CS, 1993, J BIOL CHEM, V268, P19675; HUANG CS, 1993, J BIOL CHEM, V268, P20578; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Lueder DV, 1996, J BIOL CHEM, V271, P17485, DOI 10.1074/jbc.271.29.17485; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; RICHMAN PG, 1975, J BIOL CHEM, V250, P1422; Saunders RDC, 2000, FEBS LETT, V467, P337, DOI 10.1016/S0014-5793(00)01148-0; SEELIG GF, 1984, J BIOL CHEM, V259, P3534; Soltaninassab SR, 2000, J CELL PHYSIOL, V182, P163, DOI 10.1002/(SICI)1097-4652(200002)182:2<163::AID-JCP4>3.0.CO;2-1; Spradling AC, 1999, GENETICS, V153, P135; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tipnis SR, 1999, BIOCHEM J, V337, P559, DOI 10.1042/0264-6021:3370559; Tu ZH, 1998, BIOCHEM J, V336, P675, DOI 10.1042/bj3360675; Walsh EP, 2002, BIOCHEMISTRY-US, V41, P2409, DOI 10.1021/bi015815e; Yang Y, 2002, J BIOL CHEM, V277, P49446, DOI 10.1074/jbc.M209372200	25	44	44	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46369	46377		10.1074/jbc.M308035200	http://dx.doi.org/10.1074/jbc.M308035200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12954617	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000186569400020
J	Sesma, L; Alvarez, IA; Marcilla, M; Paradela, A; de Castro, JAL				Sesma, L; Alvarez, IA; Marcilla, M; Paradela, A; de Castro, JAL			Species-specific differences in proteasomal processing and tapasin-mediated loading influence peptide presentation by HLA-B27 in murine cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I MOLECULES; CYTOTOXIC T-CELLS; TRANSGENIC MICE; ANTIGEN PRESENTATION; ANKYLOSING-SPONDYLITIS; INFLAMMATORY DISEASE; REVEALS POLYMORPHISM; NATURAL LIGAND; HLA; IDENTIFICATION	Expression of HLA- B27 in murine cells has been used to establish animal models for human spondyloarthritis and for antigen presentation studies, but the effects of xenogeneic HLA- B27 expression on peptide presentation are little known. The issue was addressed in this study. HLA- B27- bound peptide repertoires from human and murine cells overlapped by 75 - 85%, indicating that many endogenous HLA- B27 ligands are generated and presented in both species. Of 20 differentially presented peptides that were sequenced, only 40% arose from obvious inter- species protein polymorphism, suggesting that differences in antigen processing- loading accounted for many species- specific ligands. Digestion of synthetic substrates with human and murine 20 S proteasomes revealed cleavage differences that accounted for or correlated with differential expression of particular peptides. One HLA- B27 ligand found only in human cells was similarly generated in vitro by human and murine proteasomes. Differential presentation correlated with significantly decreased amounts of this ligand in human tapasin- deficient cells reconstituted with murine tapasin, indicating that species- specific interactions between HLA- B27, tapasin, and/ or other proteins in the peptide- loading complex influenced presentation of this peptide. Our results indicate that differences in proteasomal specificity and in interactions involving tapasin determine differential processing and presentation of a significant number of HLA- B27 ligands in human and murine cells.	Univ Autonoma Madrid, Fac Ciencias, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	de Castro, JAL (corresponding author), Univ Autonoma Madrid, Fac Ciencias, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	aldecastro@cbm.uam.es	Alvarez, Iñaki/A-6684-2011; Marcilla, Miguel/B-8430-2013; Paradela, Alberto/H-2113-2015	Alvarez, Iñaki/0000-0001-9484-0868; Marcilla, Miguel/0000-0001-9171-5076; Paradela, Alberto/0000-0001-6837-7056				Alvarez I, 2001, J BIOL CHEM, V276, P48740, DOI 10.1074/jbc.M108882200; Alvarez I, 2001, J BIOL CHEM, V276, P32729, DOI 10.1074/jbc.M104663200; Barnden MJ, 2000, J IMMUNOL, V165, P322, DOI 10.4049/jimmunol.165.1.322; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; BERNHARD EJ, 1987, J IMMUNOL, V139, P3614; Boisgerault F, 1998, INFECT IMMUN, V66, P4484; Braud VM, 1998, EUR J IMMUNOL, V28, P625, DOI 10.1002/(SICI)1521-4141(199802)28:02<625::AID-IMMU625>3.0.CO;2-I; BREWERTON DA, 1973, LANCET, V2, P996, DOI 10.1016/S0140-6736(73)91091-X; BREWERTON DA, 1973, LANCET, V1, P904; CALVO V, 1990, J IMMUNOL, V144, P4038; Cheuk E, 2002, J IMMUNOL, V169, P5571, DOI 10.4049/jimmunol.169.10.5571; Copeman J, 1998, EUR J IMMUNOL, V28, P3783, DOI 10.1002/(SICI)1521-4141(199811)28:11<3783::AID-IMMU3783>3.0.CO;2-9; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; GALOCHA B, 1993, J IMMUNOL, V150, P1653; Garcia F, 1997, TISSUE ANTIGENS, V49, P23, DOI 10.1111/j.1399-0039.1997.tb02705.x; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Huarte E, 2002, INT J CANCER, V97, P58, DOI 10.1002/ijc.1579; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; KALINKE U, 1990, NATURE, V348, P642, DOI 10.1038/348642a0; KHARE SD, 1995, J EXP MED, V182, P1153, DOI 10.1084/jem.182.4.1153; KIEVITS F, 1987, NATURE, V329, P447, DOI 10.1038/329447a0; Kingsbury DJ, 2000, ARTHRITIS RHEUM, V43, P2290, DOI 10.1002/1529-0131(200010)43:10<2290::AID-ANR17>3.0.CO;2-6; KOLLER TD, 1987, J IMMUNOL, V138, P2044; Komlosh A, 2001, J BIOL CHEM, V276, P30050, DOI 10.1074/jbc.M103177200; Kuon W, 1997, ARTHRITIS RHEUM-US, V40, P945, DOI 10.1002/art.1780400524; Kuon W, 2001, J IMMUNOL, V167, P4738, DOI 10.4049/jimmunol.167.8.4738; Lamas JR, 1999, ARTHRITIS RHEUM-US, V42, P1975, DOI 10.1002/1529-0131(199909)42:9<1975::AID-ANR25>3.0.CO;2-V; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; Li SL, 2000, J BIOL CHEM, V275, P1581, DOI 10.1074/jbc.275.3.1581; Luckey CJ, 2001, J IMMUNOL, V167, P1212, DOI 10.4049/jimmunol.167.3.1212; Marina A, 1999, J MASS SPECTROM, V34, P17, DOI 10.1002/(SICI)1096-9888(199901)34:1<17::AID-JMS746>3.3.CO;2-Y; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Paradela A, 2000, J IMMUNOL, V164, P329, DOI 10.4049/jimmunol.164.1.329; Paradela A, 1998, J IMMUNOL, V161, P5481; Peh CA, 2000, J IMMUNOL, V164, P292, DOI 10.4049/jimmunol.164.1.292; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Purcell AW, 2001, J IMMUNOL, V166, P1016, DOI 10.4049/jimmunol.166.2.1016; Ramos M, 2002, J BIOL CHEM, V277, P28749, DOI 10.1074/jbc.M204155200; Ramos M, 2002, J BIOL CHEM, V277, P37573, DOI 10.1074/jbc.M205470200; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; ROJO S, 1991, J IMMUNOL, V146, P634; ROTZSCHKE O, 1994, IMMUNOGENETICS, V39, P74; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Schmitt L, 2000, CHEMBIOCHEM, V1, P17; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Sesma L, 2002, J BIOL CHEM, V277, P16744, DOI 10.1074/jbc.M200371200; Solheim JC, 1997, J IMMUNOL, V158, P2236; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; TAUROG JD, 1993, J IMMUNOL, V150, P4168; Tishon A, 2000, VIROLOGY, V275, P286, DOI 10.1006/viro.2000.0517; Uebel S, 1997, P NATL ACAD SCI USA, V94, P8976, DOI 10.1073/pnas.94.17.8976; WEINREICH S, 1995, HUM IMMUNOL, V42, P103, DOI 10.1016/0198-8859(94)00034-N; Weinreich SS, 1997, IMMUNOGENETICS, V46, P35, DOI 10.1007/s002510050239; WEISDORF DJ, 1990, POSTGRAD MED, V87, P91; Yague J, 2000, J EXP MED, V191, P2083, DOI 10.1084/jem.191.12.2083; Yague J, 1998, TISSUE ANTIGENS, V52, P416, DOI 10.1111/j.1399-0039.1998.tb03067.x; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941; Zhou M, 1998, J EXP MED, V188, P877, DOI 10.1084/jem.188.5.877	63	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46461	46472		10.1074/jbc.M308816200	http://dx.doi.org/10.1074/jbc.M308816200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963723	hybrid			2022-12-27	WOS:000186569400031
J	Yang, ES; Burnstein, KL				Yang, ES; Burnstein, KL			Vitamin D inhibits G(1) to S progression in LNCaP prostate cancer cells through p27(Kip1) stabilization and Cdk2 mislocalization to the cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P27 EXPRESSION; DEPENDENT DEGRADATION; LINE LNCAP; GROWTH; PROTEIN; PROLIFERATION; ACTIVATION; PHOSPHORYLATION; UBIQUITINATION; ACCUMULATION	1,25-(OH)(2) vitamin D-3 (1,25-(OH)(2)D-3) exerts antiproliferative effects via cell cycle regulation in a variety of tumor cells, including prostate. We have previously shown that in the human prostate cancer cell line LNCaP, 1,25-(OH)(2)D-3 mediates an increase in cyclin-dependent kinase inhibitor p27(Kip1) levels, inhibition of cyclin-dependent kinase 2 (Cdk2) activity, hypophosphorylation of retinoblastoma protein, and accumulation of cells in G(1). In this study, we investigated the mechanism whereby 1,25-(OH)(2)D-3 increases p27 levels. 1,25-( OH) 2D3 had no effect on p27 mRNA levels or on the regulation of a 3.5-kb fragment of the p27 promoter. The rate of p27 protein synthesis was not affected by 1,25( OH) 2D3 as measured by luciferase activity driven by the 5'- and 3'-untranslated regions of p27 that regulate p27 protein synthesis. Pulse-chase analysis of S-35-labeled p27 revealed an increased p27 protein half-life with 1,25( OH)(2)D-3 treatment. Because Cdk2- mediated phosphorylation of p27 at Thr(187) targets p27 for Skp2-mediated degradation, we examined the phosphorylation status of p27 in 1,25-(OH)(2)D-3-treated cells. 1,25-(OH)(2)D-3 decreased levels of Thr(187) phosphorylated p27, consistent with inhibition of Thr(187) phosphorylation-dependent p27 degradation. In addition, 1,25-(OH)(2)D-3 reduced Skp2 protein levels in LNCaP cells. Cdk2 is activated in the nucleus by Cdk-activating kinase through Thr(160) phosphorylation and by cdc25A phosphatase via Thr(14) and Tyr(15) dephosphorylation. Interestingly, 1,25-(OH)(2)D-3 decreased nuclear Cdk2 levels as assessed by subcellular fractionation and confocal microscopy. Inhibition of Cdk2 by 1,25-(OH)(2)D-3 may thus involve two mechanisms: 1) reduced nuclear Cdk2 available for cyclin binding and activation and 2) impairment of cyclin E-Cdk2-dependent p27 degradation through cytoplasmic mislocalization of Cdk2. These data suggest that Cdk2 mislocalization is central to the antiproliferative effects of 1,25-(OH)(2)D-3.	Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Burnstein, KL (corresponding author), Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol R189, POB 016189 R-189, Miami, FL 33136 USA.	kburnste@miami.edu			NIDDK NIH HHS [DK 45478, R01 DK045478] Funding Source: Medline; NIEHS NIH HHS [F30 ES005910-02, F30 ES 05910-02, F30 ES005910, F30 ES005910-06, F30 ES005910-03, F30 ES005910-05, F30 ES005910-01, F30 ES005910-04] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045478, R29DK045478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES005910] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BIKLE DD, 1992, ENDOCR REV, V13, P765, DOI 10.1210/er.13.4.765; Blanchard DA, 2000, ONCOGENE, V19, P4184, DOI 10.1038/sj.onc.1203761; Blutt SE, 2000, ENDOCRINOLOGY, V141, P10, DOI 10.1210/en.141.1.10; Blutt SE, 1997, ENDOCRINOLOGY, V138, P1491, DOI 10.1210/en.138.4.1491; Campbell MJ, 1997, J MOL ENDOCRINOL, V19, P15, DOI 10.1677/jme.0.0190015; Cheng L, 2000, CLIN CANCER RES, V6, P1896; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Cote RJ, 1998, J NATL CANCER I, V90, P916, DOI 10.1093/jnci/90.12.916; Davies MA, 1999, CANCER RES, V59, P2551; Donovan JCH, 2001, J BIOL CHEM, V276, P40888, DOI 10.1074/jbc.M106448200; FELDMAN D, 1997, VITAMIN D, P1089; Fernandez PL, 1999, J PATHOL, V187, P563, DOI 10.1002/(SICI)1096-9896(199904)187:5<563::AID-PATH292>3.0.CO;2-3; Ferrando AA, 1996, HUM GENET, V97, P91; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; Gopfert U, 2003, HUM MOL GENET, V12, P1767, DOI 10.1093/hmg/ddg177; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; Guo YP, 1997, CLIN CANCER RES, V3, P2269; Halvorsen OJ, 2003, CLIN CANCER RES, V9, P1474; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Inoue T, 1999, J BIOL CHEM, V274, P32309, DOI 10.1074/jbc.274.45.32309; Kawada M, 1997, ONCOGENE, V15, P629, DOI 10.1038/sj.onc.1201228; KAWAMATA N, 1995, CANCER RES, V55, P2266; Keenan SM, 2001, J BIOL CHEM, V276, P22404, DOI 10.1074/jbc.M100409200; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Lents NH, 2002, J BIOL CHEM, V277, P47469, DOI 10.1074/jbc.M207425200; Lin R, 2003, ENDOCRINOLOGY, V144, P749, DOI 10.1210/en.2002-0026; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Luo Y, 1996, MOL CELL BIOL, V16, P6744; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Millard SS, 2000, MOL CELL BIOL, V20, P5947, DOI 10.1128/MCB.20.16.5947-5959.2000; Millard SS, 1997, J BIOL CHEM, V272, P7093, DOI 10.1074/jbc.272.11.7093; MILLER GJ, 1992, CANCER RES, V52, P515; Miller GJ, 1995, CLIN CANCER RES, V1, P997; Miskimins WK, 2001, MOL CELL BIOL, V21, P4960, DOI 10.1128/MCB.21.15.4960-4967.2001; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Moore JD, 1999, J CELL BIOL, V144, P213, DOI 10.1083/jcb.144.2.213; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; POLS HAP, 1990, J STEROID BIOCHEM, V37, P873, DOI 10.1016/0960-0760(90)90435-N; PONCECASTANEDA MV, 1995, CANCER RES, V55, P1211; SCHWARTZ GG, 1994, ANTICANCER RES, V14, P1077; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; SKOWRONSKI RJ, 1993, ENDOCRINOLOGY, V132, P1952, DOI 10.1210/en.132.5.1952; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Tsihlias J, 1998, CANCER RES, V58, P542; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wagner M, 2001, EXP GERONTOL, V37, P41, DOI 10.1016/S0531-5565(01)00165-6; WALTERS MR, 1992, ENDOCR REV, V13, P719, DOI 10.1210/er.13.4.719; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Yang ES, 2002, MOL CELL ENDOCRINOL, V186, P69, DOI 10.1016/S0303-7207(01)00671-2; Yang G, 2002, CLIN CANCER RES, V8, P3419; Yang RM, 1998, J UROLOGY, V159, P941, DOI 10.1016/S0022-5347(01)63776-5; Zhuang SH, 1998, ENDOCRINOLOGY, V139, P1197, DOI 10.1210/en.139.3.1197; Zhuang SH, 1997, MOL CELL ENDOCRINOL, V126, P83, DOI 10.1016/S0303-7207(96)03974-3	57	118	118	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46862	46868		10.1074/jbc.M306340200	http://dx.doi.org/10.1074/jbc.M306340200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12954644	hybrid			2022-12-27	WOS:000186569400079
J	Beebe, K; Merriman, E; Schimmel, P				Beebe, K; Merriman, E; Schimmel, P			Structure-specific tRNA determinants for editing a mischarged amino acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER RIBONUCLEIC-ACID; I TRANSFER-RNA; PHENYLALANINE TRANSFER-RNA; TO-SITE TRANSLOCATION; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; GENETIC-CODE; SYNTHETASE STRUCTURE; TERTIARY STRUCTURE; CELL VIABILITY	Alanyl-tRNA synthetase efficiently aminoacylates tRNA(Ala) and an RNA minihelix that comprises just one domain of the two-domain L-shaped tRNA structure. It also clears mischarged tRNA(Ala) using a specialized domain in its C-terminal half. In contrast to full-length tRNA(Ala), minihelix(Ala) was robustly mischarged and could not be edited. Addition in trans of the missing anticodon-containing domain did not activate editing of mischarged minihelix(Ala). To understand these differences between minihelix(Ala) and tRNA(Ala), several chimeric full tRNAs were constructed. These had the acceptor stem of a non-cognate tRNA replaced with the stem of tRNA(Ala). The chimeric tRNAs collectively introduced multiple sequence changes in all parts but the acceptor stem. However, although the acceptor stem in isolation (as the minihelix) lacked determinants for editing, alanyl-tRNA synthetase effectively cleared a mischarged amino acid from each chimeric tRNA. Thus, a covalently continuous two-domain structure per se, not sequence, is a major determinant for clearance of errors of aminoacylation by alanyl-tRNA synthetase. Because errors of aminoacylation are known to be deleterious to cell growth, structure-specific determinants constitute a powerful selective pressure to retain the format of the two-domain L-shaped tRNA.	Scripps Res Inst, Dept Mol Biol & Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Schimmel, P (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu			NIGMS NIH HHS [GM15539] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM015539, R01GM015539] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON JJ, 1972, J BACTERIOL, V109, P315, DOI 10.1128/JB.109.1.315-325.1972; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Bishop AC, 2003, P NATL ACAD SCI USA, V100, P490, DOI 10.1073/pnas.0237335100; Bishop AC, 2002, P NATL ACAD SCI USA, V99, P585, DOI 10.1073/pnas.012611299; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUECHTER DD, 1993, BIOCHEMISTRY-US, V32, P5267, DOI 10.1021/bi00070a039; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; CAVARELLI J, 1993, FASEB J, V7, P79, DOI 10.1096/fasebj.7.1.8422978; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; de Pouplana LR, 2001, CELL, V104, P191, DOI 10.1016/S0092-8674(01)00204-5; DEBRUIJN MHL, 1983, EMBO J, V2, P1309, DOI 10.1002/j.1460-2075.1983.tb01586.x; dePouplana LR, 1997, BIOCHEMISTRY-US, V36, P15041, DOI 10.1021/bi971788+; DIGIULIO M, 1992, J THEOR BIOL, V159, P199; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Farrow MA, 1999, BIOCHEMISTRY-US, V38, P16898, DOI 10.1021/bi9920782; Fersht A., 1985, ENZYME STRUCTURE MEC; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; FRANCKLYN C, 1989, NATURE, V337, P478, DOI 10.1038/337478a0; Hale SP, 1997, SCIENCE, V276, P1250, DOI 10.1126/science.276.5316.1250; Hale SP, 1997, TETRAHEDRON, V53, P11985, DOI 10.1016/S0040-4020(97)00711-4; Hendrickson TL, 2002, MOL CELL, V9, P353, DOI 10.1016/S1097-2765(02)00449-5; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; KIM SH, 1974, SCIENCE, V185, P435, DOI 10.1126/science.185.4149.435; LAPOINTE J, 1991, TRANSLATION EUKARYOT, P35; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Lovato MA, 2001, EMBO J, V20, P4846, DOI 10.1093/emboj/20.17.4846; LUDMERER SW, 1987, J BIOL CHEM, V262, P10801; MAIZELS N, 1994, P NATL ACAD SCI USA, V91, P6729, DOI 10.1073/pnas.91.15.6729; Martinis S A, 1997, Nucleic Acids Symp Ser, V36, P125; Martinis Susan A., 1995, P349; MCCLAIN WH, 1988, SCIENCE, V240, P793, DOI 10.1126/science.2452483; MORAS D, 1992, TRENDS BIOCHEM SCI, V17, P159, DOI 10.1016/0968-0004(92)90326-5; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; Musier-Forsyth K, 1999, ACCOUNTS CHEM RES, V32, P368, DOI 10.1021/ar970148w; Nangle LA, 2002, J BIOL CHEM, V277, P45729, DOI 10.1074/jbc.M208093200; Noller H.F., 1993, RNA WORLD, P137; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nordin BE, 1999, J BIOL CHEM, V274, P6835, DOI 10.1074/jbc.274.11.6835; NUREKI O, 1994, J MOL BIOL, V236, P710, DOI 10.1006/jmbi.1994.1184; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; PARK SJ, 1988, J BIOL CHEM, V263, P16527; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; RIBAS DP, 1993, PROTEIN SCI, V2, P2259; RICH A, 1976, ANNU REV BIOCHEM, V45, P805, DOI 10.1146/annurev.bi.45.070176.004105; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; SCHIMMEL P, 1995, CELL, V81, P983, DOI 10.1016/S0092-8674(05)80002-9; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; SCHMIDT E, 1995, BIOCHEMISTRY-US, V34, P11204, DOI 10.1021/bi00035a028; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; SCHREIER AA, 1972, BIOCHEMISTRY-US, V11, P1582, DOI 10.1021/bi00759a006; SHI JP, 1992, BIOCHEMISTRY-US, V31, P4931, DOI 10.1021/bi00136a002; Shi PY, 1998, RNA, V4, P276; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; STARZYK RM, 1987, SCIENCE, V237, P1614, DOI 10.1126/science.3306924; Steer BA, 1999, BIOCHEMISTRY-US, V38, P4965, DOI 10.1021/bi990038s; Steinberg S, 1997, J MOL BIOL, V266, P269, DOI 10.1006/jmbi.1996.0803; Steitz TA, 1991, CURR OPIN STRUC BIOL, V1, P139, DOI 10.1016/0959-440X(91)90022-L; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627; WALTER AE, 1994, P NATL ACAD SCI USA, V91, P9218, DOI 10.1073/pnas.91.20.9218; WEBSTER T, 1984, SCIENCE, V226, P1315, DOI 10.1126/science.6390679; WEINER AM, 1987, P NATL ACAD SCI USA, V84, P7383, DOI 10.1073/pnas.84.21.7383; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	74	17	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45056	45061		10.1074/jbc.M307080200	http://dx.doi.org/10.1074/jbc.M307080200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12949076	hybrid			2022-12-27	WOS:000186452300004
J	Deutscher, MP				Deutscher, MP			Degradation of stable RNA in bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ESCHERICHIA-COLI-CELLS; 16S RIBOSOMAL-RNA; MESSENGER-RNA; RIBONUCLEIC-ACID; POLYNUCLEOTIDE PHOSPHORYLASE; IN-VIVO; QUALITY-CONTROL; PROTEIN; DECAY; MATURATION		Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA.							APIRION D, 1978, GENETICS, V90, P19; BENHAMID.F, 1966, BIOCHIM BIOPHYS ACTA, V119, P183, DOI 10.1016/0005-2787(66)90049-9; BEPPU T, 1969, J BACTERIOL, V98, P888, DOI 10.1128/JB.98.3.888-897.1969; Bessarab DA, 1998, P NATL ACAD SCI USA, V95, P3157, DOI 10.1073/pnas.95.6.3157; Bremer H, 1996, ESCHERICHIA COLI SAL; CANNISTRARO VJ, 1991, J BACTERIOL, V173, P4653, DOI 10.1128/jb.173.15.4653-4659.1991; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; COHEN L, 1977, J BACTERIOL, V129, P651, DOI 10.1128/JB.129.2.651-657.1977; Condon C, 2003, MICROBIOL MOL BIOL R, V67, P157, DOI 10.1128/MMBR.67.2.157-174.2003; DAVIS BD, 1986, J BACTERIOL, V166, P439, DOI 10.1128/jb.166.2.439-445.1986; Deutscher M P, 1973, Prog Nucleic Acid Res Mol Biol, V13, P51, DOI 10.1016/S0079-6603(08)60100-2; DEUTSCHER MP, 1985, P NATL ACAD SCI USA, V82, P6427, DOI 10.1073/pnas.82.19.6427; DUBIN DT, 1964, J MOL BIOL, V8, P749, DOI 10.1016/S0022-2836(64)80122-4; EISENBERG SP, 1980, J BIOL CHEM, V255, P1128; GAUSING K, 1977, J MOL BIOL, V115, P335, DOI 10.1016/0022-2836(77)90158-9; HSU D, 1994, J BACTERIOL, V176, P4761, DOI 10.1128/JB.176.15.4761-4765.1994; JACKSON RW, 1965, J BACTERIOL, V90, P1420, DOI 10.1128/JB.90.5.1420-1425.1965; JACOBSON A, 1968, J BACTERIOL, V95, P1030, DOI 10.1128/JB.95.3.1030-1039.1968; KAPLAN R, 1975, J BIOL CHEM, V250, P3174; KAPLAN R, 1975, J BIOL CHEM, V250, P1854; KAPLAN R, 1974, J BIOL CHEM, V249, P149; Kennell D, 2002, J BACTERIOL, V184, P4645, DOI 10.1128/JB.184.17.4645-4657.2002; Kushner SR, 2002, J BACTERIOL, V184, P4658, DOI 10.1128/JB.184.17.4658-4665.2002; KUWANO M, 1977, BIOCHEM BIOPH RES CO, V75, P156, DOI 10.1016/0006-291X(77)91303-1; LAMBERT PA, 1976, MICROBIOS, V17, P35; LEWICKI BTU, 1993, J MOL BIOL, V231, P581, DOI 10.1006/jmbi.1993.1311; Li ZW, 2002, EMBO J, V21, P1132, DOI 10.1093/emboj/21.5.1132; Li ZW, 2002, RNA, V8, P97, DOI 10.1017/S1355838202014929; Li ZW, 1999, EMBO J, V18, P2878, DOI 10.1093/emboj/18.10.2878; Li ZW, 1998, P NATL ACAD SCI USA, V95, P12158, DOI 10.1073/pnas.95.21.12158; Liiv A, 1996, J MOL BIOL, V263, P396, DOI 10.1006/jmbi.1996.0584; LINDAHL L, 1975, J MOL BIOL, V92, P15, DOI 10.1016/0022-2836(75)90089-3; MANDELSTAM J, 1960, BACTERIOL REV, V24, P289, DOI 10.1128/MMBR.24.3.289-308.1960; Maquat LE, 2002, CURR BIOL, V12, pR196, DOI 10.1016/S0960-9822(02)00747-9; MARUYAMA H, 1970, BIOCHIM BIOPHYS ACTA, V199, P159, DOI 10.1016/0005-2787(70)90704-5; MCCARTHY BJ, 1962, BIOCHIM BIOPHYS ACTA, V55, P880; MISRA TK, 1976, J BIOL CHEM, V251, P7669; MISRA TK, 1978, J BIOL CHEM, V253, P5594; MOLIN S, 1977, J BACTERIOL, V131, P7, DOI 10.1128/JB.131.1.7-17.1977; NAKAJIMA K, 1966, BIKEN J, V9, P115; NEIDHARDT FC, 1964, PROG NUCLEIC ACID RE, V3, P145, DOI 10.1016/S0079-6603(08)60741-2; NEU HC, 1964, J BIOL CHEM, V239, P3893; NORRIS TE, 1972, J MOL BIOL, V64, P633, DOI 10.1016/0022-2836(72)90088-5; OHNISHI Y, 1972, NATURE-NEW BIOL, V238, P228, DOI 10.1038/newbio238228a0; Ow MC, 2002, GENE DEV, V16, P1102, DOI 10.1101/gad.983502; RAMAGOPAL S, 1984, EUR J BIOCHEM, V140, P353, DOI 10.1111/j.1432-1033.1984.tb08108.x; ROTH JS, 1958, J BIOL CHEM, V231, P1085; Schaferkordt J, 2001, NUCLEIC ACIDS RES, V29, P3394, DOI 10.1093/nar/29.16.3394; SIEHNEL RJ, 1985, J BACTERIOL, V163, P476, DOI 10.1128/JB.163.2.476-486.1985; Steege DA, 2000, RNA, V6, P1079, DOI 10.1017/S1355838200001023; SUZUKI H, 1967, J BACTERIOL, V94, P666, DOI 10.1128/JB.94.3.666-676.1967; Wachi M, 1999, BIOCHEM BIOPH RES CO, V259, P483, DOI 10.1006/bbrc.1999.0806; Zhou ZH, 1997, J BACTERIOL, V179, P4391, DOI 10.1128/jb.179.13.4391-4395.1997; ZHU LQ, 1990, J BACTERIOL, V172, P3146, DOI 10.1128/jb.172.6.3146-3151.1990; Zuo YH, 2002, J BIOL CHEM, V277, P29654, DOI 10.1074/jbc.M204252200	56	132	136	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45041	45044		10.1074/jbc.R300031200	http://dx.doi.org/10.1074/jbc.R300031200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12941949	hybrid			2022-12-27	WOS:000186452300001
J	Huang, J; Valluzzi, R; Bini, E; Vernaglia, B; Kaplan, DL				Huang, J; Valluzzi, R; Bini, E; Vernaglia, B; Kaplan, DL			Cloning, expression, and assembly of sericin-like protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRIL FORMATION; BOMBYX-MORI; CONGO RED; ROTATORY PROPERTIES; SECONDARY STRUCTURE; GLUTAMINE REPEATS; ESCHERICHIA-COLI; FORMING PEPTIDE; SILK PROTEINS; IN-VITRO	Recombinant sericin proteins of different molecular masses (17.4, 31.9, and 46.5 kDa), based on the 38-amino acid repetitive motif of native sericin, were cloned, expressed, and purified. The recombinant sericin self-assembled during dialysis (starting concentration of 2.5 mg/ml) forming twisted fibers. Circular dichroism and Fourier transform infrared spectroscopy studies demonstrated protein conformational transitions occurred from random coil to beta-sheets during the dialysis. Congo red-stained recombinant sericin fibrils exhibited apple-green birefringence, indicating long-range order in the array of beta-sheets. Biosynthetic sericin has a high content of polar amino acids (e.g. > 40 mol % serine), leading to a beta-sheet conformation formed by hydrogen bonding via polar zipper interactions. Analysis of recombinant sericin sequence using Mandel-Gutfreund's (Mandel-Gutfreund, Y., and Gregoret, L. M. (2002) J. Mol. Biol. 323, 453-461) definition of polar and non-polar amino acids showed that the hydrophobicity pattern resembles the most frequent pattern of amyloidogenic proteins, polar amino acid aggregates (PPPPP). Many beta-proteins and peptides are designed to study amyloidogenesis using a polar/non-polar alternating pattern (PNPNPN). Sericin-like proteins or peptides provide an alternative model in terms of hydrophobicity pattern with which to explore questions related to beta-sheet formation and amyloidogenesis. The glue-like property of sericin is attributed to the hydrogen bonding between serine residues of sericin with serine residues in the fibroin structural components of silk fiber.	Tufts Univ, Ctr Bioengn, Dept Biomed Engn, Medford, MA 02155 USA; Tufts Univ, Ctr Bioengn, Dept Chem Engn, Medford, MA 02155 USA; Tufts Univ, Ctr Bioengn, Dept Biol Engn, Medford, MA 02155 USA	Tufts University; Tufts University; Tufts University	Kaplan, DL (corresponding author), 4 Colby St, Medford, MA 02155 USA.	david.kaplan@tufts.edu	Ceriello, Antonio/J-9575-2016					Adamian L, 2002, PROTEINS, V47, P209, DOI 10.1002/prot.10071; Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198; Asakura T., 1994, ENCY AGR SCI, V4, P1; Balbirnie M, 2001, P NATL ACAD SCI USA, V98, P2375, DOI 10.1073/pnas.041617698; BAUER HH, 1995, J STRUCT BIOL, V115, P1, DOI 10.1006/jsbi.1995.1024; BLOUT ER, 1960, J AM CHEM SOC, V82, P3787, DOI 10.1021/ja01499a080; Carter DB, 1998, NEUROBIOL AGING, V19, P37, DOI 10.1016/S0197-4580(97)00164-4; COUBLE P, 1987, DEV BIOL, V124, P431, DOI 10.1016/0012-1606(87)90496-9; de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199; Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883; FASMAN GD, 1960, J AM CHEM SOC, V82, P2262, DOI 10.1021/ja01494a041; Fukushima Y, 1998, BIOPOLYMERS, V45, P269, DOI 10.1002/(SICI)1097-0282(19980405)45:4<269::AID-BIP1>3.0.CO;2-J; GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9; Garel A, 1997, INSECT BIOCHEM MOLEC, V27, P469, DOI 10.1016/S0965-1748(97)00022-2; GLENNER GG, 1980, NEW ENGL J MED, V302, P1283, DOI 10.1056/NEJM198006053022305; Goldsbury CS, 1997, J STRUCT BIOL, V119, P17, DOI 10.1006/jsbi.1997.3858; HAMES BD, 1981, GEL ELECTROPHORESIS, P19; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Jones DH, 2000, BIOCHEMISTRY-US, V39, P1870, DOI 10.1021/bi992495e; Kallijarvi J, 2001, BIOCHEMISTRY-US, V40, P10032, DOI 10.1021/bi002095n; Kameda T, 1999, MACROMOLECULES, V32, P7166, DOI 10.1021/ma990554q; Kaplan D, 1994, SILK POLYM MAT SCI B, P10; KAUFMANN E, 1984, FEBS LETT, V170, P81, DOI 10.1016/0014-5793(84)81373-3; Kim YC, 1998, BIOTECHNOL LETT, V20, P799, DOI 10.1023/B:BILE.0000015926.97548.cf; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Lashuel HA, 2000, J AM CHEM SOC, V122, P5262, DOI 10.1021/ja9937831; Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060; Lucas F., 1968, Comprehensive Biochem, V26, P475; Mandel-Gutfreund Y, 2002, J MOL BIOL, V323, P453, DOI 10.1016/S0022-2836(02)00973-7; MATAGNE A, 1991, BIOCHEM J, V280, P553, DOI 10.1042/bj2800553; MCGRATH KP, 1992, J AM CHEM SOC, V114, P727, DOI 10.1021/ja00028a048; MICHAILLE JJ, 1990, GENE, V86, P177, DOI 10.1016/0378-1119(90)90277-X; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Mira H, 2001, BIOCHEM J, V357, P545, DOI 10.1042/0264-6021:3570545; MITA K, 1994, J MOL EVOL, V38, P583; Nyrkova IA, 2000, EUR PHYS J B, V17, P481, DOI 10.1007/s100510070127; Okabayashi H, 2002, BIOPOLYMERS, V65, P129, DOI 10.1002/bip.10186; OKAMOTO H, 1982, J BIOL CHEM, V257, P5192; Patel H, 1996, BIOCHEM J, V318, P1041, DOI 10.1042/bj3181041; Perutz M F, 1995, Pharm Acta Helv, V69, P213, DOI 10.1016/0031-6865(95)00003-R; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022; Qu Y, 2000, J AM CHEM SOC, V122, P5014, DOI 10.1021/ja9935761; QUADRIFO.F, 1968, J AM CHEM SOC, V90, P2760, DOI 10.1021/ja01013a005; Roterman I, 2001, Med Sci Monit, V7, P771; Saeger W, 1998, PATHOLOGE, V19, P345, DOI 10.1007/s002920050296; STOTT K, 1995, P NATL ACAD SCI USA, V92, P6509, DOI 10.1073/pnas.92.14.6509; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697; TOONEY NM, 1968, BIOPOLYMERS, V6, P81, DOI 10.1002/bip.1968.360060107; TOONEY NM, 1968, J MOL BIOL, V36, P355, DOI 10.1016/0022-2836(68)90161-7; TSUKADA M, 1979, POLYM J, V11, P503, DOI 10.1295/polymj.11.503; TSUKADA M, 1985, P 7 INT WOOL TEXT RE, V1, P383; TURNELL WG, 1992, J MOL BIOL, V227, P1205, DOI 10.1016/0022-2836(92)90532-O; URUSHIZAKI S, 1976, NIPPON SANSHIGAKU ZA, V45, P469; Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211; Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5; Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w; Winkler S, 1999, INT J BIOL MACROMOL, V24, P265, DOI 10.1016/S0141-8130(98)00088-9; WOODY RW, 1977, MACROMOL REV, V12, P181, DOI 10.1002/pol.1977.230120104; Woody RW, 1974, PEPTIDES POLYPEPTIDE, P338; Wurth C, 2002, J MOL BIOL, V319, P1279, DOI 10.1016/S0022-2836(02)00399-6; Xing YM, 2002, MECH AGEING DEV, V123, P1625, DOI 10.1016/S0047-6374(02)00098-2; XIONG HY, 1995, P NATL ACAD SCI USA, V92, P6349, DOI 10.1073/pnas.92.14.6349; Xu GF, 2001, P NATL ACAD SCI USA, V98, P3652, DOI 10.1073/pnas.071400098; Yan SZ, 2001, J BIOL CHEM, V276, P8500, DOI 10.1074/jbc.M010361200; Zhou YT, 2001, BIOMACROMOLECULES, V2, P111, DOI 10.1021/bm005598h; Zhu L. J., 1996, NIPPON SANSHIGAKU ZA, V65, P270	70	62	63	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46117	46123		10.1074/jbc.M307792200	http://dx.doi.org/10.1074/jbc.M307792200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12963711	hybrid			2022-12-27	WOS:000186452300129
J	Jurado, J; Prieto-Alamo, MJ; Madrid-Risquez, J; Pueyo, C				Jurado, J; Prieto-Alamo, MJ; Madrid-Risquez, J; Pueyo, C			Absolute gene expression patterns of thioredoxin and glutaredoxin redox systems in mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; OXIDATIVE STRESS; GLUTATHIONE-REDUCTASE; THIOLTRANSFERASE GLUTAREDOXIN; MAMMALIAN THIOREDOXIN; CLONING; CELLS; MITOCHONDRIAL; SELENOCYSTEINE; INDUCTION	This work provides the first absolute expression patterns of genes coding for all known components of both thioredoxin (Trx) and glutaredoxin (Grx) systems in mouse: Trx1, Trx2, Grx1, Grx2, TrxR1, TrxR2, thioredoxin/glutathione reductase, and glutathione reductase. We devised a novel assay that, combining the advantages of multiplex and real-time PCR, streamlines the quantitation of the actual mRNA copy numbers in whole-animal experiments. Quantitations reported establish differences among adult organs and embryonic stages, compare mRNA decay rates, explore the significance of alternative mRNA isoforms derived from TrxR1 and Grx2 genes, and examine the time-course expression upon superoxide stress promoted by paraquat. Collectively, these quantitations show: i) unique expression profiles for each transcript and mouse organ examined, yet with some general trends like the higher amounts of mRNA species coding for thioredoxins than those coding for the reductases that control their redox states and activities; ii) continuous expression during embryogenesis with outstanding up-regulations of Trx1 and TrxR1 mRNAs in specific temporal sequences; iii) drastic differences in mRNA stability, liver decay rates range from 2.8 h (thioredoxin/glutathione reductase) to greater than or equal to35 h (Trx1 and Trx2), and directly correlate with mRNA steady-state values; iv) testis-specific differences in the amounts (relative to total isoforms) of transcripts yielding the mitochondrial Grx2a and 67-kDa TrxR1 variants; and v) coordinated up-regulation of TrxR1 and glutathione reductase mRNAs in response to superoxide stress in an organ-specific manner. Further insights into in vivo roles of these redox systems should be gained from more focused studies of the mechanisms underlying the vast differences reported here at the transcript level.	Univ Cordoba, Dept Bioquim & Biol Mol, E-14071 Cordoba, Spain	Universidad de Cordoba	Pueyo, C (corresponding author), Univ Cordoba, Dept Bioquim & Biol Mol, Campus Rabanales,Edificio Severo Ochoa,Planta 2A, E-14071 Cordoba, Spain.		Prieto-Alamo, Maria Jose/K-6141-2014; Pueyo, Carmen/B-4509-2016; Carpio, Juan Jurado/K-7808-2014	Prieto-Alamo, Maria Jose/0000-0002-8164-032X; Pueyo, Carmen/0000-0002-2624-2011; Carpio, Juan Jurado/0000-0003-1701-8496				Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bandyopadhyay S, 1998, J BIOL CHEM, V273, P392, DOI 10.1074/jbc.273.1.392; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Bhuyan KC, 2002, METHOD ENZYMOL, V347, P421; CAREY M, 1999, TRANSCRIPTIONAL REGU, P65; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; DREW R, 1979, TOXICOL APPL PHARM, V48, P479, DOI 10.1016/0041-008X(79)90431-9; Gallardo-Madueno R, 1998, J BIOL CHEM, V273, P18382, DOI 10.1074/jbc.273.29.18382; Gasdaska JR, 1999, J BIOL CHEM, V274, P25379, DOI 10.1074/jbc.274.36.25379; Gasdaska PY, 1999, FEBS LETT, V442, P105, DOI 10.1016/S0014-5793(98)01638-X; GASDASKA PY, 1995, FEBS LETT, V373, P5, DOI 10.1016/0014-5793(95)01003-W; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Higashikubo A, 1999, BIOL PHARM BULL, V22, P900; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; JOHNSON MT, 2003, J BIOL CHEM; Kawai H, 2000, GENE, V242, P321, DOI 10.1016/S0378-1119(99)00498-9; Kelner MJ, 2000, BIOCHEM BIOPH RES CO, V269, P366, DOI 10.1006/bbrc.2000.2267; Koishi R, 1997, J BIOL CHEM, V272, P2570; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; Miranda-Vizuete A, 1999, BBA-GENE STRUCT EXPR, V1447, P113, DOI 10.1016/S0167-4781(99)00129-3; Osborne S A, 2001, BMC Genomics, V2, P10, DOI 10.1186/1471-2164-2-10; Park YS, 2002, BIOL CHEM, V383, P683, DOI 10.1515/BC.2002.070; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; Prieto-Alamo MJ, 2003, GENE EXPRESSION, V11, P23, DOI 10.3727/000000003783992315; Pueyo C, 2002, METHOD ENZYMOL, V347, P441; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; ROSSANT J, 2002, MOUSE DEV PATTERNING; Rundlof AK, 2001, J BIOL CHEM, V276, P30542, DOI 10.1074/jbc.M101452200; SACHI Y, 1995, IMMUNOL LETT, V44, P189, DOI 10.1016/0165-2478(95)00213-O; Sadek CM, 2001, GENES CELLS, V6, P1077, DOI 10.1046/j.1365-2443.2001.00484.x; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Spyrou G, 1997, J BIOL CHEM, V272, P2936, DOI 10.1074/jbc.272.5.2936; Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Sun QA, 2001, J BIOL CHEM, V276, P3106, DOI 10.1074/jbc.M004750200; TAGAYA Y, 1989, EMBO J, V8, P757, DOI 10.1002/j.1460-2075.1989.tb03436.x; Takashima Y, 1999, IMMUNOL LETT, V68, P397, DOI 10.1016/S0165-2478(99)00087-5; Tamura T, 1997, BIOCHEM BIOPH RES CO, V237, P419, DOI 10.1006/bbrc.1997.7153; Taniguchi Y, 1996, NUCLEIC ACIDS RES, V24, P2746, DOI 10.1093/nar/24.14.2746; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Zhon LW, 1998, J BIOL CHEM, V273, P8581, DOI 10.1074/jbc.273.15.8581	44	78	83	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45546	45554		10.1074/jbc.M307866200	http://dx.doi.org/10.1074/jbc.M307866200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954614	hybrid			2022-12-27	WOS:000186452300062
J	Litterst, CM; Kliem, S; Marilley, D; Pfitzner, E				Litterst, CM; Kliem, S; Marilley, D; Pfitzner, E			NCoA-1/SRC-1 is an essential coactivator of STAT5 that binds to the FDL motif in the alpha-helical region of the STAT5 transactivation domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-RECEPTOR COACTIVATOR-1; BETA-CASEIN GENE; LIGAND-INDEPENDENT ACTIVATION; FACTOR-KAPPA-B; SIGNAL TRANSDUCER; TRANSCRIPTIONAL ACTIVATION; NUCLEAR-FACTOR; HISTONE ACETYLTRANSFERASE; GLUCOCORTICOID RECEPTOR; DNA-BINDING	Signal transducer and activator of transcription 5 (STAT5) is a transcription factor that activates prolactin (PRL)-dependent gene expression in the mammary gland. For the activation of its target genes, STAT5 recruits coactivators like p300 and the CREB-binding protein (CBP). In this study we analyzed the function of p300/CBP-associated members of the p160/SRC/NCoA-family in STAT5-mediated transactivation of beta-casein expression. We found that only one of them, NCoA-1, acts as a coactivator for both STAT5a and STAT5b. The two coactivators p300/CBP and NCoA-1 cooperatively enhance STAT5a-mediated transactivation. For NCoA-1-dependent coactivation of STAT5, both the activation domain 1 and the amino-terminal bHLH/PAS domain are required. The amino-terminal region mediates the interaction with STAT5a in cells. A motif of three amino acids in an alpha-helical region of the STAT5a-transactivation domain is essential for the binding of NCoA-1 and for the transcriptional activity of STAT5a. Moreover we observed that NCoA-1 is involved in the synergistic action of the glucocorticoid receptor and STAT5a on the beta-casein promoter. These findings support a model in which STAT5, in concert with the glucocorticoid receptor, recruits a multifunctional coactivator complex to initiate the PRL-dependent transcription.	Georg Speyer Haus, Inst Biomed Res, D-60596 Frankfurt, Germany	Octapharma	Pfitzner, E (corresponding author), Georg Speyer Haus, Inst Biomed Res, Paul Ehrlich Str 42-44, D-60596 Frankfurt, Germany.		Pfitzner, Edith/AAU-7927-2021	Pfitzner, Edith/0000-0002-3484-9649				ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barre B, 2003, J BIOL CHEM, V278, P2990, DOI 10.1074/jbc.M210422200; Belandia B, 2000, J BIOL CHEM, V275, P30801, DOI 10.1074/jbc.C000484200; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Callus BA, 2000, J BIOL CHEM, V275, P16954, DOI 10.1074/jbc.M909976199; Carsol JL, 2002, MOL ENDOCRINOL, V16, P1696, DOI 10.1210/me.16.7.1696; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Crews ST, 1999, CURR OPIN GENET DEV, V9, P580, DOI 10.1016/S0959-437X(99)00003-9; DOPPLER W, 1990, MOL ENDOCRINOL, V4, P912, DOI 10.1210/mend-4-6-912; DOPPLER W, 1989, P NATL ACAD SCI USA, V86, P104, DOI 10.1073/pnas.86.1.104; Faulds MH, 2001, MOL ENDOCRINOL, V15, P1929, DOI 10.1210/me.15.11.1929; Favre-Young H, 2000, MOL ENDOCRINOL, V14, P1411, DOI 10.1210/me.14.9.1411; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; Giraud S, 2002, J BIOL CHEM, V277, P8004, DOI 10.1074/jbc.M111486200; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Han YL, 1997, MOL ENDOCRINOL, V11, P1180, DOI 10.1210/me.11.8.1180; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kurokawa R, 1998, SCIENCE, V279, P700, DOI 10.1126/science.279.5351.700; Lee SK, 1999, MOL ENDOCRINOL, V13, P1924, DOI 10.1210/me.13.11.1924; Lee SK, 2000, MOL ENDOCRINOL, V14, P915, DOI 10.1210/me.14.6.915; Lee SK, 1998, J BIOL CHEM, V273, P16651, DOI 10.1074/jbc.273.27.16651; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; LI S, 1995, MOL CELL BIOL, V15, P2063; Litterst CM, 2001, J BIOL CHEM, V276, P45713, DOI 10.1074/jbc.M108132200; Liu XW, 1996, MOL ENDOCRINOL, V10, P1496, DOI 10.1210/me.10.12.1496; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Moriggl R, 1997, MOL CELL BIOL, V17, P3663, DOI 10.1128/MCB.17.7.3663; Moriggl R, 1996, MOL CELL BIOL, V16, P5691; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; ONATE SA, 1995, SCIENCE, V270, P1354; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Rascle A, 2003, MOL CELL BIOL, V23, P4162, DOI 10.1128/MCB.23.12.4162-4173.2003; Richer JK, 1998, J BIOL CHEM, V273, P31317, DOI 10.1074/jbc.273.47.31317; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; Rowan BG, 2000, J BIOL CHEM, V275, P4475, DOI 10.1074/jbc.275.6.4475; Sheppard HM, 2001, MOL CELL BIOL, V21, P39, DOI 10.1128/MCB.21.1.39-50.2001; Smith CL, 1996, P NATL ACAD SCI USA, V93, P8884, DOI 10.1073/pnas.93.17.8884; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Stoecklin E, 1999, J STEROID BIOCHEM, V69, P195, DOI 10.1016/S0960-0760(99)00052-7; Suen CS, 1998, J BIOL CHEM, V273, P27645, DOI 10.1074/jbc.273.42.27645; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; WAKAO H, 1992, J BIOL CHEM, V267, P16365; WAKAO H, 1995, EMBO J, V14, P854, DOI 10.1002/j.1460-2075.1995.tb07064.x; Wang DM, 2000, EMBO J, V19, P392, DOI 10.1093/emboj/19.3.392; Weiss RE, 1999, EMBO J, V18, P1900, DOI 10.1093/emboj/18.7.1900; Wyszomierski SL, 1999, MOL ENDOCRINOL, V13, P330, DOI 10.1210/me.13.2.330; Wyszomierski SL, 2001, MOL ENDOCRINOL, V15, P228, DOI 10.1210/me.15.2.228; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Xu Y, 2000, MOL CELL BIOL, V20, P2138, DOI 10.1128/MCB.20.6.2138-2146.2000; Yao TP, 1996, P NATL ACAD SCI USA, V93, P10626, DOI 10.1073/pnas.93.20.10626; Zhou YC, 1999, J BIOL CHEM, V274, P29874, DOI 10.1074/jbc.274.42.29874	69	64	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45340	45351		10.1074/jbc.M303644200	http://dx.doi.org/10.1074/jbc.M303644200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954634	hybrid			2022-12-27	WOS:000186452300037
J	Peyruchaud, O; Serre, CM; NicAmhlaoibh, R; Fournier, P; Clezardin, P				Peyruchaud, O; Serre, CM; NicAmhlaoibh, R; Fournier, P; Clezardin, P			Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; ANGIOGENESIS INHIBITOR; GROWTH; MODEL; BISPHOSPHONATES; RESORPTION; MECHANISMS; MIGRATION; CELLS	Bone is a very common metastatic site for breast cancer. In bone metastasis, there is a vicious circle wherein bone-residing metastatic cells stimulate osteoclast-mediated bone resorption, and bone-derived growth factors released from resorbed bone promote tumor growth. The contribution of tumor angiogenesis in the growth of bone metastases is, however, unknown. By using an experimental model of bone metastasis caused by MDA-MB-231/B02 breast cancer cells that quite closely mimics the conditions likely to occur in naturally arising metastatic human breast cancers, we demonstrate here that when MDA-MB-231/B02 cells were engineered to produce at the bone metastatic site an angiogenesis inhibitor, angiostatin, there was a marked inhibition in the extent of skeletal lesions. Inhibition of skeletal lesions came with a pronounced reduction in tumor burden in bone. However, although angiostatin produced by MDA-MB-231/B02 cells was effective at inhibiting in vitro endothelial cell proliferation and in vivo angiogenesis in a Matrigel implant model, we have shown that it inhibited cancer-induced bone destruction through a direct inhibition of osteoclast activity and generation. Overall, these results indicate that, besides its well known anti-angiogenic activity, angiostatin must also be considered as a very effective inhibitor of bone resorption, broadening its potential clinical use in cancer therapy.	Fac Med Laennec, INSERM, Res Unit 403, F-69372 Lyon 08, France; OSTEOPRO AS, DK-2730 Herlev, Denmark	Institut National de la Sante et de la Recherche Medicale (Inserm)	Peyruchaud, O (corresponding author), Fac Med Laennec, INSERM, Res Unit 403, Rue Guillaume Paradin, F-69372 Lyon 08, France.	peyruchaud@lyon.inserm.fr	Fournier, Pierrick/B-6560-2015; Clezardin, Philippe/M-8071-2014	Fournier, Pierrick/0000-0001-7633-8129; Clezardin, Philippe/0000-0003-0149-4463; Peyruchaud, Olivier/0000-0002-5393-4945				Barou O, 2002, BONE, V30, P604, DOI 10.1016/S8756-3282(02)00677-4; BODY JJ, 1992, BONE, V13, pS57, DOI 10.1016/S8756-3282(09)80011-2; Cao YH, 1998, J CLIN INVEST, V101, P1055, DOI 10.1172/JCI1558; Carron CP, 2000, J ENDOCRINOL, V165, P587, DOI 10.1677/joe.0.1650587; Duivenvoorden WCM, 2002, CANCER RES, V62, P1588; Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2; Fournier P, 2002, CANCER RES, V62, P6538; Guise TA, 1998, ENDOCR REV, V19, P18, DOI 10.1210/er.19.1.18; Gyorffy S, 2001, AM J PATHOL, V159, P1137, DOI 10.1016/S0002-9440(10)61790-7; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hillner BE, 2000, J CLIN ONCOL, V18, P1378, DOI 10.1200/JCO.2000.18.6.1378; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Maeshima Y, 2001, J BIOL CHEM, V276, P31959, DOI 10.1074/jbc.M103024200; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Pecheur I, 2002, FASEB J, V16, P1266, DOI 10.1096/fj.01-0911fje; Peyruchaud O, 2001, J BONE MINER RES, V16, P2027, DOI 10.1359/jbmr.2001.16.11.2027; Sasaki A, 1998, CANCER RES, V58, P462; Tarui T, 2002, J BIOL CHEM, V277, P33564, DOI 10.1074/jbc.M205514200; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; van der Pluijm G, 2000, CANCER TREAT REV, V26, P11, DOI 10.1053/ctrv.1999.0143; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Yokoyama Y, 2000, CANCER RES, V60, P2190	23	72	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45826	45832		10.1074/jbc.M309024200	http://dx.doi.org/10.1074/jbc.M309024200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954626	hybrid			2022-12-27	WOS:000186452300095
J	Huang, SJ; Blanchoin, L; Kovar, DR; Staiger, CJ				Huang, SJ; Blanchoin, L; Kovar, DR; Staiger, CJ			Arabidopsis capping protein (AtCP) is a heterodimer that regulates assembly at the barbed ends of actin filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPOLYMERIZING FACTOR; SACCHAROMYCES-CEREVISIAE; ARP2/3 COMPLEX; ADP-ACTIN; F-ACTIN; FUNCTIONALLY DISTINCT; BINDING PROTEINS; SKELETAL-MUSCLE; NULL MUTATIONS; PLANT-CELLS	The precise regulation of actin filament polymerization and depolymerization is essential for many cellular processes and is choreographed by a multitude of actin-binding proteins (ABPs). In higher plants the number of well characterized ABPs is quite limited, and some evidence points to significant differences in the biochemical properties of apparently conserved proteins. Here we provide the first evidence for the existence and biochemical properties of a heterodimeric capping protein from Arabidopsis thaliana (AtCP). The purified recombinant protein binds to actin filament barbed ends with K-d values of 12-24 nM, as assayed both kinetically and at steady state. AtCP prevents the addition of profilin actin to barbed ends during a seeded elongation reaction and suppresses dilution-mediated depolymerization. It does not, however, sever actin filaments and does not have a preference for the source of actin. During assembly from Mg-ATP-actin monomers, AtCP eliminates the initial lag period for actin polymerization and increases the maximum rate of polymerization. Indeed, the efficiency of actin nucleation of 0.042 pointed ends created per AtCP polypeptide compares favorably with mouse CapZ, which has a maximal nucleation of 0.17 pointed ends per CapZ polypeptide. AtCP activity is not affected by calcium but is sensitive to phosphatidylinositol 4,5-bisphosphate. We propose that AtCP is a major regulator of actin dynamics in plant cells that, together with abundant profilin, is responsible for maintaining a large pool of actin subunits and a surprisingly small population of F-actin.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Purdue Univ, Purdue Motil Grp, W Lafayette, IN 47907 USA; Univ Grenoble 1, CEA, CNRS, Physiol Cellulaire Vegetale Lab, F-38054 Grenoble, France; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Yale University	Staiger, CJ (corresponding author), Purdue Univ, Dept Biol Sci, 333 Hansen Life Sci Bldg,201 S Univ St, W Lafayette, IN 47907 USA.		Staiger, Christopher/AAF-2127-2019; Huang, Shanjin/M-4112-2017	Huang, Shanjin/0000-0001-9517-2515				ADAMS AEM, 1993, MOL BIOL CELL, V4, P459, DOI 10.1091/mbc.4.5.459; Allwood EG, 2002, PLANT CELL, V14, P2915, DOI 10.1105/tpc.005363; AMATRUDA JF, 1992, J CELL BIOL, V117, P1067, DOI 10.1083/jcb.117.5.1067; AMATRUDA JF, 1990, NATURE, V344, P352, DOI 10.1038/344352a0; AMATRUDA JF, 1992, J CELL BIOL, V119, P1151, DOI 10.1083/jcb.119.5.1151; BARRONCASELLA EA, 1995, J BIOL CHEM, V270, P21472, DOI 10.1074/jbc.270.37.21472; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; BRENNER SL, 1983, J BIOL CHEM, V258, P5013; CALDWELL JE, 1989, BIOCHEMISTRY-US, V28, P8506, DOI 10.1021/bi00447a036; CASELLA JF, 1986, J BIOL CHEM, V261, P915; CASELLA JF, 1994, J BIOL CHEM, V269, P6992; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; COOPER JA, 1999, GUIDEBOOK CYTOSKELET, P62; DINUBILE MJ, 1995, MOL BIOL CELL, V6, P1659, DOI 10.1091/mbc.6.12.1659; Eddy RJ, 1996, BBA-MOL CELL RES, V1314, P247, DOI 10.1016/S0167-4889(96)00108-5; EDDY RJ, 1993, J BIOL CHEM, V268, P23267; Gibbon BC, 1999, PLANT CELL, V11, P2349, DOI 10.1105/tpc.11.12.2349; Gungabissoon RA, 1998, PLANT J, V16, P689, DOI 10.1046/j.1365-313x.1998.00339.x; HAUS U, 1993, EMBO J, V12, P3763, DOI 10.1002/j.1460-2075.1993.tb06054.x; HAUS U, 1991, BIOCHEM BIOPH RES CO, V181, P833, DOI 10.1016/0006-291X(91)91265-E; HEISS SG, 1991, BIOCHEMISTRY-US, V30, P8753, DOI 10.1021/bi00100a006; Hopmann R, 2003, MOL BIOL CELL, V14, P118, DOI 10.1091/mbc.E02-05-0300; Hopmann R, 1996, J CELL BIOL, V133, P1293, DOI 10.1083/jcb.133.6.1293; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; HUG C, 1995, CELL, V81, P591, DOI 10.1016/0092-8674(95)90080-2; HUG C, 1992, J CELL BIOL, V116, P923, DOI 10.1083/jcb.116.4.923; Hussey PJ, 2002, PHILOS T R SOC B, V357, P791, DOI 10.1098/rstb.2002.1086; ISENBERG G, 1980, NATURE, V288, P455, DOI 10.1038/288455a0; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; Kang F, 1999, J BIOL CHEM, V274, P36963, DOI 10.1074/jbc.274.52.36963; KARPOVA TS, 1995, J CELL BIOL, V131, P1483, DOI 10.1083/jcb.131.6.1483; KARPOVA TS, 1993, GENETICS, V135, P693; Kashiyama T, 2000, J BIOCHEM-TOKYO, V127, P1065, DOI 10.1093/oxfordjournals.jbchem.a022699; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2000, PLANT CELL, V12, P583, DOI 10.1105/tpc.12.4.583; Kovar DR, 2001, J CELL SCI, V114, P4293; Kovar DR, 2000, PLANT J, V24, P625, DOI 10.1046/j.1365-313x.2000.00907.x; Kreis T., 1999, GUIDEBOOK CYTOSKELET, V2nd; Kuhlman PA, 1997, BIOCHEMISTRY-US, V36, P13461, DOI 10.1021/bi970601b; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Maun NA, 1996, BIOCHEMISTRY-US, V35, P3518, DOI 10.1021/bi952470p; McKinney EC, 2002, PLANT PHYSIOL, V128, P997, DOI 10.1104/pp.010906; Meagher RB, 1999, PLANT CELL, V11, P995, DOI 10.1105/tpc.11.6.995; Nakano K, 2001, MOL BIOL CELL, V12, P3515, DOI 10.1091/mbc.12.11.3515; PAL M, 1994, MOL CELL BIOCHEM, V130, P111, DOI 10.1007/BF01457392; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Ren HY, 1997, PLANT CELL, V9, P1445, DOI 10.1105/tpc.9.8.1445; SAUTERER RA, 1991, J BIOL CHEM, V266, P24533; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; SCHAFER DA, 1995, J CELL BIOL, V128, P61, DOI 10.1083/jcb.128.1.61; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Schafer DA, 1998, J CELL BIOL, V143, P1919, DOI 10.1083/jcb.143.7.1919; Sheterline P, 1998, PROTEIN PROFILE, V4, P1; Sizonenko GI, 1996, MOL BIOL CELL, V7, P1; Snowman BN, 2002, PLANT CELL, V14, P2613, DOI 10.1105/tpc.002998; Soeno Y, 1998, J MUSCLE RES CELL M, V19, P639, DOI 10.1023/A:1005329114263; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Staiger CJ, 1997, TRENDS PLANT SCI, V2, P275, DOI 10.1016/S1360-1385(97)86350-9; STAIGER CJ, 2003, PLANT CYTOSKELETON C, P32; TANG WJY, 1993, METHOD CELL BIOL, V37, P95, DOI 10.1016/S0091-679X(08)60245-9; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; Tardieux I, 1998, MOL BIOCHEM PARASIT, V93, P295, DOI 10.1016/S0166-6851(98)00044-9; Vantard M, 2002, CURR OPIN PLANT BIOL, V5, P502, DOI 10.1016/S1369-5266(02)00300-X; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Waddle JA, 1996, J CELL BIOL, V132, P861, DOI 10.1083/jcb.132.5.861; WALSH TP, 1984, BIOCHEMISTRY-US, V23, P2613, DOI 10.1021/bi00307a012; Wasteneys GO, 2003, ANNU REV PLANT BIOL, V54, P691, DOI 10.1146/annurev.arplant.54.031902.134818; Wiesner S, 2003, J CELL BIOL, V160, P387, DOI 10.1083/jcb.200207148; Xu JY, 1999, CELL MOTIL CYTOSKEL, V42, P73, DOI 10.1002/(SICI)1097-0169(1999)42:1<73::AID-CM7>3.0.CO;2-Z; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	77	81	87	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44832	44842		10.1074/jbc.M306670200	http://dx.doi.org/10.1074/jbc.M306670200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947123	Green Published, hybrid			2022-12-27	WOS:000186306700118
J	Ibdah, M; Zhang, XH; Schmidt, J; Vogt, T				Ibdah, M; Zhang, XH; Schmidt, J; Vogt, T			A novel Mg2+-dependent O-methyltransferase in the phenylpropanoid metabolism of Mesembryanthemum crystallinum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAFFEOYL-COENZYME-A; ADENOSYL-L-METHIONINE; LIGNIN BIOSYNTHESIS; MOLECULAR-CLONING; ACID 3-O-METHYLTRANSFERASE; SUBSTRATE-SPECIFICITY; METHYLATION PATHWAY; COA 3-O-METHYLTRANSFERASE; HETEROLOGOUS EXPRESSION; MONOLIGNOL BIOSYNTHESIS	Upon irradiation with elevated light intensities, the ice plant (Mesembryanthemum crystallinum) accumulates a complex pattern of methylated and glycosylated flavonol conjugates in the upper epidermal layer. Identification of a flavonol methylating activity, partial purification of the enzyme, and sequencing of the corresponding peptide fragments revealed a novel S-adenosyl-L-methionine-dependent O-methyltransferase that was specific for flavonoids and caffeoyl-CoA. Cloning and functional expression of the corresponding cDNA verified that the new methyltransferase is a multifunctional 26.6-kDa Mg2+-dependent enzyme, which shows a significant sequence similarity to the cluster of caffeoyl coenzyme A-methylating enzymes. Functional analysis of highly homologous members from chickweed (Stellaria longipes), Arabidopsis thaliana, and tobacco (Nicotiana tabacum) demonstrated that the enzymes from the ice plant, chickweed, and A. thaliana possess a broader substrate specificity toward o-hydroquinone-like structures than previously anticipated for Mg2+-dependent O-methyltransferases, and are distinctly different from the tobacco enzyme. Besides caffeoyl-CoA and flavonols, a high specificity was also observed for caffeoylglucose, a compound never before reported to be methylated by any plant O-methyltransferase. Based on phylogenetic analysis of the amino acid sequence and differences in acceptor specificities among both animal and plant O-methyltransferases, we propose that the enzymes from the Centrospermae, along with the predicted gene product from A. thaliana, form a novel subclass within the caffeoyl coenzyme A-dependent O-methyltransferases, with potential divergent functions not restricted to lignin monomer biosynthesis.	Leibniz Inst Plant Biochem, Dept Secondary Metab, D-06120 Halle An Der Saale, Germany; Leibniz Inst Plant Biochem, Dept Bioorgan Chem, D-06120 Halle An Der Saale, Germany; Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	Leibniz Institut fur Pflanzenbiochemie; Leibniz Institut fur Pflanzenbiochemie; University of Illinois System; University of Illinois Urbana-Champaign	Vogt, T (corresponding author), Inst Plant Biochem, Dept Secondary Metab, Weinberg 3, D-06120 Halle An Der Saale, Germany.	tvogt@ipb-halle.de	Zhang, Xing-Hai/AAR-6703-2021	Zhang, Xing-Hai/0000-0001-9261-4242				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anterola AM, 2002, J BIOL CHEM, V277, P18272, DOI 10.1074/jbc.M112051200; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BOKERN M, 1992, BOT ACTA, V105, P146, DOI 10.1111/j.1438-8677.1992.tb00280.x; BUSAM G, 2000, PLANT PHYSIOL, V115, P1039; Cacace S, 2003, PHYTOCHEMISTRY, V62, P127, DOI 10.1016/S0031-9422(02)00483-1; Chen CY, 2000, PLANT PHYSIOL, V123, P853, DOI 10.1104/pp.123.3.853; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; DAVIN LB, 1992, RECENT ADV PHYTOCHEM, V26, P325; Day A, 2001, PHYSIOL PLANTARUM, V113, P275, DOI 10.1034/j.1399-3054.2001.1130216.x; EDWARDS R, 1991, ARCH BIOCHEM BIOPHYS, V287, P372, DOI 10.1016/0003-9861(91)90492-2; Frick S, 1999, PLANT J, V17, P329, DOI 10.1046/j.1365-313X.1999.00379.x; Fujiwara H, 1998, PLANT J, V16, P421, DOI 10.1046/j.1365-313x.1998.00312.x; Gang DR, 2002, PLANT CELL, V14, P505, DOI 10.1105/tpc.010327; Guo DJ, 2001, PLANT CELL, V13, P73, DOI 10.1105/tpc.13.1.73; Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200; Hoffmann L, 2001, J BIOL CHEM, V276, P36831, DOI 10.1074/jbc.M104977200; Ibdah M, 2002, PLANT CELL ENVIRON, V25, P1145, DOI 10.1046/j.1365-3040.2002.00895.x; Ibrahim RK, 2000, RECENT ADV PHYTOCHEM, V34, P349, DOI 10.1016/S0079-9920(00)80012-X; Inoue K, 1998, PLANT PHYSIOL, V117, P761, DOI 10.1104/pp.117.3.761; Joshi CP, 1998, PLANT MOL BIOL, V37, P663, DOI 10.1023/A:1006035210889; Kawamoto H, 1997, PHYTOCHEMISTRY, V46, P473, DOI 10.1016/S0031-9422(97)00330-0; Li LG, 1997, P NATL ACAD SCI USA, V94, P5461, DOI 10.1073/pnas.94.10.5461; Li LG, 2000, J BIOL CHEM, V275, P6537, DOI 10.1074/jbc.275.9.6537; Li LG, 1999, PLANT MOL BIOL, V40, P555, DOI 10.1023/A:1006244325250; Mabry T. J., 1980, Encyclopedia of Plant Physiology. New Series. Volume 8. Secondary plant products [Bell, A.E.; Charlwood, B.V. (Editors)]., P513; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Markham KR, FLAVONOIDS, DOI 10.1016/0022-2860(71)87109-0; Maury S, 1999, PLANT PHYSIOL, V121, P215, DOI 10.1104/pp.121.1.215; Meng H, 1998, PLANT MOL BIOL, V38, P513, DOI 10.1023/A:1006071708728; Milkowski C, 2000, PLANTA, V211, P883, DOI 10.1007/s004250000411; Muzac I, 2000, ARCH BIOCHEM BIOPHYS, V375, P385, DOI 10.1006/abbi.1999.1681; NDong C, 2003, J BIOL CHEM, V278, P6854, DOI 10.1074/jbc.M209439200; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; O'Leary KA, 2003, BIOCHEM PHARMACOL, V65, P479, DOI 10.1016/S0006-2952(02)01510-1; Osakabe K, 1999, P NATL ACAD SCI USA, V96, P8955, DOI 10.1073/pnas.96.16.8955; PAKUSCH AE, 1989, ARCH BIOCHEM BIOPHYS, V271, P488, DOI 10.1016/0003-9861(89)90299-3; Paquette S, 2003, PHYTOCHEMISTRY, V62, P399, DOI 10.1016/S0031-9422(02)00558-7; SALMINEN M, 1990, GENE, V93, P241, DOI 10.1016/0378-1119(90)90231-F; SCHMITT D, 1991, J BIOL CHEM, V266, P17416; Schroder G, 2002, PHYTOCHEMISTRY, V59, P1, DOI 10.1016/S0031-9422(01)00421-6; STOCKIGT J, 1975, Z NATURFORSCH C, V30, P352; STRACK D, 1987, J PLANT PHYSIOL, V131, P61, DOI 10.1016/S0176-1617(87)80268-7; Taguchi G, 2001, EUR J BIOCHEM, V268, P4086, DOI 10.1046/j.1432-1327.2001.02325.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; ULMANEN I, 1991, EUR J BIOCHEM, V202, P1013, DOI 10.1111/j.1432-1033.1991.tb16464.x; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Vogt T, 1999, PHYTOCHEMISTRY, V52, P583, DOI 10.1016/S0031-9422(99)00151-X; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; Wein M, 2002, PLANT J, V31, P755, DOI 10.1046/j.1365-313X.2002.01396.x; Yamazaki M, 1999, J BIOL CHEM, V274, P7405, DOI 10.1074/jbc.274.11.7405; YE ZH, 1995, PLANT PHYSIOL, V108, P459, DOI 10.1104/pp.108.2.459; YE ZH, 1994, PLANT CELL, V6, P1427, DOI 10.1105/tpc.6.10.1427; ZHANG XH, 1995, PLANT PHYSIOL, V108, P429, DOI 10.1104/pp.108.1.429; Zhang XH, 1997, J BIOSCIENCE, V22, P161, DOI 10.1007/BF02704730; ZHU BT, 1994, J BIOL CHEM, V269, P292; Ziegler J, 1997, ANAL BIOCHEM, V250, P257, DOI 10.1006/abio.1997.2248; Zubieta C, 2002, PLANT CELL, V14, P1265, DOI 10.1105/tpc.001412; Zubieta C, 2001, NAT STRUCT BIOL, V8, P271, DOI 10.1038/85029	59	102	109	5	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					43961	43972		10.1074/jbc.M304932200	http://dx.doi.org/10.1074/jbc.M304932200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941960	hybrid			2022-12-27	WOS:000186306700011
J	Mallory, MJ; Strich, R				Mallory, MJ; Strich, R			Ume1p represses meiotic gene transcription in Saccharomyces cerevisiae through interaction with the histone deacetylase Rpd3p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; NEGATIVE REGULATOR; YEAST; COMPLEX; IDENTIFICATION; RECRUITMENT; SEQUENCE; ENCODES; KINASE; INDUCTION	Ume1p is a member of a conserved protein family including RbAp48 that associates with histone deacetylases. Consistent with this finding, Ume1p is required for the full repression of a subset of meiotic genes during vegetative growth in budding yeast. In addition to mitotic cell division, this report describes a new role for Ume1p in meiotic gene repression in precommitment sporulating cultures returning to vegetative growth. However, Ume1p is not required to re-establish repression as part of the meiotic transient transcription program. Mutational analysis revealed that two conserved domains (NEE box and a WD repeat motif) are required for Ume1p-dependent repression. Co-immunoprecipitation studies revealed that both the NEE box and the WD repeat motif are essential for normal Rpd3p binding. Finally, Ume1p-Rpd3p association is dependent on the global co-repressor Sin3p. Moreover, this activity was localized to one of the four paired amphipathic-helix domains of Sin3p shown previously to be required for transcriptional repression. These findings support a model that Ume1p binding to Rpd3p is required for its repression activity. In addition, these results suggest that Rpd3-Ume1p-Sin3p comprises an interdependent complex required for mediating transcriptional repression.	Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Strich, R (corresponding author), Fox Chase Canc Ctr, Inst Canc Res, 333 Cottman Ave, Philadelphia, PA 19111 USA.	r_strich@fccc.edu			NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NCI NIH HHS [CA-06927] Funding Source: Medline; NIGMS NIH HHS [GM57842] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; BAKER HV, 1991, P NATL ACAD SCI USA, V88, P9443, DOI 10.1073/pnas.88.21.9443; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; BOWDISH KS, 1993, MOL CELL BIOL, V13, P2172, DOI 10.1128/MCB.13.4.2172; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P5086, DOI 10.1128/MCB.8.12.5086; BUCKINGHAM LE, 1990, P NATL ACAD SCI USA, V87, P9406, DOI 10.1073/pnas.87.23.9406; CAPIEAUX E, 1989, J BIOL CHEM, V264, P7437; CHAMBERS A, 1989, MOL CELL BIOL, V9, P5516, DOI 10.1128/MCB.9.12.5516; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cooper KF, 2002, EUKARYOT CELL, V1, P66, DOI 10.1128/EC.01.1.66-74.2002; Cooper KF, 1997, EMBO J, V16, P4665, DOI 10.1093/emboj/16.15.4665; ELDER RT, 1983, P NATL ACAD SCI-BIOL, V80, P2432, DOI 10.1073/pnas.80.9.2432; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; HOLLAND MJ, 1987, MOL CELL BIOL, V7, P813, DOI 10.1128/MCB.7.2.813; Honigberg SM, 1993, CURR OPIN CELL BIOL, V5, P219, DOI 10.1016/0955-0674(93)90106-Z; HUDAK KA, 1994, GENETICS, V136, P475; Jackson JC, 1996, NUCLEIC ACIDS RES, V24, P1322, DOI 10.1093/nar/24.7.1322; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; JOHNSTON M, 1993, MOL CELLULAR BIOL YE, V2, P193; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; KASSIR Y, 1991, METHOD ENZYMOL, V194, P94; KLAPHOLZ S, 1980, GENETICS, V96, P567; KOMACHI K, 1994, GENE DEV, V8, P2857, DOI 10.1101/gad.8.23.2857; KUCHIN S, 1995, P NATL ACAD SCI USA, V92, P4006, DOI 10.1073/pnas.92.9.4006; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Miller J. H, 1972, EXPT MOL GENETICS; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; QIAN YW, 1993, NATURE, V364, P648, DOI 10.1038/364648a0; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; RUGGIERI R, 1989, P NATL ACAD SCI USA, V86, P8778, DOI 10.1073/pnas.86.22.8778; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAW P E, 1990, New Biologist, V2, P111; SIKORSKI RS, 1989, GENETICS, V122, P19; STERNBERG PW, 1987, CELL, V32, P409; STRICH R, 1989, P NATL ACAD SCI USA, V86, P10018, DOI 10.1073/pnas.86.24.10018; STRICH R, 1994, GENE DEV, V8, P796, DOI 10.1101/gad.8.7.796; SUROSKY RT, 1992, MOL CELL BIOL, V12, P3948, DOI 10.1128/MCB.12.9.3948; SUROSKY RT, 1994, MOL CELL BIOL, V14, P3446, DOI 10.1128/MCB.14.5.3446; SZENTGYORGYI C, 1995, MOL CELL BIOL, V15, P6754; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; VANDERVOORN L, 1992, FEBS LETT, V307, P131, DOI 10.1016/0014-5793(92)80751-2; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; VERSHON AK, 1992, MOL CELL BIOL, V12, P3706, DOI 10.1128/MCB.12.9.3706; VIDAL M, 1991, MOL CELL BIOL, V11, P6317, DOI 10.1128/MCB.11.12.6317; WANG HM, 1990, MOL CELL BIOL, V10, P1743, DOI 10.1128/MCB.10.4.1743; WANG HM, 1993, MOL CELL BIOL, V13, P1805, DOI 10.1128/MCB.13.3.1805; WANG HM, 1990, MOL CELL BIOL, V10, P5927, DOI 10.1128/MCB.10.11.5927; Washburn BK, 2001, MOL CELL BIOL, V21, P2057, DOI 10.1128/MCB.21.6.2057-2069.2001	56	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44727	44734		10.1074/jbc.M308632200	http://dx.doi.org/10.1074/jbc.M308632200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12954623	hybrid			2022-12-27	WOS:000186306700106
J	Pakula, TM; Laxell, M; Huuskonen, A; Uusitalo, J; Saloheimo, M; Penttila, M				Pakula, TM; Laxell, M; Huuskonen, A; Uusitalo, J; Saloheimo, M; Penttila, M			The effects of drugs inhibiting protein secretion in the filamentous fungus Trichoderma reesei - Evidence for down-regulation of genes that encode secreted proteins in the stressed cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR; BREFELDIN-A; MESSENGER-RNA; DISULFIDE-ISOMERASE; TRANSMEMBRANE PROTEIN; ASPERGILLUS-NIGER; CALCIUM; PATHWAY; ER	To study the mechanisms of protein secretion as well as the cellular responses to impaired protein folding and transport in filamentous fungi, we have analyzed Trichoderma reesei cultures treated with chemical agents that interfere with these processes, dithiothreitol, brefeldin A, and the Ca2+-ionophore A23187. The effects of the drugs on the kinetics of protein synthesis and transport were characterized using metabolic labeling of synthesized proteins. Cellobiohydrolase I (CBHI, Cel7A), the major secreted cellulase, was analyzed as a model protein. Northern analysis showed that under conditions where protein transport was inhibited ( treatments with dithiothreitol or brefeldin A) the unfolded protein response pathway was activated. The active form of the hac1 mRNA that mediates unfolded protein response signaling was induced, followed by induction of the foldase and chaperone genes pdi1 and bip1. Concomitant with the activation of the unfolded protein response pathway, the transcript levels of genes encoding secreted proteins, like cellulases and xylanases, were drastically decreased, suggesting a novel type of feedback mechanism activated in response to impairment in protein folding or transport ( repression under secretion stress (RESS)). By studying expression of the reporter gene lacZ under cbh1 promoters of different length, it was shown that the feedback response was mediated through the cellulase promoter.	VTT Biotechnol, Espoo 02044, Finland	VTT Technical Research Center Finland	Pakula, TM (corresponding author), VTT Biotechnol, POB 1500, Espoo 02044, Finland.	tiina.pakula@vtt.fi	Penttilä, Merja E/A-4710-2013	Penttila, Merja/0000-0002-6929-1032				ALBERINI CM, 1990, NATURE, V347, P485, DOI 10.1038/347485a0; [Anonymous], [No title captured]; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; BROSTROM CO, 1989, J BIOL CHEM, V264, P1644; BROSTROM CO, 1990, ANNU REV PHYSIOL, V52, P577; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Derkx PMF, 2001, MOL GENET GENOMICS, V266, P537, DOI 10.1007/s004380100587; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; HERRUER MH, 1988, NUCLEIC ACIDS RES, V16, P7917, DOI 10.1093/nar/16.16.7917; HORWITZ MS, 1969, VIROLOGY, V39, P682, DOI 10.1016/0042-6822(69)90006-3; Ilmen M, 1997, APPL ENVIRON MICROB, V63, P1298; Ilmen M, 1996, MOL GEN GENET, V253, P303, DOI 10.1007/s004380050326; JAMSA E, 1994, YEAST, V10, P355, DOI 10.1002/yea.320100308; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; KERANEN S, 1995, CURR OPIN BIOTECH, V6, P534, DOI 10.1016/0958-1669(95)80088-3; Khalaj V, 2001, FUNGAL GENET BIOL, V32, P55, DOI 10.1006/fgbi.2000.1245; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kubicek CP, 1998, TRICHODERMA GLIOCLAD, V1, P49; Li Y, 2000, MOL CELL BIOL, V20, P3843, DOI 10.1128/MCB.20.11.3843-3851.2000; LODISH HF, 1990, J BIOL CHEM, V265, P10893; LODISH HF, 1992, J BIOL CHEM, V267, P12753; LOFTFIELD RB, 1958, J BIOL CHEM, V231, P925; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; MANDELS M, 1971, APPL MICROBIOL, V21, P152, DOI 10.1128/AEM.21.1.152-154.1971; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Montenecourt B. S. ., 1979, ACS SYM SER, V181, P289, DOI DOI 10.1021/BA-1979-0181.CH014; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Mori K, 2000, P NATL ACAD SCI USA, V97, P4660, DOI 10.1073/pnas.050010197; MORI K, 1993, CELL, V74, P743; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Morinaga N, 1999, J BIOL CHEM, V274, P17417, DOI 10.1074/jbc.274.25.17417; NEVALAINEN H, 1995, MYCOTA, V2, P303; Ngiam C, 2000, APPL ENVIRON MICROB, V66, P775, DOI 10.1128/AEM.66.2.775-782.2000; Ngiam C, 1997, CURR GENET, V31, P133, DOI 10.1007/s002940050187; Nikawa J, 1996, NUCLEIC ACIDS RES, V24, P4222, DOI 10.1093/nar/24.21.4222; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; Pakula TM, 2000, MICROBIOL-SGM, V146, P223, DOI 10.1099/00221287-146-1-223; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Prieto S, 2000, J BIOL CHEM, V275, P14155, DOI 10.1074/jbc.275.19.14155; PROSTKO CR, 1992, J BIOL CHEM, V267, P16751; Punt PJ, 1998, APPL MICROBIOL BIOT, V50, P447, DOI 10.1007/s002530051319; Saloheimo A, 2000, J BIOL CHEM, V275, P5817, DOI 10.1074/jbc.275.8.5817; Saloheimo M, 2003, MOL MICROBIOL, V47, P1149, DOI 10.1046/j.1365-2958.2003.03363.x; Saloheimo M, 2002, APPL ENVIRON MICROB, V68, P4546, DOI 10.1128/AEM.68.9.4546-4553.2002; Saloheimo M, 1999, MOL GEN GENET, V262, P35, DOI 10.1007/s004380051057; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Spanfo S, 1999, J BIOL CHEM, V274, P17705, DOI 10.1074/jbc.274.25.17705; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; vanGemeren IA, 1997, GENE, V198, P43, DOI 10.1016/S0378-1119(97)00290-4; WILEMAN T, 1991, J BIOL CHEM, V266, P4500; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	62	112	115	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					45011	45020		10.1074/jbc.M302372200	http://dx.doi.org/10.1074/jbc.M302372200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941955	hybrid			2022-12-27	WOS:000186306700138
J	Pfeifer, G; Schirmer, J; Leemhuis, J; Busch, C; Meyer, DK; Aktories, K; Barth, H				Pfeifer, G; Schirmer, J; Leemhuis, J; Busch, C; Meyer, DK; Aktories, K; Barth, H			Cellular uptake of Clostridium difficile toxin B - Translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOLOGICAL-CHANGES; RHO-PROTEINS; LOCALIZATION; INFECTION; GENE	Clostridium difficile toxin B (269 kDa) is one of the causative agents of antibiotic-associated diarrhea and pseudomembranous colitis. Toxin B acts in the cytosol of eukaryotic target cells where it inactivates Rho GTPases by monoglucosylation. The catalytic domain of toxin B is located at the N terminus ( amino acid residues 1 - 546). The C-terminal and the middle region of the toxin seem to be involved in receptor binding and translocation. Here we studied whether the full-length toxin or only a part of the holotoxin is translocated into the cytosol. Vero cells were treated with recombinant glutathione S-transferase-toxin B, and thereafter, toxin B fragments were isolated by affinity precipitation of the glutathione S-transferase-tagged protein from the cytosolic fraction of intoxicated cells. The toxin fragment (similar to65 kDa) was recognized by an antibody against the N terminus of toxin B and was identified by matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis as the catalytic domain of toxin B. The toxin fragment located in the cytosol possessed glucosyltransferase activity that could modify RhoA in vitro, but it was not able to intoxicate intact cells. After treatment of Vero cells with a radiolabeled fragment of toxin B ( amino acid residues 547 - 2366), radioactivity was identified in the membrane fraction of Vero cells but not in the cytosolic fraction of Vero cells. Furthermore, analysis of cells by fluorescence microscopy revealed that the C terminus of toxin B was located in endosomes, whereas the N terminus was detected in the cytosol. Protease inhibitors, which were added to the cell medium, delayed intoxication of cells by toxin B and pH-dependent translocation of the toxin from the cell surface across the cell membrane. The data indicate that toxin B is proteolytically processed during its cellular uptake process.	Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany	University of Freiburg	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Otto Krayer Haus,Albertstr 25, D-79104 Freiburg, Germany.		Barth, Holger/E-7920-2013; Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436				BARROSO LA, 1994, MICROB PATHOGENESIS, V16, P297, DOI 10.1006/mpat.1994.1030; Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; Borriello SP, 1998, J ANTIMICROB CHEMOTH, V41, P13, DOI 10.1093/jac/41.suppl_3.13; FREY SM, 1992, INFECT IMMUN, V60, P2488, DOI 10.1128/IAI.60.6.2488-2492.1992; Hildebrand B, 1997, BRAIN RES, V759, P285, DOI 10.1016/S0006-8993(97)00268-0; Hofmann F, 1997, J BIOL CHEM, V272, P11074; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kelly CP, 1998, ANNU REV MED, V49, P375; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Lyerly David M., 1995, P867; MULLER H, 1992, INFECT IMMUN, V60, P3007; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Spyres LM, 2003, INFECT IMMUN, V71, P3294, DOI 10.1128/IAI.71.6.3294-3301.2003; Spyres LM, 2001, INFECT IMMUN, V69, P599, DOI 10.1128/IAI.69.1.599-601.2001; Thelestam M, 2000, CURR TOP MICROBIOL, V250, P85; VONEICHELSTREIBER C, 1991, BIOCHEM SOC T, V19, P1154, DOI 10.1042/bst0191154; VONEICHELSTREIBER C, 1992, J BACTERIOL, V174, P6707, DOI 10.1128/JB.174.20.6707-6710.1992	18	105	111	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44535	44541		10.1074/jbc.M307540200	http://dx.doi.org/10.1074/jbc.M307540200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941936	hybrid			2022-12-27	WOS:000186306700082
J	Sun, M; Yang, L; Feldman, RI; Sun, XM; Bhalla, KN; Jove, R; Nicosia, SV; Cheng, JQ				Sun, M; Yang, L; Feldman, RI; Sun, XM; Bhalla, KN; Jove, R; Nicosia, SV; Cheng, JQ			Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85 alpha, androgen receptor, and Src	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-HA-RAS; ESTROGEN-RECEPTOR; PROSTATE-CANCER; GROWTH-FACTORS; REGULATORY SUBUNIT; STEROID-HORMONES; TYROSINE KINASES; BREAST-CANCER; DIRECT TARGET; CELLS	Recent studies have demonstrated that the cell growth and antiapoptotic actions of androgen could be dissociated from the transcriptional activity of the receptor and were, instead, mediated by activation of a mitogen-activated protein kinase pathway. This finding suggests an important cellular function of androgen receptor (AR) outside the nucleus. In this report, we demonstrate that androgen activates phosphatidylinositol 3-kinase (PI3K) and Akt, including AKT1 and AKT2, in AR-positive cells. Androgen-induced cell growth and survival were inhibited by PI3K inhibitor and dominant-negative Akt. AR interacts with the p85alpha regulatory subunit of PI3K, and its binding affinity is increased after androgen stimulation. The sites of interaction on the two proteins were mapped to the C-terminal Src-homology 2 domain of p85alpha and N terminus of AR. Activation of PI3K/Akt by androgen was inhibited by dominant-negative Src. Neither N-terminal-truncated nor proline-rich region-deleted AR mutants, which are unable to bind to p85alpha and Src, respectively, was able to mediate androgen-induced PI3K/Akt activation. AR with deletion of C-terminal region including ligand binding domain, however, retains the ability to activate PI3K/Akt upon androgen stimulation, which supports the notion that nongenomic function of androgen is mediated by its interaction with membrane receptors (1,3,4). These findings indicate that a triple complex between AR, p85alpha, and Src is required for androgen-stimulated PI3K/Akt activation, and that the PI3K/Akt pathway, in addition to mitogen-activated protein kinase, mediates androgen-induced cell growth and cell survival.	Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA; H Lee Moffitt Canc Ctr, Tampa, FL 33612 USA; Berlex Biosci, Dept Canc Res, Richmond, CA 94804 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute	Cheng, JQ (corresponding author), Univ S Florida, Coll Med, Dept Pathol, 12901 Bruce B Downs Blvd,MDC Box 11, Tampa, FL 33612 USA.			Bhalla, Kapil/0000-0001-5209-5126	NATIONAL CANCER INSTITUTE [R29CA077935, R01CA077935, R01CA089242] Funding Source: NIH RePORTER; NCI NIH HHS [CA89242, CA77935] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Castoria G, 1999, EMBO J, V18, P2500, DOI 10.1093/emboj/18.9.2500; Chan TO, 2002, CANCER CELL, V1, P181, DOI 10.1016/S1535-6108(02)00033-8; CHAN TO, 2001, SCI STKE, V66; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cheng JQ, 1997, ONCOGENE, V14, P2793, DOI 10.1038/sj.onc.1201121; CHENG JQ, 2001, CANC RES ENCY, P35; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Datta K, 1996, J BIOL CHEM, V271, P30835, DOI 10.1074/jbc.271.48.30835; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Heinlein CA, 2002, MOL ENDOCRINOL, V16, P2181, DOI 10.1210/me.2002-0070; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Irby RB, 2002, CANCER RES, V62, P2669; Jiang K, 2000, MOL CELL BIOL, V20, P139, DOI 10.1128/MCB.20.1.139-148.2000; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kurokawa H, 2000, CANCER RES, V60, P5887; Lagrange AH, 1997, MOL PHARMACOL, V51, P605, DOI 10.1124/mol.51.4.605; Levitzki A, 2002, EUR J CANCER, V38, pS11, DOI 10.1016/S0959-8049(02)80598-6; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu AX, 1998, CANCER RES, V58, P2973; LIU XQ, 1993, MOL CELL BIOL, V13, P5225, DOI 10.1128/MCB.13.9.5225; Luconi M, 2002, J STEROID BIOCHEM, V80, P369, DOI 10.1016/S0960-0760(02)00041-9; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; McManus EJ, 2002, NAT CELL BIOL, V4, pE214, DOI 10.1038/ncb0902-e214; Migliaccio A, 2002, J STEROID BIOCHEM, V83, P31, DOI 10.1016/S0960-0760(02)00264-9; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Nakhla AM, 1996, ENDOCRINOLOGY, V137, P4126, DOI 10.1210/en.137.10.4126; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Sun M, 2001, CANCER RES, V61, P5985; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Yuan ZQ, 2000, ONCOGENE, V19, P2324, DOI 10.1038/sj.onc.1203598	37	144	145	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					42992	43000		10.1074/jbc.M306295200	http://dx.doi.org/10.1074/jbc.M306295200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12933816	hybrid			2022-12-27	WOS:000186157000034
J	Wojtyra, UA; Thibault, G; Tuite, A; Houry, WA				Wojtyra, UA; Thibault, G; Tuite, A; Houry, WA			The N-terminal zinc binding domain of ClpX is a dimerization domain that modulates the chaperone function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASES; MU-TRANSPOSASE TETRAMER; HEAT-SHOCK-PROTEIN; ESCHERICHIA-COLI; DEGRADATION MACHINE; CRYSTAL-STRUCTURE; MOLECULAR CHAPERONE; HSP100 CHAPERONE; TAGGING SYSTEM; COMPLEX	Clp ATPases are unique chaperones that promote protein unfolding and subsequent degradation by proteases. The mechanism by which this occurs is poorly understood. Here we demonstrate that the N-terminal domain of ClpX is a C4-type zinc binding domain (ZBD) involved in substrate recognition. ZBD forms a very stable dimer that is essential for promoting the degradation of some typical ClpXP substrates such as lambdaO and MuA but not GFP-SsrA. Furthermore, experiments indicate that ZBD contains a primary binding site for the lambdaO substrate and for the cofactor SspB. Removal of ZBD from the ClpX sequence renders the ATPase activity of ClpX largely insensitive to the presence of ClpP, substrates, or the SspB cofactor. All these results indicate that ZBD plays an important role in the ClpX mechanism of function and that ATP binding and/or hydrolysis drives a conformational change in ClpX involving ZBD.	Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto	Houry, WA (corresponding author), Univ Toronto, Dept Biochem, Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	walid.houry@utoronto.ca	Thibault, Guillaume/J-9730-2013	Thibault, Guillaume/0000-0002-7926-4812				BAKER TA, 1993, CELL, V74, P723, DOI 10.1016/0092-8674(93)90519-V; Banecki B, 2001, J BIOL CHEM, V276, P18843, DOI 10.1074/jbc.M007507200; Barnett ME, 2000, J BIOL CHEM, V275, P37565, DOI 10.1074/jbc.M005211200; Beinker P, 2002, J BIOL CHEM, V277, P47160, DOI 10.1074/jbc.M207853200; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bohn C, 2002, MOL GENET GENOMICS, V266, P827, DOI 10.1007/s00438-001-0601-1; BOWIE JU, 1989, BIOCHEMISTRY-US, V28, P7139, DOI 10.1021/bi00444a001; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Clarke AK, 2000, J BACTERIOL, V182, P7092, DOI 10.1128/JB.182.24.7092-7096.2000; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; FLANAGAN JM, 1995, BIOCHEMISTRY-US, V34, P10910, DOI 10.1021/bi00034a025; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Guo FS, 2002, J BIOL CHEM, V277, P46753, DOI 10.1074/jbc.M208104200; Hoskins JR, 2000, P NATL ACAD SCI USA, V97, P8892, DOI 10.1073/pnas.97.16.8892; Hoskins JR, 2002, ADV PROTEIN CHEM, V59, P413; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; Li JZ, 2003, STRUCTURE, V11, P323, DOI 10.1016/S0969-2126(03)00030-3; Lo JH, 2001, PROTEIN SCI, V10, P551, DOI 10.1110/ps.41401; MHAMMEDIALAOUI A, 1994, MOL MICROBIOL, V11, P1109, DOI 10.1111/j.1365-2958.1994.tb00387.x; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Morgan GJ, 2002, J MOL BIOL, V317, P337, DOI 10.1006/jmbi.2002.5437; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Pace CN, 2000, PROTEINS, P1; Reid BG, 2001, P NATL ACAD SCI USA, V98, P3768, DOI 10.1073/pnas.071043698; ROBERTS JD, 1983, NUCLEIC ACIDS RES, V11, P7435, DOI 10.1093/nar/11.21.7435; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5; WAWRZYNOW A, 1995, EMBO J, V14, P1867, DOI 10.1002/j.1460-2075.1995.tb07179.x; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	43	84	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					48981	48990		10.1074/jbc.M307825200	http://dx.doi.org/10.1074/jbc.M307825200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12937164	hybrid, Green Published			2022-12-27	WOS:000186829000059
J	Cieslak, M; Szymanski, J; Adamiak, RW; Cierniewski, CS				Cieslak, M; Szymanski, J; Adamiak, RW; Cierniewski, CS			Structural Rearrangements of the 10-23 DNAzyme to beta 3 integrin subunit mRNA induced by cations and their relations to the catalytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ENDOTHELIAL-CELLS; RESONANCE ENERGY-TRANSFER; CLEAVING DNA ENZYME; HAMMERHEAD RIBOZYME; CLEAVAGE REACTION; METAL-IONS; MECHANISM; DNAZYMES; BINDING; INHIBITION	The intracellular ability of the "10-23" DNAzyme to efficiently inhibit expression of targeted proteins has been evidenced by in vitro and in vivo studies. However, standard conditions for kinetic measurements of the DNAzyme catalytic activity in vitro include 25 mM Mg2+, a concentration that is very unlikely to be achieved intracellularly. To study this discrepancy, we analyzed the folding transitions of the 10 - 23 DNAzyme induced by Mg2+. For this purpose, spectroscopic analyzes such as fluorescence resonance energy transfer, fluorescence anisotropy, circular dichroism, and surface plasmon resonance measurements were performed. The global geometry of the DNAzyme in the absence of added Mg2+ seems to be essentially extended, has no catalytic activity, and shows a very low binding affinity to its RNA substrate. The folding of the DNAzyme induced by binding of Mg2+ may occur in several distinct stages. The first stage, observed at 0.5 mM Mg2+, corresponds to the formation of a compact structure with limited binding properties and without catalytic activity. Then, at 5 mM Mg2+, flanking arms are projected at right position and angles to bind RNA. In such a state, DNAzyme shows substantial binding to its substrate and significant catalytic activity. Finally, the transition occurring at 15 mM Mg2+ leads to the formation of the catalytic domain, and DNAzyme shows high binding affinity toward substrate and efficient catalytic activity. Under conditions simulating intracellular conditions, the DNAzyme was only partially folded, did not bind to its substrate, and showed only residual catalytic activity, suggesting that it may be inactive in the transfected cells and behave like antisense oligodeoxynucleotide.	Med Univ Lodz, Dept Mol & Med Biophys, PL-92215 Lodz, Poland; Polish Acad Sci, Ctr Mol & Macromol Studies, PL-92215 Lodz, Poland; Polish Acad Sci, Dept Med Biol & Microbiol, PL-92215 Lodz, Poland; Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland	Medical University Lodz; Polish Academy of Sciences; Centre of Molecular & Macromolecular Studies of the Polish Academy of Sciences; Polish Academy of Sciences; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Cierniewski, CS (corresponding author), Med Univ Lodz, Dept Mol & Med Biophys, 6-8 Mazowiecka St, PL-92215 Lodz, Poland.		Adamiak, Ryszard W/W-5089-2018; Cieslak, Marcin/ABF-2494-2020	Adamiak, Ryszard W/0000-0001-8914-9618; Cieslak, Marcin/0000-0002-9628-214X				Bassi GS, 1997, EMBO J, V16, P7481, DOI 10.1093/emboj/16.24.7481; BONDESON K, 1993, ANAL BIOCHEM, V214, P245, DOI 10.1006/abio.1993.1484; BREAKER RR, 1995, CHEM BIOL, V2, P655, DOI 10.1016/1074-5521(95)90028-4; BRUKNER I, 1994, J MOL BIOL, V236, P26, DOI 10.1006/jmbi.1994.1115; Chiu TK, 2000, J MOL BIOL, V301, P915, DOI 10.1006/jmbi.2000.4012; CIERNIEWSKI CS, 1995, EUR J BIOCHEM, V227, P494, DOI 10.1111/j.1432-1033.1995.tb20415.x; Cieslak M, 2002, J BIOL CHEM, V277, P6779, DOI 10.1074/jbc.M102325200; Clark CL, 1997, NUCLEIC ACIDS RES, V25, P4098, DOI 10.1093/nar/25.20.4098; CLEGG RM, 1993, P NATL ACAD SCI USA, V90, P2994, DOI 10.1073/pnas.90.7.2994; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Dahlgren PR, 2002, BIOCHEMISTRY-US, V41, P11372, DOI 10.1021/bi026102e; DAHM SC, 1991, BIOCHEMISTRY-US, V30, P9464, DOI 10.1021/bi00103a011; Dass CR, 2002, ANTISENSE NUCLEIC A, V12, P289, DOI 10.1089/108729002761381276; FAIRALL L, 1989, EMBO J, V8, P1809, DOI 10.1002/j.1460-2075.1989.tb03575.x; He QC, 2002, BIOMACROMOLECULES, V3, P69, DOI 10.1021/bm010095c; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; JAFFE EA, 1976, J EXP MED, V144, P209, DOI 10.1084/jem.144.1.209; Khachigian LM, 2002, CURR OPIN MOL THER, V4, P119; KUMAR PKR, 1996, NUCL ACIDS MOL BIOL, V10, P217; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Liu CH, 2001, BIOCHEM BIOPH RES CO, V284, P1077, DOI 10.1006/bbrc.2001.5077; McKay DB, 1996, RNA, V2, P395; MOORE DS, 1974, BIOPOLYMERS, V13, P977, DOI 10.1002/bip.1974.360130512; Okumoto Y, 2000, J INORG BIOCHEM, V82, P189, DOI 10.1016/S0162-0134(00)00159-8; Ota N, 1998, NUCLEIC ACIDS RES, V26, P3385, DOI 10.1093/nar/26.14.3385; PLEY HW, 1994, NATURE, V372, P111, DOI 10.1038/372111a0; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; RUFFNER DE, 1990, BIOCHEMISTRY-US, V29, P10695, DOI 10.1021/bi00499a018; Santoro SW, 1998, BIOCHEMISTRY-US, V37, P13330, DOI 10.1021/bi9812221; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Scott WG, 1996, SCIENCE, V274, P2065, DOI 10.1126/science.274.5295.2065; Scott WG, 1996, TRENDS BIOCHEM SCI, V21, P220; SCOTT WG, 1995, CELL, V81, P991, DOI 10.1016/S0092-8674(05)80004-2; SOYFER VN, 1966, TRIPLE HELICAL NUCL, P360; WELCH JB, 1993, NUCLEIC ACIDS RES, V21, P4548, DOI 10.1093/nar/21.19.4548; Zhang L, 2002, CANCER RES, V62, P5463; Zhou DM, 1996, J AM CHEM SOC, V118, P5862, DOI 10.1021/ja9606790; ZUKER M, 2003, NUCLEIC ACIDS RES, V31, P1	38	61	62	6	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47987	47996		10.1074/jbc.M300504200	http://dx.doi.org/10.1074/jbc.M300504200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12952967	hybrid			2022-12-27	WOS:000186731400077
J	Jendreyko, N; Popkov, M; Beerli, RR; Chung, JH; McGavern, DB; Rader, C; Barbas, CF				Jendreyko, N; Popkov, M; Beerli, RR; Chung, JH; McGavern, DB; Rader, C; Barbas, CF			Intradiabodies, bispecific, tetravalent antibodies for the simultaneous functional knockout of two cell surface receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHAIN ANTIBODY; GROWTH-FACTOR; GENE-THERAPY; IN-VIVO; INTRACELLULAR IMMUNIZATION; TUMOR ANGIOGENESIS; HIV-1 INFECTION; TUBE FORMATION; INTRABODIES; INHIBITION	The specific and high affinity binding properties of intracellular antibodies (intrabodies), combined with their ability to be stably expressed in defined organelles, provides powerful tools with a wide range of applications in the field of functional genomics and gene therapy. Intrabodies have been used to specifically target intracellular proteins, manipulate biological processes, and contribute to the understanding of their functions as well as for the generation of phenotypic knockouts in vivo by surface depletion of extracellular or transmembrane proteins. In order to study the biological consequences of knocking down two receptor-tyrosine kinases, we developed a novel intrabody-based strategy. Here we describe the design, engineering, and characterization of a bispecific, tetravalent endoplasmic reticulum (ER)-targeted intradiabody for simultaneous surface depletion of two endothelial transmembrane receptors, Tie-2 and vascular endothelial growth factor receptor 2 (VEGF-R2). Comparison of the ER-targeted intradiabody with the corresponding conventional ER-targeted single-chain antibody fragment ( scFv) intrabodies demonstrated that the intradiabody is significantly more efficient with respect to efficiency and duration of surface depletion of Tie-2 and VEGF-R2. In vitro endothelial cell tube formation assays suggest that the bispecific intradiabody exhibits strong antiangiogenic activity, whereas the effect of the monospecific scFv intrabodies was weaker. These findings suggest that simultaneous interference with the VEGF and the Tie-2 receptor pathways results in at least additive antiangiogenic effects, which may have implications for future drug developments. In conclusion, we have identified a highly effective ER-targeted intrabody format for the simultaneous functional knockout of two cell surface receptors.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Rader, C (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		McGavern, Dorian/HCH-3601-2022; Chung, Junho/J-2792-2012	McGavern, Dorian/0000-0001-9568-545X; Rader, Christoph/0000-0001-9955-3454	NCI NIH HHS [CA 94966, CA 86258] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA094966, R01CA086258] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bai JR, 2003, J BIOL CHEM, V278, P1433, DOI 10.1074/jbc.M208297200; Barbas C.F., 2001, PHAGE DISPLAY LAB MA; BEERLI RR, 1994, J BIOL CHEM, V269, P23931; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Coloma MJ, 1997, NAT BIOTECHNOL, V15, P159, DOI 10.1038/nbt0297-159; Dallabrida SM, 2000, J BIOL CHEM, V275, P32281, DOI 10.1074/jbc.M001446200; Deshane J, 1995, J CLIN INVEST, V96, P2980, DOI 10.1172/JCI118370; Deshane J, 1997, GYNECOL ONCOL, V64, P378, DOI 10.1006/gyno.1996.4566; FitzGerald K, 1997, PROTEIN ENG, V10, P1221, DOI 10.1093/protein/10.10.1221; Goldman CK, 1998, P NATL ACAD SCI USA, V95, P8795, DOI 10.1073/pnas.95.15.8795; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Henderson AM, 2001, J BIOL CHEM, V276, P6169, DOI 10.1074/jbc.M008506200; Hitt DC, 2000, MOL BIOTECHNOL, V14, P197, DOI 10.1385/MB:14:3:197; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Hudson PJ, 2003, NAT MED, V9, P129, DOI 10.1038/nm0103-129; Lener M, 2000, EUR J BIOCHEM, V267, P1196, DOI 10.1046/j.1432-1327.2000.01125.x; Lin PN, 1997, J CLIN INVEST, V100, P2072, DOI 10.1172/JCI119740; Lin PN, 1998, P NATL ACAD SCI USA, V95, P8829, DOI 10.1073/pnas.95.15.8829; Marasco WA, 1997, GENE THER, V4, P11, DOI 10.1038/sj.gt.3300346; MARASCO WA, 1993, P NATL ACAD SCI USA, V90, P7889, DOI 10.1073/pnas.90.16.7889; Marasco WA, 1998, HUM GENE THER, V9, P1627, DOI 10.1089/hum.1998.9.11-1627; Maur AAD, 2002, J BIOL CHEM, V277, P45075, DOI 10.1074/jbc.M205264200; MHASHILKAR AM, 1995, EMBO J, V14, P1542, DOI 10.1002/j.1460-2075.1995.tb07140.x; Millauer B, 1996, CANCER RES, V56, P1615; Muller KM, 1998, FEBS LETT, V432, P45, DOI 10.1016/S0014-5793(98)00829-1; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Popkov M, 2003, J MOL BIOL, V325, P325, DOI 10.1016/S0022-2836(02)01232-9; Rader C, 2000, J BIOL CHEM, V275, P13668, DOI 10.1074/jbc.275.18.13668; Rader C, 2002, FASEB J, V16, P2000, DOI 10.1096/fj.02-0281fje; Rajpal A, 2001, J BIOL CHEM, V276, P33139, DOI 10.1074/jbc.M101332200; Ruberti F, 2000, J NEUROSCI, V20, P2589; Siemeister G, 1999, CANCER RES, V59, P3185; Steinberger P, 2000, P NATL ACAD SCI USA, V97, P805, DOI 10.1073/pnas.97.2.805; Strube RW, 2002, J IMMUNOL METHODS, V263, P149, DOI 10.1016/S0022-1759(02)00035-2; Todorovska A, 2001, J IMMUNOL METHODS, V248, P47, DOI 10.1016/S0022-1759(00)00342-2; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; Wagner RW, 1997, MOL MED TODAY, V3, P31, DOI 10.1016/S1357-4310(96)10053-8; Zhu QA, 1999, J IMMUNOL METHODS, V231, P207, DOI 10.1016/S0022-1759(99)00158-1	39	45	99	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47812	47819		10.1074/jbc.M307002200	http://dx.doi.org/10.1074/jbc.M307002200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12947084	hybrid			2022-12-27	WOS:000186731400057
J	Bretscher, LE; Li, HY; Poulos, TL; Griffith, OW				Bretscher, LE; Li, HY; Poulos, TL; Griffith, OW			Structural characterization and kinetics of nitric-oxide synthase inhibition by novel N-5-(iminoalkyl)- and N-5-(iminoalkenyl)-ornithines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHLY SELECTIVE INHIBITOR; METHYL-L-ARGININE; NG-METHYLARGININE; ESCHERICHIA-COLI; MECHANISM; INACTIVATION; MACROPHAGE; BINDING; ISOFORMS; POTENT	Isoform-specific nitric-oxide synthase (NOS) inhibitors may prove clinically useful in reducing the pathophysiological effects associated with increased neuronal NOS ( nNOS) or inducible NOS (iNOS) activity in a variety of neurological and inflammatory disorders. Analogs of the NOS substrate L-arginine are pharmacologically attractive inhibitors because of their stability, reliable cell uptake, and good selectivity for NOS over other heme proteins. Some inhibitory arginine analogs show significant isoform selectivity although the structural or mechanistic basis of such selectivity is generally poorly understood. In the present studies, we determined by x-ray crystallography the binding interactions between rat nNOS and N-5-(1-imino-3-butenyl)-L-ornithine (L-VNIO), a previously identified mechanism-based, irreversible inactivator with moderate nNOS selectivity. We have also synthesized and mechanistically characterized several L-VNIO analogs and find, surprisingly, that even relatively minor structural changes produce inhibitors that are either iNOS-selective or nonselective. Furthermore, derivatives having a methyl group added to the butenyl moiety of L-VNIO and L-VNIO derivatives that are analogs of homoarginine rather than arginine display slow-on, slow-off kinetics rather than irreversible inactivation. These results elucidate some of the structural requirements for isoform-selective inhibition by L-VNIO and its related alkyl- and alkenylimino ornithine and lysine derivatives and may provide information useful in the ongoing rational design of isoform-selective inhibitors.	Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Program Macromol Struct, Irvine, CA 92697 USA	Medical College of Wisconsin; University of California System; University of California Irvine; University of California System; University of California Irvine	Griffith, OW (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.				NIDDK NIH HHS [DK 48423] Funding Source: Medline; NIGMS NIH HHS [GM 57353] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057353] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AISAKA K, 1989, BIOCHEM BIOPH RES CO, V160, P881, DOI 10.1016/0006-291X(89)92517-5; Babu BR, 1998, CURR OPIN CHEM BIOL, V2, P491, DOI 10.1016/S1367-5931(98)80125-7; Babu BR, 1998, J BIOL CHEM, V273, P8882, DOI 10.1074/jbc.273.15.8882; Babu BR, 1999, J BIOL CHEM, V274, P25218, DOI 10.1074/jbc.274.36.25218; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryk R, 1999, PHARMACOL THERAPEUT, V84, P157, DOI 10.1016/S0163-7258(99)00030-3; Chabrier PE, 1999, CELL MOL LIFE SCI, V55, P1029, DOI 10.1007/s000180050353; Cooper GR, 2000, ARCH BIOCHEM BIOPHYS, V375, P183, DOI 10.1006/abbi.1999.1658; Cotter G, 2000, CIRCULATION, V101, P1358, DOI 10.1161/01.CIR.101.12.1358; Fast W, 1997, BIOORGAN MED CHEM, V5, P1601, DOI 10.1016/S0968-0896(97)00109-0; Feelisch M., 1996, METHODS NITRIC OXIDE, P455; FELDMAN PL, 1993, J MED CHEM, V36, P491, DOI 10.1021/jm00056a009; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; FURFINE ES, 1994, J BIOL CHEM, V269, P26677; FURFINE ES, 1993, BIOCHEMISTRY-US, V32, P8512, DOI 10.1021/bi00084a017; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Garvey EP, 1996, METHOD ENZYMOL, V268, P339; Gerber NC, 1997, ARCH BIOCHEM BIOPHYS, V343, P249, DOI 10.1006/abbi.1997.0187; Griffith OW, 1996, METHOD ENZYMOL, V268, P375; Griffith OW, 1997, ADV ENZYME REGUL, V37, P171, DOI 10.1016/S0065-2571(96)00008-8; GROSS SS, 1990, BIOCHEM BIOPH RES CO, V170, P96, DOI 10.1016/0006-291X(90)91245-N; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; Hallinan EA, 1998, J MED CHEM, V41, P775, DOI 10.1021/jm9706675; Hobbs AJ, 1999, ANNU REV PHARMACOL, V39, P191, DOI 10.1146/annurev.pharmtox.39.1.191; Huang PL, 1998, PROG BRAIN RES, V118, P13; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KILBOURN RG, 1990, BIOCHEM BIOPH RES CO, V172, P1132, DOI 10.1016/0006-291X(90)91565-A; Lassen LH, 1997, LANCET, V349, P401, DOI 10.1016/S0140-6736(97)80021-9; Li HY, 1999, J BIOL CHEM, V274, P21276, DOI 10.1074/jbc.274.30.21276; Li HY, 2002, BIOCHEMISTRY-US, V41, P13868, DOI 10.1021/bi020417c; Li HY, 2001, BIOCHEMISTRY-US, V40, P5399, DOI 10.1021/bi002658v; MASTERS BSS, 1996, METH NEUROSCI, V31, P140; Matsui T, 1999, CELL MOL NEUROBIOL, V19, P177, DOI 10.1023/A:1006966012266; MCCALL TB, 1991, BRIT J PHARMACOL, V102, P234, DOI 10.1111/j.1476-5381.1991.tb12159.x; Moali C, 1998, BIOCHEMISTRY-US, V37, P10453, DOI 10.1021/bi980742t; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; OLKEN NM, 1994, BIOCHEMISTRY-US, V33, P14784, DOI 10.1021/bi00253a017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAND MJ, 1995, ANNU REV PHYSIOL, V57, P659; RodriguezCrespo I, 1996, ARCH BIOCHEM BIOPHYS, V336, P151, DOI 10.1006/abbi.1996.0543; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Symeonides S, 1999, INFECT DIS CLIN N AM, V13, P449, DOI 10.1016/S0891-5520(05)70085-4; Thomsen LL, 1997, ANN NY ACAD SCI, V835, P363, DOI 10.1111/j.1749-6632.1997.tb48642.x; Thomsen LL, 2001, CURR OPIN NEUROL, V14, P315, DOI 10.1097/00019052-200106000-00009; Wolff DJ, 1996, ARCH BIOCHEM BIOPHYS, V325, P227, DOI 10.1006/abbi.1996.0028; Zhang HQ, 1997, J MED CHEM, V40, P3869, DOI 10.1021/jm970550g; Zhang HQ, 1997, J AM CHEM SOC, V119, P10888, DOI 10.1021/ja964160f	51	35	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46789	46797		10.1074/jbc.M306787200	http://dx.doi.org/10.1074/jbc.M306787200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12960153	hybrid			2022-12-27	WOS:000186569400070
J	Fisette, PL; Ram, S; Andersen, JM; Guo, W; Ingalls, RR				Fisette, PL; Ram, S; Andersen, JM; Guo, W; Ingalls, RR			The Lip lipoprotein from Neisseria gonorrhoeae stimulates cytokine release and NF-kappa B activation in epithelial cells in a toll-like receptor 2-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE-DEFICIENT MUTANT; OUTER-MEMBRANE PROTEIN; INNATE IMMUNE-SYSTEM; CUTTING EDGE; PATHOGENIC NEISSERIA; MICROBIAL LIPOPROTEINS; BACTERIAL LIPOPROTEINS; MODIFIED AZURIN; H.8 ANTIGEN; TLR 2	The human pathogen Neisseria gonorrhoeae produces an array of diseases ranging from urethritis to disseminated gonococcal infections. Early events in the establishment of infection involve interactions between N. gonorrhoeae and the mucosal epithelium, which leads to the local release of inflammatory mediators. Because of this, it is important to identify the bacterial virulence factors and host cell components that contribute to inflammation. Using a series of column chromatography steps, we purified a lipoprotein from N. gonorrhoeae strain F62 called Lip. This outer membrane antigen expresses a conserved epitope known as H. 8, which is common to all pathogenic Neisseria species. We found the purified preparation of Lip to be a potent inflammatory mediator capable of inducing the release of the chemokine interleukin ( IL)-8 and the cytokine IL-6 by immortalized human endocervical epithelial cells and the production of IL-8 and the activation of the transcription factor NF-kappaB by human embryonic kidney 293 (HEK) cells transfected with toll-like receptor (TLR) 2. Upon removal of Lip by immunoprecipitation, the ability of the H.8/Lip preparation to stimulate NF-kappaB activation was abolished. In addition to TLR2, the activation of NF-kappaB by H.8/Lip in HEK cells was enhanced upon coexpression of TLR1 but not TLR6. These observations provide evidence that Lip is capable of inducing the release of inflammatory mediators from epithelial cells in a TLR2-dependent manner.	Boston Univ, Sch Med, Div Infect Dis, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Physiol & Biophys, Obes Res Unit, Boston, MA 02118 USA; Norwegian Univ Sci & Technol, N-7489 Trondheim, Norway	Boston University; Boston University; Norwegian University of Science & Technology (NTNU)	Ingalls, RR (corresponding author), Boston Univ, Sch Med, Div Infect Dis, EBRC Bldg,Rm 615,650 Albany St, Boston, MA 02118 USA.			Guo, Wen/0000-0002-4474-2837; Ingalls, Robin/0000-0003-2197-7198	NHLBI NIH HHS [T32 HL 07501] Funding Source: Medline; NIAID NIH HHS [AI 38515, AI 46613, T32 AI 52070, AI 32725] Funding Source: Medline; NIDDK NIH HHS [DK 59261] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032725, R37AI032725, U19AI038515, R01AI046613, T32AI052070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059261] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; APICELLA MA, 1990, J INFECT DIS, V162, P506, DOI 10.1093/infdis/162.2.506; BAEHR W, 1989, MOL MICROBIOL, V2, P49; BHATTACHARJEE AK, 1988, INFECT IMMUN, V56, P773, DOI 10.1128/IAI.56.4.773-778.1988; BISWAS GD, 1977, J BACTERIOL, V129, P983, DOI 10.1128/JB.129.2.983-992.1977; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; CANNON JG, 1989, CLIN MICROBIOL REV, V2, pS1, DOI 10.1128/CMR.2.Suppl.S1-S4.1989; CANNON JG, 1984, INFECT IMMUN, V43, P994, DOI 10.1128/IAI.43.3.994-999.1984; CARBONETTI N, 1990, MOL MICROBIOL, V4, P1009, DOI 10.1111/j.1365-2958.1990.tb00673.x; CHEN CY, 1984, PATHOGENIC NEISSERIA, P360; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; DENSEN P, 1987, J CLIN INVEST, V80, P78, DOI 10.1172/JCI113067; Fichorova RN, 2001, INFECT IMMUN, V69, P5840, DOI 10.1128/IAI.69.9.5840-5848.2001; Fichorova RN, 2002, J IMMUNOL, V168, P2424, DOI 10.4049/jimmunol.168.5.2424; GNEHM HE, 1985, J CLIN INVEST, V75, P1645, DOI 10.1172/JCI111872; GOTSCHLICH EC, 1987, FEMS MICROBIOL LETT, V43, P253; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; Harvey HA, 2002, INFECT IMMUN, V70, P5808, DOI 10.1128/IAI.70.10.5808-5815.2002; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; HITCHCOCK PJ, 1985, J EXP MED, V162, P2017, DOI 10.1084/jem.162.6.2017; Hobbs MM, 1999, J INFECT DIS, V179, P371, DOI 10.1086/314608; HOEHN GT, 1992, INFECT IMMUN, V60, P4704, DOI 10.1128/IAI.60.11.4704-4708.1992; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ingalls RR, 2001, INFECT IMMUN, V69, P2230, DOI 10.1128/IAI.69.4.2230-2236.2001; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; KAWULA TH, 1987, MOL MICROBIOL, V1, P179, DOI 10.1111/j.1365-2958.1987.tb00510.x; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; MANTHEY CL, 1994, J IMMUNOL, V153, P2653; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Means TK, 1999, J IMMUNOL, V163, P3920; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Naumann M, 1997, J EXP MED, V186, P247, DOI 10.1084/jem.186.2.247; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pridmore AC, 2001, J INFECT DIS, V183, P89, DOI 10.1086/317647; SCHNEIDER H, 1982, J GEN MICROBIOL, V128, P13; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; STRITTMATTER W, 1986, J EXP MED, V164, P2038, DOI 10.1084/jem.164.6.2038; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Trees DL, 2000, J CLIN MICROBIOL, V38, P2914, DOI 10.1128/JCM.38.8.2914-2916.2000; WAGNER DA, 1983, P NATL ACAD SCI-BIOL, V80, P4518, DOI 10.1073/pnas.80.14.4518; WESTPHAL O, 1952, Z NATURFORSCH B, V7, P148, DOI 10.1515/znb-1952-0303; WOODS JP, 1989, MOL MICROBIOL, V3, P43, DOI 10.1111/j.1365-2958.1989.tb00102.x; WOODS JP, 1989, MOL MICROBIOL, V3, P583, DOI 10.1111/j.1365-2958.1989.tb00205.x; Wyllie DH, 2000, J IMMUNOL, V165, P7125, DOI 10.4049/jimmunol.165.12.7125; Yoshimura A, 1999, J IMMUNOL, V163, P1; ZOLLINGER W, 1984, PATHOGENIC NEISSERIA, P579	52	85	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46252	46260		10.1074/jbc.M306587200	http://dx.doi.org/10.1074/jbc.M306587200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12966099	hybrid			2022-12-27	WOS:000186569400008
J	Marinissen, MJ; Servitja, JM; Offermanns, S; Simon, MI; Gutkind, JS				Marinissen, MJ; Servitja, JM; Offermanns, S; Simon, MI; Gutkind, JS			Thrombin protease-activated receptor-1 signals through G(q)- and G(13)-initiated MAPK cascades regulating c-Jun expression to induce cell transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; EARLY GENE-EXPRESSION; SMOOTH-MUSCLE-CELLS; NIH 3T3 CELLS; COUPLED RECEPTORS; ALPHA-SUBUNIT; BINDING PROTEINS; KINASE PATHWAY; MALIGNANT TRANSFORMATION; TYROSINE PHOSPHORYLATION	Although the ability of G protein-coupled receptors to stimulate normal and aberrant cell growth has been intensely investigated, the precise nature of the molecular mechanisms underlying their transforming potential are still not fully understood. In this study, we have taken advantage of the potent mitogenic effect of thrombin and the focus-forming activity of one of its receptors, protease-activated receptor-1, to dissect how this receptor coupled to Galpha(i), Galpha(q/11), and Galpha(12/13) transduces signals from the membrane to the nucleus to initiate transcriptional events involved in cell transformation. Using endogenous and transfected thrombin receptors in NIH 3T3 cells, ectopic expression of muscarinic receptors coupled to Galpha(q) and Galpha(i), and chimeric G protein alpha subunits and murine fibroblasts deficient in Galpha(q/11), and Galpha(12/13), we show here that, although coupling to Galpha(i) is sufficient to induce ERK activation, the ability to couple to Galpha(q) and/or Galpha(13) is necessary to induce c-jun expression and cell transformation. Furthermore, we show that Galpha(q) and Galpha(13) can initiate the activation of MAPK cascades, including JNK, p38, and ERK5, which in turn regulate the activity of transcription factors controlling expression from the c-jun promoter. We also present evidence that c-Jun and the kinases regulating its expression are integral components of the transforming pathway initiated by protease-activated receptor-1.	NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; CALTECH, Dept Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Univ Heidelberg, Inst Pharmacol, Dept Mol Pharmacol, D-69120 Heidelberg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Ruprecht Karls University Heidelberg	Gutkind, JS (corresponding author), NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bldg 30,Rm 211,9000 Rockville Pike, Bethesda, MD 20892 USA.		Gutkind, J. Silvio/J-1201-2016; Gutkind, J. Silvio/A-1053-2009; Offermanns, Stefan/L-3313-2017	Gutkind, J. Silvio/0000-0002-5150-4482; SERVITJA, JOAN-MARC/0000-0002-1241-8004; Offermanns, Stefan/0000-0001-8676-6805	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551, ZIADE000558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000558, Z01DE000551] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AARONSON SA, 1991, SCIENCE, V254, P1146, DOI 10.1126/science.1659742; ALLEN LF, 1991, P NATL ACAD SCI USA, V88, P11354, DOI 10.1073/pnas.88.24.11354; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; BROWN PH, 1993, ONCOGENE, V8, P877; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; Clarke N, 1998, MOL CELL BIOL, V18, P1065, DOI 10.1128/MCB.18.2.1065; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Coso OA, 1997, J BIOL CHEM, V272, P20691, DOI 10.1074/jbc.272.33.20691; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GUTKIND JS, 1991, P NATL ACAD SCI USA, V88, P4703, DOI 10.1073/pnas.88.11.4703; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Han JH, 1997, FEBS LETT, V403, P19, DOI 10.1016/S0014-5793(97)00021-5; HAN TH, 1995, MOL CELL BIOL, V15, P2907; HAN TH, 1992, MOL CELL BIOL, V12, P4472, DOI 10.1128/MCB.12.10.4472; Heasley LE, 2001, ONCOGENE, V20, P1563, DOI 10.1038/sj.onc.1204183; HERMOUET S, 1991, P NATL ACAD SCI USA, V88, P10455, DOI 10.1073/pnas.88.23.10455; HERR I, 1994, CARCINOGENESIS, V15, P1105, DOI 10.1093/carcin/15.6.1105; Janulis M, 1999, J BIOL CHEM, V274, P801, DOI 10.1074/jbc.274.2.801; JULIUS D, 1989, SCIENCE, V244, P1057, DOI 10.1126/science.2727693; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; O'Brien PJ, 2001, ONCOGENE, V20, P1570, DOI 10.1038/sj.onc.1204194; Offermanns S, 2001, ONCOGENE, V20, P1635, DOI 10.1038/sj.onc.1204189; Offermanns S, 1998, ONCOGENE, V17, P1375, DOI 10.1038/sj.onc.1202173; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Rao GN, 1996, J BIOL CHEM, V271, P20805, DOI 10.1074/jbc.271.34.20805; ROTHMAN A, 1994, J BIOL CHEM, V269, P6399; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMITH SE, 1993, NUCLEIC ACIDS RES, V21, P1581, DOI 10.1093/nar/21.7.1581; STEPHENS EV, 1993, ONCOGENE, V8, P19; Teramoto H, 1997, J BIOL CHEM, V272, P10751; Teramoto H, 1996, J BIOL CHEM, V271, P25731, DOI 10.1074/jbc.271.42.25731; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; TREJO J, 1992, MOL CELL BIOL, V12, P4742, DOI 10.1128/MCB.12.10.4742; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; vanLeeuwen FN, 1995, ONCOGENE, V11, P2215; VanObberghenSchilling E, 1995, ANN NY ACAD SCI, V766, P431, DOI 10.1111/j.1749-6632.1995.tb26692.x; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; WHITEHEAD I, 1995, MOL CELL BIOL, V15, P704; Whitehead IP, 1998, MOL CELL BIOL, V18, P4689, DOI 10.1128/MCB.18.8.4689; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; XU NZ, 1994, BIOCHEM BIOPH RES CO, V201, P603, DOI 10.1006/bbrc.1994.1744; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	63	79	80	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46814	46825		10.1074/jbc.M305709200	http://dx.doi.org/10.1074/jbc.M305709200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12954641	Green Accepted, hybrid			2022-12-27	WOS:000186569400073
J	Witt, H; Bordignon, E; Carbonera, D; Dekker, JP; Karapetyan, N; Teutloff, C; Webber, A; Lubitz, W; Schlodder, E				Witt, H; Bordignon, E; Carbonera, D; Dekker, JP; Karapetyan, N; Teutloff, C; Webber, A; Lubitz, W; Schlodder, E			Species-specific differences of the spectroscopic properties of P700 - Analysis of the influence of non-conserved amino acid residues by site-directed mutagenesis of photosystem I from Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY ELECTRON-DONOR; REACTION CENTERS; CHLOROPHYLL-A; EXTINCTION COEFFICIENTS; CONSERVED HISTIDINES; PROTEIN COMPLEX; AXIAL LIGANDS; ABSORPTION; STATE; ARRANGEMENT	We applied optical spectroscopy, magnetic resonance techniques, and redox titrations to investigate the properties of the primary electron donor P700 in photosystem I (PS I) core complexes from cyanobacteria (Thermosynechococcus elongatus, Spirulina platensis, and Synechocystis sp. PCC 6803), algae (Chlamydomonas reinhardtii CC2696), and higher plants (Spinacia oleracea). Remarkable species-specific differences of the optical properties of P700 were revealed monitoring the ((3)P700-P700) and (P700(+.)-P700) absorbance and CD difference spectra. The main bleaching band in the Q(y) region differs in peak position and line width for the various species. In cyanobacteria the absorbance of P700 extends more to the red compared with algae and higher plants which is favorable for energy transfer from red core antenna chlorophylls to P700 in cyanobacteria. The amino acids in the environment of P700 are highly conserved with two distinct deviations. In C. reinhardtii a Tyr is found at position PsaB659 instead of a Trp present in all other organisms, whereas in Synechocystis a Phe is found instead of a Trp at the homologous position PsaA679. We constructed several mutants in C. reinhardtii CC2696. Strikingly, no PS I could be detected in the mutant YW B659 indicating steric constraints unique to this organism. In the mutants WA A679 and YA B659 significant changes of the spectral features in the ((3)P700 - P700), the (P700(+.)-P700) absorbance difference and in the (P700(+.)-P700) CD difference spectra are induced. The results indicate structural differences among PS I from higher plants, algae, and cyanobacteria and give further insight into specific protein-cofactor interactions contributing to the optical spectra.	Tech Univ Berlin, Max Volmer Lab Biophys Chem, D-10623 Berlin, Germany; Univ Padua, Dipartimento Chim Fis, I-35131 Padua, Italy; Russian Acad Sci, AN Bakh Biochem Inst, Moscow 119071, Russia; Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; Arizona State Univ, Dept Plant Biol, Ctr Study Early Events Photosynth, Tempe, AZ 85287 USA; MPI Bioanorgan Chem, D-45470 Mulheim, Germany	Technical University of Berlin; University of Padua; Research Center of Biotechnology RAS; Russian Academy of Sciences; Vrije Universiteit Amsterdam; Arizona State University; Arizona State University-Tempe	Witt, H (corresponding author), Tech Univ Berlin, Max Volmer Lab Biophys Chem, Str 17 Juni 135, D-10623 Berlin, Germany.	h.witt.berlin@web.de; eber0535@mailbox.tu-berlin.de	Carbonera, Donatella/B-4219-2018; Schlodder, Eberhard/AAP-6766-2021	Carbonera, Donatella/0000-0002-5499-1140; Bordignon, Enrica/0000-0003-2450-5161				ANGERHOFER A, 1991, CHLOROPHYLLS, P945; Baymann D, 2001, BBA-BIOENERGETICS, V1507, P291, DOI 10.1016/S0005-2728(01)00209-2; Breton J, 2001, BBA-BIOENERGETICS, V1507, P180, DOI 10.1016/S0005-2728(01)00206-7; Brettel K, 1997, BBA-BIOENERGETICS, V1318, P322, DOI 10.1016/S0005-2728(96)00112-0; Byrdin M, 2002, BIOPHYS J, V83, P433, DOI 10.1016/S0006-3495(02)75181-3; Carbonera D, 1997, BBA-BIOENERGETICS, V1322, P115, DOI 10.1016/S0005-2728(97)00068-6; Cometta A, 2000, BIOPHYS J, V79, P3235, DOI 10.1016/S0006-3495(00)76556-8; CUI LY, 1995, BIOCHEMISTRY-US, V34, P1549, DOI 10.1021/bi00005a011; FLEMMING C, 1995, THESIS TU BERLIN; Fromme P, 1998, BBA-BIOENERGETICS, V1365, P175, DOI 10.1016/S0005-2728(98)00059-0; FROMME P, 2003, LIGHT HARVESTING ANT, P253; GILLIE JK, 1989, PHOTOSYNTH RES, V22, P233, DOI 10.1007/BF00048302; Gobets B, 2001, BIOPHYS J, V81, P407, DOI 10.1016/S0006-3495(01)75709-8; Guergova-Kuras M, 2001, P NATL ACAD SCI USA, V98, P4437, DOI 10.1073/pnas.081078898; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; HEATHCOTE P, 2001, BIOCH BIOPHYS ACTA, V1507; Hippler M, 1998, BBA-BIOENERGETICS, V1367, P1, DOI 10.1016/S0005-2728(98)00136-4; HIYAMA T, 1972, BIOCHIM BIOPHYS ACTA, V267, P160, DOI 10.1016/0005-2728(72)90147-8; HUBER M, 1986, CHEM PHYS LETT, V132, P467, DOI 10.1016/0009-2614(86)80648-0; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kass H, 2001, J PHYS CHEM B, V105, P1225, DOI 10.1021/jp0032311; KASS H, 1995, THESIS TU BERLIN; Krabben L, 2000, BIOCHEMISTRY-US, V39, P13012, DOI 10.1021/bi001200q; KRABBEN L, 1999, THESIS TU BERLIN; Kruip J, 1999, J BIOL CHEM, V274, P18181, DOI 10.1074/jbc.274.26.18181; KRUIP J, 1993, J BIOL CHEM, V268, P23353; KWA SLS, 1994, PHOTOCHEM PHOTOBIOL, V59, P219, DOI 10.1111/j.1751-1097.1994.tb05026.x; Leibl W, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P595; Lubitz W., 1991, CHLOROPHYLLS, P903; MANNA P, 1999, FUNCTION MOL GENETIC, V1; Palsson LO, 1998, BIOPHYS J, V74, P2611, DOI 10.1016/S0006-3495(98)77967-6; PHILIPSON KD, 1972, BIOCHEMISTRY-US, V11, P4591, DOI 10.1021/bi00774a027; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; RAUTTER J, 1995, BIOCHEMISTRY-US, V34, P8130, DOI 10.1021/bi00025a020; RAUTTER J, 1994, BIOCHEMISTRY-US, V33, P12077, DOI 10.1021/bi00206a010; Redding K, 1998, EMBO J, V17, P50, DOI 10.1093/emboj/17.1.50; Rochaix JD, 2001, PLANT PHYSIOL, V127, P1394, DOI 10.1104/pp.010628; RUTHERFORD AW, 1981, BIOCHIM BIOPHYS ACTA, V635, P225, DOI 10.1016/0005-2728(81)90022-0; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Schlodder E, 1998, BIOCHEMISTRY-US, V37, P9466, DOI 10.1021/bi973182r; SCHLODDER E, 2001, PS2001 P 12 INT C PH; Schwabe TME, 2000, INDIAN J BIOCHEM BIO, V37, P351; SETIF P, 1984, BIOCHIM BIOPHYS ACTA, V767, P404, DOI 10.1016/0005-2728(84)90038-0; SHUBIN VV, 1986, PHOTOSYNTH RES, V9, P3, DOI 10.1007/BF00029726; SONOIKE K, 1989, BIOCHIM BIOPHYS ACTA, V976, P210, DOI 10.1016/S0005-2728(89)80232-4; VANDERLEE J, 1993, PHOTOSYNTH RES, V35, P311, DOI 10.1007/BF00016562; Webber AN, 2001, BBA-BIOENERGETICS, V1507, P61, DOI 10.1016/S0005-2728(01)00198-0; WILLIAMS JC, 1992, BIOCHEMISTRY-US, V31, P11029, DOI 10.1021/bi00160a012; Witt H, 2002, BIOCHEMISTRY-US, V41, P8557, DOI 10.1021/bi025822i; Xu W, 2003, J BIOL CHEM, V278, P27876, DOI 10.1074/jbc.M302965200	50	56	59	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46760	46771		10.1074/jbc.M304776200	http://dx.doi.org/10.1074/jbc.M304776200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12933812	hybrid, Green Published			2022-12-27	WOS:000186569400067
J	Zhu, YF; Wang, Y; Gorman, MJ; Jiang, HB; Kanost, MR				Zhu, YF; Wang, Y; Gorman, MJ; Jiang, HB; Kanost, MR			Manduca sexta serpin-3 regulates prophenoloxidase activation in response to infection by inhibiting prophenoloxidase-activating proteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-PHENOL-OXIDASE; PLASMINOGEN-ACTIVATOR; SERINE PROTEINASES; MOLECULAR-CLONING; TOBACCO HORNWORM; BOMBYX-MORI; INSECT; PURIFICATION; HEMOLYMPH; ENZYME	Many serine proteinase inhibitors of the serpin superfamily have evolved in vertebrates and invertebrates to regulate serine proteinase cascades that mediate the host defense responses. We have isolated an immune-responsive serpin from the tobacco hornworm, Manduca sexta. This inhibitor, M. sexta serpin- 3, contains a reactive site loop strikingly similar to the proteolytic activation site in prophenoloxidase ( pro- PO). Molecular cloning and sequence comparison indicate that serpin- 3 is orthologous to Drosophila melanogaster serpin 27A, a regulator of melanization. M. sexta serpin-3 is constitutively present in hemolymph at a low concentration of 5 - 12 mug/ml and increases to 30 - 75 mug/ml after a microbial challenge. Recombinant serpin- 3 efficiently blocks pro- PO activation in the hemolymph, and it forms SDS- stable acyl- enzyme complexes with purified pro- PO- activating proteinases ( PAPs) from M. sexta. PAP- serpin- 3 complexes were isolated by immunoaffinity chromatography from hemolymph activated by treatment with Micrococcus luteus. Kinetic analysis of PAP- serpin- 3 association strongly suggests that serpin- 3 is a physiological regulator of the pro- PO activation reaction.	Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Kansas State University	Kanost, MR (corresponding author), Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA.	kanost@ksu.edu	Jiang, Haobo/A-6519-2008	Kanost, Michael/0000-0002-6827-0061; Jiang, Haobo/0000-0003-1357-1315	NIGMS NIH HHS [GM 41247, GM 58634, R37 GM041247] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058634, R01GM041247, R37GM041247, R29GM041247] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashida Masaaki, 1998, P135; ASPAN A, 1990, INSECT BIOCHEM, V20, P709, DOI 10.1016/0020-1790(90)90085-9; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BOIGEGRAIN RA, 1992, BIOCHEM BIOPH RES CO, V189, P790, DOI 10.1016/0006-291X(92)92271-X; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Djie MZ, 1997, J BIOL CHEM, V272, P16268, DOI 10.1074/jbc.272.26.16268; DOHKE K, 1973, ARCH BIOCHEM BIOPHYS, V157, P210, DOI 10.1016/0003-9861(73)90407-4; DUNN PE, 1983, J INVERTEBR PATHOL, V41, P77, DOI 10.1016/0022-2011(83)90238-0; EHRLICH HJ, 1990, J BIOL CHEM, V265, P13029; Gan H, 2001, INSECT BIOCHEM MOLEC, V31, P887, DOI 10.1016/S0965-1748(01)00034-0; *GEN COMP GROUP, 1991, PROGR MAN GCG PACK V; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; HALL M, 1995, P NATL ACAD SCI USA, V92, P7764, DOI 10.1073/pnas.92.17.7764; HARLOW E, 1999, USING ANTIBODIES LAB, P311; HERMANS JM, 1994, BIOCHEMISTRY-US, V33, P5440, DOI 10.1021/bi00184a012; JIANG HB, 1994, J BIOL CHEM, V269, P55; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 2003, J BIOL CHEM, V278, P3552, DOI 10.1074/jbc.M205743200; Jiang HB, 1996, J BIOL CHEM, V271, P28017, DOI 10.1074/jbc.271.45.28017; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Jiang HB, 1997, INSECT BIOCHEM MOLEC, V27, P835, DOI 10.1016/S0965-1748(97)00066-0; Jiang HB, 1997, J BIOL CHEM, V272, P1082, DOI 10.1074/jbc.272.2.1082; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Kanost MR, 2001, ADV EXP MED BIOL, V484, P319; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; KANOST MR, 1995, INSECT BIOCHEM MOLEC, V25, P285, DOI 10.1016/0965-1748(94)00067-R; Kawabata Shun-ichiro, 1996, P255; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE E, 1994, METHOD ENZYMOL, V237, P146; Lee SY, 1998, EUR J BIOCHEM, V254, P50, DOI 10.1046/j.1432-1327.1998.2540050.x; Lee SY, 1998, EUR J BIOCHEM, V257, P615, DOI 10.1046/j.1432-1327.1998.2570615.x; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Molnar K, 2001, J INSECT PHYSIOL, V47, P675, DOI 10.1016/S0022-1910(00)00130-X; Nappi AJ, 2000, BIOESSAYS, V22, P469, DOI 10.1002/(SICI)1521-1878(200005)22:5<469::AID-BIES9>3.3.CO;2-W; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; Park DS, 2000, MOL CELLS, V10, P186, DOI 10.1007/s10059-000-0186-2; Sambrook J., 2001, MOL CLONING LAB MANU; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; SAUL SJ, 1986, FEBS LETT, V208, P113, DOI 10.1016/0014-5793(86)81543-5; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Wang RG, 2001, EUR J BIOCHEM, V268, P895, DOI 10.1046/j.1432-1327.2001.01945.x; WANG Y, 1995, INSECT MOL BIOL, V4, P113, DOI 10.1111/j.1365-2583.1995.tb00015.x; Wang Y, 2001, PROTEIN EXPRES PURIF, V23, P328, DOI 10.1006/prep.2001.1517; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zhu Y, 2003, INSECT BIOCHEM MOLEC, V33, P541, DOI 10.1016/S0965-1748(03)00028-6	48	150	163	7	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46556	46564		10.1074/jbc.M309682200	http://dx.doi.org/10.1074/jbc.M309682200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12966082	hybrid			2022-12-27	WOS:000186569400041
J	Agarwal, R; Tang, ZY; Yu, HT; Cohen-Fix, O				Agarwal, R; Tang, ZY; Yu, HT; Cohen-Fix, O			Two distinct pathways for inhibiting Pds1 ubiquitination in response to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; SACCHAROMYCES-CEREVISIAE; ANAPHASE INHIBITOR; BUDDING YEAST; CHECKPOINT PATHWAYS; MITOSIS; CDC20; PHOSPHORYLATION; PROTEOLYSIS; APC	The presence of DNA damage activates a conserved cellular response known as the DNA damage checkpoint pathway. This pathway induces a cell cycle arrest that persists until the damage is repaired. Consequently, the failure to arrest in response to DNA damage is associated with genomic instability. In budding yeast, activation of the DNA damage checkpoint pathway leads to a mitotic cell cycle arrest. Following the detection of DNA damage, the checkpoint signal is transduced via the Mec1 kinase, which in turn activates two kinases, Rad53 and Chk1 that act in parallel pathways to bring about the cell cycle arrest. The downstream target of Rad53 is unknown. The target of Chk1 is Pds1, an inhibitor of anaphase initiation whose degradation is a prerequisite for mitotic progression. Pds1 degradation is dependent on its ubiquitination by the anaphase-promoting complex/ cyclosome ubiquitin ligase, acting in conjunction with the Cdc20 protein (APC/C-Cdc20). Previous studies showed that the Rad53 and Chk1 pathways independently lead to Pds1 stabilization but the mechanism for this was unknown. In the present study we show that both the Chk1 and the Rad53 pathways inhibit the APC/ C-Cdc20-dependent ubiquitination of Pds1 but they affect different steps of the process: the Rad53 pathway inhibits the Pds1-Cdc20 interaction whereas Chk1-dependent phosphorylation of Pds1 inhibits the ubiquitination reaction itself. Finally, we show that once the DNA damage is repaired, Pds1 dephosphorylation is involved in the recovery from the checkpoint induced cell cycle arrest.	NIDDK, Mol & Cellular Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Cohen-Fix, O (corresponding author), NIDDK, Mol & Cellular Biol Lab, NIH, Bethesda, MD 20892 USA.			Yu, Hongtao/0000-0002-8861-049X	NIGMS NIH HHS [GM61542] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK057803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061542] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal R, 2002, GENE DEV, V16, P1371, DOI 10.1101/gad.971402; AMON A, 1992, NATURE, V355, P368, DOI 10.1038/355368a0; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Cohen-Fix O, 1997, P NATL ACAD SCI USA, V94, P14361, DOI 10.1073/pnas.94.26.14361; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Gardner R, 1999, EMBO J, V18, P3173, DOI 10.1093/emboj/18.11.3173; Haber JE, 2000, CURR OPIN CELL BIOL, V12, P286, DOI 10.1016/S0955-0674(00)00090-9; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Leroy C, 2003, MOL CELL, V11, P827, DOI 10.1016/S1097-2765(03)00058-3; Lim HH, 1996, MOL GEN GENET, V253, P138, DOI 10.1007/s004380050306; Lim HH, 1998, CURR BIOL, V8, P231, DOI 10.1016/S0960-9822(98)70088-0; Marsolier MC, 2000, GENETICS, V154, P1523; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Morgan DO, 2002, NATURE, V418, P495, DOI 10.1038/418495a; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Resnick M A, 1975, Basic Life Sci, V5B, P549; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; Walworth NC, 2001, CURR OPIN GENET DEV, V11, P78, DOI 10.1016/S0959-437X(00)00160-X; Wang H, 2001, GENE DEV, V15, P1361, DOI 10.1101/gad.893201; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	33	80	82	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					45027	45033		10.1074/jbc.M306783200	http://dx.doi.org/10.1074/jbc.M306783200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947083	hybrid			2022-12-27	WOS:000186306700140
J	Chan, PC; Chen, YL; Cheng, CH; Yu, KC; Cary, LA; Shu, KH; Ho, WL; Chen, HC				Chan, PC; Chen, YL; Cheng, CH; Yu, KC; Cary, LA; Shu, KH; Ho, WL; Chen, HC			Src phosphorylates Grb2-associated binder 1 upon hepatocyte growth factor stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; FOCAL ADHESION KINASE; EPITHELIAL MORPHOGENESIS DOWNSTREAM; SIGNAL-REGULATED KINASE; DOCKING PROTEIN GAB1; GRB2 BINDING-SITE; C-MET; ADAPTER PROTEIN; FACTOR HGF; PHOSPHATIDYLINOSITOL 3-KINASE	Grb2-associated binder 1 (Gab1) is known to play an important role in hepatocyte growth factor (HGF) signaling, which rapidly becomes tyrosine-phosphorylated upon HGF stimulation. In this study, we found that the tyrosine phosphorylation of Gab1 in the cells derived from Src/Yes/Fyn null mouse embryos was similar to40% lower than that in their wild type counterparts upon HGF stimulation. Increased expression of wild-type Src enhanced HGF-induced phosphorylation of Gab1, and, in contrast, expression of the Src kinase-deficient mutant or treatment of the specific Src inhibitor PP1 suppressed it. Expression of a constitutively active Src mutant (Y527F) or oncogenic v-Src led to a prominent increase in Gab1 phosphorylation independent of HGF stimulation. Moreover, Src interacted with Gab1 via both its Src homology 2 and 3 domains and was capable of phosphorylating purified Gab1 in vitro. Finally, the increased phosphorylation of Gab1 by Src selectively potentiated HGF-induced activation of ERK and AKT. Taken together, our results establish a new role for Src in HGF-induced Gab1 phosphorylation.	Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; Natl Chung Hsing Univ, Grad Inst Biomed Sci, Taichung 40227, Taiwan; Taichung Vet Gen Hosp, Dept Pathol, Taichung 40705, Taiwan; Taichung Vet Gen Hosp, Nephrol Sect, Taichung 40705, Taiwan; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	National Chung Hsing University; National Chung Hsing University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; Fred Hutchinson Cancer Center	Chen, HC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.							Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Chan PC, 2002, J BIOL CHEM, V277, P50373, DOI 10.1074/jbc.M204691200; Chen HC, 1998, J BIOL CHEM, V273, P25777, DOI 10.1074/jbc.273.40.25777; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Cunnick JM, 2001, J BIOL CHEM, V276, P24380, DOI 10.1074/jbc.M010275200; FERRACINI R, 1991, J BIOL CHEM, V266, P19558; Fixman ED, 1997, J BIOL CHEM, V272, P20167, DOI 10.1074/jbc.272.32.20167; Garcia-Guzman M, 1999, ONCOGENE, V18, P7775, DOI 10.1038/sj.onc.1203198; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; GONZATTIHACES M, 1988, P NATL ACAD SCI USA, V85, P21, DOI 10.1073/pnas.85.1.21; GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Gual P, 2000, ONCOGENE, V19, P1509, DOI 10.1038/sj.onc.1203514; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Kong M, 2003, J BIOL CHEM, V278, P5837, DOI 10.1074/jbc.M208286200; Lehr S, 1999, BIOCHEMISTRY-US, V38, P151, DOI 10.1021/bi9818265; Lehr S, 2000, BIOCHEMISTRY-US, V39, P10898, DOI 10.1021/bi000982k; Lock LS, 2002, MOL BIOL CELL, V13, P2132, DOI 10.1091/mbc.02-02-0031; Lock LS, 2000, J BIOL CHEM, V275, P31536, DOI 10.1074/jbc.M003597200; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; NALDINI L, 1991, MOL CELL BIOL, V11, P1793, DOI 10.1128/MCB.11.4.1793; NALDINI L, 1991, ONCOGENE, V6, P501; Nguyen L, 1997, J BIOL CHEM, V272, P20811, DOI 10.1074/jbc.272.33.20811; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Ong SH, 1997, BIOCHEM BIOPH RES CO, V238, P261, DOI 10.1006/bbrc.1997.7272; PELICCI G, 1995, ONCOGENE, V10, P1631; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; RODRIGUES GA, 1991, MOL CELL BIOL, V11, P2962, DOI 10.1128/MCB.11.6.2962; RONG S, 1992, MOL CELL BIOL, V12, P5152, DOI 10.1128/MCB.12.11.5152; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Sakkab D, 2000, J BIOL CHEM, V275, P10772, DOI 10.1074/jbc.275.15.10772; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; WEIDNER KM, 1993, J CELL BIOL, V121, P145, DOI 10.1083/jcb.121.1.145; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177; ZHU H, 1994, J BIOL CHEM, V269, P29943	47	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44075	44082		10.1074/jbc.M305745200	http://dx.doi.org/10.1074/jbc.M305745200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941962	hybrid			2022-12-27	WOS:000186306700024
J	Feranchak, AP; Kilic, G; Wojtaszek, PA; Qadri, I; Fitz, JG				Feranchak, AP; Kilic, G; Wojtaszek, PA; Qadri, I; Fitz, JG			Volume-sensitive tyrosine kinases regulate liver cell volume through effects on vesicular trafficking and membrane Na+ permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-SELECTIVE CHANNELS; RAT HEPATOCYTES; PROTEIN-KINASE; CALCIUM INFLUX; ATP RELEASE; MAP KINASE; C-SRC; CONDUCTANCE; PHOSPHORYLATION; ACTIVATION	In liver cells, the influx of Na+ mediated by nonselective cation (NSC) channels in the plasma membrane contributes importantly to regulation of cell volume. Under basal conditions, channels are closed; but both physiologic (e.g. insulin) and pathologic (e.g. oxidative stress) stimuli that are known to stimulate tyrosine kinases are associated with large increases in membrane Na+ permeability to similar to 80 pA/pF or more. Consequently, the purpose of these studies was to evaluate whether volume-sensitive tyrosine kinases mediate cell volume increases through effects on the activity or distribution of NSC channel proteins. In HTC hepatoma cells, decreases in cell volume evoked by hypertonic exposure increased total cellular tyrosine kinase activity similar to20-fold. Moreover, hypertonic exposure (320 - 400 mosM) was followed after a delay by NSC channel activation and partial recovery of cell volume toward basal values ( regulatory volume increase (RVI)). The tyrosine kinase inhibitors genistein and erbstatin prevented both NSC channel activation and RVI. Similarly, hypertonic exposure resulted in an increase in p60(c-src) activity, and intracellular dialysis with recombinant p60(c-src) led to activation of NSC currents in the absence of an osmolar gradient. Utilizing FM1-43 fluorescence, exposure to hypertonic media caused a rapid increase in the rate of exocytosis of similar to 40% (p < 0.01), and genistein inhibited both exocytosis and channel activation. These findings indicate that volume-sensitive increases in p60(c-src) and/or related tyrosine kinases play a key role in the regulation of membrane Na+ permeability, suggesting that increases in the NSC conductance may be mediated in part through rapid recruitment of a distinct pool of channel-containing vesicles.	Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Fitz, JG (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pediat, Rm 6412,Campus Box B158, Denver, CO 80262 USA.		Qadri, Ishtiaq/I-6889-2013	Qadri, Ishtiaq/0000-0003-4334-0585	NIDDK NIH HHS [DK 43278, DK 46082, R01 DK078587, DK 61480, K08 DK061480] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK046082, K08DK061480, R01DK046082, R01DK043278] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALHABORI M, 1992, BIOCHEM J, V282, P789, DOI 10.1042/bj2820789; BERGER HA, 1993, J BIOL CHEM, V268, P2037; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bohmer C, 2001, FEBS LETT, V494, P125, DOI 10.1016/S0014-5793(01)02303-1; Broome MA, 1996, J BIOL CHEM, V271, P16798, DOI 10.1074/jbc.271.28.16798; BRUCK R, 1992, AM J PHYSIOL, V262, pG806, DOI 10.1152/ajpgi.1992.262.5.G806; CARINI R, 1994, BIOCHEM BIOPH RES CO, V202, P360, DOI 10.1006/bbrc.1994.1936; Daulhac L, 1999, J BIOL CHEM, V274, P20657, DOI 10.1074/jbc.274.29.20657; Dunkelberg JC, 2001, HEPATOLOGY, V33, P1349, DOI 10.1053/jhep.2001.24750; Feranchak AP, 2001, J CLIN INVEST, V108, P1495, DOI 10.1172/JCI200112190; Feranchak AP, 1998, J BIOL CHEM, V273, P14906, DOI 10.1074/jbc.273.24.14906; FITZ JG, 1994, AM J PHYSIOL, V266, pG677, DOI 10.1152/ajpgi.1994.266.4.G677; FITZ JG, 1994, AM J PHYSIOL, V266, pG544, DOI 10.1152/ajpgi.1994.266.4.G544; FITZ JG, 1991, J MEMBRANE BIOL, V122, P1, DOI 10.1007/BF01872734; Gentili C, 2002, J CELL BIOCHEM, V86, P773, DOI 10.1002/jcb.10264; Gilmore ES, 2001, J BIOL CHEM, V276, P42610, DOI 10.1074/jbc.M106919200; GOMAN RM, 1999, AM J PHYSIOL, V277, pG1222; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HEASLEY LE, 1994, AM J PHYSIOL, V267, pF366, DOI 10.1152/ajprenal.1994.267.3.F366; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Jones RJ, 2000, EUR J CANCER, V36, P1595, DOI 10.1016/S0959-8049(00)00153-2; Kapus A, 1999, J BIOL CHEM, V274, P8093, DOI 10.1074/jbc.274.12.8093; Kilic G, 2001, J BIOL CHEM, V276, P26762, DOI 10.1074/jbc.M100992200; Krump E, 1997, J BIOL CHEM, V272, P17303, DOI 10.1074/jbc.272.28.17303; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; LIDOFSKY SD, 1993, J BIOL CHEM, V268, P14632; Lidofsky SD, 1997, J MEMBRANE BIOL, V157, P231, DOI 10.1007/s002329900231; Misra S, 2003, AM J PHYSIOL-GASTR L, V285, pG316, DOI 10.1152/ajpgi.00048.2003; Ouwens DM, 2001, BBA-MOL CELL RES, V1540, P97, DOI 10.1016/S0167-4889(01)00126-4; PRINCE LS, 1994, P NATL ACAD SCI USA, V91, P5192, DOI 10.1073/pnas.91.11.5192; Qin SF, 2003, BIOCHEMISTRY-US, V42, P2995, DOI 10.1021/bi0205911; Reinehr R, 2003, FASEB J, V17, P731, DOI 10.1096/fj.02-0915fje; Rizoli SB, 1999, J BIOL CHEM, V274, P22072, DOI 10.1074/jbc.274.31.22072; Roman RM, 1997, J BIOL CHEM, V272, P21970, DOI 10.1074/jbc.272.35.21970; Schlenker T, 2000, GASTROENTEROLOGY, V118, P395, DOI 10.1016/S0016-5085(00)70222-8; Schliess F, 2000, CELL PHYSIOL BIOCHEM, V10, P403, DOI 10.1159/000016378; Szaszi K, 1997, J BIOL CHEM, V272, P16670, DOI 10.1074/jbc.272.26.16670; Tsunoda Y, 1996, BIOCHEM BIOPH RES CO, V227, P876, DOI 10.1006/bbrc.1996.1599; Wehner F, 1998, J PHYSIOL-LONDON, V506, P127, DOI 10.1111/j.1469-7793.1998.127bx.x; WONDERGEM R, 1994, ALCOHOL CLIN EXP RES, V18, P1230, DOI 10.1111/j.1530-0277.1994.tb00110.x	42	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44632	44638		10.1074/jbc.M301958200	http://dx.doi.org/10.1074/jbc.M301958200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12939281	hybrid			2022-12-27	WOS:000186306700094
J	Wang, L; Yang, L; Luo, YN; Zheng, Y				Wang, L; Yang, L; Luo, YN; Zheng, Y			A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING PROTEINS P190; BINDING-PROTEIN; BREAST-CANCER; RAS; CDC42; TRANSFORMATION; CLONING; RAC1; DBL; OVEREXPRESSION	The Rho family GTPases RhoA, RhoB, and RhoC regulate the actin cytoskeleton, cell movement, and cell growth. Unlike Ras, up-regulation or overexpression of these GDP/GTP binding molecular switches, but not activating point mutations, has been associated with human cancer. Although they share over 85% sequence identity, RhoA, RhoB, and RhoC appear to play distinct roles in cell transformation and metastasis. In NIH 3T3 cells, RhoA or RhoB overexpression causes transformation whereas RhoC increases the cell migration rate. To specifically target RhoA, RhoB, or RhoC function, we have generated a set of chimeric molecules by fusing the RhoGAP domain of p190, a GTPase-activating protein that accelerates the intrinsic GTPase activity of all three Rho GTPases, with the C-terminal hypervariable sequences of RhoA, RhoB, or RhoC. The p190-Rho chimeras were active as GTPase-activating proteins toward RhoA in vitro, co-localized with the respective active Rho proteins, and specifically down-regulated Rho protein activities in cells depending on which Rho GTPase sequences were included in the chimeras. In particular, the p190-RhoA-C chimera specifically inhibited RhoA-induced transformation whereas p190-RhoC-C specifically reversed the migration phenotype induced by the active RhoC. In human mammary epithelial-RhoC breast cancer cells, p190-RhoC-C, but not p190-RhoA-C or p190-RhoB-C, reversed the anchorage-independent growth and invasion phenotypes caused by RhoC overexpression. In the highly metastatic A375-M human melanoma cells, p190-RhoC-C specifically reversed migration, and invasion phenotypes attributed to RhoC up-regulation. Thus, we have developed a novel strategy utilizing RhoGAP-Rho chimeras to specifically down-regulate individual Rho activity and demonstrate that this approach may be applied to multiple human tumor cells to reverse the growth and/or invasion phenotypes associated with disregulation of a distinct subtype of Rho GTPase.	Univ Cincinnati, Div Expt Hematol, Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA; Univ Cincinnati, Mol Dev Biol Program, Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Zheng, Y (corresponding author), Univ Cincinnati, Div Expt Hematol, Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA.	yi.zheng@chmcc.org	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060523] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 60523, GM 53948] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; BARFOD ET, 1993, J BIOL CHEM, V268, P26059; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; BOS JL, 1989, CANCER RES, V49, P4682; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; CICCHETTI P, 1995, EMBO J, V14, P3127, DOI 10.1002/j.1460-2075.1995.tb07315.x; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Crooke ST, 1996, ANTISENSE NUCLEIC A, V6, P145, DOI 10.1089/oli.1.1996.6.145; del Peso L, 1997, ONCOGENE, V15, P3047; DEVROE E, 2002, BMC BIOTECHNOLOGY; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; GJERTSEN MK, 1995, LANCET, V346, P1399, DOI 10.1016/S0140-6736(95)92408-6; Gu Y, 2001, J BIOL CHEM, V276, P15929, DOI 10.1074/jbc.M010445200; Guo FK, 2003, J BIOL CHEM, V278, P14414, DOI 10.1074/jbc.M300341200; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Jaffe AB, 2002, ADV CANCER RES, V84, P57, DOI 10.1016/S0065-230X(02)84003-9; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Kamai T, 2001, BJU INT, V87, P227, DOI 10.1046/j.1464-410x.2001.02030.x; Keely PJ, 2001, LANCET, V358, P1744, DOI 10.1016/S0140-6736(01)06840-4; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; Lamarche-Vane N, 1998, J BIOL CHEM, V273, P29172, DOI 10.1074/jbc.273.44.29172; Lerm M, 2000, FEMS MICROBIOL LETT, V188, P1; Li R, 1997, J BIOL CHEM, V272, P32830, DOI 10.1074/jbc.272.52.32830; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Midgley RS, 2002, CRIT REV ONCOL HEMAT, V44, P109, DOI 10.1016/S1040-8428(01)00189-5; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Nur-E-Kamal MSA, 1999, ONCOGENE, V18, P7787; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; PRENDERGAST GC, 1995, ONCOGENE, V10, P2289; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schambach A, 2000, MOL THER, V2, P435, DOI 10.1006/mthe.2000.0191; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Schwieger M, 2002, J EXP MED, V196, P1227, DOI 10.1084/jem.20020824; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Tanaka T, 2003, EMBO J, V22, P1025, DOI 10.1093/emboj/cdg106; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; VAN AL, 1997, GENE DEV, V11, P2295; van Golen KL, 2000, CANCER RES, V60, P5832; Vanni C, 2002, J BIOL CHEM, V277, P19745, DOI 10.1074/jbc.M111025200; Wang DZM, 1997, CANCER RES, V57, P2478; Yang FC, 2001, P NATL ACAD SCI USA, V98, P5614, DOI 10.1073/pnas.101546898; Yoshioka K, 1998, J BIOL CHEM, V273, P5146, DOI 10.1074/jbc.273.9.5146; Yuan BZ, 1998, CANCER RES, V58, P2196; Zhang BL, 1998, BIOCHEMISTRY-US, V37, P5249, DOI 10.1021/bi9718447; Zhang BL, 1998, J BIOL CHEM, V273, P8776, DOI 10.1074/jbc.273.15.8776; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Zhu KJ, 2000, J BIOL CHEM, V275, P25993, DOI 10.1074/jbc.M003780200; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	60	60	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44617	44625		10.1074/jbc.M308929200	http://dx.doi.org/10.1074/jbc.M308929200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12939257	hybrid			2022-12-27	WOS:000186306700092
J	Chang, CSS; Olcese, R; Olsen, RW				Chang, CSS; Olcese, R; Olsen, RW			A single M1 residue in the beta 2 subunit alters channel gating of GABA(A) receptor in anesthetic modulation and direct activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-AMINOBUTYRIC-ACID; A RECEPTOR; GLYCINE RECEPTORS; ACETYLCHOLINE-RECEPTOR; GENERAL-ANESTHETICS; ANTAGONIST AFFINITY; BINDING-SITES; VOLATILE; IDENTIFICATION; ETOMIDATE	General anesthetics allosterically modulate the activity of neuronal gamma-aminobutyric acid, type A (GABA(A)), receptors. Previous mutational studies from our laboratory and others have shown that the regions in transmembrane domain 1 (M1) and pre- M1 of alpha and beta subunits in GABA receptors are essential for positive modulation of GABA binding and function by the intravenous (IV) general anesthetics. Mutation of beta2Gly-219 to Phe corresponded in rho nearly eliminated the modulatory effect of IV anesthetics in alpha1/beta2/gamma2S combination. However, the general anesthetics retained the ability to directly open the channel of mutant G219F, and the apparent affinity for GABA was increased, and desensitization rate was reduced. In this study, we made additional single mutations such as 219 Ser, Cys, Ile, Asp, Arg, Tyr, and Trp. The larger side chains of the replacement residues produced the greatest reduction in enhancement of GABA currents by IV anesthetics at clinical concentrations ( Trp > Tyr = Phe > Arg > Asp > Ile > Cys > Ser = wild type). Compared with a 2-3-fold response in wild type, pentobarbital and propofol enhanced less than 0.5-fold; etomidate and alphaxalone modulation was reduced from more than 4- to 1-fold in G219F, G219Y, and G219W. A linear correlation was observed between the volume of the residue at position 219 and the loss of modulation. An identical correlation was found for the effect of modulation on left-shift in the GABA EC50 value; furthermore, the same rank order of residues, related to size, was found for reduction in the maximal direct channel-gating by pentobarbital ( 1 mM) and etomidate ( 100 muM) and for increased apparent affinity for direct gating by the IV anesthetics.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Olsen, RW (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, 650 Young Dr S,CHS 23-338, Los Angeles, CA 90095 USA.	Rolsen@mednet.ucla.edu			NIGMS NIH HHS [GM08652] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; BARKER JL, 1978, J PHYSIOL-LONDON, V280, P355, DOI 10.1113/jphysiol.1978.sp012388; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Birnir B, 1997, SYNAPSE, V26, P324, DOI 10.1002/(SICI)1098-2396(199707)26:3<324::AID-SYN13>3.0.CO;2-V; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Bywater RP, 2001, J COMPUT AID MOL DES, V15, P533, DOI 10.1023/A:1011197908960; CARLSON BX, 1992, J PHARMACOL EXP THER, V263, P1401; Carlson BX, 2000, MOL PHARMACOL, V57, P474, DOI 10.1124/mol.57.3.474; Chang CSS, 2003, J NEUROCHEM, V85, P47; CHANGEUX JP, 1992, Q REV BIOPHYS, V25, P395, DOI 10.1017/S0033583500004352; Chiara DC, 1999, BIOCHEMISTRY-US, V38, P6689, DOI 10.1021/bi9901735; Chiara DC, 1997, J BIOL CHEM, V272, P32940, DOI 10.1074/jbc.272.52.32940; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Dalziel JE, 1999, EUR J PHARMACOL, V385, P283, DOI 10.1016/S0014-2999(99)00710-4; DAUBAS P, 1990, NEURON, V5, P49, DOI 10.1016/0896-6273(90)90032-B; Duncalfe LL, 1996, J BIOL CHEM, V271, P9209, DOI 10.1074/jbc.271.16.9209; Engblom AC, 2002, J BIOL CHEM, V277, P17438, DOI 10.1074/jbc.M111215200; Gordijn B, 2000, PATIENT EDUC COUNS, V41, P1, DOI 10.1016/S0738-3991(00)00123-3; HALES TG, 1991, BRIT J PHARMACOL, V104, P619, DOI 10.1111/j.1476-5381.1991.tb12479.x; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; HARRIS BD, 1995, MOL PHARMACOL, V47, P363; HARRISON NL, 1993, MOL PHARMACOL, V44, P628; HARRISON NL, 1984, BRAIN RES, V323, P287, DOI 10.1016/0006-8993(84)90299-3; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Jenkins A, 2002, NEUROPHARMACOLOGY, V43, P669, DOI 10.1016/S0028-3908(02)00175-2; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; JONES MV, 1995, J PHARMACOL EXP THER, V274, P962; Krasowski MD, 2000, BRIT J PHARMACOL, V129, P731, DOI 10.1038/sj.bjp.0703087; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; LONGONI B, 1992, ADV BIOCHEM PSYCHOPH, V47, P365; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; Mihic SJ, 1996, J PHARMACOL EXP THER, V277, P411; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Moody EJ, 1997, J NEUROCHEM, V69, P1310; Nishikawa K, 2002, NEUROPHARMACOLOGY, V42, P337, DOI 10.1016/S0028-3908(01)00189-7; Olsen RW, 1998, TOXICOL LETT, V101, P193, DOI 10.1016/S0378-4274(98)00185-4; Olsen RW, 2004, METH NE FRO NEUROSCI, P47; OLSEN RW, 1995, ADV BIOCHEM PSYCHOPH, V48, P57; OLSEN RW, 2003, ENCY BIOL CHEM; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; ROBERTSON B, 1989, BRIT J PHARMACOL, V98, P167, DOI 10.1111/j.1476-5381.1989.tb16878.x; Sawyer GW, 2002, J BIOL CHEM, V277, P50036, DOI 10.1074/jbc.M209281200; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; SMITH GB, 1994, J BIOL CHEM, V269, P20380; Srinivasan S, 1999, J BIOL CHEM, V274, P26633, DOI 10.1074/jbc.274.38.26633; Steinbach JH, 2001, J PHYSIOL-LONDON, V537, P715; Thompson SA, 1996, BRIT J PHARMACOL, V117, P521, DOI 10.1111/j.1476-5381.1996.tb15221.x; UCHIDA I, 1995, NEUROSCI LETT, V185, P203, DOI 10.1016/0304-3940(95)11263-V; WAFFORD KA, 1994, NEURON, V12, P775, DOI 10.1016/0896-6273(94)90330-1; Wagner DA, 2001, J NEUROSCI, V21, P67, DOI 10.1523/JNEUROSCI.21-01-00067.2001; Whiting PJ, 1995, INT REV NEUROBIOL, V38, P95, DOI 10.1016/S0074-7742(08)60525-5; Wick MJ, 1998, P NATL ACAD SCI USA, V95, P6504, DOI 10.1073/pnas.95.11.6504; YANG J, 1992, FASEB J, V6, P914, DOI 10.1096/fasebj.6.3.1740240; ZAMAN SH, 1992, EUR J PHARM-MOLEC PH, V225, P321, DOI 10.1016/0922-4106(92)90106-6	58	48	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					42821	42828		10.1074/jbc.M306978200	http://dx.doi.org/10.1074/jbc.M306978200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12939268	hybrid			2022-12-27	WOS:000186157000013
J	Kondo-Okamoto, N; Shaw, JM; Okamoto, K				Kondo-Okamoto, N; Shaw, JM; Okamoto, K			Mmm1p spans both the outer and inner mitochondrial membranes and contains distinct domains for targeting and foci formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-RELATED GTPASE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; NEUROSPORA-CRASSA; RHOMBOID PROTEASE; FUSION; DNA; INHERITANCE; MAINTENANCE; MORPHOLOGY	In the yeast Saccharomyces cerevisiae, the integral membrane protein Mmm1p is required for maintenance of mitochondrial morphology and retention of mitochondrial DNA ( mtDNA). Mmm1p localizes to discrete foci on mitochondria that are adjacent to mtDNA nucleoids in the matrix, raising the possibility that this protein plays a direct role in organizing, replicating, or segregating mtDNA. Although Mmm1p has been shown to cross the outer membrane with its C terminus facing the cytoplasm, the location of the N terminus has not been resolved. Here we show that Mmm1p spans both the outer and inner mitochondrial membranes, exposing its N terminus to the matrix. Surprisingly, deletion of the N-terminal extension decreased steady-state levels of the Mmm1 protein but did not affect mitochondrial morphology or mtDNA maintenance. Moreover, expression of Neurospora crassa MMM1, which naturally lacks a long N-terminal extension, substituted for loss of Mmm1p in budding yeast. These results indicate that the matrix-exposed portion of Mmm1p is not essential for mtDNA nucleoid maintenance. Additional studies revealed that the transmembrane segment and C-terminal domain of Mmm1p are required for foci formation and mitochondrial targeting, respectively. Our data suggest that the double membrane-spanning topology of Mmm1p at the membrane contact site is critical for formation of tubular mitochondria.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Okamoto, K (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.				NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053466] Funding Source: NIH RePORTER; NCI NIH HHS [CA42014] Funding Source: Medline; NIGMS NIH HHS [GM-53466] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Berger KH, 1997, J CELL BIOL, V136, P545, DOI 10.1083/jcb.136.3.545; Berger KH, 2000, TRENDS MICROBIOL, V8, P508, DOI 10.1016/S0966-842X(00)01862-X; Boldogh I, 1998, J CELL BIOL, V141, P1371, DOI 10.1083/jcb.141.6.1371; Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225; Boldogh IR, 2001, TRAFFIC, V2, P368, DOI 10.1034/j.1600-0854.2001.002006368.x; BURGESS SM, 1994, J CELL BIOL, V126, P1375, DOI 10.1083/jcb.126.6.1375; Burke D., 2000, METHODS YEAST GENETI; CARRINGTON JC, 1988, P NATL ACAD SCI USA, V85, P3391, DOI 10.1073/pnas.85.10.3391; Cartron PF, 2003, J BIOL CHEM, V278, P11633, DOI 10.1074/jbc.M208955200; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; DOUGHERTY WG, 1993, MICROBIOL REV, V57, P781, DOI 10.1128/MMBR.57.4.781-822.1993; Esaki M, 1999, P NATL ACAD SCI USA, V96, P11770, DOI 10.1073/pnas.96.21.11770; Esser K, 2002, J MOL BIOL, V323, P835, DOI 10.1016/S0022-2836(02)01000-8; Faber KN, 2001, J BIOL CHEM, V276, P36501, DOI 10.1074/jbc.M105828200; Fuchs F, 2002, J CELL SCI, V115, P1931; Griparic L, 2001, TRAFFIC, V2, P235, DOI 10.1034/j.1600-0854.2001.1r008.x; GUAN KL, 1993, CURR GENET, V24, P141, DOI 10.1007/BF00324678; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hermann GJ, 1998, ANNU REV CELL DEV BI, V14, P265, DOI 10.1146/annurev.cellbio.14.1.265; Hobbs AEA, 2001, J CELL BIOL, V152, P401, DOI 10.1083/jcb.152.2.401; Itoh T, 2002, MOL CELL BIOL, V22, P7744, DOI 10.1128/MCB.22.22.7744-7757.2002; Jensen RE, 2000, MICROSC RES TECHNIQ, V51, P573, DOI 10.1002/1097-0029(20001215)51:6<573::AID-JEMT7>3.0.CO;2-2; JONES BA, 1992, GENE DEV, V6, P380, DOI 10.1101/gad.6.3.380; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Mozdy AD, 2003, NAT REV MOL CELL BIO, V4, P468, DOI 10.1038/nrm1125; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Prokisch H, 2000, MOL BIOL CELL, V11, P2961, DOI 10.1091/mbc.11.9.2961; RAMAGE L, 1993, EMBO J, V12, P4115, DOI 10.1002/j.1460-2075.1993.tb06095.x; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Reichert AS, 2002, BBA-MOL CELL RES, V1592, P41, DOI 10.1016/S0167-4889(02)00263-X; Sambrook J., 2001, MOL CLONING; Scott SV, 2003, CURR OPIN CELL BIOL, V15, P482, DOI 10.1016/S0955-0674(03)00070-X; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Shepard KA, 1999, J CELL BIOL, V144, P711, DOI 10.1083/jcb.144.4.711; SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361; STEINBERG G, 1993, J CELL SCI, V106, P555; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Westermann B, 2002, EMBO REP, V3, P527, DOI 10.1093/embo-reports/kvf113; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015; Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; Yang HC, 1999, CURR BIOL, V9, P1111, DOI 10.1016/S0960-9822(99)80480-1; Yoon Y, 2001, CURR BIOL, V11, pR67, DOI 10.1016/S0960-9822(01)00011-2	52	47	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					48997	49005		10.1074/jbc.M308436200	http://dx.doi.org/10.1074/jbc.M308436200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12972421	hybrid			2022-12-27	WOS:000186829000061
J	Llompart, B; Castells, E; Rio, A; Roca, R; Ferrando, A; Stiefel, V; Nech, PP; Casacuberta, JM				Llompart, B; Castells, E; Rio, A; Roca, R; Ferrando, A; Stiefel, V; Nech, PP; Casacuberta, JM			The direct activation of MIK, a germinal center kinase (GCK)-like kinase, by MARK, a maize atypical receptor kinase, suggests a new mechanism for signaling through kinase-dead receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STE20-LIKE PROTEIN-KINASE; EPIDERMAL-GROWTH-FACTOR; TYROSINE KINASE; ARABIDOPSIS; DOMAIN; PLANT; RYK; PHOSPHORYLATION; EMBRYOGENESIS; BINDING	Signaling by receptor protein kinases (RPKs) involves their dimerization and transphosphorylation. However, atypical RPKs with kinase-defective domains have been described recently. Some of them are essential for proper signaling in animal systems, although the precise mechanism involved is unknown in most cases. Here we describe the cloning and characterization of an atypical plant receptor kinase from maize, MARK, which does not phosphorylate in vitro. A yeast two-hybrid approach has allowed us to identify a new germinal center kinase (GCK)-related protein, MIK, that interacts with MARK. Interestingly, the interaction of the intracellular domain of MARK with the regulator domain of MIK strongly induces MIK kinase activity. As some GCK-related proteins connect cell-surface receptors to the intracellular MAPK cascades, the activation of MIK by direct interaction with MARK could illustrate a new mechanism for signaling through atypical RPKs.	CSIC, IBMB, Dept Mol Genet, ES-08034 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Casacuberta, JM (corresponding author), CSIC, IBMB, Dept Mol Genet, Jordi Girona 18, ES-08034 Barcelona, Spain.	jcsgmp@cid.csic.es	Ferrando, Alejandro/F-2346-2014	Ferrando, Alejandro/0000-0002-1903-9111; Casacuberta, josep/0000-0002-5609-4152				Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Braun DM, 1997, PLANT J, V12, P83, DOI 10.1046/j.1365-313X.1997.12010083.x; Cabrillac D, 2001, NATURE, V410, P220, DOI 10.1038/35065626; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Eichinger L, 1998, J BIOL CHEM, V273, P12952, DOI 10.1074/jbc.273.21.12952; Espinas ML, 2000, EMBO REP, V1, P253, DOI 10.1093/embo-reports/kvd046; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Guertin DA, 2001, J BIOL CHEM, V276, P28185, DOI 10.1074/jbc.M103802200; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Katso RM, 1999, MOL CELL BIOL, V19, P6427; Kim HH, 1998, BIOCHEM J, V334, P189, DOI 10.1042/bj3340189; KNIGHTON DR, 1993, P NATL ACAD SCI USA, V90, P5001, DOI 10.1073/pnas.90.11.5001; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.3.CO;2-B; Kyriakis JM, 1999, J BIOL CHEM, V274, P5259, DOI 10.1074/jbc.274.9.5259; Leprince AS, 1999, BBA-GENE STRUCT EXPR, V1444, P1, DOI 10.1016/S0167-4781(98)00246-2; MORAN MF, 1988, ONCOGENE, V3, P665; MOSSIE K, 1995, ONCOGENE, V11, P2179; Nakashima M, 1998, PLANT CELL PHYSIOL, V39, P690, DOI 10.1093/oxfordjournals.pcp.a029423; Nishihama R, 2001, GENE DEV, V15, P352, DOI 10.1101/gad.863701; Parker A, 2001, J BIOL CHEM, V276, P5547, DOI 10.1074/jbc.M008463200; Pawson T, 2000, GENE DEV, V14, P1027; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Roca R, 1998, GENE, V208, P67, DOI 10.1016/S0378-1119(97)00654-9; Savant-Bhonsale S, 1999, GENE, V231, P155, DOI 10.1016/S0378-1119(99)00061-X; Shah K, 2002, GENE DEV, V16, P1707, DOI 10.1101/gad.220402; Shah K, 2001, J BIOL CHEM, V276, P41263, DOI 10.1074/jbc.M102381200; Sierke SL, 1997, BIOCHEM J, V322, P757, DOI 10.1042/bj3220757; Stein RA, 2000, J MOL EVOL, V50, P397, DOI 10.1007/s002390010043; Stone JM, 1998, PLANT PHYSIOL, V117, P1217, DOI 10.1104/pp.117.4.1217; Stone SL, 1999, SCIENCE, V286, P1729, DOI 10.1126/science.286.5445.1729; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tichtinsky G, 2003, TRENDS PLANT SCI, V8, P231, DOI 10.1016/S1360-1385(03)00062-1; Trivier E, 2002, J BIOL CHEM, V277, P23037, DOI 10.1074/jbc.M202486200; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; VALON C, 1993, PLANT MOL BIOL, V23, P415, DOI 10.1007/BF00029017	45	35	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48105	48111		10.1074/jbc.M307482200	http://dx.doi.org/10.1074/jbc.M307482200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12966093	hybrid			2022-12-27	WOS:000186731400091
J	Gardner, OS; Dewar, BJ; Earp, HS; Samet, JM; Graves, LM				Gardner, OS; Dewar, BJ; Earp, HS; Samet, JM; Graves, LM			Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; IMPROVED INSULIN-SENSITIVITY; RICH TYROSINE KINASE-2; ANGIOTENSIN-II; EGF RECEPTOR; PPAR-GAMMA; C-SRC; COUPLED RECEPTORS; REGULATED KINASE; MEDIATED PHOSPHORYLATION	Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that function as ligand-activated transcription factors regulating lipid metabolism and homeostasis. In addition to their ability to regulate PPAR-mediated gene transcription, PPARalpha and gamma ligands have recently been shown to induce activation of mitogen-activated protein kinases (MAPKs), which in turn phosphorylate PPARs, thereby affecting transcriptional activity. However, the mechanism for PPAR ligand-dependent MAPK activation is unclear. In the current study, we demonstrate that various PPARalpha (nafenopin) and gamma (ciglitazone and troglitazone) agonists rapidly induced extracellular signal-regulated kinase (Erk) and/or p38 phosphorylation in rat liver epithelial cells (GN4). The selective epidermal growth factor receptor (EGFR) kinase inhibitors, PD153035 and ZD1839 (Iressa), abolished PPARalpha and gamma agonist-dependent Erk activation. Consistent with this, PPAR agonists increased tyrosine autophosphorylation of the EGFR as well as phosphorylation at a putative Src-specific site, Tyr(845). Experiments with the Src inhibitor, PP2, and the antioxidant N-acetyl-L-cysteine revealed critical roles for Src and reactive oxygen species as upstream mediators of EGFR transactivation in response to PPAR ligands. Moreover, PPARalpha and gamma ligands increased Src autophosphorylation as well as kinase activity. EGFR phosphorylation, in turn, led to Ras-dependent Erk activation. In contrast, p38 activation by PPARalpha and gamma ligands occurred independently of Src, oxidative stress, the EGFR, and Ras. Interestingly, PPARalpha and gamma agonists caused rapid activation of proline-rich tyrosine kinase or Pyk2; Pyk2 as well as p38 phosphorylation was reduced by intracellular Ca2+ chelation without an observable effect on EGFR and Erk activation, suggesting a possible role for Pyk2 as an upstream activator of p38. In summary, PPARalpha and gamma ligands activate two distinct signaling cascades in GN4 cells leading to MAPK activation.	Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; US EPA, Human Studies Div, Natl Hlth Effects & Environm Res Lab, Res Triangle Pk, NC 27711 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; United States Environmental Protection Agency	Graves, LM (corresponding author), Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27599 USA.		Graves, Lee/AAG-5470-2021		NCI NIH HHS [CA 81503] Funding Source: Medline; NIEHS NIH HHS [ES 04325] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004325] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Baek SJ, 2003, J BIOL CHEM, V278, P5845, DOI 10.1074/jbc.M208394200; Bandyopadhyay G, 2001, J BIOL CHEM, V276, P35537, DOI 10.1074/jbc.M106042200; Barger PM, 2001, J BIOL CHEM, V276, P44495, DOI 10.1074/jbc.M105945200; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; EARP HS, 1995, J BIOL CHEM, V270, P28440; Edwards Dean P, 2003, Mol Interv, V3, P12, DOI 10.1124/mi.3.1.12; Graves Lee M, 2002, Mol Interv, V2, P208, DOI 10.1124/mi.2.4.208; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Hopkinson G. K., 1998, U.S. patent, Patent No. 5770599; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; HUANG W, 2002, EXP CELL RES, V277; HUCKLE WR, 1992, P NATL ACAD SCI USA, V89, P8837, DOI 10.1073/pnas.89.18.8837; HUCKLE WR, 1990, MOL CELL BIOL, V10, P6290, DOI 10.1128/MCB.10.12.6290; JAMES NH, 1994, CARCINOGENESIS, V15, P2687, DOI 10.1093/carcin/15.12.2687; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Juge-Aubry CE, 1999, J BIOL CHEM, V274, P10505, DOI 10.1074/jbc.274.15.10505; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lennon AM, 2002, J BIOL CHEM, V277, P29681, DOI 10.1074/jbc.M201517200; Li X, 1998, EMBO J, V17, P2574, DOI 10.1093/emboj/17.9.2574; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Masugi J, 1999, BIOCHEM BIOPH RES CO, V264, P93, DOI 10.1006/bbrc.1999.1488; Meves A, 2001, TOXICOL LETT, V122, P205, DOI 10.1016/S0378-4274(01)00359-9; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Mounho BJ, 1999, TOXICOL APPL PHARM, V159, P125, DOI 10.1006/taap.1999.8740; Nugent C, 2001, MOL ENDOCRINOL, V15, P1729, DOI 10.1210/me.15.10.1729; ORELLANA A, 1993, EUR J BIOCHEM, V215, P903, DOI 10.1111/j.1432-1033.1993.tb18108.x; Palakurthi SS, 2001, CANCER RES, V61, P6213; Pandey P, 1999, J BIOL CHEM, V274, P10140, DOI 10.1074/jbc.274.15.10140; Park JG, 2001, J BIOL CHEM, V276, P47751, DOI 10.1074/jbc.C100524200; Passilly P, 1999, BIOCHEM PHARMACOL, V58, P1001, DOI 10.1016/S0006-2952(99)00182-3; Pauley CJ, 2002, CELL SIGNAL, V14, P351, DOI 10.1016/S0898-6568(01)00260-1; Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Qiu Y, 1998, NATURE, V393, P83, DOI 10.1038/30012; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; Ristow M, 1998, NEW ENGL J MED, V339, P953, DOI 10.1056/NEJM199810013391403; Rokos CL, 1997, J BIOL CHEM, V272, P13452, DOI 10.1074/jbc.272.20.13452; Rose ML, 1999, CARCINOGENESIS, V20, P27, DOI 10.1093/carcin/20.1.27; Sajan MP, 2002, BIOCHEM J, V362, P665, DOI 10.1042/0264-6021:3620665; Shah BH, 2003, J BIOL CHEM, V278, P2866, DOI 10.1074/jbc.m208783200; Shintani M, 2001, DIABETES, V50, P2296, DOI 10.2337/diabetes.50.10.2296; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; Sorokin A, 2001, J BIOL CHEM, V276, P21521, DOI 10.1074/jbc.M008869200; Suzaki Y, 2002, J BIOL CHEM, V277, P9614, DOI 10.1074/jbc.M111790200; Teruel T, 2003, J BIOL CHEM, V278, P263, DOI 10.1074/jbc.M207200200; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; VANDENHEUVEL JP, 1999, J NUTR, V129, P575; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wong CW, 2002, P NATL ACAD SCI USA, V99, P14783, DOI 10.1073/pnas.192569699; Yan YB, 2002, J CELL BIOL, V158, P221, DOI 10.1083/jcb.200112026; Yonemitsu S, 2001, DIABETES, V50, P1093, DOI 10.2337/diabetes.50.5.1093; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993; ZOHN IE, 1995, MOL CELL BIOL, V15, P6160; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	66	93	96	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46261	46269		10.1074/jbc.M307827200	http://dx.doi.org/10.1074/jbc.M307827200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12966092	Green Published, hybrid			2022-12-27	WOS:000186569400009
J	Hellmark, T; Chen, LL; Ohlsson, S; Wieslander, R; Bolton, WK				Hellmark, T; Chen, LL; Ohlsson, S; Wieslander, R; Bolton, WK			Point mutations of single amino acids abolish ability of alpha(3) NC1 domain to elicit experimental autoimmune glomerulonephritis in rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	33rd Annual Meeting of the American-Society-of-Nephrology	OCT 10-16, 2000	TORONTO, CANADA	Amer Soc Nephrol			GLOMERULAR-BASEMENT-MEMBRANE; ANTI-GBM GLOMERULONEPHRITIS; IV COLLAGEN; GOODPASTURE AUTOANTIGEN; T-CELLS; MONOCLONAL-ANTIBODIES; NEPHRITOGENIC ANTIGEN; ALPHA-3(IV) COLLAGEN; SYNTHETIC PEPTIDES; INBRED RATS	We previously showed concordance between Goodpasture syndrome antibody binding and production of experimental glomerulonephritis using human chimeric proteins. We now examine a more limited aminoterminal region of alpha(3)( IV) non- collagenous domain ( NC1) and the impact of single amino acid ( AA) mutations of this region on glomerulonephritis induction. Rats were immunized with collagenase- solubilized glomerular basement membrane ( csGBM), D3, an alpha(1)( IV) NC1 chimeric protein with 69 AA of alpha(3)( IV) NC1 ( binds Goodpasture sera), D4, the D3 construct shortened by 4 AA ( nonbinding), P9, P10, single AA mutants ( non- binding), and S2, alpha(1)( IV) NC1 with 9 AA of alpha(3)( IV) NC1 ( binding). All rats immunized with csGBM and S2 and 50% of D3 rats developed glomerulonephritis. csGBM rats had intense GBM- bound IgG deposits, but S2 and D3 rats had minimal deposits. None of the D4, P9, or P10 rats developed glomerulonephritis. Lymphocytes from nephritic rats proliferated with csGBM, S2, and D3, but not with D4, P9, or P10. Discrete segments of alpha(3)( IV) NC1 within the alpha(1)( IV) NC1 backbone can induce glomerulonephritis. Single AA mutations within that epitope render the antigen unresponsive to Goodpasture sera and incapable of inducing glomerulonephritis. These studies support the concordance of glomerulonephritis inductivity and Goodpasture serum binding. Further, they define a critical limited AA sequence within alpha(3)( IV) NC1 of nine or fewer AA, which confers nephritogenicity to the non-nephritogenic alpha(1)( IV) NC1 without in vivo antibody binding. This region may be a T- cell epitope responsible for induction of glomerulonephritis in this model in rats and Goodpasture syndrome in man.	Univ Virginia, Hlth Sci Ctr, Dept Med, Div Nephrol, Charlottesville, VA 22908 USA; Univ Lund Hosp, Dept Nephrol, S-22185 Lund, Sweden	University of Virginia; Lund University; Skane University Hospital	Bolton, WK (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Med, Div Nephrol, POB 800133, Charlottesville, VA 22908 USA.		Hellmark, Thomas/U-6289-2017; Ohlsson, Sophie/W-9495-2019	Hellmark, Thomas/0000-0002-2952-1155; Ohlsson, Sophie/0000-0002-5253-1650	NIDDK NIH HHS [DK 55801] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055801] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOLTON WK, 1976, AM J PATHOL, V85, P277; BOLTON WK, 1984, J CLIN INVEST, V73, P1263, DOI 10.1172/JCI111328; BOLTON WK, 1988, KIDNEY INT, V34, P598, DOI 10.1038/ki.1988.224; BOLTON WK, 1993, KIDNEY INT, V44, P294, DOI 10.1038/ki.1993.244; BOLTON WK, 1995, KIDNEY INT, V47, P404, DOI 10.1038/ki.1995.53; BOLTON WK, 1978, CLIN EXP IMMUNOL, V33, P474; Bolton WK, 2002, J CLIN INVEST, V109, P713, DOI 10.1172/JCI200215285; Bolton WK, 1996, KIDNEY INT, V50, P1753, DOI 10.1038/ki.1996.495; Bolton WK, 1996, KIDNEY INT, V49, P327, DOI 10.1038/ki.1996.49; BOLTON WK, 2003, 36 ANN M AM SOC NEPH; Borza DB, 2000, J BIOL CHEM, V275, P6030, DOI 10.1074/jbc.275.8.6030; CHEN L, 2003, KIDNEY INT, V64, P1; Gunnarsson A, 2000, J BIOL CHEM, V275, P30844, DOI 10.1074/jbc.M004717200; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; Hellmark T, 1999, KIDNEY INT, V55, P936, DOI 10.1046/j.1523-1755.1999.055003936.x; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; JANEWAY CA, 1996, IMMUNO BIOL IMMUNE S; JOHANSSON C, 1991, CONNECT TISSUE RES, V25, P229, DOI 10.3109/03008209109029159; Kalluri R, 1996, J BIOL CHEM, V271, P9062, DOI 10.1074/jbc.271.15.9062; Kalluri R, 1997, J CLIN INVEST, V100, P2263, DOI 10.1172/JCI119764; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LERNER RA, 1966, J EXP MED, V124, P431, DOI 10.1084/jem.124.3.431; LERNER RA, 1967, J EXP MED, V126, P989, DOI 10.1084/jem.126.6.989; LUO AM, 1993, J CLIN INVEST, V92, P2117, DOI 10.1172/JCI116812; Luo AM, 2002, J LAB CLIN MED, V139, P303, DOI 10.1067/mlc.2002.123623; Merkel F, 1996, KIDNEY INT, V49, P1127, DOI 10.1038/ki.1996.163; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; NISHIKAWA K, 1993, J EXP MED, V177, P667, DOI 10.1084/jem.177.3.667; Phelps RG, 1998, J BIOL CHEM, V273, P11440, DOI 10.1074/jbc.273.19.11440; QUERIN S, 1986, CLIN NEPHROL, V25, P134; QUINONES S, 1992, J BIOL CHEM, V267, P19780; Reynolds J, 1998, NEPHROL DIAL TRANSPL, V13, P44, DOI 10.1093/ndt/13.1.44; REYNOLDS J, 1993, J AUTOIMMUN, V6, P571, DOI 10.1006/jaut.1993.1047; REYNOLDS J, 1991, CLIN EXP IMMUNOL, V85, P28; Reynolds J, 2000, J CLIN INVEST, V105, P643, DOI 10.1172/JCI6710; Reynolds J, 2001, J AM SOC NEPHROL, V12, P61, DOI 10.1681/ASN.V12161; RHIM SH, 1992, J CLIN INVEST, V89, P28, DOI 10.1172/JCI115572; Ryan JJ, 1998, CLIN EXP IMMUNOL, V113, P17, DOI 10.1046/j.1365-2249.1998.00623.x; Ryan JJ, 1998, NEPHROL DIAL TRANSPL, V13, P602, DOI 10.1093/ndt/13.3.602; SADO Y, 1991, VIRCHOWS ARCH B, V60, P345, DOI 10.1007/BF02899566; SADO Y, 1989, J PATHOL, V158, P325, DOI 10.1002/path.1711580410; SADO Y, 1984, J CLIN LAB IMMUNOL, V15, P199; SADO Y, 1992, J PATHOL, V168, P221, DOI 10.1002/path.1711680211; Sado Y, 1998, KIDNEY INT, V53, P664, DOI 10.1046/j.1523-1755.1998.00795.x; SADO Y, 1986, J CLIN LAB IMMUNOL, V19, P193; SHIBATA S, 1971, J IMMUNOL, V106, P1284; Sugihara K, 1996, J PATHOL, V178, P352; Wu J, 2002, J CLIN INVEST, V109, P517, DOI 10.1172/JCI200213876; Wu J, 2001, J IMMUNOL, V167, P2388, DOI 10.4049/jimmunol.167.4.2388	49	6	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46516	46522		10.1074/jbc.M211951200	http://dx.doi.org/10.1074/jbc.M211951200			7	Biochemistry & Molecular Biology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12970356	hybrid			2022-12-27	WOS:000186569400036
J	Jo, MJ; Thomas, KS; Wu, LH; Gonias, SL				Jo, MJ; Thomas, KS; Wu, LH; Gonias, SL			Soluble urokinase-type plasminogen activator receptor inhibits cancer cell growth and invasion by direct urokinase-independent effects on cell signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY BREAST-CANCER; REGULATED KINASE 1; OVARIAN-CANCER; HUMAN CARCINOMA; PROGNOSTIC-SIGNIFICANCE; DOWN-REGULATION; LIGAND-BINDING; TUMOR-GROWTH; CYCLIN D1; IN-VITRO	The urokinase-type plasminogen activator receptor ( uPAR) is released from human cancers and is readily detected in blood. In animal models, soluble uPAR (SuPAR) antagonizes cancer progression; however, the mechanism by which SuPAR functions in vivo remains unclear. It is generally thought that SuPAR scavenges uPA and prevents its interaction with membrane-anchored uPAR. In this study, we demonstrate a novel molecular mechanism by which SuPAR may inhibit cancer progression. We show that SuPAR has the potential to directly and in a uPA-independent manner block the signaling activity of membrane-anchored uPAR. Whether SuPAR inhibits signaling is cell type-specific, depending on the state of the endogenous uPA-uPAR signaling system. In uPAR-deficient cells that lack endogenous uPAR signaling, including uPAR -/- murine embryonic fibroblasts and human embryonal kidney 293 cells, SuPAR functions as a partial signaling agonist that activates ERK/mitogen-activated protein kinase. By contrast, in cells with potent autocrine uPA-uPAR signaling systems, including MDA-MB 231 breast cancer cells and low density lipoprotein receptor-related protein-1-deficient murine embryonic fibroblasts, SuPAR substantially decreases ERK activation. The mechanism probably involves competitive displacement of membrane-anchored uPAR-uPA complex from signaling adaptor proteins. As a result of its effects on cell signaling, SuPAR blocks cell growth and inhibits cellular invasion of Matrigel(TM). Cleavage of SuPAR by proteinases increases its signaling agonist activity and reverses its inhibitory effects on growth and invasion. Thus, proteolytic cleavage represents a molecular switch that neutralizes the anticancer activity of SuPAR.	Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Gonias, SL (corresponding author), Univ Virginia, Sch Med, Dept Pathol, POB 800214, Charlottesville, VA 22908 USA.	slg2t@virginia.edu			NCI NIH HHS [R01 CA 94900] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA094900] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Behrendt N, 1996, J BIOL CHEM, V271, P22885, DOI 10.1074/jbc.271.37.22885; BEHRENDT N, 1991, J BIOL CHEM, V266, P7842; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Carriero MV, 1999, CANCER RES, V59, P5307; Degryse B, 1999, BLOOD, V94, P649, DOI 10.1182/blood.V94.2.649.414k34_649_662; Duffy MJ, 2002, CLIN CHEM, V48, P1194; Duffy MJ, 1999, J SURG ONCOL, V71, P130, DOI 10.1002/(SICI)1096-9098(199906)71:2<130::AID-JSO14>3.0.CO;2-9; ESTREICHER A, 1989, J BIOL CHEM, V264, P1180; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; Fazioli F, 1997, EMBO J, V16, P7279, DOI 10.1093/emboj/16.24.7279; Filardo EJ, 1996, J CELL SCI, V109, P1615; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; GYETKO MR, 1993, J LEUKOCYTE BIOL, V53, P598, DOI 10.1002/jlb.53.5.598; Higazi AAR, 1997, J BIOL CHEM, V272, P5348, DOI 10.1074/jbc.272.8.5348; Hildenbrand R, 1998, LAB INVEST, V78, P59; Holst-Hansen C, 1999, BRIT J CANCER, V81, P203, DOI 10.1038/sj.bjc.6690678; Hoyer-Hansen G, 1997, FEBS LETT, V420, P79, DOI 10.1016/S0014-5793(97)01491-9; Jo M, 2003, J BIOL CHEM, V278, P1642, DOI 10.1074/jbc.M210877200; Jo M, 2002, J BIOL CHEM, V277, P12479, DOI 10.1074/jbc.M111147200; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Knoop A, 1998, BRIT J CANCER, V77, P932, DOI 10.1038/bjc.1998.154; Koshelnick Y, 1997, J BIOL CHEM, V272, P28563, DOI 10.1074/jbc.272.45.28563; Kruger A, 2000, CANCER GENE THER, V7, P292, DOI 10.1038/sj.cgt.7700144; Lakka SS, 2002, ONCOGENE, V21, P5601, DOI 10.1038/sj.onc.1205646; Li Y, 2003, J BIOL CHEM, V278, P29925, DOI 10.1074/jbc.M300751200; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Lutz V, 2001, BIOL CHEM, V382, P789, DOI 10.1515/BC.2001.095; Ma Z, 2002, J CELL BIOL, V159, P1061, DOI 10.1083/jcb.200207070; Ma Z, 2001, J CELL SCI, V114, P3387; Mizukami IF, 1998, J LEUKOCYTE BIOL, V64, P203, DOI 10.1002/jlb.64.2.203; Montuori N, 2002, J BIOL CHEM, V277, P46932, DOI 10.1074/jbc.M207494200; Mustjoki S, 2000, CANCER RES, V60, P7126; Nguyen DHD, 2000, J BIOL CHEM, V275, P19382, DOI 10.1074/jbc.M909575199; Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Pappot H, 1997, EUR J CANCER, V33, P867, DOI 10.1016/S0959-8049(96)00523-0; Pedersen AN, 1997, J IMMUNOL METHODS, V203, P55, DOI 10.1016/S0022-1759(97)00008-2; PEDERSEN N, 1993, J CLIN INVEST, V92, P2160, DOI 10.1172/JCI116817; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; PLOUG M, 1993, J BIOL CHEM, V268, P17539; PYKE C, 1993, FEBS LETT, V326, P69, DOI 10.1016/0014-5793(93)81763-P; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Resnati M, 1996, EMBO J, V15, P1572, DOI 10.1002/j.1460-2075.1996.tb00502.x; Riisbro R, 2002, CLIN CANCER RES, V8, P1132; Schmitt M, 1997, THROMB HAEMOSTASIS, V78, P285; Sidenius N, 2000, FEBS LETT, V470, P40, DOI 10.1016/S0014-5793(00)01282-5; Sier CFM, 1998, CANCER RES, V58, P1843; Stephens RW, 1997, CLIN CHEM, V43, P1868; Stephens RW, 1999, JNCI-J NATL CANCER I, V91, P869, DOI 10.1093/jnci/91.10.869; Weaver AM, 1997, J BIOL CHEM, V272, P14372, DOI 10.1074/jbc.272.22.14372; Webb DJ, 2000, J CELL SCI, V113, P123; Webb DJ, 1999, J BIOL CHEM, V274, P7412, DOI 10.1074/jbc.274.11.7412; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; WILHELM O, 1994, FEBS LETT, V337, P131, DOI 10.1016/0014-5793(94)80259-9; Wilhelm OG, 1999, J CELL PHYSIOL, V180, P225, DOI 10.1002/(SICI)1097-4652(199908)180:2<225::AID-JCP10>3.0.CO;2-2; WILLNOW TE, 1994, J CELL SCI, V107, P719; Xue W, 1997, CANCER RES, V57, P1682; Yao J, 2001, ONCOGENE, V20, P8066, DOI 10.1038/sj.onc.1204944; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; Yebra M, 1996, J BIOL CHEM, V271, P29393, DOI 10.1074/jbc.271.46.29393	68	53	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46692	46698		10.1074/jbc.M308808200	http://dx.doi.org/10.1074/jbc.M308808200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963722	hybrid			2022-12-27	WOS:000186569400059
J	Kotturi, MF; Carlow, DA; Lee, JC; Ziltener, HJ; Jefferies, WA				Kotturi, MF; Carlow, DA; Lee, JC; Ziltener, HJ; Jefferies, WA			Identification and functional characterization of voltage-dependent calcium channels in T lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; STATIONARY NIGHT BLINDNESS; INDUCED ERK ACTIVATION; CA2+ INFLUX; ANTIGEN-RECEPTOR; CYCLOSPORINE-A; CELLS; NIFEDIPINE; GENE; SIGNALS	In T lymphocytes, sustained calcium (Ca2+) influx through Ca2+ channels localized in the plasma membrane is critical for T cell activation and proliferation. Previous studies indicated that voltage-dependent Ca2+ channels (VDCCs) play a role in Ca2+ mobilization during T lymphocyte activation. However, the role of VDCCs in otherwise nonexcitable cells is still poorly understood. We used RT-PCR to identify a transcript encoding the pore-forming alpha(1F)-subunit of an L-type Ca2+ channel in T lymphocytes. Its identity was confirmed by DNA sequencing. To further investigate the contribution of Ca2+ influx through VDCCs, we assessed the effects of the 1,4-dihydropyridine L-type Ca2(+) channel agonist, (+/-) Bay K 8644, and antagonist, nifedipine, on the human Jurkat T cell leukemia line, human peripheral blood T lymphocytes and mouse splenocytes. We found that treatment of T lymphocytes with (+/-) Bay K 8644 increased intracellular Ca2+ and induced the activation of phosphoextracellular-regulated kinase 1/2 (Erk1/2), whereas nifedipine blocked Ca2+ influx, the activity of Erk1/2 and nuclear factor of activated T cells ( NFAT), interleukin-2 (IL-2) production, and IL-2 receptor expression. Nifedipine also significantly suppressed splenocyte proliferation in an in vitro mixed lymphocyte reaction and the proliferation of male antigen (H-Y)-specific T cell receptor-transgenic CD8(+) T cells in transplanted male mice in vivo. Taken together these novel findings indicate that an L-type Ca2+ channel plays a significant role in the Ca2+ influx pathways mediating T lymphocyte activation and proliferation in vitro and in vivo.	Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Biotechnol Lab, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Jefferies, WA (corresponding author), Univ British Columbia, Biomed Res Ctr, 2222 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.							Atherfold PA, 1999, MOL IMMUNOL, V36, P543, DOI 10.1016/S0161-5890(99)00076-0; Barger SW, 1999, NEUROSCIENCE, V89, P101, DOI 10.1016/S0306-4522(98)00312-1; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BIRX DL, 1984, J IMMUNOL, V133, P2904; Brereton HM, 1997, CELL CALCIUM, V22, P39, DOI 10.1016/S0143-4160(97)90088-9; Carlow DA, 2001, J IMMUNOL, V166, P256, DOI 10.4049/jimmunol.166.1.256; Claussen D W, 1995, Gastroenterol Nurs, V18, P71, DOI 10.1097/00001610-199503000-00008; Cui J, 2002, J BIOL CHEM, V277, P47175, DOI 10.1074/jbc.M205870200; Densmore JJ, 1996, AM J PHYSIOL-CELL PH, V271, pC1494, DOI 10.1152/ajpcell.1996.271.5.C1494; DENSMORE JJ, 1992, FEBS LETT, V312, P161, DOI 10.1016/0014-5793(92)80926-8; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; FAGNI L, 1994, PFLUG ARCH EUR J PHY, V429, P176, DOI 10.1007/BF00374310; Fomina AF, 2000, J CELL BIOL, V150, P1435, DOI 10.1083/jcb.150.6.1435; Franklin RA, 2000, MOL IMMUNOL, V37, P675, DOI 10.1016/S0161-5890(00)00087-0; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; Gamberucci A, 2002, BIOCHEM J, V364, P245, DOI 10.1042/bj3640245; GELFAND EW, 1986, EUR J IMMUNOL, V16, P907, DOI 10.1002/eji.1830160806; Guse AH, 1998, CRIT REV IMMUNOL, V18, P419, DOI 10.1615/CritRevImmunol.v18.i5.20; HAVERSTICK DM, 1991, J IMMUNOL, V146, P3306; Hirota J, 1998, BIOCHEM J, V333, P615, DOI 10.1042/bj3330615; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; Hofmann F, 1999, REV PHYSIOL BIOCH P, V139, P33, DOI 10.1007/BFb0033648; JAYARAMAN T, 1995, P NATL ACAD SCI USA, V92, P6007, DOI 10.1073/pnas.92.13.6007; KAJI DM, 1990, AM J PHYSIOL, V259, pC332, DOI 10.1152/ajpcell.1990.259.2.C332; Kerschbaum HH, 1999, SCIENCE, V283, P836, DOI 10.1126/science.283.5403.836; KITAGAWA M, 1991, FEBS LETT, V283, P210, DOI 10.1016/0014-5793(91)80590-Y; LARKIN JG, 1992, EPILEPSIA, V33, P760, DOI 10.1111/j.1528-1157.1992.tb02358.x; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; MARX M, 1990, NEPHROL DIAL TRANSPL, V5, P1038, DOI 10.1093/ndt/5.12.1038; Medema JP, 1999, HUM IMMUNOL, V60, P403, DOI 10.1016/S0198-8859(99)00008-7; Mitterdorfer J, 1996, J BIOL CHEM, V271, P30330, DOI 10.1074/jbc.271.48.30330; Mitterdorfer J, 1998, J BIOENERG BIOMEMBR, V30, P319, DOI 10.1023/A:1021933504909; MORGANO A, 1990, EUR J CLIN PHARMACOL, V39, P545, DOI 10.1007/BF00316092; PADBERG WM, 1990, TRANSPLANT P, V22, P2337; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Peterson BZ, 1997, J BIOL CHEM, V272, P18752, DOI 10.1074/jbc.272.30.18752; PORCHET HC, 1992, EUR J CLIN PHARMACOL, V43, P551, DOI 10.1007/BF02285101; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Savignac M, 2001, FASEB J, V15, P1577, DOI 10.1096/fj.00-0733fje; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Tanimura A, 2000, J BIOL CHEM, V275, P27488; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; Willmott NJ, 1996, FEBS LETT, V394, P159, DOI 10.1016/0014-5793(96)00939-8; YOUNG W, 1988, MOL PHARMACOL, V34, P239; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Zhang X, 1997, J PHARMACOL EXP THER, V281, P1247	49	90	99	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46949	46960		10.1074/jbc.M309268200	http://dx.doi.org/10.1074/jbc.M309268200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12954628	hybrid			2022-12-27	WOS:000186569400089
J	Majors, AK; Austin, RC; de la Motte, CA; Pyeritz, RE; Hascall, VC; Kessler, SP; Sen, G; Strong, SA				Majors, AK; Austin, RC; de la Motte, CA; Pyeritz, RE; Hascall, VC; Kessler, SP; Sen, G; Strong, SA			Endoplasmic reticulum stress induces hyaluronan deposition and leukocyte adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINAL PROPEPTIDE; T-CELL EXTRAVASATION; SMOOTH-MUSCLE-CELLS; PRO-ALPHA-1(I) CHAIN; CHONDROITIN SULFATE; COLLAGEN PRODUCTION; CD44; EXPRESSION; HOMOCYSTEINE; ACTIVATION	There is mounting evidence that perturbations in endoplasmic reticulum ( ER) function play a key role in the pathogenesis of a broad range of diseases. We have examined the ability of ER stress to modulate leukocyte binding to colonic and aortic smooth muscle cells. In vitro, control smooth muscle cells bind few leukocytes, but treatment with compounds that induce ER stress, including tunicamycin, A23187, and thapsigargin, promotes leukocyte binding. Likewise, dextran sulfate, another agent capable of inducing ER stress and promoting inflammation in vivo, strongly induces leukocyte adhesion. The bound leukocytes are released by hyaluronidase treatment, indicating a critical role for hyaluronan-containing structures in mediating leukocyte binding. Affinity histochemistry demonstrated that hyaluronan accumulates and is present in cable-like structures in the treated, but not the untreated, cultures and that these structures serve as attachment sites for leukocytes. Hyaluronan-rich regions of both murine and human inflamed colon contain numerous cells that stain intensely for ER-resident chaperones containing the KDEL sequence, demonstrating a relationship between ER stress and hyaluronan deposition in vivo. These results indicate that ER stress may contribute to chronic inflammation by forming a hyaluronan-rich extracellular matrix that is conducive to leukocyte binding.	Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Colorectal Surg, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Biomed Engn, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Mol Biol, Cleveland, OH 44195 USA; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8V 1C3, Canada; Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada; Univ Penn, Sch Med, Dept Med, Div Med Genet, Philadelphia, PA 19104 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; McMaster University; University of Pennsylvania	Majors, AK (corresponding author), Cleveland Clin Fdn, Dept Immunol, NB30,9500 Euclid Ave, Cleveland, OH 44195 USA.	majorsa@ccf.org			NIDDK NIH HHS [DK 58867] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058867] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; BYERS PH, 2001, METABOLIC MOL BASES, P5241; CHESSLER SD, 1993, J BIOL CHEM, V268, P18218; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; de Fougerolles AR, 2000, IMMUNITY, V13, P749, DOI 10.1016/S1074-7613(00)00073-X; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; DeGrendele HC, 1997, J IMMUNOL, V159, P2549; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DELAMOTTE CA, 2003, HYALURONAN CHEM BIOC, P381; Estess P, 1999, J EXP MED, V190, P9, DOI 10.1084/jem.190.1.9; FEDARKO NS, 1995, J BONE MINER RES, V10, P1122; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Gerdin B, 1997, J INTERN MED, V242, P49, DOI 10.1046/j.1365-2796.1997.00173.x; Goodstone NJ, 1998, ARCH BIOCHEM BIOPHYS, V350, P26, DOI 10.1006/abbi.1997.0472; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; HOBDEN AN, 1978, BIOCHEM J, V170, P57, DOI 10.1042/bj1700057; HOLBROOK KA, 1981, LAB INVEST, V44, P342; Johnson PRA, 2001, CLIN EXP PHARMACOL P, V28, P233, DOI 10.1046/j.1440-1681.2001.03426.x; Johnsson C, 2000, SURGERY, V127, P650, DOI 10.1067/msy.2000.106587; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim PS, 1998, ENDOCR REV, V19, P173, DOI 10.1210/er.19.2.173; LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642; Laurent TC, 1996, ANN MED, V28, P241, DOI 10.3109/07853899609033126; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lesley J, 1997, GLYCOCONJUGATE J, V14, P611, DOI 10.1023/A:1018540610858; Majors A, 1997, ARTERIOSCL THROM VAS, V17, P2074, DOI 10.1161/01.ATV.17.10.2074; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Nandi A, 2000, J BIOL CHEM, V275, P14939, DOI 10.1074/jbc.275.20.14939; OOHIRA A, 1989, BONE, V10, P409, DOI 10.1016/8756-3282(89)90071-9; Outinen PA, 1998, BIOCHEM J, V332, P213, DOI 10.1042/bj3320213; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481; Pyeritz RE, 1993, MCKUSICKS HERITABLE, P137; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; SHIMIZU Y, 1991, FASEB J, V5, P2292, DOI 10.1096/fasebj.5.9.1860621; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Strong SA, 1998, GASTROENTEROLOGY, V114, P1244, DOI 10.1016/S0016-5085(98)70431-7; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; TURAKAINEN H, 1980, BIOCHIM BIOPHYS ACTA, V628, P388, DOI 10.1016/0304-4165(80)90388-8; UNDERHILL C, 1992, J CELL SCI, V103, P293; Vaday GG, 2001, J LEUKOCYTE BIOL, V69, P885; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Yang R, 2002, SCAND J IMMUNOL, V55, P2, DOI 10.1046/j.0300-9475.2001.01033.x	50	132	136	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47223	47231		10.1074/jbc.M304871200	http://dx.doi.org/10.1074/jbc.M304871200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12954638	hybrid			2022-12-27	WOS:000186569400122
J	Abhyankar, MM; Zzaman, S; Bastia, D				Abhyankar, MM; Zzaman, S; Bastia, D			Reconstitution of R6K DNA replication in vitro using 22 purified proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATION HOST FACTOR; ESCHERICHIA-COLI CHROMOSOME; R-PLASMID RSF1040; INITIATOR PROTEIN; POLYMERASE-III; BINDING-SITES; ORIGIN-GAMMA; ENZYMATIC REPLICATION; NUCLEOTIDE-SEQUENCE; COPY NUMBER	We have reconstituted a multiprotein system consisting of 22 purified proteins that catalyzed the initiation of replication specifically at ori gamma of R6K, elongation of the forks, and their termination at specific replication terminators. The initiation was strictly dependent on the plasmid-encoded initiator protein pi and on the host-encoded initiator DnaA. The wild type pi was almost inert, whereas a mutant form containing 3 amino acid substitutions that tended to monomerize the protein was effective in initiating replication. The replication in vitro was primed by DnaG primase, whereas in a crude extract system that had not been fractionated, it was dependent on RNA polymerase. The DNA-bending protein IHF was needed for optimal replication and its substitution by HU, unlike in the oriC system, was less effective in promoting optimal replication. In contrast, wild type pi-mediated replication in vivo requires IHF. Using a template that contained ori gamma flanked by two asymmetrically placed Ter sites in the blocking orientation, replication proceeded in the Cairns type mode and generated the expected types of termination products. A majority of the molecules progressed counterclockwise from the ori, in the same direction that has been observed in vivo. Many features of replication in the reconstituted system appeared to mimic those of in vivo replication. The system developed here is an important milestone in continuing biochemical analysis of this interesting replicon.	Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Bastia, D (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.							ABLES AL, 1991, P NATL ACAD SCI USA, V88, P9011; BASTIA D, 1981, P NATL ACAD SCI-BIOL, V78, P2095, DOI 10.1073/pnas.78.4.2095; Bastia D., 1996, DNA REPLICATION EUKA, P177; BIEK DP, 1989, J BACTERIOL, V171, P2066, DOI 10.1128/jb.171.4.2066-2074.1989; BIEK DP, 1989, J BACTERIOL, V171, P2056, DOI 10.1128/jb.171.4.2056-2065.1989; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Bussiere DE, 1999, MOL MICROBIOL, V31, P1611, DOI 10.1046/j.1365-2958.1999.01287.x; Chattoraj D K, 1995, Genet Eng (N Y), V17, P81; Chattoraj D K, 1985, Basic Life Sci, V30, P355; CHATTORAJ DK, 1988, CELL, V52, P551, DOI 10.1016/0092-8674(88)90468-0; Crooke E, 1995, METHOD ENZYMOL, V262, P500; CROSA JH, 1978, J MOL BIOL, V124, P443, DOI 10.1016/0022-2836(78)90181-X; CROSA JH, 1980, J BIOL CHEM, V255, P1075; CROSA JH, 1976, J BACTERIOL, V126, P454, DOI 10.1128/JB.126.1.454-466.1976; Datta HJ, 1999, P NATL ACAD SCI USA, V96, P73, DOI 10.1073/pnas.96.1.73; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; FILUTOWICZ M, 1985, NUCLEIC ACIDS RES, V13, P103, DOI 10.1093/nar/13.1.103; FILUTOWICZ M, 1988, NUCLEIC ACIDS RES, V16, P3829, DOI 10.1093/nar/16.9.3829; GERMINO J, 1983, CELL, V34, P125, DOI 10.1016/0092-8674(83)90142-3; GERMINO J, 1983, CELL, V32, P131, DOI 10.1016/0092-8674(83)90503-2; INUZUKA M, 1978, P NATL ACAD SCI USA, V75, P5381, DOI 10.1073/pnas.75.11.5381; INUZUKA M, 1975, BIOCHEMISTRY-US, V17, P2567; INUZUKA N, 1980, J BIOL CHEM, V255, P1071; KAGUNI JM, 1984, CELL, V38, P183, DOI 10.1016/0092-8674(84)90539-7; KELLEY W, 1985, P NATL ACAD SCI USA, V82, P2574, DOI 10.1073/pnas.82.9.2574; KELLEY WL, 1991, J BIOL CHEM, V266, P15924; KELLEY WL, 1992, NEW BIOL, V4, P569; KELLEY WL, 1992, P NATL ACAD SCI USA, V89, P5078, DOI 10.1073/pnas.89.11.5078; KHATRI GS, 1989, CELL, V59, P667, DOI 10.1016/0092-8674(89)90012-3; Kim DR, 1996, J BIOL CHEM, V271, P20681, DOI 10.1074/jbc.271.34.20681; KITTELL BL, 1991, P NATL ACAD SCI USA, V88, P1389, DOI 10.1073/pnas.88.4.1389; KOLTER R, 1978, CELL, V15, P1199, DOI 10.1016/0092-8674(78)90046-6; Konieczny I, 1997, J BIOL CHEM, V272, P20173, DOI 10.1074/jbc.272.32.20173; Konieczny I, 1997, P NATL ACAD SCI USA, V94, P14378, DOI 10.1073/pnas.94.26.14378; LEARN B, 1993, COLD SPRING HARB SYM, V58, P389, DOI 10.1101/SQB.1993.058.01.046; LOVETT MA, 1975, P NATL ACAD SCI USA, V72, P2905, DOI 10.1073/pnas.72.8.2905; Lu YB, 1998, EMBO J, V17, P5192, DOI 10.1093/emboj/17.17.5192; Lu YB, 1996, P NATL ACAD SCI USA, V93, P12902, DOI 10.1073/pnas.93.23.12902; MACALLISTER TW, 1991, J BIOL CHEM, V266, P16056; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; MCEACHERN MJ, 1985, P NATL ACAD SCI USA, V82, P1480, DOI 10.1073/pnas.82.5.1480; MCEACHERN MJ, 1989, P NATL ACAD SCI USA, V86, P7942, DOI 10.1073/pnas.86.20.7942; MENSAWILMOT K, 1989, J BIOL CHEM, V264, P2853; MIRON A, 1994, P NATL ACAD SCI USA, V91, P6438, DOI 10.1073/pnas.91.14.6438; MIRON A, 1992, EMBO J, V11, P1205, DOI 10.1002/j.1460-2075.1992.tb05161.x; MUKHERJEE S, 1988, P NATL ACAD SCI USA, V85, P6287, DOI 10.1073/pnas.85.17.6287; MUKHERJEE S, 1988, CELL, V52, P375, DOI 10.1016/S0092-8674(88)80030-8; NASH HA, 1987, J BACTERIOL, V169, P4124, DOI 10.1128/jb.169.9.4124-4127.1987; ODONNELL M, 1990, J BIOL CHEM, V265, P1179; OGAWA T, 1985, P NATL ACAD SCI USA, V82, P3562, DOI 10.1073/pnas.82.11.3562; PAL SK, 1988, J BACTERIOL, V170, P3554, DOI 10.1128/jb.170.8.3554-3560.1988; Pellegrini O, 2000, BIOCHIMIE, V82, P693, DOI 10.1016/S0300-9084(00)01151-2; Pritchard AE, 1996, J BIOL CHEM, V271, P10291, DOI 10.1074/jbc.271.17.10291; SHON M, 1982, J BIOL CHEM, V257, P13823; STALKER DM, 1979, P NATL ACAD SCI USA, V76, P1648; STENZEL TT, 1987, CELL, V49, P709, DOI 10.1016/0092-8674(87)90547-2; VANDERENDE A, 1985, P NATL ACAD SCI USA, V82, P3954; Weigel C, 1997, EMBO J, V16, P6574, DOI 10.1093/emboj/16.21.6574; WICKNER S, 1992, P NATL ACAD SCI USA, V89, P10345, DOI 10.1073/pnas.89.21.10345; WU F, 1995, J BACTERIOL, V177, P6338, DOI 10.1128/jb.177.22.6338-6345.1995; WU F, 1992, NUCLEIC ACIDS RES, V20, P811, DOI 10.1093/nar/20.4.811	61	21	23	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45476	45484		10.1074/jbc.M308516200	http://dx.doi.org/10.1074/jbc.M308516200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12970346	hybrid			2022-12-27	WOS:000186452300053
J	Coric, T; Zhang, P; Todorovic, N; Canessa, CM				Coric, T; Zhang, P; Todorovic, N; Canessa, CM			The extracellular domain determines the kinetics of desensitization in acid-sensitive ion channel 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN DEGENERIN MDEG; SENSING ION CHANNELS; NA+ CHANNEL; H+; CONTRIBUTES; CURRENTS; ASIC1	The acid-sensitive ion channel 1 (ASIC1alpha or BNaC2a) is the most abundant of all mammalian proton-gated ion channels and the one that has the broadest distribution in the nervous system. Hallmarks of ASIC1alpha are gating by external protons and rapid desensitization. In sensory neurons ASIC1 may constitute a nociceptor for pain induced by local acidification, whereas in central neurons it may modulate synaptic activity. To gain insight into the functional roles of ASIC1, we cloned and examined the properties of the evolutionarily distant species toadfish (Opsanus tau), similar to420-million year divergent from mammals. Analysis of the protein sequence from fish ASIC1 revealed 76% amino acid identity with the rat orthologue. The regions of highest conservation are the second transmembrane domain and the ectodomain, whereas the amino and carboxyl termini and first transmembrane domain are poorly conserved. At the functional level, fish ASIC1 is gated by external protons with a half-maximal activation at pH(o) 5.6 and a half-maximal inactivation at pH(o) 7.30. The fish differs from the rat channel on having a 25-fold faster rate of desensitization. Functional studies of chimeras made from rat and fish ASIC1 indicate that the extracellular domain specifically, a cluster of three residues, confers the faster desensitization rate to the fish ASIC1.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Canessa, CM (corresponding author), 333 Cedar St, New Haven, CT 06520 USA.	cecilia.canessa@yale.edu	Todorovic, Natasa/AAB-7822-2022; Todorovic, Natasa/B-8760-2009	Todorovic, Natasa/0000-0003-2626-0794				Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Benson CJ, 2001, ANN NY ACAD SCI, V940, P96; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Coscoy S, 1999, J BIOL CHEM, V274, P10129, DOI 10.1074/jbc.274.15.10129; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Deval E, 2003, NEUROPHARMACOLOGY, V44, P662, DOI 10.1016/S0028-3908(03)00047-9; Fyfe GK, 1999, J BIOL CHEM, V274, P36415, DOI 10.1074/jbc.274.51.36415; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2001, J GEN PHYSIOL, V118, P679, DOI 10.1085/jgp.118.6.679; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; Mamet J, 2002, J NEUROSCI, V22, P10662; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; PUOTI A, 1995, AM J PHYSIOL-CELL PH, V269, pC188, DOI 10.1152/ajpcell.1995.269.1.C188; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Xie JH, 2003, J NEUROPHYSIOL, V89, P2459, DOI 10.1152/jn.00707.2002; Zhang P, 2002, J GEN PHYSIOL, V120, P553, DOI 10.1085/jgp.20028574	28	59	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45240	45247		10.1074/jbc.M304441200	http://dx.doi.org/10.1074/jbc.M304441200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12947112	hybrid			2022-12-27	WOS:000186452300025
J	Kwon, YH; Smerdon, MJ				Kwon, YH; Smerdon, MJ			Binding of zinc finger protein transcription factor IIIA to its cognate DNA sequence with single UV photoproducts at specific sites and its effect on DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; RNA GENE; DAMAGED DNA; IN-VITRO; 5S RNA; CHROMATIN; TFIIIA; MECHANISMS; INITIATION; REPLICATION	The relationship between DNA repair efficiency at specific locations in the binding site of the nine-zinc finger protein transcription factor IIIA (TFIIIA) and binding of its individual zinc fingers was studied. Homogeneously damaged oligonucleotides, which contained a single cis-syn cyclobutane thymine dimer (CTD) at one of six different sites in the internal control region (ICR) of the 5 S rRNA gene to generate a series of damaged DNA substrates, were prepared by chemical synthesis. Binding of TFIIIA to the substrates was assayed by measurement of dissociation constants (K-d), dissociation rates (k(off)), and protein-DNA contacts. The results indicated that a single CTD in the ICR does not significantly affect the K-d of TFIIIA. In contrast, CTDs at positions +55 and +72 (from the transcription start site) in the ICR markedly enhanced k(off) of TFIIIA from the complex. In addition, CTDs in these two sites increased methylation of the N-7 of guanines (by dimethyl sulfate) in the zinc finger contacts of the ICR-TFIIIA complex. Furthermore CTDs at +55 and +72 were more efficiently removed from the complex than CTDs at other sites in the ICR by Xenopus oocyte nuclear extracts. This suggests that repair of CTDs closely correlates with changes in the binding of individual zinc fingers of the ICR-TFIIIA complex. These results have implications for the mechanism of DNA damage recognition and repair in protein-DNA complexes.	Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Smerdon, MJ (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	smerdon@mail.wsu.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002614, R37ES002614] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES02614] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown ML, 1996, J MOL BIOL, V262, P600, DOI 10.1006/jmbi.1996.0539; CADET J, 1992, J PHOTOCH PHOTOBIO B, V15, P277, DOI 10.1016/1011-1344(92)85135-H; CHEN YH, 1991, P NATL ACAD SCI USA, V88, P9583, DOI 10.1073/pnas.88.21.9583; CLEMENS KR, 1992, P NATL ACAD SCI USA, V89, P10822, DOI 10.1073/pnas.89.22.10822; CLEMENS KR, 1994, J MOL BIOL, V244, P23, DOI 10.1006/jmbi.1994.1701; Conconi A, 1999, EMBO J, V18, P1387, DOI 10.1093/emboj/18.5.1387; Conconi A, 2002, P NATL ACAD SCI USA, V99, P649, DOI 10.1073/pnas.022373099; Cordonnier AM, 1999, MUTAT RES-DNA REPAIR, V435, P111, DOI 10.1016/S0921-8777(99)00047-6; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DELRIO S, 1991, NUCLEIC ACIDS RES, V19, P6197; FAIRALL L, 1986, J MOL BIOL, V192, P577, DOI 10.1016/0022-2836(86)90278-0; Gaillard H, 2003, J BIOL CHEM, V278, P17655, DOI 10.1074/jbc.M300770200; GAO SW, 1994, SCIENCE, V263, P1438, DOI 10.1126/science.8128226; HANAS JS, 1984, NUCLEIC ACIDS RES, V12, P2745, DOI 10.1093/nar/12.6.2745; Hara R, 2002, MOL CELL BIOL, V22, P6779, DOI 10.1128/MCB.22.19.6779-6787.2002; HAYES JJ, 1992, J MOL BIOL, V227, P407, DOI 10.1016/0022-2836(92)90897-S; Hess MT, 1997, P NATL ACAD SCI USA, V94, P6664, DOI 10.1073/pnas.94.13.6664; KIM JK, 1995, PHOTOCHEM PHOTOBIOL, V62, P44, DOI 10.1111/j.1751-1097.1995.tb05236.x; Kosmoski JV, 2001, P NATL ACAD SCI USA, V98, P10113, DOI 10.1073/pnas.181073398; Kosmoski JV, 1999, BIOCHEMISTRY-US, V38, P9485, DOI 10.1021/bi990297h; KOSMOSKI JV, 1999, THESIS WASHINGTON ST; Li SS, 2000, METHODS, V22, P170, DOI 10.1006/meth.2000.1058; Liu XQ, 1997, BIOCHEMISTRY-US, V36, P13710, DOI 10.1021/bi9716736; McBryant SJ, 1996, NUCLEIC ACIDS RES, V24, P2567, DOI 10.1093/nar/24.13.2567; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; Meijer M, 1999, BIOESSAYS, V21, P596, DOI 10.1002/(SICI)1521-1878(199907)21:7<596::AID-BIES8>3.0.CO;2-5; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; Oda N, 1996, J BIOL CHEM, V271, P13816, DOI 10.1074/jbc.271.23.13816; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; Patrick MH., 1976, PHOTOCHEM PHOTOBIOL, V2, P35, DOI [10.1016/B978-0-12-734602-1.50008-3, DOI 10.1016/B978-0-12-734602-1.50008-3]; PIELER T, 1987, CELL, V48, P91, DOI 10.1016/0092-8674(87)90359-X; Reid KJ, 2001, BIOTECHNIQUES, V30, P20, DOI 10.2144/01301bm01; ROMANIUK PJ, 1990, J BIOL CHEM, V265, P17593; SCHROTH GP, 1989, NATURE, V340, P487, DOI 10.1038/340487a0; Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787; SELBY CP, 1994, MICROBIOL REV, V58, P317, DOI 10.1128/MMBR.58.3.317-329.1994; Shaw PE, 2000, NUCLEIC ACID PROTOCOLS HANDBOOK, P737; Singer B., 1983, MOL BIOL MUTAGENS CA, P45; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Tommasi S, 2000, NUCLEIC ACIDS RES, V28, P3991, DOI 10.1093/nar/28.20.3991; Tommasi S, 1996, BIOCHEMISTRY-US, V35, P15693, DOI 10.1021/bi962117z; Tornaletti S, 1999, BIOCHIMIE, V81, P139, DOI 10.1016/S0300-9084(99)80046-7; Tu YQ, 1996, EMBO J, V15, P675, DOI 10.1002/j.1460-2075.1996.tb00400.x; Ura K, 2001, EMBO J, V20, P2004, DOI 10.1093/emboj/20.8.2004; VELDHOEN N, 1994, BIOCHEMISTRY-US, V33, P7568, DOI 10.1021/bi00190a009; Wakasugi M, 2002, J BIOL CHEM, V277, P1637, DOI 10.1074/jbc.C100610200; WOLFFE AP, 1994, J CELL SCI, V107, P2055; Wuttke DS, 1997, J MOL BIOL, V273, P183, DOI 10.1006/jmbi.1997.1291; YOU QM, 1991, BIOCHEMISTRY-US, V30, P2495, DOI 10.1021/bi00223a028	54	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45451	45459		10.1074/jbc.M308645200	http://dx.doi.org/10.1074/jbc.M308645200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12963720	hybrid			2022-12-27	WOS:000186452300050
J	Shimizu, T; Ihara, K; Maesaki, R; Amano, M; Kaibuchi, K; Hakoshima, T				Shimizu, T; Ihara, K; Maesaki, R; Amano, M; Kaibuchi, K; Hakoshima, T			Parallel coiled-coil association of the RhoA-binding domain in Rho-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOTONIC-DYSTROPHY KINASE; SERINE-THREONINE KINASE; SMALL GTPASE RHO; PROTEIN-KINASE; PUTATIVE TARGET; SERINE/THREONINE KINASE; ACTIN CYTOSKELETON; MYOSIN PHOSPHATASE; CATALYTIC-ACTIVITY; FOCAL ADHESIONS	Rho-kinase is a serine/threonine protein kinase that regulates cytoskeletal events in cells. The enzyme activity of Rho-kinase is auto-inhibited in the free state but is activated through direct binding to the small GTPase Rho in the GTP-bound form. The crystal structure of the Rho-binding domain (RhoBD) of Rho-kinase has been determined at 1.8-Angstrom resolution by the multi-wavelength anomalous dispersion technique. The structure shows that RhoBD dimerizes to form a parallel coiled-coil with long consecutive alpha-helices extended to similar to97 Angstrom and suggests that free Rho-kinase can also form a dimer through parallel self-association. At the middle region of the coiled-coil, the polypeptide chains are flexible and display loose "knobs-into-holes" packing of the side chains from both chains. RhoBD residues that have been shown to be critical for Rho-binding are spread in the positively charged C-terminal region. The parallel coiled-coil structure of our Rho-kinase RhoBD in the free form is different from the anti-parallel coiled-coil structure of RhoBD of protein kinase N when complexed with RhoA. Implications derived from these structural studies in relation to the mechanism of Rho-kinase activation will be addressed with previously reported experimental data.	Nara Inst Sci & Technol, Struct Biol Lab, Nara 6300192, Japan; Japan Sci & Technol Corp, CREST, Nara 6300192, Japan; Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4668550, Japan	Nara Institute of Science & Technology; Japan Science & Technology Agency (JST); Nagoya University	Hakoshima, T (corresponding author), Nara Inst Sci & Technol, Struct Biol Lab, 8916-5 Takayama, Nara 6300192, Japan.		Amano, Mutsuki/M-4820-2014	Amano, Mutsuki/0000-0002-0662-1524				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bush EW, 2000, BIOCHEMISTRY-US, V39, P8480, DOI 10.1021/bi992142f; Chen XQ, 2002, J BIOL CHEM, V277, P12680, DOI 10.1074/jbc.M109839200; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Fujisawa K, 1996, J BIOL CHEM, V271, P23022, DOI 10.1074/jbc.271.38.23022; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Hotta K, 1996, BIOCHEM BIOPH RES CO, V225, P69, DOI 10.1006/bbrc.1996.1132; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Ihara K, 2000, ACTA CRYSTALLOGR D, V56, P1042, DOI 10.1107/S0907444900007174; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Kosako H, 1997, J BIOL CHEM, V272, P10333; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kumar J, 1998, J BIOL CHEM, V273, P31738, DOI 10.1074/jbc.273.48.31738; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Leung T, 1996, MOL CELL BIOL, V16, P5313; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Madaule P, 1995, FEBS LETT, V377, P243, DOI 10.1016/0014-5793(95)01351-2; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; SAKABE N, 1991, NUCL INSTRUM METH A, V303, P448, DOI 10.1016/0168-9002(91)90282-U; Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001; VAN AL, 1997, GENE DEV, V11, P2295; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606	52	46	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46046	46051		10.1074/jbc.M306458200	http://dx.doi.org/10.1074/jbc.M306458200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954645	hybrid			2022-12-27	WOS:000186452300121
J	Tie, JK; Mutucumarana, VP; Straight, DL; Carrick, KL; Pope, RM; Stafford, DW				Tie, JK; Mutucumarana, VP; Straight, DL; Carrick, KL; Pope, RM; Stafford, DW			Determination of disulfide bond assignment of human vitamin K-dependent gamma-glutamyl carboxylase by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYGLUTAMIC ACID PROTEINS; INTEGRAL MEMBRANE-PROTEINS; LINKED PEPTIDES; IDENTIFICATION; DESORPTION; ENZYME; SITE; MS; BIOSYNTHESIS; EPOXIDATION	Vitamin K-dependent gamma-glutamyl carboxylase is a 758 amino acid integral membrane glycoprotein that catalyzes the post-translational conversion of certain protein glutamate residues to gamma-carboxyglutamate. Carboxylase has ten cysteine residues, but their form (sulfhydryl or disulfide) is largely unknown. Pudota et al. in Pudota, B.N., Miyagi, M., Hallgren, K.W., West, K.A., Crabb, J.W., Misono, K.S., and Berkner, K.L. (2000) Proc. Natl. Acad. Sci. U.S.A. 97, 13033-13038 reported that Cys-99 and Cys-450 are the carboxylase active site residues. We determined the form of all cysteines in carboxylase using in-gel protease digestion and matrix-assisted laser desorption/ionization mass spectrometry. The spectrum of non-reduced, trypsin-digested carboxylase revealed a peak at m/z 1991.9. Only this peak disappeared in the spectrum of the reduced sample. This peak's m/z is consistent with the mass of peptide 92-100 (Cys-99) disulfide-linked with peptide 446 453 (Cys-450). To confirm its identity, the m/z 1991.9 peak was isolated by a timed ion selector as the precursor ion for further MS analysis. The fragmentation pattern exhibited two groups of triplet ions characteristic of the symmetric and asymmetric cleavage of disulfide-linked tryptic peptides containing Cys-99 and Cys-450. Mutation of either Cys-99 or Cys-450 caused loss of enzymatic activity. We created a carboxylase variant with both C598A and C700A, leaving Cys-450 as the only remaining cysteine residue in the 60-kDa fragment created by limited trypsin digestion. Analysis of this fully active mutant enzyme showed a 30- and the 60-kDa fragment were joined under non-reducing conditions, thus confirming Cys-450 participates in a disulfide bond. Our results indicate that Cys-99 and Cys-450 form the only disulfide bond in carboxylase.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Stafford, DW (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.			Tie, Jian-Ke/0000-0002-8447-3408	NHLBI NIH HHS [HL48318] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048318] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Berkner KL, 2000, J NUTR, V130, P1877, DOI 10.1093/jn/130.8.1877; Bouchard BA, 1999, BIOCHEMISTRY-US, V38, P9517, DOI 10.1021/bi9907375; Bristol JA, 1996, BLOOD, V88, P2585, DOI 10.1182/blood.V88.7.2585.bloodjournal8872585; CANFIELD LM, 1987, BIOCHEM BIOPH RES CO, V148, P184, DOI 10.1016/0006-291X(87)91093-X; CANFIELD LM, 1980, ARCH BIOCHEM BIOPHYS, V202, P515, DOI 10.1016/0003-9861(80)90457-9; CARLISLE TL, 1980, BIOCHEMISTRY-US, V19, P1161, DOI 10.1021/bi00547a019; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; CRIMMINS DL, 1995, ANAL BIOCHEM, V226, P355, DOI 10.1006/abio.1995.1236; DATTA AK, 1995, NUCLEIC ACIDS RES, V23, P4530, DOI 10.1093/nar/23.21.4530; DOWD P, 1995, SCIENCE, V269, P1684, DOI 10.1126/science.7569894; Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; Giles NM, 2003, BIOCHEM BIOPH RES CO, V300, P1, DOI 10.1016/S0006-291X(02)02770-5; Happersberger HP, 2000, METH MOL B, V146, P167, DOI 10.1385/1-59259-045-4:167; Hiniker A, 2003, BIOCHEMISTRY-US, V42, P1179, DOI 10.1021/bi027141t; Jones MD, 1998, ANAL CHEM, V70, P136, DOI 10.1021/ac9707693; Kaneko R, 1999, J AGR FOOD CHEM, V47, P4950, DOI 10.1021/jf990267l; Kim JS, 2001, RAPID COMMUN MASS SP, V15, P2296, DOI 10.1002/rcm.509; Kulman JD, 1997, P NATL ACAD SCI USA, V94, P9058, DOI 10.1073/pnas.94.17.9058; Kulman JD, 2001, P NATL ACAD SCI USA, V98, P1370, DOI 10.1073/pnas.98.4.1370; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; MORRIS DP, 1993, J BIOL CHEM, V268, P8735; NASHEF AS, 1977, J AGR FOOD CHEM, V25, P245, DOI 10.1021/jf60210a020; PATTERSON SD, 1994, ANAL CHEM, V66, P3727, DOI 10.1021/ac00093a030; Presnell SR, 2002, THROMB HAEMOSTASIS, V87, P937, DOI 10.1055/s-0037-1613115; Presnell SR, 2001, BIOCHEMISTRY-US, V40, P11723, DOI 10.1021/bi010332w; PRICE PA, 1988, ANNU REV NUTR, V8, P565, DOI 10.1146/annurev.nu.08.070188.003025; Pudota BN, 2000, P NATL ACAD SCI USA, V97, P13033, DOI 10.1073/pnas.97.24.13033; Pudota BN, 2001, J BIOL CHEM, V276, P46878, DOI 10.1074/jbc.M108696200; RUDD PM, 1994, BIOCHEMISTRY-US, V33, P17, DOI 10.1021/bi00167a003; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Schnaible V, 2002, ANAL CHEM, V74, P4980, DOI 10.1021/ac025807j; Stanley TB, 1999, J BIOL CHEM, V274, P16940, DOI 10.1074/jbc.274.24.16940; STEARNS DJ, 1988, J BIOL CHEM, V263, P826; Stevens TJ, 2000, PROTEINS, V39, P417, DOI 10.1002/(SICI)1097-0134(20000601)39:4<417::AID-PROT140>3.0.CO;2-Y; Tie J, 2000, BLOOD, V96, P973, DOI 10.1182/blood.V96.3.973.015k55_973_978; van Montfort BA, 2002, J MASS SPECTROM, V37, P322, DOI 10.1002/jms.288; VERMEER C, 1990, BIOCHEM J, V266, P625, DOI 10.1042/bj2660625; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Wu CC, 2003, NAT BIOTECHNOL, V21, P262, DOI 10.1038/nbt0303-262; Wu CC, 2003, NAT BIOTECHNOL, V21, P532, DOI 10.1038/nbt819; Wu SM, 1997, J BIOL CHEM, V272, P11718, DOI 10.1074/jbc.272.18.11718; ZHOU J, 1993, INT J MASS SPECTROM, V126, P115, DOI 10.1016/0168-1176(93)80076-Q	47	33	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45468	45475		10.1074/jbc.M309164200	http://dx.doi.org/10.1074/jbc.M309164200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12963724	hybrid			2022-12-27	WOS:000186452300052
J	Wu, KP; Wu, CW; Tsao, YP; Kuo, TW; Lou, YC; Lin, CW; Wu, SC; Cheng, JW				Wu, KP; Wu, CW; Tsao, YP; Kuo, TW; Lou, YC; Lin, CW; Wu, SC; Cheng, JW			Structural basis of a flavivirus recognized by its neutralizing antibody - Solution structure of the domain III of the Japanese encephalitis virus envelope protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE ANTIGEN OSPA; CHEMICAL-SHIFT; RESISTANT MUTANTS; NMR-SPECTROSCOPY; ESCHERICHIA-COLI; DENGUE VIRUS; EPITOPE; RELAXATION; NEUROINVASIVENESS; NEUROVIRULENCE	The flavivirus envelope protein is the dominant antigen in eliciting neutralizing antibodies and plays an important role in inducing immunologic responses in the infected host. We have determined the solution structure of the major antigenic domain (domain III) of the Japanese encephalitis virus (JEV) envelope protein. The JEV domain III forms a beta-barrel type structure composed of six antiparallel beta-strands resembling the immunoglobulin constant domain. We have also identified epitopes of the JEV domain III to its neutralizing antibody by chemical shift perturbation measurements. Site-directed mutagenesis experiments are performed to confirm the NMR results. Our study provides a structural basis for understanding the mechanism of immunologic protection and for rational design of vaccines effective against flaviviruses.	Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 300, Taiwan; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan	National Tsing Hua University; National Tsing Hua University	Cheng, JW (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 300, Taiwan.		Wu, Kuen-Phon/B-7983-2009; Wu, Kuen-Phon/I-1789-2019; Wu, Suh-Chin/AAV-6233-2021	Wu, Kuen-Phon/0000-0002-1525-6004; Wu, Kuen-Phon/0000-0002-1525-6004; 				BRUNNETT B, 1993, SURVEYS MATH IND, V3, P1; Burke DS, 2001, FIELDS VIROLOGY, P1043, DOI 10.1093/emboj/cdg270; CECILIA D, 1991, VIROLOGY, V181, P70, DOI 10.1016/0042-6822(91)90471-M; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Ding W, 2000, J MOL BIOL, V302, P1153, DOI 10.1006/jmbi.2000.4119; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860; Hiramatsu K, 1996, VIROLOGY, V224, P437, DOI 10.1006/viro.1996.0550; Holzmann H, 1997, J GEN VIROL, V78, P31, DOI 10.1099/0022-1317-78-1-31; HOLZMANN H, 1990, J VIROL, V64, P5156, DOI 10.1128/JVI.64.10.5156-5159.1990; Huang XL, 1998, J MOL BIOL, V281, P61, DOI 10.1006/jmbi.1998.1930; JIANG WR, 1993, J GEN VIROL, V74, P931, DOI 10.1099/0022-1317-74-5-931; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lefevre JF, 1996, BIOCHEMISTRY-US, V35, P2674, DOI 10.1021/bi9526802; Leiting B, 1998, ANAL BIOCHEM, V265, P351, DOI 10.1006/abio.1998.2904; LIN B, 1994, VIROLOGY, V202, P885, DOI 10.1006/viro.1994.1410; Lin CW, 2003, J VIROL, V77, P2600, DOI 10.1128/JVI.77.4.2600-2606.2003; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; MARKUS MA, 1994, J MAGN RESON SER B, V105, P192, DOI 10.1006/jmrb.1994.1122; McMinn PC, 1997, J GEN VIROL, V78, P2711, DOI 10.1099/0022-1317-78-11-2711; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200; Saito Naoyuki G., 1996, Methods (Orlando), V9, P516, DOI 10.1006/meth.1996.0059; Schlesinger JJ, 1996, J GEN VIROL, V77, P1277, DOI 10.1099/0022-1317-77-6-1277; SEIF SA, 1995, VACCINE, V13, P1515, DOI 10.1016/0264-410X(95)00097-K; TASHIRO M, 1995, CURR OPIN STRUC BIOL, V5, P471, DOI 10.1016/0959-440X(95)80031-X; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wu SC, 1998, VIRUS RES, V55, P83, DOI 10.1016/S0168-1702(98)00037-9; Wu SC, 2001, VIRUS RES, V76, P59, DOI 10.1016/S0168-1702(01)00246-5; Wu SC, 1997, VIRUS RES, V51, P173, DOI 10.1016/S0168-1702(97)00098-1	35	101	117	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46007	46013		10.1074/jbc.M307776200	http://dx.doi.org/10.1074/jbc.M307776200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952958	hybrid			2022-12-27	WOS:000186452300116
J	Okamoto, O; Bachy, S; Odenthal, U; Bernaud, J; Rigal, D; Lortat-Jacob, H; Smyth, N; Rousselle, P				Okamoto, O; Bachy, S; Odenthal, U; Bernaud, J; Rigal, D; Lortat-Jacob, H; Smyth, N; Rousselle, P			Normal human keratinocytes bind to the alpha 3LG4/5 domain of unprocessed laminin-5 through the receptor syndecan-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CELL-SURFACE PROTEOGLYCAN; EPITHELIAL-CELLS; GAMMA-2 CHAIN; INTEGRIN ALPHA-3-BETA-1; WOUND REPAIR; LAMA3 GENE; ADHESION; EXPRESSION; MEMBRANE	Basal keratinocytes of the epidermis adhere to their underlying basement membrane through a specific interaction with laminin-5, which is composed by the association of alpha3, beta3, and gamma2 chains. Laminin-5 has the ability to induce either stable cell adhesion or migration depending on specific processing of different parts of the molecule. One event results in the cleavage of the carboxyl-terminal globular domains 4 and 5 (LG4/5) of the alpha3 chain. In this study, we recombinantly expressed the human alpha3LG4/5 fragment in mammalian cells, and we show that this fragment induces adhesion of normal human keratinocytes and fibrosarcoma-derived HT1080 cells in a heparan- and chondroitin sulfate-dependent manner. Immunoprecipitation experiments with (Na2SO4)-S-35-labeled keratinocyte and HT1080 cell lysates as well as immunoblotting experiments revealed that the major proteoglycan receptor for the alpha3LG4/5 fragment is syndecan-1. Syndecan-4 from keratinocytes also bound to alpha3LG4/5. Furthermore we could show for the first time that unprocessed laminin-5 specifically binds syndecan-1, while processed laminin-5 does not. These results demonstrate that the LG4/5 modules within unprocessed laminin-5 permit its cell binding activity through heparan and chondroitin sulfate chains of syndecan-1 and reinforce previous data suggesting specific properties for the precursor molecule.	Inst Federat Rech 128 Biosci Lyon Gerland, UMR 5086, IBCP, F-69367 Lyon 07, France; Fac Med, Ctr Biochem, D-50931 Cologne, Germany; Etab Francais Sang, F-69007 Lyon, France; Univ Grenoble 1, Inst Biol Struct, Commissariat Energie Atom, CNRS,UMR 5075, F-38027 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Cologne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Rousselle, P (corresponding author), Inst Federat Rech 128 Biosci Lyon Gerland, UMR 5086, IBCP, 7 Passage Vercors, F-69367 Lyon 07, France.		Rousselle, Patricia/J-5290-2019; Rousselle, Patricia/CAF-3915-2022	Rousselle, Patricia/0000-0003-0275-4562; Rousselle, Patricia/0000-0003-0275-4562; Smyth, Neil/0000-0002-3734-2149				Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; Baker SE, 1996, J CELL SCI, V109, P2509; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; CAREY DJ, 1994, J CELL BIOL, V124, P161, DOI 10.1083/jcb.124.1.161; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Champliaud MF, 1996, J CELL BIOL, V132, P1189, DOI 10.1083/jcb.132.6.1189; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; DAVID G, 1992, J CELL BIOL, V118, P961, DOI 10.1083/jcb.118.4.961; Decline F, 2003, CELL MOTIL CYTOSKEL, V54, P64, DOI 10.1002/cm.10086; Decline F, 2001, J CELL SCI, V114, P811; ELENIUS K, 1991, J CELL BIOL, V114, P585, DOI 10.1083/jcb.114.3.585; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Gallo R, 1996, J INVEST DERMATOL, V107, P676, DOI 10.1111/1523-1747.ep12365571; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633; Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200; Inki P, 1997, MOL HUM REPROD, V3, P299, DOI 10.1093/molehr/3.4.299; Jaakkola P, 1998, FASEB J, V12, P959, DOI 10.1096/fasebj.12.11.959; Kainulainen T, 1998, J HISTOCHEM CYTOCHEM, V46, P353, DOI 10.1177/002215549804600309; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Lampe PD, 1998, J CELL BIOL, V143, P1735, DOI 10.1083/jcb.143.6.1735; LANGHOFER M, 1993, J CELL SCI, V105, P753; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MATSUI C, 1995, J BIOL CHEM, V270, P23496, DOI 10.1074/jbc.270.40.23496; Mizushima H, 1997, CELL GROWTH DIFFER, V8, P979; Nguyen BP, 2000, J BIOL CHEM, V275, P31896, DOI 10.1074/jbc.M006379200; Nguyen BP, 2000, CURR OPIN CELL BIOL, V12, P554, DOI 10.1016/S0955-0674(00)00131-9; NISHIYAMA T, 2000, J DERMATOL SCI, V1, P51; OKSALA O, 1995, J HISTOCHEM CYTOCHEM, V43, P125, DOI 10.1177/43.2.7529785; OToole EA, 1997, EXP CELL RES, V233, P330, DOI 10.1006/excr.1997.3586; Perrimon N, 2001, SEMIN CELL DEV BIOL, V12, P65, DOI 10.1006/scdb.2000.0237; RAPRAEGER A, 1985, J BIOL CHEM, V260, P4103; ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; RYAN MC, 1994, J BIOL CHEM, V269, P22779; Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; SALMIVIRTA M, 1994, EXP CELL RES, V215, P180, DOI 10.1006/excr.1994.1330; SALMIVIRTA M, 1991, J BIOL CHEM, V266, P7733; Sasaki T, 2001, J MOL BIOL, V314, P751, DOI 10.1006/jmbi.2001.5176; SONNENBERG A, 1993, J CELL SCI, V106, P1083; Tsubota Y, 2000, BIOCHEM BIOPH RES CO, V278, P614, DOI 10.1006/bbrc.2000.3851; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Utani A, 2003, J BIOL CHEM, V278, P34483, DOI 10.1074/jbc.M304827200; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; VAILLY J, 1994, EUR J BIOCHEM, V219, P209, DOI 10.1111/j.1432-1033.1994.tb19932.x; Woods A, 2000, J BIOL CHEM, V275, P24233, DOI 10.1074/jbc.R000001200	51	81	85	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44168	44177		10.1074/jbc.M300726200	http://dx.doi.org/10.1074/jbc.M300726200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947106	hybrid			2022-12-27	WOS:000186306700036
J	Sarkar, J; Seshadri, V; Tripoulas, NA; Ketterer, ME; Fox, PL				Sarkar, J; Seshadri, V; Tripoulas, NA; Ketterer, ME; Fox, PL			Role of ceruloplasmin in macrophage iron efflux during hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR-I; MOUSE PERITONEAL-MACROPHAGES; TRANSCRIPTIONAL ACTIVATION; FERROXIDASE ACTIVITY; REGULATORY PROTEIN-1; TRANSFERRIN; CELLS; METABOLISM; RELEASE; SERUM	The reticuloendothelial system has a central role in erythropoiesis and iron homeostasis. An important function of reticuloendothelial macrophages is phagocytosis of senescent red blood cells. The iron liberated from heme is recycled for delivery to erythrocyte precursors for a new round of hemoglobin synthesis. The molecular mechanism by which recycled iron is released from macrophages remains unresolved. We have investigated the mechanism of macrophage iron efflux, focusing on the role of ceruloplasmin (Cp), a copper protein with a potent ferroxidase activity that converts Fe2+ to Fe3+ in the presence of molecular oxygen. As shown by others, Cp markedly increased iron binding to apotransferrin at acidic pH; however, the physiological significance of this finding is uncertain because little stimulation was observed at neutral pH. Introduction of a hypoxic atmosphere resulted in marked Cp-stimulated binding of iron to apotransferrin at physiological pH. The role of Cp in cellular iron release was examined in U937 monocytic cells induced to differentiate to the macrophage lineage. Cp added at its normal plasma concentration increased the rate of Fe-55 release from U937 cells by about 250%. The stimulation was absolutely dependent on the presence of apotransferrin and hypoxia. Cp-stimulated iron release was confirmed in mouse peritoneal macrophages. Stimulation of iron release required an intracellular "labile iron pool" that was rapidly depleted in the presence of Cp and apotransferrin. Ferroxidase-mediated loading of iron into apotransferrin was critical for iron release because ferroxidase-deficient Cp was inactive and because holotransferrin could not substitute for apotransferrin. The extracellular iron concentration was critical as shown by inhibition of iron release by exogenous free iron, and marked enhancement of release by an iron chelator. Together these data show that Cp stimulates iron release from macrophages under hypoxic conditions by a ferroxidase-dependent mechanism, possibly involving generation of a negative iron gradient.	Cleveland Clin Fdn, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA; No Arizona Univ, Dept Chem, Flagstaff, AZ 86011 USA; Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Northern Arizona University; Case Western Reserve University	Fox, PL (corresponding author), Cleveland Clin Fdn, Dept Cell Biol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	foxp@ccf.org			NHLBI NIH HHS [HL67725, HL29582] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582, R01HL067725] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; AISEN P, 1967, J BIOL CHEM, V242, P2484; ALFORD CE, 1991, J EXP MED, V174, P459, DOI 10.1084/jem.174.2.459; Anderson GJ, 2002, BLOOD CELL MOL DIS, V29, P367, DOI 10.1006/bcmd.2002.0576; Attieh ZK, 1999, J BIOL CHEM, V274, P1116, DOI 10.1074/jbc.274.2.1116; BATES GW, 1973, BIOCHEM BIOPH RES CO, V50, P84, DOI 10.1016/0006-291X(73)91067-X; BEAUMIER DL, 1984, INFECT IMMUN, V46, P489, DOI 10.1128/IAI.46.2.489-494.1984; Brittenham GM, 2000, HEMATOLOGY BASIC PRI, P397; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Danzeisen R, 2000, PLACENTA, V21, P805, DOI 10.1053/plac.2000.0582; DINI L, 1990, EUR J CELL BIOL, V52, P207; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; EHRENWALD E, 1994, J CLIN INVEST, V93, P1493, DOI 10.1172/JCI117127; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Erel O, 1998, CLIN CHEM, V44, P2313; ESPARZA I, 1981, BRIT J HAEMATOL, V49, P603, DOI 10.1111/j.1365-2141.1981.tb07270.x; Freshney R.I, 2010, CULTURE ANIMAL CELLS, Vsixth, P732; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; HUFF RL, 1951, MEDICINE, V30, P197, DOI 10.1097/00005792-195109000-00001; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; JOHNSON DA, 1967, CLIN CHEM, V13, P142; Jurrus E R, 1977, Adv Vet Sci Comp Med, V21, P309; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; KATAOKA M, 1985, EXP HEMATOL, V13, P806; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; Kuriyama-Matsumura K, 1998, BIOCHEM BIOPH RES CO, V249, P241, DOI 10.1006/bbrc.1998.9046; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; LINDER MC, 1981, JNCI-J NATL CANCER I, V67, P263; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; MARESCHAL JC, 1980, FEBS LETT, V110, P268, DOI 10.1016/0014-5793(80)80089-5; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Melillo G, 1997, J BIOL CHEM, V272, P12236, DOI 10.1074/jbc.272.18.12236; Mukhopadhyay CK, 2000, J BIOL CHEM, V275, P21048, DOI 10.1074/jbc.M000636200; Mukhopadhyay CK, 1998, SCIENCE, V279, P714, DOI 10.1126/science.279.5351.714; Musci G, 1996, J BIOL CHEM, V271, P1972, DOI 10.1074/jbc.271.4.1972; NOYES WD, 1960, BRIT J HAEMATOL, V6, P43, DOI 10.1111/j.1365-2141.1960.tb06216.x; OSAKI S, 1969, J BIOL CHEM, V244, P5757; OSAKI S, 1971, J BIOL CHEM, V246, P3018; OSAKI S, 1966, J BIOL CHEM, V241, P2746; PEDERSEN JZ, 1987, EUR J RESPIR DIS, V70, P140; Qian ZM, 2001, EXP BRAIN RES, V140, P369, DOI 10.1007/s002210100831; RAGAN HA, 1969, AM J PHYSIOL, V217, P1320, DOI 10.1152/ajplegacy.1969.217.5.1320; RAMA R, 1988, BIOCHIM BIOPHYS ACTA, V968, P51, DOI 10.1016/0167-4889(88)90043-2; Richardson DR, 1999, J LAB CLIN MED, V134, P454, DOI 10.1016/S0022-2143(99)90166-X; ROESER HP, 1973, P SOC EXP BIOL MED, V142, P1155; ROESER HP, 1970, J CLIN INVEST, V49, P2408, DOI 10.1172/JCI106460; Rolfs A, 1997, J BIOL CHEM, V272, P20055, DOI 10.1074/jbc.272.32.20055; Ryden L., 1984, COPP PROTEINS COPP E, V3, P37; SAITO K, 1986, BRIT J HAEMATOL, V62, P275, DOI 10.1111/j.1365-2141.1986.tb02930.x; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Seshadri V, 2002, J BIOL CHEM, V277, P27903, DOI 10.1074/jbc.M203610200; SHOKEIR MHK, 1972, CLIN BIOCHEM, V5, P115, DOI 10.1016/S0009-9120(72)80018-3; SURKS MI, 1966, J APPL PHYSIOL, V21, P1185; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Toth I, 1999, J BIOL CHEM, V274, P4467, DOI 10.1074/jbc.274.7.4467; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Yang FM, 2002, J BIOL CHEM, V277, P39786, DOI 10.1074/jbc.M201485200; YOSHIDA K, 1995, NAT GENET, V9, P267, DOI 10.1038/ng0395-267; Young SP, 1997, FEBS LETT, V411, P93, DOI 10.1016/S0014-5793(97)00478-X	60	70	73	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44018	44024		10.1074/jbc.M304926200	http://dx.doi.org/10.1074/jbc.M304926200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12952974	hybrid			2022-12-27	WOS:000186306700017
J	Sonawane, ND; Szoka, FC; Verkman, AS				Sonawane, ND; Szoka, FC; Verkman, AS			Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE DELIVERY; DETERMINANTS; POLYMERS; CELLS	The "proton sponge hypothesis" postulates enhanced transgene delivery by cationic polymer-DNA complexes (polyplexes) containing H+ buffering polyamines by enhanced endosomal Cl- accumulation and osmotic swelling/lysis. To test this hypothesis, we measured endosomal Cl- concentration, pH, and volume after internalization of polyplexes composed of plasmid DNA and polylysine (POL), a non-buffering polyamine, or the strongly buffering polyamines polyethylenimine (PEI) or polyamidoamine (PAM). [Cl-] and pH were measured by ratio imaging of fluorescently labeled polyplexes containing Cl- or pH indicators. [Cl-] increased from 41 to 80 mM over 60 min in endosomes-contained POL-polyplexes, whereas pH decreased from 6.8 to 5.3. Endosomal Cl- accumulation was enhanced (115 mM at 60 min) and acidification was slowed (pH 5.9 at 60 min) for PEI and PAM-polyplexes. Relative endosome volume increased 20% over 75 min for POL-polyplexes versus 140% for PEI-polyplexes. Endosome lysis was seen at >45 min for PEI but not POL-containing endosomes, and PEI-containing endosomes showed increased osmotic fragility in vitro. The slowed endosomal acidification and enhanced Cl- accumulation and swelling/lysis were accounted for by the greater H+ buffering capacity of endosomes containing PEI or PAM versus POL (>90 mM versus 46 H+/pH unit). Our results provide direct support for the proton sponge hypothesis and thus a rational basis for the design of improved non-viral vectors for gene delivery.	Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Pharm, Dept Biopharmaceut Sci & Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, 1246 Hlth Sci E Tower,Box 0521, San Francisco, CA 94143 USA.	verkman@itsa.ucsf.edu	FRECHET, Jean M/P-1497-2016		NEI NIH HHS [EY13574] Funding Source: Medline; NHLBI NIH HHS [HL73856, HL59198] Funding Source: Medline; NIBIB NIH HHS [EB03008, EB00415] Funding Source: Medline; NIDDK NIH HHS [DK46052, DK35124] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856, R01HL059198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R01EB003008, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, R01DK035124, R01DK046052] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abdallah B, 1995, BIOL CELL, V85, P1, DOI 10.1016/0248-4900(96)89122-2; BEHR JP, 1994, BIOCONJUGATE CHEM, V5, P382, DOI 10.1021/bc00029a002; Bieber T, 2002, J CONTROL RELEASE, V82, P441, DOI 10.1016/S0168-3659(02)00129-3; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Godbey WT, 2000, J BIOMED MATER RES, V51, P321, DOI 10.1002/1097-4636(20000905)51:3<321::AID-JBM5>3.3.CO;2-I; HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012; Kichler A, 2001, J GENE MED, V3, P135, DOI 10.1002/jgm.173; Lechardeur D, 2000, J CELL BIOL, V150, P321, DOI 10.1083/jcb.150.2.321; Lechardeur Delphine, 2002, Current Gene Therapy, V2, P183, DOI 10.2174/1566523024605609; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Midoux P, 1999, BIOCONJUGATE CHEM, V10, P406, DOI 10.1021/bc9801070; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349; Ogris M, 2002, DRUG DISCOV TODAY, V7, P479, DOI 10.1016/S1359-6446(02)02243-2; Pack DW, 2000, BIOTECHNOL BIOENG, V67, P217, DOI 10.1002/(SICI)1097-0290(20000120)67:2<217::AID-BIT11>3.0.CO;2-Q; Putnam D, 2001, P NATL ACAD SCI USA, V98, P1200, DOI 10.1073/pnas.031577698; Rolland A, 1998, ADV DRUG DELIVER REV, V30, P1, DOI 10.1016/S0169-409X(97)00101-4; Sonawane ND, 2003, J CELL BIOL, V160, P1129, DOI 10.1083/jcb.200211098; Sonawane ND, 2002, J BIOL CHEM, V277, P5506, DOI 10.1074/jbc.M110818200; Suh J, 2003, P NATL ACAD SCI USA, V100, P3878, DOI 10.1073/pnas.0636277100; Tang MX, 1997, GENE THER, V4, P823, DOI 10.1038/sj.gt.3300454; Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630; Thomas M, 2003, APPL MICROBIOL BIOT, V62, P27, DOI 10.1007/s00253-003-1321-8; Xu YH, 1996, BIOCHEMISTRY-US, V35, P5616, DOI 10.1021/bi9602019; ZEN K, 1992, J CELL BIOL, V119, P99, DOI 10.1083/jcb.119.1.99; Zuber G, 2001, ADV DRUG DELIVER REV, V52, P245, DOI 10.1016/S0169-409X(01)00213-7	26	851	887	6	140	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44826	44831		10.1074/jbc.M308643200	http://dx.doi.org/10.1074/jbc.M308643200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944394	hybrid			2022-12-27	WOS:000186306700117
J	Antonicka, H; Ogilvie, I; Taivassalo, T; Anitori, RP; Haller, RG; Vissing, J; Kennaway, NG; Shoubridge, EA				Antonicka, H; Ogilvie, I; Taivassalo, T; Anitori, RP; Haller, RG; Vissing, J; Kennaway, NG; Shoubridge, EA			Identification and characterization of a common set of complex I assembly intermediates in mitochondria from patients with complex I deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; BLUE-NATIVE-ELECTROPHORESIS; CYTOCHROME-C-OXIDASE; HEREDITARY OPTIC NEUROPATHY; BOVINE HEART-MITOCHONDRIA; DNA-ENCODED SUBUNITS; NEUROSPORA MITOCHONDRIA; STRUCTURAL ORGANIZATION; 3-DIMENSIONAL STRUCTURE; GEL-ELECTROPHORESIS	Deficiencies in the activity of complex I (NADH: ubiquinone oxidoreductase) are an important cause of human mitochondrial disease. Complex I is composed of at least 46 structural subunits that are encoded in both nuclear and mitochondrial DNA. Enzyme deficiency can result from either impaired catalytic efficiency or an inability to assemble the holoenzyme complex; however, the assembly process remains poorly understood. We have used two-dimensional Blue-Native/SDS gel electrophoresis and a panel of 11 antibodies directed against structural subunits of the enzyme to investigate complex I assembly in the muscle mitochondria from four patients with complex I deficiency caused by either mitochondrial or nuclear gene defects. Immunoblot analyses of second dimension denaturing gels identified seven distinct complex I subcomplexes in the patients studied, five of which could also be detected in non-denaturing gels in the first dimension. Although the abundance of these intermediates varied among the different patients, a common constellation of subcomplexes was observed in all cases. A similar profile of subcomplexes was present in a human/mouse hybrid fibroblast cell line with a severe complex I deficiency due to an almost complete lack of assembly of the holoenzyme complex. The finding that diverse causes of complex I deficiency produce a similar pattern of complex I subcomplexes suggests that these are intermediates in the assembly of the holoenzyme complex. We propose a possible assembly pathway for the complex, which differs significantly from that proposed for Neurospora, the current model for complex I assembly.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada; Presbyterian Med Ctr, Inst Exercise & Environm Med, Neuromuscular Ctr, Dallas, TX 75231 USA; Univ Texas, SW Med Ctr, Dallas, TX 75231 USA; Vet Affairs Med Ctr, Dallas, TX 75231 USA; Univ Copenhagen, Rigshosp, Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Rigshosp, Dept Neurol, DK-2100 Copenhagen, Denmark; Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA	McGill University; McGill University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Oregon Health & Science University	Shoubridge, EA (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.			Antonicka, Hana/0000-0002-2525-2867				Alves PC, 1998, BIOCHEM CELL BIOL, V76, P139, DOI 10.1139/bcb-76-1-139; Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848; Benit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; Bottcher B, 2002, J BIOL CHEM, V277, P17970, DOI 10.1074/jbc.M112357200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257; BUSCHGES R, 1994, YEAST, V10, P475, DOI 10.1002/yea.320100406; Cardol P, 2002, J MOL BIOL, V319, P1211, DOI 10.1016/S0022-2836(02)00407-2; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2002, J BIOL CHEM, V277, P50311, DOI 10.1074/jbc.M209166200; Coenen MJH, 1999, BIOCHEM BIOPH RES CO, V265, P339, DOI 10.1006/bbrc.1999.1662; DUARTE M, 1995, GENETICS, V139, P1211; Ferreirinha F, 1999, BIOCHEM J, V342, P551, DOI 10.1042/0264-6021:3420551; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Guenebaut V, 1997, J MOL BIOL, V265, P409, DOI 10.1006/jmbi.1996.0753; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; HOFHAUS G, 1995, MOL CELL BIOL, V15, P964; HOFHAUS G, 1993, EMBO J, V12, P3043, DOI 10.1002/j.1460-2075.1993.tb05973.x; Janssen R, 2002, HUM GENET, V110, P264, DOI 10.1007/s00439-001-0673-3; Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200; Karpova OV, 1999, PLANT J, V17, P511, DOI 10.1046/j.1365-313X.1999.00401.x; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; Kuffner R, 1998, J MOL BIOL, V283, P409, DOI 10.1006/jmbi.1998.2114; Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M; Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154; Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; NEHLS U, 1992, J MOL BIOL, V227, P1032, DOI 10.1016/0022-2836(92)90519-P; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; NOSEK J, 1994, J BACTERIOL, V176, P5622, DOI 10.1128/JB.176.18.5622-5630.1994; Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529; Sazanov LA, 2003, J BIOL CHEM, V278, P19483, DOI 10.1074/jbc.M208959200; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; Schulte U, 2001, J BIOENERG BIOMEMBR, V33, P205, DOI 10.1023/A:1010730919074; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Skehel JM, 1998, FEBS LETT, V438, P301, DOI 10.1016/S0014-5793(98)01317-9; Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O; Triepels R, 2000, HUM GENET, V106, P385, DOI 10.1007/s004390000278; Triepels RH, 2001, J BIOL CHEM, V276, P8892, DOI 10.1074/jbc.M009903200; TUSCHEN G, 1990, J MOL BIOL, V213, P845, DOI 10.1016/S0022-2836(05)80268-2; van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716; Videira A, 2002, BBA-BIOENERGETICS, V1555, P187, DOI 10.1016/S0005-2728(02)00276-1; Videira A, 2001, J BIOENERG BIOMEMBR, V33, P197, DOI 10.1023/A:1010778802236; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	54	147	158	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43081	43088		10.1074/jbc.M304998200	http://dx.doi.org/10.1074/jbc.M304998200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12941961	hybrid			2022-12-27	WOS:000186157000046
J	Chan, SY; Appling, DR				Chan, SY; Appling, DR			Regulation of S-adenosylmethionine levels in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE BETA-SYNTHASE; FOLIC-ACID DERIVATIVES; ADENOSYL-L-METHIONINE; ONE-CARBON METABOLISM; RED-BLOOD-CELLS; METHYLENETETRAHYDROFOLATE REDUCTASE; CYSTEINE BIOSYNTHESIS; IN-VIVO; YEAST; HOMOCYSTEINE	Methylenetetrahydrofolate reductase (MTHFR) catalyzes the reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, used to methylate homocysteine in methionine biosynthesis. Methionine can be activated by ATP to give rise to the universal methyl donor, S-adenosylmethionine (AdoMet). Previously, a chimeric MTHFR (Chimera-1) comprised of the yeast Met13p N-terminal catalytic domain and the Arabidopsis thaliana MTHFR (AtMTHFR-1) C-terminal regulatory domain was constructed (Roje, S., Chan, S. Y., Kaplan, F., Raymond, R. K., Horne, D. W., Appling, D. R., and Hanson, A. D. (2002) J. Biol. Chem. 277, 4056-4061). Engineered yeast (SCY4) expressing Chimera-1 accumulated more than 100-fold more AdoMet and 7-fold more methionine than the wild type. Surprisingly, SCY4 showed no appreciable growth defect. The ability of yeast to hyperaccumulate AdoMet was investigated by studying the intracellular compartmentation of AdoMet as well as the mode of hyperaccumulation. Previous studies have established that AdoMet is distributed between the cytosol and the vacuole. A strain expressing Chimera-1 and lacking either vacuoles (vps33 mutant) or vacuolar polyphosphate (vtc1 mutant) was not viable when grown under conditions that favored AdoMet hyperaccumulation. The hyperaccumulation of AdoMet was a robust phenomenon when these cells were grown in medium containing glycine and formate but did not occur when these supplements were replaced by serine. The basis of the nutrient-dependent AdoMet hyperaccumulation effect is discussed in relation to homocysteine biosynthesis and sulfur metabolism.	Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ Texas, Inst Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Appling, DR (corresponding author), Univ Texas, Dept Chem & Biochem, 1 Univ Stn A5300, Austin, TX 78712 USA.				NIDDK NIH HHS [DK61428] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061428] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; Bagley PJ, 1998, P NATL ACAD SCI USA, V95, P13217, DOI 10.1073/pnas.95.22.13217; Blakley R.L., 1969, N HOLLAND RES MONOGR, P1; CHEREST H, 1993, J BACTERIOL, V175, P5366, DOI 10.1128/JB.175.17.5366-5374.1993; Christopher SA, 2002, MOL GENET METAB, V75, P335, DOI 10.1016/S1096-7192(02)00003-3; Clarke S, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P63; FAROOQUI JZ, 1983, BIOCHIM BIOPHYS ACTA, V757, P342; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; FINKELSTEIN JD, 1984, J BIOL CHEM, V259, P9508; Finkelstein JD, 2000, INT J BIOCHEM CELL B, V32, P385, DOI 10.1016/S1357-2725(99)00138-7; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GREEN JM, 1988, FASEB J, V2, P42, DOI 10.1096/fasebj.2.1.3335280; Hansen J, 2000, MOL GEN GENET, V263, P535, DOI 10.1007/s004380051199; HERBERT V, 1962, J CLIN INVEST, V41, P1263, DOI 10.1172/JCI104589; HOFFMAN CS, 1997, CURRENT PROTOCOLS MO, V2; HORNE DW, 1988, CLIN CHEM, V34, P2357; JACQUEMINFAURE I, 1994, MOL GEN GENET, V244, P519, DOI 10.1007/BF00583903; Jakubowski H, 1997, J BIOL CHEM, V272, P1935; JENCKS DA, 1987, J BIOL CHEM, V262, P2485; Jhee KH, 2000, BIOCHEMISTRY-US, V39, P10548, DOI 10.1021/bi001020g; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; KUTZBACH C, 1971, BIOCHIM BIOPHYS ACTA, V250, P459, DOI 10.1016/0005-2744(71)90247-6; Maclean KN, 2000, J INORG BIOCHEM, V81, P161, DOI 10.1016/S0162-0134(00)00100-8; MATTHEWS RG, 1984, FOLATES PTERINS, V1, P497; Naoi M, 1999, MECH AGEING DEV, V111, P175, DOI 10.1016/S0047-6374(99)00064-0; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; OGUR M, 1977, J BACTERIOL, V129, P926, DOI 10.1128/JB.129.2.926-933.1977; Ono B, 1996, YEAST, V12, P1153, DOI 10.1002/(SICI)1097-0061(19960915)12:11<1153::AID-YEA16>3.0.CO;2-2; PASTERNACK LB, 1992, BIOCHEMISTRY-US, V31, P8713, DOI 10.1021/bi00152a005; Piper MD, 2000, J BIOL CHEM, V275, P30987, DOI 10.1074/jbc.M004248200; Raymond RK, 1999, ARCH BIOCHEM BIOPHYS, V372, P300, DOI 10.1006/abbi.1999.1498; ROCA J, 1992, NUCLEIC ACIDS RES, V20, P4671, DOI 10.1093/nar/20.17.4671; Roe AJ, 2002, MICROBIOL-SGM, V148, P2215, DOI 10.1099/00221287-148-7-2215; Roje S, 2002, J BIOL CHEM, V277, P4056, DOI 10.1074/jbc.M110651200; Rouillon A, 1999, J BIOL CHEM, V274, P28096, DOI 10.1074/jbc.274.40.28096; Russnak R, 2001, J BIOL CHEM, V276, P23849, DOI 10.1074/jbc.M008028200; SCHLENK F, 1970, ARCH BIOCHEM BIOPHYS, V140, P228, DOI 10.1016/0003-9861(70)90027-5; SCHLENK F, 1965, TRANSMETHYLATION MET, P48; SCHWENCKE J, 1976, EUR J BIOCHEM, V65, P49, DOI 10.1111/j.1432-1033.1976.tb10388.x; SELHUB J, 1992, AM J CLIN NUTR, V55, P131, DOI 10.1093/ajcn/55.1.131; SPENCE KD, 1971, J BACTERIOL, V106, P325, DOI 10.1128/JB.106.2.325-330.1971; STOVER P, 1992, BIOCHEMISTRY-US, V31, P2155, DOI 10.1021/bi00122a037; SVIHLA G, 1960, J BACTERIOL, V79, P841, DOI 10.1128/JB.79.6.841-848.1960; Takabatake R, 2001, J BIOCHEM, V129, P827, DOI 10.1093/oxfordjournals.jbchem.a002926; Takagi H, 2003, FEMS MICROBIOL LETT, V218, P291, DOI 10.1016/S0378-1097(02)01175-8; THOMAS D, 1989, MOL CELL BIOL, V9, P3292, DOI 10.1128/MCB.9.8.3292; THOMAS D, 1991, MOL GEN GENET, V226, P224, DOI 10.1007/BF00273607; URECH K, 1978, ARCH MICROBIOL, V116, P275, DOI 10.1007/BF00417851; VANAERTS LAGJM, 1994, TERATOLOGY, V50, P348, DOI 10.1002/tera.1420500506; VANONI MA, 1984, BIOCHEMISTRY-US, V23, P5272, DOI 10.1021/bi00317a027; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WILSON SD, 1984, ANAL BIOCHEM, V142, P529, DOI 10.1016/0003-2697(84)90502-5; Wise CK, 1997, J CHROMATOGR B, V696, P145, DOI 10.1016/S0378-4347(97)00213-2; WOHLFARTH G, 1991, ARCH MICROBIOL, V155, P378; Zhao WQ, 2002, J NEUROSCI RES, V69, P519, DOI 10.1002/jnr.10314	55	45	49	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43051	43059		10.1074/jbc.M308696200	http://dx.doi.org/10.1074/jbc.M308696200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12937179	hybrid			2022-12-27	WOS:000186157000042
J	Richie-Jannetta, R; Francis, SH; Corbin, JD				Richie-Jannetta, R; Francis, SH; Corbin, JD			Dimerization of cGMP-dependent protein kinase I beta is mediated by an extensive amino-terminal leucine zipper motif, and dimerization modulates enzyme function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOS-JUN INTERACTION; X-RAY-SCATTERING; COILED-COIL; DNA-BINDING; CYCLIC-GMP; TRANSCRIPTION FACTOR; MOLECULAR-CLONING; BOVINE AORTA; DOMAIN; ACTIVATION	All mammalian cGMP-dependent protein kinases (PKGs) are dimeric. Dimerization of PKGs involves sequences located near the amino termini, which contain a conserved, extended leucine zipper motif. In PKG Ibeta this includes eight Leu/Ile heptad repeats, and in the present study, deletion and site-directed mutagenesis have been used to systematically delete these repeats or substitute individual Leu/Ile. The enzymatic properties and quaternary structures of these purified PKG mutants have been determined. All had specific enzyme activities comparable to wild type PKG. Simultaneous substitution of alanine at four or more of the Leu/Ile heptad repeats ((L3A/L10A/L17A/I24A), (L31A/I38A/L45A/I52A), (L17A/I24A/L31A/I38A/L45A/I52A), and (L3A/L10A/L45A/I52A)) of the motif produces a monomeric PKG Ibeta. Mutation of two Leu/Ile heptad repeats can produce either a dimeric (L3A/L10A) or monomeric (L17A/I24A and L31A/I38A) PKG. Point mutation of Leu-17 or Ile-24 (L17A or I24A) does not disrupt dimerization. These results suggest that all eight Leu/Ile heptad repeats are involved in dimerization of PKG Ibeta. Six of the eight repeats are sufficient to mediate dimerization, but substitutions at some positions (Leu-17, Ile-24, Leu-31, and Ile-38) appear to have greater impact than others on dimerization. The K-alpha of cGMP for activation of monomeric mutants (PKG Ibeta (Delta1-52) and PKG Ibeta L17A/I24A/L31A/I38A/L45A/I52A) is 2- to 3-fold greater than that for wild type dimeric PKG Ibeta, and there is a corresponding 2- to 3-fold increase in cGMP-dissociation rate of the high affinity cGMP-binding site (site A) of these monomers. These results indicate that dimerization increases sensitivity for cGMP activation of the enzyme.	Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Corbin, JD (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, 702 Light Hall, Nashville, TN 37232 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040029] Funding Source: NIH RePORTER; NHLBI NIH HHS [5T32HL 07752] Funding Source: Medline; NIDDK NIH HHS [DK40029] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AITKEN A, 1984, BIOCHIM BIOPHYS ACTA, V790, P219, DOI 10.1016/0167-4838(84)90025-6; Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; ATKINSON RA, 1991, BIOCHEMISTRY-US, V30, P9387, DOI 10.1021/bi00103a001; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; BIKLE DD, 1993, J BIOL CHEM, V268, P620; BURBELO PD, 1994, GENE, V139, P241, DOI 10.1016/0378-1119(94)90763-3; Busch JL, 2002, J BIOL CHEM, V277, P34048, DOI 10.1074/jbc.M202761200; Chu DM, 1997, J BIOL CHEM, V272, P31922, DOI 10.1074/jbc.272.50.31922; CORBIN JD, 1983, J BIOL CHEM, V258, P1391; CORBIN JD, 1986, J BIOL CHEM, V261, P1208; Fautsch MP, 2001, INVEST OPHTH VIS SCI, V42, P2324; FOSTER JL, 1981, J BIOL CHEM, V256, P5029; Francis S H, 1988, Second Messengers Phosphoproteins, V12, P301; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Francis SH, 1996, J BIOL CHEM, V271, P20748, DOI 10.1074/jbc.271.34.20748; FRANCIS SH, 1993, CYCLIC GMP SYNTHESIS, P115; GAMM DM, 1995, J BIOL CHEM, V270, P27380, DOI 10.1074/jbc.270.45.27380; Gassama-Diagne A, 2001, J BIOL CHEM, V276, P18352, DOI 10.1074/jbc.M009784200; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HU JC, 1990, SCIENCE, V250, P1400, DOI 10.1126/science.2147779; JUNIUS FK, 1995, BIOCHEMISTRY-US, V34, P6164, DOI 10.1021/bi00018a020; KALDERON D, 1989, J BIOL CHEM, V264, P10738; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; Kubota R, 1997, GENOMICS, V41, P360, DOI 10.1006/geno.1997.4682; KUNKEL TA, 1994, CURRENT PROTOCOLS MO; LANDGRAF W, 1989, EUR J BIOCHEM, V181, P643, DOI 10.1111/j.1432-1033.1989.tb14771.x; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Leon DA, 1997, J BIOL CHEM, V272, P28431, DOI 10.1074/jbc.272.45.28431; LI Y, 1995, J BIOL CHEM, V270, P1935, DOI 10.1074/jbc.270.4.1935; LINCOLN TM, 1978, J BIOL CHEM, V253, P6002; Lu R, 1997, MOL CELL BIOL, V17, P5117, DOI 10.1128/MCB.17.9.5117; Marini MG, 1997, J BIOL CHEM, V272, P16490, DOI 10.1074/jbc.272.26.16490; MIGLIETTA LAP, 1988, J BIOL CHEM, V263, P16096; Moitra J, 1997, BIOCHEMISTRY-US, V36, P12567, DOI 10.1021/bi971424h; MONKEN CE, 1980, J BIOL CHEM, V255, P7067; Orstavik S, 1996, BIOCHEM BIOPH RES CO, V220, P759, DOI 10.1006/bbrc.1996.0477; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; RANNELS SR, 1983, METHOD ENZYMOL, V99, P168; RANSONE LJ, 1989, GENE DEV, V3, P770, DOI 10.1101/gad.3.6.770; RASMUSSEN R, 1991, P NATL ACAD SCI USA, V88, P561, DOI 10.1073/pnas.88.2.561; Reed RB, 1996, J BIOL CHEM, V271, P17570, DOI 10.1074/jbc.271.29.17570; Rook F, 1998, PLANT MOL BIOL, V37, P171, DOI 10.1023/A:1005964327725; SANDBERG M, 1989, FEBS LETT, V255, P321, DOI 10.1016/0014-5793(89)81114-7; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Smith JA, 1996, J BIOL CHEM, V271, P20756, DOI 10.1074/jbc.271.34.20756; Stansberry J, 2001, J NEUROCHEM, V76, P1177, DOI 10.1046/j.1471-4159.2001.00131.x; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4207, DOI 10.1021/bi00313a030; Tamura N, 1996, HYPERTENSION, V27, P552, DOI 10.1161/01.HYP.27.3.552; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; UHLER MD, 1993, J BIOL CHEM, V268, P13586; VANHEECKEREN WJ, 1992, NUCLEIC ACIDS RES, V20, P3721, DOI 10.1093/nar/20.14.3721; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wall ME, 2003, P NATL ACAD SCI USA, V100, P2380, DOI 10.1073/pnas.0534892100; WERNET W, 1989, FEBS LETT, V251, P191, DOI 10.1016/0014-5793(89)81453-X; WOLFE L, 1989, J BIOL CHEM, V264, P7734; WOLFE L, 1989, J BIOL CHEM, V264, P4157; Yuasa K, 1999, J BIOL CHEM, V274, P37429, DOI 10.1074/jbc.274.52.37429; Yuasa K, 2000, J BIOL CHEM, V275, P4897, DOI 10.1074/jbc.275.7.4897; Zeng X, 1997, P NATL ACAD SCI USA, V94, P3673, DOI 10.1073/pnas.94.8.3673; Zhao JK, 1997, J BIOL CHEM, V272, P31929, DOI 10.1074/jbc.272.50.31929	67	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 12	2003	278	50					50070	50079		10.1074/jbc.M306796200	http://dx.doi.org/10.1074/jbc.M306796200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751LH	12933804	hybrid			2022-12-27	WOS:000187068200051
J	Xiong, SQ; Zhao, QH; Rong, ZL; Huang, GR; Huang, YL; Chen, PL; Zhang, SP; Liu, L; Chang, ZJ				Xiong, SQ; Zhao, QH; Rong, ZL; Huang, GR; Huang, YL; Chen, PL; Zhang, SP; Liu, L; Chang, ZJ			hSef inhibits PC-12 cell differentiation by interfering with Ras-mitogen-activated protein kinase MAPK signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA EGF RECEPTOR; MOLECULAR CHARACTERIZATION; FEEDBACK LOOP; SPROUTY; EXPRESSION; SEF; PATHWAY; INTERLEUKIN-17; IDENTIFICATION; SPECIFICITY	Growth factor signaling by receptor tyrosine kinases regulates several cell fates, such as proliferation and differentiation. Sef was genetically identified as a negative regulator of fibroblast growth factor (FGF) signaling. Using bioinformatic methods and rapid amplification of cDNA ends-PCR, we isolated both the mouse and the human Sef genes, which encoded the Sef protein and Sef-S isoform that was generated through alternative splicing. We provide evidence that the Sef gene products were located mainly on the cell membrane. Co-immunoprecipitation and immunostaining experiments indicate that hSef interacts with FGFR1 and FGFR2 but not FGFR3. Our results demonstrated that stably expressed hSef strongly inhibits FGF2- or nerve growth factor-induced PC-12 cell differentiation. The intracellular domain of hSef is necessary for the inhibitory effect on FGF2- induced PC-12 cell differentiation. Furthermore, our data suggested Sef exerted the negative effect on FGF2- induced PC-12 cell differentiation through the prevention of Ras-mitogen-activated protein kinase signaling, possibly functioning upstream of the Ras molecule. These findings suggest that Sef may play an important role in the regulation of PC-12 cell differentiation.	Tsing Hua Univ, Tsinghua Inst Genome Res, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China	Tsinghua University	Chang, ZJ (corresponding author), Tsing Hua Univ, Tsinghua Inst Genome Res, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.		Rong, Zhili/H-7561-2014; Chang, Zhijie/AAH-8109-2019	Rong, Zhili/0000-0002-1699-7074; Chang, Zhijie/0000-0003-1567-3227				Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Cancilla B, 2001, KIDNEY INT, V60, P147, DOI 10.1046/j.1523-1755.2001.00781.x; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chambers D, 2000, MECH DEVELOP, V91, P361, DOI 10.1016/S0925-4773(99)00288-9; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Golembo M, 1996, DEVELOPMENT, V122, P223; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Haudenschild D, 2002, J BIOL CHEM, V277, P4309, DOI 10.1074/jbc.M109372200; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kovalenko D, 2003, J BIOL CHEM, V278, P14087, DOI 10.1074/jbc.C200606200; L'Allemain Gilles, 1994, Progress in Growth Factor Research, V5, P291, DOI 10.1016/0955-2235(94)90011-6; LANDOLTMARTICORENA C, 1993, J MOL BIOL, V229, P602, DOI 10.1006/jmbi.1993.1066; Lee J, 2001, J BIOL CHEM, V276, P1660, DOI 10.1074/jbc.M008289200; Lin W, 2002, MECH DEVELOP, V113, P163, DOI 10.1016/S0925-4773(02)00018-7; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Minowada G, 1999, DEVELOPMENT, V126, P4465; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; O'Neill L, 2000, BIOCHEM SOC T, V28, P557, DOI 10.1042/bst0280557; Perrimon N, 1999, CELL, V97, P13, DOI 10.1016/S0092-8674(00)80710-2; Reich A, 1999, DEVELOPMENT, V126, P4139; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Shi YG, 2000, J BIOL CHEM, V275, P19167, DOI 10.1074/jbc.M910228199; Spriggs MK, 1997, J CLIN IMMUNOL, V17, P366, DOI 10.1023/A:1027360106635; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; YANG RB, 2003, J BIOL CHEM; Yao ZB, 1997, CYTOKINE, V9, P794, DOI 10.1006/cyto.1997.0240; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	39	69	79	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 12	2003	278	50					50273	50282		10.1074/jbc.M306936200	http://dx.doi.org/10.1074/jbc.M306936200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751LH	12958313	hybrid			2022-12-27	WOS:000187068200075
J	Forrest, JC; Campbell, JA; Schelling, P; Stehle, T; Dermody, TS				Forrest, JC; Campbell, JA; Schelling, P; Stehle, T; Dermody, TS			Structure-function analysis of reovirus binding to junctional adhesion molecule 1 - Implications for the mechanism of reovirus attachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; CRYSTAL-STRUCTURE; ADENOVIRUS RECEPTOR; CELLULAR RECEPTOR; PROTEIN SIGMA-1; COXSACKIEVIRUS; FIBER; RESOLUTION; ANTIBODY; TYPE-3	Mammalian reoviruses are nonenveloped viruses with a long, filamentous attachment protein that dictates disease phenotypes following infection of newborn mice and is a structural homologue of the adenovirus attachment protein. Reoviruses use junctional adhesion molecule 1 (JAM1) as a serotype-independent cellular receptor. JAM1 is a broadly expressed immunoglobulin superfamily protein that forms stable homodimers and regulates tight-junction permeability and lymphocyte trafficking. We employed a series of structure-guided binding and infection experiments to define residues in human JAM1 (hJAM1) important for reovirus-receptor interactions and to gain insight into mechanisms of reovirus attachment. Binding and infection experiments using chimeric and domain deletion mutant receptor molecules indicate that the amino-terminal D1 domain of hJAM1 is required for reovirus attachment, infection, and replication. Reovirus binding to hJAM1 occurs more rapidly than homotypic hJAM1 association and is competed by excess hJAM1 in vitro and on cells. Crosslinking hJAM1 diminishes the capacity of reovirus to bind hJAM1 in vitro and on cells and negates the competitive effects of soluble hJAM1 on reovirus attachment. Finally, mutagenesis studies demonstrate that residues intimately associated with the hJAM1 dimer interface are critical for reovirus interactions with hJAM1. These results suggest that reovirus attachment disrupts hJAM1 dimers and highlight similarities between the attachment strategies of reovirus and adenovirus.	Vanderbilt Univ, Elizabeth B Lamb Ctr Pediat Res, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Microbiol & Immunol, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Pediat, Sch Med, Nashville, TN 37232 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Lab Dev Immunol, Boston, MA 02114 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Dermody, TS (corresponding author), Vanderbilt Univ, Elizabeth B Lamb Ctr Pediat Res, Sch Med, D7235 MCN, Nashville, TN 37232 USA.				NCI NIH HHS [CA68485, T32 CA09385] Funding Source: Medline; NIAID NIH HHS [R01 AI38296] Funding Source: Medline; NIDDK NIH HHS [DK20593] Funding Source: Medline; NIGMS NIH HHS [R01 GM67853] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA068485, T32CA009385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067853] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANERJEA AC, 1988, VIROLOGY, V167, P601, DOI 10.1016/0042-6822(88)90123-7; Barton ES, 2001, J BIOL CHEM, V276, P2200, DOI 10.1074/jbc.M004680200; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Bazzoni G, 2000, J BIOL CHEM, V275, P30970, DOI 10.1074/jbc.M003946200; Becker MM, 2001, J VIROL, V75, P1459, DOI 10.1128/JVI.75.3.1459-1475.2001; Belnap DM, 2000, P NATL ACAD SCI USA, V97, P73, DOI 10.1073/pnas.97.1.73; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; BODIAN DL, 1994, STRUCTURE, V2, P755, DOI 10.1016/S0969-2126(94)00076-X; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Chappell JD, 2000, J VIROL, V74, P8472, DOI 10.1128/JVI.74.18.8472-8479.2000; Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Del Maschio A, 1999, J EXP MED, V190, P1351, DOI 10.1084/jem.190.9.1351; FERNANDES J, 1994, J BIOL CHEM, V269, P17043; FRASER RDB, 1990, J VIROL, V64, P2990, DOI 10.1128/JVI.64.6.2990-3000.1990; Freimuth P, 1999, J VIROL, V73, P1392, DOI 10.1128/JVI.73.2.1392-1398.1999; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; He YN, 2001, NAT STRUCT BIOL, V8, P874, DOI 10.1038/nsb1001-874; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; Kolatkar PR, 1999, EMBO J, V18, P6249, DOI 10.1093/emboj/18.22.6249; Kostrewa D, 2001, EMBO J, V20, P4391, DOI 10.1093/emboj/20.16.4391; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEE PWK, 1981, VIROLOGY, V108, P156, DOI 10.1016/0042-6822(81)90535-3; LIMBIRD LE, 1996, CELL SURFACE RECEPTO; LIU Y, 2000, J CELL SCI, V113, P1; Lortat-Jacob H, 2001, J BIOL CHEM, V276, P9009, DOI 10.1074/jbc.M009304200; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; MORRISON LA, 1991, P NATL ACAD SCI USA, V88, P3852, DOI 10.1073/pnas.88.9.3852; Nemerow GR, 1999, MICROBIOL MOL BIOL R, V63, P725, DOI 10.1128/MMBR.63.3.725-734.1999; Nibert ML., 2001, FIELDS VIROLOGY, P1679; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ono N, 2001, J VIROL, V75, P1594, DOI 10.1128/JVI.75.4.1594-1600.2001; Ozaki H, 1999, J IMMUNOL, V163, P553; Prota AE, 2003, P NATL ACAD SCI USA, V100, P5366, DOI 10.1073/pnas.0937718100; SCHMID SL, 1990, J CELL BIOL, V111, P2307, DOI 10.1083/jcb.111.6.2307; Spear PG, 2002, DEV CELL, V3, P462, DOI 10.1016/S1534-5807(02)00298-8; Stehle T, 2003, REV MED VIROL, V13, P123, DOI 10.1002/rmv.379; STRONG JE, 1991, VIROLOGY, V184, P23, DOI 10.1016/0042-6822(91)90818-V; Tyler K.L., 2001, FIELDS VIROLOGY, P1729; TYLER KL, 1986, SCIENCE, V233, P770, DOI 10.1126/science.3016895; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; VIRGIN HW, 1988, J VIROL, V62, P4594, DOI 10.1128/JVI.62.12.4594-4604.1988; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; WEINER HL, 1977, P NATL ACAD SCI USA, V74, P5744, DOI 10.1073/pnas.74.12.5744; WEINER HL, 1980, J INFECT DIS, V141, P609, DOI 10.1093/infdis/141.5.609; WEINER HL, 1980, J IMMUNOL, V124, P2143	47	59	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48434	48444		10.1074/jbc.M305649200	http://dx.doi.org/10.1074/jbc.M305649200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12966102	hybrid			2022-12-27	WOS:000186731400129
J	Mogi, M; Togari, A				Mogi, M; Togari, A			Activation of caspases is required for osteoblastic differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC CELL-DEATH; MATURATION; PROTEASES; MC3T3-E1; PATHWAYS	Previous studies have shown that mouse osteoblastic MC3T3-E1 cells undergo apoptosis when exposed to a mixture of proinflammatory cytokines. Bone morphogenetic protein (BMP) s are important regulators of osteoblast differentiation. Because regulation of osteoblastic differentiation is poorly understood, we sought to determine if BMP-4-induced differentiation of osteoblastic cells depends on the activity of the key apoptotic proteases, i.e. the caspases. BMP-4 induced the growth arrest and differentiation of osteoblastic cell line MC3T3-E1, as evidenced by the appearance of osteoblastic phenotypes such as alkaline phosphatase ( ALP) activation and parathyroid hormone (PTH)-dependent production of cAMP. Surprisingly, BMP-4 induced transient and potent activation of caspase-8, caspase-2, and caspase-3, in this order. However, no apoptosis or necrosis in BMP-4-treated cells could be detected by FACS using annexin-V/propodium iodine double staining. Peptide inhibition of caspase activity led to a dramatic reduction in ALP activation and PTH-induced production of cAMP in BMP-4-treated cells. Although BMP-4 treatment resulted in cell-cycle G(0)/G(1) arrest as detected by FACS cell-cycle analysis, caspase inhibitors (caspase-8, caspase-2, and caspase-3 inhibitors) could block the G(0)/G(1) arrest in MC3T3-E1 cells. Taken together, these results confirm a unique and unanticipated role for the caspase-mediated signal cascade in the differentiation of osteoblasts.	Aichi Gakuin Univ, Sch Dent, Dept Pharmacol, Nagoya, Aichi 4648650, Japan	Aichi Gakuin University	Mogi, M (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Pharmacol, Nagoya, Aichi 4648650, Japan.							Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; Chua CC, 2002, BBA-MOL CELL RES, V1593, P1, DOI 10.1016/S0167-4889(02)00257-4; COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Gori F, 1999, J BONE MINER RES, V14, P1522, DOI 10.1359/jbmr.1999.14.9.1522; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Hay E, 2001, J BIOL CHEM, V276, P29028, DOI 10.1074/jbc.M011265200; Hoffmann A, 2001, CRIT REV EUKAR GENE, V11, P23; Ishizaki Y, 1998, J CELL BIOL, V140, P153, DOI 10.1083/jcb.140.1.153; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Metkar SS, 2003, J CELL BIOL, V160, P875, DOI 10.1083/jcb.200210158; Mogi M, 1999, BIOCHEM PHARMACOL, V58, P649, DOI 10.1016/S0006-2952(99)00131-8; Morimoto Y, 1999, J DENT RES, V78, P735, DOI 10.1177/00220345990780030501; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Ritter SJ, 1998, J BIOL CHEM, V273, P12798, DOI 10.1074/jbc.273.21.12798; Srinivasula SM, 1996, J BIOL CHEM, V271, P27099, DOI 10.1074/jbc.271.43.27099; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411; Zamzami N, 1999, NATURE, V401, P127, DOI 10.1038/43591; ZELMATI Y, 2001, J EXP MED, V193, P247	25	114	121	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47477	47482		10.1074/jbc.M307055200	http://dx.doi.org/10.1074/jbc.M307055200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12954609	hybrid			2022-12-27	WOS:000186731400018
J	Takenaka, M; Brennicke, A				Takenaka, M; Brennicke, A			In vitro RNA editing in pea mitochondria requires NTP or dNTP, suggesting involvement of an RNA helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; PLANT-MITOCHONDRIA; ARABIDOPSIS-THALIANA; CYTIDINE DEAMINASE; GENE-EXPRESSION; CHLOROPLASTS; SITE; ELEMENTS; SYSTEM; TRANSCRIPTION	To analyze the biochemical parameters of RNA editing in plant mitochondria and to eventually characterize the enzymes involved we developed a novel in vitro system. The high sensitivity of the mismatch-specific thymine glycosylase is exploited to facilitate reliable quantitative evaluation of the in vitro RNA editing products. A pea mitochondrial lysate correctly processes a C to U editing site in the cognate atp9 template. Reaction conditions were determined for a number of parameters, which allow first conclusions on the proteins involved. The apparent tolerance against specific Zn2+ chelators argues against the involvement of a cytidine deaminase enzyme, the theoretically most straightforward catalysator of the deamination reaction. Participation of a transaminase was investigated by testing potential amino group receptors, but none of these increased the RNA editing reaction. Most notable is the requirement of the RNA editing activity for NTPs. Any NTP or dNTP can substitute for ATP to the optimal concentration of 15 mM. This observation suggests the participation of an RNA helicase in the predicted RNA editing protein complex of plant mitochondria.	Univ Ulm, D-89069 Ulm, Germany	Ulm University	Takenaka, M (corresponding author), Univ Ulm, D-89069 Ulm, Germany.		Takenaka, Mizuki/AAK-9884-2020; Takenaka, Mizuki/B-2636-2013	Takenaka, Mizuki/0000-0002-3242-5092; Takenaka, Mizuki/0000-0002-3242-5092				ARAYA A, 1992, P NATL ACAD SCI USA, V89, P1040, DOI 10.1073/pnas.89.3.1040; Aubourg S, 1999, NUCLEIC ACIDS RES, V27, P628, DOI 10.1093/nar/27.2.628; BINDER S, 1995, J BIOL CHEM, V270, P22182, DOI 10.1074/jbc.270.38.22182; BLANC V, 1995, FEBS LETT, V373, P56, DOI 10.1016/0014-5793(95)00991-H; Bock R, 2000, BIOCHIMIE, V82, P549, DOI 10.1016/S0300-9084(00)00610-6; BONNARD G, 1992, CRIT REV PLANT SCI, V10, P503, DOI 10.1080/07352689209382325; Chateigner-Boutin AL, 2002, MOL CELL BIOL, V22, P8448, DOI 10.1128/MCB.22.24.8448-8456.2002; Chaudhuri S, 1996, EMBO J, V15, P5958, DOI 10.1002/j.1460-2075.1996.tb00982.x; Faivre-Nitschke SE, 1999, EUR J BIOCHEM, V263, P896, DOI 10.1046/j.1432-1327.1999.00591.x; Farre JC, 2001, MOL CELL BIOL, V21, P6731, DOI 10.1128/MCB.21.20.6731-6737.2001; Farre JC, 2001, NUCLEIC ACIDS RES, V29, P2484, DOI 10.1093/nar/29.12.2484; FLORESROZAS H, 1993, J BIOL CHEM, V268, P21372; Gagliardi D, 1999, FEBS LETT, V458, P337, DOI 10.1016/S0014-5793(99)01168-0; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Grosjean H., 1998, MODIFICATION EDITING, DOI [10.1128/9781555818296, DOI 10.1128/9781555818296]; Hirose T, 2001, EMBO J, V20, P1144, DOI 10.1093/emboj/20.5.1144; HODGES P, 1992, TRENDS BIOCHEM SCI, V17, P77, DOI 10.1016/0968-0004(92)90506-5; Hoffmann M, 2002, J MOL BIOL, V320, P943, DOI 10.1016/S0022-2836(02)00552-1; Kuhn J, 2001, MOL CELL BIOL, V21, P731, DOI 10.1128/MCB.21.3.731-742.2001; LIPPOK B, 1994, MOL GEN GENET, V243, P39, DOI 10.1007/BF00283874; Malek O, 1996, EMBO J, V15, P1403, DOI 10.1002/j.1460-2075.1996.tb00482.x; Miyamoto T, 2002, MOL CELL BIOL, V22, P6726, DOI 10.1128/MCB.22.19.6726-6734.2002; NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709; NAVARATNAM N, 1995, CELL, V81, P187, DOI 10.1016/0092-8674(95)90328-3; Okanami M, 1998, NUCLEIC ACIDS RES, V26, P2638, DOI 10.1093/nar/26.11.2638; PRING D, 1993, PLANT MOL BIOL, V21, P1163, DOI 10.1007/BF00023611; RAJASEKHAR VK, 1993, PLANT CELL, V5, P1843, DOI 10.2307/3869699; Taylor GR, 1999, ELECTROPHORESIS, V20, P1125, DOI 10.1002/(SICI)1522-2683(19990101)20:6<1125::AID-ELPS1125>3.0.CO;2-O; YU W, 1995, J BIOL CHEM, V270, P18227, DOI 10.1074/jbc.270.31.18227	29	48	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47526	47533		10.1074/jbc.M305341200	http://dx.doi.org/10.1074/jbc.M305341200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12970369	hybrid			2022-12-27	WOS:000186731400024
J	Visintin, A; Latz, E; Monks, BG; Espevik, T; Golenbock, DT				Visintin, A; Latz, E; Monks, BG; Espevik, T; Golenbock, DT			Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUTTING EDGE; KAPPA-B; LPS; ENDOTOXIN; TLR4; ACTIVATION; COMPLEX; CONFERS; CD14; RESPONSIVENESS	Three cell-surface proteins have been recognized as components of the mammalian signaling receptor for bacterial lipopolysaccharide (LPS): CD14, Toll-like receptor-4 (TLR4), and MD-2. Biochemical and visual studies shown here demonstrate that the role of CD14 in signal transduction is to enhance LPS binding to MD-2, although its expression is not essential for cellular activation. These studies clarify how MD-2 functions: we found that MD-2 enables TLR4 binding to LPS and allows the formation of stable receptor complexes. MD-2 must be bound to TLR4 on the cell surface before binding can occur. Consequently, TLR4 clusters into receptosomes ( many of which are massive) that recruit intracellular toll/IL-1/resistance domain-containing adapter proteins within minutes, thus initiating signal transduction. TLR4 activation correlates with the ability of MD-2 to bind LPS, as MD-2 mutants that still bind TLR4, but are impaired in the ability to bind LPS, conferred a greatly blunted LPS response. These findings help clarify the earliest events of TLR4 triggering by LPS and identify MD-2 as an attractive target for pharmacological intervention in endotoxin-mediated diseases.	Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; Norwegian Univ Sci & Technol, N-7489 Trondheim, Norway	University of Massachusetts System; University of Massachusetts Worcester; Norwegian University of Science & Technology (NTNU)	Golenbock, DT (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, LRB 309,364 Plantat St, Worcester, MA 01605 USA.	douglas.golenbock@umassmed.edu	Monks, Brian/B-8362-2015; Latz, Eicke/H-3951-2014	Monks, Brian/0000-0003-4008-3093; Latz, Eicke/0000-0003-1488-5666	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK050305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054060, R37GM054060, R01GM063244] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK50305] Funding Source: Medline; NIGMS NIH HHS [GM63244, GM54060] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; DELUDE RL, 1995, P NATL ACAD SCI USA, V92, P9288, DOI 10.1073/pnas.92.20.9288; Ferguson AD, 2000, STRUCTURE, V8, P585; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ingalls RR, 1999, INFECT DIS CLIN N AM, V13, P341, DOI 10.1016/S0891-5520(05)70078-7; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kawasaki K, 2001, J ENDOTOXIN RES, V7, P232, DOI 10.1177/09680519010070030701; Lamping N, 1996, J IMMUNOL, V157, P4648; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Lien E, 2002, CRIT CARE MED, V30, pS1, DOI 10.1097/00003246-200201001-00001; Mancek M, 2002, BIOCHEM BIOPH RES CO, V292, P880, DOI 10.1006/bbrc.2002.6748; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mullen GED, 2003, P NATL ACAD SCI USA, V100, P3919, DOI 10.1073/pnas.0630495100; Muroi M, 2002, J BIOL CHEM, V277, P42372, DOI 10.1074/jbc.M205966200; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Re F, 2002, J BIOL CHEM, V277, P23427, DOI 10.1074/jbc.M202554200; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; ROBARDS AW, 1999, PROCEDURES ELECT MIC; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Schumann RR, 1997, J IMMUNOL, V159, P5599; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Vasselon T, 1999, J EXP MED, V190, P509, DOI 10.1084/jem.190.4.509; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	40	187	200	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48313	48320		10.1074/jbc.M306802200	http://dx.doi.org/10.1074/jbc.M306802200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12960171	hybrid			2022-12-27	WOS:000186731400116
J	Jeong, SY; Kumagai, A; Lee, J; Dunphy, WG				Jeong, SY; Kumagai, A; Lee, J; Dunphy, WG			Phosphorylated claspin interacts with a phosphate-binding site in the kinase domain of Chk1 during ATR-mediated activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION STRESS; XENOPUS EGG EXTRACTS; CHECKPOINT CONTROL; DAMAGE CHECKPOINT; CRYSTAL-STRUCTURE; PROTEIN-KINASES; MRC1; PATHWAY; RAD53; FORK	Claspin is essential for the ATR-dependent activation of Chk1 in Xenopus egg extracts containing incompletely replicated or UV-damaged DNA. The activated form of Claspin contains two repeated phosphopeptide motifs that mediate its binding to Chk1. We show that these phosphopeptide motifs bind to Chk1 by means of its N-terminal kinase domain. The binding site on Chk1 involves a positively charged cluster of amino acids that contains lysine 54, arginine 129, threonine 153, and arginine 162. Mutagenesis of these residues strongly compromises the ability of Chk1 to interact with Claspin. These amino acids lie within regions of Chk1 that are involved in various aspects of its catalytic function. The predicted position on Chk1 of the phosphate group from Claspin corresponds to the location of activation-loop phosphorylation in various kinases. In addition, we have obtained evidence that the C-terminal regulatory domain of Chk1, which does not form a stable complex with Claspin under our assay conditions, nonetheless has some role in Claspin-dependent activation. Overall, these results indicate that Claspin docks with a phosphate-binding site in the catalytic domain of Chk1 during activation by ATR. Phosphorylated Claspin may mimic an activating phosphorylation of Chk1 during this process.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA	California Institute of Technology	Dunphy, WG (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043974, R01GM043974] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 43974] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2003, NAT CELL BIOL, V5, P161, DOI 10.1038/ncb921; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Liu QH, 2000, GENE DEV, V14, P1448; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; MORGAN DO, 1994, CURR OPIN CELL BIOL, V6, P239, DOI 10.1016/0955-0674(94)90142-2; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Wang SX, 2000, FEBS LETT, V487, P277, DOI 10.1016/S0014-5793(00)02370-X; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	23	60	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46782	46788		10.1074/jbc.M304551200	http://dx.doi.org/10.1074/jbc.M304551200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963733	Green Accepted, hybrid			2022-12-27	WOS:000186569400069
J	Lin, JY; DeCaprio, JA				Lin, JY; DeCaprio, JA			SV40 large T antigen promotes dephosphorylation of p130	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMIAN-VIRUS-40 LARGE-T; RETINOBLASTOMA SUSCEPTIBILITY GENE; PROTEIN PHOSPHATASE 2A; PRB-RELATED PROTEINS; SMALL TUMOR-ANTIGEN; HEAT-SHOCK PROTEIN; DNA-REPLICATION; CELL-CYCLE; OKADAIC ACID; J-DOMAIN	SV40 large T antigen ( Ag) binds to all members of the retinoblastoma ( RB) tumor suppressor family including pRb, p107, and p130. Although the LXCXE motif of T Ag binds directly to the RB proteins, it is not sufficient to fully inactivate their function. The N- terminal DNA J domain of T Ag cooperates with the LXCXE motif to override RB- mediated repression of E2F- dependent transcription. In addition, T Ag can reduce the overall phosphorylation state of p107 and p130 that is dependent on an intact J domain and LXCXE motif. However, the mechanism of this activity has not been described. Here we describe the use of a cell- free system to characterize the effect of T Ag on p130 phosphorylation. When incubated in extracts prepared from S phase cells, p130 undergoes specific phosphorylation. Addition of T Ag to S phase extracts leads to a reduction of p130 phosphorylation in vitro. The ability of T Ag to reduce the phosphorylation of p130 in vitro is dependent on an intact DNA J domain and can be inhibited by okadaic acid and PP2A- specific inhibitors. These results suggest that T Ag recruits a phosphatase activity in a DNA J domain- dependent manner to reduce the phosphorylation of p130.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	DeCaprio, JA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Mayer 457,44 Binney St, Boston, MA 02115 USA.	james_decaprio@dfci.harvard.edu			NCI NIH HHS [CA 063113] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA063113] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bastians H, 1999, MOL BIOL CELL, V10, P3927, DOI 10.1091/mbc.10.11.3927; Bastians H, 1998, P NATL ACAD SCI USA, V95, P15374, DOI 10.1073/pnas.95.26.15374; BEIJERSBERGEN RL, 1995, GENE DEV, V9, P1340, DOI 10.1101/gad.9.11.1340; BIKEL I, 1987, CELL, V48, P321, DOI 10.1016/0092-8674(87)90435-1; Brandeis M, 1996, EMBO J, V15, P5280, DOI 10.1002/j.1460-2075.1996.tb00913.x; Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; Canhoto AJ, 2000, ONCOGENE, V19, P5116, DOI 10.1038/sj.onc.1203893; CEGIELSKA A, 1994, J VIROL, V68, P269, DOI 10.1128/JVI.68.1.269-275.1994; CEGIELSKA A, 1994, MOL CELL BIOL, V14, P4616, DOI 10.1128/MCB.14.7.4616; CEGIELSKA A, 1993, MOL CELL BIOL, V13, P1202, DOI 10.1128/MCB.13.2.1202; Chao HHA, 2000, MOL CELL BIOL, V20, P7624, DOI 10.1128/MCB.20.20.7624-7633.2000; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Chestukhin A, 2002, MOL CELL BIOL, V22, P453, DOI 10.1128/MCB.22.2.453-468.2002; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Farkas T, 2002, J BIOL CHEM, V277, P26741, DOI 10.1074/jbc.M200381200; GRASSER FA, 1988, VIROLOGY, V165, P13, DOI 10.1016/0042-6822(88)90653-8; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hansen K, 2001, EMBO J, V20, P422, DOI 10.1093/emboj/20.3.422; KELLEY WL, 1994, TRENDS BIOCHEM SCI, V19, P277, DOI 10.1016/0968-0004(94)90003-5; Krtolica A, 1998, ONCOGENE, V17, P2295, DOI 10.1038/sj.onc.1202159; LAWSON R, 1990, J VIROL, V64, P2380, DOI 10.1128/JVI.64.5.2380-2383.1990; LUDLOW JW, 1992, ONCOGENE, V7, P1011; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Mateer SC, 1998, J BIOL CHEM, V273, P35339, DOI 10.1074/jbc.273.52.35339; Mayol X, 1996, ONCOGENE, V13, P237; MAYOL X, 1995, ONCOGENE, V11, P801; Nelson DA, 1997, ONCOGENE, V14, P2407, DOI 10.1038/sj.onc.1201081; Nelson DA, 1997, J BIOL CHEM, V272, P4528, DOI 10.1074/jbc.272.7.4528; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Parreno M, 2000, J VIROL, V74, P3166, DOI 10.1128/JVI.74.7.3166-3176.2000; Parreno M, 2001, ONCOGENE, V20, P4793, DOI 10.1038/sj.onc.1204644; PEDEN KWC, 1992, VIRUS GENES, V6, P107, DOI 10.1007/BF01703060; SAWAI ET, 1994, VIRUS RES, V31, P367, DOI 10.1016/0168-1702(94)90029-9; SAWAI ET, 1989, J VIROL, V63, P3961, DOI 10.1128/JVI.63.9.3961-3973.1989; SCHEIDTMANN KH, 1991, MOL CELL BIOL, V11, P1996, DOI 10.1128/MCB.11.4.1996; SCHEIDTMANN KH, 1991, J VIROL, V65, P2098, DOI 10.1128/JVI.65.4.2098-2101.1991; SCHONTHAL A, 1993, ONCOGENE, V8, P433; Sheppeck JE, 1997, BIOORGAN MED CHEM, V5, P1739, DOI 10.1016/S0968-0896(97)00146-6; Smith EJ, 1998, CELL GROWTH DIFFER, V9, P297; Smith EJ, 1996, MOL CELL BIOL, V16, P6965; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Srinivasan A, 1997, MOL CELL BIOL, V17, P4761, DOI 10.1128/MCB.17.8.4761; Stubdal H, 1996, J VIROL, V70, P2781, DOI 10.1128/JVI.70.5.2781-2788.1996; Stubdal H, 1997, MOL CELL BIOL, V17, P4979, DOI 10.1128/MCB.17.9.4979; Sullivan CS, 2000, MOL CELL BIOL, V20, P6233, DOI 10.1128/MCB.20.17.6233-6243.2000; TAKAI A, 1995, BIOCHEM J, V306, P657, DOI 10.1042/bj3060657; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; VIRSHUP DM, 1989, EMBO J, V8, P3891, DOI 10.1002/j.1460-2075.1989.tb08568.x; VIRSHUP DM, 1992, MOL CELL BIOL, V12, P4883, DOI 10.1128/MCB.12.11.4883; Voorhoeve PM, 1999, ONCOGENE, V18, P515, DOI 10.1038/sj.onc.1202316; Voorhoeve PM, 1999, ONCOGENE, V18, P679, DOI 10.1038/sj.onc.1202289; Yan Y, 1999, J BIOL CHEM, V274, P31917, DOI 10.1074/jbc.274.45.31917; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988; ZALVIDE J, 1995, MOL CELL BIOL, V15, P5800; Zalvide J, 1998, MOL CELL BIOL, V18, P1408, DOI 10.1128/MCB.18.3.1408	62	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46482	46487		10.1074/jbc.M307044200	http://dx.doi.org/10.1074/jbc.M307044200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12968030	hybrid			2022-12-27	WOS:000186569400033
J	Lundmark, R; Carlsson, SR				Lundmark, R; Carlsson, SR			Sorting nexin 9 participates in clathrin-mediated endocytosis through interactions with the core components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCESSORY PROTEIN; AXONAL GUIDANCE; DYNAMIN; DOMAINS; RECEPTOR; IDENTIFICATION; DSH3PX1; COMPLEX; SH3PX1; CELLS	Sorting nexin 9 (SNX9) belongs to a family of proteins, the sorting nexins, that are characterized by the presence of a subclass of the phosphoinositide-binding phox domain. SNX9 has in its amino terminus a Src homology 3 domain and a region with predicted low complexity followed by a carboxyl-terminal part containing the phox domain. We previously found that SNX9 is one of the major proteins in hematopoietic cells that binds to the alpha- and beta2-appendages of adaptor protein complex 2 (AP-2), a protein with a critical role in the formation of clathrin-coated vesicles at the plasma membrane. In the present study we show that clathrin and dynamin-2, two other essential molecules in the endocytic process, also interact with SNX9. We found that both AP-2 and clathrin bind to the low complexity region in SNX9 in a cooperative manner, whereas dynamin-2 binds to the Src homology 3 domain. In the cytosol, SNX9 is present in a 14.5 S complex containing dynamin-2 and an unidentified 41-kDa protein. In HeLa cells, SNX9 co-localized with both AP-2 and dynamin-2 at the plasma membrane or on vesicular structures derived from it but not with the early endosomal marker EEA1 or with AP-1. The results suggest that SNX9 may be recruited together with dynamin-2 and become co-assembled with AP-2 and clathrin at the plasma membrane. Overexpression in both K562 and HeLa cells of truncated forms of SNX9 interfered with the uptake of transferrin, consistent with a role of SNX9 in endocytosis.	Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden	Umea University	Carlsson, SR (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.			Carlsson, Sven R/0000-0001-5123-135X				Brett TJ, 2002, STRUCTURE, V10, P797, DOI 10.1016/S0969-2126(02)00784-0; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; D'Hondt K, 2000, ANNU REV GENET, V34, P255, DOI 10.1146/annurev.genet.34.1.255; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Dong JX, 2000, PROTEIN EXPRES PURIF, V20, P314, DOI 10.1006/prep.2000.1305; Fountoulakis M, 1997, ANAL BIOCHEM, V250, P153, DOI 10.1006/abio.1997.2213; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lin Q, 2002, J BIOL CHEM, V277, P10134, DOI 10.1074/jbc.M110329200; Lundmark R, 2002, BIOCHEM J, V362, P597, DOI 10.1042/0264-6021:3620597; MARKLUND U, 1994, J BIOL CHEM, V269, P30626; Mayer BJ, 2001, J CELL SCI, V114, P1253; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Owen DJ, 2000, CURR OPIN CELL BIOL, V12, P467, DOI 10.1016/S0955-0674(00)00118-6; Qualmann B, 2002, INT REV CYTOL, V220, P93; Sato TK, 2001, SCIENCE, V294, P1881, DOI 10.1126/science.1065763; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; SMYTHE E, 1992, METHOD ENZYMOL, V219, P223; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; Song X, 2001, BIOCHEMISTRY-US, V40, P8940, DOI 10.1021/bi0155100; Worby CA, 2002, J BIOL CHEM, V277, P9422, DOI 10.1074/jbc.M110172200; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Worby CA, 2001, J BIOL CHEM, V276, P41782, DOI 10.1074/jbc.M107080200; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699	33	118	120	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46772	46781		10.1074/jbc.M307334200	http://dx.doi.org/10.1074/jbc.M307334200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12952949	hybrid			2022-12-27	WOS:000186569400068
J	Makise, M; Takenaka, H; Kuwae, W; Takahashi, N; Tsuchiya, T; Mizushima, T				Makise, M; Takenaka, H; Kuwae, W; Takahashi, N; Tsuchiya, T; Mizushima, T			Kinetics of ATP binding to the origin recognition complex of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTED MUTATIONAL ANALYSIS; DNA-REPLICATION; ESCHERICHIA-COLI; AMINO-ACIDS; FUNCTIONAL INTERACTION; YEAST ORIGIN; IN-VITRO; MEMBRANE-BINDING; PROTEIN; INITIATOR	Origin recognition complex ( ORC), a candidate initiator of chromosomal DNA replication in eukaryotes, binds specifically to ATP through two of its subunits ( Orc1p and Orc5p). In this study, we investigated the kinetics of ATP binding to ORC by a filter binding assay. The K-d values for the ATP of wild- type ORC and ORC- 1A ( mutant ORC containing Orc1p with a defective Walker A motif) were less than 10 nM, suggesting that the affinity of Orc5p for ATP is very high. On the other hand, the K-d values for the ATP of ORC- 5A ( mutant ORC containing Orc5p with a defective Walker A motif) was much higher ( about 1.5 muM), suggesting that the affinity of Orc1p for ATP is relatively low in the absence of origin DNA. ATP dissociated more rapidly from its complex with ORC- 5A than from its complex with ORC- 1A, suggesting that the ATP- Orc5p complex is more stable than ATP- Orc1p complex. Origin DNA fragments decreased the K-d value of ORC- 5A for ATP and stabilized the complex of ATP with ORC- 5A. Wild- type ORC, ORC- 1A, and ORC- 5A required different concentrations of ATP for specific binding to origin DNA. All of these results imply that ATP binding to Orc5p, ATP binding to Orc1p, and origin DNA binding to ORC are co- operatively regulated, which may be important for the initiation of DNA replication.	Okayama Univ, Fac Pharmaceut Sci, Okayama 7008530, Japan	Okayama University	Mizushima, T (corresponding author), Okayama Univ, Fac Pharmaceut Sci, 1-1-1 Tsushima Naka, Okayama 7008530, Japan.	mizushima@pharm.okayama-u.ac.jp						BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; BELL SP, 1995, CURR OPIN GENET DEV, V5, P162, DOI 10.1016/0959-437X(95)80003-4; BELL SP, 1995, CELL, V83, P563, DOI 10.1016/0092-8674(95)90096-9; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Carpenter PB, 1996, NATURE, V379, P357, DOI 10.1038/379357a0; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; GAVIN KA, 1995, SCIENCE, V270, P1667, DOI 10.1126/science.270.5242.1667; GOSSEN M, 1995, SCIENCE, V270, P1674, DOI 10.1126/science.270.5242.1674; Grallert B, 1996, GENE DEV, V10, P2644, DOI 10.1101/gad.10.20.2644; Hase M, 1998, J BIOL CHEM, V273, P28651, DOI 10.1074/jbc.273.44.28651; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; LOO S, 1995, MOL BIOL CELL, V6, P741, DOI 10.1091/mbc.6.6.741; Makise M, 2000, J BIOL CHEM, V275, P4513, DOI 10.1074/jbc.275.6.4513; Makise M, 2001, J BIOL CHEM, V276, P7450, DOI 10.1074/jbc.M009643200; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Mizushima T, 2000, GENE DEV, V14, P1631; Mizushima T, 1997, EMBO J, V16, P3724, DOI 10.1093/emboj/16.12.3724; Mizushima T, 1998, J BIOL CHEM, V273, P20847, DOI 10.1074/jbc.273.33.20847; Mizushima T, 1996, J BIOL CHEM, V271, P25178, DOI 10.1074/jbc.271.41.25178; RAO H, 1995, P NATL ACAD SCI USA, V92, P2224, DOI 10.1073/pnas.92.6.2224; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; ROWLEY A, 1995, EMBO J, V14, P2631, DOI 10.1002/j.1460-2075.1995.tb07261.x; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7131; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7136; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Takahara K, 1996, GENOMICS, V31, P119, DOI 10.1006/geno.1996.0018	29	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46440	46445		10.1074/jbc.M307392200	http://dx.doi.org/10.1074/jbc.M307392200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12966094	hybrid			2022-12-27	WOS:000186569400028
J	Shen, JC; Loeb, LA				Shen, JC; Loeb, LA			Mutations in the alpha 8 loop of human APE1 alter binding and cleavage of DNA containing an abasic site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE; BASE EXCISION-REPAIR; ESCHERICHIA-COLI; COORDINATION; RECOGNITION; SUBSTRATE; ANALOGS; MUTANT; HAP1; ENDS	Recent crystallographic studies reveal loops in human AP endonuclease 1 (APE1) that interact with the major and minor grooves of DNA containing apurinic/apyrimidinic ( AP) sites. These loops are postulated to stabilize the DNA helix and the flipped out AP residue. The loop alpha8 interacts with the major groove on the 3' side of the AP site. To determine the essentiality of the amino acids that constitute the alpha8 loop, we created a mutant library containing random nucleotides at codons 222-229 that, in wild-type APE1, specify the sequence NPKGNKKN. Upon expression of the library (2x10(6) different clones) in Escherichia coli and multiple rounds of selection with the alkylating agent methylmethane sulfonate (MMS), we obtained similar to2x10(5) active mutants that complemented the MMS sensitivity of AP endonuclease-deficient E. coli. DNA sequencing showed that active mutants tolerated amino acid substitutions at all eight randomized positions. Basic and uncharged polar amino acids together comprised the majority of substitutions, reflecting the positively charged, polar character of the wild-type loop. Asn-222, Asn-226, and Asn-229 exhibited the least mutability, consistent with x-ray data showing that each asparagine contacts a DNA phosphate. Substitutions at residues 226-229, located nearer to the AP site, that reduced basicity or hydrogen bonding potential, increased K-m 2- to 6-fold and decreased AP site binding; substitutions at residues 222-225 exhibited lesser effects. This initial mutational analysis of the alpha8 loop supports and extends the conclusion of crystallographic studies that the loop is important for binding of AP.DNA and AP site incision.	Univ Washington, Dept Pathol, HSB, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Loeb, LA (corresponding author), Univ Washington, Dept Pathol, HSB, Box 357705,K-072,1959 NE Pacific Ave, Seattle, WA 98195 USA.				NCI NIH HHS [CA 77852, CA 80993] Funding Source: Medline; NIA NIH HHS [AG 07151] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA077852, R01CA080993] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cal S, 1998, EMBO J, V17, P7128, DOI 10.1093/emboj/17.23.7128; Chou KM, 2000, J BIOL CHEM, V275, P31009, DOI 10.1074/jbc.M004082200; Chou KM, 2002, NATURE, V415, P655, DOI 10.1038/415655a; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; DEMPLE B, 1986, P NATL ACAD SCI USA, V83, P7731, DOI 10.1073/pnas.83.20.7731; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Izumi T, 2000, CARCINOGENESIS, V21, P1329, DOI 10.1093/carcin/21.7.1329; Lucas JA, 1999, BIOCHEMISTRY-US, V38, P4958, DOI 10.1021/bi982052v; Masuda Y, 1998, J BIOL CHEM, V273, P30352, DOI 10.1074/jbc.273.46.30352; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Mol CD, 2000, MUTAT RES-DNA REPAIR, V460, P211, DOI 10.1016/S0921-8777(00)00028-8; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; Rothwell DG, 1996, NUCLEIC ACIDS RES, V24, P4217, DOI 10.1093/nar/24.21.4217; Rothwell DG, 2000, NUCLEIC ACIDS RES, V28, P2207, DOI 10.1093/nar/28.11.2207; Suh D, 1997, NUCLEIC ACIDS RES, V25, P2495, DOI 10.1093/nar/25.12.2495; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002	19	11	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46994	47001		10.1074/jbc.M309362200	http://dx.doi.org/10.1074/jbc.M309362200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12966083	hybrid			2022-12-27	WOS:000186569400094
J	Greene, TA; Powell, P; Nzerem, C; Shapiro, MJ; Shapiro, VS				Greene, TA; Powell, P; Nzerem, C; Shapiro, MJ; Shapiro, VS			Cloning and characterization of ALX, an adaptor downstream of CD28	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL DEVELOPMENT; SH2 DOMAIN; IL-2 GENE; PROTEIN; LCK; ACTIVATION; RECEPTOR; TSAD	T cell activation requires two signals: specific recognition of antigen through the T cell receptor (TCR) and a costimulatory signal provided primarily by CD28 in naive T cells. We cloned a novel gene with considerable homology to RIBP/TSAd/Lad, an adaptor involved in T cell activation and interleukin-2 (IL-2) promoter activation. Expression of this gene is limited to the spleen and thymus. We have named this gene ALX, (a) under bar daptor in (l) under bar ymphocytes of unknown function (X) under bar. Because the related adaptor RIBP is involved in IL-2 regulation, we investigated whether ALX had a similar function. ALX overexpression in Jurkat T cells results in inhibition of IL-2 promoter activation after stimulation with superantigen. The IL-2 promoter contains several binding sites for transcription factors including the composite element RE/AP, which is the primary site of CD28 transcriptional activation. ALX overexpression had the greatest effect on the activation of a RE/AP reporter as opposed to an AP-1 reporter. Interestingly, ALX overexpression strongly inhibited RE/AP activation in response to anti-CD28/phorbol 12-myristate 13-acetate (PMA) stimulation but had minimal effect when anti-TCR/PMA was used. Therefore, it appears that ALX may function downstream of CD28 costimulation during T cell activation. In addition, the mobility of ALX shifts upon TCR/CD28 costimulation to a greater extent than what is observed with either stimulus alone demonstrating that ALX is a target of both TCR and CD28 costimulatory signaling pathways.	Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Shapiro, VS (corresponding author), Univ Penn, Dept Pathol & Lab Med, 288 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	shapirov@mail.med.upenn.edu						Chambers CA, 1997, CURR OPIN IMMUNOL, V9, P396, DOI 10.1016/S0952-7915(97)80087-8; Choi YB, 1999, J IMMUNOL, V163, P5242; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Marengere LEM, 1997, J IMMUNOL, V159, P3220; Marti F, 2001, J EXP MED, V193, P1425, DOI 10.1084/jem.193.12.1425; Mustelin T, 2002, FRONT BIOSCI-LANDMRK, V7, pD918, DOI 10.2741/musteli1; Oda T, 2001, BIOCHEM BIOPH RES CO, V288, P1078, DOI 10.1006/bbrc.2001.5890; Rajagopal K, 1999, J EXP MED, V190, P1657, DOI 10.1084/jem.190.11.1657; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Shapiro VS, 1998, J IMMUNOL, V161, P6455; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Shapiro VS, 1996, J EXP MED, V184, P1663, DOI 10.1084/jem.184.5.1663; Spurkland A, 1998, J BIOL CHEM, V273, P4539, DOI 10.1074/jbc.273.8.4539; SUN W, J BIOL CHEM, V276, P5093; Sundvold V, 2000, J IMMUNOL, V165, P2927, DOI 10.4049/jimmunol.165.6.2927; UMLAUF SW, 1993, IMMUNOL REV, V133, P177, DOI 10.1111/j.1600-065X.1993.tb01516.x; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; Yamada M, 2002, MOL CELL BIOL, V22, P8648, DOI 10.1128/MCB.22.24.8648-8658.2002	21	27	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45128	45134		10.1074/jbc.M306283200	http://dx.doi.org/10.1074/jbc.M306283200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12960172	hybrid			2022-12-27	WOS:000186452300012
J	Zhong, WM; Reche, PA; Lai, CC; Reinhold, B; Reinherz, EL				Zhong, WM; Reche, PA; Lai, CC; Reinhold, B; Reinherz, EL			Genome-wide characterization of a viral cytotoxic T lymphocyte epitope repertoire	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I MOLECULES; SENDAI-VIRUS-INFECTION; CELL RESPONSE; CTL RESPONSES; MHC MOLECULES; PEPTIDES; ANTIGEN; IMMUNODOMINANCE; MOTIFS; VIVO	A genome-wide search using major histocompatibility complex (MHC) class I binding and proteosome cleavage site algorithms identified 101 influenza A PR8 virus-derived peptides as potential epitopes for CD8(+) T cell recognition in the H-2(b) mouse. Cytokine-based flow cytometry, ELISPOT, and cytotoxic T lymphocyte assays reveal that 16 are recognized by CD8(+) T cells recovered directly ex vivo from infected animals, accounting for greater than 70% of CD8(+) T cells recruited to lung after primary infection. Only six of the 22 highest affinity MHC class I binding peptides comprise cytotoxic T lymphocyte epitopes. The remaining non-immunogenic peptides have equivalent MHC affinity and MHC-peptide complex half-lives, eliciting T cell responses when given in adjuvant and with T cell receptor-ligand avidity comparable with their immunogenic counterparts. As revealed by a novel high sensitivity nanospray tandem mass spectrometry methodology, failure to process those predicted epitopes may contribute significantly to the absent response. These results have important implications for rationale design of CD8(+) T cell vaccines.	Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Reinherz, EL (corresponding author), Dana Farber Canc Inst, Immunobiol Lab, 44 Binney St, Boston, MA 02115 USA.	ellis_reinherz@dfci.harvard.edu	Reche, Pedro A/B-1881-2013	Reche, Pedro A/0000-0003-3966-5838	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050900] Funding Source: NIH RePORTER; NIAID NIH HHS [AI50900] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Belz GT, 2000, J IMMUNOL, V165, P2404, DOI 10.4049/jimmunol.165.5.2404; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Busch DH, 1998, J IMMUNOL, V160, P4441; Cole GA, 1997, J IMMUNOL, V158, P4301; DOHERTY PC, 1992, ANNU REV IMMUNOL, V10, P123; Emmerich NPN, 2000, J BIOL CHEM, V275, P21140, DOI 10.1074/jbc.M000740200; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Fu TM, 1997, J VIROL, V71, P2715, DOI 10.1128/JVI.71.4.2715-2721.1997; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; KAST WM, 1991, P NATL ACAD SCI USA, V88, P2283, DOI 10.1073/pnas.88.6.2283; Kuon W, 2001, J IMMUNOL, V167, P4738, DOI 10.4049/jimmunol.167.8.4738; Lamb R.A., 1996, FIELDS VIROLOGY, V2, P1353; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; MOSKOPHIDIS D, 1995, J VIROL, V69, P2187, DOI 10.1128/JVI.69.4.2187-2193.1995; OUKKA M, 1994, J IMMUNOL, V152, P4843; Oukka M, 1996, J IMMUNOL, V157, P3039; Preckel T, 1997, J EXP MED, V185, P1803, DOI 10.1084/jem.185.10.1803; Price GE, 2000, J EXP MED, V191, P1853, DOI 10.1084/jem.191.11.1853; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reche PA, 2002, HUM IMMUNOL, V63, P701, DOI 10.1016/S0198-8859(02)00432-9; RESTIFO NP, 1995, J IMMUNOL, V154, P4414; SASTRY KJ, 1994, VACCINE, V12, P1281; Schaible U E, 1999, Adv Immunol, V71, P267; SCHULZ M, 1991, P NATL ACAD SCI USA, V88, P991, DOI 10.1073/pnas.88.3.991; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; SETTE A, 1994, J IMMUNOL, V153, P5586; SHAPIRO GI, 1987, J VIROL, V61, P764, DOI 10.1128/JVI.61.3.764-773.1987; Sijts AJAM, 1996, J IMMUNOL, V156, P1497; Stolcke A., 2002, P INT C SPOK LANG PR, V2, P901; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; Vijh S, 1998, J IMMUNOL, V160, P3971; Vitiello A, 1996, J IMMUNOL, V157, P5555; Wang JH, 2002, MOL IMMUNOL, V38, P1039, DOI 10.1016/S0161-5890(02)00033-0; Wilson IA, 1997, CURR OPIN STRUC BIOL, V7, P839, DOI 10.1016/S0959-440X(97)80156-X; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zhong WM, 2001, J IMMUNOL, V167, P1379, DOI 10.4049/jimmunol.167.3.1379; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173	44	77	84	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45135	45144		10.1074/jbc.M307417200	http://dx.doi.org/10.1074/jbc.M307417200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12960169	hybrid, Green Accepted			2022-12-27	WOS:000186452300013
J	Anderson, PJ; Nesset, A; Bock, PE				Anderson, PJ; Nesset, A; Bock, PE			Effects of activation peptide bond cleavage and fragment 2 interactions on the pathway of exosite I expression during activation of human prethrombin 1 to thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY CRYSTAL-STRUCTURE; HUMAN-FACTOR-V; BLOOD-COAGULATION PROTEINASES; ANION-BINDING EXOSITE; BOVINE ALPHA-THROMBIN; PROTHROMBIN ACTIVATION; CHLOROMETHYL KETONES; PROEXOSITE-I; FACTOR-XA; FLUORESCENCE PROBES	Activation of prothrombin (Pro) by factor Xa to form thrombin occurs by proteolysis of Arg(271)-Thr(272) and Arg(320)-Ile(321), resulting in expression of regulatory exosites I and II. Cleavage of Pro by thrombin liberates fragment 1 and generates the zymogen analog, prethrombin 1 (Pre 1). The properties of exosite I on Pre 1 and its factor Xa activation intermediates were characterized in spectroscopic and equilibrium binding studies using the fluorescein-labeled probe, hirudin(54-65) ([5F]Hir(54-65)-(SO3-)). Prethrombin 2 (Pre 2), formed by factor Xa cleavage of Pre 1 at Arg(271)-Thr(272), had the same affinity for hirudin(54-65) peptides as Pre 1 in the absence or presence of near-saturating fragment 2 (F2). Pre 2 and thrombin also had indistinguishable affinities for F2. By contrast, cleavage of Pre 1 at Arg(320)-Ile(321), to form active meizothrombin des-fragment 1 MzT(-F1), showed a 11- to 20-fold increase in affinity for hirudin(54-65), indistinguishable from the 13- to 20-fold increase seen for conversion of Pre 2 to thrombin. Thus, factor Xa cleavage of Pre 1 at Arg(271)-Thr(272) does not effect exosite I expression, whereas cleavage at Arg(320)-Ile(321) results in concomitant activation of the catalytic site and exosite I. Furthermore, expression of exosite I on the Pre 1 activation intermediates is not modulated by F2, and exosite II is not activated conformationally. The differential expression of exosite I affinity on the Pre 1 activation intermediates and the previously demonstrated role of (pro) exosite I in factor Va-dependent substrate recognition suggest that changes in exosite I expression may regulate the rate and direction of the Pre 1 activation pathway.	Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37235 USA	Vanderbilt University	Bock, PE (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol, C3321A Med Ctr N, Nashville, TN 37235 USA.	paul.bock@vanderbilt.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038779, R01HL038779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007186] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL38779] Funding Source: Medline; NIDDK NIH HHS [DK-07186] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson PJ, 2000, J BIOL CHEM, V275, P16428, DOI 10.1074/jbc.M001254200; Anderson PJ, 2003, J BIOL CHEM, V278, P44489, DOI 10.1074/jbc.M306916200; Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; BERGMAN DA, 1988, ANAL BIOCHEM, V153, P380; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BOCK PE, 1988, BIOCHEMISTRY-US, V27, P6633, DOI 10.1021/bi00417a063; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; BODE W, 1992, PROTEIN SCI, V1, P426; Boxrud PD, 1996, J PROTEIN CHEM, V15, P231, DOI 10.1007/BF01887403; Butenas S, 2002, BIOCHEMISTRY-MOSCOW+, V67, P3; CARLISLE TL, 1990, J BIOL CHEM, V265, P22044; Chen L, 2003, J BIOL CHEM, V278, P27564, DOI 10.1074/jbc.M302707200; COLMAN RW, 2001, HEMOSTASIS THROMBOSI, P17; Cote HCF, 1997, J BIOL CHEM, V272, P6194, DOI 10.1074/jbc.272.10.6194; DEGEN SJF, 1987, BIOCHEMISTRY-US, V26, P6165, DOI 10.1021/bi00393a033; Dharmawardana KR, 1999, J BIOL CHEM, V274, P18635, DOI 10.1074/jbc.274.26.18635; Dharmawardana KR, 1998, BIOCHEMISTRY-US, V37, P13143, DOI 10.1021/bi9812165; DiCera E, 1997, CELL MOL LIFE SCI, V53, P701, DOI 10.1007/s000180050091; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; FENTON JW, 1977, J BIOL CHEM, V252, P3587; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; Han JH, 1997, J BIOL CHEM, V272, P28660, DOI 10.1074/jbc.272.45.28660; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; JENNY NS, 2001, HEMOSTASIS THROMBOSI, P171; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; LINDAHL P, 1991, BIOCHEM J, V276, P387, DOI 10.1042/bj2760387; LIU LW, 1994, J BIOL CHEM, V269, P11807; LIU LW, 1991, J BIOL CHEM, V266, P23632; Malkowski MG, 1997, PROTEIN SCI, V6, P1438, DOI 10.1002/pro.5560060708; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1990, BLOOD, V76, P1; Martin PD, 1997, STRUCTURE, V5, P1681, DOI 10.1016/S0969-2126(97)00314-6; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018; Monteiro RQ, 2001, PROTEIN SCI, V10, P1897, DOI 10.1110/ps.09001; Monteiro RQ, 2002, THROMB HAEMOSTASIS, V87, P288; Myles T, 2001, J BIOL CHEM, V276, P25143, DOI 10.1074/jbc.M011324200; NASKI MC, 1990, J BIOL CHEM, V265, P13484; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; OLSON ST, 1991, ARCH BIOCHEM BIOPHYS, V286, P533, DOI 10.1016/0003-9861(91)90076-U; Rose T, 2002, J BIOL CHEM, V277, P18875, DOI 10.1074/jbc.M110977200; ROSING J, 1986, J BIOL CHEM, V261, P4224; ROSING J, 1980, J BIOL CHEM, V255, P274; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; STUBBS MT, 1993, THROMB RES, V69, P1, DOI 10.1016/0049-3848(93)90002-6; TANS G, 1994, J BIOL CHEM, V269, P15969; TANS G, 1991, J BIOL CHEM, V266, P21864; TSIANG M, 1995, J BIOL CHEM, V270, P16854, DOI 10.1074/jbc.270.28.16854; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; WINZOR DJ, 1995, QUANTITATIVE CHARACT, P62; WU QY, 1994, J BIOL CHEM, V269, P3725; YE J, 1992, J BIOL CHEM, V267, P11023	59	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44482	44488		10.1074/jbc.M306917200	http://dx.doi.org/10.1074/jbc.M306917200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12939269	hybrid			2022-12-27	WOS:000186306700076
J	Linke, K; Wolfram, T; Bussemer, J; Jakob, U				Linke, K; Wolfram, T; Bussemer, J; Jakob, U			The roles of the two zinc binding sites in DnaJ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP70 MOLECULAR CHAPERONE; FINGER-LIKE DOMAIN; ATP HYDROLYSIS; CO-CHAPERONE; IN-VIVO; HSP40; MECHANISM; PROTEINS; GRPE; CONSERVATION	All type I DnaJ (Hsp40) homologues share the presence of two highly conserved zinc centers. To elucidate their function, we constructed DnaJ mutants that separately replaced cysteines of either zinc center I or zinc center II with serine residues. We found that in the absence of zinc center I, the autonomous, DnaK-independent chaperone activity of DnaJ is dramatically reduced. Surprisingly, this only slightly impaired the in vivo function of DnaJ, and its ability to function as a co-chaperone in the DnaK/DnaJ/GrpE foldase machine. The DnaJ zinc center II, on the other hand, was found to be absolutely essential for the in vivo and in vitro function of DnaJ. This did not seem to be caused by a lack of substrate binding affinity or an inability to work as an ATPase-stimulating factor. Rather it appears that zinc center II mutant proteins lack a necessary additional interaction site with DnaK, which seems to be crucial for locking-in substrate proteins onto DnaK. These findings led us to a model in which ATP hydrolysis in DnaK is only the first step in converting DnaK into its high affinity binding state. Additional interactions between DnaK and DnaJ are required to make the DnaK/DnaJ/GrpE foldase machinery catalytically active.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Jakob, U (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	ujakob@umich.edu			NIGMS NIH HHS [GM065318] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065318] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; BARDWELL JCA, 1986, J BIOL CHEM, V261, P1782; BUCHBERGER A, 1994, NAT STRUCT BIOL, V1, P95, DOI 10.1038/nsb0294-95; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Genevaux P, 2002, GENETICS, V162, P1045; Goffin L, 1998, MOL MICROBIOL, V30, P329, DOI 10.1046/j.1365-2958.1998.01067.x; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; Hennessy F, 2000, CELL STRESS CHAPERON, V5, P347, DOI 10.1379/1466-1268(2000)005<0347:AOTLOC>2.0.CO;2; Herbst R, 1997, J BIOL CHEM, V272, P7099, DOI 10.1074/jbc.272.11.7099; HUNT JB, 1985, ANAL BIOCHEM, V146, P150, DOI 10.1016/0003-2697(85)90409-9; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Johnson JL, 2001, J CELL BIOL, V152, P851, DOI 10.1083/jcb.152.4.851; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Martinez-Yamout M, 2000, J MOL BIOL, V300, P805, DOI 10.1006/jmbi.2000.3923; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Qian YQ, 1996, J MOL BIOL, V260, P224, DOI 10.1006/jmbi.1996.0394; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Russell R, 1999, BIOCHEMISTRY-US, V38, P4165, DOI 10.1021/bi9824036; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; SELL SM, 1990, J BACTERIOL, V172, P4827, DOI 10.1128/jb.172.9.4827-4835.1990; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; SHI WY, 1992, J BACTERIOL, V174, P6256, DOI 10.1128/JB.174.19.6256-6263.1992; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Tang W, 2001, BIOCHEMISTRY-US, V40, P14985, DOI 10.1021/bi0107593; WALL D, 1994, J BIOL CHEM, V269, P5446; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x	40	85	89	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44457	44466		10.1074/jbc.M307491200	http://dx.doi.org/10.1074/jbc.M307491200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941935	hybrid			2022-12-27	WOS:000186306700073
J	Luppen, CA; Leclerc, N; Noh, T; Barski, A; Khokhar, A; Boskey, AL; Smith, E; Frenkel, B				Luppen, CA; Leclerc, N; Noh, T; Barski, A; Khokhar, A; Boskey, AL; Smith, E; Frenkel, B			Brief bone morphogenetic protein 2 treatment of glucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; DIFFERENTIATION; EXPRESSION; DEXAMETHASONE; GROWTH; CORTISOL; INDUCTION; RAT; CORTICOSTEROIDS; PROLIFERATION	Glucocorticoids (GCs) inhibit bone formation in vivo. In MC3T3-E1 osteoblasts, chronic administration of 1 muM dexamethasone (DEX) starting at confluency results in > 98% inhibition of bone morphogenetic protein 2 (BMP-2) expression and apatite mineral deposition. Here, it is shown that brief exposure to recombinant human BMP-2 (rhBMP-2), as short as 6 h, is sufficient to induce irreversible commitment to mineralization in DEX-treated cultures. RhBMP-2 dose dependently rescued mineralization but not collagen accumulation in DEX-inhibited cultures. The selective restoration of mineralization was evident in the higher mineral to matrix ratios of DEX/rhBMP-2 co-treated cultures compared with control. We tested the involvement of the runt-related transcription factor 2 (Runx2) in the DEX inhibition and rhBMP-2 rescue of mineralization. Surprisingly, DEX did not decrease Runx2 DNA binding activity, transactivation, or association with the endogenous osteocalcin gene promoter. Furthermore, the rhBMP-2 rescue did not involve Runx2 stimulation, suggesting an important role for factors other than Runx2 in BMP-2 action. Finally, we studied the differentiation-related cell cycle, which persists during commitment to mineralization in untreated cultures, but is inhibited along with mineralization in DEX-treated cultures. Although both rhBMP-2 alone and DEX alone were antimitogenic, rhBMP-2 stimulated this cell cycle in DEX-inhibited cultures. In conclusion, brief rhBMP-2 treatment restores mineralization in DEX-inhibited MC3T3-E1 osteoblasts via a mechanism different from Runx2 stimulation. This restoration may be functionally related to the accompanying rescue of the differentiation-related cell cycle. The efficacy of short term BMP-2 treatment supports the potential of short-lived BMP vectors for skeletal therapy in both traditional and gene therapeutic approaches.	Univ So Calif, Keck Sch Med, Inst Med Genet, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Inst Med Genet, Dept Orthopaed Surg, Los Angeles, CA 90033 USA; Hosp Special Surg, Mineralized Tissues Res Lab, New York, NY 10021 USA	University of Southern California; University of Southern California	Frenkel, B (corresponding author), Univ So Calif, Keck Sch Med, Inst Med Genet, Dept Biochem & Mol Biol, 2250 Alcazar St,CSC-IGM240, Los Angeles, CA 90033 USA.	frenkel@usc.edu		Barski, Artem/0000-0002-1861-5316; Boskey, Adele/0000-0002-6181-2219	NIAMS NIH HHS [AR037661, AR47052] Funding Source: Medline; NIDCR NIH HHS [DE04141, DE07211] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047052, R01AR037661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE004141, R01DE004141] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Canalis E, 2002, ANN NY ACAD SCI, V966, P73, DOI 10.1111/j.1749-6632.2002.tb04204.x; Chang DJ, 1998, J BIOL CHEM, V273, P4892, DOI 10.1074/jbc.273.9.4892; CHEN TL, 1983, ENDOCRINOLOGY, V112, P1739, DOI 10.1210/endo-112-5-1739; Chevalley T, 1996, EUR J ENDOCRINOL, V134, P591, DOI 10.1530/eje.0.1340591; Cooper MS, 1999, J ENDOCRINOL, V163, P159, DOI 10.1677/joe.0.1630159; DELANY AM, 1995, J CELL BIOCHEM, V57, P488, DOI 10.1002/jcb.240570314; DELANY AM, 1995, J BIOL CHEM, V270, P26607, DOI 10.1074/jbc.270.44.26607; DUCY P, 1995, MOL CELL BIOL, V15, P1858; GITELMAN SE, 1994, J CELL BIOL, V126, P1595, DOI 10.1083/jcb.126.6.1595; Gori F, 1999, J BONE MINER RES, V14, P1522, DOI 10.1359/jbmr.1999.14.9.1522; Ishida Y, 1998, J BONE MINER RES, V13, P1822, DOI 10.1359/jbmr.1998.13.12.1822; KAMALIA N, 1992, BLOOD, V79, P320; Kato Y, 2001, J BONE MINER RES, V16, P1622, DOI 10.1359/jbmr.2001.16.9.1622; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; KOSTENSZKY KS, 1974, ACTA BIOL ACAD SCI H, V25, P49; LEBOY PS, 1991, J CELL PHYSIOL, V146, P370, DOI 10.1002/jcp.1041460306; Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.3.CO;2-5; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lian JB, 1997, ENDOCRINOLOGY, V138, P2117, DOI 10.1210/en.138.5.2117; Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X; LUKERT B, 1997, OSTEOPOROSIS, P801; Luppen CA, 2003, J BONE MINER RES, V18, P1186, DOI 10.1359/jbmr.2003.18.7.1186; Luppen CA, 2002, J BONE MINER RES, V17, P301, DOI 10.1359/jbmr.2002.17.2.301; Pereira RC, 2002, BONE, V30, P685, DOI 10.1016/S8756-3282(02)00687-7; Pereira RMR, 2001, BONE, V28, P484, DOI 10.1016/S8756-3282(01)00422-7; Prince M, 2001, J CELL BIOCHEM, V80, P424, DOI 10.1002/1097-4644(20010301)80:3<424::AID-JCB160>3.0.CO;2-6; RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022; SAMPATH TK, 1992, J BIOL CHEM, V267, P20352; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE74, DOI 10.1152/ajpendo.2000.279.1.E74; SHALHOUB V, 1992, J CELL BIOCHEM, V50, P425, DOI 10.1002/jcb.240500411; Smith E, 2000, J BIOL CHEM, V275, P19992, DOI 10.1074/jbc.M001758200; Smith E, 2002, J BIOL CHEM, V277, P18191, DOI 10.1074/jbc.M109708200; TENENBAUM HC, 1985, ENDOCRINOLOGY, V117, P2211, DOI 10.1210/endo-117-5-2211; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; WANG EA, 1988, P NATL ACAD SCI USA, V85, P9484, DOI 10.1073/pnas.85.24.9484; Waters RV, 2000, ACTA ORTHOP SCAND, V71, P316, DOI 10.1080/000164700317411951; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241	42	50	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44995	45003		10.1074/jbc.M306730200	http://dx.doi.org/10.1074/jbc.M306730200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12933820	hybrid			2022-12-27	WOS:000186306700136
J	Ma, CL; Wang, J; Luo, J				Ma, CL; Wang, J; Luo, J			Exposure to asphalt fumes activates activator protein-1 through the phosphatidylinositol 3-kinase/Akt signaling pathway in mouse epidermal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; NF-KAPPA-B; JB6 CELLS; NEOPLASTIC TRANSFORMATION; AP-1 TRANSACTIVATION; SKIN TUMORIGENESIS; TUMOR PROMOTION; BITUMEN FUMES; IN-VITRO; KINASE-B	Occupational exposure to asphalt fumes may pose a health risk. Experimental studies using animal and in vitro models indicate that condensates from asphalt fumes are genotoxic and can promote skin tumorigenesis. Enhanced activity of activator protein-1 (AP-1) is frequently associated with the promotion of skin tumorigenesis. The current study investigated the effect of exposure to asphalt fumes on AP-1 activation in mouse JB6 P+ epidermal cells and the skin of transgenic mice expressing the AP-1 luciferase reporter gene. Asphalt fumes were generated from a dynamic generation system that simulated road-paving conditions. Exposure to asphalt fumes significantly increased AP-1 activity in JB6 P+ cells as well as in cultured keratinocytes isolated from transgenic mice expressing AP-1 reporter. In addition, topical application of asphalt fumes by painting the tail skin of mice increased AP-1 activity by 14-fold. Exposure to asphalt fumes promoted basal as well as epidermal growth factor-stimulated anchorage-independent growth of JB6 P+ cells in soft agar. It activated phosphatidylinositol 3-kinase and induced phosphorylation of Akt at Ser-473/Thr-308, and concurrently activated downstream p70 S6 kinase as well as glycogen synthase kinase-3beta. Asphalt fumes transiently activated c-Jun NH2-terminal kinases without affecting extracellular signal-regulated kinases and p38 mitogen-activated protein kinases. Further study indicated that blockage of phosphatidylinositol 3-kinase activation eliminated asphalt fume-stimulated AP-1 activation and formation of anchorage-independent colonies in soft agar. This is the first report showing that exposure to asphalt fumes can activate AP-1 and intracellular signaling that may promote skin tumorigenesis, thus providing important evidence on the potential involvement of exposure to asphalt fumes in skin carcinogenesis.	W Virginia Univ, Sch Med, Robert C Byrd Hlth Sci Ctr, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA; Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China; NIOSH, Ctr Dis Control & Prevent, US Dept Hlth & Human Serv, Morgantown, WV 26505 USA	West Virginia University; Air Force Military Medical University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Luo, J (corresponding author), W Virginia Univ, Sch Med, Robert C Byrd Hlth Sci Ctr, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA.		Luo, Jia/E-4674-2012	Luo, Jia/0000-0002-6968-3618	NATIONAL CANCER INSTITUTE [R01CA090385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R03AA012968] Funding Source: NIH RePORTER; NCI NIH HHS [CA90385] Funding Source: Medline; NIAAA NIH HHS [AA12968] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; *ASPH I, 1989, US ASPH US REP; BERNSTEIN LR, 1989, SCIENCE, V244, P566, DOI 10.1126/science.2541502; Binet S, 2002, SCI TOTAL ENVIRON, V300, P37, DOI 10.1016/S0048-9697(02)00279-6; Brandt H, 2000, ANN OCCUP HYG, V44, P31, DOI 10.1093/annhyg/44.1.31; Burstyn I, 2000, ANN OCCUP HYG, V44, P43, DOI 10.1093/annhyg/44.1.43; Cohen C, 2002, CLIN CANCER RES, V8, P3728; COLBURN NH, 1979, NATURE, V281, P589, DOI 10.1038/281589a0; COOKE M, 1991, POLYNUCLEAR AROMATIC; Dhar A, 2002, MOL CELL BIOCHEM, V234, P185, DOI 10.1023/A:1015948505117; Dickson LM, 2001, J BIOL CHEM, V276, P21110, DOI 10.1074/jbc.M101257200; DONG ZG, 1995, CARCINOGENESIS, V16, P749, DOI 10.1093/carcin/16.4.749; Dong ZG, 1997, J BIOL CHEM, V272, P9962; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hakkinen Lari, 2001, Methods in Cell Science, V23, P189, DOI 10.1023/A:1016385109922; HARBERS M, 1992, CARCINOGENESIS, V13, P2403, DOI 10.1093/carcin/13.12.2403; Harvey R. G., 1991, POLYCYCLIC AROMATIC; Hodivala-Dilke Kairbaan, 2002, Methods Mol Biol, V188, P139; Hsu TC, 2000, FREE RADICAL BIO MED, V28, P1338, DOI 10.1016/S0891-5849(00)00220-3; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Huang CS, 1996, MOL CELL BIOL, V16, P6427; Huang CS, 1998, P NATL ACAD SCI USA, V95, P156, DOI 10.1073/pnas.95.1.156; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Leis H, 2002, MOL CARCINOGEN, V35, P180, DOI 10.1002/mc.10087; Li JJ, 1997, CANCER RES, V57, P3569; Lin SG, 2003, INT J ONCOL, V22, P829; Liu GM, 2001, P NATL ACAD SCI USA, V98, P7510, DOI 10.1073/pnas.131195198; Luo J, 1999, J NEUROSCI, V19, P10014, DOI 10.1523/jneurosci.19-22-10014.1999; LUTES CC, 1994, EVALUATION EMISSION; Ma CL, 2003, ONCOGENE, V22, P5281, DOI 10.1038/sj.onc.1206675; MACHADO ML, 1993, FUND APPL TOXICOL, V21, P492, DOI 10.1006/faat.1993.1125; Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; Segrelles C, 2002, ONCOGENE, V21, P53, DOI 10.1038/sj.onc.1205032; Sivak A, 1997, CANCER LETT, V117, P113, DOI 10.1016/S0304-3835(97)00214-0; Sun YB, 2002, J CELL PHYSIOL, V192, P225, DOI 10.1002/jcp.10132; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wang J, 2001, ANAL CHEM, V73, P3691, DOI 10.1021/ac010334m; WILDER PJ, 1991, CANCER RES, V51, P5898; Yamada KM, 2001, J CELL SCI, V114, P2375; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Young MR, 2003, TRENDS MOL MED, V9, P36, DOI 10.1016/S1471-4914(02)00009-6	47	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44265	44272		10.1074/jbc.M309023200	http://dx.doi.org/10.1074/jbc.M309023200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947100	Green Submitted, hybrid			2022-12-27	WOS:000186306700047
J	McCracken, S; Longman, D; Johnstone, IL; Caceres, JF; Blencowe, BJ				McCracken, S; Longman, D; Johnstone, IL; Caceres, JF; Blencowe, BJ			An evolutionarily conserved role for SRm160 in 3 '-end processing that functions independently of exon junction complex formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; VERTEBRATE POLY(A) POLYMERASE; CAP-BINDING COMPLEX; CAENORHABDITIS-ELEGANS; SPLICING COACTIVATOR; C-ELEGANS; IN-VITRO; CARBOXYL-TERMINUS; INTRONS INFLUENCE; GENE-EXPRESSION	SRm160 (the SR-related nuclear matrix protein of 160 kDa) functions as a splicing coactivator and 3'-end cleavage-stimulatory factor. It is also a component of the splicing-dependent exon-junction complex (EJC), which has been implicated in coupling of pre-mRNA splicing with mRNA turnover and mRNA export. We have investigated whether the association of SRm160 with the EJC is important for efficient 3'-end cleavage. The EJC components RNPS1, REF, UAP56, and Y14 interact with SRm160. However, when these factors were tethered to transcripts, only SRm160 and RNPS1 stimulated 3'-end cleavage. Whereas SRm160 stimulated cleavage to a similar extent in the presence or absence of an active intron, stimulation of 3'-end cleavage by tethered RNPS1 is dependent on an active intron. Assembly of an EJC adjacent to the cleavage and polyadenylation signal in vitro did not significantly affect cleavage efficiency. These results suggest that SRm160 stimulates cleavage independently of its association with EJC components and that the cleavage-stimulatory activity of RNPS1 may be an indirect consequence of its ability to stimulate splicing. Using RNA interference (RNAi) in Caenorhabditis elegans, we determined whether interactions between SRm160 and the cleavage machinery are important in a whole organism context. Simultaneous RNAi of SRm160 and the cleavage factor CstF-50 ( Cleavage stimulation factor 50-kDa subunit) resulted in late embryonic developmental arrest. In contrast, RNAi of CstF-50 in combination with RNPS1 or REFs did not result in an apparent phenotype. Our combined results provide evidence for an evolutionarily conserved interaction between SRm160 and the 3'-end cleavage machinery that functions independently of EJC formation.	Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Glasgow, Anderson Coll, Wellcome Ctr Mol Parasitol, Glasgow GI1 6NU, Lanark, Scotland	University of Toronto; University of Edinburgh; University of Glasgow	Blencowe, BJ (corresponding author), Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.		Caceres, Javier F/D-5260-2013	Caceres, Javier F/0000-0001-8025-6169	Medical Research Council [MC_U127584479] Funding Source: Medline; MRC [MC_U127584479] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Blencowe BJ, 2000, RNA, V6, P111, DOI 10.1017/S1355838200991982; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; Boucher L, 2001, RNA, V7, P1693; De Guzman RN, 1998, BIOPOLYMERS, V48, P181, DOI 10.1002/(SICI)1097-0282(1998)48:2<181::AID-BIP7>3.0.CO;2-L; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Eldridge AG, 1999, P NATL ACAD SCI USA, V96, P6125, DOI 10.1073/pnas.96.11.6125; Flaherty SM, 1997, P NATL ACAD SCI USA, V94, P11893, DOI 10.1073/pnas.94.22.11893; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fribourg S, 2003, NAT STRUCT BIOL, V10, P433, DOI 10.1038/nsb926; Fu GK, 1997, P NATL ACAD SCI USA, V94, P1811, DOI 10.1073/pnas.94.5.1811; Furger A, 2002, GENE DEV, V16, P2792, DOI 10.1101/gad.983602; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; Gunderson SI, 1997, GENE DEV, V11, P761, DOI 10.1101/gad.11.6.761; Hirose Y, 2000, GENE DEV, V14, P1415; Hollenbach AD, 2002, J CELL SCI, V115, P3319; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Jensen TH, 2001, CURR BIOL, V11, P1711, DOI 10.1016/S0960-9822(01)00529-2; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Kwek KY, 2002, NAT STRUCT BIOL, V9, P800, DOI 10.1038/nsb862; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO REP, V2, P1119, DOI 10.1093/embo-reports/kve245; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lewis JD, 1996, GENE DEV, V10, P1683, DOI 10.1101/gad.10.13.1683; Longman D, 2000, EMBO J, V19, P1625, DOI 10.1093/emboj/19.7.1625; Longman D, 2003, RNA, V9, P881, DOI 10.1261/rna.5420503; Longman D, 2001, CURR BIOL, V11, P1923, DOI 10.1016/S0960-9822(01)00589-9; Lou H, 1999, MOL CELL BIOL, V19, P78; Lou H, 1998, MOL CELL BIOL, V18, P4977, DOI 10.1128/MCB.18.9.4977; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Lutz CS, 1996, GENE DEV, V10, P325, DOI 10.1101/gad.10.3.325; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; MacMorris M, 2003, RNA, V9, P847, DOI 10.1261/rna.5480803; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Mayeda A, 1999, EMBO J, V18, P4560, DOI 10.1093/emboj/18.16.4560; McCracken S, 2002, MOL CELL BIOL, V22, P148, DOI 10.1128/MCB.22.1.148-160.2002; McGarvey T, 2000, J CELL BIOL, V150, P309, DOI 10.1083/jcb.150.2.309; NESIC D, 1994, GENE DEV, V8, P363, DOI 10.1101/gad.8.3.363; NIWA M, 1990, GENE DEV, V4, P1552, DOI 10.1101/gad.4.9.1552; NIWA M, 1991, GENE DEV, V5, P2086, DOI 10.1101/gad.5.11.2086; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Proudfoot N, 2000, TRENDS BIOCHEM SCI, V25, P290, DOI 10.1016/S0968-0004(00)01591-7; Reichert VL, 2002, GENE DEV, V16, P2778, DOI 10.1101/gad.1030602; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Ruegsegger U, 1998, MOL CELL, V1, P243, DOI 10.1016/S1097-2765(00)80025-8; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Szymczyna BR, 2003, GENE DEV, V17, P461, DOI 10.1101/gad.1060403; Vagner S, 2000, GENE DEV, V14, P403; Virbasius CMA, 1999, MOL CELL, V4, P219, DOI 10.1016/S1097-2765(00)80369-X; Waldmann T, 2002, J BIOL CHEM, V277, P24988, DOI 10.1074/jbc.M204045200; WAN KM, 1994, P NATL ACAD SCI USA, V91, P594, DOI 10.1073/pnas.91.2.594; WASSARMAN KM, 1993, GENE DEV, V7, P647, DOI 10.1101/gad.7.4.647; YANKULOV K, 1994, CELL, V77, P749, DOI 10.1016/0092-8674(94)90058-2; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	63	33	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44153	44160		10.1074/jbc.M306856200	http://dx.doi.org/10.1074/jbc.M306856200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944400	hybrid			2022-12-27	WOS:000186306700034
J	Parra-Palau, JL; Scheper, GC; Wilson, ML; Proud, CG				Parra-Palau, JL; Scheper, GC; Wilson, ML; Proud, CG			Features in the N and C termini of the MAPK-interacting kinase Mnk1 mediate its nucleocytoplasmic shuttling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 4E; ACTIVATED PROTEIN-KINASE; TRANSLATION INITIATION; MESSENGER-RNA; FACTOR EIF4E; FACTOR 4G; PHOSPHORYLATION; TRANSPORT; TRANSFORMATION; REGULATORS	Eukaryotic initiation factor eIF4E binds to the 5'-cap structure of the mRNA and also to the molecular scaffold protein eIF4G. eIF4E is a phosphoprotein, and the kinases that act on it have been identified as the MAPK-interacting kinases Mnk1 and Mnk2. Mnk1/2 also bind to the scaffold protein eIF4G. The N-terminal region of Mnk1 has previously been shown to bind to importin alpha, a component of the nuclear transport machinery, although Mnk1 itself is cytoplasmic. Here we identify a CRM1-type nuclear export motif in the C-terminal part of Mnk1. Substitution of hydrophobic residues in this motif results in Mnk1 becoming nuclear. This has allowed us to study the features of Mnk1 that are involved in its transport to the nucleus. This process requires part, but not all, of a polybasic region near the N terminus of Mnk1. Residues required for nuclear transport are also required for its interaction with importin alpha. This polybasic region also serves a second function in that it is required for the binding of Mnk1 to eIF4G, although the residues involved in this interaction are not identical to those involved in the binding of Mnk1 to importin alpha. Interaction of Mnk1 with eIF4G promotes the phosphorylation of eIF4E. Mutations that reduce the binding of Mnk1 to eIF4G in vivo and in vitro also decrease the ability of Mnk1 to enhance eIF4E phosphorylation in vivo, underlining the importance of the eIF4G-Mnk1 interaction in this process.	Univ Dundee, Fac Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland	University of Dundee	Proud, CG (corresponding author), Univ Dundee, Fac Life Sci, Div Mol Physiol, Dow St, Dundee DD1 5EH, Scotland.	c.g.proud@dundee.ac.uk	Scheper, Gert C/D-7001-2014	Proud, Christopher/0000-0003-0704-6442				Alefantis T, 2003, J BIOL CHEM, V278, P21814, DOI 10.1074/jbc.M211576200; Cohen N, 2001, EMBO J, V20, P4547, DOI 10.1093/emboj/20.16.4547; De Benedetti A, 1999, INT J BIOCHEM CELL B, V31, P59, DOI 10.1016/S1357-2725(98)00132-0; DEBENEDETTI A, 1990, P NATL ACAD SCI USA, V87, P8212, DOI 10.1073/pnas.87.21.8212; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Kleijn M, 2002, FEBS LETT, V532, P319, DOI 10.1016/S0014-5793(02)03694-3; Kleijn M, 1995, J CELL BIOCHEM, V59, P443, DOI 10.1002/jcb.240590405; Lachance PED, 2002, MOL CELL BIOL, V22, P1656, DOI 10.1128/MCB.22.6.1656-1663.2002; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Li W, 2001, J BIOL CHEM, V276, P29111, DOI 10.1074/jbc.C100284200; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mahalingam M, 2001, PROG MOLEC, V27, P131; McKendrick L, 2001, MOL CELL BIOL, V21, P3632, DOI 10.1128/MCB.21.11.3632-3641.2001; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Raught B, 2000, COLD SPRING HARBOR M, V39, P245; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Strudwick S, 2002, DIFFERENTIATION, V70, P10, DOI 10.1046/j.1432-0436.2002.700102.x; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Zuberek J, 2003, RNA, V9, P52, DOI 10.1261/rna.2133403	29	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44197	44204		10.1074/jbc.M302398200	http://dx.doi.org/10.1074/jbc.M302398200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12949082	hybrid			2022-12-27	WOS:000186306700039
J	Sakamoto, M; Hirata, H; Ohtsuka, T; Bessho, Y; Kageyama, R				Sakamoto, M; Hirata, H; Ohtsuka, T; Bessho, Y; Kageyama, R			The basic helix-loop-helix genes Hesr1/Hey1 and Hesr2/Hey2 regulate maintenance of neural precursor cells in the brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN ACHAETE-SCUTE; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; NEURONAL DIFFERENTIATION; GLIAL DIFFERENTIATION; TRANSCRIPTION FACTOR; CORTICAL DEVELOPMENT; FATE SPECIFICATION; PROGENITOR CELLS; DROSOPHILA HAIRY	Neural precursor cells proliferate in the ventricular zone while giving rise to neurons of deep layers first, then those of the superficial layers, and lastly, glial cells in the brain. Thus, it is essential to maintain neural precursor cells until late stages of neural development for generation of a wide variety of cell types. Here, we found that the Hes-related basic helix-loop-helix (bHLH) genes Hesr1/Hey1 and Hesr2/Hey2 are expressed in the ventricular zone, which contains neural precursor cells. Misexpression of Hesr1 and Hesr2 by electroporation in mouse brain at embryonic day 13.5 transiently maintains neural precursor cells and thereby increases late-born neurons, which are located in the superficial layers. In contrast, misexpression of the genes at later stages inhibits neurogenesis and promotes generation of astroglial cells. In transient transfection assay with cultured cells, both Hesr1 and Hesr2 inhibit transcription induced by the neuronal bHLH genes Mash1 and Math3. These results indicate that Hesr1 and Hesr2 negatively regulate neuronal bHLH genes, promote maintenance of neural precursor cells, and increase late-born cell types in the developing brain.	Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Kageyama, R (corresponding author), Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan.			Hirata, Hiromi/0000-0002-3769-7441				AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bae SK, 2000, DEVELOPMENT, V127, P2933; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Cai L, 2000, DEVELOPMENT, V127, P3021; Castella P, 1999, J NEUROSCI RES, V56, P229, DOI 10.1002/(SICI)1097-4547(19990501)56:3<229::AID-JNR2>3.0.CO;2-Z; Chin MT, 2000, J BIOL CHEM, V275, P6381, DOI 10.1074/jbc.275.9.6381; Desai AR, 2000, DEVELOPMENT, V127, P2863; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gessler M, 2002, CURR BIOL, V12, P1601, DOI 10.1016/S0960-9822(02)01150-8; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hojo M, 2000, DEVELOPMENT, V127, P2515; Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kokubo H, 1999, BIOCHEM BIOPH RES CO, V260, P459, DOI 10.1006/bbrc.1999.0880; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Lutolf S, 2002, DEVELOPMENT, V129, P373; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Sakata Y, 2002, P NATL ACAD SCI USA, V99, P16197, DOI 10.1073/pnas.252648999; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Satow T, 2001, J NEUROSCI, V21, P1265; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	52	130	135	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44808	44815		10.1074/jbc.M300448200	http://dx.doi.org/10.1074/jbc.M300448200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947105	hybrid, Green Submitted			2022-12-27	WOS:000186306700115
J	Sugimoto, I; Takahashi, Y				Sugimoto, I; Takahashi, Y			Evidence that the PsbK polypeptide is associated with the photosystem II core antenna complex CP43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; PHOTOSYNTHETIC ELECTRON-TRANSPORT; MOLECULAR-MASS PROTEINS; CHLAMYDOMONAS-REINHARDTII; CRYSTAL-STRUCTURE; GENE; NUCLEAR; SUBUNIT; IDENTIFICATION; DESTABILIZES	PsbK is encoded by the chloroplast psbK gene and is one of the small polypeptides of photosystem II ( PSII). This polypeptide is required for accumulation of the PSII complex. In the present study, we generated an antibody against recombinant mature PsbK of Chlamydomonas and used it in Western blots to localize PsbK in the PSII core complex. PsbK was found in the thylakoid membranes, and purification of the PSII core complex from detergent-solubilized thylakoid membranes showed that PsbK is tightly associated with the PSII core complex. We used potassium thiocyanate to separate PSII into subcore complexes, including the D1/D2/ cytochrome b(559) reaction center complex, CP47, and CP43, and we found that PsbK co-purifies with one of the core antenna complexes, CP43, during ion exchange chromatography. Subsequent gel filtration chromatography of the purified CP43 confirmed that PsbK is tightly associated with CP43. Steady-state levels of PsbK were also determined in Chlamydomonas mutants expressing various levels of PSII. Quantitative Western blotting revealed that the levels of PsbK in these mutants are approximately equal to those of CP43, suggesting that PsbK is stable only when associated with CP43 in the chloroplast. Together, our results indicate that PsbK is an integral part of the PSII complex and may participate in the assembly and stability of the PSII complex.	Okayama Univ, Fac Sci, Dept Biol, Okayama 7008530, Japan	Okayama University	Takahashi, Y (corresponding author), Okayama Univ, Fac Sci, Dept Biol, Okayama 7008530, Japan.		Takahashi, Yuichiro/B-2062-2011	Takahashi, Yuichiro/0000-0001-6410-0447				ANBUDURAI PR, 1993, Z NATURFORSCH C, V48, P267; ATTEIA A, 1992, J BIOL CHEM, V267, P226; BENNOUN P, 1986, PLANT MOL BIOL, V6, P151, DOI 10.1007/BF00021484; BLANKENSHIP RE, 2002, MOL MECH PHOTOSYNTHE, P95; Buchel C, 2000, J STRUCT BIOL, V131, P181, DOI 10.1006/jsbi.2000.4294; CHUA NH, 1975, P NATL ACAD SCI USA, V72, P2175, DOI 10.1073/pnas.72.6.2175; DEVITRY C, 1991, J BIOL CHEM, V266, P16614; DEVITRY C, 1989, J CELL BIOL, V109, P991, DOI 10.1083/jcb.109.3.991; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Hippler M, 2002, PROTIST, V153, P197, DOI 10.1078/1434-4610-00098; IKEUCHI M, 1989, FEBS LETT, V242, P263, DOI 10.1016/0014-5793(89)80482-X; IKEUCHI M, 1988, PLANT CELL PHYSIOL, V29, P1233; IKEUCHI M, 1992, BOT MAG TOKYO, V105, P327, DOI 10.1007/BF02489425; IKEUCHI M, 1991, J BIOL CHEM, V266, P11111; Ikeuchi M, 1995, MOL GEN GENET, V249, P622, DOI 10.1007/BF00418031; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kim SJ, 1996, FEBS LETT, V390, P175, DOI 10.1016/0014-5793(96)00658-8; KOIKE H, 1989, FEBS LETT, V244, P391, DOI 10.1016/0014-5793(89)80570-8; KUCHKA MR, 1989, CELL, V58, P869, DOI 10.1016/0092-8674(89)90939-2; KUNSTNER P, 1995, J BIOL CHEM, V270, P9651; LORKOVIC ZJ, 1995, P NATL ACAD SCI USA, V92, P8930, DOI 10.1073/pnas.92.19.8930; MAYES SR, 1993, BIOCHEMISTRY-US, V32, P1454, DOI 10.1021/bi00057a008; MAYFIELD SP, 1987, EMBO J, V6, P313, DOI 10.1002/j.1460-2075.1987.tb04756.x; MONOD C, 1992, MOL GEN GENET, V231, P449, DOI 10.1007/BF00292715; MURATA N, 1988, FEBS LETT, V235, P283, DOI 10.1016/0014-5793(88)81280-8; NANBA O, 1987, P NATL ACAD SCI USA, V84, P109, DOI 10.1073/pnas.84.1.109; Ohnishi N, 2001, J BIOL CHEM, V276, P33798, DOI 10.1074/jbc.M104454200; PAKRASI HB, 1990, Z NATURFORSCH C, V45, P423; ROCHAIX JD, 1989, EMBO J, V8, P1013, DOI 10.1002/j.1460-2075.1989.tb03468.x; ROGNER M, 1991, BIOCHEMISTRY-US, V30, P5387; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SILK GW, 1990, NUCLEIC ACIDS RES, V18, P4930, DOI 10.1093/nar/18.16.4930; TAKAHASHI Y, 1994, PLANT MOL BIOL, V24, P779, DOI 10.1007/BF00029859; TAKAHASHI Y, 1991, EMBO J, V10, P2033, DOI 10.1002/j.1460-2075.1991.tb07733.x; Takahashi Y, 1998, J PLANT RES, V111, P101, DOI 10.1007/BF02507156; Takahashi Y, 1996, PLANT CELL PHYSIOL, V37, P161, DOI 10.1093/oxfordjournals.pcp.a028927; YAMAGUCHI N, 1988, PLANT CELL PHYSIOL, V29, P123; Zheleva D, 1998, J BIOL CHEM, V273, P16122, DOI 10.1074/jbc.273.26.16122; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	39	41	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					45004	45010		10.1074/jbc.M307537200	http://dx.doi.org/10.1074/jbc.M307537200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12939265	hybrid			2022-12-27	WOS:000186306700137
J	Prasannan, P; Pike, S; Peng, K; Shane, B; Appling, DR				Prasannan, P; Pike, S; Peng, K; Shane, B; Appling, DR			Human mitochondrial C-1-tetrahydrofolate synthase - Gene structure, tissue distribution of the mRNA, and immunolocalization in Chinese hamster ovary cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT METHYLENETETRAHYDROFOLATE DEHYDROGENASE; ONE-CARBON METABOLISM; METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE; SACCHAROMYCES-CEREVISIAE; C1-TETRAHYDROFOLATE SYNTHASE; 5,10-METHYLENETETRAHYDROFOLATE DEHYDROGENASE; FORMYLTETRAHYDROFOLATE SYNTHETASE; NONKETOTIC HYPERGLYCINEMIA; TRIFUNCTIONAL ENZYME; TRANSFORMED-CELLS	C-1-tetrahydrofolate (THF) synthase is a trifunctional enzyme found in eukaryotes that contains the activities 10-formyl-THF synthetase, 5,10-methenyl-THF cyclohydrolase, and 5,10-methylene-THF dehydrogenase. The cytoplasmic isozyme of C-1-THF synthase is well characterized in a number of mammals, including humans; but a mitochondrial isozyme has been previously identified only in the yeast Saccharomyces. Here, we report the identification and characterization of the human gene encoding a functional mitochondrial C-1-THF synthase. The gene spans 236 kilobase pairs on chromosome 6 and consists of 28 exons plus one alternative exon. The gene encodes a protein of 978 amino acids, including an N-terminal mitochondrial targeting sequence. The mitochondrial isozyme is 61% identical to the human cytoplasmic isozyme. Expression of the gene was detected in most human tissues, but transcripts were highest in placenta, thymus, and brain. Two mRNAs were detected, a 3.6-kb transcript and a 1.1-kb transcript, and both transcripts were observed in varying ratios in each tissue. The shorter transcript results from an alternative splicing event, where exon 7 is spliced to exon 8a instead of exon 8. Exon 8a is derived from an exonized Alu sequence, sharing no homology with exon 8 of the long transcript, and encodes just 15 amino acids followed by a stop codon and a polyadenylation signal. This short transcript potentially encodes a bifunctional enzyme lacking 10-formyl-THF synthetase activity. Both transcripts initiate at the same 5'-site, 107 nucleotides upstream of the ATG start codon. The full-length ( 2934 bp) cDNA fused to a C-terminal V5 epitope tag was expressed in Chinese hamster ovary cells. Immunoblots of subfractionated cells revealed a 107-kDa protein only in the mitochondrial fractions of these cells, confirming the mitochondrial localization of the protein. Yeast cells expressing the full-length human cDNA exhibited elevated 10-formyl-THF synthetase activity, confirming its identification as the human mitochondrial C-1-THF synthase.	Univ Texas, Inst Mol & Cellular Biol, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Calif Berkeley, Dept Nutr Sci, Berkeley, CA 94720 USA	University of Texas System; University of Texas Austin; University of California System; University of California Berkeley	Appling, DR (corresponding author), Univ Texas, Inst Mol & Cellular Biol, Dept Chem & Biochem, 1 Univ Stn A5300, Austin, TX 78712 USA.			Pike, Schuyler/0000-0003-1366-9486	NIDDK NIH HHS [DK42033, R01 DK042033, R01 DK061428-04, R01 DK061428, DK 61428] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061428, R01DK042033] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agrotis A, 2000, FEBS LETT, V467, P128, DOI 10.1016/S0014-5793(00)01132-7; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BARLOWE C K, 1988, Biofactors, V1, P171; BARLOWE CK, 1990, MOL CELL BIOL, V10, P5679, DOI 10.1128/MCB.10.11.5679; BELANGER C, 1989, J BIOL CHEM, V264, P4837; BIANCHETTI R, 1977, J BIOL CHEM, V252, P2519; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Chang DJ, 1998, FEBS LETT, V422, P279, DOI 10.1016/S0014-5793(98)00024-6; CHEEK WD, 1989, ARCH BIOCHEM BIOPHYS, V270, P504, DOI 10.1016/0003-9861(89)90532-8; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Di Pietro E, 2002, MOL CELL BIOL, V22, P4158, DOI 10.1128/MCB.22.12.4158-4166.2002; GALPER JB, 1969, BIOCHEM BIOPH RES CO, V34, P205, DOI 10.1016/0006-291X(69)90633-0; GARCIAMARTINEZ LF, 1993, BIOCHEMISTRY-US, V32, P4671, DOI 10.1021/bi00068a027; Gregory JF, 2000, AM J CLIN NUTR, V72, P1535; Hamosh A, 1995, METABOLIC MOL BASIS, V1, P1337; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; House JD, 1999, ADV ENZYME REGUL, V39, P69, DOI 10.1016/S0065-2571(98)00008-9; HOWARD KM, 2003, IN PRESS GENE AMST; HUM DW, 1988, J BIOL CHEM, V263, P15946; HUM DW, 1991, PROTEIN ENG, V4, P493, DOI 10.1093/protein/4.4.493; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOIS M, 1989, J BIOL CHEM, V264, P3347; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kirksey TJ, 1996, ARCH BIOCHEM BIOPHYS, V333, P251, DOI 10.1006/abbi.1996.0388; KORNBERG A, 1955, METHOD ENZYMOL, V1, P441, DOI 10.1016/0076-6879(55)01072-0; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; LEWIS KF, 1978, ARCH BIOCHEM BIOPHYS, V185, P443, DOI 10.1016/0003-9861(78)90187-X; LIN BF, 1993, J BIOL CHEM, V268, P21674; MANROW RE, 1993, J MOL BIOL, V234, P281, DOI 10.1006/jmbi.1993.1583; MEJIA NR, 1988, BIOCHEM BIOPH RES CO, V155, P1, DOI 10.1016/S0006-291X(88)81040-4; MEJIA NR, 1986, J BIOL CHEM, V261, P9509; MEJIA NR, 1985, J BIOL CHEM, V260, P4616; PASTERNACK LB, 1994, BIOCHEMISTRY-US, V33, P74, DOI 10.1021/bi00167a010; Patel H, 2002, ARCH BIOCHEM BIOPHYS, V403, P145, DOI 10.1016/S0003-9861(02)00203-5; PAUKERT JL, 1976, J BIOL CHEM, V251, P5104; PAUKERT JL, 1977, BIOCHEM BIOPH RES CO, V77, P147, DOI 10.1016/S0006-291X(77)80176-9; PERI KG, 1993, BIOCHIM BIOPHYS ACTA, V1171, P281, DOI 10.1016/0167-4781(93)90066-M; Randak C, 2000, J INHERIT METAB DIS, V23, P520, DOI 10.1023/A:1005667707355; Schmidt A, 2000, BIOCHEMISTRY-US, V39, P6325, DOI 10.1021/bi992734y; SCHMIDT E, 1974, METHOD ENZYMAT AN, V2, P650; SHANNON KW, 1986, J BIOL CHEM, V261, P2266; SHANNON KW, 1988, J BIOL CHEM, V263, P7717; SMITH GK, 1980, BIOCHEMISTRY-US, V19, P4313, DOI 10.1021/bi00559a026; SMITH GK, 1990, ARCH BIOCHEM BIOPHYS, V283, P367, DOI 10.1016/0003-9861(90)90656-J; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; TAN LUL, 1979, CAN J BIOCHEM CELL B, V57, P806, DOI 10.1139/o79-100; Van Hove JLK, 1998, J INHERIT METAB DIS, V21, P799, DOI 10.1023/A:1005462400552; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; VILLAR E, 1985, J BIOL CHEM, V260, P2245; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WEST MG, 1993, J BIOL CHEM, V268, P153; West MG, 1996, BIOCHEMISTRY-US, V35, P3122, DOI 10.1021/bi952713d; Wiemann S, 2001, GENOME RES, V11, P422, DOI 10.1101/gr.GR1547R; YANG XM, 1993, BIOCHEMISTRY-US, V32, P1118, DOI 10.1021/bi00092a022	56	53	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43178	43187		10.1074/jbc.M304319200	http://dx.doi.org/10.1074/jbc.M304319200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12937168	Green Accepted, hybrid			2022-12-27	WOS:000186157000059
J	Wilson, EM; Hsieh, MM; Rotwein, P				Wilson, EM; Hsieh, MM; Rotwein, P			Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; SKELETAL-MUSCLE; H19/IGF2 LOCUS; MYOGENIN GENE; IGF-I; DIFFERENTIATION; HYPERTROPHY; EXPRESSION; MICE; METHYLATION	Skeletal muscle differentiation, maturation, and regeneration are regulated by interactions between intrinsic genetic programs controlled by myogenic transcription factors, including members of the MyoD and MEF2 families, and environmental cues mediated by hormones and growth factors. Insulin-like growth factors (IGFs) also play key roles in muscle development, and in the maintenance and repair of mature muscle, but their mechanisms of interaction with other muscle regulatory networks remain undefined. To evaluate the potential interplay between MyoD and IGF signaling pathways, we have studied muscle differentiation in C3H 10T1/2 fibroblasts acutely converted to myoblasts by quantitative infection with a recombinant adenovirus encoding mouse MyoD. In these cells, IGF-II gene and protein expression are induced as early events in differentiation, and the IGF-I receptor and downstream signaling molecules, including Akt, are rapidly activated. Interference with IGF-II production by a tetracycline-inhibited adenovirus expressing an IGF-II cDNA in the antisense orientation reversibly inhibited both production of muscle-specific structural proteins and myocyte fusion to form multinucleated myotubes. Similar results were achieved with a tetracycline-inhibited adenovirus expressing dominant-negative Akt. Our observations identify a robust autocrine amplification network in which MyoD enhances the later steps in muscle differentiation by induction of a locally acting growth factor.	Oregon Hlth & Sci Univ, Div Mol Med, Portland, OR 97239 USA	Oregon Health & Science University	Rotwein, P (corresponding author), Oregon Hlth & Sci Univ, Div Mol Med, 3181 SW Sam Jackson Pk Rd,Mail Code HRC3, Portland, OR 97239 USA.		Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	NIDDK NIH HHS [5R01-DK42748, R01 DK042748] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ainscough JFX, 2000, DEVELOPMENT, V127, P3923; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; CARONI P, 1994, J CELL BIOL, V125, P893, DOI 10.1083/jcb.125.4.893; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; FLORINI JR, 1991, J BIOL CHEM, V266, P15917; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Ishihara K, 2000, GENOME RES, V10, P664, DOI 10.1101/gr.10.5.664; Issa JPJ, 1996, NAT MED, V2, P281, DOI 10.1038/nm0396-281; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Kaffer CR, 2000, GENE DEV, V14, P1908; KOU K, 1993, MOL ENDOCRINOL, V7, P291, DOI 10.1210/me.7.2.291; LASSAR A, 1994, CURR OPIN CELL BIOL, V6, P432, DOI 10.1016/0955-0674(94)90037-X; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Paul AC, 2002, J CELL BIOL, V156, P751, DOI 10.1083/jcb.200105147; Polesskaya A, 2001, EMBO J, V20, P6816, DOI 10.1093/emboj/20.23.6816; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; ROTWEIN P, 1990, DNA CELL BIOL, V9, P725, DOI 10.1089/dna.1990.9.725; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Stewart CEH, 1996, J BIOL CHEM, V271, P11330, DOI 10.1074/jbc.271.19.11330; Tureckova J, 2001, J BIOL CHEM, V276, P39264, DOI 10.1074/jbc.M104991200; Vandromme M, 2001, J BIOL CHEM, V276, P8173, DOI 10.1074/jbc.M005587200; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3	36	74	82	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 17	2003	278	42					41109	41113		10.1074/jbc.C300299200	http://dx.doi.org/10.1074/jbc.C300299200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730TX	12941952	hybrid			2022-12-27	WOS:000185847200086
J	Evans, JP; Ahn, K; Klinman, JP				Evans, JP; Ahn, K; Klinman, JP			Evidence that dioxygen and substrate activation are tightly coupled in dopamine beta-monooxygenase - Implications for the reactive oxygen species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-HYDROXYLATING MONOOXYGENASE; ELECTRON-PARAMAGNETIC RESONANCE; ENZYME-BOUND COPPER; AMIDATING ENZYME; PEPTIDYLGLYCINE MONOOXYGENASE; CHEMICAL MECHANISM; PEPTIDE AMIDATION; ACTIVE-SITE; ATOMS; 3,4-DIHYDROXYPHENYLETHYLAMINE	Oxygen activation occurs at a wide variety of enzyme active sites. Mechanisms previously proposed for the copper monooxygenase, dopamine beta-monooxygenase (DbetaM), involve the accumulation of an activated oxygen intermediate with the properties of a copper-peroxo or copper-oxo species before substrate activation. These are reminiscent of the mechanism of cytochrome P-450, where a heme iron stabilizes the activated O-2 species. Herein, we report two experimental probes of the activated oxygen species in DbetaM. First, we have synthesized the substrate analog, beta,beta-difluorophenethylamine, and examined its capacity to induce reoxidation of the prereduced copper sites of DbetaM upon mixing with O-2 under rapid freeze-quench conditions. This experiment fails to give rise to an EPR-detectable copper species, in contrast to a substrate with a C-H active bond. This indicates either that the reoxidation of the enzyme-bound copper sites in the presence of O-2 is tightly linked to C-H activation or that a diamagnetic species Cu(II) - O-2(.) has been formed. In the context of the open and fully solvent-accessible active site for the homologous peptidyl-glycine-alpha-hydroxylating monooxygenase and by analogy to cytochrome P-450, the accumulation of a reduced and activated oxygen species in DbetaM before C-H cleavage would be expected to give some uncoupling of oxygen and substrate consumption. We have, therefore, examined the degree to which O-2 and substrate consumption are coupled in DbetaM using both end point and initial rate experimental protocols. With substrates that differ by more than three orders of magnitude in rate, we fail to detect any uncoupling of O-2 uptake from product formation. We conclude that there is no accumulation of an activated form of O-2 before C-H abstraction in the DbetaM and peptidylglycine-alpha-hydroxylating monooxygenase class of copper monooxygenases, presenting a mechanism in which a diamagnetic Cu( II)- superoxo complex, formed initially at very low levels, abstracts a hydrogen atom from substrate to generate Cu( II)- hydroperoxo and substrate-free radical as intermediates. Subsequent participation of the second copper site per subunit completes the reaction cycle, generating hydroxylated product and water.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025765, R37GM025765] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 25765] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aboelella NW, 2002, J AM CHEM SOC, V124, P10660, DOI 10.1021/ja027164v; AHN N, 1983, BIOCHEMISTRY-US, V22, P3096, DOI 10.1021/bi00282a012; ASH DE, 1984, J BIOL CHEM, V259, P3395; Bakac A, 2000, J AM CHEM SOC, V122, P1092, DOI 10.1021/ja993371s; Bell J, 2003, BIOCHEMISTRY-US, V42, P7133, DOI 10.1021/bi034247v; Blackburn NJ, 2000, J BIOL INORG CHEM, V5, P341, DOI 10.1007/PL00010663; BLACKBURN NJ, 1991, J BIOL CHEM, V266, P23120; BLACKBURN NJ, 1988, BIOCHEMISTRY-US, V27, P6001, DOI 10.1021/bi00416a026; BRENNER MC, 1989, BIOCHEMISTRY-US, V28, P4664, DOI 10.1021/bi00437a023; BRENNER MC, 1989, BIOCHEMISTRY-US, V28, P4656, DOI 10.1021/bi00437a022; BUETTNER GR, 1990, METHOD ENZYMOL, V186, P125; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; FITZPATRICK PF, 1985, BIOCHEMISTRY-US, V24, P2108, DOI 10.1021/bi00330a003; Francisco WA, 2002, J AM CHEM SOC, V124, P8194, DOI 10.1021/ja025758s; Francisco WA, 1998, BIOCHEMISTRY-US, V37, P8244, DOI 10.1021/bi973004y; Francisco WA, 2003, BIOCHEMISTRY-US, V42, P1813, DOI 10.1021/bi020592t; FREEMAN JC, 1993, J AM CHEM SOC, V115, P4923, DOI 10.1021/ja00064a077; FRIEDMAN S, 1965, J BIOL CHEM, V240, P4763; FUJISAWA K, 1994, J AM CHEM SOC, V116, P12079, DOI 10.1021/ja00105a069; HORTMANN AG, 1972, J ORG CHEM, V37, P322, DOI 10.1021/jo00967a033; Jaron S, 1999, BIOCHEMISTRY-US, V38, P15086, DOI 10.1021/bi991341w; KADKHODAYAN S, 1995, J BIOL CHEM, V270, P28042; KLINMAN JP, 1984, J BIOL CHEM, V259, P3399; KULATHILA R, 1994, ARCH BIOCHEM BIOPHYS, V311, P191, DOI 10.1006/abbi.1994.1225; Lee DH, 1995, J AM CHEM SOC, V117, P12498, DOI 10.1021/ja00155a014; LEVIN EY, 1960, J BIOL CHEM, V235, P2080; LEVINE J, 1948, J AM CHEM SOC, V60, P1930; LJONES T, 1978, FEBS LETT, V92, P81, DOI 10.1016/0014-5793(78)80726-1; MERKLER DJ, 1992, ARCH BIOCHEM BIOPHYS, V294, P594, DOI 10.1016/0003-9861(92)90730-K; MILLER SM, 1985, BIOCHEMISTRY-US, V24, P2114, DOI 10.1021/bi00330a004; MURTHY ASN, 1986, J BIOL CHEM, V261, P1815; Ortiz de Montellano PR, 1986, CYTOCHROME P450 STRU, P217; Ponce A, 2000, J AM CHEM SOC, V122, P8187, DOI 10.1021/ja000017h; POOS GI, 1963, J MED CHEM, V6, P266, DOI 10.1021/jm00339a011; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Prigge ST, 1999, NAT STRUCT BIOL, V6, P976; Prigge ST, 1997, SCIENCE, V278, P1300, DOI 10.1126/science.278.5341.1300; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; SCOTT RA, 1988, BIOCHEMISTRY-US, V27, P5411, DOI 10.1021/bi00415a005; SKOTLAND T, 1980, ARCH BIOCHEM BIOPHYS, V201, P81, DOI 10.1016/0003-9861(80)90489-0; SOUTHAN C, 1989, FEBS LETT, V255, P116, DOI 10.1016/0014-5793(89)81072-5; STEWART LC, 1987, BIOCHEMISTRY-US, V26, P5302, DOI 10.1021/bi00391a013; STEWART LC, 1988, ANNU REV BIOCHEM, V57, P551; TIAN GC, 1994, BIOCHEMISTRY-US, V33, P226, DOI 10.1021/bi00167a030; WADE TN, 1980, J ORG CHEM, V45, P5333, DOI 10.1021/jo01314a024; WALKER GA, 1977, BIOCHIM BIOPHYS ACTA, V482, P309, DOI 10.1016/0005-2744(77)90244-3; WITTAKER JW, 1990, METHOD ENZYMOL, V188, P82	47	160	162	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 12	2003	278	50					49691	49698		10.1074/jbc.M300797200	http://dx.doi.org/10.1074/jbc.M300797200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751LH	12966104	hybrid			2022-12-27	WOS:000187068200008
J	Futaki, S; Hayashi, Y; Yamashita, M; Yagi, K; Bono, H; Hayashizaki, Y; Okazaki, Y; Sekiguchi, K				Futaki, S; Hayashi, Y; Yamashita, M; Yagi, K; Bono, H; Hayashizaki, Y; Okazaki, Y; Sekiguchi, K			Molecular basis of constitutive production of basement membrane components - Gene expression profiles of Engelbreth-Holm-Swarm tumor and F9 embryonal carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY MOUSE EMBRYO; RETINOIC ACID; TRANSCRIPTION FACTOR; FUNCTIONAL ANNOTATION; STEM-CELLS; PROTEOGLYCAN SYNTHESIS; EXTRACELLULAR-MATRIX; PARIETAL ENDODERM; IV COLLAGEN; IN-VIVO	Engelbreth-Holm-Swarm (EHS) tumors produce large amounts of basement membrane ( BM) components that are widely used as cell culture substrates mimicking BM functions. To delineate the tissue/organ origin of the tumor and the mechanisms operating in the BM overproduction, a genome-wide expression profile of EHS tumor was analyzed using RIKEN cDNA microarrays containing similar to40,000 mouse cDNA clones. Expression profiles of F9 embryonal carcinoma cells that produce laminin-1 and other BM components upon differentiation into parietal endoderm-like cells ( designated F9-PE) were also analyzed. Hierarchical clustering analysis showed that the gene expression profiles of EHS and F9-PE were the most similar among 49 mouse tissues/organs in the RIKEN Expression Array Database, suggesting that EHS tumor is parietal endoderm-derived. Quantitative PCR analysis confirmed that not only BM components but also the machineries required for efficient production of BM components, such as enzymes involved in post-translational modification and molecular chaperones, were highly expressed in both EHS and F9-PE. Pairs of similar transcription factor isoforms, such as Gata4/Gata6, Sox7/Sox17, and Cited1/Cited2, were also highly expressed in both EHS tumor and F9-PE. Time course analysis of F9 differentiation showed that up-regulation of the transcription factors was associated with those of BM components, suggesting their involvement in parietal endoderm specification and overproduction of the BM components.	Aichi Med Univ, Japanese Sci & Technol Agcy, ERATO, Sekiguchi Biomatrix Signaling Project, Aichi 4801195, Japan; RIKEN, Yokohama Inst, Gen Sci Ctr, Genome Explorat Res Grp, Yokohama, Kanagawa 2300045, Japan; RIKEN, Genome Sci Lab, Discovery & Res Inst, Wako, Saitama 3510198, Japan; Osaka Univ, Inst Prot Res, Osaka 5650871, Japan	Aichi Medical University; Japan Science & Technology Agency (JST); RIKEN; RIKEN; Osaka University	Hayashi, Y (corresponding author), Aichi Med Univ, Japanese Sci & Technol Agcy, ERATO, Sekiguchi Biomatrix Signaling Project, 21 Karimata, Aichi 4801195, Japan.		Hayashizaki, Yoshihide/N-6590-2015; Hayashi, Yoshitaka/I-6168-2014; Bono, Hidemasa/AAF-3649-2020	Hayashi, Yoshitaka/0000-0002-7557-4303; Bono, Hidemasa/0000-0003-4413-0651; Okazaki, Yasushi/0000-0003-3241-5502				ALLIEL PM, 1993, EUR J BIOCHEM, V214, P347, DOI 10.1111/j.1432-1033.1993.tb17930.x; ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; BALDWIN CT, 1989, MATRIX, V9, P389, DOI 10.1016/S0934-8832(89)80044-7; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Barbacci E, 1999, DEVELOPMENT, V126, P4795; Becker S, 1997, DEV BIOL, V187, P298, DOI 10.1006/dbio.1997.8616; Bono H, 2003, GENOME RES, V13, P1318, DOI 10.1101/gr.1075103; Bono H, 2002, NUCLEIC ACIDS RES, V30, P211, DOI 10.1093/nar/30.1.211; Bono H, 2002, NUCLEIC ACIDS RES, V30, P116, DOI 10.1093/nar/30.1.116; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Byrd N, 2002, DEVELOPMENT, V129, P361; Contos JJA, 2001, GENE, V267, P243, DOI 10.1016/S0378-1119(01)00410-3; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erickson AC, 2000, J HISTOCHEM CYTOCHEM, V48, P1291, DOI 10.1177/002215540004801001; FOWLER KJ, 1990, EXP CELL RES, V191, P194, DOI 10.1016/0014-4827(90)90005-U; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Futaki S, 2000, MAMM GENOME, V11, P649, DOI 10.1007/s003350010121; Hagedorn HG, 2001, INT J ONCOL, V18, P669; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; HELAAKOSKI T, 1990, J BIOL CHEM, V265, P11413; Heller LC, 1999, J BIOL CHEM, V274, P1394, DOI 10.1074/jbc.274.3.1394; Ho HCK, 2001, BIOL REPROD, V64, P1667, DOI 10.1095/biolreprod64.6.1667; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Kadota K, 2001, PHYSIOL GENOMICS, V4, P183, DOI 10.1152/physiolgenomics.2001.4.3.183; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kemppainen RJ, 1998, J BIOL CHEM, V273, P3129, DOI 10.1074/jbc.273.6.3129; KLEINMAN HK, 1987, DEV BIOL, V122, P373, DOI 10.1016/0012-1606(87)90302-2; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kragh M, 2003, INT J ONCOL, V22, P305; KUDO H, 1994, EXP CELL RES, V212, P219, DOI 10.1006/excr.1994.1137; Laitusis AL, 1999, J BIOL CHEM, V274, P486, DOI 10.1074/jbc.274.1.486; Lang SH, 2001, CELL GROWTH DIFFER, V12, P631; LANKATBUTTGEREIT B, 1988, FEBS LETT, V236, P352, DOI 10.1016/0014-5793(88)80054-1; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; MATSUBARA S, 1994, J BIOCHEM-TOKYO, V115, P1088, DOI 10.1093/oxfordjournals.jbchem.a124462; Miki R, 2001, P NATL ACAD SCI USA, V98, P2199, DOI 10.1073/pnas.041605498; Miyaishi O, 1998, J CELL BIOCHEM, V68, P436, DOI 10.1002/(SICI)1097-4644(19980315)68:4<436::AID-JCB4>3.0.CO;2-R; Murakami A, 1999, J BIOL CHEM, V274, P17242, DOI 10.1074/jbc.274.24.17242; Murray P, 2001, MECH DEVELOP, V101, P213, DOI 10.1016/S0925-4773(00)00554-2; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; ORKIN RW, 1977, J EXP MED, V145, P204, DOI 10.1084/jem.145.1.204; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; PIHLAJANIEMI T, 1982, J BIOL CHEM, V257, P4914; Power SC, 1996, MOL CELL BIOL, V16, P778; REICHEL RR, 1994, EXP CELL RES, V214, P634, DOI 10.1006/excr.1994.1301; SALAMAT M, 1995, ANAT EMBRYOL, V192, P275; Smith ER, 2001, J BIOL CHEM, V276, P47303, DOI 10.1074/jbc.M106158200; Smith ER, 2001, J BIOL CHEM, V276, P32094, DOI 10.1074/jbc.M105009200; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; SWARM RL, 1963, J NATL CANCER I, V31, P953; Verheijen MHG, 1999, INT J DEV BIOL, V43, P711; VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q; WEWER UM, 1985, DIFFERENTIATION, V30, P61, DOI 10.1111/j.1432-0436.1985.tb00514.x; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yahata T, 2001, GENE DEV, V15, P2598, DOI 10.1101/gad.906301; Zhang LJ, 1998, J BIOL CHEM, V273, P27998, DOI 10.1074/jbc.273.43.27998	62	44	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 12	2003	278	50					50691	50701		10.1074/jbc.M304985200	http://dx.doi.org/10.1074/jbc.M304985200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751LH	12968032	Green Published, hybrid			2022-12-27	WOS:000187068200125
J	Ritter, M; Ravasio, A; Jakab, M; Chwatal, S; Furst, J; Laich, A; Gschwentner, M; Signorelli, S; Burtscher, C; Eichmuller, S; Paulmichl, M				Ritter, M; Ravasio, A; Jakab, M; Chwatal, S; Furst, J; Laich, A; Gschwentner, M; Signorelli, S; Burtscher, C; Eichmuller, S; Paulmichl, M			Cell swelling stimulates cytosol to membrane transposition of ICln	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; REGULATORY VOLUME DECREASE; RESONANCE ENERGY-TRANSFER; CANINE KIDNEY-CELLS; SM PROTEINS; CHLORIDE CONDUCTANCE; ESCHERICHIA-COLI; HYPOTONIC STRESS; EPITHELIAL-CELLS; I-CLN	ICln is a multifunctional protein that is essential for cell volume regulation. It can be found in the cytosol and is associated with the cell membrane. Besides its role in the splicing process, ICln is critically involved in the generation of ion currents activated during regulatory volume decrease after cell swelling (RVDC). If reconstituted in artificial bilayers, ICln can form ion channels with biophysical properties related to RVDC. We investigated (i) the cytosol versus cell membrane distribution of ICln in rat kidney tubules, NIH 3T3 fibroblasts, Madin-Darby canine kidney (MDCK) cells, and LLC-PK1 epithelial cells, (ii) fluorescence resonance energy transfer ( FRET) in living fibroblasts between fluorescently tagged ICln and fluorochromes in the cell membrane, and (iii) possible functional consequences of an enhanced ICln presence at the cell membrane. We demonstrate that ICln distribution in rat kidneys depends on the parenchymal localization and functional state of the tubules and that cell swelling causes ICln redistribution from the cytosol to the cell membrane in NIH 3T3 fibroblasts and LLC-PK1 cells. The addition of purified ICln protein to the extracellular solution or overexpression of farnesylated ICln leads to an increased anion permeability in NIH 3T3 fibroblasts. The swelling-induced redistribution of ICln correlates to altered kinetics of RVDC in NIH 3T3 fibroblasts, LLC-PK1 cells, and MDCK cells. In these cells, RVDC develops more rapidly, and in MDCK cells the rate of swelling-induced depolarization is accelerated if cells are swollen for a second time. This coincides with an enhanced ICln association with the cell membrane.	Univ Innsbruck, Dept Physiol, A-6020 Innsbruck, Austria; Univ Milan, Dept Biomol Sci & Biotechnol, I-20133 Milan, Italy	University of Innsbruck; University of Milan	Ritter, M (corresponding author), Univ Innsbruck, Dept Physiol, Fritz Pregl Str 3, A-6020 Innsbruck, Austria.	markus.ritter@uibk.ac.at; markus.paulmichl@uibk.ac.at	Ravasio, Andrea/G-6167-2011; Ravasio, Andrea/H-6722-2012; Ritter, Markus/AAG-4987-2020	Ravasio, Andrea/0000-0001-7835-5133; Ritter, Markus/0000-0001-7346-7750				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen LX, 1999, AM J PHYSIOL-CELL PH, V276, pC182, DOI 10.1152/ajpcell.1999.276.1.C182; Cromer BA, 2002, EUR BIOPHYS J BIOPHY, V31, P356, DOI 10.1007/s00249-002-0219-1; Emma F, 1998, BBA-MOL CELL RES, V1404, P321, DOI 10.1016/S0167-4889(98)00073-1; Emma F, 1998, AM J PHYSIOL-CELL PH, V274, pC1545, DOI 10.1152/ajpcell.1998.274.6.C1545; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Furst J, 2002, PFLUG ARCH EUR J PHY, V444, P1, DOI 10.1007/s00424-002-0805-1; Furst J, 2002, CELL PHYSIOL BIOCHEM, V12, P19, DOI 10.1159/000047823; Furst J, 2002, J BIOL CHEM, V277, P4435, DOI 10.1074/jbc.M107372200; Furst J, 2000, CELL PHYSIOL BIOCHEM, V10, P329, DOI 10.1159/000016374; Furst J, 2000, PFLUG ARCH EUR J PHY, V440, P100; Gadella TWJ, 1999, TRENDS PLANT SCI, V4, P287, DOI 10.1016/S1360-1385(99)01426-0; Garavaglia ML, 2002, PFLUG ARCH EUR J PHY, V443, P748, DOI 10.1007/s00424-001-0772-y; GSCHWENTNER M, 1995, PFLUG ARCH EUR J PHY, V430, P464, DOI 10.1007/BF00373882; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; HUANG WM, 1983, HISTOCHEMISTRY, V77, P275, DOI 10.1007/BF00506570; Hubert MD, 2000, BBA-BIOMEMBRANES, V1466, P105, DOI 10.1016/S0005-2736(00)00177-2; Jakab M, 2002, CELL PHYSIOL BIOCHEM, V12, P235, DOI 10.1159/000067895; Krapivinsky G, 1998, J BIOL CHEM, V273, P10811, DOI 10.1074/jbc.273.18.10811; KRAPIVINSKY GB, 1994, CELL, V76, P439, DOI 10.1016/0092-8674(94)90109-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laich A, 1997, KIDNEY INT, V51, P477, DOI 10.1038/ki.1997.65; LAKEY JH, 1992, FEBS LETT, V307, P26, DOI 10.1016/0014-5793(92)80895-N; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; LANG F, 1986, PFLUG ARCH EUR J PHY, V407, P158, DOI 10.1007/BF00580668; Li CH, 1998, J GEN PHYSIOL, V112, P727, DOI 10.1085/jgp.112.6.727; Li YY, 1999, J BIOCHEM-TOKYO, V126, P643, DOI 10.1093/oxfordjournals.jbchem.a022497; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Musch MW, 1997, J EXP ZOOL, V277, P460, DOI 10.1002/(SICI)1097-010X(19970415)277:6<460::AID-JEZ6>3.0.CO;2-M; Musch MW, 1998, PFLUG ARCH EUR J PHY, V436, P415, DOI 10.1007/s004240050651; PAULMICHL M, 1989, PFLUG ARCH EUR J PHY, V413, P456, DOI 10.1007/BF00594173; PAULMICHL M, 1992, NATURE, V356, P238, DOI 10.1038/356238a0; Pollok BA, 1999, TRENDS CELL BIOL, V9, P57, DOI 10.1016/S0962-8924(98)01434-2; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Pu WT, 2000, J BIOL CHEM, V275, P12363, DOI 10.1074/jbc.275.17.12363; Reeves RE, 1998, CURR EYE RES, V17, P861, DOI 10.1076/ceyr.17.9.861.5140; Ritter M, 2001, CELL PHYSIOL BIOCHEM, V11, P1, DOI 10.1159/000047787; RITTER M, 1991, PFLUG ARCH EUR J PHY, V418, P35, DOI 10.1007/BF00370449; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanchez-Olea R, 1998, BBA-GEN SUBJECTS, V1381, P49, DOI 10.1016/S0304-4165(98)00009-9; Sanchez-Torres J, 1999, CURR EYE RES, V18, P408, DOI 10.1076/ceyr.18.6.408.5266; Scandella E, 2000, J BIOL CHEM, V275, P15613, DOI 10.1074/jbc.275.21.15613; Schmarda A, 2001, CELL PHYSIOL BIOCHEM, V11, P55, DOI 10.1159/000047792; Schwartz RS, 1997, BIOCHEM J, V327, P609; STUARTTILLEY A, 1994, AM J PHYSIOL, V266, pC559, DOI 10.1152/ajpcell.1994.266.2.C559; Tang CJC, 1998, BLOOD, V92, P1442, DOI 10.1182/blood.V92.4.1442.416k14_1442_1447; Tao GZ, 1998, BIOCHEM BIOPH RES CO, V247, P668, DOI 10.1006/bbrc.1998.8837; Tao GZ, 2000, PEPTIDES, V21, P485, DOI 10.1016/S0196-9781(00)00176-5; Tao GZ, 1998, FEBS LETT, V434, P28, DOI 10.1016/S0014-5793(98)00946-6; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Woll E, 1996, PFLUG ARCH EUR J PHY, V432, P486, DOI 10.1007/s004240050160; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9	54	46	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2003	278	50					50163	50174		10.1074/jbc.M300374200	http://dx.doi.org/10.1074/jbc.M300374200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751LH	12970357	hybrid			2022-12-27	WOS:000187068200062
J	Nguyen, HP; Seto, NOL; Cai, Y; Leinala, EK; Borisova, SN; Palcic, MM; Evans, SV				Nguyen, HP; Seto, NOL; Cai, Y; Leinala, EK; Borisova, SN; Palcic, MM; Evans, SV			The influence of an intramolecular hydrogen bond in differential recognition of inhibitory acceptor analogs by human ABO(H) blood group A and B glycosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIFICITY	Human ABO( H) blood group glycosyltransferases GTA and GTB catalyze the final monosaccharide addition in the biosynthesis of the human A and B blood group antigens. GTA and GTB utilize a common acceptor, the H antigen disaccharide alpha-L-Fucp-(1-->2)-beta-D-Galp-OR, but different donors, where GTA transfers GalNAc from UDP-GalNAc and GTB transfers Gal from UDP-Gal. GTA and GTB are two of the most homologous enzymes known to transfer different donors and differ in only 4 amino acid residues, but one in particular (Leu/Met-266) has been shown to dominate the selection between donor sugars. The structures of the A and B glycosyltransferases have been determined to high resolution in complex with two inhibitory acceptor analogs alpha-L-Fucp( 1-->2)-beta-D-(3-deoxy)-Galp-OR and alpha-L-Fucp-(1-->2)-beta-D-(3-amino)- Galp-OR, in which the 3-hydroxyl moiety of the Gal ring has been replaced by hydrogen or an amino group, respectively. Remarkably, although the 3-deoxy inhibitor occupies the same conformation and position observed for the native H antigen in GTA and GTB, the 3-amino analog is recognized differently by the two enzymes. The 3-amino substitution introduces a novel intramolecular hydrogen bond between O-2' on Fuc and N-3' on Gal, which alters the minimum-energy conformation of the inhibitor. In the absence of UDP, the 3-amino analog can be accommodated by either GTA or GTB with the L-Fuc residue partially occupying the vacant UDP binding site. However, in the presence of UDP, the analog is forced to abandon the intramolecular hydrogen bond, and the L-Fuc residue is shifted to a less ordered conformation. Further, the residue Leu/Met-266 that was thought important only in distinguishing between donor substrates is observed to interact differently with the 3-amino acceptor analog in GTA and GTB. These observations explain why the 3-deoxy analog acts as a competitive inhibitor of the glycosyltransferase reaction, whereas the 3-amino analog displays complex modes of inhibition.	Univ Victoria, Dept Biochem & Microbiol, STN CSC, Victoria, BC V8W 3P6, Canada; Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; Univ Alberta, Dept Chem, Edmonton, AB T6G 2V4, Canada; Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Victoria; University of Ottawa; University of Alberta; National Research Council Canada	Evans, SV (corresponding author), Univ Victoria, Dept Biochem & Microbiol, STN CSC, POB 3800, Victoria, BC V8W 3P6, Canada.	svevans@uvic.ca		Evans, Stephen/0000-0002-0366-4027				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; EVANS SV, 1993, J MOL GRAPHICS, V11, P127; Greenwell P, 1997, GLYCOCONJUGATE J, V14, P159, DOI 10.1023/A:1018581503164; Laferte S, 2000, EUR J BIOCHEM, V267, P4840, DOI 10.1046/j.1432-1327.2000.01544.x; LOWARY TL, 1993, CARBOHYD RES, V249, P163, DOI 10.1016/0008-6215(93)84068-H; LOWARY TL, 1994, CARBOHYD RES, V251, P33, DOI 10.1016/0008-6215(94)84275-2; Marcus SL, 2003, J BIOL CHEM, V278, P12403, DOI 10.1074/jbc.M212002200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patenaude SI, 2002, NAT STRUCT BIOL, V9, P685, DOI 10.1038/nsb832; Watkins W M, 1980, Adv Hum Genet, V10, P1; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0	12	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					49191	49195		10.1074/jbc.M308770200	http://dx.doi.org/10.1074/jbc.M308770200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12972418	hybrid			2022-12-27	WOS:000186829000083
J	Sengenes, C; Bouloumie, A; Hauner, H; Berlan, M; Busse, R; Lafontan, M; Galitzky, J				Sengenes, C; Bouloumie, A; Hauner, H; Berlan, M; Busse, R; Lafontan, M; Galitzky, J			Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FAT-CELLS; PROTEIN-KINASE; CYCLIC-GMP; CYTOPLASMIC DOMAIN; ADENYLYL-CYCLASE; ADIPOSE-TISSUE; LIPOLYSIS; RECEPTOR; MECHANISMS; ACTIVATION	Our previous studies have demonstrated that natriuretic peptides (NPs), peptide hormones with natriuretic, diuretic, and vasodilating properties, exert a potent control on the lipolysis in human adipocytes via the activation of the type A guanylyl cyclase receptor ( 1, 2). In the current study we investigated the intracellular mechanisms involved in the NP-stimulated lipolytic effect in human preadipocytes and adipocytes. We demonstrate that the atrial NP (ANP)-induced lipolysis in human adipocytes was associated with an enhanced serine phosphorylation of the hormone-sensitive lipase (HSL). Both ANP-mediated lipolysis and HSL phosphorylation were inhibited in the presence of increasing concentrations of the guanylyl cyclase inhibitor LY-83583. ANP did not modulate the activity of the cAMP-dependent protein kinase (PKA). Moreover, H-89, a PKA inhibitor, did not affect the ANP-induced lipolysis. On primary cultures of human preadipocytes, the ANP-mediated lipolytic effect was dependent on the differentiation process. On differentiated human preadipocytes, ANP-mediated lipolysis, associated with an increased phosphorylation of HSL and of perilipin A, was strongly decreased by treatment with the inhibitor of the cGMP-dependent protein kinase I ( cGKI), Rp-8-pCPT-cGMPS. Thus, ANP-induced lipolysis in human adipocytes is a cGMP-dependent pathway that induces the phosphorylation of HSL and perilipin A via the activation of cGKI. The present study shows that lipolysis in human adipocytes can be controlled by an independent cGKI-mediated signaling as well as by the classical cAMP/PKA pathway.	Univ Toulouse 3, Ctr Hosp Univ Rangueil, Inst Louis Bugnard, INSERM,U586,Obes Res Unit, F-31062 Toulouse, France; Univ Dusseldorf, Diabet Res Inst, D-4000 Dusseldorf, Germany; Univ Frankfurt Klinikum, Inst Cardiovasc Physiol, D-60590 Frankfurt, Germany	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Heinrich Heine University Dusseldorf; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Sengenes, C (corresponding author), Univ Toulouse 3, Ctr Hosp Univ Rangueil, Inst Louis Bugnard, INSERM,U586,Obes Res Unit, F-31062 Toulouse, France.		Bouloumie-Diehl, Anne/M-4446-2017; Galitzky, Jean/R-6599-2017; Sengenes, Coralie/GSN-0709-2022	Bouloumie-Diehl, Anne/0000-0001-5496-8891; Sengenes, Coralie/0000-0002-4820-6660				ALLEN DO, 1986, BIOCHEM PHARMACOL, V35, P767, DOI 10.1016/0006-2952(86)90244-3; AnandSrivastava MB, 1996, J BIOL CHEM, V271, P19324, DOI 10.1074/jbc.271.32.19324; Arner P, 2001, ANN MED, V33, P542, DOI 10.3109/07853890108995964; BRADLEY DC, 1989, ANAL BIOCHEM, V180, P11, DOI 10.1016/0003-2697(89)90081-X; Burkhardt M, 2000, J BIOL CHEM, V275, P33536, DOI 10.1074/jbc.M005670200; BUTT E, 1993, NEUROCHEM RES, V18, P17; Carey GB, 1998, ADV EXP MED BIOL, V441, P157; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; EFENDIC S, 1970, Hormone and Metabolic Research, V2, P287; Galitzky J, 2001, J LIPID RES, V42, P536; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; HAUNER H, 1995, DIABETOLOGIA, V38, P764, DOI 10.1007/s001250050350; Holm C, 2000, ANNU REV NUTR, V20, P365, DOI 10.1146/annurev.nutr.20.1.365; Kalra PR, 2001, EUR HEART J, V22, P997, DOI 10.1053/euhj.2000.2395; KHOO JC, 1977, P NATL ACAD SCI USA, V74, P4843, DOI 10.1073/pnas.74.11.4843; Klein G, 2000, CARDIOVASC RES, V48, P367, DOI 10.1016/S0008-6363(00)00194-2; Kone BC, 2001, CARDIOVASC RES, V51, P429, DOI 10.1016/S0008-6363(01)00327-3; LAFONTAN M, 1993, J LIPID RES, V34, P1057; LAFONTAN M, 2000, INT J OBES RELAT S4, V24, P47; Langin D, 2000, HORM METAB RES, V32, P443, DOI 10.1055/s-2007-978670; Ledoux S, 1997, AM J PHYSIOL-CELL PH, V272, pC82, DOI 10.1152/ajpcell.1997.272.1.C82; Levin ER, 1998, NEW ENGL J MED, V339, P321; LEVIN ER, 1993, AM J PHYSIOL, V264, pE483, DOI 10.1152/ajpendo.1993.264.4.E483; LINCOLN TM, 1976, P NATL ACAD SCI USA, V73, P2559, DOI 10.1073/pnas.73.8.2559; LINCOLN TM, 1993, FASEB J, V7, P328, DOI 10.1096/fasebj.7.2.7680013; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Orstavik S, 1997, GENOMICS, V42, P311, DOI 10.1006/geno.1997.4743; Orstavik S, 1996, BIOCHEM BIOPH RES CO, V220, P759, DOI 10.1006/bbrc.1996.0477; Pagano M, 2001, J BIOL CHEM, V276, P22064, DOI 10.1074/jbc.M101587200; Potter LR, 2001, J BIOL CHEM, V276, P6057, DOI 10.1074/jbc.R000033200; RODBELL M, 1964, J BIOL CHEM, V239, P375; Ruth P, 1999, PHARMACOL THERAPEUT, V82, P355, DOI 10.1016/S0163-7258(98)00067-9; Ryden M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200; SCHIMMEL RJ, 1975, BIOCHIM BIOPHYS ACTA, V399, P181, DOI 10.1016/0304-4165(75)90224-X; Sengenes C, 2002, INT J OBESITY, V26, P24, DOI 10.1038/sj.ijo.0801845; Sengenes C, 2002, AM J PHYSIOL-REG I, V283, pR257, DOI 10.1152/ajpregu.00453.2001; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; Silberbach M, 2001, CELL SIGNAL, V13, P221, DOI 10.1016/S0898-6568(01)00139-5; Smolenski A, 1998, N-S ARCH PHARMACOL, V358, P134, DOI 10.1007/PL00005234; Sperelakis N, 1994, Adv Pharmacol, V26, P217, DOI 10.1016/S1054-3589(08)60056-3; STRALFORS P, 1983, J BIOL CHEM, V258, P5146; STRALFORS P, 1985, FEBS LETT, V180, P280, DOI 10.1016/0014-5793(85)81086-3; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Tebar F, 1996, ENDOCRINOLOGY, V137, P4181, DOI 10.1210/en.137.10.4181; van den Akker F, 2001, J MOL BIOL, V311, P923, DOI 10.1006/jmbi.2001.4922; White RE, 1999, ADV SEC MESS PHOSPH, V33, P251; Xue BZ, 1998, FASEB J, V12, P1391, DOI 10.1096/fasebj.12.13.1391; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929	48	203	207	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					48617	48626		10.1074/jbc.M303713200	http://dx.doi.org/10.1074/jbc.M303713200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12970365	hybrid			2022-12-27	WOS:000186829000014
J	Yamauchi, Y; Hayashi, M; Abe-Dohmae, S; Yokoyama, S				Yamauchi, Y; Hayashi, M; Abe-Dohmae, S; Yokoyama, S			Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED CHOLESTEROL EFFLUX; CELLULAR LIPID RELEASE; TANGIER-DISEASE; SELECTIVE-INHIBITION; EXTRACELLULAR DOMAIN; DEPENDENT EFFLUX; PHOSPHOLIPASE-C; DOWN-REGULATION; PEST SEQUENCE; ABCA1	ATP-binding cassette transporter A1 (ABCA1) plays an essential role in the helical apolipoprotein-mediated assembly of high density lipoprotein, and the apolipoporteins stabilize ABCA1 against calpain-mediated degradation during the reaction ((2002) J. Biol. Chem. 277, 22426 - 22429). Protein kinase C (PKC) inhibitors suppressed both ABCA1 stabilization and cellular lipid release mediated by apolipoprotein A-I (apoA-I) but not ABCA1 increase by calpain inhibitors. The increase of ABCA1 and the cellular lipid release by apoA-I were both suppressed by a phosphatidylcholine phospholipase C (PC-PLC) inhibitor but not by the inhibitors of phosphatidylinositol- PLC and phosphatidylinositol 3-kinase. A protein phosphatase inhibitor further enhanced the ABCA1 increase by apoA-I. Biochemical and microscopic evidence indicated that apoA-I activated PKCalpha, and phosphorylation of ABCA1 was directly demonstrated by apoA-I via PKC. Finally, digestion of sphingomyelin increased ABCA1, and a PC-PLC inhibitor suppressed it. We conclude that apoA-I activates PKCalpha by PC-PLC-mediated generation of diacylglycerol initiated by the removal of cellular sphingomyelin (( 2002) J. Biol. Chem. 277, 44709 - 44714), and subsequently phosphorylates and stabilizes ABCA1.	Nagoya City Univ, Grad Sch Med Sci, Dept Biochem Cell Biol & Metab, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Nagoya City University	Yokoyama, S (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Biochem Cell Biol & Metab, Mizuho Ku, Kawasumi 1,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	syokoyam@med.nagoya-cu.ac.jp	Yamauchi, Yoshio/I-7539-2014	Yamauchi, Yoshio/0000-0001-5559-4596				Abe-Dohmae S, 2000, BIOCHEMISTRY-US, V39, P11092, DOI 10.1021/bi0008175; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Attie AD, 2002, J LIPID RES, V43, P1610, DOI 10.1194/jlr.M200223-JLR200; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Buechler C, 2002, J BIOL CHEM, V277, P41307, DOI 10.1074/jbc.C200436200; Buechler C, 2002, BIOCHEM BIOPH RES CO, V293, P759, DOI 10.1016/S0006-291X(02)00303-0; Chambenoit O, 2001, J BIOL CHEM, V276, P9955, DOI 10.1074/jbc.M010265200; CHAMBERS TC, 1990, J BIOL CHEM, V265, P7679; Costet P, 2000, J BIOL CHEM, V275, P28240; de Thonel A, 2001, BLOOD, V98, P3770, DOI 10.1182/blood.V98.13.3770; Deeg MA, 1997, ARTERIOSCL THROM VAS, V17, P1667, DOI 10.1161/01.ATV.17.9.1667; Feng B, 2002, J BIOL CHEM, V277, P43271, DOI 10.1074/jbc.M207532200; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; Gomez-Angelats M, 2001, J BIOL CHEM, V276, P44944, DOI 10.1074/jbc.M104919200; Grewal T, 2003, J BIOL CHEM, V278, P16478, DOI 10.1074/jbc.C300085200; Haidar B, 2002, J LIPID RES, V43, P2087, DOI 10.1194/jlr.M200235-JLR200; Haidar B, 2001, J LIPID RES, V42, P249; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Ito J, 2002, J BIOL CHEM, V277, P44709, DOI 10.1074/jbc.M208379200; Jia YL, 1997, J BIOL CHEM, V272, P4978, DOI 10.1074/jbc.272.8.4978; Kojima K, 2001, BBA-MOL CELL BIOL L, V1532, P173, DOI 10.1016/S1388-1981(01)00124-X; Li QQ, 1997, BIOCHEMISTRY-US, V36, P12045, DOI 10.1021/bi970079t; LI QQ, 1995, J BIOL CHEM, V270, P26216, DOI 10.1074/jbc.270.44.26216; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Maasch C, 2000, FASEB J, V14, P1653, DOI 10.1096/fj.14.11.1653; Martinez LO, 2003, J BIOL CHEM, V278, P37368, DOI 10.1074/jbc.M307161200; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; NazihSanderson F, 1997, BBA-LIPID LIPID MET, V1346, P45, DOI 10.1016/S0005-2760(97)00017-9; NazihSanderson F, 1997, BBA-MOL CELL RES, V1358, P103, DOI 10.1016/S0167-4889(97)00055-4; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Nofer JR, 2000, BIOCHEMISTRY-US, V39, P15199, DOI 10.1021/bi001162a; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; Prevostel C, 2000, J CELL SCI, V113, P2575; Remaley AT, 1997, ARTERIOSCL THROM VAS, V17, P1813, DOI 10.1161/01.ATV.17.9.1813; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; See RH, 2002, J BIOL CHEM, V277, P41835, DOI 10.1074/jbc.M204923200; Singaraja RR, 2001, J BIOL CHEM, V276, P33969, DOI 10.1074/jbc.M102503200; Slater SJ, 2001, BIOCHEMISTRY-US, V40, P4437, DOI 10.1021/bi001654n; Smith JD, 1996, J BIOL CHEM, V271, P30647, DOI 10.1074/jbc.271.48.30647; Tanaka AR, 2001, BIOCHEM BIOPH RES CO, V283, P1019, DOI 10.1006/bbrc.2001.4891; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; THERET N, 1990, BIOCHEM BIOPH RES CO, V173, P1361, DOI 10.1016/S0006-291X(05)80938-6; Tsujita M, 1996, BIOCHEMISTRY-US, V35, P13011, DOI 10.1021/bi960734h; Tsujita M, 2000, BBA-MOL CELL BIOL L, V1485, P199, DOI 10.1016/S1388-1981(00)00061-5; Tsukamoto K, 2001, BIOCHEM BIOPH RES CO, V287, P757, DOI 10.1006/bbrc.2001.5575; Vanoye CG, 1999, AM J PHYSIOL-CELL PH, V276, pC370, DOI 10.1152/ajpcell.1999.276.2.C370; Wagner S, 2000, EXP CELL RES, V258, P204, DOI 10.1006/excr.2000.4925; WALTER M, 1995, ARTERIOSCL THROM VAS, V15, P1975, DOI 10.1161/01.ATV.15.11.1975; Walter M, 1996, J CLIN INVEST, V98, P2315, DOI 10.1172/JCI119043; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Xia P, 1999, J BIOL CHEM, V274, P33143, DOI 10.1074/jbc.274.46.33143; Yamauchi Y, 2002, BBA-MOL CELL BIOL L, V1585, P1, DOI 10.1016/S1388-1981(02)00304-9; Yokoyama S, 2000, BBA-MOL CELL BIOL L, V1529, P231, DOI 10.1016/S1388-1981(00)00152-9	61	118	122	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47890	47897		10.1074/jbc.M306258200	http://dx.doi.org/10.1074/jbc.M306258200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12952980	hybrid			2022-12-27	WOS:000186731400066
J	Bennett, EM; Li, CL; Allan, PW; Parker, WB; Ealick, SE				Bennett, EM; Li, CL; Allan, PW; Parker, WB; Ealick, SE			Structural basis for substrate specificity of Escherichia coli purine nucleoside phosphorylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE ANALYSIS; VIVO GENE-THERAPY; CRYSTAL-STRUCTURE; 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE; 3-DIMENSIONAL STRUCTURE; DIFFRACTION DATA; CELLULOMONAS SP; FORMYCIN-B; ENZYME; BINDING	Purine nucleoside phosphorylase catalyzes reversible phosphorolysis of purine nucleosides and 2'- deoxypurine nucleosides to the free base and ribose ( or 2'- deoxyribose) 1- phosphate. Whereas the human enzyme is specific for 6- oxopurine ribonucleosides, the Escherichia coli enzyme accepts additional substrates including 6- oxopurine ribonucleosides, 6- aminopurine ribonucleosides, and to a lesser extent purine arabinosides. These differences have been exploited in a potential suicide gene therapy treatment for solid tumors. In an effort to optimize this suicide gene therapy approach, we have determined the three- dimensional structure of the E. coli enzyme in complex with 10 nucleoside analogs and correlated the structures with kinetic measurements and computer modeling. These studies explain the preference of the enzyme for ribose sugars, show increased flexibility for active site residues Asp(204) and Arg(24), and suggest that interactions involving the 1- and 6- positions of the purine and the 4 '- and 5 '- positions of the ribose provide the best opportunities to increase prodrug specificity and enzyme efficiency.	Cornell Univ, Baker Lab, Dept Chem & Biol Chem, Ithaca, NY 14853 USA; So Res Inst, Birmingham, AL 35205 USA	Cornell University	Ealick, SE (corresponding author), Cornell Univ, Baker Lab, Dept Chem & Biol Chem, Ithaca, NY 14853 USA.	see3@cornell.edu	Li, Chenglong/E-7182-2010	Li, Chenglong/0000-0003-3174-8719	NCI NIH HHS [CA 67763] Funding Source: Medline; NCRR NIH HHS [RR 01646] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U19CA067763] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AGARWAL KC, 1975, BIOCHEMISTRY-US, V14, P79, DOI 10.1021/bi00672a013; Appleby TC, 2001, J BIOL CHEM, V276, P39232, DOI 10.1074/jbc.M105694200; Appleby TC, 1999, STRUCTURE, V7, P629, DOI 10.1016/S0969-2126(99)80084-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beck C, 1995, HUM GENE THER, V6, P1525, DOI 10.1089/hum.1995.6.12-1525; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1992, X PLOR SYSTEM XRAY C; Bzowska A, 2002, BBA-PROTEIN STRUCT M, V1596, P293, DOI 10.1016/S0167-4838(02)00218-2; BZOWSKA A, 1992, BIOCHIM BIOPHYS ACTA, V1120, P239, DOI 10.1016/0167-4838(92)90243-7; BZOWSKA A, 1990, Z NATURFORSCH C, V45, P59; COOK WJ, 1985, J BIOL CHEM, V260, P2968; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; DENNIG CN, 1997, KEYSTONE S; DOSKOCIL J, 1977, COLLECT CZECH CHEM C, V42, P370, DOI 10.1135/cccc19770370; Dranoff G, 1998, J CLIN ONCOL, V16, P2548, DOI 10.1200/JCO.1998.16.7.2548; EALICK SE, 1990, J BIOL CHEM, V265, P1812; Erion MD, 1997, BIOCHEMISTRY-US, V36, P11735, DOI 10.1021/bi961970v; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Fedorov A, 2001, BIOCHEMISTRY-US, V40, P853, DOI 10.1021/bi002499f; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; HART TN, 1992, PROTEINS, V13, P206, DOI 10.1002/prot.340130304; HUGHES BW, 1995, CANCER RES, V55, P3339; Hughes BW, 1998, J BIOL CHEM, V273, P2322, DOI 10.1074/jbc.273.4.2322; JENSEN KF, 1975, EUR J BIOCHEM, V51, P253, DOI 10.1111/j.1432-1033.1975.tb03925.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kierdaszuk B, 1997, BIOPHYS CHEM, V63, P107, DOI 10.1016/S0301-4622(96)02239-9; Kierdaszuk B, 2000, BBA-PROTEIN STRUCT M, V1476, P109, DOI 10.1016/S0167-4838(99)00225-3; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; KLINE PC, 1995, BIOCHEMISTRY-US, V34, P1153, DOI 10.1021/bi00004a008; KLINE PC, 1993, BIOCHEMISTRY-US, V32, P13212, DOI 10.1021/bi00211a033; Koellner G, 2002, J MOL BIOL, V315, P351, DOI 10.1006/jmbi.2001.5211; Koellner G, 1998, J MOL BIOL, V280, P153, DOI 10.1006/jmbi.1998.1799; Koellner G, 1997, J MOL BIOL, V265, P202, DOI 10.1006/jmbi.1996.0730; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LEHIKOINEN PK, 1989, BIOCHEM J, V257, P355, DOI 10.1042/bj2570355; Mao C, 1997, STRUCTURE, V5, P1373, DOI 10.1016/S0969-2126(97)00287-6; Mao C, 1998, BIOCHEMISTRY-US, V37, P7135, DOI 10.1021/bi9723919; MAO C, 1995, THESIS CORNELL U ITH; Martiniello-Wilks R, 1998, HUM GENE THER, V9, P1617, DOI 10.1089/hum.1998.9.11-1617; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MESNIL M, 1997, KEYSTONE S, P67; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; Parker WB, 1998, BIOCHEM PHARMACOL, V55, P1673, DOI 10.1016/S0006-2952(98)00034-3; Parker WB, 1997, HUM GENE THER, V8, P1637, DOI 10.1089/hum.1997.8.14-1637; PARKS RE, 1972, ENZYMES, V7, P483; Puhlmann M, 1999, HUM GENE THER, V10, P649, DOI 10.1089/10430349950018724; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rosenberg S A, 1999, Hum Gene Ther, V10, P3067; Sacco MG, 1996, GENE THER, V3, P1151; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; Shi WX, 2001, BIOCHEMISTRY-US, V40, P8204, DOI 10.1021/bi010585p; SORSCHER EJ, 1994, GENE THER, V1, P233; STEIN RL, 1981, J BIOL CHEM, V256, P767; Tebbe J, 1999, J MOL BIOL, V294, P1239, DOI 10.1006/jmbi.1999.3327; Waud W. R., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P512; Wielgus-Kutrowska B, 2002, BBA-PROTEIN STRUCT M, V1597, P320, DOI 10.1016/S0167-4838(02)00313-8; Wygoda MR, 1997, CANCER RES, V57, P1699; ZIMMERMAN TP, 1971, CAN J BIOCHEM CELL B, V49, P1050, DOI 10.1139/o71-153	61	77	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47110	47118		10.1074/jbc.M304622200	http://dx.doi.org/10.1074/jbc.M304622200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12937174	hybrid			2022-12-27	WOS:000186569400109
J	Frank, NY; Pendse, SS; Lapchak, PH; Margaryan, A; Shlain, D; Doeing, C; Sayegh, MH; Frank, MH				Frank, NY; Pendse, SS; Lapchak, PH; Margaryan, A; Shlain, D; Doeing, C; Sayegh, MH; Frank, MH			Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; MULTIDRUG-RESISTANCE; IN-VITRO; MONOCLONAL-ANTIBODIES; GENE; EXPRESSION; VIVO; LYMPHOCYTES; EFFLUX; LIVER	Cell fusion involving progenitor cells is a newly recognized phenomenon thought to contribute to tissue differentiation. The molecular mechanisms governing cell fusion are unknown. P- glycoprotein and related ATP- binding cassette transporters are expressed by progenitor cells, but their physiological role in these cell types has not been defined. Here, we have cloned ABCB5, a rhodamine efflux transporter and novel member of the human P- glycoprotein family, which marks CD133- expressing progenitor cells among human epidermal melanocytes and determines as a regulator of membrane potential the propensity of this subpopulation to undergo cell fusion. Our findings show that polyploid ABCB5 (+) cells are generated by cell fusion and that this process is specifically enhanced by ABCB5 P-glycoprotein blockade. Remarkably, multinucleated cell hybrids gave rise to mononucleated progeny, demonstrating that fusion contributes to culture growth and differentiation. Thus, our findings define a molecular mechanism for cell fusion involving progenitor cells and show that fusion and resultant growth and differentiation are not merely spontaneous events, but phenomena regulated by ABCB5 P- glycoprotein.	Brigham & Womens Hosp, Dept Med, Div Renal, Lab Immunogenet & Transplantat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Partners Ctr Human Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Nephrol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Frank, MH (corresponding author), Brigham & Womens Hosp, Dept Med, Div Renal, Lab Immunogenet & Transplantat, 75 Francis St, Boston, MA 02115 USA.		Lapchak, Peter H./B-3559-2009; Frank, Markus/O-1625-2014	Frank, Markus/0000-0002-1312-0488; Lapchak, Peter/0000-0001-8597-088X; Sayegh, Mohamed/0000-0002-2847-588X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI050783] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI 50151, K08 AI050783, K08 AI050783-03] Funding Source: Medline; PHS HHS [K08 1I 50783] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aleman C, 2003, CANCER RES, V63, P3084; Allikmets R, 1998, CANCER RES, V58, P5337; Allikmets R, 1996, HUM MOL GENET, V5, P1649, DOI 10.1093/hmg/5.10.1649; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bosch I, 1997, BIOCHEMISTRY-US, V36, P5685, DOI 10.1021/bi962728r; Bunting KD, 1999, ANN NY ACAD SCI, V872, P125, DOI 10.1111/j.1749-6632.1999.tb08459.x; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Drach J, 1996, BLOOD, V88, P1747, DOI 10.1182/blood.V88.5.1747.bloodjournal8851747; Frank MH, 2001, J IMMUNOL, V166, P2451, DOI 10.4049/jimmunol.166.4.2451; FREI E, 1993, CANCER CHEMOTH PHARM, V33, P113, DOI 10.1007/BF00685328; Gollapudi S, 2001, J CLIN IMMUNOL, V21, P420, DOI 10.1023/A:1013177710941; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; GRIMLEY PM, 1987, BIOCHEM BIOPH RES CO, V146, P300, DOI 10.1016/0006-291X(87)90725-X; GROS P, 1986, NATURE, V323, P728, DOI 10.1038/323728a0; Johnstone RW, 2000, TRENDS BIOCHEM SCI, V25, P1, DOI 10.1016/S0968-0004(99)01493-0; Leemhuis T, 1996, EXP HEMATOL, V24, P1215; Liu JH, 2003, DEVELOPMENT, V130, P3437, DOI 10.1242/dev.00562; Morandini R, 1998, J CELL PHYSIOL, V175, P276, DOI 10.1002/(SICI)1097-4652(199806)175:3<276::AID-JCP5>3.0.CO;2-L; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Occhiodoro T, 1998, FEBS LETT, V434, P177, DOI 10.1016/S0014-5793(98)00973-9; Pendse S, 2003, CURR DRUG TARGETS, V4, P469, DOI 10.2174/1389450033490894; Raghu G, 1996, EXP HEMATOL, V24, P1258; Randolph GJ, 1998, P NATL ACAD SCI USA, V95, P6924, DOI 10.1073/pnas.95.12.6924; RIORDAN JR, 1985, NATURE, V316, P817, DOI 10.1038/316817a0; Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456; RONINSON IB, 1986, P NATL ACAD SCI USA, V83, P4538, DOI 10.1073/pnas.83.12.4538; SCHINKEL AH, 1993, INT J CANCER, V55, P478, DOI 10.1002/ijc.2910550326; SCHUT TCB, 1993, BIOPHYS J, V65, P568, DOI 10.1016/S0006-3495(93)81128-7; SIMMONS DL, 1992, J IMMUNOL, V148, P267; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433, DOI 10.1073/pnas.87.19.7433; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; UEDA K, 1986, BIOCHEM BIOPH RES CO, V141, P956, DOI 10.1016/S0006-291X(86)80136-X; Valverde MA, 1996, EMBO J, V15, P4460, DOI 10.1002/j.1460-2075.1996.tb00823.x; VALVERDE MA, 1992, NATURE, V355, P830, DOI 10.1038/355830a0; VANDERBLIEK AM, 1987, EMBO J, V6, P3325, DOI 10.1002/j.1460-2075.1987.tb02653.x; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; WOLF NS, 1993, EXP HEMATOL, V21, P614; Wulf GG, 2001, BLOOD, V98, P1166, DOI 10.1182/blood.V98.4.1166; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Yu Y, 2002, J BIOL CHEM, V277, P20711, DOI 10.1074/jbc.M202349200; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; ZIJLMANS JMJM, 1995, P NATL ACAD SCI USA, V92, P8901, DOI 10.1073/pnas.92.19.8901	54	180	202	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47156	47165		10.1074/jbc.M308700200	http://dx.doi.org/10.1074/jbc.M308700200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12960149	hybrid			2022-12-27	WOS:000186569400114
J	He, ML; Gonzales-Iglesias, AE; Stojilkovic, SS				He, ML; Gonzales-Iglesias, AE; Stojilkovic, SS			Role of nucleotide P2 receptors in calcium signaling and prolactin release in pituitary lactotrophs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CALCIUM; ATP RECEPTORS; EXTRACELLULAR NUCLEOTIDES; PRIMARY CULTURES; ACTIVATION; CHANNELS; MOBILIZATION; INHIBITION; PURINES; LIGAND	Anterior pituitary cells express nucleotide-gated G protein-coupled P2 receptors (P2YRs) and cation-conducting channels (P2XRs). However, the identification of P2 receptors subtypes and their native ligands, and the distribution and function of these receptors within the secretory and non-secretory pituitary cells has been incompletely characterized. The focus in this study was on lactotroph subpopulation of cells. ATP and ADP, but not UTP and UDP, triggered calcium signaling in a majority (85%) of lactotrophs and prolactin release in mixed pituitary cells. Consistent with the role of P2 receptors in signaling and secretion, the actions of ATP and ADP were abolished in the presence of apyrase, an ectonucleotidase. Transcripts for G(q)-coupled calcium-mobilizing P2Y(1)R, P2Y(2)R, P2Y(4)R, and P2Y(6)R, as well as G(i)-coupled P2Y(12)R, were identified in mixed anterior pituitary cells. The ligand-selectivity profile of calcium mobilization-dependent signaling and prolactin secretion and the blockade of these responses by pyridoxal 5-phosphate 6-azophenyl-2', 4'-disulphonic acid indicated that P2Y(1)R mediates the stimulatory action of ATP and ADP. Within the channels expressed in anterior pituitary (P2X(2)R, P2X(3)R, P2X(4)R, and P2X(7)R), the P2X(4)R subtype provides a major pathway for calcium influx-dependent signaling and prolactin secretion. This conclusion was based on comparison of native to recombinant channels with respect to their ligand preference, sensitivity to pyridoxal 5-phosphate 6-azophenyl-2', 4'-disulphonic acid, and the rates of calcium signal desensitization.	NICHHD, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Stojilkovic, SS (corresponding author), NICHD, Sect Cellular Signaling, ERRB, NIH, Bldg 49,Room 6A-36,49 Convent Dr, Bethesda, MD 20892 USA.	stankos@helix.nih.gov	He, Mulan/C-4140-2009		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000195] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000195] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BEUKERS MW, 1995, N-S ARCH PHARMACOL, V351, P523, DOI 10.1007/BF00171044; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; CAREW MA, 1994, CELL CALCIUM, V16, P227, DOI 10.1016/0143-4160(94)90025-6; Chen ZP, 1996, ENDOCRINOLOGY, V137, P248, DOI 10.1210/en.137.1.248; CHEN ZP, 1994, ENDOCRINOLOGY, V135, P1280, DOI 10.1210/en.135.3.1280; CHEN ZP, 1995, P NATL ACAD SCI USA, V92, P5219, DOI 10.1073/pnas.92.11.5219; Chen ZP, 1996, ENDOCRINOLOGY, V137, P1833, DOI 10.1210/en.137.5.1833; Chung HS, 2000, BRIT J PHARMACOL, V130, P1843, DOI 10.1038/sj.bjp.0703253; DAVIDSON JS, 1990, ENDOCRINOLOGY, V126, P80, DOI 10.1210/endo-126-1-80; He ML, 2003, AM J PHYSIOL-CELL PH, V285, pC467, DOI 10.1152/ajpcell.00042.2003; KANYICSKA B, 1995, ENDOCRINOLOGY, V136, P990, DOI 10.1210/en.136.3.990; Kapoor JR, 2000, J NEUROSCI, V20, P8868; Khakh BS, 2001, PHARMACOL REV, V53, P107; Koshimizu T, 2000, ENDOCRINOLOGY, V141, P4091, DOI 10.1210/en.141.11.4091; Koshimizu T, 2002, J BIOL CHEM, V277, P46891, DOI 10.1074/jbc.M205274200; Koshimizu T, 1998, MOL ENDOCRINOL, V12, P901, DOI 10.1210/me.12.7.901; Koshimizu T, 1998, J BIOL CHEM, V273, P12853, DOI 10.1074/jbc.273.21.12853; MOLLARD P, 1991, EUR J PHARM-MOLEC PH, V206, P271, DOI 10.1016/0922-4106(91)90109-U; Muller CE, 2002, CURR PHARM DESIGN, V8, P2353, DOI 10.2174/1381612023392937; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Nunez L, 1997, AM J PHYSIOL-ENDOC M, V272, pE1117, DOI 10.1152/ajpendo.1997.272.6.E1117; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rees DA, 2003, J ENDOCRINOL, V177, P357, DOI 10.1677/joe.0.1770357; Rees DA, 2003, CLIN SCI, V104, P467, DOI 10.1042/CS20030053; SAMSON WK, 1990, BIOCHEM BIOPH RES CO, V169, P737, DOI 10.1016/0006-291X(90)90393-2; Stojilkovic SS, 2001, TRENDS ENDOCRIN MET, V12, P218, DOI 10.1016/S1043-2760(01)00387-3; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; Tomic M, 1996, J BIOL CHEM, V271, P21200, DOI 10.1074/jbc.271.35.21200; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Troadec JD, 1999, PFLUG ARCH EUR J PHY, V437, P745, DOI 10.1007/s004240050841; Uchiyama M, 2001, J NEUROENDOCRINOL, V13, P378, DOI 10.1046/j.1365-2826.2001.00639.x; Van Goor F, 1999, MOL ENDOCRINOL, V13, P587, DOI 10.1210/me.13.4.587; VANDERMERWE PA, 1989, FEBS LETT, V243, P333, DOI 10.1016/0014-5793(89)80156-5; Villalobos C, 1997, AM J PHYSIOL-CELL PH, V273, pC1963, DOI 10.1152/ajpcell.1997.273.6.C1963; von Kugelgen I, 2000, N-S ARCH PHARMACOL, V362, P310, DOI 10.1007/s002100000310; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	36	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46270	46277		10.1074/jbc.M309005200	http://dx.doi.org/10.1074/jbc.M309005200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12970352	hybrid			2022-12-27	WOS:000186569400010
J	Yokota, H; Goldring, MB; Sun, HB				Yokota, H; Goldring, MB; Sun, HB			CITED2-mediated regulation of MMP-1 and MMP-13 in human chondrocytes under flow shear	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMORTALIZED HUMAN CHONDROCYTES; MESSENGER-RNA EXPRESSION; MATRIX METALLOPROTEINASES; RHEUMATOID-ARTHRITIS; TRANSCRIPTION FACTORS; SYNOVIAL-MEMBRANE; TISSUE INHIBITORS; GENE-EXPRESSION; TGF-BETA; COLLAGEN	CITED2 (CBP/p300-interacting transactivator with ED-rich tail 2) is a member of the Cited family of nuclear regulators, previously known as mrg1 (melanocyte-specific gene-related gene 1). CITED2 is inducible by varying stimuli including lipopolysaccharide, hypoxia, and cytokines such as interleukin 9 and interferon gamma. Using the immortalized human chondrocyte cell line, C-28/I2, we investigated whether CITED2 could be responsive to mechanical stimuli, and if so, whether CITED2 could mediate shear-driven regulation of matrix metalloproteinase (MMP) genes. The C-28/I2 cells were cultured under flow shear at 1 - 20 dyn/cm(2), and the role of CIT-ED2 in regulation of MMPs was examined using the plasmids encoding sense and antisense CITED2 DNA sequences. The results showed that flow shear at 5 dyn/ cm(2) increased CITED2 mRNA and protein levels and down-regulated MMP-1 and MMP-13 mRNA and protein levels as well as enzyme activities. Consistent with the coordinated expression patterns of CITED2 and MMPs, overexpression of CITED2 repressed MMP-1 and MMP-13 mRNA levels and activities, whereas antisense CITED2 plasmids prevented the shear-induced downregulation of MMP expression. Interleukin-1beta induced the formation of p300-Ets-1 complexes without affecting expression of CITED2. Transforming growth factor-beta as well as flow shear at 5 dyn/ cm2 stimulated not only the expression of CITED2 but also the association of CITED2 with p300 by dissociating Ets-1 from p300. These results indicate that CITED2 plays a major role in shear-induced down-regulation of MMP-1 and MMP-13 via a transforming growth factor-beta-dependent pathway.	Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; Indiana Univ Purdue Univ, Biomed Engn Program, Indianapolis, IN 46202 USA; Harvard Univ, Inst Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Beth Israel Deaconess Medical Center	Sun, HB (corresponding author), Indiana Univ, Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr,MS-504, Indianapolis, IN 46202 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR047628, R01AR045378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022021, R56AG022021] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 45378, AR 47628] Funding Source: Medline; NIA NIH HHS [AG 22021] Funding Source: Medline; NIBIB NIH HHS [EB 01019] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Agarwal S, 2001, ARTHRITIS RHEUM-US, V44, P608, DOI 10.1002/1529-0131(200103)44:3<608::AID-ANR109>3.3.CO;2-U; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Borden P, 1997, CRIT REV EUKAR GENE, V7, P159, DOI 10.1615/CritRevEukarGeneExpr.v7.i1-2.90; Burr DB, 2002, BONE, V30, P781, DOI 10.1016/S8756-3282(02)00707-X; Czuwara-Ladykowska J, 2002, J BIOL CHEM, V277, P20399, DOI 10.1074/jbc.M200206200; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Ghosh AK, 2000, ONCOGENE, V19, P3546, DOI 10.1038/sj.onc.1203693; Goldring MB, 1999, CONNECT TISSUE RES, V40, P1, DOI 10.3109/03008209909005273; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Goldring MB, 2001, EXPERT OPIN BIOL TH, V1, P817, DOI 10.1517/14712598.1.5.817; Goodman RH, 2000, GENE DEV, V14, P1553; Heegaard JH, 1999, J ORTHOPAED RES, V17, P509, DOI 10.1002/jor.1100170408; Honda K, 2000, EUR J CELL BIOL, V79, P601, DOI 10.1078/0171-9335-00089; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Konttinen YT, 1999, ANN RHEUM DIS, V58, P691, DOI 10.1136/ard.58.11.691; Leung MK, 1999, GENOMICS, V61, P307, DOI 10.1006/geno.1999.5970; Loeser RF, 2000, OSTEOARTHR CARTILAGE, V8, P96, DOI 10.1053/joca.1999.0277; Long P, 2001, J DENT RES, V80, P1416, DOI 10.1177/00220345010800050601; Maini RN, 2000, ANNU REV MED, V51, P207, DOI 10.1146/annurev.med.51.1.207; Osaki M, 2003, BIOCHEM J, V369, P103, DOI 10.1042/BJ20020928; Qian L, 2002, FRONT BIOSCI-LANDMRK, V7, pA126, DOI 10.2741/qian; Redlich K, 2001, ARTHRITIS RHEUM, V44, P266, DOI 10.1002/1529-0131(200102)44:2<266::AID-ANR43>3.3.CO;2-7; Robling AG, 2000, J BONE MINER RES, V15, P1596, DOI 10.1359/jbmr.2000.15.8.1596; Shingleton WD, 1996, BIOCHEM CELL BIOL, V74, P759, DOI 10.1139/o96-083; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Smith RL, 2000, BIORHEOLOGY, V37, P95; Suh JK, 1999, OSTEOARTHR CARTILAGE, V7, P71, DOI 10.1053/joca.1998.0163; Sun HB, 1998, P NATL ACAD SCI USA, V95, P13555, DOI 10.1073/pnas.95.23.13555; Sun HB, 2002, MATRIX BIOL, V21, P263, DOI 10.1016/S0945-053X(02)00003-3; Sun HB, 2001, BONE, V28, P303, DOI 10.1016/S8756-3282(00)00454-3; Tan LJ, 2003, J BIOL CHEM, V278, P17688, DOI 10.1074/jbc.M301676200; Tetlow LC, 2001, ARTHRITIS RHEUM-US, V44, P585, DOI 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; WASYLYK C, 1991, EMBO J, V10, P1127, DOI 10.1002/j.1460-2075.1991.tb08053.x; Xu ZF, 2000, J IMMUNOL, V165, P453, DOI 10.4049/jimmunol.165.1.453; Yahata T, 2000, J BIOL CHEM, V275, P8825, DOI 10.1074/jbc.275.12.8825; Yang JH, 1998, J BIOL CHEM, V273, P6550, DOI 10.1074/jbc.273.11.6550; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Zwicky R, 2002, BIOCHEM J, V367, P209, DOI 10.1042/BJ20020210	40	105	108	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47275	47280		10.1074/jbc.M304652200	http://dx.doi.org/10.1074/jbc.M304652200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12960175	hybrid			2022-12-27	WOS:000186569400129
J	Mori, S; Tanaka, M; Nanba, D; Nishiwaki, E; Ishiguro, H; Higashiyama, S; Matsuura, N				Mori, S; Tanaka, M; Nanba, D; Nishiwaki, E; Ishiguro, H; Higashiyama, S; Matsuura, N			PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR; METALLOPROTEASE-DISINTEGRIN; MELTRIN-ALPHA; EGF RECEPTOR; EPITHELIAL-CELLS; C2C12 CELLS; SH3 DOMAIN; PROTEIN; TRANSACTIVATION; SRC	A disintegrin and metalloprotease 12 (ADAM12/meltrin alpha) is a key enzyme implicated in the ectodomain shedding of membrane-anchored heparin-binding epidermal growth factor (EGF)-like growth factor (proHB-EGF)-dependent epidermal growth factor receptor (EGFR) transactivation. However, the activation mechanisms of ADAM12 are obscure. To determine how ADAM12 is activated, we screened proteins that bind to the cytoplasmic domain of ADAM12 using a yeast two-hybrid system and identified a protein called PACSIN3 that contains a Src homology 3 domain. An analysis of interactions between ADAM12 and PACSIN3 using glutathione S-transferase fusion protein revealed that a proline-rich region (amino acid residues 829-840) of ADAM12 was required to bind PACSIN3. Furthermore, co-immunoprecipitation and co-localization analyses of ADAM12 and PACSIN3 proteins also revealed their interaction in mammalian cells expressing both of them. The overexpression of PACSIN3 in HT1080 cells enhanced 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced proHB-EGF shedding. Furthermore, knockdown of endogenous PACSIN3 by small interfering RNA in HT1080 cells significantly attenuated the shedding of proHB-EGF induced by TPA and angiotensin II. Our data indicate that PACSIN3 has a novel function as an up-regulator in the signaling of proHB-EGF shedding induced by TPA and angiotensin II.	Ehime Univ, Sch Med, Dept Med Biochem, Shigenobu, Ehime 7910295, Japan; Osaka Univ, Fac Med, Sch Allied Hlth Sci, Dept Mol Pathol, Suita, Osaka 5650871, Japan; Carna Biosci Inc, Kobe, Hyogo 6508543, Japan	Ehime University; Osaka University	Higashiyama, S (corresponding author), Ehime Univ, Sch Med, Dept Med Biochem, Shigenobu, Ehime 7910295, Japan.							Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Cousin H, 2000, DEV BIOL, V227, P197, DOI 10.1006/dbio.2000.9871; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Fujiyama S, 2001, CIRC RES, V88, P22, DOI 10.1161/01.RES.88.1.22; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; Hougaard S, 2000, BIOCHEM BIOPH RES CO, V275, P261, DOI 10.1006/bbrc.2000.3295; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Kadota N, 2000, J BIOCHEM-TOKYO, V128, P941, DOI 10.1093/oxfordjournals.jbchem.a022845; Kang Q, 2001, J BIOL CHEM, V276, P24466, DOI 10.1074/jbc.M101162200; Kang Q, 2000, BIOCHEM J, V352, P883, DOI 10.1042/0264-6021:3520883; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Keates S, 2001, J BIOL CHEM, V276, P48127, DOI 10.1074/jbc.M107630200; Kurisaki T, 2003, MOL CELL BIOL, V23, P55, DOI 10.1128/MCB.23.1.55-61.2003; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; Modregger J, 2000, J CELL SCI, V113, P4511; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Sumoy L, 2001, GENE, V262, P199, DOI 10.1016/S0378-1119(00)00531-X; Suzuki A, 2000, ONCOGENE, V19, P5842, DOI 10.1038/sj.onc.1203986; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; Yan YB, 2002, J CELL BIOL, V158, P221, DOI 10.1083/jcb.200112026	22	72	74	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46029	46034		10.1074/jbc.M306393200	http://dx.doi.org/10.1074/jbc.M306393200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952982	hybrid			2022-12-27	WOS:000186452300119
J	Murakami, K; Irie, K; Morimoto, A; Ohigashi, H; Shindo, M; Nagao, M; Shimizu, T; Shirasawa, T				Murakami, K; Irie, K; Morimoto, A; Ohigashi, H; Shindo, M; Nagao, M; Shimizu, T; Shirasawa, T			Neurotoxicity and physicochemical properties of A beta mutant peptides from cerebral amyloid angiopathy - Implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER-BINDING; PRECURSOR PROTEIN; SENILE PLAQUES; DUTCH-TYPE; AGGREGATION; MUTATION; FIBRILS; STATE; GENE; APP	Cerebral amyloid angiopathy (CAA) due to beta-amyloid (Abeta) is one of the specific pathological features of familial Alzheimer's disease. Abeta mainly consisting of 40- and 42-mer peptides (Abeta40 and Abeta42) exhibits neurotoxicity and aggregative abilities. All of the variants of Abeta40 and Abeta42 found in CAA were synthesized in a highly pure form and examined for neurotoxicity in PC12 cells and aggregative ability. All of the Abeta40 mutants at positions 22 and 23 showed stronger neurotoxicity than wild-type Abeta40. Similar tendency was observed for Abeta42 mutants at positions 22 and 23 whose neurotoxicity was 50-200 times stronger than that of the corresponding Abeta40 mutants, suggesting that these Abeta42 mutants are mainly involved in the pathogenesis of CAA. Although the aggregation of E22G-Abeta42 and D23N-Abeta42 was similar to that of wild-type Abeta42, E22Q-Abeta42 and E22K-Abeta42 aggregated extensively, supporting the clinical evidence that Dutch and Italian patients are diagnosed as hereditary cerebral hemorrhage with amyloidosis. In contrast, A21G mutation needs alternative explanation with the exception of physicochemical properties of Abeta mutants. Attenuated total reflection-Fourier transform infrared spectroscopy spectra suggested that beta-sheet content of the Abeta mutants correlates with their aggregation. However, beta-turn is also a critical secondary structure because residues at positions 22 and 23 that preferably form two-residue beta-turn significantly enhanced the aggregative ability.	Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Sakyo Ku, Kyoto 6068502, Japan; Appl Biosyst Japan Ltd, Tokyo 1040032, Japan; Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan; Tokyo Metropolitan Inst Gerontol, Dept Mol Gerontol, Tokyo 1730015, Japan	Kyoto University; Thermo Fisher Scientific; Applied Biosystems; Kyoto University; Tokyo Metropolitan Institute of Gerontology	Irie, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.		Murakami, Kazuma/GQA-7062-2022; Irie, Kazuhiro/A-6121-2014	Murakami, Kazuma/0000-0003-3152-1784; Irie, Kazuhiro/0000-0001-7109-8568				Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BURDICK D, 1992, J BIOL CHEM, V267, P546; CARPINO LA, 1993, J AM CHEM SOC, V115, P4397, DOI 10.1021/ja00063a082; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; CHOU PY, 1977, J MOL BIOL, V115, P135, DOI 10.1016/0022-2836(77)90094-8; Davis J, 1996, P NATL ACAD SCI USA, V93, P2996, DOI 10.1073/pnas.93.7.2996; Fukuda H, 1999, BIOORG MED CHEM LETT, V9, P953, DOI 10.1016/S0960-894X(99)00121-3; Fukuda H, 1999, BIOORGAN MED CHEM, V7, P1213, DOI 10.1016/S0968-0896(99)00037-1; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Irie K, 1998, J AM CHEM SOC, V120, P9159, DOI 10.1021/ja981087f; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; JAMES HG, 1979, SAS USERS GUIDE, P357; KAMINO K, 1992, AM J HUM GENET, V51, P998; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Melchor JP, 2000, J NEUROCHEM, V74, P2209, DOI 10.1046/j.1471-4159.2000.0742209.x; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Monji A, 2001, J NEUROCHEM, V77, P1425, DOI 10.1046/j.1471-4159.2001.00392.x; Morimoto A, 2002, BIOCHEM BIOPH RES CO, V295, P306, DOI 10.1016/S0006-291X(02)00670-8; Murakami K, 2002, BIOCHEM BIOPH RES CO, V294, P5, DOI 10.1016/S0006-291X(02)00430-8; Naiki H, 1999, METHOD ENZYMOL, V309, P305; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; Shimizu T, 2002, J NEUROSCI RES, V70, P451, DOI 10.1002/jnr.10350; Shin RW, 1997, J NEUROSCI, V17, P8187; Shindo M, 2001, BIOORGAN MED CHEM, V9, P2073, DOI 10.1016/S0968-0896(01)00100-6; Tagliavini F., 1999, ALZHEIMERS REP, V2, pS28; Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290; Tsubuki S, 2003, LANCET, V361, P1957, DOI 10.1016/S0140-6736(03)13555-6; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang ZZ, 2000, STROKE, V31, P534, DOI 10.1161/01.STR.31.2.534	39	200	207	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46179	46187		10.1074/jbc.M301874200	http://dx.doi.org/10.1074/jbc.M301874200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12944403	hybrid			2022-12-27	WOS:000186452300136
J	Suzuki, N; Nakatsuka, H; Mochizuki, M; Nishi, N; Kadoya, Y; Utani, A; Oishi, S; Fujii, N; Kleinman, HK; Nomizu, M				Suzuki, N; Nakatsuka, H; Mochizuki, M; Nishi, N; Kadoya, Y; Utani, A; Oishi, S; Fujii, N; Kleinman, HK; Nomizu, M			Biological activities of homologous loop regions in the laminin alpha chain G domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL GLOBULAR DOMAIN; CELL-BINDING SEQUENCES; HEPARIN-BINDING; SYNTHETIC PEPTIDES; NEURITE OUTGROWTH; DEVELOPMENTAL EXPRESSION; BRANCHING MORPHOGENESIS; INTEGRIN-RECOGNITION; SUBMANDIBULAR-GLAND; MOLECULAR-CLONING	Laminin alpha chains (alpha(1)-alpha(5) chains) have diverse chain-specific biological functions. The LG4 modules of laminin alpha chains consist of a 14-stranded beta-sheet (A-N) sandwich structure. Several biologically active sequences have been identified in the connecting loop regions. Here, we evaluated the biological activities of the loop regions of the E and F strands in the LG4 modules using five homologous peptides from each of the mouse alpha chains (EF-1: DYATLQLQEGRLHFMFDLG, alpha(1) chain 2747-2765; EF-2: DFGTVQLRNGFPFFSYDLG, alpha(2) chain 2808-2826; EF-3: RDSFVALYLSEGHVIFALG, alpha(3) chain 2266-2284; EF-4: DFMTLFLAHGRLVFMFNVG, alpha(4) chain 1511-1529; EF-5: SPSLVLFLNHGHFVAQTEGP, alpha(5) chain 3304-3323). These homologous peptides showed chain-specific cell attachment and neurite outgrowth activities. Well organized actin stress fibers and focal contacts with vinculin accumulation were observed in fibroblasts attached on EF-1, whereas fibroblasts on EF-2 and EF-4 showed filopodia with ruffling. Fibroblast attachment to EF-2 and EF-4 was mediated by syndecan-2. In contrast, EF-1 promoted alpha(2)beta(1) integrin-mediated fibroblast attachment and inhibited fibroblast attachment to a recombinant laminin alpha(1) chain LG4-5. The receptors for EF-3 and EF-5 are unknown. Further, when the active core sequence of EF-1 was cyclized, utilizing two additional cysteine residues at both the N and C termini through a disulfide bridge, the cyclic peptide significantly enhanced integrin-mediated cell attachment. These results indicate that integrin-mediated cell attachment to the EF-1 sequence is conformation-dependent and that the loop structure is important for the activity. The homologous peptides, which promote either integrin- or syndecan-mediated cell attachment, may be useful for understanding the cell type- and chain-specific biological activities of the laminins.	Hokkaido Univ, Grad Sch Environm Earth Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa 2288555, Japan; Chiba Univ, Sch Med, Dept Dermatol, Chiba 2608670, Japan; Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; NIDCR, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA	Hokkaido University; Kitasato University; Chiba University; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Nomizu, M (corresponding author), Hokkaido Univ, Grad Sch Environm Earth Sci, Kita Ku, Kita 10 Nishi 5, Sapporo, Hokkaido 0600810, Japan.		Oishi, Shinya/C-1350-2011	Oishi, Shinya/0000-0002-2833-2539	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000230] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABERDAM D, 1994, CELL ADHES COMMUN, V2, P115, DOI 10.3109/15419069409004431; AUMAILLEY M, 1991, FEBS LETT, V291, P50, DOI 10.1016/0014-5793(91)81101-D; BERNIER SM, 1995, MATRIX BIOL, V14, P447, DOI 10.1016/0945-053X(95)90002-0; Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Colognato H, 1997, J BIOL CHEM, V272, P29330, DOI 10.1074/jbc.272.46.29330; COLOGNATOPYKE H, 1995, J BIOL CHEM, V270, P9398, DOI 10.1074/jbc.270.16.9398; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; GALLIANO MF, 1995, J BIOL CHEM, V270, P21820, DOI 10.1074/jbc.270.37.21820; GEHLSEN KR, 1992, J CELL BIOL, V117, P449, DOI 10.1083/jcb.117.2.449; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633; Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Hosokawa Y, 1999, DEV GROWTH DIFFER, V41, P207; Iivanainen A, 1999, J BIOL CHEM, V274, P14107, DOI 10.1074/jbc.274.20.14107; Iivanainen A, 1997, J BIOL CHEM, V272, P27862, DOI 10.1074/jbc.272.44.27862; Kadoya Y, 1998, DEV DYNAM, V212, P394; KADOYA Y, 2003, IN PRESS DEV BIOL; Kato K, 2002, BIOCHEMISTRY-US, V41, P10747, DOI 10.1021/bi020180k; Kim WH, 1998, INT J CANCER, V77, P632, DOI 10.1002/(SICI)1097-0215(19980812)77:4<632::AID-IJC25>3.0.CO;2-6; KLEINMAN HK, 1989, ARCH BIOCHEM BIOPHYS, V272, P39, DOI 10.1016/0003-9861(89)90192-6; LANGUINO LR, 1989, J CELL BIOL, V109, P2455, DOI 10.1083/jcb.109.5.2455; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; Makino M, 2002, EXP CELL RES, V277, P95, DOI 10.1006/excr.2002.5540; MAKINO M, 1999, CONNECT TISSUE, V31, P227; Malinda KM, 1999, FASEB J, V13, P53, DOI 10.1096/fasebj.13.1.53; MATTER ML, 1994, J CELL BIOL, V124, P1083, DOI 10.1083/jcb.124.6.1083; MINER JH, 1995, J BIOL CHEM, V270, P28523, DOI 10.1074/jbc.270.48.28523; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje; Nielsen PK, 2000, J BIOL CHEM, V275, P14517, DOI 10.1074/jbc.275.19.14517; Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198; Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491; NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583; Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828; NUMA F, 1995, CANCER RES, V55, P4676; Okazaki I, 2002, J BIOL CHEM, V277, P37070, DOI 10.1074/jbc.M201672200; PFAFF M, 1994, J BIOL CHEM, V269, P20233; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Richard BL, 1996, EXP CELL RES, V228, P98, DOI 10.1006/excr.1996.0304; SASAKI M, 1988, J BIOL CHEM, V263, P16536; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; Simons M, 2001, CELL SIGNAL, V13, P855, DOI 10.1016/S0898-6568(01)00190-5; SKUBITZ APN, 1991, J CELL BIOL, V115, P1137, DOI 10.1083/jcb.115.4.1137; SMITH JW, 1988, J BIOL CHEM, V263, P18726; Song SY, 1997, INT J CANCER, V71, P436, DOI 10.1002/(SICI)1097-0215(19970502)71:3<436::AID-IJC22>3.0.CO;2-C; SONNENBERG A, 1990, J CELL BIOL, V110, P2145, DOI 10.1083/jcb.110.6.2145; SOROKIN L, 1990, J CELL BIOL, V111, P1265, DOI 10.1083/jcb.111.3.1265; SUNG U, 1993, J CELL BIOL, V123, P1255, DOI 10.1083/jcb.123.5.1255; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4; YAMADA KM, 1991, J BIOL CHEM, V266, P12809; Yamada Yoshihiko, 1992, Current Opinion in Cell Biology, V4, P819, DOI 10.1016/0955-0674(92)90105-L; Yamaguchi H, 2000, J BIOL CHEM, V275, P29458, DOI 10.1074/jbc.M003103200; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286	58	71	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45697	45705		10.1074/jbc.M304667200	http://dx.doi.org/10.1074/jbc.M304667200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12933811	hybrid			2022-12-27	WOS:000186452300079
J	Takahata, S; Ryu, H; Ohtsuki, K; Kasahara, K; Kawaichi, M; Kokubo, T				Takahata, S; Ryu, H; Ohtsuki, K; Kasahara, K; Kawaichi, M; Kokubo, T			Identification of a novel TATA element-binding protein binding region at the N terminus of the Saccharomyces cerevisiae TAF1 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION IN-VIVO; YEAST TFIIA/TBP/DNA COMPLEX; SHOW SYNTHETIC LETHALITY; BOX-BINDING; ACTIVATED TRANSCRIPTION; CRYSTAL-STRUCTURE; DNA-BINDING; REPRESSES TRANSCRIPTION; INHIBITORY DOMAIN	TFIID, a multiprotein complex composed of TATA element-binding protein (TBP) and 14 TBP-associated factors (TAFs), can directly recognize core promoter elements and mediate transcriptional activation. The TAF N-terminal domain (TAND) of TAF1 may play a significant role in these two principal TFIID functions by regulating the access of TBP to the TATA element. In yeast, TAND consists of two subdomains, TAND1 (10-37 amino acids (aa)) and TAND2 (46-71 aa), which interact with the concave and convex surfaces of TBP, respectively. Here we demonstrate that another region located on the C-terminal side of TAND2 (82-139 aa) can also bind to TBP and induce transcriptional activation when tethered to DNA as a GAL4 fusion protein. As these properties are the same as those of TAND1, we denoted this sequence as TAND3. Detailed mutational analyses revealed that three blocks of hydrophobic amino acid residues located within TAND3 are required not only for TBP binding and transcriptional activation but also for supporting cell growth and the efficient transcription of a subset of genes. We also show that the surface of TBP recognized by TAND3 is broader than that recognized by TAND1, although these regions overlap partially. Supporting these observations is that TAND1 can be at least partly functionally substituted by TAND3.	Yokohama City Univ, Grad Sch Integrated Sci, Div Mol & Cellular Biol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Nara Inst Sci & Technol, Div Gene Funct Anim, Ikoma 6300192, Japan	Yokohama City University; Nara Institute of Science & Technology	Kokubo, T (corresponding author), Yokohama City Univ, Grad Sch Integrated Sci, Div Mol & Cellular Biol, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.							Adams Alison, 1997, P99; ARNDT KM, 1995, EMBO J, V14, P1490, DOI 10.1002/j.1460-2075.1995.tb07135.x; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Baek HJ, 2002, MOL CELL BIOL, V22, P2842, DOI 10.1128/MCB.22.8.2842-2852.2002; Bagby S, 2000, FEBS LETT, V468, P149, DOI 10.1016/S0014-5793(00)01213-8; Bai Y, 1997, MOL CELL BIOL, V17, P3081, DOI 10.1128/MCB.17.6.3081; Banik U, 2001, J BIOL CHEM, V276, P49100, DOI 10.1074/jbc.M109246200; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bryant GO, 1996, GENE DEV, V10, P2491, DOI 10.1101/gad.10.19.2491; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Cang Y, 1999, EMBO J, V18, P6662, DOI 10.1093/emboj/18.23.6662; Cang Y, 2002, P NATL ACAD SCI USA, V99, P12727, DOI 10.1073/pnas.202236699; CHEN JL, 1994, CELL, V79, P93, DOI 10.1016/0092-8674(94)90403-0; Cheng JX, 2002, CURR BIOL, V12, P934, DOI 10.1016/S0960-9822(02)00866-7; Cheng JX, 2002, CURR BIOL, V12, P1828, DOI 10.1016/S0960-9822(02)01257-5; Chitikila C, 2002, MOL CELL, V10, P871, DOI 10.1016/S1097-2765(02)00683-4; Creton S, 2002, GENE DEV, V16, P3265, DOI 10.1101/gad.234002; Darst RP, 2003, J BIOL CHEM, V278, P13216, DOI 10.1074/jbc.M211445200; Dasgupta A, 2002, P NATL ACAD SCI USA, V99, P2666, DOI 10.1073/pnas.052397899; Deluen C, 2002, MOL CELL BIOL, V22, P6735, DOI 10.1128/MCB.22.19.6735-6749.2002; Furukawa T, 2000, J BIOL CHEM, V275, P29847, DOI 10.1074/jbc.M002989200; Gadbois EL, 1997, P NATL ACAD SCI USA, V94, P3145, DOI 10.1073/pnas.94.7.3145; Galasinski SK, 2000, MOL CELL BIOL, V20, P1923, DOI 10.1128/MCB.20.6.1923-1930.2000; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Geisberg JV, 2002, MOL CELL BIOL, V22, P8122, DOI 10.1128/MCB.22.23.8122-8134.2002; Geisberg JV, 2001, MOL CELL BIOL, V21, P2736, DOI 10.1128/MCB.21.8.2736-2742.2001; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; Goppelt A, 1996, NUCLEIC ACIDS RES, V24, P4450, DOI 10.1093/nar/24.22.4450; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Gregory PD, 1999, EMBO J, V18, P6407, DOI 10.1093/emboj/18.22.6407; Guermah M, 1998, MOL CELL BIOL, V18, P3234, DOI 10.1128/MCB.18.6.3234; Guermah M, 2001, MOL CELL BIOL, V21, P6882, DOI 10.1128/MCB.21.20.6882-6894.2001; Iratni R, 2002, SCIENCE, V298, P1996, DOI 10.1126/science.1073405; Johnson KM, 2003, CURR BIOL, V13, P772, DOI 10.1016/S0960-9822(03)00283-5; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kim S, 1997, P NATL ACAD SCI USA, V94, P820, DOI 10.1073/pnas.94.3.820; KIM TK, 1994, NATURE, V369, P252, DOI 10.1038/369252a0; Kobayashi A, 2003, NUCLEIC ACIDS RES, V31, P1261, DOI 10.1093/nar/gkg180; Kobayashi A, 2001, J BIOL CHEM, V276, P395, DOI 10.1074/jbc.M008208200; KOKUBO T, 1994, P NATL ACAD SCI USA, V91, P3520, DOI 10.1073/pnas.91.9.3520; Kokubo T, 1998, MOL CELL BIOL, V18, P1003, DOI 10.1128/MCB.18.2.1003; Kotani T, 2000, P NATL ACAD SCI USA, V97, P7178, DOI 10.1073/pnas.120074297; Kotani T, 1998, J BIOL CHEM, V273, P32254, DOI 10.1074/jbc.273.48.32254; Kou HP, 2003, MOL CELL BIOL, V23, P3186, DOI 10.1128/MCB.23.9.3186-3201.2003; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Kuras L, 2000, SCIENCE, V288, P1244, DOI 10.1126/science.288.5469.1244; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Li XY, 2002, CURR BIOL, V12, P1240, DOI 10.1016/S0960-9822(02)00932-6; Liu DJ, 1998, CELL, V94, P573, DOI 10.1016/S0092-8674(00)81599-8; Lively TN, 2001, J BIOL CHEM, V276, P25582, DOI 10.1074/jbc.M100278200; LUNDBLACK V, 1998, CURRENT PROTOCOLS MO, V2; Martel LS, 2002, MOL CELL BIOL, V22, P2788, DOI 10.1128/MCB.22.8.2788-2798.2002; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Nishikawa J, 1997, P NATL ACAD SCI USA, V94, P85, DOI 10.1073/pnas.94.1.85; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Ozer J, 1998, J BIOL CHEM, V273, P14293, DOI 10.1074/jbc.273.23.14293; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Pereira LA, 2001, MOL CELL BIOL, V21, P7523, DOI 10.1128/MCB.21.21.7523-7534.2001; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; Pugh BF, 2000, GENE, V255, P1, DOI 10.1016/S0378-1119(00)00288-2; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; SIKORSKI RS, 1989, GENETICS, V122, P19; Stargell LA, 1996, MOL CELL BIOL, V16, P4456; STARGELL LA, 1995, SCIENCE, V269, P75, DOI 10.1126/science.7604282; Sullivan SM, 1998, NUCLEIC ACIDS RES, V26, P4487, DOI 10.1093/nar/26.19.4487; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; Tsukihashi Y, 2000, MOL CELL BIOL, V20, P2385, DOI 10.1128/MCB.20.7.2385-2399.2000; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Xie YQ, 2000, J BIOL CHEM, V275, P31914, DOI 10.1074/jbc.M003760200	75	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45888	45902		10.1074/jbc.M306886200	http://dx.doi.org/10.1074/jbc.M306886200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12939271	hybrid			2022-12-27	WOS:000186452300102
J	Pantano, C; Shrivastava, P; McElhinney, B; Janssen-Heininger, Y				Pantano, C; Shrivastava, P; McElhinney, B; Janssen-Heininger, Y			Hydrogen peroxide signaling through tumor necrosis factor receptor 1 leads to selective activation of c-Jun N-terminal kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; NH2-TERMINAL KINASE; INDUCED APOPTOSIS; OXIDATIVE STRESS; EPITHELIAL-CELLS; IKK ACTIVATION; DEATH; JNK; PROTEIN; DOMAIN	Binding of tumor necrosis factor-alpha (TNFalpha) to its receptor, TNF-R1, results in the activation of inhibitor of kappaB kinase (IKK) and c-Jun N-terminal kinase (JNK) pathways that are coordinately regulated and important in survival and death. We demonstrated previously that in response to hydrogen peroxide (H2O2), the ability of TNFalpha to activate IKK in mouse lung epithelial cells (C10) was inhibited and that H2O2 alone was sufficient to activate JNK and induce cell death. In the current study, we investigated the involvement of TNF-R1 in H2O2-induced JNK activation. In lung fibroblasts from TNF-R1-deficient mice the ability of H2O2 to activate JNK was inhibited compared with fibroblasts from control mice. Additionally, in C10 cells expressing a mutant form of TNF-R1, H2O2-induced JNK activation was also inhibited. Immunoprecipitation of TNF-R1 revealed that in response to H2O2, the adapter proteins, TRADD and TRAF2, and JNK were recruited to the receptor. However, expression of the adaptor protein RIP, which is essential for IKK activation by TNFalpha, was decreased in cells exposed to H2O2, and its chaperone Hsp90 was cleaved. Furthermore, data demonstrating that expression of TRAF2 was not affected by H2O2 and that overexpression of TRAF2 was sufficient to activate JNK provide an explanation for the inability of H2O2 to activate IKK and for the selective activation of JNK by H2O2. Our data demonstrate that oxidative stress interferes with IKK activation while promoting JNK signaling, creating a signaling imbalance that may favor apoptosis.	Univ Vermont, Dept Pathol, Hlth Sci Res Facil, Burlington, VT 05405 USA	University of Vermont	Janssen-Heininger, Y (corresponding author), Univ Vermont, Dept Pathol, Hlth Sci Res Facil, Rm 216A, Burlington, VT 05405 USA.				NHLBI NIH HHS [R01 HL60014, P01 HL67004] Funding Source: Medline; PHS HHS [P20 RL15557] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067004, R01HL060014] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amdjadi K, 2000, J BIOL CHEM, V275, P22520, DOI 10.1074/jbc.M002573200; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Barinaga M, 1996, SCIENCE, V274, P724, DOI 10.1126/science.274.5288.724; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Chen K, 2001, J BIOL CHEM, V276, P16045, DOI 10.1074/jbc.M011766200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Harper N, 2003, J BIOL CHEM, V278, P25534, DOI 10.1074/jbc.M303399200; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; Hino T, 1999, AM J RESP CELL MOL, V20, P122, DOI 10.1165/ajrcmb.20.1.3217; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Janssen YMW, 1997, AM J PHYSIOL-LUNG C, V273, pL789, DOI 10.1152/ajplung.1997.273.4.L789; Janssen-Heininger YMW, 1999, AM J RESP CELL MOL, V20, P942, DOI 10.1165/ajrcmb.20.5.3452; Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5; Korn SH, 2001, J BIOL CHEM, V276, P35693, DOI 10.1074/jbc.M104321200; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Moore KA, 1997, BIOCHEM J, V326, P17, DOI 10.1042/bj3260017; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; SCHRAUFSTATTER I, 1988, J CLIN INVEST, V82, P1040, DOI 10.1172/JCI113660; SLUNGAARD A, 1990, J EXP MED, V171, P2025, DOI 10.1084/jem.171.6.2025; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Tang FM, 2002, MOL CELL BIOL, V22, P8571, DOI 10.1128/MCB.22.24.8571-8579.2002; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680	44	69	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44091	44096		10.1074/jbc.M308487200	http://dx.doi.org/10.1074/jbc.M308487200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12939259	hybrid			2022-12-27	WOS:000186306700026
J	Ryder, JW; Bassel-Duby, R; Olson, EN; Zierath, JR				Ryder, JW; Bassel-Duby, R; Olson, EN; Zierath, JR			Skeletal muscle reprogramming by activation of calcineurin improves insulin action on metabolic pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETIC-PATIENTS; GLUT4 GENE-EXPRESSION; PROTEIN-KINASE B; GLUCOSE-TRANSPORT; FIBER-TYPE; TRANSGENIC MICE; IN-VITRO; PHOSPHOINOSITIDE 3-KINASE; SIGNAL-TRANSDUCTION; STIMULATION	The protein phosphatase calcineurin is a signaling intermediate that induces the transformation of fast-twitch skeletal muscle fibers to a slow-twitch phenotype. This reprogramming of the skeletal muscle gene expression profile may have therapeutic applications for metabolic disease. Insulin-stimulated glucose uptake in skeletal muscle is both impaired in individuals with type II diabetes mellitus and positively correlated with the percentage of slow- versus fast-twitch muscle fibers. Using transgenic mice expressing activated calcineurin in skeletal muscle, we report that skeletal muscle reprogramming by calcineurin activation leads to improved insulin-stimulated 2-deoxyglucose uptake in extensor digitorum longus (EDL) muscles compared with wild-type mice, concomitant with increased protein expression of the insulin receptor, Akt, glucose transporter 4, and peroxisome proliferator-activated receptor-gamma co-activator 1. Transgenic mice exhibited elevated glycogen deposition, enhanced amino acid uptake, and increased fatty acid oxidation in EDL muscle. When fed a high-fat diet, transgenic mice maintained superior rates of insulin-stimulated glucose uptake in EDL muscle and were protected against diet-induced glucose intolerance. These results validate calcineurin as a target for enhancing insulin action in skeletal muscle.	Karolinska Inst, Dept Physiol & Pharmacol, Sect Integrat Physiol, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Surg Sci, Sect Integrat Physiol, S-17177 Stockholm, Sweden; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	Karolinska Institutet; Karolinska Institutet; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Ryder, JW (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Sect Integrat Physiol, S-17177 Stockholm, Sweden.			Zierath, Juleen/0000-0001-6891-7497				Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Daugaard JR, 2000, DIABETES, V49, P1092, DOI 10.2337/diabetes.49.7.1092; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; HENRIKSEN EJ, 1990, AM J PHYSIOL, V259, pE593, DOI 10.1152/ajpendo.1990.259.4.E593; HICKEY MS, 1995, AM J PHYSIOL-ENDOC M, V268, pE453, DOI 10.1152/ajpendo.1995.268.3.E453; HINTZ CS, 1982, AM J PHYSIOL, V242, pC218, DOI 10.1152/ajpcell.1982.242.3.C218; Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Krook A, 2000, DIABETES, V49, P284, DOI 10.2337/diabetes.49.2.284; Krook A, 1997, J BIOL CHEM, V272, P30208, DOI 10.1074/jbc.272.48.30208; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; LOWERY OH, 1972, FLEXIBLE SYSTEM ENZY, P189; Manchester J, 1996, P NATL ACAD SCI USA, V93, P10707, DOI 10.1073/pnas.93.20.10707; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; OKADA T, 1994, J BIOL CHEM, V269, P3568; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; REN JM, 1993, J BIOL CHEM, V268, P16113; Ryder JW, 1999, BIOCHEM J, V342, P321, DOI 10.1042/0264-6021:3420321; Ryder JW, 2000, DIABETES, V49, P647, DOI 10.2337/diabetes.49.4.647; Saltin B, 2010, COMPR PHYSIOL, P555; Song XM, 1999, AM J PHYSIOL-REG I, V277, pR1690, DOI 10.1152/ajpregu.1999.277.6.R1690; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; Tsao TS, 2001, FASEB J, V15, P958, DOI 10.1096/fj.00-0381; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Zierath JB, 1997, DIABETES, V46, P215, DOI 10.2337/diabetes.46.2.215	32	105	111	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44298	44304		10.1074/jbc.M304510200	http://dx.doi.org/10.1074/jbc.M304510200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941959	hybrid			2022-12-27	WOS:000186306700051
J	Takuma, A; Kaneda, T; Sato, T; Ninomiya, S; Kumegawa, M; Hakeda, Y				Takuma, A; Kaneda, T; Sato, T; Ninomiya, S; Kumegawa, M; Hakeda, Y			Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-beta by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; NECROSIS-FACTOR RECEPTOR; OSTEOBLAST-LIKE CELLS; CREB-BINDING-PROTEIN; BONE-RESORPTION; OSTEOPROTEGERIN LIGAND; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; PARATHYROID-HORMONE	Long-term administration of glucocorticoids (GCs) causes osteoporosis with a rapid and severe bone loss and with a slow and prolonged bone disruption. Although the involvement of GCs in osteoblastic proliferation and differentiation has been studied extensively, their direct action on osteoclasts is still controversial and not conclusive. In this study, we investigated the direct participation of GCs in osteoclastogenesis. Dexamethasone (Dex) at < 10(-8) M stimulated, but at > 10(-7) M depressed, receptor activator of NF-kappaB ligand (RANKL)induced osteoclast formation synergistically with transforming growth factor-beta. The stimulatory action of Dex was restricted to the early phase of osteoclast differentiation and enhanced the priming of osteoclast progenitors ( bone marrow-derived monocytes/ macrophages) toward differentiation into cells of the osteoclast lineage. The osteoclast differentiation depending on RANKL requires the activation of NF-kappaB and AP-1, and the DNA binding of these transcription factors to their respective consensus cis-elements was enhanced by Dex, consistent with the stimulation of osteoclastogenesis. However, Dex did not affect the RANKL-induced signaling pathways such as the activation of IkappaB kinase followed by NF-kappaB nuclear translocation or the activation of JNK. On the other hand, Dex significantly decreased the endogenous production of interferon-beta, and this cytokine depressed the RANKL-elicited DNA binding of NF-kappaB and AP-1, as well as osteoclast formation. Thus, the down-regulation of inhibitory cytokines such as interferon-beta by Dex may allow the osteoclast progenitors to be freed from the suppression of osteoclastogenesis, resulting in an increased number of osteoclasts, as is observed in the early phase of GC-induced osteoporosis.	Meikai Univ, Sch Dent, Dept Oral Anat, Sakado, Saitama 3500283, Japan; Saitama Med Sch, Dept Orthopaed Surg, Moroyama, Saitama 3500495, Japan; Hoshi Univ, Fac Pharmaceut Sci, Dept Pathophysiol, Shinagawa Ku, Tokyo 1428501, Japan	Meikai University; Saitama Medical University; Hoshi University	Hakeda, Y (corresponding author), Meikai Univ, Sch Dent, Dept Oral Anat, Sakado, Saitama 3500283, Japan.							Adcock IM, 2001, IMMUNOL CELL BIOL, V79, P376, DOI 10.1046/j.1440-1711.2001.01025.x; Almawi WY, 2002, J MOL ENDOCRINOL, V28, P69, DOI 10.1677/jme.0.0280069; Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; BIKLE DD, 1993, J CLIN ENDOCR METAB, V76, P456, DOI 10.1210/jc.76.2.456; Canalis E, 2002, ANN NY ACAD SCI, V966, P73, DOI 10.1111/j.1749-6632.2002.tb04204.x; CHAMBERS TJ, 1985, J CLIN PATHOL, V38, P241, DOI 10.1136/jcp.38.3.241; CHYUN YS, 1984, ENDOCRINOLOGY, V114, P477, DOI 10.1210/endo-114-2-477; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; De Bosscher K, 2000, J NEUROIMMUNOL, V109, P16, DOI 10.1016/S0165-5728(00)00297-6; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; Dempster DW, 1997, J ENDOCRINOL, V154, P397, DOI 10.1677/joe.0.1540397; Eberhardt AW, 2001, ENDOCRINOLOGY, V142, P1333, DOI 10.1210/en.142.3.1333; FELIX R, 1990, J BONE MINER RES, V5, P781; GALLWITZ WE, 1993, J BIOL CHEM, V268, P10087; GESSANI S, 1988, J BIOL CHEM, V263, P7454; Hayashi T, 2002, J BIOL CHEM, V277, P27880, DOI 10.1074/jbc.M203836200; Hirayama T, 2002, J ENDOCRINOL, V175, P155, DOI 10.1677/joe.0.1750155; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4382, DOI 10.1210/en.140.10.4382; Horowitz MC, 2001, CYTOKINE GROWTH F R, V12, P9, DOI 10.1016/S1359-6101(00)00030-7; Hu XY, 2003, J IMMUNOL, V170, P4833, DOI 10.4049/jimmunol.170.9.4833; Jenkins BD, 2001, TRENDS ENDOCRIN MET, V12, P122, DOI 10.1016/S1043-2760(00)00357-X; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Kaji H, 1997, J BONE MINER RES, V12, P734, DOI 10.1359/jbmr.1997.12.5.734; Kaneda T, 2000, J IMMUNOL, V165, P4254, DOI 10.4049/jimmunol.165.8.4254; Kitazawa R, 1999, BBA-GENE STRUCT EXPR, V1445, P134, DOI 10.1016/S0167-4781(99)00032-9; KITAZAWA R, 1994, J CLIN INVEST, V94, P2397, DOI 10.1172/JCI117606; KLEIN RG, 1977, J CLIN INVEST, V60, P253, DOI 10.1172/JCI108762; KODAMA H, 1991, J EXP MED, V173, P269, DOI 10.1084/jem.173.1.269; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LANGENEGGER T, 1999, CLIN ORTHO, V366, P22; Manolagas SC, 1999, J BONE MINER RES, V14, P1061, DOI 10.1359/jbmr.1999.14.7.1061; Martin TJ, 1998, CRIT REV EUKAR GENE, V8, P107, DOI 10.1615/CritRevEukarGeneExpr.v8.i2.10; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; McKay LI, 2000, MOL ENDOCRINOL, V14, P1222, DOI 10.1210/me.14.8.1222; MICHAEL AE, 1994, MOL CELL ENDOCRINOL, V100, P55, DOI 10.1016/0303-7207(94)90279-8; Nguyen VT, 2002, J BIOL CHEM, V277, P13796, DOI 10.1074/jbc.M111906200; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; Patschan D, 2001, BONE, V29, P498, DOI 10.1016/S8756-3282(01)00610-X; PAZPACHECO E, 1995, J BONE MINER RES, V10, P1713; Petricoin E, 1996, MOL CELL BIOL, V16, P1419; Pine R, 1997, NUCLEIC ACIDS RES, V25, P4346, DOI 10.1093/nar/25.21.4346; Pitzalis C, 2002, ANN NY ACAD SCI, V966, P108, DOI 10.1111/j.1749-6632.2002.tb04208.x; Reissland P, 1999, IMMUNOBIOLOGY, V200, P227, DOI 10.1016/S0171-2985(99)80072-2; Riccardi C, 2000, THERAPIE, V55, P165; Rubin J, 1998, ENDOCRINOLOGY, V139, P1006, DOI 10.1210/en.139.3.1006; Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291; SHUTO T, 1994, ENDOCRINOLOGY, V134, P1121, DOI 10.1210/en.134.3.1121; Smith E, 2002, J BIOL CHEM, V277, P18191, DOI 10.1074/jbc.M109708200; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; SUDA T, 1995, BONE S2, V17, P87; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; TOBIAS J, 1989, ENDOCRINOLOGY, V125, P1290, DOI 10.1210/endo-125-3-1290; UDAGAWA N, 1989, ENDOCRINOLOGY, V125, P1805, DOI 10.1210/endo-125-4-1805; Vidal NOA, 1998, J ENDOCRINOL, V159, P191, DOI 10.1677/joe.0.1590191; Weinstein R S, 2001, Rev Endocr Metab Disord, V2, P65, DOI 10.1023/A:1010007108155; Weinstein RS, 2002, J CLIN INVEST, V109, P1041, DOI 10.1172/JCI200214538; Weinstein RS, 2000, J CLIN ENDOCR METAB, V85, P2907, DOI 10.1210/jc.85.8.2907; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Wissink S, 1998, MOL ENDOCRINOL, V12, P355, DOI 10.1210/me.12.3.355; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	65	75	82	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44667	44674		10.1074/jbc.M300213200	http://dx.doi.org/10.1074/jbc.M300213200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944401	hybrid			2022-12-27	WOS:000186306700099
J	Zavala-Ruiz, Z; Sundberg, EJ; Stone, JD; DeOliveira, DB; Chan, IC; Svendsen, J; Mariuzza, RA; Stern, LJ				Zavala-Ruiz, Z; Sundberg, EJ; Stone, JD; DeOliveira, DB; Chan, IC; Svendsen, J; Mariuzza, RA; Stern, LJ			Exploration of the P6/P7 region of the peptide-binding site of the human class II major histocompatability complex protein HLA-DR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; STRUCTURAL BASIS; WATER-MOLECULES; ANTIGEN; AFFINITY; TCR; LIGANDS; DESIGN; IDENTIFICATION; INTERMEDIATE	Crystal structures of the class II major histocompatibilty complex (MHC) protein, HLA-DR1, generally show a tight fit between MHC and bound peptide except in the P6/P7 region of the peptide-binding site. In this region, there is a shallow water-filled pocket underneath the peptide and between the pockets that accommodate the P6 and P7 side chains. We investigated the properties of this pocket with the idea of engineering substitutions into the corresponding region of peptide antigens to increase their binding affinity for HLA-DR1. We investigated D-amino acids and N-alkyl modifications at both the P6 and P7 positions of the peptide and found that binding of peptides to HLA-DR1 could be increased by incorporating an N-methyl substitution at position 7 of the peptide. The crystal structure of HLA-DR1 bound to a peptide containing a P7 N-methyl alanine was determined. The N-methyl group orients in the P6/P7 pocket, displacing one of the waters usually bound in this pocket. The structure shows that the substitution does not alter the conformation of the bound peptide, which adopts the usual polyproline type II helix. An antigenic peptide carrying the N-methyl modification is taken up by antigen-presenting cells and loaded onto endogenous class II MHC molecules for presentation, and the resultant MHC-peptide complexes activate antigen-specific T-cells. These results suggest a possible strategy for increasing the affinity of weakly immunogenic peptides that might be applicable to the development of vaccines and diagnostic reagents.	Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; MIT, Dept Chem, Cambridge, MA 02139 USA; Univ Maryland, Inst Biotechnol, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA	University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland Baltimore	Stern, LJ (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Rm S2-127,55 Lake Ave N, Worcester, MA 01655 USA.	lawrence.stern@umassmed.edu		Zavala-Ruiz, Zarixia/0000-0003-1513-5840; Sundberg, Eric/0000-0003-0478-3033	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM064859] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI38996, R01-AI369000] Funding Source: Medline; NIGMS NIH HHS [F31-GM64859] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen PS, 1999, IMMUNITY, V10, P473, DOI 10.1016/S1074-7613(00)80047-3; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balaban N, 2000, INT J FOOD MICROBIOL, V61, P1, DOI 10.1016/S0168-1605(00)00377-9; BEESON C, 1994, P NATL ACAD SCI USA, V91, P8842, DOI 10.1073/pnas.91.19.8842; BHAT TN, 1994, P NATL ACAD SCI USA, V91, P1089, DOI 10.1073/pnas.91.3.1089; BOEHNCKE WH, 1993, J IMMUNOL, V150, P331; Boen E, 2000, J IMMUNOL, V165, P2040, DOI 10.4049/jimmunol.165.4.2040; Bolin DR, 2000, J MED CHEM, V43, P2135, DOI 10.1021/jm000034h; Brand DD, 2001, AUTOIMMUNITY, V34, P133, DOI 10.3109/08916930109001961; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Chung E, 1998, STRUCTURE, V6, P1141, DOI 10.1016/S0969-2126(98)00115-4; CONNELLY PR, 1994, P NATL ACAD SCI USA, V91, P1964, DOI 10.1073/pnas.91.5.1964; Cotton J, 1998, INT IMMUNOL, V10, P159, DOI 10.1093/intimm/10.2.159; de Haan EC, 2002, BIOORGAN MED CHEM, V10, P1939, DOI 10.1016/S0968-0896(01)00434-5; Delano W.L., 2002, DELANO SCI; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; Dullweber F, 2001, J MOL BIOL, V313, P593, DOI 10.1006/jmbi.2001.5062; Fan EK, 2001, ACTA CRYSTALLOGR D, V57, P201, DOI 10.1107/S0907444900016814; Figliozzi GM, 1996, METHOD ENZYMOL, V267, P437; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; Fremont DH, 2002, J EXP MED, V195, P1043, DOI 10.1084/jem.20011971; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Gregoriou M, 1998, PROTEIN SCI, V7, P915; HAMMER J, 1992, J EXP MED, V176, P1007, DOI 10.1084/jem.176.4.1007; Hart M, 2001, J MED CHEM, V44, P3700, DOI 10.1021/jm0101895; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; HILL CM, 1994, J IMMUNOL, V152, P2890; Howard SC, 1997, PROTEIN PEPTIDE LETT, V4, P63; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joshi RV, 2000, BIOCHEMISTRY-US, V39, P3751, DOI 10.1021/bi9923656; Kjellen P, 1998, EUR J IMMUNOL, V28, P755, DOI 10.1002/(SICI)1521-4141(199802)28:02<755::AID-IMMU755>3.0.CO;2-2; KRIEGER JI, 1991, J IMMUNOL, V146, P2331; LAM PYS, 1994, SCIENCE, V263, P380, DOI 10.1126/science.8278812; LAMB JR, 1982, NATURE, V300, P456, DOI 10.1038/300456a0; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; Li YL, 2000, J MOL BIOL, V304, P177, DOI 10.1006/jmbi.2000.4198; Li Z, 2003, J AM CHEM SOC, V125, P6636, DOI 10.1021/ja0299203; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8820, DOI 10.1073/pnas.132272099; Luque I, 2002, PROTEINS, V49, P181, DOI 10.1002/prot.10208; Maillere B, 1995, MOL IMMUNOL, V32, P1073, DOI 10.1016/0161-5890(95)00073-9; McFarland BJ, 2001, P NATL ACAD SCI USA, V98, P9231, DOI 10.1073/pnas.151131498; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mullen MM, 2002, MOL CELL, V9, P375, DOI 10.1016/S1097-2765(02)00465-3; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; Nguyen JT, 1998, SCIENCE, V282, P2088, DOI 10.1126/science.282.5396.2088; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; Redpath S, 1999, J IMMUNOL, V163, P6; ROCHE PA, 1990, J IMMUNOL, V144, P1849; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SADEGHNASSERI S, 1989, NATURE, V337, P274, DOI 10.1038/337274a0; Schmitt L, 1999, J MOL BIOL, V286, P207, DOI 10.1006/jmbi.1998.2463; SETTE A, 1994, ANNU REV IMMUNOL, V12, P413, DOI 10.1146/annurev.immunol.12.1.413; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Stratmann T, 2000, J IMMUNOL, V165, P3214, DOI 10.4049/jimmunol.165.6.3214; Sundberg EJ, 2002, J MOL BIOL, V319, P449, DOI 10.1016/S0022-2836(02)00370-4; TOMPKINS SM, 1993, J IMMUNOL METHODS, V163, P209; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; VARGAS LE, 2003, IN PRESS BBRC; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Wu SH, 1996, J IMMUNOL, V156, P3815; Zarutskie JA, 1999, BIOCHEMISTRY-US, V38, P5878, DOI 10.1021/bi983048m	68	27	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44904	44912		10.1074/jbc.M307652200	http://dx.doi.org/10.1074/jbc.M307652200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12952957	hybrid			2022-12-27	WOS:000186306700126
J	Dabney-Smith, C; Mori, H; Cline, K				Dabney-Smith, C; Mori, H; Cline, K			Requirement of a Tha4-conserved transmembrane glutamate in thylakoid Tat translocase assembly revealed by biochemical complementation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-TRANSPORT; ESCHERICHIA-COLI; MEMBRANES; PATHWAYS; SEC; SYSTEM; FORM; BIND	The thylakoid Tat system employs three membrane components and the pH gradient to transport folded proteins. The translocase is signal-assembled, i.e. a receptor complex containing cpTatC and Hcf106 binds the precursor protein, and upon membrane energization, Tha4 is recruited to the precursor-receptor complex to effect translocation. We developed a two-step complementation assay to examine the implied central role of Tha4 in translocation. The first step results in the inactivation of endogenous Tha4 with specific antibodies. The second step involves integrating exogenous Tha4 and presenting the system with precursor protein. We verified this approach by confirming the results obtained recently with the Escherichia coli Tha4 ortholog TatA, i.e. that the carboxyl terminus is dispensable and the amphipathic helix essential for transport. We then investigated a conserved Tha4 transmembrane glutamate in detail. Substitution of glutamate 10 with alanine, glutamine, and even aspartate largely eliminated the ability of Tha4 to complement transport, whereas a conservative substitution elsewhere in the transmembrane domain was without effect. Chemical cross-linking assays showed that the mutated Tha4s failed to be recruited to the receptor complex under transport conditions, indicating a role for the transmembrane glutamate in translocase assembly. This assay promises an avenue into understanding the role of Tha4 in both the assembly and translocation steps of the Tat translocase.	Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Cline, K (corresponding author), Univ Florida, Dept Hort Sci, Box 110690, Gainesville, FL 32611 USA.		Dabney-Smith, Carole/C-2432-2008; Cline, Kenneth/J-6238-2013	Dabney-Smith, Carole/0000-0003-1347-3870; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046951] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM46951] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; CLINE K, 1988, PLANT PHYSIOL, V86, P1120, DOI 10.1104/pp.86.4.1120; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; FINCHER V, 2001, THESIS U FLORIDA GAI; Henry R, 1997, J CELL BIOL, V136, P823, DOI 10.1083/jcb.136.4.823; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Lee PA, 2002, J BACTERIOL, V184, P5871, DOI 10.1128/JB.184.21.5871-5879.2002; Ma XY, 2000, J BIOL CHEM, V275, P10016, DOI 10.1074/jbc.275.14.10016; Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Mori H, 2001, BBA-MOL CELL RES, V1541, P80, DOI 10.1016/S0167-4889(01)00150-1; Mori H, 1999, J CELL BIOL, V146, P45, DOI 10.1083/jcb.146.1.45; Mori H, 2001, FEBS LETT, V501, P65, DOI 10.1016/S0014-5793(01)02626-6; Sargent F, 2001, EUR J BIOCHEM, V268, P3361, DOI 10.1046/j.1432-1327.2001.02263.x; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7	18	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43027	43033		10.1074/jbc.M307923200	http://dx.doi.org/10.1074/jbc.M307923200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12941940	hybrid			2022-12-27	WOS:000186157000039
J	Miyanari, Y; Hijikata, M; Yamaji, M; Hosaka, M; Takahashi, H; Shimotohno, K				Miyanari, Y; Hijikata, M; Yamaji, M; Hosaka, M; Takahashi, H; Shimotohno, K			Hepatitis C virus non-structural proteins in the probable membranous compartment function in viral genome replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; HEPATOCELLULAR-CARCINOMA; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; ION-CHANNEL; P7 PROTEIN; NON-A; IDENTIFICATION; ASSOCIATION; EXPRESSION	The molecular mechanism of hepatitis C virus(HCV) RNA replication is still unknown. Recently, a cell culture system in which the HCV subgenomic replicon is efficiently replicated and maintained for a long period in Huh-7 cells has been established. Taking advantage of this replicon system, we detected the activity to synthesize the subgenomic RNA in the digitonin-permeabilized replicon cells. To elucidate how and where this viral RNA replicates in the cells, we monitored the activity for HCV RNA synthesis in the permeabilized replicon cells under several conditions. We obtained results suggesting that HCV replication complexes functioning to synthesize the replicon RNA are protected from access of nuclease and proteinase by possible cellular lipid membranes. We also found that a large part of the replicon RNA, including newly synthesized RNA, was present in such a membranous structure but a large part of each NS protein was not. A small part of each NS protein that was resistant to the proteinase action was shown to contribute sufficiently to the synthesis of HCV subgenomic RNA in the permeabilized replicon cells. These results suggested that a major subcellular site of HCV genome replication is probably compartmentalized by lipid membranes and that only a part of each NS protein forms the active replication complex in the replicon cells.	Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Kyoto 6068507, Japan	Kyoto University	Hijikata, M (corresponding author), 53 Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan.	mhijikat@virus.kyoto-u.ac.jp	Yamaji, Masashi/ABA-5267-2020	Yamaji, Masashi/0000-0002-8215-2184				Ali N, 2002, J VIROL, V76, P12001, DOI 10.1128/JVI.76.23.12001-12007.2002; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Chen JB, 2003, J VIROL, V77, P2568, DOI 10.1128/JVI.77.4.2568-2577.2003; Chung KM, 2000, J VIROL, V74, P5233, DOI 10.1128/JVI.74.11.5233-5241.2000; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Friebe P, 2001, J VIROL, V75, P12047, DOI 10.1128/JVI.75.24.12047-12057.2001; FRIED MW, 1995, SEMIN LIVER DIS, V15, P82, DOI 10.1055/s-2007-1007265; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Gosert R, 2002, J VIROL, V76, P3697, DOI 10.1128/JVI.76.8.3697-3708.2002; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Hagiwara Y, 2003, EMBO J, V22, P344, DOI 10.1093/emboj/cdg033; Hardy RW, 2003, J VIROL, V77, P2029, DOI 10.1128/JVI.77.3.2029-2037.2003; HIJIKATA M, 1990, J VIROL, V64, P4632, DOI 10.1128/JVI.64.10.4632-4639.1990; HIJIKATA M, 1993, P NATL ACAD SCI USA, V90, P10773, DOI 10.1073/pnas.90.22.10773; HIJIKATA M, 1993, J VIROL, V67, P4665, DOI 10.1128/JVI.67.8.4665-4675.1993; HIJIKATA M, 1991, P NATL ACAD SCI USA, V88, P5547, DOI 10.1073/pnas.88.13.5547; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; Kishine H, 2002, BIOCHEM BIOPH RES CO, V293, P993, DOI 10.1016/S0006-291X(02)00342-X; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Lai VCH, 2003, J VIROL, V77, P2295, DOI 10.1128/JVI.77.3.2295-2300.2003; LIANG TJ, 1993, HEPATOLOGY, V18, P1326, DOI 10.1016/0270-9139(93)90219-D; Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Marusawa H, 1999, J VIROL, V73, P4713, DOI 10.1128/JVI.73.6.4713-4720.1999; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; MIZUSHIMA H, 1994, J VIROL, V68, P2731, DOI 10.1128/JVI.68.4.2731-2734.1994; Oh JW, 1999, J VIROL, V73, P7694, DOI 10.1128/JVI.73.9.7694-7702.1999; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; Pedersen KW, 1999, J VIROL, V73, P2016, DOI 10.1128/JVI.73.3.2016-2026.1999; PFEIFER U, 1980, VIRCHOWS ARCH B, V33, P233, DOI 10.1007/BF02899184; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schmidt-Mende J, 2001, J BIOL CHEM, V276, P44052, DOI 10.1074/jbc.M103358200; Schwartz M, 2002, MOL CELL, V9, P505, DOI 10.1016/S1097-2765(02)00474-4; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Shimotohno K, 1995, INTERVIROLOGY, V38, P162, DOI 10.1159/000150427; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; TANAKA K, 1991, CANCER RES, V51, P2842; Tanaka T, 1996, J VIROL, V70, P3307, DOI 10.1128/JVI.70.5.3307-3312.1996; TANJI Y, 1995, J VIROL, V69, P1575, DOI 10.1128/JVI.69.3.1575-1581.1995; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997; Yi MK, 2003, J VIROL, V77, P3557, DOI 10.1128/JVI.77.6.3557-3568.2003; Yuan ZH, 1997, BIOCHEM BIOPH RES CO, V232, P231, DOI 10.1006/bbrc.1997.6249	54	121	133	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2003	278	50					50301	50308		10.1074/jbc.M305684200	http://dx.doi.org/10.1074/jbc.M305684200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751LH	12963739	hybrid			2022-12-27	WOS:000187068200078
J	Kasparkova, J; Novakova, O; Marini, V; Najajreh, Y; Gibson, D; Perez, JM; Brabec, V				Kasparkova, J; Novakova, O; Marini, V; Najajreh, Y; Gibson, D; Perez, JM; Brabec, V			Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand - Mechanistic studies on antitumor action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; INTERSTRAND CROSS-LINKS; CISPLATIN-DNA ADDUCTS; GROUP DOMAIN PROTEINS; ISOMERIZATION REACTION; RECOGNITION; BINDING; CIS-DIAMMINEDICHLOROPLATINUM(II); TRANS-DIAMMINEDICHLOROPLATINUM(II); CONFORMATION	A paradigm for the structure-pharmacological activity relationship of bifunctional platinum antitumor drugs is that the trans isomer of antitumor cisplatin ( transplatin) is clinically ineffective. To this end, however, several new complexes of the trans structure have been identified that exhibit cytotoxicity in tumor cells that is even better than that of the analogous cis isomers. We reported recently ( Kasparkova, J., Marini, V., Najajreh, Y., Gibson, D., and Brabec, V. (2003) Biochemistry 42, 6321 - 6332) that the replacement of one ammine ligand by the heterocyclic ligand, such as piperidine, piperazine, or 4-picoline in the molecule of transplatin resulted in a radical enhancement of its cytotoxicity. We examined oligodeoxyribonucleotide duplexes bearing a site-specific cross- link of the transplatin analogue containing the piperidine ligand by biochemical methods. The results indicate that in contrast to transplatin, trans-(PtCl2(NH3)(piperidine)) forms stable 1,3-intrastrand cross- links in double-helical DNA that distort DNA and are not readily removed from DNA by nucleotide excision repair system. Hence, the intrastrand cross-links of trans-(PtCl2(NH3)(piperidine)) could persist for a sufficiently long time, potentiating its toxicity toward tumor cells. trans-(PtCl2(NH3)(piperidine)) also forms in DNA minor interstrand cross-links that are similar to those of transplatin so that these adducts appear less likely candidates for genotoxic lesion responsible for antitumor effects of trans-(PtCl2(NH3)( piperidine)). Hence, the role of structurally unique intrastrand cross- links in the antitumor effects of transplatin analogues in which one ammine group is replaced by a heterocyclic ligand may predominate.	Acad Sci Czech Republ, Inst Biophys, CZ-61265 Brno, Czech Republic; Hebrew Univ Jerusalem, Sch Pharm, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, David R Bloom Ctr Pharm, IL-91120 Jerusalem, Israel; Univ Autonoma Madrid, Fac Ciencias, Dept Quim Inorgan, E-28049 Madrid, Spain	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Autonomous University of Madrid	Kasparkova, J (corresponding author), Acad Sci Czech Republ, Inst Biophys, CZ-61265 Brno, Czech Republic.	jana@ibp.cz	Palomeque, María Victoria Marini/L-7480-2017; novakova, olga/H-1938-2014; Najajreh, Yousef/AAC-7498-2019; Brabec, Viktor/H-1946-2014	Najajreh, Yousef/0000-0002-0075-2726; Brabec, Viktor/0000-0002-8233-1393; Novakova, Olga/0000-0001-8653-4836				Alvarez-Valdes A, 2002, J MED CHEM, V45, P1835, DOI 10.1021/jm010968l; ANIN MF, 1990, NUCLEIC ACIDS RES, V18, P4395, DOI 10.1093/nar/18.15.4395; BANCROFT DP, 1990, J AM CHEM SOC, V112, P6860, DOI 10.1021/ja00175a020; BELLON SF, 1990, BIOPHYS CHEM, V35, P179, DOI 10.1016/0301-4622(90)80007-T; BELLON SF, 1991, BIOCHEMISTRY-US, V30, P8026, DOI 10.1021/bi00246a021; BOUDVILLAIN M, 1995, NUCLEIC ACIDS RES, V23, P2381, DOI 10.1093/nar/23.13.2381; BRABEC V, 1993, P NATL ACAD SCI USA, V90, P5345, DOI 10.1073/pnas.90.11.5345; BRABEC V, 1993, BIOCHEMISTRY-US, V32, P11676, DOI 10.1021/bi00094a025; Brabec V, 2000, J BIOL INORG CHEM, V5, P364, DOI 10.1007/PL00010665; BRABEC V, 1992, BIOCHEMISTRY-US, V31, P12397, DOI 10.1021/bi00164a014; Brabec V, 2002, PROG NUCLEIC ACID RE, V71, P1, DOI 10.1016/S0079-6603(02)71040-4; Buschta-Hedayat N, 1999, P NATL ACAD SCI USA, V96, P6090, DOI 10.1073/pnas.96.11.6090; COMESS KM, 1992, BIOCHEMISTRY-US, V31, P3975, DOI 10.1021/bi00131a013; Coste F, 1999, NUCLEIC ACIDS RES, V27, P1837, DOI 10.1093/nar/27.8.1837; DALBIES R, 1995, NUCLEIC ACIDS RES, V23, P949, DOI 10.1093/nar/23.6.949; DALBIES R, 1994, P NATL ACAD SCI USA, V91, P8147, DOI 10.1073/pnas.91.17.8147; Dunham SU, 1997, BIOCHEMISTRY-US, V36, P11428, DOI 10.1021/bi9709452; EASTMAN A, 1987, PHARMACOL THERAPEUT, V34, P155, DOI 10.1016/0163-7258(87)90009-X; Farrell N, 1996, MET IONS BIOL SYST, V32, P603; FARRELL N, 1992, CANCER RES, V52, P5065; He Q, 2000, P NATL ACAD SCI USA, V97, P5768, DOI 10.1073/pnas.100108697; He Q, 2000, BIOCHEMISTRY-US, V39, P14426, DOI 10.1021/bi001700j; Hermanson-Miller IL, 2002, BIOCHEMISTRY-US, V41, P2402, DOI 10.1021/bi0112863; Highley MS, 2000, CANC DRUG DISC DEV, V7, P171; HUANG HF, 1995, SCIENCE, V270, P1842, DOI 10.1126/science.270.5243.1842; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; Hubscher U, 2000, TRENDS BIOCHEM SCI, V25, P143, DOI 10.1016/S0968-0004(99)01523-6; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson N.P., 1989, PROG CLIN BIOCH MED, V10, P1, DOI [DOI 10.1007/978-3-642-74760-1, 10.1007/978-3-642-74760-1_1, DOI 10.1007/978-3-642-74760-1_1]; JONES SL, 1994, INT J CANCER, V59, P388, DOI 10.1002/ijc.2910590317; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P1, DOI 10.1016/s0027-5107(01)00142-7; KASPARKOVA J, 1995, BIOCHEMISTRY-US, V34, P12379, DOI 10.1021/bi00038a035; Kasparkova J, 1996, BIOCHEMISTRY-US, V35, P16705, DOI 10.1021/bi961160j; Kasparkova J, 2003, BIOCHEMISTRY-US, V42, P6321, DOI 10.1021/bi0342315; Kasparkova J, 2003, BIOCHEMISTRY-US, V42, P792, DOI 10.1021/bi026614t; Kasparkova J, 2002, J BIOL CHEM, V277, P48076, DOI 10.1074/jbc.M208016200; Kasparkova J, 2000, J BIOL CHEM, V275, P15789, DOI 10.1074/jbc.M000777200; KASPARKOVA J, 2003, IN PRESS CHEM RES TO; Khazanov E, 2002, J MED CHEM, V45, P5196, DOI 10.1021/jm020817y; Koberle B, 1999, CURR BIOL, V9, P273, DOI 10.1016/S0960-9822(99)80118-3; Kostrhunova H, 2000, BIOCHEMISTRY-US, V39, P12639, DOI 10.1021/bi000710h; Lam WC, 1999, BIOCHEMISTRY-US, V38, P2661, DOI 10.1021/bi9820762; LEMAIRE MA, 1991, P NATL ACAD SCI USA, V88, P1982, DOI 10.1073/pnas.88.5.1982; Leng M, 2000, MOL PHARMACOL, V58, P1525, DOI 10.1124/mol.58.6.1525; Leng M, 2000, CANC DRUG DISC DEV, V7, P63; Li MJ, 1999, INT J ONCOL, V15, P1177; Lokich J, 1998, ANN ONCOL, V9, P13, DOI 10.1023/A:1008215213739; Lone S, 2003, BIOCHEMISTRY-US, V42, P3826, DOI 10.1021/bi027297t; Loskotova H, 1999, EUR J BIOCHEM, V266, P392, DOI 10.1046/j.1432-1327.1999.00866.x; Malina J, 2000, BIOPHYS J, V78, P2008, DOI 10.1016/S0006-3495(00)76748-8; MANLEY JL, 1980, P NATL ACAD SCI-BIOL, V77, P3855, DOI 10.1073/pnas.77.7.3855; MATSUNAGA T, 1995, J BIOL CHEM, V270, P20862, DOI 10.1074/jbc.270.35.20862; Missura M, 2001, EMBO J, V20, P3554, DOI 10.1093/emboj/20.13.3554; Moggs JG, 1997, NUCLEIC ACIDS RES, V25, P480, DOI 10.1093/nar/25.3.480; Najajreh Y, 2002, J MED CHEM, V45, P5189, DOI 10.1021/jm0201969; Nielsen P E, 1990, J Mol Recognit, V3, P1, DOI 10.1002/jmr.300030102; O'Dwyer P. J., 1999, CISPLATIN CHEM BIOCH, P31; Ohndorf UM, 1999, NATURE, V399, P708, DOI 10.1038/21460; Paquet F, 1999, NUCLEIC ACIDS RES, V27, P4261, DOI 10.1093/nar/27.21.4261; Patrick SM, 1999, J BIOL CHEM, V274, P14972, DOI 10.1074/jbc.274.21.14972; Perez JM, 2000, CRIT REV ONCOL HEMAT, V35, P109, DOI 10.1016/S1040-8428(00)00053-6; Reardon JT, 1999, CANCER RES, V59, P3968; REARDON JT, 1998, ADV DNA DAMAGE REPAI, P377; RICE JA, 1988, P NATL ACAD SCI USA, V85, P4158, DOI 10.1073/pnas.85.12.4158; SANCAR A, 1995, J BIOL CHEM, V270, P15915, DOI 10.1074/jbc.270.27.15915; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Suo ZC, 1999, BIOCHEMISTRY-US, V38, P715, DOI 10.1021/bi981854n; Suo ZC, 1998, J BIOL CHEM, V273, P27259, DOI 10.1074/jbc.273.42.27259; Wakasugi M, 1999, J BIOL CHEM, V274, P18759, DOI 10.1074/jbc.274.26.18759; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031; Zakovska A, 1998, EUR J BIOCHEM, V254, P547, DOI 10.1046/j.1432-1327.1998.2540547.x; Zamble DB, 1996, BIOCHEMISTRY-US, V35, P10004, DOI 10.1021/bi960453+; ZAMBLE DB, 1999, CISPLATIN CHEM BIOCH, P73; Zehnulova J, 2001, J BIOL CHEM, V276, P22191, DOI 10.1074/jbc.M103118200	76	60	61	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47516	47525		10.1074/jbc.M304720200	http://dx.doi.org/10.1074/jbc.M304720200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12970368	hybrid			2022-12-27	WOS:000186731400023
J	Bernardo, PH; Brasch, N; Chai, CLL; Waring, P				Bernardo, PH; Brasch, N; Chai, CLL; Waring, P			A novel redox mechanism for the glutathione-dependent reversible uptake of a fungal toxin in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY METABOLITES; ASPERGILLUS-FUMIGATUS; SCABROSIN ESTERS; GLIOTOXIN; SPORIDESMIN; APOPTOSIS; EPIPOLYTHIODIOXOPIPERAZINES; TRANSPORTER; TOXICITY; RELEASE	The fungal metabolite gliotoxin is characterized by an internal disulfide bridge and can exist in either disulfide or dithiol forms. Gliotoxin and other members of the epipolythiodioxopiperazine class of toxins have immunosuppressive properties and have been implicated in human and animal mycotoxicoses. The bridged disulfide moiety is thought to be generally essential for biological activity. Here we show that only the natural ( oxidized) form of gliotoxin is actively concentrated in a cell line in a glutathione- dependent manner. Intracellular levels of the toxin can be up to 1500- fold greater than the applied concentration, and toxin in the cells exists almost exclusively in the reduced form. A simple model of toxin entry followed by reduction to the cell- impermeant dithiol explains active uptake, cell density dependence of EC50 values and predicts a value for the maximum concentration of toxin at limiting cell density in agreement with the experiment. Oxidation of the intracellular toxin results in rapid efflux from the cell that also occurs when glutathione levels fall following induction of apoptotic cell death by the toxin. This mechanism allows for minimal production of the toxin while enabling maximal intracellular concentration and thus maximal efficacy of killing in a competitor organism initially present at low cell density. The toxin effluxes from the apoptotic cell exclusively in the oxidized form and can further enter and kill neighboring cells, thus acting in a pseudocatalytic way.	Australian Natl Univ, The Faculties, Ctr Study Bioact Mol, Canberra, ACT 0200, Australia; Australian Natl Univ, Res Sch Chem, Canberra, ACT 0200, Australia	Australian National University; Australian National University	Waring, P (corresponding author), Australian Natl Univ, The Faculties, Ctr Study Bioact Mol, Canberra, ACT 0200, Australia.		Chai, Christina L/A-3133-2014	Chai, Christina/0000-0002-9199-851X				BEAVER JP, 1995, EUR J CELL BIOL, V68, P47; Bernardo PH, 2001, BIOORG MED CHEM LETT, V11, P483, DOI 10.1016/S0960-894X(00)00696-X; Borges-Walmsley MI, 2001, TRENDS MICROBIOL, V9, P71, DOI 10.1016/S0966-842X(00)01920-X; Brodin B, 2002, PHARMACOL TOXICOL, V90, P285, DOI 10.1034/j.1600-0773.2002.900601.x; Chai CLL, 2000, REDOX REP, V5, P257, DOI 10.1179/135100000101535799; Demain AL, 2000, ADV BIOCHEM ENG BIOT, V69, P1; Demain AL, 1999, APPL MICROBIOL BIOT, V52, P455, DOI 10.1007/s002530051546; EICHNER RD, 1988, J BIOL CHEM, V263, P3772; EICHNER RD, 1986, INT J IMMUNOPHARMACO, V8, P789, DOI 10.1016/0192-0561(86)90016-0; EICHNER RD, 1984, AUST J EXP BIOL MED, V82, P479; Ernst-Russell MA, 1999, AUST J CHEM, V52, P279, DOI 10.1071/C99019; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hurne AM, 2000, J BIOL CHEM, V275, P25202, DOI 10.1074/jbc.M002278200; JORDAN TW, 1986, J CELL SCI, V85, P33; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Moerman KL, 2003, TOXICOL APPL PHARM, V190, P232, DOI 10.1016/S0041-008X(03)00189-3; MULLBACHER A, 1986, MOL IMMUNOL, V23, P231, DOI 10.1016/0161-5890(86)90047-7; MULLBACHER A, 1988, TRANSPLANTATION, V46, P120; MUNDAY R, 1982, CHEM-BIOL INTERACT, V41, P361, DOI 10.1016/0009-2797(82)90112-0; Nagase T, 1997, BRIT J CANCER, V76, P1001, DOI 10.1038/bjc.1997.499; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; OHLER E, 1972, CHEM BER-RECL, V105, P635, DOI 10.1002/cber.19721050229; Pahl HL, 1996, J EXP MED, V183, P1829, DOI 10.1084/jem.183.4.1829; Paz MM, 2001, J MED CHEM, V44, P2834, DOI 10.1021/jm010072g; Perek N, 2002, CURR DRUG METAB, V3, P97, DOI 10.2174/1389200023338107; Rabenstein DL, 1996, J ORG CHEM, V61, P7391, DOI 10.1021/jo960917+; RICE GC, 1986, CANCER RES, V46, P6105; Richard JL, 1996, MYCOPATHOLOGIA, V134, P167, DOI 10.1007/BF00436725; SCHWEIZER M, 1994, BIOCHEMISTRY-US, V33, P13401, DOI 10.1021/bi00249a028; Tomee JFC, 2000, CLIN EXP ALLERGY, V30, P476, DOI 10.1046/j.1365-2222.2000.00796.x; vandenDobbelsteen DJ, 1996, J BIOL CHEM, V271, P15420, DOI 10.1074/jbc.271.26.15420; WARING P, 1994, TOXICON, V32, P491, DOI 10.1016/0041-0101(94)90301-8; Waring P, 1997, J BIOL CHEM, V272, P17929, DOI 10.1074/jbc.272.29.17929; WARING P, 1995, BIOCHEM PHARMACOL, V49, P1195, DOI 10.1016/0006-2952(95)00039-3; WARING P, 1988, MED RES REV, V8, P499, DOI 10.1002/med.2610080404	37	76	84	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46549	46555		10.1074/jbc.M304825200	http://dx.doi.org/10.1074/jbc.M304825200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12947114	hybrid			2022-12-27	WOS:000186569400040
J	El-Mousawi, M; Tchistiakova, L; Yurchenko, L; Pietrzynski, G; Moreno, M; Stanimirovic, D; Ahmad, D; Alakhov, V				El-Mousawi, M; Tchistiakova, L; Yurchenko, L; Pietrzynski, G; Moreno, M; Stanimirovic, D; Ahmad, D; Alakhov, V			A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-INDUCED ANGIOGENESIS; FACTOR VEGF; TYROSINE KINASE; ANGSTROM RESOLUTION; SIGNAL-TRANSDUCTION; TUMOR ANGIOGENESIS; CRYSTAL-STRUCTURE; EXPRESSION; BINDING; CELLS	Vascular endothelial growth factor ( VEGF) is known to play a predominant role in tumor angiogenesis and metastasis formation that is mediated by its interactions with two tyrosine kinase receptors, VEGFRI (Flt-1) and VEGFRII (KDR). Inhibition of VEGF-dependent events in tumor tissues is known to enhance apoptosis and to suppress tumor growth. A novel peptide, SP5.2, which selectively binds Flt-1 and inhibits a broad range of VEGF-mediated events, was identified using a phage-display library screening. The fluorescein-labeled SP5.2 specifically bound to VEGF-stimulated primary human cerebral endothelial cells (HCECs), whereas non-stimulated HCECs, as well as human neuroblastoma cells (ShyY) did not show any interaction with the peptide. SP5.2 prevented proliferation of cultured primary human umbilical vein endothelial cells induced by recombinant human VEGF(165) with an IC50 of 5 muM. SP5.2 was also shown to antagonize VEGF- and PLGF-induced, but not basic fibroblast growth factor-induced proliferation of HCECs. In contrast to "scrambled" peptide, SP5.2 was also found to selectively inhibit VEGF- stimulated migration of HCECs. The in vitro analysis of antiangiogenic activity of SP5.2 using a capillary-like tube formation assay showed that VEGF- induced angiogenesis of HCECs grown on Matrigel(TM) was completely inhibited in the presence of 10 muM SP5.2. Further studies demonstrated that SP5.2 prevented VEGF- induced permeability increase in HCECs monolayers. To explore whether SP5.2 can be used as a targeting agent, chemical and recombinant conjugates of SP5.2 with reporter proteins ( peroxidase and beta-galactosidase) were produced. The resulting products showed significant increases (200-fold for SP5.2-beta-gal and 400-fold for SP5.2-peroxidase) in binding affinity to recombinant Flt-1 compared with the original synthetic SP5.2, suggesting that conjugate with therapeutic activity in nanomolar range could potentially be developed based on SP5.2 structure.	Supratek Pharma Inc, Dorval, PQ H9S 1A9, Canada; Wyeth Res, Cambridge, MA 02140 USA; Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; Inst Natl Rech Sci, Laval, PQ H7V 1B7, Canada	Pfizer; National Research Council Canada; University of Quebec; Institut national de la recherche scientifique (INRS)	Alakhov, V (corresponding author), Supratek Pharma Inc, 215 Bouchard St, Dorval, PQ H9S 1A9, Canada.	valery.alakhov@supratek.com						Achen MG, 1998, INT J EXP PATHOL, V79, P255, DOI 10.1046/j.1365-2613.1998.700404.x; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; BALASS M, 1993, P NATL ACAD SCI USA, V90, P10638, DOI 10.1073/pnas.90.22.10638; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; Bisacchi D, 2003, CANCER DETECT PREV, V27, P229, DOI 10.1016/S0361-090X(03)00030-8; Broggini M, 2003, LEUKEMIA, V17, P52, DOI 10.1038/sj.leu.2402788; Cheng N, 2002, MOL CANCER RES, V1, P2; Drevs J, 2000, CANCER RES, V60, P4819; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Farrara N, 2000, CURR OPIN BIOTECH, V11, P617, DOI 10.1016/S0958-1669(00)00153-1; Ferrara N, 1996, Curr Opin Nephrol Hypertens, V5, P35, DOI 10.1097/00041552-199601000-00008; Ferrieres G, 2000, EUR J BIOCHEM, V267, P1819, DOI 10.1046/j.1432-1327.2000.01184.x; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gehlbach P, 2003, HUM GENE THER, V14, P129, DOI 10.1089/104303403321070829; He YL, 1999, MOL ENDOCRINOL, V13, P537, DOI 10.1210/me.13.4.537; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; HOESS R, 1993, GENE, V128, P43, DOI 10.1016/0378-1119(93)90151-R; Hong Deng-Li, 2001, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V9, P268; JELLINEK D, 1994, BIOCHEMISTRY-US, V33, P10450, DOI 10.1021/bi00200a028; JUNGER WG, 1993, J IMMUNOL METHODS, V160, P73, DOI 10.1016/0022-1759(93)90010-5; KAIPAINEN A, 1993, J EXP MED, V178, P2077, DOI 10.1084/jem.178.6.2077; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kuehne J, 2001, BIOCONJUGATE CHEM, V12, P742, DOI 10.1021/bc010001w; Lee H, 2003, J PHARM SCI-US, V92, P97, DOI 10.1002/jps.10270; Li SW, 2003, CHEM BIOL, V10, P233, DOI 10.1016/S1074-5521(03)00047-4; Matsumoto Y, 2002, J IMMUNOL, V168, P5824, DOI 10.4049/jimmunol.168.11.5824; Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1; Melnyk O, 1996, CANCER RES, V56, P921; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; Muruganandam A, 1997, FASEB J, V11, P1187, DOI 10.1096/fasebj.11.13.9367354; Partanen TA, 1999, CIRCULATION, V100, P583, DOI 10.1161/01.CIR.100.6.583; PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915; PLATE KH, 1994, BRAIN PATHOL, V4, P207, DOI 10.1111/j.1750-3639.1994.tb00835.x; Popkov M, 1998, EUR J BIOCHEM, V251, P155, DOI 10.1046/j.1432-1327.1998.2510155.x; Puduvalli VK, 2000, J NEURO-ONCOL, V50, P189, DOI 10.1023/A:1006469830739; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Sheng Ming, 2003, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V11, P74; SHIBUYA M, 1990, ONCOGENE, V5, P519; Shibuya M, 1995, ADV CANCER RES, V67, P281, DOI 10.1016/S0065-230X(08)60716-2; Shinkaruk S., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P95, DOI 10.2174/1568011033353452; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Stanimirovic D, 1996, J CELL PHYSIOL, V169, P455; Thomas KA, 1996, J BIOL CHEM, V271, P603, DOI 10.1074/jbc.271.2.603; Turetschek K, 2003, EUR J NUCL MED MOL I, V30, P448, DOI 10.1007/s00259-002-1000-5; VAISMAN N, 1990, J BIOL CHEM, V265, P19461; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang DF, 2000, J BIOL CHEM, V275, P15905, DOI 10.1074/jbc.M001847200; Wang W, 2001, AM J PHYSIOL-HEART C, V280, pH434, DOI 10.1152/ajpheart.2001.280.1.H434; Wedge SR, 2000, ADV EXP MED BIOL, V476, P307; Witte L, 1998, CANCER METAST REV, V17, P155, DOI 10.1023/A:1006094117427; Zachary I, 1998, INT J BIOCHEM CELL B, V30, P1169, DOI 10.1016/S1357-2725(98)00082-X	58	62	66	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46681	46691		10.1074/jbc.M308681200	http://dx.doi.org/10.1074/jbc.M308681200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12954624	hybrid			2022-12-27	WOS:000186569400058
J	Boulant, S; Becchi, M; Penin, F; Lavergne, JP				Boulant, S; Becchi, M; Penin, F; Lavergne, JP			Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CODING REGION; EXPRESSION; GENE; RNA; IDENTIFICATION; SUBSTITUTIONS; NOMENCLATURE; TRANSLATION; CLEAVAGE; BINDING	In addition to its involvement in the formation of the capsid shell of the virus particles, the core protein of hepatitis C virus (HCV) is believed to play an important role in the pathogenesis and/or establishment of persistent infection. We describe here alternative forms of genotype 1b HCV core protein identified after purification of various products of core protein segment 1-169 expressed in Escherichia coli and their analysis by proteolysis, mass spectrometry, and amino acid sequencing. These proteins all result from a +1 frameshift at codon 42 (a different position than that previously reported in genotype 1a) and, for some of them, from a rephasing in the normal open reading frame at the termination codon 144 in the +1 open reading frame. To test the relevance of these recoding events in a eukaryotic translational context, the nucleotide sequences surrounding the two shift sites were cloned in the three reading frames into expression vectors, allowing the production of a C-terminally fused green fluorescent protein, and expressed both in a reticulocyte lysate transcription/translation assay and in culture cells. Both recoding events were confirmed in these expression systems, strengthening the hypothesis that they might occur in HCV-infected cells. Moreover, sera from HCV-positive patients of genotype 1a or 1b were shown to react differently against synthetic peptides encoded in the +1 open reading frame. Together, these results indicate the occurrence of distinct recoding events in genotypes 1a and 1b, pointing out genotype-dependent specific features for F protein.	Univ Lyon 1, Lab Bioinformat & RMN Struct, F-69367 Lyon 07, France; Univ Lyon 1, CNRS,UMR 5086, Inst Biol & Chim Prot, Ctr Commun Sequencage, F-69367 Lyon 07, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Lavergne, JP (corresponding author), Univ Lyon 1, Lab Bioinformat & RMN Struct, 7 Passage Vercors, F-69367 Lyon 07, France.	jp.lavergne@ibcp.fr	PENIN, Francois/A-7315-2008; Boulant, Steeve/W-3754-2019	Boulant, Steeve/0000-0001-8614-4993				BRIERLEY I, 1992, J MOL BIOL, V227, P463, DOI 10.1016/0022-2836(92)90901-U; Choi JA, 2003, MOL CELL BIOL, V23, P1489, DOI 10.1128/MCB.23.5.1489-1497.2003; CHOO QL, 1991, P NATL ACAD SCI USA, V88, P2451, DOI 10.1073/pnas.88.6.2451; CORTAY JC, 1994, J BIOL CHEM, V269, P14885; Draper DE, 1998, COLD SPRING HARBOR M, P415; Farabaugh PJ, 1996, ANNU REV GENET, V30, P507, DOI 10.1146/annurev.genet.30.1.507; Farabaugh PJ, 2000, COLD SPRING HARBOR M, V39, P741; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; GRAMSTAT A, 1994, NUCLEIC ACIDS RES, V22, P3911, DOI 10.1093/nar/22.19.3911; HARADA S, 1991, J VIROL, V65, P3015, DOI 10.1128/JVI.65.6.3015-3021.1991; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; JACKS T, 1987, P NATL ACAD SCI USA, V84, P4298, DOI 10.1073/pnas.84.12.4298; JACKS T, 1985, SCIENCE, V230, P1237, DOI 10.1126/science.2416054; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; Jolivet M, 1997, Patent application, Patent No. [1015481, EP 1015481]; Jolivet-Reynaud C, 1998, J MED VIROL, V56, P300, DOI 10.1002/(SICI)1096-9071(199812)56:4&lt;300::AID-JMV3&gt;3.0.CO;2-8; Kato N, 2001, ACTA MED OKAYAMA, V55, P133; Lai MMC, 2000, CURR TOP MICROBIOL, V242, P117; LO SY, 1994, VIROLOGY, V199, P124, DOI 10.1006/viro.1994.1104; LO SY, 1995, VIROLOGY, V213, P455, DOI 10.1006/viro.1995.0018; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Penin Francois, 2003, Clin Liver Dis, V7, P1, DOI 10.1016/S1089-3261(02)00066-1; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Rijnbrand RCA, 2000, CURR TOP MICROBIOL, V242, P85; Robertson B, 1998, ARCH VIROL, V143, P2493, DOI 10.1007/s007050050479; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Roussel J, 2003, J GEN VIROL, V84, P1751, DOI 10.1099/vir.0.19065-0; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Shah AA, 2002, BIOINFORMATICS, V18, P1046, DOI 10.1093/bioinformatics/18.8.1046; Tuplin A, 2002, RNA, V8, P824, DOI 10.1017/S1355838202554066; Varaklioti A, 2002, J BIOL CHEM, V277, P17713, DOI 10.1074/jbc.M201722200; Walewski JL, 2002, RNA, V8, P557, DOI 10.1017/S1355838202029023; Walewski JL, 2001, RNA, V7, P710, DOI 10.1017/S1355838201010111; WEISS R B, 1989, New Biologist, V1, P159; *WHO, 1997, WKLY EPIDEMIOL REC, V72, P65; Xu ZM, 2001, EMBO J, V20, P3840, DOI 10.1093/emboj/20.14.3840; Yeh CT, 2000, J GASTROEN HEPATOL, V15, P182, DOI 10.1046/j.1440-1746.2000.02066.x; YELVERTON E, 1994, MOL MICROBIOL, V11, P303, DOI 10.1111/j.1365-2958.1994.tb00310.x	39	76	85	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45785	45792		10.1074/jbc.M307174200	http://dx.doi.org/10.1074/jbc.M307174200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952944	hybrid			2022-12-27	WOS:000186452300090
J	Ferguson, HA; Marietta, PM; Van Den Berg, CL				Ferguson, HA; Marietta, PM; Van Den Berg, CL			UV-induced apoptosis is mediated independent of caspase-9 in MCF-7 cells - A model for cytochrome c resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-X-L; ACTIVATION; APAF-1; CLEAVAGE; PROTEASE; MITOCHONDRIA; PATHWAY; INACTIVATION; ACCUMULATION; PROCASPASE-9	The importance of the mitochondria in UV-induced apoptosis has become increasingly apparent. Following DNA damage cytochrome c and other pro-apoptotic factors are released from the mitochondria, allowing for formation of the apoptosome and subsequent cleavage and activation of caspase-9. Active caspase-9 then activates downstream caspases-3 and/or -7, which in turn cleave poly (ADP)-ribose polymerase (PARP) and other downstream targets, resulting in apoptosis. In an effort to understand the mechanisms of Akt-mediated cell survival in breast cancer, we studied the effects of insulin-like growth factor (IGF)-I treatment on UV-treated MCF-7 human breast cancer cells. Apoptosis was induced in MCF-7 cells after UV treatment, as measured by caspase-7 and PARP cleavage, and IGF-I co-treatment protected against this response. Surprisingly caspase-9 cleavage was unchanged with UV and/or IGF-I treatment. Using MCF-7 cells overexpressing caspase-3 we have shown that resistance of caspase-9 to cleavage was not altered by the expression of caspase-3. Furthermore, overexpression of caspase-9 did not enhance PARP or caspase-7 cleavage after UV treatment. Because caspase-8 was activated with UV treatment alone, we believe that UV-induced apoptosis in MCF-7 cells occurs independently of cytochrome c and caspase-9, supporting the existence of a cytoplasmic inhibitor of cytochrome c in MCF-7 cells. We anticipate that such inhibitors may be overexpressed in cancer cells, allowing for treatment resistance.	Univ Colorado, Hlth Sci Ctr, Sch Pharm, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Van Den Berg, CL (corresponding author), Univ Colorado, Hlth Sci Ctr, Sch Pharm, 4200 E 9th Ave,Campus Box C238, Denver, CO 80262 USA.	carla.vandenberg@UCHSC.edu			NATIONAL CANCER INSTITUTE [R01CA089288] Funding Source: NIH RePORTER; NCI NIH HHS [CA89288A] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Blanc C, 2000, CANCER RES, V60, P4386; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Cain K, 1999, J BIOL CHEM, V274, P22686, DOI 10.1074/jbc.274.32.22686; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Debatin KM, 2002, ONCOGENE, V21, P8786, DOI 10.1038/sj.onc.1206039; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duan HJ, 1996, J BIOL CHEM, V271, P16720, DOI 10.1074/jbc.271.28.16720; Fang GF, 1998, CANCER RES, V58, P3202; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kharbanda S, 1997, P NATL ACAD SCI USA, V94, P6939, DOI 10.1073/pnas.94.13.6939; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Li F, 1997, J BIOL CHEM, V272, P30299, DOI 10.1074/jbc.272.48.30299; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Muzio M, 1997, J BIOL CHEM, V272, P2952, DOI 10.1074/jbc.272.5.2952; Niu MY, 2001, ONCOGENE, V20, P3506, DOI 10.1038/sj.onc.1204453; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815; Sabbatini P, 1999, J BIOL CHEM, V274, P24263, DOI 10.1074/jbc.274.34.24263; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Srinivasula SM, 1996, P NATL ACAD SCI USA, V93, P14486, DOI 10.1073/pnas.93.25.14486; Stegh AH, 2002, J BIOL CHEM, V277, P4351, DOI 10.1074/jbc.M108947200; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Tang DM, 2000, J BIOL CHEM, V275, P9303, DOI 10.1074/jbc.275.13.9303; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang XD, 2001, GENE DEV, V15, P2922; Wolf BB, 2001, J BIOL CHEM, V276, P34244, DOI 10.1074/jbc.M011778200; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	42	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45793	45800		10.1074/jbc.M307979200	http://dx.doi.org/10.1074/jbc.M307979200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954616	hybrid			2022-12-27	WOS:000186452300091
J	Hostager, BS; Haxhinasto, SA; Rowland, SL; Bishop, GA				Hostager, BS; Haxhinasto, SA; Rowland, SL; Bishop, GA			Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CLASS-II MOLECULES; LATENT MEMBRANE-PROTEIN-1; MONOCLONAL-ANTIBODIES; CELL DIFFERENTIATION; CUTTING EDGE; MURINE CD40; T-CELLS; ACTIVATION; RESPONSES	CD40 function is initiated by tumor necrosis factor (TNF) receptor-associated factor (TRAF) adapter proteins, which play important roles in signaling by numerous receptors. Characterizing roles of individual TRAFs has been hampered by limitations of available experimental models and the poor viability of most TRAF-deficient mice. Here, B cell lines made deficient in TRAF2 using a novel homologous recombination system reveal new roles for TRAF2. We demonstrate that TRAF2 participates in synergy between CD40 and B cell antigen receptor signals, and in CD40-mediated, TNF-dependent IgM production. We also find that TRAF2 participates in the degradation of TRAF3 associated with CD40 signaling, a role that may limit inhibitory actions of TRAF3. Finally, we show that TRAF2 and TRAF6 have overlapping functions in CD40-mediated NF-kappaB activation and CD80 up-regulation. These findings demonstrate previously unappreciated roles for TRAF2 in signaling by TNF receptor family members, using an approach that facilitates the analysis of genes critical to the viability of whole organisms.	Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Interdisciplinary Program Immunol, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Bishop, GA (corresponding author), Univ Iowa, Dept Microbiol, 3-570 Bowen Sci Bldg,51 Newton Rd, Iowa City, IA 52242 USA.			Bishop, Gail/0000-0002-1291-5078	NIAID NIH HHS [AI49993, AI28847] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028847, R01AI049993, R56AI049993, R29AI028847, R56AI028847] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahonen CL, 2002, NAT IMMUNOL, V3, P451, DOI 10.1038/ni792; BANIYASH M, 1984, EUR J IMMUNOL, V14, P799, DOI 10.1002/eji.1830140907; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; BISHOP GA, 1986, P NATL ACAD SCI USA, V83, P7410, DOI 10.1073/pnas.83.19.7410; BISHOP GA, 1995, EUR J IMMUNOL, V25, P1230, DOI 10.1002/eji.1830250515; BISHOP GA, 1991, J IMMUNOL, V147, P1107; Bishop GA, 2001, ARCH IMMUNOL THER EX, V49, P129; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Brown KD, 2001, J EXP MED, V193, P943, DOI 10.1084/jem.193.8.943; Brown KD, 2002, J BIOL CHEM, V277, P19433, DOI 10.1074/jbc.M111522200; Busch LK, 1999, J IMMUNOL, V162, P2555; Busch LK, 2001, J IMMUNOL, V167, P5805, DOI 10.4049/jimmunol.167.10.5805; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Catlett IM, 2001, J IMMUNOL, V166, P6019, DOI 10.4049/jimmunol.166.10.6019; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; HAMANO T, 1982, J IMMUNOL, V129, P1403; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; HANSON KD, 1995, MOL CELL BIOL, V15, P45, DOI 10.1128/MCB.15.1.45; Haxhinasto SA, 2002, J IMMUNOL, V169, P1145, DOI 10.4049/jimmunol.169.3.1145; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; Hernan R, 2000, BIOTECHNIQUES, V28, P789, DOI 10.2144/00284pf01; Hostager BS, 2002, J IMMUNOL, V168, P3318, DOI 10.4049/jimmunol.168.7.3318; Hostager BS, 1999, J IMMUNOL, V162, P6307; Hostager BS, 1996, J IMMUNOL, V157, P1047; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Hsing Y, 1999, J IMMUNOL, V162, P2804; Hsing Y, 1997, J IMMUNOL, V159, P4898; HU HM, 1994, J BIOL CHEM, V269, P30069; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; Jabara HH, 2002, IMMUNITY, V17, P265, DOI 10.1016/S1074-7613(02)00394-1; Jalukar SV, 2000, J IMMUNOL, V164, P623, DOI 10.4049/jimmunol.164.2.623; KIM KJ, 1979, J IMMUNOL, V122, P549; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; LONG EO, 1991, HUM IMMUNOL, V31, P229, DOI 10.1016/0198-8859(91)90092-N; Manning E, 2002, EUR J IMMUNOL, V32, P39, DOI 10.1002/1521-4141(200201)32:1<39::AID-IMMU39>3.0.CO;2-Y; Nakano H, 1999, P NATL ACAD SCI USA, V96, P9803, DOI 10.1073/pnas.96.17.9803; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; SAUER B, 1993, METHOD ENZYMOL, V225, P890; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Sedivy JM, 1999, TRENDS GENET, V15, P88, DOI 10.1016/S0168-9525(98)01689-8; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Stout RD, 1996, IMMUNOL TODAY, V17, P487, DOI 10.1016/0167-5699(96)10060-I; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Wagner DH, 2002, P NATL ACAD SCI USA, V99, P3782, DOI 10.1073/pnas.052247099; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Yanagawa Y, 1999, TRANSGENIC RES, V8, P215, DOI 10.1023/A:1008914020843; Yasui T, 2002, INT IMMUNOL, V14, P319, DOI 10.1093/intimm/14.3.319; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	56	101	107	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45382	45390		10.1074/jbc.M306708200	http://dx.doi.org/10.1074/jbc.M306708200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12958312	hybrid			2022-12-27	WOS:000186452300042
J	McDonald, WH; Pavlova, Y; Yates, JR; Boddy, MN				McDonald, WH; Pavlova, Y; Yates, JR; Boddy, MN			Novel essential DNA repair proteins Nse1 and Nse2 are subunits of the fission yeast Smc5-Smc6 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHECKPOINT KINASE CDS1; MMS-SENSITIVE MUTANTS; SCHIZOSACCHAROMYCES-POMBE; SMC PROTEINS; SACCHAROMYCES-CEREVISIAE; IDENTIFICATION; CONDENSATION; COHESIN; DAMAGE; RAD18	The structural maintenance of chromosomes (SMC) family of proteins play essential roles in genomic stability. SMC heterodimers are required for sister-chromatid cohesion (Cohesin: Smc1 & Smc3), chromatin condensation (Condensin: Smc2 & Smc4), and DNA repair ( Smc5 & Smc6). The SMC heterodimers do not function alone and must associate with essential non-SMC subunits. To gain further insight into the essential and DNA repair roles of the Smc5-6 complex, we have purified fission yeast Smc5 and identified by mass spectrometry the co-precipitating proteins, Nse1 and Nse2. We show that both Nse1 and Nse2 interact with Smc5 in vivo, as part of the Smc5-6 complex. Nse1 and Nse2 are essential proteins and conserved from yeast to man. Loss of Nse1 and Nse2 function leads to strikingly similar terminal phenotypes to those observed for Smc5-6 inactivation. In addition, cells expressing hypomorphic alleles of Nse1 and Nse2 are, like Smc5-6 mutants, hypersensitive to DNA damage. Epistasis analysis suggests that like Smc5-6, Nse1, and Nse2 function together with Rhp51 in the homologous recombination repair of DNA double strand breaks. The results of this study strongly suggest that Nse1 and Nse2 are novel non-SMC subunits of the fission yeast Smc5-6 DNA repair complex.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Boddy, MN (corresponding author), Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.	nboddy@scripps.edu	Boddy, Michael/A-7214-2009; McDonald, W. Hayes/B-4109-2016	McDonald, W. Hayes/0000-0002-3510-426X	NCI NIH HHS [CA81665] Funding Source: Medline; NCRR NIH HHS [RR11823] Funding Source: Medline; NEI NIH HHS [R01 EY1328801] Funding Source: Medline; NIGMS NIH HHS [GM068608] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R33CA081665] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068608] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALKHODAIRY F, 1992, EMBO J, V11, P1343, DOI 10.1002/j.1460-2075.1992.tb05179.x; Aono N, 2002, NATURE, V417, P197, DOI 10.1038/417197a; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Boddy MN, 2003, MOL CELL BIOL, V23, P5939, DOI 10.1128/MCB.23.16.5939-5946.2003; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Fousteri MI, 2000, EMBO J, V19, P1691, DOI 10.1093/emboj/19.7.1691; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Fujioka Y, 2002, J BIOL CHEM, V277, P21585, DOI 10.1074/jbc.M201523200; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hari KL, 2001, GENE DEV, V15, P1334, DOI 10.1101/gad.877901; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Jessberger R, 2002, NAT REV MOL CELL BIO, V3, P767, DOI 10.1038/nrm930; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kim JS, 2002, J BIOL CHEM, V277, P45149, DOI 10.1074/jbc.M209123200; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; McDonald WH, 2002, DIS MARKERS, V18, P99, DOI 10.1155/2002/505397; MONTELONE BA, 1995, CURR GENET, V27, P102, DOI 10.1007/BF00313423; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morishita T, 2002, MOL CELL BIOL, V22, P3537, DOI 10.1128/MCB.22.10.3537-3548.2002; PRAKASH L, 1977, GENETICS, V86, P33; PRAKASH S, 1977, GENETICS, V87, P229; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wu L, 1997, MECH DEVELOP, V65, P3, DOI 10.1016/S0925-4773(97)00032-4	36	98	104	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45460	45467		10.1074/jbc.M308828200	http://dx.doi.org/10.1074/jbc.M308828200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12966087	hybrid			2022-12-27	WOS:000186452300051
J	Scheidt, HA; Muller, P; Herrmann, A; Huster, D				Scheidt, HA; Muller, P; Herrmann, A; Huster, D			The potential of fluorescent and spin-labeled steroid analogs to mimic natural cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAPID TRANSBILAYER MOVEMENT; ACYL-CHAIN; LIPID DOMAINS; TRANSMEMBRANE MOVEMENT; ERYTHROCYTE-MEMBRANE; UNILAMELLAR VESICLES; BIOLOGICAL-MEMBRANES; MOLECULAR-DYNAMICS; BILAYER-MEMBRANES; MODEL MEMBRANES	Cholesterol analogs are often used to investigate lipid trafficking and membrane organization of native cholesterol. Here, the potential of various spin (doxyl moiety) and fluorescent (7-nitrobenz-2-oxa-1, 3-diazol-4-yl (NBD) group) labeled cholesterol analogs as well as of fluorescent cholestatrienol and the naturally occurring dehydroergosterol to mimic the unique properties of native cholesterol in lipid membranes was studied in 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) membranes by electron paramagnetic resonance, nuclear magnetic resonance, and fluorescence spectroscopy. As cholesterol, all analogs undergo fluctuating motions of large amplitude parallel to the bilayer normal. Native cholesterol keeps a strict orientation in the membrane with the long axis parallel to the bilayer normal. Depending on the chemical modification or the position of the label, cholesterol analogs may adopt an "up-side-down" orientation in the membrane or may even fluctuate between "upright" and up-side-down orientation by rotational motions about the short axis not typical for native cholesterol. Those analogs are not able to induce a comparable condensation of phospholipid membranes as known for native cholesterol revealed by H-2 nuclear magnetic resonance. However, cholesterol-induced lipid condensation is one of the key properties of native cholesterol, and, therefore, a well suited parameter to assess the potential of steroid analogs to mimic cholesterol. The study points to extreme caution when studying cholesterol behavior by the respective analogs. Among seven analogs investigated, only a spin-labeled cholesterol with the doxyl group at the end of the acyl chain and the fluorophore cholestatrienol mimic cholesterol satisfactorily. Dehydroergosterol has a similar upright orientation as cholesterol and could be used at low concentration (about 1 mol %), at which its lower potential to enhance lipid packing density does not perturb membrane organization.	Univ Leipzig, Inst Med Phys & Biophys, Biotechnol Biomed Ctr, Jr Res Grp, D-04103 Leipzig, Germany; Humboldt Univ, Inst Biol Biophys, D-10115 Berlin, Germany	Leipzig University; Humboldt University of Berlin	Huster, D (corresponding author), Univ Leipzig, Inst Med Phys & Biophys, Biotechnol Biomed Ctr, Jr Res Grp, Liebigstr 27, D-04103 Leipzig, Germany.		Scheidt, Holger A./C-1416-2014					Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; BoeszeBattaglia K, 1996, BIOCHEMISTRY-US, V35, P6664, DOI 10.1021/bi951846w; BONMATIN JM, 1990, J AM CHEM SOC, V112, P1697, DOI 10.1021/ja00161a007; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Brown RE, 1998, J CELL SCI, V111, P1; BUTKO P, 1992, J BIOCHEM BIOPH METH, V24, P15, DOI 10.1016/0165-022X(92)90043-A; BUTLER KW, 1977, CAN J BIOCHEM, V56, P117; Buton X, 2002, BIOCHEMISTRY-US, V41, P13106, DOI 10.1021/bi020385t; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; Cheng KH, 1999, BIOPHYS J, V77, P3108, DOI 10.1016/S0006-3495(99)77141-9; CHILD P, 1983, J LIPID RES, V24, P1196; DAVIES MA, 1990, BIOCHEMISTRY-US, V29, P4368, DOI 10.1021/bi00470a016; DEMEL RA, 1972, BIOCHIM BIOPHYS ACTA, V255, P321, DOI 10.1016/0005-2736(72)90031-4; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Endress E, 2002, BIOCHEMISTRY-US, V41, P13078, DOI 10.1021/bi0201670; Fellmann P, 1994, Methods Mol Biol, V27, P161; FISCHER RT, 1984, CHEM PHYS LIPIDS, V36, P1, DOI 10.1016/0009-3084(84)90086-0; FORSLIND E, 1975, J THEOR BIOL, V51, P97, DOI 10.1016/0022-5193(75)90141-1; HAPALA I, 1994, BIOCHEMISTRY-US, V33, P7682, DOI 10.1021/bi00190a023; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Huster D, 1999, J PHYS CHEM B, V103, P243, DOI 10.1021/jp983428h; Huster D, 1999, J AM CHEM SOC, V121, P1992, DOI 10.1021/ja9838413; Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g; Huster D, 2001, BIOPHYS J, V80, P822, DOI 10.1016/S0006-3495(01)76061-4; HYSLOP PA, 1990, BIOCHEMISTRY-US, V29, P1025, DOI 10.1021/bi00456a027; IPSEN JH, 1990, BIOPHYS J, V57, P405, DOI 10.1016/S0006-3495(90)82557-1; John K, 2002, BIOPHYS J, V83, P1525, DOI 10.1016/S0006-3495(02)73922-2; KAVECANSKY J, 1994, BIOCHEMISTRY-US, V33, P2880, DOI 10.1021/bi00176a018; KRAJEWSKIBERTRAND MA, 1992, CHEM PHYS LIPIDS, V63, P235, DOI 10.1016/0009-3084(92)90039-R; LANGE Y, 1981, J BIOL CHEM, V256, P5321; Leventis R, 2001, BIOPHYS J, V81, P2257, DOI 10.1016/S0006-3495(01)75873-0; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; MACURA S, 1980, MOL PHYS, V41, P95, DOI 10.1080/00268978000102601; Marsan MP, 1999, BIOPHYS J, V76, P351, DOI 10.1016/S0006-3495(99)77202-4; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; MORROT G, 1987, BIOCHIM BIOPHYS ACTA, V897, P341, DOI 10.1016/0005-2736(87)90431-7; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Mukherjee S, 1996, BIOCHEMISTRY-US, V35, P1311, DOI 10.1021/bi951953q; Muller P, 2002, BIOPHYS J, V82, P1418, DOI 10.1016/S0006-3495(02)75496-9; NEMECZ G, 1988, BIOCHIM BIOPHYS ACTA, V943, P511, DOI 10.1016/0005-2736(88)90384-7; Ohvo-Rekila H, 2000, CHEM PHYS LIPIDS, V105, P167, DOI 10.1016/S0009-3084(00)00122-5; OLDFIELD E, 1978, BIOCHEMISTRY-US, V17, P2727, DOI 10.1021/bi00607a006; ROGERS J, 1979, BIOCHIM BIOPHYS ACTA, V552, P23, DOI 10.1016/0005-2736(79)90243-8; Schiller J, 1999, ANAL BIOCHEM, V267, P46, DOI 10.1006/abio.1998.3001; SCHROEDER F, 1991, BIOCHIM BIOPHYS ACTA, V1066, P181; SEIGNEURET M, 1984, BIOCHEMISTRY-US, V23, P4271, DOI 10.1021/bi00314a002; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMUTZER G, 1986, BIOCHIM BIOPHYS ACTA, V862, P361, DOI 10.1016/0005-2736(86)90239-7; URBINA JA, 1995, BBA-BIOMEMBRANES, V1238, P163, DOI 10.1016/0005-2736(95)00117-L; Vogel A, 2003, BIOPHYS J, V85, P1691, DOI 10.1016/S0006-3495(03)74599-8; WHARTON SA, 1982, BIOCHIM BIOPHYS ACTA, V711, P398, DOI 10.1016/0005-2760(82)90053-4; White Stephen H., 1996, P127; Wustner D, 2002, J BIOL CHEM, V277, P30325, DOI 10.1074/jbc.M202626200; Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; YEAGLE PL, 1990, BIOPHYS J, V57, P413, DOI 10.1016/S0006-3495(90)82558-3; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V815, P33, DOI 10.1016/0005-2736(85)90470-5	57	155	156	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45563	45569		10.1074/jbc.M303567200	http://dx.doi.org/10.1074/jbc.M303567200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12947110	hybrid			2022-12-27	WOS:000186452300064
J	Strugatsky, D; Gottschalk, KE; Goldshleger, R; Bibi, E; Karlish, SJD				Strugatsky, D; Gottschalk, KE; Goldshleger, R; Bibi, E; Karlish, SJD			Expression of Na+,K+-ATPpase in Pichia pastoris analysis of wild type and D369N mutant proteins by Fe2+-catalyzed oxidative cleavage and molecular modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; CONSERVED PHOSPHORYLATION LOOP; ENERGY TRANSDUCTION MECHANISM; PARTICLE MESH EWALD; ALPHA-SUBUNIT; CALCIUM-PUMP; NA,K-ATPASE; BINDING; ATPASE; TRANSPORT	Na+,K+-ATPase (pig alpha1,beta1) has been expressed in the methylotrophic yeast Pichia pastoris. A protease-deficient strain was used, recombinant clones were screened for multicopy genomic integrants, and protein expression, and time and temperature of methanol induction were optimized. A 3-liter culture provides 300-500 mg of membrane protein with ouabain binding capacity of 30-50 pmol mg(-1). Turnover numbers of recombinant and renal Na+,K+-ATPase are similar, as are specific chymotryptic cleavages. Wild type (WT) and a D369N mutant have been analyzed by Fe2+- and ATP-Fe2+-catalyzed oxidative cleavage, described for renal Na+,K+-ATPase. Cleavage of the D369N mutant provides strong evidence for two Fe2+ sites: site 1 composed of residues in P and A cytoplasmic domains, and site 2 near trans-membrane segments M3/M1. The D369N mutation suppresses cleavages at site 1, which appears to be a normal Mg2+ site in E-2 conformations. The results suggest a possible role of the charge of Asp(369) on the E-1 <----> E-2 conformational equilibrium. 5'-Adenylyl-beta,gamma-imidodiphosphate(AMP-PNP)-Fe2+-catalyzed cleavage of the D369N mutant produces fragments in P ((VNDS)-V-712) and N (near (440)VAGDA) domains, described for WT, but only at high AMP-PNP-Fe2+ concentrations, and a new fragment in the P domain (near (367)CSDKTGT) resulting from cleavage. Thus, the mutation distorts the active site. A molecular dynamic simulation of ATP-Mg2+ binding to WT and D351N structures of Ca2+-ATPase (analogous to Asp(369) of Na+,K+-ATPase) supplies possible explanations for the new cleavage and for a high ATP affinity, which was observed previously for the mutant. The Asn(351) structure with bound ATP-Mg2+ may resemble the transition state of the WT poised for phosphorylation.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	steven.karlish@weizmann.ac.il	Gottschalk, Kay/D-6503-2012	Gottschalk, Kay/0000-0002-7951-0972; Bibi, Eitan/0000-0003-3700-2707				Bar Shimon M, 1998, J BIOL CHEM, V273, P34190, DOI 10.1074/jbc.273.51.34190; Beaudet L, 1998, METHOD ENZYMOL, V292, P397; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Clausen JD, 2001, J BIOL CHEM, V276, P35741, DOI 10.1074/jbc.M105434200; Cremata JA, 1998, METH MOL B, V103, P95; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FUKUSHIMA Y, 1978, J BIOL CHEM, V253, P6853; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; GLYNN IM, 1990, ANNU REV BIOCHEM, V59, P171, DOI 10.1146/annurev.bi.59.070190.001131; Goldshleger R, 1997, P NATL ACAD SCI USA, V94, P9596, DOI 10.1073/pnas.94.18.9596; Goldshleger R, 1999, J BIOL CHEM, V274, P16213, DOI 10.1074/jbc.274.23.16213; GOLDSHLEGER R, 2002, P 50 ANN M AM SOC MA; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hua SM, 2002, BIOCHEMISTRY-US, V41, P11405, DOI 10.1021/bi026181u; Jacobsen MD, 2002, BIOCHEMISTRY-US, V41, P1451, DOI 10.1021/bi015891h; JENCKS WP, 1989, METHOD ENZYMOL, V171, P145; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; Karlish SJD, 2003, ANN NY ACAD SCI, V986, P39, DOI 10.1111/j.1749-6632.2003.tb07137.x; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; McIntosh DB, 1999, J BIOL CHEM, V274, P25227, DOI 10.1074/jbc.274.36.25227; Nielsen JM, 1998, BIOCHEMISTRY-US, V37, P1961, DOI 10.1021/bi972524q; Patchornik G, 2000, P NATL ACAD SCI USA, V97, P11954, DOI 10.1073/pnas.220332897; Patchornik G, 2002, BIOCHEMISTRY-US, V41, P11740, DOI 10.1021/bi026334d; Pedersen PA, 1996, J BIOL CHEM, V271, P2514, DOI 10.1074/jbc.271.5.2514; Pedersen PA, 1996, BIOCHEMISTRY-US, V35, P16085, DOI 10.1021/bi961614c; Pedersen PA, 2000, J BIOL CHEM, V275, P37588, DOI 10.1074/jbc.M005610200; PEDERSEN PA, 2001, BIOCHIM BIOPHYS ACTA, V1505, P57; RENDI R, 1964, BIOCHIM BIOPHYS ACTA, V89, P520, DOI 10.1016/0926-6569(64)90078-1; Romanos M, 1998, METH MOL B, V103, P55; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shin JM, 2001, J BIOL CHEM, V276, P48440, DOI 10.1074/jbc.M106864200; STOKES DL, 2003, IN PRESS ANN REV BIO; Stratton J, 1998, METH MOL B, V103, P107; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Tal DM, 2001, BIOCHEMISTRY-US, V40, P12505, DOI 10.1021/bi011167n; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Valiakhmetov A, 2003, J BIOL CHEM, V278, P6330, DOI 10.1074/jbc.M208927200; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; XU C, 2002, J MOL BIOL, V61, P884	48	34	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46064	46073		10.1074/jbc.M308303200	http://dx.doi.org/10.1074/jbc.M308303200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12949069	hybrid			2022-12-27	WOS:000186452300123
J	Crider, BP; Xie, XS				Crider, BP; Xie, XS			Characterization of the functional coupling of bovine brain vacuolar-type H+-translocating ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICLE PROTON PUMP; CLATHRIN-COATED VESICLES; YEAST V-ATPASE; PLASMA-MEMBRANE; BINDING-SITES; MUTATIONAL ANALYSIS; ENTEROCOCCUS-HIRAE; 40-KDA SUBUNIT; B2 SUBUNIT; RECONSTITUTION	Vacuolar-type H+-translocating ATPases (V-ATPases or V-pumps) are complex proteins containing multiple subunits and are organized into two functional domains: a peripheral catalytic sector V-1 and a membranous proton channel V-0. The functional coupling of ATP hydrolysis activity to proton transport in V-pumps requires a regulatory component known as subunit H (SFD) as has been shown both in vivo and in vitro ( Ho, M. N., Hirata, R., Umemoto, N., Ohya, Y., Takatsuki, A., Stevens, T. H., and Anraku, Y. ( 1993) J. Biol. Chem. 268, 18286 - 18292; Xie, X. S., Crider, B. P., Ma, Y. M., and Stone, D. K. ( 1994) J. Biol. Chem. 269, 25809 - 25815). Ca2+ is thought to uncouple V-pumps because it is found to support ATP hydrolysis but not proton transport, while Mg2+ supports both activities. The direct effect of phospholipids on the coupling of V-ATPases has not been reported, likely due to the fact that phospholipids are constituents of biological membranes. We now report that Ca2+-induced uncoupling of the bovine brain V-ATPase can be reversed by imposition of a favorable membrane potential. Furthermore we report a simple "membrane-free" assay system using the V0 proton channel-specific inhibitor bafilomycin as a probe to detect the coupling of V-ATPase under certain conditions. With this system, we have characterized the functional effect of subunit H, divalent cations, and phospholipids on bovine brain V-ATPase and have found that each of these three factors plays a critical role in the functional coupling of the V-pump.	Univ Texas, SW Med Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Xie, XS (corresponding author), Univ Texas, SW Med Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.				PHS HHS [33627] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALAWQATI Q, 1986, ANNU REV CELL BIOL, V2, P179, DOI 10.1146/annurev.cellbio.2.1.179; ANRAKU Y, 1992, J BIOENERG BIOMEMBR, V24, P395, DOI 10.1007/BF00762532; ARAI K, 1993, J BIOL CHEM, V268, P5649; Arakaki N, 2001, BBA-BIOENERGETICS, V1504, P220, DOI 10.1016/S0005-2728(00)00248-6; Arata Y, 2002, BBA-BIOENERGETICS, V1555, P71, DOI 10.1016/S0005-2728(02)00257-8; Berman MC, 2001, BBA-BIOMEMBRANES, V1513, P95, DOI 10.1016/S0005-2736(01)00356-X; Boekema EJ, 1999, NATURE, V401, P37, DOI 10.1038/43369; BOWMAN BJ, 1992, J BIOENERG BIOMEMBR, V24, P361, DOI 10.1007/BF00762529; CRIDER BP, 1994, J BIOL CHEM, V269, P17379; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; DAGGETT SG, 1985, J BIOL CHEM, V260, P6213; Digel JG, 1996, J BIOL CHEM, V271, P19976, DOI 10.1074/jbc.271.33.19976; FENG Y, 1992, J BIOL CHEM, V267, P19769; FLATMARK T, 1985, FEBS LETT, V182, P25, DOI 10.1016/0014-5793(85)81146-7; GLUCK S, 1982, J BIOL CHEM, V257, P9230; GLUCK S, 1992, J EXP BIOL, V172, P29; GLUCK S, 1987, J BIOL CHEM, V262, P15780; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; Harvey WR, 1997, J EXP BIOL, V200, P203; HO MN, 1993, J BIOL CHEM, V268, P18286; INESI G, 1989, J BIOL CHEM, V264, P5929; KANE PM, 1989, J BIOL CHEM, V264, P19236; KANE PM, 1995, J BIOL CHEM, V270, P17025; LEE BS, 1995, J BIOL CHEM, V270, P7320, DOI 10.1074/jbc.270.13.7320; Lee BS, 1997, J BIOL CHEM, V272, P174; Lee BS, 1999, J BONE MINER RES, V14, P2127, DOI 10.1359/jbmr.1999.14.12.2127; LOH YP, 1984, J BIOL CHEM, V259, P8238; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; MORIYAMA Y, 1987, J BIOL CHEM, V262, P14723; MULBERG AE, 1991, J BIOL CHEM, V266, P20590; Muller ML, 2002, J MEMBRANE BIOL, V185, P209, DOI 10.1007/s00232-001-0124-z; NELSON N, 1989, J BIOENERG BIOMEMBR, V21, P553, DOI 10.1007/BF00808113; Nelson N, 1996, EXPERIENTIA, V52, P1101, DOI 10.1007/BF01952108; Niessen H, 1997, BLOOD, V90, P4598; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Papageorgiou S, 1998, J BIOENERG BIOMEMBR, V30, P533, DOI 10.1023/A:1020528432609; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; PENG SB, 1993, J BIOL CHEM, V268, P23519; PUOPOLO K, 1992, J BIOL CHEM, V267, P5171; SCHAFER G, 1992, BIOCHIM BIOPHYS ACTA, V1101, P232, DOI 10.1016/0005-2728(92)90233-R; SENIOR AE, 1980, J BIOL CHEM, V255, P7211; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Shao E, 2003, J BIOL CHEM, V278, P12985, DOI 10.1074/jbc.M212096200; SOLIOZ M, 1994, J BIOL CHEM, V269, P9453; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; STONE DK, 1988, KIDNEY INT, V33, P767, DOI 10.1038/ki.1988.65; STONE DK, 1984, J BIOL CHEM, V259, P2701; SUDHOF TC, 1989, P NATL ACAD SCI USA, V86, P6067, DOI 10.1073/pnas.86.16.6067; SZE H, 1992, J EXP BIOL, V172, P123; TAKASE K, 1994, J BIOL CHEM, V269, P11037; Van Walraven HS, 2002, J BIOENERG BIOMEMBR, V34, P455; Wieczorek H, 1999, J BIOENERG BIOMEMBR, V31, P67, DOI 10.1023/A:1005448614450; Wieczorek H, 2000, J EXP BIOL, V203, P127; Williams N, 1988, Prog Clin Biol Res, V273, P87; XIE XS, 1986, J BIOL CHEM, V261, P2492; XIE XS, 1989, J BIOL CHEM, V264, P18870; XIE XS, 1994, J BIOL CHEM, V269, P25809; XIE XS, 1983, J BIOL CHEM, V258, P4834; XIE XS, 1986, P NATL ACAD SCI USA, V83, P8913, DOI 10.1073/pnas.83.23.8913; Xie XS, 1996, J BIOL CHEM, V271, P30980; XIE XS, 1988, J BIOL CHEM, V263, P9859; XIE XS, 1993, J BIOL CHEM, V268, P25063; ZHANG K, 1992, J BIOL CHEM, V267, P9701; Zhou ZM, 1999, J BIOL CHEM, V274, P15913, DOI 10.1074/jbc.274.22.15913	64	38	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44281	44288		10.1074/jbc.M307372200	http://dx.doi.org/10.1074/jbc.M307372200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12949075	hybrid			2022-12-27	WOS:000186306700049
J	Plchova, H; Hartung, F; Puchta, H				Plchova, H; Hartung, F; Puchta, H			Biochemical characterization of an exonuclease from Arabidopsis thaliana reveals similarities to the DNA exonuclease of the human Werner syndrome protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME GENE-PRODUCT; BLOOM-SYNDROME HELICASES; FUNCTIONAL INTERACTION; POLYMERASE-DELTA; REPEAT SEQUENCE; RECQ HELICASES; DUPLEX DNA; WRN; COMPLEX; KU	The human Werner syndrome protein (hWRN-p) possessing DNA helicase and exonuclease activities is essential for genome stability. Plants have no homologue of this bifunctional protein, but surprisingly the Arabidopsis genome contains a small open reading frame (ORF) (AtWRNexo) with homology to the exonuclease domain of hWRN-p. Expression of this ORF in Escherichia coli revealed an exonuclease activity for AtWRN-exo-p with similarities but also some significant differences to hWRN-p. The protein digests recessed strands of DNA duplexes in the 3' --> 5' direction but hardly single-stranded DNA or blunt-ended duplexes. In contrast to the Werner exonuclease, AtWRNexo-p is also able to digest 3'-protruding strands. DNA with recessed 3'-PO4 and 3'-OH termini is degraded to a similar extent. AtWRNexo-p hydrolyzes the 3'-recessed strand termini of duplexes containing mismatched bases. AtWRNexo-p needs the divalent cation Mg2+ for activity, which can be replaced by Mn2+. Apurinic sites, cholesterol adducts, and oxidative DNA damage ( such as 8-oxoadenine and 8-oxoguanine) inhibit or block the enzyme. Other DNA modifications, including uracil, hypoxanthine and ethenoadenine, did not inhibit AtWRNexo-p. A mutation of a conserved residue within the exonuclease domain (E135A) completely abolished the exonucleolytic activity. Our results indicate that a type of WRN-like exonuclease activity seems to be a common feature of the DNA metabolism of animals and plants.	Inst Plant Genet & Crop Plant Res, D-06466 Gatersleben, Germany; Univ Karlsruhe, Bot Inst 2, D-76128 Karlsruhe, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Helmholtz Association; Karlsruhe Institute of Technology	Puchta, H (corresponding author), Inst Plant Genet & Crop Plant Res, Corrensstr 3, D-06466 Gatersleben, Germany.		Puchta, Holger/ABE-6271-2020; Plchová, Helena/F-7360-2014	Puchta, Holger/0000-0003-1073-8546; Plchová, Helena/0000-0003-1160-980X				Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 2002, BIOCHEMISTRY-US, V41, P12204, DOI 10.1021/bi026031j; Brosh RM, 2001, EMBO J, V20, P5791; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Brosh RM, 2001, J BIOL CHEM, V276, P3024, DOI 10.1074/jbc.M006784200; Chen CY, 2001, J CELL BIOL, V152, P985, DOI 10.1083/jcb.152.5.985; Cobb JA, 2002, FEBS LETT, V529, P43, DOI 10.1016/S0014-5793(02)03269-6; Cohen H, 2001, P NATL ACAD SCI USA, V98, P3174, DOI 10.1073/pnas.061579598; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cooper MP, 2000, GENE DEV, V14, P907; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hartung F, 2000, NUCLEIC ACIDS RES, V28, P4275, DOI 10.1093/nar/28.21.4275; Huang PH, 2001, CURR BIOL, V11, P125, DOI 10.1016/S0960-9822(01)00021-5; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Huang SR, 2000, NUCLEIC ACIDS RES, V28, P2396, DOI 10.1093/nar/28.12.2396; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Kamath-Loeb AS, 2000, P NATL ACAD SCI USA, V97, P4603, DOI 10.1073/pnas.97.9.4603; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Kamath-Loeb AS, 2001, J BIOL CHEM, V276, P16439, DOI 10.1074/jbc.M100253200; Karmakar P, 2002, NUCLEIC ACIDS RES, V30, P3583, DOI 10.1093/nar/gkf482; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Lebel M, 1999, J BIOL CHEM, V274, P37795, DOI 10.1074/jbc.274.53.37795; Li BM, 2000, J BIOL CHEM, V275, P28349, DOI 10.1074/jbc.C000289200; Li BM, 2002, NUCLEIC ACIDS RES, V30, P3653, DOI 10.1093/nar/gkf488; Li BM, 2001, J BIOL CHEM, V276, P9896, DOI 10.1074/jbc.M008575200; Machwe A, 2000, NUCLEIC ACIDS RES, V28, P2762, DOI 10.1093/nar/28.14.2762; Machwe A, 2002, J BIOL CHEM, V277, P4492, DOI 10.1074/jbc.M108880200; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Murti KG, 1999, P NATL ACAD SCI USA, V96, P14436, DOI 10.1073/pnas.96.25.14436; Ohsugi I, 2000, NUCLEIC ACIDS RES, V28, P3642, DOI 10.1093/nar/28.18.3642; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Orren DK, 2002, BIOCHEMISTRY-US, V41, P13483, DOI 10.1021/bi0266986; Orren DK, 2001, NUCLEIC ACIDS RES, V29, P1926, DOI 10.1093/nar/29.9.1926; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; SALK D, 1981, CYTOGENET CELL GENET, V30, P92, DOI 10.1159/000131596; Shen JC, 2000, NUCLEIC ACIDS RES, V28, P3260, DOI 10.1093/nar/28.17.3260; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Szekely AM, 2000, P NATL ACAD SCI USA, V97, P11365, DOI 10.1073/pnas.97.21.11365; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Wu JG, 1998, MECH AGEING DEV, V103, P27, DOI 10.1016/S0047-6374(98)00008-6; Yan H, 1998, NAT GENET, V19, P375, DOI 10.1038/1263; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	49	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44128	44138		10.1074/jbc.M303891200	http://dx.doi.org/10.1074/jbc.M303891200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12937173	hybrid, Green Published			2022-12-27	WOS:000186306700031
J	Fass, DM; Butler, JEF; Goodman, RH				Fass, DM; Butler, JEF; Goodman, RH			Deacetylase activity is required for cAMP activation of a subset of CREB target genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; C-FOS; TRANSCRIPTION FACTOR; HISTONE-DEACETYLASE; CYCLIC-AMP; CHROMOSOMAL LOCALIZATION; MEMBRANE DEPOLARIZATION; DEPENDENT TRANSCRIPTION; RESPONSIVE ELEMENT; SOMATOSTATIN GENE	Many hormones activate transcription by raising the level of cAMP within cells. In one well studied pathway, cAMP induces protein kinase A to phosphorylate the transcription factor CREB, which binds to a consensus sequence, the cAMP-regulated enhancer, found in many target genes. A generally accepted model suggests that phosphorylated CREB recruits the histone acetyltransferase CBP to activate transcription. In contrast, histone deacetylases have been linked to the cessation of CREB-dependent transcription. Here we tested this model in the regulation of endogenous CREB target genes. We used a constitutively active CREB mutant and microarray analysis to identify target genes in PC12 cells. We then tested the role of histone deacetylase activity in cAMP activation of four of these genes (c-FOS, ICER, NOR-1, and NUR77) by treating cells with the histone deacetylase inhibitor trichostatin A. Consistent with the generally accepted model, trichostatin A enhanced activation of c-FOS and NUR77 by cAMP. Surprisingly, trichostatin A blocked activation of ICER and NOR-1. The block of ICER and NOR-1 activation persisted in the presence of cycloheximide, indicating that the trichostatin A effect did not depend on new protein synthesis. This unexpected role of histone deacetylases in transcriptional activation of certain endogenous CREB target genes was not apparent in transfected reporter genes. Chromatin immunoprecipitation analysis indicated that the differential roles of histone deacetylases in activating or repressing CREB target genes was manifested at the level of preinitiation complex recruitment. These data indicate that histone deacetylases differentially regulate CREB target genes by contributing to either activation or cessation of transcription.	Oregon Hlth & Sci Univ, Vollum Inst L474, Portland, OR 97239 USA	Oregon Health & Science University	Goodman, RH (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst L474, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	goodmanr@ohsu.edu			NIDDK NIH HHS [DK 45423] Funding Source: Medline; NIGMS NIH HHS [GM 66563] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK045423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM066563] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Cammas F, 2000, GENE, V253, P231, DOI 10.1016/S0378-1119(00)00263-8; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Castillo SO, 1997, GENOMICS, V41, P250, DOI 10.1006/geno.1997.4677; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; CROSBY SD, 1992, P NATL ACAD SCI USA, V89, P4739, DOI 10.1073/pnas.89.10.4739; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; Gardier AM, 2000, J NEUROCHEM, V74, P1363, DOI 10.1046/j.1471-4159.2000.0741363.x; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; Im H, 2003, J BIOL CHEM, V278, P18346, DOI 10.1074/jbc.M300890200; Jang TH, 2000, CHINESE J PHYSIOL, V43, P149; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kimura N, 2001, ENDOCRINOLOGY, V142, P1427, DOI 10.1210/en.142.4.1427; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lu Q, 2003, J BIOL CHEM, V278, P15727, DOI 10.1074/jbc.M300546200; MARUYAMA K, 1995, CANCER LETT, V96, P117, DOI 10.1016/0304-3835(95)03921-I; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MEINKOTH J, 1990, CIBA F SYMP, V150, P47; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; NARANJO JR, 1990, NUCLEIC ACIDS RES, V18, P3605, DOI 10.1093/nar/18.12.3605; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ohkura N, 1998, GENE, V211, P79, DOI 10.1016/S0378-1119(98)00095-X; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pinaud S, 1998, J MOL BIOL, V280, P785, DOI 10.1006/jmbi.1998.1905; Plevin R, 1997, CELL SIGNAL, V9, P323, DOI 10.1016/S0898-6568(96)00193-3; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; Rascle A, 2003, MOL CELL BIOL, V23, P4162, DOI 10.1128/MCB.23.12.4162-4173.2003; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Richards JS, 2001, MOL ENDOCRINOL, V15, P209, DOI 10.1210/me.15.2.209; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Schumacher MA, 2000, J BIOL CHEM, V275, P35242, DOI 10.1074/jbc.M007293200; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Sommer A, 2000, FEBS LETT, V474, P146, DOI 10.1016/S0014-5793(00)01566-0; Tetradis S, 2001, ENDOCRINOLOGY, V142, P663, DOI 10.1210/en.142.2.663; Tinti C, 1996, J BIOL CHEM, V271, P25375, DOI 10.1074/jbc.271.41.25375; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; WATSON MA, 1989, MOL CELL BIOL, V9, P4213, DOI 10.1128/MCB.9.10.4213; Xu M, 2003, EMBO J, V22, P893, DOI 10.1093/emboj/cdg094; YOON JK, 1994, MOL CELL BIOL, V14, P7731, DOI 10.1128/MCB.14.12.7731; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	60	113	116	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43014	43019		10.1074/jbc.M305905200	http://dx.doi.org/10.1074/jbc.M305905200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12939274	hybrid			2022-12-27	WOS:000186157000037
J	Marinelli, RA; Tietz, PS; Caride, AJ; Huang, BQ; LaRusso, NF				Marinelli, RA; Tietz, PS; Caride, AJ; Huang, BQ; LaRusso, NF			Water transporting properties of hepatocyte basolateral and canalicular plasma membrane domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT HEPATOCYTES; GASTROINTESTINAL-TRACT; BRUSH-BORDER; CHANNEL; IMMUNOLOCALIZATION; AQUAPORIN-8; VESICLES; KIDNEY; LIVER; LOCALIZATION	Previous work from our laboratory supports an important role for aquaporins (AQPs), a family of water channel proteins, in bile secretion by hepatocytes. To further define the pathways and molecular mechanisms for water movement across hepatocytes, we directly assessed osmotic water permeability (P-f) and activation energy (E-a) in highly purified, rat hepatocytes basolateral membrane vesicles (BLMV) and canalicular membrane (CMV) vesicles by measuring scattered light intensity using stopped-flow spectrophotometry. The time course of scattered light for BLMV and CMV fit well to a single-exponential function. In BLMV, P-f was 108 +/- 4 mum.s(-1) (25degreesC) with an E-a of 7.7 kcal/mol; in CMV, P-f was 86 +/- 5 mum.s(-1) (25degreesC) with an E-a of 8.0 kcal/mol. The AQP blocker, dimethyl sulfoxide, significantly inhibited the P-f of both basolateral (81 +/- 4 mum.s(-1); -25%) and canalicular (59 +/- 4 mum.s(-1); -30%) membrane vesicles. When CMV were isolated from hepatocytes treated with dibutyryl cAMP, a double-exponential fit was needed, implying two functionally different vesicle populations; one population had P-f and E-a values similar to those of CMV from untreated hepatocytes, but the other population had a very high P-f (655 +/- 135 mum.s(-1), 25degreesC) and very low E-a (2.8 kcal/mol). Dimethyl sulfoxide completely inhibited the high P-f value in this second vesicle population. In contrast, P-f and E-a of BLMV were unaltered by cAMP treatment of hepatocytes. Our results are consistent with the presence of both lipid- and AQP-mediated pathways for basolateral and canalicular water movement across the hepatocyte plasma membrane barrier. Our data also suggest that the hepatocyte canalicular membrane domain is rate-limiting for transcellular water transport and that this domain becomes more permeable to water when hepatocytes are exposed to a choleretic agonist, presumably by insertion of AQP molecules. These data suggest a molecular mechanism for the efficient coupling of osmotically active solutes and water transport during canalicular bile formation.	Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Internal Med, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA; Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, CONICET, Inst Fisiol Expt, RA-2000 Rosario, Santa Fe, Argentina; Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Biochem & Mol Biol, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA	Mayo Clinic; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Mayo Clinic	LaRusso, NF (corresponding author), Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Internal Med, Ctr Basic Res Digest Dis, 200 1st St SW, Rochester, MN 55905 USA.							BENGA G, 1989, INT REV CYTOL, V114, P273; Calamita G, 2001, EUR J CELL BIOL, V80, P711, DOI 10.1078/0171-9335-00210; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; DEGIER J, 1989, WATER TRANSPORT BIOL, V1, P77; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; Elkjaer ML, 2001, AM J PHYSIOL-RENAL, V281, pF1047, DOI 10.1152/ajprenal.0158.2001; Garcia F, 2001, J BIOL CHEM, V276, P12147, DOI 10.1074/jbc.M009403200; Gradilone SA, 2003, HEPATOLOGY, V37, P1435, DOI 10.1053/jhep.2003.50241; Gradilone SA, 2002, ANAL BIOCHEM, V302, P104, DOI 10.1006/abio.2001.5533; Huebert RC, 2002, J BIOL CHEM, V277, P22710, DOI 10.1074/jbc.M202394200; MA TH, 1993, J BIOL CHEM, V268, P22756; Marinelli RA, 1999, AM J PHYSIOL-GASTR L, V276, pG280, DOI 10.1152/ajpgi.1999.276.1.G280; Masyuk AI, 2002, GASTROENTEROLOGY, V122, P545, DOI 10.1053/gast.2002.31035; MEIER PJ, 1984, J CELL BIOL, V98, P991, DOI 10.1083/jcb.98.3.991; Nicchia GP, 2001, J HISTOCHEM CYTOCHEM, V49, P1547, DOI 10.1177/002215540104901208; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Tani T, 2001, ARCH HISTOL CYTOL, V64, P159, DOI 10.1679/aohc.64.159; TIETZ PS, 1995, BIOCHEMISTRY-US, V34, P15436, DOI 10.1021/bi00047a007; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; VANHEESWIJK MPE, 1986, J MEMBRANE BIOL, V92, P183, DOI 10.1007/BF01870707; VANHOEK AN, 1990, BIOCHIM BIOPHYS ACTA, V1030, P203, DOI 10.1016/0005-2736(90)90296-Z; Verkman AS, 2000, CURR OPIN NEPHROL HY, V9, P517, DOI 10.1097/00041552-200009000-00010; VERKMAN AS, 1986, AM J PHYSIOL, V250, pF633, DOI 10.1152/ajprenal.1986.250.4.F633; VERKMAN AS, 1989, J BIOL CHEM, V264, P20608; Yano M, 1996, J BIOL CHEM, V271, P6702, DOI 10.1074/jbc.271.12.6702	28	50	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43157	43162		10.1074/jbc.M305899200	http://dx.doi.org/10.1074/jbc.M305899200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12939275				2022-12-27	WOS:000186157000056
J	Gorke, B				Gorke, B			Regulation of the Escherichia coli antiterminator protein BglG by phosphorylation at multiple sites and evidence for transfer of phosphoryl groups between monomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; TRANSCRIPTIONAL ANTITERMINATOR; PHOSPHOTRANSFERASE SYSTEM; CATABOLITE REPRESSION; LACTOBACILLUS-CASEI; NEGATIVE REGULATION; RESPONSE REGULATOR; RANDOM MUTAGENESIS; OPERON; DOMAIN	Activity of antiterminator protein BglG regulating the beta-glucoside operon in Escherichia coli is controlled by the phosphoenolpyruvate: carbohydrate phosphotransferase system (PTS) in a dual manner. It requires HPr phosphorylation to be active, whereas phosphorylation by the beta-glucoside-specific transport protein EIIBgl inhibits its activity. BglG and its relatives carry two PTS regulation domains (PRD1 and PRD2), each containing two conserved histidines. For BglG, histidine 208 in PRD2 was reported to be the negative phosphorylation site. In contrast, other antiterminators of this family are negatively regulated by phosphorylation of the first histidine in PRD1, and presumably activated by phosphorylation of the histidines in PRD2. In this work, a screen for mutant BglG proteins that escape repression by EIIBgl yielded exchanges of nine residues within PRD1, including conserved histidines His-101 and His-160, and C-terminally truncated proteins. Genetic and phosphorylation analyses indicate that His-101 in PRD1 is phosphorylated by EIIBgl and that His-160 contributes to negative regulation. His-208 in PRD2 is essential for BglG activity, suggesting that it is phosphorylated by HPr. Surprisingly, phosphorylation by HPr is not fully abolished by exchanges of His-208. However, phosphorylation by HPr is inhibited by exchanges in PRD1 and the phosphorylation of these mutants is restored in the presence of wild-type BglG. These results suggest that the activating phosphoryl group is transiently donated from HPr to PRD1 and subsequently transferred to His-208 of a second BglG monomer. The active His-208-phosphorylated BglG dimer can subsequently be inhibited in its activity by EIIBgl-catalyzed phosphorylation at His-101.	Univ Freiburg, Inst Biol 3, D-79104 Freiburg, Germany	University of Freiburg	Gorke, B (corresponding author), CNRS, Chim Bacterienne Lab, 31 Chemin Joseph Aiguier, F-13402 Marseille, France.			Gorke, Boris/0000-0002-1682-5387				AmsterChoder O, 1997, J BACTERIOL, V179, P5621, DOI 10.1128/jb.179.17.5621-5624.1997; AMSTERCHODER O, 1989, CELL, V58, P847, DOI 10.1016/0092-8674(89)90937-9; Andersen C, 1999, MOL MICROBIOL, V31, P499, DOI 10.1046/j.1365-2958.1999.01191.x; ARNAUD M, 1992, J BACTERIOL, V174, P3161, DOI 10.1128/jb.174.10.3161-3170.1992; Bachem S, 1998, J BACTERIOL, V180, P5319, DOI 10.1128/JB.180.20.5319-5326.1998; Boss A, 1999, J BACTERIOL, V181, P1755, DOI 10.1128/JB.181.6.1755-1766.1999; Chen Q, 1997, J BIOL CHEM, V272, P17263, DOI 10.1074/jbc.272.28.17263; Chen Q, 1997, EMBO J, V16, P4617, DOI 10.1093/emboj/16.15.4617; Declerck N, 2001, J MOL BIOL, V314, P671, DOI 10.1006/jmbi.2001.5185; Declerck N, 1999, J MOL BIOL, V294, P389, DOI 10.1006/jmbi.1999.3256; Dole S, 2002, MOL MICROBIOL, V43, P217, DOI 10.1046/j.1365-2958.2002.02734.x; Gorke B, 1999, EMBO J, V18, P3370, DOI 10.1093/emboj/18.12.3370; Gorke B, 2001, J MOL BIOL, V308, P131, DOI 10.1006/jmbi.2001.4590; GORKE B, 2000, THESIS U FREIBURG BR; Gosalbes MJ, 1999, J BACTERIOL, V181, P3928, DOI 10.1128/JB.181.13.3928-3934.1999; Gosalbes MJ, 2002, MICROBIOL-SGM, V148, P695, DOI 10.1099/00221287-148-3-695; Greenberg DB, 2002, RES MICROBIOL, V153, P519, DOI 10.1016/S0923-2508(02)01362-1; Gunnewijk MGW, 2001, J MOL MICROB BIOTECH, V3, P401; Henstra SA, 2000, J BIOL CHEM, V275, P7037, DOI 10.1074/jbc.275.10.7037; JUNNE T, 1990, J BACTERIOL, V172, P6615, DOI 10.1128/jb.172.12.6615-6616.1990; KRAMER W, 1984, NUCLEIC ACIDS RES, V12, P9441, DOI 10.1093/nar/12.24.9441; LENGELER JW, 1994, PHOSPHATE IN MICROORGANISMS, P182; Lindner C, 1999, MOL MICROBIOL, V31, P995, DOI 10.1046/j.1365-2958.1999.01262.x; LIVNAT L, 2003, P NATL ACAD SCI USA, V100, P7099; MAHADEVAN S, 1987, J BACTERIOL, V169, P2570, DOI 10.1128/jb.169.6.2570-2578.1987; Manival X, 1997, EMBO J, V16, P5019, DOI 10.1093/emboj/16.16.5019; Miller J.H., 1972, EXPT MOL GENETICS; Plumbridge J, 2002, CURR OPIN MICROBIOL, V5, P187, DOI 10.1016/S1369-5274(02)00296-5; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; PRASAD I, 1973, J BACTERIOL, V114, P909, DOI 10.1128/JB.114.3.909-915.1973; Rutberg B, 1997, MOL MICROBIOL, V23, P413, DOI 10.1046/j.1365-2958.1997.d01-1867.x; SCHNETZ K, 1990, P NATL ACAD SCI USA, V87, P5074, DOI 10.1073/pnas.87.13.5074; SCHNETZ K, 1987, J BACTERIOL, V169, P2579, DOI 10.1128/jb.169.6.2579-2590.1987; Schnetz K, 1996, J BACTERIOL, V178, P1971, DOI 10.1128/jb.178.7.1971-1979.1996; SPEE JH, 1993, NUCLEIC ACIDS RES, V21, P777, DOI 10.1093/nar/21.3.777; Stulke J, 2002, ARCH MICROBIOL, V177, P433, DOI 10.1007/s00203-002-0407-5; Stulke J, 1998, MOL MICROBIOL, V28, P865, DOI 10.1046/j.1365-2958.1998.00839.x; Tortosa P, 2001, MOL MICROBIOL, V41, P1381, DOI 10.1046/j.1365-2958.2001.02608.x; Tortosa P, 1997, J BIOL CHEM, V272, P17230, DOI 10.1074/jbc.272.27.17230; van Tilbeurgh H, 2001, CURR OPIN STRUC BIOL, V11, P685, DOI 10.1016/S0959-440X(01)00267-6; van Tilbeurgh H, 2001, EMBO J, V20, P3789, DOI 10.1093/emboj/20.14.3789; WITTEKIND M, 1989, BIOCHEMISTRY-US, V28, P9908, DOI 10.1021/bi00452a005; ZHOU YH, 1991, NUCLEIC ACIDS RES, V19, P6052, DOI 10.1093/nar/19.21.6052	43	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46219	46229		10.1074/jbc.M308002200	http://dx.doi.org/10.1074/jbc.M308002200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963714	hybrid			2022-12-27	WOS:000186569400005
J	Nagababu, E; Ramasamy, S; Abernethy, DR; Rifkind, JM				Nagababu, E; Ramasamy, S; Abernethy, DR; Rifkind, JM			Active nitric oxide produced in the red cell under hypoxic conditions by deoxyhemoglobin-mediated nitrite reduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-NITROSOHEMOGLOBIN; PHYSIOLOGICAL CONDITIONS; BLOOD-CELLS; BIOCHEMICAL-CHARACTERIZATION; PLASMA NITRITE; HEMOGLOBIN; NO; OXIDATION; MECHANISM; BINDING	Recent studies have generated a great deal of interest in a possible role for red blood cells in the transport of nitric oxide (NO) to the microcirculation and the vascular effect of this nitric oxide in facilitating the flow of blood through the microcirculation. Many questions have, however, been raised regarding such a mechanism. We have instead identified a completely new mechanism to explain the role of red cells in the delivery of NO to the microcirculation. This new mechanism results in the production of NO in the microcirculation where it is needed. Nitrite produced when NO reacts with oxygen in arterial blood is reutilized in the arterioles when the partial pressure of oxygen decreases and the deoxygenated hemoglobin formed reduces the nitrite regenerating NO. Nitrite reduction by hemoglobin results in a major fraction of the NO generated retained in the intermediate state where NO is bound to Hb(III) and in equilibrium with the nitrosonium cation bound to Hb(II). This pool of NO, unlike Hb(II) NO, is weakly bound and can be released from the heme. The instability of Hb(III) NO in oxygen and its displacement when flushed with argon requires that reliable determinations of red blood cell NO must be performed on freshly lysed samples without permitting the sample to be oxygenated. In fresh blood samples Hb(III) NO accounts for 75% of the red cell NO with appreciably higher values in venous blood than arterial blood. These findings confirm that nitrite reduction at reduced oxygen pressures is a major source for red cell NO. The formation and potential release from the red cell of this NO could have a major impact in regulating the flow of blood through the microcirculation.	NIA, Mol Dynam Sect, NIH, Baltimore, MD 21224 USA; NIA, Clin Invest Lab, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Rifkind, JM (corresponding author), NIA, Mol Dynam Sect, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.				NATIONAL INSTITUTE ON AGING [Z01AG000047, ZIAAG000047] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Benedict FG, 1911, AM J PHYSIOL, V28, P1; Blitzer ML, 1996, AM J PHYSIOL-HEART C, V271, pH1182, DOI 10.1152/ajpheart.1996.271.3.H1182; Butler AR, 1998, BBA-GEN SUBJECTS, V1425, P168, DOI 10.1016/S0304-4165(98)00065-8; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P9943, DOI 10.1073/pnas.180155397; Gow AJ, 1999, P NATL ACAD SCI USA, V96, P9027, DOI 10.1073/pnas.96.16.9027; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Haas H, 1999, ARZNEIMITTEL-FORSCH, V49, P318; Han TH, 2002, P NATL ACAD SCI USA, V99, P7763, DOI 10.1073/pnas.122118299; Hobbs AJ, 2002, TRENDS PHARMACOL SCI, V23, P406, DOI 10.1016/S0165-6147(02)02067-9; Huang Z, 2001, BBA-GEN SUBJECTS, V1568, P252, DOI 10.1016/S0304-4165(01)00227-6; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Joshi MS, 2002, P NATL ACAD SCI USA, V99, P10341, DOI 10.1073/pnas.152149699; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; Liao JC, 1999, P NATL ACAD SCI USA, V96, P8757, DOI 10.1073/pnas.96.15.8757; Lissi E, 1998, FREE RADICAL BIO MED, V24, P1535, DOI 10.1016/S0891-5849(98)00004-5; Luchsinger BP, 2003, P NATL ACAD SCI USA, V100, P461, DOI 10.1073/pnas.0233287100; May JM, 2000, AM J PHYSIOL-CELL PH, V279, pC1946, DOI 10.1152/ajpcell.2000.279.6.C1946; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; Patel RP, 1999, J BIOL CHEM, V274, P15487, DOI 10.1074/jbc.274.22.15487; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; PreikSteinhoff H, 1996, J CHROMATOGR B, V685, P348, DOI 10.1016/S0378-4347(96)00264-2; Ralevic V, 2002, J PHYSIOL-LONDON, V544, P2, DOI 10.1113/jphysiol.2002.028902; Rassaf T, 2003, NAT MED, V9, P481, DOI 10.1038/nm0503-481; RHODES PM, 1995, BIOCHEM BIOPH RES CO, V209, P590, DOI 10.1006/bbrc.1995.1541; RIBEIRO JMC, 1993, SCIENCE, V260, P539, DOI 10.1126/science.8386393; SHARMA VS, 1987, BIOCHEMISTRY-US, V26, P3837, DOI 10.1021/bi00387a015; SHARMA VS, 1978, J BIOL CHEM, V253, P6467; Spencer NY, 2002, FREE RADICAL BIO MED, V33, pS381; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Stepuro II, 1997, BIOCHEMISTRY-MOSCOW+, V62, P960; Vleeming W, 1997, FOOD CHEM TOXICOL, V35, P615, DOI 10.1016/S0278-6915(97)00015-X; Wang YN, 1996, J AM CHEM SOC, V118, P3972, DOI 10.1021/ja9538647; Wolzt M, 1999, J BIOL CHEM, V274, P28983, DOI 10.1074/jbc.274.41.28983	39	291	297	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46349	46356		10.1074/jbc.M307572200	http://dx.doi.org/10.1074/jbc.M307572200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12952953	hybrid			2022-12-27	WOS:000186569400018
J	Ortiz-Salmeron, E; Nuccetelli, M; Oakley, AJ; Parker, MW; Lo Bello, M; Garcia-Fuentes, L				Ortiz-Salmeron, E; Nuccetelli, M; Oakley, AJ; Parker, MW; Lo Bello, M; Garcia-Fuentes, L			Thermodynamic description of the effect of the mutation Y49F on human glutathione transferase P1-1 in binding with glutathione and the inhibitor S-hexylglutathione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCESSES INVOLVING PROTEINS; HEAT-CAPACITY CHANGES; CATALYTIC MECHANISM; SITE; ANTIBODY; ENTHALPY; WATER; RAT; DNA; MICROCALORIMETRY	The thermodynamics of binding of both the substrate glutathione (GSH) and the competitive inhibitor S-hexylglutathione to the mutant Y49F of human glutathione S-transferase (hGST P1-1), a key residue at the dimer interface, has been investigated by isothermal titration calorimetry and fluorescence spectroscopy. Calorimetric measurements indicated that the binding of these ligands to both the Y49F mutant and wild-type enzyme is enthalpically favorable and entropically unfavorable over the temperature range studied. The affinity of these ligands for the Y49F mutant is lower than those for the wild-type enzyme due mainly to an entropy change. Therefore, the thermodynamic effect of this mutation is to decrease the entropy loss due to binding. Calorimetric titrations in several buffers with different ionization heat amounts indicate a release of protons when the mutant binds GSH, whereas protons are taken up in binding S-hexylglutathione at pH 6.5. This suggests that the thiol group of GSH releases protons to buffer media during binding and a group with low pK(a) (such as Asp(98)) is responsible for the uptake of protons. The temperature dependence of the free energy of binding, DeltaG(0), is weak because of the enthalpy-entropy compensation caused by a large heat capacity change. The heat capacity change is -199.5+/-26.9 cal K-1 mol(-1) for GSH binding and -333.6+/-28.8 cal K-1 mol(-1) for S-hexylglutathione binding. The thermodynamic parameters are consistent with the mutation Tyr(49)-->Phe, producing a slight conformational change in the active site.	Univ Almeria, Fac Expt Sci, Almeria 04120, Spain; Childrens Hosp IRCCS Bambino Gesu, I-00165 Rome, Italy; St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy	Universidad de Almeria; IRCCS Bambino Gesu; St. Vincent's Institute of Medical Research; University of Rome Tor Vergata	Garcia-Fuentes, L (corresponding author), Univ Almeria, Fac Expt Sci, Almeria 04120, Spain.	lgarcia@ual.es	Garcia-Fuentes, Luis/D-1125-2016; Ortiz-Salmerón, Emilia/H-1381-2015; Parker, Michael W/F-9069-2013; Oakley, Aaron/A-9464-2013	Garcia-Fuentes, Luis/0000-0003-2471-8052; Ortiz-Salmerón, Emilia/0000-0002-7125-218X; Parker, Michael W/0000-0002-3101-1138; Oakley, Aaron/0000-0002-4764-014X				ARMSTRONG RN, 1991, CHEM RES TOXICOL, V4, P131, DOI 10.1021/tx00020a001; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Board PG, 1997, BIOCHEM J, V328, P929; Brunger A. T., 1993, XPLOR SYSTEM XRAY CR; Caccuri AM, 1999, J BIOL CHEM, V274, P19276, DOI 10.1074/jbc.274.27.19276; Caccuri AM, 1998, BIOCHEMISTRY-US, V37, P3028, DOI 10.1021/bi971903g; Caccuri AM, 1999, BIOCHEM J, V344, P419, DOI 10.1042/0264-6021:3440419; Caccuri AM, 1996, J BIOL CHEM, V271, P16193, DOI 10.1074/jbc.271.27.16193; *CCP4, 1994, ACTA CRYSTALLOGR D, V50, P750; CONNELLY PR, 1994, P NATL ACAD SCI USA, V91, P1964, DOI 10.1073/pnas.91.5.1964; Cooper A, 1994, Methods Mol Biol, V22, P109; Dam TK, 1998, J BIOL CHEM, V273, P32812, DOI 10.1074/jbc.273.49.32812; Fukada H, 1998, PROTEINS, V33, P159, DOI 10.1002/(SICI)1097-0134(19981101)33:2<159::AID-PROT2>3.0.CO;2-E; GarciaFuentes L, 1996, J BIOL CHEM, V271, P27569, DOI 10.1074/jbc.271.44.27569; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HA JH, 1989, J MOL BIOL, V209, P801, DOI 10.1016/0022-2836(89)90608-6; HIBBITS KA, 1994, BIOCHEMISTRY-US, V33, P3584, DOI 10.1021/bi00178a015; Hilser VJ, 1996, PROTEINS, V26, P123, DOI 10.1002/(SICI)1097-0134(199610)26:2<123::AID-PROT2>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1994, BIOPHYS CHEM, V51, P271, DOI 10.1016/0301-4622(94)00048-4; LoBello M, 1997, BIOCHEMISTRY-US, V36, P6207, DOI 10.1021/bi962813z; LOBELLO M, 1995, J BIOL CHEM, V270, P1249; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; MEYER DJ, 1995, BIOCHEM J, V311, P739, DOI 10.1042/bj3110739; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; MURPHY KP, 1990, SCIENCE, V247, P559, DOI 10.1126/science.2300815; MURPHY KP, 1995, PROTEINS, V21, P83, DOI 10.1002/prot.340210202; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Oakley AJ, 1998, BIOCHEMISTRY-US, V37, P9912, DOI 10.1021/bi980323w; Oakley AJ, 1997, J MOL BIOL, V274, P84, DOI 10.1006/jmbi.1997.1364; Ortiz-Salmeron E, 2001, BBA-PROTEIN STRUCT M, V1548, P106, DOI 10.1016/S0167-4838(01)00224-2; Ortiz-Salmeron E, 2001, EUR J BIOCHEM, V268, P4307, DOI 10.1046/j.1432-1327.2001.02349.x; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Pemble SE, 1996, BIOCHEM J, V319, P749, DOI 10.1042/bj3190749; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; Ricci G, 1996, J BIOL CHEM, V271, P16187, DOI 10.1074/jbc.271.27.16187; Sharp KA, 1997, J PHYS CHEM B, V101, P4343, DOI 10.1021/jp9702457; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; SPOLAR RS, 1989, P NATL ACAD SCI USA, V86, P8382, DOI 10.1073/pnas.86.21.8382; Stevens JM, 2000, BIOCHEM J, V347, P193, DOI 10.1042/0264-6021:3470193; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Swaminathan CP, 1999, J BIOL CHEM, V274, P31272, DOI 10.1074/jbc.274.44.31272; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yassin Z, 2003, INT J BIOL MACROMOL, V31, P155, DOI 10.1016/S0141-8130(02)00077-6	50	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46938	46948		10.1074/jbc.M305043200	http://dx.doi.org/10.1074/jbc.M305043200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12937169	hybrid			2022-12-27	WOS:000186569400088
J	Schmidt, H; Krauth-Siegel, RL				Schmidt, H; Krauth-Siegel, RL			Functional and physicochemical characterization of the thioredoxin system in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; SITE CYSTEINE RESIDUES; ACTIVE-SITE; DIHYDROLIPOAMIDE DEHYDROGENASE; TRYPANOTHIONE METABOLISM; CRITHIDIA-FASCICULATA; DEPENDENT SYNTHESIS; LIPOIC ACID; TRYPAREDOXIN; REDUCTASE	Trypanosoma brucei, the causative agent of African sleeping sickness, possesses a single thioredoxin that has an unusually high pI value of 8.5 and lacks a conserved aspartyl residue claimed to be involved in catalysis in other thioredoxins. Despite these peculiarities, T. brucei thioredoxin behaves like classical thioredoxins. It is reduced by thioredoxin reductases from different species, serves as donor of reducing equivalents for the ribonucleotide reductase of the parasite, and catalyzes the reduction of protein disulfides. The redox potential of -267 mV was obtained from protein-protein redox equilibration with Escherichia coli thioredoxin. The pK value of T. brucei thioredoxin was determined by two different methods. Carboxamidomethylation of the reduced protein yielded a pK value of 7.4 and generated mono-alkylated protein. The thiolate absorption at 240 nm resulted in a pK of 7.6 and, based on the extinction coefficient of 11.6 mM(-1) cm(-1), there are two (or three) cysteines titrating with very similar pK values. A thioredoxin reductase has not yet been detected in any organism of the order Kinetoplastida. T. brucei thioredoxin is spontaneously reduced by trypanothione (bis(glutathionyl) spermidine). Obviously, a specific thioredoxin reductase is not required as thioredoxin reduction can be conducted by the parasite-specific trypanothione/trypanothione reductase system.	Heidelberg Univ, Biochem Zentrum Heidelberg, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Krauth-Siegel, RL (corresponding author), Heidelberg Univ, Biochem Zentrum Heidelberg, Neuenheimer Feld 504, D-69120 Heidelberg, Germany.	krauth-siegel@urz.uni-heidelberg.de						Alphey MS, 1999, J STRUCT BIOL, V126, P76, DOI 10.1006/jsbi.1999.4091; Arner ESJ, 1996, BIOCHEM BIOPH RES CO, V225, P268, DOI 10.1006/bbrc.1996.1165; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BENESCH RE, 1955, J AM CHEM SOC, V77, P5877, DOI 10.1021/ja01627a030; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Bulaj G, 1998, BIOCHEMISTRY-US, V37, P8965, DOI 10.1021/bi973101r; BUNIK V, 1993, FEBS LETT, V336, P197, DOI 10.1016/0014-5793(93)80801-Z; Debarbieux L, 1998, P NATL ACAD SCI USA, V95, P10751, DOI 10.1073/pnas.95.18.10751; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Flohe L, 2002, METHOD ENZYMOL, V347, P244; FraserLhostis C, 1997, BIOL CHEM, V378, P1039, DOI 10.1515/bchm.1997.378.9.1039; FRIEMANN R, 2003, IN PRESS FEBS LETT; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; GLEASON FK, 1992, PROTEIN SCI, V1, P609, DOI 10.1002/pro.5560010507; Gommel DU, 1997, EUR J BIOCHEM, V248, P913, DOI 10.1111/j.1432-1033.1997.t01-1-00913.x; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; Hillebrand H, 2003, J BIOL CHEM, V278, P6809, DOI 10.1074/jbc.M210392200; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; JACKMAN SA, 1990, BIOCHEM SOC T, V18, P863, DOI 10.1042/bst0180863; KALLIS GB, 1980, J BIOL CHEM, V255, P261; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; Kern R, 2003, BIOCHEM J, V371, P965, DOI 10.1042/BJ20030093; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Krauth-Siegel RL, 2003, BIOL CHEM, V384, P539, DOI 10.1515/BC.2003.062; Krauth-Siegel RL, 2002, METHOD ENZYMOL, V347, P259; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Ludemann H, 1998, FEBS LETT, V431, P381, DOI 10.1016/S0014-5793(98)00793-5; Miranda-Vizuete A, 1997, J BIOL CHEM, V272, P30841, DOI 10.1074/jbc.272.49.30841; Mossner E, 1998, PROTEIN SCI, V7, P1233; MOUTIEZ M, 1994, CHEM PHARM BULL, V42, P2641; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Nogoceke E, 1997, BIOL CHEM, V378, P827, DOI 10.1515/bchm.1997.378.8.827; OPPERDOES FR, 1984, J CELL BIOL, V98, P1178, DOI 10.1083/jcb.98.4.1178; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; Reckenfelderbaumer N, 2000, J BIOL CHEM, V275, P7547, DOI 10.1074/jbc.275.11.7547; Reckenfelderbaumer N, 2002, J BIOL CHEM, V277, P17548, DOI 10.1074/jbc.M112115200; SAARINEN M, 1995, STRUCTURE, V3, P1097, DOI 10.1016/S0969-2126(01)00245-3; SCHEMPP H, 1994, Z NATURFORSCH C, V49, P691; Schmidt A, 2002, MOL BIOCHEM PARASIT, V125, P207, DOI 10.1016/S0166-6851(02)00215-3; Schoneck R, 1997, EUR J BIOCHEM, V243, P739, DOI 10.1111/j.1432-1033.1997.00739.x; Steinert P, 2000, BIOL CHEM, V381, P211, DOI 10.1515/BC.2000.028; SULLIVAN FX, 1991, MOL BIOCHEM PARASIT, V44, P145, DOI 10.1016/0166-6851(91)90231-T; Takahashi N, 1996, BIOCHEMISTRY-US, V35, P8342, DOI 10.1021/bi960465v; Vlamis-Gardikas A, 2002, METHOD ENZYMOL, V347, P286; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Wilkinson SM, 2002, J BIOL CHEM, V277, P17062, DOI 10.1074/jbc.M111126200; Williams CH, 2000, EUR J BIOCHEM, V267, P6110, DOI 10.1046/j.1432-1327.2000.01702.x	56	40	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46329	46336		10.1074/jbc.M305338200	http://dx.doi.org/10.1074/jbc.M305338200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12949079	hybrid			2022-12-27	WOS:000186569400016
J	Arribas, M; Valverde, AM; Benito, M				Arribas, M; Valverde, AM; Benito, M			Role of IRS-3 in the insulin signaling of IRS-1-deficient brown adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCOUPLING PROTEIN GENE; GROWTH-FACTOR-I; RECEPTOR SUBSTRATE-3 IRS-3; FATTY-ACID SYNTHASE; TRANSCRIPTIONAL ACTIVATOR; PRIMARY CULTURES; IGF-I; EXPRESSION; DIFFERENTIATION; THERMOGENESIS	Insulin receptor substrate-1 (IRS-1) plays an essential role in mediating the insulin signals that trigger mitogenesis, lipid synthesis, and uncoupling protein-1 gene expression in mouse brown adipocytes. Expression of IRS-3 is restricted mainly to white adipose tissue; expression of this IRS protein is virtually absent in brown adipocytes. We have tested the capacity of IRS-3 to mediate insulin actions in IRS-1-deficient brown adipocytes. Thus, we expressed exogenous IRS-3 in immortalized IRS-1(-/-) brown adipocytes at a level comparable with that of endogenous IRS-3 in white adipose tissue. Under these conditions, IRS-3 signaling in response to insulin was observed, as revealed by tyrosine phosphorylation of IRS-3, and the activation of phosphatidylinositol (PI)3-kinase associated with this recombinant protein. However, although insulin promoted the association of Grb-2 with recombinant IRS-3 in IRS-1(-/-) cells, the exogenous expression of this IRS family member failed to activate p42/44 MAPK and mitogenesis in brown adipocytes lacking IRS-1. Downstream of PI 3-kinase, IRS-3 expression restored insulin-induced Akt phosphorylation, which is impaired by the lack of IRS-1 signaling. Whereas the generation of IRS-3 signals enhanced adipocyte determination and differentiation-dependent factor 1/sterol regulatory element-binding protein (ADD-1/SREBP-1c) and fatty acid synthase mRNA and protein expression, activation of this pathway was unable to reconstitute CCAAT/enhancer-binding protein alpha and uncoupling protein-1 transactivation and gene expression in response to insulin. Similar results were obtained following insulin-like growth factor-I stimulation. In brown adipocytes expressing the IRS-3F4 mutant, the association of the p85alpha regulatory subunit via Src homology 2 binding was lost, but insulin nevertheless induced PI 3-kinase activity and Akt phosphorylation in a wortmannin-dependent manner. In contrast, activation of IRS-3F4 signaling failed to restore the induction of ADD-1/SREBP-1c and fatty acid synthase gene expression in IRS-1-deficient brown adipocytes. These studies demonstrate that recombinant IRS-3 may reconstitute some, but not all, of the signals required for insulin action in brown adipocytes. Thus, our data further implicate a unique role for IRS-1 in triggering insulin action in brown adipocytes.	Univ Complutense Madrid, Fac Farm, CSIC, Dept Bioquim & Biol Mol,Inst Bioquim,Ctr Mixto, E-28040 Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Benito, M (corresponding author), Univ Complutense Madrid, Fac Farm, CSIC, Dept Bioquim & Biol Mol,Inst Bioquim,Ctr Mixto, Ciudad Univ, E-28040 Madrid, Spain.		Benito, Manuel/J-5637-2014	Benito, Manuel/0000-0002-7218-406X				AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; ALVAREZ R, 1995, J BIOL CHEM, V270, P5666, DOI 10.1074/jbc.270.10.5666; AMY CM, 1989, P NATL ACAD SCI USA, V86, P3114, DOI 10.1073/pnas.86.9.3114; CASSARDDOULCIER AM, 1993, MOL ENDOCRINOL, V7, P497, DOI 10.1210/me.7.4.497; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dalgaard LT, 2001, DIABETOLOGIA, V44, P946, DOI 10.1007/s001250100596; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Guerra C, 1996, J BIOL CHEM, V271, P2076, DOI 10.1074/jbc.271.4.2076; Kaburagi Y, 1997, J BIOL CHEM, V272, P25839, DOI 10.1074/jbc.272.41.25839; Kaburagi Y, 2001, DIABETOLOGIA, V44, P992, DOI 10.1007/s001250100587; Kabuta T, 2002, J BIOL CHEM, V277, P6846, DOI 10.1074/jbc.M107058200; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; KLAUS S, 1994, J CELL SCI, V107, P313; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Laustsen PG, 2002, GENE DEV, V16, P3213, DOI 10.1101/gad.1034802; Lavan BE, 1997, J BIOL CHEM, V272, P11439; LORENZO M, 1993, J CELL BIOL, V123, P1567, DOI 10.1083/jcb.123.6.1567; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Palmer DG, 2002, BIOCHEM BIOPH RES CO, V291, P439, DOI 10.1006/bbrc.2002.6467; Porras A, 1998, MOL ENDOCRINOL, V12, P825, DOI 10.1210/me.12.6.825; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Ross SA, 1998, BIOCHEM BIOPH RES CO, V247, P487, DOI 10.1006/bbrc.1998.8821; ROSS SR, 1992, P NATL ACAD SCI USA, V89, P7561, DOI 10.1073/pnas.89.16.7561; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Teruel T, 1998, J CELL PHYSIOL, V176, P99, DOI 10.1002/(SICI)1097-4652(199807)176:1<99::AID-JCP12>3.3.CO;2-6; TERUEL T, 1995, BIOCHEM J, V310, P771, DOI 10.1042/bj3100771; Teruel T, 1996, BIOCHEM J, V319, P627, DOI 10.1042/bj3190627; TERUEL T, 1995, FEBS LETT, V364, P193, DOI 10.1016/0014-5793(95)00385-M; TRAYHURN P, 1989, CAN J PHYSIOL PHARM, V67, P811, DOI 10.1139/y89-128; Tsuruzoe K, 2001, MOL CELL BIOL, V21, P26, DOI 10.1128/MCB.21.1.26-38.2001; Valverde AM, 1998, ENDOCRINOLOGY, V139, P1229, DOI 10.1210/en.139.3.1229; Valverde AM, 1997, MOL ENDOCRINOL, V11, P595, DOI 10.1210/me.11.5.595; Valverde AM, 1999, DIABETES, V48, P2122, DOI 10.2337/diabetes.48.11.2122; Valverde AM, 2003, J BIOL CHEM, V278, P10221, DOI 10.1074/jbc.M209363200; Xu P, 1999, J BIOL CHEM, V274, P15262, DOI 10.1074/jbc.274.21.15262; YUBERO P, 1994, BIOCHEM BIOPH RES CO, V198, P653, DOI 10.1006/bbrc.1994.1095; Zhou LX, 1999, MOL ENDOCRINOL, V13, P505, DOI 10.1210/me.13.3.505	37	11	14	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45189	45199		10.1074/jbc.M301185200	http://dx.doi.org/10.1074/jbc.M301185200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12944402	hybrid, Green Published			2022-12-27	WOS:000186452300019
J	Hinrichsen, L; Harborth, J; Andrees, L; Weber, K; Ungewickell, EJ				Hinrichsen, L; Harborth, J; Andrees, L; Weber, K; Ungewickell, EJ			Effect of clathrin heavy chain- and alpha-adaptin-specific small inhibitory RNAs on endocytic accessory proteins and receptor trafficking in HeLa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; SYNAPTIC VESICLE ENDOCYTOSIS; CULTURED-MAMMALIAN-CELLS; COATED VESICLES; MEDIATED ENDOCYTOSIS; TERMINAL DOMAIN; PLASMA-MEMBRANE; EARLY ENDOSOMES; APPENDAGE DOMAIN; COMPLEX AP-2	To assess the contribution of individual endocytic proteins to the assembly of clathrin coated pits, we depleted the clathrin heavy chain and the alpha-adaptin subunit of AP-2 in HeLa-cells using RNA interference. 48 h after transfection with clathrin heavy chain-specific short interfering RNA both, the heavy and light chains were depleted by more than 80%. Residual clathrin was mainly membrane-associated, and an increase in shallow pits was noted. The membrane-association of adaptors, clathrin assembly lymphoid myeloid leukemia protein (CALM), epsin, dynamin, and Eps15 was only moderately affected by the knockdown and all proteins still displayed a punctate staining distribution. Clathrin depletion inhibited the uptake of transferrin but not that of the epidermal growth factor. However, efficient sorting of the epidermal growth factor into hepatocyte growth factor-regulated tyrosine kinase substrate-positive endosomes was impaired. Depletion of alpha-adaptin abolished almost completely the plasma membrane association of clathrin. Binding of Eps15 to membranes was strongly and that of CALM moderately reduced. Whereas the uptake of transferrin was efficiently blocked in alpha-adaptin knockdown cells, the internalization and sorting of the epidermal growth factor was not significantly impaired. Since neither clathrin nor AP-2 is essential for the internalization of EGF, we conclude that it is taken up by an alternative mechanism.	Hannover Med Sch, Ctr Anat, Dept Cell Biol, D-30623 Hannover, Germany; Max Planck Inst Biophys Chem, Dept Biochem & Cell Biol, D-37070 Gottingen, Germany	Hannover Medical School; Max Planck Society	Ungewickell, EJ (corresponding author), Hannover Med Sch, Ctr Anat, Dept Cell Biol, D-30623 Hannover, Germany.		Gimenez, Luis E Diaz/D-9291-2011					ACTON SL, 1990, J CELL BIOL, V111, P1419, DOI 10.1083/jcb.111.4.1419; AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; AHLE S, 1988, EMBO J, V7, P919, DOI 10.1002/j.1460-2075.1988.tb02897.x; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bean AJ, 2000, J BIOL CHEM, V275, P15271, DOI 10.1074/jbc.275.20.15271; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Benmerah A, 1995, J CELL BIOL, V131, P1831, DOI 10.1083/jcb.131.6.1831; Bennett EM, 2001, MOL BIOL CELL, V12, P2790, DOI 10.1091/mbc.12.9.2790; BOLL W, 1995, CURR BIOL, V5, P1168, DOI 10.1016/S0960-9822(95)00233-8; Bretscher MS, 1998, CURR BIOL, V8, P721, DOI 10.1016/S0960-9822(98)70281-7; BRODSKY FM, 1985, J CELL BIOL, V101, P2055, DOI 10.1083/jcb.101.6.2055; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; CHIN DJ, 1989, P NATL ACAD SCI USA, V86, P9289, DOI 10.1073/pnas.86.23.9289; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; De Camilli P, 2002, FEBS LETT, V513, P11, DOI 10.1016/S0014-5793(01)03306-3; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Drake MT, 2001, J BIOL CHEM, V276, P28700, DOI 10.1074/jbc.M104226200; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Greener T, 2000, J BIOL CHEM, V275, P1365, DOI 10.1074/jbc.275.2.1365; HANOVER JA, 1984, CELL, V39, P283, DOI 10.1016/0092-8674(84)90006-0; Harborth J, 2001, J CELL SCI, V114, P4557; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Iversen TG, 2003, P NATL ACAD SCI USA, V100, P5175, DOI 10.1073/pnas.0534231100; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; LINDNER R, 1992, J BIOL CHEM, V267, P16567; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Morgan JR, 2000, J NEUROSCI, V20, P8667; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; NESTEROV A, 1995, P NATL ACAD SCI USA, V92, P8719, DOI 10.1073/pnas.92.19.8719; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; NESTEROV A, 1995, J BIOL CHEM, V270, P6320, DOI 10.1074/jbc.270.11.6320; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; PEARSE BMF, 1976, P NATL ACAD SCI USA, V73, P1255, DOI 10.1073/pnas.73.4.1255; Qualmann B, 2002, INT REV CYTOL, V220, P93; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Raiborg C, 2001, J CELL SCI, V114, P2255; Rosenthal JA, 1999, J BIOL CHEM, V274, P33959, DOI 10.1074/jbc.274.48.33959; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; SORKIN A, 1991, J BIOL CHEM, V266, P23453; SORKIN A, 1995, J BIOL CHEM, V270, P619, DOI 10.1074/jbc.270.2.619; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; STAHL PD, 2002, SCI STKE; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; Torrisi MR, 1999, MOL BIOL CELL, V10, P417, DOI 10.1091/mbc.10.2.417; Umeda A, 2000, EUR J CELL BIOL, V79, P336, DOI 10.1078/S0171-9335(04)70037-0; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; VALLEE RB, 1993, CIBA F SYMP, V176, P185; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380; vanDelft S, 1997, J CELL BIOL, V136, P811, DOI 10.1083/jcb.136.4.811; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Wettey FR, 2002, SCIENCE, V297, P1521, DOI 10.1126/science.1074222; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085; Yamazaki T, 2002, J CELL SCI, V115, P1791; Zhao XH, 2001, J CELL SCI, V114, P353	77	217	220	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45160	45170		10.1074/jbc.M307290200	http://dx.doi.org/10.1074/jbc.M307290200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12960147	hybrid			2022-12-27	WOS:000186452300016
J	Kawai, H; Wiederschain, D; Kitao, H; Stuart, J; Tsai, KKC; Yuan, ZM				Kawai, H; Wiederschain, D; Kitao, H; Stuart, J; Tsai, KKC; Yuan, ZM			DNA damage-induced MDMX degradation is mediated by MDM2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53; PROTEIN; INACTIVATION; GROWTH; DOMAIN; LIGASE; ITSELF	Although genetic studies have demonstrated that MDMX is essential to maintain p53 activity at low levels in non-stressed cells, it is unknown whether MDMX regulates p53 activation by DNA damage. We show here that DNA damage-induced p53 induction is associated with rapid down-regulation of the MDMX protein. Significantly, interference with MDMX down-regulation results in the suppression of p53 activation by genotoxic stress. We also demonstrate that DNA damage-induced MDMX reduction is mediated by MDM2, which targets MDMX for proteasomal degradation by a distinct mechanism that permits preferential MDMX degradation and therefore ensures optimal p53 activation.	Harvard Univ, Sch Publ Hlth, Dept Canc Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Yuan, ZM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Canc Cell Biol, Bldg 1,Rm 507,665 Huntington Ave, Boston, MA 02115 USA.		Tsai, Kun-Chih/C-1371-2010	Kawai, Hidehiko/0000-0003-2213-7166; Tsai, Kelvin/0000-0002-1612-2868	NATIONAL CANCER INSTITUTE [R01CA085679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007155] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA85679] Funding Source: Medline; NIEHS NIH HHS [T32ES07155] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Finch RA, 2002, CANCER RES, V62, P3221; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kawai H, 2002, MOL CELL BIOL, V22, P6079, DOI 10.1128/MCB.22.17.6079-6088.2002; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; MIGLIORINI D, 2001, J BIOL CHEM, V13, P13; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5	16	141	142	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45946	45953		10.1074/jbc.M308295200	http://dx.doi.org/10.1074/jbc.M308295200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12963717	hybrid			2022-12-27	WOS:000186452300108
J	Ludewig, U; Wilken, S; Wu, BH; Jost, W; Obrdlik, P; El Bakkoury, M; Marini, AM; Andre, B; Hamacher, T; Boles, E; von Wiren, N; Frommer, WB				Ludewig, U; Wilken, S; Wu, BH; Jost, W; Obrdlik, P; El Bakkoury, M; Marini, AM; Andre, B; Hamacher, T; Boles, E; von Wiren, N; Frommer, WB			Homo- and hetero-oligomerization of ammonium transporter-1 NH4+ uniporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; SACCHAROMYCES-CEREVISIAE; K+ CHANNEL; IN-VIVO; MEMBRANE-PROTEINS; CHLORIDE CHANNEL; PLASMA-MEMBRANE; CELL-MEMBRANE; ROOT HAIRS; POLYPEPTIDES	In most organisms, high affinity ammonium uptake is catalyzed by members of the ammonium transporter family (AMT/MEP/Rh). A single point mutation (G458D) in the cytosolic C terminus of the plasma membrane transporter LeAMT1;1 from tomato leads to loss of function, although mutant and wild type proteins show similar localization when expressed in yeast or plant protoplasts. Co-expression of LeAMT1;1 and mutant in Xenopus oocytes inhibited ammonium transport in a dominant negative manner, suggesting homo-oligomerization. In vivo interaction between LeAMT1;1 proteins was confirmed by the split ubiquitin yeast two-hybrid system. LeAMT1;1 is isolated from root membranes as a high molecular mass oligomer, converted to a similar to35-kDa polypeptide by denaturation. To investigate interactions with the LeAMT1;2 paralog, co-localizing with LeAMT1;1 in root hairs, LeAMT1;2 was characterized as a lower affinity NH4+ uniporter. Co-expression of wild types with the respective G458D/G465D mutants inhibited ammonium transport in a dominant negative manner, supporting the formation of heteromeric complexes in oocytes. Thus, in yeast, oocytes, and plants, ammonium transporters are able to oligomerize, which may be relevant for regulation of ammonium uptake.	Univ Hohenheim, Inst Pflanzenernahrung, D-70599 Stuttgart, Germany; Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany; Free Univ Brussels, Inst Biol & Med Mol, Lab Physiol Cellulaire, B-6041 Gosselies, Belgium; Biozentrum, Inst Mikrobiol, D-60054 Frankfurt, Germany; Carnegie Inst Washington, Stanford, CA 94305 USA	University Hohenheim; Eberhard Karls University of Tubingen; Carnegie Institution for Science	von Wiren, N (corresponding author), Univ Hohenheim, Inst Pflanzenernahrung, Fruwirthstr 20, D-70599 Stuttgart, Germany.		Frommer, Wolf B/A-8256-2008; André, Bruno/D-1725-2010; Frommer, Wolf B/K-5042-2017	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; Boles, Eckhard/0000-0002-5713-1883; von Wiren, Nicolaus/0000-0002-4966-425X				Baizabal-Aguirre VM, 1999, J MEMBRANE BIOL, V167, P119, DOI 10.1007/s002329900476; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; BRENDON JM, 2002, FUNGAL GENET BIOL, V36, P35; Britto DT, 2001, PLANT PHYSIOL, V125, P523, DOI 10.1104/pp.125.2.523; Burckhardt BC, 1997, PFLUG ARCH EUR J PHY, V434, P306, DOI 10.1007/s004240050401; Cougnon M, 1996, PFLUG ARCH EUR J PHY, V431, P658, DOI 10.1007/BF02191917; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; Daram P, 1997, EMBO J, V16, P3455, DOI 10.1093/emboj/16.12.3455; Dreyer I, 1997, BIOPHYS J, V72, P2143, DOI 10.1016/S0006-3495(97)78857-X; DUBOIS E, 1979, MOL GEN GENET, V175, P67, DOI 10.1007/BF00267857; EYERS SAC, 1994, J BIOL CHEM, V269, P6417; Fischer WN, 2002, PLANT J, V29, P717, DOI 10.1046/j.1365-313X.2002.01248.x; Fusco C, 1999, YEAST, V15, P715, DOI 10.1002/(SICI)1097-0061(19990615)15:8<715::AID-YEA406>3.0.CO;2-K; GOJON A, 1986, PLANT PHYSIOL, V82, P254, DOI 10.1104/pp.82.1.254; HARTELSCHENK S, 1992, J BIOL CHEM, V267, P5569; Howitt SM, 2000, BBA-BIOMEMBRANES, V1465, P152, DOI 10.1016/S0005-2736(00)00136-X; Hsieh MH, 1998, P NATL ACAD SCI USA, V95, P13965, DOI 10.1073/pnas.95.23.13965; Kaiser BN, 2002, PLANT PHYSIOL, V130, P1263, DOI 10.1104/pp.102.010843; Kosolapov A, 2003, J BIOL CHEM, V278, P4305, DOI 10.1074/jbc.M209422200; Lauter FR, 1996, P NATL ACAD SCI USA, V93, P8139, DOI 10.1073/pnas.93.15.8139; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Ludewig U, 2001, GENOME BIOL, V2; MADDY AH, 1976, J THEOR BIOL, V62, P315, DOI 10.1016/0022-5193(76)90123-5; Marini AM, 2000, MOL MICROBIOL, V38, P552, DOI 10.1046/j.1365-2958.2000.02151.x; Marini AM, 2000, MOL MICROBIOL, V35, P378, DOI 10.1046/j.1365-2958.2000.01704.x; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Pilot G, 2001, J BIOL CHEM, V276, P3215, DOI 10.1074/jbc.M007303200; Reinders A, 2002, PLANT CELL, V14, P1567, DOI 10.1105/tpc.002428; SCHULZ EX, 2003, BMC BIOCH, V4, P3; Siewe RM, 1996, J BIOL CHEM, V271, P5398, DOI 10.1074/jbc.271.10.5398; SMART DR, 1988, OECOLOGIA, V76, P336, DOI 10.1007/BF00377026; Soupene E, 2001, MOL CELL BIOL, V21, P5733, DOI 10.1128/MCB.21.17.5733-5741.2001; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; STEINMEYER K, 1994, EMBO J, V13, P737, DOI 10.1002/j.1460-2075.1994.tb06315.x; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; ULLRICH WR, 1984, PHYSIOL PLANTARUM, V61, P369, DOI 10.1111/j.1399-3054.1984.tb06342.x; Veenhoff LM, 2002, TRENDS BIOCHEM SCI, V27, P242, DOI 10.1016/S0968-0004(02)02077-7; von Wiren N, 2000, PLANT J, V21, P167, DOI 10.1046/j.1365-313x.2000.00665.x; von Wiren N, 2000, CURR OPIN PLANT BIOL, V3, P254, DOI 10.1016/S1369-5266(00)00073-X; von Wiren N, 1997, PLANT PHYSIOL BIOCH, V35, P945; WANG MY, 1993, PLANT PHYSIOL, V103, P1259, DOI 10.1104/pp.103.4.1463; Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200; White PJ, 1996, J MEMBRANE BIOL, V152, P89, DOI 10.1007/s002329900088	47	132	141	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45603	45610		10.1074/jbc.M307424200	http://dx.doi.org/10.1074/jbc.M307424200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952951	hybrid			2022-12-27	WOS:000186452300069
J	O'Toole, PJ; Inoue, T; Emerson, L; Morrison, IEG; Mackie, AR; Cherry, RJ; Norton, JD				O'Toole, PJ; Inoue, T; Emerson, L; Morrison, IEG; Mackie, AR; Cherry, RJ; Norton, JD			Id proteins negatively regulate basic helix-loop-helix transcription factor function by disrupting subnuclear compartmentalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; DNA-BINDING; NUCLEAR COMPARTMENTALIZATION; GLUCOCORTICOID-RECEPTOR; DIFFERENTIATION; EXPRESSION; DOMAIN; ANGIOGENESIS; REPRESSION; DYNAMICS	Id helix-loop-helix (HLH) proteins act as global regulators of metazoan cell fate, cell growth, and differentiation. They heterodimerize with and inhibit the DNA-binding function of members of the basic helix-loop-helix (bHLH) family of transcription factors. Using real time fluorescence microscopy techniques in single living cells, we show here that nuclear pools of chromatin-associated bHLH transcription factor are freely exchangeable and in constant flux. The existence of a dynamic equilibrium between DNA-bound and free bHLH protein is also directly demonstrable in vitro. By contrast, Id protein is not associated with any subcellular, macromolecular structures and displays a more highly mobile, diffuse nuclear-cytoplasmic distribution. When co-expressed with antagonist Id protein, the chromatin-associated sublocalization of bHLH protein is abolished, and there is an accompanying 100-fold increase in its nuclear mobility to a level expected for freely diffusible Id-bHLH heterodimer. These results suggest that nuclear Id protein acts by sequestering pools of transiently diffusing bHLH protein to prevent reassociation with chromatin domains. Such a mechanism would explain how Id proteins are able to overcome the large DNA-binding free energy of bHLH proteins that is necessary to accomplish their inhibitory effect.	Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; Inst Food Res, Norwich NR4 7UA, Norfolk, England	University of Essex; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Norton, JD (corresponding author), Univ Essex, Dept Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	jnorton@essex.ac.uk	Mackie, Alan/N-7780-2018	Mackie, Alan/0000-0002-5681-0593; O'Toole, Peter John/0000-0001-5295-2001				Akiyama TE, 2002, MOL ENDOCRINOL, V16, P707, DOI 10.1210/me.16.4.707; Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398; Atherton GT, 1996, CELL GROWTH DIFFER, V7, P1059; Baumann CT, 2001, J BIOL CHEM, V276, P11237, DOI 10.1074/jbc.M011112200; Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Benezra R, 2001, ONCOGENE, V20, P8288, DOI 10.1038/sj.onc.1205161; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bradney C, 2003, J BIOL CHEM, V278, P2370, DOI 10.1074/jbc.M211464200; Carmo-Fonseca M, 2002, CELL, V108, P513, DOI 10.1016/S0092-8674(02)00650-5; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Chubb JR, 2003, CELL, V112, P403, DOI 10.1016/S0092-8674(03)00078-3; Day RN, 2001, METHODS, V25, P4, DOI 10.1006/meth.2001.1211; Deed RW, 1996, J BIOL CHEM, V271, P23603, DOI 10.1074/jbc.271.39.23603; Elbi C, 2002, MOL BIOL CELL, V13, P2001, DOI 10.1091/mboc.13.6.mk0602002001; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Engel I, 2001, NAT REV IMMUNOL, V1, P193, DOI 10.1038/35105060; FAIRMAN R, 1993, P NATL ACAD SCI USA, V90, P10429, DOI 10.1073/pnas.90.22.10429; Funato N, 2003, J BIOL CHEM, V278, P7486, DOI 10.1074/jbc.M212248200; Grande MA, 1997, J CELL SCI, V110, P1781; Inoue T, 1999, J BIOL CHEM, V274, P32309, DOI 10.1074/jbc.274.45.32309; JACOBS Y, 1994, MOL CELL BIOL, V14, P4087, DOI 10.1128/MCB.14.6.4087; Kazansky AV, 1999, J BIOL CHEM, V274, P22484, DOI 10.1074/jbc.274.32.22484; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Ladha S, 1996, BIOPHYS J, V71, P1364, DOI 10.1016/S0006-3495(96)79339-6; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Maleki SJ, 2002, BIOCHEMISTRY-US, V41, P10888, DOI 10.1021/bi025528q; Mancini MG, 1999, J CELL BIOCHEM, V72, P322, DOI 10.1002/(SICI)1097-4644(19990301)72:3<322::AID-JCB2>3.3.CO;2-0; Martinsen BJ, 1998, SCIENCE, V281, P988, DOI 10.1126/science.281.5379.988; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Narumi O, 2000, J BIOL CHEM, V275, P3510, DOI 10.1074/jbc.275.5.3510; Norton JD, 2000, J CELL SCI, V113, P3897; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Roberts EC, 2001, MOL CELL BIOL, V21, P524, DOI 10.1128/MCB.21.2.524-533.2001; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Schaaf MJM, 2003, MOL CELL BIOL, V23, P1922, DOI 10.1128/MCB.23.6.1922-1934.2003; Spinner DS, 2002, J MOL BIOL, V317, P431, DOI 10.1006/jmbi.2002.5440; Sugai M, 2003, NAT IMMUNOL, V4, P25, DOI 10.1038/ni874; TREACY MN, 1991, NATURE, V350, P577, DOI 10.1038/350577a0; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Volpert OV, 2002, CANCER CELL, V2, P473, DOI 10.1016/S1535-6108(02)00209-X; Wendt H, 1998, J BIOL CHEM, V273, P5735, DOI 10.1074/jbc.273.10.5735; Wilson JW, 2001, CANCER RES, V61, P8803; Yates PR, 1999, EMBO J, V18, P968, DOI 10.1093/emboj/18.4.968	50	39	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45770	45776		10.1074/jbc.M306056200	http://dx.doi.org/10.1074/jbc.M306056200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952978	hybrid			2022-12-27	WOS:000186452300088
J	Outten, FW; Wood, MJ; Munoz, FM; Storz, G				Outten, FW; Wood, MJ; Munoz, FM; Storz, G			The SufE protein and the SufBCD complex enhance SufS cysteine desulfurase activity as part of a sulfur transfer pathway for fe-s cluster assembly in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN SELENOCYSTEINE LYASE; NIFS-LIKE PROTEIN; AZOTOBACTER-VINELANDII; ERWINIA-CHRYSANTHEMI; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; GENE CLONING; ISCU; BIOSYNTHESIS; SCAFFOLD	The sufABCDSE operon of the Gram-negative bacterium Escherichia coli is induced by oxidative stress and iron deprivation. To examine the biochemical roles of the Suf proteins, we purified all of the proteins and assayed their effect on SufS cysteine desulfurase activity. Here we report that the SufE protein can stimulate the cysteine desulfurase activity of the SufS enzyme up to 8-fold and accepts sulfane sulfur from SufS. This sulfur transfer process from SufS to SufE is sheltered from the environment based on its resistance to added reductants and on the analysis of available crystal structures of the proteins. We also found that the SufB, SufC, and SufD proteins associate in a stable complex and that, in the presence of SufE, the SufBCD complex further stimulates SufS activity up to 32-fold. Thus, the SufE protein and the SufBCD complex act synergistically to modulate the cysteine desulfurase activity of SufS. We propose that this sulfur transfer mechanism may be important for limiting sulfide release during oxidative stress conditions in vivo.	NICHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Storz, G (corresponding author), NICHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.			Storz, Gisela/0000-0001-6698-1241; Outten, Franklin/0000-0002-9095-0194	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001608] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001608] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; BERGLIN EH, 1985, INFECT IMMUN, V49, P538, DOI 10.1128/IAI.49.3.538-543.1985; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Ellis KES, 2001, MOL MICROBIOL, V41, P973, DOI 10.1046/j.1365-2958.2001.02588.x; Flint DH, 1996, J BIOL CHEM, V271, P16068; Fujii T, 2000, BIOCHEMISTRY-US, V39, P1263, DOI 10.1021/bi991732a; Hoff KG, 2002, J BIOL CHEM, V277, P27353, DOI 10.1074/jbc.M202814200; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; Kambampati R, 1999, BIOCHEMISTRY-US, V38, P16561, DOI 10.1021/bi991119r; KAMBAMPATI R, 2000, J BIOL CHEM, V278, P38352; Kato S, 2002, P NATL ACAD SCI USA, V99, P5948, DOI 10.1073/pnas.082123599; Krebs C, 2001, BIOCHEMISTRY-US, V40, P14069, DOI 10.1021/bi015656z; Lee JH, 2003, J MICROBIOL, V41, P109; Leimkuhler S, 2001, J BIOL CHEM, V276, P22024, DOI 10.1074/jbc.M102072200; Lima CD, 2002, J MOL BIOL, V315, P1199, DOI 10.1006/jmbi.2001.5308; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mihara H, 2002, P NATL ACAD SCI USA, V99, P6679, DOI 10.1073/pnas.102176099; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Moller SG, 2001, GENE DEV, V15, P90, DOI 10.1101/gad.850101; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Nachin L, 2001, MOL MICROBIOL, V39, P960, DOI 10.1046/j.1365-2958.2001.02288.x; Ollagnier-de Choudens S, 2003, J BIOL CHEM, V278, P17993, DOI 10.1074/jbc.M300285200; Ollagnier-de-Choudens S, 2001, J BIOL CHEM, V276, P22604, DOI 10.1074/jbc.M102902200; Patzer SI, 1999, J BACTERIOL, V181, P3307, DOI 10.1128/JB.181.10.3307-3309.1999; Rangachari K, 2002, FEBS LETT, V514, P225, DOI 10.1016/S0014-5793(02)02369-4; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; SEATON BL, 1994, P NATL ACAD SCI USA, V91, P2066, DOI 10.1073/pnas.91.6.2066; Silberg JJ, 2001, J BIOL CHEM, V276, P1696, DOI 10.1074/jbc.M009542200; Smith AD, 2001, J AM CHEM SOC, V123, P11103, DOI 10.1021/ja016757n; Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	39	216	231	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45713	45719		10.1074/jbc.M308004200	http://dx.doi.org/10.1074/jbc.M308004200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12941942	hybrid			2022-12-27	WOS:000186452300081
J	Pravenec, M; Kazdova, L; Landa, V; Zidek, V; Mlejnek, P; Jansa, P; Wang, JM; Qi, NN; Kurtz, TW				Pravenec, M; Kazdova, L; Landa, V; Zidek, V; Mlejnek, P; Jansa, P; Wang, JM; Qi, NN; Kurtz, TW			Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE FATTY-ACIDS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; GENE-EXPRESSION; OBESITY; CD36; HYPERTRIGLYCERIDEMIA; PATHOGENESIS; TRIGLYCERIDE; DISEASE	Increased serum levels of resistin, a molecule secreted by fat cells, have been proposed as a possible mechanistic link between obesity and insulin resistance. To further investigate the effects of resistin on glucose metabolism, we derived a novel transgenic strain of spontaneously hypertensive rats expressing the mouse resistin gene under the control of the fat-specific aP2 promoter and also performed in vitro studies of the effects of recombinant resistin on glucose metabolism in isolated skeletal muscle. Expression of the resistin transgene was detected by Northern blot analysis in adipose tissue and by real-time PCR in skeletal muscle and was associated with increased serum fatty acids and muscle triglycerides, impaired skeletal muscle glucose metabolism, and glucose intolerance in the absence of any changes in serum resistin concentrations. In skeletal muscle isolated from non-transgenic spontaneously hypertensive rats, in vitro incubation with recombinant resistin significantly inhibited insulin-stimulated glycogenesis and reduced glucose oxidation. These findings raise the possibility that autocrine effects of resistin in adipocytes, leading to release of other prodiabetic effector molecules from fat and/or paracrine actions of resistin secreted by adipocytes embedded within skeletal muscle, may contribute to the pathogenesis of disordered skeletal muscle glucose metabolism and impaired glucose tolerance.	Acad Sci Czech Republ, Inst Physiol, CR-14220 Prague, Czech Republic; Ctr Integrated Genom, Prague 14220, Czech Republic; Charles Univ Prague, Inst Biol & Med Genet, Prague 12800, Czech Republic; Inst Clin & Expt Med, Prague 14021, Czech Republic; Acad Sci Czech Republ, Inst Mol Genet, CR-14220 Prague, Czech Republic; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; Institute for Clinical & Experimental Medicine (IKEM); Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of California System; University of California San Francisco	Pravenec, M (corresponding author), Acad Sci Czech Republ, Inst Physiol, Videnska 1083, CR-14220 Prague, Czech Republic.	pravenec@biomed.cas.cz	Zidek, Vaclav/C-6685-2012; Mlejnek, Petr/C-2305-2012; Jansa, Petr/B-8153-2019; Jansa, Petr/G-6360-2014; Landa, Vladimir/B-8908-2012; Pravenec, Michal/B-1666-2012	Mlejnek, Petr/0000-0002-4218-8983; Jansa, Petr/0000-0002-1406-1707; Pravenec, Michal/0000-0001-9197-5871	FOGARTY INTERNATIONAL CENTER [R03TW001236] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063709] Funding Source: NIH RePORTER; FIC NIH HHS [TWO1236] Funding Source: Medline; NHLBI NIH HHS [HL63709] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Banerjee RR, 2003, J MOL MED, V81, P218, DOI 10.1007/s00109-003-0428-9; Boden G, 2002, CURR OPIN CLIN NUTR, V5, P545, DOI 10.1097/00075197-200209000-00014; CHARREAU B, 1997, RAT GENOME, V3, P125; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Fujita H, 2002, BIOCHEM BIOPH RES CO, V298, P345, DOI 10.1016/S0006-291X(02)02464-6; Fukui Y, 2002, DIABETES OBES METAB, V4, P342, DOI 10.1046/j.1463-1326.2002.00215.x; Grundy SM, 1999, AM J CARDIOL, V83, p25F; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Hotamisligil GS, 2003, J CLIN INVEST, V111, P173, DOI 10.1172/JCI200317605; Jonke J, 2002, OBES RES, V10, P1; Juan CC, 2001, BIOCHEM BIOPH RES CO, V289, P1328, DOI 10.1006/bbrc.2001.6132; Kelley DE, 2001, DIABETES CARE, V24, P933, DOI 10.2337/diacare.24.5.933; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Kraegen EW, 2001, EXP CLIN ENDOCR DIAB, V109, pS189, DOI 10.1055/s-2001-18581; McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1; Moon B, 2003, AM J PHYSIOL-ENDOC M, V285, pE106, DOI 10.1152/ajpendo.00457.2002; Moore GBT, 2001, BIOCHEM BIOPH RES CO, V286, P735, DOI 10.1006/bbrc.2001.5460; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Muller PY, 2002, BIOTECHNIQUES, V33, P514; Nagaev I, 2001, BIOCHEM BIOPH RES CO, V285, P561, DOI 10.1006/bbrc.2001.5173; Pravenec M, 1999, J CLIN INVEST, V103, P1651, DOI 10.1172/JCI6691; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; Qi NN, 2002, J BIOL CHEM, V277, P48501, DOI 10.1074/jbc.M206655200; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REAVEN GM, 1990, HORM METAB RES, V22, P363, DOI 10.1055/s-2007-1004922; REAVEN GM, 1991, AM J MED, V90, pS7, DOI 10.1016/0002-9343(91)90028-V; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; VRANA A, 1978, METABOLISM, V27, P885, DOI 10.1016/0026-0495(78)90131-2; Way JM, 2001, J BIOL CHEM, V276, P25651, DOI 10.1074/jbc.C100189200	33	106	113	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45209	45215		10.1074/jbc.M304869200	http://dx.doi.org/10.1074/jbc.M304869200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12944409	hybrid			2022-12-27	WOS:000186452300021
J	Yen, TY; Macher, BA; Bryson, S; Chang, XQ; Tvaroska, I; Tse, R; Takeshita, S; Lew, AM; Datti, A				Yen, TY; Macher, BA; Bryson, S; Chang, XQ; Tvaroska, I; Tse, R; Takeshita, S; Lew, AM; Datti, A			Highly conserved cysteines of mouse core 2 beta 1,6-N-acetylglucosaminyltransferase I form a network of disulfide bonds and include a thiol that affects enzyme activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; O-LINKED OLIGOSACCHARIDES; GLYCAN BRANCH FORMATION; P-SELECTIN; N-ACETYLGLUCOSAMINYLTRANSFERASE; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; SIALYL LEWIS(X); HUMAN ALPHA-1,3/4-FUCOSYL-TRANSFERASES; DIFFERENTIAL REQUIREMENTS	Core 2 beta1,6-N-acetylglucosaminyltransferase I (C2GnT-I) plays a pivotal role in the biosynthesis of mucin-type O-glycans that serve as ligands in cell adhesion. To elucidate the three-dimensional structure of the enzyme for use in computer-aided design of therapeutically relevant enzyme inhibitors, we investigated the participation of cysteine residues in disulfide linkages in a purified murine recombinant enzyme. The pattern of free and disulfide-bonded Cys residues was determined by liquid chromatography/electrospray ionization tandem mass spectrometry in the absence and presence of dithiothreitol. Of nine highly conserved Cys residues, under both conditions, one (Cys(217)) is a free thiol, and eight are engaged in disulfide bonds, with pairs formed between Cys(59)-Cys(413), Cys(100)-Cys(172), Cys(151)-Cys(199), and Cys(372)-Cys(381). The only non-conserved residue within the beta1,6-N-acetylglucosaminyltransferase family, Cys(235), is also a free thiol in the presence of dithiothreitol; however, in the absence of reductant, Cys(235) forms an intermolecular disulfide linkage. Biochemical studies performed with thiol-reactive agents demonstrated that at least one free cysteine affects enzyme activity and is proximal to the UDP-GlcNAc binding site. A Cys(217)-->Ser mutant enzyme was insensitive to thiol reactants and displayed kinetic properties virtually identical to those of the wild-type enzyme, thereby showing that Cys(217), although not required for activity per se, represents the only thiol that causes enzyme inactivation when modified. Based on the pattern of free and disulfide-linked Cys residues, and a method of fold recognition/threading and homology modeling, we have computed a three-dimensional model for this enzyme that was refined using the T4 bacteriophage beta-glucosyltransferase fold.	GlycoDesign Inc, Toronto, ON M5G 1V2, Canada; San Francisco State Univ, Dept Chem & Biochem, San Francisco, CA 94132 USA; Seikagaku Corp, Cent Res Labs, Tokyo 2070021, Japan	California State University System; San Francisco State University; Seikagaku Corporation	Datti, A (corresponding author), GlycoDesign Inc, 480 Univ Ave,Ste 400, Toronto, ON M5G 1V2, Canada.		Tvaroška, Igor/ABF-2188-2020; Datti, Alessandro/ABA-1108-2021	Tvaroška, Igor/0000-0003-2740-944X; Datti, Alessandro/0000-0001-6824-7382; Bryson, Steve/0000-0001-8924-4201	NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD000262] Funding Source: NIH RePORTER; NIMHD NIH HHS [1P20 MD 00262] Funding Source: Medline	NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Angata K, 2001, J BIOL CHEM, V276, P15369, DOI 10.1074/jbc.M100576200; Bernimoulin MP, 2003, J BIOL CHEM, V278, P37, DOI 10.1074/jbc.M204360200; BIERHUIZEN MFA, 1995, GLYCOBIOLOGY, V5, P417, DOI 10.1093/glycob/5.4.417; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Chen C, 2000, J BIOL CHEM, V275, P13819, DOI 10.1074/jbc.275.18.13819; Dan N, 1997, J BIOL CHEM, V272, P14214, DOI 10.1074/jbc.272.22.14214; DATTI A, 1992, ANAL BIOCHEM, V206, P262, DOI 10.1016/0003-2697(92)90364-D; de Vries T, 2001, GLYCOBIOLOGY, V11, P423, DOI 10.1093/glycob/11.5.423; Donovan RS, 1999, GLYCOCONJUGATE J, V16, P607, DOI 10.1023/A:1007024916491; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; FLEISCHER B, 1993, BIOCHEMISTRY-US, V32, P2076, DOI 10.1021/bi00059a027; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Fukuda M, 2002, BBA-GEN SUBJECTS, V1573, P394, DOI 10.1016/S0304-4165(02)00409-9; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; HIGGINS EA, 1991, J BIOL CHEM, V266, P6280; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; Holmes EH, 2000, J BIOL CHEM, V275, P24237, DOI 10.1074/jbc.M000888200; Kaila N, 2002, MED RES REV, V22, P566, DOI 10.1002/med.10018; KITZ R, 1962, J BIOL CHEM, V237, P3245; Koya D, 1999, FASEB J, V13, P2329, DOI 10.1096/fasebj.13.15.2329; Kumar R, 1996, BLOOD, V88, P3872, DOI 10.1182/blood.V88.10.3872.bloodjournal88103872; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Li JH, 2000, J BIOL CHEM, V275, P41476, DOI 10.1074/jbc.M007480200; LOO JA, 1993, ANAL CHEM, V65, P425, DOI 10.1021/ac00052a020; Lowe JB, 2002, IMMUNOL REV, V186, P19, DOI 10.1034/j.1600-065X.2002.18603.x; Ma JY, 1996, J BIOL CHEM, V271, P7758, DOI 10.1074/jbc.271.13.7758; Machida E, 2001, CANCER RES, V61, P2226; Mitoma J, 2003, J BIOL CHEM, V278, P9953, DOI 10.1074/jbc.M212756200; MOREMEN KW, 1991, J BIOL CHEM, V266, P16876; Mulligan MS, 1999, J IMMUNOL, V162, P4952; MULLIGAN MS, 1993, NATURE, V364, P149, DOI 10.1038/364149a0; Nguyen AT, 1998, J BIOL CHEM, V273, P25244, DOI 10.1074/jbc.273.39.25244; Opat AS, 2000, J BIOL CHEM, V275, P11836, DOI 10.1074/jbc.275.16.11836; Patel KD, 2002, SEMIN IMMUNOL, V14, P73, DOI 10.1006/smim.2001.0344; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; PILLER F, 1988, J BIOL CHEM, V263, P15146; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Rost B, 1996, METHOD ENZYMOL, V266, P525; SANCHEZLOPEZ R, 1988, J BIOL CHEM, V263, P11892; Schachter H, 1992, GLYCOCONJUGATES COMP, P263; Schwientek T, 2000, J BIOL CHEM, V275, P11106, DOI 10.1074/jbc.275.15.11106; Schwientek T, 1999, J BIOL CHEM, V274, P4504, DOI 10.1074/jbc.274.8.4504; SEKINE M, 1994, J BIOL CHEM, V269, P31143; Senay C, 2002, BBA-PROTEIN STRUCT M, V1597, P90, DOI 10.1016/S0167-4838(02)00266-2; Shimodaira K, 1997, CANCER RES, V57, P5201; Snapp KR, 2001, BLOOD, V97, P3806, DOI 10.1182/blood.V97.12.3806; Sperandio M, 2001, J IMMUNOL, V167, P2268, DOI 10.4049/jimmunol.167.4.2268; Sperandio M, 2001, BLOOD, V97, P3812, DOI 10.1182/blood.V97.12.3812; Tenno M, 2002, EUR J BIOCHEM, V269, P4308, DOI 10.1046/j.1432-1033.2002.03123.x; Thomas S, 2002, GLYCOBIOLOGY, V12, p4G; Toki D, 1997, BIOCHEM J, V325, P63, DOI 10.1042/bj3250063; Tsuboi S, 1998, J BIOL CHEM, V273, P30680, DOI 10.1074/jbc.273.46.30680; Tsuboi S, 2001, BIOESSAYS, V23, P46, DOI 10.1002/1521-1878(200101)23:1<46::AID-BIES1006>3.3.CO;2-V; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; VanderElst IE, 1998, GLYCOBIOLOGY, V8, P731, DOI 10.1093/glycob/8.7.731; Vanderplasschen A, 2000, P NATL ACAD SCI USA, V97, P5756, DOI 10.1073/pnas.100058897; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Vo L, 1998, J BIOL CHEM, V273, P25250, DOI 10.1074/jbc.273.39.25250; VRIELINK A, 1994, EMBO J, V13, P3413, DOI 10.1002/j.1460-2075.1994.tb06646.x; Whitehouse C, 1997, J CELL BIOL, V137, P1229, DOI 10.1083/jcb.137.6.1229; WILLIAMS D, 1980, J BIOL CHEM, V255, P1247; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang XJ, 2003, BBA-PROTEINS PROTEOM, V1648, P62, DOI 10.1016/S1570-9639(03)00105-5; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; Yen TY, 2000, J MASS SPECTROM, V35, P990, DOI 10.1002/1096-9888(200008)35:8<990::AID-JMS27>3.0.CO;2-K; Yen TY, 2002, J MASS SPECTROM, V37, P15, DOI 10.1002/jms.241; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772	68	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45864	45881		10.1074/jbc.M303851200	http://dx.doi.org/10.1074/jbc.M303851200			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954635	hybrid			2022-12-27	WOS:000186452300100
J	Fuentes, L; Perez, R; Nieto, ML; Balsinde, J; Balboa, MA				Fuentes, L; Perez, R; Nieto, ML; Balsinde, J; Balboa, MA			Bromoenol lactone promotes cell death by a mechanism involving phosphatidate phosphohydrolase-1 rather than calcium-independent phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID MOBILIZATION; SIGNAL-TRANSDUCTION; DISTINCT ROLES; INHIBITION; APOPTOSIS; PHOSPHATIDYLCHOLINE; MEMBRANE; CASPASES; PHOSPHATIDYLSERINE; TRIACYLGLYCEROL	Originally described as a serine protease inhibitor, bromoenol lactone ( BEL) has recently been found to potently inhibit Group VI calcium-independent phospholipase A(2) (iPLA(2)). Thus, BEL is widely used to define biological roles of iPLA(2) in cells. However, BEL is also known to inhibit another key enzyme of phospholipid metabolism, namely the magnesium-dependent phosphatidate phosphohydrolase-1 (PAP-1). In this work we report that BEL is able to promote apoptosis in a variety of cell lines, including U937, THP-1, and MonoMac (human phagocyte), RAW264.7 ( murine macrophage), Jurkat ( human T lymphocyte), and GH3 ( human pituitary). In these cells, long term treatment with BEL ( up to 24 h) results in increased annexin-V binding to the cell surface and nuclear DNA damage, as detected by staining with both DAPI and propidium iodide. At earlier times ( 2 h), BEL induces the proteolysis of procaspase-9 and procaspase-3 and increases cleavage of poly(ADP-ribose) polymerase. These changes are preceded by variations in the mitochondrial membrane potential. All these effects of BEL are not mimicked by the iPLA(2) inhibitor methylarachidonyl fluorophosphonate or by treating the cells with a specific iPLA(2) antisense oligonucleotide. However, propranolol, a PAP-1 inhibitor, is able to reproduce these effects, suggesting that it is the inhibition of PAP-1 and not of iPLA(2) that is involved in BEL-induced cell death. In support of this view, BEL-induced apoptosis is accompanied by a very strong inhibition of PAP-1-regulated events, such as incorporation of [H-3] choline into phospholipids and de novo incorporation of [H-3] arachidonic acid into triacylglycerol. Collectively, these results stress the role of PAP-1 as a key enzyme for cell integrity and survival and in turn caution against the use of BEL in studies involving long incubation times, due to the capacity of this drug to induce apoptosis in a variety of cells.	Univ Valladolid, Fac Med, Inst Mol Biol & Genet, IBGM CSIC,Sch Med, E-47005 Valladolid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid	Balsinde, J (corresponding author), Univ Valladolid, Fac Med, Inst Mol Biol & Genet, IBGM CSIC,Sch Med, Ave Ramon & Cajal 7, E-47005 Valladolid, Spain.	jbalsinde@ibgm.uva.es	Pérez, Rebeca/M-5235-2015; Fuentes, Lucia/R-6445-2016; Balboa, María A./V-9493-2018; Balsinde, Jesús/C-7833-2018; Nieto, Maria L/G-7492-2015	Pérez, Rebeca/0000-0002-0445-868X; Balboa, María A./0000-0002-2130-5298; Balsinde, Jesús/0000-0002-4157-6714; Nieto, Maria L/0000-0001-6842-799X				ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Balboa MA, 1998, J BIOL CHEM, V273, P7684, DOI 10.1074/jbc.273.13.7684; Balboa MA, 2003, J IMMUNOL, V170, P5276, DOI 10.4049/jimmunol.170.10.5276; Balboa MA, 2002, J BIOL CHEM, V277, P40384, DOI 10.1074/jbc.M206155200; Balsinde J, 1996, EUR J BIOCHEM, V235, P480, DOI 10.1111/j.1432-1033.1996.00480.x; Balsinde J, 2000, J BIOL CHEM, V275, P22544, DOI 10.1074/jbc.M910163199; Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175; Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRATTON DL, 1992, J IMMUNOL, V148, P514; Brindley DN, 2002, BBA-MOL CELL BIOL L, V1582, P33, DOI 10.1016/S1388-1981(02)00135-X; Carnevale KA, 2001, J IMMUNOL, V167, P3414, DOI 10.4049/jimmunol.167.6.3414; Castedo M, 2002, J IMMUNOL METHODS, V265, P39, DOI 10.1016/S0022-1759(02)00069-8; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; Cui Z, 2002, BBA-MOL CELL BIOL L, V1585, P87, DOI 10.1016/S1388-1981(02)00328-1; DANIELS SB, 1983, J BIOL CHEM, V258, P5046; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Gueguen G, 2002, BIOCHEM J, V368, P447, DOI 10.1042/BJ20020273; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; MARTIN A, 1994, SIGNAL ACTIVATED PHO, P139; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; MORLOCK KR, 1991, J BIOL CHEM, V266, P3586; PETTUS B, 2003, BIOCHIM BIOPHYS ACTA, V1585, P114; Roshak AK, 2000, J BIOL CHEM, V275, P35692, DOI 10.1074/jbc.M002273200; Sanchez T, 2002, J CELL PHYSIOL, V193, P293, DOI 10.1002/jcp.10162; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4; ZHU HJ, 1995, FEBS LETT, V374, P303, DOI 10.1016/0014-5793(95)01116-V; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	43	84	86	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44683	44690		10.1074/jbc.M307209200	http://dx.doi.org/10.1074/jbc.M307209200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12952946	hybrid			2022-12-27	WOS:000186306700101
J	Narayanan, B; Islam, MN; Bartelt, D; Ochs, RS				Narayanan, B; Islam, MN; Bartelt, D; Ochs, RS			A direct mass-action mechanism explains capacitative calcium entry in Jurkat and skeletal L6 muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE CA2+ CONCENTRATION; ENDOPLASMIC-RETICULUM; SARCOPLASMIC-RETICULUM; TUMOR PROMOTER; NEURONAL CELLS; ACINAR-CELLS; RECEPTOR; RELEASE; STORES; CHANNELS	We examined capacitative calcium entry (CCE) in Jurkat and in L6 skeletal muscle cells. We found that extracellular Ca2+ can enter the endoplasmic reticulum (ER) of both cell types even in the presence of thapsigargin, which blocks entry into the ER from the cytosol through the CaATPase. Moreover, extracellular Ca2+ entry into the ER was evident even when intracellular flow of Ca2+ was in the direction of ER to cytosol due to the presence of caffeine. ER Ca2+ content was assessed by two separate means. First, we used the Mag-Fura fluorescent dye, which is sensitive only to the relatively high concentrations of Ca2+ found in the ER. Second, we transiently expressed an ER-targeted derivative of aequorin, which reports Ca2+ by luminescence. In both cases, the Ca2+ concentration in the ER increased in response to extracellular Ca2+ after the ER had been previously depleted despite blockade by thapsigargin. We found two differences between the Jurkat and L6 cells. L6, but not Jurkat cells, inhibited Ca2+ uptake at very high Ca2+ concentrations. Second, ryanodine receptor blockers inhibited the appearance of cytosolic Ca2+ during CCE if added before Ca2+ in both cases, but the L6 cells were much more sensitive to ryanodine. Both of these can be explained by the known difference in ryanodine receptors between these cell types. These findings imply that the origin of cytosolic Ca2+ during CCE is the ER. Furthermore, kinetic data demonstrated that Ca2+ filled the ER before the cytosol during CCE. Our results suggest a plasma membrane Ca2+ channel and an ER Ca2+ channel joined in tandem, allowing Ca2+ to flow directly from the extracellular space to the ER. This explains CCE; any decrease in ER [Ca2+] relative to extracellular [Ca2+] would provide the gradient for refilling the ER through a mass-action mechanism.	St Johns Univ, Sch Pharm, Dept Pharmaceut Sci, Jamaica, NY 11439 USA; St Johns Univ, Dept Biol Sci, Jamaica, NY 11439 USA	Saint John's University; Saint John's University	Ochs, RS (corresponding author), St Johns Univ, Sch Pharm, Dept Pharmaceut Sci, 8000 Utopia Pkwy, Jamaica, NY 11439 USA.		Nili, Mona/P-5570-2016	Islam, Mohammad Naimul/0000-0001-7929-9444				Barrero MJ, 1997, J BIOL CHEM, V272, P27694, DOI 10.1074/jbc.272.44.27694; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bode HP, 1996, BIOCHEM PHARMACOL, V51, P993, DOI 10.1016/0006-2952(96)00048-2; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brini M, 1997, MOL BIOL CELL, V8, P129, DOI 10.1091/mbc.8.1.129; CASTEELS R, 1981, J PHYSIOL-LONDON, V317, P263, DOI 10.1113/jphysiol.1981.sp013824; ENDO M, 1985, CURR TOP MEMBR TRANS, V25, P181; FRANZINIARMSTRO.C, 1996, RYANODINE RECEPTORS, P1; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; HOFER AM, 1999, CALCIUM SIGNALING PR; Hopf FW, 1996, J BIOL CHEM, V271, P22358, DOI 10.1074/jbc.271.37.22358; Islam MN, 2002, EXP BIOL MED, V227, P425, DOI 10.1177/153537020222700608; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; Jeyakumar LH, 1998, J BIOL CHEM, V273, P16011, DOI 10.1074/jbc.273.26.16011; KANG JJ, 1994, BRIT J PHARMACOL, V112, P1216, DOI 10.1111/j.1476-5381.1994.tb13213.x; Kiselyov KI, 2000, MOL CELL, V6, P421, DOI 10.1016/S1097-2765(00)00041-1; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; LENNARD R, 1992, GEN PHARMACOL, V23, P903, DOI 10.1016/0306-3623(92)90244-E; Liu WR, 2002, LIFE SCI, V71, P1279, DOI 10.1016/S0024-3205(02)01826-X; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; Nakai J, 1998, J BIOL CHEM, V273, P13403, DOI 10.1074/jbc.273.22.13403; Nguyen HN, 2002, BRAIN RES, V924, P159, DOI 10.1016/S0006-8993(01)03229-2; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; NORI A, 1996, RYANODINE RECEPTORS, P101; Ogawa Y, 2000, TRENDS CARDIOVAS MED, V10, P65, DOI 10.1016/S1050-1738(00)00050-5; OGDEN D, 1995, PFLUG ARCH EUR J PHY, V429, P587, DOI 10.1007/BF00704165; Philipp S, 2000, CRC METH SIG TRANS, P321; Putney Jr JW, 1997, CAPACITATIVE CALCIUM; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Putney JW, 2001, J CELL SCI, V114, P2223; Robert V, 1998, J BIOL CHEM, V273, P30372, DOI 10.1074/jbc.273.46.30372; Sonnleitner A, 1998, EMBO J, V17, P2790, DOI 10.1093/emboj/17.10.2790; SUGIYAMA T, 1995, AM J PHYSIOL-CELL PH, V269, pC698, DOI 10.1152/ajpcell.1995.269.3.C698; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Wang MC, 2002, J MOL BIOL, V323, P85, DOI 10.1016/S0022-2836(02)00890-2; Wingertzahn MA, 1999, P SOC EXP BIOL MED, V221, P234, DOI 10.1046/j.1525-1373.1999.d01-81.x; Wingertzahn MA, 2001, EXP BIOL MED, V226, P119, DOI 10.1177/153537020122600209; Zucchi R, 1997, PHARMACOL REV, V49, P1	43	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44188	44196		10.1074/jbc.M306538200	http://dx.doi.org/10.1074/jbc.M306538200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947122	hybrid			2022-12-27	WOS:000186306700038
J	Zhang, F; Lin, MH; Abidi, P; Thiel, G; Liu, JW				Zhang, F; Lin, MH; Abidi, P; Thiel, G; Liu, JW			Specific interaction of Egr1 and c/EBP beta leads to the transcriptional activation of the human low density lipoprotein receptor gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; ONCOSTATIN M; EXPRESSION; CELLS; GROWTH; INDUCTION; ELEMENT; IDENTIFICATION; PATHWAY; ZINC	The sterol-independent regulatory element ( SIRE) of the LDL receptor ( LDLR) promoter mediates oncostatin M ( OM)-induced transcription of the LDLR gene through a cholesterol-independent pathway. Our prior studies have detected specific associations of the zinc finger transcription factor Egr1 with the SIRE sequence in OM-stimulated HepG2 cells. Because the SIRE motif is composed of a c/EBP binding site and a cAMP response element, both of which are quite divergent from the classical GC-rich Egr1 recognition sequences, we hypothesized that Egr1 may regulate LDLR transcription through interacting with members of the c/EBP and CREB families. Here, we show that treating HepG2 cells with OM specifically leads to prominent increases of the levels of c/EBPbeta and Egr1 bound to the LDLR promoter in vivo. In vitro, the binding of Egr1 to the SIRE sequence is weak, but is strikingly enhanced in the presence of HepG2 nuclear extract. Mammalian two-hybrid assays demonstrate that the N-terminal transactivation domain of Egr1 specifically interacts with c/EBPbeta but not with c/EBPalpha or CREB. The OM treatment further enhances this interaction, resulting in a large increase in the Egr1 transactivating activity. The direct protein to protein contact between Egr1 and c/EBPbeta is also demonstrated by co-immunoprecipitation experiments. Furthermore, we show that a mutation of the phosphorylation motif of c/EBPbeta diminished the OM-stimulated interaction of Egr1 and c/EBPbeta. Taken together, we provide strong evidence that Egr1 regulates LDLR transcription via a novel mechanism of protein-protein interaction with c/EBPbeta.	Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; Univ Saarland, Med Ctr, D-66421 Homburg, Germany	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Saarland University	Liu, JW (corresponding author), Dept Vet Affairs Palo Alto Hlth Care Syst, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	Jingwen.Liu@med.va.gov			NATIONAL CANCER INSTITUTE [R01CA083648] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA83648-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adamson ED, 2002, TUMOR BIOL, V23, P93, DOI 10.1159/000059711; Akira S, 1997, INT J BIOCHEM CELL B, V29, P1401, DOI 10.1016/S1357-2725(97)00063-0; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; CHRISTY B, 1988, P NATL ACAD SCI USA, V85, P797; Cohen DM, 1996, P NATL ACAD SCI USA, V93, P11242, DOI 10.1073/pnas.93.20.11242; Day FL, 1999, J BIOL CHEM, V274, P23726, DOI 10.1074/jbc.274.34.23726; DIEKGRAFFE B, 1999, AM J PHYSIOL, V276, pG322; GASHLER AL, 1993, MOL CELL BIOL, V13, P4556, DOI 10.1128/MCB.13.8.4556; Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200; Kaufmann K, 2001, BIOL CHEM, V382, P1077, DOI 10.1515/BC.2001.135; Levkovitz Y, 2002, J NEUROSCI, V22, P3845, DOI 10.1523/JNEUROSCI.22-10-03845.2002; Li C, 1999, J BIOL CHEM, V274, P6747, DOI 10.1074/jbc.274.10.6747; LIM RW, 1987, ONCOGENE, V1, P263; Liu JW, 2000, J BIOL CHEM, V275, P5214, DOI 10.1074/jbc.275.7.5214; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Papanikolaou NA, 2000, J BIOL CHEM, V275, P26683; Park JA, 1999, J NEUROCHEM, V73, P450, DOI 10.1046/j.1471-4159.1999.0730450.x; Sato K, 1999, MOL BRAIN RES, V74, P182, DOI 10.1016/S0169-328X(99)00279-X; Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200; THIEL G, 1994, J BIOL CHEM, V269, P15294; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Thiel G, 2000, BBA-GENE STRUCT EXPR, V1493, P289, DOI 10.1016/S0167-4781(00)00207-4; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; Zhang F, 2002, J LIPID RES, V43, P1477, DOI 10.1194/jlr.M200126-JLR200	27	55	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44246	44254		10.1074/jbc.M305564200	http://dx.doi.org/10.1074/jbc.M305564200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947119	hybrid			2022-12-27	WOS:000186306700045
J	Zakharova, N; Lymar, ES; Yang, E; Malik, S; Zhang, JJL; Roeder, RG; Darnell, JE				Zakharova, N; Lymar, ES; Yang, E; Malik, S; Zhang, JJL; Roeder, RG; Darnell, JE			Distinct transcriptional activation functions of STAT1 alpha and STAT1 beta on DNA and chromatin templates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; INTERFERON-GAMMA; GENE-TRANSCRIPTION; STAT PROTEINS; COFACTORS; MEDIATOR; TYROSINE; BINDING; 91-KDA; DOMAIN	Interferon-induced transcription depends upon tyrosine phosphorylation, subsequent dimerization, and binding to DNA of STAT1. Other factors, including but not necessarily limited to CBP/p300, then bind within the C-terminal 38 amino acid transactivation domain (TAD) to activate transcription. We show that both tyrosine-phosphorylated STAT1alpha (full-length wild-type protein) and STAT1beta (lacking the TAD) stimulate in vitro transcription on a naked DNA template. Furthermore, in a system with purified proteins and naked DNA, STAT1alpha- and STAT1beta-dependent transcription is stimulated by the TRAP/Mediator co-activator complex. Thus STAT1, through some site other than the C-terminal TAD, can interact with TRAP/Mediator or some intermediate protein. Although both STAT1alpha and STAT1beta bind to known STAT sites within in vitro assembled chromatin templates, only STAT1alpha, and not STAT1beta, in cooperation with p300 and acetyl-CoA, stimulated in vitro transcription from chromatin. After interferon-gamma treatment, cells recruit STAT1alpha or -beta to the chromosomal interferon-1 gene, but only STAT1alpha-containing cells recruit p300 and stimulate transcription. We conclude that chromatin remodeling by p300 in vivo makes TRAP/Mediator effective in stimulating transcription.	Rockefeller Univ, Mol Cell Biol Lab, New York, NY 10021 USA; Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Cornell University	Darnell, JE (corresponding author), Rockefeller Univ, Mol Cell Biol Lab, New York, NY 10021 USA.				NCI NIH HHS [CA42567] Funding Source: Medline; NIAID NIH HHS [AI34420, AI32489] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA042567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032489, R37AI034420, R01AI034420] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Bulger M., 1994, METH MOL G, V5, P241; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Ge H, 1996, METHOD ENZYMOL, V274, P57; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Horvath CM, 1996, MOL CELL BIOL, V16, P6957; Ito T, 2000, GENE DEV, V14, P1899; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Kaiser K, 1996, TRENDS BIOCHEM SCI, V21, P342, DOI 10.1016/S0968-0004(96)10043-8; KHAN KD, 1993, P NATL ACAD SCI USA, V90, P6806, DOI 10.1073/pnas.90.14.6806; Lau JF, 2003, MOL CELL BIOL, V23, P620, DOI 10.1128/MCB.23.2.620-628.2003; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Look DC, 1995, J BIOL CHEM, V270, P30264, DOI 10.1074/jbc.270.51.30264; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Malik S, 1998, P NATL ACAD SCI USA, V95, P2192, DOI 10.1073/pnas.95.5.2192; Malik S, 1996, MOL CELL BIOL, V16, P1824; MEISTERERNST M, 1991, CELL, V66, P981, DOI 10.1016/0092-8674(91)90443-3; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Paulson M, 2002, NAT CELL BIOL, V4, P140, DOI 10.1038/ncb747; POGNONEC P, 1991, MOL CELL BIOL, V11, P5125, DOI 10.1128/MCB.11.10.5125; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; Shen Y, 2001, J VIROL, V75, P2627, DOI 10.1128/JVI.75.6.2627-2633.2001; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; Stoecklin E, 1997, MOL CELL BIOL, V17, P6708, DOI 10.1128/MCB.17.11.6708; Stoecklin Elisabeth, 1996, Nature (London), V383, P726; Vinkemeier U, 1998, SCIENCE, V279, P1048, DOI 10.1126/science.279.5353.1048; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yang E, 2002, J BIOL CHEM, V277, P13455, DOI 10.1074/jbc.M112038200; Yang E, 1999, MOL CELL BIOL, V19, P5106; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhang JJ, 1998, EMBO J, V17, P6963, DOI 10.1093/emboj/17.23.6963; Zhang XK, 1999, MOL CELL BIOL, V19, P7138	45	53	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43067	43073		10.1074/jbc.M308166200	http://dx.doi.org/10.1074/jbc.M308166200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12939262	hybrid			2022-12-27	WOS:000186157000044
J	Cesura, AM; Pinard, E; Schubenel, R; Goetschy, V; Friedlein, A; Langen, H; Polcic, P; Forte, MA; Bernardi, P; Kemp, JA				Cesura, AM; Pinard, E; Schubenel, R; Goetschy, V; Friedlein, A; Langen, H; Polcic, P; Forte, MA; Bernardi, P; Kemp, JA			The voltage-dependent anion channel is the target for a new class of inhibitors of the mitochondrial permeability transition pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOSPORINE-A; CYTOCHROME-C; INNER MEMBRANE; BM88 ANTIGEN; RAT-BRAIN; YEAST; VDAC; PROTEINS; ISOFORMS; CALCIUM	The relevance of the mitochondrial permeability transition pore (PTP) in Ca2+ homeostasis and cell death has gained wide attention. Yet, despite detailed functional characterization, the structure of this channel remains elusive. Here we report on a new class of inhibitors of the PTP and on the identification of their molecular target. The most potent among the compounds prepared, Ro 68-3400, inhibited PTP with a potency comparable to that of cyclosporin A. Since Ro 68-3400 has a reactive moiety capable of covalent modification of proteins, [H-3] Ro 68-3400 was used as an affinity label for the identification of its protein target. In intact mitochondria isolated from rodent brain and liver and in SH-SY5Y human neuroblastoma cells, [H-3] Ro 68-3400 predominantly labeled a protein of similar to 32 kDa. This protein was identified as the isoform 1 of the voltage-dependent anion channel (VDAC). Both functional and affinity labeling experiments indicated that VDAC might correspond to the site for the PTP inhibitor ubiquinone(0), whereas other known PTP modulators acted at distinct sites. While Ro 68-3400 represents a new useful tool for the study of the structure and function of VDAC and the PTP, the results obtained provide direct evidence that VDAC1 is a component of this mitochondrial pore.	F Hoffmann La Roche & Co Ltd, Drug Discovery Dept, Div Pharmaceut, CH-4070 Basel, Switzerland; F Hoffmann La Roche & Co Ltd, Gen Technol, CH-4070 Basel, Switzerland; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy	Roche Holding; Roche Holding; Oregon Health & Science University; University of Padua	Cesura, AM (corresponding author), F Hoffmann La Roche & Co Ltd, Drug Discovery Dept, Div Pharmaceut, 92-3-76,Grenzacherstr 124, CH-4070 Basel, Switzerland.	andrea.cesura@serono.com; emmanuel.pinard@roche.com	Bernardi, Paolo/C-3656-2008	Bernardi, Paolo/0000-0001-9187-3736; Polcic, Peter/0000-0003-0341-7533	NIGMS NIH HHS [R01-GM35759] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035759] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Beutner G, 1996, FEBS LETT, V396, P189, DOI 10.1016/0014-5793(96)01092-7; BlachlyDyson E, 1997, MOL CELL BIOL, V17, P5727, DOI 10.1128/MCB.17.10.5727; BLACHLYDYSON E, 1993, J BIOL CHEM, V268, P1835; Broekemeier KM, 1995, BIOCHEMISTRY-US, V34, P16440, DOI 10.1021/bi00050a027; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Chernyak BV, 1996, EUR J BIOCHEM, V238, P623, DOI 10.1111/j.1432-1033.1996.0623w.x; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Fountoulakis M, 1997, ANAL BIOCHEM, V250, P153, DOI 10.1006/abio.1997.2213; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; Gross A, 2000, MOL CELL BIOL, V20, P3125, DOI 10.1128/MCB.20.9.3125-3136.2000; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; HOEK JB, 1980, J BIOL CHEM, V255, P1458; Huizing M, 1998, J BIOENERG BIOMEMBR, V30, P277, DOI 10.1023/A:1020501021222; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Jung DW, 1997, J BIOL CHEM, V272, P21104, DOI 10.1074/jbc.272.34.21104; Khaspekov L, 1999, EUR J NEUROSCI, V11, P3194, DOI 10.1046/j.1460-9568.1999.00743.x; Krapfenbauer K, 2001, EUR J BIOCHEM, V268, P3532, DOI 10.1046/j.1432-1327.2001.02256.x; Linder MD, 2002, J BIOL CHEM, V277, P937, DOI 10.1074/jbc.M107610200; Liu GY, 1996, J BIOL CHEM, V271, P19717, DOI 10.1074/jbc.271.33.19717; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; MAMALAKI A, 1995, J BIOL CHEM, V270, P14201, DOI 10.1074/jbc.270.23.14201; Martinucci S, 2000, FEBS LETT, V480, P89, DOI 10.1016/S0014-5793(00)01911-6; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; PATSAVOUDI E, 1995, J NEUROSCI RES, V40, P506, DOI 10.1002/jnr.490400410; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Schinder AF, 1996, J NEUROSCI, V16, P6125; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shinohara Y, 2000, EUR J BIOCHEM, V267, P6067, DOI 10.1046/j.1432-1327.2000.01687.x; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; Vergun O, 1999, J PHYSIOL-LONDON, V519, P451, DOI 10.1111/j.1469-7793.1999.0451m.x; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; WARD FE, 1981, J MED CHEM, V24, P1073, DOI 10.1021/jm00141a011; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; Yoshimoto T, 1999, BRAIN RES, V839, P283, DOI 10.1016/S0006-8993(99)01733-3; YU WH, 1995, J BIOL CHEM, V270, P13998, DOI 10.1074/jbc.270.23.13998; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	52	88	93	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2003	278	50					49812	49818		10.1074/jbc.M304748200	http://dx.doi.org/10.1074/jbc.M304748200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751LH	12952973	hybrid			2022-12-27	WOS:000187068200022
J	Armstrong, JS; Whiteman, M; Rose, P; Jones, DP				Armstrong, JS; Whiteman, M; Rose, P; Jones, DP			The coenzyme Q10 analog decylubiquinone inhibits the redox-activated mitochondrial permeability transition - Role of mitochondrial respiratory complex III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; IRON-SULFUR PROTEIN; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; ELECTRON-TRANSFER; CELL-DEATH; C RELEASE; Q(O) SITE; PORE; GENERATION	The mitochondrial permeability transition (MPT) is a key event in apoptotic and necrotic cell death and is controlled by the cellular redox state. To further investigate the mechanism(s) involved in regulation of the MPT, we used diethylmaleate to deplete GSH in HL60 cells and increase mitochondrial reactive oxygen species (ROS) production. The site of mitochondrial ROS production was determined to be mitochondrial respiratory complex III ( cytochrome bc(1)), because 1) stigmatellin, a Q(o) site inhibitor, blocked ROS production and prevented the MPT and cell death and 2) cytochrome bc1 activity was abolished in cells protected from the redox-dependent MPT by stigmatellin. We next investigated the effect of pretreating cells with coenzyme Q(10) analogs decylubiquinone (dUb) and ubiquinone 0 (Ub0) on the redox-dependent MPT. Pretreatment of HL60 cells with dUb blocked ROS production induced by GSH depletion and prevented activation of the MPT and cell death, whereas Ub0 did not. Since we also found that dUb did not inhibit cytochrome bc1 activity, the mechanism of protection against redox-dependent MPT by dUb may depend on its ability to scavenge ROS generated by cytochrome bc1. These results indicate that dUb, like the clinically used ubiquinone analog idebenone, may serve as a candidate antioxidant compound for the development of pharmacological agents to treat diseases where there is an oxidative stress component.	Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; Natl Univ Singapore, Dept Community Occupat & Family Med, Singapore 117597, Singapore; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	National University of Singapore; National University of Singapore; Emory University	Armstrong, JS (corresponding author), Natl Univ Singapore, Dept Biochem, Kent Rd, Singapore 117597, Singapore.	bchjsa@nus.edu.sg	Whiteman, Matthew/C-6079-2009	Whiteman, Matthew/0000-0002-6583-6779; Rose, Pete/0000-0001-8494-0902	NEI NIH HHS [EY07892, P30 EY06360] Funding Source: Medline; NIEHS NIH HHS [ES09047] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY006360, R01EY007892, R29EY007892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009047] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Armstrong JS, 2002, FASEB J, V16, P1263, DOI 10.1096/fj.02-0097fje; Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; BASS DA, 1983, J IMMUNOL, V130, P1910; Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528; BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435; Boveris A, 2000, IUBMB LIFE, V50, P245, DOI 10.1080/15216540051080912; Bradham CA, 1998, MOL CELL BIOL, V18, P6353, DOI 10.1128/MCB.18.11.6353; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chinopoulos C, 2003, J BIOL CHEM, V278, P27382, DOI 10.1074/jbc.M303808200; Costantini P, 2000, ONCOGENE, V19, P307, DOI 10.1038/sj.onc.1203299; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15791, DOI 10.1021/bi990961u; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Fernandez-Checa JC, 1998, BIOFACTORS, V8, P7, DOI 10.1002/biof.5520080102; FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879; Genova MW, 2003, EXP BIOL MED, V228, P506, DOI 10.1177/15353702-0322805-14; Geromel V, 2002, MOL GENET METAB, V77, P21, DOI 10.1016/S1096-7192(02)00145-2; GILLIS JC, 1994, DRUG AGING, V5, P133, DOI 10.2165/00002512-199405020-00007; Graeber MB, 1998, J NEUROSCI RES, V52, P1; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Kwong LK, 2002, FREE RADICAL BIO MED, V33, P627, DOI 10.1016/S0891-5849(02)00916-4; Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0; Lenaz G, 2000, BBA-BIOENERGETICS, V1459, P397, DOI 10.1016/S0005-2728(00)00177-8; Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Moghaddas S, 2003, ARCH BIOCHEM BIOPHYS, V414, P59, DOI 10.1016/S0003-9861(03)00166-8; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Qian T, 1999, TOXICOL APPL PHARM, V154, P117, DOI 10.1006/taap.1998.8580; Rothman SM, 1999, BIOCHEM SOC SYMP, V66, P111, DOI 10.1042/bss0660111; SANTHAMMA KR, 1993, BIOCHEM BIOPH RES CO, V190, P201, DOI 10.1006/bbrc.1993.1031; Starkov AA, 2001, BIOCHEM BIOPH RES CO, V281, P645, DOI 10.1006/bbrc.2001.4409; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; VALLS V, 1994, BIOCHEM MOL BIOL INT, V33, P633; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; Yang JC, 1998, FREE RADICAL BIO MED, V24, P624, DOI 10.1016/S0891-5849(97)00367-5; Yu CA, 1998, BBA-BIOENERGETICS, V1365, P151, DOI 10.1016/S0005-2728(98)00055-3; Zamzami N, 1996, FEBS LETT, V384, P53, DOI 10.1016/0014-5793(96)00280-3; Zhang L, 2000, J BIOL CHEM, V275, P7656, DOI 10.1074/jbc.275.11.7656; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	49	66	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					49079	49084		10.1074/jbc.M307841200	http://dx.doi.org/10.1074/jbc.M307841200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12949071	hybrid			2022-12-27	WOS:000186829000070
J	Xu, Y; Wang, L; Buttice, G; Sengupta, PK; Smith, BD				Xu, Y; Wang, L; Buttice, G; Sengupta, PK; Smith, BD			Interferon gamma repression of collagen (COL1A2) transcription is mediated by the RFX5 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II TRANSACTIVATOR; BARE LYMPHOCYTE SYNDROME; CREB BINDING-PROTEIN; REGULATORY FACTOR-X; NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-BETA; GENE-EXPRESSION; HUMAN FIBROBLASTS; MOUSE ALPHA-2(I)	Interferon gamma (IFN-gamma) plays an important physiological role during inflammation by down-regulating collagen gene expression and activating major histocompatibility II (MHC-II) complex. The activation of MHC-II by IFN-gamma requires activation of a trimeric DNA binding transcriptional complex, RFX5 complex, containing RFXB (also called RFXANK or Tvl-1), RFXAP, as well as RFX5 protein. Previously, we demonstrated that RFX5 binds to the collagen transcription start site and represses collagen gene expression (Sengupta, P. K., Fargo, J., Smith, B. D. ( 2002) J. Biol. Chem. 277, 24926 24937). In this report, we have examined the role of RFXB and RFXAP proteins within the RFX5 complex to regulate collagen gene expression. The data show that all three RFX5 complex proteins are required for maximum repression. Expression of proteins with mutations known to be important for RFX5 complex formation does not repress collagen promoter activity. Two mutated forms of RFX5 act as dominant negative proteins activating collagen expression and reversing IFN-gamma down-regulation of collagen expression in human lung fibroblasts. IFN-gamma increases expression and nuclear translocation of RFX5. RFXB has a naturally occurring splice variant isoform (RFX SV). Interferon increases expression of the long form of RFXB and decreases expression of RFX SV with the same kinetics as collagen gene expression. Overexpression of the splice variant form reverses the IFN-gamma induced collagen repression in human lung fibroblasts. Finally, all three RFX5 complex proteins increase at the collagen transcription start site with IFN-gamma treatment using chromatin immunoprecipitation analysis. Thus, these studies suggest an important role for RFX5 complex in collagen repression.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Vet Affairs Boston Healthcare Syst, Boston, MA 02118 USA	Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Smith, BD (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St, Boston, MA 02118 USA.			Smith, Barbara/0000-0002-5375-7627; Buttice', Giovanna/0000-0001-6550-5585	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068094] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01-HL68094] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antoniou KM, 2003, CHEST, V123, P209, DOI 10.1378/chest.123.1.209; Chang CH, 2002, IMMUNOL RES, V25, P131, DOI 10.1385/IR:25:2:131; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; CHIN KC, 1994, IMMUNITY, V1, P687, DOI 10.1016/1074-7613(94)90039-6; Czuwara-Ladykowska J, 2001, J BIOL CHEM, V276, P20839, DOI 10.1074/jbc.M010133200; Darnell JE, 1996, RECENT PROG HORM RES, V51, P391; Das S, 2002, J BIOL CHEM, V277, P45172, DOI 10.1074/jbc.M204117200; DeSandro AM, 2000, MOL CELL BIOL, V20, P6587, DOI 10.1128/MCB.20.17.6587-6599.2000; DURAND B, 1994, MOL CELL BIOL, V14, P6839, DOI 10.1128/MCB.14.10.6839; Fontes JD, 1997, NUCLEIC ACIDS RES, V25, P2522, DOI 10.1093/nar/25.12.2522; Fontes JD, 1999, MOL CELL BIOL, V19, P941; Ghosh AK, 2001, J BIOL CHEM, V276, P11041, DOI 10.1074/jbc.M004709200; GOLDBERG H, 1992, J BIOL CHEM, V267, P19622; GRANSTEIN RD, 1990, J INVEST DERMATOL, V95, pS75, DOI 10.1111/1523-1747.ep12874789; Hasegawa T, 1997, J BIOL CHEM, V272, P4915, DOI 10.1074/jbc.272.8.4915; HATAMOCHI A, 1986, J BIOL CHEM, V261, P1310; Higashi K, 1998, MATRIX BIOL, V16, P447, DOI 10.1016/S0945-053X(98)90016-6; Higashi K, 2003, J BIOL CHEM, V278, P5156, DOI 10.1074/jbc.M208724200; Jabrane-Ferrat N, 2003, INT IMMUNOL, V15, P467, DOI 10.1093/intimm/dxg048; Jabrane-Ferrat N, 2002, MOL CELL BIOL, V22, P5616, DOI 10.1128/MCB.22.15.5616-5625.2002; JabraneFerrat N, 1996, MOL CELL BIOL, V16, P4683; JIMENEZ SA, 1984, J CLIN INVEST, V74, P1112, DOI 10.1172/JCI111480; KAHARI VM, 1990, J CLIN INVEST, V86, P1489, DOI 10.1172/JCI114866; KARSENTY G, 1991, BIOCHEM BIOPH RES CO, V177, P538, DOI 10.1016/0006-291X(91)92017-E; Kretsovali A, 1998, MOL CELL BIOL, V18, P6777, DOI 10.1128/MCB.18.11.6777; Lin JH, 1999, J BIOL CHEM, V274, P14706, DOI 10.1074/jbc.274.21.14706; Mahanta SK, 1997, P NATL ACAD SCI USA, V94, P6324, DOI 10.1073/pnas.94.12.6324; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Masternak K, 2000, GENE DEV, V14, P1156; Masternak K, 2003, NAT IMMUNOL, V4, P132, DOI 10.1038/ni883; Masternak K, 2002, EMBO J, V21, P1379, DOI 10.1093/emboj/21.6.1379; McDevitt H, 2002, IMMUNOL REV, V185, P78, DOI 10.1034/j.1600-065X.2002.18509.x; McDevitt HO, 2000, ANNU REV IMMUNOL, V18, P1, DOI 10.1146/annurev.immunol.18.1.1; Moreno CS, 1997, J IMMUNOL, V158, P5841; Nagarajan UM, 1999, IMMUNITY, V10, P153, DOI 10.1016/S1074-7613(00)80016-3; Nagarajan UM, 2000, J IMMUNOL, V164, P3666, DOI 10.4049/jimmunol.164.7.3666; Nekrep N, 2000, MOL CELL BIOL, V20, P4455, DOI 10.1128/MCB.20.12.4455-4461.2000; Patriotis C, 2001, J CELL PHYSIOL, V187, P176, DOI 10.1002/jcp.1066; Piskurich JF, 1998, J IMMUNOL, V160, P233; Raval A, 2001, MOL CELL, V7, P105, DOI 10.1016/S1097-2765(01)00159-9; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; ROSENBLOOM J, 1984, BIOCHEM BIOPH RES CO, V123, P365, DOI 10.1016/0006-291X(84)90422-4; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sengupta PK, 2002, J BIOL CHEM, V277, P24926, DOI 10.1074/jbc.M111712200; Sengupta PK, 1998, BBA-GENE STRUCT EXPR, V1443, P75, DOI 10.1016/S0167-4781(98)00188-2; Sengupta PK, 1999, J BIOL CHEM, V274, P36649, DOI 10.1074/jbc.274.51.36649; Sisk TJ, 2000, J IMMUNOL, V165, P2511, DOI 10.4049/jimmunol.165.5.2511; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; TAMAKI T, 1995, J BIOL CHEM, V270, P4299, DOI 10.1074/jbc.270.9.4299; VARGA J, 1990, EUR J CLIN INVEST, V20, P487, DOI 10.1111/j.1365-2362.1990.tb01915.x; Weissman JDJ, 2000, J BIOL CHEM, V275, P10160, DOI 10.1074/jbc.275.14.10160; Westerheide SD, 1999, NUCLEIC ACIDS RES, V27, P1635, DOI 10.1093/nar/27.7.1635; Yuan WH, 1999, J CELL PHYSIOL, V179, P97, DOI 10.1002/(SICI)1097-4652(199904)179:1<97::AID-JCP12>3.3.CO;2-5; Zhu XS, 2000, MOL CELL BIOL, V20, P6051, DOI 10.1128/MCB.20.16.6051-6061.2000; Zhu XS, 2001, MOL CELL BIOL, V21, P7078, DOI 10.1128/MCB.21.20.7078-7088.2001; Zika E, 2003, MOL CELL BIOL, V23, P3091, DOI 10.1128/MCB.23.9.3091-3102.2003	58	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					49134	49144		10.1074/jbc.M309003200	http://dx.doi.org/10.1074/jbc.M309003200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12968017				2022-12-27	WOS:000186829000077
J	Blaschke, RJ; Topfer, C; Marchini, A; Steinbeisser, H; Janssen, JWG; Rappold, GA				Blaschke, RJ; Topfer, C; Marchini, A; Steinbeisser, H; Janssen, JWG; Rappold, GA			Transcriptional and translational regulation of the Leri-Weill and Turner syndrome homeobox gene SHOX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME ENTRY SITES; OPEN READING FRAMES; MESSENGER-RNA; SHORT STATURE; INITIATING TRANSLATION; EUKARYOTIC RIBOSOMES; SECONDARY STRUCTURE; EXPRESSION; MUTATIONS; REGION	Regulation of gene expression is particularly important for gene dosage-dependent diseases and the phenomenon of clinical heterogeneity frequently associated with these phenotypes. We here report on the combined transcriptional and translational regulatory mechanisms controlling the expression of the Leri-Weill and Turner syndrome gene SHOX. We define an alternative promotor within exon 2 of the SHOX gene by transient transfections of mono- and bicistronic reporter constructs and demonstrate substantial differences in the translation efficiency of the mRNAs transcribed from these alternative promotors by in vitro translation assays and direct mRNA transfections into different cell lines. Although transcripts generated from the intragenic promotor (P-2) are translated with high efficiencies, mRNA originating from the upstream promotor (P-1) exhibit significant translation inhibitory effects due to seven AUG codons upstream of the main open reading frame (uAUGs). Site-directed mutagenesis of these uAUGs confers full translation efficiency to reporter mRNAs in different cell lines and after injection of Xenopus embryos. In conclusion, our data support a model where functional SHOX protein levels are regulated by a combination of transcriptional and translational control mechanisms.	Univ Heidelberg, Inst Human Genet, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Rappold, GA (corresponding author), Univ Heidelberg, Inst Human Genet, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.		Marchini, Antonio/AAG-7151-2019; Marchini, Antonio/ABD-3328-2020	Marchini, Antonio/0000-0003-3157-4552				Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; Blaschke RJ, 2000, TRENDS ENDOCRIN MET, V11, P227, DOI 10.1016/S1043-2760(00)00262-9; Butler JEF, 2001, GENE DEV, V15, P2515, DOI 10.1101/gad.924301; Cai HNN, 2001, DEVELOPMENT, V128, P4339; Calkhoven CF, 2002, TRENDS MOL MED, V8, P577, DOI 10.1016/S1471-4914(02)02424-3; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; Davuluri RV, 2000, GENOME RES, V10, P1807, DOI 10.1101/gr.GR-1460R; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Han BG, 2002, MOL CELL BIOL, V22, P7372, DOI 10.1128/MCB.22.21.7372-7384.2002; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hinnebusch A.G., 1996, TRANSLATIONAL CONTRO, P199; JACKSON RJ, 1988, NATURE, V334, P292, DOI 10.1038/334292a0; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kozak M, 2002, MAMM GENOME, V13, P401, DOI 10.1007/s00335-002-4002-5; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Kozak M, 2001, MOL CELL BIOL, V21, P1899, DOI 10.1128/MCB.21.6.1899-1907.2001; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Peri S, 2001, TRENDS GENET, V17, P685, DOI 10.1016/S0168-9525(01)02493-3; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Preiss T, 1999, CURR OPIN GENET DEV, V9, P515, DOI 10.1016/S0959-437X(99)00005-2; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Rao E, 2001, HUM MOL GENET, V10, P3083, DOI 10.1093/hmg/10.26.3083; Sachs AB, 2000, CELL, V101, P243, DOI 10.1016/S0092-8674(00)80834-X; Schiller S, 2000, EUR J HUM GENET, V8, P54, DOI 10.1038/sj.ejhg.5200402; Schneider R, 2001, MOL CELL BIOL, V21, P8238, DOI 10.1128/MCB.21.23.8238-8246.2001; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208	40	42	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47820	47826		10.1074/jbc.M306685200	http://dx.doi.org/10.1074/jbc.M306685200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12960152	hybrid			2022-12-27	WOS:000186731400058
J	Chen, ZH; Stokes, SL; Rice, WJ; Jones, LR				Chen, ZH; Stokes, SL; Rice, WJ; Jones, LR			Spatial and dynamic interactions between phospholamban and the canine cardiac Ca2+ pump revealed with use of heterobifunctional cross-linking agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCO(ENDO)PLASMIC RETICULUM CA2+-ATPASES; BETA-ADRENERGIC STIMULATION; SARCOPLASMIC-RETICULUM; CALCIUM-PUMP; FUNCTIONAL ASSOCIATION; ESCHERICHIA-COLI; ATP-BINDING; THAPSIGARGIN; PHOSPHORYLATION; DOMAIN	Heterobifunctional thiol to amine cross-linking agents were used to gain new insights on the dynamics and conformational factors governing the interaction between the cardiac Ca2+ pump (SERCA2a) and phospholamban (PLB). PLB is a small protein inhibitor of SERCA2a that reduces enzyme affinity for Ca2+ and thereby regulates cardiac contractility. We found that the PLB monomer with Asn(27) or Asn(30) changed to Cys (N27C-PLB or N30C-PLB) cross-linked to lysine of SERCA2a within seconds with greater than or equal to80% efficiency. Optimal cross-linking occurred at spacer chain lengths of 10 and 15 Angstrom for N27C and N30C, respectively. The rapid time course of cross-linking indicated that neither dissociation of PLB pentamers nor binding of PLB monomers to SERCA2a was rate-limiting. Cross-linking occurred only to the E2 (Ca2+-free) conformation of SERCA2a, was strongly favored by nucleotide binding to this state, and was completely inhibited by thapsigargin. Protein sequencing in combination with mutagenesis identified of Lys(328) of SERCA2a as the target of cross-linking. A three-dimensional map of interacting residues indicated that the cross-linking distances were entirely compatible with the 10-Angstrom distance recently determined between N30C of PLB and Cys(318) of SERCA2a. In contrast, Lys(3) of PLB did not cross-link to any Lys (or Cys) of SERCA2a, suggesting that previous three-dimensional models that constrain Lys3 near residues 397 - 400 of thapsigargin-inhibited SERCA2a should be viewed with caution. Furthermore, although earlier models of PLB . SERCA2a are based on thapsigargin-bound SERCA, our results suggest that the nucleotide-bound, E2 conformation is substantially different and represents the key conformational state for interacting with PLB.	Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; New York University; New York University	Jones, LR (corresponding author), Indiana Univ, Sch Med, Krannert Inst Cardiol, 1800 N Capitol Ave, Indianapolis, IN 46202 USA.	lrjones@iupui.edu		Rice, William/0000-0002-5187-255X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049428, R37HL049428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056960] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL49428] Funding Source: Medline; NIGMS NIH HHS [GM56960] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Asahi M, 2001, P NATL ACAD SCI USA, V98, P10061, DOI 10.1073/pnas.181348298; Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Back JW, 2003, J MOL BIOL, V331, P303, DOI 10.1016/S0022-2836(03)00721-6; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Cornea RL, 2000, J BIOL CHEM, V275, P41487, DOI 10.1074/jbc.M008195200; DEJESUS F, 1993, FEBS LETT, V332, P229, DOI 10.1016/0014-5793(93)80638-B; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Guan L, 2002, P NATL ACAD SCI USA, V99, P6613, DOI 10.1073/pnas.102178299; Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ; Hutter MC, 2002, CHEMBIOCHEM, V3, P1200, DOI 10.1002/1439-7633(20021202)3:12<1200::AID-CBIC1200>3.0.CO;2-H; INESI G, 1987, J BIOL CHEM, V262, P16338; INESI G, 1992, ARCH BIOCHEM BIOPHYS, V298, P313, DOI 10.1016/0003-9861(92)90416-T; Inesi G, 2002, BIOPHYS J, V83, P2327, DOI 10.1016/S0006-3495(02)75247-8; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; LACAPERE JJ, 1990, J BIOL CHEM, V265, P348; Lamberth S, 2000, HELV CHIM ACTA, V83, P2141, DOI 10.1002/1522-2675(20000906)83:9<2141::AID-HLCA2141>3.0.CO;2-W; LINDEMANN JP, 1983, J BIOL CHEM, V258, P464; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Mahaney J, 1999, ARCH BIOCHEM BIOPHYS, V372, P408, DOI 10.1006/abbi.1999.1524; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Pollesello P, 1999, BIOPHYS J, V76, P1784, DOI 10.1016/S0006-3495(99)77339-X; Schmidt AG, 2001, CARDIOVASC DRUG THER, V15, P387, DOI 10.1023/A:1013381204658; SCOFANO HM, 1979, J BIOL CHEM, V254, P227; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Slovic AM, 2003, PROTEIN SCI, V12, P337, DOI 10.1110/ps.0226603; Stokes DL, 2003, ANNU REV BIOPH BIOM, V32, P445, DOI 10.1146/annurev.biophys.32.110601.142433; TATULIAN SA, 1995, BIOCHEMISTRY-US, V34, P4448, DOI 10.1021/bi00013a038; TOYOFUKU T, 1994, J BIOL CHEM, V269, P3088; TOYOFUKU T, 1994, J BIOL CHEM, V269, P22929; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; van Montfort BA, 2002, J BIOL CHEM, V277, P14717, DOI 10.1074/jbc.M201533200; WEGENER AD, 1989, J BIOL CHEM, V264, P11468; Young HS, 2001, BIOPHYS J, V81, P884, DOI 10.1016/S0006-3495(01)75748-7; Yu MH, 1999, ARCH BIOCHEM BIOPHYS, V362, P225, DOI 10.1006/abbi.1998.1049	43	53	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48348	48356		10.1074/jbc.M309545200	http://dx.doi.org/10.1074/jbc.M309545200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12972413	hybrid			2022-12-27	WOS:000186731400120
J	Lleo, A; Berezovska, O; Ramdya, P; Fukumoto, H; Raju, S; Shah, T; Hyman, BT				Lleo, A; Berezovska, O; Ramdya, P; Fukumoto, H; Raju, S; Shah, T; Hyman, BT			Notch1 competes with the amyloid precursor protein for gamma-secretase and down-regulates presenilin-1 gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY MAMMALIAN NEURONS; INTRACELLULAR DOMAIN; TERMINAL FRAGMENT; PS1 DEFICIENCY; CELLS; FE65; APP; TRANSLOCATION; PROTEOLYSIS; INHIBITOR	Presenilin 1 (PS1) is a critical component of the gamma-secretase complex, which is involved in the cleavage of several substrates including the amyloid precursor protein (APP) and Notch1. Based on the fact that APP and Notch are processed by the same gamma-secretase, we postulated that APP and Notch compete for the enzyme activity. In this report, we examined the interactions between APP, Notch, and PS1 using the direct gamma-secretase substrates, Notch 1 Deltaextracellular domain (N1DeltaEC) and APP carboxyl-terminal fragment of 99 amino acids, and measured the effects on amyloid-beta protein production and Notch signaling, respectively. Additionally, we tested the hypothesis that downstream effects on PS1 expression may coexist with the competition phenomenon. We observed significant competition between Notch and APP for gamma-secretase activity; transfection with either of two direct substrates of gamma-secretase led to a reduction in the gamma-cleaved products, Notch intracellular domain or amyloid-beta protein. In addition, however, we found that activation of the Notch signaling pathway, by either N1DeltaEC or Notch intracellular domain, induced down-regulation of PS1 gene expression. This finding suggests that Notch activation directly engages gamma-secretase and subsequently leads to diminished PS1 expression, suggesting a complex set of feedback interactions following Notch activation.	Massachusetts Gen Hosp, Alzheimer Res Unit, Charlestown, MA 02114 USA	Harvard University; Massachusetts General Hospital	Hyman, BT (corresponding author), Massachusetts Gen Hosp, Alzheimer Res Unit, Rm 2009,114-16th St, Charlestown, MA 02129 USA.		Lleó, Alberto/K-5783-2019		NIA NIH HHS [AG15379] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG015379] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; Beher D, 2001, J BIOL CHEM, V276, P45394, DOI 10.1074/jbc.M103075200; Berezovska O, 1999, MOL BRAIN RES, V69, P273, DOI 10.1016/S0169-328X(99)00119-9; Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; Berezovska O, 2000, J NEUROCHEM, V75, P583, DOI 10.1046/j.1471-4159.2000.0750583.x; Berezovska O, 1998, J NEUROPATH EXP NEUR, V57, P738, DOI 10.1097/00005072-199808000-00003; Berezovska O, 2001, J BIOL CHEM, V276, P30018, DOI 10.1074/jbc.M008268200; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Gao YH, 2001, P NATL ACAD SCI USA, V98, P14979, DOI 10.1073/pnas.261463298; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Jack C, 2001, MOL BRAIN RES, V87, P166, DOI 10.1016/S0169-328X(01)00010-9; Kimberly WT, 2003, BIOCHEMISTRY-US, V42, P137, DOI 10.1021/bi026888g; Kinoshita A, 2002, J NEUROCHEM, V82, P839, DOI 10.1046/j.1471-4159.2002.01016.x; Kinoshita A, 2001, J NEUROSCI, V21, P8354, DOI 10.1523/JNEUROSCI.21-21-08354.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu FM, 1996, P NATL ACAD SCI USA, V93, P5663, DOI 10.1073/pnas.93.11.5663; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Palacino JJ, 2000, J BIOL CHEM, V275, P215, DOI 10.1074/jbc.275.1.215; Refolo LM, 1999, J NEUROCHEM, V73, P2383, DOI 10.1046/j.1471-4159.1999.0732383.x; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 2001, P NATL ACAD SCI USA, V98, P11039, DOI 10.1073/pnas.211352598; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200	33	47	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47370	47375		10.1074/jbc.M308480200	http://dx.doi.org/10.1074/jbc.M308480200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12960155	hybrid			2022-12-27	WOS:000186731400005
J	Barrera, FN; Poveda, JA; Gonzalez-Ros, JM; Neira, JL				Barrera, FN; Poveda, JA; Gonzalez-Ros, JM; Neira, JL			Binding of the C-terminal sterile alpha motif (SAM) domain of human p73 to lipid membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-MEMBRANES; ENERGY-TRANSFER; P53 MUTANTS; FLUORESCENCE; PROTEIN; LOCATION; FAMILY; P63; ORGANIZATION; ASSOCIATION	The alpha splice variant of p73 (p73alpha), a homologue of the tumor suppressor p53, has close to its C terminus a sterile alpha motif (SAM), SAMp73, that is thought to be involved in protein-protein interactions. Here, we report the lipid binding properties of this domain. Binding was assayed against zwitterionic (phosphatidylcholine) and anionic (phosphatidic acid) lipids and was studied by different biophysical techniques, namely, circular dichroism and fluorescence spectroscopies and differential scanning calorimetry. These techniques unambiguously indicate that SAMp73 binds to lipids. The binding involves protein surface attachment and partial membrane penetration, accompanied by changes in SAMp73 structure.	Univ Miguel Hernandez, Inst Biol Mol & Celular, Edificio Torregaitan, Alicante 03202, Spain; Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos, E-50009 Zaragoza, Spain	Universidad Miguel Hernandez de Elche; University of Zaragoza	Gonzalez-Ros, JM (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Edificio Torregaitan, Avda Ferrocarril S-N, Alicante 03202, Spain.	gonzalez.ros@umh.es; jlneira@umh.es	Barrera, Francisco/C-4513-2008; Neira, Jose/ABF-4210-2021; Poveda Larrosa, Jose Antonio/H-5925-2015	Gonzalez Ros, Jose Manuel/0000-0002-4804-6855; Neira, Jose Luis/0000-0002-4933-0428; Barrera, Francisco N./0000-0002-5200-7891; Poveda Larrosa, Jose Antonio/0000-0003-0722-3752				Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Barrera FN, 2002, BIOCHEMISTRY-US, V41, P5743, DOI 10.1021/bi0159478; Bork P, 1998, NAT GENET, V18, P313, DOI 10.1038/ng0498-313; Chi SW, 1999, EMBO J, V18, P4438, DOI 10.1093/emboj/18.16.4438; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Contreras LM, 2001, BIOPHYS J, V80, P2273, DOI 10.1016/S0006-3495(01)76199-1; COUTINHO A, 1993, J CHEM EDUC, V70, P425, DOI 10.1021/ed070p425; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; DAVENPORT L, 1985, BIOCHEMISTRY-US, V24, P4097, DOI 10.1021/bi00336a044; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; DeLano W.L, PYMOL MOL GRAPHICS S; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Eftink MR, 1997, METHOD ENZYMOL, V278, P221; FERRERMONTIEL AV, 1988, BIOCHIM BIOPHYS ACTA, V937, P379, DOI 10.1016/0005-2736(88)90260-X; FORSTER T, 1959, A NATURFORSCH A, V4, P321; Freebern WJ, 2003, J BIOL CHEM, V278, P2249, DOI 10.1074/jbc.M208517200; Garidel P, 1997, BIOPHYS J, V72, P2196, DOI 10.1016/S0006-3495(97)78863-5; Gelb MH, 1999, CURR OPIN STRUC BIOL, V9, P428, DOI 10.1016/S0959-440X(99)80059-1; Ghosh AK, 1997, BIOCHEMISTRY-US, V36, P14291, DOI 10.1021/bi971933j; Green JB, 2003, MOL CELL, V11, P1537, DOI 10.1016/S1097-2765(03)00178-3; Hall TMT, 2003, NAT STRUCT BIOL, V10, P677, DOI 10.1038/nsb0903-677; Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kaiser RD, 1998, BIOCHEMISTRY-US, V37, P8180, DOI 10.1021/bi980064a; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kim KR, 2001, INT J GYNECOL PATHOL, V20, P173, DOI 10.1097/00004347-200104000-00010; Kyba M, 1998, DEV GENET, V22, P74, DOI 10.1002/(SICI)1520-6408(1998)22:1<74::AID-DVG8>3.3.CO;2-V; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Marsh D., 1990, CRC HDB LIPID BILAYE; Mateo CR, 2000, BBA-BIOMEMBRANES, V1509, P167, DOI 10.1016/S0005-2736(00)00291-1; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Pace C. N., 1997, PROTEIN STRUCTURE PR, P253; PAPAHADJOPOULOS D, 1975, BIOCHIM BIOPHYS ACTA, V401, P317, DOI 10.1016/0005-2736(75)90233-3; PONTING CP, 1995, PROTEIN SCI, V4, P1928, DOI 10.1002/pro.5560040927; PRENDERGAST FG, 1981, BIOCHEMISTRY-US, V20, P7333, DOI 10.1021/bi00529a002; Ramachander R, 2002, J BIOL CHEM, V277, P39585, DOI 10.1074/jbc.M207273200; Rankin SE, 1998, BIOCHEMISTRY-US, V37, P12588, DOI 10.1021/bi980408x; RAPAPORT D, 1992, J BIOL CHEM, V267, P6502; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Santos NC, 1998, BIOCHEMISTRY-US, V37, P8674, DOI 10.1021/bi9803933; Schultz J, 1997, PROTEIN SCI, V6, P249; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; SUREWICZ WK, 1984, BIOCHEMISTRY-US, V23, P6072, DOI 10.1021/bi00320a026; Tabuchi K, 2002, J NEUROSCI, V22, P4264, DOI 10.1523/JNEUROSCI.22-11-04264.2002; Thanos CD, 1999, PROTEIN SCI, V8, P1708, DOI 10.1110/ps.8.8.1708; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Wang WK, 2000, ACTA CRYSTALLOGR D, V56, P769, DOI 10.1107/S0907444900005059; Wang WK, 2001, ACTA CRYSTALLOGR D, V57, P545, DOI 10.1107/S0907444901002529; White SH, 2001, J BIOL CHEM, V276, P32395, DOI 10.1074/jbc.R100008200; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; WOLBER PK, 1979, BIOPHYS J, V28, P197, DOI 10.1016/S0006-3495(79)85171-1; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zaika A, 2001, J BIOL CHEM, V276, P11310, DOI 10.1074/jbc.M005737200; Zhu JH, 1998, CANCER RES, V58, P5061	61	66	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46878	46885		10.1074/jbc.M307846200	http://dx.doi.org/10.1074/jbc.M307846200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12954612	hybrid			2022-12-27	WOS:000186569400081
J	Rial, DV; Ottado, J; Ceccarelli, EA				Rial, DV; Ottado, J; Ceccarelli, EA			Precursors with altered affinity for Hsp70 in their transit peptides are efficiently imported into chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL PROTEIN TRANSLOCATION; FERREDOXIN-NADP(+) REDUCTASE PRECURSOR; MOLECULAR CHAPERONES; ENVELOPE MEMBRANES; ESCHERICHIA-COLI; BINDING-SITE; IN-VIVO; MITOCHONDRIAL; TRANSPORT; IDENTIFICATION	Protein import into chloroplasts is postulated to occur with the involvement of molecular chaperones. We have determined that the transit peptide of ferredoxin-NADP( H) reductase precursor binds preferentially to an Hsp70 from chloroplast stroma. To investigate the role of Hsp70 molecular chaperones in chloroplast protein import, we analyzed the import into pea chloroplasts of preproteins with decreased Hsp70 binding affinity in their transit peptides. Our results indicate that the precursor with the lowest affinity for Hsp70 molecular chaperones in its transit peptide was imported to chloroplasts with similar apparent K-m as the wild type precursor and a 2- fold increase in V-max. Thus, a strong interaction between chloroplast stromal Hsp70 and the transit peptide seems not to be essential for protein import. These results indicate that in chloroplasts the main unfolding force during protein import may be applied by molecular chaperones other than Hsp70s. Although stromal Hsp70s undoubtedly participate in chloroplast biogenesis, the role of these molecular chaperones in chloroplast protein translocation differs from the one proposed in the mechanisms postulated up to date.	Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, CSIC, Inst Biol Mol & Celular Rosario,Mol Biol Div, RA-2000 Rosario, Santa Fe, Argentina	National University of Rosario	Ceccarelli, EA (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, CSIC, Inst Biol Mol & Celular Rosario,Mol Biol Div, Suipacha 531,S2002LRK, RA-2000 Rosario, Santa Fe, Argentina.		Ceccarelli, Eduardo A./V-2600-2019; Ceccarelli, Eduardo A./M-8699-2014	Ceccarelli, Eduardo A./0000-0001-5776-3306; Ceccarelli, Eduardo A./0000-0001-5776-3306				Akita M, 1997, J CELL BIOL, V136, P983, DOI 10.1083/jcb.136.5.983; Arakaki AK, 1997, FASEB J, V11, P133, DOI 10.1096/fasebj.11.2.9039955; Artigues A, 1998, J BIOL CHEM, V273, P33130, DOI 10.1074/jbc.273.50.33130; Artigues A, 2002, J BIOL CHEM, V277, P25047, DOI 10.1074/jbc.M203474200; Bruce BD, 2001, BBA-MOL CELL RES, V1541, P2, DOI 10.1016/S0167-4889(01)00149-5; CALCATERRA NB, 1995, BIOCHEMISTRY-US, V34, P12842, DOI 10.1021/bi00039a045; Ceccarelli EA, 1996, EUR J BIOCHEM, V238, P192, DOI 10.1111/j.1432-1033.1996.0192q.x; Chauwin JF, 1998, BIOPHYS J, V74, P1732, DOI 10.1016/S0006-3495(98)77884-1; Chen XJ, 1999, TRENDS CELL BIOL, V9, P222, DOI 10.1016/S0962-8924(99)01554-8; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; CREIGHTON TE, 1979, J MOL BIOL, V129, P235, DOI 10.1016/0022-2836(79)90279-1; Deng Z, 1999, NAT STRUCT BIOL, V6, P847; Elston TC, 2000, BIOPHYS J, V79, P2235, DOI 10.1016/S0006-3495(00)76471-X; Gaume B, 1998, EMBO J, V17, P6497, DOI 10.1093/emboj/17.22.6497; GLICK BS, 1995, CELL, V80, P11, DOI 10.1016/0092-8674(95)90444-1; GOLDENBERG DP, 1984, ANAL BIOCHEM, V138, P1, DOI 10.1016/0003-2697(84)90761-9; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Ivey RA, 2000, PLANT PHYSIOL, V122, P1289, DOI 10.1104/pp.122.4.1289; Ivey RA, 2000, CELL STRESS CHAPERON, V5, P62, DOI 10.1379/1466-1268(2000)005<0062:IVAIVI>2.0.CO;2; Jackson-Constan D, 2001, BBA-MOL CELL RES, V1541, P102, DOI 10.1016/S0167-4889(01)00148-3; Jackson-Constan D, 2001, PLANT PHYSIOL, V125, P1567, DOI 10.1104/pp.125.4.1567; Jarvis P, 2001, BBA-MOL CELL RES, V1541, P64, DOI 10.1016/S0167-4889(01)00147-1; KANEMORI M, 1994, J BACTERIOL, V176, P5648, DOI 10.1128/JB.176.18.5648-5653.1994; Keegstra K, 1999, CURR OPIN PLANT BIOL, V2, P471, DOI 10.1016/S1369-5266(99)00021-7; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; KLEMM JD, 1991, BIOCHEMISTRY-US, V30, P589, DOI 10.1021/bi00216a038; Lee KH, 2002, MOL CELLS, V14, P388; Liebermeister W, 2001, J MOL BIOL, V305, P643, DOI 10.1006/jmbi.2000.4302; MARSHALL JS, 1992, PLANT PHYSIOL, V100, P1048, DOI 10.1104/pp.100.2.1048; MARSHALL JS, 1990, P NATL ACAD SCI USA, V87, P374, DOI 10.1073/pnas.87.1.374; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; May T, 2000, PLANT CELL, V12, P53, DOI 10.1105/tpc.12.1.53; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; NEUPERT W, 1990, CELL, V63, P447, DOI 10.1016/0092-8674(90)90437-J; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; Ottado J, 1998, EUR J BIOCHEM, V253, P132, DOI 10.1046/j.1432-1327.1998.2530132.x; PAIN D, 1987, P NATL ACAD SCI USA, V84, P3288, DOI 10.1073/pnas.84.10.3288; PFANNER N, 1995, CURR BIOL, V5, P132; PILON M, 1992, FEBS LETT, V302, P65, DOI 10.1016/0014-5793(92)80286-P; Rial DV, 2000, EUR J BIOCHEM, V267, P6239, DOI 10.1046/j.1432-1327.2000.01707.x; Rial DV, 2002, EUR J BIOCHEM, V269, P5431, DOI 10.1046/j.1432-1033.2002.03233.x; Rial DV, 2002, PROTEIN EXPRES PURIF, V25, P503, DOI 10.1016/S1046-5928(02)00024-4; ROBINSON C, 1984, EUR J BIOCHEM, V142, P337, DOI 10.1111/j.1432-1033.1984.tb08291.x; Schleiff E, 2002, PLANT MOL BIOL, V50, P177, DOI 10.1023/A:1016027020193; Schleiff E, 2003, P NATL ACAD SCI USA, V100, P4604, DOI 10.1073/pnas.0730860100; SCHREIER PH, 1988, PLANT MOL BIOL MAN B, V5, P1; SERRA EC, 1995, J BIOL CHEM, V270, P19930, DOI 10.1074/jbc.270.34.19930; THEG SM, 1989, J BIOL CHEM, V264, P6730; UNGERMANN C, 1994, SCIENCE, V266, P1250, DOI 10.1126/science.7973708; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; WAEGEMANN K, 1991, PLANT J, V1, P149, DOI 10.1111/j.1365-313X.1991.00149.x; WAEGEMANN K, 1990, FEBS LETT, V261, P89, DOI 10.1016/0014-5793(90)80643-W; ZANETTI G, 1976, BIOCHIM BIOPHYS ACTA, V445, P14, DOI 10.1016/0005-2744(76)90157-1; Zhang XP, 1999, J MOL BIOL, V288, P177, DOI 10.1006/jmbi.1999.2669; Zhang XP, 2002, TRENDS PLANT SCI, V7, P14, DOI 10.1016/S1360-1385(01)02180-X	59	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46473	46481		10.1074/jbc.M306684200	http://dx.doi.org/10.1074/jbc.M306684200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12970339	hybrid			2022-12-27	WOS:000186569400032
J	Funderburgh, JL; Mann, MM; Funderburgh, ML				Funderburgh, JL; Mann, MM; Funderburgh, ML			Keratocyte phenotype mediates proteoglycan structure - A role for fibroblasts in corneal fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; BETA-GALACTOSIDASE DIGESTION; IN-SITU KERATOMILEUSIS; CHONDROITIN/DERMATAN SULFATE; BOVINE KERATOCYTES; RABBIT CORNEAS; STROMAL CELLS; EXPRESSION; POLYSACCHARIDES; MYOFIBROBLAST	In pathological corneas, accumulation of fibrotic extracellular matrix is characterized by proteoglycans with altered glycosaminoglycans that contribute to the reduced transparency of scarred tissue. During wound healing, keratocytes in the corneal stroma transdifferentiate into fibroblasts and myofibroblasts. In this study, molecular markers were developed to identify keratocyte, fibroblast, and myofibroblast phenotypes in primary cultures of corneal stromal cells and the structure of glycosaminoglycans secreted by these cells was characterized. Quiescent primary keratocytes expressed abundant protein and mRNA for keratocan and aldehyde dehydrogenase class 3 and secreted proteoglycans containing macromolecular keratan sulfate. Expression of these marker compounds was reduced in fibroblasts and also in transforming growth factor-beta-induced myofibroblasts, which expressed high levels of alpha-smooth muscle actin, biglycan, and the extra domain A (EDA or EIIIA) form of cellular fibronectin. Collagen types I and III mRNAs were elevated in both fibroblasts and in myofibroblasts. Expression of these molecular markers clearly distinguishes the phenotypic states of stromal cells in vitro. Glycosaminoglycans secreted by fibroblasts and myofibroblasts were qualitatively similar to and differed from those of keratocytes. Chondroitin/dermatan sulfate abundance, chain length, and sulfation were increased as keratocytes became fibroblasts and myofibroblasts. Fluorophore-assisted carbohydrate electrophoresis analysis demonstrated increased N-acetylgalactosamine sulfation at both 4- and 6-carbons. Hyaluronan, absent in keratocytes, was secreted by fibroblasts and myofibroblasts. Keratan sulfate biosynthesis, chain length, and sulfation were significantly reduced in both fibroblasts and myofibroblasts. The qualitatively similar expression of glycosaminoglycans shared by fibroblasts and myofibroblasts suggests a role for fibroblasts in deposition of non-transparent fibrotic tissue in pathological corneas.	Univ Pittsburgh, Eye & Ear Inst 1011, Dept Ophthalmol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Funderburgh, JL (corresponding author), Univ Pittsburgh, Eye & Ear Inst 1011, Dept Ophthalmol, 203 Lothrop St, Pittsburgh, PA 15213 USA.	jlfunder@pitt.edu			NATIONAL EYE INSTITUTE [R01EY003263, R01EY009368, P30EY008098] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY008098, 30-EY08098, R01 EY003263, EY09368, EY003263, R01 EY009368-11, R01 EY009368] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akama TO, 2000, NAT GENET, V26, P237, DOI 10.1038/79987; ANSETH A, 1969, EXP EYE RES, V8, P438, DOI 10.1016/S0014-4835(69)80010-2; ANSETH A, 1969, EXP EYE RES, V8, P310, DOI 10.1016/S0014-4835(69)80044-8; ANSETH A, 1972, ISRAEL J MED SCI, V8, P1543; ANSETH A, 1969, EXP EYE RES, V8, P302, DOI 10.1016/S0014-4835(69)80043-6; Badid C, 2000, HISTOL HISTOPATHOL, V15, P269, DOI 10.14670/HH-15.269; Beales MP, 1999, INVEST OPHTH VIS SCI, V40, P1658; Boesch JS, 1996, J BIOL CHEM, V271, P5150; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chen C, 2000, INVEST OPHTH VIS SCI, V41, P4108; CHENG F, 1994, GLYCOBIOLOGY, V4, P685, DOI 10.1093/glycob/4.5.685; CINTRON C, 1990, INVEST OPHTH VIS SCI, V31, P1975; Cook JR, 1999, INVEST OPHTH VIS SCI, V40, P3122; Dugina V, 2001, J CELL SCI, V114, P3285; Fini ME, 1999, PROG RETIN EYE RES, V18, P529, DOI 10.1016/S1350-9462(98)00033-0; FITZSIMMONS TD, 1994, INVEST OPHTH VIS SCI, V35, P2774; FUNDERBURGH JL, 1988, INVEST OPHTH VIS SCI, V29, P1116; FUNDERBURGH JL, 1989, INVEST OPHTH VIS SCI, V30, P435; Funderburgh JL, 1996, J BIOL CHEM, V271, P31431, DOI 10.1074/jbc.271.49.31431; FUNDERBURGH JL, 1990, INVEST OPHTH VIS SCI, V31, P419; FUNDERBURGH JL, 1987, J BIOL CHEM, V262, P11634; FUNDERBURGH JL, 1991, J BIOL CHEM, V266, P14226; FUNDERBURGH JL, 1990, J BIOL CHEM, V265, P8297; Funderburgh JL, 1998, INVEST OPHTH VIS SCI, V39, P1957; Funderburgh JL, 2001, J BIOL CHEM, V276, P44173, DOI 10.1074/jbc.M107596200; GARANA RMR, 1992, INVEST OPHTH VIS SCI, V33, P3271; GIRARD MT, 1993, J CELL SCI, V104, P1001; Harvey DJ, 2000, J AM SOC MASS SPECTR, V11, P900, DOI 10.1016/S1044-0305(00)00156-2; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P3705, DOI 10.1073/pnas.77.6.3705; HASSELL JR, 1983, ARCH BIOCHEM BIOPHYS, V222, P362, DOI 10.1016/0003-9861(83)90532-5; Huang Y, 1996, EXP EYE RES, V62, P377, DOI 10.1006/exer.1996.0043; Huckerby TN, 1998, EUR J BIOCHEM, V253, P499, DOI 10.1046/j.1432-1327.1998.2530499.x; ISHIZAKI M, 1993, INVEST OPHTH VIS SCI, V34, P3320; JESTER JV, 1987, AM J PATHOL, V127, P140; Jester JV, 1996, CORNEA, V15, P505; Jester JV, 1997, CORNEA, V16, P177; Jester JV, 1999, J CELL SCI, V112, P613; JESTER JV, 1994, INVEST OPHTH VIS SCI, V35, P730; JESTER JV, 1995, INVEST OPHTH VIS SCI, V36, P809; KOUKOULIS GK, 1995, ULTRASTRUCT PATHOL, V19, P37, DOI 10.3109/01913129509014601; Latvala T, 1996, J REFRACT SURG, V12, P677; Long CJ, 2000, J BIOL CHEM, V275, P13918, DOI 10.1074/jbc.275.18.13918; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; MEHMET H, 1986, EUR J BIOCHEM, V157, P385, DOI 10.1111/j.1432-1033.1986.tb09680.x; Nakazawa K, 1998, ARCH BIOCHEM BIOPHYS, V359, P269, DOI 10.1006/abbi.1998.0897; NAKAZAWA K, 1984, J BIOL CHEM, V259, P3751; Perez-Santonja JJ, 1998, J REFRACT SURG, V14, P602; Piatigorsky J, 2000, J OCUL PHARMACOL TH, V16, P173, DOI 10.1089/jop.2000.16.173; Plaas AH, 2001, J BIOL CHEM, V276, P39788, DOI 10.1074/jbc.M103227200; Plaas AHK, 2001, GLYCOBIOLOGY, V11, P779, DOI 10.1093/glycob/11.10.779; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; QUANTOCK AJ, 1993, CAN J OPHTHALMOL, V28, P266; RODRIGUES M, 1992, AM J OPHTHALMOL, V114, P161, DOI 10.1016/S0002-9394(14)73980-7; ROUGHLEY PJ, 1993, BIOCHEM J, V295, P421, DOI 10.1042/bj2950421; SAWAGUCHI S, 1991, INVEST OPHTH VIS SCI, V32, P1846; Stramer BM, 2001, INVEST OPHTH VIS SCI, V42, P1698; SUNDARRAJ N, 1986, J HISTOCHEM CYTOCHEM, V34, P971, DOI 10.1177/34.8.2426337; Tai GH, 1997, J BIOL CHEM, V272, P28227, DOI 10.1074/jbc.272.45.28227; Tai GH, 1996, J BIOL CHEM, V271, P23535, DOI 10.1074/jbc.271.38.23535; Tuori A, 1997, GRAEF ARCH CLIN EXP, V235, P222, DOI 10.1007/BF00941763; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Venkatesan N, 2000, AM J RESP CRIT CARE, V161, P2066, DOI 10.1164/ajrccm.161.6.9909098; Venkatesan N, 2002, AM J PHYSIOL-LUNG C, V283, pL806, DOI 10.1152/ajplung.00061.2002; WATSKY MA, 1995, INVEST OPHTH VIS SCI, V36, P2568; WOLLENSAK J, 1990, GRAEF ARCH CLIN EXP, V228, P517, DOI 10.1007/BF00918483; YUE BYJT, 1988, CURR EYE RES, V7, P81, DOI 10.3109/02713688809047024	66	188	195	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45629	45637		10.1074/jbc.M303292200	http://dx.doi.org/10.1074/jbc.M303292200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12933807	Green Accepted, hybrid			2022-12-27	WOS:000186452300072
J	Mayo, KH; Dings, RPM; Flader, C; Nesmelova, I; Hargittai, B; van der Schaft, DWJ; van Eijk, LI; Walek, D; Haseman, J; Hoye, TR; Griffioen, AW				Mayo, KH; Dings, RPM; Flader, C; Nesmelova, I; Hargittai, B; van der Schaft, DWJ; van Eijk, LI; Walek, D; Haseman, J; Hoye, TR; Griffioen, AW			Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASING PROTEIN BPI; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; ANGIOGENESIS INHIBITOR; ANGSTROM RESOLUTION; ANTITUMOR-ACTIVITY; TUMOR-GROWTH; AMINO-ACID; ENDOSTATIN; ANGIOSTATIN	Based on structure-activity relationships of the angiostatic beta-sheet-forming peptide anginex, we have designed a mimetic, 6DBF7, which inhibits angiogenesis and tumor growth in mice. 6DBF7 is composed of a beta-sheet-inducing dibenzofuran (DBF)-turn mimetic and two short key amino acid sequences from anginex. This novel antiangiogenic molecule is more effective in vivo than parent anginex. In a mouse xenograft model for ovarian carcinoma, 6DBF7 is observed to reduce tumor growth by up to 80%. It is suggested that the activity is based on antiangiogenesis, because in vitro tube formation is inhibited, and because treatment of tumor-bearing mice led to a significant reduction in microvessel density within the tumor. This partial peptide mimetic is the first endothelial cell-specific molecule designed as a substitute for an angiostatic inhibitory peptide.	Univ Minnesota, Hlth Sci Ctr, Dept Biochem, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Mol Biol & Biophys, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Univ Hosp Maastricht, Dept Pathol, Res Inst Growth & Dev, Angiogenesis Lab, NL-6202 AZ Maastricht, Netherlands; Univ Hosp Maastricht, Dept Internal Med, Res Inst Growth & Dev, Angiogenesis Lab, NL-6202 AZ Maastricht, Netherlands	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Mayo, KH (corresponding author), Univ Minnesota, Hlth Sci Ctr, Dept Biochem, 6-155 Jackson Hall,321 Church St, Minneapolis, MN 55455 USA.		Dings, Ruud/R-3772-2019; Dings, Ruud/C-6188-2008; Nesmelova, Irina/D-6033-2015	Dings, Ruud/0000-0001-7686-1331; Nesmelova, Irina/0000-0002-1835-1533	NCI NIH HHS [CA-76497, R01 CA-96090] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA096090, R01CA076497] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; Bekele H, 1997, J ORG CHEM, V62, P2259, DOI 10.1021/jo961063w; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126; BRUNGER AT, 1992, XPLOR MANUAL; CARPINO LA, 1993, J AM CHEM SOC, V115, P4397, DOI 10.1021/ja00063a082; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIAZ H, 1993, J AM CHEM SOC, V115, P3790, DOI 10.1021/ja00062a061; Dings R. P. M., 2003, BIOCHEM J, V23, P281; Dings RPM, 2003, CANCER RES, V63, P382; Dings RPM, 2003, CANCER LETT, V194, P55, DOI 10.1016/S0304-3835(03)00015-6; DINGS RPM, 2003, IN PRESS ANGIOGENESI; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Griffioen AW, 2001, BIOCHEM J, V354, P233, DOI 10.1042/0264-6021:3540233; GUPTA SK, 1994, J CELL BIOL, V127, P1121, DOI 10.1083/jcb.127.4.1121; Hohenester E, 1998, EMBO J, V17, P1656, DOI 10.1093/emboj/17.6.1656; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; Karumanchi SA, 2001, MOL CELL, V7, P811, DOI 10.1016/S1097-2765(01)00225-8; KING DS, 1990, INT J PEPT PROT RES, V36, P255; Kranenburg O, 2002, CURR BIOL, V12, P1833, DOI 10.1016/S0960-9822(02)01224-1; LUSTER AD, 1995, J EXP MED, V182, P219, DOI 10.1084/jem.182.1.219; MacDonald NJ, 2001, J BIOL CHEM, V276, P25190, DOI 10.1074/jbc.M100743200; Mayo Kevin H., 2001, Angiogenesis, V4, P45, DOI 10.1023/A:1016672117477; MAYO KH, 1995, BIOCHEMISTRY-US, V34, P11399, DOI 10.1021/bi00036a012; Molema G, 1998, IMMUNOL TODAY, V19, P392, DOI 10.1016/S0167-5699(98)01314-0; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Ramchandran R, 1999, BIOCHEM BIOPH RES CO, V255, P735, DOI 10.1006/bbrc.1999.0248; RUCKER SP, 1989, MOL PHYS, V68, P509, DOI 10.1080/00268978900102331; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; Tan DCW, 2001, FEBS LETT, V494, P150, DOI 10.1016/S0014-5793(01)02314-6; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tarui T, 2001, J BIOL CHEM, V276, P39562, DOI 10.1074/jbc.M101815200; TOLSMA SS, 1993, J CELL BIOL, V122, P497, DOI 10.1083/jcb.122.2.497; TSANG KY, 1994, J AM CHEM SOC, V116, P3988, DOI 10.1021/ja00088a039; van der Schaft DWJ, 2000, BLOOD, V96, P176, DOI 10.1182/blood.V96.1.176.013k32_176_181; van der Schaft DWJ, 2002, FASEB J, V16, P1991, DOI 10.1096/fj.02-0509fje; van der Schaft DWJ, 2002, ANN MED, V34, P19; WIDER G, 1984, J MAGN RESON, V56, P207, DOI 10.1016/0022-2364(84)90099-4; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Wild R, 2000, MICROVASC RES, V59, P368, DOI 10.1006/mvre.1999.2233	45	53	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45746	45752		10.1074/jbc.M308608200	http://dx.doi.org/10.1074/jbc.M308608200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12947097	hybrid			2022-12-27	WOS:000186452300085
J	Tesco, G; Koh, YH; Tanzi, RE				Tesco, G; Koh, YH; Tanzi, RE			Caspase activation increases beta-amyloid generation independently of caspase cleavage of the beta-amyloid precursor protein (APP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITIES; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; APOPTOSIS; PEPTIDES; INVOLVEMENT; PRESENILIN; PROTEASES; A-BETA-42; PATHWAY	The amyloid precursor protein (APP) undergoes "alternative" proteolysis mediated by caspases. Three major caspase recognition sites have been identified in the APP, i.e. one at the C terminus (Asp(720)) and two at the N terminus (Asp(197) and Asp(219)). Caspase cleavage at Asp(720) has been suggested as leading to increased production of Abeta. Thus, we set out to determine which putative caspase sites in APP, if any, are cleaved in Chinese hamster ovary cell lines concurrently with the increased Abeta production that occurs during apoptosis. We found that cleavage at Asp(720) occurred concurrently with caspase 3 activation and the increased production of total secreted Abeta and Abeta(1-42) in association with staurosporine- and etoposide-induced apoptosis. To investigate the contribution of caspase cleavage of APP to Abeta generation, we expressed an APP mutant truncated at Asp(720) that mimics APP caspase cleavage at the C-terminal site. This did not increase Abeta generation but, in contrast, dramatically decreased Abeta production in Chinese hamster ovary cells. Furthermore, the ablation of caspase-dependent cleavage at Asp(720), Asp(197), and Asp(219) (by site-directed mutagenesis) did not prevent enhanced Abeta production following etoposide-induced apoptosis. These findings indicate that the enhanced Abeta generation associated with apoptosis does not require cleavage of APP at its C-terminal (Asp(720)) and/or N-terminal caspase sites.	Massachusetts Gen Hosp, Ctr Aging Genet & Neurodegenerat, Genet & Aging Res Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Tanzi, RE (corresponding author), Massachusetts Gen Hosp, Ctr Aging Genet & Neurodegenerat, Genet & Aging Res Unit, Bldg 114,16th St C3009, Charlestown, MA 02129 USA.		Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454	NIA NIH HHS [5P01 AG15379] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG015379] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barnes NY, 1998, J NEUROSCI, V18, P5869; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; De Strooper B, 2000, J CELL SCI, V113, P1857; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Galli C, 1998, P NATL ACAD SCI USA, V95, P1247, DOI 10.1073/pnas.95.3.1247; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Klafki HW, 1996, J BIOL CHEM, V271, P28655, DOI 10.1074/jbc.271.45.28655; Lansbury PT, 1997, NEURON, V19, P1151, DOI 10.1016/S0896-6273(00)80406-7; LeBlanc A, 1995, J NEUROSCI, V15, P7837; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; Murphy MP, 2000, J BIOL CHEM, V275, P26277, DOI 10.1074/jbc.M002812200; Namura S, 1998, J NEUROSCI, V18, P3659; Pellegrini L, 1999, J BIOL CHEM, V274, P21011, DOI 10.1074/jbc.274.30.21011; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Skovronsky DM, 2000, BIOCHEMISTRY-US, V39, P810, DOI 10.1021/bi991728z; Soriano S, 2001, J BIOL CHEM, V276, P29045, DOI 10.1074/jbc.M102456200; Tesco G, 1998, J BIOL CHEM, V273, P33909, DOI 10.1074/jbc.273.51.33909; Thornberry NA, 1997, BRIT MED BULL, V53, P478; Weidemann A, 1999, J BIOL CHEM, V274, P5823, DOI 10.1074/jbc.274.9.5823; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wilson CA, 2002, NAT NEUROSCI, V5, P849, DOI 10.1038/nn898; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	28	44	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46074	46080		10.1074/jbc.M307809200	http://dx.doi.org/10.1074/jbc.M307809200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12960154	hybrid			2022-12-27	WOS:000186452300124
J	Wise, EL; Graham, DE; White, RH; Rayment, I				Wise, EL; Graham, DE; White, RH; Rayment, I			The structural determination of phosphosulfolactate synthase from Methanococcus jannaschii at 1.7-angstrom resolution - An enolase that is not an enolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUCONATE LACTONIZING ENZYME; ANOMALOUS DIFFRACTION; ANGSTROM RESOLUTION; MANDELATE RACEMASE; PSEUDOMONAS-PUTIDA; ESCHERICHIA-COLI; CARBOXYLIC-ACIDS; ALPHA-PROTONS; ACTIVE-SITE; EVOLUTION	Members of the enolase mechanistically diverse superfamily catalyze a wide variety of chemical reactions that are related by a common mechanistic feature, the abstraction of a proton adjacent to a carboxylate group. Recent investigations into the function and mechanism of the phosphosulfolactate synthase encoded by the ComA gene in Methanococcus jannaschii have suggested that ComA, which catalyzes the stereospecific Michael addition of sulfite to phosphoenolpyruvate to form phosphosulfolactate, may be a member of the enolase superfamily. The ComA-catalyzed reaction, the first step in the coenzyme M biosynthetic pathway, likely proceeds via a Mg2+ ion-stabilized enolate intermediate in a manner similar to that observed for members of the enolase superfamily. ComA, however, has no significant sequence similarity to any known enolase. Here we report the x-ray crystal structure of ComA to 1.7-Angstrom resolution. The overall fold for ComA is an (alpha/beta)(8) barrel that assembles with two other ComA molecules to form a trimer in which three active sites are created at the subunit interfaces. From the positions of two ordered sulfate ions in the active site, a model for the binding of phosphoenolpyruvate and sulfite is proposed. Despite its mechanistic similarity to the enolase superfamily, the overall structure and active site architecture of ComA are unlike any member of the enolase superfamily, which suggests that ComA is not a member of the enolase superfamily but instead acquired an enolase-type mechanism through convergent evolution.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	University of Wisconsin System; University of Wisconsin Madison; Virginia Polytechnic Institute & State University	Rayment, I (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.		Graham, David E/F-8578-2010; rayment, ivan/A-2720-2008	Graham, David E/0000-0001-8968-7344; rayment, ivan/0000-0001-9279-7835	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065155, R01GM052594] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM08293, GM-52594, GM-65155] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BABBITT PC, 1995, SCIENCE, V267, P1159, DOI 10.1126/science.7855594; Babbitt PC, 1996, BIOCHEMISTRY-US, V35, P16489, DOI 10.1021/bi9616413; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; FALLER LD, 1977, BIOCHEMISTRY-US, V16, P3864, DOI 10.1021/bi00636a023; Gerlt JA, 2003, CURR OPIN CHEM BIOL, V7, P252, DOI 10.1016/S1367-5931(03)00019-X; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Graham DE, 2002, NAT PROD REP, V19, P133, DOI 10.1039/b103714p; Graham DE, 2002, J BIOL CHEM, V277, P13421, DOI 10.1074/jbc.M201011200; Hasson MS, 1998, P NATL ACAD SCI USA, V95, P10396, DOI 10.1073/pnas.95.18.10396; HELIN S, 1995, J MOL BIOL, V254, P918, DOI 10.1006/jmbi.1995.0666; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; LANDRO JA, 1994, BIOCHEMISTRY-US, V33, P635, DOI 10.1021/bi00169a003; Larsen TM, 1996, BIOCHEMISTRY-US, V35, P4349, DOI 10.1021/bi952859c; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramakrishnan V, 1997, METHOD ENZYMOL, V276, P538, DOI 10.1016/S0076-6879(97)76077-4; Roussel A., 1991, SILICON GRAPHICS GEO, V86; Sanda S, 2001, J BIOL CHEM, V276, P3941, DOI 10.1074/jbc.M008200200; Schmidt DMZ, 2001, BIOCHEMISTRY-US, V40, P15707, DOI 10.1021/bi011640x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thompson TB, 2000, BIOCHEMISTRY-US, V39, P10662, DOI 10.1021/bi000855o	23	12	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45858	45863		10.1074/jbc.M307486200	http://dx.doi.org/10.1074/jbc.M307486200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952952	hybrid			2022-12-27	WOS:000186452300099
J	Yang, JH; Nie, YZ; Zhao, QC; Su, YJ; Pypaert, M; Su, HL; Rabinovici, R				Yang, JH; Nie, YZ; Zhao, QC; Su, YJ; Pypaert, M; Su, HL; Rabinovici, R			Intracellular localization of differentially regulated RNA-specific adenosine deaminase isoforms in inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; SPLICE-SITE VARIANTS; EDITING ENZYME ADAR1; IN-VITRO; BINDING DOMAINS; LUNG INJURY; HUMAN-CELLS; GLUR-B; INTERFERON; PROTEIN	Adenosine-to-inosine (A-to-I) RNA editing is a post-transcriptional process that amplifies the repertoire of protein production. Recently, the induction of this process through up-regulation of the editing enzyme RNA-specific adenosine deaminase 1 (ADAR1) was documented during acute inflammation. Here we report that the inflammation-induced up-regulation of ADAR1 involves differential production and intracellular localization of several isoforms with distinct RNA-binding domains and localization signals. These include the full-length ADAR1 (p150) and two functionally active short isoforms (p80 and p110). ADAR1 p80 starts at a methionine 519 (M519) due to alternative splicing in exon 2, which deletes the putative nuclear localization signal, the Z-DNA binding domain, and the entire RNA binding domain I. ADAR1 p110 is the mouse homologue of the human ADAR1 110-kDa variant (M246), which retains the second half of the Z-DNA binding domain, all RNA binding domains, and the deaminase domain. Additional variations are found in the third RNA binding domain of ADAR1; they are differentially regulated during inflammation, generating isoforms with different levels of activities. Studies in several cell types transfected with ADAR1-EGFP chimeras demonstrated that the p150 and p80 variants are localized in the cytoplasm and nucleolus, respectively. In agreement with this observation, endogenous ADAR1 was identified in the cytoplasm and nucleolus of mouse splenocytes and HeLa cells. Since the ADAR1 variants are differentially regulated during acute inflammation, it suggests that the localization of these variants and of A-to-I RNA editing in the cytoplasm, nucleus, and nucleolus is intracellularly reorganized in response to inflammatory stimulation.	Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University	Yang, JH (corresponding author), Yale Univ, Sch Med, Dept Surg, 333 Cedar St,LH118, New Haven, CT 06520 USA.	jinghua.yang@yale.edu			NIGMS NIH HHS [GM-60426] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060426] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Dabiri GA, 1996, EMBO J, V15, P34, DOI 10.1002/j.1460-2075.1996.tb00331.x; Eckmann CR, 1999, J CELL BIOL, V144, P603, DOI 10.1083/jcb.144.4.603; Eckmann CR, 2001, MOL BIOL CELL, V12, P1911, DOI 10.1091/mbc.12.7.1911; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; George CX, 1999, GENE, V229, P203, DOI 10.1016/S0378-1119(99)00017-7; Gerber A, 1998, EMBO J, V17, P4780, DOI 10.1093/emboj/17.16.4780; Hanrahan CJ, 2000, GENETICS, V155, P1149; Herbert A, 1997, P NATL ACAD SCI USA, V94, P8421, DOI 10.1073/pnas.94.16.8421; Herbert A, 2002, MOL CELL, V10, P1235, DOI 10.1016/S1097-2765(02)00737-2; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hudson LD, 1999, CHEST, V116, p74S, DOI 10.1378/chest.116.suppl_1.74S-a; Hurst SR, 1995, RNA, V1, P1051; Kabir K, 2002, SHOCK, V17, P300, DOI 10.1097/00024382-200204000-00010; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; LAI F, 1995, J BIOL CHEM, V270, P17098, DOI 10.1074/jbc.270.29.17098; Li YP, 1996, EUR J BIOCHEM, V237, P153, DOI 10.1111/j.1432-1033.1996.0153n.x; Liu Y, 1999, J BIOL CHEM, V274, P5070, DOI 10.1074/jbc.274.8.5070; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; Liu Y, 1997, J BIOL CHEM, V272, P4419, DOI 10.1074/jbc.272.7.4419; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Longacre A, 2000, CELL, V102, P541, DOI 10.1016/S0092-8674(00)00075-1; Ma E, 2001, J CLIN INVEST, V107, P685, DOI 10.1172/JCI11625; Maas S, 1996, J BIOL CHEM, V271, P12221, DOI 10.1074/jbc.271.21.12221; Maas S, 1999, P NATL ACAD SCI USA, V96, P8895, DOI 10.1073/pnas.96.16.8895; Maas S, 2000, GENE, V243, P59, DOI 10.1016/S0378-1119(99)00562-4; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neuberger MS, 2000, SCIENCE, V289, P1705, DOI 10.1126/science.289.5485.1705; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Palladino MJ, 2000, RNA, V6, P1004, DOI 10.1017/S1355838200000248; PATTERSON JB, 1995, VIROLOGY, V210, P508, DOI 10.1006/viro.1995.1370; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; Poulsen H, 2001, MOL CELL BIOL, V21, P7862, DOI 10.1128/MCB.21.22.7862-7871.2001; Rabinovici R, 2001, CIRC RES, V88, P1066, DOI 10.1161/hh1001.090877; Raitskin O, 2001, P NATL ACAD SCI USA, V98, P6571, DOI 10.1073/pnas.111153798; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Samuel CE, 1998, CURR TOP MICROBIOL, V233, P125; Schwab MS, 1997, EUR J CELL BIOL, V73, P287; Slavov D, 2000, GENE, V250, P41, DOI 10.1016/S0378-1119(00)00174-8; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; WEIER HUG, 1995, GENOMICS, V30, P372, DOI 10.1006/geno.1995.0034; YANG JH, 1995, NATURE, V374, P77, DOI 10.1038/374077a0; Yang JH, 2003, IMMUNOLOGY, V109, P15, DOI 10.1046/j.1365-2567.2003.01598.x; Yang JH, 1997, P NATL ACAD SCI USA, V94, P4354, DOI 10.1073/pnas.94.9.4354	54	44	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45833	45842		10.1074/jbc.M308612200	http://dx.doi.org/10.1074/jbc.M308612200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954622	hybrid			2022-12-27	WOS:000186452300096
J	Arima, H; Yamamoto, N; Sobue, K; Umenishi, F; Tada, T; Katsuya, H; Asai, K				Arima, H; Yamamoto, N; Sobue, K; Umenishi, F; Tada, T; Katsuya, H; Asai, K			Hyperosmolar mannitol stimulates expression of aquaporins 4 and 9 through a p38 mitogen-activated protein kinase-dependent pathway in rat astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERTONICITY-RESPONSIVE ELEMENT; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN INJURY; WATER CHANNEL; MAP KINASE; GENE-EXPRESSION; DIFFERENTIAL REGULATION; MAMMALIAN-CELLS; MESSENGER-RNA; IN-VITRO	The membrane pore proteins, aquaporins (AQPs), facilitate the osmotically driven passage of water and, in some instances, small solutes. Under hyperosmotic conditions, the expression of some AQPs changes, and some studies have shown that the expression of AQP1 and AQP5 is regulated by MAPKs. However, the mechanisms regulating the expression of AQP4 and AQP9 induced by hyperosmotic stress are poorly understood. In this study, we observed that hyperosmotic stress induced by mannitol increased the expression of AQP4 and AQP9 in cultured rat astrocytes, and intraperitoneal infusion of mannitol increased AQP4 and AQP9 in the rat brain cortex. In addition, a p38 MAPK inhibitor, but not ERK and JNK inhibitors, suppressed their expression in cultured astrocytes. AQPs play important roles in maintaining brain homeostasis. The expression of AQP4 and AQP9 in astrocytes changes after brain ischemia or traumatic injury, and some studies have shown that p38 MAPK in astrocytes is activated under similar conditions. Since mannitol is commonly used to reduce brain edema, understanding the regulation of AQPs and p38 MAPK in astrocytes under hyperosmotic conditions induced with mannitol may lead to a control of water movements and a new treatment for brain edema.	Okazaki City Hosp, Dept Anesthesia & Crit Care, Okazaki, Aichi 4448553, Japan; Nagoya City Univ, Grad Sch Med Sci, Dept Anesthesiol & Med Crisis Management, Mizuho Ku, Nagoya, Aichi 4678601, Japan; Nagoya City Univ, Grad Sch Med Sci, Dept Mol Neurobiol, Nagoya, Aichi 4678601, Japan; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Renal Dis & Hypertens, Denver, CO 80262 USA; Nagoya City Univ, Sch Nursing, Dept Pathol, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Nagoya City University; Nagoya City University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Nagoya City University	Arima, H (corresponding author), Okazaki City Hosp, Dept Anesthesia & Crit Care, 3-1 goshoai,Koryuji Cho, Okazaki, Aichi 4448553, Japan.	arima@sb.starcat.ne.jp	Asai, Kiyofumi/H-2356-2014	Asai, Kiyofumi/0000-0001-7015-2251				Agre P, 1998, J BIOL CHEM, V273, P14659, DOI 10.1074/jbc.273.24.14659; Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; BEDFORD JJ, 1993, AM J PHYSIOL, V264, pR1164, DOI 10.1152/ajpregu.1993.264.6.R1164; Borok Z, 1998, AM J RESP CELL MOL, V18, P554, DOI 10.1165/ajrcmb.18.4.2838; Burg MB, 1996, FASEB J, V10, P1598, DOI 10.1096/fasebj.10.14.9002551; Connolly DL, 1998, INT J BIOCHEM CELL B, V30, P169, DOI 10.1016/S1357-2725(97)00124-6; DaSilva J, 1997, J BIOL CHEM, V272, P28373, DOI 10.1074/jbc.272.45.28373; Endo M, 1999, MICROVASC RES, V58, P89, DOI 10.1006/mvre.1999.2158; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Furuno M, 1996, AM J PHYSIOL-RENAL, V271, pF854, DOI 10.1152/ajprenal.1996.271.4.F854; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hoffert JD, 2000, J BIOL CHEM, V275, P9070, DOI 10.1074/jbc.275.12.9070; Hozawa S, 1996, AM J PHYSIOL-CELL PH, V270, pC1695, DOI 10.1152/ajpcell.1996.270.6.C1695; Ishibashi K, 2000, REV PHYSIOL BIOCH P, V141, P1, DOI 10.1007/BFb0119576; Jenq W, 1998, BIOCHEM BIOPH RES CO, V245, P804, DOI 10.1006/bbrc.1998.8518; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; KATO T, 1979, BIOCHIM BIOPHYS ACTA, V579, P216, DOI 10.1016/0005-2795(79)90100-4; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Ko SBH, 1999, BIOCHEM MOL BIOL INT, V47, P309; Kozono D, 2002, J CLIN INVEST, V109, P1395, DOI 10.1172/JCI200215851; Kultz D, 1998, J EXP BIOL, V201, P3015; Leitch V, 2001, P NATL ACAD SCI USA, V98, P2894, DOI 10.1073/pnas.041616498; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Markert JM, 2001, PHYSIOL GENOMICS, V5, P21, DOI 10.1152/physiolgenomics.2001.5.1.21; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; MATSUDA S, 1995, J BIOL CHEM, V270, P12781, DOI 10.1074/jbc.270.21.12781; Matsuzaki T, 2001, AM J PHYSIOL-CELL PH, V281, pC55, DOI 10.1152/ajpcell.2001.281.1.C55; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Nakahama K, 1999, GLIA, V25, P240, DOI 10.1002/(SICI)1098-1136(19990201)25:3<240::AID-GLIA4>3.3.CO;2-3; Nico B, 2001, J CELL SCI, V114, P1297; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; SATO Y, 1986, AM J PATHOL, V125, P431; SCHWARTZ LM, 1993, IMMUNOL TODAY, V14, P582, DOI 10.1016/0167-5699(93)90197-S; Sugiyama Y, 2001, BBA-GENE STRUCT EXPR, V1522, P82, DOI 10.1016/S0167-4781(01)00320-7; TAKENAKA M, 1994, J BIOL CHEM, V269, P29379; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Uehara T, 1999, BRAIN RES, V823, P226, DOI 10.1016/S0006-8993(99)01178-6; Umenishi F, 2003, J BIOL CHEM, V278, P15765, DOI 10.1074/jbc.M209980200; Umenishi F, 2002, BIOCHEM BIOPH RES CO, V292, P771, DOI 10.1006/bbrc.2002.6709; Umenishi F, 1998, GENOMICS, V50, P373, DOI 10.1006/geno.1998.5337; Venero JL, 2001, PROG NEUROBIOL, V63, P321, DOI 10.1016/S0301-0082(00)00035-6; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; Wang XY, 2002, J NEUROTRAUM, V19, P615, DOI 10.1089/089771502753754082; Yamamoto N, 2002, MOL BRAIN RES, V104, P96, DOI 10.1016/S0169-328X(02)00322-4; Yamamoto N, 2001, MOL BRAIN RES, V95, P110, DOI 10.1016/S0169-328X(01)00254-6; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X; Yoneda K, 2001, MOL BRAIN RES, V89, P94, DOI 10.1016/S0169-328X(01)00067-5; Zornow MH, 1996, J NEUROSURG ANESTH, V8, P175, DOI 10.1097/00008506-199604000-00021	55	144	168	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44525	44534		10.1074/jbc.M304368200	http://dx.doi.org/10.1074/jbc.M304368200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944406	hybrid			2022-12-27	WOS:000186306700081
J	Bowman, EJ; Gustafson, KR; Bowman, BJ; Boyd, MR				Bowman, EJ; Gustafson, KR; Bowman, BJ; Boyd, MR			Identification of a new chondropsin class of antitumor compound that selectively inhibits V-ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; PROTON-TRANSLOCATING ATPASE; C-SUBUNIT; MACROLIDE LACTAMS; GENE ENCODES; EXPRESSION; ROTATION; MARINE; BAFILOMYCINS; CONCANAMYCIN	We identify a new naturally occurring class of inhibitor of vacuolar H+-ATPases (V-ATPases) isolated from vacuolar membranes of Neurospora crassa and from chromaffin granule membranes of Bos taurus. To date, the new class includes six chondropsins and poecillastrin A, large polyketide-derived macrolide lactams with 33 - 37 membered rings. In the National Cancer Institute's 60-cell screen the chondropsin class showed a tumor cell growth inhibitory fingerprint essentially indistinguishable from that of the bafilomycin/concanamycin and the salicylihalamide/lobatamide classes of well-established V-ATPase inhibitors. Half-maximal inhibition of V-ATPase activity in vitro occurred at 0.04 - 0.7 muM for the fungal vacuolar V-ATPase and at 0.4 to > 10 muM for the chromaffin granule V-ATPase. Thus, the new inhibitors are somewhat less potent than the other two classes, which typically have K-i values of < 10 nM for V-ATPases, and the new inhibitors differ from the other two classes in their specificity. The bafilomycin class inhibits all eucaryotic V-ATPases, the salicylihalamide class inhibits mammalian V-ATPases but not fungal V-ATPases, and the new chondropsin class inhibits the N. crassa V-ATPase better than the chromaffin granule V-ATPase. Two mutations in the N. crassa V-ATPase that affect the binding of bafilomycin had small but reproducible effects on the affinity of chondropsins for the V-ATPase, suggesting the possibility of a similar mechanism of inhibition.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; NCI, Mol Targets Dev Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; Univ S Alabama, USA Canc Res Inst, Mobile, AL 36688 USA	University of California System; University of California Santa Cruz; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of South Alabama	Bowman, EJ (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	rbowman@biology.ucsc.edu						Beutler JA, 2003, CURR MED CHEM, V10, P787, DOI 10.2174/0929867033457827; Bowman BJ, 2002, J BIOL CHEM, V277, P3965, DOI 10.1074/jbc.M109756200; Bowman EJ, 1997, J BIOL CHEM, V272, P14776, DOI 10.1074/jbc.272.23.14776; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BOWMAN EJ, 1997, BIOMEMBRANE, P861; Boyd MR, 2001, J PHARMACOL EXP THER, V297, P114; BOYD MR, 1995, DRUG DEVELOP RES, V34, P91, DOI 10.1002/ddr.430340203; Boyd MR, 1997, CANC DRUG DISCOVERY, P23; Cantrell CL, 2000, J AM CHEM SOC, V122, P8825, DOI 10.1021/ja0010711; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Drose S, 1997, J EXP BIOL, V200, P1; Farina C, 1999, DRUG DISCOV TODAY, V4, P163, DOI 10.1016/S1359-6446(99)01321-5; Fillingame RH, 2002, BBA-BIOENERGETICS, V1555, P29, DOI 10.1016/S0005-2728(02)00250-5; GALANIS M, 1989, FEBS LETT, V249, P333, DOI 10.1016/0014-5793(89)80653-2; Grabe M, 2000, BIOPHYS J, V78, P2798, DOI 10.1016/S0006-3495(00)76823-8; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; HUANG L, 1984, J ANTIBIOT, V37, P970, DOI 10.7164/antibiotics.37.970; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kelling DJ, 1997, ANN NY ACAD SCI, V834, P600, DOI 10.1111/j.1749-6632.1997.tb52329.x; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Martinez-Zaguilan R, 1999, BIOCHEM PHARMACOL, V57, P1037, DOI 10.1016/S0006-2952(99)00022-2; McSheehy PMJ, 2003, EUR J CANCER, V39, P532, DOI 10.1016/S0959-8049(02)00671-8; NELSON N, 1988, METHOD ENZYMOL, V157, P619; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Rashid MA, 2002, ORG LETT, V4, P3293, DOI 10.1021/ol026564k; Rashid MA, 2001, J NAT PROD, V64, P1341, DOI 10.1021/np0101907; Rashid MA, 2001, TETRAHEDRON LETT, V42, P1623, DOI 10.1016/S0040-4039(00)02348-0; Scheidt KA, 2002, J AM CHEM SOC, V124, P6981, DOI 10.1021/ja017885e; SEBALD W, 1981, CURR TOP BIOENERG, V12, P1; Shen RC, 2003, J AM CHEM SOC, V125, P7889, DOI 10.1021/ja0352350; Shen RC, 2002, ORG LETT, V4, P3103, DOI 10.1021/ol026391z; Sun-Wada GH, 2003, GENE, V302, P147, DOI 10.1016/S0378-1119(02)01099-5; Torigoe T, 2002, ANTI-CANCER DRUG, V13, P237, DOI 10.1097/00001813-200203000-00005; Torigoe T, 2002, J BIOL CHEM, V277, P36534, DOI 10.1074/jbc.M202605200; Toshima K, 2001, J ORG CHEM, V66, P1708, DOI 10.1021/jo001377q; Toshima K, 1997, J ORG CHEM, V62, P3271, DOI 10.1021/jo970314d; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Visentin L, 2000, J CLIN INVEST, V106, P309, DOI 10.1172/JCI6145; Wu YS, 2002, J AM CHEM SOC, V124, P3245, DOI 10.1021/ja0177713	45	44	53	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44147	44152		10.1074/jbc.M306595200	http://dx.doi.org/10.1074/jbc.M306595200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944415	hybrid			2022-12-27	WOS:000186306700033
J	Nehrke, K				Nehrke, K			A reduction in intestinal cell pH(i) due to loss of the Caenorhabditis elegans Na+/H+ exchanger NHX-2 increases life span	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED OLIGOPEPTIDE TRANSPORTER; PARIETAL-CELLS; C-ELEGANS; CALORIC RESTRICTION; EXPRESSION CLONING; PHARYNGEAL MUSCLE; RABBIT PARIETAL; GENE-TRANSFER; ISOFORMS; LINE	Na+/H+ exchangers are involved in cell volume regulation, fluid secretion and absorption, and pH homeostasis. NHX-2 is a Caenorhabditis elegans Na+/H+ exchanger expressed exclusively at the apical membrane of intestinal epithelial cells. The inactivation of various intestinal nutrient transport proteins has been shown previously to influence aging via metabolic potential and a mechanism resembling caloric restriction. We report here a functional coupling of NHX-2 activity with nutrient uptake that results in long lived worms. Gene inactivation of nhx-2 by RNAi led to a loss of fat stores in the intestine and a 40% increase in longevity. The NHX-2 protein was coincidentally expressed with OPT-2, an oligopeptide transporter that is driven by a transmembrane proton gradient and that is also known to be involved in fat accumulation. Gene inactivation of opt-2 led to a phenotype resembling that of nhx-2, although not as severe. In order to explore this potential functional interaction, we combined RNA interference with a genetically encoded, fluorescence-based reagent to measure intestinal intracellular pH (pH(i)) in live worms under physiological conditions. Our results suggest first that OPT-2 is the main dipeptide uptake pathway in the nematode intestine, and second that dipeptide uptake results in intestinal cell acidification, and finally that recovery following dipeptide-induced acidification is normally a function of NHX-2. The loss of NHX-2 protein results in decreased steady-state intestinal cell pHi, and we hypothesize that this change perturbs proton-coupled nutrient uptake processes such as performed by OPT-2. Our data demonstrate a functional role for a Na+/H+ exchanger in nutrient absorption in vivo and lays the groundwork for examining integrated acid-base physiology in a non-mammalian model organism.	Univ Rochester, Med Ctr, Dept Med, Gastroenterol Unit, Rochester, NY 14642 USA	University of Rochester	Nehrke, K (corresponding author), Univ Rochester, Med Ctr, Dept Med, Gastroenterol Unit, 601 Elmwood Ave,Box 646, Rochester, NY 14642 USA.	keith_nehrke@urmc.rochester.edu		Nehrke, Keith/0000-0001-9697-726X	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE008921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE008921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK062763] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE08921] Funding Source: Medline; NIDDK NIH HHS [DK062763, R21 DK062763, R21 DK062763-01] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson CMH, 2003, BRIT J PHARMACOL, V138, P564, DOI 10.1038/sj.bjp.0705049; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Attaphitaya S, 2001, AM J PHYSIOL-CELL PH, V281, pC1146, DOI 10.1152/ajpcell.2001.281.4.C1146; AVERY L, 1993, GENETICS, V133, P897; Bachmann O, 1998, AM J PHYSIOL-GASTR L, V275, pG1085, DOI 10.1152/ajpgi.1998.275.5.G1085; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; BOLL M, 1994, PFLUG ARCH EUR J PHY, V429, P146, DOI 10.1007/BF02584043; Daniel H, 2003, AM J PHYSIOL-RENAL, V284, pF885, DOI 10.1152/ajprenal.00123.2002; Fei YJ, 1998, BIOCHEM J, V332, P565, DOI 10.1042/bj3320565; Fei YJ, 2000, J BIOL CHEM, V275, P9563, DOI 10.1074/jbc.275.13.9563; Fei YJ, 2003, J BIOL CHEM, V278, P6136, DOI 10.1074/jbc.M208763200; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Franks CJ, 2002, J NEUROPHYSIOL, V87, P954, DOI 10.1152/jn.00233.2001; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Hayashi H, 2002, ANN NY ACAD SCI, V976, P248; HIMUKAI M, 1978, JPN J PHYSIOL, V28, P499; Houthoofd K, 2002, EXP GERONTOL, V37, P1371, DOI 10.1016/S0531-5565(02)00173-0; Jankowski A, 2001, J BIOL CHEM, V276, P48748, DOI 10.1074/jbc.M109003200; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennedy DJ, 2002, PFLUG ARCH EUR J PHY, V445, P139, DOI 10.1007/s00424-002-0910-1; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Knauf F, 2002, P NATL ACAD SCI USA, V99, P14315, DOI 10.1073/pnas.222531899; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; LEVINE SA, 1993, J BIOL CHEM, V268, P25527; MACHEN TE, 2003, AM J PHYSIOL, V26, pC205; MATTHEWS DM, 1974, CLIN SCI MOL MED, V46, P693, DOI 10.1042/cs0460693; Matyash V, 2001, MOL BIOL CELL, V12, P1725, DOI 10.1091/mbc.12.6.1725; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Merris M, 2003, J LIPID RES, V44, P172, DOI 10.1194/jlr.M200323-JLR200; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MUALLEM S, 1985, J BIOL CHEM, V260, P6641; Nehrke K, 2002, J BIOL CHEM, V277, P29036, DOI 10.1074/jbc.M203200200; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; Repishti M, 2001, AM J PHYSIOL-GASTR L, V281, pG159, DOI 10.1152/ajpgi.2001.281.1.G159; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; RONG LA, 1995, J BIOL CHEM, V270, P6456, DOI 10.1074/jbc.270.12.6456; Rossmann H, 2001, AM J PHYSIOL-GASTR L, V281, pG447, DOI 10.1152/ajpgi.2001.281.2.G447; Samuel A D, 2001, BMC Dev Biol, V1, P8, DOI 10.1186/1471-213X-1-8; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Shim YH, 2002, MOL REPROD DEV, V61, P358, DOI 10.1002/mrd.10099; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Thwaites DT, 1999, J CLIN INVEST, V104, P629, DOI 10.1172/JCI7192; Thwaites DT, 2002, GASTROENTEROLOGY, V122, P1322, DOI 10.1053/gast.2002.32992; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51	52	89	99	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44657	44666		10.1074/jbc.M307351200	http://dx.doi.org/10.1074/jbc.M307351200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12939266	hybrid			2022-12-27	WOS:000186306700098
J	Zhang, YW; Kaneda, M; Morita, I				Zhang, YW; Kaneda, M; Morita, I			The gap junction-independent tumor-suppressing effect of connexin 43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEIN; UBIQUITIN-DEPENDENT DEGRADATION; INTERCELLULAR COMMUNICATION; GROWTH-CONTROL; CELL-GROWTH; INHIBITOR P27(KIP1); SKP2 EXPRESSION; TYROSINE KINASE; GENES; CANCER	The gap junction gene connexin 43 (Cx43) showed tumor-suppressing effects on various tumor cell lines. We have previously demonstrated that Cx43 inhibited expression of S phase kinase-associated protein 2 (Skp2), the human F-box protein that regulates the ubiquitination of p27. Cx43 did not alter the mRNA level of SKP2, but it promoted the degradation of the Skp2 proteins (Zhang, Y.W., Nakayama, K., Nakayama K. I., and Morita, I. (2003) Cancer Res. 63, 1623-1630). In this study, we showed that the specific gap junction inhibitor 18 beta-glycyrrhetinic acid did not influence the inhibitory effect of Cx43 on Skp2 expression. Further, the deletion mutation analyses demonstrated that the C-terminal domain of Cx43 that did not form gap junctions was sufficient to inhibit expression of Skp2, whereas the N-terminal domain that formed the gap junctions did not show such an effect. Like the full-length Cx43, the C-terminal domain also increased the protein instability of Skp2, whereas the N terminus did not. Moreover, the C-terminal domain was as effective as the full-length Cx43 in inhibiting cell proliferation; however, the N-terminal domain did not show any inhibitory effect on cell proliferation. Therefore, these data revealed a gap junction-independent pathway for Cx43 to inhibit tumor growth by suppressing the Skp2 expression.	Tokyo Med & Dent Univ, Dept Cellular Physiol Chem, Bunkyo Ku, Tokyo 1138549, Japan	Tokyo Medical & Dental University (TMDU)	Zhang, YW (corresponding author), Burnham Inst, Canc Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		高, 雨莉/HGU-8187-2022					Dang XT, 2003, MOL CELL BIOCHEM, V242, P35, DOI 10.1023/A:1021152709313; Dow R, 2001, J BIOL CHEM, V276, P45945, DOI 10.1074/jbc.M103593200; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Hershko D, 2001, CANCER, V91, P1745, DOI 10.1002/1097-0142(20010501)91:9<1745::AID-CNCR1193>3.0.CO;2-H; Huang RP, 1998, CANCER RES, V58, P5089; Koga H, 2003, HEPATOLOGY, V37, P1086, DOI 10.1053/jhep.2003.50186; Kudo Y, 2001, CANCER RES, V61, P7044; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Lin R, 2003, ENDOCRINOLOGY, V144, P749, DOI 10.1210/en.2002-0026; Loewenstein W R, 1992, Semin Cell Biol, V3, P59; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; MESNIL M, 1995, CANCER RES, V55, P629; Moorby C, 2001, EXP CELL RES, V271, P238, DOI 10.1006/excr.2001.5357; Nakamura M, 2003, CELL DEATH DIFFER, V10, P230, DOI 10.1038/sj.cdd.4401125; Omori Y, 1998, INT J CANCER, V78, P446, DOI 10.1002/(SICI)1097-0215(19981109)78:4<446::AID-IJC10>3.3.CO;2-4; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; Qin H, 2002, J BIOL CHEM, V277, P29132, DOI 10.1074/jbc.M200797200; Sgambato A, 2000, J CELL PHYSIOL, V183, P18, DOI 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Yamasaki H, 1999, CR ACAD SCI III-VIE, V322, P151, DOI 10.1016/S0764-4469(99)80038-9; Yamasaki H, 1996, CARCINOGENESIS, V17, P1199, DOI 10.1093/carcin/17.6.1199; Zhang L, 2003, J BIOL CHEM, V278, P27, DOI 10.1074/jbc.M205424200; Zhang YW, 2000, PLANTA MED, V66, P119, DOI 10.1055/s-2000-11126; Zhang YW, 2001, ONCOGENE, V20, P4138, DOI 10.1038/sj.onc.1204563; Zhang YW, 1999, J CELL PHYSIOL, V180, P305, DOI 10.1002/(SICI)1097-4652(199909)180:3<305::AID-JCP1>3.0.CO;2-Z; Zhang YW, 2003, CANCER RES, V63, P1623; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	31	156	164	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44852	44856		10.1074/jbc.M305072200	http://dx.doi.org/10.1074/jbc.M305072200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12952975	hybrid			2022-12-27	WOS:000186306700120
J	Inamori, K; Endo, T; Ide, Y; Fujii, S; Gu, JG; Honke, K; Taniguchi, N				Inamori, K; Endo, T; Ide, Y; Fujii, S; Gu, JG; Honke, K; Taniguchi, N			Molecular cloning and characterization of human GnT-IX, a novel beta 1,6-N-acetylglucosaminyltransferase that is specifically expressed in the brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-V; CELL-LINES; OLIGOSACCHARIDES; BINDING; GLYCOPROTEINS; SEQUENCES; MUTATION; GLYCANS; GROWTH; GENE	A novel beta1,6-N-acetylglucosaminyltransferase (beta1, 6GnT) cDNA was identified by a BLAST search using the amino acid sequence of human GnT-V as a query. The full-length sequence was determined by a combination of 5'-rapid amplification of cDNA end analysis and a further data base search. The open reading frame encodes a 792 amino acid protein with a type II membrane protein structure typical of glycosyltransferases. The entire sequence identity to human GnT-V is 42%. When pyridylaminated (PA) agalacto biantennary N-linked oligosaccharide was used as an acceptor substrate, the recombinant enzyme generated a novel product other than the expected GnT-V product, (GlcNAc beta1,2-Manalpha1,3-)[GlcNAcbeta1,2-(GlcNAcbeta1,6-)Manalpha1,6-] Manbeta1,4-GlcNAcbeta1,4-GlcNAc-PA. This new product was identified as [GlcNAcbeta1,2-(GlcNAcbeta1,6-)Manalpha1,3-][GlcNAcbeta1,2-(GlcNAcbeta1,6-)Manalpha1,6-]Manbeta1,4-GlcNAcbeta1,4-GlcNAc-PA by mass spectrometry and H-1 NMR. Namely, the new GnT (designated as GnT-IX) has beta1,6GnT activity not only to the alpha1,6-linked mannose arm but also to the alpha1,3-linked mannose arm of N-glycan, forming a unique structure that has not been reported to date. Northern blot analysis showed that the GnT-IX gene is exclusively expressed in the brain, whereas the GnT-V gene is expressed ubiquitously. These results suggest that GnT-IX is responsible for the synthesis of a unique oligosaccharide structure in the brain.	Osaka Univ, Sch Med, Dept Biochem, Suita, Osaka 5650871, Japan; Kansai Med Univ, Chem Lab, Osaka 5731136, Japan; Kochi Med Sch, Dept Mol Genet, Nanko Ku, Kochi 7838505, Japan	Osaka University; Kansai Medical University; Kochi University	Honke, K (corresponding author), Osaka Univ, Sch Med, Dept Biochem, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	khonke@med.kochi-ms.ac.jp	Gu, Jianguo/ABC-9257-2020; Taniguchi, Naoyuki/A-7086-2016; Inamori, Kei-ichiro/ABA-2926-2020; Taniguchi, Naoyuki/I-4182-2014	Inamori, Kei-ichiro/0000-0002-5947-3633; Taniguchi, Naoyuki/0000-0001-5889-5968				CUMMINGS RD, 1984, J BIOL CHEM, V259, P6253; Fukuzumi M, 2001, GLYCOBIOLOGY, V11, P481, DOI 10.1093/glycob/11.6.481; Granovsky M, 2000, NAT MED, V6, P306; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; KNIBBS RN, 1993, J BIOL CHEM, V268, P14940; MARGOLIS RK, 1986, BIOCHEMISTRY-US, V25, P3463, DOI 10.1021/bi00359a055; NISHIKAWA A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P313, DOI 10.1016/0304-4165(90)90094-D; Puche AC, 1996, J COMP NEUROL, V364, P267, DOI 10.1002/(SICI)1096-9861(19960108)364:2<267::AID-CNE6>3.0.CO;2-3; Raju TS, 1998, J BIOL CHEM, V273, P14090, DOI 10.1074/jbc.273.23.14090; SAITO H, 1994, BIOCHEM BIOPH RES CO, V198, P318, DOI 10.1006/bbrc.1994.1045; Sasai K, 2001, J BIOL CHEM, V276, P759, DOI 10.1074/jbc.M004972200; SATO S, 1992, J BIOL CHEM, V267, P6983; SCHACHTER H, 1991, Glycobiology, V1, P453, DOI 10.1093/glycob/1.5.453; SEKO A, 1997, BIOCHIM BIOPHYS ACTA, V17, P1; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; SHOREIBAH M, 1993, J BIOL CHEM, V268, P15381; TANIGUCHI N, 1989, METHOD ENZYMOL, V179, P397; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Ujita M, 2000, J BIOL CHEM, V275, P15868, DOI 10.1074/jbc.M001034200; VANDENEIJNDEN DH, 1988, J BIOL CHEM, V263, P12461; Warren CE, 2002, J BIOL CHEM, V277, P22829, DOI 10.1074/jbc.M201390200; Weinstein J, 1996, J BIOL CHEM, V271, P27462, DOI 10.1074/jbc.271.44.27462; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772	23	71	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43102	43109		10.1074/jbc.M308255200	http://dx.doi.org/10.1074/jbc.M308255200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12941944	hybrid			2022-12-27	WOS:000186157000049
J	Yoshida, Y; Tokunaga, F; Chiba, T; Iwai, K; Tanaka, K; Tai, T				Yoshida, Y; Tokunaga, F; Chiba, T; Iwai, K; Tanaka, K; Tai, T			Fbs2 is a new member of the E3 ubiquitin ligase family that recognizes sugar chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSIDASE-LIKE PROTEIN; ER-ASSOCIATED DEGRADATION; F-BOX PROTEINS; MISFOLDED GLYCOPROTEINS; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; QUALITY-CONTROL; HIF-ALPHA; HYDROXYLATION; TRANSLOCATION	F-box proteins are substrate recognition components of Skp1-Cullin1-F-box protein-Roc1 (SCF) E3 ubiquitin-protein ligases. We reported previously that Fbs1 (F-box protein that recognizes sugar chains; equivalent to Fbx2 or NFB42) binds specifically to proteins attached with high mannose oligosaccharides and subsequently contributes to elimination of N-glycoproteins in cytosol (Yoshida, Y., Chiba, T., Tokunaga, F., Kawasaki, H., Iwai, K., Suzuki, T., Ito, Y., Matsuoka, K., Yoshida, M., Tanaka, K., and Tai, T. (2002) Nature 418, 438 - 442). Here we report the identification of another F-box protein that recognizes N-glycan, Fbs2 (called Fbx6b or FBG2 previously). Although the expression of Fbs1 was restricted to the adult brain and testis, the Fbs2 transcript was widely expressed. The Fbs2 protein forms an SCFFbs2 ubiquitin-ligase complex that targets sugar chains in N-glycoproteins for ubiquitylation. Only glycoproteins bound to concanavalin A lectin and not to wheat germ agglutinin or Ricinus communis agglutinin interacted with Fbs2 in various tissues and cell lines. Pull-down analysis using various oligosaccharides revealed that Man(3-9)GlcNAc(2) glycans were required for efficient Fbs2 binding, whereas modifications of mannose residues by other sugars or deletion of inner GlcNAc reduced Fbs2 binding. Fbs2 interacted with N-glycans of T-cell receptor alpha-subunit (TCRalpha), a typical substrate of the endoplasmic reticulum-associated degradation (ERAD) pathway, and the forced expression of mutant Fbs2DeltaF, which lacks the F-box domain essential for forming the SCF complex, and decrease of endogenous Fbs2 by small interfering RNA led to inhibition of TCRalpha degradation in cells. Thus, Fbs2 is a novel member of F-box protein family that recognizes N-glycans and plays a role in ERAD.	Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; Osaka City Univ, Grad Sch Med, Dept Mol Cell Biol, Osaka 5458585, Japan	Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Osaka Metropolitan University	Yoshida, Y (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.		IWAI, KAZUHIRO/GSN-7385-2022; Yoshida, Yukiko/ABB-7218-2020	Yoshida, Yukiko/0000-0002-0629-0219; Tokunaga, Fuminori/0000-0003-3626-9119; Iwai, Kazuhiro/0000-0001-5620-5951				Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; Castellino F, 2000, J EXP MED, V191, P1957, DOI 10.1084/jem.191.11.1957; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Erhardt JA, 1998, J BIOL CHEM, V273, P35222, DOI 10.1074/jbc.273.52.35222; Fang D, 1999, BIOCHEM BIOPH RES CO, V261, P357, DOI 10.1006/bbrc.1999.1028; FIEDLER K, 1995, CELL, V81, P309, DOI 10.1016/0092-8674(95)90380-1; HASE S, 1987, ANAL BIOCHEM, V167, P321, DOI 10.1016/0003-2697(87)90171-0; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Ilyin GP, 2002, GENE, V296, P11, DOI 10.1016/S0378-1119(02)00867-3; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jakob CA, 2001, EMBO REP, V2, P423; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kipreos ET, 2000, GENOME BIOL, V1; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; SOUSA M, 1995, EMBO J, V14, P4196, DOI 10.1002/j.1460-2075.1995.tb00093.x; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800	32	128	135	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43877	43884		10.1074/jbc.M304157200	http://dx.doi.org/10.1074/jbc.M304157200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12939278	hybrid			2022-12-27	WOS:000186157000138
J	Hiramatsu, T; Sonoda, H; Takanezawa, Y; Morikawa, R; Ishida, M; Kasahara, K; Sanai, Y; Taguchi, R; Aoki, J; Arai, H				Hiramatsu, T; Sonoda, H; Takanezawa, Y; Morikawa, R; Ishida, M; Kasahara, K; Sanai, Y; Taguchi, R; Aoki, J; Arai, H			Biochemical and molecular characterization of two phosphatidic acid-selective phospholipase A(1)s, mPA-PLA(1)alpha and mPA-PLA(1)beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN SEC23P-INTERACTING PROTEIN; SMOOTH-MUSCLE CELLS; LYSOPHOSPHATIDIC ACID; SPHINGOSINE 1-PHOSPHATE; SIGNAL-TRANSDUCTION; SEQUENCE SIMILARITY; COUPLED RECEPTOR; HEPATIC LIPASE; FAMILY; A(2)	We have identified a novel phospholipase A(1), named mPA-PLA(1)beta, which is specifically expressed in human testis and characterized it biochemically together with previously identified mPA-PLA(1)alpha. The sequence of mPA-PLA(1)beta encodes a 460-amino acid protein containing a lipase domain with significant homology to the previously identified phosphatidic acid (PA)-selective PLA(1), mPA-PLA(1)alpha. mPA-PLA(1)beta contains a short lid and deleted beta9 loop, which are characteristics of PLA(1) molecules in the lipase family, and is a member of a subfamily in the lipase family that includes mPA-PLA(1)alpha and phosphatidylserine-specific PLA(1). Both mPA-PLA(1)beta and mPA-PLA(1)alpha recombinant proteins exhibited PA-specific PLA(1) activity and were vanadate-sensitive. When mPA-PLA(1)beta-expressing cells were treated with bacterial phospholipase D, the cells produced lysophosphatidic acid (LPA). In both mPA-PLA(1)alpha and beta-expressing cells, most of the PA generated by the phospholipase D (PLD) treatment was converted to LPA, whereas in control cells it was converted to diacylglycerol. When expressed in HeLa cells most mPA-PLA(1)alpha protein was recovered from the cell supernatant. By contrast, mPA-PLA(1)beta was recovered almost exclusively from cells. Consistent with this observation, we found that mPA-PLA(1)beta has higher affinity to heparin than mPA-PLA(1)alpha. We also found that the membrane-associated mPA-PLA(1)s were insoluble in solubilization by 1% Triton X-100 and were detected in Triton X-100-insoluble buoyant fractions of sucrose gradients. The present study raises the possibility that production of LPA by mPA-PLA(1)alpha and -beta occurs on detergent-resistant membrane domains of the cells where they compete with lipid phosphate phosphatase for PA.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Nagoya City Univ, Fac Pharmaceut Sci, Mizuho Ku, Aichi 4670027, Japan; Univ Tokyo, Grad Sch Med, Dept Metabolome, Bunkyo Ku, Tokyo 1130033, Japan; Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; Japan Sci & Technol Corp, PRESTO, Bunkyo Ku, Tokyo 1138613, Japan; Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Med Sci, Dept Biochem Cell Res, Bunkyo Ku, Tokyo 1138613, Japan	University of Tokyo; Nagoya City University; University of Tokyo; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Tokyo Metropolitan Institute of Medical Science	Aoki, J (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	jaoki@mol.f.u-tokyo.ac.jp		Takanezawa, Yasukazu/0000-0002-9220-5825; Aoki, Junken/0000-0001-9435-1896; Kasahara, Kohji/0000-0001-7010-8365; Sonoda, Hirofumi/0000-0003-3353-1783				ALLAN D, 1976, BIOCHEM J, V156, P225, DOI 10.1042/bj1560225; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Aoki J, 2002, BBA-MOL CELL BIOL L, V1582, P26, DOI 10.1016/S1388-1981(02)00134-8; Baker DL, 2001, ANAL BIOCHEM, V292, P287, DOI 10.1006/abio.2001.5063; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Bandoh K, 2000, FEBS LETT, V478, P159, DOI 10.1016/S0014-5793(00)01827-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodin S, 2001, BIOCHEMISTRY-US, V40, P15290, DOI 10.1021/bi0109313; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Carriere F, 1998, BBA-REV BIOMEMBRANES, V1376, P417, DOI 10.1016/S0304-4157(98)00016-1; Connelly PW, 1999, CLIN CHIM ACTA, V286, P243, DOI 10.1016/S0009-8981(99)00105-9; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Czarny M, 1999, J BIOL CHEM, V274, P2717, DOI 10.1074/jbc.274.5.2717; Eder AM, 2000, CLIN CANCER RES, V6, P2482; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; GERRARD JM, 1989, BIOCHIM BIOPHYS ACTA, V1001, P282, DOI 10.1016/0005-2760(89)90112-4; GILLETT MPT, 1993, INT J BIOCHEM, V25, P449, DOI 10.1016/0020-711X(93)90639-V; Hayashi K, 2001, CIRC RES, V89, P251, DOI 10.1161/hh1501.094265; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; HIGASHI S, 1988, J BIOCHEM-TOKYO, V103, P442, DOI 10.1093/oxfordjournals.jbchem.a122289; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; Hirata K, 1999, J BIOL CHEM, V274, P14170, DOI 10.1074/jbc.274.20.14170; Hodgkin MN, 1999, BIOCHEM J, V339, P87, DOI 10.1042/0264-6021:3390087; HOFFMAN DR, 1994, INT ARCH ALLERGY IMM, V104, P184, DOI 10.1159/000236728; Hosono H, 2001, J BIOL CHEM, V276, P29664, DOI 10.1074/jbc.M104597200; Igarashi J, 2000, J BIOL CHEM, V275, P32363, DOI 10.1074/jbc.M003075200; Ishii J, 2002, J BIOL CHEM, V277, P39696, DOI 10.1074/jbc.M206140200; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; Kasahara K, 2000, GLYCOCONJUGATE J, V17, P153, DOI 10.1023/A:1026576804247; King TP, 1996, J ALLERGY CLIN IMMUN, V98, P588, DOI 10.1016/S0091-6749(96)70093-3; Lourenssen S, 1998, NEUROSCI LETT, V248, P77, DOI 10.1016/S0304-3940(98)00275-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Murakami M, 1997, CRIT REV IMMUNOL, V17, P225, DOI 10.1615/CritRevImmunol.v17.i3-4.10; Murakami M, 1999, J BIOL CHEM, V274, P29927, DOI 10.1074/jbc.274.42.29927; Nakajima K, 2002, J BIOL CHEM, V277, P11329, DOI 10.1074/jbc.M111092200; NANJUNDAN M, 2001, BIOCHEM J, P637; PAYNE RM, 1994, AM J PHYSIOL, V266, pG914, DOI 10.1152/ajpgi.1994.266.5.G914; Sano T, 2002, J BIOL CHEM, V277, P21197, DOI 10.1074/jbc.M201289200; SANTAMARINAFOJO S, 1994, INT J CLIN LAB RES, V24, P143, DOI 10.1007/BF02592444; Sato T, 1997, J BIOL CHEM, V272, P2192; Scanlan MJ, 2002, INT J CANCER, V98, P485, DOI 10.1002/ijc.10276; Sciorra VA, 1999, MOL BIOL CELL, V10, P3863, DOI 10.1091/mbc.10.11.3863; Shen ZZ, 1998, GYNECOL ONCOL, V71, P364, DOI 10.1006/gyno.1998.5193; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; SOLDATOVA L, 1993, FEBS LETT, V320, P145, DOI 10.1016/0014-5793(93)80080-E; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Tani K, 1999, J BIOL CHEM, V274, P20505, DOI 10.1074/jbc.274.29.20505; TOKUMURA A, 1994, AM J PHYSIOL, V267, pC204, DOI 10.1152/ajpcell.1994.267.1.C204; TOKUMURA A, 1995, PROG LIPID RES, V34, P151, DOI 10.1016/0163-7827(95)00001-G; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Walker AJ, 2001, BIOCHEM J, V353, P129, DOI 10.1042/bj3530129	58	80	85	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					49438	49447		10.1074/jbc.M213018200	http://dx.doi.org/10.1074/jbc.M213018200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12963729				2022-12-27	WOS:000186829000112
J	Sato, T; Gotoh, M; Kiyohara, K; Kameyama, A; Kubota, T; Kikuchi, N; Ishizuka, Y; Iwasaki, H; Togayachi, A; Kudo, T; Ohkura, T; Nakanishi, H; Narimatsu, H				Sato, T; Gotoh, M; Kiyohara, K; Kameyama, A; Kubota, T; Kikuchi, N; Ishizuka, Y; Iwasaki, H; Togayachi, A; Kudo, T; Ohkura, T; Nakanishi, H; Narimatsu, H			Molecular cloning and characterization of a novel human beta 1,4-N-acetylgalactosaminyltransferase, beta 4GalNAc-T3, responsible for the synthesis of N,N '-diacetyllactosediamine, GalNAc beta 1-4GlcNAc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; CHONDROITIN N-ACETYLGALACTOSAMINYLTRANSFERASE; BETA-4-GALACTOSYLTRANSFERASE GENE FAMILY; PROTEIN LINKAGE REGION; CHINESE-HAMSTER OVARY; GLYCOPROTEIN HORMONES; UDP-GALACTOSE; CAENORHABDITIS-ELEGANS; GLYCAN STRUCTURES; CRYSTAL-STRUCTURE	We found a novel human glycosyltransferase gene carrying a hypothetical beta1,4-glycosyltransferase motif during a BLAST search, and we cloned its full-length open reading frame by using the 5'-rapid amplification of cDNA ends method. It encodes a type II transmembrane protein of 999 amino acids with homology to chondroitin sulfate synthase in its C-terminal region (GenBank(TM) accession number AB089940). Its putative orthologous gene was also found in mouse (accession number AB114826). The truncated form of the human enzyme was expressed in HEK293T cells as a soluble protein. The recombinant enzyme transferred GalNAc to GlcNAc beta-benzyl. The product was deduced to be GalNAcbeta1-4GlcNAcbeta-benzyl based on mass spectrometry and NMR spectroscopy. We renamed the enzyme beta1,4-N-acetylgalactosaminyltransferase-III (beta4GalNAc-T3). beta4GalNAc-T3 effectively synthesized N,N'-diacetylgalactosediamine, GalNAcbeta1-4GlcNAc, at non-reducing termini of various acceptors derived not only from N-glycans but also from O-glycans. Quantitative real time PCR analysis showed that its transcript was highly expressed in stomach, colon, and testis. As some glycohormones contain N, N'-diacetylgalactosediamine structures in their N-glycans, we examined the ability of beta4GalNAc-T3 to synthesize N, N'-diacetylgalactosediamine structures in N-glycans on a model protein. When fetal calf fetuin treated with neuraminidase and beta1,4-galactosidase was utilized as an acceptor protein, beta4GalNAc-T3 transferred GalNAc to it. Furthermore, the majority of the signal from GalNAc disappeared on treatment with glycopeptidase F. These results suggest that beta4GalNAc-T3 could transfer GalNAc residues, producing N,N'-diacetylgalactosediamine structures at least in N-glycans and probably in both N- and O-glycans.	Natl Inst Adv Ind Sci & Technol, Res Ctr Glycosci, Glycogene Funct Team, Tsukuba, Ibaraki 3058568, Japan; Amersham Biosci KK, Shinjuku Ku, Tokyo 1690073, Japan; Mitsui Knowledge Ind Co Ltd, Nakano Ku, Tokyo 1648721, Japan; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tsukuba, Ibaraki 3058568, Japan; New Energy & Ind Technol Dev Org, Toshima Ku, Tokyo 1706028, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Narimatsu, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Glycosci, Glycogene Funct Team, OSL Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.		Sato, Takashi/M-2577-2018; Narimatsu, Hisashi/M-4757-2018; Kubota, Tomomi/J-1492-2018	Sato, Takashi/0000-0002-9973-8923; Narimatsu, Hisashi/0000-0002-8402-133X; Togayachi, Akira/0000-0003-3600-9149; Kubota, Tomomi/0000-0002-0723-135X				Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Almeida R, 1997, J BIOL CHEM, V272, P31979, DOI 10.1074/jbc.272.51.31979; Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; Do KY, 1997, GLYCOBIOLOGY, V7, P183, DOI 10.1093/glycob/7.2.183; Dohi T, 1996, INT J CANCER, V67, P626, DOI 10.1002/(SICI)1097-0215(19960904)67:5<626::AID-IJC6>3.0.CO;2-W; FEENEY J, 1986, CARBOHYD RES, V152, P63, DOI 10.1016/S0008-6215(00)90287-8; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; Gotoh M, 2002, J BIOL CHEM, V277, P38189, DOI 10.1074/jbc.M203619200; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; GREEN ED, 1988, J BIOL CHEM, V263, P25; HIYAMA J, 1992, GLYCOBIOLOGY, V2, P401, DOI 10.1093/glycob/2.5.401; Ishizuka Y, 1999, J CARBOHYD CHEM, V18, P523, DOI 10.1080/07328309908544016; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; Karlsson NG, 2002, ANAL BIOCHEM, V305, P173, DOI 10.1006/abio.2002.5657; Kawar ZS, 2002, J BIOL CHEM, V277, P34924, DOI 10.1074/jbc.M206112200; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Lo NW, 1998, GLYCOBIOLOGY, V8, P517, DOI 10.1093/glycob/8.5.517; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; Montiel MD, 2003, BIOCHEM J, V373, P369, DOI 10.1042/BJ20021892; Morris HR, 1996, J BIOL CHEM, V271, P32159, DOI 10.1074/jbc.271.50.32159; NARIMATSU H, 1986, P NATL ACAD SCI USA, V83, P4720, DOI 10.1073/pnas.83.13.4720; Ohkura T, 2002, J BIOCHEM, V132, P891, DOI 10.1093/oxfordjournals.jbchem.a003302; Okajima T, 1999, J BIOL CHEM, V274, P22915, DOI 10.1074/jbc.274.33.22915; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; Ramakrishnan B, 2001, J BIOL CHEM, V276, P37665, DOI 10.1074/jbc.M102458200; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Saarinen J, 1999, EUR J BIOCHEM, V259, P829, DOI 10.1046/j.1432-1327.1999.00105.x; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Schwientek T, 1998, J BIOL CHEM, V273, P29331, DOI 10.1074/jbc.273.45.29331; SHAPER NL, 1986, P NATL ACAD SCI USA, V83, P1573, DOI 10.1073/pnas.83.6.1573; SMITH PL, 1988, SCIENCE, V242, P930, DOI 10.1126/science.2460923; SMITH PL, 1992, J BIOL CHEM, V267, P19140; SMITH PL, 1992, P NATL ACAD SCI USA, V89, P329, DOI 10.1073/pnas.89.1.329; SPIRO RG, 1974, J BIOL CHEM, V249, P5704; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Van den Nieuwenhof IM, 2000, EUR J BIOCHEM, V267, P4753, DOI 10.1046/j.1432-1327.2000.01528.x; Woodworth A, 2002, J BIOL CHEM, V277, P50941, DOI 10.1074/jbc.M209876200; Wu A M, 1988, Adv Exp Med Biol, V228, P351; Yada T, 2003, J BIOL CHEM, V278, P39711, DOI 10.1074/jbc.M304421200; YAMASHIRO S, 1995, J BIOL CHEM, V270, P6149, DOI 10.1074/jbc.270.11.6149; YAN SB, 1993, GLYCOBIOLOGY, V3, P597, DOI 10.1093/glycob/3.6.597; YAZAWA S, 1986, CARBOHYD RES, V149, P241, DOI 10.1016/S0008-6215(00)90381-1	49	68	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47534	47544		10.1074/jbc.M308857200	http://dx.doi.org/10.1074/jbc.M308857200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12966086	hybrid			2022-12-27	WOS:000186731400025
J	Siebold, C; Arnold, I; Garcia-Alles, LF; Baumann, U; Erni, B				Siebold, C; Arnold, I; Garcia-Alles, LF; Baumann, U; Erni, B			Crystal structure of the Citrobacter freundii dihydroxyacetone kinase reveals an eight-stranded alpha-helical barrel ATP-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SHEET PROTEINS; ESCHERICHIA-COLI; PHOSPHOTRANSFERASE SYSTEM; KLEBSIELLA-PNEUMONIAE; MANNOSE TRANSPORTER; ANGSTROM RESOLUTION; HUMAN-ERYTHROCYTES; GLYCEROL; PURIFICATION; SEQUENCE	Dihydroxyacetone kinases are a sequence-conserved family of enzymes, which utilize two different phosphoryldonors, ATP in animals, plants and some bacteria, and a multiphosphoprotein of the phosphoenolpyruvate carbohydrate phosphotransferase system in bacteria. Here we report the 2.5-Angstrom crystal structure of the homodimeric Citrobacter freundii dihydroxyacetone kinase complex with an ATP analogue and dihydroxyacetone. The N-terminal domain consists of two alpha/beta-folds with a molecule of dihydroxyacetone covalently bound in hemiaminal linkage to the Nepsilon2 of His-220. The C-terminal domain consists of a regular eight-helix alpha-barrel. The eight helices form a deep pocket, which includes a tightly bound phospholipid. Only the lipid headgroup protrudes from the surface. The nucleotide is bound on the top of the barrel across from the entrance to the lipid pocket. The phosphate groups are coordinated by two Mg(2+) ions to gamma-carboxyl groups of aspartyl residues. The ATP binding site does not contain positively charged or aromatic groups. Paralogues of dihydroxyacetone kinase also occur in association with transcription regulators and proteins of unknown function pointing to biological roles beyond triose metabolism.	Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	University of Bern	Baumann, U (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.	ulrich.baumann@ibc.unibe.ch; bernhard.erni@ibc.unibe.ch	Baumann, Ulrich/B-1220-2013	Garcia-Alles, Luis/0000-0002-1141-0393				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Asawanonda P, 1999, INT J DERMATOL, V38, P916, DOI 10.1046/j.1365-4362.1999.00779.x; AZZOUT B, 1984, J NUTR, V114, P2167, DOI 10.1093/jn/114.11.2167; Beutler R, 2001, MICROBIOL-SGM, V147, P249, DOI 10.1099/00221287-147-2-249; BOSSEMEYER D, 1994, TRENDS BIOCHEM SCI, V19, P201, DOI 10.1016/0968-0004(94)90022-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Charvolin D, 1999, EUR J BIOCHEM, V264, P562, DOI 10.1046/j.1432-1327.1999.00667.x; COGOLIGREUTER M, 1981, J BIOL CHEM, V256, P5708; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CORTEZ MY, 1991, AM J CLIN NUTR, V53, P847, DOI 10.1093/ajcn/53.4.847; DANIEL R, 1995, J BACTERIOL, V177, P4392, DOI 10.1128/jb.177.15.4392-4401.1995; DANIEL R, 1995, J BACTERIOL, V177, P2151, DOI 10.1128/jb.177.8.2151-2156.1995; Fesq H, 2001, DERMATOLOGY, V203, P241, DOI 10.1159/000051757; FORAGE RG, 1982, J BACTERIOL, V151, P591, DOI 10.1128/JB.151.2.591-599.1982; Gutknecht R, 1999, J BIOL CHEM, V274, P6091, DOI 10.1074/jbc.274.10.6091; Gutknecht R, 2001, EMBO J, V20, P2480, DOI 10.1093/emboj/20.10.2480; Iushmanov S V, 1988, Mol Gen Mikrobiol Virusol, P9; Ivy JL, 1998, MED SCI SPORT EXER, V30, P837, DOI 10.1097/00005768-199806000-00010; JENKINS BT, 1976, J NEUROCHEM, V26, P377, DOI 10.1111/j.1471-4159.1976.tb04491.x; JIA ZC, 1994, J MOL BIOL, V236, P1341, DOI 10.1016/0022-2836(94)90062-0; JIN RZ, 1984, J GEN MICROBIOL, V130, P83; JOHNSON EA, 1984, J BACTERIOL, V160, P55, DOI 10.1128/JB.160.1.55-60.1984; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kates M., 1972, LAB TECH BIOCH MOL B, V3, P268, DOI [10.1016/S0075-7535(08)70544-8, DOI 10.1016/S0075-7535(08)70544-8]; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kimura T, 1998, BBA-GENE STRUCT EXPR, V1442, P361, DOI 10.1016/S0167-4781(98)00152-3; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Lanz R, 1998, J BIOL CHEM, V273, P12239, DOI 10.1074/jbc.273.20.12239; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; Luers GH, 1998, YEAST, V14, P759; MAO QC, 1995, J BIOL CHEM, V270, P18295, DOI 10.1074/jbc.270.31.18295; Molin M, 2003, J BIOL CHEM, V278, P1415, DOI 10.1074/jbc.M203030200; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nguyen BC, 2003, J INVEST DERMATOL, V120, P655, DOI 10.1046/j.1523-1747.2003.12089.x; NONOMURA AM, 1992, P NATL ACAD SCI USA, V89, P9794, DOI 10.1073/pnas.89.20.9794; Nunn RS, 1996, J MOL BIOL, V259, P502, DOI 10.1006/jmbi.1996.0335; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulsen IT, 2000, MICROBIOL-UK, V146, P2343, DOI 10.1099/00221287-146-10-2343; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; RUCH FE, 1974, J BACTERIOL, V119, P50, DOI 10.1128/JB.119.1.50-56.1974; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schulze-Gahmen U, 2003, PROTEINS, V50, P526, DOI 10.1002/prot.10305; Schurmann M, 2001, J BIOL CHEM, V276, P11055, DOI 10.1074/jbc.M008061200; SHELDRICK GM, 1995, ACTA CRYSTALLOGR B, V51, P423, DOI 10.1107/S0108768195003661; Siebold C, 2003, P NATL ACAD SCI USA, V100, P8188, DOI 10.1073/pnas.0932787100; Stewart MQ, 2001, J CELL SCI, V114, P2863; Taguchi T, 2002, CELL BIOCHEM FUNCT, V20, P223, DOI 10.1002/cbf.952; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tessier FJ, 2003, BIOCHEM J, V369, P705, DOI 10.1042/BJ20020668; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Verdino P, 2002, EMBO J, V21, P5007, DOI 10.1093/emboj/cdf526; Voet D, 1999, FUNDAMENTALS BIOCH; WAITES MJ, 1981, J GEN MICROBIOL, V124, P309; Wang WX, 2002, P NATL ACAD SCI USA, V99, P2760, DOI 10.1073/pnas.052706199; WEHMEIER UF, 1994, BBA-PROTEIN STRUCT M, V1208, P348, DOI 10.1016/0167-4838(94)90124-4	57	44	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48236	48244		10.1074/jbc.M305942200	http://dx.doi.org/10.1074/jbc.M305942200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12966101	hybrid, Green Published			2022-12-27	WOS:000186731400107
J	Zheng, W; Xie, WR; Zhang, JH; Strong, JA; Wang, L; Yu, L; Xu, M; Lu, L				Zheng, W; Xie, WR; Zhang, JH; Strong, JA; Wang, L; Yu, L; Xu, M; Lu, L			Function of gamma-aminobutyric acid receptor/channel rho(1) subunits in spinal cord	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGER SALAMANDER RETINA; GABA(C) RECEPTOR; RAT RETINA; XENOPUS OOCYTES; RHO-2 SUBUNITS; IN-VITRO; IMMUNOCYTOCHEMICAL LOCALIZATION; SYNAPTIC TRANSMISSION; TACTILE ALLODYNIA; NEUROPATHIC PAIN	gamma-Aminobutyric acid (GABA) receptor/channel rho(1) subunits are important components in inhibitory pathways in the central nervous system. However, the precise locations and roles of these receptors in the central nervous system are unknown. We studied the expression localization of GABA receptor/channel rho(1) subunit in mouse spinal cord and dorsal root ganglia (DRG). The immunohistochemistry results indicated that GABA receptor/ channel rho(1) subunits were expressed in mouse spinal cord superficial dorsal horn ( lamina I and lamina II) and in DRG. To understand the functions of the GABA receptor/ channel rho(1) subunit in these crucial sites of sensory transmission in vivo, we generated GABA receptor/ channel rho(1) subunit mutant mice (rho1(-/-)). GABA receptor/ channel rho(1) subunit expression in the rho1(-/-) mice was eliminated completely, whereas the gross neuroanatomical structures of the rho1(-/-) mice spinal cord and DRG were unchanged. Electrophysiological recording showed that GABA-mediated spinal cord response was altered in the rho1(-/-) mice. A decreased threshold for mechanical pain in the rho1(-/-) mice compared with control mice was observed with the von Frey filament test. These findings indicate that the GABA receptor/ channel rho(1) subunit plays an important role in modulating spinal cord pain transmission functions in vivo.	Univ Calif Los Angeles, David Geffen Sch Med, Harbor UCLA Med Ctr, Div Mol Med, Torrance, CA 90502 USA; Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Ohio; University of Cincinnati	Lu, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Harbor UCLA Med Ctr, Div Mol Med, 1124 W Carson St,C-2, Torrance, CA 90502 USA.		zhang, jianhua/D-3404-2009	Zhang, Jianhua/0000-0002-2128-9574; Strong, Judith/0000-0001-9363-0551	NATIONAL EYE INSTITUTE [R01EY011653, R01EY015281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013786, R29DA011284, R01DA009444, R01DA014644, R01DA013471] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY015281, EY11653] Funding Source: Medline; NIDA NIH HHS [DA13786, DA13471, DA14644, DA09444, DA11284] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Basbaum AI, 1999, REGION ANESTH PAIN M, V24, P59, DOI 10.1016/S1098-7339(99)90167-0; Bormann J, 2000, TRENDS PHARMACOL SCI, V21, P16, DOI 10.1016/S0165-6147(99)01413-3; BORMANN J, 1995, TRENDS NEUROSCI, V18, P515, DOI 10.1016/0166-2236(95)98370-E; Boue-Grabot E, 2000, ENDOCRINOLOGY, V141, P1627, DOI 10.1210/en.141.5.1627; Boue-Grabot E, 1998, J NEUROCHEM, V70, P899; BOWERY NG, 1984, NEUROPHARMACOLOGY, V23, P219, DOI 10.1016/0028-3908(84)90063-7; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Craig A D, 2000, Prog Brain Res, V129, P137; CURTIS DR, 1970, NATURE, V226, P1222, DOI 10.1038/2261222a0; CUTTING GR, 1992, GENOMICS, V12, P801, DOI 10.1016/0888-7543(92)90312-G; CUTTING GR, 1991, P NATL ACAD SCI USA, V88, P2673, DOI 10.1073/pnas.88.7.2673; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; Ekema GM, 2002, INVEST OPHTH VIS SCI, V43, P2326; Ekema GM, 2001, J MEMBRANE BIOL, V183, P205, DOI 10.1007/s00232-001-0068-3; Enz R, 1999, BRAIN RES, V846, P177, DOI 10.1016/S0006-8993(99)02008-9; Enz R, 2001, BIOL CHEM, V382, P1111, DOI 10.1515/BC.2001.141; Enz R, 1999, EUR J NEUROSCI, V11, P41, DOI 10.1046/j.1460-9568.1999.00423.x; Enz R, 1996, J NEUROSCI, V16, P4479; ENZ R, 1995, EUR J NEUROSCI, V7, P1495, DOI 10.1111/j.1460-9568.1995.tb01144.x; Feigenspan A, 1998, PROG RETIN EYE RES, V17, P99, DOI 10.1016/S1350-9462(97)00008-6; Garret M, 1997, J NEUROCHEM, V68, P1382; Garrett KM, 1997, MOL BRAIN RES, V45, P133, DOI 10.1016/S0169-328X(96)00290-2; Greka A, 2000, EUR J NEUROSCI, V12, P3575, DOI 10.1046/j.1460-9568.2000.00247.x; Greka A, 1998, NEUROREPORT, V9, P229, DOI 10.1097/00001756-199801260-00010; Hackam AS, 1997, J BIOL CHEM, V272, P13750, DOI 10.1074/jbc.272.21.13750; HENRY JL, 1982, NEUROPHARMACOLOGY, V21, P1085, DOI 10.1016/0028-3908(82)90165-4; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; HILL DR, 1981, NATURE, V290, P149, DOI 10.1038/290149a0; Hwang JH, 1997, PAIN, V70, P15, DOI 10.1016/S0304-3959(96)03249-6; Johnston GAR, 1996, TRENDS PHARMACOL SCI, V17, P319, DOI 10.1016/S0165-6147(96)10038-9; JOHNSTON GAR, 1994, PROG BRAIN RES, V100, P61; Koulen P, 1997, J COMP NEUROL, V380, P520, DOI 10.1002/(SICI)1096-9861(19970421)380:4<520::AID-CNE8>3.0.CO;2-3; Koulen P, 1998, EUR J NEUROSCI, V10, P115, DOI 10.1046/j.1460-9568.1998.00005.x; Laughlin TM, 1997, PAIN, V72, P253, DOI 10.1016/S0304-3959(97)00046-8; Lu L, 1998, J MEMBRANE BIOL, V164, P115, DOI 10.1007/s002329900398; LUKASIEWICZ PD, 1994, J NEUROSCI, V14, P1213, DOI 10.1523/JNEUROSCI.14-03-01213.1994; Malan TP, 2002, ANESTHESIOLOGY, V96, P1161, DOI 10.1097/00000542-200205000-00020; Malcangio M, 1996, TRENDS PHARMACOL SCI, V17, P457; McCall MA, 2002, J NEUROSCI, V22, P4163, DOI 10.1523/JNEUROSCI.22-10-04163.2002; MENSE S, 1983, AM J MED, V75, P4, DOI 10.1016/0002-9343(83)90226-7; Mohler H, 1996, Ion Channels, V4, P89; OGURUSU T, 1995, J NEUROCHEM, V65, P964; Ogurusu T, 1996, BBA-GENE STRUCT EXPR, V1305, P15, DOI 10.1016/0167-4781(95)00205-7; Pan ZH, 2000, EUR J NEUROSCI, V12, P3137, DOI 10.1046/j.1460-9568.2000.00198.x; POLENZANI L, 1991, P NATL ACAD SCI USA, V88, P4318, DOI 10.1073/pnas.88.10.4318; Qian HH, 1999, P ROY SOC B-BIOL SCI, V266, P2419, DOI 10.1098/rspb.1999.0941; Ragozzino D, 1996, MOL PHARMACOL, V50, P1024; Rozzo A, 2002, EUR J NEUROSCI, V15, P1747, DOI 10.1046/j.1460-9568.2002.02013.x; Rozzo A, 1999, NEUROSCIENCE, V90, P1085, DOI 10.1016/S0306-4522(98)00476-X; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; SAWYNOK J, 1987, PHARMACOL BIOCHEM BE, V26, P463, DOI 10.1016/0091-3057(87)90148-1; Todd AJ, 2002, EXP PHYSIOL, V87, P245, DOI 10.1113/eph8702351; Uusi-Oukari M, 2000, MOL CELL NEUROSCI, V16, P34, DOI 10.1006/mcne.2000.0856; WANG TL, 1994, J NEUROSCI, V14, P6524; Wegelius K, 1998, EUR J NEUROSCI, V10, P350, DOI 10.1046/j.1460-9568.1998.00023.x; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; ZHANG DX, 1995, P NATL ACAD SCI USA, V92, P11756, DOI 10.1073/pnas.92.25.11756; Zhang DX, 2001, TRENDS PHARMACOL SCI, V22, P121, DOI 10.1016/S0165-6147(00)01625-4	59	37	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48321	48329		10.1074/jbc.M307930200	http://dx.doi.org/10.1074/jbc.M307930200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12970343	hybrid			2022-12-27	WOS:000186731400117
J	Gomez, MF; Bosc, LVG; Stevenson, AS; Wilkerson, MK; Hill-Eubanks, DC; Nelson, MT				Gomez, MF; Bosc, LVG; Stevenson, AS; Wilkerson, MK; Hill-Eubanks, DC; Nelson, MT			Constitutively elevated nuclear export activity opposes Ca2+-dependent NFATc3 nuclear accumulation in vascular smooth muscle - Role of JNK2 and Crm-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED T-CELLS; NF-AT; PHOSPHATASE CALCINEURIN; TRANSCRIPTION FACTORS; CA2+; PROTEIN; DIFFERENTIATION; INHIBITION; PATHWAY; SIGNALS	The transcription factor NFAT ( nuclear factor of activated T-cells) is a cytosolic phosphoprotein that accumulates in the nucleus following dephosphorylation by the calcium (Ca2+)/calmodulin-dependent phosphatase, calcineurin. A defining feature of stimuli that induce NFAT nuclear accumulation/ activation is a sustained increase in global intracellular Ca2+. Contrary to expectations, we have found that a sustained elevation of intracellular Ca2+, induced by membrane potential depolarization and mediated by voltage-dependent Ca2+ channels, does not result in nuclear localization of the NFATc3 isoform in smooth muscle. However, vasoconstrictors (e.g. uridine triphosphate (UTP)) and growth factors, which elevate intracellular Ca2+ and engage multiple intracellular signaling pathways, induce a robust increase in smooth muscle nuclear NFATc3. Here we show that depolarizing stimuli that normally fail to induce NFATc3 nuclear accumulation in arterial smooth muscle effectively induce nuclear accumulation under conditions in which Crm-1-dependent or JNK2-mediated nuclear export processes are disrupted. Consistent with an important regulatory role for JNK, UTP exerts a suppressive effect on JNK activity in smooth muscle. Export of nuclear NFATc3 following UTP-induced nuclear accumulation is dramatically slowed in cerebral arteries from JNK2(-/-) animals. These data indicate that in smooth muscle, stimulation of Ca2+-dependent, calcineurin-mediated nuclear import and suppression of Crm-1/JNK-dependent nuclear export are both required for induction of NFATc3 nuclear accumulation. These results highlight the dynamic interplay between influences that promote and oppose NFAT nuclear accumulation and suggest that in arterial smooth muscle suppression of constitutive nuclear export activity is an important property of NFAT-activating stimuli.	Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA	University of Vermont	Nelson, MT (corresponding author), Univ Vermont, Dept Pharmacol, 89 Beaumont Ave, Burlington, VT 05405 USA.		Gomez, Maria F/D-3696-2014	Gomez, Maria F/0000-0001-6210-3142; Nelson, Mark/0000-0002-6608-8784	NHLBI NIH HHS [HL 63722, T32 HL/AR 07944, HL 07944, HL 07647-12, HL 44455] Funding Source: Medline; NIDDK NIH HHS [DK 53832] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044455, T32HL007944, R01HL063722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053832, R01DK053832] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARAMBURU J, 1995, J EXP MED, V182, P801, DOI 10.1084/jem.182.3.801; Chow CW, 2000, MOL CELL BIOL, V20, P5227, DOI 10.1128/MCB.20.14.5227-5234.2000; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; Gokina NI, 1999, AM J PHYSIOL-HEART C, V277, pH1178, DOI 10.1152/ajpheart.1999.277.3.H1178; GOMEZ DA, 2000, J BIOL CHEM, V275, P13872; Gomez MF, 2002, J BIOL CHEM, V277, P37756, DOI 10.1074/jbc.M203596200; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Hill-Eubanks DC, 2003, TRENDS CARDIOVAS MED, V13, P56, DOI 10.1016/S1050-1738(02)00212-8; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Olson EN, 2000, BIOESSAYS, V22, P510, DOI 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.3.CO;2-T; Paul A, 2000, J BIOL CHEM, V275, P13243, DOI 10.1074/jbc.275.18.13243; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stevenson AS, 2001, J BIOL CHEM, V276, P15018, DOI 10.1074/jbc.M011684200; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Wada H, 2002, J CELL BIOL, V156, P983, DOI 10.1083/jcb.200106057; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Zhu J, 2000, CELL MOL LIFE SCI, V57, P411, DOI 10.1007/PL00000703; Zhu JY, 1999, NATURE, V398, P256, DOI 10.1038/18473	28	45	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46847	46853		10.1074/jbc.M304765200	http://dx.doi.org/10.1074/jbc.M304765200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12954637	hybrid			2022-12-27	WOS:000186569400077
J	Qiu, LY; Koenderink, JB; Swarts, HGP; Willems, PHGM; De Pont, JJHHM				Qiu, LY; Koenderink, JB; Swarts, HGP; Willems, PHGM; De Pont, JJHHM			Phe(783), Thr(797), and Asp(804) in transmembrane hairpin M5-M6 of Na+,K+-ATPase play a key role in ouabain binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHIMERIC GASTRIC H+,K+-ATPASE; NA,K-ATPASE ALPHA-SUBUNIT; AMINO-ACID-RESIDUES; RANDOM MUTAGENESIS; RESISTANT ENZYME; ATPASE ACTIVITY; SENSITIVITY; INHIBITION; MECHANISM; AFFINITY	Ouabain is a glycoside that binds to and inhibits the action of Na+, K+-ATPase. Little is known, however, about the specific requirements of the protein surface for glycoside binding. Using chimeras of gastric H+, K+-ATPase and Na+, K+-ATPase, we demonstrated previously that the combined presence of transmembrane hairpins M3-M4 and M5-M6 of Na+, K+-ATPase in a backbone of H+, K+-ATPase (HN34/56) is both required and sufficient for high affinity ouabain binding. Since replacement of transmembrane hairpin M3-M4 by the N terminus up to transmembrane segment 3 (HNN3/56) resulted in a low affinity ouabain binding, hairpin M5-M6 seems to be essential for ouabain binding. To assess which residues of M5-M6 are required for ouabain action, we divided this transmembrane hairpin in seven parts and individually replaced these parts by the corresponding sequences of H+, K+-ATPase in chimera HN34/56. Three of these chimeras failed to bind ouabain following expression in Xenopus laevis oocytes. Altogether, these three chimeras contained 7 amino acids that were specific for Na+, K+-ATPase. Individual replacement of these 7 amino acids by the corresponding amino acids in H+, K+-ATPase revealed a dramatic loss of ouabain binding for F783Y, T797C, and D804E. As a proof of principle, the Na+, K+-ATPase equivalents of these 3 amino acids were introduced in different combinations in chimera HN34. The presence of all 3 amino acids appeared to be required for ouabain action. Docking of ouabain onto a three-dimensional-model of Na+, K+-ATPase suggests that Asp(804), in contrast to Phe(783) and Thr(797), does not actually form part of the ouabain-binding pocket. Most likely, the presence of this amino acid is required for adopting of the proper conformation for ouabain binding.	Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	De Pont, JJHHM (corresponding author), Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Biochem, POB 9101, NL-6500 HB Nijmegen, Netherlands.	J.dePont@ncmls.kun.nl	Willems, P.H.G.M./L-4759-2015; Koenderink, Jan/N-3578-2014	Willems, P.H.G.M./0000-0002-0915-1599; 				Asano S, 1999, J BIOL CHEM, V274, P6848, DOI 10.1074/jbc.274.11.6848; BURNS EL, 1993, J BIOL CHEM, V268, P25632; Burns EL, 1996, J BIOL CHEM, V271, P15879, DOI 10.1074/jbc.271.27.15879; Croyle ML, 1997, EUR J BIOCHEM, V248, P488, DOI 10.1111/j.1432-1033.1997.00488.x; FENG JN, 1994, BIOCHEMISTRY-US, V33, P4218, DOI 10.1021/bi00180a015; Geibel S, 2003, P NATL ACAD SCI USA, V100, P964, DOI 10.1073/pnas.0337336100; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; ISHII T, 1993, P NATL ACAD SCI USA, V90, P8881, DOI 10.1073/pnas.90.19.8881; ISHII T, 1994, P NATL ACAD SCI USA, V91, P6103, DOI 10.1073/pnas.91.13.6103; Koenderink JB, 2000, P NATL ACAD SCI USA, V97, P11209, DOI 10.1073/pnas.200109597; Koenderink JB, 2000, BIOCHEMISTRY-US, V39, P9959, DOI 10.1021/bi0001168; Koenderink JB, 1999, J BIOL CHEM, V274, P11604, DOI 10.1074/jbc.274.17.11604; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; LUTSENKO S, 1995, P NATL ACAD SCI USA, V92, P7936, DOI 10.1073/pnas.92.17.7936; MATSUI H, 1968, BIOCHIM BIOPHYS ACTA, V151, P655, DOI 10.1016/0005-2744(68)90013-2; Middleton DA, 2000, P NATL ACAD SCI USA, V97, P13602, DOI 10.1073/pnas.250471997; Palasis M, 1996, J BIOL CHEM, V271, P14176, DOI 10.1074/jbc.271.24.14176; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; SCHATZMANN HJ, 1953, HELV PHYSIOL PHARM A, V11, P346; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944	24	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47240	47244		10.1074/jbc.M308833200	http://dx.doi.org/10.1074/jbc.M308833200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12972417	hybrid, Green Published			2022-12-27	WOS:000186569400124
J	Roelle, S; Grosse, R; Aigner, A; Krell, HW; Czubayko, F; Gudermann, T				Roelle, S; Grosse, R; Aigner, A; Krell, HW; Czubayko, F; Gudermann, T			Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RAS-BINDING DOMAIN; SIGNALING PATHWAYS; COUPLED RECEPTORS; GNRH RECEPTOR; CELL-LINES; ACTIVATION; CALCIUM; CANCER; SRC	Rapid engagement of the extracellular signal-regulated kinase (ERK) cascade via the G(q/11)-coupled GnRH receptor (GnRHR) is mediated by transactivation of the epidermal growth factor receptor ( EGFR). Here we show that the cross-talk between GnRHR and EGFR in gonadotropic cells is accomplished via gelatinases A and B ( matrix metalloproteinases ( MMPs) 2 and 9), identifying gelatinases as the first distinct members of the MMP family mediating EGFR transactivation by G protein-coupled receptors. Using a specific MMP2 and MMP9 inhibitor, Ro28-2653, GnRH-dependent EGFR transactivation was abrogated. Proving the specificity of the effect, transient transfection of alphaT3-1 cells with ribozymes directed against MMP2 or MMP9 specifically blocked EGFR tyrosine phosphorylation in response to GnRH stimulation. GnRH challenge of alphaT3-1 cells furthered the release of active MMP2 and MMP9 and increased their gelatinolytic activities within 5 min. Rapid release of activated MMP2 or MMP9 was inhibited by ribozyme-targeted down-regulation of MT1-MMP or MMP2, respectively. We found that GnRH-induced Src, Ras, and ERK activation were also gelatinase-dependent. Thus, gelatinase-induced EGFR transactivation was required to engage the extracellular-signal regulated kinase cascade. Activation of c-Jun N-terminal kinase and p38 MAPK by GnRH was unaffected by EGFR or gelatinase inhibition that, however, suppressed GnRH induction of c-Jun and c-Fos. Our findings suggest a novel role for gelatinases in the endocrine regulation of pituitary gonadotropes.	Univ Marburg, Inst Pharmakol & Toxikol, D-35033 Marburg, Germany; Heidelberg Univ, Inst Mol Pharmakol, D-69120 Heidelberg, Germany; Roche Diagnost GmbH, Pharma Res Penzberg, D-82377 Penzberg, Germany	Philipps University Marburg; Ruprecht Karls University Heidelberg; Roche Holding	Gudermann, T (corresponding author), Univ Marburg, Inst Pharmakol & Toxikol, Karl von Frisch Str 1, D-35033 Marburg, Germany.	guderman@staff.uni-marburg.de	Aigner, Achim/R-4429-2017	Aigner, Achim/0000-0002-2778-6256; Grosse, Robert/0000-0002-3380-5273				Aigner A, 2002, GENE THER, V9, P1700, DOI 10.1038/sj.gt.3301839; Arlt M, 2002, CANCER RES, V62, P5543; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Beaulieu E, 1999, NEUROSURGERY, V45, P1432, DOI 10.1097/00006123-199912000-00033; Benard O, 2001, J BIOL CHEM, V276, P4554, DOI 10.1074/jbc.M006995200; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Blobel CP, 1997, CELL, V90, P589, DOI 10.1016/S0092-8674(00)80519-X; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; CARPENTER G, 2000, SCI STKE; CESNJAJ M, 1994, ENDOCRINOLOGY, V135, P692, DOI 10.1210/en.135.2.692; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Dhanasekaran N, 2001, ONCOGENE, V20, P1530, DOI 10.1038/sj.onc.1204273; English WR, 2001, J BIOL CHEM, V276, P42018, DOI 10.1074/jbc.M107783200; Grams F, 2001, BIOL CHEM, V382, P1277, DOI 10.1515/BC.2001.159; Grosse R, 2000, J BIOL CHEM, V275, P9193, DOI 10.1074/jbc.275.13.9193; Grosse R, 2000, J BIOL CHEM, V275, P12251, DOI 10.1074/jbc.275.16.12251; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Gudermann T, 2000, N-S ARCH PHARMACOL, V361, P345, DOI 10.1007/s002109900208; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Kaiser UB, 1997, ENDOCR REV, V18, P46, DOI 10.1210/er.18.1.46; Kawamoto H, 1996, ACTA NEUROCHIR, V138, P1442, DOI 10.1007/BF01411124; Kraus S, 2003, J BIOL CHEM, V278, P32618, DOI 10.1074/jbc.M303886200; Lein M, 2002, ONCOGENE, V21, P2089, DOI 10.1038/sj.onc.1205267; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; Liu FJ, 2002, MOL ENDOCRINOL, V16, P419, DOI 10.1210/me.16.3.419; McCawley LJ, 2000, MOL MED TODAY, V6, P149, DOI 10.1016/S1357-4310(00)01686-5; Mulvaney JM, 1999, J BIOL CHEM, V274, P29796, DOI 10.1074/jbc.274.42.29796; Mulvaney JM, 2000, J BIOL CHEM, V275, P14182, DOI 10.1074/jbc.275.19.14182; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pereda MP, 2000, J CLIN ENDOCR METAB, V85, P263, DOI 10.1210/jc.85.1.263; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Reiss N, 1997, ENDOCRINOLOGY, V138, P1673, DOI 10.1210/en.138.4.1673; ROBERSON MS, 1995, MOL CELL BIOL, V15, P3531; Shah BH, 2003, J BIOL CHEM, V278, P19118, DOI 10.1074/jbc.M212932200; Shah BH, 2003, J BIOL CHEM, V278, P2866, DOI 10.1074/jbc.m208783200; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sundaresan S, 1996, ENDOCRINOLOGY, V137, P304, DOI 10.1210/en.137.1.304; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; Turner HE, 2000, J CLIN ENDOCR METAB, V85, P2931, DOI 10.1210/jc.85.8.2931; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; WINDLE JJ, 1990, MOL ENDOCRINOL, V4, P597, DOI 10.1210/mend-4-4-597; WojtowiczPraga S, 1996, INVEST NEW DRUG, V14, P193	50	112	115	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47307	47318		10.1074/jbc.M304377200	http://dx.doi.org/10.1074/jbc.M304377200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963732	hybrid			2022-12-27	WOS:000186569400133
J	Trent, JO; Wang, ZX; Murray, JL; Shao, WH; Tamamura, H; Fujii, N; Peiper, SC				Trent, JO; Wang, ZX; Murray, JL; Shao, WH; Tamamura, H; Fujii, N; Peiper, SC			Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; PROTEIN-COUPLED RECEPTORS; CORECEPTOR; IDENTIFICATION; INHIBITOR; T140; GLYCOPROTEINS; RHODOPSIN; MOLECULES; RESIDUES	CXCR4 is a G protein- coupled receptor ( GPCR) that has multiple critical functions in normal and pathologic physiology that include regulation of the metastatic behavior of mammary carcinoma, and utilization as a co-receptor for infection by T- tropic strains of human immunodeficiency virus- 1. Molecular dynamic simulations of the rhodopsin- based homology model of CXCR4 were performed in a solvated lipid bilayer to reproduce the microenvironment of this integral membrane protein. The amino acids in CXCR4 necessary for interaction with an inverse agonist, T140, and a weak partial agonist, AMD3100, identified by alanine scanning mutants, were spatially consistent when computationally docked. Whereas T140 binds residues in extracellular domains and regions of the hydrophobic core proximal to the cell surface, amino acids in the central hydrophobic core are critical to binding of AMD3100. The physical localization of T140 binding to CXCR4 by biochemical analyses corroborated the molecular and computational approaches. The structural basis for the interaction of T140 and AMD3100 with CXCR4 confirms that the mechanisms used by these agents are different. This complementary utilization of molecular, physical, and computation analysis provides a powerful approach to elucidate GPCR conformation.	Univ Louisville, Brown Canc Ctr 323, Louisville, KY 40202 USA; Univ Louisville, JG Brown Modeling Facil, Louisville, KY 40202 USA; Univ Louisville, Dept Med, Louisville, KY 40202 USA; Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA; Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan	University of Louisville; University of Louisville; University of Louisville; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Kyoto University	Trent, JO (corresponding author), Univ Louisville, Brown Canc Ctr 323, 529 S Jackson St, Louisville, KY 40202 USA.		Shao, Wenhai/AAI-3363-2020	trent, John/0000-0002-7346-4231	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041346] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 41346] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15493, DOI 10.1021/bi011545o; Bissantz C, 2003, PROTEINS, V50, P5, DOI 10.1002/prot.10237; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Doranz BJ, 2001, AIDS RES HUM RETROV, V17, P475, DOI 10.1089/08892220151126508; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; Huang XQ, 2003, BIOPHYS J, V84, P171, DOI 10.1016/S0006-3495(03)74840-1; Kirkpatrick P, 2003, NAT REV DRUG DISCOV, V2, P171, DOI 10.1038/nrd1030; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Navenot JM, 2001, J MOL BIOL, V313, P1181, DOI 10.1006/jmbi.2001.5086; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Staudinger R, 2000, BIOCHEM BIOPH RES CO, V274, P153, DOI 10.1006/bbrc.2000.3109; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tamamura H, 2000, BIOORG MED CHEM LETT, V10, P2633, DOI 10.1016/S0960-894X(00)00535-7; Tamamura H, 1998, BIOCHEM BIOPH RES CO, V253, P877, DOI 10.1006/bbrc.1998.9871; Vaidehi N, 2002, P NATL ACAD SCI USA, V99, P12622, DOI 10.1073/pnas.122357199; Wang ZX, 1998, J BIOL CHEM, V273, P15007, DOI 10.1074/jbc.273.24.15007; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zhou NM, 2001, J BIOL CHEM, V276, P42826, DOI 10.1074/jbc.M106582200; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	25	98	104	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47136	47144		10.1074/jbc.M307850200	http://dx.doi.org/10.1074/jbc.M307850200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12958314	hybrid			2022-12-27	WOS:000186569400112
J	Lu, LF; Cook, WJ; Lin, LL; Noelle, RJ				Lu, LF; Cook, WJ; Lin, LL; Noelle, RJ			CD40 signaling through a newly identified tumor necrosis factor receptor-associated factor 2 (TRAF2) binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CROSS-LINKING CD40; STRUCTURAL BASIS; CUTTING EDGE; ACTIVATION; CELLS; RECOGNITION; KINASE; SPECIFICITY; INDUCTION	Tumor necrosis factor receptor-associated factors (TRAFs) belong to a family of adapter proteins that are involved in tumor necrosis factor receptor superfamily signaling. It has been shown that the recruitment of TRAFs to the CD40 cytoplasmic tail is essential for CD40-mediated B cell responses. However, it has also been shown that some early B cell responses, such as up-regulation of cell surface molecules and B cell proliferation are only marginally impaired by the disruption of previously defined TRAF binding sites (Ahonen, C., Manning, E., Erickson, L.D., O'Connor, B.P., Lind, E.F., Pullen, S.S., Kehry, M.R., and Noelle, R. J. (2002) Nat. Immunol. 3, 451-456; and Manning, E., Pullen, S.S., Souza, D. J., Kehry, M., and Noelle, R. J. (2002) Eur. J. Immunol. 32, 39-49). In this report, we identify a second TRAF2 binding site in the CD40 C terminus. The binding motif "SVQE" fits into the major TRAF2 binding consensus sequence, and its disruption resulted in the loss of remaining CD40 functions. Hence, like CD30, the CD40 cytoplasmic tail contains two distinct and functionally important TRAF2 binding sites.	Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Lebanon, NH 03756 USA	Dartmouth College	Noelle, RJ (corresponding author), Dartmouth Coll Sch Med, Dept Microbiol & Immunol, 640W Borwell,1 Med Ctr Dr, Lebanon, NH 03756 USA.			Lu, Li-Fan/0000-0002-9727-0036	NIAID NIH HHS [AI26996, AI52211] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052211] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahonen CL, 2002, NAT IMMUNOL, V3, P451, DOI 10.1038/ni792; Berberich I, 1996, EMBO J, V15, P92, DOI 10.1002/j.1460-2075.1996.tb00337.x; BERBERICH I, 1994, J IMMUNOL, V153, P4357; Boucher LM, 1997, BIOCHEM BIOPH RES CO, V233, P592, DOI 10.1006/bbrc.1997.6509; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Goldstein MD, 1996, J IMMUNOL, V157, P2837; Haxhinasto SA, 2002, J IMMUNOL, V169, P1145, DOI 10.4049/jimmunol.169.3.1145; Hostager BS, 2002, J IMMUNOL, V168, P3318, DOI 10.4049/jimmunol.168.7.3318; Hostager BS, 1999, J IMMUNOL, V162, P6307; Jabara HH, 2002, IMMUNITY, V17, P265, DOI 10.1016/S1074-7613(02)00394-1; Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699; Leo E, 1999, J BIOL CHEM, V274, P22414, DOI 10.1074/jbc.274.32.22414; Li YY, 1996, J IMMUNOL, V157, P1440; Manning E, 2002, EUR J IMMUNOL, V32, P39, DOI 10.1002/1521-4141(200201)32:1<39::AID-IMMU39>3.0.CO;2-Y; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Werneburg BG, 2001, J BIOL CHEM, V276, P43334, DOI 10.1074/jbc.M104994200; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Zhu N, 2002, J IMMUNOL, V168, P744, DOI 10.4049/jimmunol.168.2.744	21	32	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45414	45418		10.1074/jbc.M309601200	http://dx.doi.org/10.1074/jbc.M309601200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12960157	hybrid			2022-12-27	WOS:000186452300046
J	Martin, NP; Lefkowitz, RJ; Shenoy, SK				Martin, NP; Lefkowitz, RJ; Shenoy, SK			Regulation of V2 vasopressin receptor degradation by agonist-promoted ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; MEDIATED ENDOCYTOSIS; INTERNALIZATION; PHOSPHORYLATION; MONOUBIQUITIN; TRAFFICKING; PATHWAY	The seven-transmembrane-spanning vasopressin V2 receptor (V2R) is a G(s)-coupled receptor that is rapidly phosphorylated and internalized following stimulation with the agonist, arginine-vasopressin. Herein, we show that the V2R is ubiquitinated following agonist stimulation. V2R-ubiquitination is not observed in a beta-arrestin1,2 deleted mouse fibroblast cell line and is restored following introduction of beta-arrestin2, thus indicating that beta-arrestin2 is required for the ubiquitination of V2R. A mutant V2R (K268R) that is not ubiquitinated still activates G(s) and internalizes with similar kinetics as the wild type receptor. Unstimulated wild type and K268R mutant receptors degrade at similar rates and have comparable half-lives of 217 +/- 17 and 245 +/- 29 min as determined by pulse-chase experiments. However, following agonist stimulation, the rate of receptor degradation for the wild type is enhanced (half-life of 69 +/- 19 min), whereas that of the mutant is only minimally affected (half-life of 188 +/- 11 min). These data suggest that V2R levels are regulated through at least two processes. In the absence of agonist stimulation, a slow degradative pathway operates that is independent of receptor ubiquitination. However, receptor stimulation leads to rapid beta-arrestin2-dependent ubiquitination of the receptor and increased degradation.	Duke Univ, Med Ctr, Dept Med, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Howard Hughes Med Inst, Durham, NC 27710 USA.		Shenoy, Sudha/AAN-4075-2021; Lefkowitz, Robert/AAW-2649-2021	Shenoy, Sudha/0000-0002-2565-4663; Martin, Negin/0000-0003-3166-8989	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL16037] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Birnbaumer M, 2002, RECEPTOR CHANNEL, V8, P51, DOI 10.1080/10606820212134; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Horn F, 2001, NUCLEIC ACIDS RES, V29, P346, DOI 10.1093/nar/29.1.346; Innamorati G, 1999, J RECEPT SIGNAL TR R, V19, P315, DOI 10.3109/10799899909036654; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kojro E, 1999, EUR J BIOCHEM, V266, P538, DOI 10.1046/j.1432-1327.1999.00892.x; LUTZ W, 1990, P NATL ACAD SCI USA, V87, P6507, DOI 10.1073/pnas.87.17.6507; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Piper RC, 2001, TRAFFIC, V2, P612, DOI 10.1034/j.1600-0854.2001.20904.x; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Zamah AM, 2002, J BIOL CHEM, V277, P31249, DOI 10.1074/jbc.M202753200	23	99	101	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45954	45959		10.1074/jbc.M308285200	http://dx.doi.org/10.1074/jbc.M308285200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12960162	hybrid			2022-12-27	WOS:000186452300109
J	Masumoto, K; Sakata, Y; Arima, K; Nakao, I; Izuhara, K				Masumoto, K; Sakata, Y; Arima, K; Nakao, I; Izuhara, K			Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATHEPSIN-K; PROTEINASE-INHIBITOR; MEDIATED APOPTOSIS; PROTEINASE-INHIBITOR-9; PYCNODYSOSTOSIS; CHYMOTRYPSIN; DEGRADATION; DEFICIENCY; TARGET; ENZYME	The squamous cell carcinoma antigen (SCCA) 1 and its homologous molecule, SCCA2, belong to the ovalbumin-serpin family. Although SCCA2 inhibits serine proteinases such as cathepsin G and mast cell chymase, SCCA1 targets cysteine proteinases such as cathepsin S, K, L, and papain. SCCA1 is therefore called a cross-class serpin. The inhibitory mechanism of the standard serpins is well characterized; those use a suicide substrate-like inhibitory mechanism during which an acyl-enzyme intermediate by a covalent bond is formed, and this complex is stable against hydrolysis. However, the inhibitory mechanism of cross-class serpins remains unresolved. In this article, we analyzed the inhibitory mechanism of SCCA1 on a cysteine proteinase, papain. SCCA1 interacted with papain at its reactive site loop, which was then cleaved, as the standard serpins. However, gel-filtration analyses showed that SCCA1 did not form a covalent complex with papain, in contrast to other serpins. Interaction with SCCA1 severely impaired the proteinase activity of papain, probably by inducing conformational change. The decreased, but still existing, proteinase activity of papain was completely inhibited by SCCA1 according to the suicide substrate-like inhibitory mechanism; however, papain recovered its proteinase activity with the compromised level, when all of intact SCCA1 was cleaved. These results suggest that the inhibitory mechanism of SCCA1 is unique among the serpin superfamily in that SCCA1 performs its inhibitory activity in two ways, contributing the suicide substrate-like mechanism without formation of a covalent complex and causing irreversible impairment of the catalytic activity of a proteinase.	Saga Med Sch, Dept Biomol Sci, Div Med Biochem, Saga 8498501, Japan; Saga Med Sch, Ctr Comprehens Community Med, Div Med Res, Saga 8498501, Japan	Saga University; Saga University	Izuhara, K (corresponding author), Saga Med Sch, Dept Biomol Sci, Div Med Biochem, 5-1-1 Nabeshima, Saga 8498501, Japan.		Arima, Kazuhiko/I-8962-2014	Arima, Kazuhiko/0000-0002-0607-8787				Annand RR, 1999, BIOCHEM J, V342, P655, DOI 10.1042/0264-6021:3420655; Bird CH, 1998, MOL CELL BIOL, V18, P6387, DOI 10.1128/MCB.18.11.6387; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Cataltepe S, 2000, J HISTOCHEM CYTOCHEM, V48, P113, DOI 10.1177/002215540004800112; ENGHILD JJ, 1993, BIOCHEM J, V291, P933, DOI 10.1042/bj2910933; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Hou WS, 1999, J CLIN INVEST, V103, P731, DOI 10.1172/JCI653; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; Leung-Toung R, 2002, CURR MED CHEM, V9, P979, DOI 10.2174/0929867024606704; Luke C, 2000, BIOCHEMISTRY-US, V39, P7081, DOI 10.1021/bi000050g; McGettrick AF, 2001, EUR J BIOCHEM, V268, P5868, DOI 10.1046/j.0014-2956.2001.02535.x; Melo RL, 2001, BBA-PROTEIN STRUCT M, V1547, P82, DOI 10.1016/S0167-4838(01)00171-6; Murakami A, 2001, BRIT J CANCER, V84, P851, DOI 10.1054/bjoc.2000.1683; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; QUAN LT, 1995, J BIOL CHEM, V270, P10377, DOI 10.1074/jbc.270.18.10377; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Schick C, 1997, J BIOL CHEM, V272, P1849, DOI 10.1074/jbc.272.3.1849; SCHNEIDER SS, 1995, P NATL ACAD SCI USA, V92, P3147, DOI 10.1073/pnas.92.8.3147; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Stennicke HR, 2002, TRENDS BIOCHEM SCI, V27, P94, DOI 10.1016/S0968-0004(01)02045-X; Suminami Y, 2000, BRIT J CANCER, V82, P981, DOI 10.1054/bjoc.1999.1028; TAKEDA A, 1995, FEBS LETT, V359, P78, DOI 10.1016/0014-5793(94)01456-B; Ye S, 2001, CURR OPIN STRUC BIOL, V11, P740, DOI 10.1016/S0959-440X(01)00275-5; Yuyama N, 2002, CYTOKINE, V19, P287, DOI 10.1006/cyto.2002.1972; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	31	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45296	45304		10.1074/jbc.M307741200	http://dx.doi.org/10.1074/jbc.M307741200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12949073	hybrid			2022-12-27	WOS:000186452300031
J	van't Slot, KAE; van den Burg, HA; Kloks, CPAM; Hilbers, CW; Knogge, W; Papavoine, CHM				van't Slot, KAE; van den Burg, HA; Kloks, CPAM; Hilbers, CW; Knogge, W; Papavoine, CHM			Solution structure of the plant disease resistance-triggering protein NIP1 from the fungus Rhynchosporium secalis shows a novel beta-sheet fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGEN CLADOSPORIUM-FULVUM; AVIRULENCE GENE-PRODUCT; RACE-SPECIFIC ELICITOR; COUPLING-CONSTANTS; SECONDARY STRUCTURE; BARLEY PATHOGEN; TOMATO; AVR9; PEPTIDES; CLEAVAGE	Activation of the disease resistance response in a host plant frequently requires the interaction of a plant resistance gene product with a corresponding, pathogen-derived signal encoded by an avirulence gene. The products of resistance genes from diverse plant species show remarkable structural similarity. However, due to the general paucity of information on pathogen avirulence genes the recognition process remains in most cases poorly understood. NIP1, a small protein secreted by the fungal barley pathogen Rhynchosporium secalis, is one of only a few fungal avirulence proteins identified and characterized to date. The defense-activating activity of NIP1 is mediated by barley resistance gene Rrs1. In addition, a role of the protein in fungal virulence is suggested by its nonspecific toxicity in leaf tissues of host and non-host cereals as well as its resistance gene-independent stimulatory effect on the plant plasma membrane H+-ATPase. Four naturally occurring NIP1 isoforms are characterized by single amino acid alterations that affect the different activities in a similar way. As a step toward unraveling the signal perception/transduction mechanism, the solution structure of NIP1 was determined. The protein structure is characterized by a novel fold. It consists of two parts containing beta-sheets of two and three anti-parallel strands, respectively. Five intramolecular disulfide bonds, comprising a novel disulfide bond pattern, stabilize these parts and their position with respect to each other. A comparative analysis of the protein structure with the properties of the NIP1 isoforms suggests two loop regions to be crucial for the resistance-triggering activity of NIP1.	Univ Adelaide, Sch Agr & Wine, Glen Osmond, SA 5064, Australia; AstraZeneca R&D, Med Chem, S-43183 Molndal, Sweden; Univ Wageningen & Res Ctr, Dept Plant Sci, Phytopathol Lab, NL-6709 PD Wageningen, Netherlands; Univ Wageningen & Res Ctr, Dept Biomol Sci, Biochem Lab, NL-6703 HA Wageningen, Netherlands; Univ Nijmegen, NSR Ctr, Dept Biophys Chem, NL-6500 HC Nijmegen, Netherlands	University of Adelaide; AstraZeneca; Wageningen University & Research; Wageningen University & Research; Radboud University Nijmegen	Knogge, W (corresponding author), Univ Adelaide, Sch Agr & Wine, Glen Osmond, SA 5064, Australia.	wolfgang.knogge@adelaide.edu.au		van den Burg, Harrold/0000-0003-4142-374X				BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Cohn J, 2001, CURR OPIN IMMUNOL, V13, P55, DOI 10.1016/S0952-7915(00)00182-5; Creighton TE, 1983, PROTEINS STRUCTURES; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DEGANI Y, 1974, BIOCHEMISTRY-US, V13, P1, DOI 10.1021/bi00698a001; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fiegen M, 2002, PHYSIOL MOL PLANT P, V61, P299, DOI 10.1006/pmpp.2002.0442; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gierlich A, 1999, PROTEIN EXPRES PURIF, V17, P64, DOI 10.1006/prep.1999.1098; Gooley PR, 1998, J BIOMOL NMR, V12, P523, DOI 10.1023/A:1008395001008; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HAHN M, 1993, MOL PLANT MICROBE IN, V6, P745, DOI 10.1094/MPMI-6-745; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; KAY LE, 1990, J MAGN RESON, V86, P110, DOI 10.1016/0022-2364(90)90215-U; KoomanGersmann M, 1996, PLANT CELL, V8, P929, DOI 10.1105/tpc.8.5.929; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lauge R, 1998, FUNGAL GENET BIOL, V24, P285, DOI 10.1006/fgbi.1998.1076; Luderer R, 2001, MOL PLANT MICROBE IN, V14, P867, DOI 10.1094/MPMI.2001.14.7.867; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Perl D, 2000, NAT STRUCT BIOL, V7, P380; REES DC, 1982, J MOL BIOL, V160, P475, DOI 10.1016/0022-2836(82)90309-6; Rivas S, 2002, PLANT CELL, V14, P689, DOI [10.1105/tpc.010357, 10.​1105/​tpc.​010357]; ROHE M, 1995, EMBO J, V14, P4168, DOI 10.1002/j.1460-2075.1995.tb00090.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SZYPERSKI T, 1992, J MAGN RESON, V99, P552, DOI 10.1016/0022-2364(92)90209-P; van den Hooven HW, 2001, BIOCHEMISTRY-US, V40, P3458, DOI 10.1021/bi0023089; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; van't Slot KAE, 2002, CRIT REV PLANT SCI, V21, P229, DOI 10.1080/0735-260291044223; Vervoort J, 1997, FEBS LETT, V404, P153, DOI 10.1016/S0014-5793(97)00117-8; VUISTER GW, 1992, J BIOMOL NMR, V2, P401, DOI 10.1007/BF01874818; WEVELSIEP L, 1993, PLANT PHYSIOL, V101, P297, DOI 10.1104/pp.101.1.297; WEVELSIEP L, 1991, PHYSIOL MOL PLANT P, V39, P471, DOI 10.1016/0885-5765(91)90013-8; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wu J, 1998, ANAL BIOCHEM, V258, P268, DOI 10.1006/abio.1998.2596; Wu J, 1997, PROTEIN SCI, V6, P391; Wu J, 1996, ANAL BIOCHEM, V235, P161, DOI 10.1006/abio.1996.0108; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xia YL, 2000, J MAGN RESON, V146, P228, DOI 10.1006/jmre.2000.2140	40	18	18	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45730	45736		10.1074/jbc.M308304200	http://dx.doi.org/10.1074/jbc.M308304200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12944393	hybrid			2022-12-27	WOS:000186452300083
J	Vemula, M; Kandasamy, P; Oh, CS; Chellappa, R; Gonzalez, CI; Martin, CE				Vemula, M; Kandasamy, P; Oh, CS; Chellappa, R; Gonzalez, CI; Martin, CE			Maintenance and regulation of mRNA stability of the Saccharomyces cerevisiae OLE1 gene requires multiple elements within the transcript that act through translation-independent mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID DESATURASE; SACCHAROMYCES-CEREVISIAE; HYPOXIC INDUCTION; BINDING PROTEIN; YEAST; TURNOVER; DECAY; OLE1; DEADENYLATION; IDENTIFICATION	The Saccharomyces cerevisiae OLE1 gene encodes a membrane-bound Delta-9 fatty acid desaturase, whose expression is regulated by unsaturated fatty acids through both transcriptional and mRNA stability controls. In fatty acid-free medium, the mRNA has a half-life of 10+/-1.5 min (basal stability) that drops to 2+/-1.5 min when cells are exposed to unsaturated fatty acids (regulated stability). A deletion analysis of elements within the transcript revealed that the sequences within the protein-coding region that encode transmembrane sequences and a part of the cytochrome b(5) domain are essential for the basal stability of the transcript. Deletion of any of the three essential elements produced unstable transcripts and loss of regulated instability. By contrast, substitution of the 3'-untranslated region with that of the stable PGK1 gene did not affect the basal stability of the transcript and did not block regulated decay. Given that Ole1p is a membrane-bound protein whose activities are a major determinant of membrane fluidity, we asked whether membrane-associated translation of the protein was essential for basal and regulated stability. Insertion of stop codons within the transcript that blocked either translation of the entire protein or parts of the protein required for co-translation insertion of Ole1p had no effect. We conclude that the basal and regulated stability of the OLE1 transcript is resistant to the nonsense-mediated decay pathway and that the essential protein-encoding elements for basal stability act cooperatively as stabilizing sequences through RNA-protein interactions via a translation-independent mechanism.	Rutgers State Univ, Dept Cell Biol & Neurosci, Div Life Sci, Nelson Labs, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Martin, CE (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Div Life Sci, Nelson Labs, 604 Allison Rd, Piscataway, NJ 08854 USA.	martin@biology.Rutgers.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045768] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45768] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; BOSSIE MA, 1989, J BACTERIOL, V171, P6409, DOI 10.1128/jb.171.12.6409-6413.1989; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; CAPONIGRO G, 1993, MOL CELL BIOL, V13, P5141, DOI 10.1128/MCB.13.9.5141; CEREGHINO GP, 1995, MOL BIOL CELL, V6, P1125, DOI 10.1091/mbc.6.9.1125; Chellappa R, 2001, J BIOL CHEM, V276, P43548, DOI 10.1074/jbc.M107845200; Choi JY, 1996, J BIOL CHEM, V271, P3581; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Gonzalez CI, 1996, J BIOL CHEM, V271, P25801, DOI 10.1074/jbc.271.42.25801; HAGAN KW, 1995, MOL CELL BIOL, V15, P809; HE F, 1993, P NATL ACAD SCI USA, V90, P7034, DOI 10.1073/pnas.90.15.7034; HEATON B, 1992, NUCLEIC ACIDS RES, V20, P5365, DOI 10.1093/nar/20.20.5365; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jiang YD, 2001, MOL CELL BIOL, V21, P6161, DOI 10.1128/MCB.21.18.6161-6169.2001; LaGrandeur T, 1999, RNA, V5, P420, DOI 10.1017/S1355838299981748; LOMBARDO A, 1992, MOL CELL BIOL, V12, P2941, DOI 10.1128/MCB.12.7.2941; Mitchell AG, 1997, J BIOL CHEM, V272, P28281, DOI 10.1074/jbc.272.45.28281; Mitchell P, 2000, CURR OPIN GENET DEV, V10, P193, DOI 10.1016/S0959-437X(00)00063-0; Mitchell P, 2001, CURR OPIN CELL BIOL, V13, P320, DOI 10.1016/S0955-0674(00)00214-3; MUHLRAD D, 1992, GENE DEV, V6, P2100, DOI 10.1101/gad.6.11.2100; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Prieto S, 2000, J BIOL CHEM, V275, P14155, DOI 10.1074/jbc.275.19.14155; Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7; Ruiz-Echevarria MJ, 1998, EMBO J, V17, P575, DOI 10.1093/emboj/17.2.575; Ruiz-Echevarria MJ, 2001, J BIOL CHEM, V276, P30995, DOI 10.1074/jbc.M010833200; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Schwartz DC, 2000, MOL CELL BIOL, V20, P7933, DOI 10.1128/MCB.20.21.7933-7942.2000; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; Steiger M, 2003, RNA, V9, P231, DOI 10.1261/rna.2151403; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; van Hoof A, 1999, CELL, V99, P347, DOI 10.1016/S0092-8674(00)81520-2; Vasconcelles MJ, 2001, J BIOL CHEM, V276, P14374, DOI 10.1074/jbc.M009546200; Vasudevan S, 2001, MOL CELL, V7, P1191, DOI 10.1016/S1097-2765(01)00279-9; YEN TJ, 1988, NATURE, V334, P580, DOI 10.1038/334580a0	38	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45269	45279		10.1074/jbc.M308812200	http://dx.doi.org/10.1074/jbc.M308812200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12947098	hybrid			2022-12-27	WOS:000186452300028
J	Zoltan-Jones, A; Huang, L; Ghatak, S; Toole, BP				Zoltan-Jones, A; Huang, L; Ghatak, S; Toole, BP			Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; MAMMARY-CARCINOMA CELLS; EXTRACELLULAR-MATRIX; CONTACT INHIBITION; RECEPTOR RHAMM; SURFACE CD44; TUMOR-GROWTH; CANCER-CELLS; PERICELLULAR MATRIX; SCATTER-FACTOR	During carcinoma progression, tumor cells often undergo changes similar (but not identical) to epithelial-mesenchymal transitions in embryonic development. In this study, we demonstrate that experimental stimulation of hyaluronan synthesis in normal epithelial cells is sufficient to induce mesenchymal and transformed characteristics. Using recombinant adenoviral expression of hyaluronan synthase-2, we show that increased hyaluronan production promotes anchorage-independent growth and invasiveness, induces gelatinase production, and stimulates phosphoinositide 3-kinase/Akt pathway activity in phenotypically normal Madin-Darby canine kidney and MCF-10A human mammary epithelial cells. Cells infected with hyaluronan synthase-2 adenovirus also acquired mesenchymal characteristics, including up-regulation of vimentin, dispersion of cytokeratin, and loss of organized adhesion proteins at intercellular boundaries. Furthermore, we show that the transforming effects of two well described agents, hepatocyte growth factor (HGF) and beta-catenin, are dependent on hyaluronan-cell interactions. Perturbation of endogenous hyaluronan polymer interactions by treatment with hyaluronan oligomers is shown here to reverse the transforming effects of HGF and beta-catenin in Madin-Darby canine kidney and MCF-10A human mammary epithelial cells. Also, HGF and beta-catenin induced assembly of hyaluronan-dependent pericellular matrices similar to those surrounding mesenchymal cells. Thus, increased expression of hyaluronan is sufficient to induce epithelial-mesenchymal transition and acquisition of transformed properties in phenotypically normal epithelial cells.	Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA	Tufts University	Toole, BP (corresponding author), Med Univ S Carolina, Dept Cell Biol & Anat, 173 Ashley Ave, Charleston, SC 29425 USA.				NATIONAL CANCER INSTITUTE [R01CA073839, R01CA082867] Funding Source: NIH RePORTER; NCI NIH HHS [CA82867, CA73839] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahrens T, 2001, ONCOGENE, V20, P3399, DOI 10.1038/sj.onc.1204435; Anttila MA, 2000, CANCER RES, V60, P150; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; BARTOLAZZI A, 1994, J EXP MED, V180, P53, DOI 10.1084/jem.180.1.53; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Cheon SS, 2002, P NATL ACAD SCI USA, V99, P6973, DOI 10.1073/pnas.102657399; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Danen EHJ, 2001, J CELL PHYSIOL, V189, P1, DOI 10.1002/jcp.1137; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Gordon LB, 2003, HUM GENET, V113, P178, DOI 10.1007/s00439-003-0958-9; HALL CL, 1995, CELL, V82, P19, DOI 10.1016/0092-8674(95)90048-9; Hall CL, 1996, ONCOGENE, V13, P2213; Hay ED, 1995, ACTA ANAT, V154, P8; Hayen W, 1999, J CELL SCI, V112, P2241; HELDIN P, 1993, EXP CELL RES, V208, P422, DOI 10.1006/excr.1993.1264; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Itano N, 1999, CANCER RES, V59, P2499; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Jacobson A, 2002, INT J CANCER, V102, P212, DOI 10.1002/ijc.10683; Kamikura DM, 2000, MOL CELL BIOL, V20, P3482, DOI 10.1128/MCB.20.10.3482-3496.2000; Kermorgant S, 2001, CARCINOGENESIS, V22, P1035, DOI 10.1093/carcin/22.7.1035; Kim KS, 1998, EXP CELL RES, V245, P79, DOI 10.1006/excr.1998.4238; KNUDSON CB, 1985, DEV BIOL, V112, P308, DOI 10.1016/0012-1606(85)90401-4; Knudson W, 1996, AM J PATHOL, V148, P1721; KONGTAWELERT P, 1990, ANAL BIOCHEM, V185, P313, DOI 10.1016/0003-2697(90)90300-X; Kosaki R, 1999, CANCER RES, V59, P1141; Lakka SS, 2002, ONCOGENE, V21, P8011, DOI 10.1038/sj.onc.1205894; Lesley J, 2000, J BIOL CHEM, V275, P26967; Li RS, 2001, J CELL PHYSIOL, V186, P371, DOI 10.1002/1097-4652(2000)9999:999<000::AID-JCP1042>3.0.CO;2-8; Liu NF, 2001, CANCER RES, V61, P5207; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Maleski MP, 1996, EXP CELL RES, V225, P55, DOI 10.1006/excr.1996.0156; MARKWALD RR, 1978, DEV BIOL, V62, P292, DOI 10.1016/0012-1606(78)90218-X; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; MORRISWIMAN J, 1992, ANAT RECORD, V234, P575, DOI 10.1002/ar.1092340413; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Park MJ, 2002, CANCER RES, V62, P6318; Peterson RM, 2000, AM J PATHOL, V156, P2159, DOI 10.1016/S0002-9440(10)65086-9; Powell AA, 2001, BIOCHEM J, V356, P481, DOI 10.1042/0264-6021:3560481; Ropponen K, 1998, CANCER RES, V58, P342; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Sherman LS, 2000, J CELL BIOL, V150, P1071, DOI 10.1083/jcb.150.5.1071; Simpson MA, 2002, AM J PATHOL, V161, P849, DOI 10.1016/S0002-9440(10)64245-9; Sohara Y, 2001, MOL BIOL CELL, V12, P1859, DOI 10.1091/mbc.12.6.1859; Spessotto P, 2002, J CELL BIOL, V158, P1133, DOI 10.1083/jcb.200202120; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Toole BP, 2002, AM J PATHOL, V161, P745, DOI 10.1016/S0002-9440(10)64232-0; Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; UEHARA Y, 1992, J CELL BIOL, V117, P889, DOI 10.1083/jcb.117.4.889; UNDERHILL CB, 1983, J BIOL CHEM, V258, P8086; van Kempen LCL, 2002, DIFFERENTIATION, V70, P610, DOI 10.1046/j.1432-0436.2002.700914.x; Ward JA, 2003, AM J PATHOL, V162, P1403, DOI 10.1016/S0002-9440(10)64273-3; Weston J A, 1977, Prog Clin Biol Res, V15, P217; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497; Yu Q, 1997, J EXP MED, V186, P1985, DOI 10.1084/jem.186.12.1985; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu Q, 2000, GENE DEV, V14, P163; Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342; Zhang YY, 2002, CANCER RES, V62, P3962; Zucker S, 2001, AM J PATHOL, V158, P1921, DOI 10.1016/S0002-9440(10)64660-3	79	174	175	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45801	45810		10.1074/jbc.M308168200	http://dx.doi.org/10.1074/jbc.M308168200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954618	hybrid			2022-12-27	WOS:000186452300092
J	Gardoni, F; Mauceri, D; Fiorentini, C; Bellone, C; Missale, C; Cattabeni, F; Di Luca, M				Gardoni, F; Mauceri, D; Fiorentini, C; Bellone, C; Missale, C; Cattabeni, F; Di Luca, M			CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; NMDA RECEPTOR SUBUNITS; SYNAPSE-ASSOCIATED PROTEIN-97; POSTSYNAPTIC DENSITY; PSD-95; BINDING; NR2A; MOTIFS; DLG	Synapse-associated protein 97 (SAP97), a member of membrane-associated guanylate kinase protein family, has been implicated in the processes of targeting ionotropic glutamate receptors at postsynaptic sites. Here we show that SAP97 is enriched at the postsynaptic density where it co-localizes with both ionotropic glutamate receptors and downstream signaling proteins such as Ca2+/calmodulin-dependent protein kinase II (CaMKII). SAP97 and alphaCaMKII display a high co-localization pattern in hippocampal neurons as well as in transfected COS-7 cells. Metabolic labeling of hippocampal cultures reveals that N-methyl-D-aspartic acid (NMDA) receptor activation induces CaMKII-dependent phosphorylation of SAP97; co-incubation with the CaMKII-specific inhibitor KN-93 reduces SAP97 phosphorylation to basal levels. Our results show that SAP97 directly interacts with the NR2A subunit of NMDA receptor both in an in vitro "pull-out" assay and in coimmunoprecipitation experiments from homogenates and synaptosomes purified from hippocampal rat tissue. Interestingly, in the postsynaptic density fraction, SAP97 fails to co-precipitate with NR2A. We show here that SAP97 is directly associated with NR2A through its PDZ1 domain, and CaMKII-dependent phosphorylation of SAP97-Ser-232 disrupts NR2A interaction both in an in vitro pull-out assay and in transfected COS-7 cells. Moreover, expression of SAP97(S232D) mutant has effects similar to those observed upon constitutively activating CaMKII. Our findings suggest that SAP97/NR2A interaction is regulated by CaMKII-dependent phosphorylation and provide a novel mechanism for the regulation of synaptic targeting of NMDA receptor subunits.	Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy; Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; Univ Brescia, Dept Biomed Sci & Biotechnol, Div Pharmacol, I-25124 Brescia, Italy	University of Milan; University of Milan; University of Brescia	Gardoni, F (corresponding author), Univ Milan, Ctr Excellence Neurodegenerat Dis, Via Balzaretti 9, I-20133 Milan, Italy.	Fabrizio.Gardoni@unimi.it	Missale, Mariacristina/E-6600-2010; Mauceri, Daniela/C-4969-2014; Gardoni, Fabrizio/A-3135-2009; DiLuca, Monica/A-7632-2012	Mauceri, Daniela/0000-0003-1225-4633; Gardoni, Fabrizio/0000-0003-4598-5563; DiLuca, Monica/0000-0003-2298-615X; bellone, camilla/0000-0002-6774-6275				Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bassand P, 1999, EUR J NEUROSCI, V11, P2031, DOI 10.1046/j.1460-9568.1999.00611.x; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chetkovich DM, 2002, J NEUROSCI, V22, P6415; Gardoni F, 1999, FEBS LETT, V456, P394, DOI 10.1016/S0014-5793(99)00985-0; Gardoni F, 1998, J NEUROCHEM, V71, P1733; Gardoni F, 2002, EUR J NEUROSCI, V16, P777, DOI 10.1046/j.1460-9568.2002.02141.x; Gardoni F, 2001, J NEUROSCI, V21, P1501, DOI 10.1523/JNEUROSCI.21-05-01501.2001; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Goslin K., 1991, CULTURING NERVE CELL, P251; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Niethammer M, 1996, J NEUROSCI, V16, P2157; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Valtschanoff JG, 2000, EUR J NEUROSCI, V12, P3605, DOI 10.1046/j.1460-9568.2000.00256.x; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; White RR, 1998, J BIOL CHEM, V273, P3166, DOI 10.1074/jbc.273.6.3166; Yoshimura Y, 2002, BIOCHEM BIOPH RES CO, V290, P948, DOI 10.1006/bbrc.2001.6320; Yoshimura Y, 2000, MOL BRAIN RES, V81, P118, DOI 10.1016/S0169-328X(00)00170-4	24	86	89	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44745	44752		10.1074/jbc.M303576200	http://dx.doi.org/10.1074/jbc.M303576200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12933808	hybrid			2022-12-27	WOS:000186306700108
J	Mahdi, F; Shariat-Madar, Z; Schmaier, AH				Mahdi, F; Shariat-Madar, Z; Schmaier, AH			The relative priority of Prekallikrein and factors XI/XIa assembly on cultured endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT KININOGEN; PLASMINOGEN-ACTIVATOR RECEPTOR; FACTOR-XI; CONSOLIDATION PHASE; FACTOR-IX; BINDING; PLATELETS; PLASMA; IDENTIFICATION; EXPRESSION	Investigations determined the relative preference of prekallikrein (PK) or factor XI/XIa (FXI/FXIa) binding to endothelial cells (HUVECs). In microtiter plates, biotinylated high molecular weight kininogen (biotin-HK) or biotin-FXI binding to HUVEC monolayers or their matrix proteins, but not fibronectin-coated plastic microtiter plate wells, was specifically blocked by antibodies to each of the receptors of HK, uPAR, gC1qR, or cytokeratin 1. Fluorescein isothiocyanate (FITC)-PK specifically bound to HUVEC suspensions without added Zn2+, whereas FITC-FXI or -FXIa binding to HUVEC suspensions required 10 muM added Zn2+ to support specific binding. Plasma concentrations of FXI did not block FITC-PK binding to HUVECs in the absence or presence of 10 muM Zn2+. In the absence of HK, the level of FITC-FXI or -FXIa binding was half that seen in its presence. At physiologic concentrations, PK (450 nM) abolished FITC-FXI or -FXIa binding to HUVEC suspensions in the absence or presence of HK in the presence of 10 muM Zn2+. Released Zn2+ from 2-8x10(8) collagen-activated platelets/ml supported biotin-FXI binding to HUVEC monolayers, but platelet activation was not necessary to support biotin-PK binding to HUVECs. At physiologic concentrations, PK also abolished FXI binding to HUVECs in the presence of activated platelets, but FXI did not influence PK binding. PK in the presence or absence of HK preferentially bound to HUVECs over FXI or FXIa. Elevated Zn2+ concentrations are required for FXI but not PK binding, but the presence of physiologic concentrations of PK and HK also prevented FXI binding. PK preferential binding to endothelial cells contributes to their anticoagulant nature.	Univ Michigan, Dept Internal Med, Div Hematol & Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Schmaier, AH (corresponding author), Univ Michigan, Dept Internal Med & Pathol, Div Hematol & Oncol, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	aschmaie@umich.edu	Schmaier, Alvin/AAM-1063-2020	Schmaier, Alvin/0000-0002-3884-6234	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052779] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL52779] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baird TR, 2003, J BIOL CHEM, V278, P20618, DOI 10.1074/jbc.M300224200; Baird TR, 2002, J BIOL CHEM, V277, P28498, DOI 10.1074/jbc.M203427200; Baird TR, 2002, J BIOL CHEM, V277, P38462, DOI 10.1074/jbc.M205902200; Bax CMR, 1997, BIOL TRACE ELEM RES, V56, P255, DOI 10.1007/BF02785298; BERRETTINI M, 1992, J BIOL CHEM, V267, P19833; GORODETSKY R, 1993, AM J HEMATOL, V42, P278, DOI 10.1002/ajh.2830420307; GREENGARD JS, 1986, BIOCHEMISTRY-US, V25, P3884, DOI 10.1021/bi00361a022; Han ED, 2002, J CLIN INVEST, V109, P1057, DOI 10.1172/JCI200214211; Hasan AAK, 2003, AM J PHYSIOL-HEART C, V285, pH183, DOI 10.1152/ajpheart.00490.2002; HASAN AAK, 1995, BLOOD, V85, P3134, DOI 10.1182/blood.V85.11.3134.bloodjournal85113134; Ho DH, 2000, J BIOL CHEM, V275, P25139, DOI 10.1074/jbc.M001890200; Ho DH, 2000, BIOCHEMISTRY-US, V39, P316, DOI 10.1021/bi991851q; ICHINOSE A, 1986, J BIOL CHEM, V261, P3486; LENICH C, 1995, THROMB HAEMOSTASIS, V74, P698; Mahdi F, 2002, BLOOD, V99, P3585, DOI 10.1182/blood.V99.10.3585; Mahdi F, 2001, BLOOD, V97, P2342, DOI 10.1182/blood.V97.8.2342; Moreira CR, 2002, FEBS LETT, V523, P167, DOI 10.1016/S0014-5793(02)02980-0; Motta G, 2001, THROMB HAEMOSTASIS, V86, P840; Motta G, 1998, BLOOD, V91, P516, DOI 10.1182/blood.V91.2.516.516_516_528; Renne T, 2002, J BIOL CHEM, V277, P4892, DOI 10.1074/jbc.M105221200; Rojkjaer R, 1997, EUR J BIOCHEM, V247, P491, DOI 10.1111/j.1432-1033.1997.00491.x; Rojkjaer R, 1998, THROMB HAEMOSTASIS, V80, P74, DOI 10.1055/s-0037-1615142; SCHLEEF RR, 1990, J CELL BIOL, V110, P155, DOI 10.1083/jcb.110.1.155; SCHMAIER AH, 1988, J BIOL CHEM, V263, P16327; Shariat-Madar Z, 2002, INT IMMUNOPHARMACOL, V2, P1841, DOI 10.1016/S1567-5769(02)00178-9; Shariat-Madar Z, 2002, J BIOL CHEM, V277, P17962, DOI 10.1074/jbc.M106101200; Shariat-Madar Z, 2001, THROMB HAEMOSTASIS, V85, P544, DOI 10.1055/s-0037-1615619; Shariat-Madar Z, 1999, J BIOL CHEM, V274, P7137, DOI 10.1074/jbc.274.11.7137; Sheng N, 2000, BLOOD, V95, P3788; SINHA D, 1984, J CLIN INVEST, V73, P1550, DOI 10.1172/JCI111361; VANIWAARDEN F, 1988, J BIOL CHEM, V263, P4698; WHITEHOUSE RC, 1982, CLIN CHEM, V28, P475; Zhao YQ, 2001, AM J PHYSIOL-HEART C, V280, pH1821, DOI 10.1152/ajpheart.2001.280.4.H1821	33	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					43983	43990		10.1074/jbc.M304239200	http://dx.doi.org/10.1074/jbc.M304239200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944405	hybrid			2022-12-27	WOS:000186306700013
J	Marsin, S; Vidal, AE; Sossou, M; Menissier-de Murcia, J; Le Page, F; Boiteux, S; de Murcia, G; Radicella, JP				Marsin, S; Vidal, AE; Sossou, M; Menissier-de Murcia, J; Le Page, F; Boiteux, S; de Murcia, G; Radicella, JP			Role of XRCC1 in the coordination and stimulation of oxidative DNA damage repair initiated by the DNA glycosylase hOGG1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; STRAND BREAK REPAIR; POLYMERASE-BETA; LIGASE III; POLY(ADP-RIBOSE) POLYMERASE; SUBSTRATE-SPECIFICITY; AP-ENDONUCLEASE; PROTEIN XRCC1; GENE; POLYMORPHISMS	XRCC1 participates in DNA single strand break and base excision repair (BER) to preserve genetic stability in mammalian cells. XRCC1 participation in these pathways is mediated by its interactions with several of the acting enzymes. Here, we report that XRCC1 interacts physically and functionally with hOGG1, the human DNA glycosylase that initiates the repair by BER of the mutagenic oxidized base 8-oxoguanine. This interaction leads to a 2- to 3-fold stimulation of the DNA glycosylase activity of hOGG1. XRCC1 stimulates the formation of the hOGG1 Schiff-base DNA intermediate without interfering with the endonuclease activity of APE1, the second enzyme in the pathway. On the contrary, the stimulation in the appearance of the incision product seems to reflect the addition of the effects of XRCC1 on the two first enzymes of the pathway. The data presented support a model by which XRCC1 will pass on the DNA intermediate from hOGG1 to the endonuclease APE1. This results in an acceleration of the overall repair process of oxidized purines to yield an APE1-cleaved abasic site, which can be used as a substrate by DNA polymerase beta. More importantly, the results unveil a highly coordinated mechanism by which XRCC1, through its multiple protein-protein interactions, extends its orchestrating role from the base excision step to the resealing of the repaired DNA strand.	Commissariat Energie Atom, UMR 217 CNRS, Dept Radiobiol & Radiopathol, F-92265 Fontenay Aux Roses, France; Univ Strasbourg 1, UPR 9003 CNRS, Ecole Super Biotechnol Strasbourg, F-67412 Illkirch Graffenstaden, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Radicella, JP (corresponding author), Commissariat Energie Atom, UMR 217 CNRS, Dept Radiobiol & Radiopathol, BP6, F-92265 Fontenay Aux Roses, France.	jpradicella@cea.fr	Radicella, J. Pablo/AAU-3178-2020; Vidal, Antonio/ABE-5693-2020	Radicella, J. Pablo/0000-0002-8807-7226; Vidal, Antonio/0000-0001-9491-8901; MARSIN, Stephanie/0000-0002-7074-7818				Allinson SL, 2001, EMBO J, V20, P6919, DOI 10.1093/emboj/20.23.6919; Audebert M, 2002, DNA REPAIR, V1, P497, DOI 10.1016/S1568-7864(02)00034-4; Audebert M, 2000, NUCLEIC ACIDS RES, V28, P2672, DOI 10.1093/nar/28.14.2672; Boiteux S, 1999, NATO ADV SCI I A-LIF, V302, P35; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Caldecott KW, 2001, BIOESSAYS, V23, P447, DOI 10.1002/bies.1063; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Chen SQ, 2002, CARCINOGENESIS, V23, P1321, DOI 10.1093/CARCIN/23.8.1321; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; Fortini P, 1999, J BIOL CHEM, V274, P15230, DOI 10.1074/jbc.274.21.15230; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Hu JJ, 2002, ENVIRON MOL MUTAGEN, V39, P208, DOI 10.1002/em.10058; Kubota Y, 2003, DNA REPAIR, V2, P407, DOI 10.1016/S1568-7864(02)00242-2; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Ladiges W, 2003, MECH AGEING DEV, V124, P27, DOI 10.1016/S0047-6374(02)00166-5; Le Page F, 2003, J BIOL CHEM, V278, P18471, DOI 10.1074/jbc.M212905200; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Marintchev A, 2000, NUCLEIC ACIDS RES, V28, P2049, DOI 10.1093/nar/28.10.2049; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Miller J. H., 1982, EXPT MOL GENETICS; Nash HM, 1997, CHEM BIOL, V4, P693, DOI 10.1016/S1074-5521(97)90225-8; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Prasad R, 2001, J BIOL CHEM, V276, P32411, DOI 10.1074/jbc.C100292200; Rice PA, 1999, NAT STRUCT BIOL, V6, P805, DOI 10.1038/12257; Rothwell DG, 2000, NUCLEIC ACIDS RES, V28, P2207, DOI 10.1093/nar/28.11.2207; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Seedhouse C, 2002, BLOOD, V100, P3761, DOI 10.1182/blood-2002-04-1152; Smith TR, 2003, CANCER LETT, V190, P183, DOI 10.1016/S0304-3835(02)00595-5; Stern MC, 2002, CANCER EPIDEM BIOMAR, V11, P939; Taylor RM, 2000, MOL CELL BIOL, V20, P735, DOI 10.1128/MCB.20.2.735-740.2000; Taylor RM, 1998, CURR BIOL, V8, P877, DOI 10.1016/S0960-9822(07)00350-8; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; Thompson LH, 2000, MUTAT RES-DNA REPAIR, V459, P1, DOI 10.1016/S0921-8777(99)00058-0; van Gils CH, 2002, CANCER EPIDEM BIOMAR, V11, P1279; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Vidal AE, 2001, NUCLEIC ACIDS RES, V29, P1285, DOI 10.1093/nar/29.6.1285; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	43	202	209	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44068	44074		10.1074/jbc.M306160200	http://dx.doi.org/10.1074/jbc.M306160200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12933815	hybrid			2022-12-27	WOS:000186306700023
J	Fan, XL; Liu, Y; Chen, JJ				Fan, XL; Liu, Y; Chen, JJ			Activation of c-Myc contributes to bovine papillomavirus type 1 E7-induced cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN READING FRAME; DIHYDROFOLATE-REDUCTASE PROMOTER; RETINOBLASTOMA FAMILY PROTEINS; CYCLE PROGRESSION; TRANSFORMING GENE; E7 PROTEINS; INHIBITOR P27(KIP1); DEPENDENT KINASES; GROWTH-REGULATION; PRB/E2F PATHWAY	Inactivation of the tumor suppressor pRB by the human papillomavirus (HPV) oncoprotein E7 is a mechanism by which HPV promotes cell growth. The bovine papillomavirus type 1 (BPV-1) E7 does not bind pRB efficiently yet is required for full transformation of murine cells by BPV-1. In the present study, we investigated the mechanism of BPV-1 E7-induced cell proliferation. Our studies indicate that expression of BPV-1 E7 induces DNA synthesis and stimulates cells to enter S phase in quiescent cells. The induction of cell proliferation by BPV-1 E7 can occur in the retinoblastoma gene (Rb)-null cells, suggesting an Rb-independent mechanism. Consistent with this observation, BPV-1 E7 does not efficiently activate the transcription of the E2F family of transcription factors (E2F)-responsive promoters. Notably, c-Myc is able to induce cells to enter S phase in quiescent cells through an Rb/E2F-independent pathway. Significantly, c-Myc levels are increased in BPV-1 E7-expressing cells. Moreover, expression of a dominant negative c-Myc mutant inhibited BPV-1 E7-induced DNA synthesis. Consistent with the notion that c-Myc could down-regulate p27 and activate Cdk2, p27 level is decreased while both cyclin A and cyclin E-associated kinase activities are up-regulated in BPV-1 E7-expressing cells. These studies indicate an important role for c-Myc in BPV-1 E7-induced cell proliferation.	Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Chen, JJ (corresponding author), Univ Massachusetts, Sch Med, Dept Med, NRB Rm 323,364 Plantat St, Worcester, MA 01605 USA.				PHS HHS [F32] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Armstrong DJ, 1997, VIROLOGY, V239, P238, DOI 10.1006/viro.1997.8885; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Berezutskaya E, 1997, CELL GROWTH DIFFER, V8, P1277; Berns K, 2000, ONCOGENE, V19, P4822, DOI 10.1038/sj.onc.1203879; Berns K, 1997, ONCOGENE, V15, P1347, DOI 10.1038/sj.onc.1201280; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Classon M, 2001, EXP CELL RES, V264, P135, DOI 10.1006/excr.2000.5135; DIMAIO D, 1986, P NATL ACAD SCI USA, V83, P1797, DOI 10.1073/pnas.83.6.1797; DYSON N, 1992, J VIROL, V66, P6893, DOI 10.1128/JVI.66.12.6893-6902.1992; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; Gewin L, 2001, J VIROL, V75, P7198, DOI 10.1128/JVI.75.15.7198-7201.2001; GROFF DE, 1986, VIROLOGY, V150, P221, DOI 10.1016/0042-6822(86)90281-3; GUADAGNO TM, 1993, SCIENCE, V262, P1572, DOI 10.1126/science.8248807; Hiraiwa A, 1996, VIRUS GENES, V12, P27, DOI 10.1007/BF00369998; Howley M. P., 1996, FIELDS VIROLOGY, P2045; JAREBORG N, 1992, J VIROL, V66, P4957, DOI 10.1128/JVI.66.8.4957-4965.1992; Jiang W, 1998, BIOTECHNIQUES, V24, P349; Katich SC, 2001, ONCOGENE, V20, P543, DOI 10.1038/sj.onc.1204130; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Leng XH, 1997, CURR BIOL, V7, P709, DOI 10.1016/S0960-9822(06)00301-0; Liu Y, 2000, J BIOL CHEM, V275, P30894, DOI 10.1074/jbc.M000640200; Lukas J, 1997, GENE DEV, V11, P1479, DOI 10.1101/gad.11.11.1479; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; McArthur GA, 2002, MOL CELL BIOL, V22, P3014, DOI 10.1128/MCB.22.9.3014-3023.2002; MEANS AL, 1992, MOL CELL BIOL, V12, P1054, DOI 10.1128/MCB.12.3.1054; Morozov A, 1997, J VIROL, V71, P3451, DOI 10.1128/JVI.71.5.3451-3457.1997; Munger K, 2001, ONCOGENE, V20, P7888, DOI 10.1038/sj.onc.1204860; MUNGER K, 1991, J VIROL, V65, P3943; NEARY K, 1989, J VIROL, V63, P259, DOI 10.1128/JVI.63.1.259-266.1989; Nguyen DX, 2002, J VIROL, V76, P619, DOI 10.1128/JVI.76.2.619-632.2002; PATRICK DR, 1994, J BIOL CHEM, V269, P6842; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; SCHILLER JT, 1984, P NATL ACAD SCI-BIOL, V81, P7880, DOI 10.1073/pnas.81.24.7880; SCHILLER JT, 1986, J VIROL, V57, P1; SCHLEGEL R, 1986, SCIENCE, V233, P464, DOI 10.1126/science.3014660; SEDMAN SA, 1992, J VIROL, V66, P4201, DOI 10.1128/JVI.66.7.4201-4208.1992; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; STOREY A, 1990, J GEN VIROL, V71, P165, DOI 10.1099/0022-1317-71-1-165; VANDEPOL SB, 1995, J VIROL, V69, P395, DOI 10.1128/JVI.69.1.395-402.1995; Vlach J, 1996, EMBO J, V15, P6595, DOI 10.1002/j.1460-2075.1996.tb01050.x; VOUSDEN KH, 1988, ONCOGENE RES, V3, P167; WADE M, 1992, MOL CELL BIOL, V12, P4364, DOI 10.1128/MCB.12.10.4364; Wang SY, 1998, J CELL PHYSIOL, V176, P456, DOI 10.1002/(SICI)1097-4652(199809)176:3<456::AID-JCP2>3.0.CO;2-N; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; ZerfassThome K, 1996, ONCOGENE, V13, P2323; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	54	8	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43163	43168		10.1074/jbc.M306008200	http://dx.doi.org/10.1074/jbc.M306008200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12937171	hybrid			2022-12-27	WOS:000186157000057
J	McCarthy, TL; Chang, WZ; Liu, Y; Centrella, M				McCarthy, TL; Chang, WZ; Liu, Y; Centrella, M			Runx2 integrates estrogen activity in osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; FETAL-RAT BONE; TRANSCRIPTION FACTOR CBFA1; I RECEPTOR PROMOTER; CELL-CULTURES; COLLAGEN-SYNTHESIS; GENE-EXPRESSION; BINDING DOMAIN; CROSS-TALK; GLUCOCORTICOID RECEPTOR	Steroids significantly effect skeletal integrity. For example, bone mass decreases with glucocorticoid excess or with estrogen depletion after menopause. Glucocorticoid suppresses gene expression by an essential skeletal tissue transcription factor, Runx2, in rat osteoblasts. We now report that estrogen enhances Runx2 activity in dose- and estrogen receptor-dependent ways independently of changes in Runx2 levels or its DNA binding potential. Estrogen receptor and Runx2 can be collected by co-immunoprecipitation. By two-hybrid gene expression analysis, high affinity complex formation involves portions of Runx2 outside of its own DNA binding domain and the DNA binding domain of the estrogen receptor. Consistent with this interaction, the stimulatory effect of estrogen on Runx2 activity is lost when the DNA binding domain of the estrogen receptor is eliminated. Unlike the stimulatory effect of estrogen and the inhibitory effect of glucocorticoid, androgen fails to increase Runx2 activity, whereas Runx2 potently suppresses gene expression induced by all three steroids. Finally, estrogen increases gene transcription by the transforming growth factor-beta type I receptor gene promoter, which contains several Runx binding sequences, and enhances Smad dependent gene expression by transforming growth factor-beta in osteoblasts. These results reveal that Runx2 can integrate complex effects on gene transcription in hormone-, growth factor-, and tissue-restricted ways.	Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA	Yale University	McCarthy, TL (corresponding author), 333 Cedar St,POB 208041, New Haven, CT 06520 USA.	thomas.mccarthy@yale.edu			NIAMS NIH HHS [AR 39201] Funding Source: Medline; NIDDK NIH HHS [DK 56310] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039201, R29AR039201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056310] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adya N, 2000, SEMIN CELL DEV BIOL, V11, P361, DOI 10.1006/scdb.2000.0189; Amanatullah D F, 2002, Minerva Endocrinol, V27, P7; Aubin JE, 1999, J CELL BIOCHEM, V72, P396, DOI 10.1002/(SICI)1097-4644(19990301)72:3<396::AID-JCB9>3.3.CO;2-Y; Batra GS, 2003, J PATHOL, V200, P65, DOI 10.1002/path.1332; Beavan S, 2001, J BONE MINER RES, V16, P1496, DOI 10.1359/jbmr.2001.16.8.1496; Bijlsma JWJ, 1999, ANN NY ACAD SCI, V876, P366, DOI 10.1111/j.1749-6632.1999.tb07659.x; Bjornstrom L, 2002, J BIOL CHEM, V277, P48479, DOI 10.1074/jbc.C200570200; Bodine PVN, 1998, ENDOCRINOLOGY, V139, P2048, DOI 10.1210/en.139.4.2048; Bonnelye E, 2002, J BONE MINER RES, V17, P1392, DOI 10.1359/jbmr.2002.17.8.1392; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Carpenter TO, 1998, ENDOCRINOLOGY, V139, P35, DOI 10.1210/en.139.1.35; Cato A., 2002, SCI STKE; Centrella M, 1997, J CELL BIOCHEM, V67, P528, DOI 10.1002/(SICI)1097-4644(19971215)67:4<528::AID-JCB10>3.3.CO;2-5; CENTRELLA M, 1994, ENDOCRINOLOGY, V135, P1611, DOI 10.1210/en.135.4.1611; CENTRELLA M, 1989, ENDOCRINOLOGY, V125, P199, DOI 10.1210/endo-125-1-199; Centrella M, 1996, ANN NY ACAD SCI, V785, P224, DOI 10.1111/j.1749-6632.1996.tb56267.x; CENTRELLA M, 1987, J BIOL CHEM, V262, P2869; Chang DJ, 1998, J BIOL CHEM, V273, P4892, DOI 10.1074/jbc.273.9.4892; Chen TK, 1996, MOL CARCINOGEN, V15, P215, DOI 10.1002/(SICI)1098-2744(199603)15:3<215::AID-MC7>3.0.CO;2-G; Gohel A, 1999, ENDOCRINOLOGY, V140, P5339, DOI 10.1210/en.140.11.5339; Greenfield EM, 1999, LIFE SCI, V65, P1087, DOI 10.1016/S0024-3205(99)00156-3; Hsiao PW, 2002, BIOCHEM CELL BIOL, V80, P343, DOI 10.1139/O02-082; Ireland DC, 2002, J CELL BIOCHEM, V86, P251, DOI 10.1002/jcb.10228; Ito Y, 1999, GENES CELLS, V4, P685, DOI 10.1046/j.1365-2443.1999.00298.x; Jakacka M, 2002, MOL ENDOCRINOL, V16, P2188, DOI 10.1210/me.2001-0174; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Ji CH, 1996, J CELL BIOCHEM, V63, P478; Ji CH, 1997, J BIOL CHEM, V272, P21260, DOI 10.1074/jbc.272.34.21260; Ji CH, 1998, J CELL BIOCHEM, V69, P353, DOI 10.1002/(SICI)1097-4644(19980601)69:3<353::AID-JCB12>3.3.CO;2-W; Ji CH, 2001, ENDOCRINOLOGY, V142, P3873, DOI 10.1210/en.142.9.3873; Karsenty G, 2000, SEMIN CELL DEV BIOL, V11, P343, DOI 10.1006/scdb.2000.0188; Katzburg S, 1999, BONE, V25, P667, DOI 10.1016/S8756-3282(99)00225-2; Katzburg S, 2001, J ENDOCRINOL INVEST, V24, P166, DOI 10.1007/BF03343837; Kellendonk C, 1999, J STEROID BIOCHEM, V69, P253, DOI 10.1016/S0960-0760(99)00041-2; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Komori T, 2000, BIOCHEM BIOPH RES CO, V276, P813, DOI 10.1006/bbrc.2000.3460; Kousteni S, 2002, SCIENCE, V298, P843, DOI 10.1126/science.1074935; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Leboy PS, 2001, J BONE JOINT SURG AM, V83A, pS15; Lee SK, 1998, MOL ENDOCRINOL, V12, P1184, DOI 10.1210/me.12.8.1184; Liu YM, 2002, ONCOGENE, V21, P7680, DOI 10.1038/sj.onc.1205883; Lutterbach B, 2000, J BIOL CHEM, V275, P651, DOI 10.1074/jbc.275.1.651; Masi L, 2001, Q J NUCL MED, V45, P2; Matsuda T, 2001, J BIOL CHEM, V276, P42908, DOI 10.1074/jbc.M105316200; McCarthy TL, 2000, ENDOCRINOLOGY, V141, P127, DOI 10.1210/en.141.1.127; McCarthy TL, 2000, J BIOL CHEM, V275, P21746, DOI 10.1074/jbc.M002291200; McCarthy TL, 1997, J BIOL CHEM, V272, P18132, DOI 10.1074/jbc.272.29.18132; MCCARTHY TL, 1988, J BONE MINER RES, V3, P401; McLarrent FW, 2001, J BIOL CHEM, V276, P1578, DOI 10.1074/jbc.M007629200; Ning YM, 1999, J BIOL CHEM, V274, P30624, DOI 10.1074/jbc.274.43.30624; Nishimura J, 2000, J BONE MINER METAB, V18, P350, DOI 10.1007/s007740070008; Nuttall ME, 2000, AM J PHYSIOL-CELL PH, V279, pC1550, DOI 10.1152/ajpcell.2000.279.5.C1550; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Pereira RMR, 2001, BONE, V28, P484, DOI 10.1016/S8756-3282(01)00422-7; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Plant A, 2002, J CELL BIOCHEM, V84, P285, DOI 10.1002/jcb.10021; Raisz LG, 1999, OSTEOARTHR CARTILAGE, V7, P419, DOI 10.1053/joca.1998.0230; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Rosen CJ, 2000, BEST PRACT RES CL EN, V14, P181, DOI 10.1053/beem.2000.0068; Sadowski I, 1995, Genet Eng (N Y), V17, P119; Schuur ER, 2001, J BIOL CHEM, V276, P33554, DOI 10.1074/jbc.M105555200; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Simoncini T, 2002, STEROIDS, V67, P935, DOI 10.1016/S0039-128X(02)00040-5; Simoncini T, 2003, EUR J ENDOCRINOL, V148, P281, DOI 10.1530/eje.0.1480281; Suda T, 1997, J BONE MINER RES, V12, P869, DOI 10.1359/jbmr.1997.12.6.869; Sutter-Dub MT, 2002, STEROIDS, V67, P77, DOI 10.1016/S0039-128X(01)00142-8; Taranta A, 2002, BONE, V30, P368, DOI 10.1016/S8756-3282(01)00685-8; Tintut Y, 1999, J BIOL CHEM, V274, P28875, DOI 10.1074/jbc.274.41.28875; Tou LQ, 2001, MOL CELL ENDOCRINOL, V183, P71, DOI 10.1016/S0303-7207(01)00594-9; Uht RM, 1997, ENDOCRINOLOGY, V138, P2900, DOI 10.1210/en.138.7.2900; Viereck V, 2002, J CELL BIOCHEM, V86, P348, DOI 10.1002/jcb.10220; Walters MR, 2002, J BIOL CHEM, V277, P1669, DOI 10.1074/jbc.M109320200; Westendorf JJ, 1998, MOL CELL BIOL, V18, P322, DOI 10.1128/MCB.18.1.322; Wiren KM, 2002, J ENDOCRINOL, V175, P683, DOI 10.1677/joe.0.1750683; Yamamoto T, 2002, ENDOCRINOLOGY, V143, P2635, DOI 10.1210/en.143.7.2635; Zhou S, 2001, J CELL BIOCHEM, P144	76	97	102	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43121	43129		10.1074/jbc.M306531200	http://dx.doi.org/10.1074/jbc.M306531200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12951324	hybrid			2022-12-27	WOS:000186157000052
J	Rosonina, E; Bakowski, MA; McCracken, S; Blencowe, BJ				Rosonina, E; Bakowski, MA; McCracken, S; Blencowe, BJ			Transcriptional activators control splicing and 3 '-end cleavage levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PRE-MESSENGER-RNA; CARBOXY-TERMINAL DOMAIN; LARGEST SUBUNIT; ENHANCER; COMPLEX; BINDING; COACTIVATOR; ELONGATION; HOLOENZYME	We have investigated whether transcriptional activators influence the efficiency of constitutive splicing and 3'-end formation, in addition to transcription levels. Remarkably, strong activators result in higher levels of splicing and 3'-cleavage than weak activators and can control the efficiency of these steps in pre-mRNA processing separately. The pre-mRNA processing stimulatory property of activators is dependent on their binding to promoters, but is not an indirect consequence of the levels of transcripts produced. Moreover, stimulation of splicing and cleavage by a strong activator operates by a mechanism that requires the carboxyl-terminal domain of RNA polymerase II. The splicing stimulatory property of activators was observed for unrelated transcripts and for separate introns within a transcript, indicating a possible general role for strong activators in facilitating pre-mRNA processing levels. The results suggest that the efficiency of constitutive splicing and 3'-end cleavage is closely coordinated with transcription levels by promoter-bound activators.	Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1L6, Canada	University of Toronto; University of Toronto	Blencowe, BJ (corresponding author), Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, 112 Coll St,Rm 410, Toronto, ON M5G 1L6, Canada.			Rosonina, Emanuel/0000-0001-6861-3143				ALLISON LA, 1989, P NATL ACAD SCI USA, V86, P2794, DOI 10.1073/pnas.86.8.2794; ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Blau J, 1996, MOL CELL BIOL, V16, P2044; Calvo O, 2001, MOL CELL, V7, P1013, DOI 10.1016/S1097-2765(01)00236-2; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Corden JL, 1997, TRENDS BIOCHEM SCI, V22, P413, DOI 10.1016/S0968-0004(97)01125-0; CORDEN JL, 1985, P NATL ACAD SCI USA, V82, P7934, DOI 10.1073/pnas.82.23.7934; Cramer P, 2001, FEBS LETT, V498, P179, DOI 10.1016/S0014-5793(01)02485-1; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; Eldridge AG, 1999, P NATL ACAD SCI USA, V96, P6125, DOI 10.1073/pnas.96.11.6125; Emili A, 2002, RNA, V8, P1102, DOI 10.1017/S1355838202025037; Flaherty SM, 1997, P NATL ACAD SCI USA, V94, P11893, DOI 10.1073/pnas.94.22.11893; Ge H, 1998, MOL CELL, V2, P751, DOI 10.1016/S1097-2765(00)80290-7; GERBER HP, 1995, NATURE, V374, P660, DOI 10.1038/374660a0; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Hirose Y, 1999, GENE DEV, V13, P1234, DOI 10.1101/gad.13.10.1234; Hirose Y, 2000, GENE DEV, V14, P1415; INOUE K, 1992, P NATL ACAD SCI USA, V89, P8092, DOI 10.1073/pnas.89.17.8092; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Kadener S, 2002, P NATL ACAD SCI USA, V99, P8185, DOI 10.1073/pnas.122246099; Kadener S, 2001, EMBO J, V20, P5759, DOI 10.1093/emboj/20.20.5759; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Lai MC, 1999, J BIOL CHEM, V274, P11832, DOI 10.1074/jbc.274.17.11832; LIAO SM, 1991, GENE DEV, V5, P2431, DOI 10.1101/gad.5.12b.2431; Liu JH, 2001, CELL, V104, P353, DOI 10.1016/S0092-8674(01)00223-9; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; McCracken S, 2002, MOL CELL BIOL, V22, P148, DOI 10.1128/MCB.22.1.148-160.2002; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; OSSIPOW V, 1995, CELL, V83, P137, DOI 10.1016/0092-8674(95)90242-2; Pan GH, 1997, J BIOL CHEM, V272, P24563, DOI 10.1074/jbc.272.39.24563; Robert F, 2002, J BIOL CHEM, V277, P9302, DOI 10.1074/jbc.M110516200; SCAFE C, 1990, NATURE, V347, P491, DOI 10.1038/347491a0; TIAN M, 1992, SCIENCE, V256, P237, DOI 10.1126/science.1566072; WALKER S, 1993, MOL CELL BIOL, V13, P5233, DOI 10.1128/MCB.13.9.5233; YANKULOV K, 1994, CELL, V77, P749, DOI 10.1016/0092-8674(94)90058-2; Yeakley JM, 1996, P NATL ACAD SCI USA, V93, P7582, DOI 10.1073/pnas.93.15.7582; Zeng CQ, 2000, MOL CELL BIOL, V20, P8290, DOI 10.1128/MCB.20.21.8290-8301.2000	45	54	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43034	43040		10.1074/jbc.M307289200	http://dx.doi.org/10.1074/jbc.M307289200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12939267	hybrid			2022-12-27	WOS:000186157000040
J	Alappat, EC; Volkland, J; Peter, ME				Alappat, EC; Volkland, J; Peter, ME			Cell cycle effects by C-FADD depend on its C-terminal phosphorylation site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEATH DOMAIN PROTEIN; INDUCED APOPTOSIS; T-CELLS; EPITHELIAL-CELLS; FAS; FADD/MORT1; PROLIFERATION; ACTIVATION; SIGNAL; EXPRESSION	Expression of a truncated form of the death receptor adaptor FADD (C-FADD) as a transgene in mice blocks T cell proliferation. Here we provide evidence that the C-terminal phosphorylation site Ser(19)4 in C-FADD affects the cell cycle in nonlymphoid cells as well. High expression of wild type C-FADD but not C-FADD with a S194A point mutation arrested the nontumor cell line MCF10A in G(2)/M but not the tumor cell line MCF7. BJAB as well as MCF10A cells expressing moderate levels of C-FADD with a S194E mutation mimicking phosphorylated C-FADD were more susceptible to a Taxol(R)-induced G(2)/M arrest than cells expressing C-FADD S194A suggesting that C-FADD S194E lowers the threshold for G(2)/M arrest. Our data suggest that C-FADD may affect apoptosis sensitivity of cells by interfering with cell cycle progression and not only by binding to death receptors.	Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA	University of Chicago	Peter, ME (corresponding author), Univ Chicago, Ben May Inst Canc Res, 924 E 57th St, Chicago, IL 60637 USA.			Peter, Marcus Ernst/0000-0003-3216-036X				Alegre ML, 1998, J IMMUNOL, V161, P3347; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Bush JA, 2001, EXP CELL RES, V271, P305, DOI 10.1006/excr.2001.5381; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; Gil J, 2000, ONCOGENE, V19, P3665, DOI 10.1038/sj.onc.1203710; Hua ZC, 2003, IMMUNITY, V18, P513, DOI 10.1016/S1074-7613(03)00083-9; Hueber AO, 2000, J BIOL CHEM, V275, P10453, DOI 10.1074/jbc.275.14.10453; JAATTELA M, 1995, ONCOGENE, V10, P2297; Kabra NH, 2001, P NATL ACAD SCI USA, V98, P6307, DOI 10.1073/pnas.111158698; Moran TJ, 2000, CANCER RES, V60, P867; Morgan MJ, 2001, CELL DEATH DIFFER, V8, P696, DOI 10.1038/sj.cdd.4400866; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; Newton K, 2001, CURR BIOL, V11, P273, DOI 10.1016/S0960-9822(01)00067-7; Peter M E, 1999, Results Probl Cell Differ, V23, P25; Rytomaa M, 1999, CURR BIOL, V9, P1043, DOI 10.1016/S0960-9822(99)80454-0; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Strasser A, 1999, INT J BIOCHEM CELL B, V31, P533, DOI 10.1016/S1357-2725(99)00003-5; Streetz K, 2000, GASTROENTEROLOGY, V119, P446, DOI 10.1053/gast.2000.9364; Wang XZ, 2000, J VIROL, V74, P11296, DOI 10.1128/JVI.74.23.11296-11303.2000; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang J, 2001, J BIOL CHEM, V276, P29815, DOI 10.1074/jbc.M103838200; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	23	47	47	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 24	2003	278	43					41585	41588		10.1074/jbc.C300385200	http://dx.doi.org/10.1074/jbc.C300385200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FP	12954630	hybrid			2022-12-27	WOS:000185989500004
J	Babenko, AP; Bryan, J				Babenko, AP; Bryan, J			SUR domains that associate with and gate K-ATP pores define a novel gatekeeper	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE POTASSIUM CHANNELS; SULFONYLUREA RECEPTOR; ABC TRANSPORTER; INSULIN-SECRETION; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; SUBUNIT; TRAFFICKING; INHIBITION; CONDUCTION	Structure-function analyses of K+ channels identify a common pore architecture whose gating depends on diverse signal sensing elements. The "gatekeepers" of the long, ATP-inhibited K(IR)6.0 pores of K-ATP channels are ABC proteins, SURs, receptors for channel opening and closing drugs. Several competing models for SUR/K-IR coupling exist. We show that SUR TMD0, the N-terminal bundle of five transmembrane helices, specifically associates with K(IR)6.2, forcing nearly silent pores to burst like native KATP channels and enhancing surface expression. Inclusion of adjacent submembrane residues of L0, the linker between TMD0 and the stimulatory nucleotide- and drug-binding ABC core, generates constitutively active channels, whereas additional cytoplasmic residues counterbalance this activation establishing a relationship between the mean open and burst times of intact pores. SUR fragments, lacking TMD0, fail to modulate K-IR. TMD0 is thus the domain that anchors SUR to the K-IR pore. Consistent with data on chimeric ABCC/K(IR)s and a modeled channel structure, we propose that interactions of TMD0-L0 with the outer helix and N terminus of K-IR bidirectionally modulate gating. The results explain and predict pathologies associated with alteration of the 5' ends of clustered ABCC8 (9)/KCNJ11 (8) genes.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Babenko, AP (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza,112C, Houston, TX 77030 USA.				NIDDK NIH HHS [DK 44311] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044311] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Armstrong C.M., 2003, SCI STKE, V2003, pre10; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Babenko AP, 1999, J BIOL CHEM, V274, P11587, DOI 10.1074/jbc.274.17.11587; Babenko AP, 1999, FEBS LETT, V445, P131, DOI 10.1016/S0014-5793(99)00102-7; Babenko AP, 2002, J BIOL CHEM, V277, P43997, DOI 10.1074/jbc.M208085200; Babenko AP, 2001, J BIOL CHEM, V276, P49083, DOI 10.1074/jbc.M108763200; Babenko AP, 1999, BIOCHEM BIOPH RES CO, V255, P231, DOI 10.1006/bbrc.1999.0172; Babenko AP, 1999, FEBS LETT, V459, P367, DOI 10.1016/S0014-5793(99)01215-6; Bakos E, 2000, J CELL SCI, V113, P4451; Chang G, 2003, J MOL BIOL, V330, P419, DOI 10.1016/S0022-2836(03)00587-4; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Giblin JP, 1999, J BIOL CHEM, V274, P22652, DOI 10.1074/jbc.274.32.22652; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Mikhailov MV, 2000, FEBS LETT, V482, P59, DOI 10.1016/S0014-5793(00)02035-4; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Schwanstecher C, 2002, DIABETES, V51, P875, DOI 10.2337/diabetes.51.3.875; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	31	119	121	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 24	2003	278	43					41577	41580		10.1074/jbc.C300363200	http://dx.doi.org/10.1074/jbc.C300363200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FP	12941953	hybrid			2022-12-27	WOS:000185989500002
J	Wu, HY; Windmiller, DA; Wang, L; Backer, JM				Wu, HY; Windmiller, DA; Wang, L; Backer, JM			YXXM motifs in the PDGF-beta receptor serve dual roles as phosphoinositide 3-kinase binding motifs and tyrosine-based endocytic sorting signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; HAMSTER OVARY CELLS; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; MEMBRANE-TRANSPORT; KINASE; PROTEIN; CBL; TRAFFICKING; DOMAIN; UBIQUITINATION	Phosphoinositide 3-kinases (PI 3-kinases) are important regulators of endocytic trafficking. Previous studies have shown that mutant human platelet-derived growth factor-beta receptors (PDGFR), which contain Phe in place of Tyr at the two p85/p110 PI 3-kinase binding sites (PDGFR-F/F), are defective for both p85 binding and ligand-stimulated degradation. This suggested that p85/p110 regulates PDGFR trafficking. However, more recent work has identified hVPS34, and not p85/p110, as the major PI 3-kinase regulating the movement of receptors through the endosomal system. To reconcile this discrepancy, we hypothesized that YXXM motifs in the PDGFR might play a second role as Tyr-based lysosomal sorting motifs (YXXPhi). To test this, we replaced both YXXM motifs with a motif from LAMP-1, YQTI. This mutant PDGFR (PDGFR-YQTI) still underwent PDGF-stimulated autophosphorylation but did not bind p85. In CHO cells, both wild-type and YQTI receptors showed PDGF-stimulated turnover, whereas F/F receptors did not. In addition, uptake and degradation of cell surface-labeled YXXM and YQTI receptors was fast relative to F/F receptors. We also constructed chimeras containing extracellular and membrane-spanning domains from CD25 (Tac) and cytoplasmic tails containing the YQTI motif, two YXXM motifs, or two mutant FXXM motifs. The YXXM and YQTI chimeras mediated lysosomal delivery of fluorescein isothiocyanate-labeled anti-CD25 antibodies, whereas the F/F chimera was defective. Thus, YQTI motifs can target PDGFR for degradation in the absence of p85/p110 binding, and the p85/p110 binding motifs from PDGFR are sufficient to target Tac chimeras to the lysosome. These data suggest that the YXXM motifs in the PDGFR serve two distinct functions: PI 3-kinase recruitment and lysosomal targeting.	Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Backer, JM (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NIGMS NIH HHS [GM55692] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Backer Jonathan M., 2000, Molecular Cell Biology Research Communications, V3, P193, DOI 10.1006/mcbr.2000.0202; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Chuang E, 1997, J IMMUNOL, V159, P144; Clague MJ, 2001, J CELL SCI, V114, P3075; Corvera S, 1999, CURR OPIN CELL BIOL, V11, P460, DOI 10.1016/S0955-0674(99)80066-0; DUAN L, 2003, J BIOL CHEM; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hausdorff SF, 1999, J BIOL CHEM, V274, P24677, DOI 10.1074/jbc.274.35.24677; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; JADOT M, 1992, J BIOL CHEM, V267, P11069; JOLY M, 1995, J BIOL CHEM, V270, P13225, DOI 10.1074/jbc.270.22.13225; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; McEwen RK, 1999, J BIOL CHEM, V274, P33905, DOI 10.1074/jbc.274.48.33905; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; METZELAAR MJ, 1991, J BIOL CHEM, V266, P3239; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; MORI S, 1994, J BIOL CHEM, V269, P4917; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; PETERS C, 1990, EMBO J, V9, P3497, DOI 10.1002/j.1460-2075.1990.tb07558.x; POLLARD JW, 1979, J CELL PHYSIOL, V98, P571, DOI 10.1002/jcp.1040980315; Prasad SVN, 2002, J CELL BIOL, V158, P563, DOI 10.1083/jcb.200202113; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Roggo L, 2002, EMBO J, V21, P1673, DOI 10.1093/emboj/21.7.1673; ROSENWALD AG, 1992, BIOCHEMISTRY-US, V31, P3581, DOI 10.1021/bi00129a005; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Siddhanta U, 1998, J CELL BIOL, V143, P1647, DOI 10.1083/jcb.143.6.1647; STACK JH, 1994, J BIOL CHEM, V269, P31552; Stenmark H, 1999, J CELL SCI, V112, P4175; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; Virbasius JV, 2001, P NATL ACAD SCI USA, V98, P12908, DOI 10.1073/pnas.221352898; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Yokouchi M, 1999, ONCOGENE, V18, P759, DOI 10.1038/sj.onc.1202326; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757	45	30	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 17	2003	278	42					40425	40428		10.1074/jbc.C300225200	http://dx.doi.org/10.1074/jbc.C300225200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730TX	12941951	hybrid			2022-12-27	WOS:000185847200002
J	Hibbert, AP; Morris, SJ; Seidah, NG; Murphy, RA				Hibbert, AP; Morris, SJ; Seidah, NG; Murphy, RA			Neurotrophin-4, alone or heterodimerized with brain-derived neurotrophic factor, is sorted to the constitutive secretory pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; PROPROTEIN CONVERTASES; PROHORMONE CONVERTASES; REGULATED SECRETION; MAMMALIAN-CELLS; TRK RECEPTORS; RELEASE; BIOSYNTHESIS	Nerve growth factor and neurotrophin-3 (NT-3) are processed within the constitutive secretory pathway of neurons and neuroendocrine cells and are released continuously in an activity-independent fashion. In contrast, brain-derived neurotrophic factor (BDNF) is processed in the regulated secretory pathway, stored in vesicles, and released in response to neuronal activity, consistent with its role in modulating synaptic plasticity. In this study, we used vaccinia virus infection and transfection methods to monitor the processing and sorting of neurotrophin-4 (NT-4) in AtT-20 cells, which have been used as a model for the sorting of secretory proteins in neurons. Our data show that NT-4 is processed in the constitutive secretory pathway. The molecule is diffusely distributed within the cells and released, soon after being synthesized, in a manner that is not affected by cell depolarization. We further show that NT-4 and BDNF, when co-expressed, can form heterodimers that are constitutively released. In contrast, heterodimers of NT-3 and BDNF have been shown to be released through the regulated secretory pathway. Thus, NT-4, alone or when co-expressed with BDNF, is processed within and secreted by the constitutive secretory pathway.	McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; Hosp Sick Children, Dept Dev Biol, Toronto, ON M5G 1X8, Canada; Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Murphy, RA (corresponding author), Salk Inst Biol Studies, Off President, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342				ALDER M, 1983, P NATL ACAD SCI USA, V80, P2086; ARAKAWA T, 1994, J BIOL CHEM, V269, P27833; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; Brechler V, 1996, J BIOL CHEM, V271, P20636, DOI 10.1074/jbc.271.34.20636; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Chen GQ, 1999, J NEUROSCI, V19, P7983; DeBie I, 1996, J CELL BIOL, V135, P1261, DOI 10.1083/jcb.135.5.1261; EDWARDS RH, 1988, MOL CELL BIOL, V8, P2456, DOI 10.1128/MCB.8.6.2456; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Eskeland NL, 1996, J CLIN INVEST, V98, P148, DOI 10.1172/JCI118760; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Fan G, 2000, NAT NEUROSCI, V3, P350, DOI 10.1038/73921; Farhadi HF, 2000, J NEUROSCI, V20, P4059; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEYMACH JV, 1995, J BIOL CHEM, V270, P12297, DOI 10.1074/jbc.270.20.12297; Heymach JV, 1996, J BIOL CHEM, V271, P25430, DOI 10.1074/jbc.271.41.25430; Hruby D E, 1986, Methods Enzymol, V124, P295; Huang C, 1999, J BIOL CHEM, V274, P36707, DOI 10.1074/jbc.274.51.36707; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; JUNG LJ, 1993, J CELL BIOL, V121, P11, DOI 10.1083/jcb.121.1.11; JUNGBLUTH S, 1994, EUR J BIOCHEM, V221, P677, DOI 10.1111/j.1432-1033.1994.tb18780.x; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; Kruttgen A, 1998, P NATL ACAD SCI USA, V95, P9614, DOI 10.1073/pnas.95.16.9614; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; MOORE HP, 1983, J CELL BIOL, V97, P810, DOI 10.1083/jcb.97.3.810; MOORE HPH, 1986, NATURE, V321, P443, DOI 10.1038/321443a0; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; RIDDLE DR, 1995, NATURE, V378, P189, DOI 10.1038/378189a0; Robinson RC, 1999, PROTEIN SCI, V8, P2589; Schober A, 1998, J NEUROSCI, V18, P7272; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Stucky CL, 1998, J NEUROSCI, V18, P7040; TAM WWH, 1993, EUR J CELL BIOL, V62, P294; TREANOR JJS, 1995, J BIOL CHEM, V270, P23104, DOI 10.1074/jbc.270.39.23104; Wang XH, 1998, J NEUROSCI, V18, P4985; Wang XX, 2002, J NEUROSCI, V22, P931, DOI 10.1523/JNEUROSCI.22-03-00931.2002; Xie CW, 2000, P NATL ACAD SCI USA, V97, P8116, DOI 10.1073/pnas.140204597; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	47	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48129	48136		10.1074/jbc.M300961200	http://dx.doi.org/10.1074/jbc.M300961200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12970359	hybrid			2022-12-27	WOS:000186731400094
J	Marsche, G; Zimmermann, R; Horiuchi, S; Tandon, NN; Sattler, W; Malle, E				Marsche, G; Zimmermann, R; Horiuchi, S; Tandon, NN; Sattler, W; Malle, E			Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ATHEROSCLEROTIC LESIONS; MOUSE PERITONEAL-MACROPHAGES; MODIFIED PROTEINS; LIPID-PEROXIDATION; ENDOTHELIAL-CELLS; AFFINITY LIGAND; MODIFIED LDL; CLASS-A; MYELOPEROXIDASE; OXIDATION	The presence of HOCl-modified epitopes inside and outside monocytes/macrophages and the presence of HOCl-modified apolipoprotein B in atherosclerotic lesions has initiated the present study to identify scavenger receptors that bind and internalize HOCl-low density lipoprotein (LDL). The uptake of HOCl-LDL by THP-1 macrophages was not saturable and led to cholesterol/cholesteryl ester accumulation. HOCl-LDL is not aggregated in culture medium, as measured by dynamic light scattering experiments, but internalization of HOCl-LDL could be inhibited in part by cytochalasin D, a microfilament disrupting agent. This indicates that HOCl-LDL is partially internalized by a pathway resembling phagocytosis-like internalization (in part by fluid-phase endocytosis) as measured with [C-14] sucrose uptake. In contrast to uptake studies, binding of HOCl-LDL to THP-1 cells at 4degreesC was specific and saturable, indicating that binding proteins and/or receptors are involved. Competition studies on THP-1 macrophages showed that HOCl-LDL does not compete for the uptake of acetylated LDL (a ligand to scavenger receptor class A) but strongly inhibits the uptake of copper-oxidized LDL (a ligand to CD36 and SR-BI). The binding specificity of HOCl-LDL to class B scavenger receptors could be demonstrated by Chinese hamster ovary cells overexpressing CD36 and SR-BI and specific blocking antibodies. The lipid moiety isolated from the HOCl-LDL particle did not compete for cell association of labeled HOCl-LDL to CD36 or SR-BI, suggesting that the protein moiety of HOCl-LDL is responsible for receptor recognition. Experiments with Chinese hamster ovary cells overexpressing scavenger receptor class A, type I, confirmed that LDL modified at physiologically relevant HOCl concentrations is not recognized by this receptor.	Karl Franzens Univ Graz, Inst Med Biochem & Mol Biol, A-8010 Graz, Austria; Karl Franzens Univ Graz, Inst Biochem Mol Biol & Microbiol, A-8010 Graz, Austria; Kumamoto Univ, Grad Sch Med Sci, Dept Med Biochem, Komamoto 8600811, Japan; Otsuka Amer Pharmaceut Inc, Maryland Res Labs, Rockville, MD 20850 USA	University of Graz; University of Graz; Kumamoto University	Malle, E (corresponding author), Karl Franzens Univ Graz, Inst Med Biochem & Mol Biol, Harrachgasse 21, A-8010 Graz, Austria.	ernst.malle@kfunigraz.ac.at	Malle, Ernst/D-3071-2013	Marsche, Gunther/0000-0002-2422-5381; Zimmermann, Robert/0000-0002-7354-870X				Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Artl A, 2000, ARTERIOSCL THROM VAS, V20, P763, DOI 10.1161/01.ATV.20.3.763; ASHKENAS J, 1993, J LIPID RES, V34, P983; Baldus S, 2001, J CLIN INVEST, V108, P1759; Brasen JH, 2003, ATHEROSCLEROSIS, V166, P13, DOI 10.1016/S0021-9150(02)00130-2; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Carr AC, 2001, REDOX REP, V6, P343, DOI 10.1179/135100001101536526; Chisolm GM, 1999, J BIOL CHEM, V274, P25959, DOI 10.1074/jbc.274.37.25959; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; de Winther MPJ, 2000, ARTERIOSCL THROM VAS, V20, P290, DOI 10.1161/01.ATV.20.2.290; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Gillotte-Taylor K, 2001, J LIPID RES, V42, P1474; Gough PJ, 1999, ARTERIOSCL THROM VAS, V19, P461, DOI 10.1161/01.ATV.19.3.461; Grone HJ, 2002, LAB INVEST, V82, P5, DOI 10.1038/labinvest.3780390; HABERLAND ME, 1984, J BIOL CHEM, V259, P1305; Hammer A, 2001, LAB INVEST, V81, P543, DOI 10.1038/labinvest.3780263; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HAZELL LJ, 1993, BIOCHEM J, V290, P165, DOI 10.1042/bj2900165; HAZELL LJ, 1994, BIOCHEM J, V302, P297, DOI 10.1042/bj3020297; Hazell LJ, 1996, J CLIN INVEST, V97, P1535, DOI 10.1172/JCI118576; Hazen SL, 1999, CIRC RES, V85, P950; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Heinecke JW, 2002, TOXICOLOGY, V177, P11, DOI 10.1016/S0300-483X(02)00192-0; Hirano K, 1999, CIRC RES, V85, P108; Jerlich A, 1998, FREE RADICAL BIO MED, V24, P1139, DOI 10.1016/S0891-5849(97)00439-5; Jones NL, 1999, ANAT REC, V255, P57; KATRANTZIS M, 1991, FREE RADICAL BIO MED, V10, P101, DOI 10.1016/0891-5849(91)90003-L; Kettle AJ, 1997, REDOX REP, V3, P3, DOI 10.1080/13510002.1997.11747085; KHOO JC, 1988, ARTERIOSCLEROSIS, V8, P348, DOI 10.1161/01.ATV.8.4.348; Kopprasch S, 1998, ATHEROSCLEROSIS, V136, P315, DOI 10.1016/S0021-9150(97)00233-5; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Kruth HS, 2002, J BIOL CHEM, V277, P34573, DOI 10.1074/jbc.M205059200; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; LIAO LX, 1995, ARTERIOSCL THROM VAS, V15, P2305, DOI 10.1161/01.ATV.15.12.2305; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Malle E, 2000, EUR J BIOCHEM, V267, P4495, DOI 10.1046/j.1432-1327.2000.01498.x; Malle E, 1997, AM J PATHOL, V150, P603; MALLE E, 1995, ARTERIOSCL THROM VAS, V15, P982, DOI 10.1161/01.ATV.15.7.982; MALLE E, 1995, ARTERIOSCL THROM VAS, V15, P377, DOI 10.1161/01.ATV.15.3.377; Malle E, 2003, KIDNEY INT, V64, P1956, DOI 10.1046/j.1523-1755.2003.00336.x; Malle E, 2001, BIOCHEM BIOPH RES CO, V289, P894, DOI 10.1006/bbrc.2001.6074; Marcinkiewicz J, 1997, IMMUNOL TODAY, V18, P577, DOI 10.1016/S0167-5699(97)01161-4; Marsche G, 2001, FASEB J, V15, P1095, DOI 10.1096/fj.00-0532fje; Marsche G, 2002, J BIOL CHEM, V277, P32172, DOI 10.1074/jbc.M200503200; Matveev S, 1999, J LIPID RES, V40, P1647; Nagai R, 2002, J BIOL CHEM, V277, P48905, DOI 10.1074/jbc.M205688200; Nguyen-Khoa T, 1999, BIOCHEM BIOPH RES CO, V263, P804, DOI 10.1006/bbrc.1999.1438; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; Nuszkowski A, 2001, J BIOL CHEM, V276, P14212, DOI 10.1074/jbc.M007659200; Ohgami N, 2001, J BIOL CHEM, V276, P3195, DOI 10.1074/jbc.M006545200; Opper C, 1998, PLATELETS, V9, P339, DOI 10.1080/09537109876582; Panzenboeck U, 1997, J BIOL CHEM, V272, P29711, DOI 10.1074/jbc.272.47.29711; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Poussin C, 1998, J BIOL CHEM, V273, P20285, DOI 10.1074/jbc.273.32.20285; Scheuer H, 2000, AM J PHYSIOL-RENAL, V278, pF63, DOI 10.1152/ajprenal.2000.278.1.F63; Seastone DJ, 2001, J CELL SCI, V114, P2673; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; SUNG SSJ, 1983, J CELL PHYSIOL, V116, P21, DOI 10.1002/jcp.1041160105; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; SWANSON JA, 1989, J CELL SCI, V94, P135; TANDON NN, 1991, BLOOD, V78, P2809; Wang XS, 1999, BIOCHEM J, V343, P347, DOI 10.1042/0264-6021:3430347; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; Woenckhaus C, 1998, CLIN IMMUNOL IMMUNOP, V86, P27, DOI 10.1006/clin.1997.4453; Yan LJ, 1997, J LIPID RES, V38, P992; Zabe M, 1999, CELL CALCIUM, V26, P281, DOI 10.1054/ceca.1999.0081; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136; Zimmermann R, 2000, BBA-MOL CELL BIOL L, V1484, P316, DOI 10.1016/S1388-1981(00)00024-X	74	59	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47562	47570		10.1074/jbc.M308428200	http://dx.doi.org/10.1074/jbc.M308428200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12968020	hybrid			2022-12-27	WOS:000186731400028
J	Meng, XW; Chandra, J; Loegering, D; Van Becelaere, K; Kottke, TJ; Gore, SD; Karp, JE; Sebolt-Leopold, J; Kaufmann, SH				Meng, XW; Chandra, J; Loegering, D; Van Becelaere, K; Kottke, TJ; Gore, SD; Karp, JE; Sebolt-Leopold, J; Kaufmann, SH			Central role of Fas-associated death domain protein in apoptosis induction by the mitogen-activated protein kinase kinase inhibitor CI-1040 (PD184352) in acute lymphocytic leukemia cells in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; CASPASE ACTIVATION; CONSTITUTIVE ACTIVATION; HUMAN COLON; PHOSPHORYLATION; PATHWAY; HL-60; ETOPOSIDE; GROWTH; TRANSFORMATION	Because the MAPK pathway plays important roles in cell proliferation and inhibition of apoptosis, this pathway has emerged as a potential therapeutic target for solid tumors and leukemia. At the present time there is little information about activation of this pathway and the consequences of its inhibition in acute lymphocytic leukemia cells (ALL). In the present study, constitutive MAPK pathway activation, as evidenced by phosphorylation of ERK1 and ERK2, was observed in 8 of 8 human lymphoid cell lines and 33% (8: 24) of pretreatment ALL bone marrows. Inhibition of this pathway by the MEK inhibitors CI-1040 and PD098059 induced apoptosis through a unique pathway involving dephosphorylation and aggregation of Fas-associated death domain protein followed by death receptor-independent caspase-8 activation. Jurkat cell variants lacking Fas-associated death domain protein or procaspase-8 were resistant to CI-1040-induced apoptosis, as were Jurkat or Molt3 cells treated with the O-methyl ester of the caspase-8 inhibitor N-(N-alpha-benzyloxycarbonylisoleucylglutamyl) aspartate fluoromethyl ketone. In contrast, CI-1040-induced apoptosis was unaffected by blocking anti-Fas antibody, soluble tumor necrosis factor-alpha-related apoptosis-inducing ligand decoy receptor, or transfection with cDNA encoding the anti-apoptotic Bcl-2 family member Mcl-1 or dominant negative caspase-9. Collectively, these results identify the MAPK pathway as a potential therapeutic target in ALL and delineate a mechanism by which MEK inhibition triggers apoptosis in ALL cells.	Mayo Clin & Mayo Fdn, Div Oncol Res, Rochester, MN 55905 USA; Mayo Grad Sch, Dept Mol Pharmacol, Rochester, MN 55905 USA; Pfizer Inc, Global Res & Dev, Canc Mol Sci Dept, Ann Arbor, MI 48105 USA; Sidney Kimmel Johns Hopkins Oncol Ctr, Baltimore, MD 21287 USA	Mayo Clinic; Mayo Clinic; Pfizer; Johns Hopkins University; Johns Hopkins Medicine	Kaufmann, SH (corresponding author), Mayo Clin & Mayo Fdn, Div Oncol Res, Guggenheim 1342 C,200 1st St SW, Rochester, MN 55905 USA.	Kaufmann.Scott@Mayo.edu		Kaufmann, Scott/0000-0002-4900-7145	NATIONAL CANCER INSTITUTE [F32CA093055, R01CA069008] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 69008, F32 CA 93055, R01 CA069008, F32 CA093055] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Altucci L, 2001, NAT MED, V7, P680, DOI 10.1038/89050; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Bible KC, 1997, CANCER RES, V57, P3375; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.0.CO;2-0; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; Condorelli F, 2001, MOL CELL BIOL, V21, P3025, DOI 10.1128/MCB.21.9.3025-3036.2001; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Deng XM, 2000, P NATL ACAD SCI USA, V97, P1578, DOI 10.1073/pnas.97.4.1578; Dent P, 2001, CLIN CANCER RES, V7, P775; Domina AM, 2000, J BIOL CHEM, V275, P21688, DOI 10.1074/jbc.M000915200; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Eischen CM, 1997, BLOOD, V90, P935, DOI 10.1182/blood.V90.3.935.935_935_943; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; English JM, 2002, TRENDS PHARMACOL SCI, V23, P40, DOI 10.1016/S0165-6147(00)01865-4; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Grandgirard D, 1998, EMBO J, V17, P1268, DOI 10.1093/emboj/17.5.1268; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; Hoshino R, 2001, J BIOL CHEM, V276, P2686, DOI 10.1074/jbc.M006132200; Huang Y, 2001, CANCER RES, V61, P6918; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Karnes WE, 1998, GASTROENTEROLOGY, V114, P930, DOI 10.1016/S0016-5085(98)70312-9; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Kaufmann SH, 1997, BLOOD, V89, P2098, DOI 10.1182/blood.V89.6.2098; Kaufmann SH, 1996, LEUKEMIA LYMPHOMA, V23, P71, DOI 10.3109/10428199609054804; Kaufmann SH, 1998, METH MOL B, V80, P223; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kim SC, 1999, BLOOD, V93, P3893, DOI 10.1182/blood.V93.11.3893.407k14_3893_3899; Kottke TJ, 2002, J BIOL CHEM, V277, P804, DOI 10.1074/jbc.M108419200; LaVallee TM, 2003, CANCER RES, V63, P468; Litzow M R, 2000, Curr Treat Options Oncol, V1, P19, DOI 10.1007/s11864-000-0012-2; LORUSSO PM, 2002, P AN M AM SOC CLIN, V21, P81; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Martin TG, 2001, HEMATOL ONCOL CLIN N, V15, P97, DOI 10.1016/S0889-8588(05)70201-X; Martins LM, 1997, BLOOD, V90, P4283, DOI 10.1182/blood.V90.11.4283.4283_4283_4296; Martins LM, 1997, J BIOL CHEM, V272, P7421, DOI 10.1074/jbc.272.11.7421; MeighanMantha RL, 1997, EXP CELL RES, V234, P321, DOI 10.1006/excr.1997.3631; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; Mesner PW, 1999, J BIOL CHEM, V274, P22635, DOI 10.1074/jbc.274.32.22635; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; OKUDA K, 1992, BLOOD, V79, P2880; Perkins C, 1998, CANCER RES, V58, P4561; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Roos-Mattjus P, 2002, J BIOL CHEM, V277, P43809, DOI 10.1074/jbc.M207272200; Sagata N, 2002, SCIENCE, V298, P1905, DOI 10.1126/science.1079225; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Scheid MP, 1998, P NATL ACAD SCI USA, V95, P7439, DOI 10.1073/pnas.95.13.7439; Scheid MP, 1999, J BIOL CHEM, V274, P31108, DOI 10.1074/jbc.274.43.31108; Schubert KM, 2001, BIOCHEM J, V356, P473, DOI 10.1042/0264-6021:3560473; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Sebolt-Leopold JS, 2000, ONCOGENE, V19, P6594, DOI 10.1038/sj.onc.1204083; SETH A, 1991, J BIOL CHEM, V266, P23521; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stahnke K, 2001, BLOOD, V98, P3066, DOI 10.1182/blood.V98.10.3066; Svingen PA, 2000, CLIN CANCER RES, V6, P237; Thorburn J, 2003, CLIN CANCER RES, V9, P861; Tillman DM, 1999, CLIN CANCER RES, V5, P425; Towatari M, 1997, LEUKEMIA, V11, P479, DOI 10.1038/sj.leu.2400617; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Velders MP, 2001, LEUKEMIA, V15, P701, DOI 10.1038/sj.leu.2402103; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; WELHAM MJ, 1992, J IMMUNOL, V149, P1683; YONEHARA S, 1994, INT IMMUNOL, V6, P1849, DOI 10.1093/intimm/6.12.1849	85	44	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47326	47339		10.1074/jbc.M304793200	http://dx.doi.org/10.1074/jbc.M304793200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963734	hybrid			2022-12-27	WOS:000186569400135
J	Sullivan, DC; Huminiecki, L; Moore, JW; Boyle, JJ; Poulsom, R; Creamer, D; Barker, J; Bicknell, R				Sullivan, DC; Huminiecki, L; Moore, JW; Boyle, JJ; Poulsom, R; Creamer, D; Barker, J; Bicknell, R			EndoPDI, a novel protein-disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT REDUCTASE ERP57; GENE-EXPRESSION; UP-REGULATION; THIOREDOXIN; ADRENOMEDULLIN; IDENTIFICATION; CHAPERONE; DOMAINS; GROWTH; APOPTOSIS	We have identified a novel protein-disulfide isomerase and named it endothelial protein-disulfide isomerase (EndoPDI) because of its high expression in endothelial cells. Isolation of the full-length cDNA showed EndoPDI to be a 48 kDa protein that has three APWCGHC thioredoxin motifs in contrast to the two present in archetypal PDI. Ribonuclease protection and Western analysis has shown that hypoxia induces EndoPDI mRNA and protein expression. In situ hybridization analysis showed that EndoPDI expression is rare in normal tissues, except for keratinocytes of the hair bulb and syncytiotrophoblasts of the placenta, but was present in the endothelium of tumors and in other hypoxic lesions such as atherosclerotic plaques. We have compared the function of EndoPDI to that of PDI in endothelial cells using specific siRNA. PDI was shown to have a protective effect on endothelial cells under both normoxia and hypoxia. In contrast, EndoPDI has a protective effect only in endothelial cells exposed to hypoxia. The loss of EndoPDI expression under hypoxia caused a significant decrease in the secretion of adrenomedullin, endothelin-1, and CD105; molecules that protect endothelial cells from hypoxia-initiated apoptosis. The identification of an endothelial PDI further extends this increasing multigene family and EndoPDI, unlike archetypal PDI, may be a molecule with which to target tumor endothelium.	Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Canc Res UK,Mol Angiogenesis Lab, Oxford OX3 9DS, England; Univ Dublin Trinity Coll, Dept Genet, Mol Evolut Lab, Dublin 2, Ireland; Univ London, Hammersmith Hosp, Imperial Coll Med Sch, Dept Histol, London W12 0NN, England; London Res Inst, Canc Res UK, In Situ Hybridizat Lab, London WC2A 3PX, England; Kings Coll Hosp London, Sch Med & Dent, London SE5 9RS, England; Kings Coll London, St Thomass Hosp, St Johns Inst Dermatol, London SE1 7EH, England	Cancer Research UK; University of Oxford; Trinity College Dublin; Imperial College London; University of London; Cancer Research UK; King's College Hospital NHS Foundation Trust; King's College Hospital; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Bicknell, R (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Canc Res UK,Mol Angiogenesis Lab, Oxford OX3 9DS, England.	Roy.Bicknell@cancer.org.uk		Huminiecki, Lukasz/0000-0003-1943-4450; Barker, Jonathan/0000-0002-9030-183X; Bicknell, Roy/0000-0002-0941-8919				ADAMS MD, 1995, NATURE, V377, P3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bjornheden T, 1999, ARTERIOSCL THROM VAS, V19, P870, DOI 10.1161/01.ATV.19.4.870; Claudio JO, 2002, BLOOD, V100, P2175, DOI 10.1182/blood-2002-01-0008; Clissold PM, 2003, BIOESSAYS, V25, P603, DOI 10.1002/bies.10287; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; DeSilva MG, 1997, DNA CELL BIOL, V16, P269, DOI 10.1089/dna.1997.16.269; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Elliott JG, 1997, J BIOL CHEM, V272, P13849, DOI 10.1074/jbc.272.21.13849; Freedman RB, 1998, CURR BIOL, V8, pR468, DOI 10.1016/S0960-9822(98)70295-7; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Graven KK, 1998, J LAB CLIN MED, V132, P456, DOI 10.1016/S0022-2143(98)90122-6; Graven KK, 2002, AM J PHYSIOL-LUNG C, V282, pL996, DOI 10.1152/ajplung.00359.2001; HAWKINS HC, 1991, BIOCHEM J, V275, P335, DOI 10.1042/bj2750335; Ho M, 2003, PHYSIOL GENOMICS, V13, P249, DOI 10.1152/physiolgenomics.00186.2002; Huminiecki L, 2000, GENOME RES, V10, P1796, DOI 10.1101/gr.150700; JOHN DCA, 1993, EMBO J, V12, P1587, DOI 10.1002/j.1460-2075.1993.tb05803.x; Koivunen P, 1999, EMBO J, V18, P65, DOI 10.1093/emboj/18.1.65; KOUREMBANAS S, 1991, J CLIN INVEST, V88, P1054, DOI 10.1172/JCI115367; LAMANTIA ML, 1993, CELL, V74, P899, DOI 10.1016/0092-8674(93)90469-7; Lash AE, 2000, GENOME RES, V10, P1051, DOI 10.1101/gr.10.7.1051; Li CG, 2003, J CELL SCI, V116, P2677, DOI 10.1242/jcs.00470; LYLES MM, 1994, J BIOL CHEM, V269, P30946; McLaughlin SH, 1998, BIOCHEM J, V331, P793, DOI 10.1042/bj3310793; Miller MJ, 1996, J BIOL CHEM, V271, P23345; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Oehler MK, 2001, ONCOGENE, V20, P2937, DOI 10.1038/sj.onc.1204422; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Poulsom R, 1998, EUR J HISTOCHEM, V42, P121; Shichiri M, 1997, HYPERTENSION, V30, P1198, DOI 10.1161/01.HYP.30.5.1198; SUGO S, 1994, BIOCHEM BIOPH RES CO, V201, P1160, DOI 10.1006/bbrc.1994.1827; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; Tucci M, 1996, AM J PHYSIOL-LUNG C, V271, pL341, DOI 10.1152/ajplung.1996.271.3.L341; VAUPEL P, 1990, ADV EXP MED BIOL, V277, P895; Volkmer J, 1997, FEBS LETT, V406, P291, DOI 10.1016/S0014-5793(97)00288-3; Witte S, 2000, J BIOL CHEM, V275, P1902, DOI 10.1074/jbc.275.3.1902; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317; Yao Y, 1997, EMBO J, V16, P651, DOI 10.1093/emboj/16.3.651	40	142	153	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47079	47088		10.1074/jbc.M308124200	http://dx.doi.org/10.1074/jbc.M308124200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963716	hybrid			2022-12-27	WOS:000186569400105
J	French, CA; Tambini, CE; Thacker, J				French, CA; Tambini, CE; Thacker, J			Identification of functional domains in the RAD51L2 (RAD51C) protein and its requirement for gene conversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNALS; HOMOLOGY-DIRECTED REPAIR; DNA STRAND EXCHANGE; ATP BINDING-SITE; P-LOOP MOTIF; RECA PROTEIN; SACCHAROMYCES-CEREVISIAE; RECOMBINATIONAL REPAIR; CROSS-SENSITIVITY; COMPLEX-FORMATION	The RAD51 protein plays a key part in the process of homologous recombination through its catalysis of homologous DNA pairing and strand exchange. Additionally five novel mammalian RAD51-like proteins have been identified in mammalian cells, but their roles in homologous recombination are much less well established. These RAD51-like proteins form two different complexes, but only the RAD51L2 (RAD51C) protein is a part of both complexes. By using site-directed mutagenesis of RAD51L2, we show that non-conservative mutation of the putative ATP-binding domain severely reduces its function, whereas a conservative mutation shows partial loss of function. We find that the protein is localized to the nucleus by tagging RAD51L2 with the green fluorescent protein and provisionally identify a C-terminal domain that acts as a nuclear localization signal. Further, a RAD51L2-deficient cell line was found to have significantly reduced homology-directed repair of a DNA double-strand break by gene conversion. This recombination defect could be partially restored by ectopic expression of the human RAD51L2 protein. Therefore we have identified protein domains that are important for the correct functioning of RAD51L2 and have shown that there is a specific requirement for RAD51L2 in gene conversion in mammalian cells.	MRC, Radiat & Genome Stabil Unit, Didcot OX11 0RD, Oxon, England	MRC Harwell	Thacker, J (corresponding author), MRC, Radiat & Genome Stabil Unit, Didcot OX11 0RD, Oxon, England.			French, Catherine/0000-0003-2072-8413				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BOULIKAS T, 1994, J CELL BIOCHEM, V55, P32, DOI 10.1002/jcb.240550106; Brenneman MA, 2002, MOL CELL, V10, P387, DOI 10.1016/S1097-2765(02)00595-6; CALDECOTT K, 1991, MUTAT RES, V255, P111, DOI 10.1016/0921-8777(91)90046-R; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Dosanjh MK, 1998, NUCLEIC ACIDS RES, V26, P1179, DOI 10.1093/nar/26.5.1179; French CA, 2002, J BIOL CHEM, V277, P19322, DOI 10.1074/jbc.M201402200; Godthelp BC, 2002, NUCLEIC ACIDS RES, V30, P2172, DOI 10.1093/nar/30.10.2172; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; JOHNSON RD, 1995, MOL CELL BIOL, V15, P4843; JONES NJ, 1987, MUTAT RES, V183, P279, DOI 10.1016/0167-8817(87)90011-3; KONOLA JT, 1994, J MOL BIOL, V237, P20, DOI 10.1006/jmbi.1994.1206; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Leasure CS, 2001, GENE, V271, P59, DOI 10.1016/S0378-1119(01)00498-X; Lio YC, 2003, J BIOL CHEM, V278, P2469, DOI 10.1074/jbc.M211038200; Liu N, 2002, NUCLEIC ACIDS RES, V30, P1009, DOI 10.1093/nar/30.4.1009; LOGAN KM, 1993, J MOL BIOL, V232, P1048, DOI 10.1006/jmbi.1993.1459; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; Miller KA, 2002, J BIOL CHEM, V277, P8406, DOI 10.1074/jbc.M108306200; Morrison C, 1999, MOL CELL BIOL, V19, P6891; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; O'Regan P, 2001, J BIOL CHEM, V276, P22148, DOI 10.1074/jbc.M102396200; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; SUGAWARA N, 1995, NATURE, V373, P84, DOI 10.1038/373084a0; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Thacker J, 1999, TRENDS GENET, V15, P166, DOI 10.1016/S0168-9525(99)01733-3; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wiese C, 2002, NUCLEIC ACIDS RES, V30, P1001, DOI 10.1093/nar/30.4.1001; Yokoyama H, 2003, J BIOL CHEM, V278, P2767, DOI 10.1074/jbc.M210899200	41	42	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45445	45450		10.1074/jbc.M308621200	http://dx.doi.org/10.1074/jbc.M308621200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12966089	hybrid			2022-12-27	WOS:000186452300049
J	Rigas, AC; Ozanne, DM; Neal, DE; Robson, CN				Rigas, AC; Ozanne, DM; Neal, DE; Robson, CN			The scaffolding protein RACK1 interacts with androgen receptor and promotes cross-talk through a protein kinase C signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; LIGAND-INDEPENDENT ACTIVATION; PROSTATE-SPECIFIC ANTIGEN; ADENOCARCINOMA CELL-LINE; ESTROGEN-RECEPTOR; GENE-EXPRESSION; BETA-SUBUNIT; INTRACELLULAR RECEPTOR; PROGESTERONE-RECEPTOR; TRANSDUCTION PATHWAYS	The androgen receptor (AR), a member of the nuclear hormone receptor superfamily, functions as a ligand-dependent transcription factor that regulates genes involved in cell proliferation and differentiation. Using a C-terminal region of the human AR in a yeast two-hybrid screen, we have identified RACK1 (receptor for activated C kinase-1) as an AR-interacting protein. In this report we found that RACK1, which was previously shown to be a protein kinase C (PKC)-anchoring protein that determines the localization of activated PKCbetaII isoform, facilitates ligand-independent AR nuclear translocation upon PKC activation by indolactam V. We also observed RACK1 to suppress ligand-dependent and -independent AR transactivation through PKC activation. In chromatin immunoprecipitation assays, we demonstrate a decrease in AR recruitment to the AR-responsive prostate-specific antigen (PSA) promoter following stimulation of PKC. Furthermore, prolonged exposure to indolactam V, a PKC activator, caused a reduction in PSA mRNA expression in prostate cancer LNCaP cells. Finally, we found PKC activation to have a repressive effect on AR and PSA protein expression in androgen-treated LNCaP cells. Our data suggest that RACK1 may function as a scaffold for the association and modification of AR by PKC enabling translocation of AR to the nucleus but rendering AR unable to activate transcription of its target genes.	Univ Newcastle Upon Tyne, Sch Surg & Reprod Sci, Prostate Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Cambridge, Addenbrookes Hosp, Ctr Oncol, Cambridge CB2 3QQ, England	Newcastle University - UK; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Robson, CN (corresponding author), Univ Newcastle Upon Tyne, Sch Surg & Reprod Sci, Prostate Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.			Neal, David/0000-0002-6033-5086				ANDREWS PE, 1992, CANCER RES, V52, P1525; ARONICA SM, 1991, ENDOCRINOLOGY, V128, P2045, DOI 10.1210/endo-128-4-2045; ARONICA SM, 1993, MOL ENDOCRINOL, V7, P743, DOI 10.1210/me.7.6.743; Baumann M, 2000, EUR J BIOCHEM, V267, P3891, DOI 10.1046/j.1432-1327.2000.01430.x; Besson A, 2002, J BIOL CHEM, V277, P22073, DOI 10.1074/jbc.M111644200; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; CULIG Z, 1994, CANCER RES, V54, P5474; Darne C, 1998, EUR J BIOCHEM, V256, P541, DOI 10.1046/j.1432-1327.1998.2560541.x; DERUITER PE, 1995, MOL CELL ENDOCRINOL, V110, pR1, DOI 10.1016/0303-7207(95)03534-E; FARRELL PJ, 1989, EMBO J, V8, P127, DOI 10.1002/j.1460-2075.1989.tb03356.x; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Georget V, 1997, MOL CELL ENDOCRINOL, V129, P17, DOI 10.1016/S0303-7207(97)04034-3; Gnanapragasam VJ, 2000, BJU INT, V86, P1001, DOI 10.1046/j.1464-410x.2000.00943.x; Han J, 2002, MOL CELLS, V14, P420; He DY, 2002, MOL PHARMACOL, V62, P272, DOI 10.1124/mol.62.2.272; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; IGNARTROWBRIDGE DM, 1993, MOL ENDOCRINOL, V7, P992, DOI 10.1210/me.7.8.992; IKONEN T, 1994, ENDOCRINOLOGY, V135, P1359, DOI 10.1210/en.135.4.1359; Jenster G, 1999, SEMIN ONCOL, V26, P407; Kiely PA, 2002, J BIOL CHEM, V277, P22581, DOI 10.1074/jbc.M201758200; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Loy CJ, 2003, P NATL ACAD SCI USA, V100, P4562, DOI 10.1073/pnas.0736237100; Lu ML, 2001, J BIOL CHEM, V276, P13442, DOI 10.1074/jbc.M006598200; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; MOCHLYROSEN D, 1991, P NATL ACAD SCI USA, V88, P3997, DOI 10.1073/pnas.88.9.3997; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; NEWTON CJ, 1994, J STEROID BIOCHEM, V48, P481, DOI 10.1016/0960-0760(94)90197-X; Orio F, 2002, MOL CELL ENDOCRINOL, V198, P105, DOI 10.1016/S0303-7207(02)00374-X; Ozaki T, 2003, ONCOGENE, V22, P3231, DOI 10.1038/sj.onc.1206382; Ozanne DM, 2000, MOL ENDOCRINOL, V14, P1618, DOI 10.1210/me.14.10.1618; Picard D, 1997, BIOCHEM SOC T, V25, P597, DOI 10.1042/bst0250597; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Ron D, 2000, FASEB J, V14, P2303, DOI 10.1096/fj.00-0143com; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Schlegel A, 2001, BIOCHEM J, V359, P203, DOI 10.1042/0264-6021:3590203; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; Ting HJ, 2002, P NATL ACAD SCI USA, V99, P661, DOI 10.1073/pnas.022469899; TURGEON JL, 1994, MOL ENDOCRINOL, V8, P860, DOI 10.1210/me.8.7.860; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; Usacheva A, 2001, J BIOL CHEM, V276, P22948, DOI 10.1074/jbc.M100087200; VANDERVOORN L, 1992, FEBS LETT, V307, P131, DOI 10.1016/0014-5793(92)80751-2; Wang X, 2002, J BIOL CHEM, V277, P15426, DOI 10.1074/jbc.M111218200; Weigel NL, 1996, BIOCHEM J, V319, P657, DOI 10.1042/bj3190657; Wen Y, 2000, CANCER RES, V60, P6841; Wu DQ, 2002, CANCER RES, V62, P2423; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Yang L, 2003, J BIOL CHEM, V278, P16820, DOI 10.1074/jbc.M213163200; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; YOUNG CYF, 1994, ONCOL RES, V6, P203	55	42	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46087	46093		10.1074/jbc.M306219200	http://dx.doi.org/10.1074/jbc.M306219200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12958311	hybrid			2022-12-27	WOS:000186452300126
J	Takeuchi, N; Ueda, T				Takeuchi, N; Ueda, T			Down-regulation of the mitochondrial translation system during terminal differentiation of HL-60 cells by 12-O-tetradecanoyl-1-phorbol-13-acetate - Comparison with the cytoplasmic translation system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOID-LEUKEMIA CELLS; CHICK-EMBRYO CELLS; HUMAN POLYNUCLEOTIDE PHOSPHORYLASE; KINASE C-BETA; PROTEIN-SYNTHESIS; MYOBLAST DIFFERENTIATION; RESPIRATION-DEFICIENT; GENE-EXPRESSION; TRANSCRIPTION FACTOR; ETHIDIUM-BROMIDE	Mitochondrial (mt) biogenesis depends on both the nuclear and mt genomes, and a coordination of these two genetic systems is necessary for proper cell functioning. Little is known about the regulatory mechanisms of mt translation or about the expression of mt translation factors. Here, we studied the expression of mt translation factors during 12-O-tetradecanoyl-1-phorbol-13-acetate (TPA)-induced terminal differentiation of HL-60 cells. For all mt translation factors investigated, mRNA expression was markedly downregulated in a coordinate and specific manner, whereas mRNA levels for the cytoplasmic translation factors showed only a slight reduction. An actinomycin D chase study and nuclear run-on assay revealed that the TPA-induced decrease in mt elongation factor Tu (EF-Tumt) mRNA mainly results from decreased mRNA stability. Polysome analysis showed that there was no significant translational control of mt translation factor (EF-Tumt, ribosomal proteins L7/L12mt and S12mt) mRNA expression during differentiation. Thus, the decreased protein level of one of these mt translation factors (EF-Tumt) simply reflects its decreased mRNA level. It was also demonstrated by pulse labeling of mt translation products that the down-regulation of mt translational activity is actually associated with down-regulated mt translation factor expression during cellular differentiation. Our results illustrate that the regulatory mechanisms of mt translational activity upon terminal differentiation ( in response to the growth arrest) is different to that of the cytoplasmic system, where the control of mRNA translational efficiency of major translation factors is the central mechanism for their down-regulation.	Univ Tokyo, Grad Sch Frontier Sci, Dept Integrat Biosci, Kashiwa, Chiba 2778562, Japan	University of Tokyo	Takeuchi, N (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrat Biosci, Bldg FSB-401,5-1-5 Kashiwanoha, Kashiwa, Chiba 2778562, Japan.		Ueda, Takuya/K-5217-2014	Ueda, Takuya/0000-0002-7760-8271				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BATTINI R, 1987, J BIOL CHEM, V262, P4355; BIRNIE GD, 1988, BRIT J CANCER, V58, P41; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; COLLINS SJ, 1980, INT J CANCER, V25, P213, DOI 10.1002/ijc.2910250208; ENGLAND JM, 1978, J MOL BIOL, V119, P455, DOI 10.1016/0022-2836(78)90226-7; GREENBERG ME, 1997, CURRENT PROTOCOLS MO, V1; GREGOIRE M, 1984, EUR J BIOCHEM, V142, P49, DOI 10.1111/j.1432-1033.1984.tb08249.x; Hamai N, 1997, CELL STRUCT FUNCT, V22, P421, DOI 10.1247/csf.22.421; HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584; He HP, 2001, CIRC RES, V89, P461, DOI 10.1161/hh1701.096038; HERZBERG NH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P63, DOI 10.1016/0925-4439(93)90091-E; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Ito Y, 2001, CELL DEATH DIFFER, V8, P794, DOI 10.1038/sj.cdd.4400886; Juan HF, 2002, ELECTROPHORESIS, V23, P2490, DOI 10.1002/1522-2683(200208)23:15<2490::AID-ELPS2490>3.0.CO;2-3; KANEKO T, 1988, MOL CELL BIOL, V8, P3311, DOI 10.1128/MCB.8.8.3311; KOROHODA W, 1993, FOLIA HISTOCHEM CYTO, V31, P9; Krichevsky AM, 1999, J BIOL CHEM, V274, P14295, DOI 10.1074/jbc.274.20.14295; LAENG H, 1988, EXP CELL RES, V179, P222, DOI 10.1016/0014-4827(88)90361-8; LANSMAN RA, 1975, J MOL BIOL, V99, P761, DOI 10.1016/S0022-2836(75)80183-5; Laouar A, 2001, MOL CARCINOGEN, V32, P195, DOI 10.1002/mc.10012; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; LEBLONDLAROUCHE L, 1979, J GEN VIROL, V44, P323, DOI 10.1099/0022-1317-44-2-323; Leszczyniecka M, 2002, P NATL ACAD SCI USA, V99, P16636, DOI 10.1073/pnas.252643699; Lin KM, 2002, LEUKEMIA, V16, P1143, DOI 10.1038/sj.leu.2402514; Luciakova K, 2003, J BIOL CHEM, V278, P30624, DOI 10.1074/jbc.M303530200; MACFARLANE DE, 1994, J BIOL CHEM, V269, P4327; Mariottini P, 1999, J BIOL CHEM, V274, P31853, DOI 10.1074/jbc.274.45.31853; MARTIN SJ, 1990, J IMMUNOL, V145, P1859; Marty L, 1996, J BIOL CHEM, V271, P11468, DOI 10.1074/jbc.271.19.11468; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; MORAIS R, 1980, BIOCHEM BIOPH RES CO, V94, P71, DOI 10.1016/S0006-291X(80)80189-6; Orrenius S, 1997, CELL DEATH DIFFER, V4, P427, DOI 10.1038/sj.cdd.4400272; Pandey P, 2000, ONCOGENE, V19, P3941, DOI 10.1038/sj.onc.1203751; Piwowarski J, 2003, J MOL BIOL, V329, P853, DOI 10.1016/S0022-2836(03)00528-X; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Rochard P, 1996, J CELL PHYSIOL, V168, P239, DOI 10.1002/(SICI)1097-4652(199608)168:2<239::AID-JCP2>3.0.CO;2-Q; Ruan H, 1997, MRNA FORMATION FUNCT, P305, DOI 10.1016/B978-012587545-5/50017-; SAGOH T, 1988, ARCH BIOCHEM BIOPHYS, V262, P599, DOI 10.1016/0003-9861(88)90411-0; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; TONETTI DA, 1994, J BIOL CHEM, V269, P23230; TSIFTSOGLOU AS, 1985, INT J CELL CLONING, V3, P349, DOI 10.1002/stem.5530030602; VANDENBOGERT C, 1992, J CELL PHYSIOL, V152, P632, DOI 10.1002/jcp.1041520323; VAYSSIERE JL, 1992, IN VITRO CELL DEV-AN, V28A, P763; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Xu J, 1999, ONCOL RES, V11, P429; Zheng X, 2002, NUCLEIC ACIDS RES, V30, P4489, DOI 10.1093/nar/gkf580	50	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45318	45324		10.1074/jbc.M307620200	http://dx.doi.org/10.1074/jbc.M307620200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952954	hybrid			2022-12-27	WOS:000186452300034
J	Mizoguchi, Y; Kanematsu, T; Hirata, M; Nabekura, J				Mizoguchi, Y; Kanematsu, T; Hirata, M; Nabekura, J			A rapid increase in the total number of cell surface functional GABA(A) receptors induced by brain-derived neurotrophic factor in rat visual cortex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CA2+ ELEVATION; CRITICAL-PERIOD; DOWN-REGULATION; MESSENGER-RNA; NEURONS; BDNF; CURRENTS; INHIBITION; POTENTIATION; EXPRESSION	The number of postsynaptic gamma-aminobutyric acid type A (GABA(A)) receptors is a fundamental determinant of the variability of inhibitory synaptic responses in the central nervous system. In rat visual cortex, [H-3] SR-95531 binding assays revealed that brain-derived neurotrophic factor (BDNF), one of the neurotrophins, induced a rapid increase in the total number of cell surface GABA(A) receptors, through the activation of Trk B receptor tyrosine kinases. We also demonstrated that BDNF rapidly induced a sustained potentiation of GABA(A) receptor-mediated currents, using nystatin-perforated patch clamp recordings, in visual cortical layer 5 pyramidal neurons freshly isolated from P14 rats. The potentiation was caused by the activation of Trk B receptor tyrosine kinase and phospholipase C-gamma. In addition, intracellular Ca2+ was important for the potentiation of GABA(A) responses induced by BDNF. The selective increase in mean miniature inhibitory postsynaptic (mIPSC) current amplitude without effects on mIPSC time courses supports the idea that BDNF rapidly induces an increase in the total number of cell surface functional GABA(A) receptors in visual cortical pyramidal neurons. These results suggest that BDNF could alter the number of cell surface GABA(A) receptors in a region-specific manner.	Kyushu Univ, Grad Sch Med Sci, Fukuoka 8128582, Japan; Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan; Kyushu Univ, Stn Collaborat Res, Fukuoka 8128582, Japan	Kyushu University; Kyushu University; Kyushu University	Nabekura, J (corresponding author), Kyushu Univ, Grad Sch Med Sci, Fukuoka 8128582, Japan.	nabekura@mailserver.med.kyushu-u.ac.jp						Aguayo LG, 1998, PFLUG ARCH EUR J PHY, V435, P382, DOI 10.1007/s004240050527; Akaike N, 2003, TRENDS PHARMACOL SCI, V24, P44, DOI 10.1016/S0165-6147(02)00010-X; ALICKE B, 1995, J NEUROCHEM, V65, P2808; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; BERNINGER B, 1993, NEUROREPORT, V4, P1303, DOI 10.1097/00001756-199309150-00004; BOURGUIGNON JJ, 1985, PHARMACOLOGIST, V27, P518; BOZZI Y, 1995, NEUROSCIENCE, V69, P1133, DOI 10.1016/0306-4522(95)00321-9; Brunig I, 2001, EUR J NEUROSCI, V13, P1320, DOI 10.1046/j.0953-816x.2001.01506.x; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Capsoni S, 1999, NEUROSCIENCE, V93, P1033, DOI 10.1016/S0306-4522(99)00240-7; Cellerino A, 1996, EUR J NEUROSCI, V8, P1190, DOI 10.1111/j.1460-9568.1996.tb01287.x; CHEN QX, 1990, J PHYSIOL-LONDON, V420, P207, DOI 10.1113/jphysiol.1990.sp017908; Cheng Q, 2003, J PHYSIOL-LONDON, V548, P711, DOI 10.1113/jphysiol.2002.037846; Cherubini E, 2001, TRENDS NEUROSCI, V24, P155, DOI 10.1016/S0166-2236(00)01724-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Feldman DE, 2000, NAT NEUROSCI, V3, P303, DOI 10.1038/73849; FELDMAN ML, 1978, J COMP NEUROL, V179, P761, DOI 10.1002/cne.901790406; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Hajos N, 2000, EUR J NEUROSCI, V12, P810, DOI 10.1046/j.1460-9568.2000.00964.x; Hashimoto T, 1996, J PHYSIOL-LONDON, V497, P611, DOI 10.1113/jphysiol.1996.sp021794; Hata Y, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-03-j0002.2000; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; INOUE M, 1986, NATURE, V324, P156, DOI 10.1038/324156a0; Kakazu Y, 2000, J NEUROPHYSIOL, V84, P281, DOI 10.1152/jn.2000.84.1.281; Kakazu Y, 1999, J NEUROSCI, V19, P2843; Kano M, 1996, P NATL ACAD SCI USA, V93, P13351, DOI 10.1073/pnas.93.23.13351; Katz LC, 1999, CELL, V99, P673, DOI 10.1016/S0092-8674(00)81665-7; Keller AF, 2001, J NEUROSCI, V21, P7871, DOI 10.1523/JNEUROSCI.21-20-07871.2001; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kittler JT, 2000, J NEUROSCI, V20, P7972; KNUSEL B, 1992, J NEUROCHEM, V59, P1987; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; MICHAELS RL, 1990, J NEUROSCI, V10, P283; Mizoguchi Y, 2003, NEUROREPORT, V14, P1481, DOI 10.1097/00001756-200308060-00015; Mizoguchi Y, 2003, J PHYSIOL-LONDON, V548, P703, DOI 10.1113/jphysiol.2003.038935; Mizoguchi Y, 2002, EUR J NEUROSCI, V16, P1417, DOI 10.1046/j.1460-9568.2002.02198.x; MURASE K, 1990, BRAIN RES, V525, P84, DOI 10.1016/0006-8993(90)91323-9; Nabekura J, 1996, J NEUROPHYSIOL, V76, P2447, DOI 10.1152/jn.1996.76.4.2447; Nabekura J, 2002, J NEUROSCI, V22, P4412, DOI 10.1523/JNEUROSCI.22-11-04412.2002; OTIS TS, 1994, P NATL ACAD SCI USA, V91, P7698, DOI 10.1073/pnas.91.16.7698; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Perrais D, 1999, J NEUROSCI, V19, P578; PETERS A, 1985, J COMP NEUROL, V234, P218, DOI 10.1002/cne.902340208; Rhee JS, 1999, J NEUROCHEM, V72, P800, DOI 10.1046/j.1471-4159.1999.0720800.x; ROGERS CJ, 1994, J PHYSIOL-LONDON, V475, P69, DOI 10.1113/jphysiol.1994.sp020050; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; Tanaka T, 1997, J NEUROSCI, V17, P2959; TAPLEY P, 1992, ONCOGENE, V7, P371; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Tropea D, 2001, EUR J NEUROSCI, V13, P709, DOI 10.1046/j.0953-816x.2000.01436.x; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; WIDMER HR, 1993, J NEUROCHEM, V60, P2111, DOI 10.1111/j.1471-4159.1993.tb03496.x; YULE DI, 1992, J BIOL CHEM, V267, P13830; ZIVIN JA, 1982, LIFE SCI, V30, P1407, DOI 10.1016/0024-3205(82)90554-9	59	51	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44097	44102		10.1074/jbc.M305872200	http://dx.doi.org/10.1074/jbc.M305872200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941963	hybrid			2022-12-27	WOS:000186306700027
J	Shindo, K; Takaori-Kondo, A; Kobayashi, M; Abudu, A; Fukunaga, K; Uchiyama, T				Shindo, K; Takaori-Kondo, A; Kobayashi, M; Abudu, A; Fukunaga, K; Uchiyama, T			The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA EDITING ENZYME; HUMAN-IMMUNODEFICIENCY-VIRUS; CYTIDINE DEAMINASE AID; VIRAL VIF PROTEIN; CATALYTIC SUBUNIT; DNA; HYPERMUTATION; CLONING; BINDING; CELLS	Human immunodeficiency virus, type 1 (HIV-1) Vif protein plays an essential role in the regulation of the infectivity of HIV-1 virion. Vif functions to counteract an anti-HIV-1 cellular factor in non-permissive cells, CEM15/Apobec-3G, which shares a cytidine deaminase motif. CEM15/Apobec-3G deaminates dC to dU in the minus strand DNA of HIV-1, resulting in G to A hypermutation in the plus strand DNA. In this study, we have done the mutagenesis analysis on two cytidine deaminase motifs in CEM15/Apobec-3G and examined their antiviral functions as well as the DNA editing activity. Point mutations in the C-terminal active site such as E259Q and C291A almost completely abrogated the antiviral function, while those in the N-terminal active site such as E67Q and C100A retained this activity to a lesser extent as compared with that of the wild type. The DNA editing activities of E67Q and E259Q mutants were both retained but impaired to the same extent. This indicates that the enzymatic activity of this protein is essential but not a sole determinant of the antiviral activity. Furthermore, all the deletion mutants tested in this study lost the antiviral activity because of the loss of the activity for dimerization, suggesting that the entire protein structure is necessary for the antiviral function.	Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Takaori-Kondo, A (corresponding author), Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Sakyo Ku, 54 Shogoin Kawaracho, Kyoto 6068507, Japan.			Shindo, Keisuke/0000-0001-8793-8189				ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ANANT S, 1995, J BIOL CHEM, V270, P14762, DOI 10.1074/jbc.270.24.14762; Anant S, 2001, AM J PHYSIOL-CELL PH, V281, pC1904, DOI 10.1152/ajpcell.2001.281.6.C1904; Desrosiers RC, 1998, J VIROL, V72, P1431, DOI 10.1128/JVI.72.2.1431-1437.1998; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; LAU PP, 1994, P NATL ACAD SCI USA, V91, P8522, DOI 10.1073/pnas.91.18.8522; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; MACGINNITIE AJ, 1995, J BIOL CHEM, V270, P14768, DOI 10.1074/jbc.270.24.14768; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709; Navaratnam N, 1998, J MOL BIOL, V275, P695, DOI 10.1006/jmbi.1997.1506; NAVARATNAM N, 1995, CELL, V81, P187, DOI 10.1016/0092-8674(95)90328-3; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1999, J VIROL, V73, P2675, DOI 10.1128/JVI.73.4.2675-2681.1999; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; Simon JHM, 1998, EMBO J, V17, P1259, DOI 10.1093/emboj/17.5.1259; Takaori-Kondo A, 2000, BIOCHEM BIOPH RES CO, V272, P856, DOI 10.1006/bbrc.2000.2860; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; YAMANAKA S, 1994, J BIOL CHEM, V269, P21725; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	26	158	164	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44412	44416		10.1074/jbc.C300376200	http://dx.doi.org/10.1074/jbc.C300376200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12970355	hybrid, Green Submitted			2022-12-27	WOS:000186306700067
J	Kim, SJ; Martinson, HG				Kim, SJ; Martinson, HG			Poly(A)-dependent transcription termination - Continued communication of the poly(A) signal with the polymerase is required long after extrusion in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; B-CELL DIFFERENTIATION; DOUBLE-STRANDED-RNA; SACCHAROMYCES-CEREVISIAE; DOWNSTREAM ELEMENT; POLYADENYLATION; ELONGATION; MECHANISM; CSTF-64; SITE	Genes encoding polyadenylated mRNAs depend on their poly(A) signals for termination of transcription. An unsolved problem is how the poly(A) signal triggers the polymerase to terminate. A popular model is that this occurs during extrusion of the poly(A) signal, at which time it interacts with factors on the transcription complex. To test this idea we used cis-antisense inhibition in vivo to probe the temporal relationship between poly(A) signal extrusion and the commitment of the polymerase to terminate. Our rationale was to inactivate the poly(A) signal at increasing times post-extrusion to determine the point beyond which it is no longer required for termination. We found that communication with the polymerase is not temporally restricted to the time of poly(A) signal extrusion, but is ongoing and perhaps random. Some polymerases terminate almost immediately. Others have yet to receive their termination instructions from the poly(A) signal even 500 bp downstream, as indicated by the ability of an antisense at this distance to block termination. Thus, the poly(A) signal can functionally interact with the polymerase at considerable distances down the template. This is consistent with the emerging picture of a processing apparatus that assembles and matures while riding with the polymerase.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Martinson, HG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050863] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 50863] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aranda A, 2001, MOL CELL, V7, P1003, DOI 10.1016/S1097-2765(01)00235-0; Aranda A, 1998, RNA, V4, P303; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; BAGGA PS, 1995, NUCLEIC ACIDS RES, V23, P1625, DOI 10.1093/nar/23.9.1625; Barilla D, 2001, P NATL ACAD SCI USA, V98, P445, DOI 10.1073/pnas.021545298; Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2; Calvo O, 2001, MOL CELL, V7, P1013, DOI 10.1016/S1097-2765(01)00236-2; Canadillas JMP, 2003, EMBO J, V22, P2821, DOI 10.1093/emboj/cdg259; Chao LC, 1999, MOL CELL BIOL, V19, P5588; CHODCHOY N, 1991, MOL CELL BIOL, V11, P497, DOI 10.1128/MCB.11.1.497; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Condit RC, 2002, BBA-GENE STRUCT EXPR, V1577, P325, DOI 10.1016/S0167-4781(02)00461-X; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; Dichtl B, 2002, EMBO J, V21, P4125, DOI 10.1093/emboj/cdf390; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; Gu XH, 1996, NUCLEIC ACIDS RES, V24, P3797, DOI 10.1093/nar/24.19.3797; HAGLER J, 1994, J BIOL CHEM, V269, P10050; Hirose Y, 2000, GENE DEV, V14, P1415; Liang XH, 2003, P NATL ACAD SCI USA, V100, P7521, DOI 10.1073/pnas.1332001100; LIU Z, 1994, P NATL ACAD SCI USA, V91, P4258, DOI 10.1073/pnas.91.10.4258; LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306; LUTZ CS, 1994, GENE DEV, V8, P576, DOI 10.1101/gad.8.5.576; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Medlin JE, 2003, EMBO J, V22, P925, DOI 10.1093/emboj/cdg077; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Mohamed MR, 2003, J BIOL CHEM, V278, P11794, DOI 10.1074/jbc.M213263200; Mooney RA, 1998, J BACTERIOL, V180, P3265, DOI 10.1128/JB.180.13.3265-3275.1998; Orozco IJ, 2002, J BIOL CHEM, V277, P42899, DOI 10.1074/jbc.M207415200; Osheim YN, 1999, MOL CELL, V3, P379, DOI 10.1016/S1097-2765(00)80465-7; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; ROHRMANN G, 1986, CELL, V46, P1029, DOI 10.1016/0092-8674(86)90702-6; Sadowski M, 2003, EMBO J, V22, P2167, DOI 10.1093/emboj/cdg200; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Tran DP, 2001, MOL CELL BIOL, V21, P7495, DOI 10.1128/MCB.21.21.7495-7508.2001; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yankulov K, 1999, MOL CELL BIOL, V19, P6154; Yeung G, 1998, MOL CELL BIOL, V18, P276, DOI 10.1128/MCB.18.1.276; Yonaha M, 2000, EMBO J, V19, P3770, DOI 10.1093/emboj/19.14.3770; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	48	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 24	2003	278	43					41691	41701		10.1074/jbc.M306304200	http://dx.doi.org/10.1074/jbc.M306304200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FP	12933817				2022-12-27	WOS:000185989500019
J	Qu, ZQ; Wei, RW; Mann, W; Hartzell, HC				Qu, ZQ; Wei, RW; Mann, W; Hartzell, HC			Two bestrophins cloned from Xenopus laevis oocytes express Ca2+-activated Cl- currents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CONDUCTANCE MEDIATOR; GLYCINE RECEPTOR-CHANNEL; MACULAR DYSTROPHY; ELECTRO-OCULOGRAPHY; PERMEATION PATHWAY; INNER SEGMENTS; MUTATIONS; MEMBRANE; PROTEIN; ANION	Ca2+-activated Cl- channels play important diverse roles from fast block to polyspermy to olfactory transduction, but their molecular identity has not been firmly established. By searching sequence databases with the M2 pore domain of ligand-gated anion channels, we identified potential Ca2+-activated Cl- channels, which included members of the bestrophin family. We cloned two bestrophins from Xenopus oocytes, which express high levels of Ca2+-activated Cl- channels. The Xenopus bestrophins were expressed in a variety of tissues. We predict that bestrophin has six transmembrane domains with the conserved RFP domain playing an integral part in ionic selectivity. When Xenopus bestrophins were heterologously expressed in human embryonic kidney-293 cells, large Ca2+-activated Cl- currents were observed. The currents are voltage- and time-independent, do not rectify, have a K-d for Ca2+ of similar to210 nM, and exhibit a permeability ratio of I- > Br- > Cl- >> aspartate. The W93C and G299E mutations produce non-functional channels that exert a dominant negative effect on wild type channels. We conclude that bestrophins are the first molecularly identified Cl- channels that are dependent on intracellular Ca2+ in a physiological range.	Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	Emory University	Hartzell, HC (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, 535 Whitehead Biomed Res Bldg,615 Michael St, Atlanta, GA 30322 USA.	criss@cellbio.emory.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448] Funding Source: NIH RePORTER; NEI NIH HHS [EY01452] Funding Source: Medline; NIGMS NIH HHS [GM-60448] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BADER CR, 1982, J PHYSIOL-LONDON, V331, P253, DOI 10.1113/jphysiol.1982.sp014372; Bakall B, 1999, HUM GENET, V104, P383, DOI 10.1007/s004390050972; BARNES S, 1989, J GEN PHYSIOL, V94, P719, DOI 10.1085/jgp.94.4.719; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; DEUTMAN AF, 1969, ARCH OPHTHALMOL-CHIC, V81, P305, DOI 10.1001/archopht.1969.00990010307001; FRANCOIS J, 1967, ARCH OPHTHALMOL-CHIC, V77, P726; Fuller CM, 2002, CALCIUM ACTIVATED CH; GALLEMORE R, 1998, RETINAL PIGMENT EPIT; Gruber AD, 1999, AM J PHYSIOL-CELL PH, V276, pC1261; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Hille B., 1992, ION CHANNELS EXCITAB; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Keramidas A, 2000, BIOPHYS J, V79, P247, DOI 10.1016/S0006-3495(00)76287-4; Keramidas A, 2002, J GEN PHYSIOL, V119, P393, DOI 10.1085/jgp.20028552; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; LESTER HA, 1992, ANNU REV BIOPH BIOM, V21, P267, DOI 10.1146/annurev.bb.21.060192.001411; Loewen ME, 2002, AM J PHYSIOL-CELL PH, V283, pC412, DOI 10.1152/ajpcell.00477.2001; Loewen ME, 2002, BIOCHEM BIOPH RES CO, V298, P531, DOI 10.1016/S0006-291X(02)02498-1; MACHACA K, 2002, CALCIUM ACTIVATED CH; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Morgans CW, 1998, J NEUROSCI, V18, P2467; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; Papassotiriou J, 2001, PFLUG ARCH EUR J PHY, V442, P273; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; Qu ZQ, 2001, J BIOL CHEM, V276, P18423, DOI 10.1074/jbc.M101264200; Romio L, 1999, GENE, V228, P181, DOI 10.1016/S0378-1119(98)00620-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; White K, 2000, HUM MUTAT, V15, P301, DOI 10.1002/(SICI)1098-1004(200004)15:4<301::AID-HUMU1>3.0.CO;2-N; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; YAGI T, 1994, J NEUROPHYSIOL, V71, P656, DOI 10.1152/jn.1994.71.2.656	38	138	139	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					49563	49572		10.1074/jbc.M308414200	http://dx.doi.org/10.1074/jbc.M308414200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12939260	hybrid			2022-12-27	WOS:000186829000127
J	Bonnon, C; Goutebroze, L; Denisenko-Nehrbass, N; Girault, JA; Faivre-Sarrailh, C				Bonnon, C; Goutebroze, L; Denisenko-Nehrbass, N; Girault, JA; Faivre-Sarrailh, C			The paranodal complex of F3/Contactin and Caspr/Paranodin traffics to the cell surface via a non-conventional pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE; ENDOPLASMIC-RETICULUM; NEURITE OUTGROWTH; POTASSIUM CHANNEL; MEMBRANE-PROTEINS; DOMAINS; GLYCOSYLATION; GLYCOPROTEIN; JUNCTIONS; IDENTIFICATION	During myelination, membrane-specialized domains are generated by complex interactions between axon and glial cells. The cell adhesion molecules caspr/paranodin and F3/contactin play a crucial role in the generation of functional septate-like junctions at paranodes. We have previously demonstrated that association with the glycosylphosphatidylinositol-linked F3/contactin is required for the recruitment of caspr/paranodin into the lipid rafts and its targeting to the cell surface. When transfected alone in neuroblastoma N2a cells, caspr/ paranodin is retained in the endoplasmic reticulum ( ER). Using chimerical constructs, we show that the cytoplasmic region does not contain any ER retention signal, whereas the ectodomain plays a crucial role in caspr/ paranodin trafficking. A series of truncations encompassing the extracellular region of caspr/ paranodin was unable to abolish ER retention. We show that N-glycosylation and quality control by the lectin-chaperone calnexin are required for the cell surface delivery of caspr/ paranodin. Cell surface transport of F3/contactin and caspr/ paranodin is insensitive to brefeldin A and the two glycoproteins are endoglycosidase H-sensitive when associated in complex, recruited into the lipid rafts, and expressed on the cell surface. Our results indicate a Golgi-independent pathway for the paranodal cell adhesion complex that may be implicated in the segregation of axonal subdomains.	Inst Jean Roche, CNRS, FRE 2533, F-13916 Marseille, France; Inst Fer Moulin, INSERM, U536, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Faivre-Sarrailh, C (corresponding author), Inst Jean Roche, FRE 2533, Blvd Pierre Dramard, F-13916 Marseille 20, France.	sarrailh.c@jean-roche.univ-mrs.fr	Gaiser, Carine/GLT-0142-2022; Faivre-Sarrailh, Catherine/M-6738-2016; Girault, Jean-Antoine/F-7518-2013	Girault, Jean-Antoine/0000-0002-7900-1705; Faivre-Sarrailh, Catherine/0000-0002-1718-0533; Goutebroze, laurence/0000-0002-8712-000X				Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Arroyo EJ, 2000, HISTOCHEM CELL BIOL, V113, P1, DOI 10.1007/s004180050001; Baldwin TA, 2002, J BIOL CHEM, V277, P50333, DOI 10.1074/jbc.M209075200; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; Benting JH, 1999, J CELL BIOL, V146, P313, DOI 10.1083/jcb.146.2.313; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bottomley MJ, 2001, CURR BIOL, V11, P1114, DOI 10.1016/S0960-9822(01)00317-7; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brummendorf T, 1996, CURR OPIN NEUROBIOL, V6, P584, DOI 10.1016/S0959-4388(96)80089-4; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; de Souza NF, 2002, BIOCHEMISTRY-US, V41, P11351, DOI 10.1021/bi0258041; Denisenko-Nehrbass N, 2003, J NEUROCHEM, V84, P209, DOI 10.1046/j.1471-4159.2003.01503.x; Denisenko-Nehrbass N, 2003, EUR J NEUROSCI, V17, P411, DOI 10.1046/j.1460-9568.2003.02441.x; DURBEC P, 1994, EUR J NEUROSCI, V6, P461, DOI 10.1111/j.1460-9568.1994.tb00288.x; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Faivre-Sarrailh C, 2000, J CELL BIOL, V149, P491, DOI 10.1083/jcb.149.2.491; Falk J, 2002, BIOL CELL, V94, P327, DOI 10.1016/S0248-4900(02)00006-0; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; Girault JA, 2002, CURR OPIN NEUROBIOL, V12, P476, DOI 10.1016/S0959-4388(02)00370-7; Gollan L, 2002, J CELL BIOL, V157, P1247, DOI 10.1083/jcb.200203050; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Isom LL, 2002, FRONT BIOSCI, V7, P12; Kazarinova-Noyes K, 2001, J NEUROSCI, V21, P7517, DOI 10.1523/JNEUROSCI.21-19-07517.2001; Khanna R, 2001, J BIOL CHEM, V276, P34028, DOI 10.1074/jbc.M105248200; Lambert S, 1997, J NEUROSCI, V17, P7025; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Murai KK, 2002, CURR BIOL, V12, P181, DOI 10.1016/S0960-9822(02)00680-2; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; Pedraza L, 2001, NEURON, V30, P335, DOI 10.1016/S0896-6273(01)00306-3; Peles E, 2000, CURR OPIN NEUROBIOL, V10, P558, DOI 10.1016/S0959-4388(00)00122-7; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Rigato F, 2002, J NEUROSCI, V22, P6596; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27	43	57	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48339	48347		10.1074/jbc.M309120200	http://dx.doi.org/10.1074/jbc.M309120200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12972410	hybrid			2022-12-27	WOS:000186731400119
J	Dalen, KT; Ulven, SM; Bamberg, K; Gustafsson, JA; Nebb, HI				Dalen, KT; Ulven, SM; Bamberg, K; Gustafsson, JA; Nebb, HI			Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR; PPAR-GAMMA; FATTY-ACID; PRETRANSLATIONAL SUPPRESSION; CHOLESTEROL-METABOLISM; TISSUE DISTRIBUTION; GENE-EXPRESSION; TRANSGENIC MICE; ADIPOSE-TISSUE; MESSENGER-RNA	The insulin-responsive glucose transporter GLUT4 plays a crucial role in insulin-mediated facilitated glucose uptake into adipose tissue and muscle, and impaired expression of GLUT4 has been linked to obesity and diabetes. In this study, we demonstrate that liver X receptors (LXRs) regulate the expression of GLUT4 through direct interaction with a conserved LXR response element in the GLUT4 promoter. The expression of GLUT4 in WAT is induced by a potent LXR agonist in wild type, LXRalpha(-/-), and LXRbeta(-/-) mice but not in LXRalpha(-/-) beta(-/-) mice, demonstrating that both LXRs are able to mediate ligand activated transcription of the GLUT4 gene. However, basal and insulin stimulated expression of GLUT4 in epididymal WAT is reduced only in mice carrying ablation of the LXRalpha isoform. The expression of GLUT4 is furthermore correlated to the induction of LXRalpha during mouse and human adipocyte differentiation. LXRbeta is thus apparently not able to rescue basal expression of GLUT4 in the absence of LXRalpha. We have previously demonstrated that LXRalpha is downregulated in animal models of obesity and diabetes, thus revealing a striking correlation between GLUT4 and LXRalpha expression in insulin-resistant conditions. This suggests that the LXRalpha isoform has a unique role in adipose expression of GLUT4 and suggests that alteration of adipose tissue expression of LXRalpha might be a novel tool to normalize the expression of a gene that is dysregulated in diabetic and insulin-resistant conditions.	Univ Oslo, Inst Nutr Res, N-0316 Oslo, Norway; AstraZeneca Molndal, Mol Pharmacol Res Area CV & GI, S-43183 Molndal, Sweden; Novum, Dept Biosci & Med Nutr, S-14186 Huddinge, Sweden	University of Oslo; AstraZeneca; Karolinska Institutet	Nebb, HI (corresponding author), Univ Oslo, Inst Nutr Res, POB 1046,Blindern, N-0316 Oslo, Norway.	h.i.nebb@basalmed.uio.no	Dalen, Knut Tomas/C-4719-2016; Ulven, Stine Marie/ABD-7140-2020	Dalen, Knut Tomas/0000-0002-0270-5982; 				Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Auboeuf D, 1997, DIABETES, V46, P1319, DOI 10.2337/diabetes.46.8.1319; Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; BERGER J, 1989, NATURE, V340, P70, DOI 10.1038/340070a0; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Caruccio L, 1999, J IMMUNOL METHODS, V230, P1, DOI 10.1016/S0022-1759(99)00100-3; Charron MJ, 1999, J BIOL CHEM, V274, P3253, DOI 10.1074/jbc.274.6.3253; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Ciaraldi T, 1997, EUR J ENDOCRINOL, V137, P610, DOI 10.1530/eje.0.1370610; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; GARVEY WT, 1991, J CLIN INVEST, V87, P1072, DOI 10.1172/JCI115068; GARVEY WT, 1989, SCIENCE, V245, P60, DOI 10.1126/science.2662408; GARVEY WT, 1992, DIABETES, V41, P465, DOI 10.2337/diabetes.41.4.465; HOFMANN C, 1991, ENDOCRINOLOGY, V129, P1915, DOI 10.1210/endo-129-4-1915; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Luo Y, 2000, J CLIN INVEST, V105, P513, DOI 10.1172/JCI8573; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Rozen S, 2000, Methods Mol Biol, V132, P365; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schuster GU, 2002, CIRCULATION, V106, P1147, DOI 10.1161/01.CIR.0000026802.79202.96; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Simpson F, 2001, TRAFFIC, V2, P2, DOI 10.1034/j.1600-0854.2001.020102.x; Smith U, 2002, INT J OBESITY, V26, P897, DOI 10.1038/sj.ijo.0802028; SONG C, 1994, P NATL ACAD SCI USA, V91, P10809, DOI 10.1073/pnas.91.23.10809; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; TEBOUL M, 1995, P NATL ACAD SCI USA, V92, P2096, DOI 10.1073/pnas.92.6.2096; Tobin KAR, 2000, MOL ENDOCRINOL, V14, P741, DOI 10.1210/me.14.5.741; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Willy PJ, 1997, GENE DEV, V11, P289, DOI 10.1101/gad.11.3.289; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; YOUNG PW, 1995, DIABETES, V44, P1087, DOI 10.2337/diabetes.44.9.1087	51	134	143	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48283	48291		10.1074/jbc.M302287200	http://dx.doi.org/10.1074/jbc.M302287200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12970362	hybrid			2022-12-27	WOS:000186731400113
J	Saucerman, JJ; Brunton, LL; Michailova, AP; McCulloch, AD				Saucerman, JJ; Brunton, LL; Michailova, AP; McCulloch, AD			Modeling beta-adrenergic control of cardiac myocyte contractility in silico	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT VENTRICULAR MYOCYTES; PROTEIN-KINASE-A; SIGNALING PATHWAYS; ADENYLYL-CYCLASE; CYCLIC-AMP; ACTIVATION; HEART; CAMP; PHOSPHOLAMBAN; CHANNELS	The beta-adrenergic signaling pathway regulates cardiac myocyte contractility through a combination of feedforward and feedback mechanisms. We used systems analysis to investigate how the components and topology of this signaling network permit neurohormonal control of excitation-contraction coupling in the rat ventricular myocyte. A kinetic model integrating beta-adrenergic signaling with excitation-contraction coupling was formulated, and each subsystem was validated with independent biochemical and physiological measurements. Model analysis was used to investigate quantitatively the effects of specific molecular perturbations. 3-Fold overexpression of adenylyl cyclase in the model allowed an 85% higher rate of cyclic AMP synthesis than an equivalent overexpression of beta(1)-adrenergic receptor, and manipulating the affinity of G(s)alpha for adenylyl cyclase was a more potent regulator of cyclic AMP production. The model predicted that less than 40% of adenylyl cyclase molecules may be stimulated under maximal receptor activation, and an experimental protocol is suggested for validating this prediction. The model also predicted that the endogenous heat-stable protein kinase inhibitor may enhance basal cyclic AMP buffering by 68% and increasing the apparent Hill coefficient of protein kinase A activation from 1.0 to 2.0. Finally, phosphorylation of the L-type calcium channel and phospholamban were found sufficient to predict the dominant changes in myocyte contractility, including a 2.6 x increase in systolic calcium (inotropy) and a 28% decrease in calcium half-relaxation time (lusitropy). By performing systems analysis, the consequences of molecular perturbations in the beta-adrenergic signaling network may be understood within the context of integrative cellular physiology.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Bulgarian Acad Sci, Dept Biophys, BU-1113 Sofia, Bulgaria	University of California System; University of California San Diego; University of California System; University of California San Diego; Bulgarian Academy of Sciences	McCulloch, AD (corresponding author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.			Saucerman, Jeffrey/0000-0001-9464-8374	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008605] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL053773] Funding Source: NIH RePORTER; NCI NIH HHS [CA00216] Funding Source: Medline; NCRR NIH HHS [P41 RR08605] Funding Source: Medline; NHLBI NIH HHS [5 P50 HL53773-09] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEAVO JA, 1974, P NATL ACAD SCI USA, V71, P3580, DOI 10.1073/pnas.71.9.3580; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; BERS DM, 2001, EXCITATION CONTRACTI, P42; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; CHUNG MK, 1990, CIRC RES, V67, P753, DOI 10.1161/01.RES.67.3.753; CORBIN JD, 1977, J BIOL CHEM, V252, P3854; DIXON DA, 1989, J BIOL CHEM, V264, P13612; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P6400, DOI 10.1073/pnas.96.11.6400; Feldman AM, 2002, CIRCULATION, V105, P1876, DOI 10.1161/01.CIR.0000016965.24080.12; Ferrell JE, 1999, BIOESSAYS, V21, P866, DOI 10.1002/(SICI)1521-1878(199910)21:10<866::AID-BIES9>3.0.CO;2-1; Frank K, 2000, ANN MED, V32, P572, DOI 10.3109/07853890008998837; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gilman AG, 2002, NATURE, V420, P703, DOI 10.1038/nature01304; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Insel PA, 2003, TRENDS ENDOCRIN MET, V14, P100, DOI 10.1016/S1043-2760(03)00029-8; Jafri MS, 1998, BIOPHYS J, V74, P1149, DOI 10.1016/S0006-3495(98)77832-4; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Katz A.M., 2001, PHYSL HEART, P255; Khalil H.K., 1996, NONLINEAR SYSTEMS, P351; Koch WJ, 2000, ANNU REV PHYSIOL, V62, P237, DOI 10.1146/annurev.physiol.62.1.237; Konhilas JP, 2003, J PHYSIOL-LONDON, V547, P951, DOI 10.1113/jphysiol.2002.038117; KUZNETSOV V, 1995, CIRC RES, V76, P40, DOI 10.1161/01.RES.76.1.40; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Marks AR, 2003, CIRCULATION, V107, P1456, DOI 10.1161/01.CIR.0000059745.95643.83; Noble D, 2002, BIOESSAYS, V24, P1155, DOI 10.1002/bies.10186; Pandit SV, 2001, BIOPHYS J, V81, P3029, DOI 10.1016/S0006-3495(01)75943-7; Petroff MGV, 2001, CIRC RES, V89, P445, DOI 10.1161/hh1701.095716; POST SR, 1995, BIOCHEM J, V311, P75, DOI 10.1042/bj3110075; Puglisi JL, 2001, AM J PHYSIOL-CELL PH, V281, pC2049, DOI 10.1152/ajpcell.2001.281.6.C2049; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Skeberdis VA, 1997, J PHARMACOL EXP THER, V283, P452; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Tepe NM, 1999, FEBS LETT, V458, P236, DOI 10.1016/S0014-5793(99)01147-3; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vittone L, 1998, J BIOL CHEM, V273, P9804, DOI 10.1074/jbc.273.16.9804; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; XIAO RP, 1993, CIRC RES, V73, P286, DOI 10.1161/01.RES.73.2.286; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	41	170	172	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47997	48003		10.1074/jbc.M308362200	http://dx.doi.org/10.1074/jbc.M308362200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12972422	hybrid			2022-12-27	WOS:000186731400078
J	Fischer, E; Sauer, U				Fischer, E; Sauer, U			A novel metabolic cycle catalyzes glucose oxidation and anaplerosis in hungry Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL CARBON METABOLISM; ISOCITRATE DEHYDROGENASE; BACILLUS-SUBTILIS/; ENTERIC BACTERIA; FLUX ANALYSIS; ACID CYCLE; RESPONSES; KNOCKOUT; PATHWAYS; PROTEIN	Complete oxidation of carbohydrates to CO2 is considered to be the exclusive property of the ubiquitous tricarboxylic acid cycle, the central process in cellular energy metabolism of aerobic organisms. Based on metabolism- wide in vivo quantification of intracellular carbon fluxes, we describe here complete oxidation of carbohydrates via the novel P- enolpyruvate ( PEP)glyoxylate cycle, in which two PEP molecules are oxidized by means of acetyl coenzyme A, citrate, glyoxylate, and oxaloacetate to CO2, and one PEP is regenerated. Key reactions are the constituents of the glyoxylate shunt and PEP carboxykinase, whose conjoint operation in this bi- functional catabolic and anabolic cycle is in sharp contrast to their generally recognized functions in anaplerosis and gluconeogenesis, respectively. Parallel operation of the PEP- glyoxylate cycle and the tricarboxylic acid cycle was identified in the bacterium Escherichia coli under conditions of glucose hunger in a slow- growing continuous culture. Because the PEP-glyoxylate cycle was also active in glucose excess batch cultures of an NADPH- overproducing phosphoglucose isomerase mutant, one function of this new central pathway may be the decoupling of catabolism from NADPH formation that would otherwise occur in the tricarboxylic acid cycle.	ETH, Inst Biotechnol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Sauer, U (corresponding author), ETH, Inst Biotechnol, CH-8093 Zurich, Switzerland.	sauer@biotech.biol.ethz.ch	Sauer, Uwe/Y-3556-2019; Fischer, Eliane/M-2590-2013	Fischer, Eliane/0000-0002-3399-3737				[Anonymous], 1996, ESCHERICHIA COLI SAL, P1325; Canonaco F, 2001, FEMS MICROBIOL LETT, V204, P247, DOI 10.1111/j.1574-6968.2001.tb10892.x; Canovas L.J., 1969, METHODS ENZYMOLOGY, V13, P288; Chassagnole C, 2002, BIOTECHNOL BIOENG, V79, P53, DOI 10.1002/bit.10288; Cozzone AJ, 1998, ANNU REV MICROBIOL, V52, P127, DOI 10.1146/annurev.micro.52.1.127; Dauner M, 2001, J BACTERIOL, V183, P7308, DOI 10.1128/JB.183.24.7308-7317.2001; Dauner M, 2001, BIOTECHNOL BIOENG, V76, P144, DOI 10.1002/bit.1154; Dauner M, 2001, BIOTECHNOL BIOENG, V76, P132, DOI 10.1002/bit.1153; DIXON GH, 1959, BIOCHEM J, V73, pP3; Emmerling M, 2002, J BACTERIOL, V184, P152, DOI 10.1128/JB.184.1.152-164.2002; Ferenci T, 2001, ENVIRON MICROBIOL, V3, P605, DOI 10.1046/j.1462-2920.2001.00238.x; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Gottschalk G., 1986, BACTERIAL METABOLISM; Helling RB, 2002, J BACTERIOL, V184, P1041, DOI 10.1128/jb.184.4.1041-1045.2002; HOLMS WH, 1971, J GEN MICROBIOL, V65, P57, DOI 10.1099/00221287-65-1-57; Jiao Z, 2003, FEMS MICROBIOL LETT, V220, P295, DOI 10.1016/S0378-1097(03)00133-2; Konopka A, 2000, CURR OPIN MICROBIOL, V3, P244, DOI 10.1016/S1369-5274(00)00083-7; KORNBERG HL, 1960, NATURE, V185, P153, DOI 10.1038/185153a0; LAPORTE DC, 1984, J BIOL CHEM, V259, P4068; LEE WNP, 1993, J BIOL CHEM, V268, P25522; Marcotte EM, 2001, NAT BIOTECHNOL, V19, P626, DOI 10.1038/90222; MATIN A, 1982, J BACTERIOL, V149, P801, DOI 10.1128/JB.149.3.801-807.1982; NEIJSSEL OM, 1994, MOL MICROBIOL, V13, P179, DOI 10.1111/j.1365-2958.1994.tb00413.x; Noronha SB, 2000, BIOTECHNOL BIOENG, V68, P316, DOI 10.1002/(SICI)1097-0290(20000505)68:3<316::AID-BIT10>3.0.CO;2-2; NotleyMcRobb L, 1997, MICROBIOL-SGM, V143, P1909, DOI 10.1099/00221287-143-6-1909; Papin JA, 2003, TRENDS BIOCHEM SCI, V28, P250, DOI 10.1016/S0968-0004(03)00064-1; Petersen S, 2000, J BIOL CHEM, V275, P35932, DOI 10.1074/jbc.M908728199; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; RAMSEIER TM, 1995, MOL MICROBIOL, V16, P1157, DOI 10.1111/j.1365-2958.1995.tb02339.x; Saier MH, 1996, J BACTERIOL, V178, P3411, DOI 10.1128/jb.178.12.3411-3417.1996; Sauer U, 1999, J BACTERIOL, V181, P6679, DOI 10.1128/JB.181.21.6679-6688.1999; Sauer U, 1997, NAT BIOTECHNOL, V15, P448, DOI 10.1038/nbt0597-448; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Szyperski T, 1996, TRENDS BIOTECHNOL, V14, P453, DOI 10.1016/S0167-7799(96)10056-1; SZYPERSKI T, 1995, EUR J BIOCHEM, V232, P433, DOI 10.1111/j.1432-1033.1995.433zz.x; WALSH K, 1985, J BIOL CHEM, V260, P8430; Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187; Yang C, 2003, BIOTECHNOL BIOENG, V84, P129, DOI 10.1002/bit.10692	38	144	152	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46446	46451		10.1074/jbc.M307968200	http://dx.doi.org/10.1074/jbc.M307968200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963713	hybrid			2022-12-27	WOS:000186569400029
J	Hu, XQ; Zhang, L; Stewart, RR; Weight, FF				Hu, XQ; Zhang, L; Stewart, RR; Weight, FF			Arginine 222 in the pre-transmembrane domain 1 of 5-HT3A receptors links agonist binding to channel gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; AFFECTS DESENSITIZATION; MAJOR DETERMINANT; STRUCTURAL BASIS; MOLECULAR-BASIS; SUBUNIT; ACTIVATION; RESIDUE; GLUTAMATE; MUTATION	Ligand- gated ion channels are integral membrane proteins that mediate fast synaptic transmission. Molecular biological techniques have been extensively used for determining the structure- function relationships of ligand- gated ion channels. However, the transduction mechanisms that link agonist binding to channel gating remain poorly understood. Arginine 222 ( Arg- 222), located at the distal end of the extracellular N- terminal domain immediately preceding the first transmembrane domain ( TM1), is conserved in all 5- HT3A receptors and alpha7- nicotinic acetylcholine receptors that have been cloned. To elucidate the possible role of Arg- 222 in the function of 5- HT3A receptors, we mutated the arginine residue to alanine ( Ala) and expressed both the wildtype and the mutant receptor in human embryonic kidney 293 cells. Functional studies of expressed wild- type and mutant receptors revealed that the R222A mutation increased the apparent potency of the full agonist, serotonin ( 5- HT), and the partial agonist, 2- Me- 5- HT, 5- and 12- fold, respectively. In addition, the mutation increased the efficacy of 2- Me- 5- HT and converted it from a partial agonist to a full agonist. Furthermore, this mutation also converted the 5- HT3 receptor antagonist/ very weak partial agonist, apomorphine, to a potent agonist. Kinetic analysis revealed that the R222A mutation increased the rate of receptor activation and desensitization but did not affect rate of deactivation. The results suggest that the pre- TM1 amino acid residue Arg- 222 may be involved in the transduction mechanism linking agonist binding to channel gating in 5- HT3A receptors.	NIAAA, Mol & Cellular Neurobiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Hu, XQ (corresponding author), NIAAA, Mol & Cellular Neurobiol Lab, NIH, Pk Bldg,Rm 150, Bethesda, MD 20892 USA.	xhu@mail.nih.gov		Zhang, Lubo/0000-0002-9386-8938	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000479] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Akk G, 1996, J PHYSIOL-LONDON, V496, P185, DOI 10.1113/jphysiol.1996.sp021676; Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; Boess FG, 1997, NEUROPHARMACOLOGY, V36, P637, DOI 10.1016/S0028-3908(97)00044-0; CamposCaro A, 1996, P NATL ACAD SCI USA, V93, P6118, DOI 10.1073/pnas.93.12.6118; CELENTANO JJ, 1994, BIOPHYS J, V66, P1039, DOI 10.1016/S0006-3495(94)80885-9; Chang YC, 1999, BIOPHYS J, V77, P2542, DOI 10.1016/S0006-3495(99)77089-X; CHEN J, 1995, BIOPHYS J, V69, P849, DOI 10.1016/S0006-3495(95)79959-3; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Dang H, 2000, MOL PHARMACOL, V57, P1114; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; Gunthorpe MJ, 2000, J PHYSIOL-LONDON, V522, P187, DOI 10.1111/j.1469-7793.2000.00187.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HUSSY N, 1994, J PHYSIOL-LONDON, V481, P311, DOI 10.1113/jphysiol.1994.sp020441; Jackson M B, 1999, Adv Neurol, V79, P511; JACKSON MB, 1995, ANNU REV PHYSIOL, V57, P447; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; LESTER RAJ, 1993, J NEUROSCI, V13, P1088; LESTER RAJ, 1992, J NEUROSCI, V12, P635; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Morales M, 2002, J NEUROSCI, V22, P6732; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; Reeves DC, 2002, MOL MEMBR BIOL, V19, P11, DOI 10.1080/09687680110110048; Spier AD, 2000, J BIOL CHEM, V275, P5620, DOI 10.1074/jbc.275.8.5620; Steward LJ, 2000, MOL PHARMACOL, V57, P1249; Taverna F, 2000, J BIOL CHEM, V275, P8475, DOI 10.1074/jbc.275.12.8475; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; Unwin N, 2000, PHILOS T R SOC B, V355, P1813, DOI 10.1098/rstb.2000.0737; van Hooft JA, 1998, NEUROPHARMACOLOGY, V37, P259, DOI 10.1016/S0028-3908(98)00044-6; Wang HL, 1999, NAT NEUROSCI, V2, P226, DOI 10.1038/6326; Williams K, 1996, MOL PHARMACOL, V50, P701; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030; Zhang L, 2002, J BIOL CHEM, V277, P46256, DOI 10.1074/jbc.M207683200	41	48	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46583	46589		10.1074/jbc.M308974200	http://dx.doi.org/10.1074/jbc.M308974200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12970351	hybrid			2022-12-27	WOS:000186569400044
J	Brunner, C; Laumen, H; Nielsen, PJ; Kraut, N; Wirth, T				Brunner, C; Laumen, H; Nielsen, PJ; Kraut, N; Wirth, T			Expression of the aldehyde dehydrogenase 2-like gene is controlled by BOB.1/OBF.1 in B lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SPECIFIC COACTIVATOR; NF-KAPPA-B; OCA-B; TRANSCRIPTION FACTORS; VITAMIN-A; DIFFERENTIAL TRANSACTIVATION; FUNCTIONAL-CHARACTERIZATION; MURINE HOMOLOG; MICE LACKING; BINDING	BOB.1/OBF.1 is a lymphocyte-restricted transcriptional coactivator. It binds to the Oct1 and Oct2 transcription factors and increases their transactivation potential. Targeted gene disruption experiments revealed that BOB.1/OBF.1 is critical at different stages of B cell development. A large number of genes expressed in B cells contain octamer motifs in their regulatory regions. However, only few genes have been described so far whose expression is dependent on BOB.1/OBF.1. To understand the molecular basis of BOB.1/OBF.1 function in B cell development, we searched for BOB.1/OBF.1 target genes by expression profiling. We have identified genes both induced and repressed by BOB.1/OBF.1. Using different genetic systems, we demonstrate regulation of a selection of these genes. Identified targets included genes encoding Ahd2-like, AKR1C13, Rbp1, Sdh, Idh2, protocadherin gamma, alpha-catenin, Ptprs, Id3, and Creg. Classification of BOB.1/OBF.1 target genes by function suggests that they affect various aspects of B cell physiology such as cellular metabolism, cell adhesion, and differentiation. To better understand the mechanism of BOB.1/OBF.1 action, we cloned the promoter of the gene encoding Ahd2-like, the gene showing the strongest regulation by BOB.1/OBF.1. This promoter indeed contains a perfect octamer motif. Furthermore, the motif was recognized by the Oct transcription factors as well as BOB.1/OBF.1 in vitro and in vivo, as shown by electromobility shift and chromatin immunoprecipitation assays. Transient transfections confirm that this promoter is activated by BOB.1/OBF.1. Our observations suggest that by regulating genes in different functional pathways, BOB.1/OBF.1 has a widespread effect on B cell development and function.	Boehringer Ingelheim Austria GmbH, R&D Vienna Exploratory Res, A-1121 Vienna, Austria; Univ Ulm, Dept Physiol Chem, D-89081 Ulm, Germany; Max Planck Inst Immunol, D-79108 Freiburg, Germany	Boehringer Ingelheim; Ulm University; Max Planck Society	Kraut, N (corresponding author), Boehringer Ingelheim Austria GmbH, R&D Vienna Exploratory Res, Dr Boehringer Gasse 5-11, A-1121 Vienna, Austria.	norbert.kraut@vie.boehringer-ngelheim.com; thomas.wirth@medizin.uni.ulm.de	Laumen, Helmut/M-5140-2013; Brunner, Cornelia/H-8893-2018; Wirth, Thomas/X-7172-2019; Brunner, Cornelia/L-1291-2013	Laumen, Helmut/0000-0002-5885-5242; Brunner, Cornelia/0000-0002-6456-5508; 				ANNWEILER A, 1992, MOL CELL BIOL, V12, P3107, DOI 10.1128/MCB.12.7.3107; Babb R, 1997, MOL CELL BIOL, V17, P7295, DOI 10.1128/MCB.17.12.7295; Boehm J, 2001, EMBO J, V20, P4153, DOI 10.1093/emboj/20.15.4153; BOND SL, 1994, BIOCHEM MED METAB B, V52, P155, DOI 10.1006/bmmb.1994.1048; Buchanan KL, 1997, J IMMUNOL, V159, P1247; BUCK J, 1990, J EXP MED, V171, P1613, DOI 10.1084/jem.171.5.1613; BUCK J, 1991, SCIENCE, V254, P1654, DOI 10.1126/science.1749937; BUCK J, 1993, J EXP MED, V178, P675, DOI 10.1084/jem.178.2.675; Casellas R, 2002, CELL, V110, P575, DOI 10.1016/S0092-8674(02)00911-X; Cepek KL, 1996, GENE DEV, V10, P2079, DOI 10.1101/gad.10.16.2079; Chasman D, 1999, GENE DEV, V13, P2650, DOI 10.1101/gad.13.20.2650; Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; DOUER D, 1982, J CLIN INVEST, V69, P1039, DOI 10.1172/JCI110507; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Duester G, 1996, BIOCHEMISTRY-US, V35, P12221, DOI 10.1021/bi961176+; Ghatpande S, 2002, BLOOD, V99, P2379, DOI 10.1182/blood.V99.7.2379; Greiner A, 2000, AM J PATHOL, V156, P501, DOI 10.1016/S0002-9440(10)64754-2; Gstaiger M, 1996, TRENDS GENET, V12, P393, DOI 10.1016/S0168-9525(96)90096-7; GSTAIGER M, 1995, NATURE, V373, P360, DOI 10.1038/373360a0; HAHNE M, 1994, J EXP MED, V179, P1391, DOI 10.1084/jem.179.4.1391; Hess J, 2001, MOL CELL BIOL, V21, P1531, DOI 10.1128/MCB.21.5.1531-1539.2001; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; KONIG H, 1995, GENE DEV, V9, P1598, DOI 10.1101/gad.9.13.1598; Kuwata T, 2000, BLOOD, V95, P3349, DOI 10.1182/blood.V95.11.3349; Laumen H, 2000, EUR J IMMUNOL, V30, P458, DOI 10.1002/1521-4141(200002)30:2<458::AID-IMMU458>3.0.CO;2-5; LERNBECHER T, 1993, NATURE, V365, P767, DOI 10.1038/365767a0; LIBERMANN TA, 1991, HORMONAL REGULATION, P385; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; LUO Y, 1995, MOL CELL BIOL, V15, P4115; Malone CS, 2002, J IMMUNOL, V168, P3369, DOI 10.4049/jimmunol.168.7.3369; Moriuchi M, 2001, J BIOL CHEM, V276, P8639, DOI 10.1074/jbc.M008391200; Nielsen PJ, 1996, EUR J IMMUNOL, V26, P3214, DOI 10.1002/eji.1830261255; Pfisterer P, 1996, MOL CELL BIOL, V16, P6160; PFISTERER P, 1994, EMBO J, V13, P1654, DOI 10.1002/j.1460-2075.1994.tb06429.x; PFISTERER P, 1995, J BIOL CHEM, V270, P29870, DOI 10.1074/jbc.270.50.29870; PIERANI A, 1990, MOL CELL BIOL, V10, P6204, DOI 10.1128/MCB.10.12.6204; Purton LE, 2000, BLOOD, V95, P470, DOI 10.1182/blood.V95.2.470; Purton LE, 1999, BLOOD, V94, P483, DOI 10.1182/blood.V94.2.483.414k12_483_495; Qin XF, 1998, EMBO J, V17, P5066, DOI 10.1093/emboj/17.17.5066; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Remenyi A, 2001, MOL CELL, V8, P569, DOI 10.1016/S1097-2765(01)00336-7; Rempel RE, 2000, MOL CELL, V6, P293, DOI 10.1016/S1097-2765(00)00030-7; Sauter P, 1998, MOL CELL BIOL, V18, P7397, DOI 10.1128/MCB.18.12.7397; SCHAFFNER W, 1989, TRENDS GENET, V5, P37, DOI 10.1016/0168-9525(89)90017-6; Schubart DB, 1996, NUCLEIC ACIDS RES, V24, P1913, DOI 10.1093/nar/24.10.1913; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Schubart DB, 2000, J IMMUNOL, V164, P18, DOI 10.4049/jimmunol.164.1.18; Schubart K, 2001, NAT IMMUNOL, V2, P69, DOI 10.1038/83190; Shore P, 2002, NUCLEIC ACIDS RES, V30, P1767, DOI 10.1093/nar/30.8.1767; SMITH WC, 1991, EMBO J, V10, P2223, DOI 10.1002/j.1460-2075.1991.tb07758.x; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; Stevens S, 2000, J IMMUNOL, V164, P6372, DOI 10.4049/jimmunol.164.12.6372; Stevens S, 2000, J IMMUNOL, V164, P5306, DOI 10.4049/jimmunol.164.10.5306; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; Tang H, 1999, IMMUNITY, V11, P517, DOI 10.1016/S1074-7613(00)80127-2; Tiedt R, 2001, EMBO J, V20, P4143, DOI 10.1093/emboj/20.15.4143; Tomilin A, 2000, CELL, V103, P853, DOI 10.1016/S0092-8674(00)00189-6; Veal E, 1998, MOL CELL BIOL, V18, P5032, DOI 10.1128/MCB.18.9.5032; VERRIJZER CP, 1993, BIOCHIM BIOPHYS ACTA, V1173, P1, DOI 10.1016/0167-4781(93)90237-8; Webb CF, 1997, MOL IMMUNOL, V34, P743, DOI 10.1016/S0161-5890(97)00084-9; WIRTH T, 1988, EMBO J, V7, P3109, DOI 10.1002/j.1460-2075.1988.tb03177.x; WIRTH T, 1987, NATURE, V329, P174, DOI 10.1038/329174a0; Wolf I, 1998, J BIOL CHEM, V273, P28831, DOI 10.1074/jbc.273.44.28831; Yamasaki L, 1999, BBA-REV CANCER, V1423, pM9, DOI 10.1016/S0304-419X(99)00003-7; Yeh KC, 2000, GENE, V254, P163, DOI 10.1016/S0378-1119(00)00274-2; Yu X, 2001, IMMUNITY, V14, P157, DOI 10.1016/S1074-7613(09)00090-9; Zile MH, 2001, J NUTR, V131, P705, DOI 10.1093/jn/131.3.705; Zwilling S, 1997, SCIENCE, V277, P221, DOI 10.1126/science.277.5323.221	70	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45231	45239		10.1074/jbc.M302539200	http://dx.doi.org/10.1074/jbc.M302539200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12947107	hybrid			2022-12-27	WOS:000186452300024
J	Hou, SH; Guan, HC; Ricciardi, RP				Hou, SH; Guan, HC; Ricciardi, RP			Phosphorylation of serine 337 of NF-kappa B p50 is critical for DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOVIRUS-TYPE-12 TUMORIGENIC CELLS; UBIQUITIN-PROTEASOME PATHWAY; CLASS-I TRANSCRIPTION; KINASE COMPLEX; P65 SUBUNIT; COUP-TFII; ALPHA; ACTIVATION; HOMODIMER; REL	It has been demonstrated that phosphorylation of the p50 subunit of NF-kappaB is required for efficient DNA binding, yet the specific phospho-residues of p50 have not been determined. In this study, we substituted all of the serine and conserved threonine residues in the p50 Rel homology domain and identified three serine residues, Ser(65), Ser(337), and Ser(342), as critical for DNA binding without affecting dimerization. Although substitution with negatively charged aspartic acid at each of these positions failed to restore DNA binding, substitution with threonine, a potential phospho-acceptor, retained DNA binding for residues 65 and 337. In particular, Ser(337), in a consensus site for protein kinase A (PKA) and other kinases, was shown to be phosphorylated both in vitro and in vivo. Importantly, phosphorylation of Ser(337) by PKA in vitro dramatically increased DNA binding of p50. This study shows for the first time that the DNA binding ability of NF-kappaB p50 subunit is regulated through phosphorylation of residue Ser(337), which has implications for both positive and negative control of NF-kappaB transcription.	Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biochem & Mol Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Ricciardi, RP (corresponding author), Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA.				NCI NIH HHS [CA29797] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA029797] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen YQ, 1998, NAT STRUCT BIOL, V5, P67, DOI 10.1038/nsb0198-67; Chen YQ, 2000, STRUCT FOLD DES, V8, P419, DOI 10.1016/S0969-2126(00)00123-4; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; Drier EA, 1999, GENE DEV, V13, P556, DOI 10.1101/gad.13.5.556; Ghoda L, 1997, J BIOL CHEM, V272, P21281, DOI 10.1074/jbc.272.34.21281; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; HAYASHI T, 1993, J BIOL CHEM, V268, P26790; Hou SH, 2002, J VIROL, V76, P3212, DOI 10.1128/JVI.76.7.3212-3220.2002; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KRALLI A, 1992, J VIROL, V66, P6979, DOI 10.1128/JVI.66.12.6979-6988.1992; Kushner DB, 1999, MOL CELL BIOL, V19, P2169; LI CCH, 1994, BIOCHEM J, V303, P499, DOI 10.1042/bj3030499; LI CCH, 1994, J BIOL CHEM, V269, P30089; Li J, 1998, J BIOL CHEM, V273, P30736, DOI 10.1074/jbc.273.46.30736; May MJ, 1997, SEMIN CANCER BIOL, V8, P63, DOI 10.1006/scbi.1997.0057; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pereira DS, 1996, ONCOGENE, V13, P445; PERKINS ND, 1992, P NATL ACAD SCI USA, V89, P1529, DOI 10.1073/pnas.89.5.1529; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Smirnov DA, 2001, VIROLOGY, V284, P13, DOI 10.1006/viro.2001.0913; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; WHALEN AM, 1993, J CELL BIOL, V123, P523, DOI 10.1083/jcb.123.3.523; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	46	76	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45994	45998		10.1074/jbc.M307971200	http://dx.doi.org/10.1074/jbc.M307971200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12947093	hybrid			2022-12-27	WOS:000186452300114
J	Yamaguchi, M; Stout, CD				Yamaguchi, M; Stout, CD			Essential glycine in the proton channel of Escherichia coli transhydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; CYTOCHROME-C-OXIDASE; TRANSLOCATING TRANSHYDROGENASE; HYDRIDE TRANSFER; MEMBRANE DOMAIN; NADP(H)-BINDING COMPONENT; TRANSMEMBRANE HELICES; ENERGY TRANSDUCTION; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURES	The nicotinamide nucleotide transhydrogenases of mitochondria and bacteria are proton pumps that couple hydride ion transfer between NAD(H) and NADP(H) bound, respectively, to extramembranous domains I and III, to proton translocation by the membrane-intercalated domain II. Previous experiments have established the involvement of three conserved domain II residues in the proton pumping function of the enzyme: His(91), Ser(139), and Asn(222), located on helices 9, 10, and 13, respectively. Eight highly conserved domain II glycines in helices 9, 10, 13, and 14 were mutated to alanine, and the mutant enzymes were assayed for hydride transfer between domains I and III and for proton translocation by domain II. One of the glycines on helix 14, Gly(252), was further mutated to Cys, Ser, Thr, and Val, expression levels of the mutant enzymes were evaluated, and each was purified and assayed. The results show that Gly(252) is essential for function and support a model for the proton channel composed of helices 9, 10, 13, and 14. Gly(252) would allow spatial proximity of His(91), Ser(139), and Asn(222) for proton conductance within the channel. Gly(252) mutants are distinguished by high levels of cyclic transhydrogenation activity in the absence of added NADP(H) and by complete loss of proton pumping activity. The purified G252A mutant has <1% proton translocation and reverse transhydrogenation activity, retains 0.9 mol of NADP(H) per domain III, and has 96% intrinsic cyclic transhydrogenation activity, which does not exceed 100% upon the addition of NADP(H). These properties imply that Gly(252) mutants exhibit a native-like domain II conformation while blocking proton translocation and coupled exchange of NADP(H) in domain III.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Stout, CD (corresponding author), Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.				NIGMS NIH HHS [GM61545] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061545] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramson J, 2001, BBA-PROTEIN STRUCT M, V1544, P1, DOI 10.1016/S0167-4838(00)00241-7; Althage M, 2001, BIOCHEMISTRY-US, V40, P9968, DOI 10.1021/bi0103157; Bizouarn T, 2000, BBA-BIOENERGETICS, V1457, P211, DOI 10.1016/S0005-2728(00)00103-1; Bizouarn T, 2002, BBA-BIOENERGETICS, V1555, P122, DOI 10.1016/S0005-2728(02)00266-9; Bizouarn T, 2000, BBA-BIOENERGETICS, V1459, P284, DOI 10.1016/S0005-2728(00)00163-8; Bragg PD, 2000, ARCH BIOCHEM BIOPHYS, V380, P141, DOI 10.1006/abbi.2000.1923; Bragg PD, 2000, BIOCHEM BIOPH RES CO, V273, P955, DOI 10.1006/bbrc.2000.3037; Bragg PD, 1999, ARCH BIOCHEM BIOPHYS, V363, P182, DOI 10.1006/abbi.1998.1062; Bragg PD, 2001, ARCH BIOCHEM BIOPHYS, V388, P299, DOI 10.1006/abbi.2001.2298; Buckley PA, 2000, STRUCTURE, V8, P809, DOI 10.1016/S0969-2126(00)00171-4; CLARKE DM, 1985, EUR J BIOCHEM, V149, P517, DOI 10.1111/j.1432-1033.1985.tb08955.x; Cotton NPJ, 2001, STRUCTURE, V9, P165, DOI 10.1016/S0969-2126(01)00571-8; FISHER R. R., 1982, PYRIDINE NUCLEOTIDE, P279; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; GLAVAS NA, 1995, BBA-BIOENERGETICS, V1231, P297, DOI 10.1016/0005-2728(95)00089-2; GLAVAS NA, 1995, BIOCHEMISTRY-US, V34, P7694, DOI 10.1021/bi00023a016; Hatefi Y, 1996, FASEB J, V10, P444, DOI 10.1096/fasebj.10.4.8647343; HATEFI Y, 1992, MOL MECHANISMS BIOEN, P265; Hou C, 2001, BIOCHEM BIOPH RES CO, V280, P466, DOI 10.1006/bbrc.2000.4142; HUTTON M, 1994, EUR J BIOCHEM, V219, P1041, DOI 10.1111/j.1432-1033.1994.tb18587.x; Jackson JB, 1999, FEBS LETT, V464, P1, DOI 10.1016/S0014-5793(99)01644-0; Jackson JB, 2002, BIOCHEMISTRY-US, V41, P4173, DOI 10.1021/bi012078d; Karlsson J, 2003, BIOCHEMISTRY-US, V42, P6575, DOI 10.1021/bi034172v; Klingenberg M., 1974, METHOD ENZYMAT AN, V4, P2045, DOI [10. 1016/B978-0-12-091304-6. 50060-4, DOI 10.1016/B978-0-12-091304-6.50060-4]; Kuhlbrandt W, 2002, SCIENCE, V297, P1692, DOI 10.1126/science.1072574; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanyi JK, 1998, J STRUCT BIOL, V124, P164, DOI 10.1006/jsbi.1998.4044; LEVER TM, 1991, EUR J BIOCHEM, V197, P247, DOI 10.1111/j.1432-1033.1991.tb15905.x; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Maeda A, 2002, BIOCHEMISTRY-US, V41, P3803, DOI 10.1021/bi011923p; Meuller J, 1999, J BIOL CHEM, V274, P19072, DOI 10.1074/jbc.274.27.19072; Nishimura K, 2002, BIOCHEMISTRY-US, V41, P13170, DOI 10.1021/bi0262799; OLAUSSON T, 1995, BBA-BIOENERGETICS, V1231, P1, DOI 10.1016/0005-2728(95)00058-Q; PHELPS DC, 1984, BIOCHEMISTRY-US, V23, P4475, DOI 10.1021/bi00314a037; Pinheiro TJT, 2001, J BIOL CHEM, V276, P44757, DOI 10.1074/jbc.M109227200; Prasad GS, 1999, NAT STRUCT BIOL, V6, P1126; Prasad GS, 2002, BIOCHEMISTRY-US, V41, P12745, DOI 10.1021/bi020251f; Quirk PG, 1999, FEBS LETT, V446, P127, DOI 10.1016/S0014-5793(99)00198-2; Rodrigues DJ, 2002, BBA-BIOENERGETICS, V1555, P8, DOI 10.1016/S0005-2728(02)00247-5; Royant A, 2000, NATURE, V406, P645, DOI 10.1038/35020599; Sass HJ, 2000, NATURE, V406, P649, DOI 10.1038/35020607; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; TONG RCW, 1991, BIOCHIM BIOPHYS ACTA, V1080, P19, DOI 10.1016/0167-4838(91)90106-A; Venning JD, 2000, J BIOL CHEM, V275, P19490, DOI 10.1074/jbc.M000577200; Venning JD, 2001, J BIOL CHEM, V276, P30678, DOI 10.1074/jbc.M104429200; White SA, 2000, STRUCT FOLD DES, V8, P1, DOI 10.1016/S0969-2126(00)00075-7; Wikstrom M, 2000, BBA-BIOENERGETICS, V1458, P188, DOI 10.1016/S0005-2728(00)00068-2; YAMAGUCHI M, 1993, J BIOL CHEM, V268, P17871; YAMAGUCHI M, 1991, J BIOL CHEM, V266, P5728; YAMAGUCHI M, 1990, BIOCHEMISTRY-US, V29, P4136, DOI 10.1021/bi00469a017; YAMAGUCHI M, 1995, J BIOL CHEM, V270, P28165; YAMAGUCHI M, 1995, J BIOL CHEM, V270, P16653, DOI 10.1074/jbc.270.28.16653; Yamaguchi M, 1997, BBA-BIOENERGETICS, V1318, P225, DOI 10.1016/S0005-2728(96)00139-9; Yamaguchi M, 2002, J BIOL CHEM, V277, P33670, DOI 10.1074/jbc.M204170200; Yoshikawa S, 2000, J INORG BIOCHEM, V82, P1, DOI 10.1016/S0162-0134(00)00137-9; Zaslavsky D, 2000, BBA-BIOENERGETICS, V1458, P164, DOI 10.1016/S0005-2728(00)00066-9	58	14	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45333	45339		10.1074/jbc.M308236200	http://dx.doi.org/10.1074/jbc.M308236200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952962	hybrid			2022-12-27	WOS:000186452300036
J	Liu, CQ; Goshu, E; Wells, A; Fan, CM				Liu, CQ; Goshu, E; Wells, A; Fan, CM			Identification of the downstream targets of SIM1 and ARNT2, a pair of transcription factors essential for neuroendocrine cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; 2 MURINE HOMOLOGS; CNS MIDLINE; EXPRESSION PATTERNS; MOUSE HYPOTHALAMUS; FACTOR BRN-2; DNA-BINDING; GENE; OBESITY; DOMAIN	SIM1 and ARNT2 are two basic helix-loop-helix/PAS ((P) under bar er-(A) under bar rnt-(S) under bar im) transcription factors that control the differentiation of neuroendocrine lineages in the mouse hypothalamus. Heterozygous Sim1 mice also develop early onset obesity, possibly due to hypodevelopment of the hypothalamus. Although SIM1 and ARNT2 form heterodimers to direct the same molecular pathway, knowledge of this pathway is limited. To facilitate the identification of their downstream genes, we combined an inducible gene expression system in a neuronal cell line with microarray analysis to screen for their transcriptional targets. This method identified 268 potential target genes of SIM1/ARNT2 that displayed >1.7-fold induced expression. 15 of these genes were subjected to Northern analysis, and a high percentage of them were confirmed to be up-regulated. In vivo, several of these genes showed neuroendocrine hypothalamic expression correlating with that of Sim1. Furthermore, we found that expression of two of these potential targets, the Jak2 and thyroid hormone receptor beta(2) genes, was lost in the neuroendocrine hypothalamus of the Sim1 mutant. The expression and predicted functions of many of these genes provide new insight into both the Sim1/Arnt2 action in neuroendocrine hypothalamus development and the molecular basis for the Sim1 haplo-insufficient obesity phenotype.	Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21210 USA	Carnegie Institution for Science	Fan, CM (corresponding author), Carnegie Inst Washington, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.		Liu, Chunqiao/O-3391-2013	Liu, Chunqiao/0000-0002-0299-7401	NICHD NIH HHS [R01HD35596] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035596] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; Bjorbaek C, 2002, VITAM HORM, V65, P281, DOI 10.1016/S0083-6729(02)65068-X; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Crews ST, 1999, CURR OPIN GENET DEV, V9, P580, DOI 10.1016/S0959-437X(99)00003-9; Ema M, 1996, MOL CELL BIOL, V16, P5865; Epstein DJ, 2000, DEVELOPMENT, V127, P4701; Faivre L, 2002, J MED GENET, V39, P594, DOI 10.1136/jmg.39.8.594; Fan CM, 1996, MOL CELL NEUROSCI, V7, P1, DOI 10.1006/mcne.1996.0001; Feng W, 2002, J BIOL CHEM, V277, P44722, DOI 10.1074/jbc.M207675200; FRANKS RG, 1994, MECH DEVELOP, V45, P269, DOI 10.1016/0925-4773(94)90013-2; Hirose K, 1996, MOL CELL BIOL, V16, P1706; Holder JL, 2000, HUM MOL GENET, V9, P101; Hosoya T, 2001, GENES CELLS, V6, P361, DOI 10.1046/j.1365-2443.2001.00421.x; KANDEL ER, 1991, PRINCIPLE NEUROSCIEN; KARIM MA, 1980, J ANAT, V130, P341; Kasai Y, 1998, GENE EXPRESSION, V7, P171; Keith B, 2001, P NATL ACAD SCI USA, V98, P6692, DOI 10.1073/pnas.121494298; Langlois MF, 1997, J BIOL CHEM, V272, P24927, DOI 10.1074/jbc.272.40.24927; Lee YS, 2002, J CLIN ENDOCR METAB, V87, P1423, DOI 10.1210/jc.87.3.1423; LI P, 1993, GENE DEV, V7, P2483, DOI 10.1101/gad.7.12b.2483; Michaud JL, 2000, MECH DEVELOP, V90, P253, DOI 10.1016/S0925-4773(99)00328-7; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Michaud JL, 2001, HUM MOL GENET, V10, P1465, DOI 10.1093/hmg/10.14.1465; Moffett P, 2000, FEBS LETT, V466, P80, DOI 10.1016/S0014-5793(99)01750-0; Nakai S, 1995, GENE DEV, V9, P3109, DOI 10.1101/gad.9.24.3109; OKAMURA H, 1983, DEV BRAIN RES, V9, P223, DOI 10.1016/0165-3806(83)90055-X; Probst MR, 1997, J BIOL CHEM, V272, P4451, DOI 10.1074/jbc.272.7.4451; Ramkumar T, 1999, MOL ENDOCRINOL, V13, P1237, DOI 10.1210/me.13.8.1237; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Satoh T, 1999, MOL CELL ENDOCRINOL, V154, P137, DOI 10.1016/S0303-7207(99)00032-5; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schonemann MD, 1995, GENE DEV, V9, P3122, DOI 10.1101/gad.9.24.3122; Semenza GL, 1997, KIDNEY INT, V51, P553, DOI 10.1038/ki.1997.77; Sonnenfeld M, 1997, DEVELOPMENT, V124, P4571; Suzuki M, 2003, J BIOL CHEM, V278, P14640, DOI 10.1074/jbc.M300239200; Uchino S, 1997, NEUROREPORT, V8, P445, DOI 10.1097/00001756-199701200-00014; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; WHARTON KA, 1994, DEVELOPMENT, V120, P3563; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X	41	34	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44857	44867		10.1074/jbc.M304489200	http://dx.doi.org/10.1074/jbc.M304489200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947113	hybrid			2022-12-27	WOS:000186306700121
J	Murai, N; Murakami, Y; Matsufuji, S				Murai, N; Murakami, Y; Matsufuji, S			Identification of nuclear export signals in antizyme-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE-ANTIZYME; TISSUE-CULTURE CELLS; AMINO-ACID-SEQUENCE; EXPRESSION; POLYAMINES; PROTEINS; CRM1; LOCALIZATION; RECEPTOR; COMPLEX	Antizyme-1 (AZ1) is a protein that negatively regulates polyamine synthesis by inhibiting the key synthetic enzyme ornithine decarboxylase and targeting it for degradation by the 26 S proteasome. Recent work shows that antizyme protein translocates to the nucleus during mouse development (Gritli-Linde, A., Nilssom, J., Bohlooly, Y.M., Heby, O., and Linde, A. (2001) Dev. Dyn. 220, 259-275). However, the significance and mechanism of this phenomenon remain unclear. In this study, we expressed AZ1 fused with enhanced green fluorescent protein (EGFP) to study its localization in a living cell. We found that EGFP-AZ1 was predominantly localized in the cytoplasm and that treatment with leptomycin B, a specific inhibitor of chromosomal region maintenance 1 (CRM1) induced nuclear accumulation of EGFP-AZ1 in Chinese hamster ovary and NIH3T3 cells. Two independent nuclear export signal (NES) sequences, each containing essential hydrophobic residues, were identified in the 50 N-terminal amino acid residues and in the central part of AZ1. The activity of the second NES was inhibited by an N-terminal adjacent region and was only revealed in N-terminal truncated constructs. Both NESs were active when fused to an artificial nuclear protein SV40-NLS-EGFP-EGFP. The ability of AZ1 to shuttle between the nucleus and the cytoplasm suggests that it has a novel function in the nucleus.	Jikei Univ, Sch Med, Dept Biochem 2, Minato Ku, Tokyo 1058461, Japan; LTT Biopharma Co Ltd, Minato Ku, Tokyo 1056201, Japan	Jikei University	Murai, N (corresponding author), Jikei Univ, Sch Med, Dept Biochem 2, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	nmurai@jikei.ac.jp	MURAI, NORIYUKI/V-5747-2018	MURAI, NORIYUKI/0000-0002-1552-5104				DAVIS LI, 1995, ANNU REV BIOCHEM, V64, P865, DOI 10.1146/annurev.bi.64.070195.004245; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Fasken MB, 2000, J BIOL CHEM, V275, P1878, DOI 10.1074/jbc.275.3.1878; FISHER RP, 1995, CELL, V83, P47, DOI 10.1016/0092-8674(95)90233-3; FONG WF, 1976, BIOCHIM BIOPHYS ACTA, V428, P456, DOI 10.1016/0304-4165(76)90054-4; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Gandre S, 2003, MITOCHONDRION, V2, P245, DOI 10.1016/S1567-7249(02)00105-8; Gritli-Linde A, 2001, DEV DYNAM, V220, P259, DOI 10.1002/1097-0177(20010301)220:3<259::AID-DVDY1100>3.0.CO;2-#; Gruendler C, 2001, J BIOL CHEM, V276, P46533, DOI 10.1074/jbc.M105500200; HELLER JS, 1976, P NATL ACAD SCI USA, V73, P1858, DOI 10.1073/pnas.73.6.1858; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; ICHIBA T, 1994, BIOCHEM BIOPH RES CO, V200, P1721, DOI 10.1006/bbrc.1994.1651; Ivanov IP, 2000, P NATL ACAD SCI USA, V97, P4808, DOI 10.1073/pnas.070055897; Ivanov IP, 2000, NUCLEIC ACIDS RES, V28, P3185, DOI 10.1093/nar/28.17.3185; Ivanov IP, 2000, EMBO J, V19, P1907, DOI 10.1093/emboj/19.8.1907; Jullien D, 1999, EMBO J, V18, P4348, DOI 10.1093/emboj/18.15.4348; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; LI XQ, 1994, MOL CELL BIOL, V14, P87, DOI 10.1128/MCB.14.1.87; Lin Y, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-15; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; Mitchell JLA, 1998, BIOCHEM J, V329, P453; Mitchell JLA, 1998, BIOCHEM SOC T, V26, P591, DOI 10.1042/bst0260591; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; MURAKAMI Y, 1992, J BIOL CHEM, V267, P13138; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Pante N, 1995, J CELL SCI, P1; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; SUZUKI T, 1994, P NATL ACAD SCI USA, V91, P8930, DOI 10.1073/pnas.91.19.8930; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tosaka Y, 2000, GENES CELLS, V5, P265, DOI 10.1046/j.1365-2443.2000.00324.x; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2	37	35	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44791	44798		10.1074/jbc.M308059200	http://dx.doi.org/10.1074/jbc.M308059200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941943	hybrid			2022-12-27	WOS:000186306700113
J	Robert, F; Brakier-Gingras, L				Robert, F; Brakier-Gingras, L			A functional interaction between ribosomal proteins S7 and S11 within the bacterial ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION COMPLEX-FORMATION; TRANSFER-RNA-BINDING; MESSENGER-RNA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TRANSLATIONAL ACCURACY; ANGSTROM RESOLUTION; ATOMIC-RESOLUTION; CROSS-LINKING; 70S RIBOSOME	In this study, we used site-directed mutagenesis to disrupt an interaction that had been detected between ribosomal proteins S7 and S11 in the crystal structure of the bacterial 30 S subunit. This interaction, which is located in the E site, connects the head of the 30 S subunit to the platform and is involved in the formation of the exit channel through which passes the 30 S-bound messenger RNA. Neither mutations in S7 nor mutations in S11 prevented the incorporation of the proteins into the 30 S subunits but they perturbed the function of the ribosome. In vivo assays showed that ribosomes with either mutated S7 or S11 were altered in the control of translational fidelity, having an increased capacity for frameshifting, readthrough of a nonsense codon and codon misreading. Toeprinting and filter-binding assays showed that 30 S subunits with either mutated S7 or S11 have an enhanced capacity to bind mRNA. The effects of the S7 and S11 mutations can be related to an increased flexibility of the head of the 30 S, to an opening of the mRNA exit channel and to a perturbation of the proposed allosteric coupling between the A and E sites. Altogether, our results demonstrate that S7 and S11 interact in a functional manner and support the notion that protein-protein interactions contribute to the dynamics of the ribosome.	Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Brakier-Gingras, L (corresponding author), Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada.	lea.brakier.gingras@umontreal.ca						Agrawal RK, 1999, INT J BIOCHEM CELL B, V31, P243, DOI 10.1016/S1357-2725(98)00149-6; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; ANDERSSON DI, 1982, MOL GEN GENET, V187, P467, DOI 10.1007/BF00332630; Belanger F, 2002, J MOL BIOL, V320, P979, DOI 10.1016/S0022-2836(02)00550-8; BRETSCHER MS, 1968, NATURE, V220, P1088, DOI 10.1038/2201088a0; Brimacombe R, 2000, STRUCTURE, V8, pR195, DOI 10.1016/S0969-2126(00)00510-4; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; BROUDE NE, 1983, EUR J BIOCHEM, V132, P139, DOI 10.1111/j.1432-1033.1983.tb07338.x; Brunelle MN, 1999, NUCLEIC ACIDS RES, V27, P4783, DOI 10.1093/nar/27.24.4783; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cooperman BS, 1995, BIOCHEM CELL BIOL, V73, P1087, DOI 10.1139/o95-117; Culver GM, 2001, STRUCTURE, V9, P751, DOI 10.1016/S0969-2126(01)00649-9; Dahlberg AE, 2001, SCIENCE, V292, P868, DOI 10.1126/science.1061513; Dallas A, 2001, MOL CELL, V8, P855, DOI 10.1016/S1097-2765(01)00356-2; Davies C, 1998, J MOL BIOL, V279, P873, DOI 10.1006/jmbi.1998.1780; Diedrich G, 2000, EMBO J, V19, P5241, DOI 10.1093/emboj/19.19.5241; DORING T, 1994, EMBO J, V13, P2677, DOI 10.1002/j.1460-2075.1994.tb06558.x; Farabaugh PJ, 1999, EMBO J, V18, P1427, DOI 10.1093/emboj/18.6.1427; Feinberg JS, 2001, P NATL ACAD SCI USA, V98, P11120, DOI 10.1073/pnas.211184098; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2003, BIOPOLYMERS, V68, P223, DOI 10.1002/bip.10210; Frank J, 2001, COLD SPRING HARB SYM, V66, P67, DOI 10.1101/sqb.2001.66.67; Fredrick K, 2000, J MOL BIOL, V298, P379, DOI 10.1006/jmbi.2000.3563; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Greuer B, 1999, RNA, V5, P1521, DOI 10.1017/S1355838299991550; GREUER B, 1987, NUCLEIC ACIDS RES, V15, P3241, DOI 10.1093/nar/15.8.3241; Grill S, 2000, EMBO J, V19, P4101, DOI 10.1093/emboj/19.15.4101; GUALERZI C, 1977, BIOCHEMISTRY-US, V16, P1684, DOI 10.1021/bi00627a025; Gualerzi CO, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P477; Gualerzi CO, 2001, COLD SPRING HARB SYM, V66, P363, DOI 10.1101/sqb.2001.66.363; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; Herr AJ, 2001, J MOL BIOL, V309, P1029, DOI 10.1006/jmbi.2001.4717; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Joseph S, 1998, EMBO J, V17, P3478, DOI 10.1093/emboj/17.12.3478; Joseph S, 2003, RNA, V9, P160, DOI 10.1261/rna.2163103; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Khaitovich P, 1999, P NATL ACAD SCI USA, V96, P85, DOI 10.1073/pnas.96.1.85; Komarova AV, 2002, RNA, V8, P1137, DOI 10.1017/S1355838202029990; Maguire BA, 2001, CELL, V104, P813, DOI 10.1016/S0092-8674(01)00278-1; Marquez V, 2002, BIOCHEM SOC T, V30, P133, DOI 10.1042/BST0300133; McCutcheon JP, 1999, P NATL ACAD SCI USA, V96, P4301, DOI 10.1073/pnas.96.8.4301; Moore PB, 2002, NATURE, V418, P229, DOI 10.1038/418229a; Moore PB, 2001, BIOCHEMISTRY-US, V40, P3243, DOI 10.1021/bi0029402; NIERHAUS KH, 1990, BIOCHEMISTRY-US, V29, P4997, DOI 10.1021/bi00473a001; Noller HF, 2002, BIOCHEM SOC T, V30, P1159, DOI 10.1042/BST0301159; Noller HF, 2002, FEBS LETT, V514, P11, DOI 10.1016/S0014-5793(02)02327-X; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; PIEPERSBERG W, 1979, MOL GEN GENET, V171, P23, DOI 10.1007/BF00274011; PINARD R, 1995, BIOCHEMISTRY-US, V34, P9611, DOI 10.1021/bi00029a038; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Robert F, 2000, RNA, V6, P1649, DOI 10.1017/S1355838200001199; Robert F, 2001, NUCLEIC ACIDS RES, V29, P677, DOI 10.1093/nar/29.3.677; Rodnina MV, 2002, BIOCHIMIE, V84, P745, DOI 10.1016/S0300-9084(02)01409-8; SAITO K, 1994, J MOL BIOL, V235, P111, DOI 10.1016/S0022-2836(05)80020-8; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; SPEDDING G, 1993, J MOL BIOL, V229, P609, DOI 10.1006/jmbi.1993.1067; SPEDDING G, 1990, RIBOSOMES PROTEIN SY, P1; Stahl G, 2002, TRENDS BIOCHEM SCI, V27, P178, DOI 10.1016/S0968-0004(02)02064-9; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; Viviani VR, 2002, PHOTOCHEM PHOTOBIOL, V76, P538, DOI 10.1562/0031-8655(2002)076&lt;0538:TIOAGA&gt;2.0.CO;2; Wilson KS, 2000, NAT STRUCT BIOL, V7, P866, DOI 10.1038/82818; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOWER J, 1993, EMBO J, V12, P617, DOI 10.1002/j.1460-2075.1993.tb05694.x; Yonath A, 2002, ANNU REV BIOPH BIOM, V31, P257, DOI 10.1146/annurev.biophys.31.082901.134439; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	72	36	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44913	44920		10.1074/jbc.M306534200	http://dx.doi.org/10.1074/jbc.M306534200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12937172	hybrid			2022-12-27	WOS:000186306700127
J	Saxena, S; Jonsson, ZO; Dutta, A				Saxena, S; Jonsson, ZO; Dutta, A			Small RNAs with imperfect match to endogenous mRNA repress translation - Implications for off-target activity of small inhibitory RNA in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; DIRECTED INHIBITION; FUNCTIONAL-ANATOMY; GENE; EXPRESSION; INTERFERENCE; MICRORNA; SIRNAS; REPLICATION; DROSOPHILA	A 21-base pair RNA duplex that perfectly matches an endogenous target mRNA selectively degrades the mRNA and suppresses gene expression in mammalian tissue culture cells. A single base mismatch with the target is believed to protect the mRNA from degradation, making this type of interference highly specific to the targeted gene. A short RNA with mismatches to a target sequence present in multiple copies in the 3'-untranslated region of an exogenously expressed gene can, however, silence it by translational repression. Here we report that a mismatched RNA, targeted to a single site in the coding sequence of an endogenous gene, can efficiently silence gene expression by repressing translation. The antisense strand of such a mismatched RNA requires a 5'-phosphate but not a 3'-hydroxyl group. G . U wobble base pairing is tolerated as a match for both RNA degradation and translation repression. Together, these findings suggest that a small inhibitory RNA duplex can suppress expression of off-target cellular proteins by RNA degradation or translation repression. Proper design of experimental small inhibitory RNAs or a search for targets of endogenous microRNAs must therefore take into account that these short RNAs can affect expression of cellular genes with as many as 3 - 4 base mismatches and additional G . U mismatches.	Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Virginia; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Dutta, A (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, 1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Jónsson, Zophonías Oddur/AAO-1354-2020; Jónsson, Zophonías/E-1960-2015; Dutta, Anindya/P-3203-2016	Jónsson, Zophonías Oddur/0000-0001-5798-9647; Dutta, Anindya/0000-0002-4319-0073	NATIONAL CANCER INSTITUTE [R01CA089406] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA89406] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Angell SM, 1997, EMBO J, V16, P3675, DOI 10.1093/emboj/16.12.3675; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boutla A, 2001, CURR BIOL, V11, P1776, DOI 10.1016/S0960-9822(01)00541-3; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chi JT, 2003, P NATL ACAD SCI USA, V100, P6343, DOI 10.1073/pnas.1037853100; Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GAUTHERET D, 1995, RNA, V1, P807; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamasaki K, 2003, FEBS LETT, V543, P51, DOI 10.1016/S0014-5793(03)00400-9; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Hu WY, 2002, CURR BIOL, V12, P1301, DOI 10.1016/S0960-9822(02)00975-2; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Jorgensen RA, 1996, PLANT MOL BIOL, V31, P957, DOI 10.1007/BF00040715; Kawasaki H, 2003, NATURE, V423, P838, DOI 10.1038/nature01730; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Que QD, 1998, DEV GENET, V22, P100, DOI 10.1002/(SICI)1520-6408(1998)22:1&lt;100::AID-DVG10&gt;3.0.CO;2-D; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yokota T, 2003, EMBO REP, V4, P602, DOI 10.1038/sj.embor.embor840; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	43	324	375	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44312	44319		10.1074/jbc.M307089200	http://dx.doi.org/10.1074/jbc.M307089200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12952966	hybrid			2022-12-27	WOS:000186306700053
J	Zufferey, R; Allen, S; Barron, T; Sullivan, DR; Denny, PW; Almeida, IC; Smith, DF; Turco, SJ; Ferguson, MAJ; Beverley, SM				Zufferey, R; Allen, S; Barron, T; Sullivan, DR; Denny, PW; Almeida, IC; Smith, DF; Turco, SJ; Ferguson, MAJ; Beverley, SM			Ether phospholipids and glycosylinositolphospholipids are not required for amastigote virulence or for inhibition of macrophage activation by Leishmania major	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOZOAN PARASITE LEISHMANIA; PROTEIN-KINASE-C; DIHYDROXYACETONE-PHOSPHATE SYNTHASE; NITRIC-OXIDE SYNTHASE; GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS; DONOVANI LIPOPHOSPHOGLYCAN; TRYPANOSOMA-BRUCEI; MURINE MACROPHAGES; GLYCOINOSITOL PHOSPHOLIPIDS; MEXICANA PROMASTIGOTES	Ether phospholipids are major components of the membranes of humans and Leishmania. In protozoan parasites they occur separately or as part of the glycosylphosphatidylinositol (GPI) anchor of molecules implicated in virulence, such as lipophosphoglycan (LPG), smaller glycosylinositolphospholipids (GIPLs), and GPI-anchored proteins. We generated null mutants of the Leishmania major alkyldihydroxyacetonephosphate synthase ( ADS), the first committed step of ether lipid synthesis. Enzymatic analysis and comprehensive mass spectrometric analysis showed that ads1(-) knock-outs lacked all ether phospholipids, including plasmalogens, LPG, and GIPLs. Leishmania ads1(-) thus represents the first ether lipid- synthesizing eukaryote for which a completely null mutant could be obtained. Remarkably ads1(-) grew well and maintained lipid rafts (detergent-resistant membranes). In virulence tests it closely resembled LPG-deficient L. major, including sensitivity to complement and an inability to survive the initial phase of macrophage infection. Likewise it retained the ability to inhibit host cell signaling and to form infectious amastigotes from the few parasites surviving the establishment defect. These findings counter current proposals that GIPLs are required for amastigote survival in the mammalian host or that parasite lyso-alkyl or alkylacyl-GPI anchors are solely responsible for inhibition of macrophage activation.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Univ Dundee, Wellcome Trust Bioctr, Dundee DD1 4HN, Scotland; Univ Kentucky, Med Ctr, Dept Biochem, Lexington, KY 40506 USA; Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Labs Mol Parasitol, Dept Biol Sci, London SW7 1AZ, England; Univ Sao Paulo, Dept Parasitol, BR-05508900 Sao Paulo, Brazil	Washington University (WUSTL); University of Dundee; University of Kentucky; Imperial College London; Universidade de Sao Paulo	Beverley, SM (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Campus Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA.	beverley@borcim.wustl.edu	Almeida, Igor C./AAF-9409-2019; Ferguson, Michael A. J./F-7829-2010; Denny, Paul/B-8431-2013	Almeida, Igor C./0000-0002-2443-8213; Ferguson, Michael A. J./0000-0003-1321-8714; Denny, Paul/0000-0002-5051-1613; Beverley, Stephen/0000-0001-5319-0811	Wellcome Trust [061343] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BEACH DH, 1979, J PARASITOL, V65, P203, DOI 10.2307/3280147; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Chawla M, 2003, J LIPID RES, V44, P594, DOI 10.1194/jlr.M200296-JLR200; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Croft SL, 2003, MOL BIOCHEM PARASIT, V126, P165, DOI 10.1016/S0166-6851(02)00283-9; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; Denny PW, 2001, FEBS LETT, V491, P148, DOI 10.1016/S0014-5793(01)02172-X; Ferguson MAJ, 1997, PHILOS T ROY SOC B, V352, P1295, DOI 10.1098/rstb.1997.0113; Garami A, 2001, EMBO J, V20, P3657, DOI 10.1093/emboj/20.14.3657; Garami A, 2001, MOL CELL BIOL, V21, P8168, DOI 10.1128/MCB.21.23.8168-8183.2001; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Heise N, 1997, MOL BIOCHEM PARASIT, V89, P61, DOI 10.1016/S0166-6851(97)00101-1; Ilgoutz SC, 1999, EMBO J, V18, P2746, DOI 10.1093/emboj/18.10.2746; Ilgoutz SC, 2001, INT J PARASITOL, V31, P899, DOI 10.1016/S0020-7519(01)00197-7; JARDIM A, 1991, J IMMUNOL, V147, P3538; JOSHI PB, 1995, GENE, V156, P145, DOI 10.1016/0378-1119(95)00042-5; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; KARP CL, 1991, J IMMUNOL, V147, P680; KATAKURA K, 1988, INFECT IMMUN, V56, P2856, DOI 10.1128/IAI.56.11.2856-2860.1988; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lux H, 2000, MOL BIOCHEM PARASIT, V111, P1, DOI 10.1016/S0166-6851(00)00278-4; McConville MJ, 2002, MICROBIOL MOL BIOL R, V66, P122, DOI 10.1128/MMBR.66.1.122-154.2002; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P7385; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P19611; MCCONVILLE MJ, 1989, J BIOL CHEM, V264, P757; MCNEELY TB, 1989, BIOCHEM J, V259, P601, DOI 10.1042/bj2590601; Mengeling BJ, 1997, GLYCOBIOLOGY, V7, P873, DOI 10.1093/glycob/7.7.873-c; Mensa-Wilmot K, 1999, MOL BIOCHEM PARASIT, V99, P103, DOI 10.1016/S0166-6851(99)00003-1; MOODY SF, 1993, J BIOL CHEM, V268, P18457; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; OPPERDOES FR, 1993, BIOCHIMIE, V75, P231, DOI 10.1016/0300-9084(93)90081-3; ORLANDI PA, 1987, J BIOL CHEM, V262, P10384; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; PIMENTA PFP, 1991, EXP PARASITOL, V72, P191, DOI 10.1016/0014-4894(91)90137-L; PROUDFOOT L, 1995, BIOCHEM J, V308, P45, DOI 10.1042/bj3080045; PROUDFOOT L, 1995, EUR J IMMUNOL, V25, P745, DOI 10.1002/eji.1830250318; Proudfoot L, 1996, P NATL ACAD SCI USA, V93, P10984, DOI 10.1073/pnas.93.20.10984; Racoosin EL, 1997, EXP PARASITOL, V85, P283, DOI 10.1006/expr.1996.4139; Ralton JE, 1998, J BIOL CHEM, V273, P4245, DOI 10.1074/jbc.273.7.4245; Ralton JE, 2002, BIOCHEM J, V363, P365, DOI 10.1042/0264-6021:3630365; RYAN KA, 1993, GENE, V131, P145, DOI 10.1016/0378-1119(93)90684-U; RYU EK, 1979, J LIPID RES, V20, P561; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHNEIDER P, 1994, BIOCHEM J, V304, P603, DOI 10.1042/bj3040603; SCHNEIDER P, 1993, BIOCHEM J, V295, P555, DOI 10.1042/bj2950555; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; SCHRAKAMP G, 1985, J LIPID RES, V26, P867; SERRANO AA, 1995, J BIOL CHEM, V270, P27244, DOI 10.1074/jbc.270.45.27244; Shakarian AM, 1997, GENE, V196, P127, DOI 10.1016/S0378-1119(97)00218-7; Shakarian AM, 2000, EXP PARASITOL, V95, P79, DOI 10.1006/expr.2000.4511; Shih S, 1998, J BIOL CHEM, V273, P1534, DOI 10.1074/jbc.273.3.1534; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGH BN, 1988, BIOCHEM BIOPH RES CO, V157, P1239, DOI 10.1016/S0006-291X(88)81007-6; Smith TK, 2002, J BIOL CHEM, V277, P37147, DOI 10.1074/jbc.M203371200; SOMMER JM, 1994, ANNU REV MICROBIOL, V48, P105, DOI 10.1146/annurev.mi.48.100194.000541; Spath GF, 2000, P NATL ACAD SCI USA, V97, P9258, DOI 10.1073/pnas.160257897; Spath GF, 2003, SCIENCE, V301, P1241, DOI 10.1126/science.1087499; Spath GF, 2003, P NATL ACAD SCI USA, V100, P9536, DOI 10.1073/pnas.1530604100; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; Tachado SD, 1999, PARASITE IMMUNOL, V21, P609, DOI 10.1046/j.1365-3024.1999.00268.x; Tachado SD, 1996, J IMMUNOL, V156, P1897; Thai TP, 2001, HUM MOL GENET, V10, P127, DOI 10.1093/hmg/10.2.127; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; TOLSON DL, 1989, MOL BIOCHEM PARASIT, V35, P109, DOI 10.1016/0166-6851(89)90113-8; Turco SJ, 1999, PARASITE IMMUNOL, V21, P597, DOI 10.1046/j.1365-3024.1999.00266.x; Turco SJ, 2001, TRENDS PARASITOL, V17, P223, DOI 10.1016/S1471-4922(01)01895-5; vandenBosch H, 1997, BBA-LIPID LIPID MET, V1348, P35, DOI 10.1016/S0005-2760(97)00107-0; WASSEF MK, 1985, LIPIDS, V20, P108, DOI 10.1007/BF02534216; Watanabe R, 1998, EMBO J, V17, P877, DOI 10.1093/emboj/17.4.877; Wilson IBH, 1999, MOL BIOCHEM PARASIT, V100, P207, DOI 10.1016/S0166-6851(99)00061-4; Zomer AWM, 1999, MOL BIOCHEM PARASIT, V104, P55, DOI 10.1016/S0166-6851(99)00141-3	76	87	90	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44708	44718		10.1074/jbc.M308063200	http://dx.doi.org/10.1074/jbc.M308063200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944391	hybrid			2022-12-27	WOS:000186306700104
J	Hahn, D; Pischitzis, A; Roesmann, S; Hansen, MK; Leuenberger, B; Luginbuehl, U; Sterchi, EE				Hahn, D; Pischitzis, A; Roesmann, S; Hansen, MK; Leuenberger, B; Luginbuehl, U; Sterchi, EE			Phorbol 12-myristate 13-acetate-induced ectodomain shedding and phosphorylation of the human meprin beta metalloprotease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; AMINOBENZOIC ACID HYDROLASE; AMYLOID PRECURSOR PROTEIN; NON-PANCREATIC HYDROLYSIS; NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-ALPHA; PABA-PEPTIDE; COLORECTAL-CANCER; MEDIATED RELEASE; MEMBRANE	Shedding of proteins localized at the cell surface is an important regulatory step in the function of many of these proteins. Human meprin (N-benzoyl-L-tyrosyl-paminobenzoic acid hydrolase, PPH, EC 3.4.24.18) a zinc-metalloendopeptidase of the astacin family is an oligomeric protein complex of alpha- and beta-subunits and is expressed abundantly in the intestine and kidney as well as in leukocytes of the lamina propria and in cancer cells. In transfected cells intracellular proteolytic removal of the membrane anchor results in the secretion of the meprin alpha-subunit. In rats and mice, the beta-subunit exists in a membrane-anchored form. In contrast, human meprinbeta is constitutively converted into a secretable form. We now show that phorbol 12-myristate 13-acetate (PMA) stimulates an increased release of hmeprinbeta from transfected COS-1 cells, whereas hme-prinalpha secretion is not influenced. This stimulatory effect is inhibited by the protein kinase C (PKC) inhibitor staurosporine, suggesting that activation of PKC mediates PMA-induced hmeprinbeta shedding. The use of different protease inhibitors shows that two different metalloprotease activities are responsible for the constitutive and the PMA-stimulated hmeprinbeta shedding. We identified tumor necrosis factor alpha-converting enzyme (TACE or ADAM17) as the protease that mediates the PMA-induced release. We also demonstrate that hmeprinbeta is phosphorylated by PMA treatment on Ser(687) within a PKC consensus sequence in the cytosolic domain of the protein. This phosphorylation of hmeprinbeta is not, however, implicated in the enhanced secretion by PMA treatment.	Univ Bern, Inst Biochem & Mol Biol, CH-3012 Bern, Switzerland; Univ Bern, Dept Pediat, CH-3012 Bern, Switzerland	University of Bern; University of Bern	Sterchi, EE (corresponding author), Univ Bern, Inst Biochem & Mol Biol, Buhlstr 28, CH-3012 Bern, Switzerland.	erwin.sterchi@mci.unibe.ch						Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; ARRIBAS J, 1995, J CELL BIOL, V128, P433, DOI 10.1083/jcb.128.3.433; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Bauvois B, 2001, J LEUKOCYTE BIOL, V70, P11; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; BEYNON RJ, 1981, BIOCHEM J, V199, P591, DOI 10.1042/bj1990591; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; CROWE PD, 1993, J IMMUNOL, V151, P6882; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; DUMERMUTH E, 1993, FEBS LETT, V335, P367, DOI 10.1016/0014-5793(93)80421-P; EHLERS MRW, 1995, BIOCHEM BIOPH RES CO, V206, P541, DOI 10.1006/bbrc.1995.1077; Eldering JA, 1997, EUR J BIOCHEM, V247, P920, DOI 10.1111/j.1432-1033.1997.00920.x; Garton KJ, 2001, J BIOL CHEM, V276, P37993; GORBEA CM, 1993, J BIOL CHEM, V268, P21035; GORBEA CM, 1991, ARCH BIOCHEM BIOPHYS, V290, P549, DOI 10.1016/0003-9861(91)90580-C; GRUNBERG J, 1993, FEBS LETT, V335, P376, DOI 10.1016/0014-5793(93)80422-Q; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; Hahn D, 1997, EUR J BIOCHEM, V247, P933, DOI 10.1111/j.1432-1033.1997.00933.x; HANSEN HP, 1995, INT J CANCER, V63, P750, DOI 10.1002/ijc.2910630524; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; JOHNSON GD, 1994, J BIOL CHEM, V269, P7682; KAUSHAL GP, 1994, J CELL BIOL, V126, P1319, DOI 10.1083/jcb.126.5.1319; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KENNY AJ, 1987, BIOCHEM J, V245, P515, DOI 10.1042/bj2450515; KIMMEL AR, 1987, METHOD ENZYMOL, V152, P307; Kohler D, 2000, FEBS LETT, V465, P2, DOI 10.1016/S0014-5793(99)01712-3; LEUENBERGER B, 2003, BIOCHEM J, V369, P1; Liu JP, 1996, MOL CELL ENDOCRINOL, V116, P1, DOI 10.1016/0303-7207(95)03706-3; Lottaz D, 1999, CANCER RES, V59, P1127; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; Mahon TM, 1997, BIOCHEM J, V325, P39; MARCHAND P, 1994, J BIOL CHEM, V269, P15388; MARCHAND P, 1995, J BIOL CHEM, V270, P5449, DOI 10.1074/jbc.270.10.5449; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; Matters GL, 1999, MOL CARCINOGEN, V25, P169, DOI 10.1002/(SICI)1098-2744(199907)25:3<169::AID-MC3>3.0.CO;2-Y; McLaughlin M, 1999, J NEUROCHEM, V72, P273, DOI 10.1046/j.1471-4159.1999.0720273.x; MILHIET PE, 1994, BIOCHEM J, V300, P37, DOI 10.1042/bj3000037; Mufson RA, 1997, FASEB J, V11, P37, DOI 10.1096/fasebj.11.1.9034164; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; Mullberg J, 1997, FEBS LETT, V401, P235, DOI 10.1016/S0014-5793(96)01480-9; MULLBERG J, 1995, J IMMUNOL, V155, P5198; MULLBERG J, 1992, BIOCHEM BIOPH RES CO, V189, P794, DOI 10.1016/0006-291X(92)92272-Y; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PANDIELLA A, 1991, P NATL ACAD SCI USA, V88, P1726, DOI 10.1073/pnas.88.5.1726; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pischitzis A, 1999, EUR J BIOCHEM, V261, P421, DOI 10.1046/j.1432-1327.1999.00268.x; RAMCHANDRAN R, 1994, J BIOL CHEM, V269, P2125; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Rosmann S, 2002, J BIOL CHEM, V277, P40650, DOI 10.1074/jbc.M206203200; SHENOLIKAR S, 1988, FASEB J, V2, P2753, DOI 10.1096/fasebj.2.12.2842213; SLATER SJ, 1994, J BIOL CHEM, V269, P17160; SLATER SJ, 1995, J BIOL CHEM, V270, P6639, DOI 10.1074/jbc.270.12.6639; STERCHI EE, 1983, J PEDIATR GASTR NUTR, V2, P539, DOI 10.1097/00005176-198302030-00024; STERCHI EE, 1982, CLIN SCI, V62, P557, DOI 10.1042/cs0620557; STERCHI EE, 1988, ARCH BIOCHEM BIOPHYS, V265, P119, DOI 10.1016/0003-9861(88)90377-3; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tang J, 1998, ARCH BIOCHEM BIOPHYS, V349, P192, DOI 10.1006/abbi.1997.0453; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Yaffe MB, 2001, STRUCTURE, V9, pR33, DOI 10.1016/S0969-2126(01)00580-9; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zhu GZ, 2001, J CELL SCI, V114, P1787	68	49	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					42829	42839		10.1074/jbc.M211169200	http://dx.doi.org/10.1074/jbc.M211169200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12941954	hybrid			2022-12-27	WOS:000186157000014
J	Tao, TY; Liu, FL; Klomp, L; Wijmenga, C; Gitlin, JD				Tao, TY; Liu, FL; Klomp, L; Wijmenga, C; Gitlin, JD			The copper toxicosis gene product Murr1 directly interacts with the Wilson disease protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL DI-LEUCINE; MENKES PROTEIN; BIOCHEMICAL-CHARACTERIZATION; CHAPERONE; ATOX1; LOCALIZATION; IDENTIFICATION; HOMEOSTASIS; TRAFFICKING; MECHANISM	Copper toxicosis in Bedlington terriers is an autosomal recessive disorder characterized by excessive hepatic copper accumulation in association with a marked decrease in biliary copper excretion. Recent genetic data have revealed that MURR1, a single copy gene on dog chromosome 10q26, is mutated in this disorder. This gene encodes a 190-amino acid open reading frame of unknown function that is highly conserved in vertebrate species. The Wilson disease protein is a copper transporting ATPase shown to play a critical role in biliary copper excretion. Here we demonstrate that the Wilson disease protein directly interacts with the human homologue of Murr1 in vitro and in vivo and that this interaction is mediated via the copper binding, amino terminus of this ATPase. Importantly, this interaction is specific for this copper transporter, a finding consistent with the observation that impaired copper homeostasis in affected terriers is confined to the liver. Our findings reveal involvement of Murr1 in the defined pathway of hepatic biliary copper excretion, suggest a potential mechanism for Murr1 function in this process, and provide biochemical evidence in support of the proposed role of the MURR1 gene in hepatic copper toxicosis.	Washington Univ, Sch Med, Edward Mallinckrodt Dept Pediat, St Louis, MO 63110 USA; Univ Med Ctr Utrecht, Dept Med Genet, NL-3583 EA Utrecht, Netherlands	Washington University (WUSTL); Utrecht University; Utrecht University Medical Center	Gitlin, JD (corresponding author), Washington Univ, Sch Med, Edward Mallinckrodt Dept Pediat, McDonnell Pediat Res Bldg,660 S Euclid Ave, St Louis, MO 63110 USA.		Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009	Wijmenga, Cisca/0000-0002-5635-1614; 				Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Hamza I, 2003, P NATL ACAD SCI USA, V100, P1215, DOI 10.1073/pnas.0336230100; Hamza I, 1999, P NATL ACAD SCI USA, V96, P13363, DOI 10.1073/pnas.96.23.13363; Hamza I, 2001, P NATL ACAD SCI USA, V98, P6848, DOI 10.1073/pnas.111058498; Hellman NE, 2002, J BIOL CHEM, V277, P46632, DOI 10.1074/jbc.M206246200; HULTGREN BD, 1986, AM J VET RES, V47, P365; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; Huster D, 2003, GASTROENTEROLOGY, V124, P335, DOI 10.1053/gast.2003.50066; Larin D, 1999, J BIOL CHEM, V274, P28497, DOI 10.1074/jbc.274.40.28497; Li ZB, 2002, BIOCHEM BIOPH RES CO, V294, P700, DOI 10.1016/S0006-291X(02)00534-X; Loudianos G, 2000, SEMIN LIVER DIS, V20, P353, DOI 10.1055/s-2000-9389; Lutsenko S, 2003, J MEMBRANE BIOL, V191, P1, DOI 10.1007/s00232-002-1040-6; Muller T, 1999, Eur J Med Res, V4, P293; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Petris MJ, 1999, HUM MOL GENET, V8, P2107, DOI 10.1093/hmg/8.11.2107; Petris MJ, 1998, HUM MOL GENET, V7, P2063, DOI 10.1093/hmg/7.13.2063; Roelofsen H, 2000, GASTROENTEROLOGY, V119, P782, DOI 10.1053/gast.2000.17834; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG639, DOI 10.1152/ajpgi.1999.276.3.G639; Starcevic M, 2002, SEMIN CELL DEV BIOL, V13, P271, DOI 10.1016/S1084952102000563; Strausak D, 2003, J BIOL CHEM, V278, P20821, DOI 10.1074/jbc.M212437200; Tao TY, 2003, HEPATOLOGY, V37, P1241, DOI 10.1053/jhep.2003.50281; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; Voskoboinik I, 2002, ADV PROTEIN CHEM, V60, P123; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Yamaguchi Y, 1996, P NATL ACAD SCI USA, V93, P14030, DOI 10.1073/pnas.93.24.14030	25	140	152	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 24	2003	278	43					41593	41596		10.1074/jbc.C300391200	http://dx.doi.org/10.1074/jbc.C300391200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FP	12968035	hybrid			2022-12-27	WOS:000185989500006
J	Chiba, T; Hagihara, Y; Higurashi, T; Hasegawa, K; Naiki, H; Goto, Y				Chiba, T; Hagihara, Y; Higurashi, T; Hasegawa, K; Naiki, H; Goto, Y			Amyloid fibril formation in the context of full-length protein - Effects of proline mutations on the amyloid fibril formation of beta(2)-microglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA-2-MICROGLOBULIN REVEALS; EXTENSION IN-VITRO; DISULFIDE BOND; ALTERNATIVE CONFORMATIONS; MAJOR DETERMINANT; PRION PROTEIN; KINETIC-MODEL; DISEASE; TRANSTHYRETIN; AGGREGATION	beta(2)-Microglobulin (beta2-m), a typical immunoglobulin domain made of seven beta-strands, is a major component of amyloid fibrils formed in dialysis-related amyloidosis. To understand the mechanism of amyloid fibril formation in the context of full-length protein, we prepared various mutants in which proline (Pro) was introduced to each of the seven beta-strands of beta2-m. The mutations affected the amyloidogenic potential of beta2-m to various degrees. In particular, the L23P, H51P, and V82P mutations significantly retarded fibril extension at pH 2.5. Among these, only L23P is included in the known "minimal" peptide sequence, which can form amyloid fibrils when isolated as a short peptide. This indicates that the residues in regions other than the minimal sequence, such as H51P and V82P, determine the amyloidogenic potential in the full-length protein. To further clarify the mutational effects, we measured their stability against guanidine hydrochloride of the native state at pH 8.0 and the amyloid fibrils at pH 2.5. The amyloidogenicity of mutants showed a significant correlation with the stability of the amyloid fibrils, and little correlation was observed with that of the native state. It has been proposed that the stability of the native state and the unfolding rate to the amyloidogenic precursor as well as the conformational preference of the denatured state determine the amyloidogenicity of the proteins. The present results reveal that, in addition, stability of the amyloid fibrils is a key factor determining the amyloidogenic potential of the proteins.	Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Suita, Osaka 5650871, Japan; Natl Inst Adv Ind Sci & Technol, Special Div Human Life Technol, Osaka 5638577, Japan; Japan Sci & Technol Corp, CREST, Fukui 9101193, Japan; Fukui Med Univ, Dept Pathol, Fukui 9101193, Japan	Osaka University; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); University of Fukui	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.		HAGIHARA, Yoshihisa/K-4996-2016; Naiki, Hironobu/G-5599-2014	HAGIHARA, Yoshihisa/0000-0002-5980-1764; 				BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Brett M, 1999, BRAIN, V122, P183, DOI 10.1093/brain/122.2.183; CASEY TT, 1986, HUM PATHOL, V17, P731, DOI 10.1016/S0046-8177(86)80183-6; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; DOHURA K, 1989, BIOCHEM BIOPH RES CO, V163, P974, DOI 10.1016/0006-291X(89)92317-6; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GUSTAVSSON A, 1991, BIOCHEM BIOPH RES CO, V175, P1159, DOI 10.1016/0006-291X(91)91687-8; Hagihara Y, 2002, J BIOL CHEM, V277, P51043, DOI 10.1074/jbc.M208893200; Hagihara Y, 2002, P NATL ACAD SCI USA, V99, P6619, DOI 10.1073/pnas.102172099; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Hasegawa K, 2003, BIOCHEM BIOPH RES CO, V304, P101, DOI 10.1016/S0006-291X(03)00543-6; Hong DP, 2002, J BIOL CHEM, V277, P21554, DOI 10.1074/jbc.M200188200; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Jones S, 2003, J MOL BIOL, V325, P249, DOI 10.1016/S0022-2836(02)01227-5; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Katou H, 2002, PROTEIN SCI, V11, P2218, DOI 10.1110/ps.0213202; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; KOCH KM, 1992, KIDNEY INT, V41, P1416, DOI 10.1038/ki.1992.207; Kozhukh GV, 2002, J BIOL CHEM, V277, P1310, DOI 10.1074/jbc.M108753200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; MCCUTCHEN SL, 1993, BIOCHEMISTRY-US, V32, P12119, DOI 10.1021/bi00096a024; McParland VJ, 2002, NAT STRUCT BIOL, V9, P326, DOI 10.1038/nsb791; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; MINOR DL, 1994, NATURE, V371, P264, DOI 10.1038/371264a0; Monti M, 2002, PROTEIN SCI, V11, P2362, DOI 10.1110/ps.0206902; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Naiki H, 1996, LAB INVEST, V74, P374; NAIKI H, 1991, LAB INVEST, V65, P104; Ohhashi Y, 2002, J BIOCHEM, V131, P45, DOI 10.1093/oxfordjournals.jbchem.a003076; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; SELVAGGINI C, 1993, BIOCHEM BIOPH RES CO, V194, P1380, DOI 10.1006/bbrc.1993.1977; Sigurdsson EM, 2002, TRENDS MOL MED, V8, P411, DOI 10.1016/S1471-4914(02)02403-6; Souillac PO, 2002, J BIOL CHEM, V277, P12657, DOI 10.1074/jbc.M109230200; Trinh CH, 2002, P NATL ACAD SCI USA, V99, P9771, DOI 10.1073/pnas.152337399; Verdone G, 2002, PROTEIN SCI, V11, P487, DOI 10.1110/ps.29002; Yamada M, 1999, NEUROLOGY, V53, P181, DOI 10.1212/WNL.53.1.181	47	111	114	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47016	47024		10.1074/jbc.M304473200	http://dx.doi.org/10.1074/jbc.M304473200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12958308	Green Published, hybrid			2022-12-27	WOS:000186569400097
J	Kumar, MJ; Nicholls, DG; Andersen, JK				Kumar, MJ; Nicholls, DG; Andersen, JK			Oxidative alpha-ketoglutarate dehydrogenase inhibition via subtle elevations in monoamine oxidase B levels results in loss of spare respiratory capacity - Implications for Parkinson's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL COMPLEX-I; HYDROGEN-PEROXIDE; HUMAN-BRAIN; NERVE-TERMINALS; FRONTAL-CORTEX; NEURONS; GLUTATHIONE; STRESS; CELLS; METABOLITES	Age-related increases in brain monoamine oxidase B (MAO-B) and its ability to produce reactive oxygen species as a by-product of catalysis could contribute to neurodegeneration associated with Parkinson's disease. This may be via increased oxidative stress and/or mitochondrial dysfunction either on its own or through its interaction with endogenous or exogenous neurotoxic species. We have created genetically engineered dopaminergic PC12 cell lines with subtly increased levels of MAO-B mimicking those observed during normal aging. In our cells, increased MAO-B activity was found to result in increased H2O2 production. This was found to correlate with a decrease in mitochondrial complex I activity which may involve both direct oxidative damage to the complex itself as well as oxidative effects on the tricarboxylic acid cycle enzyme alpha-ketoglutarate dehydrogenase (KGDH) which provides substrate for the complex. Both complex I and KGDH activities have been reported to be decreased in the Parkinsonian brain. These in vitro events are reversible by catalase addition. Importantly, MAO-B elevation was found to abolish the spare KGDH threshold capacity, which can normally be significantly inhibited before it affects maximal mitochondrial oxygen consumption rates. Our data suggest that H2O2 production via subtle elevations in MAO-B levels can result in oxidative effects on KGDH that can compromise the ability of dopaminergic neurons to cope with increased energetic stress.	Buck Inst Age Res, Novato, CA 94945 USA	Buck Institute for Research on Aging	Kumar, MJ (corresponding author), Buck Inst Age Res, 8001 Redwood Blvd, Novato, CA 94945 USA.	jkumar@buckinstitute.org	NICHOLLS, DAVID G/K-4300-2012	Andersen, Julie/0000-0003-1324-4875	NIA NIH HHS [R01 AG 15980] Funding Source: Medline; NINDS NIH HHS [R01 NS 41908] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015980] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BARBEAU A, 1973, J AM GERIATR SOC, V21, P145, DOI 10.1111/j.1532-5415.1973.tb00865.x; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; BENCH CJ, 1993, PSYCHOPHARMACOLOGY, V112, P308, DOI 10.1007/BF02244926; BENEDETTI MS, 1989, BIOCHEM PHARMACOL, V38, P555, DOI 10.1016/0006-2952(89)90198-6; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bignami Amico, 1995, P843; BUCKMAN TD, 1993, J NEUROCHEM, V60, P2046, DOI 10.1111/j.1471-4159.1993.tb03489.x; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; CALNE DB, 1983, LANCET, V2, P1457, DOI 10.1016/S0140-6736(83)90802-4; Chinopoulos C, 2001, J NEUROCHEM, V76, P302, DOI 10.1046/j.1471-4159.2001.00060.x; Chinopoulos C, 1999, ANN NY ACAD SCI, V893, P269, DOI 10.1111/j.1749-6632.1999.tb07834.x; Cohen G, 1990, J Neural Transm Suppl, V32, P229; Cohen G, 1983, J Neural Transm Suppl, V19, P89; Cohen G, 1999, J NEUROCHEM, V73, P2310, DOI 10.1046/j.1471-4159.1999.0732310.x; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; EKBLOM J, 1993, GLIA, V8, P122, DOI 10.1002/glia.440080208; FAHN S, 1992, ANN NEUROL, V32, P804, DOI 10.1002/ana.410320616; FOWLER CJ, 1980, J NEURAL TRANSM, V49, P1, DOI 10.1007/BF01249185; Fowler JS, 1997, NEUROBIOL AGING, V18, P431, DOI 10.1016/S0197-4580(97)00037-7; GALVA MD, 1995, J NEURAL TRANSM-GEN, V101, P83, DOI 10.1007/BF01271547; Gibson GE, 2003, NEUROCHEM INT, V43, P129, DOI 10.1016/S0197-0186(02)00225-5; Glover V, 1980, J Neural Transm Suppl, P163; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hauptmann N, 1996, ARCH BIOCHEM BIOPHYS, V335, P295, DOI 10.1006/abbi.1996.0510; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P552, DOI 10.1021/bi971958i; Irwin I, 1997, NEUROBIOL AGING, V18, P235, DOI 10.1016/S0197-4580(97)00003-1; Jenner P, 1998, ANN NEUROL, V44, pS72, DOI 10.1002/ana.410440712; Jha N, 2000, J BIOL CHEM, V275, P26096, DOI 10.1074/jbc.M000120200; Kang YS, 1997, NEUROREPORT, V8, P2053, DOI 10.1097/00001756-199705260-00049; KNOLL J, 1986, ADV NEUROL, V45, P107; KORNHUBER J, 1989, BRAIN RES, V499, P81, DOI 10.1016/0006-8993(89)91136-0; LANGSTON JW, 1986, CLIN NEUROPHARMACOL, V9, P485, DOI 10.1097/00002826-198612000-00001; Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336; Li H, 2001, J NEURAL TRANSM, V108, P1363, DOI 10.1007/s007020100013; MAKAR TK, 1994, J NEUROCHEM, V62, P45; MANN JJ, 1985, CLIN PHARM STUDIES P, P37; MIZUNO Y, 1990, J NEUROL SCI, V96, P49, DOI 10.1016/0022-510X(90)90056-S; MIZUNO Y, 1994, ANN NEUROL, V35, P204, DOI 10.1002/ana.410350212; MIZUNO Y, 1988, J NEUROL SCI, V86, P97, DOI 10.1016/0022-510X(88)90010-X; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; RAPS SP, 1989, BRAIN RES, V493, P398, DOI 10.1016/0006-8993(89)91178-5; RICAURTE GA, 1986, BRAIN RES, V376, P117, DOI 10.1016/0006-8993(86)90905-4; ROBINSON DS, 1971, ARCH GEN PSYCHIAT, V24, P536; SAGARA J, 1993, J NEUROCHEM, V61, P1672, DOI 10.1111/j.1471-4159.1993.tb09802.x; SASTRE M, 1993, J NEUROCHEM, V61, P881, DOI 10.1111/j.1471-4159.1993.tb03599.x; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Sheehan JP, 1997, J NEUROCHEM, V68, P1221; Shih JC, 1979, MONOAMINE OXIDASE ST, P413; Sims NR, 2000, MOL BRAIN RES, V77, P176, DOI 10.1016/S0169-328X(00)00049-8; SOONG NW, 1992, NAT GENET, V2, P318; SZUTOWICZ A, 1989, J BIOL CHEM, V264, P17660; TERRY RD, 1987, ANN NEUROL, V21, P530, DOI 10.1002/ana.410210603; Tretter L, 1997, J NEUROCHEM, V69, P2529; Tretter L, 2000, J NEUROSCI, V20, P8972; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Ward MW, 2000, J NEUROSCI, V20, P7208; WESTLUND KN, 1988, NEUROSCIENCE, V25, P439, DOI 10.1016/0306-4522(88)90250-3; WESTLUND KN, 1985, SCIENCE, V230, P181, DOI 10.1126/science.3875898; WHITTEMORE ER, 1994, NEUROREPORT, V5, P1485, DOI 10.1097/00001756-199407000-00019; Xin WK, 2000, CHEM RES TOXICOL, V13, P749, DOI 10.1021/tx990170t; Zhou MJ, 1997, ANAL BIOCHEM, V253, P169, DOI 10.1006/abio.1997.2392	67	104	108	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46432	46439		10.1074/jbc.M306378200	http://dx.doi.org/10.1074/jbc.M306378200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963742	hybrid			2022-12-27	WOS:000186569400027
J	Lorentzen, E; Pohl, E; Zwart, P; Stark, A; Russell, RB; Knura, T; Hensel, R; Siebers, B				Lorentzen, E; Pohl, E; Zwart, P; Stark, A; Russell, RB; Knura, T; Hensel, R; Siebers, B			Crystal structure of an archaeal class I aldolase and the evolution of (beta alpha)(8) barrel proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MUSCLE ALDOLASE; FAMILY; MODEL; FRUCTOSE-1,6-BISPHOSPHATE; CRYSTALLOGRAPHY; RESOLUTION; SEQUENCES; ISOMERASE; MOLSCRIPT; PROGRAM	Fructose-1,6-bisphosphate aldolase (FBPA) catalyzes the reversible cleavage of fructose 1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate in the glycolytic pathway. FBPAs from archaeal organisms have recently been identified and characterized as a divergent family of proteins. Here, we report the first crystal structure of an archaeal FBPA at 1.9-Angstrom resolution. The structure of this 280-kDa protein complex was determined using single wavelength anomalous dispersion followed by 10-fold non-crystallographic symmetry averaging and refined to an R-factor of 14.9% (R-free 17.9%). The protein forms a dimer of pentamers, consisting of subunits adopting the ubiquitous (betaalpha)(8) barrel fold. Additionally, a crystal structure of the archaeal FBPA covalently bound to dihydroxyacetone phosphate was solved at 2.1-Angstrom resolution. Comparison of the active site residues with those of classical FBPAs, which share no significant sequence identity but display the same overall fold, reveals a common ancestry between these two families of FBPAs. Structural comparisons, furthermore, establish an evolutionary link to the triosephosphate isomerases, a superfamily hitherto considered independent from the superfamily of aldolases.	European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany; European Mol Biol Lab, D-69012 Heidelberg, Germany; Univ Essen Gesamthsch, Dept Microbiol, D-45117 Essen, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); University of Duisburg Essen	Pohl, E (corresponding author), European Mol Biol Lab, Hamburg Outstn, Notkestr 85, D-22603 Hamburg, Germany.	ehmke@embl-hamburg.de	Russell, Rob/AAH-9145-2019; Lorentzen, Esben/AAX-8077-2020; Russell, Robert/GWU-6389-2022; Pohl, Ehmke/I-2408-2012; Stark, Alexander/D-1473-2012	Russell, Rob/0000-0002-1905-4717; Russell, Robert/0000-0002-7213-1398; Pohl, Ehmke/0000-0002-9949-4471; Stark, Alexander/0000-0003-2611-0841; Lorentzen, Esben/0000-0001-6493-7220; Siebers, Bettina/0000-0002-9905-541X				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Choi KH, 2001, BIOCHEMISTRY-US, V40, P13868, DOI 10.1021/bi0114877; Copley RR, 2000, J MOL BIOL, V303, P627, DOI 10.1006/jmbi.2000.4152; Dalby A, 1999, PROTEIN SCI, V8, P291; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FARBER GK, 1990, TRENDS BIOCHEM SCI, V15, P228, DOI 10.1016/0968-0004(90)90035-A; Galperin MY, 2000, FEMS MICROBIOL LETT, V183, P259, DOI 10.1016/S0378-1097(99)00612-6; GAMBLIN SJ, 1990, FEBS LETT, V262, P282, DOI 10.1016/0014-5793(90)80211-Z; Jia J, 1996, STRUCTURE, V4, P715, DOI 10.1016/S0969-2126(96)00077-9; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kollman JM, 2000, J MOL EVOL, V51, P173, DOI 10.1007/s002390010078; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lazcano A, 1999, J MOL EVOL, V49, P424, DOI 10.1007/PL00006565; LEBHERZ HG, 1969, BIOCHEMISTRY-US, V8, P109, DOI 10.1021/bi00829a016; Lindqvist Y, 1997, CURR OPIN STRUC BIOL, V7, P422, DOI 10.1016/S0959-440X(97)80061-9; Lo Conte L, 2002, NUCLEIC ACIDS RES, V30, P264; MANDE SC, 1994, PROTEIN SCI, V3, P810, DOI 10.1002/pro.5560030510; MAVRIDIS IM, 1982, J MOL BIOL, V162, P419, DOI 10.1016/0022-2836(82)90536-8; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MORRIS AJ, 1993, J BIOL CHEM, V268, P1095; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1993, J MOL BIOL, V230, P689, DOI 10.1006/jmbi.1993.1186; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE NR, 1991, CELL, V65, P531, DOI 10.1016/0092-8674(91)90082-A; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pohl E, 2001, J SYNCHROTRON RADIAT, V8, P1113, DOI 10.1107/S0909049501005891; Puchkaev AV, 2003, ARCH BIOCHEM BIOPHYS, V409, P52, DOI 10.1016/S0003-9861(02)00402-2; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Sheldrick GM, 1998, NATO ADV SCI I C-MAT, V507, P401; Siebers B, 2001, J BIOL CHEM, V276, P28710, DOI 10.1074/jbc.M103447200; Stark A, 2003, J MOL BIOL, V326, P1307, DOI 10.1016/S0022-2836(03)00045-7; TENG TY, 1990, J APPL CRYSTALLOGR, V23, P387, DOI 10.1107/S0021889890005568; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomson GJ, 1998, BIOCHEM J, V331, P437, DOI 10.1042/bj3310437; Thorell S, 2002, J MOL BIOL, V319, P161, DOI 10.1016/S0022-2836(02)00258-9; Walden H, 2001, J MOL BIOL, V306, P745, DOI 10.1006/jmbi.2000.4433; WILMANNS M, 1991, BIOCHEMISTRY-US, V30, P9161, DOI 10.1021/bi00102a006; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987	49	45	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47253	47260		10.1074/jbc.M305922200	http://dx.doi.org/10.1074/jbc.M305922200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12941964	hybrid			2022-12-27	WOS:000186569400126
J	Mancini, R; Aebi, M; Helenius, A				Mancini, R; Aebi, M; Helenius, A			Multiple endoplasmic reticulum-associated pathways degrade mutant yeast carboxypeptidase Y in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; MANNOSIDASE-LIKE PROTEIN; ER-ASSOCIATED DEGRADATION; QUALITY-CONTROL; SECRETORY PATHWAY; MISFOLDED GLYCOPROTEINS; MOLECULAR CHAPERONES; SACCHAROMYCES-CEREVISIAE; RETRO-TRANSLOCATION; IN-VIVO	The degradation of misfolded and unassembled proteins by the endoplasmic reticulum (ER)-associated degradation (ERAD) has been shown to occur mainly through the ubiquitin-proteasome pathway after transport of the protein to the cytosol. Recent work has revealed a role for N-linked glycans in targeting aberrant glycoproteins to ERAD. To further characterize the molecular basis of substrate recognition and sorting during ERAD in mammalian cells, we expressed a mutant yeast carboxypeptidase Y (CPY*) in CHO cells. CPY* was retained in the ER in un-aggregated form, and degraded after a 45-min lag period. Degradation was predominantly by a proteasome-independent, non-lysosomal pathway. The inhibitor of ER mannosidase I, kifunensine, blocked the degradation by the alternate pathway but did not affect the proteasomal fraction of degradation. Upon inhibition of glucose trimming, the initial lag period was eliminated and degradation thus accelerated. Our results indicated that, although the proteasome is a major player in ERAD, alternative routes are present in mammalian cells and can play an important role in the disposal of both glycoproteins and non-glycoproteins.	Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland; Swiss Fed Inst Technol, Inst Microbiol, CH-8092 Zurich, Switzerland	ETH Zurich; ETH Zurich	Helenius, A (corresponding author), Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland.							Amshoff C, 1999, BIOL CHEM, V380, P669, DOI 10.1515/BC.1999.083; BIRD P, 1987, J CELL BIOL, V105, P2905, DOI 10.1083/jcb.105.6.2905; Bodendorf U, 2001, J BIOL CHEM, V276, P12019, DOI 10.1074/jbc.M008861200; BRAAKMAN I, 1992, NATURE, V356, P260, DOI 10.1038/356260a0; Braakman I, 2001, EMBO REP, V2, P666, DOI 10.1093/embo-reports/kve162; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; Cabral CM, 2000, J BIOL CHEM, V275, P25015, DOI 10.1074/jbc.M910172199; Cannon KS, 1999, J BIOL CHEM, V274, P7537, DOI 10.1074/jbc.274.11.7537; Chillaron J, 2000, BIOL CHEM, V381, P1155, DOI 10.1515/BC.2000.143; Chung DH, 2000, J BIOL CHEM, V275, P4981, DOI 10.1074/jbc.275.7.4981; de Virgilio M, 1999, MOL BIOL CELL, V10, P4059, DOI 10.1091/mbc.10.12.4059; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; ELBEIN AD, 1991, FASEB J, V5, P3055, DOI 10.1096/fasebj.5.15.1743438; ENDRIZZI JA, 1994, BIOCHEMISTRY-US, V33, P11106, DOI 10.1021/bi00203a007; Fagioli C, 2001, J BIOL CHEM, V276, P12885, DOI 10.1074/jbc.M009603200; Fayadat L, 2000, J BIOL CHEM, V275, P15948, DOI 10.1074/jbc.M905763199; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Frigerio L, 2000, CURR BIOL, V10, pR674, DOI 10.1016/S0960-9822(00)00680-1; GRINNA LS, 1980, J BIOL CHEM, V255, P2255; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HAMMOND C, 1994, SCIENCE, V266, P456, DOI 10.1126/science.7939687; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Heinemann FS, 1998, MOL BIOL CELL, V9, P3445, DOI 10.1091/mbc.9.12.3445; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Holst B, 1996, EMBO J, V15, P3538, DOI 10.1002/j.1460-2075.1996.tb00723.x; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jakob CA, 2001, EMBO REP, V2, P423; Joly JC, 1997, BIOCHEMISTRY-US, V36, P10067, DOI 10.1021/bi9707739; Jung GM, 1999, J BIOCHEM-TOKYO, V126, P1; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Loo TW, 1998, J BIOL CHEM, V273, P32373, DOI 10.1074/jbc.273.49.32373; Miller SC, 1998, J BIOL CHEM, V273, P32618, DOI 10.1074/jbc.273.49.32618; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Parodi AJ, 1999, BBA-GEN SUBJECTS, V1426, P287, DOI 10.1016/S0304-4165(98)00130-5; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; SOUSA M, 1995, EMBO J, V14, P4196, DOI 10.1002/j.1460-2075.1995.tb00093.x; SU K, 1993, J BIOL CHEM, V268, P14301; Tokunaga F, 2000, J BIOL CHEM, V275, P40757, DOI 10.1074/jbc.M001073200; Trombetta ES, 1998, CURR OPIN STRUC BIOL, V8, P587, DOI 10.1016/S0959-440X(98)80148-6; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; URADE R, 1993, J BIOL CHEM, V268, P22004; Wang EW, 2000, P NATL ACAD SCI USA, V97, P9990, DOI 10.1073/pnas.180328897; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wilson CM, 2000, J BIOL CHEM, V275, P21224, DOI 10.1074/jbc.M000567200; WINTHER JR, 1991, EUR J BIOCHEM, V197, P681, DOI 10.1111/j.1432-1033.1991.tb15959.x; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	63	37	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46895	46905		10.1074/jbc.M302979200	http://dx.doi.org/10.1074/jbc.M302979200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12954632	hybrid			2022-12-27	WOS:000186569400083
J	Amoui, M; Baylink, DJ; Tillman, JB; Lau, KHW				Amoui, M; Baylink, DJ; Tillman, JB; Lau, KHW			Expression of a structurally unique osteoclastic protein-tyrosine phosphatase is driven by an alternative intronic, cell type-specific promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; TARGETED DISRUPTION; DIFFERENTIATION; OSTEOPETROSIS; GENE; DEFICIENCY; REPRESSOR; GLEPP1	An osteoclastic protein-tyrosine phosphatase ( PTP-oc), essential for osteoclast activity, shows sequence identity with the intracellular domain of GLEPP1, a renal receptor-like transmembrane PTP. PTP-oc has been assumed to be a truncated variant of GLEPP1, resulting from alternative splicing. However, the 5'-untranslated region sequence of PTP-oc mRNA contains 217 bp from an intron of GLEPP1. There are no splicing acceptor sites at the PTP-oc transcription site. The intronic sequence flanking the 5' end of the PTP-oc transcription start site contains potential promoter elements essential for transcriptional initiation. To test the hypothesis that the PTP-oc gene has an alternative, tissue-specific, intronic promoter, the promoter activity of a 1.3-kb PCR fragment covering the 5'-flanking region of the PTP-oc gene was measured. The putative PTP-oc promoter fragment showed strong promoter activity in U937 cells. Mutation of the putative TATA box within the PTP-oc promoter abolished 60 - 90% of its promoter activity. The PTP-oc promoter fragment showed strong promoter activity in cells that express PTP-oc ( U937 cells and RAW264.7 cells) but not in cells that do not express the enzyme ( skin fibroblasts, TE85 cells, and HEK293 cells). These findings strongly support the conclusion that the 1.3-kb intronic fragment contains the tissue-specific, PTP-oc proximal promoter. Deletion and functional analyses indicate that the proximal 5' sequence flanking the TATA box of the PTP-oc contains potential repressor elements. The removal of the putative repressor elements led to the apparent loss of tissue specificity. In summary, we conclude that an intronic promoter within the GLEPP1 gene drives the expression of the PTP-oc in a cell type-specific manner. This GLEPP1/PTP-oc gene system is one of the very few systems in which two important tissue-specific enzymes are derived from the same gene by the use of alternative intronic promoters.	Jerry L Pettis Mem Vet Affairs Med Ctr, Musculoskeletal Dis Ctr 151, Loma Linda, CA 92357 USA; Loma Linda Univ, Dept Med, Loma Linda, CA 92357 USA; Loma Linda Univ, Dept Biochem, Loma Linda, CA 92357 USA	Loma Linda University; Loma Linda University	Lau, KHW (corresponding author), Jerry L Pettis Mem Vet Affairs Med Ctr, Musculoskeletal Dis Ctr 151, 11201 Benton St, Loma Linda, CA 92357 USA.	laub@lom.med.va.gov		Tillman, John/0000-0003-2912-2370; Lau, Kin-Hing/0000-0003-1109-5052	NIDCR NIH HHS [R01DE13097] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013097] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aguiar RCT, 1999, BLOOD, V94, P2403, DOI 10.1182/blood.V94.7.2403.419k39_2403_2413; Barber MC, 1998, BIOCHEM J, V333, P17, DOI 10.1042/bj3330017; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Jones FS, 1999, BIOESSAYS, V21, P372, DOI 10.1002/(SICI)1521-1878(199905)21:5<372::AID-BIES3>3.0.CO;2-3; MATSUI T, 1995, MOL CELL BIOL, V15, P1961; Moroni E, 2000, J BIOL CHEM, V275, P10567, DOI 10.1074/jbc.275.14.10567; PIXLEY FJ, 1995, J BIOL CHEM, V270, P27339, DOI 10.1074/jbc.270.45.27339; RHIM JS, 1975, INT J CANCER, V15, P23, DOI 10.1002/ijc.2910150104; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P3068, DOI 10.1073/pnas.93.7.3068; SEIMIYA H, 1995, ONCOGENE, V10, P1731; Seimiya H, 1998, J BIOL CHEM, V273, P21187, DOI 10.1074/jbc.273.33.21187; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Suhr SM, 2001, J BONE MINER RES, V16, P1795, DOI 10.1359/jbmr.2001.16.10.1795; Tagawa M, 1997, BIOCHEM J, V321, P865, DOI 10.1042/bj3210865; THOMAS PE, 1994, J BIOL CHEM, V269, P19953; Umeda S, 1999, AM J PATHOL, V155, P223, DOI 10.1016/S0002-9440(10)65116-4; Wang RX, 2000, KIDNEY INT, V57, P1847, DOI 10.1046/j.1523-1755.2000.00034.x; WERGEDAL JE, 1984, P SOC EXP BIOL MED, V176, P60; Wharram BL, 2000, J CLIN INVEST, V106, P1281, DOI 10.1172/JCI7236; WIGGINS RC, 1995, GENOMICS, V27, P174, DOI 10.1006/geno.1995.1021; Wu LW, 1996, BIOCHEM J, V316, P515, DOI 10.1042/bj3160515; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	23	33	37	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44273	44280		10.1074/jbc.M303933200	http://dx.doi.org/10.1074/jbc.M303933200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12949066	hybrid			2022-12-27	WOS:000186306700048
J	Cunchillos, C; Lecointre, G				Cunchillos, C; Lecointre, G			Evolution of amino acid metabolism inferred through cladistic analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLE; PARSIMONY; ORIGIN	Because free amino acids were most probably available in primitive abiotic environments, their metabolism is likely to have provided some of the very first metabolic pathways of life. What were the first enzymatic reactions to emerge? A cladistic analysis of metabolic pathways of the 16 aliphatic amino acids and 2 portions of the Krebs cycle was performed using four criteria of homology. The analysis is not based on sequence comparisons but, rather, on coding similarities in enzyme properties. The properties used are shared specific enzymatic activity, shared enzymatic function without substrate specificity, shared coenzymes, and shared functional family. The tree shows that the earliest pathways to emerge are not portions of the Krebs cycle but metabolisms of aspartate, asparagine, glutamate, and glutamine. The views of Horowitz (Horowitz, N. H. (1945) Proc. Natl. Acad. Sci. U. S. A. 31, 153-157) and Cordon (Cordon, F. (1990) Tratado Evolucionista de Biologia, Aguilar, Madrid, Spain), according to which the upstream reactions in the catabolic pathways and the downstream reactions in the anabolic pathways are the earliest in evolution, are globally corroborated; however, with some exceptions. These are due to later opportunistic connections of pathways ( actually already suggested by these authors). Earliest enzymatic functions are mostly catabolic; they were deaminations, transaminations, and decarboxylations. From the consensus tree we extracted four time spans for amino acid metabolism development. For some amino acids catabolism and biosynthesis occurred at the same time (Asp, Glu, Lys, Leu, Ala, Val, Ile, Pro, Arg). For others ultimate reactions that use amino acids as a substrate or as a product are distinct in time, with catabolism preceding anabolism for Asn, Gln, and Cys and anabolism preceding catabolism for Ser, Met, and Thr. Cladistic analysis of the structure of biochemical pathways makes hypotheses in biochemical evolution explicit and parsimonious.	Inst Charles Darwin Int, F-93230 Romainville, France; Museum Natl Hist Nat, CNRS, UMR 7138, Dept Systemat,Serv Systemat Mol, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Lecointre, G (corresponding author), Inst Charles Darwin Int, BP 70, F-93230 Romainville, France.	lecointr@mnhn.fr						[Anonymous], 1983, ADV CLADISTICS; CAVALIERSMITH T, 1987, COLD SPRING HARB SYM, V52, P805, DOI 10.1101/SQB.1987.052.01.089; Copley SD, 2000, TRENDS BIOCHEM SCI, V25, P261, DOI 10.1016/S0968-0004(00)01562-0; Cordon F., 1990, TRATADO EVOLUCIONIST; Cunchillos C, 2002, CR BIOL, V325, P119, DOI 10.1016/S1631-0691(02)01411-7; CUNCHILLOS C, 1997, DARWIN, P425; Cunchillos Chomin, 2000, Biosystema, V18, P87; DARLU P, 1993, RECONSTRUCTION PHYLO; DEPINNA MCC, 1991, CLADISTICS, V7, P367; FOREY PL, 1992, CLADISTICS PRACTICAL; Forst CV, 2001, J MOL EVOL, V52, P471, DOI 10.1007/s002390010178; FOTHERGILLGILMORE LA, 1993, PROG BIOPHYS MOL BIO, V59, P105, DOI 10.1016/0079-6107(93)90001-Z; GEST H, 1981, FEMS MICROBIOL LETT, V12, P209; GEST H, 1987, BIOCHEM SOC SYMP, P3; GOLOBOFF P, 1998, NONA COMPUTER PROGRA; Hennig W., 1950, GRUNDZUGE THEORIE PH; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; HOLDEN JT, 1968, J THEOR BIOL, V21, P97, DOI 10.1016/0022-5193(68)90062-3; HOROWITZ NH, 1945, P NATL ACAD SCI USA, V31, P153, DOI 10.1073/pnas.31.6.153; JALLON JM, 1983, EVOLUTION PROTEINES, P92; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kluge AG, 2001, CLADISTICS, V17, P199, DOI 10.1111/j.1096-0031.2001.tb00117.x; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; MelendezHevia E, 1996, J MOL EVOL, V43, P293, DOI 10.1007/PL00006089; Michal G, 1999, BIOCH PATHWAYS; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Nixon KC, 1999, WINCLADA BETA VERSIO; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; PETSKO GA, 1993, TRENDS BIOCHEM SCI, V18, P372, DOI 10.1016/0968-0004(93)90091-Z; PIERARD A, 1983, EVOLUTION PROTEINES, P53; SANDERSON MJ, 1996, HOMOPLASY; SCHOFFENIELS E, 1984, BIOCH COMP; SCHOFFENIELS E, 1981, CAHIERS BIOCH PARIS; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; TAKIGUCHI M, 1989, BIOESSAYS, V10, P163, DOI 10.1002/bies.950100506; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	38	13	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47960	47970		10.1074/jbc.M213028200	http://dx.doi.org/10.1074/jbc.M213028200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12949083	hybrid			2022-12-27	WOS:000186731400074
J	Rauch, J; Gumperz, J; Robinson, C; Skold, M; Roy, C; Young, DC; Lafleur, M; Moody, DB; Brenner, MB; Costello, CE; Behar, SM				Rauch, J; Gumperz, J; Robinson, C; Skold, M; Roy, C; Young, DC; Lafleur, M; Moody, DB; Brenner, MB; Costello, CE; Behar, SM			Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-GALACTOSYLCERAMIDE; T-CELLS; MOUSE CD1; CRYSTAL-STRUCTURE; LIPID ANTIGEN; ACTIVATION; BINDING; LIGAND; REQUIREMENTS; GLYCOLIPIDS	Little is known about the antigen specificity of CD1d-restricted T cells, except that they frequently recognize CD1d-expressing antigen-presenting cells in the absence of exogenous antigen. We previously demonstrated that the 24.8.A iNKT cell hybridoma was broadly reactive with CD1d-transfected cell lines and recognized the polar lipid fraction of a tumor cell extract. In the present study, the antigen recognized by the 24.8.A iNKT cell hybridoma was purified to homogeneity and identified as palmitoyl-oleoyl-sn-glycero-3-phosphoethanolamine (16: 0 - 18: 1 PE). The 24.8. A iNKT cell hybridoma recognized synthetic 16: 0-18: 1[cis] PE, confirming that this phospholipid is antigenic. Recognition correlated with the degree of unsaturation of the acyl chains. Using a panel of synthetic PEs, the 24.8. A iNKT cell hybridoma was shown to be activated by PEs that contained at least one unsaturated acyl chain. The configuration of the double bonds was important, as the 24.8. A iNKT cell hybridoma recognized unsaturated acyl chains in the cis, but not the trans, configuration. PEs with multiple double bonds were recognized better than those with a single double bond, and increasing acyl chain unsaturation correlated with increased binding of PE to CD1d. These data illustrate the potential importance of the acyl chain structure for phospholipid antigen binding to CD1d.	Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; McGill Univ, Ctr Hlth, Res Inst, Div Rheumatol, Montreal, PQ H3G 1A4, Canada; Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada	Harvard University; Brigham & Women's Hospital; McGill University; Boston University; Universite de Montreal	Behar, SM (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Smith Bldg,Rm 516,1 Jimmy Fund Way, Boston, MA 02115 USA.	sbehar@rics.bwh.harvard.edu	Behar, Samuel M/C-3541-2009	Costello, Catherine/0000-0003-1594-5122; Behar, Samuel/0000-0002-3374-6699	Canadian Institutes of Health Research [42391] Funding Source: Medline; NHLBI NIH HHS [R01 HL071590] Funding Source: Medline; NIAID NIH HHS [R01 AI049313, R01-AI49313] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049313] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Behar SM, 1999, J IMMUNOL, V162, P161; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Burdin N, 1998, J IMMUNOL, V161, P3271; Cantu C, 2003, J IMMUNOL, V170, P4673, DOI 10.4049/jimmunol.170.9.4673; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; CASTANO AR, 1995, SCIENCE, V269, P223, DOI 10.1126/science.7542403; Cronan JE, 2002, CURR OPIN MICROBIOL, V5, P202, DOI 10.1016/S1369-5274(02)00297-7; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Cullis P.R., 1985, PHOSPHOLIPIDS CELLUL, P1; D'Andrea A, 2000, EUR J IMMUNOL, V30, P1544, DOI 10.1002/1521-4141(200006)30:6<1544::AID-IMMU1544>3.0.CO;2-I; De Silva AD, 2002, J IMMUNOL, V168, P723, DOI 10.4049/jimmunol.168.2.723; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Exley MA, 2001, J LEUKOCYTE BIOL, V69, P713; Gadola SD, 2002, J IMMUNOL, V168, P5514, DOI 10.4049/jimmunol.168.11.5514; Gonzalez-Aseguinolaza G, 2000, P NATL ACAD SCI USA, V97, P8461, DOI 10.1073/pnas.97.15.8461; Grant EP, 2002, J IMMUNOL, V168, P3933, DOI 10.4049/jimmunol.168.8.3933; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kawano T, 1999, CANCER RES, V59, P5102; Kawano T, 1998, P NATL ACAD SCI USA, V95, P5690, DOI 10.1073/pnas.95.10.5690; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; LJUNGGREN HG, 1991, INT J CANCER, P38; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Naidenko OV, 1999, J EXP MED, V190, P1069, DOI 10.1084/jem.190.8.1069; Niazi KR, 2001, J IMMUNOL, V166, P2562, DOI 10.4049/jimmunol.166.4.2562; Park SH, 1998, J IMMUNOL, V160, P3128; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; Porcelli SA, 1997, CURR BIOL, V7, pR508, DOI 10.1016/S0960-9822(06)00250-8; Schofield L, 1999, SCIENCE, V283, P225, DOI 10.1126/science.283.5399.225; SMITH PBW, 1995, ANAL CHEM, V67, P1824, DOI 10.1021/ac00107a011; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; TILCOCK CPS, 1982, BIOCHIM BIOPHYS ACTA, V684, P212, DOI 10.1016/0005-2736(82)90008-6; van der Vliet HJJ, 2000, BLOOD, V95, P2440, DOI 10.1182/blood.V95.7.2440.007k35_2440_2442; Wang B, 2001, J EXP MED, V194, P313, DOI 10.1084/jem.194.3.313; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	44	116	119	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47508	47515		10.1074/jbc.M308089200	http://dx.doi.org/10.1074/jbc.M308089200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12963715	hybrid, Green Accepted			2022-12-27	WOS:000186731400022
J	Guo, C; Piacentini, L				Guo, C; Piacentini, L			Type I collagen-induced MMP-2 activation coincides with up-regulation of membrane type 1-matrix metalloproteinase and TIMP-2 in cardiac fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1 MATRIX-METALLOPROTEINASE; INTEGRIN ALPHA(V) SUBUNIT; GELATINASE-A; ENDOTHELIAL-CELLS; TISSUE INHIBITOR; PROGELATINASE-A; CARCINOMA-CELLS; ANGIOTENSIN-II; TUMOR-CELLS; EXPRESSION	Migration of cardiac fibroblasts is implicated in infarct healing and ventricular remodeling. Activation of matrix metalloproteinases induced by three-dimensional type I collagen, the principal component of the myocardial interstitium, is hypothesized to be essential for this migration. By utilizing primary cultures of cardiac fibroblasts and collagen lattice models, we demonstrated that type I collagen induced MMP-2 activation, and cells undergoing a change from isometric tension to mechanical unloading were associated with increased levels of total and active MMP-2 species. The collagen-induced MMP-2 activation coincided with up-regulated cellular levels of both membrane type 1-matrix metalloproteinase (MT1-MMP) and TIMP-2. A fraction of cellular membrane prepared from cells embedded in the collagen lattice containing active MT1-MMP and TIMP-2 was capable of activating pro-MMP-2, and exogenous TIMP-2 had a biphasic effect on this membrane-mediated MMP-2 activation. Interestingly, the presence of 43-kDa MT1-MMP species in a fraction of intracellular soluble proteins prepared from monolayer cells but not cells embedded in the lattices indicates that MT1-MMP metabolizes differently under the two different culture conditions. Treatment of cells embedded in the lattice with furin inhibitor attenuated pro-MT1-MMP processing and MMP-2 activation and impeded cell migration and invasion. These results suggest that the migration and invasion of cardiac fibroblasts is furin-dependent and that the active species of MT1-MMP and MMP-2 may be involved in both events.	De Montfort Univ, Sch Pharm & Pharmaceut Sci, Leicester LE1 9BH, Leics, England	De Montfort University	Guo, C (corresponding author), Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.		Guo, Chun/AAM-5894-2020	Guo, Chun/0000-0002-1540-3166				AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; ALBINI A, 1987, CANCER RES, V47, P3239; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Aznavoorian S, 2001, CANCER RES, V61, P6264; Bafetti LM, 1998, J BIOL CHEM, V273, P143, DOI 10.1074/jbc.273.1.143; Bassi DE, 2001, P NATL ACAD SCI USA, V98, P10326, DOI 10.1073/pnas.191199198; Borg KT, 1997, CARDIOVASC PATHOL, V6, P261, DOI 10.1016/S1054-8807(96)00138-X; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; Deryugina EI, 1997, J CELL SCI, V110, P2473; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Graf K, 2000, HYPERTENSION, V35, P978, DOI 10.1161/01.HYP.35.4.978; Grinnell F, 1999, EXP CELL RES, V248, P608, DOI 10.1006/excr.1999.4440; Grinnell F, 1999, J BIOL CHEM, V274, P918, DOI 10.1074/jbc.274.2.918; Haas TL, 1998, J BIOL CHEM, V273, P3604, DOI 10.1074/jbc.273.6.3604; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kanekar S, 2000, CELL ADHES COMMUN, V7, P513, DOI 10.3109/15419060009040308; Kurschat P, 1999, J BIOL CHEM, V274, P21056, DOI 10.1074/jbc.274.30.21056; Lee AY, 1997, P NATL ACAD SCI USA, V94, P4424, DOI 10.1073/pnas.94.9.4424; Li L, 1997, EXP CELL RES, V232, P322, DOI 10.1006/excr.1997.3510; Maquoi E, 1998, FEBS LETT, V424, P262, DOI 10.1016/S0014-5793(98)00187-2; MAYER U, 1993, EUR J BIOCHEM, V217, P877, DOI 10.1111/j.1432-1033.1993.tb18316.x; MONSKY WL, 1993, CANCER RES, V53, P3159; MURPHY G, 1981, BIOCHEM J, V199, P807, DOI 10.1042/bj1990807; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Nakamura H, 1999, CANCER RES, V59, P467; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nguyen M, 2000, INT J BIOCHEM CELL B, V32, P621, DOI 10.1016/S1357-2725(00)00013-3; NOMURA H, 1995, CANCER RES, V55, P3263; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; OKADA Y, 1990, EUR J BIOCHEM, V194, P721, DOI 10.1111/j.1432-1033.1990.tb19462.x; PAULY RR, 1994, CIRC RES, V75, P41, DOI 10.1161/01.RES.75.1.41; Pei DQ, 2000, J BIOL CHEM, V275, P33988, DOI 10.1074/jbc.M006493200; Piacentini L, 2000, J MOL CELL CARDIOL, V32, P565, DOI 10.1006/jmcc.2000.1109; Ratnikov BI, 2002, J BIOL CHEM, V277, P7377, DOI 10.1074/jbc.M109580200; Rosenfeldt H, 2000, J BIOL CHEM, V275, P3088, DOI 10.1074/jbc.275.5.3088; Ruangpanit N, 2001, MATRIX BIOL, V20, P193, DOI 10.1016/S0945-053X(01)00135-4; Sato T, 1997, J CELL SCI, V110, P589; SELTZER JL, 1994, EXP CELL RES, V213, P365, DOI 10.1006/excr.1994.1211; Shofuda KI, 2001, ANN NY ACAD SCI, V947, P337; STETLERSTEVENSON WG, 1994, INVAS METAST, V14, P259; Theret N, 1999, HEPATOLOGY, V30, P462, DOI 10.1002/hep.510300236; Tomasek JJ, 1997, J BIOL CHEM, V272, P7482, DOI 10.1074/jbc.272.11.7482; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; VRACKO R, 1988, LAB INVEST, V58, P77; Weber KT, 1997, CIRCULATION, V96, P4065; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Zigrino P, 2001, EUR J CELL BIOL, V80, P68, DOI 10.1078/0171-9335-00134; ZUCKER S, 1995, J BIOL CHEM, V270, P23730, DOI 10.1074/jbc.270.40.23730	53	46	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46699	46708		10.1074/jbc.M307238200	http://dx.doi.org/10.1074/jbc.M307238200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12970340	hybrid			2022-12-27	WOS:000186569400060
J	Igarashi, N; Okada, T; Hayashi, S; Fujita, T; Jahangeer, S; Nakamura, S				Igarashi, N; Okada, T; Hayashi, S; Fujita, T; Jahangeer, S; Nakamura, S			Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; IMPORTIN-BETA; KINASE; SPHINGOSINE-1-PHOSPHATE; 1-PHOSPHATE; RECEPTORS; GROWTH; PHOSPHATE; INTERACTS	Sphingosine kinase-1 (SPHK1) is a key enzyme catalyzing the formation of an important bioactive lipid messenger, sphingosine 1-phosphate, and is implicated in the regulation of cell proliferation and antiapoptotic processes. Biological features of another isozyme SPHK2, however, remain unclear. The present studies were undertaken to characterize SPHK2 by comparison with SPHK1. When SPHK2 was transiently expressed in various cell lines, it was localized in the nuclei as well as in the cytosol, whereas SPHK1 was distributed in the cytosol but not in the nucleus. We have mapped a functional nuclear localization signal (NLS) to the N-terminal region of SPHK2. We have observed that the expression of SPHK2 in various cell types causes inhibition of DNA synthesis, resulting in the cell cycle arrest at G(1)/S phase. We have also demonstrated that an NLS mutant of SPHK2, SPHK2R93E/R94E, failed to enter the nucleus and to inhibit DNA synthesis. Moreover, a fusion protein, NLS-SPHK1, where SPHK1 was fused to the NLS sequence of SPHK2 acquired the ability to enter nuclei and inhibited DNA synthesis. These results indicate that SPHK2 localizes in the nuclei and causes inhibition of DNA synthesis, and this may affect subsequent cellular events.	Kobe Univ, Grad Sch Med, Dept Mol & Cellular Biol, Div Biochem, Kobe, Hyogo 6500017, Japan	Kobe University	Nakamura, S (corresponding author), Kobe Univ, Grad Sch Med, Dept Mol & Cellular Biol, Div Biochem, Kobe, Hyogo 6500017, Japan.							BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUNCE CM, 1988, ANAL BIOCHEM, V175, P67, DOI 10.1016/0003-2697(88)90362-4; CHAUVEAU J, 1956, EXP CELL RES, V11, P317, DOI 10.1016/0014-4827(56)90107-0; Goetzl EJ, 1998, FASEB J, V12, P1589, DOI 10.1096/fasebj.12.15.1589; Hayashi S, 2002, J BIOL CHEM, V277, P33319, DOI 10.1074/jbc.M201442200; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Kleuser B, 2001, FEBS LETT, V503, P85, DOI 10.1016/S0014-5793(01)02697-7; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; KREK W, 1995, METHOD ENZYMOL, V254, P114; Lacana E, 2002, J BIOL CHEM, V277, P32947, DOI 10.1074/jbc.M202841200; Le Stunff H, 2002, BBA-MOL CELL BIOL L, V1582, P8, DOI 10.1016/S1388-1981(02)00132-4; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Palmeri D, 1999, MOL CELL BIOL, V19, P1218; Perander M, 2001, J BIOL CHEM, V276, P13015, DOI 10.1074/jbc.M010356200; Pyne S, 2002, BBA-MOL CELL BIOL L, V1582, P121, DOI 10.1016/S1388-1981(02)00146-4; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Spiegel S, 2000, BBA-MOL CELL BIOL L, V1484, P107, DOI 10.1016/S1388-1981(00)00010-X; Truant R, 1999, MOL CELL BIOL, V19, P1210; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200	21	327	336	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46832	46839		10.1074/jbc.M306577200	http://dx.doi.org/10.1074/jbc.M306577200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12954646	hybrid			2022-12-27	WOS:000186569400075
J	Nguyen, QGV; Buskin, JN; Himeda, CL; Shield, MA; Haushka, SD				Nguyen, QGV; Buskin, JN; Himeda, CL; Shield, MA; Haushka, SD			Differences in the function of three conserved E-boxes of the muscle creatine kinase gene in cultured myocytes and in transgenic mouse skeletal and cardiac muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAS DOMAIN PROTEIN-1; LOOP-HELIX PROTEINS; TRANSCRIPTION FACTORS; REGULATORY ELEMENTS; DNA-BINDING; CHLORAMPHENICOL ACETYLTRANSFERASE; DEVELOPMENTAL REGULATION; EXPRESSION; ENHANCER; MYOD	The 1256-base pair enhancer-promoter of the mouse muscle creatine kinase gene includes three CAnnTG E-boxes that are conserved among mammals and have flanking and middle sequences conforming to consensus muscle regulatory factor binding sites. This study seeks to determine whether these E-boxes are critical for muscle creatine kinase expression in physiologically distinct muscles. Mutations of the "right" and "left" E-boxes in the enhancer decreased expression in cultured skeletal myocytes similar to 10- and 2-fold, respectively, whereas a "promoter" E-box mutation had little effect. In neonatal myocardiocytes, the left E-box mutation decreased expression similar to 3-fold, whereas right or promoter E-box mutations had no effect. Very different effects were seen in transgenic mice, where the promoter E-box mutation decreased expression in quadriceps, extensor digitorum longus, and soleus similar to 10-fold, and similar to 100-fold in distal tongue, diaphragm, and ventricle. The right E-box mutation, tested in the presence of the other two mutations, caused a significant decrease in distal tongue, but not in quadriceps, extensor digitorum longus, soleus, or ventricle. Mutation of the left E-box actually raised expression in soleus, suggesting a possible repressor role for this control element. The discrepancies between mutation effects in differentiating skeletal muscle cultures, neonatal myocardiocytes, and adult mice suggested that the E-boxes might play different roles during muscle development and adult steady-state function. However, transgenic analysis of embryonic and early postnatal mice indicated no positive role for these three E-boxes in early development, implying that differences in E-box function between adult muscle and cultured cells are the result of physiological signals.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Haushka, SD (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	haus@u.washington.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL064387, R01HL064387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR018860, R37AR018860] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 64387] Funding Source: Medline; NIAMS NIH HHS [AR 18860] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; AMACHER SL, 1993, MOL CELL BIOL, V13, P2753, DOI 10.1128/MCB.13.5.2753; APONE S, 1995, J BIOL CHEM, V270, P21420, DOI 10.1074/jbc.270.36.21420; Arnold HH, 1996, INT J DEV BIOL, V40, P345; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; BUSKIN JN, 1989, MOL CELL BIOL, V9, P2627, DOI 10.1128/MCB.9.6.2627; Calvo S, 1999, MOL CELL BIOL, V19, P515; Calvo S, 2001, MOL CELL BIOL, V21, P8490, DOI 10.1128/MCB.21.24.8490-8503.2001; Chin MT, 2000, J BIOL CHEM, V275, P6381, DOI 10.1074/jbc.275.9.6381; Chu K, 2001, RECENT PROG HORM RES, V56, P23, DOI 10.1210/rp.56.1.23; CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949; Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823; CSERJESI P, 1992, DEVELOPMENT, V115, P1087; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Dambly-Chaudiere C, 1998, INT J DEV BIOL, V42, P269; Dean J, 2002, J REPROD IMMUNOL, V53, P171, DOI 10.1016/S0165-0378(01)00100-0; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Donoviel DB, 1996, MOL CELL BIOL, V16, P1649; FabreSuver C, 1996, J BIOL CHEM, V271, P4646, DOI 10.1074/jbc.271.9.4646; Freitas EMS, 2002, TOXICON, V40, P1471, DOI 10.1016/S0041-0101(02)00165-4; Garami M, 1996, HYPERTENSION, V28, P315, DOI 10.1161/01.HYP.28.2.315; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Grange RW, 2001, AM J PHYSIOL-CELL PH, V281, pC1487, DOI 10.1152/ajpcell.2001.281.5.C1487; Hauser MA, 2000, MOL THER, V2, P16, DOI 10.1006/mthe.2000.0089; Hilfiker-Kleiner D, 2002, CARDIOVASC RES, V53, P460, DOI 10.1016/S0008-6363(01)00463-1; HORLICK RA, 1989, MOL CELL BIOL, V9, P2396, DOI 10.1128/MCB.9.6.2396; Hughes SM, 1997, MECH DEVELOP, V61, P151, DOI 10.1016/S0925-4773(96)00631-4; HUGHES SM, 1993, DEVELOPMENT, V118, P1137; IWAKI K, 1990, J BIOL CHEM, V265, P13809; JAYNES JB, 1988, MOL CELL BIOL, V8, P62, DOI 10.1128/MCB.8.1.62; JAYNES JB, 1986, MOL CELL BIOL, V6, P2855, DOI 10.1128/MCB.6.8.2855; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; JOHNSON JE, 1989, DEV BIOL, V134, P258, DOI 10.1016/0012-1606(89)90095-X; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; Kaufman M.H., 1992, ATLAS MOUSE DEV; Kiefer JC, 2001, DEV BIOL, V232, P77, DOI 10.1006/dbio.2000.0114; Kophengnavong T, 2000, MOL CELL BIOL, V20, P261, DOI 10.1128/MCB.20.1.261-272.2000; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LEDENT V, 2002, GENOME BIOL, V3; LIN H, 1991, MOL CELL BIOL, V11, P267, DOI 10.1128/MCB.11.1.267; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; LYONS GE, 1991, DEVELOPMENT, V113, P1017; Maemura K, 2002, J MOL CELL CARDIOL, V34, P703, DOI 10.1006/jmcc.2002.2043; Maxwell PH, 2001, ADV EXP MED BIOL, V502, P365; MILLER J, 1981, P NATL ACAD SCI-BIOL, V78, P3829, DOI 10.1073/pnas.78.6.3829; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Muroya S, 2002, ZOOL SCI, V19, P755, DOI 10.2108/zsj.19.755; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Nguyen QGV, 2003, TRANSGENIC RES, V12, P337, DOI 10.1023/A:1023369225799; Norton JD, 2000, J CELL SCI, V113, P3897; Pin CL, 2002, BIOCHEM BIOPH RES CO, V299, P7, DOI 10.1016/S0006-291X(02)02571-8; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Ritter O, 1999, J CELL BIOCHEM, V74, P551, DOI 10.1002/(SICI)1097-4644(19990915)74:4<551::AID-JCB5>3.3.CO;2-0; Rowitch DH, 2002, TRENDS NEUROSCI, V25, P417, DOI 10.1016/S0166-2236(02)02201-4; Schwitzgebel VM, 2001, MOL CELL ENDOCRINOL, V185, P99, DOI 10.1016/S0303-7207(01)00628-1; Seward DJ, 2001, AM J PHYSIOL-CELL PH, V280, pC408, DOI 10.1152/ajpcell.2001.280.2.C408; SHAW WV, 1968, J BACTERIOL, V95, P28, DOI 10.1128/JB.95.1.28-36.1968; Shield MA, 1996, MOL CELL BIOL, V16, P5058; SKERJANC IS, 1994, DEV BIOL, V163, P125, DOI 10.1006/dbio.1994.1128; Spits H, 1998, IMMUNOL REV, V165, P75, DOI 10.1111/j.1600-065X.1998.tb01231.x; Srivastava D, 1999, TRENDS CARDIOVAS MED, V9, P11, DOI 10.1016/S1050-1738(98)00033-4; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Tanaka T, 2002, J MOL CELL CARDIOL, V34, P739, DOI 10.1006/jmcc.2002.2012; Thattaliyath BD, 2002, BIOCHEM BIOPH RES CO, V297, P870, DOI 10.1016/S0006-291X(02)02297-0; Thomas T, 1998, DEV BIOL, V196, P228, DOI 10.1006/dbio.1998.8849; TRASK RV, 1988, J BIOL CHEM, V263, P17142; Vetter ML, 2001, SEMIN CELL DEV BIOL, V12, P491, DOI 10.1006/scdb.2001.0273; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; Walters EH, 2000, J MUSCLE RES CELL M, V21, P647, DOI 10.1023/A:1005683825960; Walters EH, 2000, AM J PHYSIOL-REG I, V278, pR1381, DOI 10.1152/ajpregu.2000.278.5.R1381; Wang G L, 1996, Curr Opin Hematol, V3, P156; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; WIGSTON DJ, 1992, J NEUROBIOL, V23, P61, DOI 10.1002/neu.480230107; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104; Xiao QX, 2002, AM J PHYSIOL-HEART C, V283, pH213, DOI 10.1152/ajpheart.01085.2001; Yamagishi H, 2000, J CLIN INVEST, V105, P261, DOI 10.1172/JCI8856; Yamagishi H, 2001, DEV BIOL, V239, P190, DOI 10.1006/dbio.2001.0417; YAMASHITA K, 1991, J MUSCLE RES CELL M, V12, P37, DOI 10.1007/BF01781172; Yan Z, 2001, J BIOL CHEM, V276, P17361, DOI 10.1074/jbc.M101251200; YI JM, 1991, NUCLEIC ACIDS RES, V19, P3027	87	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46494	46505		10.1074/jbc.M308194200	http://dx.doi.org/10.1074/jbc.M308194200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12968024	hybrid			2022-12-27	WOS:000186569400138
J	Olivera, A; Rosenfeldt, HM; Bektas, M; Wang, F; Ishii, I; Chun, J; Milstien, S; Spiegel, S				Olivera, A; Rosenfeldt, HM; Bektas, M; Wang, F; Ishii, I; Chun, J; Milstien, S; Spiegel, S			Sphingosine kinase type 1 induces G(12/13)-mediated stress fiber formation, yet promotes growth and survival independent of G protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; HETEROTRIMERIC G-PROTEINS; BREAST-CANCER CELLS; DEPENDENT ACTIVATION; SIGNAL-TRANSDUCTION; INTRACELLULAR SPHINGOSINE-1-PHOSPHATE; TYROSINE PHOSPHORYLATION; LYSOPHOSPHATIDIC ACID; EXTRACELLULAR-MATRIX; RHO GTPASES	Sphingosine 1- phosphate ( S1P) is the ligand for a family of specific G protein- coupled receptors ( GPCRs) that regulate a wide variety of important cellular functions, including growth, survival, cytoskeletal rearrangements, and cell motility. However, whether it also has an intracellular function is still a matter of great debate. Overexpression of sphingosine kinase type 1, which generated S1P, induced extensive stress fibers and impaired formation of the Src- focal adhesion kinase signaling complex, with consequent aberrant focal adhesion turnover, leading to inhibition of cell locomotion. We have dissected biological responses dependent on intracellular S1P from those that are receptor- mediated by specifically blocking signaling of Galpha(q), Galpha(i), Galpha(12/13), and Gbetagamma subunits, the G proteins that S1P receptors ( S1PRs) couple to and signal through. We found that intracellular S1P signaled " inside out" through its cell- surface receptors linked to G(12/ 13) -mediated stress fiber formation, important for cell motility. Remarkably, cell growth stimulation and suppression of apoptosis by endogenous S1P were independent of GPCRs and inside- out signaling. Using fibroblasts from embryonic mice devoid of functional S1PRs, we also demonstrated that, in contrast to exogenous S1P, intracellular S1P formed by overexpression of sphingosine kinase type 1 promoted growth and survival independent of its GPCRs. Hence, exogenous and intracellularly generated S1Ps affect cell growth and survival by divergent pathways. Our results demonstrate a receptor- independent intracellular function of S1P, reminiscent of its action in yeast cells that lack S1PRs.	Virginia Commonwealth Univ, Sch Med, Dept Biochem, Richmond, VA 23298 USA; NIAMS, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; NIMH, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA; Natl Inst Neurosci, Dept Mol Genet, Tokyo 1878502, Japan; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Center for Neurology & Psychiatry - Japan; Scripps Research Institute	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem, Med Coll Virginia Campus, Richmond, VA 23298 USA.	sspiegel@vcu.edu		Ishii, Isao/0000-0002-5367-205X; Bektas, Meryem/0000-0001-8080-7557	NATIONAL CANCER INSTITUTE [R01CA061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH001039, K02MH001723] Funding Source: NIH RePORTER; NCI NIH HHS [CA 61774] Funding Source: Medline; NIMH NIH HHS [MH 01723] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alderton F, 2001, J BIOL CHEM, V276, P28578, DOI 10.1074/jbc.M102771200; An SZ, 2000, J BIOL CHEM, V275, P288, DOI 10.1074/jbc.275.1.288; Ancellin N, 1999, J BIOL CHEM, V274, P18997, DOI 10.1074/jbc.274.27.18997; Boujaoude LC, 2001, J BIOL CHEM, V276, P35258, DOI 10.1074/jbc.M105442200; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; CRESPO P, 1995, J BIOL CHEM, V270, P25259, DOI 10.1074/jbc.270.42.25259; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Edsall LC, 2001, J NEUROCHEM, V76, P1573, DOI 10.1046/j.1471-4159.2001.00164.x; English D, 2000, FASEB J, V14, P2255, DOI 10.1096/fj.00-0134com; English D, 1999, J HEMATOTH STEM CELL, V8, P627, DOI 10.1089/152581699319795; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Fukushima N, 2001, ANNU REV PHARMACOL, V41, P507, DOI 10.1146/annurev.pharmtox.41.1.507; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GOODEMOTE KA, 1995, J BIOL CHEM, V270, P10272, DOI 10.1074/jbc.270.17.10272; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hall A, 1998, SCIENCE, V280, P2074, DOI 10.1126/science.280.5372.2074; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heringdorf DMZ, 1998, EMBO J, V17, P2830, DOI 10.1093/emboj/17.10.2830; Heringdorf DMZ, 2001, EUR J PHARMACOL, V414, P145, DOI 10.1016/S0014-2999(01)00789-0; Hisano N, 1999, BLOOD, V93, P4293, DOI 10.1182/blood.V93.12.4293.412k26_4293_4299; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; ILLC D, 1995, NATURE, V377, P539; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kleuser B, 2001, FEBS LETT, V503, P85, DOI 10.1016/S0014-5793(01)02697-7; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; Mao CG, 1999, BIOCHEM J, V342, P667, DOI 10.1042/0264-6021:3420667; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Ohmori T, 2001, J BIOL CHEM, V276, P5274, DOI 10.1074/jbc.M005405200; Okamoto H, 2000, MOL CELL BIOL, V20, P9247, DOI 10.1128/MCB.20.24.9247-9261.2000; Olivera A, 2001, PROSTAG OTH LIPID M, V64, P123, DOI 10.1016/S0090-6980(01)00108-3; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Paris F, 2002, NAT MED, V8, P901, DOI 10.1038/nm0902-901; Pitcher JA, 1998, J BIOL CHEM, V273, P12316, DOI 10.1074/jbc.273.20.12316; Radhika V, 2001, ONCOGENE, V20, P1607, DOI 10.1038/sj.onc.1204274; Rani CSS, 1997, J BIOL CHEM, V272, P10777; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ronnstrand L, 2001, INT J CANCER, V91, P757, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1136>3.0.CO;2-J; Rosenfeldt HM, 2001, FASEB J, V15, P2649, DOI 10.1096/fj.01-0523com; Ryu Y, 2002, CIRC RES, V90, P325, DOI 10.1161/hh0302.104455; Salazar EP, 1999, J BIOL CHEM, V274, P28371, DOI 10.1074/jbc.274.40.28371; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Scheschonka A, 2000, MOL PHARMACOL, V58, P719, DOI 10.1124/mol.58.4.719; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Shu XD, 2002, MOL CELL BIOL, V22, P7758, DOI 10.1128/MCB.22.22.7758-7768.2002; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Spiegel S, 2002, TRENDS CELL BIOL, V12, P236, DOI 10.1016/S0962-8924(02)02277-8; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; van Koppen CJ, 2001, LIFE SCI, V68, P2535, DOI 10.1016/S0024-3205(01)01049-9; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Wang F, 1999, CANCER RES, V59, P6185; Wang F, 1999, EXP CELL RES, V247, P17, DOI 10.1006/excr.1998.4327; Wang F, 1997, BIOCHEM J, V324, P481, DOI 10.1042/bj3240481; Watterson KR, 2002, J BIOL CHEM, V277, P5767, DOI 10.1074/jbc.M110647200; Xia P, 1998, P NATL ACAD SCI USA, V95, P14196, DOI 10.1073/pnas.95.24.14196; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499	75	134	142	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46452	46460		10.1074/jbc.M308749200	http://dx.doi.org/10.1074/jbc.M308749200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963721	hybrid			2022-12-27	WOS:000186569400030
J	Collet, JF; D'Souza, JC; Jakob, U; Bardwell, JCA				Collet, JF; D'Souza, JC; Jakob, U; Bardwell, JCA			Thioredoxin 2, an oxidative stress-induced protein, contains a high affinity zinc binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; ESCHERICHIA-COLI; REDOX SWITCH; REDUCTION; ACTIVATION; MECHANISM; HSP33; ROLES	Two thioredoxins have been described in Escherichia coli, TrxA and Trx2. Both thioredoxins are capable of reducing disulfide bonds using a conserved pair of cysteine residues present in a WCGPC motif. A number of unique structural and regulatory features distinguish the Trx2 subfamily from the much larger TrxA family. The Trx2 subfamily has an additional N-terminal domain of +/-30 residues, which contains two additional conserved CXXC motifs. Moreover, the gene coding for Trx2 is under control of the oxidative stress transcription factor OxyR in E. coli. This suggests that Trx2 may play a role in the cellular defense against oxidative stress. We show here that Trx2 contains zinc in a 1:1 stoichiometry, making it the first identified zinc-binding thioredoxin. The zinc atom is coordinated by the four cysteines of the two N-terminal CXXC motifs. The zinc center of Trx2 binds zinc with a very high affinity (K-a of > 10(18) M-1). We show that in vitro oxidation of the zinc binding cysteines by H2O2 releases the zinc and induces a conformational change. The zinc-free protein conserves its reductase activity. Altogether, our results suggest that the zinc center might play the role of a redox switch, changing a yet to be identified activity.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Univ Catholique Louvain, Chim Physiol Lab, B-1200 Brussels, Belgium	University of Michigan System; University of Michigan; Universite Catholique Louvain	Bardwell, JCA (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.		Collet, Jean Francois/F-2105-2010	Collet, Jean-Francois/0000-0001-8069-7036	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065318, R01GM064662] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM065318, GM064662] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; GALANG CK, 1993, MOL CELL BIOL, V13, P4609, DOI 10.1128/MCB.13.8.4609; Graf PCF, 2002, CELL MOL LIFE SCI, V59, P1624, DOI 10.1007/PL00012489; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Hunt JA, 1997, J BIOL CHEM, V272, P20364, DOI 10.1074/jbc.272.33.20364; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; KOH YS, 1995, J BACTERIOL, V177, P2673, DOI 10.1128/jb.177.10.2673-2678.1995; Lillig CH, 1999, J BIOL CHEM, V274, P7695, DOI 10.1074/jbc.274.12.7695; Maret W, 1998, P NATL ACAD SCI USA, V95, P3478, DOI 10.1073/pnas.95.7.3478; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Miranda-Vizuete A, 1997, J BIOL CHEM, V272, P30841, DOI 10.1074/jbc.272.49.30841; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; Ren B, 1998, NAT STRUCT BIOL, V5, P602, DOI 10.1038/862; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Ritz D, 2000, J BIOL CHEM, V275, P2505, DOI 10.1074/jbc.275.4.2505; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Romero-Isart N, 2002, J INORG BIOCHEM, V88, P388, DOI 10.1016/S0162-0134(01)00347-6; RUSSEL M, 1995, METHOD ENZYMOL, V252, P264; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Vlamis-Gardikas A, 2002, METHOD ENZYMOL, V347, P286; Wisz MS, 1998, BIOCHEMISTRY-US, V37, P8269, DOI 10.1021/bi980718f; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zhou ZHS, 1999, BIOCHEMISTRY-US, V38, P15915, DOI 10.1021/bi992062b	28	71	73	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45325	45332		10.1074/jbc.M307818200	http://dx.doi.org/10.1074/jbc.M307818200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952960	hybrid			2022-12-27	WOS:000186452300035
J	Eghbali, M; Toro, L; Stefani, E				Eghbali, M; Toro, L; Stefani, E			Diminished surface clustering and increased perinuclear accumulation of large conductance Ca(2+-)activated K+ channel in mouse myometrium with pregnancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; EXPRESSION; CURRENTS; MYOCYTES; SUBUNIT; POTENT	Large conductance Ca2+-activated K+ channels play a critical role in regulating myometrium contractility. Their current density, mRNA, and total protein are greatly diminished in myometrium of late pregnant rats versus nonpregnant animals. Opposite to rats, in mice, channel mRNA and total protein increase in late pregnancy, but current density decreases as in rats. Here, we investigated the mechanism of these differences. Real time PCR and Western blots demonstrate that, in late pregnancy, channel transcript quantities and total protein were diminished in rats but up-regulated in mice. High resolution confocal microscopy of single myocytes showed that, in nonpregnant mice, channels were expressed in clusters at the surface membrane. In late pregnancy, although there was an overall increase in channel protein, its majority was accumulated in perinuclear organelles, and channel clustering practically disappeared from the surface membrane. This contrasts with rat myometrium, where there is a reduction of channel transcripts and overall protein levels including the surface membrane. We conclude that large conductance Ca2+-activated K+ channel surface expression is reduced in both rat and mouse late pregnant myometrium. However, in rats, the main mechanism for the reduced channel expression at the cell surface is a diminished transcription, whereas in mice, it is an altered traffic to the surface.	Univ Calif Los Angeles, Sch Med, Dept Anesthesiol, Div Mol Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Stefani, E (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Anesthesiol, Div Mol Med, BH-520A CHS,Box 957115, Los Angeles, CA 90095 USA.	estefani@ucla.edu			NHLBI NIH HHS [HL47382, HL54970] Funding Source: Medline; NICHD NIH HHS [HD38983] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038983] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047382, R01HL054970, R29HL047382] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andrews PD, 2002, TRAFFIC, V3, P29, DOI 10.1034/j.1600-0854.2002.30105.x; Antonucci DE, 2001, NEUROSCIENCE, V108, P69, DOI 10.1016/S0306-4522(01)00476-6; ANWER K, 1993, AM J PHYSIOL, V265, pC976, DOI 10.1152/ajpcell.1993.265.4.C976; Benkusky NA, 2002, FEBS LETT, V524, P97, DOI 10.1016/S0014-5793(02)03011-9; Benkusky NA, 2000, J BIOL CHEM, V275, P27712; CANDIA S, 1992, BIOPHYS J, V63, P583, DOI 10.1016/S0006-3495(92)81630-2; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Holdiman AJ, 2002, MOL CELL ENDOCRINOL, V192, P1, DOI 10.1016/S0303-7207(02)00136-3; Holmes TJ, 2000, J MICROSC-OXFORD, V200, P114, DOI 10.1046/j.1365-2818.2000.00751.x; McNally JG, 1999, METHODS, V19, P373, DOI 10.1006/meth.1999.0873; Meera P, 1996, FEBS LETT, V382, P84, DOI 10.1016/0014-5793(96)00151-2; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; PEREZ GJ, 1993, AM J OBSTET GYNECOL, V168, P652, DOI 10.1016/0002-9378(93)90513-I; Scriven DRL, 2000, BIOPHYS J, V79, P2682, DOI 10.1016/S0006-3495(00)76506-4; Shaw Peter J., 1995, P373; Song M, 1999, FEBS LETT, V460, P427, DOI 10.1016/S0014-5793(99)01394-0; Song M, 2001, J BIOL CHEM, V276, P31883, DOI 10.1074/jbc.M101058200; Wang SY, 1998, J GEN PHYSIOL, V112, P737, DOI 10.1085/jgp.112.6.737; ZhuGe R, 2002, J GEN PHYSIOL, V120, P15, DOI 10.1085/jgp.20028571	20	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45311	45317		10.1074/jbc.M306564200	http://dx.doi.org/10.1074/jbc.M306564200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952984	hybrid			2022-12-27	WOS:000186452300033
J	Harding, A; Hsu, V; Kornfeld, K; Hancock, JF				Harding, A; Hsu, V; Kornfeld, K; Hancock, JF			Identification of residues and domains of Raf important for function in vivo and in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MAP-KINASE; PLASMA-MEMBRANE; CAENORHABDITIS-ELEGANS; SIGNAL-TRANSDUCTION; POSITIVE REGULATOR; SCAFFOLD PROTEINS; LET-60 RAS; MEK KINASE; CELL FATES	Random mutagenesis and genetic screens for impaired Raf function in Caenorhabditis elegans were used to identify six loss-of-function alleles of lin-45 raf that result in a substitution of a single amino acid. The mutations were classified as weak, intermediate, and strong based on phenotypic severity. We engineered these mutations into the homologous residues of vertebrate Raf-1 and analyzed the mutant proteins for their underlying biochemical defects. Surprisingly, phenotype strength did not correlate with the catalytic activity of the mutant proteins. Amino acid substitutions Val-589 and Ser-619 severely compromised Raf kinase activity, yet these mutants displayed weak phenotypes in the genetic screen. Interestingly, this is because these mutant Raf proteins efficiently activate the MAPK (mitogen-activated protein kinase) cascade in living cells, a result that may inform the analysis of knockout mice. Equally intriguing was the observation that mutant proteins with non-functional Ras-binding domains, and thereby deficient in Ras-mediated membrane recruitment, displayed only intermediate strength phenotypes. This confirms that secondary mechanisms exist to couple Ras to Raf in vivo. The strongest phenotype in the genetic screens was displayed by a S508N mutation that again did not correlate with a significant loss of kinase activity or membrane recruitment by oncogenic Ras in biochemical assays. Ser-508 lies within the Raf-1 activation loop, and mutation of this residue in Raf-1 and the equivalent Ser-615 in B-Raf revealed that this residue regulates Raf binding to MEK. Further characterization revealed that in response to activation by epidermal growth factor, the Raf-S508N mutant protein displayed both reduced catalytic activity and aberrant activation kinetics: characteristics that may explain the C. elegans phenotype.	Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ Queensland, Dept Mol & Cellular Pathol, Brisbane, Qld 4072, Australia; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	University of Queensland; University of Queensland; Washington University (WUSTL)	Hancock, JF (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	j.hancock@imb.uq.edu.au	Harding, Angus/B-4120-2012	Hancock, John/0000-0003-0542-4710				Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Adams JA, 2003, BIOCHEMISTRY-US, V42, P601, DOI 10.1021/bi020617o; ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; CHURCH DL, 1995, DEVELOPMENT, V121, P2525; Cissel DS, 2000, J BIOL CHEM, V275, P7066, DOI 10.1074/jbc.275.10.7066; Clark GJ, 1997, J BIOL CHEM, V272, P20990, DOI 10.1074/jbc.272.34.20990; DICKSON B, 1992, NATURE, V360, P600, DOI 10.1038/360600a0; Elion EA, 1998, SCIENCE, V281, P1625, DOI 10.1126/science.281.5383.1625; FABIAN JR, 1994, P NATL ACAD SCI USA, V91, P5982, DOI 10.1073/pnas.91.13.5982; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; FINNEY R, 1995, METHOD ENZYMOL, V255, P310; GARDNER AM, 1994, MOL BIOL CELL, V5, P193, DOI 10.1091/mbc.5.2.193; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; HAN M, 1993, NATURE, V363, P133, DOI 10.1038/363133a0; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; HORVITZ HR, 1991, NATURE, V351, P535, DOI 10.1038/351535a0; Hsu V, 2002, GENETICS, V160, P481; HUANG DCS, 1993, MOL CELL BIOL, V13, P2420, DOI 10.1128/MCB.13.4.2420; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Li WQ, 2000, GENE DEV, V14, P895; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; McPherson RA, 1999, ONCOGENE, V18, P3862, DOI 10.1038/sj.onc.1202730; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Mitsuhashi S, 2003, J BIOL CHEM, V278, P82, DOI 10.1074/jbc.M208888200; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Pritchard CA, 1996, CURR BIOL, V6, P614, DOI 10.1016/S0960-9822(02)00548-1; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Roy S, 1997, J BIOL CHEM, V272, P20139, DOI 10.1074/jbc.272.32.20139; Roy S, 1998, MOL CELL BIOL, V18, P3947, DOI 10.1128/MCB.18.7.3947; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Silverstein AM, 1998, J BIOL CHEM, V273, P20090, DOI 10.1074/jbc.273.32.20090; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; TROPPMAIR J, 1992, ONCOGENE, V7, P1867; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wojnowski L, 2000, MECH DEVELOP, V91, P97, DOI 10.1016/S0925-4773(99)00276-2; Wojnowski L, 1998, MECH DEVELOP, V76, P141, DOI 10.1016/S0925-4773(98)00111-7; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; Yochem J, 1997, MOL CELL BIOL, V17, P2716, DOI 10.1128/MCB.17.5.2716; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x	57	12	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45519	45527		10.1074/jbc.M303106200	http://dx.doi.org/10.1074/jbc.M303106200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954633	hybrid			2022-12-27	WOS:000186452300059
J	Jeong, HS; Lee, MH; Lee, KH; Park, SJ; Choi, SH				Jeong, HS; Lee, MH; Lee, KH; Park, SJ; Choi, SH			SmcR and cyclic AMP receptor protein coactivate Vibrio vulnificus vvpE encoding elastase through the RpoS-dependent promoter in a synergistic manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; HARVEYI LUXR; VIRULENCE DETERMINANTS; ELASTOLYTIC PROTEASE; SUICIDE VECTOR; TRANSCRIPTION; HOMOLOG; METALLOPROTEASE; PATHOGENESIS	The putative virulence factors of Vibrio vulnificus include an elastase, the gene product of vvpE. We previously demonstrated that vvpE expression is differentially directed by two different promoters in a growth phase-dependent manner. The activity of the stationary-phase promoter (promoter S (PS)) is dependent on RpoS and is also under the positive control of cyclic AMP receptor protein (CRP). In this study, primer extension analyses revealed that SmcR, the Vibrio harveyi LuxR homolog, is also involved in the regulation of vvpE transcription by activating PS. Although the influence of CRP on PS is mediated by SmcR, the level of PS activity observed when CRP and SmcR function together was found to be greater than the sum of the PS activities achieved by each activator alone. Western blot analyses demonstrated that the cellular levels of RpoS, CRP, and SmcR were not significantly affected by one other, indicating that CRP and SmcR function cooperatively to activate PS rather than sequentially in a regulatory cascade. The binding sites for CRP and SmcR were mapped based on a deletion analysis of the vvpE promoter region and confirmed by in vitro DNase I protection assays. The binding sites for CRP and SmcR were juxtapositioned and centered 220 and 198 bp upstream of the transcription start site of PS, respectively. Accordingly, these results reveal that CRP and SmcR function synergistically to coactivate the expression of vvpE by the RpoS-dependent promoter (PS) and that the activators exert their effect by directly binding to the promoter in the stationary phase.	Chonnam Natl Univ, Biotechnol Res Inst, Dept Food Sci & Technol, Kwangju 500757, South Korea; Chonnam Natl Univ, Biotechnol Res Inst, Dept Mol Biotechnol, Kwangju 500757, South Korea; Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin 449791, Kyunggi Do, South Korea; Yonsei Univ, Coll Med, Dept Parasitol, Seoul 133791, South Korea	Chonnam National University; Chonnam National University; Hankuk University Foreign Studies; Yonsei University; Yonsei University Health System	Choi, SH (corresponding author), Chonnam Natl Univ, Biotechnol Res Inst, Dept Food Sci & Technol, Kwangju 500757, South Korea.			Park, Soon-Jung/0000-0002-0423-1944; Choi, Sang Ho/0000-0003-3865-1039				Adhya Sankar, 1996, P181; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Busby Stephen, 1996, P255; Cheng JC, 1996, GENE, V183, P255, DOI 10.1016/S0378-1119(96)00488-X; Choi HK, 2002, J BIOL CHEM, V277, P47292, DOI 10.1074/jbc.M206893200; Choi SH, 2000, APPL ENVIRON MICROB, V66, P3911, DOI 10.1128/AEM.66.9.3911-3916.2000; Croxatto A, 2002, J BACTERIOL, V184, P1617, DOI 10.1128/JB.184.6.1617-1629.2002; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Estrem ST, 1998, P NATL ACAD SCI USA, V95, P9761, DOI 10.1073/pnas.95.17.9761; GOOSEN N, 1995, MOL MICROBIOL, V16, P1, DOI 10.1111/j.1365-2958.1995.tb02386.x; Jeong HS, 2001, J BIOL CHEM, V276, P13875, DOI 10.1074/jbc.M010567200; Jeong KC, 2000, INFECT IMMUN, V68, P5096, DOI 10.1128/IAI.68.9.5096-5106.2000; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim SY, 1999, J BIOL CHEM, V274, P25398, DOI 10.1074/jbc.274.36.25398; KOTHARY MH, 1987, J GEN MICROBIOL, V133, P1783; Kovacikova G, 2002, MOL MICROBIOL, V46, P1135, DOI 10.1046/j.1365-2958.2002.03229.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linkous DA, 1999, FEMS MICROBIOL LETT, V174, P207, DOI 10.1111/j.1574-6968.1999.tb13570.x; McCarter LL, 1998, J BACTERIOL, V180, P3166, DOI 10.1128/JB.180.12.3166-3173.1998; McDougald D, 2001, J BACTERIOL, V183, P758, DOI 10.1128/JB.183.2.758-762.2001; McDougald D, 2000, GENE, V248, P213, DOI 10.1016/S0378-1119(00)00117-7; McLeod SM, 2000, J BACTERIOL, V182, P4180, DOI 10.1128/JB.182.15.4180-4187.2000; MEKALANOS JJ, 1992, J BACTERIOL, V174, P1; MILLER JF, 1989, SCIENCE, V243, P916, DOI 10.1126/science.2537530; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Miyoshi S, 1997, J BACTERIOL, V179, P7606, DOI 10.1128/jb.179.23.7606-7609.1997; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Nagai S, 1998, VET MICROBIOL, V60, P227, DOI 10.1016/S0378-1135(98)00144-8; OBYRNE CP, 1994, J BACTERIOL, V176, P905, DOI 10.1128/jb.176.3.905-912.1994; OKA A, 1981, J MOL BIOL, V147, P217, DOI 10.1016/0022-2836(81)90438-1; OLIVER JD, 1986, DIAGN MICR INFEC DIS, V5, P99, DOI 10.1016/0732-8893(86)90112-4; Rhodius VA, 1998, CURR OPIN MICROBIOL, V1, P152, DOI 10.1016/S1369-5274(98)80005-2; SAMBROOK J, 2000, MOL CLONING LAB MANU; SCOTT S, 1995, MOL MICROBIOL, V18, P521, DOI 10.1111/j.1365-2958.1995.mmi_18030521.x; Shao CP, 2001, J BACTERIOL, V183, P1369, DOI 10.1128/JB.183.4.1369-1375.2001; Skorupski K, 1997, P NATL ACAD SCI USA, V94, P265, DOI 10.1073/pnas.94.1.265; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; SWARTZMAN E, 1993, J BIOL CHEM, V268, P16706; Vicente M, 1999, MOL MICROBIOL, V33, P8, DOI 10.1046/j.1365-2958.1999.01445.x; Weyand NJ, 2001, MOL MICROBIOL, V39, P1504, DOI 10.1046/j.1365-2958.2001.02338.x; Williams P, 2000, PHILOS T R SOC B, V355, P667, DOI 10.1098/rstb.2000.0607	41	82	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45072	45081		10.1074/jbc.M308184200	http://dx.doi.org/10.1074/jbc.M308184200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12947096	hybrid			2022-12-27	WOS:000186452300006
J	Mills, JC; Andersson, N; Stappenbeck, TS; Chen, CCM; Gordon, JI				Mills, JC; Andersson, N; Stappenbeck, TS; Chen, CCM; Gordon, JI			Molecular characterization of mouse gastric zymogenic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PROTEIN; EPITHELIAL-CELLS; PARIETAL-CELLS; STOMACH; GROWTH; CORPUS; DYNAMICS; MIGRATION; FURIN; INHIBITION	Zymogenic cells (ZCs), acid-producing parietal cells (PCs), and mucus-secreting pit cells are the principal epithelial lineages in the stomachs of adult mice and humans. Each lineage is derived from the multipotent gastric stem cell and undergoes perpetual renewal within discrete mucosal invaginations (gastric units). In this report, we analyze the molecular features of ZCs and their contributions to gastric epithelial homeostasis. GeneChip analysis yielded a dataset of 57 mRNAs encoding known proteins and 14 ESTs enriched in adult mouse ZCs. This dataset, obtained from comparisons of cellular populations purified by counterflow elutriation and lectin panning, was validated by real-time quantitative reverse transcription-PCR studies of the in vivo expression of selected genes using cells harvested from different regions of gastric units by laser capture microdissection. ZC-enriched mRNAs include regulators of angiogenesis (e.g. platelet-derived growth factors A and B). Because PCs are enriched in transcripts encoding other angiogenic factors (e.g. Vegfb), the contributions of these two lineages to vascular development was examined by performing quantitative three-dimensional imaging of the capillary networks that surround gastric units in two types of mice. In normal adult gnotobiotic FVB/N animals, network density is on average 2-fold higher in ZC- and PC-containing units located in the proximal (corpus) region of the stomach compared with units positioned in the distal (antral) region that lack these lineages (p < 0.01). Gnotobiotic transgenic mice with an engineered ablation of all ZCs and PCs have a 2-fold reduction in capillary network density in their corpus region gastric units compared with the corpus units of normal littermates (p < 0.01). These results support an emerging theme that angiogenesis in the adult mouse gut is modulated by cross-talk between its epithelial lineages and the underlying mesenchyme.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, 660 S Euclid Ave, St Louis, MO 63110 USA.	jgordon@molecool.wustl.edu	Mills, Jason/AAA-6688-2021	Mills, Jason/0000-0002-0402-4662; Andersson, Niklas/0000-0002-3493-7358	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058529, K08DK002954] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK02954, DK58529] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersson N, 1999, BBA-MOL CELL RES, V1451, P297, DOI 10.1016/S0167-4889(99)00101-9; Arceiz E, 1997, EUR J GASTROEN HEPAT, V9, P1179; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Bjerknes M, 2002, AM J PHYSIOL-GASTR L, V283, pG767, DOI 10.1152/ajpgi.00415.2001; Blandizzi C, 1999, EUR J PHARMACOL, V373, P71, DOI 10.1016/S0014-2999(99)00212-5; CORREA P, 1992, CANCER RES, V52, P6735; CROFT DN, 1966, GUT, V7, P333, DOI 10.1136/gut.7.4.333; DEMPSEY PJ, 1992, GASTROENTEROLOGY, V103, P1950, DOI 10.1016/0016-5085(92)91455-D; DONALDSON RM, 1987, PHYSL GASTROINTESTIN, P957; Dougherty KM, 1999, CANCER RES, V59, P6015; FALK P, 1994, AM J PHYSIOL, V266, pG987, DOI 10.1152/ajpgi.1994.266.6.G987; GORVEL JP, 1985, CELL TISSUE RES, V239, P241, DOI 10.1007/BF00214925; Greer P, 2002, NAT REV MOL CELL BIO, V3, P278, DOI 10.1038/nrm783; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hooper LV, 2002, METHOD MICROBIOL, V31, P559, DOI 10.1016/S0580-9517(02)31030-4; Kamimura H, 1999, AM J PHYSIOL-GASTR L, V277, pG183, DOI 10.1152/ajpgi.1999.277.1.G183; KARAM SM, 1993, ANAT RECORD, V236, P280, DOI 10.1002/ar.1092360203; KARAM SM, 1993, ANAT REC, V236, P314, DOI 10.1002/ar.1092360205; KARAM SM, 1993, ANAT REC, V236, P333, DOI 10.1002/ar.1092360206; KARAM SM, 1993, ANAT REC, V236, P297, DOI 10.1002/ar.1092360204; KARAM SM, 1992, ANAT RECORD, V232, P231, DOI 10.1002/ar.1092320208; KARAM SM, 1993, ANAT REC, V236, P259, DOI 10.1002/ar.1092360202; Karam SM, 1997, AM J PHYSIOL-GASTR L, V272, pG1209, DOI 10.1152/ajpgi.1997.272.5.G1209; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Kawano J, 2001, HISTOCHEM CELL BIOL, V115, P421; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; KOELZ HR, 1992, SCAND J GASTROENTERO, V27, P2, DOI 10.3109/00365529209095998; Lazure C, 1998, J BIOL CHEM, V273, P8572, DOI 10.1074/jbc.273.15.8572; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Li L, 2002, GASTROENTEROLOGY, V123, P764, DOI 10.1053/gast.2002.35386; Li QT, 1996, J BIOL CHEM, V271, P3671, DOI 10.1074/jbc.271.7.3671; Mills JC, 2002, P NATL ACAD SCI USA, V99, P14819, DOI 10.1073/pnas.192574799; Mills JC, 2001, P NATL ACAD SCI USA, V98, P13687, DOI 10.1073/pnas.231332398; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nakajima T, 2002, DIGEST DIS SCI, V47, P2729, DOI 10.1023/A:1021005221934; Patel AR, 1999, AM J PHYSIOL-GASTR L, V276, pG441, DOI 10.1152/ajpgi.1999.276.2.G441; Pommier Gilbert J., 1995, Progress in Growth Factor Research, V6, P197, DOI 10.1016/0955-2235(95)00022-4; PRINZ C, 1993, GASTROENTEROLOGY, V105, P449, DOI 10.1016/0016-5085(93)90719-S; QuHong, 1997, J HISTOCHEM CYTOCHEM, V45, P21; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Stappenbeck TS, 2002, METHOD ENZYMOL, V356, P167; Syder AJ, 2003, P NATL ACAD SCI USA, V100, P3467, DOI 10.1073/pnas.0230380100; Syder AJ, 1999, MOL CELL, V3, P263, DOI 10.1016/S1097-2765(00)80454-2; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Weiss TS, 2001, P NATL ACAD SCI USA, V98, P14961, DOI 10.1073/pnas.261572098; Westwood M, 2001, J BIOL CHEM, V276, P41668, DOI 10.1074/jbc.M102793200; Wysolmerski JJ, 1998, ANNU REV PHYSIOL, V60, P431, DOI 10.1146/annurev.physiol.60.1.431; Zirngibl R, 2001, EXP CELL RES, V266, P87, DOI 10.1006/excr.2001.5217	49	30	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46138	46145		10.1074/jbc.M308385200	http://dx.doi.org/10.1074/jbc.M308385200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12963718	hybrid			2022-12-27	WOS:000186452300131
J	Wagner, LE; Li, WH; Yule, DI				Wagner, LE; Li, WH; Yule, DI			Phosphorylation of type-1 inositol 1,4,5-trisphosphate receptors by cyclic nucleotide-dependent protein kinases - A mutational analysis of the functionally important sites in the S2(+) and S2(-) splice variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECONSTITUTED LIPID VESICLES; PANCREATIC ACINAR-CELLS; VASCULAR SMOOTH-MUSCLE; LIGAND-BINDING SITE; INTACT RAT AORTA; TRISPHOSPHATE RECEPTOR; CA2+ RELEASE; MOLECULAR DETERMINANTS; SIGNALING COMPLEX; INSP3 RECEPTOR	Inositol 1,4,5-trisphosphate receptors (InsP(3)R) are the major route of intracellular calcium release in eukaryotic cells and as such are pivotal for stimulation of Ca2+-dependent effectors important for numerous physiological processes. Modulation of this release has important consequences for defining the particular spatio-temporal characteristics of Ca2+ signals. In this study, regulation of Ca2+ release by phosphorylation of type-1 InsP(3)R (InsP(3)R-1) by cAMP (PKA)- and cGMP (PKG)-dependent protein kinases was investigated in the two major splice variants of InsP(3)R-1. InsP(3)R-1 was expressed in DT-40 cells devoid of endogenous InsP3R. In cells expressing the neuronal, S2+ splice variant of the InsP(3)R-1, Ca2+ release was markedly enhanced when either PKA or PKG was activated. The sites of phosphorylation were investigated by mutation of serine residues present in two canonical phosphorylation sites present in the protein. Potentiated Ca2+ release was abolished when serine 1755 was mutated to alanine (S1755A) but was unaffected by a similar mutation of serine 1589 (S1589A). These data demonstrate that Ser-1755 is the functionally important residue for phosphoregulation by PKA and PKG in the neuronal variant of the InsP(3)R-1. Activation of PKA also resulted in potentiated Ca2+ release in cells expressing the non-neuronal, S2+ splice variant of the InsP(3)R-1. However, the PKA-induced potentiation was still evident in S1589A or S1755A InsP(3)R-1 mutants. The effect was abolished in the double (S1589A/S1755A) mutant, indicating both sites are phosphorylated and contribute to the functional effect. Activation of PKG had no effect on Ca2+ release in cells expressing the S2- variant of InsP(3)R-1. Collectively, these data indicate that phosphoregulation of InsP(3)R-1 has dramatic effects on Ca2+ release and defines the molecular sites phosphorylated in the major variants expressed in neuronal and peripheral tissues.	Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Rochester; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Yule, DI (corresponding author), Univ Rochester, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	David_yule@urmc.rochester.edu			NIDCR NIH HHS [R01-DE14756, P01-DE13539] Funding Source: Medline; NIDDK NIH HHS [R01-DK54568] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE013539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054568] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Cavallini L, 1996, J BIOL CHEM, V271, P5545, DOI 10.1074/jbc.271.10.5545; COLBRAN JL, 1992, J BIOL CHEM, V267, P9589; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; den Dekker E, 2002, ARTERIOSCL THROM VAS, V22, P179, DOI 10.1161/hq0102.101515; deSouza N, 2002, J BIOL CHEM, V277, P39397, DOI 10.1074/jbc.M207059200; EHRLICH BE, 1988, NATURE, V336, P583, DOI 10.1038/336583a0; FERRIS CD, 1991, BIOCHEM BIOPH RES CO, V175, P192, DOI 10.1016/S0006-291X(05)81219-7; FERRIS CD, 1991, P NATL ACAD SCI USA, V88, P2232, DOI 10.1073/pnas.88.6.2232; FURUICHI T, 1989, NUCLEIC ACIDS RES, V17, P5385, DOI 10.1093/nar/17.13.5385; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Giovannucci DR, 2000, J BIOL CHEM, V275, P33704, DOI 10.1074/jbc.M004278200; Haug LS, 1999, J BIOL CHEM, V274, P7467, DOI 10.1074/jbc.274.11.7467; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; IINO M, 1991, J GEN PHYSIOL, V98, P681, DOI 10.1085/jgp.98.4.681; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; JOSEPH SK, 1993, J BIOL CHEM, V268, P23059; KOGA T, 1994, J BIOL CHEM, V269, P11640; KOMALAVILAS P, 1994, J BIOL CHEM, V269, P8701; Komalavilas P, 1996, J BIOL CHEM, V271, P21933, DOI 10.1074/jbc.271.36.21933; Kubista H, 1998, BBA-MOL CELL RES, V1448, P299, DOI 10.1016/S0167-4889(98)00132-3; LeBeau AP, 1999, J GEN PHYSIOL, V113, P851, DOI 10.1085/jgp.113.6.851; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; MARANTO AR, 1994, J BIOL CHEM, V269, P1222; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; MIGNERY GA, 1992, J BIOL CHEM, V267, P7450; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; NAKADE S, 1994, J BIOL CHEM, V269, P6735; NAKAGAWA T, 1991, P NATL ACAD SCI USA, V88, P6244, DOI 10.1073/pnas.88.14.6244; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Pieper AA, 2001, NEUROSCIENCE, V102, P433, DOI 10.1016/S0306-4522(00)00470-X; RAPOPORT RM, 1982, P NATL ACAD SCI-BIOL, V79, P6470, DOI 10.1073/pnas.79.21.6470; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Straub SV, 2002, J BIOL CHEM, V277, P31949, DOI 10.1074/jbc.M204318200; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; Tertyshnikova S, 1998, P NATL ACAD SCI USA, V95, P1613, DOI 10.1073/pnas.95.4.1613; Tertyshnikova X, 1998, J PHYSIOL-LONDON, V512, P89, DOI 10.1111/j.1469-7793.1998.089bf.x; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; YAMADA M, 1995, BIOCHEM J, V308, P83, DOI 10.1042/bj3080083; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277	52	83	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45811	45817		10.1074/jbc.M306270200	http://dx.doi.org/10.1074/jbc.M306270200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12939273	hybrid			2022-12-27	WOS:000186452300093
J	Hashimoto, M; Asai, Y; Ogawa, T				Hashimoto, M; Asai, Y; Ogawa, T			Treponemal phospholipids inhibit innate immune responses induced by pathogen-associated molecular patterns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE-BINDING-PROTEIN; TOLL-LIKE RECEPTORS; NF-KAPPA-B; BORRELIA-BURGDORFERI LIPOPROTEINS; CYTOKINE GENE-EXPRESSION; HUMAN MONOCYTIC CELLS; ACUTE PHASE REACTANT; SOLUBLE CD14; ORAL TREPONEMES; PERITONEAL-MACROPHAGES	Host innate immune responses to microbial components, known as pathogen-associated molecular patterns (PAMPs), are regulated and modified by cellular receptors and serum proteins, including Toll-like receptors (TLRs), CD14, and LPS-binding protein (LBP). We demonstrated that a treponemal membrane lipid inhibited PAMPs-induced immune responses. The chemical structure of the lipid was elucidated as a phosphatidylglycerol ( PG) derivative, which is scarce in most mammalian tissues, but relatively abundant in treponemal membrane lipids. Natural and synthetic PG counterparts as well as related natural anionic phospholipids, phosphatidylinositol, phosphatidylserine, and cardiolipin, also demonstrated an inhibitory effect. Further, we noted that PG inhibited PAMPs-induced immune responses by blocking the binding of PAMPs with LBP and CD14. In addition, PG decreased proinflammatory cytokine production in serum of LPS-injected mice and depressed abscess formation in mice infected with treponemes. These results suggest that treponemal phospholipid interfere the function of LBP/CD14 and act as a modulator of innate immune responses.	Asahi Univ Sch Dent, Dept Oral Microbiol, Mizuho Ku, Gifu 5010296, Japan	Asahi University	Ogawa, T (corresponding author), Asahi Univ Sch Dent, Dept Oral Microbiol, Mizuho Ku, 1851-1 Hozumi, Gifu 5010296, Japan.	tomo527@dent.asahi-u.ac.jp	Eckhardt, Erik/G-1567-2010					Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Asai Y, 2003, INFECT IMMUN, V71, P717, DOI 10.1128/IAI.71.2.717-725.2003; Asai Y, 2002, J CLIN MICROBIOL, V40, P3334, DOI 10.1128/JCM.40.9.3334-3340.2002; BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Cunningham MD, 1996, INFECT IMMUN, V64, P3601, DOI 10.1128/IAI.64.9.3601-3608.1996; Dziarski R, 1998, J BIOL CHEM, V273, P8680, DOI 10.1074/jbc.273.15.8680; EHLERS S, 1992, J IMMUNOL, V149, P3016; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; HARRIS EN, 1988, J INFECT DIS, V157, P23, DOI 10.1093/infdis/157.1.23; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Iwaki D, 2002, J BIOL CHEM, V277, P24315, DOI 10.1074/jbc.M107057200; JOHNSON R C, 1970, Infection and Immunity, V2, P606; Kesavalu L, 1997, INFECT IMMUN, V65, P5096, DOI 10.1128/IAI.65.12.5096-5102.1997; Lamping N, 1996, J IMMUNOL, V157, P4648; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; LIVERMORE BP, 1974, J BACTERIOL, V120, P1268, DOI 10.1128/JB.120.3.1268-1273.1974; Luk JM, 1995, ANAL BIOCHEM, V232, P217, DOI 10.1006/abio.1995.0010; MARTIN TR, 1992, J CLIN INVEST, V90, P2209, DOI 10.1172/JCI116106; Matsumoto K, 2001, MOL MICROBIOL, V39, P1427, DOI 10.1046/j.1365-2958.2001.02320.x; MATTHEWS HM, 1980, J BACTERIOL, V143, P1151, DOI 10.1128/JB.143.3.1151-1155.1980; MATTHEWS HM, 1980, BIOCHIM BIOPHYS ACTA, V618, P273, DOI 10.1016/0005-2760(80)90033-8; McCormack FX, 2002, J CLIN INVEST, V109, P707, DOI 10.1172/JCI200215293; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; MONTGOMERY RA, 1991, J IMMUNOL, V147, P554; MORRISON DC, 1976, IMMUNOCHEMISTRY, V13, P813, DOI 10.1016/0019-2791(76)90181-6; MUTA T, 1993, METHOD ENZYMOL, V223, P336; Norgard MV, 1996, INFECT IMMUN, V64, P3845, DOI 10.1128/IAI.64.9.3845-3852.1996; Norris SJ, 2001, J MOL MICROB BIOTECH, V3, P37; OGAWA T, 1982, INFECT IMMUN, V38, P817, DOI 10.1128/IAI.38.3.817-824.1982; Opitz B, 2001, J BIOL CHEM, V276, P22041, DOI 10.1074/jbc.M010481200; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; RADOLF JD, 1989, P NATL ACAD SCI USA, V86, P2051, DOI 10.1073/pnas.86.6.2051; RADOLF JD, 1988, INFECT IMMUN, V56, P490, DOI 10.1128/IAI.56.2.490-498.1988; Rosen G, 1999, INFECT IMMUN, V67, P1180, DOI 10.1128/IAI.67.3.1180-1186.1999; Salez L, 2001, J IMMUNOL, V166, P6376, DOI 10.4049/jimmunol.166.10.6376; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Schroder NW, 2001, J BIOL CHEM, V276, P9713, DOI 10.1074/jbc.M008954200; Schroder NWJ, 2000, J IMMUNOL, V165, P2683, DOI 10.4049/jimmunol.165.5.2683; Schultz CP, 1998, J BIOL CHEM, V273, P15661, DOI 10.1074/jbc.273.25.15661; Schumann RR, 2000, CHEM IMMUNOL, V74, P42; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Sela MN, 2001, CRIT REV ORAL BIOL M, V12, P399, DOI 10.1177/10454411010120050301; Sela MN, 1997, J PERIODONTAL RES, V32, P455, DOI 10.1111/j.1600-0765.1997.tb00558.x; Sellati TJ, 1999, J IMMUNOL, V163, P2049; Singh AE, 1999, CLIN MICROBIOL REV, V12, P187, DOI 10.1128/CMR.12.2.187; Stelter F, 2000, CHEM IMMUNOL, V74, P25; Sugiyama T, 2001, J IMMUNOL, V166, P826, DOI 10.4049/jimmunol.166.2.826; TAKAYAMA K, 1994, J BIOL CHEM, V269, P2241; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; TOBIAS PS, 1989, J BIOL CHEM, V264, P10867; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Umemoto T, 1997, INT J SYST BACTERIOL, V47, P67, DOI 10.1099/00207713-47-1-67; Underhill DM, 2002, CURR OPIN IMMUNOL, V14, P103, DOI 10.1016/S0952-7915(01)00304-1; Vance D., 1996, BIOCH LIPIDS LIPOPRO, V31, P1; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; WRIGHT SD, 1995, J IMMUNOL, V155, P6; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wurfel MM, 1997, J IMMUNOL, V158, P3925; Yu B, 1997, J CLIN INVEST, V99, P315, DOI 10.1172/JCI119160	67	46	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44205	44213		10.1074/jbc.M306735200	http://dx.doi.org/10.1074/jbc.M306735200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947124	hybrid			2022-12-27	WOS:000186306700040
J	Lam, AMI; Keeney, D; Frick, DN				Lam, AMI; Keeney, D; Frick, DN			Two novel conserved motifs in the hepatitis C virus NS3 protein critical for helicase action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-SEPARATING ACTIVITY; INITIATION-FACTOR 4A; RNA HELICASE; CRYSTAL-STRUCTURE; DNA HELICASE; NONSTRUCTURAL PROTEIN-3; DISPLACE STREPTAVIDIN; MUTATIONAL ANALYSIS; KINETIC-ANALYSIS; DOMAIN	The hepatitis C virus (HCV) NS3 helicase shares several conserved motifs with other superfamily 2 (SF2) helicases. Besides these sequences, several additional helicase motifs are conserved among the various HCV genotypes and quasispecies. The roles of two such motifs are examined here. The first motif (YRGXDV) forms a loop that connects SF2 helicase motifs 4 and 5, at the tip of which is Arg(393). When Arg(393) is changed to Ala, the resulting protein (R393A) retains a nucleic acid stimulated ATPase but cannot unwind RNA. R393A also unwinds DNA more slowly than wild type and translocates poorly on single-stranded DNA (ssDNA). DNA and RNA stimulate ATP hydrolysis catalyzed by R393A like the wild type, but the mutant protein binds ssDNA more weakly both in the presence and absence of the nonhydrolyzable ATP analog ADP( BeF3). The second motif ( DFSLDPTF) forms a loop that connects two anti-parallel sheets between SF2 motifs 5 and 6. When Phe(444) in this Phe-loop is changed to Ala, the resulting protein (F444A) is devoid of all activities. When Phe(438) is changed to Ala, the protein (F438A) retains nucleic acid-stimulated ATPase, but does not unwind RNA. F438A unwinds DNA and translocates on ssDNA at about half the rate of the wild type. Equilibrium binding data reveal that this uncoupling of ATP hydrolysis and unwinding is due to the fact that the F438A mutant does not release ssDNA upon ATP binding like the wild type. A model is presented explaining the roles of the Arg-clamp and the Phe-loop in the unwinding reaction.	New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA	New York Medical College	Frick, DN (corresponding author), New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA.	David_Frick@NYMC.edu		Frick, David/0000-0002-2434-7223	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052395] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI052395-02, R01 AI052395, R01 AI052395-01A1, AI052395] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Chamberlain RW, 1997, J GEN VIROL, V78, P1341, DOI 10.1099/0022-1317-78-6-1341; Chao L, 1999, J VIROL, V73, P8798, DOI 10.1128/JVI.73.10.8798-8807.1999; Cho HS, 1998, J BIOL CHEM, V273, P15045, DOI 10.1074/jbc.273.24.15045; Du MX, 2002, BIOCHEM J, V363, P147, DOI 10.1042/0264-6021:3630147; DUBENDORFF JW, 1991, J MOL BIOL, V219, P45, DOI 10.1016/0022-2836(91)90856-2; FRICK DN, 2003, IN PRESS CURR ORG CH, V7; Gesell JJ, 2001, PROTEIN ENG, V14, P573, DOI 10.1093/protein/14.8.573; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gwack Y, 1997, EUR J BIOCHEM, V250, P47, DOI 10.1111/j.1432-1033.1997.00047.x; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kim JW, 2003, J VIROL, V77, P571, DOI 10.1128/JVI.77.1.571-582.2003; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Korolev S, 1998, PROTEIN SCI, V7, P605, DOI 10.1002/pro.5560070309; Kwong AD, 2000, CURR TOP MICROBIOL, V242, P171; Lam AMI, 2003, J VIROL, V77, P3950, DOI 10.1128/JVI.77.7.3950-3961.2003; Leveque VJP, 2002, CELL MOL LIFE SCI, V59, P909, DOI 10.1007/s00018-002-8478-7; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Levin MK, 2002, J BIOL CHEM, V277, P29377, DOI 10.1074/jbc.M112315200; Liu DJ, 2001, J MOL BIOL, V314, P543, DOI 10.1006/jmbi.2001.5146; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Morris PD, 2002, BIOCHEMISTRY-US, V41, P2372, DOI 10.1021/bi012058b; Narjes F, 2003, EXPERT OPIN INV DRUG, V12, P153, DOI 10.1517/eoid.12.2.153.21407; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Paolini C, 2000, J GEN VIROL, V81, P1649, DOI 10.1099/0022-1317-81-7-1649; PONOMAREV MA, 1995, FEBS LETT, V371, P261, DOI 10.1016/0014-5793(95)00898-J; Porter DJT, 2000, BIOCHEMISTRY-US, V39, P5166, DOI 10.1021/bi992384f; Porter DJT, 1998, J BIOL CHEM, V273, P7390, DOI 10.1074/jbc.273.13.7390; Preugschat F, 2000, BIOCHEMISTRY-US, V39, P5174, DOI 10.1021/bi9923860; Preugschat F, 1996, J BIOL CHEM, V271, P24449, DOI 10.1074/jbc.271.40.24449; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Tai CL, 2001, J VIROL, V75, P8289, DOI 10.1128/JVI.75.17.8289-8297.2001; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463	41	53	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44514	44524		10.1074/jbc.M306444200	http://dx.doi.org/10.1074/jbc.M306444200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944414	hybrid, Green Accepted			2022-12-27	WOS:000186306700080
J	Lee, SJ; Kim, SJ; Kim, IK; Ko, J; Jeong, CS; Kim, GH; Park, C; Kang, SO; Suh, PG; Lee, HS; Cha, SS				Lee, SJ; Kim, SJ; Kim, IK; Ko, J; Jeong, CS; Kim, GH; Park, C; Kang, SO; Suh, PG; Lee, HS; Cha, SS			Crystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONSET PARKINSONS-DISEASE; UBIQUITIN-PROTEIN LIGASE; YEDU GENE-PRODUCT; MOLECULAR CHAPERONE; ANDROGEN RECEPTOR; TRICORN PROTEASE; ALPHA-SYNUCLEIN; DEGRADATION; SUPPRESSION; DROSOPHILA	Human DJ-1 and Escherichia coli Hsp31 belong to ThiJ/PfpI family, whose members contain a conserved domain. DJ-1 is associated with autosomal recessive early onset parkinsonism and Hsp31 is a molecular chaperone. Structural comparisons between DJ-1, Hsp31, and an Archaea protease, a member of ThiJ/PfpI family, lead to the identification of the chaperone activity of DJ-1 and the proteolytic activity of Hsp31. Moreover, the comparisons provide insights into how the functional diversity is realized in proteins that share an evolutionarily conserved domain. On the basis of the chaperone activity the possible role of DJ-1 in the pathogenesis of Parkinson's disease is discussed.	Pohang Accelerator Lab, Beamline Div, Pohang 790784, Kyungbuk, South Korea; Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; Seoul Natl Univ, Biophys Lab, Sch Biol Sci, Seoul 151742, South Korea; Seoul Natl Univ, Inst Microbiol, Seoul 151742, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Natl Creat Res Initiat Ctr Behav Genet, Taejon 305710, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST)	Cha, SS (corresponding author), Pohang Accelerator Lab, Beamline Div, Pohang 790784, Kyungbuk, South Korea.		Park, Chankyu/C-1936-2011; Suh, Pann-Ghill/F-3610-2010; Cha, Sun Shin/B-7370-2009	Cha, Sun-Shin/0000-0002-0913-8706				Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Bitto E, 2002, STRUCTURE, V10, P1489, DOI 10.1016/S0969-2126(02)00877-8; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; BRAVO J, 1995, STRUCTURE, V3, P491, DOI 10.1016/S0969-2126(01)00182-4; Cookson MR, 2003, NEURON, V37, P7, DOI 10.1016/S0896-6273(02)01166-2; de Nobel H, 2001, YEAST, V18, P1413, DOI 10.1002/yea.793; Du XL, 2000, P NATL ACAD SCI USA, V97, P14079, DOI 10.1073/pnas.260503597; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Giasson BI, 2002, FREE RADICAL BIO MED, V32, P1264, DOI 10.1016/S0891-5849(02)00804-3; Griffiths SW, 2002, J BIOL CHEM, V277, P25486, DOI 10.1074/jbc.M203089200; Hod Y, 1999, J CELL BIOCHEM, V72, P435, DOI 10.1002/(SICI)1097-4644(19990301)72:3<435::AID-JCB12>3.3.CO;2-8; HOLMAN CM, 1994, BIOCHEMISTRY-US, V33, P2672, DOI 10.1021/bi00175a041; Honbou K, 2003, J BIOL CHEM, V278, P31380, DOI 10.1074/jbc.M305878200; Horvath MM, 2001, PROTEINS, V42, P230, DOI 10.1002/1097-0134(20010201)42:2<230::AID-PROT100>3.3.CO;2-A; Huai Q, 2003, FEBS LETT, V549, P171, DOI 10.1016/S0014-5793(03)00764-6; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kim OG, 2002, ACTA CRYSTALLOGR D, V58, P1217, DOI 10.1107/S0907444902007369; Kim SJ, 2001, NAT STRUCT BIOL, V8, P459, DOI 10.1038/87639; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Malki A, 2003, BIOCHEM BIOPH RES CO, V301, P430, DOI 10.1016/S0006-291X(02)03053-X; Mitsumoto A, 2001, FREE RADICAL RES, V35, P885, DOI 10.1080/10715760100301381; Mitsumoto A, 2001, FREE RADICAL RES, V35, P301, DOI 10.1080/10715760100300831; Mouradian MM, 2002, NEUROLOGY, V58, P179, DOI 10.1212/WNL.58.2.179; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Quigley PM, 2003, P NATL ACAD SCI USA, V100, P3137, DOI 10.1073/pnas.0530312100; Sastry MSR, 2002, J BIOL CHEM, V277, P46026, DOI 10.1074/jbc.M205800200; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Tamura N, 1998, CELL, V95, P637, DOI 10.1016/S0092-8674(00)81634-7; Tamura T, 1996, SCIENCE, V274, P1385, DOI 10.1126/science.274.5291.1385; Tao X, 2003, J BIOL CHEM, V278, P31372, DOI 10.1074/jbc.M304221200; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wagenfeld A, 2000, J ANDROL, V21, P954; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Xu ZH, 2000, NAT STRUCT BIOL, V7, P1172, DOI 10.1038/82040; Zalkin H, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P203; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	50	187	194	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44552	44559		10.1074/jbc.M304517200	http://dx.doi.org/10.1074/jbc.M304517200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12939276	hybrid			2022-12-27	WOS:000186306700084
J	Ma, QJ; Guo, CS; Barnewitz, K; Sheldrick, GM; Soling, HD; Uson, I; Ferrari, DM				Ma, QJ; Guo, CS; Barnewitz, K; Sheldrick, GM; Soling, HD; Uson, I; Ferrari, DM			Crystal structure and functional analysis of Drosophila Wind, a protein-disulfide isomerase-related protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-LUMENAL PROTEIN; THIOREDOXIN-LIKE DOMAIN; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; MOLECULAR-CLONING; IDENTIFICATION; PROGRAM; ERP29; LOCALIZATION; WINDBEUTEL	In the developing Drosophila melanogaster embryo, dorsal-ventral patterning displays an absolute requirement for the product of the essential windbeutel gene, Wind. In homozygous windbeutel mutant flies, dorsal-ventral patterning fails to initiate because of the failure of the Golgi-resident proteoglycan- modifying protein, Pipe, to exit the endoplasmic reticulum, and this leads to the death of the embryo. Here, we describe the three-dimensional structure of Wind at 1.9-Angstrom resolution and identify a candidate surface for interaction with Pipe. This represents the first crystal structure of a eukaryotic protein-disulfide isomerase-related protein of the endoplasmic reticulum to be described. The dimeric protein is composed of an N-terminal thioredoxin domain and a C-terminal alpha-helical domain unique to protein-disulfide isomerase D proteins. Although Wind carries a CXXC motif that is partially surface accessible, this motif is redox inactive, and the cysteines are not required for the targeting of Pipe to the Golgi. However, both domains are required for targeting Pipe to the Golgi, and, although the mouse homologue ERp28 cannot replace the function of Wind, exchange of the Wind D-domain with that of ERp28 allows for efficient Golgi transport of Pipe.	Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; Univ Gottingen, Dept Struct Chem, D-37077 Gottingen, Germany	Max Planck Society; University of Gottingen	Ferrari, DM (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassbert 11, D-37077 Gottingen, Germany.	dferrar@gwdg.de						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bashford D, 1997, LECT NOTES COMPUTER, P233, DOI [10.1007/3-540-63827-X, DOI 10.1007/3-540-63827-X_66]; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAI H, 1994, J BIOL CHEM, V269, P24550; DECROUYCHANEL A, 1995, J BIOL CHEM, V270, P22669, DOI 10.1074/jbc.270.39.22669; Demmer J, 1997, FEBS LETT, V402, P145, DOI 10.1016/S0014-5793(96)01513-X; Ferrari DM, 1998, EUR J BIOCHEM, V255, P570, DOI 10.1046/j.1432-1327.1998.2550570.x; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Katzen F, 2002, EMBO J, V21, P3960, DOI 10.1093/emboj/cdf405; Kemmink J, 1996, BIOCHEMISTRY-US, V35, P7684, DOI 10.1021/bi960335m; Kemmink J, 1999, J BIOMOL NMR, V13, P357, DOI 10.1023/A:1008341820489; Kemmink J, 1997, CURR BIOL, V7, P239, DOI 10.1016/S0960-9822(06)00119-9; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kobayashi M, 1997, J BIOL CHEM, V272, P13980, DOI 10.1074/jbc.272.21.13980; Konsolaki M, 1998, GENE DEV, V12, P120, DOI 10.1101/gad.12.1.120; Kortemme T, 1996, BIOCHEMISTRY-US, V35, P14503, DOI 10.1021/bi9617724; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Langenbach KJ, 1999, J BIOL CHEM, V274, P7032, DOI 10.1074/jbc.274.11.7032; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levitt DG, 2001, ACTA CRYSTALLOGR D, V57, P1013, DOI 10.1107/S0907444901006394; Liepinsh E, 2001, STRUCTURE, V9, P457, DOI 10.1016/S0969-2126(01)00607-4; Majoul IV, 1996, J CELL BIOL, V133, P777, DOI 10.1083/jcb.133.4.777; McLaughlin SH, 1998, BIOCHEM J, V331, P793, DOI 10.1042/bj3310793; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mkrtchian S, 1998, EUR J BIOCHEM, V251, P304, DOI 10.1046/j.1432-1327.1998.2510304.x; Monnat J, 2000, MOL BIOL CELL, V11, P3469, DOI 10.1091/mbc.11.10.3469; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; O'Neill S, 2000, J BIOL CHEM, V275, P36984, DOI 10.1074/jbc.M003279200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Richarme G, 1998, BIOCHEM BIOPH RES CO, V252, P156, DOI 10.1006/bbrc.1998.9591; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Sargsyan E, 2002, J BIOL CHEM, V277, P17009, DOI 10.1074/jbc.M200539200; Sen J, 2000, DEVELOPMENT, V127, P5541; Sergeev P, 2001, DEV DYNAM, V220, P122, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1094>3.0.CO;2-A; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Wang L, 1997, J BIOL CHEM, V272, P27644, DOI 10.1074/jbc.272.44.27644; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389	46	32	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44600	44607		10.1074/jbc.M307966200	http://dx.doi.org/10.1074/jbc.M307966200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941941	hybrid, Green Published			2022-12-27	WOS:000186306700090
J	Scacco, S; Petruzzella, V; Budde, S; Vergari, R; Tamborra, R; Panelli, D; van den Heuvel, LP; Smeitink, JA; Papa, S				Scacco, S; Petruzzella, V; Budde, S; Vergari, R; Tamborra, R; Panelli, D; van den Heuvel, LP; Smeitink, JA; Papa, S			Pathological mutations of the human NDUFS4 gene of the 18-kDa (AQDQ) subunit of complex I affect the expression of the protein and the assembly and function of the complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH DEHYDROGENASE; RESPIRATORY-CHAIN; RNA SURVEILLANCE; MAMMALIAN-CELLS; NUCLEAR GENES; AAA PROTEASES; CAMP CASCADE; MITOCHONDRIA; OXIDOREDUCTASE; DEFICIENCY	Presented is a study of the impact on the structure and function of human complex I of three different homozygous mutations in the NDUFS4 gene coding for the 18-kDa subunit of respiratory complex I, inherited by autosomal recessive mode in three children affected by a fatal neurological Leigh-like syndrome. The mutations consisted, respectively, of a AAGTC duplication at position 466 - 470 of the coding sequence, a single base deletion at position 289/290, and a G44A nonsense mutation in the first exon of the gene. All three mutations were found to be associated with a defect of the assembly of a functional complex in the inner mitochondrial membrane. In all the mutations, in addition to destruction of the carboxyl-terminal segment of the 18-kDa subunit, the amino-terminal segment of the protein was also missing. In the mutation that was expected to produce a truncated subunit, the disappearance of the protein was associated with an almost complete disappearance of the NDUFS4 transcript. These observations show the essential role of the NDUFS4 gene in the structure and function of complex I and give insight into the pathogenic mechanism of NDUFS4 gene mutations in a severe defect of complex I.	Univ Bari, Dept Med Biochem & Mol Biol, I-70124 Bari, Italy; Univ Med Ctr Nijmegen, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, NL-6500 HB Nijmegen, Netherlands; Italian Res Council, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Radboud University Nijmegen	Papa, S (corresponding author), Univ Bari, Dept Med Biochem & Biol, Piazza G Cesare, I-70124 Bari, Italy.		petruzzella, vittoria/K-8863-2016; van den Heuvel, L.P.W.J./H-8044-2014; van den Heuvel, Lambertus/AAM-1772-2021; Scacco, Salvatore/AAC-7406-2022; Smeitink, Jan/C-1351-2013	petruzzella, vittoria/0000-0001-8771-6033; van den Heuvel, L.P.W.J./0000-0003-3917-6727; van den Heuvel, Lambertus/0000-0003-3917-6727; Scacco, Salvatore/0000-0003-2717-2489; Papa, Sergio/0000-0002-4417-1763				Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848; Boffoli D, 1996, BBA-MOL BASIS DIS, V1315, P66, DOI 10.1016/0925-4439(95)00107-7; Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2002, J BIOL CHEM, V277, P50311, DOI 10.1074/jbc.M209166200; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; GOPALAKRISHNAN L, 1994, J BIOL CHEM, V269, P105; HOFHAUS G, 1993, EMBO J, V12, P3043, DOI 10.1002/j.1460-2075.1993.tb05973.x; Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216; Janssen R, 2002, HUM GENET, V110, P264, DOI 10.1007/s00439-001-0673-3; Langer T, 2001, BIOCHEM SOC T, V29, P431, DOI 10.1042/BST0290431; Lenaz G, 1998, BIOFACTORS, V8, P195, DOI 10.1002/biof.5520080305; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Mitchell P, 2001, CURR OPIN CELL BIOL, V13, P320, DOI 10.1016/S0955-0674(00)00214-3; Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200; Papa S, 2002, BBA-BIOENERGETICS, V1555, P147, DOI 10.1016/S0005-2728(02)00270-0; Papa S, 2002, J BIOENERG BIOMEMBR, V34, P1, DOI 10.1023/A:1013863018115; Papa S, 1996, FEBS LETT, V379, P299, DOI 10.1016/0014-5793(95)01532-9; Papa S, 2001, FEBS LETT, V489, P259, DOI 10.1016/S0014-5793(00)02334-6; Petruzzella V, 2002, GENE, V286, P149, DOI 10.1016/S0378-1119(01)00810-1; Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529; Scacco S, 2000, J BIOL CHEM, V275, P17578, DOI 10.1074/jbc.M001174200; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; Schulte U, 2001, J BIOENERG BIOMEMBR, V33, P205, DOI 10.1023/A:1010730919074; Signorile A, 2002, FEBS LETT, V512, P91, DOI 10.1016/S0014-5793(02)02226-3; Smeitink J, 1999, AM J HUM GENET, V64, P1505, DOI 10.1086/302432; Smeitink JAM, 1998, HUM MOL GENET, V7, P1573, DOI 10.1093/hmg/7.10.1573; van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716; Wagner E, 2002, J CELL SCI, V115, P3033; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Yadava N, 2002, J BIOL CHEM, V277, P21221, DOI 10.1074/jbc.M202016200; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131; Zhang J, 1997, EMBO J, V16, P826, DOI 10.1093/emboj/16.4.826	36	108	108	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44161	44167		10.1074/jbc.M307615200	http://dx.doi.org/10.1074/jbc.M307615200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944388	Green Published, hybrid			2022-12-27	WOS:000186306700035
J	Nishikubo, S; Ohara, M; Ueno, Y; Ikura, M; Kurihara, H; Komatsuzawa, H; Oswald, E; Sugai, M				Nishikubo, S; Ohara, M; Ueno, Y; Ikura, M; Kurihara, H; Komatsuzawa, H; Oswald, E; Sugai, M			An N-terminal segment of the active component of the bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; AGROBACTERIUM VIRD2; LOCALIZATION SIGNAL; MAMMALIAN-CELLS; PROTEIN IMPORT; VIRE2 PROTEINS; HELA-CELLS; BINDING; RECOGNITION; TRANSPORT	Cytolethal distending toxin (CDT), produced by Actinobacillus actinomycetemcomitans, is a putative virulence factor in the pathogenesis of periodontal diseases. It is a cell cycle specific inhibitor at the G(2)/M transition. CDTB, one of the subunits of the CDT holotoxin, is implicated in a genotoxic role after entering the target cells, whereby chromosomal damage induces checkpoint phosphorylation cascades. CDTB microinjected into the cytoplasm was shown to localize in the nucleus and induce chromatin collapse. To investigate the molecular mechanism involved in nuclear transport of CDTB, we used transient expression and microinjection of a CDTB-green fluorescent protein (GFP) fusion protein. After microinjection, His-tagged CDTB-GFP entered the nucleus in 3-4 h. Leptomycin B did not increase the speed of entry of the fusion protein, suggesting that the relatively slow entry of the fusion protein is not due to the CRM1-dependent nuclear export of the protein. Nuclear localization of the CDTB-GFP was temperature-dependent. An in vitro transport assay demonstrated that the nuclear localization of CDTB is mediated by active transport. An assay using transient expression of a series of truncated CDTB-GFP fusion proteins revealed that residues 48-124 constitute the minimum region involved in nuclear transport of CDTB. A domain swapping experiment of the region involved in nuclear transport of CDTB with an SV40 T nuclear localization signal indicated that CDTB is composed of two domains, an N-terminal domain for nuclear transport and a C-terminal active domain. Our results strongly suggest that nuclear localization of CDTB is required for the holotoxin to induce cytodistension and cell cycle block. This is the first demonstration that a bacterial toxin possessing a unique domain for nuclear transport is transferred to the animal cell nucleus by active transport.	Hiroshima Univ, Grad Sch Biomed Sci, Dept Bacteriol, Minami Ku, Hiroshima 7348553, Japan; Hiroshima Univ, Grad Sch Biomed Sci, Dept Periodontal Med, Minami Ku, Hiroshima 7348553, Japan; Ecole Natl Vet Toulouse, Inst Natl Rech Agron Interact Hotes Agents Pathog, UMR 1225, F-31076 Toulouse, France	Hiroshima University; Hiroshima University; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Sugai, M (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Bacteriol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	sugai@hiroshima-u.ac.jp	Komatsuzawa, Hitoshi/AAC-7731-2019	Oswald, Eric/0000-0002-3017-0081; Nishikubo, Shuichi/0000-0002-9060-2974				ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; CITOVSKY V, 1994, P NATL ACAD SCI USA, V91, P3210, DOI 10.1073/pnas.91.8.3210; CITOVSKY V, 1992, SCIENCE, V256, P1802, DOI 10.1126/science.1615325; Comayras C, 1997, INFECT IMMUN, V65, P5088, DOI 10.1128/IAI.65.12.5088-5095.1997; Corbett AH, 1997, MICROBIOL MOL BIOL R, V61, P193, DOI 10.1128/.61.2.193-211.1997; Cortes-Bratti X, 1999, J CLIN INVEST, V103, P107, DOI 10.1172/JCI3831; Cortes-Bratti X, 2000, INFECT IMMUN, V68, P6903, DOI 10.1128/IAI.68.12.6903-6911.2000; De Rycke J, 2000, EUR J CELL BIOL, V79, P192, DOI 10.1078/S0171-9335(04)70022-9; Deng KP, 2001, BIOCHEM BIOPH RES CO, V285, P609, DOI 10.1006/bbrc.2001.5223; Elwell C, 2001, INFECT IMMUN, V69, P3418, DOI 10.1128/IAI.69.5.3418-3422.2001; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Escalas N, 2000, EXP CELL RES, V257, P206, DOI 10.1006/excr.2000.4878; Gelvin SB, 1998, J BACTERIOL, V180, P4300, DOI 10.1128/JB.180.16.4300-4302.1998; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Hassane DC, 2003, INFECT IMMUN, V71, P541, DOI 10.1128/IAI.71.1.541-545.2003; HERRERAESTRELLA A, 1990, P NATL ACAD SCI USA, V87, P9534, DOI 10.1073/pnas.87.24.9534; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P115, DOI 10.1016/0882-4010(88)90053-8; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P103, DOI 10.1016/0882-4010(88)90052-6; Jullien D, 1999, EMBO J, V18, P4348, DOI 10.1093/emboj/18.15.4348; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Li LQ, 2002, CELL MICROBIOL, V4, P87, DOI 10.1046/j.1462-5822.2002.00174.x; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Miyamoto Y, 1997, J BIOL CHEM, V272, P26375, DOI 10.1074/jbc.272.42.26375; MOROIANU J, 1995, P NATL ACAD SCI USA, V96, P12542; Nagoshi E, 2001, MOL CELL BIOL, V21, P2779, DOI 10.1128/MCB.21.8.2779-2789.2001; NEWMEYER DD, 1988, CELL, V52, P641, DOI 10.1016/0092-8674(88)90402-3; Peres SY, 1997, MOL MICROBIOL, V24, P1095, DOI 10.1046/j.1365-2958.1997.4181785.x; PICKETT CL, 1994, INFECT IMMUN, V62, P1046, DOI 10.1128/IAI.62.3.1046-1051.1994; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; RICHARDSON WD, 1988, CELL, V52, P655, DOI 10.1016/0092-8674(88)90403-5; Sert V, 1999, ONCOGENE, V18, P6296, DOI 10.1038/sj.onc.1203007; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; SHURVINTON CE, 1992, P NATL ACAD SCI USA, V89, P11837, DOI 10.1073/pnas.89.24.11837; Sugai M, 1998, INFECT IMMUN, V66, P5008, DOI 10.1128/IAI.66.10.5008-5019.1998; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Weis K, 1998, TRENDS BIOCHEM SCI, V23, P185, DOI 10.1016/S0968-0004(98)01204-3; Whitehouse CA, 1998, INFECT IMMUN, V66, P1934, DOI 10.1128/IAI.66.5.1934-1940.1998; WORNIAK RW, 1998, TRENDS CELL BIOL, V8, P184; Yoneda Y, 2000, GENES CELLS, V5, P777, DOI 10.1046/j.1365-2443.2000.00366.x; ZAMBRYSKI P, 1988, ANNU REV GENET, V22, P1, DOI 10.1146/annurev.ge.22.120188.000245	43	75	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2003	278	50					50671	50681		10.1074/jbc.M305062200	http://dx.doi.org/10.1074/jbc.M305062200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751LH	12947116	hybrid, Green Published			2022-12-27	WOS:000187068200123
J	Do Lee, S; Colla, E; Sheen, MR; Na, KY; Kwon, HM				Do Lee, S; Colla, E; Sheen, MR; Na, KY; Kwon, HM			Multiple domains of TonEBP cooperate to stimulate transcription in response to hypertonicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING PROTEIN; NF-KAPPA-B; GENE-TRANSCRIPTION; DNA-BINDING; TONICITY; ACTIVATION; CELLS; PHOSPHORYLATION; DROSOPHILA; SCREEN	Tonicity-responsive enhancer binding protein (TonEBP), also known as NFAT5, belongs to the Rel family of transcriptional activators. In the kidney medulla and thymus, TonEBP plays a major role in protecting renal cells and T cells from the deleterious effects of ambient hypertonicity. TonEBP is stimulated by hypertonicity via several pathways: increased expression of protein, nuclear translocation, and increased transactivation. In this study, we identified five domains of TonEBP involved in transactivation. The two conserved glutamine repeats were not involved in transactivation. There were three activation domains that could stimulate transcription independently. In addition, there were two modulation domains that potentiated the activity of the activation domains. One of the activation domains is unique to a splice isoform that is more active than others, indicating that alternative splicing can affect the activity of TonEBP. Another activation domain and one of the modulation domains were stimulated by hypertonicity. All the five domains acted in synergy in every combination. Although overall phosphorylation of TonEBP increased in response to hypertonicity, phosphorylation of the activation and modulation domains did not increase in isolation. In sum, TonEBP possesses far more elaborate domains involved in transactivation compared with other Rel proteins.	Univ Maryland, Dept Med, Baltimore, MD 21201 USA; Univ Parma, Grad Program Mol Biol & Pathol, I-43100 Parma, Italy	University System of Maryland; University of Maryland Baltimore; University of Parma	Kwon, HM (corresponding author), N3W143,22 S Greene St, Baltimore, MD 21201 USA.		Colla, Emanuela/H-2483-2013; Lee-Kwon, Whaseon/D-6021-2011	Colla, Emanuela/0000-0002-4755-7450; lee, sang do/0000-0003-1778-6575	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061677] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK61677] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Cha JH, 2001, J AM SOC NEPHROL, V12, P2221, DOI 10.1681/ASN.V12112221; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; Huang AM, 2000, GENETICS, V156, P1219; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Ko BCB, 2002, J BIOL CHEM, V277, P46085, DOI 10.1074/jbc.M208138200; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; Kultz D, 2001, P NATL ACAD SCI USA, V98, P1999, DOI 10.1073/pnas.98.4.1999; Lee SD, 2002, BIOCHEM BIOPH RES CO, V294, P968, DOI 10.1016/S0006-291X(02)00572-7; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Luo C, 1996, MOL CELL BIOL, V16, P3955; LUO C, 1996, J EXP MED, V184, P8907; Maouyo D, 2002, AM J PHYSIOL-RENAL, V282, pF802, DOI 10.1152/ajprenal.00123.2001; Michea L, 2000, AM J PHYSIOL-RENAL, V278, pF209, DOI 10.1152/ajprenal.2000.278.2.F209; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Nahm O, 2002, AM J PHYSIOL-CELL PH, V282, pC49, DOI 10.1152/ajpcell.00267.2001; Nakayama Y, 2000, J BIOL CHEM, V275, P38275, DOI 10.1074/jbc.M004678200; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Sands J.M., 2000, KIDNEY PHYSL PATHOPH, V3, P1175; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; STOTT K, 1995, P NATL ACAD SCI USA, V92, P6509, DOI 10.1073/pnas.92.14.6509; Stroud JC, 2002, NAT STRUCT BIOL, V9, P90, DOI 10.1038/nsb749; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; Trama J, 2002, J IMMUNOL, V169, P5477, DOI 10.4049/jimmunol.169.10.5477; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Woo SK, 2000, AM J PHYSIOL-CELL PH, V278, pC323, DOI 10.1152/ajpcell.2000.278.2.C323; Woo SK, 2002, PFLUG ARCH EUR J PHY, V444, P579, DOI 10.1007/s00424-002-0849-2; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	35	10	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47571	47577		10.1074/jbc.M308795200	http://dx.doi.org/10.1074/jbc.M308795200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12970349	hybrid			2022-12-27	WOS:000186731400029
J	Liu, Y; Sinha, S; Owens, G				Liu, Y; Sinha, S; Owens, G			A transforming growth factor-beta control element required for SM alpha-actin expression in vivo also partially mediates GKLF-dependent transcriptional repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR; SMOOTH-MUSCLE CELLS; TGF-BETA; GENE-EXPRESSION; CARG ELEMENTS; GROWTH-FACTOR-BETA-1; PROMOTER; DIFFERENTIATION; MICE; INHIBITION	We previously demonstrated that a conserved transforming growth factor-beta control element (TCE) within the 5'-region of the smooth muscle cell (SMC) differentiation marker gene SM alpha-actin could mediate both transcriptional activation and repression in cultured SMCs through interaction with members of the zinc finger Kruppel-like transcription factor (KLF) family. The aims of the present studies were to: 1) determine the role of the SM alpha-actin TCE in vivo through mutagenesis studies in transgenic mice and 2) further characterize the possible role and mechanisms by which the TCE-binding factor GKLF/KLF4 induces repression of SMC marker genes in various SMC model systems in vitro. Our results showed that the TCE was required for SM alpha-actin promoter activity in transgenic mice in vivo. Results of transient transfection studies showed that GKLF-induced repression of a SM alpha-actin promoter/luciferase reporter gene partially depended on the TCE. Furthermore, a GKLF overexpressing adenovirus inhibited whereas GKLF morpholino antisense oligos increased expression of endogenous SMC marker genes. Results of chromatin immunoprecipitation assays showed GKLF binding to TCE containing regions of various SMC marker gene promoters within intact chromatin. Finally, results of co-transfection studies showed that overexpression of IKLF/KLF5 reversed GKLF-dependent repression thus supporting a model of reciprocal activation-repression of SMC gene expression by different members of the KLF gene family.	Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Virginia	Owens, G (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, 415 Lane Rd,MR 5,Rm 1220,POB 801394, Charlottesville, VA 22908 USA.		Sinha, Sanjay/AAF-1692-2021	Sinha, Sanjay/0000-0001-5900-1209	NHLBI NIH HHS [R37HL57353, P01HL19242, P01HL38854] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL057353, P01HL019242, R01HL057353, R01HL038854] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adam PJ, 2000, J BIOL CHEM, V275, P37798, DOI 10.1074/jbc.M006323200; ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020; ASSOIAN RK, 1986, J CELL BIOL, V102, P1217, DOI 10.1083/jcb.102.4.1217; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Foster KW, 2000, CANCER RES, V60, P6488; Geiman DE, 2000, NUCLEIC ACIDS RES, V28, P1106, DOI 10.1093/nar/28.5.1106; Hautmann MB, 1999, ARTERIOSCL THROM VAS, V19, P2049, DOI 10.1161/01.ATV.19.9.2049; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hudziak RM, 1996, ANTISENSE NUCLEIC A, V6, P267, DOI 10.1089/oli.1.1996.6.267; Hungerford JE, 1999, J VASC RES, V36, P2, DOI 10.1159/000025622; Jenkins TD, 1998, J BIOL CHEM, V273, P10747, DOI 10.1074/jbc.273.17.10747; KERR LD, 1990, CELL, V61, P267, DOI 10.1016/0092-8674(90)90807-Q; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; LAWLER S, 1994, DEVELOPMENT, V120, P165; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Mack CP, 1999, CIRC RES, V84, P852; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415; Manabe I, 2001, J CLIN INVEST, V107, P823, DOI 10.1172/JCI11385; NIKOL S, 1992, J CLIN INVEST, V90, P1582, DOI 10.1172/JCI116027; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; OWENS GK, 1995, PHYSIOL REV, V75, P487; OWENS GK, 1988, J CELL BIOL, V107, P771, DOI 10.1083/jcb.107.2.771; OWENS GK, 1996, ATHEROSCLEROSIS CORO, P401; Regan CP, 2000, J CLIN INVEST, V106, P1139, DOI 10.1172/JCI10522; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Spencer JA, 1996, J BIOL CHEM, V271, P16535, DOI 10.1074/jbc.271.28.16535; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P63, DOI 10.1089/oli.1.1997.7.63; VERBEEK MM, 1994, AM J PATHOL, V144, P372; WOLF YG, 1994, J CLIN INVEST, V93, P1172, DOI 10.1172/JCI117070; Yet SF, 1998, J BIOL CHEM, V273, P1026, DOI 10.1074/jbc.273.2.1026; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhang WQ, 1998, J BIOL CHEM, V273, P17917, DOI 10.1074/jbc.273.28.17917	45	89	92	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48004	48011		10.1074/jbc.M301902200	http://dx.doi.org/10.1074/jbc.M301902200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12970361	hybrid			2022-12-27	WOS:000186731400079
J	Soldano, KL; Jivan, A; Nicchitta, CV; Gewirth, DT				Soldano, KL; Jivan, A; Nicchitta, CV; Gewirth, DT			Structure of the N-terminal domain of GRP94 - Basis for ligand specificity and regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; HSP90 MOLECULAR CHAPERONE; NUCLEOTIDE-BINDING DOMAIN; ATP BINDING; CRYSTAL-STRUCTURE; PEPTIDE BINDING; GELDANAMYCIN; ACTIVATION; HYDROLYSIS; RADICICOL	GRP94, the endoplasmic reticulum (ER) paralog of the chaperone Hsp90, plays an essential role in the structural maturation or secretion of a subset of proteins destined for transport to the cell surface, such as the Toll-like receptors 2 and 4, and IgG, respectively. GRP94 differs from cytoplasmic Hsp90 by exhibiting very weak ATP binding and hydrolysis activity. GRP94 also binds selectively to a series of substituted adenosine analogs. The high resolution crystal structures at 1.75-2.1 Angstrom of the N-terminal and adjacent charged domains of GRP94 in complex with N-ethylcarboxamidoadenosine, radicicol, and 2-chlorodideoxyadenosine reveals a structural mechanism for ligand discrimination among hsp90 family members. The structures also identify a putative subdomain that may act as a ligand-responsive switch. The residues of the charged region fold into a disordered loop whose termini are ordered and continue the twisted beta sheet that forms the structural core of the N-domain. This continuation of the beta sheet past the charged domain suggests a structural basis for the association of the N-terminal and middle domains of the full-length chaperone.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University	Gewirth, DT (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Box 3711, Durham, NC 27710 USA.	gewirth@duke.edu						Baker-LePain JC, 2002, J EXP MED, V196, P1447, DOI 10.1084/jem.20020436; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; Hartson SD, 1996, BIOCHEMISTRY-US, V35, P13451, DOI 10.1021/bi961332c; HUTCHISON KA, 1989, J BIOL CHEM, V264, P19898; HUTCHISON KA, 1990, BIOCHEMISTRY-US, V29, P5138, DOI 10.1021/bi00473a020; IANNOTTI AM, 1988, ARCH BIOCHEM BIOPHYS, V264, P54, DOI 10.1016/0003-9861(88)90569-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOYASU S, 1986, P NATL ACAD SCI USA, V83, P8054, DOI 10.1073/pnas.83.21.8054; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lusty CJ, 1999, J APPL CRYSTALLOGR, V32, P106, DOI 10.1107/S002188989801053X; Maruya M, 1999, J MOL BIOL, V285, P903, DOI 10.1006/jmbi.1998.2349; MELNICK J, 1992, J BIOL CHEM, V267, P21303; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; MINAMI Y, 1991, J BIOL CHEM, V266, P10099; NEMOTO T, 1995, EUR J BIOCHEM, V233, P1, DOI 10.1111/j.1432-1033.1995.001_1.x; Nganga A, 2000, BIOCHEM J, V352, P865, DOI 10.1042/0264-6021:3520865; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen BAL, 2002, J BIOL CHEM, V277, P7086, DOI 10.1074/jbc.M111450200; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; RICHARDS FM, 1988, PROTEINS, V3, P71, DOI 10.1002/prot.340030202; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rosser MFN, 2000, J BIOL CHEM, V275, P22798, DOI 10.1074/jbc.M001477200; Sastry S, 1999, J BIOL CHEM, V274, P12023, DOI 10.1074/jbc.274.17.12023; Schulte TW, 1996, MOL CELL BIOL, V16, P5839; Schulte TW, 1999, MOL ENDOCRINOL, V13, P1435, DOI 10.1210/me.13.9.1435; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Stancato LF, 1997, J BIOL CHEM, V272, P4013, DOI 10.1074/jbc.272.7.4013; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Supino-Rosin L, 2000, J BIOL CHEM, V275, P21850, DOI 10.1074/jbc.M001834200; Vega VL, 2003, MOL BIOL CELL, V14, P764, DOI 10.1091/mbc.E02-08-0498; Wassenberg JJ, 2000, J BIOL CHEM, V275, P22806, DOI 10.1074/jbc.M001476200; Wearsch PA, 1998, BIOCHEMISTRY-US, V37, P5709, DOI 10.1021/bi9801006; Wearsch PA, 1996, BIOCHEMISTRY-US, V35, P16760, DOI 10.1021/bi962068q; Wearsch PA, 1997, J BIOL CHEM, V272, P5152, DOI 10.1074/jbc.272.8.5152; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400	53	107	116	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48330	48338		10.1074/jbc.M308661200	http://dx.doi.org/10.1074/jbc.M308661200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12970348	hybrid			2022-12-27	WOS:000186731400118
J	Coulet, F; Nadaud, S; Agrapart, M; Soubrier, F				Coulet, F; Nadaud, S; Agrapart, M; Soubrier, F			Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR-I; PAS DOMAIN PROTEIN-1; DNA-BINDING ACTIVITY; ADULT-RAT LUNG; POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTIONAL ACTIVATION; SIGNAL-TRANSDUCTION; DOWN-REGULATION; MESSENGER-RNA; UP-REGULATION	The human endothelial nitric-oxide synthase gene (heNOS) is constitutively expressed in endothelial cells, and its expression is induced under hypoxia. The goal of this study was to search for regulatory elements of the endothelial nitric-oxide synthase (eNOS) gene responsive to hypoxia. Levels of eNOS mRNA, measured by real time reverse transcriptase-PCR analysis, were increased, and heNOS promoter activity was enhanced by hypoxia as compared with normoxia control experiments. Promoter truncation followed by footprint analysis allowed the mapping and identification of the hypoxia-responsive elements at position -5375 to -5366, closely related to hypoxia-inducible factor (HIF)-responsive element (HRE). To test whether known HIF-1 and HIF-2 are involved in hypoxia-induced heNOS promoter activation, HMEC-1 and HUVEC were transiently transfected with HIF-1alpha and HIF-1beta or HIF-2alpha and HIF-1beta expression vectors. Exogenous HIF-2 markedly increased luciferase reporter activity driven by the heNOS promoter in its native location. The induction of luciferase was conserved with the antisense construct and was increased in cotransfection experiments when this fragment was cloned 5' to the proximal 785-bp fragment of the eNOS promoter. Deletion analysis and site-directed mutagenesis demonstrated that the two contiguous HIF consensus binding sites spanning bp -5375 to -5366 relative to the transcription start site were both functional for heNOS promoter activity induction by hypoxia and by HIF-2 overexpression. In conclusion, we demonstrate that heNOS is a hypoxia-inducible gene, whose transcription is stimulated through HIF-2 interaction with two contiguous HRE sites located at -5375 to -5366 of the heNOS promoter.	Univ Paris 06, Fac Med Pitie Salpetriere, INSERM, U525, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Soubrier, F (corresponding author), Univ Paris 06, Fac Med Pitie Salpetriere, INSERM, U525, 91 Bd Hop, F-75013 Paris, France.	florent.soubrier@chups.jussieu.fr	Nadaud, Sophie/A-7063-2013; Nadaud, Sophie/GXV-0505-2022	Nadaud, Sophie/0000-0002-1452-6009; 				ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Arnet UA, 1996, J BIOL CHEM, V271, P15069, DOI 10.1074/jbc.271.25.15069; Avantaggiati ML, 1996, EMBO J, V15, P2236, DOI 10.1002/j.1460-2075.1996.tb00577.x; Damert A, 1997, BIOCHEM J, V327, P419, DOI 10.1042/bj3270419; Dhar AK, 2001, J CLIN MICROBIOL, V39, P2835, DOI 10.1128/JCM.39.8.2835-2845.2001; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Fink T, 2002, BLOOD, V99, P2077, DOI 10.1182/blood.V99.6.2077; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; Graven KK, 2003, BBA-GENE STRUCT EXPR, V1626, P10, DOI 10.1016/S0167-4781(03)00049-6; GREENBERG B, 1993, AM J PHYSIOL, V265, pH1712, DOI 10.1152/ajpheart.1993.265.5.H1712; Hoffmann A, 2001, J CELL PHYSIOL, V188, P33, DOI 10.1002/jcp.1092; Isozumi Kazuo, 1994, Keio Journal of Medicine, V43, P31; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kappel A, 1999, BLOOD, V93, P4284, DOI 10.1182/blood.V93.12.4284.412k25_4284_4292; KHACHIGIAN LM, 1995, J BIOL CHEM, V270, P27679, DOI 10.1074/jbc.270.46.27679; Kimura H, 2000, BLOOD, V95, P189, DOI 10.1182/blood.V95.1.189.001k05_189_197; Kimura H, 2001, J BIOL CHEM, V276, P2292, DOI 10.1074/jbc.M008398200; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Laumonnier Y, 2000, J BIOL CHEM, V275, P40732, DOI 10.1074/jbc.M004696200; Le Cras TD, 1998, J CLIN INVEST, V101, P795, DOI 10.1172/JCI786; Leach RM, 2002, RESP PHYSIOL NEUROBI, V132, P55, DOI 10.1016/S1569-9048(02)00049-6; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P132, DOI 10.1016/S1089-8603(02)00127-1; Li YX, 2003, J BIOL CHEM, V278, P16899, DOI 10.1074/jbc.M300596200; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; MCPHERSON RW, 1994, AM J PHYSIOL, V266, pH476, DOI 10.1152/ajpheart.1994.266.2.H476; McQuillan Lynda P., 1994, American Journal of Physiology, V267, pH1921; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Murata T, 2001, EUR J PHARMACOL, V421, P45, DOI 10.1016/S0014-2999(01)01015-9; NATHAN C, 1994, J BIOL CHEM, V269, P13725; Navarro-Antolin J, 2000, J BIOL CHEM, V275, P3075, DOI 10.1074/jbc.275.5.3075; NORRIS ML, 1995, J BIOL CHEM, V270, P23774, DOI 10.1074/jbc.270.40.23774; POHL U, 1989, AM J PHYSIOL, V256, pH1595, DOI 10.1152/ajpheart.1989.256.6.H1595; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Searles CD, 1999, CIRC RES, V85, P588, DOI 10.1161/01.RES.85.7.588; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; SHAUL PW, 1995, AM J RESP CELL MOL, V13, P167, DOI 10.1165/ajrcmb.13.2.7542896; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Takemoto M, 2002, CIRCULATION, V106, P57, DOI 10.1161/01.CIR.0000020682.73694.AB; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Templeton DM, 2003, BBA-GEN SUBJECTS, V1619, P113, DOI 10.1016/S0304-4165(02)00497-X; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Toporsian M, 2000, CIRC RES, V86, P671, DOI 10.1161/01.RES.86.6.671; WANG GL, 1993, BLOOD, V82, P3610; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Xiao DL, 2001, AM J PHYSIOL-HEART C, V280, pH812, DOI 10.1152/ajpheart.2001.280.2.H812; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; YOSHIZUMI M, 1993, CIRC RES, V73, P205, DOI 10.1161/01.RES.73.1.205; Ziegler T, 1998, HYPERTENSION, V32, P351, DOI 10.1161/01.HYP.32.2.351	57	156	165	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46230	46240		10.1074/jbc.M305420200	http://dx.doi.org/10.1074/jbc.M305420200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963737	hybrid			2022-12-27	WOS:000186569400006
J	Nishi, T; Nishi, SK; Forgac, M				Nishi, T; Nishi, SK; Forgac, M			Expression and function of the mouse V-ATPase d subunit isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; PROTON-TRANSLOCATING ATPASE; RENAL TUBULAR-ACIDOSIS; IN-VIVO DISSOCIATION; MUTATIONAL ANALYSIS; GENE ENCODES; LUMINAL ACIDIFICATION; MOLECULAR-CLONING; CATALYTIC SUBUNIT; NEUROSPORA-CRASSA	We have identified a cDNA encoding a novel isoform of the mouse V-ATPase d subunit (d2). The protein encoded is 350 amino acids in length and shows 42 and 67% identity to the yeast d subunit (Vma6p) and the mouse d1 isoform, respectively. Reverse transcriptase-PCR analysis using isoform-specific primers demonstrate that d2 is expressed mainly in kidney and at lower levels in heart, spleen, skeletal muscle, and testis. Although d1 and d2 show similar levels of sequence homology to Vma6p, only the d1 isoform can complement the phenotype of a yeast strain in which VMA6 has been disrupted when cells are grown at 30degreesC. The d2 isoform, however, can complement the vma6Delta phenotype when cells are grown at 25degreesC. Moreover, partial assembly of the V-ATPase complex on the vacuolar membrane can be detected under these conditions, although assembly is significantly lower than that observed for the strain expressing Vma6p. This reduced assembly is also reflected in a reduced level of concanamycin-sensitive ATPase activity and proton transport in isolated vacuoles. Comparison of the kinetic properties of V-ATPase complexes containing Vma6p and d1 demonstrate that although the K-m for ATP hydrolysis is similar (0.26 and 0.31 mM, respectively), the coupling ratio (proton transport/ATP hydrolysis) is similar to3-6-fold higher for d1-containing complexes than for Vma6p-containing complexes. These results suggest that subunit d may play a role in coupling of proton transport and ATP hydrolysis.	Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA.	michael.forgac@tufts.edu			NIDDK NIH HHS [DK 34928] Funding Source: Medline; NIGMS NIH HHS [R01 GM034478, R37 GM034478, GM 34478] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034478, R01GM034478] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI I, 1990, J BIOL CHEM, V265, P967; ADACHI I, 1990, J BIOL CHEM, V265, P960; BAUERLE C, 1993, J BIOL CHEM, V268, P12749; Bauerle C, 1998, PLANT PHYSIOL, V117, P859, DOI 10.1104/pp.117.3.859; Bowman EJ, 2000, J EXP BIOL, V203, P97; Brown D, 2000, J EXP BIOL, V203, P137; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; Futai M, 2000, J EXP BIOL, V203, P107; Graham LA, 1998, J CELL BIOL, V142, P39, DOI 10.1083/jcb.142.1.39; Graham LA, 2000, J EXP BIOL, V203, P61; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; HORAZDOVSKY BF, 1993, J BIOL CHEM, V268, P4953; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kane PM, 2000, J EXP BIOL, V203, P81; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE BS, 1995, J BIOL CHEM, V270, P7320, DOI 10.1074/jbc.270.13.7320; Leng XH, 1996, J BIOL CHEM, V271, P22487, DOI 10.1074/jbc.271.37.22487; Leng XH, 1998, J BIOL CHEM, V273, P6717, DOI 10.1074/jbc.273.12.6717; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; MacLeod KJ, 1998, J BIOL CHEM, V273, P150, DOI 10.1074/jbc.273.1.150; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; Melnik VI, 1996, BBA-BIOENERGETICS, V1273, P77, DOI 10.1016/0005-2728(95)00144-1; Merzendorfer H, 1997, J EXP BIOL, V200, P225; Murata Y, 2002, J BIOL CHEM, V277, P36296, DOI 10.1074/jbc.M200586200; Nanda A, 1996, J BIOL CHEM, V271, P15963, DOI 10.1074/jbc.271.27.15963; Nelson N, 2000, J EXP BIOL, V203, P89; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishi T, 1997, J BIOCHEM, V121, P922; Nishi T, 2001, J BIOL CHEM, V276, P34122, DOI 10.1074/jbc.M104682200; NOUMI T, 1991, P NATL ACAD SCI USA, V88, P1938, DOI 10.1073/pnas.88.5.1938; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; PUOPOLO K, 1992, J BIOL CHEM, V267, P3696; Shao E, 2003, J BIOL CHEM, V278, P12985, DOI 10.1074/jbc.M212096200; Smith AN, 2002, GENE, V297, P169, DOI 10.1016/S0378-1119(02)00884-3; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Sun-Wada GH, 2003, GENE, V302, P147, DOI 10.1016/S0378-1119(02)01099-5; Sun-Wada GH, 2002, J BIOL CHEM, V277, P18098, DOI 10.1074/jbc.M111567200; Sze H, 2002, TRENDS PLANT SCI, V7, P157, DOI 10.1016/S1360-1385(02)02240-9; Sze H, 1999, PLANT CELL, V11, P677, DOI 10.1105/tpc.11.4.677; TEMESVARI L, 1994, J BIOL CHEM, V269, P25719; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; VANHILLE B, 1993, BIOCHEM BIOPH RES CO, V197, P15, DOI 10.1006/bbrc.1993.2434; WANG SY, 1988, J BIOL CHEM, V263, P17638; Wieczorek H, 2000, J EXP BIOL, V203, P127; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Xu T, 2000, J BIOL CHEM, V275, P22075, DOI 10.1074/jbc.M002983200	53	42	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46396	46402		10.1074/jbc.M303924200	http://dx.doi.org/10.1074/jbc.M303924200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963731	hybrid			2022-12-27	WOS:000186569400023
J	Anyatonwu, GI; Buck, ED; Ehrlich, BE				Anyatonwu, GI; Buck, ED; Ehrlich, BE			Methanethiosulfonate ethylammonium block of amine currents through the ryanodine receptor reveals single pore architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; CARDIAC SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; CYSTEINE-SUBSTITUTION; POTASSIUM CHANNELS; ORGANIC CATIONS; K+ CHANNEL; CONDUCTION; RECONSTITUTION; STABILIZATION	The homotetrameric structure of the ryanodine-sensitive intracellular calcium (Ca2+) release channel (ryanodine receptor (RyR)) suggests that the four RyR subunits either combine to form a single pore or that each RyR subunit is an independently conducting pathway. Previously we showed that methanethiosulfonate ethylammonium (MTSEA(+)) covalently modifies the RyR to reduce current amplitudes in a time-dependent and stepwise manner. To ascertain the number of functionally conducting pores in the RyR, two approaches were combined: modification of the receptor by MTSEA(+) and the use of different sized current carriers. Previous reports (Tinker, A., and Williams, A.J. (1993) J. Gen. Physiol. 102, 1107-1129) have shown that the organic cations methylamine, dimethylamine, ethylamine, and trimethylamine are permeant through the RyR but with reduced current amplitude depending upon the diameter of the respective amine. Experiments using the thiol reagent MTSEA(+) to modify the channel protein showed that the current amplitudes decrease in steps leading to complete block of the channel when cesium (Cs+) is the current carrier. MTSEA(+) modification decreased the number of channel substates as the diameter of the current carrier increased. Comparison of the degree of inhibition of MTSEA(+)-modified currents allows for differentiation between the two models for channel architecture. These results demonstrate that the conduction pathway for the RyR is comprised of a single central pore.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; Warner Instruments Inc, Hamden, CT 06514 USA	Yale University; Yale University	Ehrlich, BE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	barbara.ehrlich@yale.edu	/AAX-8408-2021	/0000-0001-9657-9704				AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Betanzos M, 2002, NAT STRUCT BIOL, V9, P704, DOI 10.1038/nsb828; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Buck ED, 1999, J PHARMACOL EXP THER, V289, P477; DANI JA, 1991, J THEOR BIOL, V153, P401, DOI 10.1016/S0022-5193(05)80578-8; Ding SH, 2002, J GEN PHYSIOL, V120, P87, DOI 10.1085/jgp.20028611; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dulhunty A, 2000, ANTIOXID REDOX SIGN, V2, P27, DOI 10.1089/ars.2000.2.1-27; FEHER JJ, 1991, J MOL CELL CARDIOL, V23, P249, DOI 10.1016/0022-2828(91)90061-P; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kaftan E, 1996, CIRC RES, V78, P990, DOI 10.1161/01.RES.78.6.990; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Liu J, 2000, NEURON, V28, P899, DOI 10.1016/S0896-6273(00)00162-8; Manjunatha B, 1997, J GEN PHYSIOL, V110, P749, DOI 10.1085/jgp.110.6.749; Marks AR, 1997, AM J PHYSIOL-HEART C, V272, pH597, DOI 10.1152/ajpheart.1997.272.2.H597; Orlova EV, 1996, NAT STRUCT BIOL, V3, P547, DOI 10.1038/nsb0696-547; Quinn KE, 1997, J GEN PHYSIOL, V109, P255, DOI 10.1085/jgp.109.2.255; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Serysheva II, 1999, BIOPHYS J, V77, P1936, DOI 10.1016/S0006-3495(99)77035-9; SERYSHEVA II, 1995, NAT STRUCT BIOL, V2, P18, DOI 10.1038/nsb0195-18; Shah PK, 2001, PROTEIN ENG, V14, P867, DOI 10.1093/protein/14.11.867; Sitsapesan R, 1998, STRUCTURE FUNCTION R; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TINKER A, 1992, J GEN PHYSIOL, V100, P479, DOI 10.1085/jgp.100.3.479; TINKER A, 1993, J GEN PHYSIOL, V102, P1107, DOI 10.1085/jgp.102.6.1107; TINKER A, 1993, BIOPHYS J, V65, P1678, DOI 10.1016/S0006-3495(93)81201-3; TINKER A, 1995, BIOPHYS J, V68, P111, DOI 10.1016/S0006-3495(95)80165-7; WAGENKNECHT T, 1989, NATURE, V338, P167, DOI 10.1038/338167a0; Wagenknecht T, 1997, CURR OPIN STRUC BIOL, V7, P258, DOI 10.1016/S0959-440X(97)80034-6; Williams AJ, 2001, Q REV BIOPHYS, V34, P61, DOI 10.1017/S0033583501003675; XU M, 1993, J BIOL CHEM, V268, P21505; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	36	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45528	45538		10.1074/jbc.M307863200	http://dx.doi.org/10.1074/jbc.M307863200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12963712	hybrid			2022-12-27	WOS:000186452300060
J	Nakayamada, S; Okada, Y; Saito, K; Tamura, M; Tanaka, Y				Nakayamada, S; Okada, Y; Saito, K; Tamura, M; Tanaka, Y			beta(1) integrin/focal adhesion kinase-mediated signaling induces intercellular adhesion molecule 1 and receptor activator of nuclear factor kappa B ligand on Osteoblasts and osteoclast maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-CELLS; DOWN-REGULATION; GROWTH-FACTOR; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; OSTEOPOROSIS; MECHANISMS; APOPTOSIS; MIGRATION	We have assessed characteristics of primary human osteoblasts, shedding light on signaling mediated by beta(1) integrin. beta(1) integrins are major receptors for these matrix glycoproteins. 1) Integrins beta(1), alpha(2), alpha(3), alpha(4), alpha(5), alpha(6), and alpha(v) were highly expressed on primary osteoblasts. 2) Engagement of beta(1) integrins on osteoblasts by cross-linking with specific antibody or ligand matrices, such as fibronectin or collagen, augmented expression of intercellular adhesion molecule 1 (ICAM-1) and receptor activator of nuclear factor kappaB ligand (RANKL) on the surface. 3) Up-regulation of ICAM-1 and RANKL on osteoblasts by beta(1) stimulation was completely abrogated by pretreatment with herbimycin A and genistein, tyrosine kinase inhibitors, or transfection of dominant negative truncations of focal adhesion kinase (FAK). 4) Engagement of beta(1) integrins on osteoblasts induced tartrate-resistant acid phosphatase-positive multinuclear cell formation in the coculture system of osteoblasts and peripheral monocytes. 5) Up-regulation of tartrate-resistant acid phosphatase-positive multinuclear cell formation by beta(1) stimulation was completely abrogated by transfection of dominant negative truncations of FAK. Our results indicate that beta(1) integrin-dependent adhesion of osteoblasts to bone matrices induces ICAM-1 and RANKL expression and osteoclast formation via tyrosine kinase, especially FAK. We here propose that beta(1) integrin/FAK-mediated signaling on osteoblasts could be involved in ICAM-1- and RANKL-dependent osteoclast maturation.	Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka 8078555, Japan; Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka 8078555, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Tanaka, Y (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka 8078555, Japan.	tanaka@med.uoeh-u.ac.jp	Okada, Yosuke/AAT-3173-2020					Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Bennett JH, 2001, HISTOL HISTOPATHOL, V16, P603, DOI 10.14670/HH-16.603; Bennett JH, 2001, ARCH ORAL BIOL, V46, P229, DOI 10.1016/S0003-9969(00)00114-X; BERESFORD JN, 1984, METAB BONE DIS RELAT, V5, P229, DOI 10.1016/0221-8747(84)90064-X; Brakebusch C, 2002, J CLIN INVEST, V109, P999, DOI 10.1172/JCI200215468; CLOVER J, 1992, J CELL SCI, V103, P267; Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Duong L T, 2001, Rev Endocr Metab Disord, V2, P95, DOI 10.1023/A:1010063225902; Fujimoto H, 2001, GENES CELLS, V6, P337, DOI 10.1046/j.1365-2443.2001.00428.x; Globus RK, 1998, J CELL SCI, V111, P1385; GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; HUGHES DE, 1993, J BONE MINER RES, V8, P527; Kotake S, 1996, J BONE MINER RES, V11, P88; Koyama Y, 1996, J IMMUNOL, V157, P5097; Liu SC, 2000, J CELL SCI, V113, P3563; Liu ZJ, 1999, J IMMUNOL, V163, P4901; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652; Mundy G R, 2001, Rev Endocr Metab Disord, V2, P105, DOI 10.1023/A:1010015309973; Nakayamada S, 2003, ARTHRITIS RHEUM, V48, P1239, DOI 10.1002/art.10941; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Raisz LG, 1999, CLIN CHEM, V45, P1353; Raisz LG, 2001, J BONE MINER RES, V16, P1948, DOI 10.1359/jbmr.2001.16.11.1948; Rodan GA, 1998, J CELL BIOCHEM, P55; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tamura M, 2003, KIDNEY INT, V63, P722, DOI 10.1046/j.1523-1755.2003.00772.x; Tanaka Y, 1999, J IMMUNOL, V163, P6209; Tanaka Y, 1998, BLOOD, V91, P3909; TANAKA Y, 1995, J BONE MINER RES, V10, P1462; Tanaka Y, 2002, J BIOL CHEM, V277, P21446, DOI 10.1074/jbc.M202238200; TANAKA Y, 1992, J EXP MED, V176, P245, DOI 10.1084/jem.176.1.245; Tanaka Y, 2000, J BONE MINER RES, V15, P1912, DOI 10.1359/jbmr.2000.15.10.1912; Tanaka Yoshiya, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P443; Vassiliou G, 1998, J IMMUNOL METHODS, V215, P9, DOI 10.1016/S0022-1759(98)00030-1; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zimmerman D, 2000, DEV BIOL, V220, P2, DOI 10.1006/dbio.2000.9633	46	59	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45368	45374		10.1074/jbc.M308786200	http://dx.doi.org/10.1074/jbc.M308786200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954625	hybrid			2022-12-27	WOS:000186452300040
J	Wang, HQ; Quan, TH; He, TY; Franke, TF; Voorhees, JJ; Fisher, GJ				Wang, HQ; Quan, TH; He, TY; Franke, TF; Voorhees, JJ; Fisher, GJ			Epidermal growth factor receptor-dependent, NF-kappa B-independent activation of the phosphatidylinositol 3-kinase/Akt pathway inhibits ultraviolet irradiation-induced caspases-3,-8, and-9 in human keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; UV-INDUCED APOPTOSIS; SERINE-THREONINE KINASE; PROMOTES CELL-SURVIVAL; CYTOCHROME-C; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; SKIN-CANCER; AKT	Both phosphatidylinositol 3-kinase (PI3K)/Akt and NF-kappaB pathways function to promote cellular survival following stress. Recent evidence indicates that the antiapoptotic activity of these two pathways may be functionally dependent. Ultraviolet (UV) irradiation causes oxidative stress, which can lead to apoptotic cell death. Human skin cells (keratinocytes) are commonly exposed to UV irradiation from the sun. We have investigated activation of the PI3K/Akt and NF-kappaB pathways and their roles in protecting human keratinocytes (KCs) from UV irradiation-induced apoptosis. This activation of PI3K preceded increased levels (3-fold) of active/phosphorylated Akt. UV (50 mJ/cm(2) from UVB source) irradiation caused rapid recruitment of PI3K to the epidermal growth factor receptor ( EGFR). Pretreatment of KCs with EGFR inhibitor PD169540 abolished UV-induced Akt activation/phosphorylation, as did the PI3K inhibitors LY294002 or wortmannin. This inhibition of Akt activation was associated with a 3-4-fold increase of UV-induced apoptosis, as measured by flow cytometry and DNA fragmentation ELISA. In contrast to Akt, UV irradiation did not detectably increase nuclear localization of NF-kappaB, indicating that it was not strongly activated. Consistent with this observation, interference with NF-kappaB activation by adenovirus-mediated overexpression of dominant negative IKK-beta or IkappaB-alpha did not increase UV-induced apoptosis. However, adenovirus-mediated overexpression of constitutively active Akt completely blocked UV-induced apoptosis observed with PI3K inhibition by LY294002, whereas adenovirus mediated overexpression of dominant negative Akt increased UV-induced apoptosis by 2-fold. Inhibition of UV-induced activation of Akt increased release of mitochondrial cytochrome c 3.5-fold, and caused appearance of active forms of caspase-9, caspase-8, and caspase-3. Constitutively active Akt abolished UV-induced cytochrome c release and activation of caspases-9, -8, and -3. These data demonstrate that PI3K/Akt is essential for protecting human KCs against UV-induced apoptosis, whereas NF-kappaB pathway provides little, if any, protective role.	Univ Michigan, Dept Dermatol, Sch Med, Ann Arbor, MI 48109 USA; Columbia Univ, Dept Pharmacol, New York, NY 10032 USA	University of Michigan System; University of Michigan; Columbia University	Fisher, GJ (corresponding author), Univ Michigan, Dept Dermatol, Sch Med, Med Sci 1,Room 6447,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.			Quan, Taihao/0000-0002-0954-5109				Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Aragane Y, 1998, J CELL BIOL, V140, P171, DOI 10.1083/jcb.140.1.171; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Caricchio R, 1998, J IMMUNOL, V161, P241; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Delhase M, 1999, COLD SPRING HARB SYM, V64, P491, DOI 10.1101/sqb.1999.64.491; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Fisher GJ, 1998, J CLIN INVEST, V101, P1432, DOI 10.1172/JCI2153; FISHER GJ, 1993, J INVEST DERMATOL, V101, P553, DOI 10.1111/1523-1747.ep12365967; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; GERARD R, 1995, DNA CLONING PRACTICA, P300; Goswami R, 1999, J NEUROSCI RES, V57, P884, DOI 10.1002/(SICI)1097-4547(19990915)57:6<884::AID-JNR14>3.3.CO;2-1; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; HATANO E, 2001, AM J PHYSIOL-GASTR L, V1, pG1357; Hermann C, 2000, ARTERIOSCL THROM VAS, V20, P402, DOI 10.1161/01.ATV.20.2.402; Hill LL, 1999, SCIENCE, V285, P898, DOI 10.1126/science.285.5429.898; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; KOHN AD, 1995, EMBO J, V14, P4288, DOI 10.1002/j.1460-2075.1995.tb00103.x; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Kulms D, 2000, PHOTODERMATOL PHOTO, V16, P195, DOI 10.1034/j.1600-0781.2000.160501.x; Lee JW, 2000, MOL BIOL CELL, V11, P1973, DOI 10.1091/mbc.11.6.1973; Leverkus M, 1997, EXP CELL RES, V232, P255, DOI 10.1006/excr.1997.3514; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Li LW, 1999, MOL CELL BIOL, V19, P8547; Lin JQ, 1999, CANCER RES, V59, P2891; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Meng FY, 2002, J BIOL CHEM, V277, P29674, DOI 10.1074/jbc.M112464200; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; MIYASHITA T, 1995, CELL, V80, P293; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Ozes ON, 1999, NATURE, V401, P82; Panka DJ, 2001, J BIOL CHEM, V276, P6893, DOI 10.1074/jbc.C000569200; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Peus D, 2000, PHOTOCHEM PHOTOBIOL, V72, P135, DOI 10.1562/0031-8655(2000)072<0135:UIEGFR>2.0.CO;2; Piette J, 1997, BIOL CHEM, V378, P1237; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Seitz CS, 2000, J CLIN INVEST, V105, P253, DOI 10.1172/JCI7630; Shea CR, 1991, PHYSL BIOCH MOL BIOL, V2, P910; Sitailo LA, 2002, J BIOL CHEM, V277, P19346, DOI 10.1074/jbc.M200401200; Stein RC, 2000, MOL MED TODAY, V6, P347, DOI 10.1016/S1357-4310(00)01770-6; STOVER D, 1995, J BIOL CHEM, V26, P15591; Suhara T, 2001, CIRC RES, V89, P13, DOI 10.1161/hh1301.092506; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tiganis T, 1999, J BIOL CHEM, V274, P27768, DOI 10.1074/jbc.274.39.27768; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Wang HQ, 1999, J CELL SCI, V112, P3497; Weedon D, 1979, Am J Dermatopathol, V1, P133; Yang CH, 2001, J BIOL CHEM, V276, P13756, DOI 10.1074/jbc.M011006200; Yuan ZQ, 2002, J BIOL CHEM, V277, P29973, DOI 10.1074/jbc.M203636200; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	68	90	95	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45737	45745		10.1074/jbc.M300574200	http://dx.doi.org/10.1074/jbc.M300574200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952968	hybrid			2022-12-27	WOS:000186452300084
J	Basran, J; Harris, RJ; Sutcliffe, MJ; Scrutton, NS				Basran, J; Harris, RJ; Sutcliffe, MJ; Scrutton, NS			H-tunneling in the multiple H-transfers of the catalytic cycle of morphinone reductase and in the reductive half-reaction of the homologous pentaerythritol tetranitrate reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROBACTER-CLOACAE PB2; PSEUDOMONAS-PUTIDA M10; BARRIER HYDROGEN-BOND; OLD YELLOW ENZYME; PROTON-TRANSFER; ALCOHOL-DEHYDROGENASE; BIOLOGICAL CATALYSIS; CRYSTAL-STRUCTURE; PROTEIN DYNAMICS; MECHANISM	The mechanism of flavin reduction in morphinone reductase (MR) and pentaerythritol tetranitrate (PETN) reductase, and flavin oxidation in MR, has been studied by stopped-flow and steady-state kinetic methods. The temperature dependence of the primary kinetic isotope effect for flavin reduction in MR and PETN reductase by nicotinamide coenzyme indicates that quantum mechanical tunneling plays a major role in hydride transfer. In PETN reductase, the kinetic isotope effect (KIE) is essentially independent of temperature in the experimentally accessible range, contrasting with strongly temperature-dependent reaction rates, consistent with a tunneling mechanism from the vibrational ground state of the reactive C-H/D bond. In MR, both the reaction rates and the KIE are dependent on temperature, and analysis using the Eyring equation suggests that hydride transfer has a major tunneling component, which, unlike PETN reductase, is gated by thermally induced vibrations in the protein. The oxidative half-reaction of MR is fully rate-limiting in steady-state turnover with the substrate 2-cyclohexenone and NADH at saturating concentrations. The KIE for hydride transfer from reduced flavin to the alpha/beta unsaturated bond of 2-cyclohexenone is independent of temperature, contrasting with strongly temperature-dependent reaction rates, again consistent with ground-state tunneling. A large solvent isotope effect (SIE) accompanies the oxidative half-reaction, which is also independent of temperature in the experimentally accessible range. Double isotope effects indicate that hydride transfer from the flavin N5 atom to 2-cyclohexenone, and the protonation of 2-cyclohexenone, are concerted and both the temperature-independent KIE and SIE suggest that this reaction also proceeds by ground-state quantum tunneling. Our results demonstrate the importance of quantum tunneling in the reduction of flavins by nicotinamide coenzymes. This is the first observation of (i) three H-nuclei in an enzymic reaction being transferred by tunneling and (ii) the utilization of both passive and active dynamics within the same native enzyme.	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England	University of Leicester; University of Leicester	Scrutton, NS (corresponding author), Univ Leicester, Dept Biochem, Univ Rd, Leicester LE1 7RH, Leics, England.			Sutcliffe, Mike/0000-0003-0414-1700				Antoniou D, 1999, J CHEM PHYS, V110, P7359, DOI 10.1063/1.478667; Antoniou D, 1999, J CHEM PHYS, V110, P465, DOI 10.1063/1.478107; Antoniou D, 1997, P NATL ACAD SCI USA, V94, P12360, DOI 10.1073/pnas.94.23.12360; Antoniou D, 2002, EUR J BIOCHEM, V269, P3103, DOI 10.1046/j.1432-1033.2002.03021.x; BAHNSON BJ, 1995, METHOD ENZYMOL, V249, P373; Bahnson BJ, 1997, P NATL ACAD SCI USA, V94, P12797, DOI 10.1073/pnas.94.24.12797; BAHNSON BJ, 1993, BIOCHEMISTRY-US, V32, P5503, DOI 10.1021/bi00072a003; Barna T, 2002, J BIOL CHEM, V277, P30976, DOI 10.1074/jbc.M202846200; Barna TM, 2001, J MOL BIOL, V310, P433, DOI 10.1006/jmbi.2001.4779; Basran J, 2001, J BIOL CHEM, V276, P24581, DOI 10.1074/jbc.M101178200; Basran J, 2001, J BIOL CHEM, V276, P6234, DOI 10.1074/jbc.M008141200; Basran J, 1999, BIOCHEMISTRY-US, V38, P3218, DOI 10.1021/bi982719d; Bell R. P., 1980, TUNNEL EFFECT CHEM, P51; Binks PR, 1996, APPL ENVIRON MICROB, V62, P1214, DOI 10.1128/AEM.62.4.1214-1219.1996; BOCANEGRA JA, 1993, BIOCHEMISTRY-US, V32, P2737, DOI 10.1021/bi00062a001; Borgis D, 1996, J PHYS CHEM-US, V100, P1118, DOI 10.1021/jp9522324; BRUNO WJ, 1992, BIOPHYS J, V63, P689, DOI 10.1016/S0006-3495(92)81654-5; Buckman J, 1998, BIOCHEMISTRY-US, V37, P14326, DOI 10.1021/bi981106y; Cameron CE, 1997, BIOCHEMISTRY-US, V36, P15792, DOI 10.1021/bi9716231; Cannon WR, 1998, J BIOL CHEM, V273, P26257, DOI 10.1074/jbc.273.41.26257; Cannon WR, 1996, NAT STRUCT BIOL, V3, P821, DOI 10.1038/nsb1096-821; Cleland W. W., 1991, ENZYME MECH ISOTOPE, P247; CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219; Cleland WW, 1998, J BIOL CHEM, V273, P25529, DOI 10.1074/jbc.273.40.25529; Craig DH, 1998, BIOCHEMISTRY-US, V37, P7598, DOI 10.1021/bi980345i; Craig DH, 2001, BIOCHEM J, V359, P315, DOI 10.1042/0264-6021:3590315; Faulder PF, 2001, J AM CHEM SOC, V123, P8604, DOI 10.1021/ja016219a; FOX KM, 1994, STRUCTURE, V2, P1089, DOI 10.1016/S0969-2126(94)00111-1; FRENCH CE, 1994, BIOCHEM J, V301, P97, DOI 10.1042/bj3010097; French CE, 1996, J BACTERIOL, V178, P6623, DOI 10.1128/jb.178.22.6623-6627.1996; FREY PA, 1994, SCIENCE, V264, P1927, DOI 10.1126/science.7661899; GAO J, 1998, METHODS APPL COMBINE; GERLT JA, 1993, BIOCHEMISTRY-US, V32, P11943, DOI 10.1021/bi00096a001; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; Harris RJ, 2000, BIOCHEMISTRY-US, V39, P1189, DOI 10.1021/bi991941v; Jonsson T, 1996, J AM CHEM SOC, V118, P10319, DOI 10.1021/ja961827p; Khan H, 2002, J BIOL CHEM, V277, P21906, DOI 10.1074/jbc.M200637200; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; Knapp MJ, 2002, EUR J BIOCHEM, V269, P3113, DOI 10.1046/j.1432-1033.2002.03022.x; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; KRAUT J, 1988, SCIENCE, V242, P533, DOI 10.1126/science.3051385; Kuznetsov AM, 1999, CAN J CHEM, V77, P1085, DOI 10.1139/cjc-77-5-6-1085; Lad C, 2003, P NATL ACAD SCI USA, V100, P5607, DOI 10.1073/pnas.0631607100; MASSEY V, 1986, J BIOL CHEM, V261, P1215; MELMON K, 1972, CLIN PHARM BASIC PRI; Mincer JS, 2003, J PHYS CHEM B, V107, P366, DOI 10.1021/jp027017j; Moffat A.C, 1986, CLARKES ISOLATION ID, DOI DOI 10.1002/JPS.2600760520; Neet KE, 1998, J BIOL CHEM, V273, P25527, DOI 10.1074/jbc.273.40.25527; Pollock VV, 2001, BIOCHEMISTRY-US, V40, P1430, DOI 10.1021/bi001842d; Rajagopalan PTR, 2002, BIOCHEMISTRY-US, V41, P12618, DOI 10.1021/bi026369d; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; Sutcliffe MJ, 2002, EUR J BIOCHEM, V269, P3096, DOI 10.1046/j.1432-1033.2002.03020.x; VIOLA RE, 1979, ANAL BIOCHEM, V96, P334, DOI 10.1016/0003-2697(79)90590-6; Warshel A, 1998, J BIOL CHEM, V273, P27035, DOI 10.1074/jbc.273.42.27035	54	87	90	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					43973	43982		10.1074/jbc.M305983200	http://dx.doi.org/10.1074/jbc.M305983200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941965	hybrid			2022-12-27	WOS:000186306700012
J	Osborne, A; Teng, QC; Miles, EW; Phillips, RS				Osborne, A; Teng, QC; Miles, EW; Phillips, RS			Detection of open and closed conformations of tryptophan synthase by N-15-heteronuclear single-quantum coherence nuclear magnetic resonance of bound 1-N-15-L-tryptophan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIENZYME COMPLEX; BETA-SUBUNIT; ALPHA(2)BETA(2) COMPLEX; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; SUBSTRATE-SPECIFICITY; ALLOSTERIC REGULATION; ALPHA-SUBUNIT; ACTIVE-SITES	1-N-15-L-Tryptophan (1-N-15-L-Trp) was synthesized from N-15-aniline by a Sandmeyer reaction, followed by cyclization to isatin, reduction to indole with LiAlH4, and condensation of the N-15-indole with L-serine, catalyzed by tryptophan synthase. 1-N-15-L-Trp was complexed with wild-type tryptophan synthase and beta-subunit mutants, betaK87T, betaD305A, and betaE109D, in the absence or presence of the allosteric ligands sodium chloride and disodium alpha-glycerophosphate. The enzyme complexes were observed by N-15-heteronuclear single-quantum coherence nuclear magnetic resonance (N-15-HSQC NMR) spectroscopy for the presence of 1-N-15-L-Trp bound to the beta- active site. No N-15-HSQC signal was detected for 1-N-15-L-Trp in 10 mM triethanolamine hydrochloride buffer at pH 8.1-N-15-L-Trp in the presence of wild-type tryptophan synthase in the absence or presence of 50 mM sodium chloride showed a cross peak at 10.25 ppm on the H-1 axis and 129 ppm on the N-15 axis as a result of reduced solvent exchange for the bound 1-N-15-L-Trp, consistent with formation of a closed conformation of the active site. The addition of disodium alpha-glycerophosphate produced a signal twice as intense, suggesting that the equilibrium favors the closed conformation. 15N-HSQC NMR spectra of betaK87T and betaE109D mutant Trp synthase with 1-N-15-L-Trp showed a similar cross peak either in the presence or absence of disodium alpha-glycerophosphate, indicating the preference for a closed conformation for these mutant proteins. In contrast, the betaD305A Trp synthase mutant only showed a N-15-HSQC signal in the presence of disodium alpha-glycerophosphate. Thus, this mutant Trp synthase favored an open conformation in the absence of disodium alpha-glycerophosphate but was able to form a closed conformation in the presence of disodium alpha-glycerophosphate. Our results demonstrate that the N-15-HSQC NMR spectra of 1-N-15-L-Trp bound to Trp synthase can be used to determine the conformational state of mutant forms in solution rapidly. In contrast, UV-visible spectra of wild-type and mutant Trp synthase in the presence of L-Trp with NaCl and/or disodium alpha-glycerophosphate are more difficult to interpret in terms of altered conformational equilibria.	Univ Georgia, Dept Chem, Athens, GA 30602 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; Univ Georgia, Ctr Metalloenzyme Studies, Athens, GA 30602 USA; NIDDKD, NIH, Bethesda, MD 20892 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Phillips, RS (corresponding author), Univ Georgia, Dept Chem, Athens, GA 30602 USA.	rsphillips@chem.uga.edu		Phillips, Robert/0000-0001-8710-562X	NIGMS NIH HHS [GM42588-13] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMED SA, 1991, J BIOL CHEM, V266, P21548; ANDERSON KS, 1991, J BIOL CHEM, V266, P8020; BANIK U, 1995, BIOCHEMISTRY-US, V34, P12704, DOI 10.1021/bi00039a029; BRZOVIC PS, 1992, BIOCHEMISTRY-US, V31, P1180, DOI 10.1021/bi00119a030; CREIGHTO.TE, 1970, EUR J BIOCHEM, V13, P1, DOI 10.1111/j.1432-1033.1970.tb00892.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEMOSS JA, 1962, BIOCHIM BIOPHYS ACTA, V62, P279, DOI 10.1016/0006-3002(62)90041-0; DUNN MF, 1990, BIOCHEMISTRY-US, V29, P8598, DOI 10.1021/bi00489a015; Ferrari D, 2003, BIOCHEMISTRY-US, V42, P7807, DOI 10.1021/bi034291a; Ferrari D, 2001, BIOCHEMISTRY-US, V40, P7421, DOI 10.1021/bi002892l; GIOVANNI E, 1957, HELV CHIM ACTA, V161, P1552; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; HOUBEN KF, 1990, BIOCHEMISTRY-US, V29, P2421, DOI 10.1021/bi00461a028; HYDE CC, 1988, J BIOL CHEM, V263, P17857; KIRSCHNER K, 1975, EUR J BIOCHEM, V60, P513, DOI 10.1111/j.1432-1033.1975.tb21030.x; KIRSCHNER K, 1991, BIOCHEMISTRY-US, V30, P472, DOI 10.1021/bi00216a024; Kirschner K., 1975, PROTEIN LIGAND INTER, P27, DOI [10.1515/9783110830811-006, DOI 10.1515/9783110830811-006]; LU ZC, 1993, J BIOL CHEM, V268, P8727; Marvel C. S., 1941, ORG SYNTH, V1, P327; MATCHETT WH, 1974, J BIOL CHEM, V249, P4041; MCDOWELL LM, 1995, J AM CHEM SOC, V117, P12352, DOI 10.1021/ja00154a045; Miles E W, 1995, Subcell Biochem, V24, P207; Miles E W, 1979, Adv Enzymol Relat Areas Mol Biol, V49, P127; MILES EW, 1986, BIOCHEMISTRY-US, V25, P4240, DOI 10.1021/bi00363a011; MILES EW, 1989, J BIOL CHEM, V264, P6280; MILES EW, 1991, ADV ENZYMOL RAMB, V64, P93; PERACCHI A, 1995, BIOCHEMISTRY-US, V34, P9459, DOI 10.1021/bi00029a022; Peracchi A, 1996, BIOCHEMISTRY-US, V35, P1872, DOI 10.1021/bi951889c; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rhee S, 1997, BIOCHEMISTRY-US, V36, P7664, DOI 10.1021/bi9700429; Rhee S, 1996, BIOCHEMISTRY-US, V35, P4211, DOI 10.1021/bi952506d; RUVINOV SB, 1995, J BIOL CHEM, V270, P17333, DOI 10.1074/jbc.270.29.17333; Sandmeyer T, 1919, HELV CHIM ACTA, V2, P234, DOI 10.1002/hlca.19190020125; Schneider TR, 1998, BIOCHEMISTRY-US, V37, P5394, DOI 10.1021/bi9728957; UNKEFER CJ, 1991, J LABELLED COMPD RAD, V29, P1247, DOI 10.1002/jlcr.2580291109; VANDENBERG EMM, 1988, RECL TRAV CHIM PAY B, V107, P73; VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V; Weber-Ban E, 2001, BIOCHEMISTRY-US, V40, P3497, DOI 10.1021/bi002690p; WEYLAND M, 1999, BIOCHEMISTRY-US, V38, P16469; Yang LH, 1996, PROTEIN EXPRES PURIF, V8, P126, DOI 10.1006/prep.1996.0082; YANOFSKY C, 1958, BIOCHIM BIOPHYS ACTA, V28, P640, DOI 10.1016/0006-3002(58)90533-X; YANOFSKY C, 1972, ENZYMES, V3, P1; YUAN SS, 1982, TETRAHEDRON, V38, P2051, DOI 10.1016/0040-4020(82)85150-8; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	44	22	22	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44083	44090		10.1074/jbc.M308276200	http://dx.doi.org/10.1074/jbc.M308276200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12939261	hybrid			2022-12-27	WOS:000186306700025
J	Patel, M; Morrow, J; Maxfield, FR; Strickland, DK; Greenberg, S; Tabas, I				Patel, M; Morrow, J; Maxfield, FR; Strickland, DK; Greenberg, S; Tabas, I			The cytoplasmic domain of the low density lipoprotein (LDL) receptor-related protein, but not that of the LDL receptor, triggers phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATHEROSCLEROTIC LESION FORMATION; SMOOTH-MUSCLE-CELLS; TYROSINE PHOSPHORYLATION; MACROPHAGE UPTAKE; MEDIATED PHAGOCYTOSIS; APOPTOTIC CELLS; ADAPTER PROTEIN; BINDING; INTERNALIZATION; MATRIX	The macrophage LDL receptor and LDL receptor-related protein (LRP, CD91) mediate the phagocytic-like uptake of atherogenic lipoproteins and apoptotic cells, yet the structural basis of their phagocytic functions is not known. To address this issue, we transfected macrophages with chimeric proteins containing the cytoplasmic tails and transmembrane regions of the LDL receptor or LRP and the ectodomain of CD2, which can bind non-opsonized sheep red blood cells (SRBCs). Macrophages expressing receptors containing the LDL receptor domains were able to bind but not internalize SRBCs. In contrast, macrophages expressing receptors containing the cytoplasmic tail of LRP were able to bind and internalize SRBCs. Chimeras in which the LRP cytoplasmic tail was mutated in two di-leucine motifs and a tyrosine in an NPXYXXL motif were able to endocytose anti-CD2 antibody and bind SRBCs, but SRBC phagocytosis was decreased by 70%. Thus, the phagocytic-like functions of LRP, but not those of the LDL receptor, can be explained by the ability of the LRP cytoplasmic tail to trigger phagocytosis. These findings have important implications for atherogenesis and apoptotic cell clearance and for a fundamental cell biological understanding of how the LDL receptor and LRP function in internalization processes.	Columbia Univ, Dept Med, New York, NY 10032 USA; Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Amer Red Cross, Jerome H Holland Lab Biomed Sci, Dept Vasc Biol, Rockville, MD 20855 USA	Columbia University; Columbia University; Columbia University; Cornell University; American Red Cross	Tabas, I (corresponding author), Columbia Univ, Dept Med, 630 W 168th St, New York, NY 10032 USA.		Maxfield, Fred/A-1718-2011; Maxfield, Fred/M-6747-2019	Maxfield, Fred/0000-0003-4396-8866; Morrow, John/0000-0002-9264-5273	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056984, R01HL054164, R01HL057560, P01HL054710] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-54710, HL-54164, HL-57560, HL-56984] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barnes H, 2003, ONCOGENE, V22, P3589, DOI 10.1038/sj.onc.1206504; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Buton X, 1999, J BIOL CHEM, V274, P32112, DOI 10.1074/jbc.274.45.32112; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Cox D, 2001, J EXP MED, V193, P61, DOI 10.1084/jem.193.1.61; DAUGHERTY A, 1994, ARTERIOSCLER THROMB, V14, P2017, DOI 10.1161/01.ATV.14.12.2017; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Goretzki L, 1998, BIOCHEM J, V336, P381, DOI 10.1042/bj3360381; Greenberg S, 1996, P NATL ACAD SCI USA, V93, P1103, DOI 10.1073/pnas.93.3.1103; GREENBERG S, 1999, INFLAMMATION BASIC P, P681; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Herijgers N, 2000, ARTERIOSCL THROM VAS, V20, P1961, DOI 10.1161/01.ATV.20.8.1961; Hiltunen TP, 1998, ATHEROSCLEROSIS, V137, pS81, DOI 10.1016/S0021-9150(97)00307-9; HOFF HF, 1991, LAB INVEST, V64, P254; HOFF HF, 1990, EUR HEART J, V11, P105, DOI 10.1093/eurheartj/11.suppl_E.105; HUTCHINSON MJ, 1995, EUR J IMMUNOL, V25, P481, DOI 10.1002/eji.1830250226; INDIK ZK, 1995, IMMUNOL LETT, V44, P133, DOI 10.1016/0165-2478(94)00204-5; ISHIKAWA Y, 1991, Journal of Biomaterials Science Polymer Edition, V2, P53, DOI 10.1163/156856291X00052; KHOO JC, 1988, ARTERIOSCLEROSIS, V8, P348, DOI 10.1161/01.ATV.8.4.348; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; Koval M, 1998, EXP CELL RES, V242, P265, DOI 10.1006/excr.1998.4110; KRUSKAL BA, 1992, J EXP MED, V176, P1673, DOI 10.1084/jem.176.6.1673; Kruth HS, 2002, CURR OPIN LIPIDOL, V13, P483, DOI 10.1097/00041433-200210000-00003; KUBOTA Y, 1983, Journal of Toxicological Sciences, V8, P189; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Linton MF, 1999, J BIOL CHEM, V274, P19204, DOI 10.1074/jbc.274.27.19204; Llorente-Cortes V, 2000, ARTERIOSCL THROM VAS, V20, P1572, DOI 10.1161/01.ATV.20.6.1572; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; LUND H, 1989, P NATL ACAD SCI USA, V86, P9318, DOI 10.1073/pnas.86.23.9318; LUPU F, 1994, ARTERIOSCLER THROMB, V14, P1438, DOI 10.1161/01.ATV.14.9.1438; Misra UK, 1999, ARCH BIOCHEM BIOPHYS, V372, P238, DOI 10.1006/abbi.1999.1521; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; PRATTEN MK, 1986, BIOCHIM BIOPHYS ACTA, V881, P307, DOI 10.1016/0304-4165(86)90020-6; Sakr SW, 2001, J BIOL CHEM, V276, P37649, DOI 10.1074/jbc.M105129200; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; SUITS AG, 1989, P NATL ACAD SCI USA, V86, P2713, DOI 10.1073/pnas.86.8.2713; TABAS I, 1993, J BIOL CHEM, V268, P20419; Tabas I, 1999, ANNU REV NUTR, V19, P123, DOI 10.1146/annurev.nutr.19.1.123; Tridandapani S, 2002, J IMMUNOL, V169, P4370, DOI 10.4049/jimmunol.169.8.4370; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Tse SML, 2003, J BIOL CHEM, V278, P3331, DOI 10.1074/jbc.M207966200; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; VanNhieu GT, 1996, J BIOL CHEM, V271, P7665, DOI 10.1074/jbc.271.13.7665; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; XU XX, 1991, J BIOL CHEM, V266, P24849	49	26	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44799	44807		10.1074/jbc.M308982200	http://dx.doi.org/10.1074/jbc.M308982200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941948	hybrid			2022-12-27	WOS:000186306700114
J	Sun-Wada, GH; Murata, Y; Namba, M; Yamamoto, A; Wada, Y; Futai, M				Sun-Wada, GH; Murata, Y; Namba, M; Yamamoto, A; Wada, Y; Futai, M			Mouse proton pump ATPase C subunit Isoforms (C2-a and C2-b) specifically expressed in kidney and lung	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; DUCT INTERCALATED CELLS; RENAL TUBULAR-ACIDOSIS; COLLECTING DUCT; TRANSLOCATING ATPASE; MOLECULAR-CLONING; LAMELLAR BODIES; PLASMA-MEMBRANE; RAT-KIDNEY; V-ATPASE	The vacuolar-type H+-ATPases (V-ATPases) are multimeric proton pumps involved in a wide variety of physiological processes. We have identified two alternative splicing variants of C2 subunit isoforms: C2-a, a lung-specific isoform containing a 46-amino acid insertion, and C2-b, a kidney-specific isoform without the insert. Immunohistochemistry with isoform-specific antibodies revealed that V-ATPase with C2-a is localized specifically in lamellar bodies of type II alveolar cells, whereas the C2-b isoform is found in the plasma membranes of renal alpha and beta intercalated cells. Immunoprecipitation combined with immunohistological analysis revealed that C2-b together with other kidney-specific isoforms was selectively assembled to form a unique proton pump in intercalated cells. Furthermore, a chimeric yeast V-ATPase with mouse the C2-a or C2-b isoform showed a lower K-m(ATP) and lower proton transport activity than that with C1 or Vma5p (yeast C subunit). These results suggest that V-ATPases with the C2-a and C2-b isoform are involved in luminal acidification of lamellar bodies and regulation of the renal acid-base balance, respectively.	Osaka Univ, Inst Sci & Ind Res, Div Biol Sci, Osaka 5670047, Japan; Kansai Med Univ, Dept Physiol, Osaka 5708506, Japan	Osaka University; Kansai Medical University	Futai, M (corresponding author), Osaka Univ, Inst Sci & Ind Res, Div Biol Sci, Osaka 5670047, Japan.							ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; BROWN D, 1987, J CELL BIOL, V105, P1637, DOI 10.1083/jcb.105.4.1637; BROWN D, 1988, NATURE, V331, P622, DOI 10.1038/331622a0; BROWN D, 1988, J CLIN INVEST, V82, P2114, DOI 10.1172/JCI113833; CHANDER A, 1986, J BIOL CHEM, V261, P6126; CHANDER A, 1990, AM J PHYSIOL, V258, P241; DRENCKHAHN D, 1985, SCIENCE, V230, P1287, DOI 10.1126/science.2933809; Futai M, 2000, J EXP BIOL, V203, P107; Futai M, 1998, J BIOCHEM-TOKYO, V124, P259, DOI 10.1093/oxfordjournals.jbchem.a022105; Gluck SL, 1996, KIDNEY INT, V49, P1660, DOI 10.1038/ki.1996.242; HANADA H, 1991, BIOCHEM BIOPH RES CO, V176, P1062, DOI 10.1016/0006-291X(91)90391-J; Hayami K, 2001, GENE, V273, P199, DOI 10.1016/S0378-1119(01)00590-X; Hirata T, 2000, J BIOL CHEM, V275, P386, DOI 10.1074/jbc.275.1.386; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; HO MN, 1993, J BIOL CHEM, V268, P221; Iko Y, 2001, J BIOL CHEM, V276, P47508, DOI 10.1074/jbc.M108803200; Imai-Senga Y, 2002, GENE, V289, P7, DOI 10.1016/S0378-1119(02)00542-5; Kane PM, 1999, J BIOL CHEM, V274, P17275, DOI 10.1074/jbc.274.24.17275; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P17941, DOI 10.1074/jbc.M010790200; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Mattsson JP, 2000, EUR J BIOCHEM, V267, P4115, DOI 10.1046/j.1432-1327.2000.01445.x; MORIYAMA Y, 1992, J EXP BIOL, V172, P171; Murata Y, 2002, J BIOL CHEM, V277, P36296, DOI 10.1074/jbc.M200586200; Nakamura N, 2000, J BIOL CHEM, V275, P6523, DOI 10.1074/jbc.275.9.6523; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishio K, 2002, P NATL ACAD SCI USA, V99, P13448, DOI 10.1073/pnas.202149599; Oka T, 1998, J BIOL CHEM, V273, P22570, DOI 10.1074/jbc.273.35.22570; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Peng SB, 1999, J BIOL CHEM, V274, P2549, DOI 10.1074/jbc.274.4.2549; PUOPOLO K, 1992, J BIOL CHEM, V267, P5171; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; SCHUSTER VL, 1987, AM J PHYSIOL, V253, pF203, DOI 10.1152/ajprenal.1987.253.2.F203; SCHUSTER VL, 1991, AM J PHYSIOL, V260, pF506, DOI 10.1152/ajprenal.1991.260.4.F506; SCHUSTER VL, 1993, ANNU REV PHYSIOL, V55, P267, DOI 10.1146/annurev.ph.55.030193.001411; Smith AN, 2001, J BIOL CHEM, V276, P42382, DOI 10.1074/jbc.M107267200; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; STADLER H, 1984, EMBO J, V3, P3333, DOI 10.1002/j.1460-2075.1984.tb02300.x; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Sun-Wada GH, 2003, GENE, V302, P147, DOI 10.1016/S0378-1119(02)01099-5; Sun-Wada GH, 2002, J BIOL CHEM, V277, P18098, DOI 10.1074/jbc.M111567200; Sun-Wada GH, 2000, DEV BIOL, V228, P315, DOI 10.1006/dbio.2000.9963; Sun-Wada GH, 2000, J BIOCHEM-TOKYO, V127, P703, DOI 10.1093/oxfordjournals.jbchem.a022660; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanabe M, 2001, J BIOL CHEM, V276, P15269, DOI 10.1074/jbc.M100289200; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Wada Y, 1997, J CELL SCI, V110, P1299; Wadsworth SJ, 2000, J MEMBRANE BIOL, V174, P41, DOI 10.1007/s002320001030; Wadsworth SJ, 1997, AM J PHYSIOL-LUNG C, V273, pL427, DOI 10.1152/ajplung.1997.273.2.L427; ZHANG K, 1992, J BIOL CHEM, V267, P14539; ZHANG K, 1992, J BIOL CHEM, V267, P9701	59	59	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44843	44851		10.1074/jbc.M307197200	http://dx.doi.org/10.1074/jbc.M307197200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12947086	hybrid			2022-12-27	WOS:000186306700119
J	Yanaka, N; Imai, Y; Kawai, E; Akatsuka, H; Wakimoto, K; Nogusa, Y; Kato, N; Chiba, H; Kotani, E; Omori, K; Sakurai, N				Yanaka, N; Imai, Y; Kawai, E; Akatsuka, H; Wakimoto, K; Nogusa, Y; Kato, N; Chiba, H; Kotani, E; Omori, K; Sakurai, N			Novel membrane protein containing glycerophosphodiester phosphodiesterase motif is transiently expressed during osteoblast differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARREST; GENE; PHOSPHORYLATION; PROLIFERATION; BINDING; CULTURE; SYSTEM; SHAPE; CBFA1; CELLS	Osteoblast maturation is a multistep series of events characterized by an integrated cascade of gene expression that are accompanied by specific phenotypic alterations. To find new osteoblast-related genes we cloned differentially expressed cDNAs characteristic of specific differentiation stages in the mouse osteoblast-like MC3T3-E1 cells by a differential display method. We identified a novel cDNA encoding a putative glycerophosphodiester phosphodiesterase, GDE3, which specifically was expressed at the stage of matrix maturation. Interestingly, the deduced amino acid sequence contains 539 amino acids including seven putative transmembrane domains and a glycerophosphodiester phosphodiesterase region in one of the extracellular loops. Northern blot analysis revealed that GDE3 was also expressed in spleen as well as primary calvarial osteoblasts and femur. We next transfected HEK293T cells with GDE3 with green fluorescent protein fused to the C terminus. The green fluorescent protein-fused protein accumulated at the cell periphery, and the transfected cells overexpressing the protein changed from a spread form to rounded form with disappearance of actin filaments. Immunofluorescence staining with GDE3 antibody and phalloidin in MC3T3-E1 cells indicated that endogenous GDE3 might be co-localized with the actin cytoskeleton. To identify a role for GDE3 in osteoblast differentiation, MC3T3-E1 cells stably expressing the full-length protein were constructed. Expression of GDE3 showed morphological changes, resulting in dramatic increases in alkaline phosphatase activity and calcium deposit. These results suggest that GDE3 might be a novel seven-transmembrane protein with a GP-PDE-like extracellular motif expressed during the osteoblast differentiation that dramatically accelerates the program of osteoblast differentiation and is involved in the morphological change of cells.	Tanabe Seiyaku Co Ltd, Discovery Res Lab, Toda, Saitama 3358305, Japan; Tanabe Seiyaku Co Ltd, Discovery Res Lab, Yodogawa Ku, Osaka 5328505, Japan; Hiroshima Univ, Grad Sch Biosphere Sci, Dept Mol & Appl Biosci, Higashihiroshima 7398528, Japan	Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation; Hiroshima University	Imai, Y (corresponding author), Tanabe Seiyaku Co Ltd, Discovery Res Lab, 2-50 Kawagishi 2 Chome, Toda, Saitama 3358305, Japan.		Yanaka, Noriyuki/P-9096-2016					Aubin JE, 1999, J CELL BIOCHEM, V72, P396, DOI 10.1002/(SICI)1097-4644(19990301)72:3<396::AID-JCB9>3.3.CO;2-Y; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fan X, 2001, MOL MICROBIOL, V41, P1029, DOI 10.1046/j.1365-2958.2001.02571.x; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Hagiwara H, 1996, AM J PHYSIOL-CELL PH, V270, pC1311, DOI 10.1152/ajpcell.1996.270.5.C1311; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; JONES SJ, 1976, CELL TISSUE RES, V169, P449; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MILLER SS, 1976, SCIENCE, V192, P1340, DOI 10.1126/science.1273593; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MUNSON RS, 1993, J BACTERIOL, V175, P4569, DOI 10.1128/JB.175.14.4569-4571.1993; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Raouf A, 2002, BONE, V30, P463, DOI 10.1016/S8756-3282(01)00699-8; RODAN GA, 1981, CALCIFIED TISSUE INT, V33, P349, DOI 10.1007/BF02409454; Sakurai N, 2002, J BONE MINER RES, V17, pS194; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Tanaka-Kamioka K, 1998, J BONE MINER RES, V13, P1555, DOI 10.1359/jbmr.1998.13.10.1555; TERADA Y, 1995, NATURE, V376, P358, DOI 10.1038/376358a0; TOMMASSEN J, 1991, MOL GEN GENET, V226, P321, DOI 10.1007/BF00273621; Tsuda M, 1997, J NEUROSCI, V17, P6678; Yang RS, 1998, BONE, V22, P629, DOI 10.1016/S8756-3282(98)00055-6; Yuasa K, 2000, J BIOL CHEM, V275, P4897, DOI 10.1074/jbc.275.7.4897; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100; Zheng B, 2000, P NATL ACAD SCI USA, V97, P3999, DOI 10.1073/pnas.97.8.3999	27	36	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43595	43602		10.1074/jbc.M302867200	http://dx.doi.org/10.1074/jbc.M302867200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12933806	hybrid			2022-12-27	WOS:000186157000107
J	Perbandt, M; Burmeister, C; Walter, RD; Betzel, C; Liebau, E				Perbandt, M; Burmeister, C; Walter, RD; Betzel, C; Liebau, E			Native and inhibited structure of a Mu class-related glutathione S-transferase from Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; COMPLEX; ENZYME; CRYSTALLIZATION; DETOXIFICATION; REFINEMENT; MALARIA; DRUG	The parasite Plasmodium falciparum causes malaria tropica, the most prevailing parasitic disease worldwide, with 300 - 500 million infections and 1.5 - 2.7 million deaths/year. The emergence of strains resistant to drugs used for prophylaxis and treatment and no vaccine available makes the structural analysis of potential drug targets essential. For that reason, we analyzed the three-dimensional structure of the glutathione S-transferase from P. falciparum (Pf-GST1) in the apoform and in complex with its inhibitor S-hexyl-glutathione. The structures have been analyzed to 2.6 and 2.2 Angstrom, respectively. Pf-GST1 shares several structural features with the Mu-type GSTs and is therefore closely related to this class, even though alignments with its members display low sequence identities in the range of 20 - 33%. Upon S-hexyl-glutathione binding, the overall structure and the glutathione-binding site (G-site) remain almost unchanged with the exception of the flexible C terminus. The detailed comparison of the parasitic enzyme with the human host Mu-class enzyme reveals that, although the overall structure is homologue, the shape of the hydrophobic binding pocket ( H-site) differs substantially. In the human enzyme, it is shielded from one side by the large Mu-loop, whereas in Pf-GST1 the Mu-loop is truncated and the space to recognize and bind voluminous substrates is extended. This structural feature can be exploited to support the design of specific and parasite-selective inhibitors.	Univ Hamburg, Dept Biochem & Mol Biol, D-20146 Hamburg, Germany; Univ Hosp Eppendorf, Inst Biochem & Mol Biol 1, Ctr Med Expt, DESY, D-22603 Hamburg, Germany; Bernhard Nocht Inst Trop Med, Dept Biochem, D-20359 Hamburg, Germany	University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; University Medical Center Hamburg-Eppendorf; Bernhard Nocht Institut fur Tropenmedizin	Perbandt, M (corresponding author), Univ Hamburg, Dept Biochem & Mol Biol, Martin Luther King Pl 6, D-20146 Hamburg, Germany.	markus.perbandt@desy.de	Betzel, Christian/G-8105-2018; Perbandt, Markus/K-7603-2018	Betzel, Christian/0000-0002-3879-5019; 				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Burmeister C, 2003, ACTA CRYSTALLOGR D, V59, P1469, DOI 10.1107/S0907444903011090; CAMERON AD, 1995, STRUCTURE, V3, P717, DOI 10.1016/S0969-2126(01)00206-4; Cardoso RMF, 2003, PROTEINS, V51, P137, DOI 10.1002/prot.10345; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; DUBOIS VL, 1995, EXP PARASITOL, V81, P117, DOI 10.1006/expr.1995.1099; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Harwaldt P, 2002, BIOL CHEM, V383, P821, DOI 10.1515/BC.2002.086; Hemingway J, 2000, INSECT BIOCHEM MOLEC, V30, P1009, DOI 10.1016/S0965-1748(00)00079-5; HOLMGREN A, 1975, P NATL ACAD SCI USA, V72, P2305, DOI 10.1073/pnas.72.6.2305; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; JAKOBY WB, 1990, J BIOL CHEM, V265, P20715; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liebau E, 2002, MOL BIOCHEM PARASIT, V124, P85, DOI 10.1016/S0166-6851(02)00160-3; LISTOWSKI I, 1994, HEPATIC TRANSPORT BI, P1; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Neuefeind T, 1997, BIOL CHEM, V378, P199; Neuefeind T, 1997, J MOL BIOL, V274, P577, DOI 10.1006/jmbi.1997.1401; Neuefeind T, 1997, J MOL BIOL, V274, P446, DOI 10.1006/jmbi.1997.1402; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patskovsky YV, 2000, J BIOL CHEM, V275, P3296, DOI 10.1074/jbc.275.5.3296; Platel DFN, 1999, MOL BIOCHEM PARASIT, V98, P215, DOI 10.1016/S0166-6851(98)00170-4; RAGHUNATHAN S, 1994, J MOL BIOL, V238, P815, DOI 10.1006/jmbi.1994.1336; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; REINEMER P, 1991, EMBO J, V10, P1997, DOI 10.1002/j.1460-2075.1991.tb07729.x; ROUSSELL A, 1991, SILICON GRAPHICS DIR; Salinas AE, 1999, CURR MED CHEM, V6, P279; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; SODERBERG BO, 1978, P NATL ACAD SCI USA, V75, P5827, DOI 10.1073/pnas.75.12.5827; Srivastava P, 1999, TROP MED INT HEALTH, V4, P251, DOI 10.1046/j.1365-3156.1999.00387.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Townsend Danyelle, 2003, Am J Pharmacogenomics, V3, P157, DOI 10.2165/00129785-200303030-00002; VORE M, 1994, ENVIRON HEALTH PERSP, V102, P422, DOI 10.2307/3432028	42	38	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2004	279	2					1336	1342		10.1074/jbc.M309663200	http://dx.doi.org/10.1074/jbc.M309663200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	759DJ	12972411	hybrid			2022-12-27	WOS:000187722800061
J	Chang, TS; Kim, MJ; Ryoo, K; Park, J; Eom, SJ; Shim, J; Nakayama, KI; Nakayama, K; Tomita, M; Takahashi, K; Lee, MJ; Choi, EJ				Chang, TS; Kim, MJ; Ryoo, K; Park, J; Eom, SJ; Shim, J; Nakayama, KI; Nakayama, K; Tomita, M; Takahashi, K; Lee, MJ; Choi, EJ			P57(KIP2) modulates stress-activated signaling by inhibiting c-Jun NH2-terminal kinase/stress-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BECKWITH-WIEDEMANN-SYNDROME; N-TERMINAL KINASE; CDK INHIBITOR; CELL-DIFFERENTIATION; MICE LACKING; MAP KINASES; APOPTOSIS; JNK; TRANSDUCTION; PROLIFERATION	p57(KIP2), a member of the Cip/Kip family of enzymes that inhibit several cyclin-dependent kinases, plays a role in many biological events including cell proliferation, differentiation, apoptosis, tumorigenesis and developmental changes. The human p57(KIP2) gene is located in chromosome 11p15.5, a region implicated in sporadic cancers and Beckwith-Wiedemann syndrome. We here report that p57(KIP2) physically interacts with and inhibits c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK). The carboxyl-terminal QT domain of p57(KIP2) is crucial for the inhibition of JNK/ SAPK. Overexpressed p57(KIP2) also suppressed UV- and MEKK1-induced apoptotic cell death. p57(KIP2) expression during C2C12 myoblast differentiation resulted in repression of the JNK activity stimulated by UV light. Furthermore, UV- stimulated JNK1 activity was higher in mouse embryonic fibroblasts derived from p57(-/-) mice than in the cells from wild-type mice. Taken together, these findings suggest that p57(KIP2) modulates stress-activated signaling by functioning as an endogenous inhibitor of JNK/ SAPK.	Korea Univ, Sch Life Sci & Biotechnol, Natl Creat Res Initiat Ctr Cell Death, Seoul 136701, South Korea; Kyushu Univ, Dept Cellular & Mol Biol, Div Cell Biol, Fukuoka 8128582, Japan; Kyushu Univ, Med Inst Bioregulat, Lab Embryon & Genet Engn, Higashi Ku, Fukuoka 8128582, Japan; Showa Univ, Sch Pharmaceut Sci, Dept Physiol Chem, Shinagawa Ku, Tokyo 1428555, Japan; Samsung Biomed Res Inst, Dept Lab Anim Res, Seoul 135710, South Korea; Sejong Univ, Coll Nat Sci, Dept Mol Biol, Seoul 143747, South Korea	Korea University; Kyushu University; Kyushu University; Showa University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sejong University	Choi, EJ (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Natl Creat Res Initiat Ctr Cell Death, Seoul 136701, South Korea.							Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Harper JW, 1996, CURR OPIN GENET DEV, V6, P56; Hatada I, 1996, NAT GENET, V14, P171, DOI 10.1038/ng1096-171; Hatada I, 1997, HUM GENET, V100, P681, DOI 10.1007/s004390050573; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Minden A., 1997, BIOCHIM BIOPHYS ACTA, V1333, P85, DOI DOI 10.1016/S0304-419X(97)00018-8; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nagata Y, 1999, BLOOD, V94, P853, DOI 10.1182/blood.V94.3.853.415a12_853_863; Park HS, 2001, EMBO J, V20, P446, DOI 10.1093/emboj/20.3.446; Reynaud EG, 1999, MOL CELL BIOL, V19, P7621; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shim J, 2000, J BIOL CHEM, V275, P14107, DOI 10.1074/jbc.275.19.14107; Shim J, 1996, NATURE, V381, P804, DOI 10.1038/381804a0; Takahashi K, 2000, J BIOCHEM-TOKYO, V127, P73, DOI 10.1093/oxfordjournals.jbchem.a022586; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213	26	54	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48092	48098		10.1074/jbc.M309421200	http://dx.doi.org/10.1074/jbc.M309421200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12963725	hybrid			2022-12-27	WOS:000186731400089
J	Salmona, M; Morbin, M; Massignan, T; Colombo, L; Mazzoleni, G; Capobianco, R; Diomede, L; Thaler, F; Mollica, L; Musco, G; Kourie, JJ; Bugiani, O; Sharma, D; Inouye, H; Kirschner, DA; Forloni, G; Tagliavini, F				Salmona, M; Morbin, M; Massignan, T; Colombo, L; Mazzoleni, G; Capobianco, R; Diomede, L; Thaler, F; Mollica, L; Musco, G; Kourie, JJ; Bugiani, O; Sharma, D; Inouye, H; Kirschner, DA; Forloni, G; Tagliavini, F			Structural properties of Gerstmann-Straussler-Scheinker disease amyloid protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; HUMAN PRION PROTEIN; SCRAPIE PRION; ALPHA-HELICES; PRP PEPTIDES; IN-VITRO; FRAGMENT; INDIANA; RESIDUES-106-126; FIBRILS	Prion protein (PrP) amyloid formation is a central feature of genetic and acquired forms of prion disease such as Gerstmann-Straussler-Scheinker disease (GSS) and variant Creutzfeldt-Jakob disease. The major component of GSS amyloid is a PrP fragment spanning residues similar to 82 - 146. To investigate the determinants of the physicochemical properties of this fragment, we synthesized PrP-(82 - 146) and variants thereof, including entirely and partially scrambled peptides. PrP-( 82 - 146) readily formed aggregates that were partially resistant to protease digestion. Peptide assemblies consisted of 9.8-nm-diameter fibrils having a parallel cross-beta-structure. Second derivative of infrared spectra indicated that PrP-( 82 - 146) aggregates are primarily composed of beta-sheet (54%) and turn (24%) which is consistent with their amyloid-like properties. The peptide induced a remarkable increase in plasma membrane microviscosity of primary neurons. Modification of the amino acid sequence 106 - 126 caused a striking increase in aggregation rate, with formation of large amount of protease-resistant amorphous material and relatively few amyloid fibrils. Alteration of the 127 - 146 region had even more profound effects, with the inability to generate amyloid fibrils. These data indicate that the intrinsic properties of PrP-( 82 - 146) are dependent upon the integrity of the C-terminal region and account for the massive deposition of PrP amyloid in GSS.	Ist Ric Farmacol Mario Negri, I-20157 Milan, Italy; Ist Nazl Neurol Carlo Besta, I-20133 Milan, Italy; DIBIT, Dulbecco Telethon Inst, I-20132 Milan, Italy; Australian Natl Univ, Dept Chem, Membrane Transport Grp, Canberra, ACT 0200, Australia; Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Istituto Neurologico Besta; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Australian National University; Boston College	Salmona, M (corresponding author), Ist Ric Farmacol Mario Negri, Via Eritrea 62, I-20157 Milan, Italy.	salmona@marionegri.it	salmona, mario/ABI-4066-2020; Diomede, Luisa/P-3417-2014; Musco, Giovanna/Q-2756-2019; salmona, mario/AAA-7116-2020; musco, giovanna/I-7122-2012; Tagliavini, Fabrizio/AAO-7891-2021; colombo, laura/AAA-6716-2020; Forloni, Gianluigi/AAB-2115-2020	Diomede, Luisa/0000-0002-2258-0531; salmona, mario/0000-0002-9098-9873; musco, giovanna/0000-0002-0469-2994; Tagliavini, Fabrizio/0000-0003-1039-7315; colombo, laura/0000-0002-3243-0270; Forloni, Gianluigi/0000-0001-5374-3914; Sharma, Deepak/0000-0001-8436-1759; massignan, tania/0000-0002-6176-2696; Morbin, Michela/0000-0001-8034-3123; Kirschner, Daniel/0000-0003-3498-1452; MOLLICA, LUCA/0000-0001-8164-7663	Telethon [TCP99035] Funding Source: Medline	Telethon(Fondazione Telethon)		Balbirnie M, 2001, P NATL ACAD SCI USA, V98, P2375, DOI 10.1073/pnas.041617698; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P468; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; DEGIOIA L, 1994, J BIOL CHEM, V269, P7859; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; GIACCONE G, 1992, P NATL ACAD SCI USA, V89, P9349, DOI 10.1073/pnas.89.19.9349; Inouye H, 1998, J STRUCT BIOL, V122, P247, DOI 10.1006/jsbi.1998.3998; Inouye H, 2000, J MOL BIOL, V300, P1283, DOI 10.1006/jmbi.2000.3926; INOUYE H, 1993, BIOPHYS J, V64, P502, DOI 10.1016/S0006-3495(93)81393-6; Inouye H, 1997, J MOL BIOL, V268, P375, DOI 10.1006/jmbi.1997.0949; KRISTENSSON K, 1993, NEUROLOGY, V43, P2335, DOI 10.1212/WNL.43.11.2335; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MAKOWSKI L, 1989, BROOKH S SYNCHR RAD, P341; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Nilsson MR, 2003, BIOCHEMISTRY-US, V42, P375, DOI 10.1021/bi0204746; OLDENBOURG R, 1986, REV SCI INSTRUM, V57, P2362, DOI 10.1063/1.1138680; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1998, P NATL ACAD SCI USA, V95, P8322, DOI 10.1073/pnas.95.14.8322; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; Piccardo P, 1996, J NEUROPATH EXP NEUR, V55, P1157, DOI 10.1097/00005072-199611000-00007; Pillot T, 1997, J MOL BIOL, V274, P381, DOI 10.1006/jmbi.1997.1382; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Salmona M, 1999, BIOCHEM J, V342, P207, DOI 10.1042/0264-6021:3420207; Salmona M, 1997, NEUROBIOL DIS, V4, P47, DOI 10.1006/nbdi.1997.0133; SELVAGGINI C, 1993, BIOCHEM BIOPH RES CO, V194, P1380, DOI 10.1006/bbrc.1993.1977; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; TAGLIAVINI F, 1994, CELL, V79, P695, DOI 10.1016/0092-8674(94)90554-1; TAGLIAVINI F, 1991, EMBO J, V10, P513, DOI 10.1002/j.1460-2075.1991.tb07977.x; Tagliavini F, 2001, ADV PROTEIN CHEM, V57, P171; Tagliavini F, 2001, J BIOL CHEM, V276, P6009, DOI 10.1074/jbc.M007062200; Tagliavini F, 2000, J MOL BIOL, V300, P1309, DOI 10.1006/jmbi.2000.3840; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	43	65	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48146	48153		10.1074/jbc.M307295200	http://dx.doi.org/10.1074/jbc.M307295200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12970341	hybrid, Green Published			2022-12-27	WOS:000186731400096
J	Zhou, H; Cadigan, KM; Thiele, DJ				Zhou, H; Cadigan, KM; Thiele, DJ			A copper-regulated transporter required for copper acquisition, pigmentation, and specific stages of development in Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; BIOCHEMICAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; PLASMA-MEMBRANE; FACTOR MTF-1; YEAST; EXPRESSION; TRANSCRIPTION; MECHANISM; GENES	The trace element copper is required for normal growth and development, serving as an essential catalytic co-factor for enzymes involved in energy generation, oxidative stress protection, neuropeptide maturation, and other fundamental processes. In yeast and mammals copper acquisition occurs through the action of the Ctr1 family of high affinity copper transporters. Here we describe studies using Drosophila melanogaster to investigate the role of copper acquisition through Ctr1 in normal growth and development. Three distinct Drosophila Ctr1 genes (Ctr1A, Ctr1B, and Ctr1C) have been identified, which have unique expression patterns over the course of development. Interestingly, Ctr1B, which is expressed exclusively during the late embryonic and larval stages of development, is transcriptionally activated in response to nutritionally induced copper deprivation and down-regulated in response to copper adequacy. The generation of Ctr1B mutant flies results in decreased larval copper accumulation, marked body pigmentation defects that parallel defects in tyrosinase activity, and specific developmental arrest under conditions of both nutritional copper limitation and excess. These studies establish that copper acquisition through the Drosophila Ctr1B transporter is crucial for normal growth and in early and specific stages of metazoan development.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cadigan, KM (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	cadigan@umich.edu; dennis.thiele@duke.edu		Cadigan, Ken/0000-0003-2431-1703	NIGMS NIH HHS [GM62555] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062555] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashburner M., 1989, DROSOPHILA LAB HDB; Askwith C, 1998, TRENDS BIOCHEM SCI, V23, P135, DOI 10.1016/S0968-0004(98)01192-X; Culotta VC, 1999, ADV EXP MED BIOL, V448, P247; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Egli D, 2003, EMBO J, V22, P100, DOI 10.1093/emboj/cdg012; Eide DJ, 2000, ADV MICROB PHYSIOL, V43, P1, DOI 10.1016/S0065-2911(00)43001-8; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; FILSHIE BK, 1971, TISSUE CELL, V3, P77, DOI 10.1016/S0040-8166(71)80033-2; Graden JA, 1997, P NATL ACAD SCI USA, V94, P5550, DOI 10.1073/pnas.94.11.5550; HALLIWELL B, 1985, MOL ASPECTS MED, V8, P89, DOI 10.1016/0098-2997(85)90001-9; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; Jiang N, 2000, DEV BIOL, V226, P118, DOI 10.1006/dbio.2000.9832; KAMPFENKEL K, 1995, J BIOL CHEM, V270, P28479, DOI 10.1074/jbc.270.47.28479; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Kolhekar AS, 1997, J NEUROSCI, V17, P1363, DOI 10.1523/jneurosci.17-04-01363.1997; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; LASTOWSKIPERRY D, 1985, J BIOL CHEM, V260, P1527; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Lee J, 2000, GENE, V254, P87, DOI 10.1016/S0378-1119(00)00287-0; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Lutsenko S, 2003, J MEMBRANE BIOL, V191, P1, DOI 10.1007/s00232-002-1040-6; MARCHALSEGAULT D, 1990, BIOL CELL, V70, P129, DOI 10.1016/0248-4900(90)90368-D; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; PROHASKA JR, 1990, ADV EXP MED BIOL, V262, P123; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SOLIOZ M, 1995, J BIOL CHEM, V270, P9217, DOI 10.1074/jbc.270.16.9217; Suzuki M, 1999, PEDIATR INT, V41, P436; Szczypka MS, 1997, YEAST, V13, P1423, DOI 10.1002/(SICI)1097-0061(199712)13:15<1423::AID-YEA190>3.3.CO;2-3; TAPP RL, 1975, J CELL SCI, V17, P449; Waggoner DJ, 1999, NEUROBIOL DIS, V6, P221, DOI 10.1006/nbdi.1999.0250; Woodhouse LR, 2001, CRC MOD NUT, P1; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5; Zhang B, 2001, MOL CELL BIOL, V21, P4505, DOI 10.1128/MCB.21.14.4505-4514.2001; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	52	92	94	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48210	48218		10.1074/jbc.M309820200	http://dx.doi.org/10.1074/jbc.M309820200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12966081	hybrid			2022-12-27	WOS:000186731400104
J	Hao, N; Yildirim, N; Wang, YQ; Elston, TC; Dohlman, HG				Hao, N; Yildirim, N; Wang, YQ; Elston, TC; Dohlman, HG			Regulators of G protein signaling and transient activation of signaling - Experimental and computational analysis reveals negative and positive feedback controls on G protein activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; ALPHA-FACTOR PHEROMONES; END RULE PATHWAY; A-FACTOR; N-MYRISTOYLATION; FACTOR RECEPTOR; UBIQUITINATION; SUBUNIT; PHOSPHORYLATION; GPA1	Cellular responses to hormones and neurotransmitters are necessarily transient. The mating pheromone signal in yeast is typical. Signal initiation requires cell surface receptors, a G protein heterotrimer, and downstream effectors. Signal inactivation requires Sst2, a regulator of G protein signaling ( RGS) protein that accelerates GTPase activity. We conducted a quantitative analysis of RGS and G protein expression and devised computational models that describe their activity in vivo. These results indicated that pheromone- dependent transcriptional induction of the RGS protein constitutes a negative feedback loop that leads to desensitization. Modeling also suggested the presence of a positive feedback loop leading to resensitization of the pathway. In confirmation of the model, we found that the RGS protein is ubiquitinated and degraded in response to pheromone stimulation. We identified and quantitated these positive and negative feedback loops, which account for the transient response to external signals observed in vivo.	Univ N Carolina, Dept Math, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Elston, TC (corresponding author), Univ N Carolina, Dept Math, Chapel Hill, NC 27599 USA.	telston@amath.unc.edu; hdohlman@med.unc.edu	Hao, Nan/O-3462-2016	Hao, Nan/0000-0003-2857-4789; Dohlman, Henrik/0000-0003-2443-0729	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM055316, R01GM055316, R01GM059167] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM055316, GM 59167, R01 GM059167, GM 55316] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apanovitch DM, 1998, BIOCHEMISTRY-US, V37, P4815, DOI 10.1021/bi9729965; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; CHAN RK, 1982, MOL CELL BIOL, V2, P21, DOI 10.1128/MCB.2.1.21; CHAN RK, 1982, MOL CELL BIOL, V2, P11, DOI 10.1128/MCB.2.1.11; COLE GM, 1991, CELL, V64, P703, DOI 10.1016/0092-8674(91)90500-X; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; DiBello PR, 1998, J BIOL CHEM, V273, P5780, DOI 10.1074/jbc.273.10.5780; Dohlman HG, 2002, ANNU REV PHYSIOL, V64, P129, DOI 10.1146/annurev.physiol.64.081701.133448; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; DOHLMAN HG, 1993, P NATL ACAD SCI USA, V90, P9688, DOI 10.1073/pnas.90.20.9688; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Guo M, 2003, MOL CELL, V12, P517, DOI 10.1016/S1097-2765(03)00307-1; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; JENNESS DD, 1986, MOL CELL BIOL, V6, P318, DOI 10.1128/MCB.6.1.318; Kallal L, 2000, YEAST, V16, P387, DOI 10.1002/(SICI)1097-0061(20000330)16:5<387::AID-YEA525>3.0.CO;2-U; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kim E, 1999, P NATL ACAD SCI USA, V96, P6371, DOI 10.1073/pnas.96.11.6371; MADURA K, 1994, SCIENCE, V265, P1454, DOI 10.1126/science.8073290; Marotti LA, 2002, BIOCHEMISTRY-US, V41, P5067, DOI 10.1021/bi015940q; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Portiz MA, 2001, YEAST, V18, P1331, DOI 10.1002/yea.777; Riccobene TA, 1999, J THEOR BIOL, V200, P207, DOI 10.1006/jtbi.1999.0988; Roth AF, 1998, J CELL BIOL, V142, P949, DOI 10.1083/jcb.142.4.949; Shea L, 1997, BIOCHEM PHARMACOL, V53, P519, DOI 10.1016/S0006-2952(96)00768-X; Shea LD, 2000, LIFE SCI, V68, P647, DOI 10.1016/S0024-3205(00)00977-2; Siekhaus DE, 2003, NAT CELL BIOL, V5, P231, DOI 10.1038/ncb941; SIKORSKI RS, 1989, GENETICS, V122, P19; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; STONE DE, 1991, GENE DEV, V5, P1969, DOI 10.1101/gad.5.11.1969; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Versele M, 1999, EMBO J, V18, P5577, DOI 10.1093/emboj/18.20.5577; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; Wang YQ, 2002, J BIOL CHEM, V277, P15766, DOI 10.1074/jbc.M111733200; WHITEWAY M, 1990, MOL CELL BIOL, V10, P217, DOI 10.1128/MCB.10.1.217	44	72	72	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46506	46515		10.1074/jbc.M308432200	http://dx.doi.org/10.1074/jbc.M308432200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12968019	hybrid			2022-12-27	WOS:000186569400035
J	Orelle, C; Dalmas, O; Gros, P; Di Pietro, A; Jault, JM				Orelle, C; Dalmas, O; Gros, P; Di Pietro, A; Jault, JM			The conserved glutamate residue adjacent to the Walker-B motif is the catalytic base for ATP hydrolysis in the ATP-binding cassette transporter BmrA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P-GLYCOPROTEIN; RESISTANCE PROTEIN MRP1; NUCLEOTIDE-BINDING; ABC TRANSPORTER; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MECHANISM; CYCLE; DOMAIN	ATP-binding cassette (ABC) proteins constitute one of the widest families in all organisms, whose P-glycoprotein involved in resistance of cancer cells to chemotherapy is an archetype member. Although three-dimensional structures of several nucleotide-binding domains of ABC proteins are now available, the catalytic mechanism triggering the functioning of these proteins still remains elusive. In particular, it has been postulated that ATP hydrolysis proceeds via an acid-base mechanism catalyzed by the Glu residue adjacent to the Walker-B motif (Geourjon, C., Orelle, C., Steinfels, E., Blanchet, C., Deleage, G., Di Pietro, A., and Jault, J.M. (2001) Trends Biochem. Sci. 26, 539-544), but the involvement of such residue as the catalytic base in ABC transporters was recently questioned (Sauna, Z.E., Muller, M., Peng, X. H., and Ambudkar, S. V. (2002) Biochemistry, 41, 13989-14000). The equivalent glutamate residue (Glu(504)) of a half-ABC transporter involved in multidrug resistance in Bacillus subtilis, BmrA ( formerly known as YvcC), was therefore mutated to Asp, Ala, Gln, Ser, and Cys residues. All these mutants were fully devoid of ATPase activity, yet they showed a high level of vanadate-independent trapping of 8-N-3-alpha-P-32-labeled nucleotide(s), following preincubation with 8-N-3-[alpha-P-32]ATP. However, and in contrast to the wild-type enzyme, the use of 8-N-3-[gamma-P-32]ATP unequivocally showed that all the mutants trapped exclusively the triphosphate form of the analogue, suggesting that they were not able to perform even a single hydrolytic turnover. These results demonstrate that Glu(504) is the catalytic base for ATP hydrolysis in BmrA, and it is proposed that equivalent glutamate residues in other ABC transporters play the same role.	UJF, CEA, CNRS,UMR 5090, Lab Biophys Mol & Cellulaire, F-38054 Grenoble 9, France; UCBL1, CNRS, UMR 5086, Inst Biol & Chim Prot, F-69367 Lyon 07, France; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); McGill University	Jault, JM (corresponding author), UJF, CEA, CNRS,UMR 5090, Lab Biophys Mol & Cellulaire, CEA 17 Rue Martyrs,Batiment K, F-38054 Grenoble 9, France.	jault@dsvsud.cea.fr	jault, jean-michel/G-2086-2012; Orelle, Cédric/AAI-1495-2020	jault, jean-michel/0000-0003-1743-2777; Orelle, Cédric/0000-0003-3418-3290				Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Chami M, 2002, J MOL BIOL, V315, P1075, DOI 10.1006/jmbi.2001.5309; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Daumke O, 2001, EUR J BIOCHEM, V268, P4776, DOI 10.1046/j.1432-1327.2001.02406.x; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Fetsch EE, 2002, P NATL ACAD SCI USA, V99, P9685, DOI 10.1073/pnas.152204499; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Geourjon C, 2001, TRENDS BIOCHEM SCI, V26, P539, DOI 10.1016/S0968-0004(01)01907-7; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Hrycyna CA, 1999, BIOCHEMISTRY-US, V38, P13887, DOI 10.1021/bi991115m; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Karttunen JT, 2001, P NATL ACAD SCI USA, V98, P7431, DOI 10.1073/pnas.121180198; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Muneyuki E, 2000, BBA-BIOENERGETICS, V1458, P467, DOI 10.1016/S0005-2728(00)00095-5; Nagata K, 2000, J BIOL CHEM, V275, P17626, DOI 10.1074/jbc.M000792200; Peracchi A, 2001, TRENDS BIOCHEM SCI, V26, P497, DOI 10.1016/S0968-0004(01)01911-9; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; Sauna ZE, 2001, J BIOENERG BIOMEMBR, V33, P481, DOI 10.1023/A:1012875105006; Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Steinfels E, 2002, BBA-BIOMEMBRANES, V1565, P1, DOI 10.1016/S0005-2736(02)00515-1; Todd AE, 2002, TRENDS BIOCHEM SCI, V27, P419, DOI 10.1016/S0968-0004(02)02158-8; Ueda K, 1999, BBA-BIOMEMBRANES, V1461, P305, DOI 10.1016/S0005-2736(99)00157-1; Urbatsch IL, 2000, J BIOL CHEM, V275, P25031, DOI 10.1074/jbc.M003962200; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P14138, DOI 10.1021/bi001128w; Van Bambeke F, 2000, BIOCHEM PHARMACOL, V60, P457, DOI 10.1016/S0006-2952(00)00291-4; van Endert PM, 2002, TRENDS BIOCHEM SCI, V27, P454, DOI 10.1016/S0968-0004(02)02090-X; VanVeen HW, 1996, P NATL ACAD SCI USA, V93, P10668, DOI 10.1073/pnas.93.20.10668; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x	49	139	141	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47002	47008		10.1074/jbc.M308268200	http://dx.doi.org/10.1074/jbc.M308268200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12968023	hybrid			2022-12-27	WOS:000186569400095
J	Bae, SH; Cheong, HK; Cheong, C; Kang, SH; Hwang, DS; Choi, BS				Bae, SH; Cheong, HK; Cheong, C; Kang, SH; Hwang, DS; Choi, BS			Structure and dynamics of hemimethylated GATC sites Implications for DNA-SeqA recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; NUCLEIC-ACID CONFORMATIONS; ADENINE METHYLATION; PROTON-EXCHANGE; DAM METHYLASE; AMINO-GROUPS; REPLICATION; STABILITY; SEQUENCE; INITIATION	DNA methylation occurs in most organisms from bacteria to mammals and provides a mechanism for epigenetic control of a variety of cellular processes. In Escherichia coli, most of the N-6 positions in adenines found in the sequence GATC are methylated by DNA adenine methyltransferase. After DNA replication, the GATC sites exist transiently in the hemimethylated state, and the specific recognition of these hemimethylated GATC sites is essential for several processes, including sequestration of the site of replication initiation by the SeqA protein, strand discrimination in DNA mismatch repair by the MutH protein, and transcription of several genes. Here, we characterize the solution structure and dynamics of two dodecamer DNA duplexes that each contains a single GATC site in either unmethylated or hemimethylated state. We found that the N-6-methylated adenine of a hemimethylated GATC site undergoes a slow trans-cis interconversion. The release of a tightly bound cation from hemimethylated DNA explains the instability of this structure. In addition, quantitative structural analysis revealed that hemimethylated DNA has unusual backbone structures and a remarkably narrow major groove. These dynamic and structural features provide insights into the specific recognition of hemimethylated GATC sites by the SeqA protein.	Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr, Taejon 305701, South Korea; Korea Basic Sci Inst, Magnet Resonance Team, Taejon 305333, South Korea; Seoul Natl Univ, Dept Microbiol, Seoul 151742, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Basic Science Institute (KBSI); Seoul National University (SNU)	Choi, BS (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, 373-1 Guseong Dong, Taejon 305701, South Korea.	byongseok.choi@kaist.ac.kr	Cheong, Chaejoon/GWC-3135-2022; Choi, Byong-Seok/C-1937-2011	Kang, Sukhyun/0000-0002-7567-0231				Bae SH, 2001, P NATL ACAD SCI USA, V98, P10602, DOI 10.1073/pnas.191268798; BAIKALOV I, 1993, J MOL BIOL, V231, P768, DOI 10.1006/jmbi.1993.1325; BARRAS F, 1988, NUCLEIC ACIDS RES, V16, P9821, DOI 10.1093/nar/16.20.9821; BORGIAS BA, 1989, METHOD ENZYMOL, V176, P169; Brendler T, 1999, EMBO J, V18, P2304, DOI 10.1093/emboj/18.8.2304; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHUPRINA VP, 1991, P NATL ACAD SCI USA, V88, P9087, DOI 10.1073/pnas.88.20.9087; ENGEL JD, 1974, BIOCHEMISTRY-US, V13, P4143, DOI 10.1021/bi00717a013; ENGEL JD, 1978, J BIOL CHEM, V253, P927; FAZAKERLEY GV, 1985, BIOCHEMISTRY-US, V24, P4540, DOI 10.1021/bi00338a009; FAZAKERLEY GV, 1987, EUR J BIOCHEM, V167, P397, DOI 10.1111/j.1432-1033.1987.tb13351.x; FoltaStogniew E, 1996, BIOCHEMISTRY-US, V35, P8439, DOI 10.1021/bi952932z; GEEK H, 1991, J MAGN RESON, V93, P93; Guarne A, 2002, NAT STRUCT BIOL, V9, P839, DOI 10.1038/nsb857; Gueron M, 1995, METHOD ENZYMOL, V261, P383; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo Q, 1995, BIOCHEMISTRY-US, V34, P16359, DOI 10.1021/bi00050a016; Hud NV, 1998, J AM CHEM SOC, V120, P6403, DOI 10.1021/ja9811039; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Kang S, 1999, J BIOL CHEM, V274, P11463, DOI 10.1074/jbc.274.17.11463; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LACKS S, 1977, J MOL BIOL, V114, P153, DOI 10.1016/0022-2836(77)90289-3; Lavery R., 1997, CURVES 5 2 HELICAL A; LEONARD GA, 1993, J MOL BIOL, V234, P198, DOI 10.1006/jmbi.1993.1574; Lingbeck J, 1996, BIOCHEMISTRY-US, V35, P719, DOI 10.1021/bi951364k; Lu XJ, 2000, J MOL BIOL, V300, P819, DOI 10.1006/jmbi.2000.3690; MARINUS MG, 1985, MOL GEN GENET, V200, P185, DOI 10.1007/BF00383334; Michalczyk R, 1999, BIOPHYS J, V76, P2679, DOI 10.1016/S0006-3495(99)77420-5; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; OGDEN GB, 1988, CELL, V54, P127, DOI 10.1016/0092-8674(88)90186-9; Pastor N, 2000, J MOL BIOL, V304, P55, DOI 10.1006/jmbi.2000.4173; RASZKA M, 1974, BIOCHEMISTRY-US, V13, P4616, DOI 10.1021/bi00719a023; RINKEL LJ, 1987, EUR J BIOCHEM, V163, P275, DOI 10.1111/j.1432-1033.1987.tb10798.x; ROBERTS D, 1985, CELL, V43, P117, DOI 10.1016/0092-8674(85)90017-0; RUSSELL DW, 1987, CELL, V50, P1071, DOI 10.1016/0092-8674(87)90173-5; Stancheva I, 1999, EMBO J, V18, P6542, DOI 10.1093/emboj/18.22.6542; STERNGLANZ H, 1973, SCIENCE, V182, P833, DOI 10.1126/science.182.4114.833; THEISEN PW, 1993, MOL MICROBIOL, V10, P575, DOI 10.1111/j.1365-2958.1993.tb00929.x; Varnai P, 2002, NUCLEIC ACIDS RES, V30, P5398, DOI 10.1093/nar/gkf680	39	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45987	45993		10.1074/jbc.M306038200	http://dx.doi.org/10.1074/jbc.M306038200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12944412	hybrid			2022-12-27	WOS:000186452300113
J	Chavakis, T; Santoso, S; Clemetson, KJ; Sachs, UJH; Isordia-Salas, I; Pixley, RA; Nawroth, PP; Colman, RW; Preissner, KT				Chavakis, T; Santoso, S; Clemetson, KJ; Sachs, UJH; Isordia-Salas, I; Pixley, RA; Nawroth, PP; Colman, RW; Preissner, KT			High molecular weight kininogen regulates platelet-leukocyte interactions by bridging Mac-1 and glycoprotein Ib	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-ADHERENT PLATELETS; BINDING-PROTEIN; UROKINASE RECEPTOR; ENDOTHELIAL-CELLS; VESSEL WALL; P-SELECTIN; INTEGRIN; ADHESION; IDENTIFICATION; MECHANISMS	Leukocyte-platelet interaction is important in mediating leukocyte adhesion to a thrombus and leukocyte recruitment to a site of vascular injury. This interaction is mediated at least in part by the beta(2)-integrin Mac-1 (CD11b/CD18) and its counter-receptor on platelets, glycoprotein Ibalpha (GPIbalpha). High molecular weight kininogen (HK) was previously shown to interact with both GPIbalpha and Mac-1 through its domains 3 and 5, respectively. In this study we investigated the ability of HK to interfere with the leukocyte-platelet interaction. In a purified system, HK binding to GPIbalpha was inhibited by HK domain 3 and the monoclonal antibody (mAb) SZ2, directed against the epitope 269-282 of GPIbalpha, whereas mAb AP1, directed to the region 201-268 of GPIbalpha had no effect. In contrast, mAb AP1 inhibited the Mac-1-GPIbalpha interaction. Binding of GPIbalpha to Mac-1 was enhanced 2-fold by HK. This effect of HK was abrogated in the presence of HK domains 3 or 5 or peptides from the 475-497 region of the carboxyl terminus of domain 5 as well as in the presence of mAb SZ2 but not mAb AP1. Whereas no difference in the affinity of the Mac-1-GPIbalpha interaction was observed in the absence or presence of HK, maximal binding of GPIbalpha to Mac-1 doubled in the presence of HK. Moreover, HK/HKa increased the Mac-1-dependent adhesion of myelomonocytic U937 cells and K562 cells transfected with Mac-1 to immobilized GPIbalpha or to GPIbalpha-transfected Chinese hamster ovary cells. Finally, Mac-1-dependent adhesion of neutrophils to surface-adherent platelets was enhanced by HK. Thus, HK can bridge leukocytes with platelets by interacting via its domain 3 with GPIbalpha and via its domain 5 with Mac-1 thereby augmenting the Mac-1-GPIbalpha interaction. These distinct molecular interactions of HK with leukocytes and platelets contribute to the regulation of the adhesive behavior of vascular cells and provide novel molecular targets for reducing atherothrombotic pathologies.	Heidelberg Univ, Dept Internal Med 1, D-69115 Heidelberg, Germany; Univ Giessen, Inst Clin Immunol & Transfus Med, D-35392 Giessen, Germany; Univ Giessen, Inst Biochem, D-35392 Giessen, Germany; Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland; Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA	Ruprecht Karls University Heidelberg; Justus Liebig University Giessen; Justus Liebig University Giessen; University of Bern; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Chavakis, T (corresponding author), Univ Klinikum Heidelberg, Med Klin 1, Bergheimer Str 58, D-69115 Heidelberg, Germany.	triantafyllos.chavakis@med.uni-heidelberg.de	Sachs, Ulrich/GSI-7824-2022; Chavakis, Triantafyllos/ABE-8845-2020		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056914] Funding Source: NIH RePORTER; NCI NIH HHS [CA63938] Funding Source: Medline; NHLBI NIH HHS [HL56914] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bradford HN, 1997, BLOOD, V90, P1508, DOI 10.1182/blood.V90.4.1508.1508_1508_1515; CARLOS TM, 1994, BLOOD, V84, P2068; Chavakis T, 2000, BLOOD, V96, P514; Chavakis T, 1999, BLOOD, V93, P2976; Chavakis T, 2002, J BIOL CHEM, V277, P23157, DOI 10.1074/jbc.M202529200; Chavakis T, 2002, J BIOL CHEM, V277, P32677, DOI 10.1074/jbc.M204010200; Chavakis T, 2002, NAT MED, V8, P687, DOI 10.1038/nm728; Chavakis T, 2001, FASEB J, V15, P2365, DOI 10.1096/fj.01-0201com; Chavakis Triantafyllos, 2003, Current Vascular Pharmacology, V1, P59, DOI 10.2174/1570161033386790; Colman RW, 1997, J CLIN INVEST, V100, P1481, DOI 10.1172/JCI119669; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Colman RW, 2000, BLOOD, V95, P543, DOI 10.1182/blood.V95.2.543; DELACADENA RA, 1994, THROMB HAEMOSTASIS, V72, P125; Diacovo TG, 1996, BLOOD, V88, P146; DIACOVO TG, 1994, J CLIN INVEST, V94, P1243, DOI 10.1172/JCI117442; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; Evangelista V, 1996, BLOOD, V88, P4183, DOI 10.1182/blood.V88.11.4183.bloodjournal88114183; Hasan AAK, 1998, P NATL ACAD SCI USA, V95, P3615, DOI 10.1073/pnas.95.7.3615; Herwald H, 1996, J BIOL CHEM, V271, P13040, DOI 10.1074/jbc.271.22.13040; JANDROTPERRUS M, 1992, BLOOD, V80, P2781; Joseph K, 1996, P NATL ACAD SCI USA, V93, P8552, DOI 10.1073/pnas.93.16.8552; Kuijper PHM, 1997, BLOOD, V89, P166, DOI 10.1182/blood.V89.1.166.166_166_175; KUNAPULI SP, 1993, J BIOL CHEM, V268, P2486; Kunapuli SP, 1996, J BIOL CHEM, V271, P11228, DOI 10.1074/jbc.271.19.11228; LANGUINO LR, 1995, P NATL ACAD SCI USA, V92, P1505, DOI 10.1073/pnas.92.5.1505; MARCUS AJ, 1994, SEMIN HEMATOL, V31, P261; McEver RP, 2001, THROMB HAEMOSTASIS, V86, P746; MOORE KL, 1991, J CELL BIOL, V112, P491, DOI 10.1083/jcb.112.3.491; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Renne T, 2000, J BIOL CHEM, V275, P33688, DOI 10.1074/jbc.M000313200; RINDER CS, 1992, BLOOD, V79, P1201; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Santoso S, 1999, BLOOD, V94, P4103, DOI 10.1182/blood.V94.12.4103.424k27_4103_4111; SILVERSTEIN RL, 1989, J CLIN INVEST, V84, P546, DOI 10.1172/JCI114197; Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193; SKINNER MP, 1991, J BIOL CHEM, V266, P5371; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Weber C, 1997, J CLIN INVEST, V100, P2085, DOI 10.1172/JCI119742; XIE JL, 1995, J IMMUNOL, V155, P3619	40	51	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45375	45381		10.1074/jbc.M304344200	http://dx.doi.org/10.1074/jbc.M304344200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952972	hybrid			2022-12-27	WOS:000186452300041
J	Fedorov, R; Hartmann, E; Ghosh, DK; Schlichting, I				Fedorov, R; Hartmann, E; Ghosh, DK; Schlichting, I			Structural basis for the specificity of the nitric-oxide synthase inhibitors W1400 and N-omega-propyl-L-Arg for the inducible and neuronal isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE INHIBITORS; OXYGENASE DOMAIN; HEME DOMAIN; L-ARGININE; CRYSTAL-STRUCTURES; BINDING MODE; IN-VIVO; CYTOCHROME-P-450; MECHANISM; PTERIN	The high level of amino acid conservation and structural similarity in the immediate vicinity of the substrate binding sites of the oxygenase domains of the nitric-oxide synthase (NOS) isoforms (eNOSoxy, iNOSoxy, and nNOSoxy) make the interpretation of the structural basis of inhibitor isoform specificity a challenge and provide few clues for the design of new selective compounds. Crystal structures of iNOSoxy and nNOSoxy complexed with the inhibitors W1400 and N-omega-propyl-L-arginine provide a rationale for their isoform specificity. It involves differences outside the immediate active site as well as a conformational flexibility in the active site that allows the adoption of distinct conformations in response to interactions with the inhibitors. This flexibility is determined by isoform-specific residues outside the active site.	Max Planck Inst Med Res, Abt Biomol Mech, D-69120 Heidelberg, Germany; Max Planck Inst Mol Physiol, Abt Biophys Chem, D-44227 Dortmund, Germany; Duke Univ, Durham, NC 27713 USA; Vet Adm Med Ctr, Durham, NC 27713 USA	Max Planck Society; Max Planck Society; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Schlichting, I (corresponding author), Max Planck Inst Med Res, Abt Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany.		Schlichting, Ilme/I-1339-2013	Fedorov, Roman/0000-0002-5240-4205				ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Babu BR, 1998, CURR OPIN CHEM BIOL, V2, P491, DOI 10.1016/S1367-5931(98)80125-7; Babu BR, 1999, J BIOL CHEM, V274, P25218, DOI 10.1074/jbc.274.36.25218; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collins JL, 1998, J MED CHEM, V41, P2858, DOI 10.1021/jm980072p; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; DEMONTELLANO PRO, 1981, BIOCHEMISTRY-US, V20, P7266, DOI 10.1021/bi00528a033; DEMONTELLANO PRO, 1906, CYTOCHROME P 450; Fast W, 1997, BIOORGAN MED CHEM, V5, P1601, DOI 10.1016/S0968-0896(97)00109-0; Fedorov R, 2003, ARCH BIOCHEM BIOPHYS, V409, P25, DOI 10.1016/S0003-9861(02)00555-6; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; GERBER NC, 1995, J BIOL CHEM, V270, P17791, DOI 10.1074/jbc.270.30.17791; Ghosh DK, 2001, P NATL ACAD SCI USA, V98, P10392, DOI 10.1073/pnas.181251298; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; GROVES JT, 1988, J AM CHEM SOC, V110, P8443, DOI 10.1021/ja00233a021; Huang H, 1999, J MED CHEM, V42, P3147, DOI 10.1021/jm990111c; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KNOWLES RG, 1990, BIOCHEM J, V270, P833, DOI 10.1042/bj2700833; Kotsonis P, 2001, J BIOL CHEM, V276, P49133, DOI 10.1074/jbc.M011469200; Li HY, 1999, J BIOL CHEM, V274, P21276, DOI 10.1074/jbc.274.30.21276; Li HY, 2002, BIOCHEMISTRY-US, V41, P13868, DOI 10.1021/bi020417c; Li HY, 2001, BIOCHEMISTRY-US, V40, P5399, DOI 10.1021/bi002658v; Li HY, 2000, J INORG BIOCHEM, V81, P133, DOI 10.1016/S0162-0134(00)00099-4; MANSUY D, 1987, PURE APPL CHEM, V59, P759, DOI 10.1351/pac198759060759; Raman CS, 2001, J BIOL CHEM, V276, P26486, DOI 10.1074/jbc.M102255200; Raman CS, 2001, BIOCHEMISTRY-US, V40, P13448, DOI 10.1021/bi010957u; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; Reif DW, 2000, FREE RADICAL BIO MED, V28, P1470, DOI 10.1016/S0891-5849(00)00250-1; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; TAYLOR WR, 1989, J MOL BIOL, V208, P1, DOI 10.1016/0022-2836(89)90084-3; Zhang HQ, 1997, J MED CHEM, V40, P3869, DOI 10.1021/jm970550g	35	66	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45818	45825		10.1074/jbc.M306030200	http://dx.doi.org/10.1074/jbc.M306030200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954642	hybrid			2022-12-27	WOS:000186452300094
J	Jongstra-Bilen, J; Harrison, R; Grinstein, S				Jongstra-Bilen, J; Harrison, R; Grinstein, S			Fc gamma-receptors induce Mac-1 (CD11b/CD18) mobilization and accumulation in the phagocytic cup for optimal phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT RECEPTOR; PHOSPHOLIPASE C-GAMMA-1; MEDIATED PHAGOCYTOSIS; HUMAN-NEUTROPHILS; TYROSINE PHOSPHORYLATION; MONOCLONAL-ANTIBODIES; LEUKOCYTE INTEGRINS; LECTIN SITE; I-DOMAIN; ADHESION	Functional interactions between Fcgamma-receptors (FcgammaR) and the beta(2) integrin Mac-1 (CD11b/CD18) have been described, but the molecular basis of this relationship remains unclear. Although the glycosylphosphatidylinositol-linked receptor FcgammaRIIIB of human neutrophils is constitutively associated with Mac-1, we found no evidence for direct physical association between Mac-1 and the FcgammaR of mouse macrophages, which are transmembrane proteins. Nevertheless, Mac-1 accumulated in the phagocytic cup following engagement of FcgammaR by IgG-opsonized particles. Blocking the CD18 chains of beta(2) integrins by using specific antibodies reduced Mac-1 accumulation in the cup. These antibodies or the addition of the recombinant CD11b I-domain inhibited the ingestion of IgG-opsonized particles. FcgammaR cross-linking stimulated cell adhesion to surfaces coated with Mac-1 ligands and in addition enabled macrophages to bind C3bi-opsonized particles, indicating that FcgammaR-derived signals induce activation of Mac-1. Measurements of fluorescence recovery after photobleaching revealed that whereas most (>80%) of Mac-1 is immobile in resting cells, stimulation of FcgammaR markedly increases the mobile fraction of the integrin. Activation of Mac-1 by FcgammaR required the activity of Src family tyrosine kinases, phosphatidylinositol 3-kinase and phospholipase C, with the release of diacylglycerol and stimulation of protein kinase C. Because elevated cytosolic Ca2+ was not required, we suggest that novel protein kinase C isoforms are involved in Mac-1 activation. These results suggest that FcgammaR stimulation promotes Mac-1 clustering into high avidity complexes in phagocytic cups by releasing the integrin from cytoskeletal constraints and enhancing its lateral diffusion. FcgammaR can enhance host defense by activating Mac-1 (and possibly other integrins), having a synergistic effect on pathogen engulfment and promoting the adherence of phagocytes at sites of infection.	Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada; Univ Toronto, Univ Hlth Network, Toronto Western Res Inst, Div Cell & Mol Biol, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Grinstein, S (corresponding author), Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada.							Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; ANDERSSON T, 1988, FEBS LETT, V239, P371, DOI 10.1016/0014-5793(88)80954-2; AZZONI L, 1992, J EXP MED, V176, P1745, DOI 10.1084/jem.176.6.1745; BELLER DI, 1982, J EXP MED, V156, P1000, DOI 10.1084/jem.156.4.1000; Berrier AL, 2000, J CELL BIOL, V151, P1549, DOI 10.1083/jcb.151.7.1549; Booth JW, 2002, EMBO J, V21, P251, DOI 10.1093/emboj/21.3.251; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; BROWN EJ, 1988, J CLIN INVEST, V81, P365, DOI 10.1172/JCI113328; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Chan JR, 2000, J IMMUNOL, V164, P746, DOI 10.4049/jimmunol.164.2.746; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Dewitt S, 2002, J CELL BIOL, V159, P181, DOI 10.1083/jcb.200206089; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Etzioni A, 1999, BLOOD, V94, P3281, DOI 10.1182/blood.V94.10.3281.422k37_3281_3288; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; GRAHAM IL, 1989, J IMMUNOL, V142, P2352; GRESHAM HD, 1991, J CLIN INVEST, V88, P588, DOI 10.1172/JCI115343; Hogg N, 2001, J LEUKOCYTE BIOL, V69, P893; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Jones SL, 1998, J BIOL CHEM, V273, P10556, DOI 10.1074/jbc.273.17.10556; Kim MK, 2001, CLIN IMMUNOL, V98, P125, DOI 10.1006/clim.2000.4955; Kolanus W, 1997, CURR OPIN CELL BIOL, V9, P725, DOI 10.1016/S0955-0674(97)80127-5; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; KUSUNOKI T, 1994, J LEUKOCYTE BIOL, V55, P735, DOI 10.1002/jlb.55.6.735; Kwiatkowska K, 1999, BIOESSAYS, V21, P422, DOI 10.1002/(SICI)1521-1878(199905)21:5<422::AID-BIES9>3.0.CO;2-#; Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809; Li M, 1996, J EXP MED, V183, P1259, DOI 10.1084/jem.183.3.1259; LIAO F, 1992, P NATL ACAD SCI USA, V89, P3659, DOI 10.1073/pnas.89.8.3659; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; Morrissette NS, 1999, J CELL SCI, V112, P4705; Orchekowski RP, 2000, J LEUKOCYTE BIOL, V68, P641; POO H, 1995, J MOL BIOL, V247, P597; RAVETCH JV, 1989, J EXP MED, V170, P481, DOI 10.1084/jem.170.2.481; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; ROSEN H, 1987, J EXP MED, V166, P1685, DOI 10.1084/jem.166.6.1685; Ross GD, 2000, CRIT REV IMMUNOL, V20, P197; ROSS GD, 1992, J LEUKOCYTE BIOL, V51, P109, DOI 10.1002/jlb.51.2.109; Tan SM, 2000, J IMMUNOL, V165, P2574, DOI 10.4049/jimmunol.165.5.2574; Tang T, 1997, J EXP MED, V186, P1853, DOI 10.1084/jem.186.11.1853; Thornton BP, 1996, J IMMUNOL, V156, P1235; Todd RF, 1997, J LAB CLIN MED, V129, P492, DOI 10.1016/S0022-2143(97)90003-2; Ustinov VA, 2002, J BIOL CHEM, V277, P18769, DOI 10.1074/jbc.M110242200; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Vetvicka V, 1996, J CLIN INVEST, V98, P50, DOI 10.1172/JCI118777; ZHANG F, 1995, FEBS LETT, V376, P77, DOI 10.1016/0014-5793(95)01249-X; Zhang FH, 2001, INT IMMUNOPHARMACOL, V1, P1375, DOI 10.1016/S1567-5769(01)00069-8; ZHOU MJ, 1993, J IMMUNOL, V150, P3030; Zhou XM, 2000, J BIOL CHEM, V275, P20217, DOI 10.1074/jbc.M909129199	51	100	103	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45720	45729		10.1074/jbc.M303704200	http://dx.doi.org/10.1074/jbc.M303704200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12941957	hybrid			2022-12-27	WOS:000186452300082
J	Kozlov, G; Lee, J; Elias, D; Gravel, M; Gutierrez, P; Ekiel, I; Braun, PE; Gehring, K				Kozlov, G; Lee, J; Elias, D; Gravel, M; Gutierrez, P; Ekiel, I; Braun, PE; Gehring, K			Structural evidence that brain cyclic nucleotide phosphodiesterase is a member of the 2H phosphodiesterase superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; MYELIN-ASSOCIATED ENZYME; CARBONIC-ANHYDRASE-II; RNA TRAFFICKING; BASIC-PROTEIN; MESSENGER-RNA; 3-PHOSPHODIESTERASE; 3'-PHOSPHODIESTERASE; LOCALIZATION; DOMAIN	2',3'-Cyclic-nucleotide 3'-phosphodiesterase (CNP) is an enzyme abundantly present in the central nervous system of mammals and some vertebrates. In vitro, CNP specifically catalyzes the hydrolysis of 2',3'-cyclic nucleotides to produce 2'-nucleotides, but the physiologically relevant in vivo substrate remains obscure. Here, we report the medium resolution NMR structure of the catalytic domain of rat CNP with phosphate bound and describe its binding to CNP inhibitors. The structure has a bilobal arrangement of two modules, each consisting of a four-stranded beta-sheet and two alpha-helices. The beta-sheets form a large cavity containing a number of positively charged and aromatic residues. The structure is similar to those of the cyclic phosphodiesterase from Arabidopsis thaliana and the 2'-5' RNA ligase from Thermus thermophilus, placing CNP in the superfamily of 2H phosphodiesterases that contain two tetrapeptide HX(T/S)X motifs. NMR titrations of the CNP catalytic domain with inhibitors and kinetic studies of site-directed mutants reveal a protein conformational change that occurs upon binding.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; Natl Res Council Canada, Biotechnol Res Inst, Hlth Sector, Montreal, PQ H4P 2R2, Canada	McGill University; National Research Council Canada	Gehring, K (corresponding author), McGill Univ, Dept Biochem, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	kalle.gehring@bri.nrc.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184				Arn EA, 1998, COLD SPRING HARBOR M, P695; Ballestero RP, 1997, J BIOL CHEM, V272, P11479; BALLESTERO RP, 1995, P NATL ACAD SCI USA, V92, P8621, DOI 10.1073/pnas.92.19.8621; Barbarese E, 1999, J NEUROCYTOL, V28, P263, DOI 10.1023/A:1007097226688; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bifulco M, 2002, P NATL ACAD SCI USA, V99, P1807, DOI 10.1073/pnas.042678799; BRAUN PE, 1988, J NEUROSCI, V8, P3057; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson J H, 2001, Results Probl Cell Differ, V34, P69; Carson JH, 1998, CURR OPIN NEUROBIOL, V8, P607, DOI 10.1016/S0959-4388(98)80088-3; Chini EN, 2002, AM J PHYSIOL-CELL PH, V282, pC1191, DOI 10.1152/ajpcell.00475.2001; CULVER GM, 1993, SCIENCE, V261, P206, DOI 10.1126/science.8392224; DEANGELIS DA, 1994, J NEUROSCI RES, V39, P386, DOI 10.1002/jnr.490390405; DeAngelis DA, 1996, J NEUROCHEM, V66, P2523; DYER CA, 1989, J NEUROSCI RES, V24, P201, DOI 10.1002/jnr.490240211; Genschik P, 1997, J BIOL CHEM, V272, P13211, DOI 10.1074/jbc.272.20.13211; GHANDOUR MS, 1991, GLIA, V4, P1, DOI 10.1002/glia.440040102; Gravel M, 1996, MOL CELL NEUROSCI, V7, P453, DOI 10.1006/mcne.1996.0033; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Hofmann A, 2002, BIOCHEM BIOPH RES CO, V291, P875, DOI 10.1006/bbrc.2002.6527; Hofmann A, 2002, J BIOL CHEM, V277, P1419, DOI 10.1074/jbc.M107889200; Hofmann A, 2000, EMBO J, V19, P6207, DOI 10.1093/emboj/19.22.6207; Kato M, 2003, J MOL BIOL, V329, P903, DOI 10.1016/S0022-2836(03)00448-0; Kim T, 1999, J NEUROCYTOL, V28, P281, DOI 10.1023/A:1007001427597; KOONIN EV, 1990, FEBS LETT, V268, P231, DOI 10.1016/0014-5793(90)81015-G; Kozlov G, 2002, J BIOMOL NMR, V22, P99, DOI 10.1023/A:1013898222817; Kurihara T., 1992, MYELIN BIOL CHEM; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee J, 2001, J BIOL CHEM, V276, P14804, DOI 10.1074/jbc.M009434200; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; McFerran BW, 1997, J CELL SCI, V110, P2979; Nasr F, 2000, NUCLEIC ACIDS RES, V28, P1676, DOI 10.1093/nar/28.8.1676; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Pons JL, 1996, J BIOMOL NMR, V8, P445, DOI 10.1007/BF00228146; SOGIN DC, 1976, J NEUROCHEM, V27, P1333, DOI 10.1111/j.1471-4159.1976.tb02612.x; SPRINKLE TJ, 1987, BIOCHEM BIOPH RES CO, V145, P686, DOI 10.1016/0006-291X(87)91019-9; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; Tansey FA, 1996, NEUROCHEM RES, V21, P411, DOI 10.1007/BF02527704; TRAPP BD, 1988, J NEUROCHEM, V51, P859, DOI 10.1111/j.1471-4159.1988.tb01822.x; TYC K, 1987, J BIOL CHEM, V262, P12994; Varani G, 1998, ANNU REV BIOPH BIOM, V27, P407, DOI 10.1146/annurev.biophys.27.1.407; VOGEL US, 1988, J NEUROCHEM, V50, P1667, DOI 10.1111/j.1471-4159.1988.tb02461.x; XU Q, 1990, BIOCHEMISTRY-US, V29, P6132, DOI 10.1021/bi00478a004; Yin X, 1997, J NEUROSCI RES, V50, P238, DOI 10.1002/(SICI)1097-4547(19971015)50:2<238::AID-JNR12>3.0.CO;2-4	47	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46021	46028		10.1074/jbc.M305176200	http://dx.doi.org/10.1074/jbc.M305176200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12947117	hybrid			2022-12-27	WOS:000186452300118
J	Omi, R; Goto, M; Miyahara, I; Mizuguchi, H; Hayashi, H; Kagamiyama, H; Hirotsu, K				Omi, R; Goto, M; Miyahara, I; Mizuguchi, H; Hayashi, H; Kagamiyama, H; Hirotsu, K			Crystal structures of threonine synthase from Thermus thermophilus HB8 - Conformational change, substrate recognition, and mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; AMINO-ACID AMINOTRANSFERASE; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; ASPARTATE; EVOLUTION; MOLSCRIPT; GLUTAMATE; PROGRAM; COMPLEX	Threonine synthase, which is a PLP-dependent enzyme, catalyzes the beta,gamma-replacement reaction of L-homoserine phosphate to yield threonine and inorganic phosphate. The three-dimensional structures of the enzyme from Thermus thermophilus HB8 in its unliganded form and complexed with the substrate analogue 2-amino-5-phosphonopentanoic acid have been determined at 2.15 and 2.0 Angstrom resolution, respectively. The complexed form, assigned as an enamine, uncovered the interactions of the cofactor-analogue conjugate with the active site residues. The binding of the substrate analogue induces a large conformational change at the domain level. The small domain rotates by about 25degrees and approaches the large domain to close the active site. The complicated catalytic process of the enzyme has been elucidated based on the complex structure to reveal the stereochemistry of the reaction and to present the released inorganic phosphate as a possible catalyst to carry a proton to the Cgamma atom of the substrate.	Osaka City Univ, Grad Sch Sci, Dept Chem, Osaka 5588585, Japan; RIKEN, Inst Phys & Chem Res, Sayo, Hyogo 6795148, Japan; Osaka Univ, Grad Sch Sci, Dept Biol, Osaka 5600043, Japan; Osaka Med Coll, Dept Biochem, Osaka 5698686, Japan	Osaka Metropolitan University; RIKEN; Osaka University; Osaka Medical College	Hirotsu, K (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Chem, Osaka 5588585, Japan.	hirotsu@sci.osaka-cu.ac.jp	Mizuguchi, Hiroyuki/B-5676-2013	Mizuguchi, Hiroyuki/0000-0001-7055-316X				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; COOK PF, 2003, BIOCHIM BIOPHYS ACTA, V1647, P321; DeLano W.L, PYMOL MOL GRAPHICS S; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FLAVIN M, 1960, J BIOL CHEM, V235, P1112; Fromme JC, 2003, NAT STRUCT BIOL, V10, P204, DOI 10.1038/nsb902; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; Garrido-Franco M, 2002, J BIOL CHEM, V277, P12396, DOI 10.1074/jbc.M108734200; Goto M, 2003, BIOCHEMISTRY-US, V42, P3725, DOI 10.1021/bi026722f; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HYDE CC, 1988, J BIOL CHEM, V263, P17857; JAGER J, 1994, J MOL BIOL, V239, P285, DOI 10.1006/jmbi.1994.1368; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; JANSONIUS JN, 1987, STRUCTURAL BASIS CAT, P187; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laber B, 1999, EUR J BIOCHEM, V263, P212, DOI 10.1046/j.1432-1327.1999.00487.x; LABER B, 1994, BIOCHEMISTRY-US, V33, P3413, DOI 10.1021/bi00177a035; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, JOINT CCP4 ESRF EESF; MALASHKEVICH VN, 1993, BIOCHEMISTRY-US, V32, P13451, DOI 10.1021/bi00212a010; Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; METZLER DE, 1954, J AM CHEM SOC, V76, P648, DOI 10.1021/ja01632a004; MITCHELL JBO, 1992, J MOL BIOL, V226, P251, DOI 10.1016/0022-2836(92)90137-9; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Okada K, 2001, BIOCHEMISTRY-US, V40, P7453, DOI 10.1021/bi010384l; OKAMOTO A, 1994, J BIOCHEM, V116, P95, DOI 10.1093/oxfordjournals.jbchem.a124509; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rhee S, 1997, BIOCHEMISTRY-US, V36, P7664, DOI 10.1021/bi9700429; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schneider TR, 1998, BIOCHEMISTRY-US, V37, P5394, DOI 10.1021/bi9728957; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thomazeau K, 2001, PROTEIN SCI, V10, P638, DOI 10.1110/ps.44301; Yao M, 2000, J BIOL CHEM, V275, P34557, DOI 10.1074/jbc.M004681200	44	29	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					46035	46045		10.1074/jbc.M308065200	http://dx.doi.org/10.1074/jbc.M308065200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952961	hybrid			2022-12-27	WOS:000186452300120
J	Tanowitz, M; von Zastrow, M				Tanowitz, M; von Zastrow, M			A novel endocytic recycling signal that distinguishes the membrane trafficking of naturally occurring opioid receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED RECEPTOR-1; EXCHANGER REGULATORY FACTOR; C-TERMINAL TAIL; DOWN-REGULATION; COUPLED RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; MU; UBIQUITINATION; DESENSITIZATION	delta and mu opioid receptors are homologous G protein-coupled receptors that are differentially sorted between divergent degradative and recycling membrane pathways following agonist-induced endocytosis. Whereas delta opioid receptors are selectively sorted to lysosomes, mu opioid receptors recycle rapidly to the plasma membrane by a process that has been proposed to occur via bulk membrane flow. We have observed that mu opioid receptors do not recycle by default and have defined a specific sequence present in the cytoplasmic tail of the cloned mu opioid receptor that is both necessary and sufficient for rapid recycling of internalized receptors. This sequence is completely distinct from a sequence shown previously to be required for recycling of the beta(2) adrenergic receptor yet is functionally interchangeable when tested in chimeric mutant receptors. These results indicate that signal-dependent recycling is a more common property of G protein-coupled receptors than previously appreciated and demonstrate that such a modular recycling signal distinguishes the regulation of homologous receptors that are naturally co-expressed.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tanowitz, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, N-216 Genentech Hall,600 16th St, San Francisco, CA 94143 USA.	mbt2m@itsa.ucsf.edu						Anborgh PH, 2000, MOL ENDOCRINOL, V14, P2040, DOI 10.1210/me.14.12.2040; Beland B, 2001, PAIN, V90, P143, DOI 10.1016/S0304-3959(00)00397-3; Cahill CM, 2001, J NEUROSCI, V21, P7598, DOI 10.1523/JNEUROSCI.21-19-07598.2001; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cheng PY, 1997, BRAIN RES, V778, P367, DOI 10.1016/S0006-8993(97)00891-3; Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; Ferguson SSG, 1998, LIFE SCI, V62, P1561, DOI 10.1016/S0024-3205(98)00107-6; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Galet C, 2003, MOL ENDOCRINOL, V17, P411, DOI 10.1210/me.2002-0161; Goodman O B Jr, 1998, Adv Pharmacol, V42, P429; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Innamorati G, 1998, P NATL ACAD SCI USA, V95, P2222, DOI 10.1073/pnas.95.5.2222; KAUFMAN DL, 1995, J BIOL CHEM, V270, P15877, DOI 10.1074/jbc.270.26.15877; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kishi M, 2001, MOL ENDOCRINOL, V15, P1624, DOI 10.1210/me.15.9.1624; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Law PY, 1999, J PHARMACOL EXP THER, V289, P607; Lee MC, 2002, SYNAPSE, V43, P102, DOI 10.1002/syn.10014; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Li J, 2001, MOL PHARMACOL, V60, P1064, DOI 10.1124/mol.60.5.1064; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Paasche JD, 2001, J BIOL CHEM, V276, P34041, DOI 10.1074/jbc.M103243200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Tao PL, 1998, EUR J PHARMACOL, V344, P137, DOI 10.1016/S0014-2999(97)01596-3; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Wang YJ, 2002, MOL BIOL CELL, V13, P1965, DOI 10.1091/mbc.E01-11-0131; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	45	142	146	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45978	45986		10.1074/jbc.M304504200	http://dx.doi.org/10.1074/jbc.M304504200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12939277	hybrid			2022-12-27	WOS:000186452300112
J	Hong, R; Chakravarti, D				Hong, R; Chakravarti, D			The human proliferating cell nuclear antigen regulates transcriptional coactivator p300 activity and promotes transcriptional repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE-BINDING-PROTEIN; RECEPTOR COACTIVATOR; DNA-REPLICATION; MUSCLE DIFFERENTIATION; FACTOR PCNA; COMPLEX; REPAIR; ACETYLATION; CHROMATIN; CBP	Chromatin structure plays an important role in DNA replication, repair, and transcription. p300 is a transcriptional coactivator with protein acetyltransferase activity, and proliferating cell nuclear antigen (PCNA) plays important roles in DNA replication and repair. It has been shown recently that p300 is necessary for DNA synthesis and repair. However, it is not known whether human PCNA, in a reciprocal manner, can regulate the enzymatic activity and transcriptional regulatory properties of p300. Here we show that human PCNA associates with p300 and potently inhibits the acetyltransferase activity and transcriptional activation properties of p300. Surprisingly, PCNA fails to inhibit p300/CBP-associated factor (PCAF) acetyltransferase function as well as PCAF-dependent transcription. Additionally, PCNA potently represses transcription when targeted to chromatin in vivo. Consistent with these observations, using chromatin immunoprecipitation assays, we demonstrate that PCNA recruitment to promoters causes hypoacetylation of chromatin. Together, our results demonstrate for the first time a novel role for human PCNA in transcriptional repression and in modulating chromatin modification. The reciprocal modulation of p300 and PCNA activities by each other provides an example of integrative regulatory cross-talk among chromatin-based processes such as DNA transcription, repair, and synthesis.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Chakravarti, D (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 810 BRB2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.			Chakravarti, Debabrata/0000-0001-8446-8599	NIDDK NIH HHS [R01-DK57079, P30-DK50306, R01 DK057079] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057079, P30DK050306] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Ait-Si-Ali S, 1999, BIOCHEM BIOPH RES CO, V262, P157, DOI 10.1006/bbrc.1999.1132; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Assy N, 1997, J HEPATOL, V26, P945, DOI 10.1016/S0168-8278(97)80266-8; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Chakravarti D, 2003, CELL, V112, P589, DOI 10.1016/S0092-8674(03)00151-X; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Cheung WL, 2000, CURR OPIN CELL BIOL, V12, P326, DOI 10.1016/S0955-0674(00)00096-X; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Elias JM, 1997, BIOTECH HISTOCHEM, V72, P78, DOI 10.3109/10520299709082216; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; HALL PA, 1995, ONCOGENE, V10, P2427; Hanstein B, 1996, P NATL ACAD SCI USA, V93, P11540, DOI 10.1073/pnas.93.21.11540; Hasan S, 2001, MOL CELL, V7, P1221, DOI 10.1016/S1097-2765(01)00272-6; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; HENDERSON DS, 1994, EMBO J, V13, P1450, DOI 10.1002/j.1460-2075.1994.tb06399.x; Hong W, 2002, MOL CELL BIOL, V22, P3729, DOI 10.1128/MCB.22.11.3729-3743.2002; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kraus WL, 1999, MOL CELL BIOL, V19, P8123; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Li FS, 2002, J BIOL CHEM, V277, P45004, DOI 10.1074/jbc.M205259200; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; MATHEWS MB, 1984, NATURE, V309, P374, DOI 10.1038/309374a0; Meijer M, 1999, BIOESSAYS, V21, P596, DOI 10.1002/(SICI)1521-1878(199907)21:7<596::AID-BIES8>3.0.CO;2-5; Milutinovic S, 2002, J BIOL CHEM, V277, P20974, DOI 10.1074/jbc.M202504200; Mizzen CA, 2000, SCIENCE, V289, P2290, DOI 10.1126/science.289.5488.2290; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Perlmann T, 1997, CELL, V90, P391, DOI 10.1016/S0092-8674(00)80498-5; Polesskaya A, 2001, EMBO J, V20, P6816, DOI 10.1093/emboj/20.23.6816; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; REEVES R, 1985, NUCLEIC ACIDS RES, V13, P3599, DOI 10.1093/nar/13.10.3599; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SHIVJI MKK, 1995, BIOCHEMISTRY-US, V34, P5011, DOI 10.1021/bi00015a012; Stoilov L, 2000, INT J RADIAT BIOL, V76, P1485, DOI 10.1080/09553000050176243; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Tsurimoto T, 1998, BBA-GENE STRUCT EXPR, V1443, P23, DOI 10.1016/S0167-4781(98)00204-8; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Vairapandi M, 1996, ONCOGENE, V12, P2579; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zhang QH, 2000, MOL CELL BIOL, V20, P4970, DOI 10.1128/MCB.20.14.4970-4978.2000; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601	60	40	41	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44505	44513		10.1074/jbc.M303138200	http://dx.doi.org/10.1074/jbc.M303138200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12937166	hybrid			2022-12-27	WOS:000186306700079
J	Lindner, HA; Lunin, VV; Alary, A; Hecker, R; Cygler, M; Menard, R				Lindner, HA; Lunin, VV; Alary, A; Hecker, R; Cygler, M; Menard, R			Essential roles of zinc ligation and enzyme dimerization for catalysis in the aminoacylase-1/M20 family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-GRISEUS AMINOPEPTIDASE; CRYSTAL-STRUCTURE; CARBOXYPEPTIDASE G(2); SEQUENCE-ANALYSIS; PURIFICATION; HYDROLASE; ACID; HYDROLYSIS; PEPV; DESUCCINYLASE	Members of the aminoacylase-1 (Acy1)/M20 family of aminoacylases and exopeptidases exist as either monomers or homodimers. They contain a zinc-binding domain and a second domain mediating dimerization in the latter case. The roles that both domains play in catalysis have been investigated for human Acy1 (hAcy1) by x-ray crystallography and by site-directed mutagenesis. Structure comparison of the dinuclear zinc center in a mutant of hAcy1 reported here with dizinc centers in related enzymes points to a difference in zinc ligation in the Acy1/M20 family. Mutational analysis supports catalytic roles of zinc ions, a vicinal glutamate, and a histidine from the dimerization domain. By complementing different active site mutants of hAcy1, we show that catalysis occurs at the dimer interface. Reinterpretation of the structure of a monomeric homolog, peptidase V, reveals that a domain insertion mimics dimerization. We conclude that monomeric and dimeric Acy1/M20 family members share a unique active site architecture involving both enzyme domains. The study may provide means to improve homologous carboxypeptidase G2 toward application in antibody-directed enzyme prodrug therapy.	Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	National Research Council Canada	Lindner, HA (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	Holger.Lindner@cnrc-nrc.gc.ca	Lindner, Holger A/C-5106-2014	Lindner, Holger A/0000-0002-6679-4355				BARRETT AJ, 1998, HDB PROTEOLYTIC ENZY, P1412; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biagini A, 2001, COMP BIOCHEM PHYS B, V128, P469, DOI 10.1016/S1096-4959(00)00341-9; Bommarius A. S., 2002, ENZYME CATALYSIS ORG, P741; Born TL, 1998, BIOCHEMISTRY-US, V37, P10478, DOI 10.1021/bi9806807; BOSMAN BW, 1990, APPL ENVIRON MICROB, V56, P1839, DOI 10.1128/AEM.56.6.1839-1843.1990; BOYEN A, 1992, GENE, V116, P1, DOI 10.1016/0378-1119(92)90621-U; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke PJ, 2000, EXPERT OPIN THER PAT, V10, P209, DOI 10.1517/13543776.10.2.209; CHENAULT HK, 1989, J AM CHEM SOC, V111, P6354, DOI 10.1021/ja00198a055; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Francis RJ, 2002, BRIT J CANCER, V87, P600, DOI 10.1038/sj.bjc.6600517; GADE W, 1981, BIOCHIM BIOPHYS ACTA, V662, P86, DOI 10.1016/0005-2744(81)90227-8; Gilboa R, 2001, PROTEINS, V44, P490, DOI 10.1002/prot.1115; GOLDMAN P, 1967, P NATL ACAD SCI USA, V58, P1299, DOI 10.1073/pnas.58.4.1299; Greenblatt HM, 1997, J MOL BIOL, V265, P620, DOI 10.1006/jmbi.1996.0729; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hakansson K, 2002, EUR J BIOCHEM, V269, P443, DOI 10.1046/j.0014-2956.2001.02665.x; HEESE D, 1990, EUR J BIOCHEM, V188, P175, DOI 10.1111/j.1432-1033.1990.tb15385.x; Hellendoorn MA, 1997, J BACTERIOL, V179, P3410, DOI 10.1128/jb.179.11.3410-3415.1997; Holz RC, 2003, CURR OPIN CHEM BIOL, V7, P197, DOI 10.1016/S1367-5931(03)00033-4; Javid-Majd F, 2000, BIOCHEMISTRY-US, V39, P1285, DOI 10.1021/bi992177f; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JONES WM, 1991, P NATL ACAD SCI USA, V88, P2194, DOI 10.1073/pnas.88.6.2194; Jozic D, 2002, STRUCTURE, V10, P1097, DOI 10.1016/S0969-2126(02)00805-5; Kawasaki S, 2000, PLANT CELL PHYSIOL, V41, P864, DOI 10.1093/pcp/pcd005; KORDEL W, 1977, Z NATURFORSCH C, V32, P342; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEVY CC, 1967, J BIOL CHEM, V242, P2933; Lindner H, 2000, BIOL CHEM, V381, P1055, DOI 10.1515/BC.2000.130; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALM GJ, 1995, J PROTEIN CHEM, V14, P233, DOI 10.1007/BF01886764; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pittelkow S, 1998, PROTEIN EXPRES PURIF, V12, P269, DOI 10.1006/prep.1997.0816; PRESCOTT JM, 1983, BIOCHEM BIOPH RES CO, V114, P646, DOI 10.1016/0006-291X(83)90829-X; Rawlings ND, 1997, BBA-PROTEIN STRUCT M, V1339, P247, DOI 10.1016/S0167-4838(97)00008-3; Rawlings ND, 2002, NUCLEIC ACIDS RES, V30, P343, DOI 10.1093/nar/30.1.343; REES DC, 1983, J MOL BIOL, V168, P367, DOI 10.1016/S0022-2836(83)80024-2; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; SCHMIEDEBERG O, 1881, N-S ARCH PHARMACOL, V14, P379; SCHROEDER U, 1994, FEMS MICROBIOL LETT, V123, P153, DOI 10.1111/j.1574-6968.1994.tb07215.x; Schrogel O, 1996, FEMS MICROBIOL LETT, V145, P341, DOI 10.1016/S0378-1097(96)00429-6; SHERWOOD RF, 1985, EUR J BIOCHEM, V148, P447, DOI 10.1111/j.1432-1033.1985.tb08860.x; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Spencer DIR, 2002, PROTEOMICS, V2, P271, DOI 10.1002/1615-9861(200203)2:3<271::AID-PROT271>3.0.CO;2-W; SPORMANN DO, 1992, J BIOL CHEM, V267, P8021; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; VONGERICHTEN KF, 1994, MICROBIOL-SGM, V140, P2591, DOI 10.1099/00221287-140-10-2591; Wouters MA, 2001, J MOL BIOL, V314, P1191, DOI 10.1006/jmbi.2000.5161	54	63	69	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44496	44504		10.1074/jbc.M304233200	http://dx.doi.org/10.1074/jbc.M304233200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12933810	hybrid			2022-12-27	WOS:000186306700078
J	Wu, JH; Peppel, K; Nelson, CD; Lin, FT; Kohout, TA; Miller, WE; Exum, ST; Freedman, NJ				Wu, JH; Peppel, K; Nelson, CD; Lin, FT; Kohout, TA; Miller, WE; Exum, ST; Freedman, NJ			The adaptor protein beta-arrestin2 enhances endocytosis of the low density lipoprotein receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE-TURN CONFORMATION; BETA-ADRENERGIC-RECEPTOR; LDL RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; MEDIATED ENDOCYTOSIS; ANGIOTENSIN-II; CYTOPLASMIC DOMAIN; COUPLED RECEPTORS; CLATHRIN ADAPTER; KINASE-C	Endocytosis of the low density lipoprotein (LDL) receptor ( LDLR) in coated pits employs the clathrin adaptor protein ARH. Similarly, agonist-dependent endocytosis of heptahelical receptors in coated pits employs the clathrin adaptor beta-arrestin proteins. In mice fed a high fat diet, we found that homozygous deficiency of beta-arrestin2 increased total and LDL plus intermediate-density lipoprotein cholesterol levels by 23 and 53%, respectively ( p < 0.05), but had no effect on high density lipoprotein cholesterol levels. We therefore tested whether &beta;-arrestins could affect the constitutive endocytosis of the LDLR. When overexpressed in cells, &beta;-arrestin1 and &beta;-arrestin2 each associated with the LDLR, as judged by co-immunoprecipitation, and augmented LDLR endocytosis by &SIM; 70%, as judged by uptake of fluorescent LDL. However, physiologic expression levels of only &beta;-arrestin2, and not &beta;-arrestin1, enhanced endogenous LDLR endocytosis ( by 65%) in stably transfected &beta;-arrestin1/&beta;-arrestin2 double-knockout mouse embryonic fibroblasts (MEFs). Concordantly, when RNA interference was used to suppress expression of &beta;-arrestin2, but not &beta;-arrestin1, LDLR endocytosis was reduced. Moreover, &beta;-arrestin2(-/-) MEFs demonstrated LDLR endocytosis that was 50% less than cognate wild type MEFs. In fusion protein pull-down assays, &beta;-arrestin2 bound to the LDLR cytoplasmic tail stoichiometrically, and binding was abolished by mutation of LDLR Tyr(807) to Ala. Mutation of LDLR cytoplasmic tail Ser(833) to Asp enhanced both the affinity of LDLR fusion protein binding to &beta;-arrestin2, and the efficiency of LDLR endocytosis in cells expressing &beta;-arrestin2 physiologically. We conclude that &beta;-arrestin2 can bind to and enhance endocytosis of the LDLR, both in vitro and in vivo, and may thereby influence lipoprotein metabolism.	Duke Univ, Med Ctr, Dept Med Cardiol, Durham, NC 27710 USA	Duke University	Freedman, NJ (corresponding author), Duke Univ, Med Ctr, Dept Med Cardiol, Box 3187, Durham, NC 27710 USA.				NHLBI NIH HHS [HL64744, HL63288] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063288, R01HL064744] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; ANDERSON RGW, 1982, J CELL BIOL, V93, P523, DOI 10.1083/jcb.93.3.523; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CHUNG BH, 1986, METHOD ENZYMOL, V128, P181; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; DUELAND S, 1993, J LIPID RES, V34, P923; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Haddad G, 1997, REGUL PEPTIDES, V68, P111, DOI 10.1016/S0167-0115(96)02112-X; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; Hein L, 1997, MOL ENDOCRINOL, V11, P1266, DOI 10.1210/me.11.9.1266; Innerarity T L, 1986, Methods Enzymol, V129, P542; KESANIEMI YA, 1983, J CLIN INVEST, V71, P950, DOI 10.1172/JCI110849; Kibbey RG, 1998, J CELL BIOL, V142, P59, DOI 10.1083/jcb.142.1.59; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; KISHIMOTO A, 1987, J BIOL CHEM, V262, P9367; KISHIMOTO A, 1987, J BIOL CHEM, V262, P1344; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin FT, 2002, BIOCHEMISTRY-US, V41, P10692, DOI 10.1021/bi025705n; MEHTA KD, 1991, J BIOL CHEM, V266, P10406; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; VON ZM, 1992, J BIOL CHEM, V267, P3530; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; YOKODE M, 1992, J CELL BIOL, V117, P39, DOI 10.1083/jcb.117.1.39	46	43	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44238	44245		10.1074/jbc.M309450200	http://dx.doi.org/10.1074/jbc.M309450200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944399	hybrid			2022-12-27	WOS:000186306700044
J	Fanning, PJ; Emkey, G; Smith, RJ; Grodzinsky, AJ; Szasz, N; Trippel, SB				Fanning, PJ; Emkey, G; Smith, RJ; Grodzinsky, AJ; Szasz, N; Trippel, SB			Mechanical regulation of mitogen-activated protein kinase signaling in articular cartilage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; MATRIX SYNTHESIS; DYNAMIC COMPRESSION; INTERSTITIAL FLUID; GENE-EXPRESSION; CHONDROCYTES; AGGRECAN; EXPLANTS; CELLS; INTERLEUKIN-1	Articular chondrocytes respond to mechanical forces by alterations in gene expression, proliferative status, and metabolic functions. Little is known concerning the cell signaling systems that receive, transduce, and convey mechanical information to the chondrocyte interior. Here, we show that ex vivo cartilage compression stimulates the phosphorylation of ERK1/ 2, p38 MAPK, and SAPK/ ERK kinase- 1 ( SEK1) of the JNK pathway. Mechanical compression induced a phased phosphorylation of ERK consisting of a rapid induction of ERK1/ 2 phosphorylation at 10 min, a rapid decay, and a sustained level of ERK2 phosphorylation that persisted for at least 24 h. Mechanical compression also induced the phosphorylation of p38 MAPK in strictly a transient fashion, with maximal phosphorylation occurring at 10 min. Mechanical compression stimulated SEK1 phosphorylation, with a maximum at the relatively delayed time point of 1 h and with a higher amplitude than ERK1/ 2 and p38 MAPK phosphorylation. These data demonstrate that mechanical compression alone activates MAPK signaling in intact cartilage. In addition, these data demonstrate distinct temporal patterns of MAPK signaling in response to mechanical loading and to the anabolic insulin- like growth factor- I. Finally, the data indicate that compression coactivates distinct signaling pathways that may help define the nature of mechanotransduction in cartilage.	Massachusetts Gen Hosp, Orthopaed Res Labs, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Joslin Diabet Ctr, Boston, MA 02215 USA; MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.; Massachusetts Institute of Technology (MIT)	Trippel, SB (corresponding author), Indiana Univ, Sch Med, Dept Orthoped Surg, 541 Clin Dr, Indianapolis, IN 46202 USA.	strippel@iupui.edu			NIAMS NIH HHS [AR45749, AR33236] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045749, R37AR033236, R01AR033236] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bonassar LJ, 2000, ARCH BIOCHEM BIOPHYS, V379, P57, DOI 10.1006/abbi.2000.1820; Bonassar LJ, 2001, J ORTHOP RES, V19, P11, DOI 10.1016/S0736-0266(00)00004-8; BOUSTANY NN, 1995, J ORTHOPAED RES, V13, P733, DOI 10.1002/jor.1100130513; BOUSTANY NN, 1995, J ORTHOPAED RES, V13, P740, DOI 10.1002/jor.1100130514; Buschmann MD, 1999, ARCH BIOCHEM BIOPHYS, V366, P1, DOI 10.1006/abbi.1999.1197; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; Dhanasekaran N, 1998, ONCOGENE, V17, P1447, DOI 10.1038/sj.onc.1202251; FREEMAN PM, 1994, J ORTHOPAED RES, V12, P311, DOI 10.1002/jor.1100120303; Garcia AM, 2003, ARCH BIOCHEM BIOPHYS, V415, P69, DOI 10.1016/S0003-9861(03)00215-7; Geng Y, 1996, J CLIN INVEST, V98, P2425, DOI 10.1172/JCI119056; GOLDRING MB, 1988, J CLIN INVEST, V82, P2026, DOI 10.1172/JCI113823; GRITZKA TL, 1973, J BONE JOINT SURG AM, VA 55, P1698, DOI 10.2106/00004623-197355080-00015; Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691; Guilak F, 1994, Osteoarthritis Cartilage, V2, P91, DOI 10.1016/S1063-4584(05)80059-7; HALL AC, 1991, J ORTHOPAED RES, V9, P1, DOI 10.1002/jor.1100090102; Herberhold C, 1999, J BIOMECH, V32, P1287, DOI 10.1016/S0021-9290(99)00130-X; HODGE WA, 1986, P NATL ACAD SCI USA, V83, P2879, DOI 10.1073/pnas.83.9.2879; Huber M, 2000, INVEST RADIOL, V35, P573, DOI 10.1097/00004424-200010000-00003; HUFF K, 1981, J CELL BIOL, V88, P189, DOI 10.1083/jcb.88.1.189; Hung CT, 2000, J BIOMECH, V33, P73, DOI 10.1016/S0021-9290(99)00176-1; Jin G, 2000, J ORTHOPAED RES, V18, P899, DOI 10.1002/jor.1100180608; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kim YJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P331, DOI 10.1006/abbi.1996.0181; KIM YJ, 1994, ARCH BIOCHEM BIOPHYS, V311, P1, DOI 10.1006/abbi.1994.1201; Lee DA, 1998, BIOCHEM BIOPH RES CO, V251, P580, DOI 10.1006/bbrc.1998.9520; Loening AM, 2000, ARCH BIOCHEM BIOPHYS, V381, P205, DOI 10.1006/abbi.2000.1988; MELOCHE S, 1992, MOL ENDOCRINOL, V6, P845, DOI 10.1210/me.6.5.845; Millward-Sadler SJ, 1999, J CELL BIOL, V145, P183, DOI 10.1083/jcb.145.1.183; MORALES TI, 1989, CONNECT TISSUE RES, V19, P255, DOI 10.3109/03008208909043900; Mow VC, 1999, OSTEOARTHR CARTILAGE, V7, P41, DOI 10.1053/joca.1998.0161; MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Quinn TM, 1999, ANN NY ACAD SCI, V878, P420, DOI 10.1111/j.1749-6632.1999.tb07700.x; Quinn TM, 1998, J CELL SCI, V111, P573; Ragan PM, 1999, J ORTHOPAED RES, V17, P836, DOI 10.1002/jor.1100170608; REPO RU, 1977, J BONE JOINT SURG AM, V59, P1068, DOI 10.2106/00004623-197759080-00012; SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502; SCHALKWIJK J, 1989, ARTHRITIS RHEUM, V32, P66, DOI 10.1002/anr.1780320111; Scherle PA, 1997, BIOCHEM BIOPH RES CO, V230, P573, DOI 10.1006/bbrc.1996.5985; Talts JF, 1998, ANN NY ACAD SCI, V857, P74, DOI 10.1111/j.1749-6632.1998.tb10108.x; THOMPSON RC, 1991, J BONE JOINT SURG AM, V73A, P990, DOI 10.2106/00004623-199173070-00005; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; TRIPPEL SB, 1989, PEDIATR RES, V25, P76, DOI 10.1203/00006450-198901000-00017; Trippel ST, 1992, BIOL REGULATION CHON, P161; TYLER JA, 1985, BIOCHEM J, V227, P869, DOI 10.1042/bj2270869; URBAN JPG, 1993, J CELL PHYSIOL, V154, P262, DOI 10.1002/jcp.1041540208; Urban JPG, 2000, BIORHEOLOGY, V37, P185; Valhmu WB, 1998, ARCH BIOCHEM BIOPHYS, V353, P29, DOI 10.1006/abbi.1998.0633; WILKINS RJ, 1995, J CELL PHYSIOL, V164, P474, DOI 10.1002/jcp.1041640305; Wu QQ, 2000, EXP CELL RES, V256, P383, DOI 10.1006/excr.2000.4847	52	112	116	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2003	278	51					50940	50948		10.1074/jbc.M305107200	http://dx.doi.org/10.1074/jbc.M305107200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	752ZM	12952976	hybrid			2022-12-27	WOS:000187206300015
J	Yamagami, T; Tsuchisaka, A; Yamada, K; Haddon, WF; Harden, LA; Theologis, A				Yamagami, T; Tsuchisaka, A; Yamada, K; Haddon, WF; Harden, LA; Theologis, A			Biochemical diversity among the 1-amino-cyclopropane-1-carboxylate synthase isozymes encoded by the Arabidopsis gene family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID SYNTHASE; ETHYLENE BIOSYNTHESIS; ESCHERICHIA-COLI; KEY ENZYME; ASPARTATE-AMINOTRANSFERASE; DIFFERENTIAL EXPRESSION; MULTIGENE FAMILY; ACTIVE-SITE; WILD-TYPE; TOMATO	1-Amino-cyclopropane-1-carboxylate synthase (ACS, EC 4.4.1.14) is the key enzyme in the ethylene biosynthetic pathway in plants. The completion of the Arabidopsis genome sequence revealed the presence of twelve putative ACS genes, ACS1-12, dispersed among five chromosomes. ACS1-5 have been previously characterized. However, ACS1 is enzymatically inactive whereas ACS3 is a pseudogene. Complementation analysis with the Escherichia coli aminotransferase mutant DL39 shows that ACS10 and 12 encode aminotransferases. The remaining eight genes are authentic ACS genes and together with ACS1 constitute the Arabidopsis ACS gene family. All genes, except ACS3, are transcriptionally active and differentially expressed during Arabidopsis growth and development. IAA induces all ACS genes, except ACS7 and ACS9; CHX enhances the expression of all functional ACS genes. The ACS genes were expressed in E. coli, purified to homogeneity by affinity chromatography, and biochemically characterized. The quality of the recombinant proteins was verified by N-terminal amino acid sequence and MALDI-TOF mass spectrometry. The analysis shows that all ACS isozymes function as dimers and have an optimum pH, ranging between 7.3 and 8.2. Their K-m values for AdoMet range from 8.3 to 45 muM, whereas their k(cat) values vary from 0.19 to 4.82 s(-1) per monomer. Their K-i values for AVG and sinefungin vary from 0.019 to 0.80 muM and 0.15 to 12 muM, respectively. The results indicate that the Arabidopsis ACS isozymes are biochemically distinct. It is proposed that biochemically diverse ACS isozymes function in unique cellular environments for the biosynthesis of C2H4, permitting the signaling molecule to exert its unique effects in a tissue- or cell-specific fashion.	USDA, Ctr Plant Gene Express, Albany, CA 94710 USA; USDA, Food Safety & Hlth Res Unit, Western Reg Res Ctr, Albany, CA 94710 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Theologis, A (corresponding author), USDA, Ctr Plant Gene Express, Albany, CA 94710 USA.	theo@nature.berkeley.edu						Abeles F, 1992, ETHYLENE PLANT BIOL; An YQ, 1996, PLANT J, V10, P107, DOI 10.1046/j.1365-313X.1996.10010107.x; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Arteca JM, 1999, PLANT MOL BIOL, V39, P209, DOI 10.1023/A:1006177902093; Barry CS, 1996, PLANT J, V9, P525, DOI 10.1046/j.1365-313X.1996.09040525.x; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Bazzanella A, 1998, J CHROMATOGR A, V809, P231, DOI 10.1016/S0021-9673(98)00144-7; Beh CT, 2001, GENETICS, V157, P1117; BERG CM, 1988, GENE, V65, P195, DOI 10.1016/0378-1119(88)90456-8; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; BLEECKER AB, 1986, P NATL ACAD SCI USA, V83, P7755, DOI 10.1073/pnas.83.20.7755; BOLLER T, 1979, PLANTA, V145, P293, DOI 10.1007/BF00454455; BOLLER T, 1984, ETHYLENE BIOCH PHYSL, P87; BOTELLA JR, 1993, GENE, V123, P249, DOI 10.1016/0378-1119(93)90132-M; BURNS JK, 1986, PHYSIOL PLANTARUM, V66, P609, DOI 10.1111/j.1399-3054.1986.tb05588.x; Capitani G, 1999, J MOL BIOL, V294, P745, DOI 10.1006/jmbi.1999.3255; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; DESTEFANOBELTRAN LJC, 1995, MOL GEN GENET, V246, P496, DOI 10.1007/BF00290453; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; GRAUR D, 2000, FUNDAMENTALS MOL EVO, P249; GREGERSON RG, 1994, PLANT MOL BIOL, V25, P387, DOI 10.1007/BF00043868; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HARRIS H, 1979, CIBA F SYMP, V27, P187; Huai Q, 2001, J BIOL CHEM, V276, P38210; HUANG PL, 1991, P NATL ACAD SCI USA, V88, P7021, DOI 10.1073/pnas.88.16.7021; HYODO H, 1985, PLANT CELL PHYSIOL, V26, P161; ICEKSON I, 1983, BIOCHEM BIOPH RES CO, V113, P586, DOI 10.1016/0006-291X(83)91766-7; KENDE H, 1993, ANNU REV PLANT PHYS, V44, P283, DOI 10.1146/annurev.pp.44.060193.001435; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI N, 1994, J BIOL CHEM, V269, P6908; Li YS, 1997, BIOCHEMISTRY-US, V36, P15477, DOI 10.1021/bi971625l; Liang XW, 1995, GENE, V167, P17, DOI 10.1016/0378-1119(95)00694-X; LIANG XW, 1992, P NATL ACAD SCI USA, V89, P11046, DOI 10.1073/pnas.89.22.11046; Liang XW, 1996, PLANT J, V10, P1027, DOI 10.1046/j.1365-313X.1996.10061027.x; LINCOLN JE, 1993, J BIOL CHEM, V268, P19422; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; LIZADA MCC, 1979, ANAL BIOCHEM, V100, P140, DOI 10.1016/0003-2697(79)90123-4; Lochmann H, 1998, J CHROMATOGR A, V817, P337, DOI 10.1016/S0021-9673(98)00383-5; McCarthy DL, 2001, BIOCHEMISTRY-US, V40, P12276, DOI 10.1021/bi011050z; MEHTA PK, 1994, BIOCHEM BIOPH RES CO, V198, P138, DOI 10.1006/bbrc.1994.1020; MEHTA PK, 1989, EUR J BIOCHEM, V186, P249, DOI 10.1111/j.1432-1033.1989.tb15202.x; MIURA GA, 1985, ANAL BIOCHEM, V147, P217, DOI 10.1016/0003-2697(85)90030-2; MIYAZAKI JH, 1987, PHYTOCHEMISTRY, V26, P2655, DOI 10.1016/S0031-9422(00)83566-9; NAKAGAWA N, 1988, PLANT CELL PHYSIOL, V29, P1255; NAKAJIMA N, 1990, PLANT CELL PHYSIOL, V31, P1021; NAKAJIMA N, 1986, PLANT CELL PHYSIOL, V27, P969; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; OELLER PW, 1991, SCIENCE, V254, P437, DOI 10.1126/science.1925603; OLSON DC, 1991, P NATL ACAD SCI USA, V88, P5340, DOI 10.1073/pnas.88.12.5340; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; ROTTMANN WH, 1991, J MOL BIOL, V222, P937, DOI 10.1016/0022-2836(91)90587-V; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SATO T, 1991, J BIOL CHEM, V266, P3752; SATO T, 1989, P NATL ACAD SCI USA, V86, P6621, DOI 10.1073/pnas.86.17.6621; SATOH S, 1993, CURR PLANT SCI BIOT, V16, P7; SATOH S, 1988, PLANT PHYSIOL, V88, P109, DOI 10.1104/pp.88.1.109; SCHUNCK B, 1995, J VIROL METHODS, V55, P427, DOI 10.1016/0166-0934(95)00069-3; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; Tarun AS, 1998, J BIOL CHEM, V273, P12509, DOI 10.1074/jbc.273.20.12509; Tarun AS, 1998, P NATL ACAD SCI USA, V95, P9796, DOI 10.1073/pnas.95.17.9796; Tatsuki M, 2001, J BIOL CHEM, V276, P28051, DOI 10.1074/jbc.M101543200; THEOLOGIS A, 1993, DEV GENET, V14, P282, DOI 10.1002/dvg.1020140406; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vogel JP, 1998, P NATL ACAD SCI USA, V95, P4766, DOI 10.1073/pnas.95.8.4766; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WHITE MF, 1994, P NATL ACAD SCI USA, V91, P12428, DOI 10.1073/pnas.91.26.12428; Woeste KE, 1999, PLANT PHYSIOL, V119, P521, DOI 10.1104/pp.119.2.521; YANG SF, 1993, BOT BULL ACAD SINICA, V34, P89; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; YIP WK, 1990, P NATL ACAD SCI USA, V87, P7930, DOI 10.1073/pnas.87.20.7930; YIP WK, 1992, P NATL ACAD SCI USA, V89, P2475, DOI 10.1073/pnas.89.6.2475; YOSHII H, 1981, PLANT CELL PHYSIOL, V22, P369; YU YB, 1979, ARCH BIOCHEM BIOPHYS, V198, P280, DOI 10.1016/0003-9861(79)90420-X; ZAREMBINSKI TI, 1994, PLANT MOL BIOL, V26, P1579, DOI 10.1007/BF00016491	79	249	279	3	50	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					49102	49112		10.1074/jbc.M308297200	http://dx.doi.org/10.1074/jbc.M308297200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	747WL	12968022	hybrid			2022-12-27	WOS:000186829000073
J	Chowdhury, S; Ragaz, C; Kreuger, E; Narberhaus, F				Chowdhury, S; Ragaz, C; Kreuger, E; Narberhaus, F			Temperature-controlled structural alterations of an RNA thermometer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOSENSOR CONTROLS EXPRESSION; MESSENGER-RNA; BRADYRHIZOBIUM-JAPONICUM; SMALL MOLECULES; GENE; PROTEIN; TRANSCRIPTION; TRANSLATION; SIGMA(32); HOMOLOGS	Thermoresponsive structures in the 5'-untranslated region of mRNA are known to control translation of heat shock and virulence genes. Expression of many rhizobial heat shock genes is regulated by a conserved sequence element called ROSE for repression of heat shock gene expression. This cis-acting, untranslated mRNA is thought to prevent ribosome access at low temperature through an extended secondary structure, which partially melts when the temperature rises. We show here by a series of in vivo and in vitro approaches that ROSE is a sensitive thermometer responding in the physiologically relevant temperature range between 30 and 40 degreesC. Point mutations predicted to disrupt base pairing enhanced expression at 30 degreesC. Compensatory mutations restored repression, emphasizing the importance of secondary structures in the sensory RNA. Only moderate inducibility of a 5'-truncated ROSE variant suggests that interactions between individual stem loops coordinate temperature sensing. In the presence of a complementary oligonucleotide, the functionally important stem loop of ROSE was rendered susceptible to RNase H treatment at heat shock temperatures. Since major structural rearrangements were not observed during UV and CD spectroscopy, subtle structural changes involving the Shine-Dalgarno sequence are proposed to mediate translational control. Temperature perception by the sensory RNA is an ordered process that most likely occurs without the aid of accessory factors.	ETH, Inst Microbiol, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Narberhaus, F (corresponding author), ETH, Inst Microbiol, Schmelzbergstr 7, CH-8092 Zurich, Switzerland.	fnarber@micro.biol.ethz.ch	Taylor, Graham/A-4027-2012	Narberhaus, Franz/0000-0002-8552-5310; Kreuger, Emma/0000-0002-7797-8854				ALTUVIA S, 1989, J MOL BIOL, V210, P265, DOI 10.1016/0022-2836(89)90329-X; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; Gross CA, 1996, ESCHERICHIA COLI SAL, P1382; HOE NP, 1993, J BACTERIOL, V175, P7901, DOI 10.1128/JB.175.24.7901-7909.1993; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; KULLIK I, 1991, J BACTERIOL, V173, P1125, DOI 10.1128/jb.173.3.1125-1138.1991; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lai EC, 2003, CURR BIOL, V13, pR285, DOI 10.1016/S0960-9822(03)00203-3; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Minder AC, 2000, J BACTERIOL, V182, P14, DOI 10.1128/JB.182.1.14-22.2000; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Morita M, 1999, J BACTERIOL, V181, P401, DOI 10.1128/JB.181.2.401-410.1999; Morita MT, 1999, GENE DEV, V13, P655, DOI 10.1101/gad.13.6.655; Munchbach M, 1999, J BACTERIOL, V181, P83; NAKAHIGASHI K, 1995, NUCLEIC ACIDS RES, V23, P4383; Narberhaus F, 1996, J BACTERIOL, V178, P5337, DOI 10.1128/jb.178.18.5337-5346.1996; Narberhaus F, 2002, ARCH MICROBIOL, V178, P404, DOI 10.1007/s00203-002-0481-8; Narberhaus F, 1998, ARCH MICROBIOL, V169, P89, DOI 10.1007/s002030050547; Narberhaus F, 1998, MOL MICROBIOL, V28, P315, DOI 10.1046/j.1365-2958.1998.00794.x; Nocker A, 2001, NUCLEIC ACIDS RES, V29, P4800, DOI 10.1093/nar/29.23.4800; Nocker A, 2001, ARCH MICROBIOL, V176, P44, DOI 10.1007/s002030100294; Nou XW, 1998, J BACTERIOL, V180, P6719, DOI 10.1128/JB.180.24.6719-6728.1998; Nou XW, 2000, P NATL ACAD SCI USA, V97, P7190, DOI 10.1073/pnas.130013897; Ravnum S, 2001, MOL MICROBIOL, V39, P1585, DOI 10.1046/j.1365-2958.2001.02346.x; REGENSBURGER B, 1983, ARCH MICROBIOL, V135, P103, DOI 10.1007/BF00408017; Repoila F, 2001, J BACTERIOL, V183, P4012, DOI 10.1128/JB.183.13.4012-4023.2001; Sambrook J., 2001, MOL CLONING LAB MANU; Serganov A, 2003, EMBO J, V22, P1898, DOI 10.1093/emboj/cdg170; Stormo GD, 2001, P NATL ACAD SCI USA, V98, P9465, DOI 10.1073/pnas.181334498; Storz G, 1999, GENE DEV, V13, P633, DOI 10.1101/gad.13.6.633; Weisberg RA, 2002, MOL CELL, V10, P1266, DOI 10.1016/S1097-2765(02)00788-8; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Yamanaka K, 1999, J BACTERIOL, V181, P6284, DOI 10.1128/JB.181.20.6284-6291.1999; Yura T, 2000, BACTERIAL STRESS RESPONSES, P3; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	37	76	78	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47915	47921		10.1074/jbc.M306874200	http://dx.doi.org/10.1074/jbc.M306874200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12963744	hybrid			2022-12-27	WOS:000186731400069
J	Sohn, J; Youn, HS; Jeoung, MK; Koo, YB; Yi, CS; Ji, I; Ji, TH				Sohn, J; Youn, HS; Jeoung, MK; Koo, YB; Yi, CS; Ji, I; Ji, TH			Orientation of follicle-stimulating hormone (FSH) subunits complexed with the FSH receptor - beta subunit toward the N terminus of exodomain and alpha subunit to exoloop 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUTROPIN-CHORIOGONADOTROPIN RECEPTOR; CHORIONIC-GONADOTROPIN RECEPTOR; LEUCINE-RICH REPEATS; EXTRACELLULAR DOMAIN; LIGAND INTERACTIONS; HIGH-AFFINITY; HINGE REGION; LH RECEPTOR; BINDING; PROTEIN	Follicle-stimulating hormone (FSH) comprises an alpha subunit and a beta subunit, whereas the FSH receptor consists of two halves with distinct functions: the N-terminal extracellular exodomain and C-terminal membrane-associated endodomain. FSH initially binds to exodomain, and the resulting FSH/exodomain complex modulates the endodomain and generates signal. However, it has been difficult to determine which subunit of FSH contacts the exodomain or endodomain and in what orientation FSH interacts with them. To address these crucial issues, the receptor was Ala-scanned and the hormone subunits were probed with photoaffinity labeling with receptor peptides corresponding to the N-terminal region of the exodomain and exoloop 3 of the endodomain. Our results show that both regions of the receptors are important for hormone binding and signal generation. In addition, the FSH beta subunit is specifically labeled with the N-terminal peptide, whereas the alpha subunit is labeled with the exoloop 3 peptide. These contrasting results show that the FSH beta subunit is close to the N-terminal region and that the alpha subunit is projected toward exoloop 3 in the endodomain. The results raise the fundamental question whether the alpha subunit, common among the glycoprotein hormones, plays a major role in generating the hormone signal common to all glycoprotein hormones.	Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; Univ Kentucky, Dept Biol, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky	Ji, TH (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.				NICHD NIH HHS [HD-18702] Funding Source: Medline; NIDDK NIH HHS [DK-51469] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051469] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANGELOVA K, 2002, J BIOL CHEM, V17, P17; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Babu P S, 1999, Mol Cell Biol Res Commun, V2, P21, DOI 10.1006/mcbr.1999.0139; Bayley H, 1983, PHOTOGENERATED REAGE; Bhowmick N, 1996, MOL ENDOCRINOL, V10, P1147, DOI 10.1210/me.10.9.1147; Bradbury FA, 1997, J BIOL CHEM, V272, P5921, DOI 10.1074/jbc.272.9.5921; Couture L, 1996, J MOL ENDOCRINOL, V16, P15, DOI 10.1677/jme.0.0160015; DAVIS D, 1995, MOL ENDOCRINOL, V9, P159, DOI 10.1210/me.9.2.159; Dias JA, 1998, BIOL REPROD, V58, P1331, DOI 10.1095/biolreprod58.6.1331; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Dufau ML, 1998, ANNU REV PHYSIOL, V60, P461, DOI 10.1146/annurev.physiol.60.1.461; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; Garcia-Campayo V, 2002, ENDOCRINOLOGY, V143, P3773, DOI 10.1210/en.2002-220336; Hong SH, 1998, J BIOL CHEM, V273, P13835, DOI 10.1074/jbc.273.22.13835; Hong SH, 1997, J BIOL CHEM, V272, P4166, DOI 10.1074/jbc.272.7.4166; Jackson AM, 1999, MOL ENDOCRINOL, V13, P2175, DOI 10.1210/me.13.12.2175; JI I, 1993, J BIOL CHEM, V268, P20851; JI I, 1980, P NATL ACAD SCI-BIOL, V77, P7167, DOI 10.1073/pnas.77.12.7167; JI I, 1981, P NATL ACAD SCI-BIOL, V78, P5465, DOI 10.1073/pnas.78.9.5465; JI IH, 1991, ENDOCRINOLOGY, V128, P2648, DOI 10.1210/endo-128-5-2648; Ji IH, 1995, ENDOCRINE, V3, P907, DOI 10.1007/BF02738896; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; JI TH, 1995, ENDOCRINE, V3, P187, DOI 10.1007/BF02994442; Jiang XL, 1995, STRUCTURE, V3, P1341, DOI 10.1016/S0969-2126(01)00272-6; KAUER JC, 1986, J BIOL CHEM, V261, P695; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; KOO YB, 1991, ENDOCRINOLOGY, V128, P2297, DOI 10.1210/endo-128-5-2297; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; LOOSFELT H, 1989, SCIENCE, V245, P525, DOI 10.1126/science.2502844; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; Nakabayashi K, 2000, J BIOL CHEM, V275, P30264, DOI 10.1074/jbc.M005568200; Narayan P, 2002, MOL ENDOCRINOL, V16, P2733, DOI 10.1210/me.2002-0208; Nechamen CA, 2003, MOL CELL ENDOCRINOL, V201, P123, DOI 10.1016/S0303-7207(02)00424-0; Nechamen CA, 2000, MOL CELL ENDOCRINOL, V166, P101, DOI 10.1016/S0303-7207(00)00281-1; Nishi S, 2002, J BIOL CHEM, V277, P3958, DOI 10.1074/jbc.M109617200; Osuga Y, 1997, MOL ENDOCRINOL, V11, P1659, DOI 10.1210/me.11.11.1659; Phang T, 1998, J BIOL CHEM, V273, P13841, DOI 10.1074/jbc.273.22.13841; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; ROCHE PC, 1985, LUTEINIZING HORMONE, P17; ROZELL T, 1995, MOL ENDOCRINOL, P1727; Schmidt A, 2001, J BIOL CHEM, V276, P23373, DOI 10.1074/jbc.M100057200; SEETHARAMAIAH GS, 1994, ENDOCRINOLOGY, V134, P549, DOI 10.1210/en.134.2.549; Sohn J, 2002, J BIOL CHEM, V277, P50165, DOI 10.1074/jbc.M207646200; Song YS, 2001, J BIOL CHEM, V276, P3426, DOI 10.1074/jbc.M003772200; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; Tao YX, 2002, MOL ENDOCRINOL, V16, P1881, DOI 10.1210/me.2001-0199; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSAIMORRIS CH, 1990, J BIOL CHEM, V265, P19385; Vischer HF, 2003, J BIOL CHEM, V278, P15505, DOI 10.1074/jbc.M300634200; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; XIE YB, 1990, J BIOL CHEM, V265, P21411; Zeng HW, 2001, J BIOL CHEM, V276, P3451, DOI 10.1074/jbc.M007488200	52	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47868	47876		10.1074/jbc.M307751200	http://dx.doi.org/10.1074/jbc.M307751200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12963710	hybrid			2022-12-27	WOS:000186731400064
J	Hwang, J; Saha, A; Boo, YC; Sorescu, GP; McNally, JS; Holland, SM; Dikalov, S; Giddens, DP; Griendling, KK; Harrison, DG; Jo, H				Hwang, J; Saha, A; Boo, YC; Sorescu, GP; McNally, JS; Holland, SM; Dikalov, S; Giddens, DP; Griendling, KK; Harrison, DG; Jo, H			Oscillatory shear stress stimulates endothelial production of O2- from p47(phox)-dependent NAD(P)H oxidases, leading to monocyte adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; HUMAN CAROTID BIFURCATION; PROTEIN-KINASE-A; NADPH OXIDASE; SUPEROXIDE-DISMUTASE; UP-REGULATION; CELLS; ATHEROSCLEROSIS; EXPRESSION; FLOW	Arterial regions exposed to oscillatory shear (OS) in branched arteries are lesion-prone sites of atherosclerosis, whereas those of laminar shear (LS) are relatively well protected. Here, we examined the hypothesis that OS and LS differentially regulate production of O-2(-) from the endothelial NAD(P)H oxidase, which, in turn, is responsible for their opposite effects on a critical atherogenic event, monocyte adhesion. We used aortic endothelial cells obtained from C57BL/6 (MAE-C57) and p47(phox-/-) (MAE- p47(-/-)) mice, which lack a component of NAD(P)H oxidase. O-2(-) production was determined by dihydroethidium staining and an electron spin resonance using an electron spin trap methoxycarbonyl-2,2,5,5- tetramethyl-pyrrolidine. Chronic exposure (18 h) to an arterial level of OS (+/- 5 dynes/cm(2)) increased O-2(-) (2-fold) and monocyte adhesion (3-fold) in MAE-C57 cells, whereas chronic LS (15 dynes/cm(2), 18 h) significantly decreased both monocyte adhesion and O-2(-) compared with static conditions. In contrast, neither LS nor OS were able to induce O-2(-) production and monocyte adhesion to MAE- p47(-/-). Treating MAE-C57 with a cell-permeable superoxide dismutase compound, polyethylene glycol-superoxide dismutase, also inhibited OS-induced monocyte adhesion. In addition, over-expressing p47(phox) in MAE-p47(-/-) restored OS-induced O-2(-) production and monocyte adhesion. These results suggest that chronic exposure of endothelial cells to OS stimulates O-2(-) and/or its derivatives produced from p47(phox)-dependent NAD(P) H oxidase, which, in turn, leads to monocyte adhesion, an early and critical atherogenic event.	Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA	University System of Georgia; Georgia Institute of Technology; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jo, H (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.		Jo, Hanjoong/L-6216-2019; Giddens, Don P/AAD-5531-2019	Jo, Hanjoong/0000-0003-1833-372X; Dikalov, Sergey/0000-0003-2976-6184; Boo, Yong Chool/0000-0001-9895-2066; Griendling, Kathy/0000-0002-9456-8582	NHLBI NIH HHS [HL 71014, HL 67413] Funding Source: Medline; NIGMS NIH HHS [T32 GM008169] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067413, R01HL071014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Babior BM, 2002, ISRAEL MED ASSOC J, V4, P1023; Berk BC, 2001, ANN NY ACAD SCI, V947, P93; Boo YC, 2002, AM J PHYSIOL-HEART C, V283, pH1819, DOI 10.1152/ajpheart.00214.2002; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Chappell DC, 1998, CIRC RES, V82, P532, DOI 10.1161/01.RES.82.5.532; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094; Dimmeler S, 1999, ARTERIOSCL THROM VAS, V19, P656, DOI 10.1161/01.ATV.19.3.656; Endres M, 1997, STROKE, V28, P77, DOI 10.1161/01.STR.28.1.77; Garcia-Cardena G, 2001, P NATL ACAD SCI USA, V98, P4478, DOI 10.1073/pnas.071052598; Go YM, 1999, AM J PHYSIOL-HEART C, V277, pH1647, DOI 10.1152/ajpheart.1999.277.4.H1647; Go YM, 1998, AM J PHYSIOL-HEART C, V275, pH1898, DOI 10.1152/ajpheart.1998.275.5.H1898; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Holland JA, 2000, ENDOTHELIUM-J ENDOTH, V7, P109, DOI 10.3109/10623320009072206; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jo H, 1997, J BIOL CHEM, V272, P1395, DOI 10.1074/jbc.272.2.1395; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Kuzkaya N, 2003, J BIOL CHEM, V278, P22546, DOI 10.1074/jbc.M302227200; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Li JM, 2002, J BIOL CHEM, V277, P19952, DOI 10.1074/jbc.M110073200; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Patel RP, 2000, FREE RADICAL BIO MED, V28, P1780, DOI 10.1016/S0891-5849(00)00235-5; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; Sorescu GP, 2003, J BIOL CHEM, V278, P31128, DOI 10.1074/jbc.M300703200; Suh SH, 1999, PFLUG ARCH EUR J PHY, V438, P612, DOI 10.1007/s004240051084; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Szocs K, 2002, ARTERIOSCL THROM VAS, V22, P21, DOI 10.1161/hq0102.102189; Takeshita S, 2000, BIOCHEM BIOPH RES CO, V273, P66, DOI 10.1006/bbrc.2000.2898; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417; Tsao PS, 1996, CIRCULATION, V94, P1682, DOI 10.1161/01.CIR.94.7.1682; ZARINS CK, 1983, CIRC RES, V53, P502, DOI 10.1161/01.RES.53.4.502; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Ziegler T, 1998, HYPERTENSION, V32, P351, DOI 10.1161/01.HYP.32.2.351	36	230	235	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47291	47298		10.1074/jbc.M305150200	http://dx.doi.org/10.1074/jbc.M305150200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12958309	Green Submitted, hybrid			2022-12-27	WOS:000186569400131
J	Keizer, DW; West, PJ; Lee, EF; Yoshikami, D; Olivera, BM; Bulaj, G; Norton, RS				Keizer, DW; West, PJ; Lee, EF; Yoshikami, D; Olivera, BM; Bulaj, G; Norton, RS			Structural basis for tetrodotoxin-resistant sodium channel binding by mu-conotoxin SmIIIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; SKELETAL-MUSCLE; SYMPATHETIC-GANGLIA; POTASSIUM CHANNELS; AQUEOUS-SOLUTIONS; POTENT INHIBITOR; H-3 SAXITOXIN; SHK TOXIN; GIIIA; NMR	SmIIIA is a new mu-conotoxin isolated recently from Conus stercusmuscarum. Although it shares several biochemical characteristics with other mu-conotoxins ( the arrangement of cysteine residues and a conserved arginine believed to interact with residues near the channel pore), it has several distinctive features, including the absence of hydroxyproline, and is the first specific antagonist of tetrodotoxin-resistant voltage-gated sodium channels to be characterized. It therefore represents a potentially useful tool to investigate the functional roles of these channels. We have determined the three-dimensional structure of SmIIIA in aqueous solution. Consistent with the absence of hydroxyprolines, SmIIIA adopts a single conformation with all peptide bonds in the trans configuration. The spatial orientations of several conserved Arg and Lys side chains, including Arg(14) ( using a consensus numbering system), which plays a key role in sodium channel binding, are similar to those in other mu-conotoxins but the N-terminal regions differ, reflecting the trans conformation for the peptide bond preceding residue 8 in SmIIIA, as opposed to the cis conformation in mu-conotoxins GIIIA and GIIIB. Comparison of the surfaces of SmIIIA with other mu-conotoxins suggests that the affinity of SmIIIA for TTX-resistant channels is influenced by the Trp(15) side chain, which is unique to SmIIIA. Arg(17), which replaces Lys in the other mu-conotoxins, may also be important. Consistent with these inferences from the structure, assays of two chimeras of SmIIIA and PIIIA in which their N- and C-terminal halves were recombined, indicated that residues in the C-terminal half of SmIIIA confer affinity for tetrodotoxin-resistant sodium channels in the cell bodies of frog sympathetic neurons. SmIIIA and the chimera possessing the C-terminal half of SmIIIA also inhibit tetrodotoxin-resistant sodium channels in the postganglionic axons of sympathetic neurons, as indicated by their inhibition of C-neuron compound action potentials that persist in the presence of tetrodotoxin.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Utah, Interdepartmental Program Neurosci, Salt Lake City, UT 84112 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Cognetix Inc, Salt Lake City, UT 84108 USA	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Norton, RS (corresponding author), Walter & Eliza Hall Inst Med Res, NMR Lab, 381 Royal Parade, Parkville, Vic 3052, Australia.		Keizer, David/P-9196-2014; Lee, Erinna/N-1523-2015	Keizer, David/0000-0002-0442-0999; Lee, Erinna/0000-0003-1255-9808; Norton, Raymond/0000-0001-8893-0584	NIGMS NIH HHS [GM 48677] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; BECKER S, 1992, BIOCHEMISTRY-US, V31, P8229, DOI 10.1021/bi00150a016; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; BUNDI A, 1979, BIOPOLYMERS, V18, P285, DOI 10.1002/bip.1979.360180206; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; Case DA, 1995, J BIOMOL NMR, V6, P341; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chahine M, 1995, RECEPTOR CHANNEL, V3, P161; CHEN LQ, 1992, FEBS LETT, V309, P253, DOI 10.1016/0014-5793(92)80783-D; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; Dudley SC, 1995, BIOPHYS J, V69, P1657, DOI 10.1016/S0006-3495(95)80045-7; French RJ, 1996, NEURON, V16, P407, DOI 10.1016/S0896-6273(00)80058-6; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hill JM, 1996, BIOCHEMISTRY-US, V35, P8824, DOI 10.1021/bi960073o; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hui Chen, 1996, Life Sciences, V58, P359; Hui KY, 2002, J GEN PHYSIOL, V119, P45, DOI 10.1085/jgp.119.1.45; Jones RM, 2000, CURR PHARM DESIGN, V6, P1249, DOI 10.2174/1381612003399653; JONES SW, 1987, J PHYSIOL-LONDON, V389, P605, DOI 10.1113/jphysiol.1987.sp016674; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; KEIM P, 1973, J BIOL CHEM, V248, P7811; Koradi R, 1996, J MOL GRAPHICS, V14, P29; LANCELIN JM, 1991, BIOCHEMISTRY-US, V30, P6908, DOI 10.1021/bi00242a014; Lanigan MD, 2002, BIOCHEMISTRY-US, V41, P11963, DOI 10.1021/bi026400b; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li RA, 2003, J BIOL CHEM, V278, P8717, DOI 10.1074/jbc.M210882200; Li RA, 2002, FEBS LETT, V511, P159, DOI 10.1016/S0014-5793(01)03316-6; LUDVIGSEN S, 1992, J BIOMOL NMR, V2, P227, DOI 10.1007/BF01875318; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Miles LA, 2002, J BIOL CHEM, V277, P43033, DOI 10.1074/jbc.M206690200; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; MOCZYDLOWSKI E, 1986, P NATL ACAD SCI USA, V83, P5321, DOI 10.1073/pnas.83.14.5321; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nielsen KJ, 2002, J BIOL CHEM, V277, P27247, DOI 10.1074/jbc.M201611200; OHIZUMI Y, 1986, J BIOL CHEM, V261, P6149; OLIVERA BM, 1995, TRENDS BIOTECHNOL, V13, P422, DOI 10.1016/S0167-7799(00)88996-9; OTT KH, 1991, FEBS LETT, V278, P160, DOI 10.1016/0014-5793(91)80107-E; Pennington MW, 1996, BIOCHEM BIOPH RES CO, V219, P696, DOI 10.1006/bbrc.1996.0297; PERUTZ MF, 1985, J MOL BIOL, V183, P491, DOI 10.1016/0022-2836(85)90016-6; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Safo P, 2000, J NEUROSCI, V20, P76, DOI 10.1523/JNEUROSCI.20-01-00076.2000; SATO K, 1991, J BIOL CHEM, V266, P16989; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; SELYANKO AA, 1990, J PHYSIOL-LONDON, V425, P471, DOI 10.1113/jphysiol.1990.sp018114; SHIRE SJ, 1974, BIOCHEMISTRY-US, V13, P2967, DOI 10.1021/bi00711a028; Shon KJ, 1998, J NEUROSCI, V18, P4473; SMITH PA, 1994, PROG NEUROBIOL, V43, P439, DOI 10.1016/0301-0082(94)90062-0; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; TANOKURA M, 1976, BIOPOLYMERS, V15, P393, DOI 10.1002/bip.1976.360150215; Tavazoie SF, 1997, BRIT J PHARMACOL, V120, P995, DOI 10.1038/sj.bjp.0700993; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P12577, DOI 10.1021/bi00165a006; West PJ, 2002, BIOCHEMISTRY-US, V41, P15388, DOI 10.1021/bi0265628	55	50	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46805	46813		10.1074/jbc.M309222200	http://dx.doi.org/10.1074/jbc.M309222200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12970353	hybrid			2022-12-27	WOS:000186569400072
J	Robbe, C; Capon, C; Maes, E; Rousset, M; Zweibaum, A; Zanetta, JP; Michalski, JC				Robbe, C; Capon, C; Maes, E; Rousset, M; Zweibaum, A; Zanetta, JP; Michalski, JC			Evidence of regio-specific glycosylation in human intestinal mucins - Presence of an acidic gradient along the intestinal tract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP-A; BRONCHIAL-MUCUS GLYCOPROTEINS; HOST-MICROBIAL INTERACTIONS; WEIGHT SALIVARY MUCIN; HUMAN COLONIC MUCIN; OLIGOSACCHARIDE-ALDITOLS; H-1-NMR SPECTROSCOPY; MAMMALIAN INTESTINE; ANTIGEN EXPRESSION; CYSTIC-FIBROSIS	Mucin glycans were isolated from different regions of the normal human intestine (ileum, cecum, transverse and sigmoid colon, and rectum) of two individuals with ALe(b) blood group. A systematic study of the monosaccharides and oligosaccharide alditols released by reductive beta-elimination from mucins was performed using gas chromatography, matrix-assisted laser desorption ionization time-of-flight mass spectrometry, and nuclear magnetic resonance spectroscopy techniques. Important variations were observed in the mucin-associated oligosaccharide content with an increasing gradient of sialic acid from the ileum to the colon associated with a reverse gradient of fucose. Moreover, a comparative study of the Sda/Cad and ABH blood group determinants along the gastrointestinal tract showed the same reverse distribution in the two kinds of antigens. In addition, besides their heterogeneity, sialic acids presented considerable variations in the degree of O-acetylation in relation to glycan sialylation level. These data are discussed in view of recent concepts suggesting that the oligosaccharide composition of the gut constitutes a varied ecosystem for microorganisms that are susceptible to adapt there and possess the specific adhesion system and specific enzymes able to provide a carbohydrate nutrient.	Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct, Unite Mixte Rech CNRS USTL 8576, IFR 118, F-59655 Villeneuve Dascq, France; Fac Sci Pharmaceut & Biol Lille 2, Biochim Lab, F-59006 Lille, France; Inst Biomed Cordeliers, UMR INSERM UPMC U505, F-75006 Paris, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Michalski, JC (corresponding author), Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct, Unite Mixte Rech CNRS USTL 8576, IFR 118, F-59655 Villeneuve Dascq, France.			Robbe Masselot, Catherine/0000-0001-6266-6033				AUDIE JP, 1993, J HISTOCHEM CYTOCHEM, V41, P1479, DOI 10.1177/41.10.8245407; Bansil R, 1996, MACROMOL SYMP, V109, P105, DOI 10.1002/masy.19961090110; BREG J, 1987, EUR J BIOCHEM, V168, P57, DOI 10.1111/j.1432-1033.1987.tb13387.x; Bresalier RS, 1996, GASTROENTEROLOGY, V110, P1354, DOI 10.1053/gast.1996.v110.pm8613039; Bulai T, 2003, FEBS LETT, V534, P185, DOI 10.1016/S0014-5793(02)03838-3; Capon C, 2001, BIOCHEM J, V358, P657, DOI 10.1042/bj3580657; Capon C, 1997, J BIOL CHEM, V272, P31957, DOI 10.1074/jbc.272.51.31957; CAPON C, 1989, EUR J BIOCHEM, V182, P39; CARLSON DM, 1968, J BIOL CHEM, V243, P616; CHANG SK, 1994, GASTROENTEROLOGY, V107, P28, DOI 10.1016/0016-5085(94)90057-4; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; Corfield AP, 1999, GLYCOCONJUGATE J, V16, P307, DOI 10.1023/A:1007026314792; DEBOLOS C, 1995, GASTROENTEROLOGY, V109, P723, DOI 10.1016/0016-5085(95)90379-8; Dohi T, 1996, INT J CANCER, V67, P626, DOI 10.1002/(SICI)1097-0215(19960904)67:5<626::AID-IJC6>3.0.CO;2-W; DUA VK, 1986, J BIOL CHEM, V261, P1599; Falk PG, 1998, MICROBIOL MOL BIOL R, V62, P1157, DOI 10.1128/MMBR.62.4.1157-1170.1998; FEENEY J, 1986, CARBOHYD RES, V152, P63, DOI 10.1016/S0008-6215(00)90287-8; Forstner G., 1994, PHYSL GASTROINTESTIN, P1245; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; Gordon JI, 1997, AM J PHYSIOL, V273, P565; Groenink J, 1996, ANTON LEEUW INT J G, V70, P79, DOI 10.1007/BF00393572; HOLGERSSON J, 1990, J BIOL CHEM, V265, P20790; Hooper LV, 1998, BIOESSAYS, V20, P336, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;336::AID-BIES10&gt;3.0.CO;2-3; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, GLYCOBIOLOGY, V11, p1R, DOI 10.1093/glycob/11.2.1R; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; KAMERLING JP, 1975, BIOCHEM J, V151, P491, DOI 10.1042/bj1510491; KAMERLING JP, 1992, BIOL MAGN RESON, V10, P1; KARLSSON KA, 1995, CURR OPIN STRUC BIOL, V5, P622, DOI 10.1016/0959-440X(95)80054-9; Karlsson NG, 1997, J BIOL CHEM, V272, P27025, DOI 10.1074/jbc.272.43.27025; Kim Young S., 1998, Keio Journal of Medicine, V47, P10; LAMBLIN G, 1984, EUR J BIOCHEM, V143, P227, DOI 10.1111/j.1432-1033.1984.tb08363.x; LAMBLIN G, 1991, AM REV RESPIR DIS, V144, P519; LESUFFLEUR T, 1995, J BIOL CHEM, V270, P13655; LEVINE MJ, 1978, INFECT IMMUN, V19, P107, DOI 10.1128/IAI.19.1.107-115.1978; Maes E, 1997, GLYCOCONJUGATE J, V14, P127, DOI 10.1023/A:1018577302255; MALAGOLINI N, 1989, CANCER RES, V49, P6466; MALAGOLINI N, 1991, BIOCHEM BIOPH RES CO, V180, P681, DOI 10.1016/S0006-291X(05)81119-2; Montreuil J, 1986, CARBOHYDRATE ANAL PR, P143; MORTON JA, 1988, IMMUNOL INVEST, V17, P217, DOI 10.3109/08820138809052961; NASIRUDDIN, 1986, J BIOL CHEM, V261, P1992; PILLER F, 1986, CARBOHYD RES, V149, P171, DOI 10.1016/S0008-6215(00)90376-8; PODOLSKY DK, 1985, J BIOL CHEM, V260, P5510; PODOLSKY DK, 1985, J BIOL CHEM, V260, P8262; PORCHET N, 1991, BIOCHEM BIOPH RES CO, V175, P414, DOI 10.1016/0006-291X(91)91580-6; Prakobphol A, 1998, BIOCHEMISTRY-US, V37, P4916, DOI 10.1021/bi972612a; Prakobphol A, 1999, BIOCHEMISTRY-US, V38, P6817, DOI 10.1021/bi990145m; Reddy MS, 1996, INFECT IMMUN, V64, P1477, DOI 10.1128/IAI.64.4.1477-1479.1996; Rosen SD, 1999, AM J PATHOL, V155, P1013, DOI 10.1016/S0002-9440(10)65201-7; SCHAUER R, 1997, GLYCOPROTEINS 2 B, V29, P243; SLOMIANY BL, 1980, J BIOL CHEM, V255, P9719; STRECKER G, 1992, BIOCHIMIE, V74, P39, DOI 10.1016/0300-9084(92)90182-E; STRECKER G, 1989, GLYCOCONJUGATE J, V6, P271, DOI 10.1007/BF01047847; VANDERREIJDEN WA, 1993, BIORHEOLOGY, V30, P141; VANHALBEEK H, 1982, EUR J BIOCHEM, V127, P7; VANHALBEEK H, 1988, EUR J BIOCHEM, V177, P443; VANKLINKEN BJ, 1995, AM J PHYSIOL, V269, P613; WIERUSZESKI JM, 1990, GLYCOCONJUGATE J, V7, P13, DOI 10.1007/BF01050400; WU AM, 1994, MOL CELL BIOCHEM, V137, P39, DOI 10.1007/BF00926038; Zanetta JP, 2001, GLYCOBIOLOGY, V11, P663, DOI 10.1093/glycob/11.8.663; ZWEIBAUM A, 1975, TISSUE ANTIGENS, V6, P121	63	144	147	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46337	46348		10.1074/jbc.M302529200	http://dx.doi.org/10.1074/jbc.M302529200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12952970	hybrid			2022-12-27	WOS:000186569400017
J	Zhang, Q; Chieu, HK; Low, CP; Zhang, SC; Heng, CK; Yang, HY				Zhang, Q; Chieu, HK; Low, CP; Zhang, SC; Heng, CK; Yang, HY			Schizosaccharomyces pombe cells deficient in triacylglycerols synthesis undergo apoptosis upon entry into the stationary phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; DIACYLGLYCEROL ACYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; ACYL-COENZYME; PATHWAY; DEATH; IDENTIFICATION; CLONING; ESTERIFICATION	Triacylglycerols ( TAG) are important energy storage molecules for nearly all eukaryotic organisms. In this study, we found that two gene products ( Plh1p and Dga1p) are responsible for the terminal step of TAG synthesis in the fission yeast Schizosaccharomyces pombe through two different mechanisms: Plh1p is a phospholipid diacylglycerol acyltransferase, whereas Dga1p is an acyl- CoA: diacylglycerol acyltransferase. Cells with both dga1(+) and plh1(+) deleted ( DKO cells) lost viability upon entry into the stationary phase and demonstrated prominent apoptotic markers. Exponentially growing DKO cells also underwent dramatic apoptosis when briefly treated with diacylglycerols ( DAGs) or free fatty acids. We provide strong evidence suggesting that DAG, not sphingolipids, mediates fatty acids- induced lipoapoptosis in yeast. Lastly, we show that generation of reactive oxygen species is essential to lipoapoptosis.	Natl Univ Singapore, Fac Med, Dept Biochem, Singapore 119260, Singapore; Natl Univ Singapore, Fac Med, Dept Pediat, Singapore 119260, Singapore	National University of Singapore; National University of Singapore	Yang, HY (corresponding author), Natl Univ Singapore, Fac Med, Dept Biochem, Singapore 119260, Singapore.	bchyangr@nus.edu.sg	Heng, Chew-Kiat/A-5530-2009; Yang, Hongyuan/AAR-1326-2020	Heng, Chew-Kiat/0000-0002-7309-9473; Yang, Hongyuan/0000-0002-8482-6031				Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Buszczak M, 2002, GENETICS, V160, P1511; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Cheng JJ, 2003, MOL CELL BIOL, V23, P163, DOI 10.1128/MCB.23.1.163-177.2003; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Farese RV, 2000, CURR OPIN LIPIDOL, V11, P229, DOI 10.1097/00041433-200006000-00002; FISHBEIN JD, 1993, J BIOL CHEM, V268, P9255; Forsburg SL, 1999, TRENDS GENET, V15, P340, DOI 10.1016/S0168-9525(99)01798-9; Gangar A, 2002, BIOCHEM J, V365, P577, DOI 10.1042/bj20011654; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; Ink B, 1997, MOL CELL BIOL, V17, P2468, DOI 10.1128/MCB.17.5.2468; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; James C, 1997, CURR BIOL, V7, P246, DOI 10.1016/S0960-9822(06)00120-5; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; LEHNER R, 1993, J BIOL CHEM, V268, P8781; Li TW, 2000, BIOCHEM BIOPH RES CO, V272, P270, DOI 10.1006/bbrc.2000.2767; LIGHTNER VA, 1983, J BIOL CHEM, V258, P856; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Madeo F, 2002, CURR GENET, V41, P208, DOI 10.1007/s00294-002-0310-2; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Mazzoni C, 2003, MOL BIOL CELL, V14, P721, DOI 10.1091/mbc.E02-05-0258; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Perez P, 2002, J BIOCHEM, V132, P513, DOI 10.1093/oxfordjournals.jbchem.a003250; PRENTICE HL, 1992, NUCLEIC ACIDS RES, V20, P621, DOI 10.1093/nar/20.3.621; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; Song Y, 1999, MOL BIOL CELL, V10, P1609, DOI 10.1091/mbc.10.5.1609; Toone WM, 1998, GENES CELLS, V3, P485, DOI 10.1046/j.1365-2443.1998.00211.x; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WernerWashburne M, 1996, MOL MICROBIOL, V19, P1159, DOI 10.1111/j.1365-2958.1996.tb02461.x; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	52	105	109	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47145	47155		10.1074/jbc.M306998200	http://dx.doi.org/10.1074/jbc.M306998200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12963726	hybrid			2022-12-27	WOS:000186569400113
J	Zhang, ZY; Charsky, C; Kane, PM; Wilkens, S				Zhang, ZY; Charsky, C; Kane, PM; Wilkens, S			Yeast V1-ATPase - Affinity purification and structural features by electron microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; V-TYPE ATPASE; CROSS-LINKING; 3-DIMENSIONAL STRUCTURE; PERIPHERAL STALK; DELTA-SUBUNIT; PROTON PUMP; RESOLUTION; F-1-ATPASE; INTERACTS	V-1-ATPase from the yeast Saccharomyces cerevisiae was purified via a FLAG affinity tag introduced into the N terminus of the G subunit. The preparation migrated as a single band in native gel electrophoresis and contained subunits ABCDEFGH ( with subunit C present at substoichiometric amounts) as determined by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. The initial specific Ca-ATPase activity was similar to6 mumol/min/mg. The structure of the yeast V-1-ATPase was studied by electron microscopy of negatively stained and frozen hydrated samples. A 25-Angstrom resolution three-dimensional model of the complex was calculated from two-dimensional projections by the angular reconstitution technique. The model shows six elongated densities arranged in pseudo-3-fold symmetry around a large central cavity. At the top of the molecule, various protrusions can be seen. At the bottom of the complex, two large masses are visible that are connected to the main body of the molecule. Comparison of the yeast V-1 structure with the structure of the intact V1V0-ATPase from bovine brain clathrin-coated vesicles (Wilkens, S., Vasilyeva, E., and Forgac, M. (1999) J. Biol. Chem. 274, 31804 - 31810) indicates that the structure of the isolated V1 from yeast is very similar to the structure of the V-1 domain in the intact V-ATPase complex.	Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	University of California System; University of California Riverside; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	stephan.wilkens@ucr.edu			NIGMS NIH HHS [GM 58600, R01 GM050322, GM 50322] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322, R01GM058600] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ARAI H, 1988, J BIOL CHEM, V263, P8796; Arata Y, 2002, BIOCHEMISTRY-US, V41, P11301, DOI 10.1021/bi0262449; Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Bianchet MA, 1998, P NATL ACAD SCI USA, V95, P11065, DOI 10.1073/pnas.95.19.11065; Boekema EJ, 1997, P NATL ACAD SCI USA, V94, P14291, DOI 10.1073/pnas.94.26.14291; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Charsky CMH, 2000, J BIOL CHEM, V275, P37232, DOI 10.1074/jbc.M006640200; Cross RL, 2000, BBA-BIOENERGETICS, V1458, P270, DOI 10.1016/S0005-2728(00)00079-7; Domgall I, 2002, J BIOL CHEM, V277, P13115, DOI 10.1074/jbc.M112011200; DSCHIDA WJ, 1992, J BIOL CHEM, V267, P18783; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Finbow ME, 1997, BIOCHEM J, V324, P697, DOI 10.1042/bj3240697; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; Gruber G, 2000, BIOCHEMISTRY-US, V39, P8609, DOI 10.1021/bi000103u; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; KANE PM, 1995, J BIOL CHEM, V270, P17025; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Lu M, 2002, J BIOL CHEM, V277, P38409, DOI 10.1074/jbc.M203521200; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Ogilvie I, 1997, J BIOL CHEM, V272, P16652, DOI 10.1074/jbc.272.26.16652; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Radermacher M, 2001, J STRUCT BIOL, V135, P26, DOI 10.1006/jsbi.2001.4395; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; SCHATZ M, 1995, J STRUCT BIOL, V114, P28, DOI 10.1006/jsbi.1995.1003; SIKORSKI RS, 1989, GENETICS, V122, P19; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; SUPEKOVA L, 1995, J BIOL CHEM, V270, P13726; Tomashek JJ, 1997, J BIOL CHEM, V272, P26787, DOI 10.1074/jbc.272.42.26787; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Weber J, 2003, J BIOL CHEM, V278, P13623, DOI 10.1074/jbc.C300061200; Wieczorek H, 2000, J EXP BIOL, V203, P127; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 2001, CELL BIOCHEM BIOPHYS, V34, P191, DOI 10.1385/CBB:34:2:191; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Xie XS, 1996, J BIOL CHEM, V271, P30980; Xu T, 1999, J BIOL CHEM, V274, P28909, DOI 10.1074/jbc.274.41.28909; Xu T, 2000, J BIOL CHEM, V275, P22075, DOI 10.1074/jbc.M002983200; ZHANG X, 2000, J BIOL CHEM, V275, P35592	47	53	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47299	47306		10.1074/jbc.M309445200	http://dx.doi.org/10.1074/jbc.M309445200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12960158	hybrid			2022-12-27	WOS:000186569400132
J	Chandrasekharan, MB; Li, GG; Bishop, KJ; Hall, TC				Chandrasekharan, MB; Li, GG; Bishop, KJ; Hall, TC			S phase progression is required for transcriptional activation of the beta-phaseolin promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSCISIC-ACID; CHROMATIN-STRUCTURE; DNA-REPLICATION; GENE-EXPRESSION; KINASE INHIBITOR; TOBACCO; ARREST; ABI3; EMBRYOGENESIS; INDUCTION	Elucidating the mechanisms by which the transcription machinery accesses promoters in their chromatin environment is a fundamental aspect of understanding gene regulation. The phas promoter is normally constrained by a rotationally and translationally positioned nucleosome over its TATA region except during embryogenesis when it is potentiated by the presence of Phaseolus vulgaris ABI3-like factor (PvALF), a plant-specific transcription factor, and activated by an abscisic acid (ABA)-induced signal transduction cascade. Ectopic expression of PvALF and the supply of ABA in transgenic tobacco or Arabidopsis leaves can activate expression from phas. We confirmed by [H-3] thymidine incorporation that active DNA replication occurred concomitant with the presence of PvALF and ABA. Arrest of DNA synthesis or S phase progression by infiltration of the leaves with replication inhibitors (hydroxyurea, roscovitine, mimosine) strongly inhibited transcriptional activation, especially the ABA-mediated activation step. Similarly, activation of endogenous Arabidopsis MAT and LEA genes in leaf tissue by the presence of ABA and ectopically expressed PvALF was inhibited by DNA replication arrest. No change in transcript levels on the arrest of replication was detected for abi1, abi2, and era1, negative regulators of the ABA signal transduction cascade or for cell cycle components ick1 and aip3. However, a reduction in transcript accumulation for the crucial ABA signaling effector, abi5, occurred upon DNA replication arrest (probably reflected in the decrease in MAT and LEA gene expression). Contrary to the conventional view that ABA inhibits DNA replication, our findings show that ABA acts in concert with S phase progression to activate gene expression.	Texas A&M Univ, Inst Dev & Mol Biol, College Stn, TX 77843 USA; Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Hall, TC (corresponding author), Texas A&M Univ, Inst Dev & Mol Biol, College Stn, TX 77843 USA.	tim@idmb.tamu.edu	Chandrasekharan, Mahesh/AAF-4793-2020	Chandrasekharan, Mahesh/0000-0002-9956-8354				Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Bechtold N, 1998, METH MOL B, V82, P259; BINO RJ, 1993, ANN BOT-LONDON, V72, P181, DOI 10.1006/anbo.1993.1097; BOBB AJ, 1995, PLANT J, V8, P331, DOI 10.1046/j.1365-313X.1995.08030331.x; Busk PK, 1998, PLANT MOL BIOL, V37, P425, DOI 10.1023/A:1006058700720; Bustos MM, 1998, PLANT MOL BIOL, V37, P265, DOI 10.1023/A:1005999725715; Chandrasekharan MB, 2003, PLANT J, V33, P853, DOI 10.1046/j.1365-313X.2003.01678.x; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Combettes Bruno, 1999, Methods in Cell Science, V21, P109, DOI 10.1023/A:1009880705257; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; DAVIES JW, 1969, ANAL BIOCHEM, V27, P77, DOI 10.1016/0003-2697(69)90221-8; Dewitte W, 2003, ANNU REV PLANT BIOL, V54, P235, DOI 10.1146/annurev.arplant.54.031902.134836; FEDOROFF NV, 2002, SCI STKE; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; GAMBLE PE, 1986, EUR J BIOCHEM, V160, P117, DOI 10.1111/j.1432-1033.1986.tb09947.x; Gampala SSL, 2002, J BIOL CHEM, V277, P1689, DOI 10.1074/jbc.M109980200; GILBERT DM, 1995, J BIOL CHEM, V270, P9597, DOI 10.1074/jbc.270.16.9597; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Hall TC, 1999, SEED PROTEINS, P209; JACQMARD A, 1995, J EXP BOT, V46, P663, DOI 10.1093/jxb/46.6.663; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jones HD, 2000, PLANT J, V21, P133, DOI 10.1046/j.1365-313x.2000.00662.x; Kirchmaier AL, 2001, SCIENCE, V291, P646, DOI 10.1126/science.291.5504.646; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Kurup S, 2000, PLANT J, V21, P143, DOI 10.1046/j.1365-313x.2000.00663.x; Li GF, 1998, P NATL ACAD SCI USA, V95, P4772, DOI 10.1073/pnas.95.8.4772; Li GF, 1999, P NATL ACAD SCI USA, V96, P7104, DOI 10.1073/pnas.96.12.7104; Li GF, 2001, PLANT MOL BIOL, V46, P121, DOI 10.1023/A:1010693703421; Li GF, 2001, J BIOL CHEM, V276, P2062, DOI 10.1074/jbc.M007504200; LIU YQ, 1994, PLANTA, V194, P368, DOI 10.1007/BF00197537; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Lu C, 2002, P NATL ACAD SCI USA, V99, P15812, DOI 10.1073/pnas.242607499; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; Nakamura S, 2001, PLANT J, V26, P627, DOI 10.1046/j.1365-313x.2001.01069.x; PARCY F, 1994, PLANT CELL, V6, P1567, DOI 10.1105/tpc.6.11.1567; Planchais S, 1997, PLANT J, V12, P191, DOI 10.1046/j.1365-313X.1997.12010191.x; Planchais S, 2000, FEBS LETT, V476, P78, DOI 10.1016/S0014-5793(00)01675-6; Raz V, 2001, DEVELOPMENT, V128, P243; Rock CD, 2000, NEW PHYTOL, V148, P357, DOI 10.1046/j.1469-8137.2000.00769.x; Siddiqui NU, 1998, PLANT PHYSIOL, V118, P1181, DOI 10.1104/pp.118.4.1181; Sussex I. M., 1979, The plant seed: development, preservation, and germination [Rubinstein, I.; Phillips, R.L.; Green, C.E.; Gengenbach, B.G. (Editors)]., P129; Suzuki M, 2001, PLANT J, V28, P409, DOI 10.1046/j.1365-313X.2001.01165.x; Suzuki M, 1997, PLANT CELL, V9, P799, DOI 10.1105/tpc.9.5.799; Swiatek A, 2002, PLANT PHYSIOL, V128, P201, DOI 10.1104/pp.010592; VANDERGEEST AHM, 1995, PLANT PHYSIOL, V109, P1151, DOI 10.1104/pp.109.4.1151; VANDERGEEST AHM, 1994, PLANT J, V6, P413, DOI 10.1046/j.1365-313X.1994.06030413.x; Varga-Weisz P, 2001, ONCOGENE, V20, P3076, DOI 10.1038/sj.onc.1204332; Venturi CB, 2000, MOL CELL BIOL, V20, P6435, DOI 10.1128/MCB.20.17.6435-6448.2000; Wang H, 1998, PLANT J, V15, P501, DOI 10.1046/j.1365-313X.1998.00231.x; WOLFFE AP, 1994, J CELL SCI, V107, P2055; YOUNG CW, 1967, CANCER RES, V27, P535; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	53	13	13	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45397	45405		10.1074/jbc.M307787200	http://dx.doi.org/10.1074/jbc.M307787200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12960166	hybrid			2022-12-27	WOS:000186452300044
J	Lehtimaki, KK; Valonen, PK; Griffin, JL; Vaisanen, TH; Grohn, OHJ; Kettunen, MI; Vepsalainen, J; Yla-Herttuala, S; Nicholson, J; Kauppinen, RA				Lehtimaki, KK; Valonen, PK; Griffin, JL; Vaisanen, TH; Grohn, OHJ; Kettunen, MI; Vepsalainen, J; Yla-Herttuala, S; Nicholson, J; Kauppinen, RA			Metabolite changes in BT4C rat gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death as studied by H-1 NMR spectroscopy in vivo, ex vivo, and in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVERSE CORRELATION; H-1 MRS; BRAIN; APOPTOSIS; CHOLINE; ACCUMULATION; INHIBITION; RELAXATION; INDUCTION; PULSES	Programmed cell death was induced by HSV-tk gene therapy in rat BT4C glioma cells, and metabolite changes associated with cell damage were monitored in vivo by H-1 NMR spectroscopy and ex vivo by high resolution magic angle spinning (HRMAS) H-1 NMR, and in vitro in perchloric acid extracts of tumors. Metabolite concentrations, as quantified in vivo using water as an internal reference and in vitro in extracts, were correlated with cell density. The results showed that both in vivo and in vitro glycine and creatine concentrations followed volume-averaged cell density, whereas that of total choline-containing compounds was unaffected by a cell loss approaching 60%. Meanwhile, both saturated and unsaturated 1H NMR visible lipids increased. HRMAS H-1 NMR spectroscopy of the tumor samples at 14.1 tesla demonstrated the presence of nucleotide peaks from adenosine and uridine nucleotides in glioma samples ex vivo. The assignment of a doublet at 7.95 ppm to UDP was confirmed by spiking experiments of tumor extracts in conjunction with H-1 and P-31 NMR spectroscopy. HRMAS also resolved the choline-containing peak at 3.2 ppm in vivo into resonances from choline (3.20 ppm), phosphocholine (3.22 ppm), glycerophosphocholine (3.24 ppm), and taurine (3.26 ppm). These resonances were uncorrelated with temporal progression through programmed cell death. Our results show that H-1 NMR-detected lipids and some of the small molecular weight metabolites respond to gene therapy. However, the choline-containing compounds are unaffected by severe decline in cell density. The latter observation supports the idea that triacylglycerols, rather than membrane phospholipids, are the key components of H-1 NMR visible lipids, and it also casts doubt on the validity of resonance of choline-containing compounds as a diagnostic marker of programmed cell death in vivo.	Univ Kuopio, Dept Biomed NMR, FIN-70211 Kuopio, Finland; Univ Kuopio, Natl BioNMR Facil, FIN-70211 Kuopio, Finland; Univ Kuopio, Dept Chem, FIN-70211 Kuopio, Finland; Univ Kuopio, AI Virtanen Inst mol SCi, Dept Biotechnol & Mol Med, FIN-70211 Kuopio, Finland; Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Biol Chem, London, England	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Imperial College London	Kauppinen, RA (corresponding author), Univ Manchester, Sch Biol Sci, 1-33 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	risto.kauppinen@man.ac.uk	Nicholson, Jeremy K/B-3395-2012; Kettunen, Mikko I/K-2299-2012; Lehtimäki, Kimmo K/A-6018-2009; Kauppinen, Risto A/F-3274-2011	Nicholson, Jeremy K/0000-0002-8123-8349; Kettunen, Mikko I/0000-0002-2004-660X; Lehtimäki, Kimmo K/0000-0003-2750-8229; Yla-Herttuala, Seppo/0000-0001-7593-2708				ALSAFFAR MMS, 2001, BRIT J CANCER, V86, P963; Anthony ML, 1999, J BIOL CHEM, V274, P19686, DOI 10.1074/jbc.274.28.19686; Beckwith-Hall BM, 1998, CHEM RES TOXICOL, V11, P260, DOI 10.1021/tx9700679; Bhakoo KK, 1997, CELL MOL BIOL, V43, P621; Blankenberg FG, 1996, BLOOD, V87, P1951; CUMMINS CJ, 1983, J NEUROCHEM, V40, P128, DOI 10.1111/j.1471-4159.1983.tb12662.x; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; GARWOOD M, 1991, J MAGN RESON, V94, P511, DOI 10.1016/0022-2364(91)90137-I; Grand S, 1999, RADIOLOGY, V213, P785, DOI 10.1148/radiology.213.3.r99dc10785; Griffin JL, 2003, CANCER RES, V63, P3195; Griffin JL, 2003, BBA-GEN SUBJECTS, V1619, P151, DOI 10.1016/S0304-4165(02)00475-0; Griffin JL, 2001, FEBS LETT, V509, P263, DOI 10.1016/S0014-5793(01)03175-1; Griffin JL, 2001, CHEM RES TOXICOL, V14, P1428, DOI 10.1021/tx015521u; Grohn OHJ, 1999, MAGNET RESON MED, V42, P268, DOI 10.1002/(SICI)1522-2594(199908)42:2<268::AID-MRM8>3.0.CO;2-A; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Gupta RK, 1999, MAGNET RESON MED, V41, P2, DOI 10.1002/(SICI)1522-2594(199901)41:1<2::AID-MRM2>3.0.CO;2-Y; Hakumaki JM, 1999, NAT MED, V5, P1323, DOI 10.1038/15279; Hakumaki JM, 1998, CANCER RES, V58, P3791; Hakumaki JM, 2002, CANCER GENE THER, V9, P338, DOI 10.1038/sj.cgt.7700450; Hakumaki JM, 2000, TRENDS BIOCHEM SCI, V25, P357, DOI 10.1016/S0968-0004(00)01614-5; KAUPPINEN RA, 1991, J NEUROCHEM, V57, P1136, DOI 10.1111/j.1471-4159.1991.tb08271.x; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kizu O, 1998, MAGN RESON IMAGING, V16, P197, DOI 10.1016/S0730-725X(97)00255-5; KUESEL AC, 1994, NMR BIOMED, V7, P149, DOI 10.1002/nbm.1940070308; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Miquel K, 1998, J BIOL CHEM, V273, P26179, DOI 10.1074/jbc.273.40.26179; MORI S, 1995, MAGNET RESON MED, V33, P41, DOI 10.1002/mrm.1910330107; Nelson SJ, 1999, NMR BIOMED, V12, P123, DOI 10.1002/(SICI)1099-1492(199905)12:3<123::AID-NBM541>3.0.CO;2-Y; Paxinos G., 1996, RAT BRAIN STEREOTAXI; PONTEN U, 1973, J NEUROCHEM, V21, P1127, DOI 10.1111/j.1471-4159.1973.tb07567.x; Poptani H, 1998, CANCER GENE THER, V5, P101; Ronen SM, 1999, BRIT J CANCER, V80, P1035, DOI 10.1038/sj.bjc.6690459; Sandmair AM, 2000, CANCER GENE THER, V7, P413, DOI 10.1038/sj.cgt.7700132; Sijens PE, 1995, INVEST RADIOL, V30, P738, DOI 10.1097/00004424-199512000-00008; SIMINOVITCH DJ, 1988, BIOPHYS J, V54, P373, DOI 10.1016/S0006-3495(88)82970-9; Sze D Y, 1994, Immunomethods, V4, P113, DOI 10.1006/immu.1994.1013; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tugnoli V, 2001, BIOPOLYMERS, V62, P297, DOI 10.1002/bip.10005; Williams SNO, 1998, MAGNET RESON MED, V40, P411, DOI 10.1002/mrm.1910400311	40	70	76	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45915	45923		10.1074/jbc.M306209200	http://dx.doi.org/10.1074/jbc.M306209200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12954643	hybrid			2022-12-27	WOS:000186452300104
J	Zhong, ZP; Helinski, D; Toukdarian, A				Zhong, ZP; Helinski, D; Toukdarian, A			A specific region in the N terminus of a replication initiation protein of plasmid RK2 is required for recruitment of Pseudomonas aeruginosa DnaB helicase to the plasmid origin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; DISTANTLY RELATED BACTERIA; NUCLEOPROTEIN STRUCTURES; TRFA; PRIMASE; FORK; COMPLEX; GENES	Broad host range plasmid RK2 encodes two versions of its essential replication initiation protein, TrfA, using in-frame translational starts spaced 97 amino acids apart. The smaller protein, TrfA-33, is sufficient for plasmid replication in many bacterial hosts. Efficient replication in Pseudomonas aeruginosa, however, specifically requires the larger TrfA-44 protein. With the aim of identifying sequences of TrfA-44 required for stable replication of RK2 in P. aeruginosa, specific deletions and a substitution mutant within the N terminus sequence unique to TrfA-44 were constructed, and the mutant proteins were tested for activity. Deletion mutants were targeted to three of the four predicted helical regions in the first 97 amino acids of TrfA-44. Deletion of TrfA-44 amino acids 21-32 yielded a mutant protein, TrfA-44Delta2, that had lost the ability to bind and load the DnaB helicase of P. aeruginosa or Pseudomonas putida onto the RK2 origin in vitro and did not support stable replication of an RK2 mini-replicon in P. aeruginosa in vivo. A substitution of amino acid 22 within this essential region resulted in a protein, TrfA-44E22A, with reduced activity in vitro, particularly with the P. putida helicase. Deletion of amino acids 37-55 (TrfA-44Delta3) slightly affected protein activity in vitro with the P. aeruginosa helicase and significantly with the P. putida helicase, whereas deletion of amino acids 71-88 (TrfA-44Delta4) had no effect on TrfA activity in vitro with either helicase. These results identify regions of the TrfA-44 protein that are required for recruitment of the Pseudomonas DnaB helicases in the initiation of RK2 replication.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Toukdarian, A (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.				NIAID NIH HHS [AI-07194] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALFANO C, 1989, J BIOL CHEM, V264, P10709; ALFANO C, 1989, J BIOL CHEM, V264, P10699; BAKER TA, 1986, CELL, V45, P53, DOI 10.1016/0092-8674(86)90537-4; Blasina A, 1996, P NATL ACAD SCI USA, V93, P3559, DOI 10.1073/pnas.93.8.3559; Caspi R, 2000, J BIOL CHEM, V275, P18454, DOI 10.1074/jbc.M000552200; Caspi R, 2001, EMBO J, V20, P3262, DOI 10.1093/emboj/20.12.3262; Datta HJ, 1999, P NATL ACAD SCI USA, V96, P73, DOI 10.1073/pnas.96.1.73; Dennis J J, 1995, Methods Mol Biol, V47, P125; Doran KS, 1998, J BIOL CHEM, V273, P8447, DOI 10.1074/jbc.273.14.8447; Doran KS, 1999, MOL MICROBIOL, V33, P490, DOI 10.1046/j.1365-2958.1999.01491.x; DURLAND RH, 1987, PLASMID, V18, P164, DOI 10.1016/0147-619X(87)90044-8; FANG FC, 1991, J BACTERIOL, V173, P5861, DOI 10.1128/jb.173.18.5861-5868.1991; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; Hiasa H, 1999, J BIOL CHEM, V274, P27244, DOI 10.1074/jbc.274.38.27244; Jiang Y, 2003, P NATL ACAD SCI USA, V100, P8692, DOI 10.1073/pnas.1532393100; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; KOBORI JA, 1982, J BIOL CHEM, V257, P13770; Konieczny I, 1997, J BIOL CHEM, V272, P20173, DOI 10.1074/jbc.272.32.20173; Konieczny I, 1997, J BIOL CHEM, V272, P33312, DOI 10.1074/jbc.272.52.33312; Lu YB, 1998, EMBO J, V17, P5192, DOI 10.1093/emboj/17.17.5192; Lu YB, 1996, P NATL ACAD SCI USA, V93, P12902, DOI 10.1073/pnas.93.23.12902; Marszalek J, 1996, J BIOL CHEM, V271, P18535, DOI 10.1074/jbc.271.31.18535; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; Messer W, 1999, BIOCHIMIE, V81, P819, DOI 10.1016/S0300-9084(00)87165-5; Odegrip R, 2000, J VIROL, V74, P4057, DOI 10.1128/JVI.74.9.4057-4063.2000; Ratnakar PVAL, 1996, P NATL ACAD SCI USA, V93, P5522, DOI 10.1073/pnas.93.11.5522; ROBERTS RC, 1990, J BACTERIOL, V172, P6204, DOI 10.1128/jb.172.11.6204-6216.1990; Rost B, 1996, METHOD ENZYMOL, V266, P525; SCHMIDHAUSER TJ, 1983, PLASMID, V9, P325, DOI 10.1016/0147-619X(83)90010-0; SHINGLER V, 1989, BIOCHIM BIOPHYS ACTA, V1007, P301, DOI 10.1016/0167-4781(89)90152-8; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; THOMAS CM, 1981, MOL GEN GENET, V181, P1, DOI 10.1007/BF00338996; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorsted PB, 1996, PLASMID, V36, P95, DOI 10.1006/plas.1996.0037; Tougu K, 1996, J BIOL CHEM, V271, P21398, DOI 10.1074/jbc.271.35.21398; Tougu K, 1996, J BIOL CHEM, V271, P21391, DOI 10.1074/jbc.271.35.21391; Toukdarian AE, 1996, J BIOL CHEM, V271, P7072, DOI 10.1074/jbc.271.12.7072; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4	38	18	18	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45305	45310		10.1074/jbc.M306058200	http://dx.doi.org/10.1074/jbc.M306058200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12952979	hybrid			2022-12-27	WOS:000186452300032
J	Zhou, M; Zhang, YH; Ardans, JA; Wahl, LM				Zhou, M; Zhang, YH; Ardans, JA; Wahl, LM			Interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN-H SYNTHASE-2; IFN-GAMMA; INTERSTITIAL COLLAGENASE; HUMAN MACROPHAGES; INDUCED APOPTOSIS; TIMP-1 PRODUCTION; TNF-ALPHA; IN-VITRO; ACTIVATION; SUPPRESSION	Tumor necrosis factor-alpha (TNFalpha) and granulocyte macrophage colony-stimulating factor (GM-CSF) individually enhance monocyte matrix metalloproteinase-9 (MMP-9) but induce MMP-1 only when added in combination. Because interferon-gamma (IFNgamma) is also found at inflammatory sites, we determined its effect on monocyte MMPs in the presence or absence of TNFalpha and GM-CSF. IFNgamma alone did not stimulate monocyte MMP-9 or MMP-1; however, in the presence of GM-CSF it induced MMP-1 and enhanced MMP-1 stimulated by GM-CSF and TNFalpha. IFNgamma induced MMP-1 in the presence of GM-CSF through the stimulation of TNFalpha production through a mechanism involving both p38 and ERK1/2 MAPKs, in which GM-CSF stimulated ERK1/2 whereas IFNgamma activated p38. In support of this conclusion TNFalpha neutralizing antibody and antibodies against TNF receptor I and -II blocked the induction of MMP-1 by GM-CSF and IFNgamma. In contrast to its effects on MMP-1, IFNgamma inhibited TNFalpha-induced MMP-9 through a caspase 8-dependent pathway as demonstrated by the restoration of MMP-9 with caspase 8 inhibitors. Moreover, the phosphorylation of STAT1 by IFNgamma was blocked by an inhibitor of caspase 8, indicating that STAT1 had a suppressive effect on MMP-9. Caspase 8-mediated phosphorylation of STAT1 through p38 MAPK as shown by the inhibition of IFNgamma-induced phosphorylation of p38 by caspase 8 inhibitors. Activation of caspase 8 by IFNgamma did not result in increased apoptosis. Thus IFNgamma in the presence of GM-CSF and/or TNFalpha differentially regulates monocyte MMPs through induction of TNFalpha and a novel mechanism involving caspase 8 that is independent of apoptosis.	NIDCR, Immunopathol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Wahl, LM (corresponding author), NIDCR, Immunopathol Sect, NIH, 30 Convent Dr,Bldg 30,Rm 325, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000456] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; CORCORAN ML, 1992, J BIOL CHEM, V267, P515; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; HAYES MP, 1995, CYTOKINE, V7, P427, DOI 10.1006/cyto.1995.0058; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Huang SY, 2002, ONCOGENE, V21, P2504, DOI 10.1038/sj.onc.1205341; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; LACRAZ S, 1992, J CLIN INVEST, V90, P382, DOI 10.1172/JCI115872; LACRAZ S, 1995, J CLIN INVEST, V96, P2304, DOI 10.1172/JCI118286; Mertz PM, 1996, CELL IMMUNOL, V173, P252, DOI 10.1006/cimm.1996.0275; MERTZ PM, 1994, J BIOL CHEM, V269, P21322; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Quiding-Jarbrink M, 2001, INFECT IMMUN, V69, P5661, DOI 10.1128/IAI.69.9.5661-5670.2001; Randow F, 1997, J IMMUNOL, V158, P2911; Rathbun RK, 2000, BLOOD, V96, P4204; Rokhlin OW, 1998, CANCER RES, V58, P5870; Ruiz-Ruiz C, 2000, CANCER RES, V60, P5673; Sanceau J, 2002, J BIOL CHEM, V277, P35766, DOI 10.1074/jbc.M202959200; Saren P, 1996, J IMMUNOL, V157, P4159; SHAPIRO SD, 1990, J CLIN INVEST, V86, P1204, DOI 10.1172/JCI114826; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; WAHL LM, 1984, CELL IMMUNOL, V85, P373, DOI 10.1016/0008-8749(84)90251-X; WAHL LM, 1990, J IMMUNOL, V144, P3518; WAHL LM, 1991, CURRENT PROTOCOLS IM; WAHL SM, 1987, J IMMUNOL, V139, P1342; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Zhang YH, 1998, J IMMUNOL, V161, P3071	29	55	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45406	45413		10.1074/jbc.M309075200	http://dx.doi.org/10.1074/jbc.M309075200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12960156	hybrid			2022-12-27	WOS:000186452300045
J	Koivisto, P; Duncan, T; Lindahl, T; Sedgwick, B				Koivisto, P; Duncan, T; Lindahl, T; Sedgwick, B			Minimal methylated substrate and extended substrate range of Escherichia coli AlkB protein, a 1-methyladenine-DNA dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE DEMETHYLATION; ALKYLATION DAMAGE; DNA; REPAIR; BASE; MUTAGENESIS; INHIBITION; AGENTS	The Escherichia coli AlkB protein, and two human homologs ABH2 and ABH3, directly demethylate 1-methyladenine and 3-methylcytosine in DNA. They couple Fe(II)-dependent oxidative demethylation of these damaged bases to decarboxylation of alpha-ketoglutarate. Here, we have determined the kinetic parameters for AlkB oxidation of 1-methyladenine in poly(dA), short oligodeoxyribonucleotides, nucleotides, and nucleoside triphosphates. Methylated poly(dA) was the preferred AlkB substrate of those tested. The oligonucleotide trimer d(Tp1meApT) and even 5'-phosphorylated 1-me-dAMP were relatively efficiently demethylated, and competed with methylated poly( dA) for AlkB activity. A polynucleotide structure was clearly not essential for AlkB to repair 1-methyladenine effectively, but a nucleotide 5' phosphate group was required. Consequently, 1-me-dAMP(5') was identified as the minimal effective AlkB substrate. The nucleoside triphosphate, 1-me-dATP, was inefficiently but actively demethylated by AlkB; a reaction with 1-me-ATP was even slower. E. coli DNA polymerase I Klenow fragment could employ 1-me-dATP as a precursor for DNA synthesis in vitro, suggesting that demethylation of alkylated deoxynucleoside triphosphates by AlkB could have biological significance. Although the human enzymes, ABH2 and ABH3, demethylated 1-methyladenine residues in poly(dA), they were inefficient with shorter substrates. Thus, ABH3 had very low activity on the trimer, d(Tp1meApT), whereas no activity was detected with ABH2. AlkB is known to repair methyl and ethyl adducts in DNA; to extend this substrate range, AlkB was shown to reduce the toxic effects of DNA damaging agents that generate hydroxyethyl, propyl, and hydroxypropyl adducts.	Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Lindahl, T (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	Tomas.Lindahl@cancer.org.uk		Koivisto, Pertti/0000-0002-0416-0357				Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Anderson J, 1998, GENE DEV, V12, P3650, DOI 10.1101/gad.12.23.3650; ARAVIND L, 2001, GENOME BIOL, V2, DOI DOI 10.1186/gb-2001-2-3-research0007; BODELL WJ, 1979, BIOCHEMISTRY-US, V18, P2860, DOI 10.1021/bi00580a029; BOITEUX S, 1982, BIOCHIMIE, V64, P637, DOI 10.1016/S0300-9084(82)80103-X; Daniels DS, 2000, MUTAT RES-DNA REPAIR, V460, P151, DOI 10.1016/S0921-8777(00)00024-0; Delaney JC, 2003, P NATL ACAD SCI USA, V100, P4469, DOI 10.1073/pnas.0837277100; Dinglay S, 2000, GENE DEV, V14, P2097; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g; HOCHHAUSER SJ, 1978, J BACTERIOL, V134, P157, DOI 10.1128/JB.134.1.157-166.1978; Hollis T, 2000, MUTAT RES-DNA REPAIR, V460, P201, DOI 10.1016/S0921-8777(00)00027-6; HURTER J, 1974, PHOTOCHEM PHOTOBIOL, V19, P185, DOI 10.1111/j.1751-1097.1974.tb06497.x; KARRAN P, 1985, P NATL ACAD SCI USA, V82, P5285, DOI 10.1073/pnas.82.16.5285; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; KIM ST, 1991, BIOCHEMISTRY-US, V30, P8623, DOI 10.1021/bi00099a019; Kumar R, 1996, CARCINOGENESIS, V17, P485, DOI 10.1093/carcin/17.3.485; LARSON K, 1985, MUTAT RES, V150, P77, DOI 10.1016/0027-5107(85)90103-4; LI FJ, 1992, CHEM-BIOL INTERACT, V83, P35, DOI 10.1016/0009-2797(92)90090-8; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Melnick RL, 2002, ANN NY ACAD SCI, V982, P177; Mishina Y, 2003, J AM CHEM SOC, V125, P8730, DOI 10.1021/ja034636c; PEGG AE, 1988, CHEM-BIOL INTERACT, V65, P275, DOI 10.1016/0009-2797(88)90112-3; PEGG AE, 1995, PROG NUCLEIC ACID RE, V51, P167, DOI 10.1016/S0079-6603(08)60879-X; Sedgwick B, 2002, ONCOGENE, V21, P8886, DOI 10.1038/sj.onc.1205998; SINGER B, 1974, BIOCHEMISTRY-US, V13, P1913, DOI 10.1021/bi00706a021; TOPAL MD, 1982, NATURE, V298, P863, DOI 10.1038/298863a0; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tudek B, 1998, MUTAT RES-DNA REPAIR, V407, P169, DOI 10.1016/S0921-8777(98)00005-6; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; VARSHNEY U, 1991, BIOCHEMISTRY-US, V30, P4055, DOI 10.1021/bi00230a033; Welford RWD, 2003, J BIOL CHEM, V278, P10157, DOI 10.1074/jbc.M211058200; WILSON K, 2000, PRINCIPLES TECHNIQUE, P360	34	73	74	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44348	44354		10.1074/jbc.M307361200	http://dx.doi.org/10.1074/jbc.M307361200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12944387	hybrid			2022-12-27	WOS:000186306700058
J	Basbous, J; Arpin, C; Gaudray, G; Piechaczyk, M; Devaux, C; Mesnard, JM				Basbous, J; Arpin, C; Gaudray, G; Piechaczyk, M; Devaux, C; Mesnard, JM			The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEIN; DNA-BINDING; TAX PROTEIN; PROMOTER TRANSACTIVATION; ACTIVATES TRANSCRIPTION; CONSTITUTIVE EXPRESSION; FOS-JUN; K-BZIP; GENE; AP-1	The human T-cell leukemia virus type I (HTLV-I)-encoded Tax protein activates transcription from the viral promoter via association with the cellular basic leucine zipper factor cAMP-response element-binding protein-2. Tax is also able to induce cellular transformation of T lymphocytes probably by modulating transcriptional activity of cellular factors, including nuclear factor-kappaB, E2F, activator protein-1 (AP-1), and p53. Recently, we characterized in HTLV-I-infected cells the presence of a novel viral protein, HBZ, encoded by the complementary strand of the HTLV-I RNA genome (Gaudray, G., Gachon, F., Basbous, J., Biard-Piechaczyk, M., Devaux, C., and Mesnard, J.-M. (2002) J. Virol. 76, 12813-12822). HBZ is a nuclear basic leucine zipper protein that downregulates Tax-dependent viral transcription by inhibiting the binding of cAMP-response element-binding protein-2 to the HTLV-I promoter. In searching for other cellular targets of HBZ, we identified two members of the Jun family, JunB and c-Jun. Co-immunoprecipitation and cellular colocalization confirmed that HBZ interacts in vivo with JunB and c-Jun. When transiently introduced into CEM cells with a reporter gene containing the AP-1 site from the collagenase promoter, HBZ suppressed transactivation by c-Jun. On the other hand, the combination of HBZ with Jun-B had higher transcriptional activity than JunB alone. Consistent with the structure of its basic domain, we demonstrate that HBZ decreases the DNA-binding activity of c-Jun and JunB. Last, we show that c-Jun is no longer capable of activating the basal expression of the HTLV-I promoter in the presence of HBZ in vivo. Our results support the hypothesis that HBZ could be a negative modulator of the Tax effect by controlling Tax expression at the transcriptional level and by attenuating activation of AP-1 by Tax.	Univ Montpellier I, CNRS, Lab Infect Retrovirales & Signalisat Cellulaire, Inst Biol,UMR 5121,Inst Federat Rech 122, F-34960 Montpellier 2, France; Inst Genet Mol, UMR 5535, F-34293 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Mesnard, JM (corresponding author), Univ Montpellier I, CNRS, Lab Infect Retrovirales & Signalisat Cellulaire, Inst Biol,UMR 5121,Inst Federat Rech 122, 4 Blvd Henri 4,CS 89508, F-34960 Montpellier 2, France.	jean-michel.mesnard@univ-montp1.fr	Basbous, Jihane/AAQ-2040-2021; PIECHACZYK, Marc/E-7896-2013	Basbous, Jihane/0000-0002-3943-627X; PIECHACZYK, Marc/0000-0003-1367-2597; Mesnard, Jean-Michel/0000-0003-3344-5367				ALEXANDRE C, 1991, ONCOGENE, V6, P543; BASBOUS J, 2002, RECENT RES DEV MOL C, V3, P155; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; COHEN DR, 1990, ONCOGENE, V5, P929; Curtiss VE, 1996, MOL CELL BIOL, V16, P3567; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; FUJII M, 1988, P NATL ACAD SCI USA, V85, P8526, DOI 10.1073/pnas.85.22.8526; FUJII M, 1991, ONCOGENE, V6, P1023; Gachon F, 2002, VIROLOGY, V299, P271, DOI 10.1006/viro.2002.1501; Gachon F, 2001, FEBS LETT, V502, P57, DOI 10.1016/S0014-5793(01)02646-1; Gachon F, 1998, J VIROL, V72, P8332, DOI 10.1128/JVI.72.10.8332-8337.1998; Gachon F, 2000, MOL CELL BIOL, V20, P3470, DOI 10.1128/MCB.20.10.3470-3481.2000; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; Georges SA, 2002, MOL CELL BIOL, V22, P127, DOI 10.1128/MCB.22.1.127-137.2002; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HOOPER WC, 1991, BIOCHEM BIOPH RES CO, V181, P976, DOI 10.1016/0006-291X(91)92032-F; Iwai K, 2001, VIROLOGY, V279, P38, DOI 10.1006/viro.2000.0669; Izumiya Y, 2003, J VIROL, V77, P1441, DOI 10.1128/JVI.77.2.1441-1451.2003; JEANG KT, 1991, VIROLOGY, V181, P218, DOI 10.1016/0042-6822(91)90487-V; KERPPOLA TK, 1994, ONCOGENE, V9, P675; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; LAROCCA D, 1989, BIOCHEM BIOPH RES CO, V163, P1006, DOI 10.1016/0006-291X(89)92322-X; Lemasson I, 1998, J BIOL CHEM, V273, P23598, DOI 10.1074/jbc.273.36.23598; Lemasson I, 2002, J BIOL CHEM, V277, P49459, DOI 10.1074/jbc.M209566200; Liao W, 2003, J VIROL, V77, P3809, DOI 10.1128/JVI.77.6.3809-3815.2003; Liu XD, 1999, J GEN VIROL, V80, P3073, DOI 10.1099/0022-1317-80-12-3073; MACGREGOR PF, 1990, ONCOGENE, V5, P451; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Mesnard JM, 1999, VIROLOGY, V257, P277, DOI 10.1006/viro.1999.9685; Mori N, 1998, CANCER RES, V58, P3993; Mori N, 2000, BLOOD, V95, P3915; NAGATA K, 1989, J VIROL, V63, P3220, DOI 10.1128/JVI.63.8.3220-3226.1989; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NAKABEPPU Y, 1989, EMBO J, V8, P3833, DOI 10.1002/j.1460-2075.1989.tb08561.x; RANSONE LJ, 1990, MOL CELL BIOL, V10, P4565, DOI 10.1128/MCB.10.9.4565; RANSONE LJ, 1989, GENE DEV, V3, P770, DOI 10.1101/gad.3.6.770; Reddy TR, 1997, ONCOGENE, V14, P2785, DOI 10.1038/sj.onc.1201119; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; RYSECK RP, 1991, ONCOGENE, V6, P533; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sok J, 1999, MOL CELL BIOL, V19, P495; Suzuki T, 1999, ONCOGENE, V18, P4137, DOI 10.1038/sj.onc.1202766; Thebault S, 2000, EUR J CELL BIOL, V79, P834, DOI 10.1078/0171-9335-00111; Thebault S, 2000, J BIOL CHEM, V275, P4848, DOI 10.1074/jbc.275.7.4848; THEBAULT S, 2001, RRD VIROLOGY I, V3, P151; TSUCHIYA H, 1993, J VIROL, V67, P7001, DOI 10.1128/JVI.67.12.7001-7007.1993; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; UCHIJIMA M, 1994, J BIOL CHEM, V269, P14946; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; WAGNER S, 1993, SCIENCE, V262, P395, DOI 10.1126/science.8211160; Wells SI, 2000, EMBO J, V19, P5762, DOI 10.1093/emboj/19.21.5762; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Yamagata T, 1997, MOL CELL BIOL, V17, P4272, DOI 10.1128/MCB.17.8.4272	61	149	158	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43620	43627		10.1074/jbc.M307275200	http://dx.doi.org/10.1074/jbc.M307275200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12937177	Green Published, hybrid			2022-12-27	WOS:000186157000110
J	Rafiee, P; Shi, Y; Pritchard, KA; Ogawa, H; Eis, ALW; Komorowski, RA; Fitzpatrick, CM; Tweddell, JS; Litwin, SB; Mussatto, K; Jaquiss, RD; Baker, JE				Rafiee, P; Shi, Y; Pritchard, KA; Ogawa, H; Eis, ALW; Komorowski, RA; Fitzpatrick, CM; Tweddell, JS; Litwin, SB; Mussatto, K; Jaquiss, RD; Baker, JE			Cellular redistribution of inducible hsp70 protein in the human and rabbit heart in response to the stress of chronic hypoxia - Role of protein kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK TRANSCRIPTION FACTOR-1; NITRIC-OXIDE SYNTHASE; SIZE IN-VIVO; GENE-EXPRESSION; HEME OXYGENASE-1; ISCHEMIC-INJURY; MESSENGER-RNAS; CELLS; PROTECTION; HEAT-SHOCK-PROTEIN-70	Many infants who undergo cardiac surgery have a congenital cyanotic defect where the heart is chronically perfused with hypoxemic blood. Infant hearts adapt to chronic hypoxemia by activation of intracellular protein kinase signal transduction pathways. However, the involvement of heat shock protein 70 in adaptation to chronic hypoxemia and its role in protein kinase signaling pathways is unknown. We determined expression of message and subcellular protein distribution for inducible (Hsp70i) and constitutive heat shock protein 70 (Hsc70) in chronically hypoxic and normoxic infant human and rabbit hearts and their relationship to protein kinases. In chronically hypoxic human and rabbit hearts message levels for Hsp70i were elevated 4- to 5-fold compared with normoxic hearts, Hsp70i protein was redistributed from the particulate to the cytosolic fraction. In normoxic infants Hsp70i protein was distributed almost equally between the cytosolic and particulate fractions. Hsc70 message and subcellular distribution of Hsc70 protein were unaffected by chronic hypoxia. We then determined if protein kinases influence Hsp70i protein subcellular distribution. In rabbit hearts SB203580 and chelerythrine reduced Hsp70i message levels, whereas SB203580, chelerythrine, and curcumin reversed the subcellular redistribution of Hsp70i protein caused by chronic hypoxia, with no effect in normoxic hearts, indicating regulation of Hsp70i message and subcellular distribution of Hsp70i protein in chronically hypoxic rabbit hearts is influenced by protein kinase C and mitogen-activated protein kinases, specifically p38 MAPK and JNK. We conclude the Hsp70 signal transduction pathway plays an important role in adaptation of infant human and rabbit hearts to chronic hypoxemia.	Med Coll Wisconsin, Div Pediat Surg, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Div Gastroenterol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Div Cardiothorac Surg, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Childrens Hosp Wisconsin, Sect Cardiothorac Surg, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; Medical College of Wisconsin	Baker, JE (corresponding author), Med Coll Wisconsin, Div Pediat Surg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.		Baker, John/V-8897-2019	Baker, John/0000-0001-7899-3266	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054075, P50HL065203] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL65203, HL61414, HL54075] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMRANI M, 1994, ANN THORAC SURG, V57, P157, DOI 10.1016/0003-4975(94)90385-9; ANG D, 1991, J BIOL CHEM, V266, P24233; Baker JE, 1999, CIRCULATION, V99, P1249, DOI 10.1161/01.CIR.99.9.1249; Bellmann K, 2000, J BIOL CHEM, V275, P18172, DOI 10.1074/jbc.M000340200; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; Das DK, 1998, ANN NY ACAD SCI, V851, P129, DOI 10.1111/j.1749-6632.1998.tb08986.x; Di YP, 1997, J CELL PHYSIOL, V172, P44, DOI 10.1002/(SICI)1097-4652(199707)172:1<44::AID-JCP5>3.0.CO;2-D; ERDOS G, 1994, BIOCHEM BIOPH RES CO, V202, P476, DOI 10.1006/bbrc.1994.1953; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Grabellus F, 2002, J PATHOL, V197, P230, DOI 10.1002/path.1106; Hung JJ, 1998, J BIOL CHEM, V273, P31924, DOI 10.1074/jbc.273.48.31924; Hutter JJ, 1996, CIRCULATION, V94, P1408, DOI 10.1161/01.CIR.94.6.1408; JAATTELA M, 1989, EUR J IMMUNOL, V19, P1413, DOI 10.1002/eji.1830190810; Kiemer AK, 2003, ENDOCRINOLOGY, V144, P802, DOI 10.1210/en.2002-220610; Kukreja RC, 1999, MOL CELL BIOCHEM, V195, P123, DOI 10.1023/A:1006977311448; LARRICK JW, 1990, FASEB J, V4, P3215, DOI 10.1096/fasebj.4.14.2172061; LEE YJ, 1994, BIOCHEM BIOPH RES CO, V199, P714, DOI 10.1006/bbrc.1994.1287; Lewis ML, 2000, J CELL BIOCHEM, V77, P127, DOI 10.1002/(SICI)1097-4644(20000401)77:1<127::AID-JCB13>3.3.CO;2-S; Li F, 2000, Acta Anaesthesiol Sin, V38, P207; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; MARGULIS BA, 1991, DIABETES, V40, P1418, DOI 10.2337/diabetes.40.11.1418; Martin JL, 1997, CIRCULATION, V96, P4343; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Mestril R, 1996, J MOL CELL CARDIOL, V28, P2351, DOI 10.1006/jmcc.1996.0228; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Ohnishi K, 1999, MOL CELL BIOCHEM, V197, P129, DOI 10.1023/A:1006937513154; Okubo S, 2001, CIRCULATION, V103, P877, DOI 10.1161/01.CIR.103.6.877; Ping PP, 1997, CIRC RES, V81, P404, DOI 10.1161/01.RES.81.3.404; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Rafiee P, 2002, CIRCULATION, V106, P239, DOI 10.1161/01.CIR.0000022018.68965.6D; Sheikh-Hamad D, 1998, J BIOL CHEM, V273, P1832, DOI 10.1074/jbc.273.3.1832; Shi Y, 2000, FREE RADICAL BIO MED, V29, P695, DOI 10.1016/S0891-5849(00)00364-6; Snoeckx LHEH, 2001, PHYSIOL REV, V81, P1461, DOI 10.1152/physrev.2001.81.4.1461; Trost SU, 1998, J CLIN INVEST, V101, P855, DOI 10.1172/JCI265; Uehara T, 1999, BRAIN RES, V823, P226, DOI 10.1016/S0006-8993(99)01178-6; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Zhao MJ, 2002, J BIOL CHEM, V277, P44539, DOI 10.1074/jbc.M208408200; ZHAO Y, 1995, MOL CELL BIOCHEM, V148, P1, DOI 10.1007/BF00929496	39	44	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43636	43644		10.1074/jbc.M212993200	http://dx.doi.org/10.1074/jbc.M212993200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12937165	hybrid			2022-12-27	WOS:000186157000112
J	Vines, CM; Revankar, CM; Maestas, DC; LaRusch, LL; Cimino, DF; Kohout, TA; Lefkowitz, RJ; Prossnitz, ER				Vines, CM; Revankar, CM; Maestas, DC; LaRusch, LL; Cimino, DF; Kohout, TA; Lefkowitz, RJ; Prossnitz, ER			N-formyl peptide receptors internalize but do not recycle in the absence of arrestins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTINS; DEPENDENT ENDOCYTOSIS; AGONIST AFFINITY; TRAFFICKING; DESENSITIZATION; PHOSPHORYLATION; IDENTIFICATION; KINASES; SRC	Arrestins mediate phosphorylation-dependent desensitization, internalization, and initiation of signaling cascades for the majority of G protein-coupled receptors (GPCRs). Many GPCRs undergo agonist-mediated internalization through arrestin-dependent mechanisms, wherein arrestin serves as an adapter between the receptor and endocytic proteins. To understand the role of arrestins in N-formyl peptide receptor (FPR) trafficking, we stably expressed the FPR in a mouse embryonic fibroblast cell line (MEF) that lacked endogenous arrestin 2 and arrestin 3 (arrestin-deficient). We compared FPR internalization and recycling kinetics in these cells to congenic wild type MEF cell lines. Internalization of the FPR was not altered in the absence of arrestins. Since the FPR remains associated with arrestins following internalization, we investigated whether the rate of FPR recycling was altered in arrestin-deficient cells. While the FPR was able to recycle in the wild type cells, receptor recycling was largely absent in the arrestin double knockout cells. Reconstitution of the arrestin-deficient line with either arrestin 2 or arrestin 3 restored receptor recycling. Confocal fluorescence microscopy studies demonsrated that in arrestin-deficient cells the FPR may become trapped in the perinuclear recycling compartment. These observations indicate that, although the FPR can internalize in the absence of arrestins, recycling of internalized receptors to the cell surface is prevented. Our results suggest a novel role for arrestins in the post-endocytic trafficking of GPCRs.	Univ New Mexico, Hlth Sci Ctr, Canc Res & Treatment Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	University of New Mexico; University of New Mexico's Health Sciences Center; Duke University; Howard Hughes Medical Institute; Duke University; Duke University	Prossnitz, ER (corresponding author), Univ New Mexico, Hlth Sci Ctr, Canc Res & Treatment Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA.		Lefkowitz, Robert/AAW-2649-2021; Prossnitz, Eric/I-4599-2019; Prossnitz, Eric R./B-4543-2008	Prossnitz, Eric/0000-0001-9190-8302; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037, R01HL070631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036357, R01AI043932, R29AI036357, T32AI007538] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 70631, HL 16037] Funding Source: Medline; NIAID NIH HHS [AI 36357, AI 43932, T32 AI 007538] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anborgh PH, 2000, MOL ENDOCRINOL, V14, P2040, DOI 10.1210/me.14.12.2040; Bennett TA, 2000, J BIOL CHEM, V275, P24590, DOI 10.1074/jbc.C000314200; Bennett TA, 2001, J BIOL CHEM, V276, P49195, DOI 10.1074/jbc.M106414200; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; Gaborik Z, 2001, MOL PHARMACOL, V59, P239, DOI 10.1124/mol.59.2.239; Gilbert TL, 2001, BIOCHEMISTRY-US, V40, P3467, DOI 10.1021/bi001320y; Imamura T, 2001, J BIOL CHEM, V276, P43663, DOI 10.1074/jbc.M105364200; Innamorati G, 2001, J BIOL CHEM, V276, P13096, DOI 10.1074/jbc.M009780200; Key TA, 2003, J BIOL CHEM, V278, P4041, DOI 10.1074/jbc.M204687200; Key TA, 2001, J BIOL CHEM, V276, P49204, DOI 10.1074/jbc.M109475200; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Maestes DC, 1999, J BIOL CHEM, V274, P29791, DOI 10.1074/jbc.274.42.29791; McDonald PH, 1999, J BIOL CHEM, V274, P10677, DOI 10.1074/jbc.274.16.10677; McDonald PH, 2001, CELL SIGNAL, V13, P683, DOI 10.1016/S0898-6568(01)00203-0; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Mundell SJ, 2000, BIOCHEMISTRY-US, V39, P12828, DOI 10.1021/bi0010928; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PROSSNITZ ER, 1991, BIOCHEM BIOPH RES CO, V179, P471, DOI 10.1016/0006-291X(91)91394-R; Prossnitz ER, 1997, PHARMACOL THERAPEUT, V74, P73, DOI 10.1016/S0163-7258(96)00203-3; Rosenfeld JL, 2002, RECEPTOR CHANNEL, V8, P87, DOI 10.1080/10606820212398; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200	33	85	87	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 24	2003	278	43					41581	41584		10.1074/jbc.C300291200	http://dx.doi.org/10.1074/jbc.C300291200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FP	12947104	hybrid			2022-12-27	WOS:000185989500003
J	Grether-Beck, S; Felsner, I; Brenden, H; Krutmann, J				Grether-Beck, S; Felsner, I; Brenden, H; Krutmann, J			Mitochondrial cytochrome c release mediates ceramide-induced activator protein 2 activation and gene expression in keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; INDUCED APOPTOSIS; CARCINOMA-CELLS; ADP/ATP CARRIER; SPHINGOMYELIN PATHWAY; HYDROGEN-PEROXIDE; EPITHELIAL-CELLS; UVA RADIATION; REDOX STATE	The intracellular signaling pathway(s) through which second messenger ceramides induce gene expression in human cells has not yet been characterized. In the present study, ceramide-induced expression of intercellular adhesion molecule-1 (ICAM-1), which requires activation of transcription factor activator protein 2 (AP-2), was found to be mediated through a mitochondrial pathway. Inhibitors of mitochondrial electron transport chain (e.g. rotenone, thenoyltrifluoroacetone, and antimycin A) reduced ceramide-induced ICAM-1 expression. Stimulation of human keratinocytes with cell-permeant ceramides at concentrations that did not induce apoptosis ( no activation of caspases 3, 8, and 9 and no nucleosomal fragmentation) but caused AP-2 activation and ICAM-1 induction released cytochrome c (cyt c) from mitochondria into the cytoplasm of cells. This cyt c release was an indispensable prerequisite for effective ceramide signaling, because its inhibition by modulating the mitochondrial megachannel with bonkrekic acid or carboxyatractyloside prevented ceramide-induced AP-2 activation and ICAM-1 expression. Analysis of the interaction between cyt c and AP-2 revealed that cyt c oxidized AP-2 and that this redox regulation greatly enhanced the DNA binding capacity of AP-2. Mitochondria thus have a previously unrecognized function in signaling ceramide-induced transcription factor activation and gene regulation.	Univ Dusseldorf gGmBH, Inst Umweltmed Forsch, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Krutmann, J (corresponding author), Univ Dusseldorf gGmBH, Inst Umweltmed Forsch, Hennekamp 50, D-40225 Dusseldorf, Germany.							Ahrens C, 1997, P NATL ACAD SCI USA, V94, P6837, DOI 10.1073/pnas.94.13.6837; Amarante-Mendes GP, 1998, BLOOD, V91, P1700, DOI 10.1182/blood.V91.5.1700.1700_1700_1705; Asakuma J, 2003, CANCER RES, V63, P1365; Ballou LR, 1996, BBA-LIPID LIPID MET, V1301, P273, DOI 10.1016/0005-2760(96)00004-5; Bello RI, 2001, J BIOL CHEM, V276, P44379, DOI 10.1074/jbc.M107168200; Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345; BONIFACINO JS, 2001, CURRENT PROTOCOLS IM; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Bossy-Wetzel E, 2000, METHOD ENZYMOL, V322, P235; Brustovetsky N, 1996, P NATL ACAD SCI USA, V93, P664, DOI 10.1073/pnas.93.2.664; Burek C, 2001, ONCOGENE, V20, P6493, DOI 10.1038/sj.onc.1204841; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; Corsini E, 1996, J INVEST DERMATOL, V107, P720, DOI 10.1111/1523-1747.ep12365608; Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9; Di Nardo A, 2000, BRIT J DERMATOL, V143, P491, DOI 10.1111/j.1365-2133.2000.03700.x; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Driscoll KE, 1998, ENVIRON HEALTH PERSP, V106, P1171, DOI 10.2307/3433981; DUTTON PL, 1975, BIOCHIM BIOPHYS ACTA, V387, P536, DOI 10.1016/0005-2728(75)90092-4; FISHER WR, 1973, J BIOL CHEM, V248, P3188; Gallagher S. R., 2001, CURRENT PROTOCOLS IM; Gaubin Y, 2000, BBA-MOL CELL RES, V1495, P4, DOI 10.1016/S0167-4889(99)00149-4; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Grether-Beck S, 2000, EMBO J, V19, P5793, DOI 10.1093/emboj/19.21.5793; GretherBeck S, 1996, P NATL ACAD SCI USA, V93, P14586, DOI 10.1073/pnas.93.25.14586; Gropp T, 1999, BIOPHYS J, V77, P714, DOI 10.1016/S0006-3495(99)76926-2; Hampton MB, 1998, BIOCHEM J, V329, P95; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; HANNUN YA, 2002, J BIOL CHEM, V277, P25447; HENNINGER HP, 1993, BIOL CHEM H-S, V374, P625, DOI 10.1515/bchm3.1993.374.7-12.625; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Huber T, 1999, BIOCHEMISTRY-US, V38, P762, DOI 10.1021/bi981431l; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JARVIS WD, 1994, P NATL ACAD SCI USA, V91, P73, DOI 10.1073/pnas.91.1.73; JOSEPH P, 1994, ONCOL RES, V6, P525; Knaapen AM, 2002, CARCINOGENESIS, V23, P1111, DOI 10.1093/carcin/23.7.1111; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; KOLESNICK RN, 1994, BIOCHEM CELL BIOL, V72, P471, DOI 10.1139/o94-063; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; KRUTMANN J, 1992, SPRINGER SEMIN IMMUN, V13, P333; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEENDERS HJ, 1972, J CELL BIOL, V55, P257, DOI 10.1083/jcb.55.2.257; LIAO XS, 1991, MOL CELL BIOL, V11, P38, DOI 10.1128/MCB.11.1.38; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Martinou JC, 1999, NATURE, V399, P411, DOI 10.1038/20804; MATHIAS S, 1991, P NATL ACAD SCI USA, V88, P10009, DOI 10.1073/pnas.88.22.10009; Matroule JY, 1999, J BIOL CHEM, V274, P2988, DOI 10.1074/jbc.274.5.2988; Miguet C, 2001, CELL DEATH DIFFER, V8, P83, DOI 10.1038/sj.cdd.4400792; Morita A, 1997, PHOTOCHEM PHOTOBIOL, V65, P630, DOI 10.1111/j.1751-1097.1997.tb01904.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P517; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Pahan K, 1998, J BIOL CHEM, V273, P2591, DOI 10.1074/jbc.273.5.2591; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; Piette J, 1997, BIOL CHEM, V378, P1237; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; RAINES MA, 1993, J BIOL CHEM, V268, P14572; Rippo MR, 2000, FASEB J, V14, P2047, DOI 10.1096/fj.99-1028com; SACCHETTA P, 1986, ANAL BIOCHEM, V154, P205, DOI 10.1016/0003-2697(86)90516-6; SCHULZEOSTHOFF K, 1993, EMBO J, V12, P3095, DOI 10.1002/j.1460-2075.1993.tb05978.x; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; STADE BG, 1990, IMMUNOBIOLOGY, V182, P79, DOI 10.1016/S0171-2985(11)80585-1; SUGITA M, 1975, BIOCHIM BIOPHYS ACTA, V398, P125, DOI 10.1016/0005-2760(75)90176-9; Suzuki S, 1999, ONCOGENE, V18, P6380, DOI 10.1038/sj.onc.1203024; Taanman JW, 1996, BBA-MOL BASIS DIS, V1315, P199, DOI 10.1016/0925-4439(95)00127-1; von Haefen C, 2002, ONCOGENE, V21, P4009, DOI 10.1038/sj.onc.1205497	67	28	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47498	47507		10.1074/jbc.M309511200	http://dx.doi.org/10.1074/jbc.M309511200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12952965	hybrid			2022-12-27	WOS:000186731400021
J	Hwang, M; Morasso, MI				Hwang, M; Morasso, MI			The novel murine Ca2+-binding protein, scarf, is differentially expressed during epidermal differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-LIKE PROTEIN; BINDING; FAMILY; S100; IDENTIFICATION; LOCALIZATION; SENSORS; MARKER; TISSUE	Calcium (Ca2+) signaling-dependent systems, such as the epidermal differentiation process, must effectively respond to variations in Ca2+ concentration. Members of the Ca2+-binding proteins play a central function in the transduction of Ca2+ signals, exerting their roles through a Ca2+-dependent interaction with their target proteins, spatially and temporally. By performing a suppression subtractive hybridization screen we identified a novel mouse gene, Scarf (skin calmodulin-related factor), which has homology to calmodulin (CaM)- like Ca2+-binding protein genes and is exclusively expressed in differentiating keratinocytes in the epidermis. The Scarf open reading frame encodes a 148-amino acid protein that contains four conserved EF-hand motifs ( predicted to be Ca2+-binding domains) and has homology to mouse CaM, human CaM-like protein, hClp, and human CaM-like skin protein, hClsp. The functionality of Scarf EF-hand domains was assayed with a radioactive Ca2+-binding method. By Southern blot and computational genome sequence analysis, a highly related gene, Scarf2, was found 15 kb downstream of Scarf on mouse chromosome 13. The functional Scarf Ca2+-binding domains suggest a role in the regulation of epidermal differentiation through the control of Ca2+-mediated signaling.	NIAMS, Dev Skin Biol Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Morasso, MI (corresponding author), NIAMS, Dev Skin Biol Unit, NIH, Bldg 50,Rm 1525, Bethesda, MD 20892 USA.	morasso@nih.gov			NIAMS NIH HHS [Z01 AR041124-06] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041124] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Broome AM, 2003, J HISTOCHEM CYTOCHEM, V51, P675, DOI 10.1177/002215540305100513; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Durussel I, 2002, BIOCHEMISTRY-US, V41, P5439, DOI 10.1021/bi016062z; Eckert RL, 1996, MOL BIOL REP, V23, P59, DOI 10.1007/BF00357073; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GAO ZH, 1993, J BIOL CHEM, V268, P20096; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; KAWASAKI H, 1985, ANAL BIOCHEM, V148, P297, DOI 10.1016/0003-2697(85)90232-5; Krieg P, 1997, GENOMICS, V43, P339, DOI 10.1006/geno.1997.4818; LICHTI U, 1988, CANCER RES, V48, P74; MACKEM S, 1991, DEVELOPMENT, V112, P791; Mehul B, 2000, J BIOL CHEM, V275, P12841, DOI 10.1074/jbc.275.17.12841; Mehul B, 2001, J INVEST DERMATOL, V116, P905, DOI 10.1046/j.0022-202x.2001.01376.x; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; Nelson MR, 1998, CALMODULIN AND SIGNAL TRANSDUCTION, P17; Park GT, 2002, J BIOL CHEM, V277, P45195, DOI 10.1074/jbc.M205380200; PRESLAND RB, 1995, J INVEST DERMATOL, V104, P218, DOI 10.1111/1523-1747.ep12612770; Rogers MS, 2001, EXP CELL RES, V267, P216, DOI 10.1006/excr.2001.5254; Rogers MS, 2001, J BIOL CHEM, V276, P12182, DOI 10.1074/jbc.M010056200; Ruse M, 2001, BIOCHEMISTRY-US, V40, P3167, DOI 10.1021/bi0019747; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207	29	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					47827	47833		10.1074/jbc.M306561200	http://dx.doi.org/10.1074/jbc.M306561200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12970338	hybrid, Green Accepted			2022-12-27	WOS:000186731400059
J	Drew, ME; Morris, JC; Wang, ZF; Wells, L; Sanchez, M; Landfear, SM; Englund, PT				Drew, ME; Morris, JC; Wang, ZF; Wells, L; Sanchez, M; Landfear, SM; Englund, PT			The adenosine analog tubercidin inhibits glycolysis in Trypanosoma brucei as revealed by an RNA interference library	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; PHOSPHOGLYCERATE KINASE; FUNCTIONAL EXPRESSION; ESCHERICHIA-COLI; TRANSPORTER; COMPARTMENTATION; PURIFICATION; MICROBODY; ENZYMES; CLONING	We used an RNA interference ( RNAi) library in a forward genetic selection to study the mechanism of toxicity of tubercidin ( 7- deazaadenosine) to procyclic Trypanosoma brucei. Following transfection of cells with an RNAi-based genomic library, we used 5 muM tubercidin to select a drug- resistant cell line. Surprisingly, we found in these resistant cells that the hexose transporters had been silenced. We subsequently found that silencing of hexokinase, a glycolytic enzyme, also yielded tubercidin-resistant parasites. These observations suggested that glycolysis could be a target of tubercidin action and that RNAi silencing of glycolytic enzymes was gradual enough to allow the parasites to adapt to alternative sources of energy. Indeed, adaptation of procyclic trypanosomes to a glucose- independent metabolism by reduction of glucose in the culture medium caused tubercidin resistance. High pressure liquid chromatography analysis of glycolytic intermediates from parasites treated with tubercidin showed a dose- dependent increase in concentration of 1,3- bisphosphoglycerate, a substrate of phosphoglycerate kinase. Furthermore, tubercidin triphosphate inhibited recombinant T. brucei phosphoglycerate kinase activity in vitro with an IC50 of 7.5 muM. We conclude that 5 muM tubercidin kills trypanosomes by targeting glycolysis, especially by inhibition of phosphoglycerate kinase.	Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Oregon Hlth Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	Johns Hopkins University; Johns Hopkins Medicine; Oregon Health & Science University	Englund, PT (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.		Drew, Mark/E-2993-2011; Wells, Lance/H-3118-2013	Wang, Zefeng/0000-0002-6605-3637; Morris, James/0000-0003-2515-5714; Wells, Lance/0000-0003-4956-5363; Landfear, Scott/0000-0002-1643-6664	NIAID NIH HHS [R01 AI044138, AI 21334, AI 44138] Funding Source: Medline; NIGMS NIH HHS [GM 27605] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021334, R01AI044138] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACS G, 1964, P NATL ACAD SCI USA, V52, P493, DOI 10.1073/pnas.52.2.493; ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; Barrett MP, 1998, MOL BIOCHEM PARASIT, V91, P195, DOI 10.1016/S0166-6851(97)00192-8; BHATTACHARYA M, 1995, ANAL BIOCHEM, V232, P98, DOI 10.1006/abio.1995.9954; Blattner J, 1998, P NATL ACAD SCI USA, V95, P11596, DOI 10.1073/pnas.95.20.11596; Clayton CE, 1996, PARASITOL TODAY, V12, P465, DOI 10.1016/S0169-4758(96)10073-9; IOVANNISCI DM, 1984, MOL BIOCHEM PARASIT, V12, P139, DOI 10.1016/0166-6851(84)90131-2; LANGFORD CK, 1994, J BIOL CHEM, V269, P17939; Morris JC, 2002, EMBO J, V21, P4429, DOI 10.1093/emboj/cdf474; OPPERDOES FR, 1977, FEBS LETT, V80, P360, DOI 10.1016/0014-5793(77)80476-6; OSINGA KA, 1985, EMBO J, V4, P3811, DOI 10.1002/j.1460-2075.1985.tb04152.x; PARSONS M, 1990, MOL BIOCHEM PARASIT, V42, P197, DOI 10.1016/0166-6851(90)90162-F; Sanchez MA, 1999, J BIOL CHEM, V274, P30244, DOI 10.1074/jbc.274.42.30244; Sanchez MA, 2002, J BIOL CHEM, V277, P21499, DOI 10.1074/jbc.M202319200; SCHOBERT B, 1995, ANAL BIOCHEM, V226, P288, DOI 10.1006/abio.1995.1227; terKuile BH, 1997, J BACTERIOL, V179, P4699, DOI 10.1128/jb.179.15.4699-4705.1997; Verlinde CLM, 2001, DRUG RESIST UPDATE, V4, P50, DOI 10.1054/drup.2000.0177; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zomer AWM, 1998, BBA-PROTEIN STRUCT M, V1386, P179, DOI 10.1016/S0167-4838(98)00095-8	20	53	53	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46596	46600		10.1074/jbc.M309320200	http://dx.doi.org/10.1074/jbc.M309320200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12972414	hybrid			2022-12-27	WOS:000186569400046
J	Jones, LH; Liu, AM; Davidson, VL				Jones, LH; Liu, AM; Davidson, VL			An engineered Cu-A amicyanin capable of intermolecular electron transfer reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITROUS-OXIDE REDUCTASE; SITE-DIRECTED MUTAGENESIS; BLUE COPPER PROTEIN; PARACOCCUS-DENITRIFICANS; METHYLAMINE DEHYDROGENASE; CYTOCHROME C-551I; SPECTROSCOPIC CHARACTERIZATION; THIOBACILLUS-VERSUTUS; PSEUDOMONAS-STUTZERI; TRANSFER COMPLEX	The type I copper center of amicyanin was replaced with a binuclear Cu-A center. To create this model Cu-A protein, a portion of the amino acid sequence that contains three of the ligands to the native type I copper center of Paracoccus denitrificans amicyanin was replaced with the corresponding portion of sequence that provides five ligands for the Cu-A center of cytochrome c oxidase from P. denitrificans. UV-visible and electron paramagnetic resonance spectroscopy confirm that the engineered protein as isolated possesses the mixed-valence (CuCu1.5)-Cu-1.5 (purple) Cu-A center. Comparison of the spectroscopic properties of this Cu-A amicyanin with those of the Cu-A centers of other natural and engineered Cu-A proteins suggests that the spectroscopic features may be dictated more by the protein host than the sequence of the Cu-A loop. Novel reactions for a simple Cu-A model protein are also described. In contrast to other natural and engineered Cu-A proteins, the fully reduced Cu-A amicyanin may be reoxidized by molecular oxygen to the mixed-valence state. It is also shown that Cu-A amicyanin can serve as an electron donor and an electron acceptor for other redox proteins. The mixed-valence form accepts electrons from cytochromes c-551i and c-550 from P. denitrificans. The fully reduced form donates electrons to native and P94F amicyanin. The function as either an electron donor or acceptor is consistent with the measured redox potential of Cu-A amicyanin of + 273 mV. These data indicate that this Cu-A amicyanin will be a particularly useful model protein for structure-function studies of reactivity and the electron transfer properties of the Cu-A redox center.	Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Davidson, VL (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, 2500 N State St, Jackson, MS 39216 USA.		Liu, Aimin/C-1572-2017	Liu, Aimin/0000-0002-4182-8176; Davidson, Victor/0000-0002-1966-7302	NIGMS NIH HHS [GM 41574] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041574, R01GM041574] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADMAN ET, 1991, ADV PROTEIN CHEM, V42, P145; ANTHOLINE WE, 1992, EUR J BIOCHEM, V209, P875, DOI 10.1111/j.1432-1033.1992.tb17360.x; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BISHOP GR, 1995, BIOCHEMISTRY-US, V34, P12082, DOI 10.1021/bi00037a052; Bishop GR, 1998, BIOCHEMISTRY-US, V37, P11026, DOI 10.1021/bi980265e; Bishop GR, 1996, BIOCHEMISTRY-US, V35, P8948, DOI 10.1021/bi960404x; Bishop GR, 1997, BIOCHEMISTRY-US, V36, P13586, DOI 10.1021/bi970586a; BROOKS HB, 1994, BIOCHEMISTRY-US, V33, P5696, DOI 10.1021/bi00185a005; Brown K, 2000, NAT STRUCT BIOL, V7, P191; Charnock JM, 2000, EUR J BIOCHEM, V267, P1368, DOI 10.1046/j.1432-1327.2000.01131.x; CHEN LY, 1992, BIOCHEMISTRY-US, V31, P4959, DOI 10.1021/bi00136a006; CHEN LY, 1994, SCIENCE, V264, P86, DOI 10.1126/science.8140419; Cooper C. E., 1995, BIOENERGETICS PRACTI, P85; Cunane LM, 1996, ACTA CRYSTALLOGR D, V52, P676, DOI 10.1107/S0907444996001072; DAVIDSON VL, 1990, METHOD ENZYMOL, V188, P241; Davidson VL, 2002, METHOD ENZYMOL, V353, P121; Davidson VL, 1997, BIOCHEMISTRY-US, V36, P12733, DOI 10.1021/bi971353m; DAVIDSON VL, 1995, J BIOL CHEM, V270, P23941, DOI 10.1074/jbc.270.41.23941; Davidson VL, 2001, ADV PROTEIN CHEM, V58, P95; Davidson VL, 2000, BBA-BIOENERGETICS, V1457, P27, DOI 10.1016/S0005-2728(00)00052-9; Davidson VL, 1996, BIOCHEMISTRY-US, V35, P8120, DOI 10.1021/bi952854f; DEGIER JWL, 1995, EUR J BIOCHEM, V229, P148; Dennison C, 1996, FEBS LETT, V394, P340, DOI 10.1016/0014-5793(96)00981-7; DENNISON C, 1995, FEBS LETT, V365, P92, DOI 10.1016/0014-5793(95)00429-D; Epel B, 2002, J AM CHEM SOC, V124, P8152, DOI 10.1021/ja012514j; FARRAR JA, 1995, EUR J BIOCHEM, V232, P294, DOI 10.1111/j.1432-1033.1995.tb20811.x; Farver O, 1999, P NATL ACAD SCI USA, V96, P899, DOI 10.1073/pnas.96.3.899; Gamelin DR, 1998, J AM CHEM SOC, V120, P5246, DOI 10.1021/ja973161k; GRAY KA, 1986, FEBS LETT, V207, P239, DOI 10.1016/0014-5793(86)81496-X; Hay M, 1996, P NATL ACAD SCI USA, V93, P461, DOI 10.1073/pnas.93.1.461; Hay MT, 2000, J BIOL INORG CHEM, V5, P699, DOI 10.1007/s007750000158; Hay MT, 1998, INORG CHEM, V37, P191, DOI 10.1021/ic971232a; HUSAIN M, 1986, J BIOL CHEM, V261, P8577; HUSAIN M, 1985, J BIOL CHEM, V260, P4626; HUSAIN M, 1987, J BACTERIOL, V169, P1712, DOI 10.1128/jb.169.4.1712-1717.1987; HUSAIN M, 1986, BIOCHEMISTRY-US, V25, P2431, DOI 10.1021/bi00357a020; KRONECK PMH, 1989, FEBS LETT, V248, P212, DOI 10.1016/0014-5793(89)80464-8; KRONECK PMH, 1990, FEBS LETT, V268, P274, DOI 10.1016/0014-5793(90)81026-K; LAPPALAINEN P, 1993, J BIOL CHEM, V268, P26416; LOMMEN A, 1990, J BIOL CHEM, V265, P2768; LOMMEN A, 1988, EUR J BIOCHEM, V176, P213, DOI 10.1111/j.1432-1033.1988.tb14271.x; Lukoyanov D, 2002, BIOPHYS J, V82, P2758, DOI 10.1016/S0006-3495(02)75616-6; Machczynski MC, 2002, J INORG BIOCHEM, V88, P375, DOI 10.1016/S0162-0134(02)00364-1; Neese F, 1996, J AM CHEM SOC, V118, P8692, DOI 10.1021/ja960125x; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; RAITIO M, 1987, EMBO J, V6, P2825, DOI 10.1002/j.1460-2075.1987.tb02579.x; RIESTER J, 1989, EUR J BIOCHEM, V178, P751, DOI 10.1111/j.1432-1033.1989.tb14506.x; Robinson H, 1999, BIOCHEMISTRY-US, V38, P5677, DOI 10.1021/bi9901634; Salgado J, 1998, BIOCHEMISTRY-US, V37, P7378, DOI 10.1021/bi9728598; Slutter CE, 1996, BIOCHEMISTRY-US, V35, P3387, DOI 10.1021/bi9525839; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; VANSPANNING RJM, 1990, FEBS LETT, V275, P217, DOI 10.1016/0014-5793(90)81475-4; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Zhen YJ, 2002, BIOCHEMISTRY-US, V41, P2288, DOI 10.1021/bi0114628; Zhu ZY, 1998, BIOCHEMISTRY-US, V37, P17128, DOI 10.1021/bi9817919; ZUMFT WG, 1996, ADV INORG BIOCHEM, V11, P193	56	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47269	47274		10.1074/jbc.M308863200	http://dx.doi.org/10.1074/jbc.M308863200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12970350	hybrid			2022-12-27	WOS:000186569400128
J	Maneg, O; Ludwig, B; Malatesta, F				Maneg, O; Ludwig, B; Malatesta, F			Different interaction modes of two cytochrome-c oxidase soluble Cu-A fragments with their substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARACOCCUS-DENITRIFICANS; THERMUS-THERMOPHILUS; SUBUNIT-II; ELECTRON-TRANSFER; ESCHERICHIA-COLI; SITE; C(552); PROTEIN; DOMAIN; DOCKING	Cytochrome-c oxidase is the terminal enzyme in the respiratory chains of mitochondria and many bacteria and catalyzes the formation of water by reduction of dioxygen. The first step in the cytochrome oxidase reaction is the bimolecular electron transfer from cytochrome c to the homobinuclear mixed-valence Cu-A center of subunit II. In Thermus thermophilus a soluble cytochrome c(552) acts as the electron donor to ba(3) cytochrome-c oxidase, an interaction believed to be mainly hydrophobic. In Paracoccus denitrificans, electrostatic interactions appear to play a major role in the electron transfer process from the membrane-spanning cytochrome c552. In the present study, soluble fragments of the CuA domains and their respective cytochrome c electron donors were analyzed by stopped-flow spectroscopy to further characterize the interaction modes. The forward and the reverse electron transfer reactions were studied as a function of ionic strength and temperature, in all cases yielding monoexponential time-dependent reaction profiles in either direction. From the apparent second-order rate constants, equilibrium constants were calculated, with values of 4.8 and of 0.19, for the T. thermophilus and P. denitrificans c552 and CuA couples, respectively. Ionic strength strongly affects the electron transfer reaction in P. denitrificans indicating that about five charges on the protein interfaces control the interaction, when analyzed according to the Bronsted equation, whereas in the T. thermophilus only 0.5 charges are involved. Overall the results indicate that the soluble CuA domains are excellent models for the initial electron transfer processes in cytochrome-c oxidases.	Univ Aquila, Dipartimento Biol Base & Applicata, I-67010 Coppito, Laquila, Italy; Goethe Univ Frankfurt, Biozentrum, D-60439 Frankfurt, Germany	University of L'Aquila; Goethe University Frankfurt	Malatesta, F (corresponding author), Univ Aquila, Dipartimento Biol Base & Applicata, Via Vetoio, I-67010 Coppito, Laquila, Italy.	malatest@univaq.it	Malatesta, Francesco/AAT-4757-2020					ALAYASH AI, 1979, BIOCHEM J, V177, P641, DOI 10.1042/bj1770641; ANTALIS TM, 1982, J BIOL CHEM, V257, P6194; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; ATKINS PW, 1990, PHYSICAL CHEM, P851; Baker SC, 1998, MICROBIOL MOL BIOL R, V62, P1046, DOI 10.1128/MMBR.62.4.1046-1078.1998; BERRY EA, 1985, J BIOL CHEM, V260, P2458; Bronsted JN, 1924, J AM CHEM SOC, V46, P555, DOI 10.1021/ja01668a006; Crowley PB, 2001, J AM CHEM SOC, V123, P10444, DOI 10.1021/ja0112700; DETHMERS JK, 1979, J BIOL CHEM, V254, P1973; Drosou V, 2002, EUR J BIOCHEM, V269, P2980, DOI 10.1046/j.1432-1033.2002.02979.x; Drosou V, 2002, BIOCHEMISTRY-US, V41, P10629, DOI 10.1021/bi020094k; DROSOU V, 2002, THESIS U FRANKFURT F; Fee JA, 2000, PROTEIN SCI, V9, P2074, DOI 10.1110/ps.9.11.2074; Flock D, 2002, PROTEINS, V47, P75, DOI 10.1002/prot.10066; Giuffre A, 1999, BIOCHEMISTRY-US, V38, P1057, DOI 10.1021/bi9815389; Harrenga A, 2000, J MOL BIOL, V295, P667, DOI 10.1006/jmbi.1999.3382; Hart SE, 2003, BIOCHEMISTRY-US, V42, P4829, DOI 10.1021/bi020674h; HONNAMI K, 1977, J BIOCHEM, V82, P769, DOI 10.1093/oxfordjournals.jbchem.a131753; INMOOS C, 1996, J BIOL INORG CHEM, V1, P529; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; LAPPALAINEN P, 1993, J BIOL CHEM, V268, P26416; MYER YP, 1980, J BIOL CHEM, V255, P9666; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Reincke B, 1999, BBA-BIOENERGETICS, V1411, P114, DOI 10.1016/S0005-2728(99)00037-7; Salgado J, 1998, BIOCHEMISTRY-US, V37, P7378, DOI 10.1021/bi9728598; SCHNEIDER M, 2000, THESIS U FRANKFURT F; Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23; Slutter CE, 1996, BIOCHEMISTRY-US, V35, P3387, DOI 10.1021/bi9525839; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Soulimane T, 1997, BIOCHEM BIOPH RES CO, V237, P572, DOI 10.1006/bbrc.1997.7041; STEINRUCKE P, 1987, EUR J BIOCHEM, V167, P431, DOI 10.1111/j.1432-1033.1987.tb13356.x; Szundi I, 2001, BIOCHEMISTRY-US, V40, P2186, DOI 10.1021/bi002341v; Than ME, 1997, J MOL BIOL, V271, P629, DOI 10.1006/jmbi.1997.1181; TURBA A, 1995, EUR J BIOCHEM, V231, P259, DOI 10.1111/j.1432-1033.1995.0259f.x; TURBA A, 1993, THESIS U FRANKFURT F; VONWACHENFELDT C, 1994, FEBS LETT, V340, P109, DOI 10.1016/0014-5793(94)80182-7; Wienk H, 2003, BIOCHEMISTRY-US, V42, P6005, DOI 10.1021/bi027198f; Wingfield P. T., 1998, CURRENT PROTOCOLS PR; Witt H, 1998, J BIOL CHEM, V273, P5132, DOI 10.1074/jbc.273.9.5132; Witt H, 1998, EUR J BIOCHEM, V251, P367, DOI 10.1046/j.1432-1327.1998.2510367.x	41	42	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46734	46740		10.1074/jbc.M307594200	http://dx.doi.org/10.1074/jbc.M307594200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12937163	hybrid			2022-12-27	WOS:000186569400064
J	Maynes, JT; Garen, C; Cherney, MM; Newton, G; Arad, D; Av-Gay, Y; Fahey, RC; James, MNG				Maynes, JT; Garen, C; Cherney, MM; Newton, G; Arad, D; Av-Gay, Y; Fahey, RC; James, MNG			The crystal structure of 1-D-myo-inosityl-2-acetamido-2-deoxy-alpha-D-glucopyranoside deacetylase (MshB) from Mycobacterium tuberculosis reveals a zinc hydrolase with a lactate dehydrogenase fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT FORMALDEHYDE DEHYDROGENASE; MYCOTHIOL BIOSYNTHESIS; SMEGMATIS MUTANTS; ENZYME; MODEL; IDENTIFICATION; ANTIBIOTICS; REFINEMENT; PROGRAM; DENSITY	Mycothiol ( 1- D- myo- inosityl 2-( N- acetyl- L- cysteinyl)amido- 2- deoxy- alpha- D- glucopyranoside, MSH or AcCys-GlcN- inositol ( Ins)) is the major reducing agent in actinomycetes, including Mycobacterium tuberculosis. The biosynthesis of MSH involves a deacetylase that removes the acetyl group from the precursor GlcNAc- Ins to yield GlcN- Ins. The deacetylase ( MshB) corresponds to Rv1170 of M. tuberculosis with a molecular mass of 33,400 Da. MshB is a Zn2+ metalloprotein, and the deacetylase activity is completely dependent on the presence of a divalent metal cation. We have determined the x- ray crystallographic structure of MshB, which reveals a protein that folds in a manner resembling lactate dehydrogenase in the N- terminal domain and a C-terminal domain consisting of two beta- sheets and two alpha- helices. The zinc binding site is in the N- terminal domain occupying a position equivalent to that of the NAD(+) co- factor of lactate dehydrogenase. The Zn2+ is 5 coordinate with 3 residues from MshB ( His- 13, Asp- 16, His- 147) and two water molecules. One water would be displaced upon binding of substrate ( GlcNAc- Ins); the other is proposed as the nucleophilic water assisted by the general base carboxylate of Asp- 15. In addition to the Zn2+ providing electrophilic assistance in the hydrolysis, His- 144 imidazole could form a hydrogen bond to the oxyanion of the tetrahedral intermediate. The extensive sequence identity of MshB, the deacetylase, with mycothiol S- conjugate amidase, an amide hydrolase that mediates detoxification of mycothiol S-conjugate xenobiotics, has allowed us to construct a faithful model of the catalytic domain of mycothiol S-conjugate amidase based on the structure of MshB.	Univ Alberta, Fac Med, Dept Biochem, Canadian Inst Hlth Res,Grp Prot Struct & Funct, Edmonton, AB T6G 2H7, Canada; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ British Columbia, Dept Med, Vancouver, BC V5Z 2J5, Canada	Institute for Work & Health; University of Alberta; University of California System; University of California San Diego; University of British Columbia	James, MNG (corresponding author), Univ Alberta, Fac Med, Dept Biochem, Canadian Inst Hlth Res,Grp Prot Struct & Funct, Edmonton, AB T6G 2H7, Canada.		Av-Gay, Yossef/H-5128-2019; Maynes, Jason/AAE-4344-2020; Av-Gay, Yossef/H-2311-2014	Av-Gay, Yossef/0000-0002-9547-0237; Garen, Craig/0000-0002-7772-9890				Amaral L, 2001, TROP MED INT HEALTH, V6, P1016, DOI 10.1046/j.1365-3156.2001.00804.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown ID, 1996, J APPL CRYSTALLOGR, V29, P479, DOI 10.1107/S002188989600163X; Buchmeier NA, 2003, MOL MICROBIOL, V47, P1723, DOI 10.1046/j.1365-2958.2003.03416.x; Chang TH, 2002, J BIOL CHEM, V277, P50176, DOI 10.1074/jbc.M208374200; DeLano W.L, PYMOL MOL GRAPHICS S; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Handa N, 2003, PROTEIN SCI, V12, P1621, DOI 10.1110/gad.03104003; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Koledin T, 2002, ARCH MICROBIOL, V178, P331, DOI 10.1007/s00203-002-0462-y; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MissetSmits M, 1997, FEBS LETT, V409, P221, DOI 10.1016/S0014-5793(97)00510-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newton GL, 2003, J BACTERIOL, V185, P3476, DOI 10.1128/JB.185.11.3476-3479.2003; Newton GL, 2002, ARCH MICROBIOL, V178, P388, DOI 10.1007/s00203-002-0469-4; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Newton GL, 2000, J BACTERIOL, V182, P6958, DOI 10.1128/JB.182.24.6958-6963.2000; Newton GL, 1999, BIOCHEM BIOPH RES CO, V255, P239, DOI 10.1006/bbrc.1999.0156; Newton GL, 2000, BIOCHEMISTRY-US, V39, P10739, DOI 10.1021/bi000356n; Norin A, 1997, EUR J BIOCHEM, V248, P282, DOI 10.1111/j.1432-1033.1997.00282.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; QUIOCHO FA, 1993, BIOCHEM SOC T, V21, P442, DOI 10.1042/bst0210442; Rawat M, 2002, ANTIMICROB AGENTS CH, V46, P3348, DOI 10.1128/AAC.46.11.3348-3355.2002; REES DC, 1983, J MOL BIOL, V168, P367, DOI 10.1016/S0022-2836(83)80024-2; Roe RR, 1999, J MOL MODEL, V5, P134, DOI 10.1007/s008940050113; Sareen D, 2002, BIOCHEMISTRY-US, V41, P6885, DOI 10.1021/bi012212u; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1763, DOI 10.1107/S0907444901013749; Vogt RN, 2003, BIOCHEM J, V374, P657, DOI 10.1042/BJ20030642; WHITE JL, 1976, J MOL BIOL, V102, P759, DOI 10.1016/0022-2836(76)90290-4; WHO, 1998, GLOB SURV DIAGN THER, V2, P1, DOI DOI 10.1016/J.KJMS	34	63	67	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					47166	47170		10.1074/jbc.M308914200	http://dx.doi.org/10.1074/jbc.M308914200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12958317	hybrid			2022-12-27	WOS:000186569400115
J	Guaragnella, N; Butow, RA				Guaragnella, N; Butow, RA			ATO3 encoding a putative outward ammonium transporter is an RTG-independent retrograde responsive gene regulated by GCN4 and the Ssy1-Ptr3-Ssy5 amino acid sensor system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; SACCHAROMYCES-CEREVISIAE; GENOME-WIDE; YEAST; EXPRESSION; MITOCHONDRIA; COMMUNICATION; NUCLEUS; COMPLEX; TARGET	Respiratory deficient yeast cells such as rho(o) petites activate an inter-organelle signaling pathway called retrograde regulation. This results in changes in the expression of a subset of nuclear genes leading to major reconfigurations of metabolism that enable cells to adapt to the respiratory deficient state. Previous studies have focused on the role of three positive regulatory factors in the retrograde pathway, Rtg1p, Rtg2p, and Rtg3p, which are essential for both basal and elevated expressions of some, but not all, retrograde responsive genes. Here we characterize the retrograde regulation of one of those genes, ATO3, whose elevated expression in rho(o) petites is largely independent of RTG gene function. ATO3 encodes a member of the YaaH family of proteins that is a putative outward ammonium transporter. We show that Ato3p-green fluorescent protein is preferentially localized to the plasma membrane of mother cells. rho(o) petites express more Ato3p-green fluorescent protein in their plasma membrane than do rho(+) cells, consistent with the elevated level of ATO3 transcripts in rho(o) cells. We find that ATO3 expression has two levels of control, both of which are connected to amino acid sensing and regulation. The first involves GCN4, which is required for the bulk of ATO3 expression. The second involves the Ssy1-Ptr3-Ssy5 amino acid sensor system, which is preferentially required for elevated ATO3 expression in rho(o) cells. We propose that ATO3 is induced in rho(o) cells to eliminate the excess ammonia that arises because of a potential defect in ammonia assimilation in those cells.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Butow, RA (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	ronald.butow@utsouthwestern.edu			NIGMS NIH HHS [GM 22525] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022525, R37GM022525] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altamura N, 1996, FEBS LETT, V382, P111, DOI 10.1016/0014-5793(96)00165-2; Bateman JM, 2002, J BIOL CHEM, V277, P47946, DOI 10.1074/jbc.M209071200; CHELSTOWSKA A, 1995, J BIOL CHEM, V270, P18141, DOI 10.1074/jbc.270.30.18141; Chelstowska A, 1999, YEAST, V15, P1377, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1377::AID-YEA473>3.0.CO;2-0; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Devaux F, 2002, FEBS LETT, V515, P25, DOI 10.1016/S0014-5793(02)02387-6; Dilova I, 2002, CURR BIOL, V12, P389, DOI 10.1016/S0960-9822(02)00677-2; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Forsberg H, 2001, MOL MICROBIOL, V42, P215, DOI 10.1046/j.1365-2958.2001.02627.x; Forsberg H, 2001, MOL CELL BIOL, V21, P814, DOI 10.1128/MCB.21.3.814-826.2001; Hallstrom TC, 2000, J BIOL CHEM, V275, P37347, DOI 10.1074/jbc.M007338200; Hinnebusch A. G., 1992, MOL CELLULAR BIOL YE, P319, DOI DOI 10.1016/J.ACA.2008.01.060; Jia YK, 1997, MOL CELL BIOL, V17, P1110, DOI 10.1128/MCB.17.3.1110; Kermorgant M, 1997, CURR GENET, V31, P302, DOI 10.1007/s002940050209; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; Liu ZC, 2003, MOL CELL, V12, P401, DOI 10.1016/S1097-2765(03)00285-5; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Liu ZC, 2001, EMBO J, V20, P7209, DOI 10.1093/emboj/20.24.7209; Palkova Z, 2002, MOL BIOL CELL, V13, P3901, DOI 10.1091/mbc.E01-12-0149; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; Riego L, 2002, BIOCHEM BIOPH RES CO, V293, P79, DOI 10.1016/S0006-291X(02)00174-2; Rose MD., 1990, METHODS YEAST GENETI; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Sekito T, 2002, MOL BIOL CELL, V13, P795, DOI 10.1091/mbc.01-10-0473; Tate JJ, 2002, J BIOL CHEM, V277, P20477, DOI 10.1074/jbc.M200962200; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; Zikanova B, 2002, BIOCHEM BIOPH RES CO, V294, P962, DOI 10.1016/S0006-291X(02)00589-2	30	41	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45882	45887		10.1074/jbc.M309301200	http://dx.doi.org/10.1074/jbc.M309301200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12966084	hybrid			2022-12-27	WOS:000186452300101
J	Nishi, J; Sheikh, J; Mizuguchi, K; Luisi, B; Burland, V; Boutin, A; Rose, DJ; Blattner, FR; Nataro, JP				Nishi, J; Sheikh, J; Mizuguchi, K; Luisi, B; Burland, V; Boutin, A; Rose, DJ; Blattner, FR; Nataro, JP			The export of coat protein from enteroaggregative Escherichia coli by a specific ATP-binding cassette transporter system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEIN; GRAM-NEGATIVE BACTERIA; STRUCTURE PREDICTION; MULTIDRUG EFFLUX; DNA-SEQUENCE; HEP-2 CELLS; ADHERENCE; VIRULENCE; SECRETION; FAMILIES	Enteroaggregative Escherichia coli (EAEC) is an emerging enteric pathogen characterized by aggregative adherence (AA) to cultured human mucosal epithelium cells. We have recently characterized a 10.2-kDa protein, called dispersin, which is exported from the bacteria and which promotes dispersal of EAEC across the intestinal mucosa. Here, we present evidence that dispersin is exported by a putative ABC transporter complex, which is encoded by a genetic locus of the EAEC virulence plasmid pAA2. We demonstrate that the locus comprises a cluster of five genes (designated aat-PABCD), including homologs of an inner-membrane permease (AatP), an ATP-binding cassette protein (AatC) and the outer membrane protein TolC (AatA). We show that, like TolC, AatA localizes to the outer membrane independently of its ABC partner. Dispersin appears to require the Aat complex for outer membrane translocation but not for secretion across the inner membrane. We also show that, like the dispersin gene, transcription of the aat cluster is dependent on AggR, a regulator of virulence genes in EAEC. We propose that the aat cluster encodes a specialized ABC transporter, which plays a role in the pathogenesis of EAEC by transporting dispersin out of the bacterial cell.	Univ Maryland, Sch Med, Ctr Vaccine Dev, Dept Pediat, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Ctr Vaccine Dev, Dept Med, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Ctr Vaccine Dev, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; Univ Wisconsin, Lab Mol & Computat Genom, Madison, WI 53706 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Cambridge; University of Wisconsin System; University of Wisconsin Madison	Nishi, J (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pediat, Sakuragaoka 8-35-1, Kagoshima 8908520, Japan.		Mizuguchi, Kenji/GVS-5857-2022	Mizuguchi, Kenji/0000-0003-3021-7078	NIAID NIH HHS [AI33096, AI44387] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI033096, R01AI033096, U01AI044387, R01AI044387] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amako K, 1996, MICROBIOL IMMUNOL, V40, P749, DOI 10.1111/j.1348-0421.1996.tb01136.x; Bao QY, 2002, GENOME RES, V12, P689, DOI 10.1101/gr.219302; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; BAUDRY B, 1990, J INFECT DIS, V161, P1249, DOI 10.1093/infdis/161.6.1249; Bernier C, 2002, INFECT IMMUN, V70, P4302, DOI 10.1128/IAI.70.8.4302-4311.2002; Binet R, 1997, GENE, V192, P7, DOI 10.1016/S0378-1119(96)00829-3; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; BURLAND V, 1993, GENOMICS, V16, P551, DOI 10.1006/geno.1993.1230; Calladine CR, 2001, J MOL BIOL, V305, P603, DOI 10.1006/jmbi.2000.4320; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Czeczulin JR, 1997, INFECT IMMUN, V65, P4135, DOI 10.1128/IAI.65.10.4135-4145.1997; Czeczulin JR, 1999, INFECT IMMUN, V67, P2692, DOI 10.1128/IAI.67.6.2692-2699.1999; Elias WP, 1999, J BACTERIOL, V181, P1779, DOI 10.1128/JB.181.6.1779-1785.1999; Eslava C, 1998, INFECT IMMUN, V66, P3155, DOI 10.1128/IAI.66.7.3155-3163.1998; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harlow E, 1998, ANTIBODIES LAB MANUA; Henderson IR, 1999, INFECT IMMUN, V67, P5338, DOI 10.1128/IAI.67.10.5338-5344.1999; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Johnson JM, 1999, J MOL BIOL, V287, P695, DOI 10.1006/jmbi.1999.2630; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letoffe S, 1996, EMBO J, V15, P5804, DOI 10.1002/j.1460-2075.1996.tb00967.x; Linton KJ, 1998, MOL MICROBIOL, V28, P5, DOI 10.1046/j.1365-2958.1998.00764.x; Mahillon J, 1998, GENE, V223, P47, DOI 10.1016/S0378-1119(98)00365-5; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MERITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; NATARO JP, 1994, J BACTERIOL, V176, P4691, DOI 10.1128/JB.176.15.4691-4699.1994; NATARO JP, 1985, J INFECT DIS, V152, P560, DOI 10.1093/infdis/152.3.560; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nataro JP, 1996, INFECT IMMUN, V64, P4761, DOI 10.1128/IAI.64.11.4761-4768.1996; Nataro JP, 1998, EMERG INFECT DIS, V4, P251, DOI 10.3201/eid0402.980212; NATARO JP, 1992, INFECT IMMUN, V60, P2297, DOI 10.1128/IAI.60.6.2297-2304.1992; NATARO JP, 1987, PEDIATR INFECT DIS J, V6, P829, DOI 10.1097/00006454-198709000-00008; NATARO JP, 1995, J INFECT DIS, V171, P465, DOI 10.1093/infdis/171.2.465; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Okeke I N, 2001, Lancet Infect Dis, V1, P304, DOI 10.1016/S1473-3099(01)00144-X; Okeke IN, 2000, J INFECT DIS, V181, P252, DOI 10.1086/315204; PENFOLD RJ, 1992, GENE, V118, P145, DOI 10.1016/0378-1119(92)90263-O; Piva IC, 2003, J CLIN MICROBIOL, V41, P1827, DOI 10.1128/JCM.41.5.1827-1832.2003; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; SCHMIDT H, 1995, J CLIN MICROBIOL, V33, P701, DOI 10.1128/JCM.33.3.701-705.1995; Servant Florence, 2002, Brief Bioinform, V3, P246, DOI 10.1093/bib/3.3.246; Sharff A, 2001, EUR J BIOCHEM, V268, P5011, DOI 10.1046/j.0014-2956.2001.02442.x; Sheikh J, 2002, J CLIN INVEST, V110, P1329, DOI 10.1172/JCI200216172; Sheikh J, 2001, MOL MICROBIOL, V41, P983, DOI 10.1046/j.1365-2958.2001.02512.x; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Skare JT, 1996, J BACTERIOL, V178, P4909, DOI 10.1128/jb.178.16.4909-4918.1996; Steiner TS, 1998, J INFECT DIS, V177, P88, DOI 10.1086/513809; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Thorstenson YR, 1997, J BACTERIOL, V179, P5333, DOI 10.1128/jb.179.17.5333-5339.1997; TZIPORI S, 1992, INFECT IMMUN, V60, P5302, DOI 10.1128/IAI.60.12.5302-5306.1992; WANDERSMAN C, 1990, P NATL ACAD SCI USA, V87, P4776, DOI 10.1073/pnas.87.12.4776; [No title captured]	59	132	139	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45680	45689		10.1074/jbc.M306413200	http://dx.doi.org/10.1074/jbc.M306413200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12933818	hybrid			2022-12-27	WOS:000186452300077
J	Espeli, O; Lee, C; Marians, KJ				Espeli, O; Lee, C; Marians, KJ			A physical and functional interaction between Escherichia coli FtsK and topoisomerase IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; DNA-REPLICATION; CELL-DIVISION; CHROMOSOME SEGREGATION; PROTEIN; LOCALIZATION; RESOLUTION; DIF; DECATENATION; POLYMERASE	FtsK and topoisomerase (Topo) IV are both involved in chromosome segregation in Escherichia coli. The former protein resides at the septal ring and is required for resolution of chromosome dimers. The latter protein is the chromosomal decatenase. We have demonstrated recently that Topo IV activity is concentrated at the septal proximal regions of the nucleoids late in the cell cycle. Here we demonstrate that FtsK and Topo IV physically and functionally interact. Topo IV was recovered in immunoprecipitates of FtsK. Two-hybrid analysis and immunoblotting showed that this interaction was mediated by the ParC subunit of Topo IV. In addition, we show that the C-terminal motor domain of FtsK stimulates the decatenation activity of Topo IV but not that of DNA gyrase, the other type II topoisomerase in the cell. Topo IV and FtsK appear to cooperate in the cell as well. Rescue of a parE temperature-sensitive mutation by overproduction of DnaX, which leads to stabilization of the temperature-sensitive Topo IV, required both the C-terminal domain of FtsK and dif, whereas rescue by overproduction of Topo III, which bypasses Topo IV function, did not. The interaction between FtsK and Topo IV may provide a means for concentrating the latter enzyme at the cell center.	Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA.		espeli, olivier/A-6337-2009	espeli, olivier/0000-0003-2804-2192	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34558] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS DE, 1992, CELL, V71, P277, DOI 10.1016/0092-8674(92)90356-H; Aussel L, 2002, CELL, V108, P195, DOI 10.1016/S0092-8674(02)00624-4; Barre FX, 2000, GENE DEV, V14, P2976, DOI 10.1101/gad.188700; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Brendler T, 2000, EMBO J, V19, P6249, DOI 10.1093/emboj/19.22.6249; CONWAY TW, 1964, P NATL ACAD SCI USA, V52, P1462, DOI 10.1073/pnas.52.6.1462; DIEDERICH L, 1994, BIOTECHNIQUES, V16, P916; Draper GC, 1998, J BACTERIOL, V180, P4621, DOI 10.1128/JB.180.17.4621-4627.1998; Dworkin J, 2002, P NATL ACAD SCI USA, V99, P14089, DOI 10.1073/pnas.182539899; Espeli O, 2003, MOL CELL, V11, P189, DOI 10.1016/S1097-2765(03)00013-3; Hendricks EC, 2000, MOL MICROBIOL, V36, P973, DOI 10.1046/j.1365-2958.2000.01920.x; Hiasa H, 1996, J BIOL CHEM, V271, P21529, DOI 10.1074/jbc.271.35.21529; Hojgaard A, 1999, MOL MICROBIOL, V33, P1027, DOI 10.1046/j.1365-2958.1999.01545.x; KATO J, 1990, CELL, V63, P393, DOI 10.1016/0092-8674(90)90172-B; KATO JI, 1988, J BACTERIOL, V170, P3967, DOI 10.1128/jb.170.9.3967-3977.1988; Koppes LJH, 1999, BIOCHIMIE, V81, P803, DOI 10.1016/S0300-9084(00)87163-1; KRASNOW MA, 1982, J BIOL CHEM, V257, P2687; Lemon KP, 2001, GENE DEV, V15, P2031, DOI 10.1101/gad.913301; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lemon KP, 2000, MOL CELL, V6, P1321, DOI 10.1016/S1097-2765(00)00130-1; LESLIE NR, 1995, EMBO J, V14, P1561, DOI 10.1002/j.1460-2075.1995.tb07142.x; Levine C, 1998, J BACTERIOL, V180, P1232, DOI 10.1128/JB.180.5.1232-1240.1998; Li YF, 2002, MOL MICROBIOL, V46, P985, DOI 10.1046/j.1365-2958.2002.03234.x; Liu GW, 1998, MOL MICROBIOL, V29, P893, DOI 10.1046/j.1365-2958.1998.00986.x; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; MARIANS KJ, 1987, J BIOL CHEM, V262, P10362; Nurse P, 2003, J BIOL CHEM, V278, P8653, DOI 10.1074/jbc.M211211200; Ohsumi K, 2001, MOL MICROBIOL, V40, P835, DOI 10.1046/j.1365-2958.2001.02447.x; PENG H, 1993, P NATL ACAD SCI USA, V90, P8571, DOI 10.1073/pnas.90.18.8571; PENG H, 1993, J BIOL CHEM, V268, P24481; Recchia GD, 1999, EMBO J, V18, P5724, DOI 10.1093/emboj/18.20.5724; Sherratt DJ, 2001, CURR OPIN MICROBIOL, V4, P653, DOI 10.1016/S1369-5274(01)00265-X; Steiner W, 1999, MOL MICROBIOL, V31, P579, DOI 10.1046/j.1365-2958.1999.01198.x; Ullsperger C, 1996, J BIOL CHEM, V271, P31549, DOI 10.1074/jbc.271.49.31549; WU LJ, 1995, GENE DEV, V9, P1316, DOI 10.1101/gad.9.11.1316	35	94	95	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44639	44644		10.1074/jbc.M308926200	http://dx.doi.org/10.1074/jbc.M308926200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12939258	hybrid			2022-12-27	WOS:000186306700095
J	Alphey, MS; Williams, RAM; Mottram, JC; Coombs, GH; Hunter, WN				Alphey, MS; Williams, RAM; Mottram, JC; Coombs, GH; Hunter, WN			The crystal structure of Leishmania major 3-mercaptopyruvate sulfurtransferase - A three-domain architecture with a serine protease-like triad at the active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE LIVER RHODANESE; ESCHERICHIA-COLI; MERCAPTOPYRUVATE SULFURTRANSFERASE; MITOCHONDRIAL RHODANESE; SUBSTITUTED RHODANESE; CATALYTIC DOMAIN; SULFUR; SEQUENCE; THIOREDOXIN; PHOSPHATASE	Leishmania major 3-mercaptopyruvate sulfurtransferase is a crescent-shaped molecule comprising three domains. The N-terminal and central domains are similar to the thiosulfate sulfurtransferase rhodanese and create the active site containing a persulfurated catalytic cysteine (Cys-253) and an inhibitory sulfite coordinated by Arg-74 and Arg-185. A serine protease-like triad, comprising Asp-61, His-75, and Ser-255, is near Cys-253 and represents a conserved feature that distinguishes 3-mercaptopyruvate sulfurtransferases from thiosulfate sulfurtransferases. During catalysis, Ser-255 may polarize the carbonyl group of 3- mercaptopyruvate to assist thiophilic attack, whereas Arg-74 and Arg-185 bind the carboxylate group. The enzyme hydrolyzes benzoyl-Arg-p-nitroanilide, an activity that is sensitive to the presence of the serine protease inhibitor N-alpha-p-tosyl-L- lysine chloromethyl ketone, which also lowers 3- mercaptopyruvate sulfurtransferase activity, presumably by interference with the contribution of Ser-255. The L. major 3- mercaptopyruvate sulfurtransferase is unusual with an 80-amino acid C-terminal domain, bearing remarkable structural similarity to the FK506-binding protein class of peptidylprolyl cis/trans-isomerase. This domain may be involved in mediating protein folding and sulfurtransferase-protein interactions.	Univ Dundee, Sch Life Sci, Div Biol Chem & Mol Microbiol, Dundee DD1 5EH, Scotland; Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Anderson Coll, Wellcome Ctr Mol Parasitol, Glasgow G11 6NU, Lanark, Scotland	University of Dundee; University of Glasgow; University of Glasgow	Hunter, WN (corresponding author), Univ Dundee, Sch Life Sci, Div Biol Chem & Mol Microbiol, Dundee DD1 5EH, Scotland.	w.n.hunter@dundee.ac.uk	Williams, Roderick/V-4317-2019; Hunter, William/AAE-3947-2019	Williams, Roderick/0000-0001-5065-9768; Mottram, Jeremy/0000-0001-5574-3766				Adams H, 2002, FEBS LETT, V518, P173, DOI 10.1016/S0014-5793(02)02695-9; Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Colnaghi R, 2001, FEBS LETT, V500, P153, DOI 10.1016/S0014-5793(01)02610-2; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Fauman EB, 1998, CELL, V93, P617, DOI 10.1016/S0092-8674(00)81190-3; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FISCHER G, 1994, ANGEW CHEM INT EDIT, V33, P1415, DOI 10.1002/anie.199414151; Gliubich F, 1996, J BIOL CHEM, V271, P21054, DOI 10.1074/jbc.271.35.21054; Gliubich F, 1998, ACTA CRYSTALLOGR D, V54, P481, DOI 10.1107/S090744499701216X; HANNESTAD U, 1981, BIOCHEM MED METAB B, V26, P106, DOI 10.1016/0006-2944(81)90035-1; Hofmann K, 1998, J MOL BIOL, V282, P195, DOI 10.1006/jmbi.1998.1998; HOL WGJ, 1983, FUND APPL TOXICOL, V3, P370, DOI 10.1016/S0272-0590(83)80007-4; HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamphausen T, 2002, PLANT J, V32, P263, DOI 10.1046/j.1365-313X.2002.01420.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krauth-Siegel RL, 1999, PARASITOL TODAY, V15, P404, DOI 10.1016/S0169-4758(99)01516-1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levitt DG, 2001, ACTA CRYSTALLOGR D, V57, P1013, DOI 10.1107/S0907444901006394; LIKJ LJ, 1983, BIOCHEMISTRY-US, V22, P2952; Meister A., 1953, FED PROC, V12, P245; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; Mueller EG, 2001, J BIOL CHEM, V276, P33588, DOI 10.1074/jbc.M104067200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGAHARA N, 1995, J BIOL CHEM, V270, P16230, DOI 10.1074/jbc.270.27.16230; Nagahara N, 1996, J BIOL CHEM, V271, P27395, DOI 10.1074/jbc.271.44.27395; Nagahara N, 1999, HISTOL HISTOPATHOL, V14, P1277, DOI 10.14670/HH-14.1277; Nakamura T, 2000, EUR J BIOCHEM, V267, P5621, DOI 10.1046/j.1432-1327.2000.01633.x; Nandi DL, 2000, INT J BIOCHEM CELL B, V32, P465, DOI 10.1016/S1357-2725(99)00035-7; Nandi DL, 1998, INT J BIOCHEM CELL B, V30, P973, DOI 10.1016/S1357-2725(98)00050-8; NICHOLLS A, 1993, GRASP MANUAL VERSION; NISHINO T, 1983, P NATL ACAD SCI-BIOL, V80, P1826, DOI 10.1073/pnas.80.7.1826; Ogasawara Y, 2001, P NATL ACAD SCI USA, V98, P9494, DOI 10.1073/pnas.171320998; OGATA K, 1990, J BIOL CHEM, V265, P8087; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; PAGANI S, 1984, EUR J BIOCHEM, V142, P361, DOI 10.1111/j.1432-1033.1984.tb08295.x; Palenchar PM, 2000, J BIOL CHEM, V275, P8283, DOI 10.1074/jbc.275.12.8283; Papenbrock J, 2000, EUR J BIOCHEM, V267, P145, DOI 10.1046/j.1432-1327.2000.00980.x; Pereira PJB, 2002, EMBO REP, V3, P88, DOI 10.1093/embo-reports/kvf009; PERRAKIS A, 1997, ACTA CRYSTALLOGR D, V30, P551; PLOEGMAN JH, 1978, J MOL BIOL, V123, P557, DOI 10.1016/0022-2836(78)90207-3; PLOEGMAN JH, 1979, J MOL BIOL, V127, P149, DOI 10.1016/0022-2836(79)90236-5; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; Quigley PM, 2003, P NATL ACAD SCI USA, V100, P3137, DOI 10.1073/pnas.0530312100; Ray WK, 2000, J BACTERIOL, V182, P2277, DOI 10.1128/JB.182.8.2277-2284.2000; Riboldi-Tunnicliffe A, 2001, NAT STRUCT BIOL, V8, P779, DOI 10.1038/nsb0901-779; SCHLESINGER P, 1974, J BIOL CHEM, V249, P780; Sinars CR, 2003, P NATL ACAD SCI USA, V100, P868, DOI 10.1073/pnas.0231020100; SORBO B, 1957, BIOCHIM BIOPHYS ACTA, V24, P324, DOI 10.1016/0006-3002(57)90201-9; Spallarossa A, 2001, STRUCTURE, V9, P1117, DOI 10.1016/S0969-2126(01)00666-9; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Williams RAM, 2003, J BIOL CHEM, V278, P1480, DOI 10.1074/jbc.M209395200; WILSON KP, 1995, ACTA CRYSTALLOGR D, V51, P511, DOI 10.1107/S0907444994014514	63	32	33	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48219	48227		10.1074/jbc.M307187200	http://dx.doi.org/10.1074/jbc.M307187200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12952945	hybrid			2022-12-27	WOS:000186731400105
J	Goransson, U; Craik, DJ				Goransson, U; Craik, DJ			Disulfide mapping of the cyclotide kalata B1 - Chemical proof of the cyclic cystine knot motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROCYCLIC PEPTIDES; PLANT CYCLOTIDES; 3-DIMENSIONAL STRUCTURE; SELECTIVE REDUCTION; STRUCTURAL MOTIF; PROTEINS; POLYPEPTIDES; CIRCULIN; TRYPSIN; ELUCIDATION	The cyclotides are a recently discovered family of plant proteins that have the fascinating structural feature of a continuous cyclic backbone and, putatively, a knotted arrangement of their three conserved disulfide bonds. We here show definite chemical proof of the I-IV, II-V, III-VI knotted disulfide connectivity of the prototypic cyclotide kalata B1. This has been achieved by a new approach for disulfide analysis, involving partial reduction and stepwise alkylation including introduction of charges and enzymatic cleavage sites by aminoethylation of cysteines. The approach overcomes the intrinsic difficulties for disulfide mapping of cyclotides, i.e. the cyclic amide backbone, lack of cleavage sites between cysteines, and a low or clustered content of basic amino acids, and allowed a direct determination of the disulfide bonds in kalata B1 using analysis by mass spectrometry. The established disulfide connectivity is unequivocally shown to be cystine knotted by a topological analysis. This is the first direct chemical determination of disulfides in native cyclotides and unambiguously confirms the unique cyclic cystine knot motif.	Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Uppsala Univ, Ctr Biomed, Dept Med Chem, Div Pharmacognosy, S-75123 Uppsala, Sweden	University of Queensland; Uppsala University		d.craik@imb.uq.edu.au	Craik, David/B-1695-2010	Craik, David/0000-0003-0007-6796; Goransson, Ulf/0000-0002-5005-9612				Bokesch HR, 2001, J NAT PROD, V64, P249, DOI 10.1021/np000372l; Broussalis AM, 2001, PHYTOCHEMISTRY, V58, P47, DOI 10.1016/S0031-9422(01)00173-X; BURNS JA, 1991, J ORG CHEM, V56, P2648, DOI 10.1021/jo00008a014; Claeson P, 1998, J NAT PROD, V61, P77, DOI 10.1021/np970342r; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2001, TOXICON, V39, P1809, DOI 10.1016/S0041-0101(01)00129-5; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Craik DJ, 2002, CURR OPIN DRUG DI DE, V5, P251; Daly NL, 2003, J BIOL CHEM, V278, P6314, DOI 10.1074/jbc.M210492200; Derua R, 1996, BIOCHEM BIOPH RES CO, V228, P632, DOI 10.1006/bbrc.1996.1708; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; Goransson U, 2003, ANAL BIOCHEM, V318, P107, DOI 10.1016/S0003-2697(03)00114-3; Goransson U, 1999, J NAT PROD, V62, P283, DOI 10.1021/np9803878; GRAN L, 1973, ACTA PHARMACOL TOX, V33, P400; GRAN L, 1973, LLOYDIA, V36, P174; GRAY W. R., 1997, PROTEIN STRUCTURE PR, P165; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; GRAY WR, 1993, PROTEIN SCI, V2, P1749, DOI 10.1002/pro.5560021018; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Gustafson KR, 2000, J NAT PROD, V63, P176, DOI 10.1021/np990432r; Hallock YF, 2000, J ORG CHEM, V65, P124, DOI 10.1021/jo990952r; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; ISHII Y, 1986, BIOPHYS J, V50, P75, DOI 10.1016/S0006-3495(86)83440-3; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; LIANG CZ, 1995, J AM CHEM SOC, V117, P4201, DOI 10.1021/ja00120a001; Lindholm P, 2002, MOL CANCER THER, V1, P365; LINDLEY H, 1956, NATURE, V178, P647, DOI 10.1038/178647a0; Mislow K, 1996, CROAT CHEM ACTA, V69, P1385; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Rucker C, 2002, MATCH-COMMUN MATH CO, P153; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SHON KJ, 1994, BIOCHEMISTRY-US, V33, P11420, DOI 10.1021/bi00204a003; Skjeldal L, 2002, ARCH BIOCHEM BIOPHYS, V399, P142, DOI 10.1006/abbi.2002.2769; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Trabi M, 2001, BIOCHEMISTRY-US, V40, P4211, DOI 10.1021/bi002028t; van den Hooven HW, 2001, BIOCHEMISTRY-US, V40, P3458, DOI 10.1021/bi0023089; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002; Wu J, 1998, ANAL BIOCHEM, V258, P268, DOI 10.1006/abio.1998.2596; Wu J, 1998, PROTEIN SCI, V7, P1017; Wu J, 1997, PROTEIN SCI, V6, P391; Wu J, 1996, ANAL BIOCHEM, V235, P161, DOI 10.1006/abio.1996.0108	44	122	122	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48188	48196		10.1074/jbc.M308771200	http://dx.doi.org/10.1074/jbc.M308771200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12960160	hybrid			2022-12-27	WOS:000186731400101
J	Im, YJ; Lee, JH; Park, SH; Park, SJ; Rho, SH; Kang, GB; Kim, E; Eom, SH				Im, YJ; Lee, JH; Park, SH; Park, SJ; Rho, SH; Kang, GB; Kim, E; Eom, SH			Crystal structure of the Shank PDZ-ligand complex reveals a class IPDZ interaction and a novel PDZ-PDZ dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC DENSITY PROTEINS; SYNAPTIC PROTEINS; CARBOXYL-TERMINI; BETA-PIX; FAMILY; DOMAIN; RECOGNITION; MULTIMERIZATION; ASSOCIATION; REGULATOR	The Shank/proline-rich synapse-associated protein family of multidomain proteins is known to play an important role in the organization of synaptic multiprotein complexes. For instance, the Shank PDZ domain binds to the C termini of guanylate kinase-associated proteins, which in turn interact with the guanylate kinase domain of postsynaptic density-95 scaffolding proteins. Here we describe the crystal structures of Shank1 PDZ in its peptide free form and in complex with the C-terminal hexapeptide (EAQTRL) of guanylate kinase-associated protein (GKAP1a) determined at 1.8- and 2.25-Angstrom resolutions, respectively. The structure shows the typical class I PDZ interaction of PDZ-peptide complex with the consensus sequence -X-(Thr/Ser)-X-Leu. In addition, Asp-634 within the Shank1 PDZ domain recognizes the positively charged Arg at - 1 position and hydrogen bonds, and salt bridges between Arg-607 and the side chains of the ligand at - 3 and - 5 positions contribute further to the recognition of the peptide ligand. Remarkably, whether free or complexed, Shank1 PDZ domains form dimers with a conserved betaB/betaC loop and N-terminal betaA strands, suggesting a novel model of PDZ-PDZ homodimerization. This implies that antiparallel dimerization through the N-terminal betaA strands could be a common configuration among PDZ dimers. Within the dimeric structure, the two-peptide binding sites are arranged so that the N termini of the bound peptide ligands are in close proximity and oriented toward the 2-fold axis of the dimer. This configuration may provide a means of facilitating dimeric organization of PDZ-target assemblies.	Kwangju Inst Sci & Technol, Dept Life Sci, Gwangju 500712, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Natl Creat Res Initiat Ctr Synaptogenesis, Taejon 305701, South Korea	Gwangju Institute of Science & Technology (GIST); Korea Advanced Institute of Science & Technology (KAIST)	Eom, SH (corresponding author), Kwangju Inst Sci & Technol, Dept Life Sci, Gwangju 500712, South Korea.		Kim, Eunjoon/C-1566-2011	Rho, Seong-Hwan/0000-0002-8650-8205; Park, Soo Jeong/0000-0002-9224-9932				Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Karthikeyan S, 2001, J MOL BIOL, V308, P963, DOI 10.1006/jmbi.2001.4634; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kim S, 2001, J BIOL CHEM, V276, P10581, DOI 10.1074/jbc.C000806200; Kimple ME, 2001, EMBO J, V20, P4414, DOI 10.1093/emboj/20.16.4414; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Oh WK, 1997, BIOCHEM BIOPH RES CO, V235, P794, DOI 10.1006/bbrc.1997.6875; Park E, 2003, J BIOL CHEM, V278, P19220, DOI 10.1074/jbc.M301052200; Park SH, 2002, ACTA CRYSTALLOGR D, V58, P1353, DOI 10.1107/S0907444902009162; Sheng M, 2000, J CELL SCI, V113, P1851; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Yao I, 1999, J BIOL CHEM, V274, P27463, DOI 10.1074/jbc.274.39.27463	38	85	92	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48099	48104		10.1074/jbc.M306919200	http://dx.doi.org/10.1074/jbc.M306919200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12954649	hybrid			2022-12-27	WOS:000186731400090
J	Numao, S; Kuntz, DA; Withers, SG; Rose, DR				Numao, S; Kuntz, DA; Withers, SG; Rose, DR			Insights into the mechanism of Drosophila melanogaster Golgi alpha-mannosidase II through the structural analysis of covalent reaction intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-SEQUENCE SIMILARITIES; GLYCOSIDASE MECHANISMS; CATALYTIC NUCLEOPHILE; IDENTIFICATION; CRYSTALLOGRAPHY; CLASSIFICATION; METASTASIS; DISTORTION; FLUORIDES; FAMILIES	The family 38 golgi alpha-mannosidase II, thought to cleave mannosidic bonds through a double displacement mechanism involving a reaction intermediate, is a clinically important enzyme involved in glycoprotein processing. The structure of three different covalent glycosyl-enzyme intermediates have been determined to 1.2-Angstrom resolution for the Golgi alpha-mannosidase II from Drosophila melanogaster by use of fluorinated sugar analogues, both with the wild-type enzyme and a mutant enzyme in which the acid/base catalyst has been removed. All these structures reveal sugar intermediates bound in a distorted S-1(5) skew boat conformation. The similarity of this conformation with that of the substrate in the recently determined structure of the Michaelis complex of a beta-mannanase (Ducros, V. M. A., Zechel, D. L., Murshudov, G. N., Gilbert, H. J., Szabo, L., Stoll, D., Withers, S. G., and Davies, G. J. (2002) Angew. Chem. Int. Ed. Engl. 41, 2824 - 2827) suggests that these disparate enzymes have recruited common stereoelectronic features in evolving their catalytic mechanisms.	Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; Princess Margaret Hosp, Ontario Canc Inst, Div Mol & Struct Biol, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of British Columbia; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Rose, DR (corresponding author), Ontario Canc Inst, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.			Numao, Shin/0000-0002-6204-7117				Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunger AT, 2002, ACCOUNTS CHEM RES, V35, P404, DOI 10.1021/ar010034r; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURDA P, 1999, IOCH BIOPHYS ACTA, V1426, P239; Couldrey C, 2000, BREAST CANCER RES, V2, P321, DOI 10.1186/bcr75; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; DeLano W, 2002, PYMOL 0 99; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Deslongchamps P., 1983, ORGANIC CHEM SERIES, V1; Ducros VMA, 2002, ANGEW CHEM INT EDIT, V41, P2824, DOI 10.1002/1521-3773(20020802)41:15<2824::AID-ANIE2824>3.0.CO;2-G; Goss PE, 1997, CLIN CANCER RES, V3, P1077; Goss PE, 1995, CLIN CANCER RES, V1, P935; Granovsky M, 2000, NAT MED, V6, P306; HALL LD, 1971, CAN J CHEMISTRY, V49, P118, DOI 10.1139/v71-017; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Henrissat B, 1998, BIOCHEM SOC T, V26, P153, DOI 10.1042/bst0260153; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Herscovics A, 1999, BBA-GEN SUBJECTS, V1473, P96, DOI 10.1016/S0304-4165(99)00171-3; Howard S, 1997, BIOCHEM BIOPH RES CO, V238, P896, DOI 10.1006/bbrc.1997.7148; Howard S, 1998, J BIOL CHEM, V273, P2067, DOI 10.1074/jbc.273.4.2067; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; LEATHERBARROW RJ, 2001, GRAFIT VERSION 4 0 1; Lowry T. H., 1987, MECH THEORY ORGANIC; McCarter JD, 1996, J BIOL CHEM, V271, P6889, DOI 10.1074/jbc.271.12.6889; Numao S, 2000, FEBS LETT, V484, P175, DOI 10.1016/S0014-5793(00)02148-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SHARMA SK, 1995, TETRAHEDRON LETT, V36, P5627; Sidhu G, 1999, BIOCHEMISTRY-US, V38, P5346, DOI 10.1021/bi982946f; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; STODDART JF, 1971, STEREOCHEMISTRY CARB, P49; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; van den Elsen JMH, 2001, EMBO J, V20, P3008, DOI 10.1093/emboj/20.12.3008; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	36	86	86	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48074	48083		10.1074/jbc.M309249200	http://dx.doi.org/10.1074/jbc.M309249200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12960159	hybrid			2022-12-27	WOS:000186731400087
J	Bianchi, V; Spychala, J				Bianchi, V; Spychala, J			Mammalian 5 '-nucleotidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CYTOSOLIC 5'-NUCLEOTIDASE; PYRIMIDINE 5'-NUCLEOTIDASE; ADENOSINE FORMATION; ESCHERICHIA-COLI; 5-NUCLEOTIDASE; CLONING; IMP; OVEREXPRESSION; CELLS; 5'(3')-DEOXYRIBONUCLEOTIDASE		Univ Padua, Dept Biol, I-35131 Padua, Italy; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Padua; University of North Carolina; University of North Carolina Chapel Hill	Bianchi, V (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.	vbianchi@mail.bio.unipd.it			NCI NIH HHS [R01 CA 34085] Funding Source: Medline; Telethon [GP0140Y01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA034085] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Telethon(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allegrin S, 2001, J BIOL CHEM, V276, P33526, DOI 10.1074/jbc.M104088200; Amici A, 2000, BLOOD, V96, P1596, DOI 10.1182/blood.V96.4.1596.h8001596_1596_1598; Amici A, 1997, FEBS LETT, V419, P263, DOI 10.1016/S0014-5793(97)01464-6; CARSON DA, 1991, BIOCHIM BIOPHYS ACTA, V1091, P22, DOI 10.1016/0167-4889(91)90216-K; Gallinaro L, 2002, J BIOL CHEM, V277, P35080, DOI 10.1074/jbc.M203755200; Galmarini CM, 2003, BRIT J HAEMATOL, V122, P53, DOI 10.1046/j.1365-2141.2003.04386.x; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Garvey EP, 1998, BIOCHEMISTRY-US, V37, P9043, DOI 10.1021/bi980209d; Gazziola C, 2001, J BIOL CHEM, V276, P6185, DOI 10.1074/jbc.M007623200; Gazziola C, 1999, EXP CELL RES, V253, P474, DOI 10.1006/excr.1999.4681; Hansen KR, 1995, GENE, V167, P307, DOI 10.1016/0378-1119(95)00574-9; HOGLUND L, 1990, J BIOL CHEM, V265, P6589; Hunsucker SA, 2001, J BIOL CHEM, V276, P10498, DOI 10.1074/jbc.M011218200; ITOH R, 1993, COMP BIOCHEM PHYS B, V105, P13, DOI 10.1016/0305-0491(93)90163-Y; JOHNSON MA, 1989, MOL PHARMACOL, V36, P291; KELLER PM, 1985, J BIOL CHEM, V260, P8664; Knofel T, 1999, NAT STRUCT BIOL, V6, P448; Knofel T, 2001, J MOL BIOL, V309, P239, DOI 10.1006/jmbi.2001.4656; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Marinaki AM, 2001, BLOOD, V97, P3327, DOI 10.1182/blood.V97.11.3327; Mazzon C, 2003, BIOCHEM PHARMACOL, V66, P471, DOI 10.1016/S0006-2952(03)00290-9; MISUMI Y, 1990, EUR J BIOCHEM, V191, P563, DOI 10.1111/j.1432-1033.1990.tb19158.x; OKA J, 1994, BIOCHEM BIOPH RES CO, V205, P917, DOI 10.1006/bbrc.1994.2752; PESI R, 1994, ARCH BIOCHEM BIOPHYS, V312, P75, DOI 10.1006/abbi.1994.1282; PIEC G, 1991, BIOCHEM J, V273, P409, DOI 10.1042/bj2730409; Rampazzo C, 2000, J BIOL CHEM, V275, P5409, DOI 10.1074/jbc.275.8.5409; Rampazzo C, 2002, BIOCHEM BIOPH RES CO, V293, P258, DOI 10.1016/S0006-291X(02)00206-1; Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239; Rampazzo C, 1999, EUR J BIOCHEM, V261, P689, DOI 10.1046/j.1432-1327.1999.00320.x; Rees DC, 2003, BRIT J HAEMATOL, V120, P375, DOI 10.1046/j.1365-2141.2003.03980.x; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Resta R, 1998, IMMUNOL REV, V161, P95, DOI 10.1111/j.1600-065X.1998.tb01574.x; Rinaldo-Matthis A, 2002, NAT STRUCT BIOL, V9, P779, DOI 10.1038/nsb846; Sala-Newby GB, 1999, J BIOL CHEM, V274, P17789, DOI 10.1074/jbc.274.25.17789; Sala-Newby GB, 2003, AM J PHYSIOL-HEART C, V285, pH991, DOI 10.1152/ajpheart.00053.2003; Sala-Newby GB, 2001, BBA-GENE STRUCT EXPR, V1521, P12, DOI 10.1016/S0167-4781(01)00278-0; Sala-Newby GB, 2000, J BIOL CHEM, V275, P11666, DOI 10.1074/jbc.275.16.11666; SKLADANOWSKI AC, 1989, BIOCHEM J, V262, P203, DOI 10.1042/bj2620203; Spychala J, 1999, J BIOL CHEM, V274, P22705, DOI 10.1074/jbc.274.32.22705; Spychala J, 1999, EUR J BIOCHEM, V259, P851, DOI 10.1046/j.1432-1327.1999.00099.x; Spychala J, 2000, PHARMACOL THERAPEUT, V87, P161, DOI 10.1016/S0163-7258(00)00053-X; SPYCHALA J, 1988, J BIOL CHEM, V263, P18759; WORKU Y, 1982, BIOCHEM J, V205, P503, DOI 10.1042/bj2050503; Yegutkin GG, 2002, BIOCHEM J, V367, P121, DOI 10.1042/BJ20020439; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	46	175	177	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46195	46198		10.1074/jbc.R300032200	http://dx.doi.org/10.1074/jbc.R300032200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12947102	hybrid, Green Published			2022-12-27	WOS:000186569400001
J	Crimeen-Irwin, B; Ellis, S; Christiansen, D; Ludford-Menting, MJ; Milland, J; Lanteri, M; Loveland, BE; Gerlier, D; Russell, SM				Crimeen-Irwin, B; Ellis, S; Christiansen, D; Ludford-Menting, MJ; Milland, J; Lanteri, M; Loveland, BE; Gerlier, D; Russell, SM			Ligand binding determines whether CD46 is internalized by clathrin-coated pits or macropinocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE COFACTOR PROTEIN; II-RESTRICTED PRESENTATION; MEASLES-VIRUS INFECTION; MHC CLASS-II; DIFFERENTIAL DOWN-REGULATION; COMPLEMENT-MEDIATED LYSIS; CELLULAR PILUS RECEPTOR; T-CELLS; NEISSERIA-GONORRHOEAE; CYTOPLASMIC DOMAINS	CD46 is a ubiquitous human cell surface receptor for the complement components C3b and C4b and for various pathogens, including the measles virus and human herpes virus 6. Ligand binding to CD46 affects (i) protection of autologous cells from complement attack by breakdown of complement components, (ii) intracellular signals that affect the regulation of immune cell function, (iii) antigen presentation, and (iv) down-regulation of cell surface CD46. Recent evidence indicates that CD46 signaling can link innate and acquired immune function. The molecular mechanisms for these processes and the importance of intracellular trafficking of the receptor have not yet been elucidated. We demonstrate here that, in nonlymphoid cells, CD46 is constitutively internalized via clathrin-coated pits, traffics to multivesicular bodies, and is recycled to the cell surface. However, cross-linking of CD46 at the cell surface, by either multivalent antibody or by measles virus, induces pseudopodia that engulf the ligand in a process similar to macropinocytosis, and leads to the degradation of cell surface CD46. Thus, we have elucidated two pathways for CD46 internalization, which are regulated by the valence of cross-linking of CD46 and which utilize either clathrin-coated pits or pseudopodial extension. This has important implications for CD46 signaling, antigen presentation, CD46 down-regulation, and engulfment of pathogens.	Peter MacCallum Canc Ctr, Trescowthick Res Labs, Melbourne, Vic 3002, Australia; Austin Hlth, Austin Res Inst, Heidelberg, Vic 3084, Australia; UCBL, CNRS, UMR 5537, Inst Federatif Laennec, F-69372 Lyon, France	Peter Maccallum Cancer Center; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Russell, SM (corresponding author), Peter MacCallum Canc Ctr, Trescowthick Res Labs, St Andrews Pl, Melbourne, Vic 3002, Australia.		Gerlier, Denis/L-6094-2014; Russell, Sarah M/B-9341-2009	Gerlier, Denis/0000-0001-5539-456X; Russell, Sarah M/0000-0001-5826-9641; Milland, Julie/0000-0003-1368-220X; Ellis, Sarah/0000-0002-5772-6051				Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Astier A, 2000, J IMMUNOL, V164, P6091, DOI 10.4049/jimmunol.164.12.6091; BACALLAO R, 1995, SEMIN NEPHROL, V15, P285; Bansal P, 1999, J IMMUNOL, V162, P4430; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bremnes T, 1998, J BIOL CHEM, V273, P8638, DOI 10.1074/jbc.273.15.8638; Brown BK, 1999, J BIOL CHEM, V274, P11439, DOI 10.1074/jbc.274.16.11439; Cardoso AI, 1996, J GEN VIROL, V77, P2695, DOI 10.1099/0022-1317-77-11-2695; CARDOSO AI, 1995, VIROLOGY, V212, P255, DOI 10.1006/viro.1995.1479; Christiansen D, 2000, J GEN VIROL, V81, P911, DOI 10.1099/0022-1317-81-4-911; Clague MJ, 2001, J CELL SCI, V114, P3075; COYNE KE, 1992, J IMMUNOL, V149, P2906; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Eugene E, 2002, J CELL SCI, V115, P1231; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; FENICHEL P, 1989, J REPROD FERTIL, V87, P699; Firsching R, 1999, J VIROL, V73, P5265, DOI 10.1128/JVI.73.7.5265-5273.1999; GERLIER D, 1994, CELL BIOL INT, V18, P315, DOI 10.1006/cbir.1994.1080; GERLIER D, 1994, J EXP MED, V179, P353, DOI 10.1084/jem.179.1.353; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Hirano A, 1996, J VIROL, V70, P6929, DOI 10.1128/JVI.70.10.6929-6936.1996; Hirano A, 1999, J VIROL, V73, P4776, DOI 10.1128/JVI.73.6.4776-4785.1999; Hoffmann I, 2001, J CELL BIOL, V155, P133, DOI 10.1083/jcb.200106148; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Inverardi L, 1997, TRANSPLANTATION, V63, P1318, DOI 10.1097/00007890-199705150-00021; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kallstrom H, 2001, CELL MICROBIOL, V3, P133, DOI 10.1046/j.1462-5822.2001.00095.x; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; Katayama Y, 2000, J VIROL, V74, P1252, DOI 10.1128/JVI.74.3.1252-1257.2000; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Kleijmeer MJ, 2001, TRAFFIC, V2, P124, DOI 10.1034/j.1600-0854.2001.020207.x; KRANTIC S, 1995, J GEN VIROL, V76, P2793, DOI 10.1099/0022-1317-76-11-2793; Kurita-Taniguchi M, 2000, J IMMUNOL, V165, P5143, DOI 10.4049/jimmunol.165.9.5143; LAMAZE C, 1995, CURR OPIN CELL BIOL, V7, P573, DOI 10.1016/0955-0674(95)80015-8; Lecouturier V, 1996, J VIROL, V70, P4200, DOI 10.1128/JVI.70.7.4200-4204.1996; Lee SW, 2002, J CELL BIOL, V156, P951, DOI 10.1083/jcb.200109005; Ludford-Menting MJ, 2002, J BIOL CHEM, V277, P4477, DOI 10.1074/jbc.M108479200; Maisner A, 1997, J BIOL CHEM, V272, P20793, DOI 10.1074/jbc.272.33.20793; MALVOISIN E, 1993, J GEN VIROL, V74, P2365, DOI 10.1099/0022-1317-74-11-2365; Marie JC, 2001, IMMUNITY, V14, P69, DOI 10.1016/S1074-7613(01)00090-5; Marie JC, 2002, NAT IMMUNOL, V3, P659, DOI 10.1038/ni810; Milland J, 2002, J BIOL CHEM, V277, P10374, DOI 10.1074/jbc.M111799200; Milland J, 1996, EUR J BIOCHEM, V238, P221, DOI 10.1111/j.1432-1033.1996.0221q.x; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; NANICHE D, 1993, J GEN VIROL, V74, P1073, DOI 10.1099/0022-1317-74-6-1073; Nobes C, 2000, CURR BIOL, V10, pR739, DOI 10.1016/S0960-9822(00)00736-3; OGLESBY TJ, 1992, J EXP MED, V175, P1547, DOI 10.1084/jem.175.6.1547; OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489; Pelchen-Matthews A, 1998, EUR J IMMUNOL, V28, P3639, DOI 10.1002/(SICI)1521-4141(199811)28:11<3639::AID-IMMU3639>3.0.CO;2-Q; PELCHENMATTHEWS A, 1993, J EXP MED, V178, P1209, DOI 10.1084/jem.178.4.1209; Peppelenbosch MP, 2000, J IMMUNOL, V165, P1984, DOI 10.4049/jimmunol.165.4.1984; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; PURCELL DFJ, 1990, IMMUNOLOGY, V70, P155; PURCELL DFJ, 1991, IMMUNOGENETICS, V33, P335, DOI 10.1007/BF00216692; Rivailler P, 1998, EUR J IMMUNOL, V28, P1301, DOI 10.1002/(SICI)1521-4141(199804)28:04<1301::AID-IMMU1301>3.0.CO;2-S; RUSSELL SM, 1992, EUR J IMMUNOL, V22, P1513, DOI 10.1002/eji.1830220625; SANDRIN MS, 1987, IMMUNOGENETICS, V25, P279, DOI 10.1007/BF00404419; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; SchneiderSchaulies J, 1996, J VIROL, V70, P255, DOI 10.1128/JVI.70.1.255-263.1996; SCHNEIDERSCHAULIES J, 1995, J VIROL, V69, P7257, DOI 10.1128/JVI.69.11.7257-7259.1995; SCHNEIDERSCHAULIES J, 1995, P NATL ACAD SCI USA, V92, P3943, DOI 10.1073/pnas.92.9.3943; SCHNORR JJ, 1995, EUR J IMMUNOL, V25, P976, DOI 10.1002/eji.1830250418; SEYA T, 1990, J EXP MED, V172, P1673, DOI 10.1084/jem.172.6.1673; SPARROW RL, 1983, HUM IMMUNOL, V7, P1, DOI 10.1016/0198-8859(83)90002-2; Teuchert M, 1999, J BIOL CHEM, V274, P19979, DOI 10.1074/jbc.274.28.19979; VARIORKRISHNAN G, 1994, J VIROL, V68, P7891, DOI 10.1128/JVI.68.12.7891-7899.1994; Wang GX, 2000, J IMMUNOL, V164, P1839, DOI 10.4049/jimmunol.164.4.1839; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8; Yamazaki T, 2002, J CELL SCI, V115, P1791; Yant S, 1997, J VIROL, V71, P766, DOI 10.1128/JVI.71.1.766-770.1997; Zaffran Y, 2001, J IMMUNOL, V167, P6780, DOI 10.4049/jimmunol.167.12.6780	75	66	67	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 21	2003	278	47					46927	46937		10.1074/jbc.M308261200	http://dx.doi.org/10.1074/jbc.M308261200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	743JV	12958316	hybrid			2022-12-27	WOS:000186569400087
J	Benderdour, M; Charron, G; deBlois, D; Comte, B; Des Rosiers, C				Benderdour, M; Charron, G; deBlois, D; Comte, B; Des Rosiers, C			Cardiac mitochondrial NADP(+)-isocitrate dehydrogenase is inactivated through 4-hydroxynonenal adduct formation - An event that precedes hypertrophy development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ISOCITRATE DEHYDROGENASE; ALPHA-KETOGLUTARATE DEHYDROGENASE; SPONTANEOUSLY HYPERTENSIVE RATS; OXIDATIVE STRESS; LIPID-PEROXIDATION; CARDIOVASCULAR-DISEASES; SELECTIVE INACTIVATION; FAILING MYOCARDIUM; SUPEROXIDE ANION; HEART-FAILURE	Mitochondrial NADP(+)-isocitrate dehydrogenase activity is crucial for cardiomyocyte energy and redox status, but much remains to be learned about its role and regulation. We obtained data in spontaneously hypertensive rat hearts that indicated a partial inactivation of this enzyme before hypertrophy development. We tested the hypothesis that cardiac mitochondrial NADP(+)-isocitrate dehydrogenase is a target for modification by the lipid peroxidation product 4-hydroxynonenal, an aldehyde that reacts readily with protein sulfhydryl and amino groups. This hypothesis is supported by the following in vitro and in vivo evidence. In isolated rat heart mitochondria, enzyme inactivation occurred within a few minutes upon incubation with 4-hydroxynonenal and was paralleled by 4-hydroxynonenal/NADP(+)-isocitrate dehydrogenase adduct formation. Enzyme inactivation was prevented by the addition of its substrate isocitrate or a thiol, cysteine or glutathione, suggesting that 4-hydroxynonenal binds to a cysteine residue near the substrate's binding site. Using an immunoprecipitation approach, we demonstrated the formation of 4-hydroxynonenal/NADP(+)-isocitrate dehydrogenase adducts in the heart and their increased level (210%) in 7-week-old spontaneously hypertensive rats compared with control Wistar Kyoto rats. To the best of our knowledge, this is the first study to demonstrate that mitochondrial NADP(+)-isocitrate dehydrogenase is a target for inactivation by 4-hydroxynonenal binding. Furthermore, the pathophysiological significance of our finding is supported by in vivo evidence. Taken altogether, our results have implications that extend beyond mitochondrial NADP(+)-isocitrate dehydrogenase. Indeed, they emphasize the implication of post-translational modifications of mitochondrial metabolic enzymes by 4-hydroxynonenal in the early oxidative stress-related pathophysiological events linked to cardiac hypertrophy development.	Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Des Rosiers, C (corresponding author), Ctr Hosp Univ Montreal, Hop Notre Dame Y3616, Lab Metab Intermediaire, 1560 Rue Sherbrooke E, Montreal, PQ H2L 4M1, Canada.		Rosiers, Christine Des/O-6285-2014					Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; BLASIG IE, 1995, AM J PHYSIOL-HEART C, V269, pH14, DOI 10.1152/ajpheart.1995.269.1.H14; Borutaite V, 2003, FEBS LETT, V541, P1, DOI 10.1016/S0014-5793(03)00278-3; Burcham PC, 2002, TOXICOLOGY, V181, P229, DOI 10.1016/S0300-483X(02)00287-1; Chen JJ, 2001, J MOL CELL CARDIOL, V33, P1919, DOI 10.1006/jmcc.2001.1454; Cheung PY, 1998, ARCH BIOCHEM BIOPHYS, V350, P104, DOI 10.1006/abbi.1997.0496; Comte B, 2002, AM J PHYSIOL-HEART C, V283, pH1505, DOI 10.1152/ajpheart.00287.2002; Cosentino F, 1998, J CLIN INVEST, V101, P1530, DOI 10.1172/JCI650; Dai LJ, 2001, AM J PHYSIOL-HEART C, V281, pH2261, DOI 10.1152/ajpheart.2001.281.6.H2261; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Eaton P, 1999, AM J PHYSIOL-HEART C, V276, pH935, DOI 10.1152/ajpheart.1999.276.3.H935; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; GRUNE T, 1994, CELL BIOCHEM FUNCT, V12, P143, DOI 10.1002/cbf.290120210; HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715; Haraguchi CM, 2003, J HISTOCHEM CYTOCHEM, V51, P215, DOI 10.1177/002215540305100210; HUH TL, 1993, BIOCHEM J, V292, P705, DOI 10.1042/bj2920705; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P552, DOI 10.1021/bi971958i; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Korotchkina LG, 2001, FREE RADICAL BIO MED, V30, P992, DOI 10.1016/S0891-5849(01)00491-9; Leonarduzzi G, 2000, FREE RADICAL BIO MED, V28, P1370, DOI 10.1016/S0891-5849(00)00216-1; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Lucas DT, 1998, P NATL ACAD SCI USA, V95, P510, DOI 10.1073/pnas.95.2.510; Lucas DT, 1999, P NATL ACAD SCI USA, V96, P6689, DOI 10.1073/pnas.96.12.6689; Mak S, 2001, CHEST, V120, P2035, DOI 10.1378/chest.120.6.2035; McIntyre M, 1999, HYPERTENSION, V34, P539, DOI 10.1161/01.HYP.34.4.539; Nakagami H, 2003, J MOL CELL CARDIOL, V35, P851, DOI 10.1016/S0022-2828(03)00145-7; Nakamura K, 2002, CIRCULATION, V105, P2867, DOI 10.1161/01.CIR.0000018605.14470.DD; Nulton-Persson AC, 2003, BIOCHEMISTRY-US, V42, P4235, DOI 10.1021/bi027370f; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Poli G, 2000, IUBMB LIFE, V50, P315, DOI 10.1080/15216540051081092; Reckelhoff JF, 2003, AM J PHYSIOL-REG I, V284, pR893, DOI 10.1152/ajpregu.00491.2002; Sadek HA, 2002, ARCH BIOCHEM BIOPHYS, V406, P222, DOI 10.1016/S0003-9861(02)00446-0; Sawyer DB, 2002, J MOL CELL CARDIOL, V34, P379, DOI 10.1006/jmcc.2002.1526; SAZANOV LA, 1994, FEBS LETT, V344, P109, DOI 10.1016/0014-5793(94)00370-X; SHIMAMOTO N, 1982, BASIC RES CARDIOL, V77, P359, DOI 10.1007/BF02005337; SMYTH GE, 1991, J BIOL CHEM, V266, P14918; Srivastava S, 1998, J BIOL CHEM, V273, P10893, DOI 10.1074/jbc.273.18.10893; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Toyokuni S, 2000, ANTIOXID REDOX SIGN, V2, P681, DOI 10.1089/ars.2000.2.4-681; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; Veronneau M, 2002, FREE RADICAL BIO MED, V33, P1380; Yang ES, 2002, FREE RADICAL BIO MED, V33, P927, DOI 10.1016/S0891-5849(02)00981-4; Yang LP, 1996, J CELL BIOCHEM, V60, P400, DOI 10.1002/(SICI)1097-4644(19960301)60:3<400::AID-JCB11>3.3.CO;2-2; Yang YS, 2003, ACTA BIOCHIM POL, V50, P319; Zalba G, 2001, HYPERTENSION, V38, P1395, DOI 10.1161/hy1201.099611	50	105	108	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45154	45159		10.1074/jbc.M306285200	http://dx.doi.org/10.1074/jbc.M306285200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12960146	hybrid			2022-12-27	WOS:000186452300015
J	Lee, JH; Ghirlando, R; Bhaskara, V; Hoffmeyer, MR; Gu, J; Paull, TT				Lee, JH; Ghirlando, R; Bhaskara, V; Hoffmeyer, MR; Gu, J; Paull, TT			Regulation of Mre11/Rad50 by Nbs1 - Effects on nucleotide-dependent DNA binding and association with ataxia-telangiectasia-like disorder mutant complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIJMEGEN BREAKAGE SYNDROME; DOUBLE-STRAND BREAKS; FORKHEAD-ASSOCIATED DOMAIN; SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; HUMAN RAD50/MRE11; DAMAGE RESPONSE; PROTEIN COMPLEX; FOCUS FORMATION; REPAIR COMPLEX	The Mre11/Rad50 complex is a critical component of the cellular response to DNA double-strand breaks, in organisms ranging from archaebacteria to humans. In mammalian cells, Mre11/Rad50 (M/R) associates with a third component, Nbs1, that regulates its activities and is targeted by signaling pathways that initiate DNA damage-induced checkpoint responses. Mutations in the genes that encode Nbs1 and Mre11 are responsible for the human radiation sensitivity disorders Nijmegen breakage syndrome (NBS) and ataxia-telangiectasia-like disorder (ATLD), respectively, which are characterized by defective checkpoint responses and high levels of chromosomal abnormalities. Here we demonstrate nucleotide-dependent DNA binding by the human M/R complex that requires the Nbs1 protein and is specific for double-strand DNA duplexes. Efficient DNA binding is only observed with non-hydrolyzable analogs of ATP, suggesting that ATP hydrolysis normally effects DNA release. The alleles of MRE11 associated with ATLD and the C-terminal Nbs1 polypeptide associated with NBS were expressed with the other components and found to form triple complexes except in the case of ATLD 3/4, which exhibits variability in Nbs1 association. The ATLD 1/2, ATLD 3/4, and p70 M/R/N complexes exhibit nucleotide-dependent DNA binding and exonuclease activity equivalent to the wild-type enzyme, although the ATLD complexes both show reduced activity in endonuclease assays. Sedimentation equilibrium analysis of the recombinant human complexes indicates that Mre11 is a stable dimer, Mre11 and Nbs1 form a 1: 1 complex, and both M/R and M/R/N form large multimeric assemblies of similar to1.2 MDa. Models of M/R/N stoichiometry in light of this and previous data are discussed.	Univ Texas, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; Univ Texas, Inst Cellular & Mol Biol, Austin, TX 78712 USA; Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA; NIDDK, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Paull, TT (corresponding author), Univ Texas, Dept Mol Genet & Microbiol, 1 Univ Stn,A4800, Austin, TX 78712 USA.		Ghirlando, Rodolfo/A-8880-2009; Lee, Jihoon/AAK-3497-2021	Lee, Jihoon/0000-0001-7387-935X; Paull, Tanya/0000-0002-2991-651X; Bhaskara, Venugopal/0000-0002-8807-3292	NATIONAL CANCER INSTITUTE [P01CA094000] Funding Source: NIH RePORTER; NCI NIH HHS [CA94000-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AJIMURA M, 1993, GENETICS, V133, P51; ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Anderson DE, 2001, J BIOL CHEM, V276, P37027, DOI 10.1074/jbc.M106179200; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cerosaletti KM, 2003, J BIOL CHEM, V278, P21944, DOI 10.1074/jbc.M211689200; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Connelly JC, 1998, P NATL ACAD SCI USA, V95, P7969, DOI 10.1073/pnas.95.14.7969; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; de Jager M, 2002, NUCLEIC ACIDS RES, V30, P4425, DOI 10.1093/nar/gkf574; Desai-Mehta A, 2001, MOL CELL BIOL, V21, P2184, DOI 10.1128/MCB.21.6.2184-2191.2001; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0027-5107(74)90176-6; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; GHIRLANDO R, 1995, BIOCHEMISTRY-US, V34, P13320, DOI 10.1021/bi00041a007; Gonzalez-Barrera S, 2003, MOL CELL, V11, P1661, DOI 10.1016/S1097-2765(03)00183-7; Grenon M, 2001, NAT CELL BIOL, V3, P844, DOI 10.1038/ncb0901-844; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; IVANOV EL, 1992, GENETICS, V132, P651; JOHZUKA K, 1995, GENETICS, V139, P1521; Kironmai KM, 1997, GENES CELLS, V2, P443; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2000, P NATL ACAD SCI USA, V97, P6409, DOI 10.1073/pnas.110144297; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; RAYMOND WE, 1993, NUCLEIC ACIDS RES, V21, P3851, DOI 10.1093/nar/21.16.3851; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Tauchi H, 2001, J BIOL CHEM, V276, P12, DOI 10.1074/jbc.C000578200; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Williams BR, 2002, CURR BIOL, V12, P648, DOI 10.1016/S0960-9822(02)00763-7; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhao S, 2002, NUCLEIC ACIDS RES, V30, P4815, DOI 10.1093/nar/gkf612	50	80	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 14	2003	278	46					45171	45181		10.1074/jbc.M308705200	http://dx.doi.org/10.1074/jbc.M308705200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	741HH	12966088	hybrid			2022-12-27	WOS:000186452300017
J	Malli, R; Frieden, M; Osibow, K; Zoratti, C; Mayer, M; Demaurex, N; Graier, WF				Malli, R; Frieden, M; Osibow, K; Zoratti, C; Mayer, M; Demaurex, N; Graier, WF			Sustained Ca2+ transfer across mitochondria is essential for mitochondrial Ca2+ buffering, store-operated Ca2+ entry, and Ca2+ store refilling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; VASCULAR ENDOTHELIAL-CELLS; GREEN FLUORESCENT PROTEINS; ACTIVATED CALCIUM CURRENT; ENDOPLASMIC-RETICULUM; INTACT-CELLS; FEEDBACK INHIBITION; PLASMA-MEMBRANE; T-LYMPHOCYTES; HOMEOSTASIS	Mitochondria have been found to sequester and release Ca2+ during cell stimulation with inositol 1,4,5-triphosphate-generating agonists, thereby generating subplasmalemmal microdomains of low Ca2+ that sustain activity of capacitative Ca2+ entry (CCE). Procedures that prevent mitochondrial Ca2+ uptake inhibit local Ca2+ buffering and CCE, but it is not clear whether Ca2+ has to transit through or remains trapped in the mitochondria. Thus, we analyzed the contribution of mitochondrial Ca2+ efflux on the ability of mitochondria to buffer subplasmalemmal Ca2+, to maintain CCE, and to facilitate endoplasmic reticulum (ER) refilling in endothelial cells. Upon the addition of histamine, the initial mitochondrial Ca2+ transient, monitored with ratio-metric-pericam-mitochondria, was largely independent of extracellular Ca2+. However, subsequent removal of extracellular Ca2+ produced a reversible decrease in [Ca2+](mito), indicating that Ca2+ was continuously taken up and released by mitochondria, although [Ca2+](mito) had returned to basal levels. Accordingly, inhibition of the mitochondrial Na+/Ca2+ exchanger with CGP 37157 increased [Ca2+](mito) and abolished the ability of mitochondria to buffer subplasmalemmal Ca2+, resulting in an increased activity of BKCa channels and a decrease in CCE. Hence, CGP 37157 also reversibly inhibited ER refilling during cell stimulation. These effects of CGP 37157 were mimicked if mitochondrial Ca2+ uptake was prevented with oligomycin/antimycin A. Thus, during cell stimulation a continuous Ca2+ flux through mitochondria underlies the ability of mitochondria to generate subplasmalemmal microdomains of low Ca2+, to facilitate CCE, and to relay Ca2+ from the plasma membrane to the ER.	Graz Univ, Dept Med Biochem & Med Mol Biol, A-8010 Graz, Austria; Univ Geneva, Dept Physiol, CH-1211 Geneva 4, Switzerland	University of Graz; University of Geneva	Graier, WF (corresponding author), Graz Univ, Dept Med Biochem & Med Mol Biol, Harrachgasse 21-3, A-8010 Graz, Austria.		Malli, Roland/B-7369-2008; Graier, Wolfgang F./B-7052-2008	Graier, Wolfgang F./0000-0003-1871-3298; Malli, Roland/0000-0001-6327-8729; Demaurex, Nicolas/0000-0002-9933-6772; Osibow, Karin/0000-0002-9703-595X; Frieden, Maud/0000-0001-7135-0874				Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; Babcock DF, 1998, CURR OPIN NEUROBIOL, V8, P398, DOI 10.1016/S0959-4388(98)80067-6; Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; Bowser DN, 2002, FASEB J, V16, P1105, DOI 10.1096/fj.01-0828fje; Broad LM, 1999, J BIOL CHEM, V274, P32881, DOI 10.1074/jbc.274.46.32881; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; COX DA, 1993, J CARDIOVASC PHARM, V21, P595, DOI 10.1097/00005344-199304000-00013; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Encabo A, 1996, BRIT J PHARMACOL, V119, P702, DOI 10.1111/j.1476-5381.1996.tb15729.x; Frieden M, 2002, J PHYSIOL-LONDON, V540, P73, DOI 10.1113/jphysiol.2002.017053; Gilabert JA, 2000, EMBO J, V19, P6401, DOI 10.1093/emboj/19.23.6401; Gilabert JA, 2001, EMBO J, V20, P2672, DOI 10.1093/emboj/20.11.2672; Glitsch MD, 2002, J PHYSIOL-LONDON, V539, P93, DOI 10.1113/jphysiol.2001.012826; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; Hofer AM, 1998, EMBO J, V17, P1986, DOI 10.1093/emboj/17.7.1986; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Johnson PR, 2002, CELL CALCIUM, V32, P59, DOI 10.1016/S0143-4160(02)00091-X; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; Landolfi B, 1998, J CELL BIOL, V142, P1235, DOI 10.1083/jcb.142.5.1235; Ma HT, 2001, J BIOL CHEM, V276, P18888, DOI 10.1074/jbc.M100944200; Malli R, 2003, J BIOL CHEM, V278, P10807, DOI 10.1074/jbc.M212971200; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Pacher P, 2001, BIOL SIGNAL RECEPT, V10, P200; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Parekh AB, 2003, J PHYSIOL-LONDON, V547, P333, DOI 10.1113/jphysiol.2002.034140; Park KS, 2002, PFLUG ARCH EUR J PHY, V443, P344, DOI 10.1007/s004240100703; Petersen OH, 2002, BIOL RES, V35, P177, DOI 10.4067/S0716-97602002000200008; Pozzan T, 2000, CELL CALCIUM, V28, P279, DOI 10.1054/ceca.2000.0166; Putney J W Jr, 1991, Adv Pharmacol, V22, P251, DOI 10.1016/S1054-3589(08)60037-X; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Putney JW, 2001, J CELL SCI, V114, P2223; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; Rizzuto R, 1999, CELL CALCIUM, V26, P193, DOI 10.1054/ceca.1999.0076; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Robert V, 2001, EMBO J, V20, P4998, DOI 10.1093/emboj/20.17.4998; SCHILLING WP, 1992, BIOCHEM J, V284, P521, DOI 10.1042/bj2840521; Sedova M, 2000, J BIOL CHEM, V275, P35402, DOI 10.1074/jbc.M006058200; Szabadkai G, 2003, J BIOL CHEM, V278, P15153, DOI 10.1074/jbc.M300180200; Thyagarajan B, 2002, BRIT J PHARMACOL, V137, P821, DOI 10.1038/sj.bjp.0704949; Tinel H, 1999, EMBO J, V18, P4999, DOI 10.1093/emboj/18.18.4999; Yu R, 2000, J BIOL CHEM, V275, P23648, DOI 10.1074/jbc.M002684200	47	147	152	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44769	44779		10.1074/jbc.M302511200	http://dx.doi.org/10.1074/jbc.M302511200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941956	Green Published, hybrid			2022-12-27	WOS:000186306700111
J	Sachs, RK; Halverson, KM; Barry, BA				Sachs, RK; Halverson, KM; Barry, BA			Specific isotopic labeling and photooxidation-linked structural changes in the manganese-stabilizing subunit of photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; DIFFERENCE FT-IR; S-STATE CYCLE; ELECTRON-PARAMAGNETIC-RES; WATER-OXIDIZING COMPLEX; KDA EXTRINSIC PROTEIN; AMINO-ACID-SEQUENCES; ESCHERICHIA-COLI; SECONDARY STRUCTURE; 33-KDA POLYPEPTIDE	Photosystem II (PSII) oxidizes water to molecular oxygen; the catalytic site is a cluster of four manganese ions. The catalytic site undergoes four sequential light-driven oxidation steps to form oxygen; these sequentially oxidized states are referred to as the S-n states, where n refers to the number of oxidizing equivalents stored. The extrinsic manganese stabilizing protein (MSP) of PSII influences the efficiency and stability of the manganese cluster, as well as the rates of the S state transitions. To understand how MSP influences photosynthetic water oxidation, we have employed isotope editing and difference Fourier transform infrared spectroscopy. MSP was expressed in Escherichia coli under conditions in which MSP aspartic and glutamic acid residues label at yields of 65 and 41%, respectively. Asparagine and glutamine were also labeled by this approach. GC/MS analysis was consistent with minimal scrambling of label into other amino acid residues and with no significant scrambling into the peptide bond. Selectively labeled MSP was then reconstituted to PSII, which had been stripped of native MSP. Difference Fourier transform infrared spectroscopy was used to probe the S(1)Q(A) to S(2)Q(A)(-) transition at 200 K, as well as the S(1)Q(B) to S(2)Q(B)(-) transition at 277 K. These experiments show that aspargine, glutamine, and glutamate residues in MSP are perturbed by photooxidation of manganese during the S-1 to S-2 transition.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA; Colorado Coll, Dept Chem, Colorado Springs, CO 80903 USA; Messiah Coll, Dept Chem & Biochem, Grantham, PA 17027 USA	University of Minnesota System; University of Minnesota Twin Cities; Colorado College	Barry, BA (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	barry@cbs.umn.edu						AHMED A, 1995, FEBS LETT, V363, P65, DOI 10.1016/0014-5793(95)00282-E; Anderson LB, 2000, J BIOL CHEM, V275, P4920, DOI 10.1074/jbc.275.7.4920; ARNSTEIN HRV, 1978, INT REV BIOCH, V18; BARRY BA, 1995, METHOD ENZYMOL, V258, P303; Barry BA, 2000, PHOTOSYNTH RES, V65, P197, DOI 10.1023/A:1006466531431; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Betts SD, 1996, BBA-BIOENERGETICS, V1274, P135, DOI 10.1016/0005-2728(96)00023-0; Betts SD, 1998, BIOCHEMISTRY-US, V37, P14230, DOI 10.1021/bi981305h; BETTS SD, 1994, PLANT MOL BIOL, V26, P117, DOI 10.1007/BF00039525; Bricker TM, 2002, PHOTOSYNTH RES, V72, P131, DOI 10.1023/A:1016128715865; BRICKER TM, 1992, BIOCHEMISTRY-US, V31, P4623, DOI 10.1021/bi00134a012; Bricker TM, 1998, PHOTOSYNTH RES, V56, P157, DOI 10.1023/A:1006068615220; BRITT RD, 1996, OXYGENIC PHOTOSYNTHE, V4, P137; De Las Rivas J, 1999, PHOTOSYNTH RES, V61, P11, DOI 10.1023/A:1006265816104; DEPAULA JC, 1985, BIOCHEMISTRY-US, V24, P8114, DOI 10.1021/bi00348a042; DISMUKES GC, 1981, P NATL ACAD SCI-BIOL, V78, P274, DOI 10.1073/pnas.78.1.274; EATONRYE JJ, 1989, BIOCHIM BIOPHYS ACTA, V977, P219, DOI 10.1016/S0005-2728(89)80075-1; Enami I, 1998, J BIOL CHEM, V273, P4629, DOI 10.1074/jbc.273.8.4629; FARINEAU J, 1985, BIOCHIM BIOPHYS ACTA, V808, P103, DOI 10.1016/0005-2728(85)90032-5; Frankel LK, 1999, BIOCHEMISTRY-US, V38, P14271, DOI 10.1021/bi991366v; GRIFFEY RH, 1985, BIOCHEMISTRY-US, V24, P817, DOI 10.1021/bi00325a001; Halverson KM, 2003, BIOPHYS J, V85, P2581, DOI 10.1016/S0006-3495(03)74680-3; Halverson KM, 2003, BIOPHYS J, V85, P1317, DOI 10.1016/S0006-3495(03)74566-4; Hillier W, 2001, BIOCHEMISTRY-US, V40, P1503, DOI 10.1021/bi002436x; Hutchison RS, 1998, BIOCHEMISTRY-US, V37, P5643, DOI 10.1021/bi9724467; Hutchison RS, 1999, J BIOL CHEM, V274, P31987, DOI 10.1074/jbc.274.45.31987; Joliot P., 1975, BIOENERG PHOTOSYNTH, P388; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kim SY, 1998, BIOPHYS J, V74, P2588, DOI 10.1016/S0006-3495(98)77965-2; Kitson F. G., 1996, GAS CHROMATOGRAPHY M, P3; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lydakis-Simantiris N, 1999, BIOCHEMISTRY-US, V38, P404, DOI 10.1021/bi981847z; Lydakis-Simantiris N, 1999, BIOCHEMISTRY-US, V38, P15528, DOI 10.1021/bi991599m; MACDONALD GM, 1995, J BIOL CHEM, V270, P8420, DOI 10.1074/jbc.270.15.8420; MACDONALD GM, 1992, BIOCHEMISTRY-US, V31, P9848, DOI 10.1021/bi00155a043; MACDONALD GM, 1993, P NATL ACAD SCI USA, V90, P11024, DOI 10.1073/pnas.90.23.11024; MIYAO M, 1983, FEBS LETT, V164, P375, DOI 10.1016/0014-5793(83)80320-2; MIYAO M, 1984, FEBS LETT, V170, P350, DOI 10.1016/0014-5793(84)81342-3; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; NANBA O, 1987, P NATL ACAD SCI USA, V84, P109, DOI 10.1073/pnas.84.1.109; Noguchi T, 2003, BIOCHEMISTRY-US, V42, P6035, DOI 10.1021/bi0341612; Noguchi T, 2001, BIOCHEMISTRY-US, V40, P1497, DOI 10.1021/bi0023807; NOGUCHI T, 1995, BIOCHIM BIOPHYS ACTA, V1232, P65; ODOM WR, 1992, BIOCHEMISTRY-US, V31, P5616, DOI 10.1021/bi00139a027; OETTMEIER W, 1983, BIOCHIM BIOPHYS ACTA, V724, P287, DOI 10.1016/0005-2728(83)90147-0; OHOKA H, 1986, FEBS LETT, V197, P63, DOI 10.1016/0014-5793(86)80299-X; ONO TA, 1983, FEBS LETT, V164, P255, DOI 10.1016/0014-5793(83)80297-X; PATTERSON BW, 1993, BIOL MASS SPECTROM, V22, P518, DOI 10.1002/bms.1200220905; Pazos F, 2001, PROTEINS, V45, P372, DOI 10.1002/prot.10012; Popelkova H, 2003, PHOTOSYNTH RES, V77, P21, DOI 10.1023/A:1024970926655; Popelkova H, 2003, BIOCHEMISTRY-US, V42, P6193, DOI 10.1021/bi0207115; Popelkova H, 2002, BIOCHEMISTRY-US, V41, P2702, DOI 10.1021/bi0118761; Popelkova H, 2002, BIOCHEMISTRY-US, V41, P10038, DOI 10.1021/bi020228u; RAMESH V, 1994, EUR J BIOCHEM, V225, P601, DOI 10.1111/j.1432-1033.1994.00601.x; Ramirez FJ, 1998, J PHYS CHEM B, V102, P6290, DOI 10.1021/jp981831i; Roelofs TA, 1996, P NATL ACAD SCI USA, V93, P3335, DOI 10.1073/pnas.93.8.3335; SEIDLER A, 1990, EMBO J, V9, P1743, DOI 10.1002/j.1460-2075.1990.tb08298.x; Seidler A, 1996, BBA-BIOENERGETICS, V1277, P35, DOI 10.1016/S0005-2728(96)00102-8; Shutova T, 1997, BIOCHEMISTRY-US, V36, P6350, DOI 10.1021/bi963115h; Steenhuis JJ, 1996, J AM CHEM SOC, V118, P11927, DOI 10.1021/ja961691v; Steenhuis JJ, 1999, J BIOL CHEM, V274, P14609, DOI 10.1074/jbc.274.21.14609; Steenhuis JJ, 1998, J PHYS CHEM B, V102, P4, DOI 10.1021/jp9730609; Steenhuis JJ, 1997, J PHYS CHEM B, V101, P6652, DOI 10.1021/jp971260e; STYRING S, 1988, BIOCHIM BIOPHYS ACTA, V933, P378, DOI 10.1016/0005-2728(88)90046-1; Svensson B, 2002, J PHYS CHEM B, V106, P8485, DOI 10.1021/jp0258199; Tohri A, 2002, PLANT CELL PHYSIOL, V43, P429, DOI 10.1093/pcp/pcf053; Waugh DS, 1996, J BIOMOL NMR, V8, P184; WILSON NA, 1995, BIOCHEMISTRY-US, V34, P8931, DOI 10.1021/bi00028a001; XU Q, 1994, BBA-BIOENERGETICS, V1188, P427, DOI 10.1016/0005-2728(94)90065-5; Zhang HM, 1998, BIOCHEMISTRY-US, V37, P5511, DOI 10.1021/bi971787h; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589; Zubrzycki IZ, 1998, BIOCHEMISTRY-US, V37, P13553, DOI 10.1021/bi981469y	72	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2003	278	45					44222	44229		10.1074/jbc.M307148200	http://dx.doi.org/10.1074/jbc.M307148200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	738UR	12941934	hybrid			2022-12-27	WOS:000186306700042
J	Cherian, PP; Cheng, BX; Gu, SM; Sprague, E; Bonewald, LF; Jiang, JX				Cherian, PP; Cheng, BX; Gu, SM; Sprague, E; Bonewald, LF; Jiang, JX			Effects of mechanical strain on the function of gap junctions in osteocytes are mediated through the prostaglandin EP2 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; FETAL-RAT CALVARIAE; CYCLIC-AMP; INTERCELLULAR COMMUNICATION; FLUID-FLOW; BONE-CELLS; PROSTANOID RECEPTORS; OSTEOCLAST FORMATION; SMOOTH-MUSCLE; PROTEIN	Osteocytes embedded in the matrix of bone are thought to be mechanosensory cells that translate mechanical strain into biochemical signals that regulate bone modeling and remodeling. We have shown previously that fluid flow shear stress dramatically induces prostaglandin release and COX-2 mRNA expression in osteocyte-like MLO-Y4 cells, and that prostaglandin E-2 (PGE(2)) released by these cells functions in an autocrine manner to regulate gap junction function and connexin 43 (Cx43) expression. Here we show that fluid flow regulates gap junctions through the PGE(2) receptor EP2 activation of cAMP-dependent protein kinase A (PKA) signaling. The expression of the EP2 receptor, but not the subtypes EP1, EP3, and EP4, increased in response to fluid flow. Application of PGE(2) or conditioned medium from fluid flow-treated cells to non-stressed MLO-Y4 cells increased expression of the EP2 receptor. The EP2 receptor antagonist, AH6809, suppressed the stimulatory effects of PGE(2) and fluid flow-conditioned medium on the expression of the EP2 receptor, on Cx43 protein expression, and on gap junction-mediated intercellular coupling. In contrast, the EP2 receptor agonist butaprost, not the E-1/E-3 receptor agonist sulprostone, stimulated the expression of Cx43 and gap junction function. Fluid flow conditioned medium and PGE(2) stimulated cAMP production and PKA activity suggesting that PGE(2) released by mechanically stimulated cells is responsible for the activation of cAMP and PKA. The adenylate cyclase activators, forskolin and 8-bromo-cAMP, enhanced intercellular connectivity, the number of functional gap junctions, and Cx43 protein expression, whereas the PKA inhibitor, H89, inhibited the stimulatory effect of PGE(2) on gap junctions. These studies suggest that the EP2 receptor mediates the effects of autocrine PGE(2) on the osteocyte gap junction in response to fluid flow-induced shear stress. These data support the hypothesis that the EP2 receptor, cAMP, and PKA are critical components of the signaling cascade between mechanical strain and gap junction-mediated communication between osteocytes.	Univ Texas, Hlth Sci Ctr, Dept Biochem, MSC 7760, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Dept Radiol, San Antonio, TX 78229 USA; Univ Missouri, Sch Dent, Dept Oral Biol, Kansas City, MO 64108 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Missouri System; University of Missouri Kansas City	Jiang, JX (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem, MSC 7760, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu	Bonewald, Lynda/Q-3638-2019	Jiang, Jean/0000-0002-2185-5716	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR046798] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR46798] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ajubi NE, 1996, BIOCHEM BIOPH RES CO, V225, P62, DOI 10.1006/bbrc.1996.1131; ATKINSON MM, 1995, J CELL SCI, V108, P3079; AZARNIA R, 1981, J MEMBRANE BIOL, V63, P133, DOI 10.1007/BF01969454; BASTIEN L, 1994, J BIOL CHEM, V269, P11873; Baylink TM, 1996, J BONE MINER RES, V11, P1413; BENNETT MVL, 1978, NEUROSCI RES PROG B, V16, P377; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; BEYER EC, 1988, GAP JUNCTIONS, P167; Boie Y, 1997, EUR J PHARMACOL, V340, P227, DOI 10.1016/S0014-2999(97)01383-6; Bonewald LF, 2000, J BONE MINER RES, V15, pS502; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Cass LA, 1999, MOL CELL BIOL, V19, P5882; Cheng BX, 2001, ENDOCRINOLOGY, V142, P3464, DOI 10.1210/en.142.8.3464; Cheng BX, 2001, J BONE MINER RES, V16, P249, DOI 10.1359/jbmr.2001.16.2.249; Civitelli R, 1998, J CELL BIOCHEM, V68, P8, DOI 10.1002/(SICI)1097-4644(19980101)68:1<8::AID-JCB2>3.0.CO;2-#; COLEMAN RA, 1989, BRIT J PHARMACOL, V96, P688, DOI 10.1111/j.1476-5381.1989.tb11869.x; COLLINS DA, 1992, J BONE MINER RES, V7, P555; COLLINS DA, 1991, J BONE MINER RES, V6, P157; COWIN SC, 1991, J BIOMECH ENG-T ASME, V113, P191, DOI 10.1115/1.2891234; Del Toro F, 2000, J CELL PHYSIOL, V182, P196, DOI 10.1002/(SICI)1097-4652(200002)182:2<196::AID-JCP8>3.0.CO;2-E; Donahue HJ, 1998, CALCIFIED TISSUE INT, V62, P85, DOI 10.1007/s002239900398; DOTY SB, 1981, CALCIFIED TISSUE INT, V33, P509, DOI 10.1007/BF02409482; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; FISCH A, 1995, EUR J PHARM-MOLEC PH, V289, P455, DOI 10.1016/0922-4106(95)90154-X; FLANAGAN AM, 1992, ENDOCRINOLOGY, V130, P443, DOI 10.1210/en.130.1.443; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Frost HM, 1996, ANAT RECORD, V244, P139, DOI 10.1002/(SICI)1097-0185(199602)244:2<139::AID-AR1>3.0.CO;2-X; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Grima J, 2000, BIOL REPROD, V63, P1648, DOI 10.1095/biolreprod63.6.1648; GRIMSTON SK, 1993, MED SCI SPORT EXER, V25, P1293; He DS, 1999, P NATL ACAD SCI USA, V96, P6495, DOI 10.1073/pnas.96.11.6495; JEE WSS, 1990, BONE, V11, P253, DOI 10.1016/8756-3282(90)90078-D; JEE WSS, 1985, CALCIFIED TISSUE INT, V37, P148, DOI 10.1007/BF02554834; JONES SJ, 1993, ANAT EMBRYOL, V187, P343; JULIANI MH, 1990, J BIOL CHEM, V265, P9077; Kaji H, 1996, J BONE MINER RES, V11, P62; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; KATSUYAMA M, 1995, FEBS LETT, V372, P151, DOI 10.1016/0014-5793(95)00966-D; KEERY RJ, 1988, BRIT J PHARMACOL, V94, P745, DOI 10.1111/j.1476-5381.1988.tb11584.x; KELLER J, 1993, ACTA ORTHOP SCAND, V64, P59, DOI 10.3109/17453679308994530; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; KleinNulend J, 1997, J BONE MINER RES, V12, P45, DOI 10.1359/jbmr.1997.12.1.45; Mason DJ, 1996, J BONE MINER RES, V11, P350; MEHTA PP, 1992, MOL BIOL CELL, V3, P839, DOI 10.1091/mbc.3.8.839; MERY PF, 1993, J BIOL CHEM, V268, P26286; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; NAGATA T, 1994, CALCIFIED TISSUE INT, V55, P451, DOI 10.1007/BF00298559; PALUMBO C, 1990, BONE, V11, P401, DOI 10.1016/8756-3282(90)90134-K; Paulson AF, 2000, J CELL SCI, V113, P3037; PICO C, 1994, BIOCHEM J, V302, P81, DOI 10.1042/bj3020081; PONTECORVI A, 1988, EMBO J, V7, P1489, DOI 10.1002/j.1460-2075.1988.tb02967.x; PRASAD ARS, 1993, CIRC RES, V72, P827, DOI 10.1161/01.RES.72.4.827; RAISZ LG, 1990, ENDOCRINOLOGY, V126, P1654, DOI 10.1210/endo-126-3-1654; RAISZ LG, 1993, ENDOCRINOLOGY, V133, P1504, DOI 10.1210/en.133.4.1504; RAKOVSKA A, 1984, ARCH INT PHARMACOD T, V268, P59; REGAN JW, 1994, MOL PHARMACOL, V46, P213; REICH KM, 1990, J CELL PHYSIOL, V143, P100, DOI 10.1002/jcp.1041430113; Romanello M, 2001, BIOCHEM BIOPH RES CO, V282, P1138, DOI 10.1006/bbrc.2001.4710; SAEZ JC, 1986, P NATL ACAD SCI USA, V83, P2473, DOI 10.1073/pnas.83.8.2473; SCHILLER PC, 1992, MOL ENDOCRINOL, V6, P1433, DOI 10.1210/me.6.9.1433; TenBroek EM, 2001, J CELL BIOL, V155, P1307, DOI 10.1083/jcb.200102017; TURNER CH, 1994, FASEB J, V8, P875, DOI 10.1096/fasebj.8.11.8070637; TURNER CH, 1995, BONE, V16, P283, DOI 10.1016/8756-3282(94)00052-2; WATABE A, 1993, J BIOL CHEM, V268, P20175; WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8; WHITE TW, 1992, MOL BIOL CELL, V3, P711, DOI 10.1091/mbc.3.7.711; WOODWARD DF, 1995, BIOCHEM PHARMACOL, V50, P1731, DOI 10.1016/0006-2952(95)02035-7; Yellowley CE, 2000, J BONE MINER RES, V15, P209, DOI 10.1359/jbmr.2000.15.2.209	70	146	158	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2003	278	44					43146	43156		10.1074/jbc.M302993200	http://dx.doi.org/10.1074/jbc.M302993200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	736EA	12939279	hybrid			2022-12-27	WOS:000186157000055
J	Xu, P; Yoshioka, K; Yoshimura, D; Tominaga, Y; Nishioka, T; Ito, M; Nakabeppu, Y				Xu, P; Yoshioka, K; Yoshimura, D; Tominaga, Y; Nishioka, T; Ito, M; Nakabeppu, Y			In vitro development of mouse embryonic stem cells lacking JNK/stress-activated protein kinase-associated protein 1 (JSAP1) scaffold protein revealed its requirement during early embryonic neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; C-JUN; TRANSCRIPTION FACTOR; MICE LACKING; EXPRESSION; GENE; JNK; DIFFERENTIATION; WNT; PHOSPHORYLATION	The Jsap1 gene encodes a scaffold protein for c-Jun N-terminal kinase cascades. We established c-Jun N-terminal kinase (JNK)/stress-activated protein kinase-associated protein 1 (JSAP1)-null mouse embryonic stem cell lines by homologous recombination. The JSAP1-null embryonic stem cells were viable, however, exhibited hyperplasia of the ectoderm during embryoid body formation, and spontaneously differentiated into neurons more efficiently than did wild type. The expression of components of c-Jun N-terminal kinase cascades and a subset of marker mRNAs during early embryogenesis was altered in the JSAP1-null mutants. Retinoic acid dramatically increased the expression of JSAP1 and JNK3, which were co-precipitated with anti-JNK3 in the neuroectoderm of wild type but not JSAP1-null embryoid bodies. In the neurons differentiated from the wild type embryoid bodies, JSAP1 was localized in the soma, neurites, and growth cone-like structure of the neurites, and neurite outgrowth from the JSAP1-null embryoid bodies was apparently less efficient than from wild type. JSAP1 and c-Jun N-terminal kinase 3 were coexpressed in the embryonic ectoderm of E7.5 mouse embryo, whereas Wnt1 and Pax2 were coexpressed with JSAP1 at the midbrain-hindbrain junction in E12.5 mouse embryo, thus suggesting that JSAP1 is required for early embryonic neurogenesis.	Kyushu Univ, Med Inst Bioregulat, Div Neurofunct Genom, Dept Immunobiol & Neurosci, Fukuoka 8128582, Japan; CREST, Japan Sci & Technol Corp, Fukuoka 8128582, Japan; Kanazawa Univ, Canc Res Inst, Dept Mol & Cellular Biol, Div Cell Cycle Regulat, Kanazawa, Ishikawa 9200934, Japan; Kitasato Univ, Dept Biosci, Sch Sci, Kanagawa 2288555, Japan	Kyushu University; Japan Science & Technology Agency (JST); Kanazawa University; Kitasato University	Nakabeppu, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Neurofunct Genom, Dept Immunobiol & Neurosci, Fukuoka 8128582, Japan.	yusaku@bioreg.kyushu-u.ac.jp	Nakabeppu, Yusaku/A-8902-2011; Sakai, Yasunari/S-7965-2018	Nakabeppu, Yusaku/0000-0002-6739-242X; Sakai, Yasunari/0000-0002-5747-8692				BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Bain G., 1998, CULTURING NERVE CELL, P189; BEDDINGTON R, 2002, PRINCIPLES DEV, P109; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Cassia R, 1997, J NEUROSCI RES, V50, P421, DOI 10.1002/(SICI)1097-4547(19971101)50:3<421::AID-JNR8>3.0.CO;2-K; CEREGHINI S, 1992, DEVELOPMENT, V116, P783; Cipelletti B, 2002, NEUROSCIENCE, V115, P657, DOI 10.1016/S0306-4522(02)00531-6; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Elion EA, 2001, J CELL SCI, V114, P3967; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; Funahashi J, 1999, DEV GROWTH DIFFER, V41, P59; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Ide Y, 2003, GENOMICS, V81, P47, DOI 10.1016/S0888-7543(02)00009-5; Ito M, 1999, MOL CELL BIOL, V19, P7539; Ito M, 2000, GENE, V255, P229, DOI 10.1016/S0378-1119(00)00335-8; JOYNER AL, 1993, GENE TARGETING PRACT, P1; KAUFMAN MH, 1992, ATLAS MOUSE DEV, P17; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kuboki Y, 2000, J BIOL CHEM, V275, P39815, DOI 10.1074/jbc.C000403200; Kudoh T, 2002, DEVELOPMENT, V129, P4335; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Martinez S, 2001, INT J DEV BIOL, V45, P367; Matsuura H, 2002, J BIOL CHEM, V277, P40703, DOI 10.1074/jbc.M202004200; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MURPHY TH, 1991, J NEUROCHEM, V57, P1862, DOI 10.1111/j.1471-4159.1991.tb06396.x; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; O'Shea KS, 1999, ANAT RECORD, V257, P32, DOI 10.1002/(SICI)1097-0185(19990215)257:1<32::AID-AR6>3.0.CO;2-2; Sano Y, 2001, GENOME RES, V11, P1833, DOI 10.1101/gr.194301; Schimenti J, 2000, TRENDS GENET, V16, P240, DOI 10.1016/S0168-9525(00)02020-5; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Stronach BE, 1999, ONCOGENE, V18, P6172, DOI 10.1038/sj.onc.1203125; Tsuchimoto D, 2001, NUCLEIC ACIDS RES, V29, P2349, DOI 10.1093/nar/29.11.2349; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; WILSON V, 1995, DEVELOPMENT, V121, P877; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Xu P, 1998, VIRCHOWS ARCH, V432, P17, DOI 10.1007/s004280050129; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Zandstra PW, 2000, BIOTECHNOL BIOENG, V69, P607, DOI 10.1002/1097-0290(20000920)69:6<607::AID-BIT4>3.3.CO;2-6	59	143	149	3	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2003	278	48					48422	48433		10.1074/jbc.M307888200	http://dx.doi.org/10.1074/jbc.M307888200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746DM	12857738	hybrid			2022-12-27	WOS:000186731400128
